PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pesek, J; Buchler, R; Albrecht, R; Boland, W; Zeth, K				Pesek, Jelena; Buechler, Rita; Albrecht, Reinhard; Boland, Wilhelm; Zeth, Kornelius			Structure and Mechanism of Iron Translocation by a Dps Protein from Microbacterium arborescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE DETOXIFICATION; LISTERIA-INNOCUA DPS; DNA-BINDING PROTEIN; MYCOBACTERIUM-SMEGMATIS; STRESS RESISTANCE; ESCHERICHIA-COLI; STARVED CELLS; GROWTH-PHASE; FERRITIN; GENE	Dps (DNA protection during starvation) enzymes are a major class of dodecameric proteins that bacteria use to detoxify their cytosol through the uptake of reactive iron species. In the stationary growth phase of bacteria, Dps enzymes are primarily used to protect DNA by biocrystallization. To characterize the wild type Dps protein from Microbacterium arborescens that displays additional catalytic functions (amide hydrolysis and synthesis), we determined the crystal structure to a resolution of 2.05 angstrom at low iron content. The structure shows a single iron at the ferroxidase center coordinated by an oxo atom, one water molecule, and three ligating residues. An iron-enriched protein structure was obtained at 2 angstrom and shows the stepwise uptake of two hexahydrated iron atoms moving along channels at the 3-fold axis before a restriction site inside the channels requires removal of the hydration sphere. Supporting biochemical data provide insight into the regulation of this acylamino acid hydrolase. Moreover, the peroxidase activity of the protein was determined. The influence of iron and siderophores on the expression of acylamino acid hydrolase was monitored during several stages of cell growth. Altogether our data provide an interesting view of an unusual Dps-like enzyme evolutionarily located apart from the large Dps sequence clusters.	[Pesek, Jelena; Buechler, Rita; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Albrecht, Reinhard; Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Boland, W (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Hans Knoll Str 8, D-07745 Jena, Germany.	Boland@ice-mpg.de; Kornelius.Zeth@tuebingen.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534	MaxPlanck Society; German Science Foundation Deutsche Forschungsgemeinschaft [ZE522/3-2]; Human Frontier Science Program Foundation; Jena School of Microbial Communication	MaxPlanck Society(Max Planck Society); German Science Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Foundation; Jena School of Microbial Communication	This work was supported by institutional funds from the MaxPlanck Society, German Science Foundation Deutsche Forschungsgemeinschaft Grant ZE522/3-2, a grant from the Human Frontier Science Program Foundation (to K. Z.), and the Jena School of Microbial Communication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Ali Azam T., 1999, J BACTERIOL, V181, P6361; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], PYMOL MOL GRAPH SYST; Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaji V, 2011, PHYTOPATHOLOGY, V101, P349, DOI 10.1094/PHYTO-05-10-0132; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chiancone E., 2003, IRON PROTEINS IRON S; Chiancone E, 2010, FRONT BIOSCI, V15, P122, DOI 10.2741/3610; Chiancone E, 2008, REND LINCEI-SCI FIS, V19, P261, DOI 10.1007/s12210-008-0018-4; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haikarainen T, 2010, J BIOL INORG CHEM, V15, P183, DOI 10.1007/s00775-009-0582-9; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hong Y, 2006, FREE RADICAL RES, V40, P597, DOI 10.1080/10715760600618882; Ilari A, 2005, BIOCHEMISTRY-US, V44, P5579, DOI 10.1021/bi050005e; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Michan C, 1999, J BACTERIOL, V181, P2759; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nicodeme M, 2004, CURR MICROBIOL, V48, P51, DOI 10.1007/s00284-003-4116-3; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Polidoro M, 2002, GENE, V296, P121, DOI 10.1016/S0378-1119(02)00839-9; Reindel S, 2006, BIOMETALS, V19, P19, DOI 10.1007/s10534-005-3682-1; Sen A, 2000, ARCH MICROBIOL, V173, P352, DOI 10.1007/s002030000153; Strand KR, 2010, ARCH MICROBIOL, V192, P447, DOI 10.1007/s00203-010-0570-z; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Wang SW, 2009, J BACTERIOL, V191, P4522, DOI 10.1128/JB.00272-09; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Wiedenheft B, 2005, P NATL ACAD SCI USA, V102, P10551, DOI 10.1073/pnas.0501497102; Zeth K, 2004, P NATL ACAD SCI USA, V101, P13780, DOI 10.1073/pnas.0401821101; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	54	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34872	34882		10.1074/jbc.M111.246108	http://dx.doi.org/10.1074/jbc.M111.246108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768097	hybrid, Green Published			2022-12-27	WOS:000295406300041
J	Verpelli, C; Dvoretskova, E; Vicidomini, C; Rossi, F; Chiappalone, M; Schoen, M; Di Stefano, B; Mantegazza, R; Broccoli, V; Bockers, TM; Dityatev, A; Sala, C				Verpelli, Chiara; Dvoretskova, Elena; Vicidomini, Cinzia; Rossi, Francesca; Chiappalone, Michela; Schoen, Michael; Di Stefano, Bruno; Mantegazza, Renato; Broccoli, Vania; Boeckers, Tobias M.; Dityatev, Alexander; Sala, Carlo			Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; POSTSYNAPTIC DENSITY PROTEINS; DENDRITIC SPINE MORPHOLOGY; 22Q13.3 DELETION SYNDROME; POSITIVE ALLOSTERIC MODULATOR; X MENTAL-RETARDATION; HIPPOCAMPAL AREA CA1; SYNAPTIC PLASTICITY; SCAFFOLD PROTEINS; DNA METHYLATION	Shank3/PROSAP2 gene mutations are associated with cognitive impairment ranging from mental retardation to autism. Shank3 is a large scaffold postsynaptic density protein implicated in dendritic spines and synapse formation; however, its specific functions have not been clearly demonstrated. We have used RNAi to knockdown Shank3 expression in neuronal cultures and showed that this treatment specifically reduced the synaptic expression of the metabotropic glutamate receptor 5 (mGluR5), but did not affect the expression of other major synaptic proteins. The functional consequence of Shank3 RNAi knockdown was impaired signaling via mGluR5, as shown by reduction in ERK1/2 and CREB phosphorylation induced by stimulation with (S)-3,5-dihydroxyphenylglycine (DHPG) as the agonist of mGluR5 receptors, impaired mGluR5-dependent synaptic plasticity (DHPG-induced long-term depression), and impaired mGluR5-dependent modulation of neural network activity. We also found morphological abnormalities in the structure of synapses (spine number, width, and length) and impaired glutamatergic synaptic transmission, as shown by reduction in the frequency of miniature excitatory postsynaptic currents (mEPSC). Notably, pharmacological augmentation of mGluR5 activity using 3-cyano-N-(1,3-diphenyl-1H- pyrazol-5-yl)-benzamide as the positive allosteric modulator of these receptors restored mGluR5-dependent signaling (DHPG-induced phosphorylation of ERK1/2) and normalized the frequency of mEPSCs in Shank3-knocked down neurons. These data demonstrate that a deficit in mGluR5-mediated intracellular signaling in Shank3 knockdown neurons can be compensated by 3-cyano-N-(1,3-diphenyl- 1H-pyrazol-5-yl)-benzamide; this raises the possibility that pharmacological augmentation of mGluR5 activity represents a possible new therapeutic approach for patients with Shank3 mutations.	[Verpelli, Chiara; Vicidomini, Cinzia; Rossi, Francesca; Sala, Carlo] Univ Milan, Dept Pharmacol, CNR Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Mantegazza, Renato; Sala, Carlo] Neurol Inst Fdn Carlo Besta, Dept Neuromuscular Dis & Neuroimmunol, I-20133 Milan, Italy; [Dvoretskova, Elena; Chiappalone, Michela; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Schoen, Michael; Boeckers, Tobias M.] Univ Ulm, Fac Med, Inst Anat & Cell Biol, D-89081 Ulm, Germany; [Di Stefano, Bruno; Broccoli, Vania] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan; IRCCS Istituto Neurologico Besta; Istituto Italiano di Tecnologia - IIT; Ulm University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Sala, C (corresponding author), Via Vanvitelli 32, I-20129 Milan, Italy.	c.sala@in.cnr.it	Broccoli, Vania/K-3464-2016; Verpelli, Chiara/K-6673-2016; Cabrera, Mariel/GMX-2706-2022; Di Stefano, Bruno/H-7232-2015; Verpelli, Chiara/AAH-1140-2020; Sala, Carlo/A-2493-2009; Dityatev, Alexander/A-4034-2008; Di Stefano, Bruno/K-5020-2017; Mantegazza, Renato/AAB-7569-2019	Broccoli, Vania/0000-0003-4050-0926; Verpelli, Chiara/0000-0003-2949-9725; Di Stefano, Bruno/0000-0003-2532-3087; Verpelli, Chiara/0000-0003-2949-9725; Sala, Carlo/0000-0003-0662-9523; Dityatev, Alexander/0000-0002-0472-0553; Di Stefano, Bruno/0000-0003-2532-3087; Mantegazza, Renato/0000-0002-9810-5737; Chiappalone, Michela/0000-0003-1427-5147	Telethon-Italy [GGP09196]; Fondazione CARIPLO [2009.264]; Regione Lombardia [SAL-50-16983]; Italian Institute of Technology; San Paolo Foundation	Telethon-Italy(Fondazione Telethon); Fondazione CARIPLO(Fondazione Cariplo); Regione Lombardia(Regione Lombardia); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); San Paolo Foundation(Compagnia di San Paolo)	This work was supported in part by Telethon-Italy Grant GGP09196, Fondazione CARIPLO Project number 2009.264, RSTL-CNR, Regione Lombardia Project number SAL-50-16983 TERDISMENTAL, and an Italian Institute of Technology, Seed Grant (to C. S. and V. B.).; Supported by a grant from the San Paolo Foundation and the Italian Institute of Technology.	Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Beri S, 2007, J NEUROCHEM, V101, P1380, DOI 10.1111/j.1471-4159.2007.04539.x; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Blau A, 2009, J BIOSCIENCES, V34, P59, DOI 10.1007/s12038-009-0009-3; Bockmann J, 2002, J NEUROCHEM, V83, P1013, DOI 10.1046/j.1471-4159.2002.01204.x; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Delahaye A, 2009, EUR J MED GENET, V52, P328, DOI 10.1016/j.ejmg.2009.05.004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gong YS, 2009, BRAIN RES, V1292, P191, DOI 10.1016/j.brainres.2009.07.056; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Jo J, 2006, NAT NEUROSCI, V9, P170, DOI 10.1038/nn1637; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pasquale V, 2010, J COMPUT NEUROSCI, V29, P213, DOI 10.1007/s10827-009-0175-1; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Piccoli G, 2007, J PROTEOME RES, V6, P3203, DOI 10.1021/pr0701308; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Sheng M, 2000, J CELL SCI, V113, P1851; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Simonyi A, 2010, EUR J PHARMACOL, V639, P17, DOI 10.1016/j.ejphar.2009.12.039; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Uslaner JM, 2009, NEUROPHARMACOLOGY, V57, P531, DOI 10.1016/j.neuropharm.2009.07.022; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Wilson CA, 2003, J NEUROSCI RES, V74, P361, DOI 10.1002/jnr.10776; Wilson HL, 2008, EUR J HUM GENET, V16, P1301, DOI 10.1038/ejhg.2008.107; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575	70	132	137	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34839	34850		10.1074/jbc.M111.258384	http://dx.doi.org/10.1074/jbc.M111.258384			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21795692	Green Published, hybrid			2022-12-27	WOS:000295406300038
J	Chritton, JJ; Wickens, M				Chritton, Jacqueline J.; Wickens, Marvin			A Role for the Poly(A)-binding Protein Pab1p in PUF Protein-mediated Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; MSL-2 MESSENGER-RNA; TRANSLATION INITIATION; FUNCTIONAL INTERACTION; XENOPUS PUMILIO; IN-VITRO; YEAST; DROSOPHILA; INTERACTS; GERMLINE	PUF proteins regulate translation and mRNA stability throughout eukaryotes. Using a cell-free translation assay, we examined the mechanisms of translational repression of PUF proteins in the budding yeast Saccharomyces cerevisiae. We demonstrate that the poly(A)-binding protein Pab1p is required for PUF-mediated translational repression for two distantly related PUF proteins: S. cerevisiae Puf5p and Caenorhabditis elegans FBF-2. Pab1p interacts with oligo(A) tracts in the HO 3'-UTR, a target of Puf5p, to dramatically enhance the efficiency of Puf5p repression. Both the Pab1p ability to activate translation and interact with eukaryotic initiation factor 4G (eIF4G) were required to observe maximal repression by Puf5p. Repression was also more efficient when Pab1p was bound in close proximity to Puf5p. Puf5p may disrupt translation initiation by interfering with the interaction between Pab1p and eIF4G. Finally, we demonstrate two separable mechanisms of translational repression employed by Puf5p:a Pab1p-dependent mechanism and a Pab1p-independent mechanism.	[Chritton, Jacqueline J.] Univ Wisconsin Madison, Dept Genet, Madison, WI 53706 USA; [Wickens, Marvin] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), 433 Babcock Dr,315B Biochem Addit, Madison, WI 53706 USA.	wickens@biochem.wisc.edu			National Institutes of Health [GM31892, GM50942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031892, R01GM050942, R37GM031892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM31892 and GM50942 from the National Institutes of Health (to M. W. and J. J. C.).	ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Burgess HM, 2010, BIOCHEM SOC T, V38, P1517, DOI 10.1042/BST0381517; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; Petrone PM, 2008, P NATL ACAD SCI USA, V105, P16549, DOI 10.1073/pnas.0801795105; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Winstall E, 2000, J BIOL CHEM, V275, P21817, DOI 10.1074/jbc.M002412200; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535; Zappavigna V, 2004, P NATL ACAD SCI USA, V101, P14800, DOI 10.1073/pnas.0406451101; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	57	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33268	33278		10.1074/jbc.M111.264572	http://dx.doi.org/10.1074/jbc.M111.264572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21768112	hybrid, Green Published			2022-12-27	WOS:000294968800046
J	Delint-Ramirez, I; Willoughby, D; Hammond, GVR; Ayling, LJ; Cooper, DMF				Delint-Ramirez, Ilse; Willoughby, Debbie; Hammond, Gerald V. R.; Ayling, Laura J.; Cooper, Dermot M. F.			Palmitoylation Targets AKAP79 Protein to Lipid Rafts and Promotes Its Regulation of Calcium-sensitive Adenylyl Cyclase Type 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ANCHORING PROTEIN; CAPACITATIVE CA2+ ENTRY; ADULT CARDIAC MYOCYTES; CHOLESTEROL DEPLETION; SIGNALING COMPONENTS; CAMP SYNTHESIS; LIVING CELLS; RICH DOMAINS; LOCALIZATION; MEMBRANE	PKA anchoring proteins (AKAPs) optimize the efficiency of cAMP signaling by clustering interacting partners. Recently, AKAP79 has been reported to directly bind to adenylyl cyclase type 8 (AC8) and to regulate its responsiveness to store-operated Ca2+ entry (SOCE). Although AKAP79 is well targeted to the plasma membrane via phospholipid associations with three N-terminal polybasic regions, recent studies suggest that AKAP79 also has the potential to be palmitoylated, which may specifically allow it to target the lipid rafts where AC8 resides and is regulated by SOCE. In this study, we have addressed the role of palmitoylation of AKAP79 using a combination of pharmacological, mutagenesis, and cell biological approaches. We reveal that AKAP79 is palmitoylated via two cysteines in its N-terminal region. This palmitoylation plays a key role in targeting the AKAP to lipid rafts in HEK-293 cells. Mutation of the two critical cysteines results in exclusion of AKAP79 from lipid rafts and alterations in its membrane diffusion behavior. This is accompanied by a loss of the ability of AKAP79 to regulate SOCE-dependent AC8 activity in intact cells and decreased PKA-dependent phosphorylation of raft proteins, including AC8. We conclude that palmitoylation plays a key role in the targeting and action of AKAP79. This novel property of AKAP79 adds an unexpected regulatory and targeting option for AKAPs, which may be exploited in the cellular context.	[Delint-Ramirez, Ilse; Willoughby, Debbie; Hammond, Gerald V. R.; Ayling, Laura J.; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk	Hammond, Gerald R/A-5759-2016	Hammond, Gerald R/0000-0002-6660-3272	Wellcome Trust [RG31760]; European Commission [037189]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Wellcome Trust Program Grant RG31760 and European Commission Grant 037189 (led by Prof. Enno Klussmann).	Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Anania VG, 2011, J VIROL, V85, P2288, DOI 10.1128/JVI.01961-10; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Faruque OM, 2009, AM J PHYSIOL-CELL PH, V296, pC306, DOI 10.1152/ajpcell.00216.2008; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gao XJ, 2008, GENOMICS, V92, P457, DOI 10.1016/j.ygeno.2008.08.013; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Gomez LL, 2002, J NEUROSCI, V22, P7027; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; JACKSON CS, 1995, BIOCHEM SOC T, V23, P568, DOI 10.1042/bst0230568; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Saxton MJ, 2008, BIOPHYS J, V94, P760, DOI 10.1529/biophysj.107.114074; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Simson R, 1998, BIOPHYS J, V74, P297, DOI 10.1016/S0006-3495(98)77787-2; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Suzuki T, 2001, MOL BRAIN RES, V89, P20, DOI 10.1016/S0169-328X(01)00051-1; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725	61	68	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32962	32975		10.1074/jbc.M111.243899	http://dx.doi.org/10.1074/jbc.M111.243899			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21771783	hybrid, Green Published			2022-12-27	WOS:000294968800014
J	Wan, XY; Hu, B; Liu, JX; Feng, X; Xiao, WH				Wan, Xiaoyang; Hu, Bo; Liu, Jing-xia; Feng, Xi; Xiao, Wuhan			Zebrafish mll Gene Is Essential for Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTO-ONCOPROTEIN MLL; HOX GENES; STEM-CELL; DROSOPHILA-TRITHORAX; 11Q23 TRANSLOCATIONS; DNA METHYLATION; HISTONE; MII; MAINTENANCE; EXPRESSION	Studies implicate an important role for the mixed lineage leukemia (Mll) gene in hematopoiesis, mainly through maintaining Hox gene expression. However, the mechanisms underlying Mll-mediated hematopoiesis during embryogenesis remain largely unclear. Here, we investigate the role of mll during zebrafish embryogenesis, particularly hematopoiesis. Mll depletion caused severe defects in hematopoiesis as indicated by a lack of blood flow and mature blood cells as well as a significant reduction in expression of hematopoietic progenitor and mature blood cell markers. Furthermore, mll depletion prevented the differentiation of hematopoietic progenitors. In addition, we identified the N-terminal mini-peptide of Mll that acted as a dominant negative form to disrupt normal function of mll during embryogenesis. As expected, mll knockdown altered the expression of a subset of Hox genes. However, overexpression of these down-regulated Hox genes only partially rescued the blood deficiency, suggesting that mll may target additional genes to regulate hematopoiesis. In the mll morphants, microarray analysis revealed a dramatic up-regulation of gadd45 alpha a. Multiple assays indicate that mll inhibited gadd45 alpha a expression and that overexpression of gadd45 alpha a mRNA led to a phenotype similar to the one seen in the mll morphants. Taken together, these findings demonstrate that zebrafish mll plays essential roles in hematopoiesis and that gadd45 alpha a may serve as a potential downstream target for mediating the function of mll in hematopoiesis.	[Wan, Xiaoyang; Hu, Bo; Liu, Jing-xia; Feng, Xi; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Feng, Xi/N-7160-2016; hu, bo/ABC-3810-2021; Xiao, Wuhan/GLU-7352-2022	Feng, Xi/0000-0002-6920-1519; hu, bo/0000-0001-5656-9632; Wan, Xiaoyang/0000-0002-8871-2015	National Science Foundation of China [30971667, 31071212, 91019008, 20890113]; National Transgene Project [2009ZX08010-021B]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgene Project	Supported by "973" Grants 2010CB126306 and 2007CB815705, National Science Foundation of China Grants 30971667, 31071212, 91019008, and 20890113, and National Transgene Project Grant 2009ZX08010-021B.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dobson CL, 2000, EMBO J, V19, P843, DOI 10.1093/emboj/19.5.843; Dorshkind K, 2004, MOL CELL, V13, P765, DOI 10.1016/S1097-2765(04)00159-5; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Krishnaraju K, 1997, BLOOD, V90, P1840, DOI 10.1182/blood.V90.5.1840; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; MCCABE NR, 1992, P NATL ACAD SCI USA, V89, P11794, DOI 10.1073/pnas.89.24.11794; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mende M, 2008, MECH DEVELOP, V125, P947, DOI 10.1016/j.mod.2008.08.005; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robinson BW, 2011, BRIT J HAEMATOL, V152, P307, DOI 10.1111/j.1365-2141.2010.08398.x; Schilling TF, 2001, PHILOS T R SOC B, V356, P1599, DOI 10.1098/rstb.2001.0918; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Tittle RK, 2011, DEV BIOL, V350, P50, DOI 10.1016/j.ydbio.2010.11.009; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tu CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004249; Wan XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009118; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	54	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33345	33357		10.1074/jbc.M111.253252	http://dx.doi.org/10.1074/jbc.M111.253252			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784840	Green Published, hybrid			2022-12-27	WOS:000294968800053
J	Fraser, J; Boo, I; Poumbourios, P; Drummer, HE				Fraser, Johanna; Boo, Irene; Poumbourios, Pantelis; Drummer, Heidi E.			Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; B TYPE-I; MEMBRANE-FUSION; CD81 BINDING; NEUTRALIZING ANTIBODIES; HEPARAN-SULFATE; CELL-CULTURE; VIRAL ENTRY; INFECTION; PARTICLES	The HCV envelope glycoproteins E1 and E2 contain eight and 18 highly conserved cysteine residues, respectively. Here, we examined the oxidation state of E1E2 heterodimers incorporated into retroviral pseudotyped particles (HCVpp) and investigated the significance of free sulfhydryl groups in cell culture-derived HCV (HCVcc) and HCVpp entry. Alkylation of free sulfhydryl groups on HCVcc/pp with a membrane-impermeable sulfhydryl-alkylating reagent 4-(N-maleimido)benzyl-alpha-trimethylammonium iodide (M135) prior to virus attachment to cells abolished infectivity in a dose-dependent manner. Labeling of HCVpp envelope proteins with EZ-Link maleimide-PEG2-biotin (maleimide-biotin) detected free thiol groups in both E1 and E2. Unlike retroviruses that employ disulfide reduction to facilitate virus entry, the infectivity of alkylated HCVcc could not be rescued by addition of exogenous reducing agents. Furthermore, the infectivity of HCVcc bound to target cells was not affected by addition of M135 indicative of a change in glycoprotein oxidation state from reduced to oxidized following virus attachment to cells. By contrast, HCVpp entry was reduced by 61% when treated with M135 immediately following attachment to cells, suggesting that the two model systems might demonstrate variations in oxidation kinetics. Glycoprotein oxidation was not altered following binding of HCVpp incorporated E1E2 to soluble heparin or recombinant CD81. These results suggest that HCV entry is dependent on the presence of free thiol groups in E1 and E2 prior to cellular attachment and reveals a new essential component of the HCV entry process.	[Fraser, Johanna; Boo, Irene; Poumbourios, Pantelis; Drummer, Heidi E.] Burnet Inst, Melbourne, Vic 3004, Australia; [Fraser, Johanna; Poumbourios, Pantelis; Drummer, Heidi E.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Burnet Institute; Monash University; University of Melbourne	Drummer, HE (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	hdrummer@burnet.edu.au	Fraser, Johanna/I-2938-2014	Fraser, Johanna/0000-0002-8020-2985; Drummer, Heidi/0000-0002-0042-6277	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bonnafous P, 2010, J GEN VIROL, V91, P1919, DOI 10.1099/vir.0.021071-0; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Drummer HE, 2004, J BIOL CHEM, V279, P30066, DOI 10.1074/jbc.M405098200; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fenouillet E, 2008, J BIOL CHEM, V283, P26340, DOI 10.1074/jbc.M805221200; Flint M, 2004, J VIROL, V78, P6875, DOI 10.1128/JVI.78.13.6875-6882.2004; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Li KJ, 2008, J VIROL, V82, P7135, DOI 10.1128/JVI.00448-08; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McCaffrey K, 2007, J VIROL, V81, P9584, DOI 10.1128/JVI.02782-06; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Roingeard P, 2004, BIOL CELL, V96, P103, DOI 10.1016/j.biolcel.2003.11.006; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wallin M, 2004, EMBO J, V23, P54, DOI 10.1038/sj.emboj.7600012; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038; Zahn A, 2005, J GEN VIROL, V86, P677, DOI 10.1099/vir.0.80614-0; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zeisel MB, 2009, FUTURE MICROBIOL, V4, P511, DOI 10.2217/FMB.09.34; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	68	37	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31984	31992		10.1074/jbc.M111.269605	http://dx.doi.org/10.1074/jbc.M111.269605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768113	Green Published, hybrid			2022-12-27	WOS:000294726800007
J	Li, X; Lu, DF; He, FJ; Zhou, HB; Liu, Q; Wang, Y; Shao, CS; Gong, YQ				Li, Xi; Lu, Defen; He, Fengjuan; Zhou, Haibin; Liu, Qiao; Wang, Yu; Shao, Changshun; Gong, Yaoqin			Cullin 4B Protein Ubiquitin Ligase Targets Peroxiredoxin III for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; DNA-DAMAGE; HUMAN HOMOLOG; STEM-CELLS; S-PHASE; COMPLEX; UBIQUITYLATION; SUBSTRATE; APOPTOSIS; RECEPTOR	Cullin 4B (CUL4B) is a scaffold protein that assembles cullin-RING ubiquitin ligase (E3) complexes. Recent studies have revealed that germ-line mutations in CUL4B can cause mental retardation, short stature, and many other abnormalities in humans. Identifying specific CUL4B substrates will help to better understand the physiological functions of CUL4B. Here, we report the identification of peroxiredoxin III (PrxIII) as a novel substrate of the CUL4B ubiquitin ligase complex. Two-dimensional gel electrophoresis coupled with mass spectrometry showed that PrxIII was among the proteins up-regulated in cells after RNAi-mediated CUL4B depletion. The impaired degradation of PrxIII observed in CUL4B knockdown cells was confirmed by Western blot. We further demonstrated that DDB1 and ROC1 in the DDB1-CUL4B-ROC1 complex are also indispensable for the proteolysis of PrxIII. In addition, the degradation of PrxIII is independent of CUL4A, a cullin family member closely related to CUL4B. In vitro and in vivo ubiquitination assays revealed that CUL4B promoted the polyubiquitination of PrxIII. Furthermore, we observed a significant decrease in cellular reactive oxygen species (ROS) production in CUL4B-silenced cells, which was associated with increased resistance to hypoxia and H2O2-induced apoptosis. These findings are discussed with regard to the known function of PrxIII as a ROS scavenger and the high endogenous ROS levels required for neural stem cell proliferation. Together, our study has identified a specific target substrate of CUL4B ubiquitin ligase that may have significant implications for the pathogenesis observed in patients with mutations in CUL4B.	[Li, Xi; Lu, Defen; He, Fengjuan; Zhou, Haibin; Liu, Qiao; Wang, Yu; Shao, Changshun; Gong, Yaoqin] Shandong Univ, Sch Med, Inst Med Genet, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China	Shandong University	Gong, YQ (corresponding author), 44 Wen Hua Xi Lu, Jinan 250012, Shandong, Peoples R China.	yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Natural Science Foundation of China [30830065, 30800614, 81070223, 60974117, 30901987]; National Basic Research Program of China [2007CB512001, 2011CB966201]; Science Foundation of Shandong Province [ZR2010HM038]; Science Foundation for the Excellent Youth Scholars of Ministry of Education of China [200804221067]; Scientific Research Foundation for the Returned Overseas Chinese Scholars	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science Foundation for the Excellent Youth Scholars of Ministry of Education of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by National Natural Science Foundation of China Grants 30830065, 30800614, 81070223, 60974117, and 30901987, National Basic Research Program of China Grants 2007CB512001 and 2011CB966201, Science Foundation of Shandong Province Grant ZR2010HM038, Science Foundation for the Excellent Youth Scholars of Ministry of Education of China Grant 200804221067, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen LC, 1998, CANCER RES, V58, P3677; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kong L, 2007, J BIOL CHEM, V282, P26381, DOI 10.1074/jbc.M702195200; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lehtonen ST, 2005, AM J PHYSIOL-LUNG C, V288, pL997, DOI 10.1152/ajplung.00432.2004; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mauro C, 2006, J BIOL CHEM, V281, P2631, DOI 10.1074/jbc.M502181200; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nasu J, 2010, J CELL BIOCHEM, V111, P676, DOI 10.1002/jcb.22752; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Nonn L, 2003, MOL CANCER RES, V1, P682; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Schindl M, 2007, ANTICANCER RES, V27, P949; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	53	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32344	32354		10.1074/jbc.M111.249003	http://dx.doi.org/10.1074/jbc.M111.249003			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795677	hybrid, Green Published			2022-12-27	WOS:000294726800044
J	Nho, RS; Peterson, M				Nho, Richard Seonghun; Peterson, Mark			Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (4EBP-1) Function Is Suppressed by Src and Protein Phosphatase 2A (PP2A) on Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CELL-SURFACE RECEPTORS; PHAS-I; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAY; EPITHELIAL-CELLS; KINASE; STIMULATION; ACTIVATION; REPRESSOR	Human lung fibroblasts utilize integrins to attach and proliferate on type I collagen. beta 1 integrin is the major integrin subunit for this attachment. Integrins coordinate cellular responses to cell-cell and cell-extracellular matrix interactions that regulate a variety of biological processes. Although beta 1 integrin-mediated signaling pathways in lung fibroblasts have been studied, a detailed molecular mechanism regulating translational control of gene expression by 4EBP-1 is not understood. 4EBP-1 inhibits cap-dependent translation by binding to the eIF4E translation initiation factor. We found that when lung fibroblasts attach to collagen via beta 1 integrin, high Src activity suppresses 4EBP-1 expression via PP2A, and the decrease of 4EBP-1 is due to protein degradation. The inhibition of Src activity dramatically increases PP2A and 4EBP-1 expression. Furthermore ectopic expression of PP2A, or PP2A silencing using PP2A siRNA confirmed that 4EBP-1 is regulated by PP2A. In addition, we found that 4EBP-1 inhibition by fibroblast attachment to collagen increases cap-dependent translation. Our study showed that when lung fibroblasts are attached to collagen matrix, the beta 1 integrin/Src/PP2A-mediated 4EBP-1 regulatory pathway is activated. We suggest that beta 1 integrin-mediated signaling pathway may be a crucial event in regulating fibroblast translational control machinery on collagen matrix.	[Nho, Richard Seonghun; Peterson, Mark] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu			American Heart Association; American Lung Association	American Heart Association(American Heart Association); American Lung Association	This work was supported by the Scientist Development grant and the Pulmonary Fibrosis Research grant from the American Heart Association and the American Lung Association (to R. S. N.).	AKIYAMA SK, 1990, BIOCHIM BIOPHYS ACTA, V1031, P91, DOI 10.1016/0304-4157(90)90004-V; Barisic S, 2010, BIOCHEM PHARMACOL, V80, P439, DOI 10.1016/j.bcp.2010.04.028; BEAULIEU JF, 1999, FRONT BIOSCI, V4, P310; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Fadden P, 1997, J BIOL CHEM, V272, P10240; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hu XH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-74; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Lantry LE, 1999, CARCINOGENESIS, V20, P343, DOI 10.1093/carcin/20.2.343; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Park KW, 2005, ARTERIOSCL THROM VAS, V25, P742, DOI 10.1161/01.ATV.0000156288.70849.26; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rousseau D, 1996, ONCOGENE, V13, P2415; RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119; Takada Y, 1997, MATRIX BIOL, V16, P143, DOI 10.1016/S0945-053X(97)90002-0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Yeh CJ, 2011, VIRCHOWS ARCH, V458, P171, DOI 10.1007/s00428-010-0994-5	38	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31953	31965		10.1074/jbc.M111.222299	http://dx.doi.org/10.1074/jbc.M111.222299			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784851	Green Published, hybrid			2022-12-27	WOS:000294726800004
J	Wassef, L; Quadro, L				Wassef, Lesley; Quadro, Loredana			Uptake of Dietary Retinoids at the Maternal-Fetal Barrier IN VIVO EVIDENCE FOR THE ROLE OF LIPOPROTEIN LIPASE AND ALTERNATIVE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HIGH-DENSITY-LIPOPROTEIN; RETINYL ESTER; VITAMIN-A; BINDING-PROTEIN; CHYLOMICRON METABOLISM; LIPID-METABOLISM; APOLIPOPROTEIN-E; HEPATIC-UPTAKE; LDL RECEPTOR	Dietary retinoids (vitamin A and its derivatives) contribute to normal embryonic development. However, the mechanism(s) involved in the transfer of recently ingested vitamin A from mother to embryo is not fully understood. We investigated in vivo whether lipoprotein lipase (LPL) facilitates the placental uptake of dietary retinyl ester incorporated in chylomicrons and their remnants and its transfer to the embryo. We examined the effects of both genetic ablation (MCK-L0 mice) and pharmacological inhibition (P-407) of LPL by maintaining wild type and MCK-L0 mice on diets with different vitamin A content or administering them an oral gavage dose of [H-3]retinol with or without P-407 treatment. We showed that LPL expressed in placenta facilitates uptake of retinoids by this organ and their transfer to the embryo, mainly through its catalytic activity. In addition, through its "bridging function," LPL can mediate the acquisition of nascent chylomicrons by the placenta, although less efficiently. Quantitative real-time PCR and Western blot analysis showed that placental LPL acts in concert with LDL receptor and LRP1. Finally, by knocking out the retinol-binding protein (RBP) gene in the MCK-L0 background (MCK-L0-RBP-/- mice) we demonstrated that the placenta acquires dietary retinoids also via the maternal circulating RBP-retinol complex. RBP expressed in the placenta facilitate the transfer of postprandial retinoids across the placental layers toward the embryo.	[Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Quadro, L (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.	quadro@aesop.rutgers.edu			National Institutes of Health [R01HD057493, R01HD057493-02S1]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Component for Optimal Health [2006-35200-16580, 31.0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Component for Optimal Health(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD057493 and R01HD057493-02S1 (to L. Q.). This work was also supported by National Research Initiative Award 2006-35200-16580 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Component for Optimal Health (31.0) (to L. Q.)	BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; BLANER WS, 1994, J BIOL CHEM, V269, P16559; BLOMHOFF R, 1982, P NATL ACAD SCI-BIOL, V79, P7326, DOI 10.1073/pnas.79.23.7326; BONET B, 1992, METABOLISM, V41, P596, DOI 10.1016/0026-0495(92)90051-B; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Campbell FM, 1998, PLACENTA, V19, P409, DOI 10.1016/S0143-4004(98)90081-9; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Council N. R, 1996, GUID CAR US LAB AN; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; GOODMAN DS, 1965, J LIPID RES, V6, P390; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; HARRISON EH, 1995, J LIPID RES, V36, P1498; Hatzopoulos AK, 1998, J LIPID RES, V39, P495; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Hultin M, 1996, J LIPID RES, V37, P1022; Johnston TP, 2010, J PHARM PHARMACOL, V62, P1807, DOI 10.1111/j.2042-7158.2010.01138.x; JOHNSTON TP, 1993, BIOCHEM PHARMACOL, V46, P1037, DOI 10.1016/0006-2952(93)90668-M; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; KIRCHGESSNER TG, 1989, J BIOL CHEM, V264, P1473; Lafond J, 1999, PLACENTA, V20, P583, DOI 10.1053/plac.1999.0412; Lassiter TL, 1999, TOXICOL SCI, V52, P92, DOI 10.1093/toxsci/52.1.92; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; Lindegaard MLS, 2006, J LIPID RES, V47, P2581, DOI 10.1194/jlr.M600236-JLR200; Lindegaard MLS, 2005, J LIPID RES, V46, P2339, DOI 10.1194/jlr.M500277-JLR200; Linke T, 2005, J BIOL CHEM, V280, P23287, DOI 10.1074/jbc.M413585200; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; O'Byrne SM, 2010, AM J PHYSIOL-ENDOC M, V298, pE862, DOI 10.1152/ajpendo.00491.2009; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OVERBERGH L, 1995, J LIPID RES, V36, P1774; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sapin V, 1997, DEV DYNAM, V208, P199, DOI 10.1002/(SICI)1097-0177(199702)208:2<199::AID-AJA7>3.0.CO;2-D; Savonen R, 1999, J LIPID RES, V40, P1336; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Soprano Dianne Robert, 1994, P257; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; van Bennekum AM, 1999, J LIPID RES, V40, P565; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waterman IJ, 1998, BBA-LIPID LIPID MET, V1394, P169, DOI 10.1016/S0005-2760(98)00105-2; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; World Health Organization (WHO), 1998, SAF VIT DOS PREGN LA; Yan B, 1999, PLACENTA, V20, P599, DOI 10.1053/plac.1999.0407; Zhang WH, 2002, APPL IMMUNOHISTO M M, V10, P374, DOI 10.1097/00022744-200212000-00015; Zile MH, 1998, J NUTR, V128, p455S, DOI 10.1093/jn/128.2.455S	57	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32198	32207		10.1074/jbc.M111.253070	http://dx.doi.org/10.1074/jbc.M111.253070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795711	hybrid, Green Published			2022-12-27	WOS:000294726800030
J	Kouno, T; Kizuka, Y; Nakagawa, N; Yoshihara, T; Asano, M; Oka, S				Kouno, Tetsuya; Kizuka, Yasuhiko; Nakagawa, Naoki; Yoshihara, Toru; Asano, Masahide; Oka, Shogo			Specific Enzyme Complex of beta-1,4-Galactosyltransferase-II and Glucuronyltransferase-P Facilitates Biosynthesis of N-linked Human Natural Killer-1 (HNK-1) Carbohydrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; NERVOUS-SYSTEM; GOLGI ENZYMES; EPITOPE HNK-1; MOUSE-BRAIN; GLCAT-P; EXPRESSION; CLONING; FAMILY	Human natural killer-1 (HNK-1) carbohydrate is highly expressed in the nervous system and is involved in synaptic plasticity and dendritic spine maturation. This unique carbohydrate, consisting of a sulfated trisaccharide (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-), is biosynthesized by the successive actions of beta-1,4-galactosyltransferase (beta 4GalT), glucuronyltransferase (GlcAT-P and GlcAT-S), and sulfotransferase (HNK-1ST). A previous study showed that mice lacking beta 4GalT-II, one of seven beta 4GalTs, exhibited a dramatic loss of HNK-1 expression in the brain, although beta 4GalT-I-deficient mice did not. Here, we investigated the underlying molecular mechanism of the regulation of HNK-1 expression. First, focusing on a major HNK-1 carrier, neural cell adhesion molecule, we found that reduced expression of an N-linked HNK-1 carbohydrate caused by a deficiency of beta 4GalT-II is not likely due to a general loss of the beta 1,4-galactose residue as an acceptor for GlcAT-P. Instead, we demonstrated by co-immunoprecipitation and endoplasmic reticulum-retention analyses using Neuro2a (N2a) cells that beta 4GalT-II physically and specifically associates with GlcAT-P. In addition, we revealed by pull-down assay that Golgi luminal domains of beta 4GalT-II and GlcAT-P are sufficient for the complex to form. With an in vitro assay system, we produced the evidence that the kinetic efficiency k(cat)/K-m of GlcAT-P in the presence of beta 4GalT-II was increased about 2.5-fold compared with that in the absence of beta 4GalT-II. Finally, we showed that co-expression of beta 4GalT-II and GlcAT-P increased HNK-1 expression on various glycoproteins in N2a cells, including neural cell adhesion molecule. These results indicate that the specific enzyme complex of beta 4GalT-II with GlcAT-P plays an important role in the biosynthesis of HNK-1 carbohydrate.	[Kouno, Tetsuya; Nakagawa, Naoki; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Kizuka, Yasuhiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068507, Japan; [Yoshihara, Toru; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan; [Yoshihara, Toru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan	Kyoto University; Kyoto University; Kanazawa University; Kanazawa University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Ministry of Education, Culture, Sports, Science and Technology [21370053]; Ministry of Health, Labor, and Welfare of Japan Health and Labour Sciences [H21-012]; Grants-in-Aid for Scientific Research [23500493] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan Health and Labour Sciences(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) 21370053 (to S.O.) from the Ministry of Education, Culture, Sports, Science and Technology and in part by the Ministry of Health, Labor, and Welfare of Japan Health and Labour Sciences Research Grant on Comprehensive Research on Disability Health and Welfare, H21-012.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Inoue M, 2007, BRAIN RES, V1179, P1, DOI 10.1016/j.brainres.2007.05.012; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kakuda S, 2005, GLYCOBIOLOGY, V15, P203, DOI 10.1093/glycob/cwi001; Kakuda S, 2004, PROTEIN EXPRES PURIF, V35, P111, DOI 10.1016/j.pep.2003.12.021; Kido M, 1998, BIOCHEM BIOPH RES CO, V245, P860, DOI 10.1006/bbrc.1998.8537; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2009, J BIOL CHEM, V284, P9247, DOI 10.1074/jbc.M807517200; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Kudo M, 1996, J BIOL CHEM, V271, P32667, DOI 10.1074/jbc.271.51.32667; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Marzban H, 2004, J NEUROCYTOL, V33, P117, DOI 10.1023/B:NEUR.0000029652.96456.0d; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKA S, 1992, J BIOL CHEM, V267, P22711; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHWARTING GA, 1987, DEV BIOL, V120, P65, DOI 10.1016/0012-1606(87)90104-7; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Seko A, 2006, TRENDS GLYCOSCI GLYC, V18, P209, DOI 10.4052/tigg.18.209; Seko A, 2008, J BIOL CHEM, V283, P33094, DOI 10.1074/jbc.M806933200; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200; YOSHIHARA Y, 1991, J CELL BIOL, V115, P731, DOI 10.1083/jcb.115.3.731	46	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31337	31346		10.1074/jbc.M111.233353	http://dx.doi.org/10.1074/jbc.M111.233353			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771787	Green Published, hybrid			2022-12-27	WOS:000294487500029
J	Zhou, YG; Madej, MG; Guan, L; Nie, YL; Kaback, HR				Zhou, Yonggang; Madej, M. Gregor; Guan, Lan; Nie, Yiling; Kaback, H. Ronald			An Early Event in the Transport Mechanism of LacY Protein INTERACTION BETWEEN HELICES V AND I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; SITE-DIRECTED ALKYLATION; INDUCED CONFORMATIONAL-CHANGES; POLYTOPIC MEMBRANE-PROTEINS; LACTOSE PERMEASE; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; PERIPLASMIC PATHWAY; ALTERNATING ACCESS; SUGAR	Helix V in LacY, which abuts and crosses helix I in the N-terminal helix bundle of LacY, contains Arg(144) and Trp(151), two residues that play direct roles in sugar recognition and binding, as well as Cys(154), which is important for conformational flexibility. In this study, paired Cys replacement mutants in helices V and I were strategically constructed with tandem factor Xa protease cleavage sites in the loop between the two helices to test cross-linking. None of the mutants form disulfides spontaneously; however, three mutants (Pro(28) -> Cys/Cys(154), Pro(28) -> Cys/Val(158) -> Cys, and Phe(29) -> Cys/Val(158) -> Cys) exhibit crosslinking after treatment with copper/1,10-phenanthroline (Cu/Ph) or 1,1-methanediyl bismethanethiosulfonate ((MTS)(2)-1), 3-4 angstrom), and cross-linking is quantitative in the presence of ligand. Remarkably, with one mutant, complete cross-linking with (MTS) 2-1 has no effect on lactose transport, whereas quantitative disulfide cross-linking catalyzed by Cu/Ph markedly inhibits transport activity. The findings are consistant with a number of previous conclusions suggesting that sugar binding to LacY causes a localized scissors-like movement between helices V and I near the point where the two helices cross in the middle of the membrane. This ligand-induced movement may act to initiate the global conformational change resulting from sugar binding.	[Zhou, Yonggang; Madej, M. Gregor; Guan, Lan; Nie, Yiling; Kaback, H. Ronald] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kaback, HR (corresponding author), Univ Calif Los Angeles, Dept Physiol, Macdonald Res Bldg,Rm 6-720,675 Charles E Young D, Los Angeles, CA 90095 USA.	rkaback@mednet.ucla.edu		Madej, M. Gregor/0000-0001-9181-6387	National Institutes of Health [DK51131, DK069463, GM073210, GM074929]; National Science Foundation [0450970]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069463, R01DK051131, R56DK051131, R01DK069463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074929, P50GM073210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK51131, DK069463, GM073210, and GM074929 and National Science Foundation Grant 0450970 (to H. R. K.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; CARRASCO N, 1984, P NATL ACAD SCI-BIOL, V81, P4672, DOI 10.1073/pnas.81.15.4672; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; COSTELLO MJ, 1987, J BIOL CHEM, V262, P17072; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; Ermolova N, 2003, P NATL ACAD SCI USA, V100, P10187, DOI 10.1073/pnas.1434239100; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; JUNG K, 1995, BIOCHEMISTRY-US, V34, P1030, DOI 10.1021/bi00003a038; Kaback H R, 1974, Methods Enzymol, V31, P698; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KONINGS WN, 1971, J BIOL CHEM, V246, P5857; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; LeCoutre J, 1997, P NATL ACAD SCI USA, V94, P10167, DOI 10.1073/pnas.94.19.10167; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; MENICK DR, 1985, BIOCHEM BIOPH RES CO, V132, P162, DOI 10.1016/0006-291X(85)91002-2; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Nie W, 2008, J MOL BIOL, V379, P695, DOI 10.1016/j.jmb.2008.04.015; Nie Y, 2007, J MOL BIOL, V374, P356, DOI 10.1016/j.jmb.2007.09.006; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; Nie YL, 2010, P NATL ACAD SCI USA, V107, P9903, DOI 10.1073/pnas.1004515107; Nie Y, 2009, BIOCHEMISTRY-US, V48, P738, DOI 10.1021/bi801976r; OVERATH P, 1987, P NATL ACAD SCI USA, V84, P5535, DOI 10.1073/pnas.84.16.5535; Patzlaff JS, 1998, BIOCHEMISTRY-US, V37, P15363, DOI 10.1021/bi981142x; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; SAHINTOTH M, 1995, BIOCHEMISTRY-US, V34, P1107, DOI 10.1021/bi00004a001; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sayeed WMH, 2009, BBA-BIOMEMBRANES, V1788, P1108, DOI 10.1016/j.bbamem.2009.01.010; SHORT SA, 1975, J BIOL CHEM, V250, P4291; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; SMITH SO, 1995, P NATL ACAD SCI USA, V92, P488, DOI 10.1073/pnas.92.2.488; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; VANIWAARDEN PR, 1993, BIOCHEMISTRY-US, V32, P5419, DOI 10.1021/bi00071a017; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; Wolin CD, 2000, BIOCHEMISTRY-US, V39, P6130, DOI 10.1021/bi0001269; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; Wu JH, 1998, J MOL BIOL, V282, P959, DOI 10.1006/jmbi.1998.2065; Wu JH, 1998, BIOCHEMISTRY-US, V37, P15785, DOI 10.1021/bi981501o; Wu JH, 1999, BIOCHEMISTRY-US, V38, P2320, DOI 10.1021/bi982288z; Wu JH, 1999, BIOCHEMISTRY-US, V38, P1715, DOI 10.1021/bi982342b; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105; Zhou YG, 2009, J MOL BIOL, V394, P219, DOI 10.1016/j.jmb.2009.09.043	64	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30415	30422		10.1074/jbc.M111.268433	http://dx.doi.org/10.1074/jbc.M111.268433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730060	Green Published, hybrid			2022-12-27	WOS:000294283600020
J	Sorrentino, V; Scheer, L; Santos, A; Reits, E; Bleijlevens, B; Zelcer, N				Sorrentino, Vincenzo; Scheer, Lilith; Santos, Ana; Reits, Eric; Bleijlevens, Boris; Zelcer, Noam			Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING DOMAIN; FAMILIAL HYPERCHOLESTEROLEMIA; DEPENDENT UBIQUITINATION; POLYUBIQUITIN CHAIN; ADAPTER PROTEIN; ERM PROTEINS; COMPLEX; MUTATIONS; BINDING; INTEGRATORS	We recently identified the liver X receptor-regulated E3 ubiquitin ligase inducible degrader of the LDL receptor (IDOL) as a modulator of lipoprotein metabolism. Acting as an E3 ubiquitin ligase, IDOL triggers ubiquitination and subsequent degradation of the low density lipoprotein receptor (LDLR). We demonstrate here that this outcome requires the conserved FERM and RING domains present in IDOL. The RING domain promotes ubiquitination in vitro and Lys-63-specific ubiquitination of the LDLR in vivo in response to IDOL or liver X receptor activation. We further identify RING residues that differentially influence ubiquitination of the LDLR or stability of IDOL. The FERM domain interacts with the LDLR and in living cells co-localizes with the receptor at the plasma membrane. Homology modeling revealed a phosphotyrosine-binding element embedded in the FERM domain. Mutating residues within this region or residues in the LDLR preceding the NPVY endocytosis motif abrogate LDLR degradation by IDOL. Collectively, our results indicate that both the FERM and RING domains are required for promoting lysosomal degradation of the LDLR by IDOL. Our findings may facilitate development of structure-based IDOL inhibitors aimed at increasing LDLR abundance in therapeutic strategies to treat cardiovascular disease.	[Sorrentino, Vincenzo; Scheer, Lilith; Santos, Ana; Bleijlevens, Boris; Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Reits, Eric] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Zelcer, N (corresponding author), Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	n.zelcer@amc.uva.nl	; Sorrentino, Vincenzo/R-4403-2018	Zelcer, Noam/0000-0001-6935-7532; Sorrentino, Vincenzo/0000-0002-7212-370X	Human Frontier Science Program Organization; Netherlands Organization for Scientific Research	Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by a career development award from the Human Frontier Science Program Organization and by a VIDI grant from the Netherlands Organization for Scientific Research. To whom correspondence should be addressed: Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Tel.: 31-20-5665131; Fax: 31-20-6915519; E-mail: n.zelcer@amc.uva.nl.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Michaely P, 2004, J BIOL CHEM, V279, P34023, DOI 10.1074/jbc.M405242200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	37	37	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30190	30199		10.1074/jbc.M111.249557	http://dx.doi.org/10.1074/jbc.M111.249557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21734303	hybrid, Green Published			2022-12-27	WOS:000294046600076
J	Xue, Y; Lee, SW; Wang, YC; Ha, Y				Xue, Yi; Lee, Sangwon; Wang, Yongcheng; Ha, Ya			Crystal Structure of the E2 Domain of Amyloid Precursor Protein-like Protein 1 in Complex with Sucrose Octasulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; HEPARIN-BINDING; CORTICAL-NEURONS; BETA-SECRETASE; MICE LACKING; APP; SULFATE; SURFACE; GENE; IDENTIFICATION	Missense mutations in the amyloid precursor protein (APP) gene can cause familial Alzheimer disease. It is thought that APP and APP-like proteins (APLPs) may play a role in adhesion and signal transduction because their ectodomains interact with components of the extracellular matrix. Heparin binding induces dimerization of APP and APLPs. To help explain how these proteins interact with heparin, we have determined the crystal structure of the E2 domain of APLP1 in complex with sucrose octasulfate (SOS). A total of three SOS molecules are bound to the E2 dimer. Two SOSs are bound inside a narrow intersubdomain groove, and the third SOS is bound near the two-fold axis of the protein. Mutational analyses show that most residues interacting with SOS also contribute to heparin binding, although in varying degrees; a deep pocket, defined by His-376, Lys-422, and Arg-429, and an interfacial site between Lys-314 and its symmetry mate are most important in the binding of the negatively charged polysaccharide. Comparison with a lower resolution APP structure shows that all key heparin binding residues are conserved and identically positioned, suggesting that APLP1 and APP may bind heparin similarly. In transfected HEK-293 cells, mutating residues responsible for heparin binding causes little change in the proteolysis of APP by the secretases. However, mutating a pair of conserved basic residues (equivalent to Arg-414 and Arg-415 of APLP1) immediately adjacent to the heparin binding site affects both the maturation and the processing of APP.	[Xue, Yi; Lee, Sangwon; Wang, Yongcheng; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu		Lee, Sangwon/0000-0002-9441-6546	National Institutes of Health [GM077547]; United States Department of Energy; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077547 (to Y. H.).; We thank S. Bian, D. Calderwood, and C. Chen for advice on mammalian cell culture. We also thank A. Heroux, H. Robinson, and A. Soares at NSLS X25 and X29 for assistance during x-ray diffraction data collection. Financial support for the beamlines comes principally from the United States Department of Energy and from the National Institutes of Health.	Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoopes JT, 2010, J BIOL CHEM, V285, P2165, DOI 10.1074/jbc.M109.018432; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Klaver D, 2010, NEURODEGENER DIS, V7, P187, DOI 10.1159/000295661; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Leveugle B, 1998, J NEUROCHEM, V70, P736; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; READ RJ, 1998, ACTA CRYSTALLOGR D, V54, P905; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Storey E, 1996, BRAIN RES, V735, P217, DOI 10.1016/0006-8993(96)00608-7; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yamazaki T, 1997, J NEUROSCI, V17, P1004; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	41	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29748	29757		10.1074/jbc.M111.219659	http://dx.doi.org/10.1074/jbc.M111.219659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715329	Green Published, hybrid			2022-12-27	WOS:000294046600034
J	Zhang, XZ; Rossi, JJ				Zhang, Xizhe; Rossi, John J.			Phylogenetic Comparison of Small RNA-triggered Transcriptional Gene Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIRECTED DNA METHYLATION; H3 LYSINE-9 METHYLATION; DOUBLE-STRANDED-RNA; HUMAN-CELLS; FISSION YEAST; INTERFERING RNA; POLYMERASE-IV; ARABIDOPSIS-THALIANA; HISTONE METHYLATION; SIRNA ACCUMULATION	The discovery of RNA interference has revealed complex roles for small RNAs in regulating gene expression and cellular physiology. Small RNAs have been demonstrated to be involved in post-transcriptional suppression of translation, targeted degradation of messenger RNAs, and transcriptional suppression via epigenetic modifications of histones and DNA. In fission yeast, RNAi mediates suppression of centromeric transcripts, whereas in plants, transcriptional gene silencing appears to be primarily an antiviral mechanism. In mammals, the well annotated functional role of RNAi is primarily post-transcriptional, but there is increasing evidence that this mechanism can also work to suppress or modulate gene transcription, although it is not clear what primary function this serves. We overview, compare, and contrast the transcriptional silencing pathways in yeast, plants, and mammals in this article. This minireview is intended to provide the reader with a framework of how the RNAi machinery appears to be universally involved in various aspects of transcriptional regulation with discussions of similarities and differences in the components and mechanisms of achieving transcriptional silencing.	[Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Rossi, JJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA.	jrossi@coh.org	Zhang, Xizhe/J-7630-2019	Zhang, Xizhe/0000-0001-9008-4604	National Institutes of Health [AI29329, HL07470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029329, R01AI042552, R37AI029329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI29329 and HL07470 (to J.J.R.). This is the fifth article in the Thematic Minireview Series on Epigenetics. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Castanotto D, 2009, P NATL ACAD SCI USA, V106, P21655, DOI 10.1073/pnas.0912384106; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; FROM WWW, AUGUST; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Haag JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004110; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kankel MW, 2003, GENETICS, V163, P1109; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Li HT, 2009, MOL CELL, V34, P155, DOI 10.1016/j.molcel.2009.02.032; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Simmer F, 2010, EMBO REP, V11, P112, DOI 10.1038/embor.2009.273; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	67	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29443	29448		10.1074/jbc.R111.276378	http://dx.doi.org/10.1074/jbc.R111.276378			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730056	Green Published, hybrid			2022-12-27	WOS:000294046600001
J	Reese, ML; Boothroyd, JC				Reese, Michael L.; Boothroyd, John C.			A Conserved Non-canonical Motif in the Pseudoactive Site of the ROP5 Pseudokinase Domain Mediates Its Effect on Toxoplasma Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; FAMILY; FEATURES; REVEALS; GONDII; PARASITE; BINDING; ROLES; FOLD	The ROP5 family is a closely related set of polymorphic pseudokinases that are critical to the ability of Toxoplasma to cause disease. Polymorphisms in ROP5 also make it a major determinant of strain-specific differences in virulence. ROP5 possesses all of the major kinase motifs required for catalysis except for a substitution at the catalytic Asp. We show that this substitution in the catalytic loop of ROP5 is part of a motif conserved in other pseudokinases of both Toxoplasma and human origin, and that this motif is required for the full activity in vivo of ROP5. This suggests evolutionary selection at this site for a biochemical function, rather than simple drift away from catalysis. We present the crystal structures of a virulent isoform of ROP5 both in its ATP-bound and -unbound states and have demonstrated that despite maintaining the canonical ATP-binding motifs, ROP5 binds ATP in a distorted conformation mediated by unusual magnesium coordination sites that would not be predicted from the primary sequence. In addition, we have mapped the polymorphisms spread throughout the primary sequence of ROP5 to two major surfaces, including the activation segment of ROP5. This suggests that the pseudoactive site of this class of pseudokinases may have evolved to use the canonical ATP-binding motifs for non-catalytic signaling through allostery.	[Reese, Michael L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Boothroyd, JC (corresponding author), Fairchild Bldg,Rm D305,299 Campus Dr, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Reese, Michael/0000-0001-9401-9594; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [AI73756]; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI73756.; Supported, in part, by a postdoctoral fellowship from the American Cancer Society.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Golebiowski A, 2005, BIOORG MED CHEM LETT, V15, P2285, DOI 10.1016/j.bmcl.2005.03.007; Turjanski AG, 2009, J AM CHEM SOC, V131, P6141, DOI 10.1021/ja8071995; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Henkelman G, 2005, P NATL ACAD SCI USA, V102, P15347, DOI 10.1073/pnas.0506425102; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	47	63	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29366	29375		10.1074/jbc.M111.253435	http://dx.doi.org/10.1074/jbc.M111.253435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708941	Green Published, hybrid			2022-12-27	WOS:000293837000071
J	Tanioka, T; Tamura, Y; Fukaya, M; Shinozaki, S; Mao, J; Kim, M; Shimizu, N; Kitamura, T; Kaneki, M				Tanioka, Toshihiro; Tamura, Yoshiaki; Fukaya, Makiko; Shinozaki, Shohei; Mao, Ji; Kim, Minhye; Shimizu, Nobuyuki; Kitamura, Tadahiro; Kaneki, Masao			Inducible Nitric-oxide Synthase and Nitric Oxide Donor Decrease Insulin Receptor Substrate-2 Protein Expression by Promoting Proteasome-dependent Degradation in Pancreatic beta-Cells INVOLVEMENT OF GLYCOGEN SYNTHASE KINASE-3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONOBESE DIABETIC MICE; HIGH-FAT DIET; GLUCOSE-HOMEOSTASIS; HUMAN ISLETS; NOD MICE; KINASE-B; MASS; INHIBITOR; IRS-2; INOS	Insulin receptor substrate-2 (IRS-2) plays a critical role in the survival and function of pancreatic beta-cells. Gene disruption of IRS-2 results in failure of the beta-cell compensatory mechanism and diabetes. Nonetheless, the regulation of IRS-2 protein expression in beta-cells remains largely unknown. Inducible nitricoxide synthase (iNOS), a major mediator of inflammation, has been implicated in beta-cell damage in type 1 and type 2 diabetes. The effects of iNOS on IRS-2 expression have not yet been investigated in beta-cells. Here, we show that iNOS and NO donor decreased IRS-2 protein expression in INS-1/832 insulinoma cells and mouse islets, whereas IRS-2 mRNA levels were not altered. Interleukin-1 beta (IL-1 beta), alone or in combination with interferon-gamma(IFN-gamma), reduced IRS-2 protein expression in an iNOS-dependent manner without altering IRS-2 mRNA levels. Proteasome inhibitors, MG132 and lactacystin, blocked the NO donor-induced reduction in IRS-2 protein expression. Treatment with NO donor led to activation of glycogen synthase kinase-3 beta (GSK-3 beta) and c-Jun N-terminal kinase (JNK/SAPK) in beta-cells. Inhibition of GSK-3 beta by pharmacological inhibitors or siRNA-mediated knockdown significantly prevented NO donor-induced reduction in IRS-2 expression in beta-cells. In contrast, a JNK inhibitor, SP600125, did not effectively block reduced IRS-2 expression in NO donor-treated beta-cells. These data indicate that iNOS-derived NO reduces IRS-2 expression by promoting protein degradation, at least in part, through a GSK-3 beta-dependent mechanism. Our findings suggest that iNOS-mediated decreased IRS-2 expresssion may contribute to the progression and/or exacerbation of beta-cell failure in diabetes.	[Tanioka, Toshihiro; Tamura, Yoshiaki; Fukaya, Makiko; Shinozaki, Shohei; Mao, Ji; Kim, Minhye; Shimizu, Nobuyuki; Kaneki, Masao] Harvard Univ, Shriners Hosp Children, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med,Med Sch, Charlestown, MA 02129 USA; [Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Gunma 3718512, Japan	Harvard University; Massachusetts General Hospital; Gunma University	Kaneki, M (corresponding author), 149 13th St,Rm 6604, Charlestown, MA 02129 USA.	mkaneki@helix.mgh.harvard.edu	Shinozaki, Shohei/AAT-3018-2021		National Institutes of Health [R01DK05827, P30NS045776, 5 u42 RR006042]; American Diabetes Association [7-08-RA-77]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23590474] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK05827 (to M. K.) and P30NS045776 (to the Microscopy and Image Analysis Core of Massachusetts General Hospital). This work was also supported by American Diabetes Association Grant 7-08-RA-77 (to M. K.).; We are grateful to Dr. C. B. Newgard for providing INS-1/832 cells. We acknowledge use of human islets provided by the National Disease Research Interchange, with support from National Institutes of Health Grant 5 u42 RR006042.	Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Baylis SA, 1999, MOL HUM REPROD, V5, P277, DOI 10.1093/molehr/5.3.277; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Brandhorst D, 2001, TRANSPLANTATION, V71, P179, DOI 10.1097/00007890-200101270-00002; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Chen YT, 2009, TRANSPL P, V41, P1786, DOI 10.1016/j.transproceed.2008.10.093; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kato Y, 2003, DIABETOLOGIA, V46, P1228, DOI 10.1007/s00125-003-1173-x; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Liu Z, 2008, DIABETOLOGIA, V51, P623, DOI 10.1007/s00125-007-0914-7; McCabe C, 2007, BIOCHEM BIOPH RES CO, V357, P75, DOI 10.1016/j.bbrc.2007.03.115; Montolio M, 2007, J ENDOCRINOL, V192, P169, DOI 10.1677/joe.1.06968; Norquay LD, 2009, ENDOCRINOLOGY, V150, P4531, DOI 10.1210/en.2009-0395; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Papaccio G, 2000, J CELL BIOCHEM, V77, P82, DOI 10.1002/(SICI)1097-4644(20000401)77:1<82::AID-JCB9>3.3.CO;2-M; Park SM, 2007, J APPL PHYSIOL, V103, P1764, DOI 10.1152/japplphysiol.00434.2007; Pfleger C, 2008, DIABETES, V57, P929, DOI 10.2337/db07-1697; Rabinovitch A, 1996, ENDOCRINOLOGY, V137, P2093, DOI 10.1210/en.137.5.2093; Reddy S, 1999, HISTOCHEM J, V31, P303, DOI 10.1023/A:1003765918017; Reddy S, 2001, HISTOCHEM J, V33, P317, DOI 10.1023/A:1012422821187; Rydgren T, 2002, EUR J ENDOCRINOL, V147, P543, DOI 10.1530/eje.0.1470543; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Thomas HE, 2004, DIABETES, V53, P113, DOI 10.2337/diabetes.53.1.113; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yasuda H, 2009, DIABETES RES CLIN PR, V83, P200, DOI 10.1016/j.diabres.2008.11.029; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	55	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29388	29396		10.1074/jbc.M110.192732	http://dx.doi.org/10.1074/jbc.M110.192732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700708	Green Published, hybrid			2022-12-27	WOS:000293837000073
J	Hong, EH; Yun, HS; Kim, J; Um, HD; Lee, KH; Kang, CM; Lee, SJ; Chun, JS; Hwang, SG				Hong, Eun-Hee; Yun, Hong Shik; Kim, Jongdoo; Um, Hong-Duck; Lee, Kee-Ho; Kang, Chang-Mo; Lee, Su-Jae; Chun, Jang-Soo; Hwang, Sang-Gu			Nicotinamide Phosphoribosyltransferase Is Essential for Interleukin-1 beta-mediated Dedifferentiation of Articular Chondrocytes via SIRT1 and Extracellular Signal-regulated Kinase (ERK) Complex Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DIFFERENTIATED PHENOTYPE; LIFE-SPAN; CARTILAGE; APOPTOSIS; INFLAMMATION; RESTRICTION; EXTENSION; VISFATIN	Although much is known about interleukin (IL)-1 beta and its role as a key mediator of cartilage destruction in osteoarthritis, only limited information is available on IL-1 beta signaling in chondrocyte dedifferentiation. Here, we have characterized the molecular mechanisms leading to the dedifferentiation of primary cultured articular chondrocytes by IL-1 beta treatment. IL-1 beta or lipopolysaccharide, but not phorbol 12-myristate 13-acetate, retinoic acid, or epidermal growth factor, induced nicotinamide phosphoribosyltransferase (NAMPT) expression, showing the association of inflammatory cytokines with NAMPT regulation. SIRT1, in turn, was activated NAMPT-dependently, without any alteration in the expression level. Activation or inhibition of SIRT1 oppositevely regulates IL-1 beta-mediated chondrocyte dedifferentiation, suggesting this protein as a key regulator of chondrocytes phenotype. SIRT1 activation promotes induction of ERK and p38 kinase activities, but not JNK, in response to IL-1 beta. Subsequently, ERK and p38 kinase activated by SIRT1 also induce SIRT1 activation, forming a positive feedback loop to sustain downstream signaling of these kinases. Moreover, we found that the SIRT1-ERK complex, but not SIRT1-p38, is engaged in IL-1 beta-induced chondrocyte dedifferentiation via a Sox-9-mediated mechanism. JNK is activated by IL-1 beta and modulates dedifferentiation of chondrocytes, but this pathway is independent on NAMPT-SIRT1 signaling. Based on these findings, we propose that IL-1 beta induces dedifferentiation of articular chondrocytes by up-regulation of SIRT1 activity enhanced by both NAMPT and ERK signaling.	[Hong, Eun-Hee; Yun, Hong Shik; Kim, Jongdoo; Um, Hong-Duck; Lee, Kee-Ho; Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Kang, Chang-Mo] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Hong, Eun-Hee; Yun, Hong Shik; Lee, Su-Jae] Hanyang Univ, Coll Nat Sci, Dept Chem, Seoul 133791, South Korea; [Chun, Jang-Soo] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Hanyang University; Gwangju Institute of Science & Technology (GIST)	Hwang, SG (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, 215-4 Gongneung Dong, Seoul 139706, South Korea.	sgh63@kcch.re.kr	Um, Hong-Duk/AAH-3733-2021		National Research Foundation of Korea; Korea Research Foundation [KRF-2008-313-C00260]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Nuclear Research and Development Program of the National Research Foundation of Korea and in part by Korea Research Foundation Grant KRF-2008-313-C00260.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bobacz K, 2007, ARTHRITIS RHEUM-US, V56, P1880, DOI 10.1002/art.22637; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Goldring MB, 2008, ANN RHEUM DIS, V67, P75, DOI 10.1136/ard.2008.098764; Heraud F, 2000, ANN RHEUM DIS, V59, P959, DOI 10.1136/ard.59.12.959; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Hwang SG, 2005, FEBS LETT, V579, P4837, DOI 10.1016/j.febslet.2005.07.067; Hwang SG, 2005, J BIOL CHEM, V280, P29780, DOI 10.1074/jbc.M411793200; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022	34	48	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28619	28631		10.1074/jbc.M111.219832	http://dx.doi.org/10.1074/jbc.M111.219832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697093	hybrid, Green Published			2022-12-27	WOS:000293557800076
J	Kisiela, DI; Kramer, JJ; Tchesnokova, V; Aprikian, P; Yarov-Yarovoy, V; Clegg, S; Sokurenko, EV				Kisiela, Dagmara I.; Kramer, Jeremy J.; Tchesnokova, Veronika; Aprikian, Pavel; Yarov-Yarovoy, Vladimir; Clegg, Steven; Sokurenko, Evgeni V.			Allosteric Catch Bond Properties of the FimH Adhesin from Salmonella enterica Serovar Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TYPE-1 FIMBRIAE; BINDING SPECIFICITIES; DIFFERENTIAL BINDING; BACTERIAL ADHESION; PROTEIN-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-BASIS; CELLS; COLONIZATION	Despite sharing the name and the ability to mediate mannose-sensitive adhesion, the type 1 fimbrial FimH adhesins of Salmonella Typhimurium and Escherichia coli share only 15% sequence identity. In the present study, we demonstrate that even with this limited identity in primary sequence, these two proteins share remarkable similarity of complex receptor binding and structural properties. In silico simulations suggest that, like E. coli FimH, Salmonella FimH has a two-domain tertiary structure topology, with a mannose-binding pocket located on the apex of a lectin domain. Structural analysis of mutations that enhance S. Typhimurium FimH binding to eukaryotic cells and mannose-BSA demonstrated that they are not located proximal to the predicted mannose-binding pocket but rather occur in the vicinity of the predicted interface between the lectin and pilin domains of the adhesin. This implies that the functional effect of such mutations is indirect and probably allosteric in nature. By analogy with E. coli FimH, we suggest that Salmonella FimH functions as an allosteric catch bond adhesin, where shear-induced separation of the lectin and pilin domains results in a shift from a low affinity to a high affinity binding conformation of the lectin domain. Indeed, we observed shear-enhanced binding of whole bacteria expressing S. Typhimurium type 1 fimbriae. In addition, we observed that anti-FimH antibodies activate rather than inhibit S. Typhimurium FimH mannose binding, consistent with the allosteric catch bond properties of this adhesin.	[Kisiela, Dagmara I.; Kramer, Jeremy J.; Tchesnokova, Veronika; Aprikian, Pavel; Yarov-Yarovoy, Vladimir; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Clegg, Steven] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa	Sokurenko, EV (corresponding author), Univ Washington, Dept Microbiol, Rm J267A HSB,Box 357242, Seattle, WA 98195 USA.	evs@u.washington.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	National Institutes of Health [RO1 GM084318, RO1 AI050940, RO1 AI74693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940, R01AI074693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM084318, RO1 AI050940, and RO1 AI74693.	Althouse C, 2003, INFECT IMMUN, V71, P6446, DOI 10.1128/IAI.71.11.6446-6452.2003; Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BHATTACHARJEE JW, 1978, J GEN MICROBIOL, V107, P407, DOI 10.1099/00221287-107-2-407; Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boyd EF, 1999, J BACTERIOL, V181, P1301, DOI 10.1128/JB.181.4.1301-1308.1999; Bullitt E, 1998, BIOPHYS J, V74, P623, DOI 10.1016/S0006-3495(98)77821-X; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CLEGG S, 1985, INFECT IMMUN, V48, P275, DOI 10.1128/IAI.48.2.275-279.1985; Collinson SK, 1996, GENE, V169, P75, DOI 10.1016/0378-1119(95)00763-6; Duguid J. L., 1980, BACTERIAL ADHERENCE, V6, P185; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Ewen SWB, 1997, FEMS IMMUNOL MED MIC, V18, P185, DOI 10.1016/S0928-8244(97)00038-2; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; GERLACH GF, 1989, INFECT IMMUN, V57, P764, DOI 10.1128/IAI.57.3.764-770.1989; Guo AZ, 2007, MICROBIOL-SGM, V153, P1059, DOI 10.1099/mic.0.2006/000331-0; Guo AZ, 2009, MICROBIOL-SGM, V155, P1623, DOI 10.1099/mic.0.026286-0; Hancox LS, 1997, FEMS IMMUNOL MED MIC, V19, P289, DOI 10.1016/S0928-8244(97)00095-3; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Kisiela D, 2005, INFECT IMMUN, V73, P6187, DOI 10.1128/IAI.73.9.6187-6190.2005; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; KORHONEN TK, 1980, J BACTERIOL, V144, P800, DOI 10.1128/JB.144.2.800-805.1980; Langermann S, 2003, ADV EXP MED BIOL, V539, P635; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Le Trong I, 2010, J STRUCT BIOL, V172, P380, DOI 10.1016/j.jsb.2010.06.002; MADISON B, 1994, INFECT IMMUN, V62, P843, DOI 10.1128/IAI.62.3.843-848.1994; Merckel MC, 2003, J MOL BIOL, V331, P897, DOI 10.1016/S0022-2836(03)00841-6; Naughton PJ, 2001, J MED MICROBIOL, V50, P191, DOI 10.1099/0022-1317-50-2-191; Nilsson LM, 2007, MOL MICROBIOL, V65, P1158, DOI 10.1111/j.1365-2958.2007.05858.x; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; OFEK I, 1977, NATURE, V265, P623, DOI 10.1038/265623a0; Pettigrew D, 2004, J BIOL CHEM, V279, P46851, DOI 10.1074/jbc.M409284200; Poggio TV, 2006, CAN J MICROBIOL, V52, P1093, DOI 10.1139/W06-065; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; SOKURENKO EV, 1995, J BACTERIOL, V177, P3680, DOI 10.1128/jb.177.13.3680-3686.1995; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Stahlhut SG, 2009, J BACTERIOL, V191, P6592, DOI 10.1128/JB.00786-09; Sung YH, 2001, J BIOL CHEM, V276, P44229, DOI 10.1074/jbc.M104239200; Tchesnokova V., 2011, INFECT IMMU IN PRESS; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thankavel K, 1999, J BIOL CHEM, V274, P5797, DOI 10.1074/jbc.274.9.5797; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	57	19	21	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38136	38147		10.1074/jbc.M111.237511	http://dx.doi.org/10.1074/jbc.M111.237511			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21795699	hybrid, Green Published			2022-12-27	WOS:000296594200027
J	Ariza, A; Eklof, JM; Spadiut, O; Offen, WA; Roberts, SM; Besenmatter, W; Friis, EP; Skjot, M; Wilson, KS; Brumer, H; Davies, G				Ariza, Antonio; Eklof, Jens M.; Spadiut, Oliver; Offen, Wendy A.; Roberts, Shirley M.; Besenmatter, Werner; Friis, Esben P.; Skjot, Michael; Wilson, Keith S.; Brumer, Harry; Davies, Gideon			Structure and Activity of Paenibacillus polymyxa Xyloglucanase from Glycoside Hydrolase Family 44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDO-TRANSGLYCOSYLASES; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; CELL-WALLS; K-I; PROTEINS; ENDO-BETA-1,4-GLUCANASE; ENDOGLUCANASES; CEL44C-MAN26A; ISOFAGOMINE	The enzymatic degradation of plant polysaccharides is emerging as one of the key environmental goals of the early 21st century, impacting on many processes in the textile and detergent industries as well as biomass conversion to biofuels. One of the well known problems with the use of nonstarch (nonfood)-based substrates such as the plant cell wall is that the cellulose fibers are embedded in a network of diverse polysaccharides, including xyloglucan, that renders access difficult. There is therefore increasing interest in the "accessory enzymes," including xyloglucanases, that may aid biomass degradation through removal of "hemicellulose" polysaccharides. Here, we report the biochemical characterization of the endo-beta-1,4-(xylo)glucan hydrolase from Paenibacillus polymyxa with polymeric, oligomeric, and defined chromogenic aryl-oligosaccharide substrates. The enzyme displays an unusual specificity on defined xyloglucan oligosaccharides, cleaving the XXXG-XXXG repeat into XXX and GXXXG. Kinetic analysis on defined oligosaccharides and on aryl-glycosides suggests that both the -4 and +1 subsites show discrimination against xylose-appended glucosides. The three-dimensional structures of PpXG44 have been solved both in apo-form and as a series of ligand complexes that map the -3 to -1 and +1 to +5 subsites of the extended ligand binding cleft. Complex structures are consistent with partial intolerance of xylosides in the -4' subsites. The atypical specificity of PpXG44 may thus find use in industrial processes involving xyloglucan degradation, such as biomass conversion, or in the emerging exciting applications of defined xyloglucans in food, pharmaceuticals, and cellulose fiber modification.	[Ariza, Antonio; Offen, Wendy A.; Roberts, Shirley M.; Wilson, Keith S.; Davies, Gideon] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Eklof, Jens M.; Spadiut, Oliver; Brumer, Harry] Royal Inst Technol, Sch Biotechnol, Div Glycosci, SE-10691 Stockholm, Sweden; [Spadiut, Oliver; Brumer, Harry] Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10691 Stockholm, Sweden; [Besenmatter, Werner; Friis, Esben P.; Skjot, Michael] Novozymes AS, DK-2880 Bagsvaerd, Denmark	University of York - UK; Royal Institute of Technology; Royal Institute of Technology; Novozymes	Wilson, KS (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	keith@ysbl.york.ac.uk; harry@biotech.kth.se; davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011; Ariza, Antonio/H-7830-2019	Davies, Gideon J/0000-0002-7343-776X; Ariza, Antonio/0000-0003-4364-823X; Wilson, Keith/0000-0002-3581-2194	Biotechnology and Biological Sciences Research Council; Swedish Research Council; Swedish Center for Biomimetic Fiber Engineering (Biomime); Novozymes A/S; Royal Society; Biotechnology and Biological Sciences Research Council [BB/D522511/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Center for Biomimetic Fiber Engineering (Biomime); Novozymes A/S; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the Swedish Research Council, the Swedish Center for Biomimetic Fiber Engineering (Biomime), and by Novozymes A/S. W. B., E. P. S., and M. S. are employed by Novozymes A/S.; Recipient of a Royal Society/Wolfson research merit award. To whom correspondence may be addressed. E-mail: davies@ysbl.york.ac.uk.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Brumer H, 2004, J AM CHEM SOC, V126, P5715, DOI 10.1021/ja0316770; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; Burlingham BT, 2003, J CHEM EDUC, V80, P214, DOI 10.1021/ed080p214; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Cho KM, 2006, APPL MICROBIOL BIOT, V73, P618, DOI 10.1007/s00253-006-0523-2; Cho KM, 2008, BIOTECHNOL LETT, V30, P1061, DOI 10.1007/s10529-008-9640-6; CLAEYSSENS M, 1992, PROTEIN SCI, V1, P1293, DOI 10.1002/pro.5560011008; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hilz H, 2007, CARBOHYD RES, V342, P170, DOI 10.1016/j.carres.2006.12.005; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; Hsieh YSY, 2009, MOL PLANT, V2, P943, DOI 10.1093/mp/ssp061; Ibatullin FM, 2008, BIOCHEMISTRY-US, V47, P7762, DOI 10.1021/bi8009168; Juhasz T, 2005, PROCESS BIOCHEM, V40, P3519, DOI 10.1016/j.procbio.2005.03.057; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar CS, 2008, CRIT REV FOOD SCI, V48, P1, DOI 10.1080/10408390600948600; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Macdonald JM, 2002, AUST J CHEM, V55, P747, DOI 10.1071/CH02165; Maris A, 2011, J EXP BOT, V62, P261, DOI 10.1093/jxb/erq263; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; Meloncelli PJ, 2007, AUST J CHEM, V60, P549, DOI 10.1071/CH07188; Mishra A, 2009, J MATER CHEM, V19, P8528, DOI 10.1039/b911150f; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Nam KH, 2009, BIOCHEM BIOPH RES CO, V383, P183, DOI 10.1016/j.bbrc.2009.03.149; Nishikubo N, 2007, PLANT CELL PHYSIOL, V48, P843, DOI 10.1093/pcp/pcm055; Pauly M, 1999, PLANT J, V20, P629, DOI 10.1046/j.1365-313X.1999.00630.x; Pena MJ, 2008, GLYCOBIOLOGY, V18, P891, DOI 10.1093/glycob/cwn078; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Powlowski J, 2009, CARBOHYD RES, V344, P1175, DOI 10.1016/j.carres.2009.04.020; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; Schnorr K., 2004, U. S. Patent, Patent No. 6815192; Sevcik J, 1998, ACTA CRYSTALLOGR D, V54, P854, DOI 10.1107/S0907444998002005; Sinitsyna OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P41, DOI 10.1134/S0006297910010062; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Vincken JP, 1997, CARBOHYD RES, V298, P299, DOI 10.1016/S0008-6215(96)00325-4; VINCKEN JP, 1994, PLANT PHYSIOL, V104, P99, DOI 10.1104/pp.104.1.99; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warner CD, 2011, ENZYME MICROB TECH, V48, P27, DOI 10.1016/j.enzmictec.2010.08.009; Warner CD, 2010, APPL ENVIRON MICROB, V76, P338, DOI 10.1128/AEM.02026-09; Wong DDWS, 2010, PROTEIN PEPTIDE LETT, V17, P803; Wong DDWS, 2010, APPL MICROBIOL BIOT, V86, P1463, DOI 10.1007/s00253-009-2364-2; Yaoi K, 2005, APPL ENVIRON MICROB, V71, P7670, DOI 10.1128/AEM.71.12.7670-7678.2005; Yaoi K, 2004, STRUCTURE, V12, P1209, DOI 10.1016/j.str.2004.04.020; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; Yaoi K, 2009, FEBS J, V276, P5094, DOI 10.1111/j.1742-4658.2009.07205.x; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	65	29	30	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33890	33900		10.1074/jbc.M111.262345	http://dx.doi.org/10.1074/jbc.M111.262345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795708	Green Published, hybrid			2022-12-27	WOS:000295159200021
J	Schieb, H; Kratzin, H; Jahn, O; Mobius, W; Rabe, S; Staufenbiel, M; Wiltfang, J; Klafki, HW				Schieb, Heinke; Kratzin, Hartmut; Jahn, Olaf; Moebius, Wiebke; Rabe, Sabine; Staufenbiel, Matthias; Wiltfang, Jens; Klafki, Hans W.			beta-Amyloid Peptide Variants in Brains and Cerebrospinal Fluid from Amyloid Precursor Protein (APP) Transgenic Mice COMPARISON WITH HUMAN ALZHEIMER AMYLOID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; AMINO-ACID-SEQUENCE; ELECTROPHORETIC SEPARATION; CELL BIOLOGY; GEL-ELECTROPHORESIS; MOUSE MODELS; TAU TAU; DISEASE; FIBRIL; DEPOSITION	In this study, we report a detailed analysis of the different variants of amyloid-beta (A beta) peptides in the brains and the cerebrospinal fluid from APP23 transgenic mice, expressing amyloid precursor protein with the Swedish familial Alzheimer disease mutation, at different ages. Using one-and two-dimensional gel electrophoresis, immunoblotting, and mass spectrometry, we identified the A beta peptides A beta(1-40), -(1-42), -(1-39), -(1-38), -(1-37), -(2-40), and -(3-40) as well as minor amounts of pyroglutamate-modified A beta (A beta(N3pE)) and endogenous murine A beta in brains from 24-month-old mice. Chemical modifications of the N-terminal amino group of A beta were identified that had clearly been introduced during standard experimental procedures. To address this issue, we additionally applied amyloid extraction in ultrapure water. Clear differences between APP23 mice and Alzheimer disease (AD) brain samples were observed in terms of the relative abundance of specific variants of A beta peptides, such as A beta(N3pE), A beta(1-42), and N-terminally truncated A beta(2/3-42). These differences to human AD amyloid were also noticed in a related mouse line transgenic for human wild type amyloid precursor protein. Taken together, our findings suggest different underlying molecular mechanisms driving the amyloid deposition in transgenic mice and AD patients.	[Klafki, Hans W.] Univ Duisburg Essen, LVR Klinikum, Dept Psychiat & Psychotherapy, D-45147 Essen, Germany; [Kratzin, Hartmut; Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany; [Moebius, Wiebke] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Rabe, Sabine; Staufenbiel, Matthias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland	University of Duisburg Essen; Max Planck Society; Max Planck Society; Novartis	Klafki, HW (corresponding author), Univ Duisburg Essen, Mol Neurobiol Lab, Dept Psychiat & Psychotherapy, LVR Klinikum Essen, Virchowstr 171, D-45147 Essen, Germany.	hans.klafki@uni-due.de	Jahn, Olaf/AAD-8212-2020; Cruz e Silva, Odete/AAH-5595-2020	Jahn, Olaf/0000-0002-3397-8924; /0000-0002-2902-7165; Smirnov, Alexander/0000-0003-1123-1253; Wiltfang, Jens/0000-0003-1492-5330	European Union [LSHM-CT-2007-037950, LSHB-CT-2006-037953]; State Government of North Rhine-Westphalia	European Union(European Commission); State Government of North Rhine-Westphalia	This work was supported by European Union cNEUPRO Contract LSHM-CT-2007-037950, NeuroTAS Contract LSHB-CT-2006-037953, and by Grant PURE (Protein Research Unit Ruhr within Europe) from the State Government of North Rhine-Westphalia.	Andra K, 1996, NEUROBIOL AGING, V17, P183, DOI 10.1016/0197-4580(95)02066-7; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bibl M, 2006, BRAIN, V129, P1177, DOI 10.1093/brain/awl063; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; KLAFKI HW, 1992, BIOCHEMISTRY-US, V31, P3265, DOI 10.1021/bi00127a031; KLAFKI HW, 1993, BIOL CHEM H-S, V374, P1117, DOI 10.1515/bchm3.1993.374.7-12.1117; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lewczuk P, 2004, ELECTROPHORESIS, V25, P3336, DOI 10.1002/elps.200406068; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Lutter P, 2001, ELECTROPHORESIS, V22, P2888, DOI 10.1002/1522-2683(200108)22:14<2888::AID-ELPS2888>3.0.CO;2-C; Maler JM, 2007, PROTEOMICS, V7, P3815, DOI 10.1002/pmic.200700311; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; PRAS M, 1968, J CLIN INVEST, V47, P924; Schaefer H, 2006, BBA-PROTEINS PROTEOM, V1764, P1948, DOI 10.1016/j.bbapap.2006.10.004; Schieb H, 2010, PROTEOMICS, V10, P3539, DOI 10.1002/pmic.201000227; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; SLETTEN K, 1976, BIOCHEM BIOPH RES CO, V69, P19, DOI 10.1016/S0006-291X(76)80266-5; SLETTEN K, 1976, J EXP MED, V143, P993, DOI 10.1084/jem.143.4.993; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Vanderstichele H, 2005, CLIN CHEM, V51, P1650, DOI 10.1373/clinchem.2005.051201; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; WESTERMARK P, 1982, MOL IMMUNOL, V19, P447, DOI 10.1016/0161-5890(82)90210-3; WESTERMARK P, 1982, CLIN EXP IMMUNOL, V49, P725; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; WILTFANG J, 1991, ELECTROPHORESIS, V12, P352, DOI 10.1002/elps.1150120507; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wiltfang J, 2001, J BIOL CHEM, V276, P42645, DOI 10.1074/jbc.M102790200; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	54	46	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33747	33758		10.1074/jbc.M111.246561	http://dx.doi.org/10.1074/jbc.M111.246561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795681	hybrid, Green Published			2022-12-27	WOS:000295159200005
J	Jurgensen, HJ; Madsen, DH; Ingvarsen, S; Melander, MC; Gardsvoll, H; Patthy, L; Engelholm, LH; Behrendt, N				Jurgensen, Henrik J.; Madsen, Daniel H.; Ingvarsen, Signe; Melander, Maria C.; Gardsvoll, Henrik; Patthy, Laszlo; Engelholm, Lars H.; Behrendt, Niels			A Novel Functional Role of Collagen Glycosylation INTERACTION WITH THE ENDOCYTIC COLLAGEN RECEPTOR uPARAP/ENDO180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE MANNOSE RECEPTOR; PLASMINOGEN-ACTIVATOR RECEPTOR; GLUCOSYL-GALACTOSYL-PYRIDINOLINE; LYSYL HYDROXYLASE 3; UROKINASE RECEPTOR; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; TRANSMEMBRANE GLYCOPROTEIN; ENDOCYTIC RECEPTOR; LECTIN RECEPTOR	Collagens make up the most abundant component of interstitial extracellular matrices and basement membranes. Collagen remodeling is a crucial process in many normal physiological events and in several pathological conditions. Some collagen subtypes contain specific carbohydrate side chains, the function of which is poorly known. The endocytic collagen receptor urokinase plasminogen activator receptor-associated protein (uPARAP)/Endo180 plays an important role in matrix remodeling through its ability to internalize collagen for lysosomal degradation. uPARAP/Endo180 is a member of the mannose receptor protein family. These proteins all include a fibronectin type II domain and a series of C-type lectin-like domains, of which only a minor part possess carbohydrate recognition activity. At least two of the family members, uPARAP/Endo180 and the mannose receptor, interact with collagens. The molecular basis for this interaction is known to involve the fibronectin type II domain but nothing is known about the function of the lectin domains in this respect. In this study, we have investigated a possible role of the single active lectin domain of uPARAP/Endo180 in the interaction with collagens. By expressing truncated recombinant uPARAP/Endo180 proteins and analyzing their interaction with collagens with high and low levels of glycosylation we demonstrated that this lectin domain interacts directly with glycosylated collagens. This interaction is functionally important because it was found to modulate the endocytic efficiency of the receptor toward highly glycosylated collagens such as basement membrane collagen IV. Surprisingly, this property was not shared by the mannose receptor, which internalized glycosylated collagens independently of its lectin function. This role of modulating its uptake efficiency by a specific receptor is a previously unrecognized function of collagen glycosylation.	[Behrendt, Niels] Rigshosp, BRIC, Finsen Lab, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark; [Jurgensen, Henrik J.; Madsen, Daniel H.; Ingvarsen, Signe; Melander, Maria C.; Gardsvoll, Henrik; Engelholm, Lars H.; Behrendt, Niels] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Ingvarsen, Signe] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Patthy, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Rigshospitalet; University of Copenhagen; University of Copenhagen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Behrendt, N (corresponding author), Rigshosp, BRIC, Finsen Lab, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	niels.behrendt@finsenlab.dk	Patthy, Laszlo/A-2353-2013; Patthy, Laszlo/Q-6058-2019; Ingvarsen, Signe Ziir/AAT-3296-2020	Ingvarsen, Signe Ziir/0000-0001-7800-6443; Behrendt, Niels/0000-0003-1833-3922; Engelholm, Lars/0000-0002-6616-1232; Madsen, Daniel Hargboel/0000-0002-3183-6201	Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Lundbeck Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation [R67-2010-6200] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Cancer Society, Danish Medical Research Council, Danish Cancer Research Foundation, Lundbeck Foundation, Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer), European Community's Seventh Framework Programme FP7/2007-2011 under Grant agreement 201279 (to N. B.), grants from the "Grosserer Alfred Nielsen og Hustrus" foundation (to L. H. E.), the Copenhagen University Hospital (to D. H. M. and H. J. J.), and the University of Copenhagen, Faculty of Science (to S. I.).	AGUILAR JH, 1973, J BIOL CHEM, V248, P5106; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; Brinckmann J, 1999, J INVEST DERMATOL, V113, P617, DOI 10.1046/j.1523-1747.1999.00735.x; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Gardsvoll H, 2007, PROTEIN EXPRES PURIF, V52, P384, DOI 10.1016/j.pep.2006.11.013; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P21, DOI 10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gineyts E, 2001, RHEUMATOLOGY, V40, P315, DOI 10.1093/rheumatology/40.3.315; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-9; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x; HONG BS, 1979, BIOCHEMISTRY-US, V18, P4278, DOI 10.1021/bi00587a003; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; Howard MJ, 2004, OSTEOARTHR CARTILAGE, V12, P74, DOI 10.1016/j.joca.2003.07.001; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mousavi SA, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-39; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rasch MG, 2008, J IMMUNOL METHODS, V339, P55, DOI 10.1016/j.jim.2008.08.002; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; SAGE H, 1979, J BIOL CHEM, V254, P9893; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Sheikh H, 2000, J CELL SCI, V113, P1021; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Smith L, 2008, GENE EXPR PATTERNS, V8, P486, DOI 10.1016/j.gep.2008.06.006; Song FY, 2006, FRONT BIOSCI-LANDMRK, V11, P3100, DOI 10.2741/2036; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Takahashi S, 2011, J NEURO-ONCOL, V103, P267, DOI 10.1007/s11060-010-0398-z; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Thomas EK, 2005, J BIOL CHEM, V280, P22596, DOI 10.1074/jbc.M501155200; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; WATTS C, 1992, J CELL SCI, V103, P1; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323	71	62	65	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32736	32748		10.1074/jbc.M111.266692	http://dx.doi.org/10.1074/jbc.M111.266692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768090	hybrid, Green Published			2022-12-27	WOS:000294726800082
J	Maruyama, S; Shibata, R; Ohashi, K; Ohashi, T; Daida, H; Walsh, K; Murohara, T; Ouchi, N				Maruyama, Sonomi; Shibata, Rei; Ohashi, Koji; Ohashi, Taiki; Daida, Hiroyuki; Walsh, Kenneth; Murohara, Toyoaki; Ouchi, Noriyuki			Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CARDIAC MYOCYTE SURVIVAL; SPHINGOSINE 1-PHOSPHATE; MYOCARDIAL ISCHEMIA/REPERFUSION; CARDIOVASCULAR-DISEASE; INDUCED CARDIOMYOPATHY; ADIPOSE-TISSUE; APOPTOSIS; MICE; RECEPTORS	Accumulating evidence shows that obesity is associated with doxorubicin cardiac toxicity in the heart, but the molecular mechanisms that contribute to this pathological response are not understood. Adiponectin is an adipose-derived, cardioprotective factor that is down-regulated in obesity. Here, we investigated the effect of adiponectin on doxorubicin (DOX)-induced cardiotoxicity and assessed the mechanisms of this effect. A single dose of DOX was intraperitoneally injected into the abdomen of adiponectin knock-out (APN-KO) and wild-type (WT) mice. APN-KO mice had increased mortality and exacerbated contractile dysfunction of left ventricle compared with WT mice. APN-KO mice also showed increased apoptotic activity and diminished Akt signaling in the failing myocardium. Systemic delivery of adenoviral vector expressing adiponectin improved left ventricle dysfunction and myocardial apoptosis following DOX injection in WT and APN-KO mice but not in Akt1 heterozygous KO mice. In cultured rat neonatal cardiomyocytes, adiponectin stimulated Akt phosphorylation and inhibited DOX-stimulated apoptosis. Treatment with sphingosine kinase-1 inhibitor or sphingosine 1-phosphate receptor antagonist diminished adiponectin-induced Akt phosphorylation and reversed the inhibitory effects of adiponectin on myocyte apoptosis. Pretreatment with anti-calreticulin antibody reduced the binding of adiponectin to cardiac myocytes and blocked the adiponectin-stimulated increase in Akt activation and survival in cardiomyocytes. Interference of the LRP1/calreticulin co-receptor system by siRNA or blocking antibodies diminished the stimulatory actions of adiponectin on Akt activation and myocyte survival. These data show that adiponectin protects against DOX-induced cardiotoxicity by its ability to promote Akt signaling.	[Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Maruyama, Sonomi; Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 1138421, Japan; [Walsh, Kenneth] Boston Univ, Sch Med, Boston, MA 02118 USA	Nagoya University; Nagoya University; Juntendo University; Boston University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014		Uehara Memorial Foundation; Japan Heart Foundation/Novartis; NATIONAL INSTITUTE ON AGING [R37AG015052] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by a grant-in-aid for young scientists B, the Uehara Memorial Foundation, and the Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology 2011 (to R. S.).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arola OJ, 2000, CANCER RES, V60, P1789; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; de Azambuja E, 2010, BREAST CANCER RES TR, V119, P145, DOI 10.1007/s10549-009-0512-0; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Ikeda Y, 2008, FEBS LETT, V582, P1147, DOI 10.1016/j.febslet.2008.03.002; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kondo K, 2010, CIRC-CARDIOVASC INTE, V3, P166, DOI 10.1161/CIRCINTERVENTIONS.109.872044; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mitra MS, 2008, TOXICOL APPL PHARM, V231, P413, DOI 10.1016/j.taap.2008.05.006; Mitra MS, 2007, TOXICOL APPL PHARM, V225, P90, DOI 10.1016/j.taap.2007.07.018; Negoro S, 2001, CIRCULATION, V103, P555, DOI 10.1161/01.CIR.103.4.555; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Weinstein DM, 2000, J PHARMACOL EXP THER, V294, P396; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang JQ, 2007, AM J PHYSIOL-HEART C, V293, pH3150, DOI 10.1152/ajpheart.00587.2006	44	69	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32790	32800		10.1074/jbc.M111.245985	http://dx.doi.org/10.1074/jbc.M111.245985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784858	hybrid, Green Published			2022-12-27	WOS:000294726800086
J	Szeto, MD; Boissel, SJS; Baker, D; Thyme, SB				Szeto, Mindy D.; Boissel, Sandrine J. S.; Baker, David; Thyme, Summer B.			Mining Endonuclease Cleavage Determinants in Genomic Sequence Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL HOMING ENDONUCLEASE; GROUP-I INTRON; DNA; SPECIFICITY; BINDING; RECOGNITION; EVOLUTION; DESIGN	Homing endonucleases have great potential as tools for targeted gene therapy and gene correction, but identifying variants of these enzymes capable of cleaving specific DNA targets of interest is necessary before the widespread use of such technologies is possible. We identified homologues of the LAGLIDADG homing endonuclease I-AniI and their putative target insertion sites by BLAST searches followed by examination of the sequences of the flanking genomic regions. Amino acid substitutions in these homologues that were located close to the target site DNA, and thus potentially conferring differences in target specificity, were grafted onto the I-AniI scaffold. Many of these grafts exhibited novel and unexpected specificities. These findings show that the information present in genomic data can be exploited for endonuclease specificity redesign.	[Szeto, Mindy D.; Boissel, Sandrine J. S.; Baker, David; Thyme, Summer B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Thyme, Summer B.] Univ Washington, Dept Biomol Struct & Design, Seattle, WA 98195 USA; [Boissel, Sandrine J. S.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Thyme, SB (corresponding author), Box 357350, Seattle, WA 98195 USA.	sthyme@u.washington.edu	Baker, David/K-8941-2012; Szeto, Mindy/GPP-5886-2022	Baker, David/0000-0001-7896-6217; Thyme, Summer/0000-0003-3593-4148; Szeto, Mindy/0000-0003-3642-3753	National Institutes of Health [GM084433, RL1CA133832]; Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [RL1CA133832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084433 and RL1CA133832, the Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative, and the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Barzel A., 2011, NUCL ACIDS IN PRESS; Becker NB, 2006, NUCLEIC ACIDS RES, V34, P5638, DOI 10.1093/nar/gkl683; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Bolduc JM, 2003, GENE DEV, V17, P2875, DOI 10.1101/gad.1109003; Chevalier B, 2005, NUCL ACID M, V16, P33; Chevalier B, 2003, J MOL BIOL, V329, P253, DOI 10.1016/S0022-2836(03)00447-9; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Gimble FS, 2001, NUCLEIC ACIDS RES, V29, P4215, DOI 10.1093/nar/29.20.4215; Grishin Alexander, 2010, Journal of Bioinformatics and Computational Biology, V8, P453, DOI 10.1142/S0219720010004665; Ho Y, 1997, P NATL ACAD SCI USA, V94, P8994, DOI 10.1073/pnas.94.17.8994; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Longo A, 2005, NAT STRUCT MOL BIOL, V12, P779, DOI 10.1038/nsmb976; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeuchi R, 2009, NUCLEIC ACIDS RES, V37, P877, DOI 10.1093/nar/gkn1007; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022	33	15	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32617	32627		10.1074/jbc.M111.259572	http://dx.doi.org/10.1074/jbc.M111.259572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778233	Green Published, hybrid			2022-12-27	WOS:000294726800071
J	Walsh, JG; Logue, SE; Luthi, AU; Martin, SJ				Walsh, John G.; Logue, Susan E.; Luethi, Alexander U.; Martin, Seamus J.			Caspase-1 Promiscuity Is Counterbalanced by Rapid Inactivation of Processed Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; NF-KAPPA-B; INFLAMMATORY CASPASES; ACTIVATION; PROTEIN; APOPTOSIS; SUBSTRATE; FORMS; SPECIFICITIES; PROTEASES	Members of the caspase family of cysteine proteases coordinate the highly disparate processes of apoptosis and inflammation. However, although hundreds of substrates for the apoptosis effector caspases (caspase-3 and caspase-7) have been identified, only two confirmed substrates for the key inflammatory protease (caspase-1) are known. Whether this reflects intrinsic differences in the substrate specificity of inflammatory versus apoptotic caspases or their relative abundance in vivo is unknown. To address this issue, we have compared the specificity of caspases-1, -3, and -7 toward peptide and protein substrates. Contrary to expectation, caspase-1 displayed concentration-dependent promiscuity toward a variety of substrates, suggesting that caspase-1 specificity is maintained by restricting its abundance. Although endogenous concentrations of caspase-1 were found to be similar to caspase-3, processed caspase-1 was found to be much more labile, with a half-life of similar to 9 min. This contrasted sharply with the active forms of caspase-3 and caspase-7, which exhibited half-lives of 8 and 11 h, respectively. We propose that the high degree of substrate specificity displayed by caspase-1 is maintained through rapid spontaneous inactivation of this protease.	[Walsh, John G.; Logue, Susan E.; Luethi, Alexander U.; Martin, Seamus J.] Trinity Coll Dublin, Dept Genet, Smurfit Inst, Mol Cell Biol Lab, Dublin 2, Ireland	Trinity College Dublin	Martin, SJ (corresponding author), Trinity Coll Dublin, Dept Genet, Smurfit Inst, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Logue, Susan/G-3002-2010; Logue, Susan/K-7748-2019	Logue, Susan/0000-0001-7938-3558; Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [07/SRC/B1144, 08/IN.1/B2031]; Wellcome Trust United Kingdom [082749]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust United Kingdom(Wellcome Trust)	This work was supported by Strategic Research Cluster and Principal Investigator grants from the Science Foundation Ireland (07/SRC/B1144 and 08/IN.1/B2031) and The Wellcome Trust United Kingdom (082749).	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brodbeck WG, 1996, J IMMUNOL, V156, P2528; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Dang LC, 1996, BIOCHEMISTRY-US, V35, P14910, DOI 10.1021/bi9617771; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kahns S, 2003, J BIOL CHEM, V278, P23376, DOI 10.1074/jbc.M300495200; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talanian RV, 1996, J BIOL CHEM, V271, P21853, DOI 10.1074/jbc.271.36.21853; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	34	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32513	32524		10.1074/jbc.M111.225862	http://dx.doi.org/10.1074/jbc.M111.225862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757759	Green Published, hybrid			2022-12-27	WOS:000294726800061
J	Li, G; Deng, XY; Wu, C; Zhou, Q; Chen, LJ; Shi, Y; Huang, HS; Zhou, NM				Li, Guo; Deng, Xiaoyan; Wu, Chun; Zhou, Qi; Chen, Linjie; Shi, Ying; Huang, Haishan; Zhou, Naiming			Distinct Kinetic and Spatial Patterns of Protein Kinase C (PKC)- and Epidermal Growth Factor Receptor (EGFR)-dependent Activation of Extracellular Signal-regulated Kinases 1 and 2 by Human Nicotinic Acid Receptor GPR109A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; COUPLED RECEPTORS; MOLECULAR-IDENTIFICATION; BETA-ARRESTIN; PATHWAY; NIACIN; ERK1/2; ALPHA; GAMMA; TRANSACTIVATION	Nicotinic acid (niacin) has been widely used as a lipid-lowering drug for several decades, and recently, orphan G protein-coupled receptor GPR109A has been identified as a receptor for niacin. Mechanistic investigations have shown that, upon niacin activation, GPR109A couples to a G(i) protein and inhibits adenylate cyclase activity, leading to inhibition of liberation of free fatty acid. However, the underlying molecular mechanisms for GPR109A signaling remain largely unknown. Using CHO-K1 cells stably expressing GPR109A and A431 cells, which are a human epidermoid cell line with high levels of endogenous expression of functional GPR109A receptors, we found that activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) by niacin was rapid, peaking at 5 min, and was significantly blocked by pertussis toxin. Furthermore, time course experiments with different kinase inhibitors demonstrated that GPR109A induced ERK1/2 activation via the matrix metalloproteinase/epidermal growth factor receptor transactivation pathway at both early and later time points (2-5 min); this pathway was distinct from the PKC pathway-mediated ERK1/2 phosphorylation that occurs at early time points (<= 2 min) in response to niacin. Overexpression of G beta gamma subunit scavengers beta ARK1-CT and the G alpha subunit of transducin led to a significant reduction of ERK1/2 phosphorylation, suggesting a critical role for beta gamma subunits in GPR109A-activated ERK1/2 phosphorylation. Using arrestin-2/3-specific siRNA and an internalization-deficient GPR109A mutant, we found that arrestin-2 and arrestin-3 were not involved in GPR109A-mediated ERK1/2 activation. In conclusion, our findings demonstrate that upon binding to niacin GPR109A receptors initially activate G(i), leading to dissociation of the G beta gamma subunit from activated G(i), and subsequently induce ERK1/2 activation via two distinct pathways, one PKC-dependent pathway occurring at a peak time of <= 2 min and the other matrix metalloproteinase-dependent growth factor receptor trans-activation occurring at both early and later time points (2-5 min).	[Li, Guo; Deng, Xiaoyan; Wu, Chun; Zhou, Qi; Chen, Linjie; Shi, Ying; Huang, Haishan; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus,388 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022	Wu, Chun/0000-0003-2858-8064	Ministry of Science and Technology [2008AA02Z138]; Zhejiang Natural Science Foundation [Z2080207]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by Ministry of Science and Technology Grant 2008AA02Z138 and Zhejiang Natural Science Foundation Grant Z2080207.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Antonelli V, 2000, MOL BIOL CELL, V11, P1129, DOI 10.1091/mbc.11.4.1129; Assefa Z, 1999, BIOCHEM BIOPH RES CO, V261, P641, DOI 10.1006/bbrc.1999.1090; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; Bodor ET, 2008, BRIT J PHARMACOL, V153, pS68, DOI 10.1038/sj.bjp.0707528; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; FAURE M, 1994, J BIOL CHEM, V269, P7851; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gripentrog JM, 2005, CELL SIGNAL, V17, P1300, DOI 10.1016/j.cellsig.2005.01.006; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Guyton JR, 2007, CURR OPIN LIPIDOL, V18, P415, DOI 10.1097/MOL.0b013e3282364add; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; HUNNINGHAKE DB, 1985, CLIN PHARMACOL THER, V38, P313, DOI 10.1038/clpt.1985.177; Kamanna VS, 2007, AM J CARDIOL, V100, p53N, DOI 10.1016/j.amjcard.2007.09.080; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kranenburg O, 1997, EMBO J, V16, P3097, DOI 10.1093/emboj/16.11.3097; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; MACK WJ, 1993, STROKE, V24, P1779, DOI 10.1161/01.STR.24.12.1779; Mahboubi K, 2006, BIOCHEM BIOPH RES CO, V340, P482, DOI 10.1016/j.bbrc.2005.12.022; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Meyers CD, 2007, ATHEROSCLEROSIS, V192, P253, DOI 10.1016/j.atherosclerosis.2006.07.014; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NIKKILA EA, 1984, BMJ-BRIT MED J, V289, P220, DOI 10.1136/bmj.289.6439.220; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pritzker LB, 1998, CRIT REV CL LAB SCI, V35, P603, DOI 10.1080/10408369891234291; Ptasznik Andrzej, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P27; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; Semple G, 2008, J MED CHEM, V51, P5101, DOI 10.1021/jm800258p; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shah BH, 2003, J BIOL CHEM, V278, P19118, DOI 10.1074/jbc.M212932200; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Tang YT, 2006, BIOCHEM BIOPH RES CO, V345, P29, DOI 10.1016/j.bbrc.2006.04.051; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van Herk T, 2003, J MED CHEM, V46, P3945, DOI 10.1021/jm030888c; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141; Zhou LB, 2007, MOL CELL BIOCHEM, V294, P243, DOI 10.1007/s11010-006-9150-6	59	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31199	31212		10.1074/jbc.M111.241372	http://dx.doi.org/10.1074/jbc.M111.241372			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768093	Green Published, hybrid			2022-12-27	WOS:000294487500015
J	Zhu, QB; Sun, WY; Okano, K; Chen, Y; Zhang, N; Maeda, T; Palczewski, K				Zhu, Qubo; Sun, Wenyu; Okano, Kiichiro; Chen, Yu; Zhang, Ning; Maeda, Tadao; Palczewski, Krzysztof			Sponge Transgenic Mouse Model Reveals Important Roles for the MicroRNA-183 (miR-183)/96/182 Cluster in Postmitotic Photoreceptors of the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN RETINA; KNOCKOUT MOUSE; LIGHT DAMAGE; CELL-DEATH; SMALL RNAS; IN-VIVO; DEGENERATION; IDENTIFICATION; APOPTOSIS; CASPASE-3	MicroRNA-183 (miR-183), miR-96, and miR-182 comprising the miR-183/96/182 cluster are highly expressed in photoreceptor cells. Although in vitro data have indicated an important role for this cluster in the retina, details of its in vivo biological activity are still unknown. To observe the impact of the miR-183/96/182 cluster on retinal maintenance and light adaptation, we generated a sponge transgenic mouse model that disrupted the activities of the three-component microRNAs simultaneously and selectively in the retina. Although our morphological and functional studies showed no differences between transgenic and wild type mice under normal laboratory lighting conditions, sponge transgenic mice displayed severe retinal degeneration after 30 min of exposure to 10,000 lux light. Histological studies showed that the outer nuclear layer thickness was dramatically reduced in the superior retina of transgenic mice. Real time PCR experiments in both the sponge transgenic mouse model and different microRNA stable cell lines identified Arrdc3, Neurod4, and caspase-2 (Casp2) as probable downstream targets of this cluster, a result also supported by luciferase assay and immuno-blotting analyses. Further studies indicated that expression of both the cluster and Casp2 increased in response to light exposure. Importantly, Casp2 expression was enhanced in transgenic mice, and inhibition of Casp2 partially rescued their light-induced retinal degeneration. By connecting the microRNA and apoptotic pathways, these findings imply an important role for the miR-183/96/182 cluster in acute light-induced retinal degeneration of mice. This study demonstrates a clear involvement of miRs in the physiology of postmitotic cells in vivo.	[Zhu, Qubo; Okano, Kiichiro; Chen, Yu; Zhang, Ning; Maeda, Tadao; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Sun, Wenyu] Polgenix Inc, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Zhu, Qubo/ACT-7180-2022	Zhu, Qubo/0000-0001-5202-7887	National Institutes of Health [EY008061, K08EY019880]; NATIONAL EYE INSTITUTE [R01EY008061, K08EY019880, R29EY008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and K08EY019880.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bode C, 2003, MOL VIS, V9, P144; Chahory S, 2010, NEUROCHEM INT, V57, P278, DOI 10.1016/j.neuint.2010.06.006; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Hahn P, 2004, CELL DEATH DIFFER, V11, P1192, DOI 10.1038/sj.cdd.4401486; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Jin ZB, 2009, MOL VIS, V15, P523; Jomary C, 2006, INVEST OPHTH VIS SCI, V47, P1620, DOI 10.1167/iovs.05-1176; Jomary C, 2001, MOL CELL NEUROSCI, V18, P335, DOI 10.1006/mcne.2001.1036; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P1802; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liu CD, 1999, J NEUROSCI, V19, P4778; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luo Y, 2009, GENE, V428, P41, DOI 10.1016/j.gene.2008.09.022; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; MUSTAFI D, 2011, FASEB J IN PRESS; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Perche O, 2007, INVEST OPHTH VIS SCI, V48, P2753, DOI 10.1167/iovs.06-1258; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Rodieck RW, 1998, 1 STEPS SEEING, P38; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; Zhang C, 2004, INVEST OPHTH VIS SCI, V45, P2753, DOI 10.1167/iovs.03-1344; Zhu YA, 2010, MOL VIS, V16, P740	47	98	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31749	31760		10.1074/jbc.M111.259028	http://dx.doi.org/10.1074/jbc.M111.259028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768104	Green Published, hybrid			2022-12-27	WOS:000294487500068
J	Hirschler-Laszkiewicz, I; Tong, Q; Waybill, K; Conrad, K; Keefer, K; Zhang, WY; Chen, SJ; Cheung, JY; Miller, BA				Hirschler-Laszkiewicz, Iwona; Tong, Qin; Waybill, Kathleen; Conrad, Kathleen; Keefer, Kerry; Zhang, Wenyi; Chen, Shu-jen; Cheung, Joseph Y.; Miller, Barbara A.			The Transient Receptor Potential (TRP) Channel TRPC3 TRP Domain and AMP-activated Protein Kinase Binding Site Are Required for TRPC3 Activation by Erythropoietin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; FREE CALCIUM-CONCENTRATION; NUCLEOTIDE-GATED CHANNELS; CARDIAC-HYPERTROPHY; HUMAN ERYTHROBLASTS; SURFACE EXPRESSION; OXIDATIVE-STRESS; PHOSPHOLIPASE-C; ION CHANNELS; CA2+ INFLUX	Modulation of intracellular calcium ([Ca2+](i)) by erythropoietin (Epo) is an important signaling pathway controlling erythroid proliferation and differentiation. Transient receptor potential (TRP) channels TRPC3 and homologous TRPC6 are expressed on normal human erythroid precursors, but Epo stimulates an increase in [Ca2+](i) through TRPC3 but not TRPC6. Here, the role of specific domains in the different responsiveness of TRPC3 and TRPC6 to erythropoietin was explored. TRPC3 and TRPC6 TRP domains differ in seven amino acids. Substitution of five amino acids (DDKPS) in the TRPC3 TRP domain with those of TRPC6 (EERVN) abolished the Epo-stimulated increase in [Ca2+](i). Substitution of EERVN in TRPC6 TRP domain with DDKPS in TRPC3 did not confer Epo responsiveness. However, substitution of TRPC6 TRP with DDKPS from TRPC3 TRP, as well as swapping the TRPC6 distal C terminus (C2) with that of TRPC3, resulted in a chimeric TRPC6 channel with Epo responsiveness similar to TRPC3. Substitution of TRPC6 with TRPC3 TRP and the putative TRPC3 C-terminal AMP-activated protein kinase (AMPK) binding site straddling TRPC3 C1/C2 also resulted in TRPC6 activation. In contrast, substitution of the TRPC3 C-terminal leucine zipper motif or TRPC3 phosphorylation sites Ser-681, Ser-708, or Ser-764 with TRPC6 sequence did not affect TRPC3 Epo responsiveness. TRPC3, but not TRPC6, and TRPC6 chimeras expressing TRPC3 C2 showed significantly increased plasma membrane insertion following Epo stimulation and substantial cytoskeletal association. The TRPC3 TRP domain, distal C terminus (C2), and AMPK binding site are critical elements that confer Epo responsiveness. In particular, the TRPC3 C2 and AMPK site are essential for association of TRPC3 with the cytoskeleton and increased channel translocation to the cell surface in response to Epo stimulation.	[Miller, Barbara A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Cheung, Joseph Y.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Jefferson University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu			National Institutes of Health [R01 DK46778, R01 HL58672, R01 HL74854]; Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL058672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK46778 (to B. A. M.) and R01 HL58672 and R01 HL74854 (to J. Y. C.). This work was also supported by the Four Diamonds Fund of the Pennsylvania State University College of Medicine.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Bomben VC, 2008, CELL PROLIFERAT, V41, P98, DOI 10.1111/j.1365-2184.2007.00504.x; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; CHEUNG JY, 1992, J CLIN INVEST, V90, P1850, DOI 10.1172/JCI116061; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chu X, 2004, J BIOL CHEM, V279, P10514, DOI 10.1074/jbc.M308478200; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; GILLO B, 1993, BLOOD, V81, P783; Glitsch MD, 2010, FASEB J, V24, P318, DOI 10.1096/fj.09-134973; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Goel M, 2010, AM J PHYSIOL-RENAL, V298, pF988, DOI 10.1152/ajprenal.00586.2009; Goswami C, 2008, FEBS J, V275, P4684, DOI 10.1111/j.1742-4658.2008.06617.x; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; HENSOLD JO, 1991, BLOOD, V77, P1362; Hirschler-Laszkiewicz I, 2009, J BIOL CHEM, V284, P4567, DOI 10.1074/jbc.M804734200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Ko Kyung Dae, 2009, Commun Integr Biol, V2, P133; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; LEVENSON R, 1980, P NATL ACAD SCI-BIOL, V77, P5948, DOI 10.1073/pnas.77.10.5948; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; MILLER BA, 1989, BLOOD, V73, P1188; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; MILLER BA, 1988, J CLIN INVEST, V82, P309, DOI 10.1172/JCI113588; MISITI J, 1979, J CLIN INVEST, V64, P1573, DOI 10.1172/JCI109618; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Ribelayga C, 2010, CURR BIOL, V20, pR278, DOI 10.1016/j.cub.2010.02.012; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sharif-Naeini R, 2010, J MOL CELL CARDIOL, V48, P83, DOI 10.1016/j.yjmcc.2009.03.020; Sims B, 2010, BRAIN RES, V1321, P88, DOI 10.1016/j.brainres.2010.01.040; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tong Q, 2004, AM J PHYSIOL-CELL PH, V287, pC1667, DOI 10.1152/ajpcell.00265.2004; Tong Q, 2008, J BIOL CHEM, V283, P10385, DOI 10.1074/jbc.M710231200; Trebak M, 2010, PFLUG ARCH EUR J PHY, V459, P369, DOI 10.1007/s00424-009-0740-5; Tu P, 2010, J NEUROCHEM, V112, P204, DOI 10.1111/j.1471-4159.2009.06446.x; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	72	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30636	30646		10.1074/jbc.M111.238360	http://dx.doi.org/10.1074/jbc.M111.238360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757714	Green Published, hybrid			2022-12-27	WOS:000294283600043
J	Gallo, LI; Lagadari, M; Piwien-Pilipuk, G; Galigniana, MD				Gallo, Luciana I.; Lagadari, Mariana; Piwien-Pilipuk, Graciela; Galigniana, Mario D.			The 90-kDa Heat-shock Protein (Hsp90)-binding Immunophilin FKBP51 Is a Mitochondrial Protein That Translocates to the Nucleus to Protect Cells against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYLPROLYL ISOMERASE DOMAIN; GLUCOCORTICOID-RECEPTOR; HSP90-BINDING IMMUNOPHILINS; TETRATRICOPEPTIDE REPEATS; MINERALOCORTICOID RECEPTOR; CYTOPLASMIC DYNEIN; IN-VIVO; HSP90; COMPLEXES; CHAPERONES	Confocal microscopy images revealed that the tetratricopeptide repeat motif (TPR) domain immunophilin FKBP51 shows colocalization with the specific mitochondrial marker MitoTracker. Signal specificity was tested with different antibodies and by FKBP51 knockdown. This unexpected subcellular localization of FKBP51 was confirmed by colocalization studies with other mitochondrial proteins, biochemical fractionation, and electron microscopy imaging. Interestingly, FKBP51 forms complexes in mitochondria with the glucocorticoid receptor and the Hsp90/Hsp70-based chaperone heterocomplex. Although Hsp90 inhibitors favor FKBP51 translocation from mitochondria to the nucleus in a reversible manner, TPR domain-deficient mutants of FKBP51 are constitutively nuclear and fully excluded from mitochondria, suggesting that a functional TPR domain is required for its mitochondrial localization. FKBP51 overexpression protects cells against oxidative stress, whereas FKBP51 knockdown makes them more sensitive to injury. In summary, this is the first demonstration that FKBP51 is a major mitochondrial factor that undergoes nuclear-mitochondrial shuttling, an observation that may be related to antiapoptotic mechanisms triggered during the stress response.	[Gallo, Luciana I.; Lagadari, Mariana; Piwien-Pilipuk, Graciela; Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn, IBYME, Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina; [Galigniana, Mario D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Galigniana, MD (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	mgali@qb.fcen.uba	Lagadari, Mariana/ABE-2248-2021; Gallo, Luciana I/S-4451-2019	Lagadari, Mariana/0000-0002-9355-1439; Gallo, Luciana I./0000-0001-7050-0121; GALIGNIANA, MARIO/0000-0002-9130-8574	Guggenheim Foundation; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica ProyectoS de Investigacion Cientifica y Tecnologica (ANPCyT PICT) [2010-1170]; National Institutes of Health [R03TW008143-01A1]; ANPCyT [PICT 2007-00640]; FOGARTY INTERNATIONAL CENTER [R03TW008143] Funding Source: NIH RePORTER	Guggenheim Foundation; Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica ProyectoS de Investigacion Cientifica y Tecnologica (ANPCyT PICT)(ANPCyT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANPCyT(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants from the Guggenheim Foundation, Universidad de Buenos Aires (UBACyT Program), and Agencia Nacional de Promocion Cientifica y Tecnologica ProyectoS de Investigacion Cientifica y Tecnologica (ANPCyT PICT) 2010-1170 (to M. D. G.) and by National Institutes of Health Fogarty International Research Collaboration Award (FIRCA) Award R03TW008143-01A1 and ANPCyT PICT 2007-00640 (to G. P. P.).	Aviezer-Hagai K, 2007, PLANT MOL BIOL, V63, P237, DOI 10.1007/s11103-006-9085-z; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Colo GP, 2008, ONCOGENE, V27, P2430, DOI 10.1038/sj.onc.1210900; Cox M.B., 2006, NETWORKING CHAPERONE, P13; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; DEMONACOS C, 1993, J STEROID BIOCHEM, V46, P401, DOI 10.1016/0960-0760(93)90231-K; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; EVANSSTORMS RB, 1995, J STEROID BIOCHEM, V53, P1, DOI 10.1016/0960-0760(95)00034-W; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2004, J BIOL CHEM, V279, P55754, DOI 10.1074/jbc.M406259200; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Galigniana MD, 2004, MOL BRAIN RES, V123, P27, DOI 10.1016/j.molbrainres.2003.12.015; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; Galigniana MD, 1999, J BIOL CHEM, V274, P16222, DOI 10.1074/jbc.274.23.16222; Galigniana MD, 1998, BIOCHEM J, V333, P555, DOI 10.1042/bj3330555; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Giordano A, 2006, AM J PHYSIOL-HEART C, V290, pH2459, DOI 10.1152/ajpheart.00750.2005; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Mukhopadhyay A, 2002, ARCH BIOCHEM BIOPHYS, V400, P97, DOI 10.1006/abbi.2002.2777; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Quinta HR, 2010, J NEUROCHEM, V115, P716, DOI 10.1111/j.1471-4159.2010.06970.x; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; SIVILS JC, 2011, TOP PHARM IN PRESS, V11; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Zhao WH, 2006, VIROLOGY, V353, P283, DOI 10.1016/j.virol.2006.04.042	58	73	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30152	30160		10.1074/jbc.M111.256610	http://dx.doi.org/10.1074/jbc.M111.256610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730050	Green Published, hybrid			2022-12-27	WOS:000294046600072
J	Ida-Eto, M; Ohgami, N; Iida, M; Yajima, I; Kumasaka, MY; Takaiwa, K; Kimitsuki, T; Sone, M; Nakashima, T; Tsuzuki, T; Komune, S; Yanagisawa, M; Kato, M				Ida-Eto, Michiru; Ohgami, Nobutaka; Iida, Machiko; Yajima, Ichiro; Kumasaka, Mayuko Y.; Takaiwa, Kazutaka; Kimitsuki, Takashi; Sone, Michihiko; Nakashima, Tsutomu; Tsuzuki, Toyonori; Komune, Shizuo; Yanagisawa, Masashi; Kato, Masashi			Partial Requirement of Endothelin Receptor B in Spiral Ganglion Neurons for Postnatal Development of Hearing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAARDENBURG-HIRSCHSPRUNG-DISEASE; PRIMARY AUDITORY NEURONS; ENTERIC NERVOUS-SYSTEM; STRIA VASCULARIS; MOUSE MODEL; COAT COLOR; INNER-EAR; MICE; GENE; MUTATION	Impairments of endothelin receptor B (Ednrb/EDNRB) cause the development of Waardenburg-Shah syndrome with congenital hearing loss, hypopigmentation, and megacolon disease in mice and humans. Hearing loss in WaardenburgShah syndrome has been thought to be caused by an Ednrbmediated congenital defect of melanocytes in the stria vascularis (SV) of inner ears. Here we show that Ednrb expressed in spiral ganglion neurons (SGNs) in inner ears is required for postnatal development of hearing in mice. Ednrb protein was expressed in SGNs from WT mice on postnatal day 19 (P19), whereas it was undetectable in SGNs from WT mice on P3. Correspondingly, Ednrb homozygously deleted mice (Ednrb(-/-) mice) with congenital hearing loss showed degeneration of SGNs on P19 but not on P3. The congenital hearing loss involving neurodegeneration of SGNs as well as megacolon disease in Ednrb(-/-) mice were markedly improved by introducing an Ednrb transgene under control of the dopamine beta-hydroxylase promoter (Ednrb(-/-); DBH-Ednrb mice) on P19. Neither defects of melanocytes nor hypopigmentation in the SV and skin in Ednrb(-/-) mice was rescued in the Ednrb(-/-); DBH-Ednrb mice. Thus, the results of this study indicate a novel role of Ednrb expressed in SGNs distinct from that in melanocytes in the SV contributing partially to postnatal hearing development.	[Ida-Eto, Michiru; Ohgami, Nobutaka; Iida, Machiko; Yajima, Ichiro; Kumasaka, Mayuko Y.; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Aichi 4878501, Japan; [Takaiwa, Kazutaka; Kimitsuki, Takashi; Komune, Shizuo] Kyushu Univ, Grad Sch Med, Dept Otorhinolaryngol, Fukuoka 8128582, Japan; [Sone, Michihiko; Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4668550, Japan; [Tsuzuki, Toyonori] Nagoya Daini Red Cross Hosp, Dept Pathol, Nagoya, Aichi 4668650, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Chubu University; Kyushu University; Nagoya University; Japanese Red Cross Nagoya Daini Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kato, M (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, 50 Bldg,1200 Matsumoto, Aichi 4878501, Japan.	katomasa@isc.chubu.ac.jp	Ohgami, Nobutaka/I-4572-2014; Tsuzuki, Toyonori/GRJ-7409-2022; KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014; Nakashima, Tsutomu/B-8259-2012; Ida-Eto, Michiru/J-9615-2019	Tsuzuki, Toyonori/0000-0002-4855-4366; Nakashima, Tsutomu/0000-0003-3930-9120; Ida-Eto, Michiru/0000-0002-2469-4006	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19390168, 20406003, 18790738, 20791232]; Chubu University [S0801055]; Lydia O'Leary Memorial Foundation; Japan Society for the Promotion of Science; Tokyo Biochemical Research Foundation; Adaptable and Seamless Technology Transfer Program through Target-driven RD; Japan Science and Technology Agency; Research Foundation, Institute of Science and Technology Research in Chubu University; Chubu University; Grants-in-Aid for Scientific Research [23791891] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University; Lydia O'Leary Memorial Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Biochemical Research Foundation; Adaptable and Seamless Technology Transfer Program through Target-driven RD; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Research Foundation, Institute of Science and Technology Research in Chubu University; Chubu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (B) 19390168 and 20406003 (to M. K.), Grants-in-aid for Young Scientists (B) 18790738 (to N. O.) and 20791232 (to M. I.-E.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Center of Excellence Project (Health Science Hills) for Private Universities from MEXT and Chubu University Grant S0801055 (to N. O. and M. K.), Lydia O'Leary Memorial Foundation (to M. K.), Asia and Africa Science Platform Program from the Japan Society for the Promotion of Science (to M. K.), a research grant from the Tokyo Biochemical Research Foundation (to M. K.), Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency (to N. O.), Research Foundation from the Institute of Science and Technology Research in Chubu University (to M. K.), and Chubu University Grants A, B, and C (to N. O. and M. K.).	Bagnato A, 2005, ENDOCR-RELAT CANCER, V12, P761, DOI 10.1677/erc.1.01077; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Graham CE, 2011, J NEUROSCI, V31, P1267, DOI 10.1523/JNEUROSCI.4545-10.2011; Gurtler N, 2002, OTOLARYNG CLIN N AM, V35, P891, DOI 10.1016/S0030-6665(02)00053-1; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; KAPUR RP, 1992, DEVELOPMENT, V116, P167; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; Laghmani K, 2001, J CLIN INVEST, V107, P1563, DOI 10.1172/JCI11234; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Matsushima Y, 2002, MAMM GENOME, V13, P30, DOI 10.1007/s00335-001-3038-2; Moller A, 1985, AUDITORY BRAINSTEM R, P13; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; OHGAMI N, 2011, NEUROBIOL A IN PRESS; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Pardono E, 2003, AM J MED GENET A, V117A, P223, DOI 10.1002/ajmg.a.10193; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SEWELL WF, 1984, J PHYSIOL-LONDON, V347, P685, DOI 10.1113/jphysiol.1984.sp015090; SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; STEEL KP, 1989, DEVELOPMENT, V107, P453; STEEL KP, 1992, DEVELOPMENT, V115, P1111; STOCKARD JJ, 1977, NEUROLOGY, V27, P316, DOI 10.1212/WNL.27.4.316; Trigueiros-Cunha N, 2003, EUR J NEUROSCI, V18, P2653, DOI 10.1046/j.1460-9568.2003.02989.x; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	33	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29621	29626		10.1074/jbc.M111.236802	http://dx.doi.org/10.1074/jbc.M111.236802			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715336	Green Published, hybrid			2022-12-27	WOS:000294046600020
J	Jascur, T; Fotedar, R; Greene, S; Hotchkiss, E; Boland, CR				Jascur, Thomas; Fotedar, Rati; Greene, Serena; Hotchkiss, Erin; Boland, C. Richard			N-Methyl-N '-nitro-N-nitrosoguanidine (MNNG) Triggers MSH2 and Cdt2 Protein-dependent Degradation of the Cell Cycle and Mismatch Repair (MMR) Inhibitor Protein p21(Waf1/Cip1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ETA; HUMAN TUMOR-CELLS; NUCLEAR ANTIGEN; UV-IRRADIATION; MUTS-ALPHA; MICROSATELLITE INSTABILITY; REPLICATIVE DNA; IN-VIVO; PCNA; P21	p21(Waf1/Cip1) protein levels respond to DNA damage; p21 is induced after ionizing radiation, but degraded after UV. p21 degradation after UV is necessary for optimal DNA repair, presumably because p21 inhibits nucleotide excision repair by blocking proliferating cell nuclear antigen (PCNA). Because p21 also inhibits DNA mismatch repair (MMR), we investigated how p21 levels respond to DNA alkylation by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), which triggers the MMR system. We show that MNNG caused rapid degradation of p21, and this involved the ubiquitin ligase Cdt2 and the proteasome. p21 degradation further required MSH2 but not MLH1. p21 mutants that cannot bind PCNA or cannot be ubiquitinated were resistant to MNNG. MNNG induced the formation of PCNA complexes with MSH6 and Cdt2. Finally, when p21 degradation was blocked, MNNG treatment resulted in reduced recruitment of MMR proteins to chromatin. This study describes a novel pathway that removes p21 to allow cells to efficiently activate the MMR system.	[Jascur, Thomas; Greene, Serena; Hotchkiss, Erin; Boland, C. Richard] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA; [Jascur, Thomas; Greene, Serena; Hotchkiss, Erin; Boland, C. Richard] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX 75246 USA; [Fotedar, Rati] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Sanford Burnham Prebys Medical Discovery Institute	Jascur, T (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA.	thomasja@baylorhealth.edu			National Institutes of Health [R01 CA72851]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA072851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA72851 (to C. R. B.). This work was also supported by funds from the Baylor Research Institute.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Berardini M, 2000, J BIOL CHEM, V275, P27851; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Carethers JM, 1996, J CLIN INVEST, V98, P199, DOI 10.1172/JCI118767; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; HARPER JW, 1993, CELL, V75, P805; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; KOI M, 1994, CANCER RES, V54, P4308; Kreklau EL, 1999, J PHARMACOL EXP THER, V291, P1269; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; Schroering AG, 2008, DNA REPAIR, V7, P951, DOI 10.1016/j.dnarep.2008.03.023; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Soria G, 2006, ONCOGENE, V25, P2829, DOI 10.1038/sj.onc.1209315; Stuart SA, 2009, J BIOL CHEM, V284, P15061, DOI 10.1074/jbc.M808810200; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Umar A, 1997, CANCER RES, V57, P3949; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Wang Y, 2000, GENE DEV, V14, P927; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	46	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29531	29539		10.1074/jbc.M111.221341	http://dx.doi.org/10.1074/jbc.M111.221341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21725088	hybrid, Green Published			2022-12-27	WOS:000294046600010
J	Jensen, JK; Thompson, LC; Bucci, JC; Nissen, P; Gettins, PGW; Peterson, CB; Andrease, PA; Morth, JP				Jensen, Jan K.; Thompson, Lawrence C.; Bucci, Joel C.; Nissen, Poul; Gettins, Peter G. W.; Peterson, Cynthia B.; Andrease, Peter A.; Morth, J. Preben			Crystal Structure of Plasminogen Activator Inhibitor-1 in an Active Conformation with Normal Thermodynamic Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-CENTER LOOP; METALS AFFECT; SERPIN; PAI-1; VITRONECTIN; MECHANISM; TARGET; FIBRINOLYSIS; FORM	The serpin plasminogen activator inhibitor-1 (PAI-1) is a crucial regulator in fibrinolysis and tissue remodeling. PAI-1 has been associated with several pathological conditions and is a validated prognostic marker in human cancers. However, structural information about the native inhibitory form of PAI-1 has been elusive because of its inherent conformational instability and rapid conversion to a latent, inactive structure. Here we report the crystal structure of PAI-1 W175F at 2.3 angstrom resolution as the first model of the metastable native molecule. Structural comparison with a quadruple mutant (14-1B) previously used as representative of the active state uncovered key differences. The most striking differences occur near the region that houses three of the four mutations in the 14-1B PAI-1 structure. Prominent changes are localized within a loop connecting beta-strand 3A with the F helix, in which a previously observed 3(10)-helix is absent in the new structure. Notably these structural changes are found near the binding site for the cofactor vitronectin. Because vitronectin is the only known physiological regulator of PAI-1 that slows down the latency conversion, the structure of this region is important. Furthermore, the previously identified chloride-binding site close to the F-helix is absent from the present structure and likely to be artifactual, because of its dependence on the 14-1B mutations. Instead we found a different chlorine-binding site that is likely to be present in wild type PAI-1 and that more satisfactorily accounts for the chlorine stabilizing effect on PAI-1.	[Jensen, Jan K.; Nissen, Poul; Andrease, Peter A.; Morth, J. Preben] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Jensen, Jan K.; Andrease, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, DK-8000 Aarhus C, Denmark; [Nissen, Poul; Morth, J. Preben] Aarhus Univ, Struct Biol Ctr, DK-8000 Aarhus C, Denmark; [Thompson, Lawrence C.; Bucci, Joel C.; Peterson, Cynthia B.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Morth, J. Preben] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med, N-0318 Oslo, Norway	Aarhus University; Aarhus University; Aarhus University; University of Tennessee System; University of Tennessee Knoxville; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oslo	Jensen, JK (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark.	jkj@mb.au.dk	Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628	Danish National Research Foundation; American Heart Association [10GRNT4430033]; Lundbeck Foundation; Carlsbergfondet; Lundbeck Foundation [R34-2009-3616] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); American Heart Association(American Heart Association); Lundbeck Foundation(Lundbeckfonden); Carlsbergfondet(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a center of excellence grant from the Danish National Research Foundation (to P. A. A. and P. N.) and by American Heart Association Grant 10GRNT4430033 (to C. B. P.).; Supported by the Lundbeck Foundation.; Supported by Carlsbergfondet.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; DAY DD, 2006, Patent No. 7015021; De Taeye B, 2004, THROMB HAEMOSTASIS, V92, P898, DOI 10.1160/TH04-05-0269; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, FEBS LETT, V523, P2, DOI 10.1016/S0014-5793(02)02924-1; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gils A, 2004, THROMB HAEMOSTASIS, V91, P425, DOI 10.1160/TH03-12-0764; Gorlatova NV, 2003, J BIOL CHEM, V278, P16329, DOI 10.1074/jbc.M208420200; Hagglof P, 2004, J MOL BIOL, V335, P823, DOI 10.1016/j.jmb.2003.11.005; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Li SH, 2008, J BIOL CHEM, V283, P18147, DOI 10.1074/jbc.M709455200; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Thompson LC, 2011, PROTEIN SCI, V20, P353, DOI 10.1002/pro.568; Thompson LC, 2011, PROTEIN SCI, V20, P366, DOI 10.1002/pro.567; Verhamme I, 1999, J BIOL CHEM, V274, P17511, DOI 10.1074/jbc.274.25.17511; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	34	29	29	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29709	29717		10.1074/jbc.M111.236554	http://dx.doi.org/10.1074/jbc.M111.236554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697084	Green Published, hybrid			2022-12-27	WOS:000294046600030
J	Chauleau, M; Mora, L; Serba, J; de Zamaroczy, M				Chauleau, Mathieu; Mora, Liliana; Serba, Justyna; de Zamaroczy, Miklos			FtsH-dependent Processing of RNase Colicins D and E3 Means That Only the Cytotoxic Domains Are Imported into the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEASE; ESCHERICHIA-COLI; IMMUNITY PROTEIN; CRYSTAL-STRUCTURE; LEADER PEPTIDASE; NUCLEOTIDE-SEQUENCE; SIGNAL PEPTIDASE; RECEPTOR-BINDING; CHOLERA-TOXIN; OMPT PROTEASE	It has long been suggested that the import of nuclease colicins requires protein processing; however it had never been formally demonstrated. Here we show that two RNase colicins, E3 and D, which appropriate two different translocation machineries to cross the outer membrane (BtuB/Tol and FepA/TonB, respectively), undergo a processing step inside the cell that is essential to their killing action. We have detected the presence of the C-terminal catalytic domains of these colicins in the cytoplasm of target bacteria. The same processed forms were identified in both colicin-sensitive cells and in cells immune to colicin because of the expression of the cognate immunity protein. We demonstrate that the inner membrane protease FtsH is necessary for the processing of colicins D and E3 during their import. We also show that the signal peptidase LepB interacts directly with the central domain of colicin D in vitro and that it is a specific but not a catalytic requirement for in vivo processing of colicin D. The interaction of colicin D with LepB may ensure a stable association with the inner membrane that in turn allows the colicin recognition by FtsH. We have also shown that the outer membrane protease OmpT is responsible for alternative and distinct endoproteolytic cleavages of colicins D and E3 in vitro, presumably reflecting its known role in the bacterial defense against antimicrobial peptides. Even though the OmpT-catalyzed in vitro cleavage also liberates the catalytic domain from colicins D and E3, it is not involved in the processing of nuclease colicins during their import into the cytoplasm.	[Chauleau, Mathieu; Mora, Liliana; Serba, Justyna; de Zamaroczy, Miklos] Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	de Zamaroczy, M (corresponding author), 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	zamaroczy@ibpc.fr			Centre National de la Recherche Scientifique [UPR 9073]; Ecole Doctorale GGC (Genes, Genomes, Cellules), Universite Paris	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ecole Doctorale GGC (Genes, Genomes, Cellules), Universite Paris	This work was supported by the Centre National de la Recherche Scientifique (UPR 9073) and by a studentship from the Ecole Doctorale GGC (Genes, Genomes, Cellules), Universite Paris 11 ( to M. C.).	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485, DOI 10.1074/jbc.270.40.23485; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Ayuso-Tejedor S, 2010, J STRUCT BIOL, V171, P117, DOI 10.1016/j.jsb.2010.05.001; BENEDETTI H, 1991, J MOL BIOL, V217, P429, DOI 10.1016/0022-2836(91)90747-T; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; BOWMAN CM, 1971, P NATL ACAD SCI USA, V68, P964, DOI 10.1073/pnas.68.5.964; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; de Zamaroczy M, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P255, DOI 10.1007/978-1-4419-7692-5_14; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Duche D, 2006, J BACTERIOL, V188, P8593, DOI 10.1128/JB.00941-06; Duche D, 2009, J BIOCHEM, V145, P95, DOI 10.1093/jb/mvn149; ELISH ME, 1988, J GEN MICROBIOL, V134, P1355; FREY J, 1986, J BACTERIOL, V166, P15, DOI 10.1128/jb.166.1.15-19.1986; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; GRODBERG J, 1988, NUCLEIC ACIDS RES, V16, P1209, DOI 10.1093/nar/16.3.1209; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kramer RA, 2000, FEBS LETT, V468, P220, DOI 10.1016/S0014-5793(00)01231-X; Kramer RA, 2002, EUR J BIOCHEM, V269, P1746, DOI 10.1046/j.1432-1327.2002.02820.x; Kramer RA, 2001, FEBS LETT, V505, P426, DOI 10.1016/S0014-5793(01)02863-0; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; KRONE WJA, 1986, J BACTERIOL, V166, P260, DOI 10.1128/jb.166.1.260-268.1986; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Liao CC, 2001, BIOCHEM BIOPH RES CO, V284, P556, DOI 10.1006/bbrc.2001.5016; MASAKI H, 1985, J MOL BIOL, V182, P217, DOI 10.1016/0022-2836(85)90340-7; Masi M, 2007, J BACTERIOL, V189, P2667, DOI 10.1128/JB.01448-06; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Mora L, 2008, J BIOL CHEM, V283, P4993, DOI 10.1074/jbc.M706846200; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paquelin A, 2001, MOL MICROBIOL, V42, P995, DOI 10.1046/j.1365-2958.2001.02628.x; Qiagen, 2003, QIA EXPR HDB HIGH LE; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sharma O, 2007, J BACTERIOL, V189, P363, DOI 10.1128/JB.01344-06; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; van Roosmalen ML, 2001, MICROBIOL-UK, V147, P909, DOI 10.1099/00221287-147-4-909; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Vankemmelbeke M, 2009, J BIOL CHEM, V284, P18932, DOI 10.1074/jbc.M806149200; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Zhang Y, 2008, J BACTERIOL, V190, P4342, DOI 10.1128/JB.00047-08	70	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29397	29407		10.1074/jbc.M111.242354	http://dx.doi.org/10.1074/jbc.M111.242354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700705	hybrid, Green Published			2022-12-27	WOS:000293837000074
J	Popiolek, M; Ross, JF; Charych, E; Chanda, P; Gundelfinger, ED; Moss, SJ; Brandon, NJ; Pausch, MH				Popiolek, Michael; Ross, John F.; Charych, Erik; Chanda, Pranab; Gundelfinger, Eckart D.; Moss, Stephen J.; Brandon, Nicholas J.; Pausch, Mark H.			D-Amino Acid Oxidase Activity Is Inhibited by an Interaction with Bassoon Protein at the Presynaptic Active Zone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTORS; D-SERINE LEVELS; IMMUNOCYTOCHEMICAL LOCALIZATION; POSTSYNAPTIC DENSITIES; RAT CEREBELLUM; HIGH-AFFINITY; MUTANT MICE; SCHIZOPHRENIA; BRAIN; PEROXISOMES	Schizophrenia is a highly heritable neuropsychiatric disorder affecting similar to 1% of the world's population. Linkage and association studies have identified multiple candidate schizophrenia susceptibility genes whose functions converge on the glutamatergic neurotransmitter system. One such susceptibility gene encoding D-amino acid oxidase (DAO), an enzyme that metabolizes the NMDA receptor (NMDAR) co-agonist D-serine, has the potential to modulate NMDAR function in the context of schizophrenia. To further investigate its cellular regulation, we sought to identify DAO-interacting proteins that participate in its functional regulation in rat cerebellum, where DAO expression is especially high. Immunoprecipitation with DAO-specific antibodies and subsequent mass spectrometric analysis of co-precipitated proteins yielded 24 putative DAO-interacting proteins. The most robust interactions occurred with known components of the presynaptic active zone, such as bassoon (BSN) and piccolo (PCLO). The interaction of DAO with BSN was confirmed through co-immunoprecipitation assays using DAO- and BSN-specific antibodies. Moreover, DAO and BSN colocalized with one another in cultured cerebellar granule cells and in synaptic junction membrane protein fractions derived from rat cerebellum. The functional consequences of this interaction were studied through enzyme assay experiments, where DAO enzymatic activity was significantly inhibited as a result of its interaction with BSN. Taking these results together, we hypothesize that synaptic D-serine concentrations may be under tight regulation by a BSN-DAO complex. We therefore predict that this mechanism plays a role in the modulation of glutamatergic signaling through NMDARs. It also furthers our understanding of the biology underlying this potential therapeutic entry point for schizophrenia and other psychiatric disorders.	[Popiolek, Michael; Charych, Erik; Chanda, Pranab; Brandon, Nicholas J.; Pausch, Mark H.] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA; [Ross, John F.] Aileron Therapeut, Cambridge, MA USA; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Magdenburg, Germany; [Pausch, Mark H.] Merck, West Point, PA 19486 USA; [Moss, Stephen J.] Tufts Univ, Boston, MA 02111 USA	Pfizer; Leibniz Institut fur Neurobiologie (LIN); Tufts University	Brandon, NJ (corresponding author), Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA.	nick.brandon@pfizer.com		Brandon, Nicholas/0000-0002-3917-0096	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS081986] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051195, R01 NS081986] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almond SL, 2006, MOL CELL NEUROSCI, V32, P324, DOI 10.1016/j.mcn.2006.05.003; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Andersen JD, 2004, NEUROPSYCHOPHARMACOL, V29, P1080, DOI 10.1038/sj.npp.1300394; ARNOLD G, 1979, J HISTOCHEM CYTOCHEM, V27, P735, DOI 10.1177/27.3.39097; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Burnet PWJ, 2008, MOL PSYCHIATR, V13, P658, DOI 10.1038/mp.2008.47; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Corvin A, 2007, AM J MED GENET B, V144B, P949, DOI 10.1002/ajmg.b.30452; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Cristiano L, 2001, J NEUROCYTOL, V30, P671, DOI 10.1023/A:1016525716209; DANIELLO A, 1993, COMP BIOCHEM PHYS B, V105, P731, DOI 10.1016/0305-0491(93)90113-J; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Ghiglieri V, 2009, EUR J NEUROSCI, V29, P1979, DOI 10.1111/j.1460-9568.2009.06733.x; Hamase K, 2005, BIOL PHARM BULL, V28, P1578, DOI 10.1248/bpb.28.1578; Hashimoto A, 2005, BRAIN RES, V1033, P210, DOI 10.1016/j.brainres.2004.11.031; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto K, 2009, BIOL PSYCHIAT, V65, P1103, DOI 10.1016/j.biopsych.2009.01.002; Helboe L, 2003, EUR J NEUROSCI, V18, P2227, DOI 10.1046/j.1460-9568.2003.02966.x; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; HORIIKE K, 1987, BRAIN RES BULL, V19, P587, DOI 10.1016/0361-9230(87)90076-1; Kapoor R, 2006, BRAIN RES, V1106, P205, DOI 10.1016/j.brainres.2006.05.082; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; KONNO R, 1983, GENETICS, V103, P277; Korostishevsky M, 2006, AM J MED GENET B, V141B, P91, DOI 10.1002/ajmg.b.30212; Labrie V, 2010, GENES BRAIN BEHAV, V9, P11, DOI 10.1111/j.1601-183X.2009.00529.x; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu XM, 2004, NEUROSCI LETT, V369, P228, DOI 10.1016/j.neulet.2004.07.078; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Maekawa M, 2005, NEUROSCI RES, V53, P34, DOI 10.1016/j.neures.2005.05.008; Marino MJ, 2008, J MED CHEM, V51, P1077, DOI 10.1021/jm701094q; Matsuo H, 2004, NEUROSCI LETT, V358, P123, DOI 10.1016/j.neulet.2004.01.014; Moreno S, 1999, J NEUROCYTOL, V28, P169, DOI 10.1023/A:1007064504007; Nakauchi J, 2000, NEUROSCI LETT, V287, P231, DOI 10.1016/S0304-3940(00)01169-1; NEIMS AH, 1966, J NEUROCHEM, V13, P163, DOI 10.1111/j.1471-4159.1966.tb07508.x; Ono K, 2009, J NEURAL TRANSM, V116, P1335, DOI 10.1007/s00702-009-0289-7; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Rutter AR, 2007, EUR J NEUROSCI, V25, P1757, DOI 10.1111/j.1460-9568.2007.05446.x; Sacchi S, 2008, J BIOL CHEM, V283, P22244, DOI 10.1074/jbc.M709153200; Sakata K, 1999, BIOCHEMISTRY-US, V38, P10099, DOI 10.1021/bi990246k; SASAKI M, 1992, BIOCHIM BIOPHYS ACTA, V1139, P315, DOI 10.1016/0925-4439(92)90107-X; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Shao ZJ, 2009, J NEUROSCI RES, V87, P2520, DOI 10.1002/jnr.22086; Shi JJ, 2008, SCHIZOPHR RES, V98, P89, DOI 10.1016/j.schres.2007.10.004; Smith SM, 2009, J PHARMACOL EXP THER, V328, P921, DOI 10.1124/jpet.108.147884; TANII Y, 1994, J PHARMACOL EXP THER, V269, P1040; USUDA N, 1986, J HISTOCHEM CYTOCHEM, V34, P1709, DOI 10.1177/34.12.2878022; Vilella E, 2008, J PSYCHIATR RES, V42, P278, DOI 10.1016/j.jpsychires.2007.02.005; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Weidenhofer J, 2008, J PSYCHIATR RES, V43, P282, DOI 10.1016/j.jpsychires.2008.04.001; WEIMAR WR, 1977, J NEUROCHEM, V29, P649, DOI 10.1111/j.1471-4159.1977.tb07782.x; Wirgenes KV, 2009, NEUROPSYCHOBIOLOGY, V60, P31, DOI 10.1159/000235799; Wolosker Herman, 2006, Sci STKE, V2006, ppe41, DOI 10.1126/stke.3562006pe41; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018	71	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28867	28875		10.1074/jbc.M111.262063	http://dx.doi.org/10.1074/jbc.M111.262063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700703	Green Published, hybrid			2022-12-27	WOS:000293837000024
J	Sugiura, N; Setoyama, Y; Chiba, M; Kimata, K; Watanabe, H				Sugiura, Nobuo; Setoyama, Yuka; Chiba, Mie; Kimata, Koji; Watanabe, Hideto			Baculovirus Envelope Protein ODV-E66 Is a Novel Chondroitinase with Distinct Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; MOLECULAR-CLONING; CATALYTIC MACHINERY; STRUCTURAL-ANALYSIS; HEPARAN-SULFATE; ACTIVE-SITE; TOUT-VELU; IN-VIVO; ABC-I; POLYMERASE	Chondroitin sulfate is a linear polysaccharide of alternating D-glucuronic acid and N-acetyl-D-galactosamine residues with sulfate groups at various positions of the sugars. It interacts with and regulates cytokine and growth factor signal transduction, thus influencing development, organ morphogenesis, inflammation, and infection. We found chondroitinase activity in medium conditioned by baculovirus-infected insect cells and identified a novel chondroitinase. Sequence analysis revealed that the enzyme was a truncated form of occlusion-derived virus envelope protein 66 (ODV-E66) of Autographa californica nucleopolyhedrovirus. The enzyme was a novel chondroitin lyase with distinct substrate specificity. The enzyme was active over a wide range of pH (pH 4-9) and temperature (30-60 degrees C) and was unaffected by divalent metal ions. The ODV-E66 truncated protein digested chondroitin most efficiently followed by chondroitin 6-sulfate. It degraded hyaluronan to a minimal extent but did not degrade dermatan sulfate, heparin, and N-acetylheparosan. Further analysis using chemo-enzymatically synthesized substrates revealed that the enzyme specifically acted on glucuronate residues in non-sulfated and chondroitin 6-sulfate structures but not in chondroitin 4-sulfate structures. These results suggest that this chondroitinase is useful for detailed structural and compositional analysis of chondroitin sulfate, preparation of specific chondroitin oligosaccharides, and study of baculovirus infection mechanism.	[Sugiura, Nobuo; Setoyama, Yuka; Chiba, Mie; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Aichi Medical University	Sugiura, N (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	nsugiura@aichi-med-u.ac.jp		Watanabe, Hideto/0000-0001-5291-0696	New Energy and Industrial Technology Development Organization (NEDO); Seikagaku Corporation; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Seikagaku Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) and by special research funding from Seikagaku Corporation.	Baker JR, 1997, BIOCHEM J, V327, P65, DOI 10.1042/bj3270065; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P15882, DOI 10.1073/pnas.0706340104; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hamai A, 1997, J BIOL CHEM, V272, P9123; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; HIYAMA K, 1975, J BIOL CHEM, V250, P1824; HONG T, 1994, VIROLOGY, V204, P210, DOI 10.1006/viro.1994.1525; Hong T, 1997, P NATL ACAD SCI USA, V94, P4050, DOI 10.1073/pnas.94.8.4050; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; KATO F, 1990, CLIN ORTHOP RELAT R, P301; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinto DO, 2004, GLYCOBIOLOGY, V14, P529, DOI 10.1093/glycob/cwh070; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; Prabhakar V, 2006, BIOCHEMISTRY-US, V45, P11130, DOI 10.1021/bi0605484; Prabhakar V, 2009, J BIOL CHEM, V284, P974, DOI 10.1074/jbc.M806630200; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sugiura N, 2008, GLYCOCONJUGATE J, V25, P521, DOI 10.1007/s10719-008-9105-0; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; Takeo S, 2004, J BIOL CHEM, V279, P18920, DOI 10.1074/jbc.M314293200; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; TOYODA H, 1988, ANAL SCI, V4, P381, DOI 10.2116/analsci.4.381; Vigdorovich V, 2007, J VIROL, V81, P3124, DOI 10.1128/JVI.02177-06; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975	37	31	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29026	29034		10.1074/jbc.M111.251157	http://dx.doi.org/10.1074/jbc.M111.251157			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715327	Green Published, hybrid			2022-12-27	WOS:000293837000039
J	Tian, XB; Ye, JB; Alonso-Basanta, M; Hahn, SM; Koumenis, C; Dorsey, JF				Tian, Xiaobing; Ye, Jiangbin; Alonso-Basanta, Michelle; Hahn, Stephen M.; Koumenis, Constantinos; Dorsey, Jay F.			Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN-MELANOMA CELLS; MALIGNANT GLIOMA-CELLS; UP-REGULATION; CANCER-CELLS; DEATH RECEPTORS; APO2 LIGAND; ER STRESS; INHIBITOR; HYPOXIA	Human glioblastoma multiforme cells demonstrate varying levels of sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Endoplasmic reticulum (ER) stress has been shown to trigger cell death through apoptosis. We therefore pursued a strategy of integrating clinically relevant investigational agents that cooperate mechanistically through the regulation of ER stress and apoptosis pathways. Nelfinavir belongs to the protease inhibitor class of drugs currently used to treat patients with HIV and is in clinical trials as an anti-tumor agent. We found that Nelfinavir treatment led to ER stress-induced up-regulation of the DR5 receptor. This transactivation was mediated by the transcription factor CCAAT/enhancer binding protein homologous protein (CHOP). We also determined that ER stress-induced ATF4 up-regulation was responsible for modulation of CHOP. In contrast, DR4 receptor expression was unchanged by Nelfinavir treatment. Combining Nelfinavir with TRAIL led to a significantly enhanced level of apoptosis that was abrogated by siRNA silencing of DR5. We provide evidence that Nelfinavir-induced ER stress modulates DR5 expression in human glioblastoma multiforme cells and can enhance TRAIL efficacy. These studies provide a potential mechanistic rationale for the use of the Food and Drug Administration-approved agent Nelfinavir in combination with DR5 agonists to induce apoptosis in human malignancies.	[Dorsey, Jay F.] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Radiat Biol & Imaging Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dorsey, JF (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, 180-1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	JayD@uphs.upenn.edu	Ye, Jiangbin/A-1094-2007; Koumenis, Constantinos/B-2002-2008	Ye, Jiangbin/0000-0003-1117-4869; Koumenis, Costas/0000-0001-5945-4726	Burroughs Wellcome Career Award for Medical Scientists [1006792]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076548] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Burroughs Wellcome Career Award for Medical Scientists 1006792 ( to J. F. D.).	Arakawa Y, 2005, ACTA NEUROPATHOL, V109, P294, DOI 10.1007/s00401-004-0956-6; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bruning A, 2009, CANCER BIOL THER, V8, P222; Bruning A, 2008, BIOCHEM BIOPH RES CO, V377, P1309, DOI 10.1016/j.bbrc.2008.10.167; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Hao CH, 2001, CANCER RES, V61, P1162; Hetschko H, 2008, FEBS J, V275, P1925, DOI 10.1111/j.1742-4658.2008.06351.x; Ikezoe T, 2004, MOL CANCER THER, V3, P473; Jang YJ, 2003, CANCER LETT, V194, P107, DOI 10.1016/S0304-3835(02)00680-8; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Jiang W, 2007, CANCER RES, V67, P1221, DOI 10.1158/0008-5472.CAN-06-3377; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Li YC, 2006, CLIN CANCER RES, V12, P2716, DOI 10.1158/1078-0432.CCR-05-1980; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Pore N, 2006, CANCER RES, V66, P9252, DOI 10.1158/0008-5472.CAN-06-1239; Pyrko P, 2007, CANCER RES, V67, P10920, DOI 10.1158/0008-5472.CAN-07-0796; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; Steinbach JP, 2004, J NEURO-ONCOL, V70, P245, DOI 10.1007/s11060-004-2753-4; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	41	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29408	29416		10.1074/jbc.M110.197665	http://dx.doi.org/10.1074/jbc.M110.197665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697087	hybrid, Green Published			2022-12-27	WOS:000293837000075
J	James, JR; McColl, J; Oliveira, MI; Dunne, PD; Huang, E; Jansson, A; Nilsson, P; Sleep, DL; Goncalves, CM; Morgan, SH; Felce, JH; Mahen, R; Fernandes, RA; Carmo, AM; Klenerman, D; Davis, SJ				James, John R.; McColl, James; Oliveira, Marta I.; Dunne, Paul D.; Huang, Elizabeth; Jansson, Andreas; Nilsson, Patric; Sleep, David L.; Goncalves, Carine M.; Morgan, Sara H.; Felce, James H.; Mahen, Robert; Fernandes, Ricardo A.; Carmo, Alexandre M.; Klenerman, David; Davis, Simon J.			The T Cell Receptor Triggering Apparatus Is Composed of Monovalent or Monomeric Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE CD45; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; STRUCTURAL BASIS; CYTOPLASMIC DOMAIN; KINASE-ACTIVITY; ACTIVATION; MOLECULE; ASSOCIATION; TCR	Understanding the component stoichiometry of the T cell antigen receptor (TCR) triggering apparatus is essential for building realistic models of signal initiation. Recent studies suggesting that the TCR and other signaling-associated proteins are preclustered on resting T cells relied on measurements of the behavior of membrane proteins at interfaces with functionalized glass surfaces. Using fluorescence recovery after photo-bleaching, we show that, compared with the apical surface, the mobility of TCRs is significantly reduced at Jurkat T cell/glass interfaces, in a signaling-sensitive manner. Using two biophysical approaches that mitigate these effects, bioluminescence resonance energy transfer and two-color coincidence detection microscopy, we show that, within the uncertainty of the methods, the membrane components of the TCR triggering apparatus, i.e. the TCR complex, MHC molecules, CD4/Lck and CD45, are exclusively monovalent or monomeric in human T cell lines, implying that TCR triggering depends only on the kinetics of TCR/pMHC interactions. These analyses also showed that constraining proteins to two dimensions at the cell surface greatly enhances random interactions versus those between the membrane and the cytoplasm. Simulations of TCR-pMHC complex formation based on these findings suggest how unclustered TCR triggering-associated proteins might nevertheless be capable of generating complex signaling outputs via the differential recruitment of cytosolic effectors to the cell membrane.	[McColl, James; Dunne, Paul D.; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [James, John R.; Huang, Elizabeth; Sleep, David L.; Morgan, Sara H.; Felce, James H.; Fernandes, Ricardo A.; Davis, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Med, Oxford OX3 9DS, England; [James, John R.; Huang, Elizabeth; Sleep, David L.; Morgan, Sara H.; Felce, James H.; Fernandes, Ricardo A.; Davis, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England; [Oliveira, Marta I.; Goncalves, Carine M.; Carmo, Alexandre M.] Univ Porto, Inst Biol Mol & Celular, Grp Cell Activat & Gene Express, P-4150180 Oporto, Portugal; [Oliveira, Marta I.; Goncalves, Carine M.; Carmo, Alexandre M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal; [Jansson, Andreas; Nilsson, Patric] Univ Skovde, Sch Life Sci, Syst Biol Res Ctr, Skovde, Sweden; [Mahen, Robert] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 0XZ, England	University of Cambridge; University of Oxford; University of Oxford; Universidade do Porto; Universidade do Porto; University of Skovde	Klenerman, D (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	dk10012@cam.ac.uk; simon.davis@ndm.ox.ac.uk	Carmo, Alexandre/B-5191-2011; Oliveira, Marta I A/M-9386-2013; Fernandes, Ricardo/AAB-8165-2019; James, John R/B-5547-2008; James, John/AAP-3607-2021	Carmo, Alexandre/0000-0002-2508-9799; Oliveira, Marta I A/0000-0002-0578-9202; Fernandes, Ricardo/0000-0001-5343-3334; James, John R/0000-0003-1452-7578; James, John/0000-0003-1452-7578; Klenerman, David/0000-0001-7116-6954; Felce, James/0000-0001-5531-9244; Mahen, Robert/0000-0002-4748-3690; McColl, James/0000-0002-6692-3663; Goncalves, Carine/0000-0002-4512-6147	Wellcome Trust; Biotechnology and Biological Sciences and Research Council; United Kingdom Medical Research Council; Fundacao para a Ciencia e a Tecnologia of Portugal; Biotechnology and Biological Sciences Research Council [BB/D000467/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, the Biotechnology and Biological Sciences and Research Council, the United Kingdom Medical Research Council, and the Fundacao para a Ciencia e a Tecnologia of Portugal.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cairo CW, 2010, J BIOL CHEM, V285, P11392, DOI 10.1074/jbc.M109.075648; Cambier JC, 2010, IMMUNOL LETT, V128, P6, DOI 10.1016/j.imlet.2009.09.006; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Clarke RW, 2007, ANAL CHEM, V79, P2771, DOI 10.1021/ac062188w; Corry B, 2006, BIOPHYS J, V91, P1032, DOI 10.1529/biophysj.106.080713; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Dushek O, 2008, J BIOCHEM BIOPH METH, V70, P1224, DOI 10.1016/j.jbbm.2007.07.002; Dushek O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003913; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Gratton S, 1996, J IMMUNOL, V157, P3305; Haugh JM, 1997, BIOPHYS J, V72, P2014, DOI 10.1016/S0006-3495(97)78846-5; Hayball JD, 2005, MOL CELL BIOCHEM, V273, P1, DOI 10.1007/s11010-005-5281-4; Hoffmann KMV, 1997, J BIOL CHEM, V272, P27505, DOI 10.1074/jbc.272.44.27505; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Irie A, 2003, EUR J IMMUNOL, V33, P1497, DOI 10.1002/eji.200323618; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; ROTHSTEIN DM, 1992, J BIOL CHEM, V267, P7139; Salzmann M, 1998, MOL IMMUNOL, V35, P271, DOI 10.1016/S0161-5890(98)00035-2; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Tiganos E, 1997, J VIROL, V71, P4452, DOI 10.1128/JVI.71.6.4452-4460.1997; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vignali DAA, 1999, J IMMUNOL, V162, P1431; Wray V, 1998, BIOCHEMISTRY-US, V37, P8527, DOI 10.1021/bi9723111; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yousefi S, 2003, CLIN EXP IMMUNOL, V133, P78, DOI 10.1046/j.1365-2249.2003.02187.x; YUNIS JJ, 1989, BLOOD, V73, P931	55	38	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31993	32001		10.1074/jbc.M111.219212	http://dx.doi.org/10.1074/jbc.M111.219212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757710	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000294726800008
J	Li, Y; Yang, JD; Li, SQ; Zhang, J; Zheng, J; Hou, WG; Zhao, HD; Guo, YY; Liu, XP; Dou, KF; Situ, Z; Yao, LB				Li, Yan; Yang, Jiandong; Li, Shaoqing; Zhang, Jian; Zheng, Jin; Hou, Wugang; Zhao, Huadong; Guo, Yanyan; Liu, Xinping; Dou, Kefeng; Situ, Zhenqiang; Yao, Libo			N-myc Downstream-regulated Gene 2, a Novel Estrogen-targeted Gene, Is Involved in the Regulation of Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; SODIUM-PUMP; K+-ATPASE; PLASMA-MEMBRANE; GAMMA-SUBUNIT; IN-VIVO; NDRG2; EXPRESSION; RECEPTOR; LOCALIZATION	Na+/K+-ATPase, a plasma membrane protein abundantly expressed in epithelial tissues, has been identified and linked to numerous biological events, including ion transport and reabsorption. In Na+/K+-ATPase, the beta-subunit plays a fundamental role in the structural integrity and functional maturation of holoenzyme. Estrogens are important circulating hormones that can regulateNa(+)/K+-ATPase abundance and activity; however, the specific molecules participating in this process are largely unknown. Here, we characterize that N-myc down-stream-regulated gene 2 (NDRG2) is an estrogen up-regulated gene. 17 beta-Estradiol binds with estrogen receptor beta but not estrogen receptor alpha to up-regulate NDRG2 expression via transcriptional activation. We also find that NDRG2 interacts with the beta 1-subunit of Na+/K+-ATPase and stabilizes the beta 1-subunit by inhibiting its ubiquitination and degradation. NDRG2-induced prolongation of the beta 1-subunit protein half-life is accompanied by a similar increase in Na+/K+-ATPase-mediated Na+ transport and Na+ current in epithelial cells. In addition, NDRG2 silencing largely attenuates the accumulation of beta 1-subunit regulated by 17 beta-estradiol. Our results demonstrate that estrogen/NDRG2/Na+/K+-ATPase beta 1 pathway is important in promoting Na+/K+-ATPase activity and suggest this novel pathway might have substantial roles in ion transport, fluid balance, and homeostasis.	[Situ, Zhenqiang] Fourth Mil Med Univ, Dept Oral Biol, Stomatol Sch, Xian 710032, Shaanxi, Peoples R China; [Li, Yan; Zhang, Jian; Liu, Xinping; Yao, Libo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Yang, Jiandong; Dou, Kefeng] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Zheng, Jin] Fourth Mil Med Univ, Dept Oncol, Xian 710032, Shaanxi, Peoples R China; [Hou, Wugang] Fourth Mil Med Univ, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Huadong] Fourth Mil Med Univ, Dept Gen Surg, Xian 710032, Shaanxi, Peoples R China; [Guo, Yanyan] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Situ, Z (corresponding author), Fourth Mil Med Univ, Dept Oral Biol, Stomatol Sch, 145 Changle Western Rd, Xian 710032, Shaanxi, Peoples R China.	situzhq@fmmu.edu.cn; bioyao@fmmu.edu.cn	Li, Yan/AAA-6908-2021; Li, Yan/A-7115-2018	Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0003-0096-0813	Chinese National Key Basic Research and Development Program [2010CB529705]; National Natural Science Foundation of China [31070681, 30830054, 30801121, 81100764, 81072973, 81000563]	Chinese National Key Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Key Basic Research and Development Program Grant 2010CB529705 and National Natural Science Foundation of China Grants 31070681, 30830054, 30801121, 81100764, 81072973, and 81000563.	Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Boulkroun S, 2005, PFLUG ARCH EUR J PHY, V451, P388, DOI 10.1007/s00424-005-1410-x; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Chen L, 2004, NUCLEIC ACIDS RES, V32, P1251, DOI 10.1093/nar/gkh297; CHOW DC, 1995, J EXP BIOL, V198, P1; Dempski RE, 2008, BIOCHEMISTRY-US, V47, P257, DOI 10.1021/bi701799b; Dempski RE, 2009, BBA-BIOENERGETICS, V1787, P714, DOI 10.1016/j.bbabio.2009.03.021; Deng YC, 2001, PROG BIOCHEM BIOPHYS, V28, P72; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Dzurba A, 1997, MOL CELL BIOCHEM, V176, P113, DOI 10.1023/A:1006835214312; Efendiev R, 2007, BRIT J PHARMACOL, V151, P1006, DOI 10.1038/sj.bjp.0707304; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; Foletta VC, 2009, J PHYSIOL-LONDON, V587, P1619, DOI 10.1113/jphysiol.2008.167882; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Kaur G, 1997, MOL CELL BIOCHEM, V167, P107, DOI 10.1023/A:1006876718783; Laube M, 2011, PEDIATR RES, V69, P200, DOI 10.1203/PDR.0b013e3182070ec8; Lefranc F, 2008, NEOPLASIA, V10, P198, DOI 10.1593/neo.07928; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu CG, 2007, CLIN EXP PHARMACOL P, V34, P998, DOI 10.1111/j.1440-1681.2007.04675.x; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MELIS M G, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P679; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Rivard CJ, 2005, FRONT BIOSCI-LANDMRK, V10, P2604, DOI 10.2741/1724; SIMSSAMPSON G, 1984, ANAT RECORD, V210, P53, DOI 10.1002/ar.1092100109; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Tang CH, 2010, J COMP PHYSIOL B, V180, P813, DOI 10.1007/s00360-010-0458-x; Vagin O, 2007, J BIOENERG BIOMEMBR, V39, P367, DOI 10.1007/s10863-007-9103-0; Wakabayashi Y, 2007, HISTOCHEM CELL BIOL, V127, P463, DOI 10.1007/s00418-007-0274-x; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wielputz MO, 2007, J BIOL CHEM, V282, P28264, DOI 10.1074/jbc.M702168200; Yang GZ, 2011, CELL MOL BIOL, V57, P1480, DOI 10.1170/170; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200; Zhang J, 2007, BIOCHEM BIOPH RES CO, V352, P6, DOI 10.1016/j.bbrc.2006.10.141; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Ziegelhoffer A, 1990, Bratisl Lek Listy, V91, P902	52	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32289	32299		10.1074/jbc.M111.247825	http://dx.doi.org/10.1074/jbc.M111.247825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771789	Green Published, hybrid			2022-12-27	WOS:000294726800039
J	Meng, QY; Cai, DS				Meng, Qingyuan; Cai, Dongsheng			Defective Hypothalamic Autophagy Directs the Central Pathogenesis of Obesity via the I kappa B Kinase beta (IKK beta)/NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; N-TERMINAL KINASE; HIGH-FAT DIET; INSULIN-RESISTANCE; LEPTIN RESISTANCE; CELL MASS; ER STRESS; MICE; INFLAMMATION; DISEASE	Autophagy has been recently demonstrated to control cell and tissue homeostasis, including the functions of various metabolic tissues. However, it remains unclear whether autophagy is critical for the central nervous system and particularly the hypothalamus for exerting metabolic regulation. Using autophagy-related protein 7 (Atg7) as an autophagic marker, this work showed that autophagy was highly active in the mediobasal hypothalamus of normal mice. In contrast, chronic development of dietary obesity was associated with autophagic decline in the mediobasal hypothalamus. To investigate the potential role of autophagy in the hypothalamic control of metabolic physiology, a mouse model was developed with autophagic inhibition in the mediobasal hypothalamus using site-specific delivery of lentiviral shRNA against Atg7. This model revealed that hypothalamic inhibition of autophagy increased energy intake and reduced energy expenditure. These metabolic changes were sufficient to increase body weight gain under normal chow feeding and exacerbate the progression of obesity and whole-body insulin resistance under high-fat diet feeding. To explore the underlying mechanism, this study found that defective hypothalamic autophagy led to hypothalamic inflammation, including the activation of proinflammatory I kappa B kinase beta pathway. Using brain-specific I kappa B kinase beta knockout mice, it was found that the effects of defective hypothalamic autophagy in promoting obesity were reversed by I kappa B kinase beta inhibition in the brain. In conclusion, hypothalamic autophagy is crucial for the central control of feeding, energy, and body weight balance. Conversely, decline of hypothalamic autophagy under conditions of chronic caloric excess promotes hypothalamic inflammation and thus impairs hypothalamic control of energy balance, leading to accelerated development of obesity and comorbidities.	[Cai, Dongsheng] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu			National Institutes of Health [R01 DK078750, R01 AG031774]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078750 and R01 AG031774 (to D.C.). This work was also supported by the internal support of the Albert Einstein College of Medicine (to D.C.). Part of this work was presented in 71st Annual Meeting of the American Diabetes Association.	Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Fujitani Y, 2009, AUTOPHAGY, V5, P280, DOI 10.4161/auto.5.2.7656; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Oh-I S, 2010, AM J PHYSIOL-ENDOC M, V299, pE47, DOI 10.1152/ajpendo.00026.2010; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	49	184	187	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32324	32332		10.1074/jbc.M111.254417	http://dx.doi.org/10.1074/jbc.M111.254417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784844	Green Published, hybrid			2022-12-27	WOS:000294726800042
J	Sarangapani, KK; Qian, J; Chen, W; Zarnitsyna, VI; Mehta, P; Yago, T; McEver, RP; Zhu, C				Sarangapani, Krishna K.; Qian, Jin; Chen, Wei; Zarnitsyna, Veronika I.; Mehta, Padmaja; Yago, Tadayuki; McEver, Rodger P.; Zhu, Cheng			Regulation of Catch Bonds by Rate of Force Application	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; P-SELECTIN; CELL-ADHESION; CONFORMATIONAL DYNAMICS; THRESHOLD SHEAR; MOLECULAR-BONDS; LEWIS-X; SINGLE; DISSOCIATION; SPECTROSCOPY	The current paradigm for receptor-ligand dissociation kinetics assumes off-rates as functions of instantaneous force without impact from its prior history. This a priori assumption is the foundation for predicting dissociation from a given initial state using kinetic equations. Here we have invalidated this assumption by demonstrating the impact of force history with single-bond kinetic experiments involving selectins and their ligands that mediate leukocyte tethering and rolling on vascular surfaces during inflammation. Dissociation of bonds between L-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) loaded at a constant ramp rate to a constant hold force behaved as catchslip bonds at low ramp rates that transformed to slip-only bonds at high ramp rates. Strikingly, bonds between L-selectin and 6-sulfo-sialyl Lewis X were impervious to ramp rate changes. This ligand-specific force history effect resembled the effect of a point mutation at the L-selectin surface (L-selectinA108H) predicted to contact the former but not the latter ligand, suggesting that the high ramp rate induced similar structural changes as the mutation. Although the A108H substitution in L-selectin eliminated the ramp rate responsiveness of its dissociation from PSGL-1, the inverse mutation H108A in P-selectin acquired the ramp rate responsiveness. Our data are well explained by the sliding-rebinding model for catch-slip bonds extended to incorporate the additional force history dependence, with Ala-108 playing a pivotal role in this structural mechanism. These results call for a paradigm shift in modeling the mechanical regulation of receptor-ligand bond dissociation, which includes conformational coupling between binding pocket and remote regions of the interacting molecules.	[Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chen, Wei; Zarnitsyna, Veronika I.; Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Mehta, Padmaja; Yago, Tadayuki; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), 315 Ferst Dr,IBB Bldg,Rm 3312, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Qian, Jin/C-6115-2008; Chen, Wei/C-4823-2009	Zarnitsyna, Veronika/0000-0003-3096-3695; Chen, Wei/0000-0001-5366-7253	National Institutes of Health [R01AI077343, R01HL090923]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI077343 (to C. Z. and R. P. M.) and R01HL090923 (to R. P. M.). This work was also supported by an American Heart Association predoctoral scholarship (to W. C.).	Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Klopocki AG, 2008, J BIOL CHEM, V283, P11493, DOI 10.1074/jbc.M709785200; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Prezhdo OV, 2009, ACCOUNTS CHEM RES, V42, P693, DOI 10.1021/ar800202z; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Walton EB, 2008, BIOPHYS J, V94, P2621, DOI 10.1529/biophysj.107.114454; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yago T, 2007, BIOPHYS J, V92, P330, DOI 10.1529/biophysj.106.090969; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zhang XH, 2004, CHEMPHYSCHEM, V5, P175, DOI 10.1002/cphc.200300813; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhang Y, 2008, BIOPHYS J, V95, P5439, DOI 10.1529/biophysj.108.137141; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	50	41	41	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32749	32761		10.1074/jbc.M111.240044	http://dx.doi.org/10.1074/jbc.M111.240044			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775439	hybrid, Green Published			2022-12-27	WOS:000294726800083
J	Choi, JY; Eoff, RL; Pence, MG; Wang, J; Martin, MV; Kim, EJ; Folkmann, LM; Guengerich, FP				Choi, Jeong-Yun; Eoff, Robert L.; Pence, Matthew G.; Wang, Jian; Martin, Martha V.; Kim, Eun-Jin; Folkmann, Lindsay M.; Guengerich, F. Peter			Roles of the Four DNA Polymerases of the Crenarchaeon Sulfolobus solfataricus and Accessory Proteins in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL CYTOCHROME-P-450; SLIDING-CLAMP; UV DAMAGE; FIDELITY; GENOME; BYPASS; GENE; PCNA; DPO4; P2	The hyperthermophilic crenarchaeon Sulfolobus solfataricus P2 encodes three B-family DNA polymerase genes, B1 (Dpo1), B2 (Dpo2), and B3 (Dpo3), and one Y-family DNA polymerase gene, Dpo4, which are related to eukaryotic counterparts. Both mRNAs and proteins of all four DNA polymerases were constitutively expressed in all growth phases. Dpo2 and Dpo3 possessed very low DNA polymerase and 3' to 5' exonuclease activities in vitro. Steady-state kinetic efficiencies (k(cat)/K-m) for correct nucleotide insertion by Dpo2 and Dpo3 were several orders of magnitude less than Dpo1 and Dpo4. Both the accessory proteins proliferating cell nuclear antigen and the clamp loader replication factor C facilitated DNA synthesis with Dpo3, as with Dpo1 and Dpo4, but very weakly with Dpo2. DNA synthesis by Dpo2 and Dpo3 was remarkably decreased by single-stranded binding protein, in contrast to Dpo1 and Dpo4. DNA synthesis in the presence of proliferating cell nuclear antigen, replication factor C, and single-stranded binding protein was most processive with Dpo1, whereas DNA lesion bypass was most effective with Dpo4. Both Dpo2 and Dpo3, but not Dpo1, bypassed hypoxanthine and 8-oxoguanine. Dpo2 and Dpo3 bypassed uracil and cis-syn cyclobutane thymine dimer, respectively. High concentrations of Dpo2 or Dpo3 did not attenuate DNA synthesis by Dpo1 or Dpo4. We conclude that Dpo2 and Dpo3 are much less functional and more thermolabile than Dpo1 and Dpo4 in vitro but have bypass activities across hypoxanthine, 8-oxoguanine, and either uracil or cis-syn cyclobutane thymine dimer, suggesting their catalytically limited roles in translesion DNA synthesis past deaminated, oxidized base lesions and/or UV-induced damage.	[Choi, Jeong-Yun; Eoff, Robert L.; Pence, Matthew G.; Wang, Jian; Martin, Martha V.; Folkmann, Lindsay M.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Choi, Jeong-Yun; Eoff, Robert L.; Pence, Matthew G.; Wang, Jian; Martin, Martha V.; Folkmann, Lindsay M.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Choi, Jeong-Yun; Kim, Eun-Jin] Sungkyunkwan Univ, Dept Mol Cell Biol, Div Pharmacol, Sch Med, Suwon 440746, Gyeonggi Do, South Korea; [Choi, Jeong-Yun; Kim, Eun-Jin] Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea	Vanderbilt University; Vanderbilt University; Sungkyunkwan University (SKKU)	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X	National Institutes of Health [R01 ES010375, F32 CA119776, K99 GM084460, T32 ES007028, P30 ES000267]; Ministry of Education, Science and Technology [2010-0006538]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A084187]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028, R01ES010375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM084460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), K99 GM084460 (to R. L. E.), T32 ES007028 (to F. P. G. and M. G. P.), and P30 ES000267 (to F. P. G.). This work was also supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology Grant 2010-0006538 (to J.-Y. C.) and a grant of the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Grant A084187 (to J.-Y. C.).	Bohlke K, 2002, EXTREMOPHILES, V6, P1, DOI 10.1007/s007920100222; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; Connolly BA, 2009, BIOCHEM SOC T, V37, P65, DOI 10.1042/BST0370065; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dionne I, 2008, MOL MICROBIOL, V68, P216, DOI 10.1111/j.1365-2958.2008.06150.x; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Edgell DR, 1997, J BACTERIOL, V179, P2632, DOI 10.1128/jb.179.8.2632-2640.1997; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Frols S, 2009, BIOCHEM SOC T, V37, P36, DOI 10.1042/BST0370036; Frols S, 2007, J BACTERIOL, V189, P8708, DOI 10.1128/JB.01016-07; Gotz D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r220; Gruz P, 2003, NUCLEIC ACIDS RES, V31, P4024, DOI 10.1093/nar/gkg447; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kornberg A., 1992, DNA REPLICATION; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Pisani FM, 2000, J MOL BIOL, V301, P61, DOI 10.1006/jmbi.2000.3964; PRANGISHVILI D, 1993, NUCLEIC ACIDS RES, V21, P2768, DOI 10.1093/nar/21.11.2768; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; ROBB FT, 1995, ARCHAEA LAB MANUAL, V3, P167; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Savino C, 2004, STRUCTURE, V12, P2001, DOI 10.1016/j.str.2004.09.007; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Soucek P, 1995, BIOCHEMISTRY-US, V34, P16013, DOI 10.1021/bi00049a015; van Passel M. W. J., 2007, Archaea, V2, P137, DOI 10.1155/2007/165723; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wong JHY, 2010, EMBO J, V29, P2059, DOI 10.1038/emboj.2010.101; Wu ZL, 2006, ARCH BIOCHEM BIOPHYS, V445, P138, DOI 10.1016/j.abb.2005.11.002; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zaparty M, 2010, EXTREMOPHILES, V14, P119, DOI 10.1007/s00792-009-0280-0; Zhang LK, 2009, BIOCHEMISTRY-US, V48, P7492, DOI 10.1021/bi900532w	42	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31180	31193		10.1074/jbc.M111.258038	http://dx.doi.org/10.1074/jbc.M111.258038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784862	Green Published, hybrid			2022-12-27	WOS:000294487500013
J	Ferraro, GB; Morrison, CJ; Overall, CM; Strittmatter, SM; Fournier, AE				Ferraro, Gino B.; Morrison, Charlotte J.; Overall, Christopher M.; Strittmatter, Stephen M.; Fournier, Alyson E.			Membrane-type Matrix Metalloproteinase-3 Regulates Neuronal Responsiveness to Myelin through Nogo-66 Receptor 1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; P75 NEUROTROPHIN RECEPTOR; SPINAL-CORD-INJURY; AXONAL REGENERATION; NEURITE OUTGROWTH; CELL-MIGRATION; INHIBITORS; GROWTH; GLYCOPROTEIN; PROTEIN	Nogo-66 receptor 1 (NgR1) is a glycosylphosphatidylinositol-anchored receptor for myelin-associated inhibitors that restricts plasticity and axonal regrowth in the CNS. NgR1 is cleaved from the cell surface of SH-SY5Y neuroblastoma cells in a metalloproteinase-dependent manner; however, the mechanism and physiological consequence of NgR1 shedding have not been explored. We now demonstrate that NgR1 is shed from multiple populations of primary neurons. Through a loss-of-function approach, we found that membrane-type matrix metalloproteinase-3 (MT3-MMP) regulates endogenous NgR1 shedding in primary neurons. Neuronal knockdown of MT3-MMP resulted in the accumulation of NgR1 at the cell surface and reduced the accumulation of the NgR1 cleavage fragment in medium conditioned by cortical neurons. Recombinant MT1-, MT2-, MT3-, and MT5-MMPs promoted NgR1 shedding from the surface of primary neurons, and this treatment rendered neurons resistant to myelin-associated inhibitors. Introduction of a cleavage-resistant form of NgR1 reconstitutes the neuronal response to these inhibitors, demonstrating that specific metalloproteinases attenuate neuronal responses to myelin in an NgR1-dependent manner.	[Ferraro, Gino B.; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Morrison, Charlotte J.; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA	McGill University; University of British Columbia; Yale University	Fournier, AE (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Rue Univ,BT-109, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante du Quebec; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a grant from the Canadian Institutes of Health Research (CIHR; to A. E. F.) and by a studentship from the Fonds de la Recherche en Sante du Quebec (to G. B. F.).	Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; McDonald CL, 2011, CURR MED CHEM, V18, P234; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Park JH, 2007, CURR ALZHEIMER RES, V4, P568, DOI 10.2174/156720507783018235; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Reeves TM, 2003, J NEUROSCI, V23, P10182; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Voineskos AN, 2009, J NEUROSCI, V29, P5045, DOI 10.1523/JNEUROSCI.0477-09.2009; Walmsley AR, 2004, J CELL SCI, V117, P4591, DOI 10.1242/jcs.01324; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yoshiyama Y, 1998, ACTA NEUROPATHOL, V96, P347, DOI 10.1007/s004010050904	43	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31418	31424		10.1074/jbc.M111.249169	http://dx.doi.org/10.1074/jbc.M111.249169			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768085	hybrid, Green Published			2022-12-27	WOS:000294487500036
J	Liao, BS; Hu, Y; Brewer, G				Liao, Baisong; Hu, Yan; Brewer, Gary			RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BECKWITH-WIEDEMANN SYNDROME; K562 LEUKEMIA-CELLS; CODING REGION; CANCER-CELLS; BIOLOGICAL ACTIONS; IGF-II; EXPRESSION; PROLIFERATION; TRANSLATION; MICRORNA	Ionizing radiation (IR) induces proapoptotic gene expression programs that inhibit cell survival. These programs often involve RNA-binding proteins that associate with their mRNA targets to elicit changes in mRNA stability and/or translation. The RNA-binding protein IMP-3 is an oncofetal protein overexpressed in many human malignancies. IMP-3 abundance correlates with tumor aggressiveness and poor prognosis. As such, IMP-3 is proving to be a highly significant biomarker in surgical pathology. Among its many mRNA targets, IMP-3 binds to and promotes translation of insulin-like growth factor II (IGFII) mRNA. Our earlier studies showed that reducing IMP-3 abundance with siRNAs reduced proliferation of human K562 chronic myeloid leukemia cells because of reduced IGF-II biosynthesis. However, the role of IMP-3 in apoptosis is unknown. Here, we have used IR-induced apoptosis of K562 cells as a model to explore a role for IMP-3 in cell survival. Knockdown of IMP-3 with siRNA increased susceptibility of cells to IR-induced apoptosis and led to reduced IGF-II production. Gene reporter assays revealed that IMP-3 acts through the 5' UTR of IGFII mRNA during apoptosis to promote translation. Finally, culture of IR-treated cells with recombinant IGF-II partially reversed the effects of IMP-3 knockdown on IR-induced apoptosis. Together, these results indicate that IMP-3 acts in part through the IGF-II pathway to promote cell survival in response to IR. Thus, IMP-3 might serve as a new drug target to increase sensitivity of CML cells or other cancers to IR therapy.	[Liao, Baisong; Hu, Yan; Brewer, Gary] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Brewer, G (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	brewerga@umdnj.edu			National Institutes of Health [R01 CA052443]; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA052443 (to G. B.).	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Boudoukha S, 2010, MOL CELL BIOL, V30, P5710, DOI 10.1128/MCB.00665-10; Coxon KM, 2011, METHODS MOL BIOL, V731, P293, DOI 10.1007/978-1-61779-080-5_24; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Diamond JM, 2011, LEUKEMIA LYMPHOMA, V52, P12, DOI 10.3109/10428194.2010.546920; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; ELISHA Z, 1995, EMBO J, V14, P5109, DOI 10.1002/j.1460-2075.1995.tb00193.x; Findeis-Hosey JJ, 2011, HUM PATHOL, V42, P303, DOI 10.1016/j.humpath.2010.06.003; George Ajish D, 2006, RNA Biol, V3, P57; HAMMARBERG B, 1991, J BIOL CHEM, V266, P11058; Havin L, 1998, GENE DEV, V12, P1593, DOI 10.1101/gad.12.11.1593; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kim CG, 2006, MOL CELLS, V21, P343; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Liao BS, 2004, J BIOL CHEM, V279, P48716, DOI 10.1074/jbc.M405853200; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; Masuda K, 2011, EMBO J, V30, P1040, DOI 10.1038/emboj.2011.24; Mueller F, 2003, BRIT J CANCER, V88, P699, DOI 10.1038/sj.bjc.6600790; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; PEPE MG, 1987, J CELL PHYSIOL, V133, P219, DOI 10.1002/jcp.1041330204; Perrotti D, 2011, LEUKEMIA LYMPHOMA, V52, P30, DOI 10.3109/10428194.2010.546914; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; SANDBERG AC, 1988, NEUROSCI LETT, V93, P114, DOI 10.1016/0304-3940(88)90022-5; SINGH P, 1994, AM J PHYSIOL-GASTR L, V267, pG608, DOI 10.1152/ajpgi.1994.267.4.G608; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; TALLY M, 1987, BIOCHEM BIOPH RES CO, V148, P811, DOI 10.1016/0006-291X(87)90948-X; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; van Dijk EL, 2001, NUCLEIC ACIDS RES, V29, P3477, DOI 10.1093/nar/29.17.3477; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Yi HK, 2001, EUR J CANCER, V37, P2257, DOI 10.1016/S0959-8049(01)00269-6; Yisraeli JK, 2005, BIOL CELL, V97, P87; ZAPF J, 1986, HORM RES, V24, P121, DOI 10.1159/000180551; ZHANG H, 2011, CELL DEATH IN PRESS; Zhang QM, 1997, J BIOL CHEM, V272, P23703, DOI 10.1074/jbc.272.38.23703	52	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31145	31152		10.1074/jbc.M111.263913	http://dx.doi.org/10.1074/jbc.M111.263913			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757716	hybrid, Green Published			2022-12-27	WOS:000294487500009
J	Smock, RG; Blackburn, ME; Gierasch, LM				Smock, Robert G.; Blackburn, Mandy E.; Gierasch, Lila M.			Conserved, Disordered C Terminus of DnaK Enhances Cellular Survival upon Stress and DnaK in Vitro Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; QUALITY-CONTROL; PROTEIN; ATPASE; MECHANISM	The 70-kDa heat shock proteins (Hsp70s) function as molecular chaperones through the allosteric coupling of their nucleotide- and substrate-binding domains, the structures of which are highly conserved. In contrast, the roles of the poorly structured, variable length C-terminal regions present on Hsp70s remain unclear. In many eukaryotic Hsp70s, the extreme C-terminal EEVD tetrapeptide sequence associates with co-chaperones via binding to tetratricopeptide repeat domains. It is not known whether this is the only function for this region in eukaryotic Hsp70s and what roles this region performs in Hsp70s that do not form complexes with tetratricopeptide repeat domains. We compared C-terminal sequences of 730 Hsp70 family members and identified a novel conservation pattern in a diverse subset of 165 bacterial and organellar Hsp70s. Mutation of conserved C-terminal sequence in DnaK, the predominant Hsp70 in Escherichia coli, results in significant impairment of its protein refolding activity in vitro without affecting interdomain allostery, interaction with co-chaperones DnaJ and GrpE, or the binding of a peptide substrate, defying classical explanations for the chaperoning mechanism of Hsp70. Moreover, mutation of specific conserved sites within the DnaK C terminus reduces the capacity of the cell to withstand stresses on protein folding caused by elevated temperature or the absence of other chaperones. These features of the C-terminal region support a model in which it acts as a disordered tether linked to a conserved, weak substrate-binding motif and that this enhances chaperone function by transiently interacting with folding clients.	[Smock, Robert G.; Blackburn, Mandy E.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu			National Institutes of Health [GM027616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM027616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM027616.	ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Aponte RA, 2010, J MOL BIOL, V399, P154, DOI 10.1016/j.jmb.2010.03.060; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fraga H, 2005, FEBS J, V272, P5206, DOI 10.1111/j.1742-4658.2005.04895.x; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hu SM, 1996, ARCH BIOCHEM BIOPHYS, V332, P163, DOI 10.1006/abbi.1996.0328; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kthiri F, 2008, BIOCHEM BIOPH RES CO, V374, P668, DOI 10.1016/j.bbrc.2008.07.080; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lin JS, 2011, J BIOL CHEM, V286, P19459, DOI 10.1074/jbc.M111.238741; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Posfai G, 1997, J BACTERIOL, V179, P4426, DOI 10.1128/jb.179.13.4426-4428.1997; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; TSAI MY, 1994, J BIOL CHEM, V269, P5958; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	59	44	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31821	31829		10.1074/jbc.M111.265835	http://dx.doi.org/10.1074/jbc.M111.265835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768118	Green Published, hybrid			2022-12-27	WOS:000294487500075
J	Abe, T; Sugimura, K; Hosono, Y; Takami, Y; Akita, M; Yoshimura, A; Tada, S; Nakayama, T; Murofushi, H; Okumura, K; Takeda, S; Horikoshi, M; Seki, M; Enomoto, T				Abe, Takuya; Sugimura, Kazuto; Hosono, Yoshifumi; Takami, Yasunari; Akita, Motomu; Yoshimura, Akari; Tada, Shusuke; Nakayama, Tatsuo; Murofushi, Hiromu; Okumura, Katsuzumi; Takeda, Shunichi; Horikoshi, Masami; Seki, Masayuki; Enomoto, Takemi			The Histone Chaperone Facilitates Chromatin Transcription (FACT) Protein Maintains Normal Replication Fork Rates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; DNA-REPLICATION; S-PHASE; FUNCTIONAL COOPERATION; DORMANT ORIGINS; EXCESS MCM2-7; HUMAN-CELLS; SPT16; PROGRESSION; ELONGATION	Ordered nucleosome disassembly and reassembly are required for eukaryotic DNA replication. The facilitates chromatin transcription (FACT) complex, a histone chaperone comprising Spt16 and SSRP1, is involved in DNA replication as well as transcription. FACT associates with the MCM helicase, which is involved in DNA replication initiation and elongation. Although the FACT-MCM complex is reported to regulate DNA replication initiation, its functional role in DNA replication elongation remains elusive. To elucidate the functional role of FACT in replication fork progression during DNA elongation in the cells, we generated and analyzed conditional SSRP1 gene knock-out chicken (Gallus gallus) DT40 cells. SSRP1-depleted cells ceased to grow and exhibited a delay in S-phase cell cycle progression, although SSRP1 depletion did not affect the level of chromatin-bound DNA polymerase alpha or nucleosome reassembly on daughter strands. The tracking length of newly synthesized-DNA, but not origin firing, was reduced in SSRP1-depleted cells, suggesting that the S-phase cell cycle delay is mainly due to the inhibition of replication fork progression rather than to defects in the initiation of DNA replication in these cells. We discuss the mechanisms of how FACT promotes replication fork progression in the cells.	[Horikoshi, Masami] Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Tokyo 1110032, Japan; [Abe, Takuya; Hosono, Yoshifumi; Akita, Motomu; Yoshimura, Akari; Tada, Shusuke; Seki, Masayuki; Enomoto, Takemi] Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Sendai, Miyagi 9808578, Japan; [Sugimura, Kazuto; Okumura, Katsuzumi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie 5148507, Japan; [Sugimura, Kazuto] Mie Univ, Grad Sch Med, Dept Biochem & Prote, Tsu, Mie 5148507, Japan; [Takami, Yasunari; Nakayama, Tatsuo] Miyazaki Univ, Sect Biochem & Mol Biol, Miyazaki Med Coll, Dept Med Sci, Miyazaki 8891692, Japan; [Yoshimura, Akari; Enomoto, Takemi] Musashino Univ, Fac Pharm, Pharmaceut Sci Res Inst, Tokyo 2028585, Japan; [Murofushi, Hiromu] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi 7538512, Japan; [Takeda, Shunichi] Kyoto Univ, Fac Med, Dept Radiat Genet, Kyoto 6068501, Japan	University of Tokyo; Tohoku University; Mie University; Mie University; University of Miyazaki; Yamaguchi University; Kyoto University	Horikoshi, M (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan.	horikosh@am.iu-tokyo.ac.jp; seki@mail.pharm.tohoku.ac.jp; t_eno@musashino-u.ac.jp	ABE, TAKUYA/A-2861-2015; Yoshimura, Akari/ABE-5626-2020	ABE, TAKUYA/0000-0001-5298-082X; Yoshimura, Akari/0000-0003-4883-8497; Takeda, Shunichi/0000-0002-7924-7991	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22380188, 21370075] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe T, 2008, CELL SIGNAL, V20, P1978, DOI 10.1016/j.cellsig.2008.07.006; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; GRUSS C, 1992, BIOESSAYS, V14, P1, DOI 10.1002/bies.950140102; HAND R, 1975, J HISTOCHEM CYTOCHEM, V23, P475, DOI 10.1177/23.7.1095649; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kang SW, 2000, GENES CELLS, V5, P251, DOI 10.1046/j.1365-2443.2000.00323.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tan BCM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-11; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994	65	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30504	30512		10.1074/jbc.M111.264721	http://dx.doi.org/10.1074/jbc.M111.264721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757688	Green Published, hybrid			2022-12-27	WOS:000294283600029
J	Frisdal, E; Lesnik, P; Olivier, M; Robillard, P; Chapman, MJ; Huby, T; Guerin, M; Le Goff, W				Frisdal, Eric; Lesnik, Philippe; Olivier, Maryline; Robillard, Paul; Chapman, M. John; Huby, Thierry; Guerin, Maryse; Le Goff, Wilfried			Interleukin-6 Protects Human Macrophages from Cellular Cholesterol Accumulation and Attenuates the Proinflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELLS; ABCA1-DEFICIENT MACROPHAGES; INFLAMMATORY RESPONSE; PATHWAY INHIBITOR; ATHEROSCLEROSIS; MICE; EXPRESSION; RECEPTOR	Cholesterol-laden monocyte-derived macrophages are phagocytic cells characteristic of early and advanced atherosclerotic lesions. Interleukin-6 (IL-6) is a macrophage secretory product that is abundantly expressed in atherosclerotic plaques but whose precise role in atherogenesis is unclear. The capacity of macrophages to clear apoptotic cells, through the efferocytosis mechanism, as well as to reduce cellular cholesterol accumulation contributes to prevent plaque progression and instability. By virtue of its capacity to promote cellular cholesterol efflux from phagocyte-macrophages, ABCA1 was reported to reduce atherosclerosis. We demonstrated that lipid loading in human macrophages was accompanied by a strong increase of IL-6 secretion. Interestingly, IL-6 markedly induced ABCA1 expression and enhanced ABCA1-mediated cholesterol efflux from human macrophages to apoAI. Stimulation of ABCA1-mediated cholesterol efflux by IL-6 was, however, abolished by selective inhibition of the Jak-2/Stat3 signaling pathway. In addition, we observed that the expression of molecules described to promote efferocytosis, i.e. c-mer proto-oncogene-tyrosine kinase, thrombospondin-1, and transglutaminase 2, was significantly induced in human macrophages upon treatment with IL-6. Consistent with these findings, IL-6 enhanced the capacity of human macrophages to phagocytose apoptotic cells; moreover, we observed that IL-6 stimulates the ABCA1-mediated efflux of cholesterol derived from the ingestion of free cholesterol-loaded apoptotic macrophages. Finally, the treatment of human macrophages with IL-6 led to the establishment of an anti-inflammatory cytokine profile, characterized by an increased secretion of IL-4 and IL-10 together with a decrease of that of IL-1 beta. Taken together, our results indicate that IL-6 favors the elimination of excess cholesterol in human macrophages and phagocytes by stimulation of ABCA1-mediated cellular free cholesterol efflux and attenuates the macrophage proinflammatory phenotype. Thus, high amounts of IL-6 secreted by lipid laden human macrophages may constitute a protective response from macrophages to prevent accumulation of cytotoxic-free cholesterol. Such a cellular recycling of free cholesterol may contribute to reduce both foam cell formation and the accumulation of apoptotic bodies as well as intraplaque inflammation in atherosclerotic lesions.	Univ Paris 06, INSERM, UMR S939, F-75013 Paris, France; ICAN Inst CardioMetab & Nutr, F-75013 Paris, France; Univ Paris 06, UMR S939, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Le Goff, W (corresponding author), Hop Pitie, INSERM, UMR S939, Pavillon Benjamin Delessert,83 Blvd Hop, F-75651 Paris 13, France.	wilfried.le_goff@upmc.fr	Lesnik, Philippe/AAD-7393-2020; Guerin, Maryse/N-5794-2017; 应, 宁宁/G-9472-2011; Le Goff, Wilfried/N-7593-2019; HUBY, Thierry/N-4820-2019; chapman, john/Y-2742-2019; Lesnik, Philippe F/F-7803-2011; Huby, Thierry/E-6768-2017; Le Goff, Wilfried/N-6326-2017	Lesnik, Philippe/0000-0002-6909-7715; Le Goff, Wilfried/0000-0002-7611-9644; HUBY, Thierry/0000-0001-6634-551X; Huby, Thierry/0000-0001-6634-551X; Le Goff, Wilfried/0000-0002-7611-9644; GUERIN, Maryse/0000-0003-0150-1360	INSERM; Fondation de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France)	This work was supported by INSERM and the Fondation de France.	Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cui D, 2007, J LEUKOCYTE BIOL, V82, P1040, DOI 10.1189/jlb.0307192; Daugherty A, 2005, J LIPID RES, V46, P1812, DOI 10.1194/jlr.R500009-JLR200; Dentan C, 1996, EUR J BIOCHEM, V236, P48, DOI 10.1111/j.1432-1033.1996.00048.x; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kawashiri SY, 2011, RHEUMATOL INT, V31, P451, DOI 10.1007/s00296-009-1303-y; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petit L, 1999, ARTERIOSCL THROM VAS, V19, P309, DOI 10.1161/01.ATV.19.2.309; Rebe C, 2009, CIRC RES, V105, P393, DOI 10.1161/CIRCRESAHA.109.201855; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Song L, 2004, ATHEROSCLEROSIS, V177, P43, DOI 10.1016/j.atherosclerosis.2004.06.018; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thakore AH, 2007, AM J CARDIOL, V99, P1598, DOI 10.1016/j.amjcard.2007.01.036; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Van Lenten BJ, 2001, J BIOL CHEM, V276, P1923, DOI 10.1074/jbc.M004074200; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Woods A, 2000, EUR HEART J, V21, P1574, DOI 10.1053/euhj.1999.2207; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; ZHONG WW, 1993, ARCH SURG-CHICAGO, V128, P158; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	56	79	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30926	30936		10.1074/jbc.M111.264325	http://dx.doi.org/10.1074/jbc.M111.264325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757719	hybrid, Green Published			2022-12-27	WOS:000294283600071
J	Kendall, T; Mukai, L; Jannuzi, AL; Bunch, TA				Kendall, Timmy; Mukai, Leona; Jannuzi, Alison L.; Bunch, Thomas A.			Identification of Integrin beta Subunit Mutations That Alter Affinity for Extracellular Matrix Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; METAL-BINDING SITE; CYTOPLASMIC DOMAIN; GLANZMANN THROMBASTHENIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POINT MUTATION; ALPHA-IIB-BETA-3 INTEGRIN; RECEPTOR FUNCTION; ACTIVATION	We examined over 50 mutations in the Drosophila beta PS integrin subunit that alter integrin function in situ for their ability to bind a soluble monovalent ligand, TWOW-1. Surprisingly, very few of the mutations, which were selected for conditional lethality in the fly, reduce the ligand binding ability of the integrin. The most prevalent class of mutations activates the integrin heterodimer. These findings emphasize the importance of integrin affinity regulation and point out how molecular interactions throughout the integrin molecule are important in keeping the integrin in a low affinity state. Mutations strongly support the controversial deadbolt hypothesis, where the CD loop in the beta tail domain acts to restrain the I domain in the inactive, bent conformation. Site-directed mutations in the cytoplasmic domains of beta PS and alpha PS2C reveal different effects on ligand binding from those observed for alpha IIb beta 3 integrins and identify for the first time a cytoplasmic cysteine residue, conserved in three human integrins, as being important in affinity regulation. In the fly, we find that genetic interactions of the beta PS mutations with reduction in talin function are consistent with the integrin affinity differences measured in cells. Additionally, these genetic interactions report on increased and decreased integrin functions that do not result in affinity changes in the PS2C integrin measured in cultured cells.	[Kendall, Timmy; Mukai, Leona; Jannuzi, Alison L.; Bunch, Thomas A.] Univ Arizona, Arizona Canc Ctr, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA	Arizona Center Cancer Care; University of Arizona	Bunch, TA (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Mol & Cellular Biol, Rm 3951A,1515 N Campbell Ave, Tucson, AZ 85724 USA.	tbunch@email.arizona.edu			National Institutes of Health [R01GM42474]; Cancer Center, NCI [CA 023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM42474 and CA 023074 (Cancer Center support grant from NCI).	Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bunch TA, 2006, J BIOL CHEM, V281, P5050, DOI 10.1074/jbc.M508550200; BUNCH TA, 1992, DEVELOPMENT, V116, P239; BUNCH TA, 1992, GENETICS, V132, P519; Bunch TA, 2010, J BIOL CHEM, V285, P1841, DOI 10.1074/jbc.M109.057349; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Grimaldi CM, 1996, BLOOD, V88, P1666; Helsten TL, 2008, MOL BIOL CELL, V19, P3589, DOI 10.1091/mbc.E08-01-0085; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jannuzi AL, 2004, MOL BIOL CELL, V15, P3829, DOI 10.1091/mbc.E04-02-0085; Jannuzi AL, 2002, MOL BIOL CELL, V13, P1352, DOI 10.1091/mbc.01-08-0429; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Kieffer N, 1996, CELL ADHES COMMUN, V4, P25, DOI 10.3109/15419069609010761; Krukonis ES, 2000, CELL MICROBIOL, V2, P219, DOI 10.1046/j.1462-5822.2000.00048.x; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Lindsley D. L., 1992, ANNU REV GENOM HUM G, V4, P1133; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; Matsumoto A, 2008, BIOPHYS J, V95, P2895, DOI 10.1529/biophysj.108.131045; McKay BS, 1996, J BIOL CHEM, V271, P30544, DOI 10.1074/jbc.271.48.30544; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Nair S, 2004, HAEMATOLOGICA, V89, P1529; Nurden AT, 2002, PLATELETS, V13, P101, DOI 10.1080/09537100220122466; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Perrault C, 1998, CELL ADHES COMMUN, V6, P335, DOI 10.3109/15419069809010792; Prout M, 1997, GENETICS, V146, P275; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P20438, DOI 10.1074/jbc.271.34.20438; Ruiz C, 2001, BLOOD, V98, P2432, DOI 10.1182/blood.V98.8.2432; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi ML, 2005, J BIOL CHEM, V280, P30586, DOI 10.1074/jbc.M502525200; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Sun QH, 2002, BLOOD, V100, P2094, DOI 10.1182/blood-2002-02-0418; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Vanhoorelbeke K, 2009, J BIOL CHEM, V284, P14914, DOI 10.1074/jbc.M809167200; Wright T. R., 1968, P 12 INT C GEN, V1, P41; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	65	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30981	30993		10.1074/jbc.M111.254797	http://dx.doi.org/10.1074/jbc.M111.254797			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757698	Green Published, hybrid			2022-12-27	WOS:000294283600076
J	McDowell, MA; Johnson, S; Deane, JE; Cheung, M; Roehrich, AD; Blocker, AJ; McDonnell, JM; Lea, SM				McDowell, Melanie A.; Johnson, Steven; Deane, Janet E.; Cheung, Martin; Roehrich, A. Dorothea; Blocker, Ariel J.; McDonnell, James M.; Lea, Susan M.			Structural and Functional Studies on the N-terminal Domain of the Shigella Type III Secretion Protein MxiG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEEDLE COMPLEX; FHA DOMAIN; SUPRAMOLECULAR STRUCTURE; LARGER PROTEINS; SYSTEM; PHOSPHORYLATION; SPECIFICITY; ASSIGNMENT; KINASE; IDENTIFICATION	MxiG is a single-pass membrane protein that oligomerizes within the inner membrane ring of the Shigella flexneri type III secretion system (T3SS). The MxiG N-terminal domain (MxiG-N) is the predominant cytoplasmic structure; however, its role in T3SS assembly and secretion is largely uncharacterized. We have determined the solution structure of MxiG-N residues 6-112 (MxiG-N(6-112)), representing the first published structure of this T3SS domain. The structure shows strong structural homology to forkhead-associated (FHA) domains. Canonically, these cell-signaling modules bind phosphothreonine (Thr(P)) via highly conserved residues. However, the putative phosphate-binding pocket of MxiG-N(6-112) does not align with other FHA domain structures or interact with Thr(P). Furthermore, mutagenesis of potential phosphate-binding residues has no effect on S. flexneri T3SS assembly and function. Therefore, MxiG-N has a novel function for an FHA domain. Positioning of MxiG-N(6-112) within the EM density of the S. flexneri needle complex gives insight into the ambiguous stoichiometry of the T3SS, supporting models with 24 MxiG subunits in the inner membrane ring.	[McDowell, Melanie A.; Johnson, Steven; Deane, Janet E.; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [McDonnell, James M.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Cheung, Martin; Roehrich, A. Dorothea; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Cheung, Martin; Roehrich, A. Dorothea; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Oxford; University of Oxford; University of Bristol; University of Bristol	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk	Blocker, Ariel/Q-6617-2016; Johnson, Steven J/F-9182-2016; Lea, Susan M/B-7678-2009	Johnson, Steven J/0000-0002-7877-3543; Lea, Susan M/0000-0001-9287-8053; Deane, Janet/0000-0002-4863-0330; McDowell, Melanie/0000-0002-5231-8809; McDonnell, James/0000-0001-9037-2980	Wellcome Trust [086833, 059011]; MRC [G0401595] Funding Source: UKRI; Medical Research Council [G1000758B, G1000758, G0401595] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by Wellcome Trust-funded studentship 086833.; Supported by Wellcome Trust Programme Grant 059011 (to S. M. L.).	Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; ALLAOUI A, 1995, MOL MICROBIOL, V17, P461, DOI 10.1111/j.1365-2958.1995.mmi_17030461.x; ALLAOUI A, 1992, J BACTERIOL, V174, P7661, DOI 10.1128/JB.174.23.7661-7669.1992; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deane JE, 2006, ACTA CRYSTALLOGR F, V62, P302, DOI 10.1107/S1744309106006555; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARMER BT, 1995, J AM CHEM SOC, V117, P4187, DOI 10.1021/ja00119a042; Goddard T. D., SPARKY 3; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kim JF, 2001, TRENDS GENET, V17, P65, DOI 10.1016/S0168-9525(00)02175-2; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lario PI, 2005, EMBO J, V24, P1111, DOI 10.1038/sj.emboj.7600610; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Meitert T, 1991, Roum Arch Microbiol Immunol, V50, P45; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Morita-Ishihara T., 2007, Bioscience and Microflora, V26, P29; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; PLANO GV, 1995, J BACTERIOL, V177, P3843, DOI 10.1128/jb.177.13.3843-3854.1995; Ross JA, 2011, J BACTERIOL, V193, P2276, DOI 10.1128/JB.01137-10; Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007; Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Tsai MD, 2002, STRUCTURE, V10, P887, DOI 10.1016/S0969-2126(02)00795-5; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zenk SF, 2007, MICROBIOL-SGM, V153, P2405, DOI 10.1099/mic.0.2007/007781-0	69	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30606	30614		10.1074/jbc.M111.243865	http://dx.doi.org/10.1074/jbc.M111.243865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733840	Green Published, hybrid			2022-12-27	WOS:000294283600040
J	Osanai, T; Oikawa, A; Azuma, M; Tanaka, K; Saito, K; Hirai, MY; Ikeuchi, M				Osanai, Takashi; Oikawa, Akira; Azuma, Miyuki; Tanaka, Kan; Saito, Kazuki; Hirai, Masami Yokota; Ikeuchi, Masahiko			Genetic Engineering of Group 2 sigma Factor SigE Widely Activates Expressions of Sugar Catabolic Genes in Synechocystis Species PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; ESCHERICHIA-COLI; RNA-POLYMERASE; OPCA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; CYANOBACTERIA; INACTIVATION; MECHANISMS; PATHWAYS; PRODUCT	Metabolic engineering of photosynthetic organisms is required for utilization of light energy and for reducing carbon emissions. Control of transcriptional regulators is a powerful approach for changing cellular dynamics, because a set of genes is concomitantly regulated. Here, we show that overexpression of a group 2 sigma factor, SigE, enhances the expressions of sugar catabolic genes in the unicellular cyanobacterium, Synechocystis sp. PCC 6803. Transcriptome analysis revealed that genes for the oxidative pentose phosphate pathway and glycogen catabolism are induced by overproduction of SigE. Immunoblotting showed that protein levels of sugar catabolic enzymes, such as glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, glycogen phosphorylase, and isoamylase, are increased. Glycogen levels are reduced in the SigE-overexpressing strain grown under light. Metabolome analysis revealed that metabolite levels of the TCA cycle and acetyl-CoA are significantly altered by SigE overexpression. The SigE-overexpressing strain also exhibited defective growth under mixotrophic or dark conditions. Thus, SigE overexpression changes sugar catabolism at the transcript to phenotype levels, suggesting a sigma factor-based engineering method for modifying carbon metabolism in photosynthetic bacteria.	[Osanai, Takashi; Ikeuchi, Masahiko] Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; [Osanai, Takashi; Oikawa, Akira; Saito, Kazuki; Hirai, Masami Yokota] RIKEN Plant Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Osanai, Takashi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Azuma, Miyuki; Tanaka, Kan] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Tanaka, Kan] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo; Chiba University; Chiba University	Osanai, T (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Kanagawa 2300045, Japan.	tosanai@psc.riken.jp	Oikawa, Akira/D-2715-2017; Hirai, Masami Y/D-5319-2009; Azuma, Miyuki/AAT-8928-2021; Tanaka, Kan/E-3724-2015; Saito, Kazuki/D-2670-2009	Hirai, Masami Y/0000-0003-0802-6208; Azuma, Miyuki/0000-0002-3529-4585; Tanaka, Kan/0000-0001-7560-7884; Saito, Kazuki/0000-0001-6310-5342	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nara Institute of Science and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nara Institute of Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for Japanese Society for the Promotion of Science fellows from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.O.), grant-in-aid for scientific research for plant graduate students from the Nara Institute of Science and Technology (to T.O. and M.A.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grant-in-aid for CREST (project name "Elucidation of Amino Acid Metabolism in Plants Based on Integrated Omics Analyses") from the Japan Science and Technology Agency (to M.Y.H.).	Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Perez-Perez ME, 2009, MOL PLANT, V2, P270, DOI 10.1093/mp/ssn070; Perez-Perez ME, 2006, PROTEOMICS, V6, pS186, DOI 10.1002/pmic.200500215; Fu J, 2006, FEMS MICROBIOL LETT, V260, P201, DOI 10.1111/j.1574-6968.2006.00312.x; Hagen KD, 2001, J BIOL CHEM, V276, P11477, DOI 10.1074/jbc.M010472200; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Koksharova O, 1998, PLANT MOL BIOL, V36, P183, DOI 10.1023/A:1005925732743; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Laurent S, 2008, MICROBIOL-SGM, V154, P2161, DOI 10.1099/mic.0.2007/016196-0; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Min HT, 2000, J BACTERIOL, V182, P6214, DOI 10.1128/JB.182.21.6214-6221.2000; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Osanai T, 2008, PHYSIOL PLANTARUM, V133, P490, DOI 10.1111/j.1399-3054.2008.01078.x; Osanai T, 2007, PHOTOCH PHOTOBIO SCI, V6, P508, DOI 10.1039/b616219n; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Pollari M, 2008, PLANT PHYSIOL, V147, P1994, DOI 10.1104/pp.108.122713; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; Singh AK, 2005, J BACTERIOL, V187, P2368, DOI 10.1128/JB.187.7.2368-2376.2005; Summerfield TC, 2007, J BACTERIOL, V189, P7829, DOI 10.1128/JB.01036-07; Sundaram S, 1998, MICROBIOL-SGM, V144, P1549, DOI 10.1099/00221287-144-6-1549; Tabei Y, 2007, BIOCHEM BIOPH RES CO, V355, P1045, DOI 10.1016/j.bbrc.2007.02.065; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang C, 2002, APPL MICROBIOL BIOT, V58, P813, DOI 10.1007/s00253-002-0949-0	34	77	81	1	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30962	30971		10.1074/jbc.M111.231183	http://dx.doi.org/10.1074/jbc.M111.231183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757761	Green Published, hybrid			2022-12-27	WOS:000294283600074
J	Tanaka, N; Meineke, B; Shuman, S				Tanaka, Naoko; Meineke, Birthe; Shuman, Stewart			RtcB, a Novel RNA Ligase, Can Catalyze tRNA Splicing and HAC1 mRNA Splicing in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; POLYNUCLEOTIDE KINASE; JUNCTION PHOSPHATE; CRYSTAL-STRUCTURE; CELL EXTRACT; ENZYME; EUKARYOTES; MECHANISM; PRECURSOR; LIGATION	RtcB enzymes are novel RNA ligases that join 2',3' -cyclic phosphate and 5' -OH ends. The phylogenetic distribution of RtcB points to its candidacy as a tRNA splicing/repair enzyme. Here we show that Escherichia coli RtcB is competent and sufficient for tRNA splicing in vivo by virtue of its ability to complement growth of yeast cells that lack the endogenous "healing/sealing-type" tRNA ligase Trl1. RtcB also protects yeast trl1 Delta cells against a fungal ribotoxin that incises the anticodon loop of cellular tRNAs. Moreover, RtcB can replace Trl1 as the catalyst of HAC1 mRNA splicing during the unfolded protein response. Thus, RtcB is a bona fide RNA repair enzyme with broad physiological actions. Biochemical analysis of RtcB highlights the uniqueness of its active site and catalytic mechanism. Our findings draw attention to tRNA ligase as a promising drug target.	[Tanaka, Naoko; Meineke, Birthe; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046330, R37GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330 (to S. S.).	AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Brooks MA, 2008, PROTEIN SCI, V17, P1336, DOI 10.1110/ps.035493.108; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Kato-Murayama M, 2005, J MOL BIOL, V348, P295, DOI 10.1016/j.jmb.2005.02.049; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Schwer B, 2004, P NATL ACAD SCI USA, V101, P2788, DOI 10.1073/pnas.0305859101; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Spinelli SL, 1998, P NATL ACAD SCI USA, V95, P14136, DOI 10.1073/pnas.95.24.14136; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Torchia C, 2008, NUCLEIC ACIDS RES, V36, P6218, DOI 10.1093/nar/gkn602; Wang LK, 2005, RNA, V11, P966, DOI 10.1261/rna.2170305; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	26	69	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30253	30257		10.1074/jbc.C111.274597	http://dx.doi.org/10.1074/jbc.C111.274597			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757685	hybrid, Green Published			2022-12-27	WOS:000294283600002
J	Castonguay, R; Werner, ED; Matthews, RG; Presman, E; Mulivor, AW; Solban, N; Sako, D; Pearsall, RS; Underwood, KW; Seehra, J; Kumar, R; Grinberg, AV				Castonguay, Roselyne; Werner, Eric D.; Matthews, Robert G.; Presman, Eleonora; Mulivor, Aaron W.; Solban, Nicolas; Sako, Dianne; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.			Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; BETA-RECEPTOR COMPLEX; ENDOTHELIAL-CELLS; ANGIOGENESIS; IDENTIFICATION; EXPRESSION; MICE; PROLIFERATION; BETAGLYCAN; MUTATIONS	Endoglin (CD105), a transmembrane protein of the transforming growth factor beta superfamily, plays a crucial role in angiogenesis. Mutations in endoglin result in the vascular defect known as hereditary hemorrhagic telangiectasia (HHT1). The soluble form of endoglin was suggested to contribute to the pathogenesis of preeclampsia. To obtain further insight into its function, we cloned, expressed, purified, and characterized the extracellular domain (ECD) of mouse and human endoglin fused to an immunoglobulin Fc domain. We found that mouse and human endoglin ECD-Fc bound directly, specifically, and with high affinity to bone morphogenetic proteins 9 and 10 (BMP9 and BMP10) in surface plasmon resonance (Biacore) and cell-based assays. We performed a function mapping analysis of the different domains of endoglin by examining their contributions to the selectivity and biological activity of the protein. The BMP9/BMP10 binding site was localized to the orphan domain of human endoglin composed of the amino acid sequence 26-359. We established that endoglin and type II receptors bind to overlapping sites on BMP9. In the in vivo chick chorioallantoic membrane assay, the mouse and the truncated human endoglin ECD-Fc both significantly reduced VEGF-induced vessel formation. Finally, murine endoglin ECD-Fc acted as an anti-angiogenic factor that decreased blood vessel sprouting in VEGF/FGF-induced angiogenesis in in vivo angioreactors and reduced the tumor burden in the colon-26 mouse tumor model. Together our findings indicate an important role of soluble endoglin ECD in the regulation of angiogenesis and highlight efficacy of endoglin-Fc as a potential anti-angiogenesis therapeutic agent.	[Castonguay, Roselyne; Werner, Eric D.; Matthews, Robert G.; Presman, Eleonora; Mulivor, Aaron W.; Solban, Nicolas; Sako, Dianne; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.] Acceleron Pharma Inc, Cambridge, MA 02139 USA	Acceleron Pharma	Grinberg, AV (corresponding author), Acceleron Pharma Inc, 128 Sidney St, Cambridge, MA 02139 USA.	agrinberg@acceleronpharma.com			Acceleron Pharma	Acceleron Pharma	We thank Tim Ahern, a scientific/technical writer supported by Acceleron Pharma, who provided editorial assistance during preparation of this manuscript. We also thank Erin Ronayne and Tiffany Travis for preparation and purification of several endoglin constructs, Eileen Pobre, Dianne Mitchell, and June Liu for assay development work, Erik Vogan for secondary structure prediction, John Knopf and John Quisel for critical review of the manuscript, and all members of Acceleron Pharma Cell Biology, Protein Biochemistry, and Preclinical Pharmacology groups for contributions in support of this work.	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Nockowski Piotr, 2004, Acta Dermatovenerol Croat, V12, P2; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Signore C, 2008, PRENATAL DIAG, V28, P852, DOI 10.1002/pd.2065; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; VENTURA F, 1994, EMBO J, V13, P5581, DOI 10.1002/j.1460-2075.1994.tb06895.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wehner LE, 2006, CLIN GENET, V69, P239, DOI 10.1111/j.1399-0004.2006.00574.x	36	151	165	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30034	30046		10.1074/jbc.M111.260133	http://dx.doi.org/10.1074/jbc.M111.260133			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737454	hybrid, Green Published			2022-12-27	WOS:000294046600062
J	Choi, UB; Xiao, SF; Wollmuth, LP; Bowen, ME				Choi, Ucheor B.; Xiao, Shifeng; Wollmuth, Lonnie P.; Bowen, Mark E.			Effect of Src Kinase Phosphorylation on Disordered C-terminal Domain of N-Methyl-D-aspartic Acid (NMDA) Receptor Subunit GluN2B Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NR2 SUBUNITS; TRAFFICKING; ZINC; PALMITOYLATION; HIPPOCAMPAL; CHARGE	NMDA receptors are ligand-gated ion channels with a regulatory intracellular C-terminal domain (CTD). In GluN2B, the CTD is the largest domain in the protein but is intrinsically disordered. The GluN2B subunit is the major tyrosine-phosphorylated protein in synapses. Src kinase phosphorylates the GluN2B CTD, but it is unknown how this affects channel activity. In disordered proteins, phosphorylation can tip the balance between order and disorder. Transitions can occur in both directions, so it is not currently possible to predict the effects of phosphorylation. We used single molecule fluorescence to characterize the effects of Src phosphorylation on GluN2B. Scanning fluorescent labeling sites throughout the domain showed no positional dependence of the energy transfer. Instead, efficiency only scaled with the separation between labeling sites suggestive of a relatively featureless conformational energy landscape. Src phosphorylation led to a general expansion of the polypeptide, which would result in greater exposure of known protein-binding sites and increase the physical separation between contiguous sites. Phosphorylation makes the CTD more like a random coil leaving open the question of how Src exerts its effects on the NMDA receptor.	[Choi, Ucheor B.; Bowen, Mark E.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Xiao, Shifeng] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bowen, ME (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, BST 5-121, Stony Brook, NY 11794 USA.	mark.bowen@sunysb.edu		Wollmuth, Lonnie/0000-0002-8179-1259; Bowen, Mark/0000-0002-9525-6986	National Institutes of Health [MH081923, MH066892]; National Research Service Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081923, R01MH066892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH081923 (to M. E. B.) and MH066892 (to L. P. W.). This work was also supported by a National Research Service Award (to U. B. C.).	Ascher P, 1998, NAT NEUROSCI, V1, P173, DOI 10.1038/619; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McCann JJ, 2011, STRUCTURE, V19, P810, DOI 10.1016/j.str.2011.02.017; McCann JJ, 2010, BIOPHYS J, V99, P961, DOI 10.1016/j.bpj.2010.04.063; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sass LE, 2010, BIOCHEMISTRY-US, V49, P3174, DOI 10.1021/bi901871u; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Xiong ZG, 1999, J NEUROSCI, V19; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	38	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29904	29912		10.1074/jbc.M111.258897	http://dx.doi.org/10.1074/jbc.M111.258897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712388	Green Published, hybrid			2022-12-27	WOS:000294046600049
J	Evans, SF; Irmady, K; Ostrow, K; Kim, T; Nykjaer, A; Saftig, P; Blobel, C; Hempstead, BL				Evans, Sarah Felice; Irmady, Krithi; Ostrow, Katya; Kim, Taeho; Nykjaer, Anders; Saftig, Paul; Blobel, Carl; Hempstead, Barbara L.			Neuronal Brain-derived Neurotrophic Factor Is Synthesized in Excess, with Levels Regulated by Sortilin-mediated Trafficking and Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; ACTIVITY-DEPENDENT SECRETION; BDNF MESSENGER-RNA; CONVERTING-ENZYME; GROWTH-FACTOR; FACTOR-RECEPTOR; CELL-DEATH; VAL66MET POLYMORPHISM; ALZHEIMERS-DISEASE	Brain-derived neurotrophic factor (BDNF) regulates neuronal differentiation, synaptic plasticity, and morphology, and modest changes in BDNF levels results in complex behavioral phenotypes. BDNF levels and intracellular localization in neurons are regulated by multiple mechanisms, including use of distinct promoters, mRNA and protein transport, and regulated cleavage of proBDNF to mature BDNF. Sortilin is an intracellular chaperone that binds to the prodomain of BDNF to traffic it to the regulated secretory pathway. However, sortilin binds to numerous ligands and plays a major role in mannose 6-phosphate receptor-independent transport of lysosomal hydrolases utilizing motifs in the intracellular domain that mediate trafficking from the Golgi and late endosomes. Sortilin is modified by ectodomain shedding, although the biological implications of this are not known. Here we demonstrate that ADAM10 is the preferred protease to cleave sortilin in the extracellular stalk region, to release the ligand binding sortilin ectodomain from the transmembrane and cytoplasmic domains. We identify sortilin shedding at the cell surface and in an intracellular compartment. Both sortilin and BDNF are trafficked to and degraded by the lysosome in neurons, and this is dependent upon the sortilin cytoplasmic tail. Indeed, expression of the sortilin ectodomain, which corresponds to the domain released after shedding, impairs lysosomal targeting and degradation of BDNF. These findings characterize the regulation of sortilin shedding and identify a novel mechanism by which sortilin ectodomain shedding acts as a regulatory switch for delivery of BDNF to the secretory pathway or to the lysosome, thus modulating the bioavailability of endogenous BDNF.	[Irmady, Krithi; Ostrow, Katya; Hempstead, Barbara L.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10065 USA; [Evans, Sarah Felice; Hempstead, Barbara L.] Cornell Univ, Grad Program Neurosci, New York, NY 10065 USA; [Kim, Taeho] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nykjaer, Anders] Univ Aarhus, Dept Med Biochem, MIND Ctr, DK-8000 Aarhus, Denmark; [Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, York, Germany; [Blobel, Carl] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA	Cornell University; Cornell University; Stanford University; Aarhus University; University of Kiel	Hempstead, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10065 USA.	blhempst@med.cornell.edu	Saftig, Paul/A-7966-2010; Evans, Sarah/AAI-1228-2021	Nykjaer, Anders/0000-0001-6422-6736; Irmady, Krithi/0000-0003-2034-1809	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687, R01NS064114] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS064114, R01 NS030687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Akaneya Y, 1997, J NEUROSCI, V17, P6707; Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Canuel M, 2008, BIOCHEM BIOPH RES CO, V373, P292, DOI 10.1016/j.bbrc.2008.06.021; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Canuel M, 2009, HISTOL HISTOPATHOL, V24, P481, DOI 10.14670/HH-24.481; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ehlers MRW, 1996, BIOCHEMISTRY-US, V35, P9549, DOI 10.1021/bi9602425; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Gatta L, 2009, J NEURAL TRANSM, V116, P79, DOI 10.1007/s00702-008-0147-z; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kieseier BC, 2003, GLIA, V42, P398, DOI 10.1002/glia.10226; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; Navarro V, 2002, BIOCHEM BIOPH RES CO, V298, P760, DOI 10.1016/S0006-291X(02)02564-0; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rybakowski JK, 2008, PHARMACOGENOMICS, V9, P1589, DOI 10.2217/14622416.9.11.1589; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Solomon KA, 1997, J IMMUNOL, V159, P4524; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001	71	80	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29556	29567		10.1074/jbc.M111.219675	http://dx.doi.org/10.1074/jbc.M111.219675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730062	Green Published, hybrid			2022-12-27	WOS:000294046600013
J	Geraghty, P; Dabo, AJ; D'Armiento, J				Geraghty, Patrick; Dabo, Abdoulaye J.; D'Armiento, Jeanine			TLR4 Protein Contributes to Cigarette Smoke-induced Matrix Metalloproteinase-1 (MMP-1) Expression in Chronic Obstructive Pulmonary Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NEUTRAL SPHINGOMYELINASE 2; GENE-EXPRESSION; DIFFERENTIAL REGULATION; LUNG INFLAMMATION; HUMAN MONOCYTES; KAPPA-B; EMPHYSEMA; KINASE; ACTIVATION	Cigarette smoke is the major risk factor associated with the development of chronic obstructive pulmonary disease and alters expression of proteolytic enzymes that contribute to disease pathology. Previously, we reported that smoke exposure leads to the induction of matrix metalloproteinase-1 (MMP-1) through the activation of ERK1/2, which is critical to the development of emphysema. To date, the upstream signaling pathway by which cigarette smoke induces MMP-1 expression has been undefined. This study demonstrates that cigarette smoke mediates MMP-1 expression via activation of the TLR4 signaling cascade. In vitro cell culture studies demonstrated that cigarette smoke-induced MMP-1 was regulated by TLR4 via MyD88/IRAK1. Blockade of TLR4 or inhibition of IRAK1 prevented cigarette smoke induction of MMP-1. Mice exposed to acute levels of cigarette smoke exhibited increased TLR4 expression. To further confirm the in vivo relevance of this signaling pathway, rabbits exposed to acute cigarette smoke were found to have elevated TLR4 signaling and subsequent MMP-1 expression. Additionally, lungs from smokers exhibited elevated TLR4 and MMP-1 levels. Therefore, our data indicate that TLR4 signaling, through MyD88 and IRAK1, plays a predominant role in MMP-1 induction by cigarette smoke. The identification of the TLR4 pathway as a regulator of smoke-induced protease production presents a series of novel targets for future therapy in chronic obstructive pulmonary disease.	[D'Armiento, Jeanine] Columbia Univ, Coll Phys & Surg, Dept Med, Med Ctr, New York, NY 10032 USA	Columbia University	D'Armiento, J (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	jmd12@columbia.edu		Geraghty, Patrick/0000-0003-1647-5505	National Institutes of Health [R01 HL086936, T32 HL007343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL086936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL086936 (to J.D.) and Training Grant T32 HL007343 (to P.G.).	Ahmad R, 2007, CELL SIGNAL, V19, P2549, DOI 10.1016/j.cellsig.2007.08.013; Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Cuschieri J, 2006, J LEUKOCYTE BIOL, V80, P407, DOI 10.1189/jlb.1105622; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Foronjy R, 2001, RESPIR RES, V2, P348, DOI 10.1186/rr85; Foronjy RF, 2003, AM J PHYSIOL-LUNG C, V284, pL727, DOI 10.1152/ajplung.00349.2002; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Friedland JS, 2002, MATRIX BIOL, V21, P103, DOI 10.1016/S0945-053X(01)00175-5; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Greene CM, 2008, EXPERT OPIN THER TAR, V12, P1481, DOI [10.1517/14728220802515293, 10.1517/14728220802515293 ]; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koch S, 2009, J MOL MED, V87, P261, DOI 10.1007/s00109-008-0420-5; Lai WC, 2003, J IMMUNOL, V170, P6244, DOI 10.4049/jimmunol.170.12.6244; LAURENT P, 1983, CHEST, V83, pS63, DOI 10.1378/chest.83.5.63S; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Maes T, 2006, INT ARCH ALLERGY IMM, V141, P354, DOI 10.1159/000095462; McColgan P, 2009, INT J CANCER, V125, P1473, DOI 10.1002/ijc.24441; McGettrick AF, 2010, SUBCELL BIOCHEM, V53, P153, DOI 10.1007/978-90-481-9078-2_7; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Mercer Becky, 2006, Proc Am Thorac Soc, V3, P477, DOI 10.1513/pats.200603-041MS; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; O'Neill LAJ, 2005, NAT MED, V11, P1161, DOI 10.1038/nm1105-1161; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Pauly JL, 2010, IMMUNOL RES, V46, P127, DOI 10.1007/s12026-009-8117-6; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Sarir H, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-12; SHAH SA, J THORAC CARDIOVASC, V139, P984; SHAH SA, J THORAC CARDIOVASC, V139, P990; Shiomi T, 2003, EXP LUNG RES, V29, P1, DOI 10.1080/01902140303761; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Su SL, 2005, OSTEOARTHR CARTILAGE, V13, P879, DOI 10.1016/j.joca.2005.04.017; Sundararaj KP, 2008, J LEUKOCYTE BIOL, V84, P1120, DOI 10.1189/jlb.0108064; Togbe D, 2006, LAB INVEST, V86, P1126, DOI 10.1038/labinvest.3700473; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; Walters MJ, 2005, MOL PHARMACOL, V68, P1343, DOI 10.1124/mol.105.012591; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	57	60	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30211	30218		10.1074/jbc.M111.238824	http://dx.doi.org/10.1074/jbc.M111.238824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730072	Green Published, hybrid			2022-12-27	WOS:000294046600078
J	Wojtala, RL; Tavares, IA; Morton, PE; Valderrama, F; Thomas, NSB; Morris, JDH				Wojtala, Rachael L.; Tavares, Ignatius A.; Morton, Penny E.; Valderrama, Ferran; Thomas, N. Shaun B.; Morris, Jonathan D. H.			Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Are Activated in Mitosis and Contribute to Mitotic Cell Rounding and Spindle Positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; STE20-LIKE KINASE; PROTEIN-KINASE; MICROTUBULE ORGANIZATION; P21-ACTIVATED KINASES; PHOSPHORYLATION; ACTIN; SLK; GROWTH; TAO1	Prostate-derived sterile 20-like kinases (PSKs) 1-alpha, 1-beta, and 2 are members of the germinal-center kinase-like sterile 20 family of kinases. Previous work has shown that PSK 1-alpha binds and stabilizes microtubules whereas PSK2 destabilizes microtubules. Here, we have investigated the activation and autophosphorylation of endogenous PSKs and show that their catalytic activity increases as cells accumulate in G(2)/M and declines as cells exit mitosis. PSKs are stimulated in synchronous HeLa cells as they progress through mitosis, and these proteins are activated catalytically during each stage of mitosis. During prophase and metaphase activated PSKs are located in the cytoplasm and at the spindle poles, and during telophase and cytokinesis stimulated PSKs are present in trans-Golgi compartments. In addition, small interferingRNA(siRNA) knockdown of PSK1-alpha/beta or PSK2 expression inhibits mitotic cell rounding as well as spindle positioning and centralization. These results show that PSK catalytic activity increases during mitosis and suggest that these proteins can contribute functionally to mitotic cell rounding and spindle centralization during cell division.	[Wojtala, Rachael L.; Tavares, Ignatius A.; Morton, Penny E.; Morris, Jonathan D. H.] Kings Coll London, Canc Div, London SE1 1UL, England; [Valderrama, Ferran] St George Hosp, Div Biomed Sci, London SW17 0RE, England; [Thomas, N. Shaun B.] Kings Coll London, Canc Div, Rayne Inst, London SE5 9NU, England	University of London; King's College London; St Georges University London; University of London; King's College London	Morris, JDH (corresponding author), Kings Coll London, Canc Div, New Hunts House,Guys Campus, London SE1 1UL, England.	jonathan.morris@kcl.ac.uk		Morris, Jonathan/0000-0002-3211-1798	Association for International Cancer Research (St. Andrews, Scotland); King's Medical Research Trust; Biotechnology and Biological Sciences Research Council United Kingdom [29/C14086]; Laura Price; Leukemia and Lymphoma Research	Association for International Cancer Research (St. Andrews, Scotland); King's Medical Research Trust; Biotechnology and Biological Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Laura Price; Leukemia and Lymphoma Research	This work was supported by the Association for International Cancer Research (St. Andrews, Scotland), King's Medical Research Trust, the Biotechnology and Biological Sciences Research Council United Kingdom Grant 29/C14086, and by a donation from Laura Price.; Supported by Leukemia and Lymphoma Research.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Banerjee M, 2002, CURR BIOL, V12, P1233, DOI 10.1016/S0960-9822(02)00956-9; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bompard G, 2010, J CELL BIOL, V190, P807, DOI 10.1083/jcb.200912056; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; Dallol A, 2009, CURR BIOL, V19, P1227, DOI 10.1016/j.cub.2009.05.064; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Johnson TM, 2008, BIOCHEMISTRY-US, V47, P3688, DOI 10.1021/bi702134c; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Liu T, 2010, J CELL SCI, V123, P2708, DOI 10.1242/jcs.068726; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Timm T, 2006, NEURODEGENER DIS, V3, P207, DOI 10.1159/000095258; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Tsutsumi T, 2008, ARCH BIOCHEM BIOPHYS, V477, P267, DOI 10.1016/j.abb.2008.07.013; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Westhorpe FG, 2010, CHROMOSOMA, V119, P371, DOI 10.1007/s00412-010-0261-1; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wuhr M, 2009, CELL CYCLE, V8, P1115; Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021; Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200; Zihni C, 2007, J BIOL CHEM, V282, P6484, DOI 10.1074/jbc.M608336200; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	58	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30161	30170		10.1074/jbc.M111.228320	http://dx.doi.org/10.1074/jbc.M111.228320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705329	Green Published, hybrid			2022-12-27	WOS:000294046600073
J	Fernandez, N; Gottardo, FL; Alonso, MN; Monczor, F; Shayo, C; Davio, C				Fernandez, Natalia; Gottardo, Federico L.; Alonso, Maria N.; Monczor, Federico; Shayo, Carina; Davio, Carlos			Roles of Phosphorylation-dependent and -independent Mechanisms in the Regulation of Histamine H2 Receptor by G Protein-coupled Receptor Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; ADENYLYL-CYCLASE; BETA-ARRESTINS; RGS PROTEINS; DESENSITIZATION; INTERNALIZATION; CELLS; INVOLVEMENT; RECEPTOR-KINASE-2; INHIBITION	It is widely assumed that G protein-coupled receptor kinase 2 (GRK2)-mediated specific inhibition of G protein-coupled receptors (GPCRs) response involves GRK-mediated receptor phosphorylation followed by beta-arrestin binding and subsequent uncoupling from the heterotrimeric G protein. It has recently become evident that GRK2-mediated GPCRs regulation also involves phosphorylation-independent mechanisms. In the present study we investigated whether the histamine H2 receptor (H2R), a G alpha(s)-coupled GPCR known to be desensitized by GRK2, needs to be phosphorylated for its desensitization and/or internalization and resensitization. For this purpose we evaluated the effect of the phosphorylating-deficient GRK2K220R mutant on H2R signaling in U937, COS7, and HEK293T cells. We found that although this mutant functioned as dominant negative concerning receptor internalization and resensitization, it desensitized H2R signaling in the same degree as the GRK2 wild type. To identify the domains responsible for the kinase-independent receptor desensitization, we co-transfected the receptor with constructions encoding the GRK2 RGS-homology domain (RH) and the RH or the kinase domain fused to the pleckstrin-homology domain. Results demonstrated that the RH domain of GRK2 was sufficient to desensitize the H2R. Moreover, disruption of RGS functions by the use of GRK2D110A/K220R double mutant, although coimmunoprecipitating with the H2R, reversed GRK2K220R-mediated H2R desensitization. Overall, these results indicate that GRK2 induces desensitization of H2R through a phosphorylation-independent and RGS-dependent mechanism and extends the GRK2 RH domain-mediated regulation of GPCRs beyond G alpha(q)-coupled receptors. On the other hand, GRK2 kinase activity proved to be necessary for receptor internalization and the resulting resensitization.	[Fernandez, Natalia; Gottardo, Federico L.; Monczor, Federico; Davio, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Lab Farmacol Receptores, Catedra Quim Med, RA-1113 Buenos Aires, DF, Argentina; [Alonso, Maria N.; Shayo, Carina] Inst Biol & Med Expt, Lab Farmacol & Patol Mol, RA-1426 Buenos Aires, DF, Argentina; [Fernandez, Natalia; Alonso, Maria N.; Monczor, Federico; Shayo, Carina; Davio, Carlos] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez, N (corresponding author), Junin 956, RA-1113 Buenos Aires, DF, Argentina.	natycfernandez@gmail.com			Universidad de Buenos Aires [UBACyT B050, B808]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 38318]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [CONICET-PIP 6110]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	This work was supported by Universidad de Buenos Aires Grants UBACyT B050 and B808, Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 38318, and Consejo Nacional de Investigaciones Cientificas y Tecnologicas Grant CONICET-PIP 6110. This work was also supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas fellowships (to M. N. A.).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Day PW, 2004, METHOD ENZYMOL, V390, P295; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Fernandez N, 2002, MOL PHARMACOL, V62, P1506, DOI 10.1124/mol.62.6.1506; Fernandez N, 2008, MOL PHARMACOL, V74, P1109, DOI 10.1124/mol.108.045336; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Horie K, 2000, J BIOL CHEM, V275, P29433, DOI 10.1074/jbc.M003413200; Jean-Baptiste G, 2006, CELL MOL LIFE SCI, V63, P1969, DOI 10.1007/s00018-006-6066-y; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lazari MDM, 1999, MOL ENDOCRINOL, V13, P866, DOI 10.1210/me.13.6.866; Legnazzi BL, 2000, BIOCHEM PHARMACOL, V60, P159, DOI 10.1016/S0006-2952(00)00295-1; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Luttrell LM, 2002, J CELL SCI, V115, P455; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PEI G, 1995, MOL PHARMACOL, V48, P173; Reiter E, 2001, BIOCHEM BIOPH RES CO, V282, P71, DOI 10.1006/bbrc.2001.4534; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Sachs G, 2002, BEST PRACT RES CL GA, V16, P835, DOI 10.1053/bega.2002.0338; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Shayo C, 2004, BIOCHEM BIOPH RES CO, V314, P798, DOI 10.1016/j.bbrc.2003.12.166; Shayo C, 2001, MOL PHARMACOL, V60, P1049, DOI 10.1124/mol.60.5.1049; Spitaler MM, 2002, CLIN EXP PHARMACOL P, V29, P711, DOI 10.1046/j.1440-1681.2002.03704.x; Sterne-Marr R, 2004, METHOD ENZYMOL, V390, P310; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440	36	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28697	28706		10.1074/jbc.M111.269613	http://dx.doi.org/10.1074/jbc.M111.269613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705320	hybrid, Green Published			2022-12-27	WOS:000293837000007
J	van 't Veer, C; van den Pangaart, PS; Kruijswijk, D; Florquin, S; de Vos, AF; van der Poll, T				van 't Veer, Cornelis; van den Pangaart, Petra S.; Kruijswijk, Danielle; Florquin, Sandrine; de Vos, Alex F.; van der Poll, Tom			Delineation of the Role of Toll-like Receptor Signaling during Peritonitis by a Gradually Growing Pathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE SEPSIS; PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; ACCELERATED BACTERIAL CLEARANCE; IFN-GAMMA PRODUCTION; INTRAABDOMINAL INFECTIONS; CYTOKINE SIGNALING-1; HOST RESPONSE; IN-VIVO; IRAK-M; MICE	In a mouse model of Escherichia coli sepsis characterized by a primary peritoneal infection with 10(4) E. coli and a gradually growing bacterial load, we here show that the early cytokine response and antibacterial defense are dominated by TLR4 via a cooperative action of MyD88 and Trif. Although MyD88(-/-) mice succumbed earlier than WT mice in this E. coli peritonitis model, Trif(-/-) mice displayed a small but significant survival advantage. Despite a large early deficit in antimicrobial defense, TLR4(-/-) mice showed an unaltered survival with normal neutrophil attraction to the peritoneal cavity and normal or even elevated late cytokine release. TLR2 compensated for the lack of TLR4 because TLR2(-/-)/TLR4(-/-) mice did show decreased neutrophil attraction and increased mortality compared with WT mice. Nearly normal early peritoneal TNF alpha production and lack of early counterregulating systemic levels of the chemoattractant KC were associated with normal peritoneal neutrophil attraction in TLR4(-/-) mice. Late stage increased TNF, IL-1 beta, IFN-beta, and typical IFN-gamma production in TLR4(-/-) mice prompted us to evaluate expression of the negative feedback regulator SOCS-1. Lack of early hepatic SOCS-1 expression in TLR4(-/-) mice explained the late innate production of IFN-gamma by the liver in TLR4(-/-) mice in this low dose E. coli peritonitis model. In contrast, early TLR4-induced IFN-gamma production is described as a hallmark in high dose E. coli peritonitis models. The present study displays how the kinetics of pro-and anti-inflammatory mechanisms are regulated by TLRs during peritonitis by a gradually growing E. coli load and how these kinetics may affect outcome.	[van 't Veer, Cornelis] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van 't Veer, Cornelis; van den Pangaart, Petra S.; Kruijswijk, Danielle; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam	van 't Veer, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, G2-131,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.vantveer@amc.uva.nl	Florquin, Sandrine/B-8242-2012	Florquin, Sandrine/0000-0002-9676-1722				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ami K, 2002, J IMMUNOL, V169, P4437, DOI 10.4049/jimmunol.169.8.4437; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brook I, 2008, DIGEST DIS SCI, V53, P2585, DOI 10.1007/s10620-007-0194-6; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Hajishengallis G, 2005, INFECT IMMUN, V73, P1343, DOI 10.1128/IAI.73.3.1343-1349.2005; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Haziot A, 2001, J IMMUNOL, V166, P1075, DOI 10.4049/jimmunol.166.2.1075; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOLZHEIMER RG, 1991, INFECTION, V19, P447, DOI 10.1007/BF01726463; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Hoshino K, 1999, J IMMUNOL, V162, P3749; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; MCCLEAN KL, 1994, CLIN INFECT DIS, V19, P100, DOI 10.1093/clinids/19.1.100; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nazareth H, 2007, INFECT IMMUN, V75, P2776, DOI 10.1128/IAI.01095-06; Newman N, 2009, SCAND J INFECT DIS, V41, P720, DOI 10.1080/00365540903159261; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Renckens R, 2006, J IMMUNOL, V177, P1189, DOI 10.4049/jimmunol.177.2.1189; Sewnath ME, 2001, J IMMUNOL, V166, P6323, DOI 10.4049/jimmunol.166.10.6323; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang MC, 2009, CLIN MICROBIOL INFEC, V15, P372, DOI 10.1111/j.1469-0691.2009.02708.x; Weijer S, 2003, INFECT IMMUN, V71, P5488, DOI 10.1128/IAI.71.10.5488-5497.2003; Wiersinga WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003494; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	47	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36603	36618		10.1074/jbc.M110.189126	http://dx.doi.org/10.1074/jbc.M110.189126			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21690093	Green Published, hybrid			2022-12-27	WOS:000296538300044
J	Dubois, D; Baron, O; Cougnoux, A; Delmas, J; Pradel, N; Boury, M; Bouchon, B; Bringer, MA; Nougayrede, JP; Oswald, E; Bonnet, R				Dubois, Damien; Baron, Olivier; Cougnoux, Antony; Delmas, Julien; Pradel, Nathalie; Boury, Michele; Bouchon, Bernadette; Bringer, Marie-Agnes; Nougayrede, Jean-Philippe; Oswald, Eric; Bonnet, Richard			ClbP Is a Prototype of a Peptidase Subgroup Involved in Biosynthesis of Nonribosomal Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; SERINE BETA-LACTAMASES; ESCHERICHIA-COLI; CATALYTIC MECHANISM; MOLECULAR-GRAPHICS; SPECIFICITY; INHIBITION; POLYKETIDE; EVOLUTION; SUBSTRATE	The pks genomic island of Escherichia coli encodes polyketide (PK) and nonribosomal peptide (NRP) synthases that allow assembly of a putative hybrid PK-NRP compound named colibactin that induces DNA double-strand breaks in eukaryotic cells. The pks-encoded machinery harbors an atypical essential protein, ClbP. ClbP crystal structure and mutagenesis experiments revealed a serine-active site and original structural features compatible with peptidase activity, which was detected by biochemical assays. Ten ClbP homologs were identified in silico in NRP genomic islands of closely and distantly related bacterial species. All tested ClbP homologs were able to complement a clbP-deficient E. coli mutant. ClbP is therefore a prototype of a new subfamily of extracytoplasmic peptidases probably involved in the maturation of NRP compounds. Such peptidases will be powerful tools for the manipulation of NRP biosynthetic pathways.	[Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] INSERM, U1043, F-31076 Toulouse, France; [Dubois, Damien; Delmas, Julien; Bonnet, Richard] Ctr Hosp Clermont Ferrand, Lab Bacteriol Clin, F-63003 Clermont Ferrand, France; [Dubois, Damien; Cougnoux, Antony; Delmas, Julien; Pradel, Nathalie; Bringer, Marie-Agnes; Bonnet, Richard] Univ Clermont Ferrand 2, Inst Natl Rech Agron, JE Univ Auvergne 2526, Unite Contrat 2018, F-63001 Clermont Ferrand, France; [Bouchon, Bernadette] INSERM, U990, Clermont Ferrand, France; [Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] CNRS, U5282, F-31076 Toulouse, France; [Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] INRA, Unite Contrat, F-31076 Toulouse, France; [Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31076 Toulouse, France; [Baron, Olivier; Oswald, Eric] Hop Purpan, Ctr Hosp Univ Toulouse, Serv Bacteriol Hyg, F-31059 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Oswald, E (corresponding author), INSERM, U1043, F-31076 Toulouse, France.	e.oswald@envt.fr; rbonnet@chu-clermontferrand.fr	Bringer, Marie-Agnès/Q-1752-2018; Bouchon, Bernadette/L-5698-2015; Bonnet, Richard/C-8544-2015; Nougayrede, Jean-Philippe/I-6362-2019	Bringer, Marie-Agnès/0000-0002-3746-4998; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; Cougnoux, Antony/0000-0001-9407-7540	le Ministere Francais de l'Education Nationale, de la Recherche, et de la Technologie [JE2526]; l'Institut National de la Recherche Agronomique [USC-2018]; National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	le Ministere Francais de l'Education Nationale, de la Recherche, et de la Technologie; l'Institut National de la Recherche Agronomique; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by le Ministere Francais de l'Education Nationale, de la Recherche, et de la Technologie Grant JE2526 and l'Institut National de la Recherche Agronomique Grant USC-2018. Molecular graphics images were produced using the University of California, San Francisco Chimera package (National Institutes of Health Grant P41 RR-01081).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bauvois C, 2005, ANTIMICROB AGENTS CH, V49, P4240, DOI 10.1128/AAC.49.10.4240-4246.2005; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; Beadle BM, 2002, STRUCTURE, V10, P413, DOI 10.1016/S0969-2126(02)00725-6; Bompard-Gilles G, 2000, STRUCTURE, V8, P971, DOI 10.1016/S0969-2126(00)00188-X; Chen Y, 2006, J AM CHEM SOC, V128, P2970, DOI 10.1021/ja056806m; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Delfosse V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004712; Delmarcelle M, 2005, PROTEIN SCI, V14, P2296, DOI 10.1110/ps.051475305; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Drawz SM, 2010, BIOCHEMISTRY-US, V49, P329, DOI 10.1021/bi9015988; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALLENI M, 1995, BIOCHEM PHARMACOL, V49, P1171, DOI 10.1016/0006-2952(94)00502-D; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Komatsuzawa H, 2000, FEMS MICROBIOL LETT, V188, P35, DOI 10.1016/S0378-1097(00)00194-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; MATAGNE A, 1993, BIOCHEM J, V295, P705, DOI 10.1042/bj2950705; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meroueh SO, 2003, J AM CHEM SOC, V125, P9612, DOI 10.1021/ja034861u; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI [10.1093/bioinformatics/btn575, 10.1093/bioinformatics/btp666]; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Okazaki S, 2008, J SYNCHROTRON RADIAT, V15, P250, DOI 10.1107/S0909049507064655; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Pratt RF, 2008, CELL MOL LIFE SCI, V65, P2138, DOI 10.1007/s00018-008-7591-7; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; SCHMITT CK, 1994, J BACTERIOL, V176, P368, DOI 10.1128/JB.176.2.368-377.1994; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Wagner UG, 2002, PROTEIN SCI, V11, P467, DOI 10.1110/ps.33002	40	70	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35562	35570		10.1074/jbc.M111.221960	http://dx.doi.org/10.1074/jbc.M111.221960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21795676	Green Published, hybrid			2022-12-27	WOS:000295927100028
J	Chen, VP; Choi, RCY; Chan, WKB; Leung, KW; Guo, AJY; Chan, GKL; Luk, WKW; Tsim, KWK				Chen, Vicky P.; Choi, Roy C. Y.; Chan, Wallace K. B.; Leung, K. Wing; Guo, Ava J. Y.; Chan, Gallant K. L.; Luk, Wilson K. W.; Tsim, Karl W. K.			The Assembly of Proline-rich Membrane Anchor (PRiMA)-linked Acetylcholinesterase Enzyme GLYCOSYLATION IS REQUIRED FOR ENZYMATIC ACTIVITY BUT NOT FOR OLIGOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED CHICK MYOTUBES; ASYMMETRIC ACETYLCHOLINESTERASE; ALZHEIMERS-DISEASE; ATTACHMENT DOMAIN; GOLGI-APPARATUS; CYCLIC-AMP; PRIMA; EXPRESSION; MUSCLE; PROTEIN	Acetylcholinesterase (AChE) anchors onto cell membranes by a transmembrane protein PRiMA (proline-rich membrane anchor) as a tetrameric form in vertebrate brain. The assembly of AChE tetramer with PRiMA requires the C-terminal "t-peptide" in AChE catalytic subunit (AChE(T)). Although mature AChE is well known N-glycosylated, the role of glycosylation in forming the physiologically active PRiMA-linked AChE tetramer has not been studied. Here, several lines of evidence indicate that the N-linked glycosylation of AChET plays a major role for acquisition of AChE full enzymatic activity but does not affect its oligomerization. The expression of the AChET mutant, in which all N-glycosylation sites were deleted, together with PRiMA in HEK293T cells produced a glycan-depleted PRiMA-linked AChE tetramer but with a much higher K-m value as compared with the wild type. This glycan-depleted enzyme was assembled in endoplasmic reticulum but was not transported to Golgi apparatus or plasma membrane.	[Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	CHEN, VICKY/C-9223-2016	CHEN, VICKY/0000-0003-3753-7170; Tsim, Karl/0000-0003-4808-1674; Leung, Ka Wing/0000-0002-6137-3877	Research Grants Council of Hong Kong [662407, 660409, 662911, F-HK21/06T]; Croucher Foundation [CAS-CF07/08.SC03]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation	This work was supported by grants from the Research Grants Council of Hong Kong (662407, 660409, 662911, F-HK21/06T) and the Croucher Foundation (CAS-CF07/08.SC03) (to K. W. K. T. and R. C. Y. C.).	Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Chen VP, 2010, J BIOL CHEM, V285, P27265, DOI 10.1074/jbc.M110.113647; Choi RCY, 1998, J NEUROCHEM, V71, P152; Choi RCY, 2001, MOL CELL NEUROSCI, V17, P732, DOI 10.1006/mcne.2001.0968; Choi RCY, 1996, NEUROSCI LETT, V217, P165, DOI 10.1016/0304-3940(96)13102-5; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GOUGH NR, 1995, J NEUROCHEM, V65, P2734; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Liang D, 2009, FEBS J, V276, P94, DOI 10.1111/j.1742-4658.2008.06756.x; LIAO J, 1991, EUR J BIOCHEM, V198, P59, DOI 10.1111/j.1432-1033.1991.tb15986.x; LIAO J, 1992, J NEUROCHEM, V58, P1230, DOI 10.1111/j.1471-4159.1992.tb11333.x; Luzikov VN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P171, DOI 10.1023/A:1014457813037; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 2009, CURR OPIN PHARMACOL, V9, P316, DOI 10.1016/j.coph.2009.04.004; MEFLAH K, 1984, BIOCHIMIE, V66, P59, DOI 10.1016/0300-9084(84)90192-5; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Mimori Y, 1997, BEHAV BRAIN RES, V83, P25, DOI 10.1016/S0166-4328(97)86041-X; Mok MKW, 2009, NEUROSCI LETT, V461, P202, DOI 10.1016/j.neulet.2009.06.015; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; Ruiz CA, 2009, J BIOL CHEM, V284, P21488, DOI 10.1074/jbc.M109.030049; Saez-Valero J, 2000, J NEUROL NEUROSUR PS, V69, P664, DOI 10.1136/jnnp.69.5.664; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TSIM KWK, 1988, J NEUROCHEM, V51, P95, DOI 10.1111/j.1471-4159.1988.tb04840.x; Tung EKK, 2004, MOL PHARMACOL, V66, P794, DOI 10.1124/mol.104.003269; VELAN B, 1993, BIOCHEM J, V296, P649, DOI 10.1042/bj2960649; Xie HQ, 2007, J BIOL CHEM, V282, P11765, DOI 10.1074/jbc.M608265200; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711	41	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32948	32961		10.1074/jbc.M111.261248	http://dx.doi.org/10.1074/jbc.M111.261248			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795704	Green Published, hybrid			2022-12-27	WOS:000294968800013
J	Shim, JY; Bertalovitz, AC; Kendall, DA				Shim, Joong-Youn; Bertalovitz, Alexander C.; Kendall, Debra A.			Identification of Essential Cannabinoid-binding Domains STRUCTURAL INSIGHTS INTO EARLY DYNAMIC EVENTS IN RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; CB1 RECEPTOR; INVERSE AGONIST; HIGH-AFFINITY; BETA(2)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVATION; FORCE-FIELD	The classical cannabinoid agonist HU210, a structural analog of (-)-Delta(9)-tetrahydrocannabinol, binds to brain cannabinoid (CB1) receptors and activates signal transduction pathways. To date, an exact molecular description of the CB1 receptor is not yet available. Utilizing the minor binding pocket of the CB1 receptor as the primary ligand interaction site, we explored HU210 binding using lipid bilayer molecular dynamics (MD) simulations. Among the potential ligand contact residues, we identified residues Phe-174(2.61), Phe-177(2.64), Leu-193(3.29), and Met-363(6.55) as being critical for HU210 binding by mutational analysis. Using these residues to guide the simulations, we determined essential cannabinoid-binding domains in the CB1 receptor, including the highly sought after hydrophobic pocket important for the binding of the C3 alkyl chain of classical and nonclassical cannabinoids. Analyzing the simulations of the HU210-CB1 receptor complex, the CP55940-CB1 receptor complex, and the (-)-Delta(9)-tetrahydrocannabinol-CB1 receptor complex, we found that the positioning of the C3 alkyl chain and the aromatic stacking between Trp-356(6.48) and Trp-279(5.43) is crucial for the Trp-356(6.48) rotamer change toward receptor activation through the rigid-body movement of H6. The functional data for the mutant receptors demonstrated reductions in potency for G protein activation similar to the reductions seen in ligand binding affinity for HU210.	[Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Bertalovitz, Alexander C.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of North Carolina; North Carolina Central University; University of Connecticut	Shim, JY (corresponding author), N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	jyshim@nccu.edu			National Institutes of Health [5K01 DA020663, DA020763]; National Science Foundation through TeraGrid resources; TACC and Indiana University; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763, K01DA020663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); TACC and Indiana University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 5K01 DA020663 (to J.-Y. S.) and DA020763 (to D. A. K.). This work was also supported in part by the National Science Foundation through TeraGrid resources provided by TACC and Indiana University.	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; ADAMS R, 1949, J AM CHEM SOC, V71, P1624, DOI 10.1021/ja01173a023; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; [Anonymous], [No title captured]; Ashton JC, 2008, CURR MED CHEM, V15, P1428, DOI 10.2174/092986708784567716; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Busch-Petersen J, 1996, J MED CHEM, V39, P3790, DOI 10.1021/jm950934b; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chin CN, 1998, J NEUROCHEM, V70, P366; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; DEVANE WA, 1992, J MED CHEM, V35, P2065, DOI 10.1021/jm00089a018; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2005, BIOCHEMISTRY-US, V44, P8757, DOI 10.1021/bi0472651; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; HOWLETT AC, 1988, MOL PHARMACOL, V33, P297; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Huffman JW, 1996, J MED CHEM, V39, P3875, DOI 10.1021/jm960394y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kapur A, 2007, MOL PHARMACOL, V71, P1512, DOI 10.1124/mol.107.034645; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Klein-Seetharaman J, 2004, P NATL ACAD SCI USA, V101, P3409, DOI 10.1073/pnas.0308713101; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; LOEV B, 1973, J MED CHEM, V16, P1200, DOI 10.1021/jm00269a002; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin BR, 1999, J PHARMACOL EXP THER, V290, P1065; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; MELVIN LS, 1993, MOL PHARMACOL, V44, P1008; Meschler JP, 2000, BIOCHEM PHARMACOL, V60, P1315, DOI 10.1016/S0006-2952(00)00447-0; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Murphy JW, 2003, BIOCHEM PHARMACOL, V65, P1623, DOI 10.1016/S0006-2952(03)00155-2; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Shen CP, 2006, EUR J PHARMACOL, V531, P41, DOI 10.1016/j.ejphar.2005.12.026; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Shim JY, 2011, PROTEINS, V79, P581, DOI 10.1002/prot.22907; Shim JY, 2010, CURR TOP MED CHEM, V10, P779, DOI 10.2174/156802610791164210; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Shim JY, 2004, J CHEM INF COMP SCI, V44, P1466, DOI 10.1021/ci040040c; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Song ZH, 1999, MOL PHARMACOL, V56, P834; Song ZH, 1996, MOL PHARMACOL, V49, P891; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walsh D, 2003, SUPPORT CARE CANCER, V11, P137, DOI 10.1007/s00520-002-0387-7; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1	91	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33422	33435		10.1074/jbc.M111.261651	http://dx.doi.org/10.1074/jbc.M111.261651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795705	hybrid, Green Published			2022-12-27	WOS:000294968800060
J	Zuo, T; Shi, XL; Liu, ZH; Guo, LL; Zhao, Q; Guan, TX; Pan, XM; Jia, N; Cao, WC; Zhou, BP; Goldin, M; Zhang, LQ				Zuo, Teng; Shi, Xuanling; Liu, Zhonghua; Guo, Linlin; Zhao, Qing; Guan, Tianxia; Pan, Xianming; Jia, Na; Cao, Wuchun; Zhou, Boping; Goldin, Mark; Zhang, Linqi			Comprehensive Analysis of Pathogen-specific Antibody Response in Vivo Based on an Antigen Library Displayed on Surface of Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; HUMAN MONOCLONAL-ANTIBODIES; B-CELLS; SITES; IDENTIFICATION; GENERATION; DIVERSITY; MOLECULE; MEMORY; MICE	Host antibody response is a crucial defense against pathogenic infection. Here, we report a novel technique allowing quantitative measurement of polyclonal antibody response in vivo. This involves expression of a combinatorial library of target proteins from a candidate pathogen on the surface of yeast Saccharomyces cerevisiae. After mixing with serum/plasma from infected or immunized subjects, positive yeast clones were isolated via fluorescence-activated cell sorting (FACS). Using this technique, we have studied mouse immunized serum with recombinant hemagglutinin (HA) protein from a human influenza H5N1 strain (A/Anhui/1/2005) and convalescent plasma from an infected human in China. Our technique has identified novel antigenic domains targeted by serum/plasma and allowed calculation of the relative proportion of the antibody response against each domain. We believe such systematic measurement of an antibody response is unprecedented, and applying this method to different pathogens will improve understanding of protective immunity and guide development of vaccines and therapeutics.	[Zuo, Teng; Shi, Xuanling; Liu, Zhonghua; Guo, Linlin; Zhao, Qing; Guan, Tianxia; Pan, Xianming; Goldin, Mark; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China; [Jia, Na; Cao, Wuchun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Zhou, Boping] Shenzhen Donghu Hosp, Shenzhen 518020, Peoples R China	Tsinghua University; Beijing Institute of Microbiology & Epidemiology	Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	Guan, Tianxia/B-5559-2017; ZHANG, LIN/GYD-9123-2022	Guan, Tianxia/0000-0001-6187-5431; Zhao, Qing/0000-0003-2862-3886	National Institutes of Health CIPRA [U19 AI51915]; National Science and Technology Major [2008ZX10001-011, 2009ZX10004-016]; National Basic Research Program (973 Program) [2006CB504200]; National Outstanding Youth Award [30825035]; Tsinghua University Initiative Scientific Research; Tsinghua Yue-Yuen Medical Sciences Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	National Institutes of Health CIPRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major; National Basic Research Program (973 Program)(National Basic Research Program of China); National Outstanding Youth Award; Tsinghua University Initiative Scientific Research; Tsinghua Yue-Yuen Medical Sciences Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health CIPRA Grant U19 AI51915. This work was also supported by National Science and Technology Major Projects 2008ZX10001-011 and 2009ZX10004-016, National Basic Research Program (also called the 973 Program) Grant 2006CB504200, the National Outstanding Youth Award 30825035, Tsinghua University Initiative Scientific Research Program, and Tsinghua Yue-Yuen Medical Sciences Fund.	Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Janeway CA, 2001, IMMUNOBIOLOGY; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Lin Zhanglin, 2009, V515, P261, DOI 10.1007/978-1-59745-559-6_18; PHILPOTT M, 1989, J VIROL, V63, P3453, DOI 10.1128/JVI.63.8.3453-3458.1989; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	30	17	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33511	33519		10.1074/jbc.M111.270553	http://dx.doi.org/10.1074/jbc.M111.270553			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795672	Green Published, hybrid			2022-12-27	WOS:000294968800068
J	Chaudhuri, A; Xie, MH; Yang, B; Mahapatra, K; Liu, JF; Marsters, S; Bodepudi, S; Ashkenazi, A				Chaudhuri, Amitabha; Xie, Ming-Hong; Yang, Becky; Mahapatra, Kaushiki; Liu, Jinfeng; Marsters, Scot; Bodepudi, Sweta; Ashkenazi, Avi			Distinct Involvement of the Gab1 and Grb2 Adaptor Proteins in Signal Transduction by the Related Receptor Tyrosine Kinases RON and MET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; MACROPHAGE-STIMULATING PROTEIN; CELL-TRANSFORMATION; DOCKING PROTEIN; SCATTER-FACTOR; C-MET; PATHWAYS DOWNSTREAM; SCAFFOLDING PROTEIN; REGULATED KINASE; BINDING-SITES	Although the signal transduction mechanisms of the receptor tyrosine kinase MET are well defined, less is known about its close relative RON. MET initiates intracellular signaling by autophosphorylation on specific cytoplasmic tyrosines that form docking sites for the adaptor proteins Grb2 and Gab1. Grb2 binds directly and is essential for all of the biological activities of MET. Gab1 docks either directly or indirectly via Grb2 and controls only a subset of MET functions. Because MET and RON possess similar adaptor binding sites, it was anticipated that their adaptor interactions would be conserved. Here we show that in contrast to MET, RON relies primarily on Gab1 for signal transmission. Surprisingly, disruption of the Grb2 docking site of RON or Grb2 depletion augments activity, whereas enhancement of Grb2 binding attenuates Gab1 recruitment and signaling. Hence, RON and MET differ in their adaptor interactions; furthermore, Grb2 performs a novel antagonistic role in the context of RON signaling.	[Chaudhuri, Amitabha; Xie, Ming-Hong; Yang, Becky; Mahapatra, Kaushiki; Liu, Jinfeng; Marsters, Scot; Bodepudi, Sweta; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Chaudhuri, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	amitabha@gene.com; aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Liu, Jinfeng/0000-0002-0343-8222				Bardelli A, 1997, ONCOGENE, V15, P3103, DOI 10.1038/sj.onc.1201561; Chan EL, 2005, ONCOGENE, V24, P479, DOI 10.1038/sj.onc.1208231; Cowin AJ, 2001, CELL TISSUE RES, V306, P239, DOI 10.1007/s004410100443; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Eulenfeld R, 2009, J CELL SCI, V122, P55, DOI 10.1242/jcs.037226; FIXMAN ED, 1995, ONCOGENE, V10, P237; Fixman ED, 1996, J BIOL CHEM, V271, P13116, DOI 10.1074/jbc.271.22.13116; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano S, 1997, P NATL ACAD SCI USA, V94, P13868, DOI 10.1073/pnas.94.25.13868; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HUFF JL, 1993, P NATL ACAD SCI USA, V90, P6140, DOI 10.1073/pnas.90.13.6140; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Kretschmann KL, 2010, CURR DRUG TARGETS, V11, P1157; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leonard E J, 1979, Adv Exp Med Biol, V121B, P181; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Lock LS, 2003, J BIOL CHEM, V278, P30083, DOI 10.1074/jbc.M302675200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 2003, MOL BIOL CELL, V14, P1691, DOI 10.1091/mbc.E02-06-0352; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumura I, 2008, CANCER SCI, V99, P479, DOI 10.1111/j.1349-7006.2007.00717.x; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Park CY, 1999, J BIOL CHEM, V274, P7583, DOI 10.1074/jbc.274.11.7583; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RONSIN C, 1993, ONCOGENE, V8, P1195; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Saucier C, 2002, ONCOGENE, V21, P1800, DOI 10.1038/sj.onc.1205261; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seiden-Long I, 2008, CARCINOGENESIS, V29, P647, DOI 10.1093/carcin/bgn009; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; ZHU H, 1994, J BIOL CHEM, V269, P29943	58	22	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32762	32774		10.1074/jbc.M111.239384	http://dx.doi.org/10.1074/jbc.M111.239384			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784853	Green Published, hybrid			2022-12-27	WOS:000294726800084
J	Tann, AW; Boldogh, I; Meiss, G; Qian, W; Van Houten, B; Mitra, S; Szczesny, B				Tann, Anne W.; Boldogh, Istvan; Meiss, Gregor; Qian, Wei; Van Houten, Bennett; Mitra, Sankar; Szczesny, Bartosz			Apoptosis Induced by Persistent Single-strand Breaks in Mitochondrial Genome CRITICAL ROLE OF EXOG (5 '-EXO/ENDONUCLEASE) IN THEIR REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE-GAMMA; ENDONUCLEASE-G; HUMAN-CELLS; ENZYMATIC-PROPERTIES; MAMMALIAN-CELLS; DAMAGE RESPONSE; FREE-RADICALS; CANCER CELLS; COPY NUMBER	Reactive oxygen species (ROS), continuously generated as by-products of respiration, inflict more damage on the mitochondrial (mt) than on the nuclear genome because of the nonchromatinized nature and proximity to the ROS source of the mitochondrial genome. Such damage, particularly single-strand breaks (SSBs) with 5'-blocking deoxyribose products generated directly or as repair intermediates for oxidized bases, is repaired via the base excision/SSB repair pathway in both nuclear and mt genomes. Here, we show that EXOG, a 5'-exo/endonuclease and unique to the mitochondria unlike FEN1 or DNA2, which, like EXOG, has been implicated in the removal of the 5'-blocking residue, is required for repairing endogenous SSBs in the mt genome. EXOG depletion induces persistent SSBs in the mtDNA, enhances ROS levels, and causes apoptosis in normal cells but not in mt genome-deficient rho0 cells. Thus, these data show for the first time that persistent SSBs in the mt genome alone could provide the initial trigger for apoptotic signaling in mammalian cells.	[Szczesny, Bartosz] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Meiss, Gregor] Univ Giessen, Fac Biol & Chem, Inst Biochem, D-35392 Giessen, Germany; [Qian, Wei; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Justus Liebig University Giessen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Szczesny, B (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	baszczes@utmb.edu	Van Houten, Bennett/K-2284-2019; Qian, Wei/B-8231-2013		National Institutes of Health [P01 AG10514, R01 CA53791, P01 AG021830]; USPHS; Pennsylvania CURE; Dr.-Herbert-Stolzenberg-Stiftung of the Justus-Liebig-University Giessen;  [T32 ES07254];  [5F30 ES017207-02]; NATIONAL CANCER INSTITUTE [R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019566, R01ES018948, T32ES007254, F30ES017207, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830, P01AG010514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Pennsylvania CURE; Dr.-Herbert-Stolzenberg-Stiftung of the Justus-Liebig-University Giessen; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG10514 and R01 CA53791 (to S. M.) and P01 AG021830 (to I. B.) from USPHS and Training Grants T32 ES07254 and 5F30 ES017207-02 (to A. W. T.). This work was also supported by Pennsylvania CURE (to B. V. H.) and the Dr.-Herbert-Stolzenberg-Stiftung of the Justus-Liebig-University Giessen (to G. M.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kieper J, 2010, PROTEIN EXPRES PURIF, V73, P99, DOI 10.1016/j.pep.2010.04.001; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Koczor CA, 2009, J BIOL CHEM, V284, P36191, DOI 10.1074/jbc.M109.036020; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lizard G, 1997, ANN PATHOL, V17, P61; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Marchetti P, 1996, CANCER RES, V56, P2033; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Panduri V, 2004, AM J PHYSIOL-LUNG C, V286, pL1220, DOI 10.1152/ajplung.00371.2003; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712; Stuart JA, 2004, NUCLEIC ACIDS RES, V32, P2181, DOI 10.1093/nar/gkh533; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Yang XH, 2005, INT J ONCOL, V26, P1675; Yang XH, 2001, CANCER RES, V61, P348; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	73	110	113	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31975	31983		10.1074/jbc.M110.215715	http://dx.doi.org/10.1074/jbc.M110.215715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768646	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000294726800006
J	Villani, G; Hubscher, U; Gironis, N; Parkkinen, S; Pospiech, H; Shevelev, I; di Cicco, G; Markkanen, E; Syvaaja, JE; Le Gac, NT				Villani, Giuseppe; Hubscher, Ulrich; Gironis, Nadege; Parkkinen, Sinikka; Pospiech, Helmut; Shevelev, Igor; di Cicco, Giulia; Markkanen, Enni; Syvaoja, Juhani E.; Le Gac, Nicolas Tanguy			In Vitro Gap-directed Translesion DNA Synthesis of an Abasic Site Involving Human DNA Polymerases epsilon, lambda, and beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; NUCLEOTIDE EXCISION-REPAIR; REPLICATION PROTEIN-A; DAMAGE TOLERANCE; HELA-CELLS; DELTA; MECHANISMS; LESIONS; STRAND; FORK	DNA polymerase (pol) epsilon is thought to be the leading strand replicase in eukaryotes, whereas pols lambda and beta are believed to be mainly involved in re-synthesis steps of DNA repair. DNA elongation by the human pol epsilon is halted by an abasic site (apurinic/apyrimidinic (AP) site). In this study, we present in vitro evidence that human pols lambda, beta, and eta can perform translesion synthesis (TLS) of an AP site in the presence of pol epsilon, likely by initiating the 3'OHs created at the lesion by the arrested pol epsilon. However, in the case of pols lambda and beta, this TLS requires the presence of a DNA gap downstream from the product synthesized by the pol epsilon, and the optimal gap for efficient TLS is different for the two polymerases. The presence of gaps did not affect the TLS capacity of human pol eta. Characterization of the reaction products showed that pol beta inserted dAMP opposite the AP site, whereas gap filling synthesis by pol lambda resulted in single or double deletions opposite the lesion. The synthesis up to the AP site by pol epsilon and the subsequent TLS by pols lambda and beta are not influenced by human processivity factor proliferating cell nuclear antigen and human single-stranded DNA-binding protein replication protein A. The bypass capacity of pol lambda at the AP site is greatly reduced when a truncated form of the enzyme, which has lost the BRCA1 C-terminal and proline-rich domains, is used. Collectively, our in vitro results support the existence of a mechanism of gap-directed TLS at an AP site involving a switch between the replicative pol epsilon and the repair pols lambda and beta.	[Villani, Giuseppe; Gironis, Nadege; di Cicco, Giulia; Le Gac, Nicolas Tanguy] Univ Toulouse 3, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [Pospiech, Helmut] Fritz Lipman Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Pospiech, Helmut] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Hubscher, Ulrich; Markkanen, Enni] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Parkkinen, Sinikka; Syvaoja, Juhani E.] Univ Eastern Finland, Dept Biol, FI-80101 Joensuu, Finland; [Shevelev, Igor] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Finland National Institute for Health & Welfare; University of Oulu; University of Zurich; University of Eastern Finland; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Le Gac, NT (corresponding author), Univ Toulouse 3, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	ntlg@ipbs.fr	Markkanen, Enni/V-9784-2017; Pospiech, Helmut/J-8598-2015	Markkanen, Enni/0000-0001-7780-8233; 	Electricite de France; Academy of Finland [106986, 123082]; University of Zurich; Swiss National Science Foundation	Electricite de France; Academy of Finland(Academy of Finland); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by a grant from Electricite de France (to G. V.) and by Grants 106986 (to H. P.) and 123082 (to J. E. S.) from the Academy of Finland.; Supported by the University of Zurich and the Swiss National Science Foundation.	Araujo SJ, 2000, GENE DEV, V14, P349; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Bebenek K, 2008, EMBO REP, V9, P459, DOI 10.1038/embor.2008.33; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Blanca G, 2003, BIOCHEMISTRY-US, V42, P7467, DOI 10.1021/bi034198m; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brown JA, 2011, DNA REPAIR, V10, P24, DOI 10.1016/j.dnarep.2010.09.005; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Daube SS, 2000, BIOCHEMISTRY-US, V39, P348, DOI 10.1021/bi9917784; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fiala KA, 2006, J BIOL CHEM, V281, P19038, DOI 10.1074/jbc.M601178200; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hubscher U., 2010, DNA POLYM DISCOVERY; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LEE SH, 1991, J BIOL CHEM, V266, P22707; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Locatelli GA, 2010, BIOCHEM J, V429, P573, DOI 10.1042/BJ20100405; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sabouri N, 2009, J BIOL CHEM, V284, P31555, DOI 10.1074/jbc.M109.043927; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Sherrer SM, 2011, NUCLEIC ACIDS RES, V39, P609, DOI 10.1093/nar/gkq719; Shevelev I, 2003, NUCLEIC ACIDS RES, V31, P6916, DOI 10.1093/nar/gkg896; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08	44	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32094	32104		10.1074/jbc.M111.246611	http://dx.doi.org/10.1074/jbc.M111.246611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757740	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000294726800019
J	Ding, YF; Winters, A; Ding, M; Graham, S; Akopova, I; Muallem, S; Wang, YX; Hong, JH; Gryczynski, Z; Yang, SH; Birnbaumer, L; Ma, R				Ding, Yanfeng; Winters, Ali; Ding, Min; Graham, Sarabeth; Akopova, Irina; Muallem, Shmuel; Wang, Yanxia; Hong, Jeong Hee; Gryczynski, Zygmunt; Yang, Shao-Hua; Birnbaumer, Lutz; Ma, Rong			Reactive Oxygen Species-mediated TRPC6 Protein Activation in Vascular Myocytes, a Mechanism for Vasoconstrictor-regulated Vascular Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; SMOOTH-MUSCLE-CELLS; HYDROGEN-PEROXIDE; CATION CHANNEL; NAD(P)H OXIDASE; RECEPTOR; STIMULATION; EXPRESSION; MODULATION; PATHWAYS	Both TRPC6 and reactive oxygen species (ROS) play an important role in regulating vascular function. However, their interplay has not been explored. The present study examined whether activation of TRPC6 in vascular smooth muscle cells (VSMCs) by ROS was a physiological mechanism for regulating vascular tone by vasoconstrictors. In A7r5 cells, arginine vasopressin (AVP) evoked a striking Ca2+ entry response that was significantly attenuated by either knocking down TRPC6 using siRNA or inhibition of NADPH oxidases with apocynin or diphenyleneiodonium. Inhibition of TRPC6 or ROS production also decreased AVP-stimulated membrane currents. In primary cultured aortic VSMCs, catalase and diphenyleneiodonium significantly suppressed AVP- and angiotensin II-induced whole cell currents and Ca2+ entry, respectively. In freshly isolated and endothelium-denuded thoracic aortas, hyperforin (an activator of TRPC6), but not its vehicle, induced dose- and time-dependent constriction in TRPC6 wide type (WT) mice. This response was not observed in TRPC6 knock-out (KO) mice. Consistent with the ex vivo study, hyperforin stimulated a robust Ca2+ entry in the aortic VSMCs from WT mice but not from KO mice. Phenylephrine induced a dose-dependent contraction of WT aortic segments, and this response was inhibited by catalase. Moreover, H2O2 itself evoked Ca2+ influx and inward currents in A7r5 cells, and these responses were significantly attenuated by either inhibition of TRPC6 or blocking vesicle trafficking. H2O2 also induced inward currents in primary VSMCs from WT but not from TRPC6 KO mice. Additionally, H2O2 stimulated a dose-dependent constriction of the aortas from WT mice but not from the vessels of KO mice. Furthermore, TIRFM showed that H2O2 triggered membrane trafficking of TRPC6 in A7r5 cells. These results suggest a new signaling pathway of ROS-TRPC6 in controlling vessel contraction by vasoconstrictors.	[Ding, Yanfeng; Winters, Ali; Ding, Min; Graham, Sarabeth; Wang, Yanxia; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [Ding, Yanfeng; Winters, Ali; Ding, Min; Graham, Sarabeth; Wang, Yanxia; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA; [Akopova, Irina; Gryczynski, Zygmunt] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Yang, Shao-Hua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Muallem, Shmuel; Hong, Jeong Hee] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Birnbaumer, Lutz] NIH, Transmembrane Signaling Grp, Res Triangle Pk, NC 27709 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA	Ma, R (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	rong.ma@unthsc.edu	ma, rong/GVU-3096-2022; Yang, Shaohua/D-1738-2013		NIDDK [5 RO1 DK079968-01A2, 5R21CA149897-02]; American Heart Association South Central Affiliate [09GRNT2260926]; NATIONAL CANCER INSTITUTE [R21CA149897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101684] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association South Central Affiliate(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 RO1 DK079968-01A2 from NIDDK (to R. M.) and 5R21CA149897-02 (to Z. G.). This work was also supported by Grant-in-aid 09GRNT2260926 from American Heart Association South Central Affiliate (to R. M.).	Ardanaz N, 2006, EXP BIOL MED, V231, P237; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2007, CELL CALCIUM, V42, P233, DOI 10.1016/j.ceca.2007.02.009; Du J, 2007, J AM SOC NEPHROL, V18, P1437, DOI 10.1681/ASN.2006091067; Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; GROVER AK, 1992, AM J PHYSIOL, V263, pH537, DOI 10.1152/ajpheart.1992.263.2.H537; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Mizuno N, 1999, MOL BRAIN RES, V64, P41, DOI 10.1016/S0169-328X(98)00296-4; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	37	68	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31799	31809		10.1074/jbc.M111.248344	http://dx.doi.org/10.1074/jbc.M111.248344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768109	Green Published, hybrid			2022-12-27	WOS:000294487500073
J	Groer, CE; Schmid, CL; Jaeger, AM; Bohn, LM				Groer, Chad E.; Schmid, Cullen L.; Jaeger, Alex M.; Bohn, Laura M.			Agonist-directed Interactions with Specific beta-Arrestins Determine mu-Opioid Receptor Trafficking, Ubiquitination, and Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; DOWN-REGULATION; ANTINOCICEPTIVE TOLERANCE; E3 LIGASE; DESENSITIZATION; INTERNALIZATION; ENDOCYTOSIS; MICE; PHOSPHORYLATION; ACTIVATION	Morphine and other opiates mediate their effects through activation of the mu-opioid receptor (MOR), and regulation of the MOR has been shown to critically affect receptor responsiveness. Activation of the MOR results in receptor phosphorylation, beta-arrestin recruitment, and internalization. This classical regulatory process can differ, depending on the ligand occupying the receptor. There are two forms of beta-arrestin, beta-arrestin1 and beta-arrestin2 (also known as arrestin2 and arrestin3, respectively); however, most studies have focused on the consequences of recruiting beta-arrestin2 specifically. In this study, we examine the different contributions of beta-arrestin1- and beta-arrestin2-mediated regulation of the MOR by comparing MOR agonists in cells that lack expression of individual or both beta-arrestins. Here we show that morphine only recruits beta-arrestin2, whereas the MOR-selective enkephalin [D-Ala(2), N-Me-Phe(4), Gly(5)-ol] enkephalin (DAMGO), recruits either beta-arrestin. We show that beta-arrestins are required for receptor internalization and that only beta-arrestin2 can rescue morphine-induced MOR internalization, whereas either beta-arrestin can rescue DAMGO-induced MOR internalization. DAMGO activation of the receptor promotes MOR ubiquitination over time. Interestingly, beta-arrestin1 proves to be critical for MOR ubiquitination as modification does not occur in the absence of beta-arrestin1 nor when morphine occupies the receptor. Moreover, the selective interactions between the MOR and beta-arrestin1 facilitate receptor dephosphorylation, which may play a role in the resensitization of the MOR and thereby contribute to overall development of opioid tolerance.	[Groer, Chad E.; Schmid, Cullen L.; Bohn, Laura M.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Jaeger, Alex M.] Ohio State Univ, Undergrad Program Biomed Sci, Columbus, OH 43210 USA	Scripps Research Institute; University System of Ohio; Ohio State University	Bohn, LM (corresponding author), Scripps Res Inst, Dept Mol Therapeut, 130 Scripps Way 2A2, Jupiter, FL 33458 USA.	LBohn@scripps.edu	Bohn, Laura M/A-7483-2014	Bohn, Laura M/0000-0002-6474-8179	National Institutes of Health, National Institute on Drug Abuse [DA14600, DA18860]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA014600, R01DA018860] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, National Institute on Drug Abuse, Grants DA14600 and DA18860 (to L. M. B.).	Alvarez VA, 2002, J NEUROSCI, V22, P5769; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Bohn LM, 2002, J NEUROSCI, V22, P10494; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Deng HB, 2000, BIOCHEMISTRY-US, V39, P5492, DOI 10.1021/bi991938b; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Haberstock-Debic H, 2003, J NEUROSCI, V23, P4324; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 2002, J CELL SCI, V115, P455; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Pak Y, 1997, J BIOL CHEM, V272, P24961, DOI 10.1074/jbc.272.40.24961; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; RAEHAL KM, 2011, PHARMACOL REV, V63, P4; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Shen J, 2000, SYNAPSE, V38, P322, DOI 10.1002/1098-2396(20001201)38:3<322::AID-SYN11>3.0.CO;2-1; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Stafford K, 2001, PHARMACOL BIOCHEM BE, V69, P233, DOI 10.1016/S0091-3057(01)00525-1; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; YOBURN BC, 1993, J PHARMACOL EXP THER, V265, P314; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	54	94	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31731	31741		10.1074/jbc.M111.248310	http://dx.doi.org/10.1074/jbc.M111.248310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757712	hybrid, Green Published			2022-12-27	WOS:000294487500066
J	Fujishiro, T; Shoji, O; Nagano, S; Sugimoto, H; Shiro, Y; Watanabe, Y				Fujishiro, Takashi; Shoji, Osami; Nagano, Shingo; Sugimoto, Hiroshi; Shiro, Yoshitsugu; Watanabe, Yoshihito			Crystal Structure of H2O2-dependent Cytochrome P450(SP alpha) with Its Bound Fatty Acid Substrate INSIGHT INTO THE REGIOSELECTIVE HYDROXYLATION OF FATTY ACIDS AT THE alpha POSITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC RESONANCE; SITE-DIRECTED MUTAGENESIS; HYDROGEN-PEROXIDE; THERMOPHILIC CYTOCHROME-P450; MACROMOLECULAR STRUCTURES; SULFOLOBUS-SOLFATARICUS; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; BACILLUS-SUBTILIS; OPEN CONFORMATION	Cytochrome P450(SP alpha) (CYP152B1) isolated from Sphingomonas paucimobilis is the first P450 to be classified as a H2O2-dependent P450. P450(SP alpha) hydroxylates fatty acids with high alpha-regioselectivity. Herein we report the crystal structure of P450(SP alpha) with palmitic acid as a substrate at a resolution of 1.65 angstrom. The structure revealed that the C-alpha of the bound palmitic acid in one of the alternative conformations is 4.5 angstrom from the heme iron. This conformation explains the highly selective alpha-hydroxylation of fatty acid observed in P450(SP alpha). Mutations at the active site and the F-G loop of P450(SP alpha) did not impair its regioselectivity. The crystal structures of mutants (L78F and F288G) revealed that the location of the bound palmitic acid was essentially the same as that in the WT, although amino acids at the active site were replaced with the corresponding amino acids of cytochrome P450(BS alpha) (CYP152A1), which shows beta-regioselectivity. This implies that the high regioselectivity of P450(SP alpha) is caused by the orientation of the hydrophobic channel, which is more perpendicular to the heme plane than that of P450(BS alpha)	[Watanabe, Yoshihito] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Fujishiro, Takashi; Shoji, Osami] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808550, Japan; [Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr Harima Inst, Sayo, Hyogo 6795148, Japan	Nagoya University; Nagoya University; Tottori University; RIKEN	Watanabe, Y (corresponding author), Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	yoshi@nucc.cc.nagoya-u.ac.jp	Fujishiro, Takashi/F-4804-2013; Sugimoto, Hiroshi/K-4041-2017; Sugimoto, Hiroshi/AAR-5442-2021; Shiro, Yoshitsugu Y/J-3757-2014	Fujishiro, Takashi/0000-0001-7967-8380; Sugimoto, Hiroshi/0000-0002-3140-8362; Shiro, Yoshitsugu Y/0000-0003-0695-8327; Shoji, Osami/0000-0003-3522-0065	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [19105044, 22105012, 21685018]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21245041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (S) 19105044 (to Y. W.), Grant-in-Aid for Scientific Research on Innovative Areas 22105012 (to Y. S.), and Grant-in-Aid for Young Scientists (A) 21685018 (to O. S.) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan).; Supported by Japan Society for the Promotion of Science Research Fellowships for Young Scientists.	Allen EE, 2000, J BACTERIOL, V182, P1264, DOI 10.1128/JB.182.5.1264-1271.2000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DeLano W.L, PYMOL MOL GRAPHICS S; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; Matsunaga I, 1996, FEBS LETT, V386, P252, DOI 10.1016/0014-5793(96)00451-6; Matsunaga I, 2000, LIPIDS, V35, P365, DOI 10.1007/s11745-000-533-y; MATSUNAGA I, 1994, BIOCHEM BIOPH RES CO, V201, P1554, DOI 10.1006/bbrc.1994.1881; Matsunaga I, 2001, ARCH BIOCHEM BIOPHYS, V394, P45, DOI 10.1006/abbi.2001.2512; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Nagano S, 2004, J BIOL CHEM, V279, P42844, DOI 10.1074/jbc.M404217200; Oku Y, 2004, J INORG BIOCHEM, V98, P1194, DOI 10.1016/j.jinorgbio.2004.05.002; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Ozaki S, 1997, J AM CHEM SOC, V119, P6666, DOI 10.1021/ja970453c; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; POULOS TL, 1980, J BIOL CHEM, V255, P8199; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shoji O, 2007, ANGEW CHEM INT EDIT, V46, P3656, DOI 10.1002/anie.200700068; Shoji O, 2010, J BIOL INORG CHEM, V15, P1331, DOI 10.1007/s00775-010-0692-4; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Sundaramoorthy M, 1998, CHEM BIOL, V5, P461, DOI 10.1016/S1074-5521(98)90003-5; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WANG JM, 1990, BIOCHEMISTRY-US, V29, P7160, DOI 10.1021/bi00483a003; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yano JK, 2003, J BIOL CHEM, V278, P608, DOI 10.1074/jbc.M206568200; [No title captured]	65	83	84	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29941	29950		10.1074/jbc.M111.245225	http://dx.doi.org/10.1074/jbc.M111.245225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719702	Green Published, hybrid			2022-12-27	WOS:000294046600053
J	Ognibene, M; Vanni, C; Segalerba, D; Mancini, P; Merello, E; Torrisi, MR; Bosco, MC; Varesio, L; Eva, A				Ognibene, Marzia; Vanni, Cristina; Segalerba, Daniela; Mancini, Patrizia; Merello, Elisa; Torrisi, Maria Rosaria; Bosco, Maria Carla; Varesio, Luigi; Eva, Alessandra			The Tumor Suppressor Hamartin Enhances Dbl Protein Transforming Activity through Interaction with Ezrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; EZRIN/RADIXIN/MOESIN ERM PROTEINS; T-CELL-ACTIVATION; RHO-KINASE; SIGNALING PATHWAY; EPITHELIAL-CELLS; IN-VIVO; PHOSPHORYLATION; ADHESION; BINDING	The Rho guanine nucleotide exchange factor (GEF) Dbl binds to the N-terminal region of ezrin, a member of the ERM (ezrin, radixin, moesin) proteins known to function as linkers between the plasma membrane and the actin cytoskeleton. Here we have characterized the interaction between ezrin and Dbl. We show that binding of Dbl with ezrin involves positively charged amino acids within the region of the pleckstrin homology (PH) domain comprised between beta 1 and beta 2 sheets. In addition, we show that Dbl forms a complex with the tuberous sclerosis-1 (TSC-1) gene product hamartin and with ezrin. We demonstrate that hamartin and ezrin are both required for activation of Dbl. In fact, the knock-down of ezrin and hamartin, as well as the expression of a mutant hamartin, unable to bind ezrin, inhibit Dbl transforming and exchange activity. These results suggest that Dbl is regulated by hamartin through association with ezrin.	[Ognibene, Marzia; Vanni, Cristina; Segalerba, Daniela; Bosco, Maria Carla; Varesio, Luigi; Eva, Alessandra] Ist Giannina Gaslini, Mol Biol Lab, I-16147 Genoa, Italy; [Mancini, Patrizia; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Dipartimento Med Chim & Mol, I-00161 Rome, Italy; [Merello, Elisa] Ist Giannina Gaslini, Lab Neurochirurg, I-16147 Genoa, Italy; [Torrisi, Maria Rosaria] Azienda Osped St Andrea, I-00189 Rome, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Eva, A (corresponding author), Ist Giannina Gaslini, Mol Biol Lab, Largo Gaslini 5, I-16147 Genoa, Italy.	alessandraeva@ospedale-gaslini.ge.it	Segalerba, Daniela/AAB-2023-2020; Eva, Alessandra/J-8268-2016; Ognibene, Marzia/AAA-7275-2020; varesio, luigi/J-8261-2016; Bosco, Maria Carla/J-7928-2016	Segalerba, Daniela/0000-0002-3232-5497; Eva, Alessandra/0000-0003-2949-078X; Ognibene, Marzia/0000-0003-3698-9319; varesio, luigi/0000-0001-5659-2218; Bosco, Maria Carla/0000-0003-1857-7193; mancini, patrizia/0000-0003-0556-2056	Italian Association for Cancer Researc; Compagnia di S. Paolo; Ministero della Salute; MIUR	Italian Association for Cancer Researc(Fondazione AIRC per la ricerca sul cancro); Compagnia di S. Paolo(Compagnia di San Paolo); Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Association for Cancer Research, from the Compagnia di S. Paolo, from the Ministero della Salute, and from MIUR.	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Nakamura F, 1996, BIOCHEM BIOPH RES CO, V226, P650, DOI 10.1006/bbrc.1996.1410; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Vanni C, 2002, J BIOL CHEM, V277, P19745, DOI 10.1074/jbc.M111025200; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; Vanni C, 2007, CELL CYCLE, V6, P2058, DOI 10.4161/cc.6.16.4574; Vanni C, 2006, CELL CYCLE, V5, P2657, DOI 10.4161/cc.5.22.3445; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168	48	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29973	29983		10.1074/jbc.M111.270785	http://dx.doi.org/10.1074/jbc.M111.270785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712385	hybrid, Green Published			2022-12-27	WOS:000294046600056
J	Cerda, O; Trimmer, JS				Cerda, Oscar; Trimmer, James S.			Activity-dependent Phosphorylation of Neuronal Kv2.1 Potassium Channels by CDK5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; RAT-BRAIN; PROTEIN PHOSPHATASE-1; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; NMDA RECEPTOR; EXCITABILITY; MODULATION; STATE; P35	Dynamic modulation of ion channel expression, localization, and/or function drives plasticity in intrinsic neuronal excitability. Voltage-gated Kv2.1 potassium channels are constitutively maintained in a highly phosphorylated state in neurons. Increased neuronal activity triggers rapid calcineurin-dependent dephosphorylation, loss of channel clustering, and hyperpolarizing shifts in voltage-dependent activation that homeostatically suppress neuronal excitability. These changes are reversible, such that rephosphorylation occurs after removal of excitatory stimuli. Here, we show that cyclin-dependent kinase 5 (CDK5), a Pro-directed Ser/Thr protein kinase, directly phosphorylates Kv2.1, and determines the constitutive level of Kv2.1 phosphorylation, the rapid increase in Kv2.1 phosphorylation upon acute blockade of neuronal activity, and the recovery of Kv2.1 phosphorylation after stimulus-induced dephosphorylation. We also demonstrate that although the phosphorylation state of Kv2.1 is also shaped by the activity of the PP1 protein phosphatase, the regulation of Kv2.1 phosphorylation by CDK5 is not mediated through the previously described regulation of PP1 activity by CDK5. Together, these studies support a novel role for CDK5 in regulating Kv2.1 channels through direct phosphorylation.	[Cerda, Oscar; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 196 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu	Cerda, Oscar/N-3895-2018	Cerda, Oscar/0000-0003-2873-5722	National Institutes of Health [NS42225]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS42225 (to J. S. T.).	Baranauskas G, 1999, J NEUROSCI, V19, P6394; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Buraei Z, 2007, NEUROPHARMACOLOGY, V52, P883, DOI 10.1016/j.neuropharm.2006.10.006; Cai XH, 1997, NEUROSCI RES, V28, P355, DOI 10.1016/S0168-0102(97)00063-1; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Ito T, 2010, NEUROBIOL DIS, V38, P85, DOI 10.1016/j.nbd.2010.01.002; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Mulholland PJ, 2008, J NEUROSCI, V28, P8801, DOI 10.1523/JNEUROSCI.2405-08.2008; Mulholland PJ, 2009, ALCOHOL, V43, P45, DOI 10.1016/j.alcohol.2008.10.001; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nataraj K, 2010, NEURON, V68, P750, DOI 10.1016/j.neuron.2010.09.033; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schuman EM, 2003, PHILOS T ROY SOC B, V358, P749, DOI 10.1098/rstb.2002.1256; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Vacher H, 2011, J CELL BIOL, V192, P813, DOI 10.1083/jcb.201007113; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214	42	45	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28738	28748		10.1074/jbc.M111.251942	http://dx.doi.org/10.1074/jbc.M111.251942			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712386	Green Published, hybrid			2022-12-27	WOS:000293837000012
J	Gopalakrishna, KN; Doddapuneni, K; Boyd, KK; Masuho, I; Martemyanov, KA; Artemyev, NO				Gopalakrishna, Kota N.; Doddapuneni, Krishnarao; Boyd, Kimberly K.; Masuho, Ikuo; Martemyanov, Kirill A.; Artemyev, Nikolai O.			Interaction of Transducin with Uncoordinated 119 Protein (UNC119) IMPLICATIONS FOR THE MODEL OF TRANSDUCIN TRAFFICKING IN ROD PHOTORECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT REDISTRIBUTION; HETEROTRIMERIC G-PROTEIN; PRENYL-BINDING PROTEIN; CGMP PHOSPHODIESTERASE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; DRIVEN TRANSLOCATION; RETINAL DEGENERATION; LIPID MODIFICATIONS; GTP-BINDING	The key visual G protein, transducin undergoes bi-directional translocations between the outer segment (OS) and inner compartments of rod photoreceptors in a light-dependent manner thereby contributing to adaptation and neuroprotection of rods. A mammalian uncoordinated 119 protein (UNC119), also known as Retina Gene 4 protein (RG4), has been recently implicated in transducin transport to the OS in the dark through its interaction with the N-acylated GTP-bound transducin-alpha subunit (G alpha(t1)). Here, we demonstrate that the interaction of human UNC119 (HRG4) with transducin is dependent on the N-acylation, but does not require the GTP-bound form of G alpha(t1). The lipid specificity of UNC119 is unique: UNC119 bound the myristoylated N terminus of G alpha(t1) with much higher affinity than a prenylated substrate, whereas the homologous prenyl-binding protein PrBP/delta did not interact with the myristoylated peptide. UNC119 was capable of interacting with G alpha(t1) GDP as well as with heterotrimeric transducin (G(t)). This interaction of UNC119 with G(t) led to displacement of G beta(1)gamma(1) from the heterotrimer. Furthermore, UNC119 facilitated solubilization of G(t) from dark-adapted rod OS membranes. Consistent with these observations, UNC119 inhibited rhodopsin-dependent activation of G(t), but had no effect on the GTP-hydrolysis by G alpha(t1). A model for the role of UNC119 in the IS -> OS translocation of G(t) is proposed based on the UNC119 ability to dissociate G(t) subunits from each other and the membrane. We also found that UNC119 inhibited activation of G(o) by D2 dopamine receptor in cultured cells. Thus, UNC119 may play conserved inhibitory role in regulation of GPCR-G protein signaling in non-visual tissues.	[Gopalakrishna, Kota N.; Doddapuneni, Krishnarao; Boyd, Kimberly K.; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Artemyev, Nikolai O.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Iowa; University of Iowa; Scripps Research Institute	Artemyev, NO (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu	Masuho, Ikuo/J-6115-2014	Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-12682, DAO21743, DAO26405, EYO18135]; NATIONAL EYE INSTITUTE [R01EY018139, R01EY012682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY-12682 (to N. O. A.), DAO21743, DAO26405, and EYO18135 (to K. A. M.).	Artemyev NO, 2008, MOL NEUROBIOL, V37, P44, DOI 10.1007/s12035-008-8015-2; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Ishiba Y, 2007, EXP EYE RES, V84, P473, DOI 10.1016/j.exer.2006.10.016; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Karim Z, 2010, CELL SIGNAL, V22, P128, DOI 10.1016/j.cellsig.2009.09.022; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kerov V, 2011, MOL CELL NEUROSCI, V46, P340, DOI 10.1016/j.mcn.2010.10.006; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; MADURO M, 1995, GENETICS, V141, P977; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Posokhova E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000570; RAMDAS L, 1991, BIOCHEMISTRY-US, V30, P11637, DOI 10.1021/bi00114a005; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SOKOLOV M, 2011, ARVO ANN M; Song H, 2007, J BIOL CHEM, V282, P23613, DOI 10.1074/jbc.M701974200; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; YAMAZAKI A, 1988, METHOD ENZYMOL, V159, P702; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang HB, 2003, MOL VIS, V9, P231; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835	55	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28954	28962		10.1074/jbc.M111.268821	http://dx.doi.org/10.1074/jbc.M111.268821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712387	Green Published, hybrid			2022-12-27	WOS:000293837000032
J	Lee, B; Park, I; Jin, S; Choi, H; Kwon, JT; Kim, J; Jeong, J; Cho, BN; Eddy, EM; Cho, C				Lee, Boyeon; Park, Inju; Jin, Sora; Choi, Heejin; Kwon, Jun Tae; Kim, Jihye; Jeong, Juri; Cho, Byung-Nam; Eddy, Edward M.; Cho, Chunghee			Impaired Spermatogenesis and Fertility in Mice Carrying a Mutation in the Spink2 Gene Expressed Predominantly in Testes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; PANCREATIC ACINAR-CELLS; TRYPSIN-INHIBITOR; MATRIX METALLOPROTEINASES; NETHERTON-SYNDROME; MOLECULAR-CLONING; AMINO-ACID; HUSI-II; KAZAL; APOPTOSIS	Spermatogenesis is a complex process involving an intrinsic genetic program composed of germ cell-specific and -predominant genes. In this study, we investigated the mouse Spink2 (serine protease inhibitor Kazal-type 2) gene, which belongs to the SPINK family of proteins characterized by the presence of a Kazal-type serine protease inhibitor-pancreatic secretory trypsin inhibitor domain. We showed that recombinant mouse SPINK2 has trypsin-inhibitory activity. Distribution analyses revealed that Spink2 is transcribed strongly in the testis and weakly in the epididymis, but is not detected in other mouse tissues. Expression of Spink2 is specific to germ cells in the testis and is first evident at the pachytene spermatocyte stage. Immunoblot analyses demonstrated that SPINK2 protein is present in male germ cells at all developmental stages, including in testicular spermatogenic cells, testicular sperm, and mature sperm. To elucidate the functional role of SPINK2 in vivo, we generated mutant mice with diminished levels of SPINK2 using a gene trap mutagenesis approach. Mutant male mice exhibit significantly impaired fertility; further phenotypic analyses revealed that testicular integrity is disrupted, resulting in a reduction in sperm number. Moreover, we found that testes from mutant mice exhibit abnormal spermatogenesis and germ cell apoptosis accompanied by elevated serine protease activity. Our studies thus provide the first demonstration that SPINK2 is required for maintaining normal spermatogenesis and potentially regulates serine protease-mediated apoptosis in male germ cells.	[Lee, Boyeon; Park, Inju; Jin, Sora; Choi, Heejin; Kwon, Jun Tae; Kim, Jihye; Jeong, Juri; Cho, Chunghee] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Cho, Byung-Nam] Catholic Univ Korea, Dept Sci, Puchon 420743, South Korea; [Eddy, Edward M.] NIEHS, Gamete Biol Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	Gwangju Institute of Science & Technology (GIST); Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea.	choch@gist.ac.kr		Park, Inju/0000-0002-8850-5032	Korea Science and Engineering Foundation [2010-0028776]; Korea Research Foundation [KRF-2008-313-C00736]; Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070076] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Korea Science and Engineering Foundation Grant 2010-0028776, a Korea Research Foundation Grant KRF-2008-313-C00736, and a Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment Grant.	Araki M, 2009, CURR PHARM BIOTECHNO, V10, P221, DOI 10.2174/138920109787315006; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Eddy EM, 1995, REPROD FERT DEVELOP, V7, P695, DOI 10.1071/RD9950695; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FINK E, 1990, FEBS LETT, V270, P222, DOI 10.1016/0014-5793(90)81273-Q; Gong BD, 1999, CELL GROWTH DIFFER, V10, P491; Hooper NM, 2002, PROTEASES BIOL MED; Jalkanen J, 2006, BIOCHEM BIOPH RES CO, V349, P245, DOI 10.1016/j.bbrc.2006.08.023; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krane SM, 2003, ARTHRITIS RES THER, V5, P2, DOI 10.1186/ar600; Krause R, 1998, DIFFERENTIATION, V63, P285, DOI 10.1046/j.1432-0436.1998.6350285.x; Lamontagne J, 2010, J VIROL, V84, P907, DOI 10.1128/JVI.01249-09; LEYTUS SP, 1983, BIOCHEM J, V215, P253, DOI 10.1042/bj2150253; Lin MH, 2008, REPRODUCTION, V136, P559, DOI 10.1530/REP-07-0375; Lu XY, 2008, APOPTOSIS, V13, P483, DOI 10.1007/s10495-008-0193-x; Luttun A, 2000, Curr Atheroscler Rep, V2, P407, DOI 10.1007/s11883-000-0079-z; Marchbank T, 1998, DIGESTION, V59, P167, DOI 10.1159/000007485; MORITZ A, 1991, FEBS LETT, V278, P127, DOI 10.1016/0014-5793(91)80099-O; Oh J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-314; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; PHELPS BM, 1990, J CELL BIOL, V111, P1839, DOI 10.1083/jcb.111.5.1839; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Rockett JC, 2004, MUTAT RES-FUND MOL M, V549, P225, DOI 10.1016/j.mrfmmm.2003.11.017; RUGGIERO V, 1987, CELL IMMUNOL, V107, P317, DOI 10.1016/0008-8749(87)90240-1; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Thiemmara V, 2002, CELL DEATH DIFFER, V9, P1343, DOI 10.1038/sj.cdd.4401098; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	36	39	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29108	29117		10.1074/jbc.M111.244905	http://dx.doi.org/10.1074/jbc.M111.244905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705336	Green Published, hybrid			2022-12-27	WOS:000293837000047
J	Lin, JF; Tritschler, D; Song, KK; Barber, CF; Cobb, JS; Porter, ME; Nicastro, D				Lin, Jianfeng; Tritschler, Douglas; Song, Kangkang; Barber, Cynthia F.; Cobb, Jennifer S.; Porter, Mary E.; Nicastro, Daniela			Building Blocks of the Nexin-Dynein Regulatory Complex in Chlamydomonas Flagella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ARM DYNEINS; INTERMEDIATE CHAIN; GENE-EXPRESSION; RADIAL SPOKES; I1 DYNEIN; BENDING PATTERNS; CILIARY MOTILITY; PROTEIN; PHOSPHORYLATION; SUBUNIT	The directional flow generated by motile cilia and flagella is critical for many processes, including human development and organ function. Normal beating requires the control and coordination of thousands of dynein motors, and the nexin-dynein regulatory complex (N-DRC) has been identified as an important regulatory node for orchestrating dynein activity. The nexin link appears to be critical for the transformation of dynein-driven, linear microtubule sliding to flagellar bending, yet the molecular composition and mechanism of the N-DRC remain largely unknown. Here, we used proteomics with special attention to protein phosphorylation to analyze the composition of the N-DRC and to determine which subunits may be important for signal transduction. Two-dimensional electrophoresis and MALDI-TOF mass spectrometry of WT and mutant flagellar axonemes from Chlamydomonas identified 12 N-DRC-associated proteins, including all seven previously observed N-DRC components. Sequence and PCR analyses identified the mutation responsible for the phenotype of the sup-pf-4 strain, and biochemical comparison with a radial spoke mutant revealed two components that may link the N-DRC and the radial spokes. Phosphoproteomics revealed eight proteins with phosphorylated isoforms for which the isoform patterns changed with the genotype as well as two components that may play pivotal roles in N-DRC function through their phosphorylation status. These data were assembled into a model of the N-DRC that explains aspects of its regulatory function.	[Lin, Jianfeng; Song, Kangkang; Barber, Cynthia F.; Nicastro, Daniela] Brandeis Univ, Dept Biol, Rosenstiel Ctr, Waltham, MA 02454 USA; [Tritschler, Douglas; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Cobb, Jennifer S.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA	Brandeis University; University of Minnesota System; University of Minnesota Twin Cities; Brandeis University	Nicastro, D (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Ctr, MS029,415 South St, Waltham, MA 02454 USA.	nicastro@brandeis.edu		Lin, Jianfeng/0000-0003-1215-0906; Lin, Jianfeng/0000-0001-5732-1209; Nicastro, Daniela/0000-0002-0122-7173	National Institutes of Health [GM083122, GM55667]; Pew Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055667, R01GM083122, R37GM055667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083122 (to D. N.) and GM55667 (to M. E. P.). This work was also supported by a Pew Scholars award (to D. N.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Boesger J, 2009, EUKARYOT CELL, V8, P922, DOI 10.1128/EC.00067-09; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROKAW CJ, 1985, CELL MOTIL CYTOSKEL, V5, P195, DOI 10.1002/cm.970050303; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Chamberlain KL, 2008, GENETICS, V179, P7, DOI 10.1534/genetics.107.082149; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gaillard AR, 2001, J CELL BIOL, V153, P443, DOI 10.1083/jcb.153.2.443; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; Habermacher G, 1996, J CELL SCI, V109, P1899; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hozumi A, 2008, CELL MOTIL CYTOSKEL, V65, P249, DOI 10.1002/cm.20258; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Juneja R, 1998, J ANDROL, V19, P183; Kabututu ZP, 2010, J CELL SCI, V123, P3587, DOI 10.1242/jcs.073817; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; Nematollahi G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-321; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; PIPERNO G, 1981, J CELL BIOL, V88, P73, DOI 10.1083/jcb.88.1.73; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Raggiaschi R, 2006, PROTEOMICS, V6, P748, DOI 10.1002/pmic.200500064; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Rupp G, 1996, J CELL BIOL, V135, P1853, DOI 10.1083/jcb.135.6.1853; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Smith EF, 2002, CELL MOTIL CYTOSKEL, V52, P33, DOI 10.1002/cm.10031; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; WARGO MJ, 2005, TEST, V118, P4655; WEEKS DP, 1979, DEV BIOL, V69, P400, DOI 10.1016/0012-1606(79)90300-2; Wirschell M, 2007, CELL MOTIL CYTOSKEL, V64, P569, DOI 10.1002/cm.20211; Wirschell M, 2009, MOL BIOL CELL, V20, P3044, DOI 10.1091/mbc.E09-04-0276; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854; Yang PF, 2000, J BIOL CHEM, V275, P18905, DOI 10.1074/jbc.M002134200; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yang Y, 2011, MOL BIOL CELL, V22, P976, DOI 10.1091/mbc.E10-04-0331; Zheng Y, 2006, INT J MOL MED, V18, P1119	64	66	67	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29175	29191		10.1074/jbc.M111.241760	http://dx.doi.org/10.1074/jbc.M111.241760			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700706	Green Published, hybrid			2022-12-27	WOS:000293837000054
J	Luo, KT; Yuan, J; Lou, ZK				Luo, Kuntian; Yuan, Jian; Lou, Zhenkun			Oligomerization of MDC1 Protein Is Important for Proper DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ATM-DEPENDENT PHOSPHORYLATION; S-PHASE CHECKPOINT; CHROMATIN; MEDIATOR; DOMAIN; SITES; BRCA1; NBS1; AUTOPHOSPHORYLATION	Mediator of DNA damage checkpoint 1 (MDC1) plays an important role in the DNA damage response (DDR). MDC1 functions as a mediator protein and binds multiple proteins involved in different aspects of the DDR. However, little is know about the organization of MDC1 complexes. Here we show that ataxia telangiectasia, mutated (ATM) phosphorylates MDC1 at Thr-98 following DNA damage, which promotes its oligomerization. Oligomerization of MDC1 is important for the accumulation of MDC1 complex at the sites of DNA damage. Mutation of Thr-98 (T98A) would abolish its oligomerization and result in a defect in DNA damage checkpoint activation and increased sensitivity to irradiation. Taken together, these results suggest that the oligomerization of MDC1 plays an important role in DDR and help understand the formation of proteins complexes at the sites of DNA damage.	[Luo, Kuntian; Yuan, Jian] Tongji Univ, Sch Med, Key Lab Arrhythmias, Minist Educ, Shanghai 200120, Peoples R China; [Luo, Kuntian; Yuan, Jian] Tongji Univ, Sch Med, Inst Med Genet, East Hosp, Shanghai 200120, Peoples R China; [Luo, Kuntian; Yuan, Jian; Lou, Zhenkun] Mayo Clin, Div Oncol Res, Rochester, MN 55902 USA	Tongji University; Tongji University; Mayo Clinic	Luo, KT (corresponding author), Tongji Univ, Sch Med, Key Lab Arrhythmias, Minist Educ, Shanghai 200120, Peoples R China.	luo.kuntian@gmail.com; Lou.Zhenkun@mayo.edu		Yuan, Jian/0000-0002-2801-8849	National Institutes of Health [CA130996]; National Natural Science Foundation of China; "973" Program Fund of China [2007CB512100, 2011CB504006]; Ministry of Education of China; Kendall-Mayo; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA148940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Program Fund of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); Kendall-Mayo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA130996. This work was also supported by the Young Scientists Fund of the National Natural Science Foundation of China, the "973" Program Fund of China (Grants 2007CB512100 and 2011CB504006), and the Program Fund for Innovative Research Teams of the Ministry of Education of China.; Recipients of a Kendall-Mayo Fellowship in biochemistry.	Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Inoue K, 2008, BIOCHEM BIOPH RES CO, V371, P829, DOI 10.1016/j.bbrc.2008.04.155; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Nakanishi M, 2007, J BIOL CHEM, V282, P22993, DOI 10.1074/jbc.M611412200; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	36	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28192	28199		10.1074/jbc.M111.258087	http://dx.doi.org/10.1074/jbc.M111.258087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21705321	Green Published, hybrid			2022-12-27	WOS:000293557800037
J	Cao, XX; Xue, LX; Han, LM; Ma, LW; Chen, TD; Tong, TJ				Cao, Xiaoxiao; Xue, Lixiang; Han, Limin; Ma, Liwei; Chen, Tianda; Tong, Tanjun			WW Domain-containing E3 Ubiquitin Protein Ligase 1 (WWP1) Delays Cellular Senescence by Promoting p27(Kip1) Degradation in Human Diploid Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; CAENORHABDITIS-ELEGANS; BREAST-CANCER; PATHWAY; TARGET; TRANSCRIPTION; BINDING; CELLS; RB	WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) plays an important role in the proliferation of tumor cells and the lifespan of Caenorhabditis elegans. However, the role of WWP1 in cellular senescence is still unknown. Here, we show that the expression patterns of p27(Kip1) and WWP1 are inversely correlated during cellular senescence. Moreover, the overexpression of WWP1 delayed senescence, whereas the knockdown of WWP1 led to premature senescence in human fibroblasts. Furthermore, we demonstrate that WWP1 repressed endogenous p27(Kip1) expression through ubiquitin-proteasome-mediated degradation. Additionally, WWP1 had a strong preference for catalyzing the Lys-48-linked polyubiquitination of p27(Kip1) in vitro. Finally, we demonstrate that WWP1 markedly inhibited the replicative senescence induced by p27(Kip1) by promoting p27(Kip1) degradation. Therefore, our study provides a new molecular mechanism for the regulation of cellular senescence.	[Cao, Xiaoxiao; Xue, Lixiang; Han, Limin; Ma, Liwei; Chen, Tianda; Tong, Tanjun] Peking Univ, Res Ctr Aging, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China	Peking University	Tong, TJ (corresponding author), Peking Univ, Res Ctr Aging, Dept Biochem & Mol Biol, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	ttj@bjmu.edu.cn			Special Funds for Major State Basis Research of China [2007CB507400]; National Natural Science Foundation of China [30973146]	Special Funds for Major State Basis Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Special Funds for Major State Basis Research of China (Grant 2007CB507400) and the National Natural Science Foundation of China (Grant 30973146).	Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b; Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633; Huang K, 2000, GENE, V252, P137, DOI 10.1016/S0378-1119(00)00216-X; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Schulz L, 2005, MOL CELL, V17, P168, DOI 10.1016/j.molcel.2005.01.003; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	35	33	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33447	33456		10.1074/jbc.M111.225565	http://dx.doi.org/10.1074/jbc.M111.225565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795702	Green Published, hybrid			2022-12-27	WOS:000294968800062
J	Jokela, TA; Makkonen, KM; Oikari, S; Karna, R; Koli, E; Hart, GW; Tammi, RH; Carlberg, C; Tammi, MI				Jokela, Tiina A.; Makkonen, Katri M.; Oikari, Sanna; Karna, Riikka; Koli, Elina; Hart, Gerald W.; Tammi, Raija H.; Carlberg, Carsten; Tammi, Markku I.			Cellular Content of UDP-N-acetylhexosamines Controls Hyaluronan Synthase 2 Expression and Correlates with O-Linked N-Acetylglucosamine Modification of Transcription Factors YY1 and SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; SKIN ORGAN-CULTURE; GENE-EXPRESSION; RETINOIC ACID; KERATINOCYTE ACTIVATION; INSULIN-RESISTANCE; BINDING PROTEIN; DOWN-REGULATION; MESSENGER-RNA	Hyaluronan, a high molecular mass polysaccharide on the vertebrate cell surface and extracellular matrix, is produced at the plasma membrane by hyaluronan synthases using UDP-GlcNAc and UDP-GlcUA as substrates. The availability of these UDP-sugar substrates can limit the synthesis rate of hyaluronan. In this study, we show that the cellular level of UDP-HexNAc also controls hyaluronan synthesis by modulating the expression of HAS2 (hyaluronan synthase 2). Increasing UDP-HexNAc in HaCaT keratinocytes by adding glucosamine down-regulated HAS2 gene expression, whereas a decrease in UDP-HexNAc, realized by mannose treatment or siRNA for GFAT1 (glutamine: fructose-6-phosphate amidotransferase 1), enhanced expression of the gene. Tracing the UDP-HexNAc-initiated signal to the HAS2 promoter revealed no change in the binding of STAT3, NF-kappa B, and cAMP response element-binding protein, shown previously to mediate growth factor and cytokine signals on HAS2 expression. Instead, altered binding of SP1 and YY1 to the promoter correlated with cellular UDP-HexNAc content and inhibition of HAS2 expression. siRNA silencing of YY1 and SP1 confirmed their inhibitory effects on HAS2 expression. Reduced and increased levels of O-GlcNAc-modified SP1 and YY1 proteins were associated with stimulation or inhibition of HAS2 expression, respectively. Our data are consistent with the hypothesis that, by regulating the level of protein O-GlcNAc modifications, cellular UDP-HexNAc content controls HAS2 transcription and decreases the effects on hyaluronan synthesis that would result from cellular fluctuations of this substrate.	[Jokela, Tiina A.; Makkonen, Katri M.; Oikari, Sanna; Karna, Riikka; Koli, Elina; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Inst Biomed, Ctr Canc, FIN-70211 Kuopio, Finland; [Makkonen, Katri M.; Carlberg, Carsten] Univ Eastern Finland, Inst Biosci, Ctr Canc, FIN-70211 Kuopio, Finland; [Makkonen, Katri M.] Univ Eastern Finland, Inst Dent, Ctr Canc, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Bioctr Kuopio, FIN-70211 Kuopio, Finland; [Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Johns Hopkins University	Tammi, MI (corresponding author), Univ Eastern Finland, Inst Biomed, Ctr Canc, POB 1627, FIN-70211 Kuopio, Finland.	tammi@uef.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021; Carlberg, Carsten/C-9075-2011	Jokela, Tiina/0000-0002-7521-3866; Carlberg, Carsten/0000-0003-2633-0684; Hart, Gerald/0000-0001-7812-4351	Academy of Finland; Sigrid Juselius Foundation; Cancer Center of the University of Eastern Finland; Kuopio University Hospital; Mizutani Foundation; National Glycoscience Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Center of the University of Eastern Finland; Kuopio University Hospital; Mizutani Foundation; National Glycoscience Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Academy of Finland (to M. I. T. and C. C.), the Sigrid Juselius Foundation and the Cancer Center of the University of Eastern Finland (to M. I. T. and R. H. T.), the EVO (Erityisvaltionosuus) Funds of the Kuopio University Hospital and the Mizutani Foundation (to M. I. T.), and the National Glycoscience Graduate School.	AGREN UM, 1995, J CELL PHYSIOL, V164, P240, DOI 10.1002/jcp.1041640204; BADEN HP, 1983, J INVEST DERMATOL, V81, P558, DOI 10.1111/1523-1747.ep12523220; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Dunlop TW, 2004, J STEROID BIOCHEM, V89-90, P257, DOI 10.1016/j.jsbmb.2004.03.079; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Kuroda K, 2001, J DERMATOL SCI, V26, P156, DOI 10.1016/S0923-1811(00)00155-9; Maier KG, 2010, J VASC SURG, V51, P1238, DOI 10.1016/j.jvs.2009.11.073; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; Sainio A, 2010, GLYCOBIOLOGY, V20, P1117, DOI 10.1093/glycob/cwq076; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Sugiura K, 2009, MOL REPROD DEV, V76, P537, DOI 10.1002/mrd.20971; Taguchi S, 2011, J INVEST DERMATOL, V131, P37, DOI 10.1038/jid.2010.229; TAMMI R, 1985, ARCH DERMATOL RES, V277, P276, DOI 10.1007/BF00509080; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	53	51	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33632	33640		10.1074/jbc.M111.265637	http://dx.doi.org/10.1074/jbc.M111.265637			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795679	Green Published, hybrid			2022-12-27	WOS:000294968800079
J	Decaillot, FM; Kazmi, MA; Lin, Y; Ray-Saha, S; Sakmar, TP; Sachdev, P				Decaillot, Fabien M.; Kazmi, Manija A.; Lin, Ying; Ray-Saha, Sarmistha; Sakmar, Thomas P.; Sachdev, Pallavi			CXCR7/CXCR4 Heterodimer Constitutively Recruits beta-Arrestin to Enhance Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR7; ERK ACTIVATION; EXPRESSION; BREAST; PROLIFERATION; LIGAND; MAPK; BETA-ARRESTIN-1; CXCL12/SDF-1; DIMERIZATION	G protein-coupled receptor hetero-oligomerization is emerging as an important regulator of ligand-dependent transmembrane signaling, but precisely how receptor heteromers affect receptor pharmacology remains largely unknown. In this study, we have attempted to identify the functional significance of the heteromeric complex between CXCR4 and CXCR7 chemokine receptors. We demonstrate that co-expression of CXCR7 with CXCR4 results in constitutive recruitment of beta-arrestin to the CXCR4 center dot CXCR7 complex and simultaneous impairment of G(i)-mediated signaling. CXCR7/CXCR4 co-expression also results in potentiation of CXCL12 (SDF-1)-mediated downstream beta-arrestin-dependent cell signaling pathways, including ERK1/2, p38 MAPK, and SAPK as judged from the results of experiments using siRNA knockdown to deplete beta-arrestin. Interestingly, CXCR7/CXCR4 co-expression enhances cell migration in response to CXCL12 stimulation. Again, inhibition of beta-arrestin using either siRNA knockdown or a dominant negative mutant abrogates the enhanced CXCL12-dependent migration of CXCR4/CXCR7-expressing cells. These results show how CXCR7, which cannot signal directly through G protein-linked pathways, can nevertheless affect cellular signaling networks by forming a heteromeric complex with CXCR4. The CXCR4 center dot CXCR7 heterodimer complex recruits beta-arrestin, resulting in preferential activation of beta-arrestin-linked signaling pathways over canonical G protein pathways. CXCL12-dependent signaling of CXCR4 and its role in cellular physiology, including cancer metastasis, should be evaluated in the context of potential functional hetero-oligomerization with CXCR7.	[Decaillot, Fabien M.; Kazmi, Manija A.; Lin, Ying; Ray-Saha, Sarmistha; Sakmar, Thomas P.; Sachdev, Pallavi] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	sakmar@rockefeller.edu; Pallavi_Sachdev@eisai.com	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953	National Institutes of Health from NIDDK [5T32 DK07313]; Tri-Institutional Stem Cell Initiative; Murray Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007313] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Tri-Institutional Stem Cell Initiative; Murray Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32 DK07313 from NIDDK. This work was also supported by the Tri-Institutional Stem Cell Initiative and the Murray Foundation.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bjorndal A, 1997, J VIROL, V71, P7478; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; Calatozzolo C, 2011, CANCER BIOL THER, V11, P242, DOI 10.4161/cbt.11.2.13951; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Chu YW, 2007, CANCER IMMUNOL IMMUN, V56, P1539, DOI 10.1007/s00262-007-0296-1; D'Alterio C, 2010, CURR CANCER DRUG TAR, V10, P772, DOI 10.2174/156800910793605839; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; do Carmo A, 2010, CANCER BIOL THER, V9, P56, DOI 10.4161/cbt.9.1.10342; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Iwakiri S, 2009, CANCER-AM CANCER SOC, V115, P2580, DOI 10.1002/cncr.24281; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2000, PHARMACOL REV, V52, P145; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Salmaggi A, 2009, CANCER BIOL THER, V8, P1615, DOI 10.4161/cbt.8.17.9202; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Walser Tonya C, 2004, Breast Dis, V20, P137; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wu MH, 2008, J CELL PHYSIOL, V214, P65, DOI 10.1002/jcp.21163; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	66	260	266	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32188	32197		10.1074/jbc.M111.277038	http://dx.doi.org/10.1074/jbc.M111.277038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21730065	hybrid, Green Published			2022-12-27	WOS:000294726800029
J	Frankel, MB; Hendrickx, APA; Missiakas, DM; Schneewind, O				Frankel, Matthew B.; Hendrickx, Antoni P. A.; Missiakas, Dominique M.; Schneewind, Olaf			LytN, a Murein Hydrolase in the Cross-wall Compartment of Staphylococcus aureus, Is Involved in Proper Bacterial Growth and Envelope Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; CELL-WALL; SURFACE-PROTEINS; N-ACETYLGLUCOSAMINIDASE; MOLECULAR CHARACTERIZATION; PEPTIDOGLYCAN HYDROLASE; LACTOCOCCUS-LACTIS; ANCHOR STRUCTURE; RESISTANCE GENE; MAJOR AUTOLYSIN	Cell cycle progression for the spherical microbe Staphylococcus aureus requires the coordinated synthesis and remodeling of peptidoglycan. The majority of these rearrangements takes place at the mid-cell, in a compartment designated the cross-wall. Secreted polypeptides endowed with a YSIRK-G/S signal peptide are directly delivered to the cross-wall compartment. One such YSIRK-containing protein is the murein hydrolase LytN. lytN mutations precipitate structural damage to the cross-wall and interfere with staphylococcal growth. Overexpression of lytN also affects growth and triggers rupture of the cross-wall. The lytN phenotype can be reversed by the controlled expression of lytN but not by adding purified LytN to staphylococcal cultures. LytN harbors LysM and CHAP domains, the latter of which functions as both an N-acetylmuramoyl-L-alanine amidase and D-alanyl-glycine endopeptidase. Thus, LytN secretion into the cross-wall promotes peptidoglycan separation and completion of the staphylococcal cell cycle.	[Frankel, Matthew B.; Hendrickx, Antoni P. A.; Missiakas, Dominique M.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu	Hendrickx, Antoni/AAN-1789-2021	Hendrickx, Antoni P.A./0000-0003-4431-9323	National Institutes of Health, Infectious Disease Branch, NIAID [AI038897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, F32AI085709, R01AI038897] Funding Source: NIH RePORTER	National Institutes of Health, Infectious Disease Branch, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI038897 from Infectious Disease Branch, NIAID (to O. S.).	Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 1998, TRENDS MICROBIOL, V6, P66, DOI 10.1016/S0966-842X(97)01196-7; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Berger-Bachi Brigitte, 1994, Trends in Microbiology, V2, P389, DOI 10.1016/0966-842X(94)90617-3; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CHATTERJEE AN, 1964, P NATL ACAD SCI USA, V51, P9, DOI 10.1073/pnas.51.1.9; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Frankel MB, 2010, MOL MICROBIOL, V78, P238, DOI 10.1111/j.1365-2958.2010.07334.x; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; GIESBRECHT P, 1976, INT REV CYTOL, V44, P225, DOI 10.1016/S0074-7696(08)61651-4; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Klevens RM, 2008, CLIN INFECT DIS, V47, P927, DOI 10.1086/591698; Komatsuzawa H, 1997, MICROBIOL IMMUNOL, V41, P469, DOI 10.1111/j.1348-0421.1997.tb01880.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; STROMINGER JL, 1967, FED PROC, V26, P9; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; Sugai M, 1998, GENE, V224, P67, DOI 10.1016/S0378-1119(98)00508-3; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TIPPER DJ, 1968, J BIOL CHEM, V243, P3169; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; TZAGOLOFF H, 1977, J BACTERIOL, V129, P343, DOI 10.1128/JB.129.1.343-350.1977; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156	53	47	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32593	32605		10.1074/jbc.M111.258863	http://dx.doi.org/10.1074/jbc.M111.258863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784864	Green Published, hybrid			2022-12-27	WOS:000294726800069
J	Geng, F; Tang, L; Li, Y; Yang, L; Choi, KS; Kazim, AL; Zhang, YS				Geng, Feng; Tang, Li; Li, Yun; Yang, Lu; Choi, Kyoung-Soo; Kazim, A. Latif; Zhang, Yuesheng			Allyl Isothiocyanate Arrests Cancer Cells in Mitosis, and Mitotic Arrest in Turn Leads to Apoptosis via Bcl-2 Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER-CANCER; BETA-TUBULIN; DIETARY ISOTHIOCYANATES; CRUCIFEROUS VEGETABLES; BINDING-SITE; GROWTH; IDENTIFICATION; DEATH; CYSTEINE-354; SERINE-70	Allyl isothiocyanate (AITC) occurs in many commonly consumed cruciferous vegetables and exhibits significant anti-cancer activities. Available data suggest that it is particularly promising for bladder cancer prevention and/or treatment. Here, we show that AITC arrests human bladder cancer cells in mitosis and also induces apoptosis. Mitotic arrest by AITC was associated with increased ubiquitination and degradation of alpha- and beta-tubulin. AITC directly binds to multiple cysteine residues of the tubulins. AITC induced mitochondrion-mediated apoptosis, as shown by cytochrome c release from mitochondria to cytoplasm, activation of caspase-9 and caspase-3, and formation of TUNEL-positive cells. Inhibition of caspase-9 blocked AITC-induced apoptosis. Moreover, we found that apoptosis induction by AITC depended entirely on mitotic arrest and was mediated via Bcl-2 phosphorylation at Ser-70. Pre-arresting cells in G(1) phase by hydroxyurea abrogated both AITC-induced mitotic arrest and Bcl-2 phosphorylation. Overexpression of a Bcl-2 mutant prevented AITC from inducing apoptosis. We further showed that AITC-induced Bcl-2 phosphorylation was caused by c-Jun N-terminal kinase (JNK), and AITC activates JNK. Taken together, this study has revealed a novel anticancer mechanism of a phytochemical that is commonly present in human diet.	[Geng, Feng; Tang, Li; Li, Yun; Yang, Lu; Zhang, Yuesheng] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Choi, Kyoung-Soo; Kazim, A. Latif] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhang, YS (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	yuesheng.zhang@roswellpark.org	Geng, Feng/R-8287-2016	Zhang, Yuesheng/0000-0002-0976-2875; Yang, Lu/0000-0003-2532-8638	National Institutes of Health [R01CA124627]; NATIONAL CANCER INSTITUTE [R01CA124627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA124627.	Bai RL, 1996, J BIOL CHEM, V271, P12639, DOI 10.1074/jbc.271.21.12639; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; Basu A, 1998, INT J ONCOL, V13, P659; Bhattacharya A, 2010, CARCINOGENESIS, V31, P2105, DOI 10.1093/carcin/bgq202; Bhattacharya A, 2010, CARCINOGENESIS, V31, P281, DOI 10.1093/carcin/bgp303; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Gupta ML, 2001, CELL MOTIL CYTOSKEL, V49, P67, DOI 10.1002/cm.1021; Haldar S, 1996, CANCER RES, V56, P1253; Haldar S, 1998, CANCER RES, V58, P1609; HASEGAWA T, 1993, ANTI-CANCER DRUG, V4, P273, DOI 10.1097/00001813-199304000-00021; Jo H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010318; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Smith TK, 2004, CARCINOGENESIS, V25, P1409, DOI 10.1093/carcin/bgh149; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Tang L, 2004, J NUTR, V134, P2004, DOI 10.1093/jn/134.8.2004; Tang L, 2008, CANCER EPIDEM BIOMAR, V17, P938, DOI 10.1158/1055-9965.EPI-07-2502; Tang L, 2006, ANTI-CANCER DRUG, V17, P297, DOI 10.1097/00001813-200603000-00008; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xu WH, 2009, MOL CANCER THER, V8, P3318, DOI 10.1158/1535-7163.MCT-09-0548; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XY, 2007, CANCER LETT, V255, P95, DOI 10.1016/j.canlet.2007.03.025; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	29	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32259	32267		10.1074/jbc.M111.278127	http://dx.doi.org/10.1074/jbc.M111.278127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778226	hybrid, Green Published			2022-12-27	WOS:000294726800036
J	Talwar, S; Jin, JF; Carroll, B; Liu, AG; Gillespie, MB; Palanisamy, V				Talwar, Sudha; Jin, Junfei; Carroll, Brittany; Liu, Angen; Gillespie, Marion Boyd; Palanisamy, Viswanathan			Caspase-mediated Cleavage of RNA-binding Protein HuR Regulates c-Myc Protein Expression after Hypoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; CELL CARCINOMA; TRANSLATION; CANCER; CYTOPLASM; PHOSPHORYLATION; STABILIZATION; BIOGENESIS	Altered expression of RNA-binding proteins modulates gene expression in association with mRNAs encoding many proto-oncogenes, cytokines, chemokines, and proinflammatory factors. Huantigen R (HuR), a ubiquitously expressed protein, controls a range of cellular functions such as tumor progression, apoptosis, invasion, and metastasis by stabilizing the AU-rich element located at the 3'-untranslated region (UTR) of target mRNAs. Although significant progress has been made in understanding HuR regulation in gene expression, little is known about how HuR undergoes post-translational modifications and recruits target mRNAs during hypoxic stress. Here, we report that during CoCl2-induced hypoxic stress, HuR is significantly overexpressed and undergoes caspase-dependent cleavage in head and neck squamous cell carcinoma cells. Unexpectedly, the HuR-cleavage product 1 (HuR-CP1) was found to strongly associate with the 3'-UTR of c-myc mRNA and block mRNA translation. The binding efficiency of HuR to the 3'-UTR of c-myc mRNA was confirmed using ribonucleoprotein immunoprecipitation and site-directed mutagenesis at the AU-rich element sequences of the c-myc mRNA. Overexpression of a non-cleavable isoform, HuR-D226A, revealed a potent dominant-negative effect, repressing cleavage of endogenous HuR and promoting cell viability. Surprisingly, under hypoxia, siRNA knockdown of HuR elevated c-Myc protein expression. These findings suggest an important role for HuR in hypoxia, and we may have revealed a novel post-transcriptional mechanism that controls c-Myc expression in oral cancer progression.	[Talwar, Sudha; Jin, Junfei; Carroll, Brittany; Palanisamy, Viswanathan] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Liu, Angen] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Gillespie, Marion Boyd] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA; [Palanisamy, Viswanathan] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, V (corresponding author), Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA.	visu@musc.edu		Palanisamy, Viswanathan/0000-0001-5128-2878; Jin, Junfei/0000-0002-9237-9024	National Institutes of Health [R00DE018165]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R00DE018165 (to V.P.).	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Atasoy U, 1998, J CELL SCI, V111, P3145; Balasubramanian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011470; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brunelle JK, 2004, J BIOL CHEM, V279, P4305, DOI 10.1074/jbc.M312241200; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Corn PG, 2005, CANCER BIOL THER, V4, P1285, DOI 10.4161/cbt.4.11.2299; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hasegawa H, 2009, BRIT J CANCER, V100, P1943, DOI 10.1038/sj.bjc.6605084; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lafon I, 1998, ONCOGENE, V16, P3413, DOI 10.1038/sj.onc.1201895; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Leo C, 2004, SEMIN RADIAT ONCOL, V14, P207, DOI 10.1016/j.semradonc.2004.04.007; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li Q, 2009, BIOCHIMIE, V91, P1307, DOI 10.1016/j.biochi.2009.07.001; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	50	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32333	32343		10.1074/jbc.M111.255927	http://dx.doi.org/10.1074/jbc.M111.255927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795698	Green Published, hybrid			2022-12-27	WOS:000294726800043
J	Taneike, M; Mizote, I; Morita, T; Watanabe, T; Hikoso, S; Yamaguchi, O; Takeda, T; Oka, T; Tamai, T; Oyabu, J; Murakawa, T; Nakayama, H; Nishida, K; Takeda, J; Mochizuki, N; Komuro, I; Otsu, K				Taneike, Manabu; Mizote, Isamu; Morita, Takashi; Watanabe, Tetsuya; Hikoso, Shungo; Yamaguchi, Osamu; Takeda, Toshihiro; Oka, Takafumi; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Nakayama, Hiroyuki; Nishida, Kazuhiko; Takeda, Junji; Mochizuki, Naoki; Komuro, Issei; Otsu, Kinya			Calpain Protects the Heart from Hemodynamic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCES INFARCT SIZE; SMALL-SUBUNIT GENE; PLASMA-MEMBRANE; CONTRACTILE DYSFUNCTION; EMBRYONIC-DEVELOPMENT; UBIQUITOUS CALPAINS; PRESSURE-OVERLOAD; RAT-HEART; DISRUPTION; REPAIR	Calpains make up a family of Ca2+-dependent intracellular cysteine proteases that include ubiquitously expressed mu- and m-calpains. Both are heterodimers consisting of a distinct large catalytic subunit (calpain 1 for mu-calpain and calpain 2 for m-calpain) and a common regulatory subunit (calpain 4). The physiological roles of calpain remain unclear in the organs, including the heart, but it has been suggested that calpain is activated by Ca2+ overload in diseased hearts, resulting in cardiac dysfunction. In this study, cardiac-specific calpain 4-deficient mice were generated to elucidate the role of calpain in the heart in response to hemodynamic stress. Cardiac-specific deletion of calpain 4 resulted in decreased protein levels of calpains 1 and 2 and showed no cardiac phenotypes under base-line conditions but caused left ventricle dilatation, contractile dysfunction, and heart failure with interstitial fibrosis 1 week after pressure overload. Pressure-overloaded calpain 4-deficient hearts took up a membrane-impermeant dye, Evans blue, indicating plasma membrane disruption. Membrane repair assays using a two-photon laser-scanning microscope revealed that calpain 4-deficient cardiomyocytes failed to reseal a plasma membrane that had been disrupted by laser irradiation. Thus, the data indicate that calpain protects the heart from hemodynamic stresses, such as pressure overload.	[Takeda, Toshihiro; Oka, Takafumi; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogen, Suita, Osaka 5650871, Japan; [Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Osaka 5658565, Japan	Osaka University; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Otsu, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kotsu@medone.med.osaka-u.ac.jp	Hikoso, Shungo/R-4281-2018	Yamaguchi, Osamu/0000-0002-7461-369X; Hikoso, Shungo/0000-0003-2284-1970	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greyson CR, 2008, J MOL CELL CARDIOL, V44, P59, DOI 10.1016/j.yjmcc.2007.10.010; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Iwamoto H, 1999, J CARDIOVASC PHARM, V33, P580, DOI 10.1097/00005344-199904000-00010; Khalil PN, 2005, EUR J PHARMACOL, V528, P124, DOI 10.1016/j.ejphar.2005.10.032; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Larsen AK, 2008, BIOCHEM J, V411, P657, DOI 10.1042/BJ20070522; Mani SK, 2008, AM J PHYSIOL-HEART C, V295, pH314, DOI 10.1152/ajpheart.00085.2008; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Papp Z, 2000, CARDIOVASC RES, V45, P981, DOI 10.1016/S0008-6363(99)00374-0; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Shimada M, 2008, J BIOL CHEM, V283, P21002, DOI 10.1074/jbc.M710354200; Singh RB, 2004, J MOL CELL CARDIOL, V37, P101, DOI 10.1016/j.yjmcc.2004.04.009; Suryakumar G, 2010, J CARDIOVASC PHARM, V55, P567, DOI 10.1097/FJC.0b013e3181d9f5d4; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tsuji T, 2001, AM J PHYSIOL-HEART C, V281, pH1286, DOI 10.1152/ajpheart.2001.281.3.H1286; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	40	39	39	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32170	32177		10.1074/jbc.M111.248088	http://dx.doi.org/10.1074/jbc.M111.248088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795695	Green Published, hybrid			2022-12-27	WOS:000294726800027
J	Thomas, SV; Kathpalia, PP; Rajagopal, M; Charlton, C; Zhang, JN; Eaton, DC; Helms, MN; Pao, AC				Thomas, Sheela V.; Kathpalia, Paru P.; Rajagopal, Madhumitha; Charlton, Carol; Zhang, Jianning; Eaton, Douglas C.; Helms, My N.; Pao, Alan C.			Epithelial Sodium Channel Regulation by Cell Surface-associated Serum- and Glucocorticoid-regulated Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT CELLS; ALDOSTERONE-INDUCED KINASE; INDUCIBLE PROTEIN-KINASE; NA+ CHANNEL; LIDDLES-SYNDROME; MOUSE MODEL; MINERALOCORTICOID REGULATION; UBIQUITIN LIGASE; APICAL MEMBRANE; PLASMA-MEMBRANE	Serum- and glucocorticoid-regulated kinase 1 (sgk1) participates in diverse biological processes, including cell growth, apoptosis, and sodium homeostasis. In the cortical collecting duct of the kidney, sgk1 regulates sodium transport by stimulating the epithelial sodium channel (ENaC). Control of subcellular localization of sgk1 may be an important mechanism for modulating specificity of sgk1 function; however, which subcellular locations are required for sgk1-regulated ENaC activity in collecting duct cells has yet to be established. Using cell surface biotinylation studies, we detected endogenous sgk1 at the apical cell membrane of aldosterone-stimulated mpkCCD(c14) collecting duct cells. The association of sgk1 with the cell membrane was enhanced when ENaC was co-transfected with sgk1 in kidney cells, suggesting that ENaC brings sgk1 to the cell surface. Furthermore, association of endogenous sgk1 with the apical cell membrane of mpkCCD(c14) cells could be modulated by treatments that increase or decrease ENaC expression at the apical membrane; forskolin increased the association of sgk1 with the apical surface, whereas methyl-beta-cyclodextrin decreased the association of sgk1 with the apical surface. Single channel recordings of excised inside-out patches from the apical membrane of aldosterone-stimulated A6 collecting duct cells revealed that the open probability of ENaC was sensitive to the sgk1 inhibitor GSK650394, indicating that endogenous sgk1 is functionally active at the apical cell membrane. We propose that the association of sgk1 with the apical cell membrane, where it interacts with ENaC, is a novel means by which sgk1 specifically enhances ENaC activity in aldosterone-stimulated collecting duct cells.	[Thomas, Sheela V.; Kathpalia, Paru P.; Rajagopal, Madhumitha; Charlton, Carol; Pao, Alan C.] Stanford Univ, Dept Med, Div Nephrol, Stanford, CA 94305 USA; [Zhang, Jianning] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dept Med, Dallas, TX 75390 USA; [Eaton, Douglas C.; Helms, My N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Pao, AC (corresponding author), 780 Welch Rd,Ste 106, Palo Alto, CA 94304 USA.	paoman@stanford.edu		Eaton, Douglas/0000-0002-2686-6692	National Institutes of Health [K08-DK-073487, R00-HL-09222601, P30-DK-079328, T32-DK07357-26A1]; Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL092226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, T32DK007357, K08DK073487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08-DK-073487 (to A. C. P.), R00-HL-09222601 (to M. N. H.), P30-DK-079328 (to J. Z.), and T32-DK07357-26A1 (to P. P. K.). This work was also supported by Stanford University Dean's Fellowship award (to S. V. T.).	Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Auberson M, 2003, AM J PHYSIOL-RENAL, V285, pF459, DOI 10.1152/ajprenal.00071.2003; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cordas E, 2007, AM J PHYSIOL-CELL PH, V292, pC1971, DOI 10.1152/ajpcell.00399.2006; Dahlmann A, 2003, AM J PHYSIOL-RENAL, V285, pF310, DOI 10.1152/ajprenal.00016.2003; de la Rosa DA, 2006, AM J PHYSIOL-CELL PH, V290, pC492, DOI 10.1152/ajpcell.00556.2004; de la Rosa DA, 2003, J PHYSIOL-LONDON, V551, P455, DOI 10.1113/jphysiol.2003.042903; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Engelsberg A, 2006, BIOCHEM J, V399, P69, DOI 10.1042/BJ20060386; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Maiyar AC, 2003, MOL BIOL CELL, V14, P1221, DOI 10.1091/mbc.E02-03-0170; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Naray-Fejes-Toth A, 2004, MOL CELL ENDOCRINOL, V217, P197, DOI 10.1016/j.mce.2003.10.043; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pradervand S, 2003, J AM SOC NEPHROL, V14, P2219, DOI 10.1097/01.ASN.0000080204.65527.E6; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V295, pF1440, DOI 10.1152/ajprenal.90239.2008; Rajagopal M., 2011, AM J PHYSL IN PRESS; Rajagopal M, 2010, HYPERTENSION, V55, P1123, DOI 10.1161/HYPERTENSIONAHA.109.143404; Setiawan I, 2002, PFLUG ARCH EUR J PHY, V444, P426, DOI 10.1007/s00424-002-0823-z; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	54	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32074	32085		10.1074/jbc.M111.278283	http://dx.doi.org/10.1074/jbc.M111.278283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784856	hybrid, Green Published			2022-12-27	WOS:000294726800017
J	Oberg, F; Sjohamn, J; Fischer, G; Moberg, A; Pedersen, A; Neutze, R; Hedfalk, K				Oberg, Fredrik; Sjohamn, Jennie; Fischer, Gerhard; Moberg, Andreas; Pedersen, Anders; Neutze, Richard; Hedfalk, Kristina			Glycosylation Increases the Thermostability of Human Aquaporin 10 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; METHYLOTROPHIC YEAST; SURFACE EXPRESSION; EPITHELIAL-CELLS; WATER; STABILITY; OLIGOSACCHARIDES; GLYCEROL; CHANNEL; BINDING	Human aquaporin10 (hAQP10) is a transmembrane facilitator of both water and glycerol transport in the small intestine. This aquaglyceroporin is located in the apical membrane of enterocytes and is believed to contribute to the passage of water and glycerol through these intestinal absorptive cells. Here we overproduced hAQP10 in the yeast Pichia pastoris and observed that the protein is glycosylated at Asn-133 in the extracellular loop C. This finding confirms one of three predicted glycosylation sites for hAQP10, and its glycosylation is unique for the human aquaporins overproduced in this host. Nonglycosylated protein was isolated using both glycan affinity chromatography and through mutating asparagine 133 to a glutamine. All three forms of hAQP10 where found to facilitate the transport of water, glycerol, erythritol, and xylitol, and glycosylation had little effect on functionality. In contrast, glycosylated hAQP10 showed increased thermostability of 3-6 degrees C compared with the nonglycosylated protein, suggesting a stabilizing effect of the N-linked glycan. Because only one third of hAQP10 was glycosylated yet the thermostability titration was mono-modal, we suggest that the presence of at least one glycosylated protein within each tetramer is sufficient to convey an enhanced structural stability to the remaining hAQP10 protomers of the tetramer.	[Oberg, Fredrik; Sjohamn, Jennie; Fischer, Gerhard; Moberg, Andreas; Neutze, Richard; Hedfalk, Kristina] Univ Gothenburg, Dept Chem Biochem, SE-40530 Gothenburg, Sweden; [Pedersen, Anders] Univ Gothenburg, Swedish NMR Ctr, SE-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hedfalk, K (corresponding author), Univ Gothenburg, Dept Chem Biochem, POB 462, SE-40530 Gothenburg, Sweden.	kristina.hedfalk@chem.gu.se	Öberg, Fredrik Kryh/B-1241-2011; Sjöhamn, Jennie/A-8266-2011; Hedfalk, Kristina/A-8244-2010; Neutze, Richard/A-7573-2010; Fischer, Gerhard/B-2900-2011; Pedersen, Anders/N-3888-2014	Öberg, Fredrik Kryh/0000-0002-7089-2118; Neutze, Richard/0000-0003-0986-6153; Fischer, Gerhard/0000-0001-9861-1528; Pedersen, Anders/0000-0001-8704-5129; Sjohamn, Jennie/0000-0001-9360-6279	Swedish Science Research Council; European Commission; Integrated Project EDICT	Swedish Science Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); Integrated Project EDICT	This work was supported by the Swedish Science Research Council, the European Commission Marie Curie Training Network Aquaglyceroporins, and the Integrated Project EDICT.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ATKINSON PH, 1984, J CELL BIOL, V98, P2245, DOI 10.1083/jcb.98.6.2245; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Branden M, 2010, BIOPHYS J, V99, P124, DOI 10.1016/j.bpj.2010.03.059; Buck E, 2002, METHOD ENZYMOL, V344, P513; Buck TM, 2004, AM J PHYSIOL-CELL PH, V287, pC1292, DOI 10.1152/ajpcell.00561.2003; CREIGHTON TE, 1997, PROTEIN STRUCTURE PR, P268; ELBEIN AD, 1991, TRENDS BIOTECHNOL, V9, P346, DOI 10.1016/0167-7799(91)90117-Z; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; Heymann JB, 1998, J STRUCT BIOL, V121, P191, DOI 10.1006/jsbi.1997.3951; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Invitrogen, 2002, PICH FERM PROC GUID; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; ISHIMURA K, 1984, CELL TISSUE RES, V238, P653; ITO S, 1974, PHILOS T ROY SOC B, V268, P55, DOI 10.1098/rstb.1974.0015; JAMIESON JD, 1968, J CELL BIOL, V39, P589, DOI 10.1083/jcb.39.3.589; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Keller P, 1997, J CELL SCI, V110, P3001; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Li HP, 2005, BIOL CELL, V97, P823, DOI 10.1042/BC20040091; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; Marshall R D, 1974, Biochem Soc Symp, P17; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Mobasheri A, 2004, HISTOCHEM CELL BIOL, V121, P463, DOI 10.1007/s00418-004-0657-1; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Munro IC, 1998, FOOD CHEM TOXICOL, V36, P1139, DOI 10.1016/S0278-6915(98)00091-X; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Newby Zachary E R, 2008, Nat Struct Mol Biol, V15, P619, DOI 10.1038/nsmb.1431; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; Oberg F, 2009, MOL MEMBR BIOL, V26, P215, DOI 10.1080/09687680902862085; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pfeil W, 2002, THERMOCHIM ACTA, V382, P169, DOI 10.1016/S0040-6031(01)00727-4; Sato Y, 2010, GERIATR GERONTOL INT, V10, pS32, DOI 10.1111/j.1447-0594.2010.00602.x; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; TRIMBLE RB, 1991, J BIOL CHEM, V266, P22807; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; VOET D, 2004, BIOCHEMISTRY-US, P369; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	57	44	49	0	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31915	31923		10.1074/jbc.M111.242677	http://dx.doi.org/10.1074/jbc.M111.242677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733844	hybrid, Green Published			2022-12-27	WOS:000294487500084
J	Rajasekaran, K; Chu, HY; Kumar, P; Xiao, YC; Tinguely, M; Samarakoon, A; Kim, TW; Li, XX; Thakar, MS; Zhang, JW; Malarkannan, S				Rajasekaran, Kamalakannan; Chu, Haiyan; Kumar, Pawan; Xiao, Yechen; Tinguely, Mathew; Samarakoon, Asanga; Kim, Tae Whan; Li, Xiaoxia; Thakar, Monica S.; Zhang, Jiwang; Malarkannan, Subramaniam			Transforming Growth Factor-beta-activated Kinase 1 Regulates Natural Killer Cell-mediated Cytotoxicity and Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NK CELLS; NKG2D RECEPTOR; IKK ACTIVATION; T-CELLS; GRANULE POLARIZATION; IMMUNE-RESPONSES; CARMA1; TAK1; PROTEIN	Carma1, a caspase recruitment domain-containing membrane-associated guanylate kinase, initiates a unique signaling cascade via Bcl10 and Malt1 in NK cells. Carma1 deficiency results in reduced phosphorylation of JNK1/2 and activation of NF-kappa B that lead to impaired NK cell-mediated cytotoxicity and cytokine production. However, the precise identities of the downstream signaling molecules that link Carma1 to these effector functions were not defined. Here we show that transforming growth factor-beta (TGF-beta)-activated kinase 1 (TAK1) is abundantly present in NK cells, and activation via NKG2D results in its phosphorylation. Lack of Carma1 considerably reduced TAK1 phosphorylation, demonstrating the dependence of TAK1 on Carma1 in NKG2D-mediated NK cell activations. Pharmacological inhibitor to TAK1 significantly reduced NK-mediated cytotoxicity and its potential to generate IFN-gamma, GM-CSF, MIP-1 alpha, MIP-1 beta, and RANTES. Conditional in vivo knockdown of TAK1 in NK cells from Mx1Cre(+) TAK1(fx/fx) mice resulted in impaired NKG2D-mediated cytotoxicity and cytokine/chemokine production. Inhibition or conditional knockdown of TAK1 severely impaired the NKG2D-mediated phosphorylation of ERK1/2 and JNK1/2 and activation of NF-kappa B and AP1. Our results show that TAK1 links Carma1 to NK cell-mediated effector functions.	[Rajasekaran, Kamalakannan; Chu, Haiyan; Kumar, Pawan; Samarakoon, Asanga; Thakar, Monica S.; Malarkannan, Subramaniam] Med Coll Wisconsin, Lab Mol Immunol & Immunotherapy, Blood Res Inst, Milwaukee, WI 53226 USA; [Tinguely, Mathew; Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Thakar, Monica S.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Kim, Tae Whan; Li, Xiaoxia] Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Xiao, Yechen; Zhang, Jiwang] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Cleveland Clinic Foundation; Loyola University Chicago	Malarkannan, S (corresponding author), Med Coll Wisconsin, Lab Mol Immunol & Immunotherapy, Blood Res Inst, Milwaukee, WI 53226 USA.	subra.malar@bcw.edu	Malarkannan, Subra/AAQ-9617-2020; Zhang, Jiwang/AAG-2706-2021; RAJASEKARAN, KAMALAKANNAN/F-7350-2015; Malarkannan, Subramaniam/AAQ-3934-2020	RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007; Malarkannan, Subramaniam/0000-0002-7511-2731	National Institutes of Health [R01 A1064826]; Cancer Center of the Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center of the Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 A1064826 (to S. M.).; Recipient of a Breast Cancer Show House Postdoctoral Fellowship from the Cancer Center of the Medical College of Wisconsin.	ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; DJEU JY, 1979, J IMMUNOL, V122, P182; Dorner BG, 2004, J IMMUNOL, V172, P3119, DOI 10.4049/jimmunol.172.5.3119; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samarakoon A, 2009, MOL IMMUNOL, V46, P1011, DOI 10.1016/j.molimm.2008.09.035; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; SAYO SJ, 2000, INT IMMUNOL, V12, P1749; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Trotta R, 2000, J IMMUNOL, V165, P1782, DOI 10.4049/jimmunol.165.4.1782; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	60	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31213	31224		10.1074/jbc.M111.261917	http://dx.doi.org/10.1074/jbc.M111.261917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771792	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000294487500016
J	Song, XZ; Yu, H; Chen, X; Lasanajak, Y; Tappert, MM; Air, GM; Tiwari, VK; Cao, HZ; Chokhawala, HA; Zheng, HJ; Cummings, RD; Smith, DF				Song, Xuezheng; Yu, Hai; Chen, Xi; Lasanajak, Yi; Tappert, Mary M.; Air, Gillian M.; Tiwari, Vinod K.; Cao, Hongzhi; Chokhawala, Harshal A.; Zheng, Haojie; Cummings, Richard D.; Smith, David F.			A Sialylated Glycan Microarray Reveals Novel Interactions of Modified Sialic Acids with Proteins and Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE-MEMBRANE; N-GLYCOLYLNEURAMINIC ACID; H3N2 INFLUENZA-VIRUSES; CHEMOENZYMATIC SYNTHESIS; SPECIFICITY; SIALOSIDES; DIVERSITY; OLIGOSACCHARIDES; NEURAMINIDASE; RECEPTORS	Many glycan-binding proteins in animals and pathogens recognize sialic acid or its modified forms, but their molecular recognition is poorly understood. Here we describe studies on sialic acid recognition using a novel sialylated glycan microarray containing modified sialic acids presented on different glycan backbones. Glycans terminating in beta-linked galactose at the non-reducing end and with an alkylamine-containing fluorophore at the reducing end were sialylated by a one-pot three-enzyme system to generate alpha 2-3- and alpha 2-6-linked sialyl glycans with 16 modified sialic acids. The resulting 77 sialyl glycans were purified and quantified, characterized by mass spectrometry, covalently printed on activated slides, and interrogated with a number of key sialic acid-binding proteins and viruses. Sialic acid recognition by the sialic acid-binding lectins Sambucus nigra agglutinin and Maackia amurensis lectin-I, which are routinely used for detecting alpha 2-6- and alpha 2-3-linked sialic acids, are affected by sialic acid modifications, and both lectins bind glycans terminating with 2-keto-3-deoxy-D-glycero-D-galactonononic acid (Kdn) and Kdn derivatives stronger than the derivatives of more common N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). Three human parainfluenza viruses bind to glycans terminating with Neu5Ac or Neu5Gc and some of their derivatives but not to Kdn and its derivatives. Influenza A virus also does not bind glycans terminating in Kdn or Kdn derivatives. An especially novel aspect of human influenza A virus binding is its ability to equivalently recognize glycans terminated with either alpha 2-6-linked Neu5Ac9Lt or alpha 2-6-linked Neu5Ac. Our results demonstrate the utility of this sialylated glycan microarray to investigate the biological importance of modified sialic acids in protein-glycan interactions.	[Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Song, Xuezheng; Lasanajak, Yi; Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Glyc Ctr, Atlanta, GA 30322 USA; [Yu, Hai; Chen, Xi; Tiwari, Vinod K.; Cao, Hongzhi; Chokhawala, Harshal A.; Zheng, Haojie] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Tappert, Mary M.; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA	Emory University; Emory University; University of California System; University of California Davis; University of Oklahoma System; University of Oklahoma Health Sciences Center	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu; dfsmith@emory.edu	TIWARI, VINOD K/L-9595-2019; Chen, Xi/H-1811-2018	TIWARI, VINOD K/0000-0001-9244-8889; Chen, Xi/0000-0002-3160-614X; Air, Gillian/0000-0001-5724-3108; CAO, HONGZHI/0000-0003-4736-3143	National Institutes of Health (NIH) [RO1GM085448, GM62116, GM076360]; Consortium for Functional Glycomics under NIGMS; Defense Advanced Research Projects Agency [HR0011-10-00]; Oklahoma Center for the Advancement of Science and Technology [HR09-001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076360, U54GM062116, R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Functional Glycomics under NIGMS; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1GM085448 (to D. F. S.), a bridging grant from the Consortium for Functional Glycomics under NIGMS, NIH Grant GM62116 (to R. D. C.), and NIH Grant GM076360 (to X. C.). This work was also supported by Defense Advanced Research Projects Agency Grant HR0011-10-00 (to R. D. C.) and Oklahoma Center for the Advancement of Science and Technology Grant HR09-001 (to G. M. A.).	Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Bratosin D, 2007, BIOCHIMIE, V89, P355, DOI 10.1016/j.biochi.2006.11.004; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Cao HZ, 2009, ORG BIOMOL CHEM, V7, P5137, DOI 10.1039/b916305k; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Chokhawala HA, 2008, ACS CHEM BIOL, V3, P567, DOI 10.1021/cb800127n; CUMMINGS RD, 1994, METHOD ENZYMOL, V230, P66; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Gagneux P, 2001, MOL PHYLOGENET EVOL, V18, P2, DOI 10.1006/mpev.2000.0799; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Inoue S, 1998, J BIOL CHEM, V273, P27199, DOI 10.1074/jbc.273.42.27199; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHULTZE B, 1990, ADV EXP MED BIOL, V276, P115; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Sillanaukee P, 1999, EUR J CLIN INVEST, V29, P413; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Song XZ, 2008, GLYCOCONJUGATE J, V25, P15, DOI 10.1007/s10719-007-9066-8; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; UCHIDA Y, 1979, J BIOCHEM-TOKYO, V86, P1573, DOI 10.1093/oxfordjournals.jbchem.a132675; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; WANG WC, 1988, J BIOL CHEM, V263, P4576; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Yu H, 2004, BIOORGAN MED CHEM, V12, P6427, DOI 10.1016/j.bmc.2004.09.030; YU H, 2011, BIOORG MED IN PRESS; Yu H, 2006, NAT PROTOC, V1, P2485, DOI 10.1038/nprot.2006.401; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Yu H, 2009, J AM CHEM SOC, V131, P18467, DOI 10.1021/ja907750r	49	104	111	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31610	31622		10.1074/jbc.M111.274217	http://dx.doi.org/10.1074/jbc.M111.274217			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757734	Green Published, hybrid			2022-12-27	WOS:000294487500055
J	Douglas, AE; Heim, JA; Shen, F; Almada, LL; Riobo, NA; Fernandez-Zapico, ME; Manning, DR				Douglas, Andrew E.; Heim, Jennifer A.; Shen, Feng; Almada, Luciana L.; Riobo, Natalia A.; Fernandez-Zapico, Martin E.; Manning, David R.			The alpha Subunit of the G Protein G(13) Regulates Activity of One or More Gli Transcription Factors Independently of Smoothened	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; KINASE-II INHIBITOR; SONIC HEDGEHOG; SIGNAL-TRANSDUCTION; G(12) FAMILY; STEM-CELLS; IN-VIVO; ACTIVATION; CANCER; PATHWAYS	Smoothened (Smo) is a seven-transmembrane (7-TM) receptor that is essential to most actions of the Hedgehog family of morphogens. We found previously that Smo couples to members of the G(i) family of heterotrimeric G proteins, which in some cases are integral although alone insufficient in the activation of Gli transcription factors through Hedgehog signaling. In response to a report that the G(12/13) family is relevant to Hedgehog signaling as well, we re-evaluated the coupling of Smo to one member of this family, G(13), and investigated the capacity of this and other G proteins to activate one or more of forms of Gli. We found no evidence that Smo couples directly to G(13). We found nonetheless that G alpha(13) and to some extent G alpha(q) and G alpha(12) are able to effect activation of Gli(s). This capacity is realized in some cells, e.g. C3H10T1/2, MC3T3, and pancreatic cancer cells, but not all cells. The mechanism employed is distinct from that achieved through canonical Hedgehog signaling, as the activation does not involve autocrine signaling or in any other way require active Smo and does not necessarily involve enhanced transcription of Gli1. The activation by G alpha(13) can be replicated through a G(q)/G(12/13)-coupled receptor, CCKA, and is attenuated by inhibitors of p38 mitogen-activated protein kinase and Tec tyrosine kinases. We posit that G proteins, and perhaps G(13) in particular, provide access to Gli that is independent of Smo and that they thus establish a basis for control of at least some forms of Gli-mediated transcription apart from Hedgehogs.	[Douglas, Andrew E.; Shen, Feng; Manning, David R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Heim, Jennifer A.; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Riobo, Natalia A.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Riobo, Natalia A.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Jefferson University; Jefferson University	Manning, DR (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	manning@mail.med.upenn.edu	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873	NIDDK [GM080396, CA136526, P50 CA102701, P30 DK084567]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080396, Mayo Clinic Cancer Center Grant CA136526, Mayo Clinic Pancreatic SPORE Grant P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK084567 from the NIDDK.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Itoh H, 2010, N-S ARCH PHARMACOL, V382, P235, DOI 10.1007/s00210-010-0540-7; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Murthy KS, 2001, AM J PHYSIOL-GASTR L, V280, pG381, DOI 10.1152/ajpgi.2001.280.3.G381; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trousse F, 2001, DEVELOPMENT, V128, P3927; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhang L, 2006, MOL PHARMACOL, V69, P1433, DOI 10.1124/mol.105.019703	49	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30714	30722		10.1074/jbc.M111.219279	http://dx.doi.org/10.1074/jbc.M111.219279			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757753	hybrid, Green Published			2022-12-27	WOS:000294283600051
J	McDougall, WM; Okany, C; Smith, HC				McDougall, William M.; Okany, Chinelo; Smith, Harold C.			Deaminase Activity on Single-stranded DNA (ssDNA) Occurs in Vitro when APOBEC3G Cytidine Deaminase Forms Homotetramers and Higher-order Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FUNCTIONAL IMPLICATIONS; SOMATIC HYPERMUTATION; CATALYTIC DOMAIN; EDITING FACTORS; HIV-1 VIRIONS; RNA; RESTRICTION; MODEL; IDENTIFICATION	APOBEC3G (A3G) is a cytidine deaminase that catalyzes deamination of deoxycytidine (dC) on single-stranded DNA (ssDNA). The oligomeric state of A3G required to support deaminase activity remains unknown. We show under defined in vitro conditions that full-length and native A3G formed complexes with ssDNA in an A3G concentration-dependent but temperature-independent manner. Complexes assembled and maintained at 4 C did not have significant deaminase activity, but their enzymatic function could be restored by subsequent incubation at 37 C. This approach enabled complexes of a defined size range to be isolated and subsequently evaluated for their contribution to enzymatic activity. The composition of A3G bound to ssDNA was determined by protein-protein chemical cross-linking. A3G-ssDNA complexes of 16 S were necessary for deaminase activity and consisted of cross-linked A3G homotetramers and homodimers. At lower concentrations, A3G only formed 5.8 S homodimers on ssDNA with low deaminase activity. Monomeric A3G was not identified in 5.8 S or 16 S complexes. We propose that deaminase-dependent antiviral activity of A3G in vivo may require a critical concentration of A3G in viral particles that will promote oligomerization on ssDNA during reverse transcription.	[McDougall, William M.; Okany, Chinelo; Smith, Harold C.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [McDougall, William M.; Smith, Harold C.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Smith, Harold C.] Univ Rochester, Med Ctr, Ctr Canc, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Smith, HC (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	harold.smith@rochester.edu		Smith, Harold/0000-0001-6257-6791	Bill and Melinda Gates foundation; National Institutes of Health Developmental Center for AIDS (NIAID) [P30 078498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110119] Funding Source: NIH RePORTER	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); National Institutes of Health Developmental Center for AIDS (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Bill and Melinda Gates foundation Grand Challenges in Exploration grant awarded (to H. C. S.) and by a National Institutes of Health Developmental Center for AIDS Research grant (NIAID Grant P30 078498) awarded to Steve Dewhurst.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; HARRIS SG, 1988, BIOCHEMISTRY-US, V27, P4595, DOI 10.1021/bi00413a002; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; MACELREVEY C, 2008, RNA DNA EDITING MOL, P369; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Smith H., 2010, DNA RNA MODIFICATION, P181; Smith HC, 2007, METHOD ENZYMOL, V424, P389, DOI 10.1016/S0076-6879(07)24018-2; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Sowden MP, 2002, J CELL SCI, V115, P1027; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	40	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30655	30661		10.1074/jbc.M111.269506	http://dx.doi.org/10.1074/jbc.M111.269506			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737457	Green Published, hybrid			2022-12-27	WOS:000294283600045
J	Sanchez, FA; Rana, R; Gonzalez, FG; Iwahashi, T; Duran, RG; Fulton, DJ; Beuve, AV; Kim, DD; Duran, WN				Sanchez, Fabiola A.; Rana, Roshniben; Gonzalez, Francisco G.; Iwahashi, Toru; Duran, Ricardo G.; Fulton, David J.; Beuve, Annie V.; Kim, David D.; Duran, Walter N.			Functional Significance of Cytosolic Endothelial Nitric-oxide Synthase (eNOS) REGULATION OF HYPERPERMEABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; PHOSPHORYLATION; GOLGI; PERMEABILITY; ECV304; CELLS; INTERNALIZATION; LOCALIZATION; MECHANISM; PATHWAYS	Endothelial NOS (eNOS)-derived NO is a key factor in regulating microvascular permeability. We demonstrated previously that eNOS translocation from the plasma membrane to the cytosol is required for hyperpermeability. Herein, we tested the hypothesis that eNOS activation in the cytosol is necessary for agonist-induced hyperpermeability. To study the fundamental properties of endothelial cell monolayer permeability, we generated ECV-304 cells that stably express cDNA constructs targeting eNOS to the cytosol or plasma membrane. eNOS-transfected ECV-304 cells recapitulate the eNOS translocation and permeability properties of postcapillary venular endothelial cells (Sanchez, F. A., Rana, R., Kim, D. D., Iwahashi, T., Zheng, R., Lal, B. K., Gordon, D. M., Meininger, C. J., and Duran, W. N. (2009) Proc. Natl. Acad. Sci. U.S.A. 106, 6849-6853). We used platelet-activating factor (PAF) as a proinflammatory agonist. PAF activated eNOS by increasing phosphorylation of Ser-1177 and inducing dephosphorylation of Thr-495, increasing NO production, and elevating permeability to FITC-dextran 70 in monolayers of cells expressing wild-type and cytosolic eNOS. PAF failed to increase permeability to FITC-dextran 70 in monolayers of cells transfected with eNOS targeted to the plasma membrane. Interestingly, this occurred despite eNOS Ser-1177 phosphorylation and production of comparable amounts of NO. Our results demonstrate that the presence of eNOS in the cytosol is necessary for PAF-induced hyperpermeability. Our data provide new insights into the dynamics of eNOS and eNOS-derived NO in the process of inflammation.	[Beuve, Annie V.; Kim, David D.; Duran, Walter N.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Sanchez, Fabiola A.] Univ Austral Chile, Escuela Med, Inst Inmunol, Valdivia 5110566, Chile; [Fulton, David J.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad Austral de Chile; University System of Georgia; Augusta University	Duran, WN (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07101 USA.	duran@umdnj.edu			National Institutes of Health [5R01 HL070634, 5R01 HL088479]; Fondo Nacional de Desarrollo Cientifico Technologico (FONDECYT) [1100569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070634, R01HL088479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Nacional de Desarrollo Cientifico Technologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01 HL070634 and 5R01 HL088479. This work was also supported by Fondo Nacional de Desarrollo Cientifico Technologico (FONDECYT) Grant 1100569.	Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bohlen HG, 1998, AM J PHYSIOL-HEART C, V275, pH542, DOI 10.1152/ajpheart.1998.275.2.H542; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; DILLON PK, 1988, CIRC RES, V62, P732, DOI 10.1161/01.RES.62.4.732; Drexler HG, 2002, IN VITRO CELL DEV-AN, V38, P185; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gil'yano N. Y., 2009, CELL TISSUE BIOL, V3, P274; Hatakeyama T, 2006, J PHYSIOL-LONDON, V574, P275, DOI 10.1113/jphysiol.2006.108175; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Lenasi H, 2003, CARDIOVASC RES, V59, P844, DOI 10.1016/S0008-6363(03)00505-4; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; Sanchez FA, 2008, AM J PHYSIOL-HEART C, V295, pH1642, DOI 10.1152/ajpheart.00629.2008; Sanchez FA, 2006, AM J PHYSIOL-HEART C, V291, pH1058, DOI 10.1152/ajpheart.00370.2006; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505; Varma S, 2002, MICROVASC RES, V63, P172, DOI 10.1006/mvre.2001.2381; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4; Zimmermann K, 2002, P NATL ACAD SCI USA, V99, P17167, DOI 10.1073/pnas.252345399	30	26	26	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30409	30414		10.1074/jbc.M111.234294	http://dx.doi.org/10.1074/jbc.M111.234294			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757745	Green Published, hybrid			2022-12-27	WOS:000294283600019
J	Wu, CY; Kang, HY; Yang, WL; Wu, J; Jeong, YS; Wang, J; Chan, CH; Lee, SW; Zhang, X; Lamothe, B; Campos, AD; Darnay, BG; Lin, HK				Wu, Ching-Yuan; Kang, Hong-Yo; Yang, Wei-Lei; Wu, Juan; Jeong, Yun Seong; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Zhang, Xian; Lamothe, Betty; Campos, Alejandro D.; Darnay, Bryant G.; Lin, Hui-Kuan			Critical Role of Monoubiquitination of Histone H2AX Protein in Histone H2AX Phosphorylation and DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; UBIQUITINATION; UBIQUITYLATION; GAMMA-H2AX; ATM; RECOGNITION; FOCI; PK	DNA damage response is an important surveillance mechanism used to maintain the integrity of the human genome in response to genotoxic stress. Histone variant H2AX is a critical sensor that undergoes phosphorylation at serine 139 upon genotoxic stress, which provides a docking site to recruit the mediator of DNA damage checkpoint protein 1 (MDC1) and DNA repair protein complex to sites of DNA breaks for DNA repair. Here, we show that monoubiquitination of H2AX is induced upon DNA double strand breaks and plays a critical role in H2AX Ser-139 phosphorylation (gamma-H2AX), in turn facilitating the recruitment of MDC1 to DNA damage foci. Mechanistically, we show that monoubiquitination of H2AX induced by RING finger protein 2 (RNF2) is required for the recruitment of active ataxia telangiectasia mutated to DNA damage foci, thus affecting the formation of gamma-H2AX. Importantly, a defect in monoubiquitination of H2AX profoundly enhances ionizing radiation sensitivity. Our study therefore suggests that monoubiquitination of H2AX is an important step for DNA damage response and may have important clinical implications for the treatment of cancers.	[Wu, Ching-Yuan; Kang, Hong-Yo] Kaohsiung Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Kaohsiung 833, Taiwan; [Wu, Ching-Yuan; Kang, Hong-Yo] Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan; [Wu, Ching-Yuan; Yang, Wei-Lei; Wu, Juan; Jeong, Yun Seong; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Zhang, Xian; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wu, Ching-Yuan] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung 833, Taiwan; [Yang, Wei-Lei; Jeong, Yun Seong; Lee, Szu-Wei; Zhang, Xian; Lin, Hui-Kuan] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Wu, Juan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Wu, Juan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Lamothe, Betty; Campos, Alejandro D.; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; Chang Gung Memorial Hospital; University of Texas System; University of Texas Health Science Center Houston; Sun Yat Sen University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center	Kang, HY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Kaohsiung 833, Taiwan.	hkang3@adm.cgmh.org.tw; hklin@mdanderson.org	Chan, Chia-Hsin/AAT-7782-2020; Yang, Wei-Lei/E-2598-2012; Kang, Hong-Yo/W-9031-2019	Kang, Hong-Yo/0000-0003-0626-5037; Zhang, Xian/0000-0001-9674-7886; Chan, Chia-Hsin/0000-0001-8506-7500	National Institutes of Health [1RO1CA149321-01, 1R01CA136787-01A2]; M.D. Anderson Cancer Center; Department of Defense [PC081292]; NATIONAL CANCER INSTITUTE [R01CA149321, R01CA136787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.D. Anderson Cancer Center; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1CA149321-01 and 1R01CA136787-01A2. This work was also supported by the Trust Scholar Fund from M.D. Anderson Cancer Center and New Investigator Award PC081292 from the Department of Defense (to H.K.L.).	Ayoub N, 2009, CELL CYCLE, V8, P1494, DOI 10.4161/cc.8.10.8501; Bassing CH, 2004, CELL CYCLE, V3, P149; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUEN MSSY, 2010, MOL CELLS, V11, P457; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	31	66	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30806	30815		10.1074/jbc.M111.257469	http://dx.doi.org/10.1074/jbc.M111.257469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21690091	hybrid, Green Published			2022-12-27	WOS:000294283600060
J	Zhang, Q; Liu, W				Zhang, Qi; Liu, Wen			Complex Biotransformations Catalyzed by Radical S-Adenosylmethionine Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOLYBDENUM COFACTOR BIOSYNTHESIS; PEPTIDE ANTIBIOTIC NOSIHEPTIDE; ESCHERICHIA-COLI; RIBOSOMAL-RNA; SAM SUPERFAMILY; POSTTRANSLATIONAL MODIFICATIONS; THIOPEPTIDE ANTIBIOTICS; STREPTOMYCES-ACTUOSUS; PROTEIN SUPERFAMILY; STRUCTURAL BIOLOGY	The radical S-adenosylmethionine (AdoMet) superfamily currently comprises thousands of proteins that participate in numerous biochemical processes across all kingdoms of life. These proteins share a common mechanism to generate a powerful 5'-deoxyadenosyl radical, which initiates a highly diverse array of biotransformations. Recent studies are beginning to reveal the role of radical AdoMet proteins in the catalysis of highly complex and chemically unusual transformations, e. g. the ThiC-catalyzed complex rearrangement reaction. The unique features and intriguing chemistries of these proteins thus demonstrate the remarkable versatility and sophistication of radical enzymology.	[Zhang, Qi; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Zhang, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	qizhang@sioc.ac.cn; wliu@sioc.ac.cn			National Natural Science Foundation [20832009, 30525001, 20921091]; Ministry of Science and Technology [2009ZX09501-008]; National Basic Research Program (973 Program) [2010CB833200]; Chinese Academy of Sciences [KJCX2-YW-H08]; Science and Technology Commission of Shanghai Municipality [09QH1402700]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Basic Research Program (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by National Natural Science Foundation Grants 20832009, 30525001, and 20921091; Ministry of Science and Technology Grant 2009ZX09501-008; National Basic Research Program (973 Program) Grant 2010CB833200; Chinese Academy of Sciences Grant KJCX2-YW-H08; and Science and Technology Commission of Shanghai Municipality Grant 09QH1402700. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bai Y, 2000, J BIOL CHEM, V275, P28731, DOI 10.1074/jbc.M002174200; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Bonifacic M, 1998, J AM CHEM SOC, V120, P9930, DOI 10.1021/ja9815428; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; BURG AW, 1968, J BIOL CHEM, V243, P2349; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; de Crecky-Lagard V, 2007, METHOD ENZYMOL, V425, P153; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Dougherty MJ, 2006, MICROBIOL-SGM, V152, P2345, DOI 10.1099/mic.0.28926-0; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; Farrar CE, 2009, BIOCHEMISTRY-US, V48, P2448, DOI 10.1021/bi8022569; FLOSS HG, 1993, ACCOUNTS CHEM RES, V26, P116, DOI 10.1021/ar00027a007; FRENZEL T, 1990, ARCH BIOCHEM BIOPHYS, V278, P35, DOI 10.1016/0003-9861(90)90227-P; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Frey PA, 2006, CHEM REV, V106, P3302, DOI 10.1021/cr050292s; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HOUCK DR, 1988, J AM CHEM SOC, V110, P5800, DOI 10.1021/ja00225a035; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kanaujia SP, 2010, ACTA CRYSTALLOGR D, V66, P821, DOI 10.1107/S0907444910019074; KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Lawhorn BG, 2004, ORG BIOMOL CHEM, V2, P2538, DOI 10.1039/b405429f; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Marsh ENG, 2004, BIOORG CHEM, V32, P326, DOI 10.1016/j.bioorg.2004.06.001; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2009, BIOCHEMISTRY-US, V48, P217, DOI 10.1021/bi802154j; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; MOCEK U, 1993, J AM CHEM SOC, V115, P7557, DOI 10.1021/ja00070a001; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; NEWELL PC, 1968, BIOCHEM J, V106, P279, DOI 10.1042/bj1060279; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Pohl M, 2004, CURR OPIN BIOTECH, V15, P335, DOI 10.1016/j.copbio.2004.06.002; Rachid S, 2009, CHEM BIOL, V16, P70, DOI 10.1016/j.chembiol.2008.11.005; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Renaud P., 2001, RADICALS ORGANIC SYN; Rizzi M, 2002, CURR OPIN STRUC BIOL, V12, P709, DOI 10.1016/S0959-440X(02)00385-8; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; SUHADOLN.RJ, 1970, J BIOL CHEM, V245, P4365; Suhadolnik R. J., 1970, NUCLEOSIDE ANTIBIOTI, P298; Szu PH, 2005, ANGEW CHEM INT EDIT, V44, P6742, DOI 10.1002/anie.200501998; Szu PH, 2009, J AM CHEM SOC, V131, P14030, DOI 10.1021/ja903354k; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; Wuebbens MM, 2000, STRUCTURE, V8, P709, DOI 10.1016/S0969-2126(00)00157-X; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]; ZHOU P, 1989, J AM CHEM SOC, V111, P7274, DOI 10.1021/ja00200a065	80	22	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30245	30252		10.1074/jbc.R111.272690	http://dx.doi.org/10.1074/jbc.R111.272690			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21771780	Green Published, hybrid			2022-12-27	WOS:000294283600001
J	Molitoris, JK; McColl, KS; Swerdlow, S; Matsuyama, M; Lam, M; Finkel, TH; Matsuyama, S; Distelhorst, CW				Molitoris, Jason K.; McColl, Karen S.; Swerdlow, Sarah; Matsuyama, Mieko; Minh Lam; Finkel, Terri H.; Matsuyama, Shigemi; Distelhorst, Clark W.			Glucocorticoid Elevation of Dexamethasone-induced Gene 2 (Dig2/RTP801/REDD1) Protein Mediates Autophagy in Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED APOPTOSIS; INOSITOL 1,4,5-TRISPHOSPHATE; OLIGONUCLEOTIDE ARRAYS; RAPAMYCIN PATHWAY; MAMMALIAN TARGET; LYMPHOMA-CELLS; INHIBITION; EXPRESSION; BCL-2	Glucocorticoid hormones, including dexamethasone, induce apoptosis in lymphocytes and consequently are used clinically as chemotherapeutic agents in many hematologic malignancies. Dexamethasone also induces autophagy in lymphocytes, although the mechanism is not fully elucidated. Through gene expression analysis, we found that dexamethasone induces the expression of a gene encoding a stress response protein variously referred to as Dig2, RTP801, or REDD1. This protein is reported to inhibit mammalian target of rapamycin (mTOR) signaling. Because autophagy is one outcome of mTOR inhibition, we investigated the hypothesis that Dig2/RTP801/REDD1 elevation contributes to autophagy induction in dexamethasone-treated lymphocytes. In support of this hypothesis, RNAi-mediated suppression of Dig2/RTP801/REDD1 reduces mTOR inhibition and autophagy in glucocorticoid-treated lymphocytes. We observed similar results in Dig2/Rtp801/Redd1 knock-out murine thymocytes treated with dexamethasone. Dig2/RTP801/REDD1 knockdown also leads to increased levels of dexamethasone-induced cell death, suggesting that Dig2/RTP801/REDD1-mediated autophagy promotes cell survival. Collectively, these findings demonstrate for the first time that elevation of Dig2/RTP801/REDD1 contributes to the induction of autophagy.	[Distelhorst, Clark W.] Case Western Reserve Univ, Div Hematol Oncol, Ctr Comprehens Canc, Dept Med, Cleveland, OH 44106 USA; [Molitoris, Jason K.; Swerdlow, Sarah] Case Western Reserve Univ, Ctr Comprehens Canc, Dept Pathol, Cleveland, OH 44106 USA; [Minh Lam] Case Western Reserve Univ, Ctr Comprehens Canc, Dept Dermatol, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Finkel, Terri H.] Univ Penn, Sch Med, Div Rheumatol, Dept Pediat, Philadelphia, PA 19104 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Pennsylvania	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Div Hematol Oncol, Ctr Comprehens Canc, Dept Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	cwd@case.edu			National Institutes of Health [RO1 CA42755, CA85804, RO1 AG031903, T32HL007147, T32 GM007250]; Ohio Center for Innovative Immunosuppressive Therapeutics; NATIONAL CANCER INSTITUTE [R01CA042755, R01CA085804] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Center for Innovative Immunosuppressive Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA42755 and CA85804 (to C. W. D.), RO1 AG031903 (to S. M.), T32HL007147 (to S. J. S. and J. K. M.), and T32 GM007250 (to J. K. M.). This work was also supported in part by an Ohio Center for Innovative Immunosuppressive Therapeutics grant.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; BAXTER JD, 1971, P NATL ACAD SCI USA, V68, P932, DOI 10.1073/pnas.68.5.932; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bowen DA, 2007, LEUKEMIA LYMPHOMA, V48, P2412, DOI 10.1080/10428190701724801; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Davis MC, 2008, J BIOL CHEM, V283, P10357, DOI 10.1074/jbc.M800269200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dougherty Thomas F., 1943, SCIENCE, V98, P367, DOI 10.1126/science.98.2547.367; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Gaynon PS, 1999, ADV EXP MED BIOL, V457, P593; Harr MW, 2010, AUTOPHAGY, V6, P912, DOI 10.4161/auto.6.7.13290; HENCH PS, 1949, P STAFF M MAYO CLIN, V24, P181; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Obexer P, 2001, ONCOGENE, V20, P4324, DOI 10.1038/sj.onc.1204573; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; PEARSON OH, 1949, CANCER, V2, P943, DOI 10.1002/1097-0142(194911)2:6<943::AID-CNCR2820020602>3.0.CO;2-P; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reed J C, 1996, Cancer Treat Res, V84, P31; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; SIBLEY CH, 1974, CELL, V2, P213, DOI 10.1016/0092-8674(74)90013-0; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Swerdlow S, 2008, AUTOPHAGY, V4, P612, DOI 10.4161/auto.5920; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAMAMOTO KR, 1974, P NATL ACAD SCI USA, V71, P3901, DOI 10.1073/pnas.71.10.3901; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	52	73	76	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30181	30189		10.1074/jbc.M111.245423	http://dx.doi.org/10.1074/jbc.M111.245423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733849	Green Published, hybrid			2022-12-27	WOS:000294046600075
J	Ngo, S; Gu, L; Guo, ZF				Ngo, Sam; Gu, Lei; Guo, Zhefeng			Hierarchical Organization in the Amyloid Core of Yeast Prion Protein Ure2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN FIBRILS; BETA-SHEET STRUCTURE; SOLID-STATE NMR; SPIN-LABELED PROTEINS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; SIDE-CHAINS; IN-VITRO; PARALLEL; DOMAIN	Formation of amyloid fibrils is involved in a range of fatal human disorders including Alzheimer, Parkinson, and prion diseases. Yeast prions, despite differences in sequence from their mammalian counterparts, share similar features with mammalian prions including infectivity, prion strain phenomenon, and species barrier and thus are good model systems for human prion diseases. Yeast prions normally have long prion domains that presumably form multiple beta strands in the fibril, and structural knowledge about the yeast prion fibrils has been limited. Here we use site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy to investigate the structures of amyloid fibrils of Ure2 prion domain. We show that 15 spin-labeled Ure2 mutants, with spin labels at every 5th residue from position 5 to position 75, show a single-line or nearly single-line feature in their EPR spectra as a result of strong spin exchange interactions. These results suggest that a parallel in-register beta structure exists at these spin-labeled positions. More interestingly, we also show that residues in the segment 30-65 have stronger spin exchange interactions, higher local stability, and lower solvent accessibility than segments 5-25 and 70-75, suggesting different local environment at these segments. We propose a hierarchical organization in the amyloid core of Ure2, with the segment 30-65 forming an inner core and the segments 5-25 and 70-75 forming an outer core. The hierarchical organization in the amyloid core may be a structural origin for polymorphism in fibrils and prion strains.	[Ngo, Sam; Gu, Lei; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013; Gu, Lei/GWQ-6785-2022	Guo, Zhefeng/0000-0003-1992-7255; 	Larry L. Hillblom Foundation; Alzheimer's Association	Larry L. Hillblom Foundation; Alzheimer's Association(Alzheimer's Association)	This work was supported by the Larry L. Hillblom Foundation and the Alzheimer's Association.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Langen R, 1999, BIOCHEMISTRY-US, V38, P7918, DOI 10.1021/bi990010g; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Molin Y. N., 1980, SPIN EXCHANGE; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schneider D. J., 1989, BIOL MAGN RESON, V8, P1; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Zielke V, 2008, ACTA CRYSTALLOGR C, V64, pO586, DOI 10.1107/S0108270108032113	60	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29691	29699		10.1074/jbc.M111.269092	http://dx.doi.org/10.1074/jbc.M111.269092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730048	Green Published, hybrid			2022-12-27	WOS:000294046600028
J	Ou, L; Ferreira, AM; Otieno, S; Xiao, LM; Bashford, D; Kriwacki, RW				Ou, Li; Ferreira, Antonio M.; Otieno, Steve; Xiao, Limin; Bashford, Donald; Kriwacki, Richard W.			Incomplete Folding upon Binding Mediates Cdk4/Cyclin D Complex Activation by Tyrosine Phosphorylation of Inhibitor p27 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; RETINOBLASTOMA PROTEIN; CDK INHIBITORS; P27(KIP1); ARREST; MOTIF; G1; SITE; IDENTIFICATION	p27(Kip1) (p27), an intrinsically disordered protein, regulates the various Cdk/cyclin complexes that control cell cycle progression. The kinase inhibitory domain of p27 contains a cyclin-binding subdomain (D1), a Cdk-binding subdomain (D2), and a linker helix subdomain that connects D1 and D2. Here, we report that, despite extensive sequence conservation between Cdk4/cyclin D1 (hereafter Cdk4/cyclin D) and Cdk2/cyclin A, the thermodynamic details describing how the individual p27 subdomains contribute to equally high affinity binding to these two Cdk/cyclin complexes are strikingly different. Differences in enthalpy/entropy compensation revealed that the D2 subdomain of p27 folds incompletely when binding Cdk4/cyclin D versus Cdk2/cyclin A. Incomplete binding-induced folding exposes tyrosine 88 of p27 for phosphorylation by the nonreceptor tyrosine kinase Abl. Importantly, tyrosine phosphorylation (of p27) relieves Cdk inhibition by p27, enabling cell cycle entry. Furthermore, the interaction between a conserved hydrophobic patch on cyclin D and subdomain D1 is much weaker than that with cyclin A; consequently, a construct containing subdomains D1 and LH (p27-D1LH) does not inhibit substrate binding to Cdk4/cyclin D as it does to Cdk2/cyclin A. Our results provide a mechanism by which Cdk4 (within the p27/Cdk4/cyclin D complex) is poised to be activated by extrinsic mitogenic signals that impinge upon p27 at the earliest stage of cell division. More broadly, our results further illustrate the regulatory versatility of intrinsically disordered proteins.	[Ou, Li; Ferreira, Antonio M.; Otieno, Steve; Xiao, Limin; Bashford, Donald; Kriwacki, Richard W.] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Kriwacki, Richard W.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, RW (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org	Kriwacki, Richard/N-8154-2018; Ou, Li/F-8416-2012; Ferreira, Antonio/I-4423-2013; Bashford, Donald/F-5905-2011	Kriwacki, Richard/0000-0002-9798-6018; Bashford, Donald/0000-0001-5776-3744; Ferreira, Antonio/0000-0002-6581-6233	NCI, National Institutes of Health [R01 CA082491]; American Lebanese Syrian Associated Charities (ALSAC); Cancer Center [2P30CA021765]; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA082491] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01 CA082491 (to R. W. K.). This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) and by Cancer Center Support Grant 2P30CA021765 (to St. Jude Children's Research Hospital).	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 1996, MOL CELL BIOL, V16, P6623; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; Chen IT, 1996, ONCOGENE, V12, P595; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HARPER JW, 1993, CELL, V75, P805; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liu S, 2010, ACS CHEM BIOL, V5, P1169, DOI 10.1021/cb1001262; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Pan WJ, 2001, CANCER RES, V61, P2885; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	44	33	35	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30142	30151		10.1074/jbc.M111.244095	http://dx.doi.org/10.1074/jbc.M111.244095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715330	Green Published, hybrid			2022-12-27	WOS:000294046600071
J	Fakas, S; Qiu, YX; Dixon, JL; Han, GS; Ruggles, KV; Garbarino, J; Sturley, SL; Carman, GM				Fakas, Stylianos; Qiu, Yixuan; Dixon, Joseph L.; Han, Gil-Soo; Ruggles, Kelly V.; Garbarino, Jeanne; Sturley, Stephen L.; Carman, George M.			Phosphatidate Phosphatase Activity Plays Key Role in Protection against Fatty Acid-induced Toxicity in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE ENCODES; NUCLEAR-MEMBRANE GROWTH; DYSTROPHY FLD MUTATION; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; DIACYLGLYCEROL KINASE; ENDOPLASMIC-RETICULUM; MEDIATED REPRESSION; SIGNALING FUNCTIONS; GLOBAL ANALYSIS	The PAH1-encoded phosphatidate (PA) phosphatase in Saccharomyces cerevisiae is a pivotal enzyme that produces diacylglycerol for the synthesis of triacylglycerol (TAG) and simultaneously controls the level of PA used for phospholipid synthesis. Quantitative lipid analysis showed that the pah1 Delta mutation caused a reduction in TAG mass and an elevation in the mass of phospholipids and free fatty acids, changes that were more pronounced in the stationary phase. The levels of unsaturated fatty acids in the pah1 Delta mutant were unaltered, although the ratio of palmitoleic acid to oleic acid was increased with a similar change in the fatty acid composition of phospholipids. The pah1 Delta mutant exhibited classic hallmarks of apoptosis in stationary phase and a marked reduction in the quantity of cytoplasmic lipid droplets. Cells lacking PA phosphatase were sensitive to exogenous fatty acids in the order of toxicity palmitoleic acid > oleic acid > palmitic acid. In contrast, the growth of wild type cells was not inhibited by fatty acid supplementation. In addition, wild type cells supplemented with palmitoleic acid exhibited an induction in PA phosphatase activity and an increase in TAG synthesis. Deletion of the DGK1-encoded diacylglycerol kinase, which counteracts PA phosphatase in controlling PA content, suppressed the defect in lipid droplet formation in the pah1 Delta mutant. However, the sensitivity of the pah1 Delta mutant to palmitoleic acid was not rescued by the dgk1 Delta mutation. Overall, these findings indicate a key role of PA phosphatase in TAG synthesis for protection against fatty acid-induced toxicity.	[Fakas, Stylianos; Qiu, Yixuan; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Dixon, Joseph L.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Fakas, Stylianos; Qiu, Yixuan; Dixon, Joseph L.; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Ruggles, Kelly V.; Garbarino, Jeanne; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Ruggles, Kelly V.; Garbarino, Jeanne; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; Columbia University	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/R-9908-2019; Fakas, Stylianos/AAQ-7594-2020	Fakas, Stylianos/0000-0001-8692-1326; Fakas, Stylianos/0000-0001-8692-1326; Ruggles, Kelly/0000-0002-0152-0863	National Institutes of Health [GM-28140, DK-54320, DK-007647]; National Center for Research Resources [RR-02415803, RR-021120]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, T32DK007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-28140 (to G. M. C.), DK-54320 (to S. L. S.), and DK-007647 (to J. G.); Clinical and Translational Science Award Training Grant RR-02415803 (to K. V. R.); and Grant RR-021120 from the National Center for Research Resources (for purchase of the liquid chromatography-mass spectrometry system).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; CHIRALA SS, 1992, P NATL ACAD SCI USA, V89, P10232, DOI 10.1073/pnas.89.21.10232; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kohlwein SD, 2010, BBA-MOL CELL BIOL L, V1801, P222, DOI 10.1016/j.bbalip.2009.12.016; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LIN YP, 1989, J BIOL CHEM, V264, P8641; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rockenfeller P, 2010, CELL CYCLE, V9, P2836, DOI 10.4161/cc.9.14.12346; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Stukey J, 1997, PROTEIN SCI, V6, P469; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	108	90	96	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29074	29085		10.1074/jbc.M111.258798	http://dx.doi.org/10.1074/jbc.M111.258798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708942	hybrid, Green Published			2022-12-27	WOS:000293837000044
J	Gonzalez-Bulnes, P; Bobenchik, AM; Augagneur, Y; Cerdan, R; Vial, HJ; Llebaria, A; Ben Mamoun, C				Gonzalez-Bulnes, Patricia; Bobenchik, April M.; Augagneur, Yoann; Cerdan, Rachel; Vial, Henri J.; Llebaria, Amadeu; Ben Mamoun, Choukri			PG12, a Phospholipid Analog with Potent Antimalarial Activity, Inhibits Plasmodium falciparum CTP:Phosphocholine Cytidylyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; INFECTED ERYTHROCYTES; TRYPANOSOMA-BRUCEI; MALARIA; PATHWAY; 1-O-OCTADECYL-2-O-METHYL-RAC-GLYCERO-3-PHOSPHOCHOLINE; LYSOPHOSPHATIDYLCHOLINE	In the human malaria parasite Plasmodium falciparum, the synthesis of the major and essential membrane phospholipid, phosphatidylcholine, occurs via the CDP-choline and the serine decarboxylase phosphoethanolamine methylation (SDPM) pathways, which are fueled by host choline, serine, and fatty acids. Both pathways share the final two steps catalyzed by two essential enzymes, P. falciparum CTP:phosphocholine cytidylyltransferase (PfCCT) and choline-phosphate transferase (PfCEPT). We identified a novel class of phospholipid mimetics, which inhibit the growth of P. falciparum as well as Leishmania and Trypanosoma species. Metabolic analyses showed that one of these compounds, PG12, specifically blocks phosphatidylcholine biosynthesis from both the CDP-choline and SDPM pathways via inhibition of PfCCT. In vitro studies using recombinant PfCCT showed a dose-dependent inhibition of the enzyme by PG12. The potent antimalarial of this compound, its low cytotoxicity profile, and its established mode of action make it an excellent lead to advance for further drug development and efficacy in vivo.	[Gonzalez-Bulnes, Patricia; Llebaria, Amadeu] CSIC, Res Unit BioAct Mol RUBAM, Dept Quim Biomed, Inst Quim Avanzada Cataluna IQAC, ES-08034 Barcelona, Spain; [Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Cerdan, Rachel; Vial, Henri J.] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Llebaria, A (corresponding author), CSIC, Res Unit BioAct Mol RUBAM, Dept Quim Biomed, Inst Quim Avanzada Cataluna IQAC, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	alsqob@cid.csic.es; Choukri.benmamoun@yale.edu	augagneur, yoann/L-2000-2015; Llebaria, Amadeu/C-4287-2015	augagneur, yoann/0000-0002-6816-5931; Llebaria, Amadeu/0000-0002-8200-4827; CERDAN, Rachel/0000-0001-8214-8006	National Institutes of Health, NIAID [AI51507]; Generalitat de Catalunya [2009SGR-1072]; "Ministerio de Ciencia e Innovacion," Spain [CTQ2008-01426/BQU]; Department of Defense [PR033005]; Burroughs Wellcome Fund; Burroughs Wellcome Award [1006267]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051507] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Generalitat de Catalunya(Generalitat de Catalunya); "Ministerio de Ciencia e Innovacion," Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Burroughs Wellcome Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI51507 (to C. B. M.). This work was also supported by "Generalitat de Catalunya" Grant 2009SGR-1072 and "Ministerio de Ciencia e Innovacion," Spain (Project CTQ2008-01426/BQU and a fellowship to P. G. B.), Department of Defense Grant PR033005 (to C. B. M.), and the Burroughs Wellcome Fund (to C. B. M.).; Recipient of Burroughs Wellcome Award 1006267, Investigators of Pathogenesis of Infectious Diseases. To whom correspondence may be addressed: Dept. of Internal Medicine, Section of Infectious Disease, Yale University School of Medicine, P. O. Box 20822, 15 York Street, www-403D, New Haven, CT 06520. Tel./Fax:203-737-1972; E-mail: Choukri.benmamoun@yale.edu.	ANCELIN ML, 1989, BIOCHIM BIOPHYS ACTA, V1001, P82, DOI 10.1016/0005-2760(89)90310-X; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Biagini GA, 2004, BLOOD, V104, P3372, DOI 10.1182/blood-2004-03-1084; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Boggs K, 1998, BBA-LIPID LIPID MET, V1389, P1, DOI 10.1016/S0005-2760(97)00145-8; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Dua VK, 2011, J ETHNOPHARMACOL, V136, P123, DOI 10.1016/j.jep.2011.04.024; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalez-Bulnes P, 2010, BIOORGAN MED CHEM, V18, P8549, DOI 10.1016/j.bmc.2010.10.031; Hanada K, 2000, BIOCHEM J, V346, P671, DOI 10.1042/0264-6021:3460671; Hanada K, 2002, J EXP MED, V195, P23, DOI 10.1084/jem.20010724; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Matile H., 1990, PLASMODIUM FALCIPARU; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Richier E, 2006, ANTIMICROB AGENTS CH, V50, P3381, DOI 10.1128/AAC.00443-06; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; Vogler WR, 1996, LEUKEMIA RES, V20, P947, DOI 10.1016/S0145-2126(96)00070-7; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Yeo HJ, 1997, BIOCHEM J, V324, P903, DOI 10.1042/bj3240903	37	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28940	28947		10.1074/jbc.M111.268946	http://dx.doi.org/10.1074/jbc.M111.268946			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705805	Green Published, hybrid			2022-12-27	WOS:000293837000031
J	Mahmood, DFD; Jguirim-Souissi, I; Khadija, E; Blondeau, N; Diderot, V; Amrani, S; Slimane, MN; Syrovets, T; Simmet, T; Rouis, M				Mahmood, Dler Faieeq Darweesh; Jguirim-Souissi, Imene; Khadija, El-Hadri; Blondeau, Nicolas; Diderot, Vimala; Amrani, Souliman; Slimane, Mohamed-Naceur; Syrovets, Tatiana; Simmet, Thomas; Rouis, Mustapha			Peroxisome Proliferator-activated Receptor gamma Induces Apoptosis and Inhibits Autophagy of Human Monocyte-derived Macrophages via Induction of Cathepsin L POTENTIAL ROLE IN ATHEROSCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LYSOSOMAL CYSTEINE PROTEASES; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; DEFICIENT MICE; TUMOR-SUPPRESSOR; LIPID-METABOLISM; GENE-EXPRESSION; KNOCKOUT MICE; UP-REGULATION	Macrophages play a pivotal role in the pathophysiology of atherosclerosis. These cells express cathepsin L (CatL), a cysteine protease that has been implicated in atherogenesis and the associated arterial remodeling. In addition, macrophages highly express peroxisome proliferator-activated receptor (PPAR) gamma, a transcription factor that regulates numerous genes important for lipid and lipoprotein metabolism, for glucose homeostasis, and inflammation. Hence, PPAR gamma might affect macrophage function in the context of chronic inflammation such as atherogenesis. In the present study, we examined the effect of PPAR gamma activation on the expression of CatL in human monocyte-derived macrophages (HMDM). Activation of PPAR gamma by the specific agonist GW929 concentration-dependently increased the levels of CatL mRNA and protein in HMDM. By promoter analysis, we identified a functional PPAR response element-like sequence that positively regulates CatL expression. In addition, we found that PPAR gamma-induced CatL promotes the degradation of Bcl2 without affecting Bax protein levels. Consistently, degradation of Bcl2 could be prevented by a specific CatL inhibitor, confirming the causative role of CatL. PPAR gamma-induced CatL was found to decrease autophagy through reduction of beclin 1 and LC3 protein levels. The reduction of these proteins involved in autophagic cell death was antagonized either by the CatL inhibitor or by CatL knockdown. In conclusion, our data show that PPAR gamma can specifically induce CatL, a proatherogenic protease, in HMDM. In turn, CatL inhibits autophagy and induces apoptosis. Thus, the proatherogenic effect of CatL could be neutralized by apoptosis, a beneficial phenomenon, at least in the early stages of atherosclerosis.	[Mahmood, Dler Faieeq Darweesh; Jguirim-Souissi, Imene; Khadija, El-Hadri; Diderot, Vimala; Rouis, Mustapha] Univ Paris 06, Unite Rech Vieillissement Stress & Inflammat, F-75252 Paris 5, France; [Blondeau, Nicolas] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Amrani, Souliman] Fac Sci Oujda, Biochim Lab, Oujda 60000, Morocco; [Slimane, Mohamed-Naceur] Fac Med Monastir, Biochim Lab, Monastir 5000, Tunisia; [Syrovets, Tatiana; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89081 Ulm, Germany	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Mohammed First University of Oujda; Universite de Monastir; Ulm University	Rouis, M (corresponding author), Univ Paris 06, Vieillissement Stress & Inflammat UR 04, Bat A 5Eme Etage Case Courrier 256-7, F-75252 Paris 5, France.	mustapha.rouis@snv.jussieu.fr	Rouis, Mustapha/E-4993-2016; Blondeau, Nicolas P/M-5002-2016; Syrovets, Tatiana/J-4594-2019; Blondeau, Nicolas/T-1136-2019; AMRANI, Souliman/AAK-7617-2020; Mahmood, Dler/G-9107-2015	Blondeau, Nicolas P/0000-0001-5954-4094; AMRANI, Souliman/0000-0003-0243-7583; EL HADRI, KHADIJA/0000-0002-1275-9861; Syrovets, Tatiana/0000-0002-6751-2233; Mahmood, Dler/0000-0002-6536-1427; Rouis, Mustapha/0000-0003-4197-6555	Fondation Coeur et Arteres; Fondation de France; Comite Mixte de Cooperation Universitaire exchange program between Tunisia and France	Fondation Coeur et Arteres; Fondation de France(Fondation de France); Comite Mixte de Cooperation Universitaire exchange program between Tunisia and France	This work was supported by Fondation Coeur et Arteres, Fondation de France, and the Comite Mixte de Cooperation Universitaire exchange program between Tunisia and France.	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Billiet L, 2008, J CELL PHYSIOL, V214, P183, DOI 10.1002/jcp.21179; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]; Han KH, 2000, J CLIN INVEST, V106, P793, DOI 10.1172/JCI10052; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kim DE, 2010, ARTERIOSCL THROM VAS, V30, P449, DOI 10.1161/ATVBAHA.109.194613; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Kockx MM, 2000, CARDIOVASC RES, V45, P736, DOI 10.1016/S0008-6363(99)00235-7; Kockx MM, 1998, CIRC RES, V83, P378, DOI 10.1161/01.RES.83.4.378; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Mattock KL, 2010, ATHEROSCLEROSIS, V208, P83, DOI 10.1016/j.atherosclerosis.2009.07.022; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salvesen GS, 2001, J CLIN INVEST, V107, P21, DOI 10.1172/JCI11829; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Steinberg D, 1997, CIRCULATION, V95, P1062; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	33	36	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28858	28866		10.1074/jbc.M111.273292	http://dx.doi.org/10.1074/jbc.M111.273292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700710	Green Published, hybrid			2022-12-27	WOS:000293837000023
J	Paavola, KJ; Stephenson, JR; Ritter, SL; Alter, SP; Hall, RA				Paavola, Kevin J.; Stephenson, Jason R.; Ritter, Stefanie L.; Alter, Shawn P.; Hall, Randy A.			The N Terminus of the Adhesion G Protein-coupled Receptor GPR56 Controls Receptor Signaling Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; ADRENERGIC-RECEPTOR; TRAFFICKING; UBIQUITINATION; ROLES; LONG; GPCR; MUTATIONS; FLAMINGO; ARRESTIN	GPR56 is an adhesionGprotein-coupled receptor that plays a key role in cortical development. Mutations to GPR56 in humans cause malformations of the cerebral cortex, but little is known about the normal function of the receptor. We found that the large N terminus (NT) of GPR56 is cleaved from the rest of the receptor during processing but remains non-covalently associated with the seven-transmembrane region of the receptor, as indicated by coimmunoprecipitation of the two GPR56 fragments from both transfected cells and native tissue. We also found that truncation of the GPR56 NT results in constitutive activation of receptor signaling, as revealed by increased GPR56-stimulated signaling upon transfection of HEK-293 cells with truncated GPR56, greatly enhanced binding of beta-arrestins by truncated GPR56 relative to the full-length receptor, extensive ubiquitination of truncated GPR56, and cytotoxicity induced by truncated GPR56 that could be rescued by cotransfection of cells with beta-arrestin 2. Furthermore, we found that the GPR56 NT is capable of homophilic trans-trans interactions that enhance receptor signaling activity. On the basis of these findings, we suggest a model of receptor activation in which the large N terminus of GPR56 constrains receptor activity but N-terminal interactions (GPR56 NT with an extracellular ligand and/or GPR56 NT homophilic trans-trans associations) can remove this inhibitory influence of the N terminus to activate receptor signaling.	[Paavola, Kevin J.; Stephenson, Jason R.; Ritter, Stefanie L.; Alter, Shawn P.; Hall, Randy A.] Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Room 5113,1510 Clifton Rd, Atlanta, GA 30322 USA.	rhall@pharm.emory.edu	Ritter, Stefanie L/D-9312-2012	Hall, Randy/0000-0002-8318-8728; Stephenson, Jason/0000-0002-7926-8055	National Institutes of Health [R21-NS063029, R01-NS072394, T32-GM008602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394, R21NS063029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-NS063029 and R01-NS072394 (to R. A. H.) and Training Grant T32-GM008602 (to K.J.P.).	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Carreira-Barbosa F, 2009, DEVELOPMENT, V136, P383, DOI 10.1242/dev.026542; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; DIXON RAF, 1987, NATURE, V326, P73, DOI 10.1038/326073a0; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Huang Y, 2008, MOL CELL BIOCHEM, V308, P133, DOI 10.1007/s11010-007-9621-4; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Ke N, 2008, BIOCHEM BIOPH RES CO, V366, P314, DOI 10.1016/j.bbrc.2007.11.071; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; MULLER I, 2009, APPL BIOCH BIOTECHNO; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Quellari M, 2003, EUR J BIOCHEM, V270, P3486, DOI 10.1046/j.1432-1033.2003.03718.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	38	123	125	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28914	28921		10.1074/jbc.M111.247973	http://dx.doi.org/10.1074/jbc.M111.247973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708946	Green Published, hybrid			2022-12-27	WOS:000293837000028
J	Ruan, YB; Cheng, M; Ou, Y; Oko, R; van der Hoorn, FA				Ruan, Yibing; Cheng, Min; Ou, Young; Oko, Richard; van der Hoorn, Frans A.			Ornithine Decarboxylase Antizyme Oaz3 Modulates Protein Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ODC ACTIVITY; TESTIS; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; SUBUNIT; BINDING; CLONING; MYPT3	Ornithine decarboxylase antizyme 3 (Oaz3) is expressed in spermatids, makes up the antizyme family of Oaz genes with Oaz1 and Oaz2, and was proposed to encode a 22 kDa antizyme protein involved in polyamine regulation similar to the 22 kDa OAZ1 and OAZ2 proteins. Here we demonstrate however that the major product encoded by Oaz3 is a 12 kDa protein, p12, which lacks the antizyme domain that interacts with ornithine decarboxylase. We show that p12 does not affect ornithine decarboxylase levels, providing an explanation for the surprising observation made in Oaz3 knock-out male mice, which do not display altered testis polyamine metabolism. This suggested a novel activity for Oaz3 p12. Using immuno-electron microscopy we localized p12 to two structures in the mammalian sperm tail, viz. the outer dense fibers and fibrous sheath, as well as to the connecting piece linking head and tail. We identified myosin phosphatase targeting subunit 3 (MYPT3), a regulator of protein phosphatase PP1 beta, as a major p12-interacting protein, and show that MYPT3 is present in sperm tails and that its ankyrin repeat binds p12. We show that MYPT3 can also bind protein phosphatase PP1 gamma 2, the only protein phosphatase present in sperm tails, and that p12-MYPT3 interaction modulates the activity of both PP1 beta and PP1 gamma 2. This is, to our knowledge, the first demonstration of a novel activity for an Oaz-encoded protein.	[Ruan, Yibing; Cheng, Min; Ou, Young; van der Hoorn, Frans A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Oko, Richard] Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	University of Calgary; Queens University - Canada	van der Hoorn, FA (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	fvdhoorn@ucalgary.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to F. A. v. d. H. and R. O.).	ALCIVAR AA, 1989, BIOL REPROD, V41, P1133, DOI 10.1095/biolreprod41.6.1133; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Chakrabarti R, 2007, ASIAN J ANDROL, V9, P445, DOI 10.1111/j.1745-7262.2007.00307.x; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Chun YS, 2000, BIOCHEM BIOPH RES CO, V273, P972, DOI 10.1006/bbrc.2000.3045; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Goto N, 2009, J REPROD DEVELOP, V55, P327, DOI 10.1262/jrd.20170; Howard MT, 2001, GENES CELLS, V6, P931, DOI 10.1046/j.1365-2443.2001.00477.x; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Shao XP, 1997, J BIOL CHEM, V272, P6105, DOI 10.1074/jbc.272.10.6105; Skinner JA, 2001, BIOCHEM J, V356, P257, DOI 10.1042/0264-6021:3560257; Snapir Z, 2009, BIOCHEM J, V419, P99, DOI 10.1042/BJ20081874; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; WEINER KXB, 1992, BIOL REPROD, V46, P617, DOI 10.1095/biolreprod46.4.617; Yong J, 2006, J BIOL CHEM, V281, P31202, DOI 10.1074/jbc.M607287200; Zarsky HA, 2003, BIOL REPROD, V68, P543, DOI [10.1095/BIOLREPROD.102.009076, 10.1095/biolreprod.102.009076]	25	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29417	29427		10.1074/jbc.M111.274647	http://dx.doi.org/10.1074/jbc.M111.274647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712390	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000293837000076
J	Sasahara, A; Nanatani, K; Enomoto, M; Kuwahara, S; Abe, K				Sasahara, Ayako; Nanatani, Kei; Enomoto, Masaru; Kuwahara, Shigefumi; Abe, Keietsu			Substrate Specificity of the Aspartate:Alanine Antiporter (AspT) of Tetragenococcus halophilus in Reconstituted Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER CLASSIFICATION DATABASE; BACTERIAL ANION-EXCHANGE; AMINO-ACID ANTIPORTER; OXALOBACTER-FORMIGENES; ALANINE ANTIPORTER; ESCHERICHIA-COLI; AGMATINE ANTIPORTER; MEMBRANE TOPOLOGY; OXLT; MECHANISM	The aspartate: alanine antiporter (AspT) of the lactic acid bacterium Tetragenococcus halophilus is a member of the aspartate: alanine exchanger (AAEx) transporter family. T. halophilus AspT catalyzes the electrogenic exchange of L-aspartate(1-) with L-alanine(0). Although physiological functions of AspT were well studied, L-aspartate(1-) : L-alanine(0) antiport mechanisms are still unsolved. Here we report that the binding sites of L-aspartate and L-alanine are independently present in AspT by means of the kinetic studies. We purified His(6)-tagged T. halophilus AspT and characterized its kinetic properties when reconstituted in liposomes (K-m = 0.35 +/- 0.03 mM for L-aspartate, K-m = 0.098 +/- 0 mM for D-aspartate, K-m = 26 +/- 2 mM for L-alanine, K-m = 3.3 +/- 0.2 mM for D-alanine). Competitive inhibition by various amino acids of L-aspartate or L-alanine in self-exchange reactions revealed that L-cysteine selectively inhibited L-aspartate self-exchange but only weakly inhibited L-alanine self-exchange. Additionally, L-serine selectively inhibited L-alanine self-exchange but barely inhibited L-aspartate self-exchange. The aspartate analogs L-cysteine sulfinic acid, L-cysteic acid, and D-cysteic acid competitively and strongly inhibited L-aspartate self-exchange compared with L-alanine self-exchange. Taken together, these kinetic data suggest that the putative binding sites of L-aspartate and L-alanine are independently located in the substrate translocation pathway of AspT.	[Sasahara, Ayako; Abe, Keietsu] Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Appl Microbiol Lab, Sendai, Miyagi 9818555, Japan; [Enomoto, Masaru; Kuwahara, Shigefumi] Tohoku Univ, Grad Sch Agr Sci, Dept Appl Bioorgan Chem, Lab Appl Bioorgan Chem, Sendai, Miyagi 9818555, Japan; [Nanatani, Kei] Tohoku Univ, Grad Sch Engn, Lab Appl Biophys Chem, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Abe, Keietsu] Tohoku Univ, New Ind Creat Hatchery Ctr, Microbial Genom Lab, Sendai, Miyagi 9808579, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Abe, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Appl Microbiol Lab, Sendai, Miyagi 9818555, Japan.	kabe@biochem.tohoku.ac.jp	Enomoto, Masaru/T-6967-2019	Enomoto, Masaru/0000-0001-6342-217X	Japan Society for the Promotion of Science (JSPS) [2265108]; Kato Memorial Bioscience Foundation; NISR (Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research [23780073] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kato Memorial Bioscience Foundation; NISR (Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for challenging exploratory research from Japan Society for the Promotion of Science (JSPS) Grant 2265108 (to K. A.), the Kato Memorial Bioscience Foundation (to K. N.), and a NISR (Noda Institute for Scientific Research) Research grant (to K. A.).	Abe K, 1996, J BIOL CHEM, V271, P6789, DOI 10.1074/jbc.271.12.6789; Abe K, 2002, J BACTERIOL, V184, P2906, DOI 10.1128/JB.184.11.2906-2913.2002; Abe K, 1996, J BIOL CHEM, V271, P3079, DOI 10.1074/jbc.271.6.3079; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P79; ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; Barabote RD, 2006, BBA-BIOMEMBRANES, V1758, P1557, DOI 10.1016/j.bbamem.2006.06.018; CLARKE HT, 1955, ORGANIC SYNTHESES CO, P226; CORNISHB.A, 1974, BIOCHEM J, V139, P721, DOI 10.1042/bj1390721; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Fujiki T, 2007, J BIOCHEM, V141, P85, DOI 10.1093/jb/mvm010; Fukui K, 2011, J BIOTECHNOL, V154, P25, DOI 10.1016/j.jbiotec.2011.03.010; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; MALONEY PC, 1992, J BIOL CHEM, V267, P10531; MALONEY PC, 1994, J EXP BIOL, V196, P471; Nanatani K, 2005, BIOCHEM BIOPH RES CO, V328, P20, DOI 10.1016/j.bbrc.2004.12.133; Nanatani K, 2007, J BACTERIOL, V189, P7089, DOI 10.1128/JB.00088-07; Nanatani K, 2009, J BACTERIOL, V191, P2122, DOI 10.1128/JB.00830-08; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Wang XC, 2006, BIOCHEMISTRY-US, V45, P10344, DOI 10.1021/bi060746v; Ye LW, 2002, J BIOL CHEM, V277, P20372, DOI 10.1074/jbc.M111140200	25	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29044	29052		10.1074/jbc.M111.260224	http://dx.doi.org/10.1074/jbc.M111.260224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21719707	hybrid, Green Published			2022-12-27	WOS:000293837000041
J	Parsons, P; Gilbert, SJ; Vaughan-Thomas, A; Sorrell, DA; Notman, R; Bishop, M; Hayes, AJ; Mason, DJ; Duance, VC				Parsons, Philippa; Gilbert, Sophie J.; Vaughan-Thomas, Anne; Sorrell, David A.; Notman, Rebecca; Bishop, Mark; Hayes, Anthony J.; Mason, Deborah J.; Duance, Victor C.			Type IX Collagen Interacts with Fibronectin Providing an Important Molecular Bridge in Articular Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; EXTRACELLULAR-MATRIX; MESSENGER-RNA; OSTEOARTHRITIC CARTILAGE; ESCHERICHIA-COLI; CROSS-LINKING; ED-A; CHONDROCYTES; EXPRESSION	Type IX collagen is covalently bound to the surface of type II collagen fibrils within the cartilage extracellular matrix. The N-terminal, globular noncollagenous domain (NC4) of the alpha 1(IX) chain protrudes away from the surface of the fibrils into the surrounding matrix and is available for molecular interactions. To define these interactions, we used the NC4 domain in a yeast two-hybrid screen of a human chondrocyte cDNA library. 73% of the interacting clones encoded fibronectin. The interaction was confirmed using in vitro immunoprecipitation and was further characterized by surface plasmon resonance. Using whole and pepsin-derived preparations of type IX collagen, the interaction was shown to be specific for the NC4 domain with no interaction with the triple helical collagenous domains. The interaction was shown to be of high affinity with nanomolar K-d values. Analysis of the fibronectin-interacting clones indicates that the constant domain is the likely site of interaction. Type IX collagen and fibronectin were shown to co-localize in cartilage. This novel interaction between the NC4 domain of type IX collagen and fibronectin may represent an in vivo interaction in cartilage that could contribute to the matrix integrity of the tissue.	[Gilbert, Sophie J.; Notman, Rebecca; Bishop, Mark; Hayes, Anthony J.; Mason, Deborah J.; Duance, Victor C.] Cardiff Univ, Sch Biosci, Pathophysiol & Repair Div, Cardiff CF10 3AX, S Glam, Wales; [Parsons, Philippa] Res Ctr, York YO10 5DF, N Yorkshire, England; [Vaughan-Thomas, Anne] Univ Liverpool, Fac Vet Sci, Liverpool L69 7ZJ, Merseyside, England; [Sorrell, David A.] Horizon Discovery Serv, Cambridge CB4 0WE, England	Cardiff University; University of Liverpool	Duance, VC (corresponding author), Cardiff Univ, Sch Biosci, Pathophysiol & Repair Div, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	Duance@Cardiff.ac.uk	Gilbert, Sophie/AAT-9908-2020; Notman, Rebecca/C-2066-2009; Hayes, Anthony/F-2658-2012; Mason, Deborah J/F-8265-2010	Gilbert, Sophie/0000-0001-9828-132X; Notman, Rebecca/0000-0002-9721-0375; Mason, Deborah J/0000-0003-4926-3365; Hayes, Anthony/0000-0002-2918-3723	Arthritis Research UK [D0596]; Cardiff University; National Institutes of Health, NICHD	Arthritis Research UK(Versus Arthritis); Cardiff University; National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Arthritis Research UK Grant D0596 and in part by a Cardiff University studentship.; We thank Karl E. Kadler (Manchester University) for the NC4 domain primary antibody. The FN monoclonal antibody (clone HFN36.3) was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institutes of Health, NICHD, and maintained by the University of Iowa, Iowa City, IA 52242.	Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; BENNETT VD, 1991, J BIOL CHEM, V266, P5918; Blumbach K, 2009, ARTHRITIS RHEUM-US, V60, P3676, DOI 10.1002/art.24979; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Burton-Wurster N, 1998, MATRIX BIOL, V17, P193, DOI 10.1016/S0945-053X(98)90058-0; BURTONWURSTER N, 1988, BIOCHEM BIOPH RES CO, V154, P1088, DOI 10.1016/0006-291X(88)90252-5; BurtonWurster N, 1997, MATRIX BIOL, V15, P441, DOI 10.1016/S0945-053X(97)90018-4; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; DUANCE V C, 1991, Biochemical Society Transactions, V19, p376S; Duance V. C., 1999, BIOL SYNOVIAL JOINT, P135; DUANCE VC, 1984, BIOCHEM J, V221, P885, DOI 10.1042/bj2210885; DUANCE VC, 1982, BIOSCIENCE REP, V2, P223, DOI 10.1007/BF01136720; DUANCE VC, 1990, ANN NY ACAD SCI, V580, P480; ELENIUS K, 1990, J BIOL CHEM, V265, P17837; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fernandes RJ, 2003, EUR J BIOCHEM, V270, P3243, DOI 10.1046/j.1432-1033.2003.03711.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gietz R Daniel, 2006, Methods Mol Biol, V313, P345; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Haimes H. B., 1995, INFLAMM RES S2, V44, P127; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; HOMANDBERG GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P213, DOI 10.1006/abbi.1994.1229; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; Homandberg GA, 1997, BIOCHEM J, V321, P751, DOI 10.1042/bj3210751; HOMANDBERG GA, 1993, J RHEUMATOL, V20, P1378; HOMANDBERG GA, 1999, FRONT BIOSCI, V4, P713; HYNES RO, 1990, FIBRONECTINS, P1; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Pfander D, 1999, J RHEUMATOL, V26, P386; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; POOLE CA, 1988, HISTOCHEM J, V20, P567, DOI 10.1007/BF01002611; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; RENCIC A, 1995, OSTEOARTHR CARTILAGE, V3, P187, DOI 10.1016/S1063-4584(05)80053-6; SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231; Sambrook J., 2002, MOL CLONING LAB MANU; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Schwarzbauer JE, 1991, CURR OPIN CELL BIOL, V3, P786, DOI 10.1016/0955-0674(91)90051-Y; SHIMOKOMAKI M, 1980, FEBS LETT, V121, P51, DOI 10.1016/0014-5793(80)81265-8; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; Vaughan-Thomas A, 2008, CONNECT TISSUE RES, V49, P374, DOI 10.1080/03008200802325417; WOTTON SF, 1991, HISTOCHEM J, V23, P328, DOI 10.1007/BF01044964; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517; WU JJ, 1992, J BIOL CHEM, V267, P23007; ZHANG DW, 1995, J BIOL CHEM, V270, P1817, DOI 10.1074/jbc.270.4.1817	61	25	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34986	34997		10.1074/jbc.M111.238188	http://dx.doi.org/10.1074/jbc.M111.238188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768108	hybrid, Green Published			2022-12-27	WOS:000295406300052
J	Vigetti, D; Rizzi, M; Moretto, P; Deleonibus, S; Dreyfuss, JM; Karousou, E; Viola, M; Clerici, M; Hascall, VC; Ramoni, MF; De Luca, G; Passi, A				Vigetti, Davide; Rizzi, Manuela; Moretto, Paola; Deleonibus, Sara; Dreyfuss, Jonathan M.; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; Hascall, Vincent C.; Ramoni, Marco F.; De Luca, Giancarlo; Passi, Alberto			Glycosaminoglycans and Glucose Prevent Apoptosis in 4-Methylumbelliferone-treated Human Aortic Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HYALURONAN; INHIBITS APOPTOSIS; XENOPUS-LAEVIS; CD44; INJURY; EXPRESSION; ADHESION; ACID; P53; OLIGOSACCHARIDES	Smooth muscle cells (SMCs) have a pivotal role in cardiovascular diseases and are responsible for hyaluronan (HA) deposition in thickening vessel walls. HA regulates SMC proliferation, migration, and inflammation, which accelerates neointima formation. We used the HA synthesis inhibitor 4-methylumbelliferone (4-MU) to reduce HA production in human aortic SMCs and found a significant increase of apoptotic cells. Interestingly, the exogenous addition of HA together with 4-MU reduced apoptosis. A similar anti-apoptotic effect was observed also by adding other glycosaminoglycans and glucose to 4-MU-treated cells. Furthermore, the anti-apoptotic effect of HA was mediated by Toll-like receptor 4, CD44, and PI3K but not by ERK1/2.	[Vigetti, Davide; Rizzi, Manuela; Moretto, Paola; Deleonibus, Sara; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Dreyfuss, Jonathan M.; Ramoni, Marco F.] Harvard Univ, Harvard Partners Ctr Genet & Gen, Boston, MA 02115 USA; [Hascall, Vincent C.] Cleveland Clin, Biomed Engn ND20, Cleveland, OH 44195 USA	University of Insubria; Harvard University; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Viola, Manuela/B-7120-2011; Vigetti, Davide/C-9861-2010; Rizzi, Manuela/AAE-9202-2021; passi, alberto g/A-1752-2018	Viola, Manuela/0000-0002-0634-6390; Vigetti, Davide/0000-0002-6339-8453; Rizzi, Manuela/0000-0002-6174-7111; passi, alberto g/0000-0003-3328-3089; Dreyfuss, Jonathan/0000-0001-7242-3991	"Centro Grandi Attrezzature per la Ricerca Biomedica" Universita degli Studi dell'Insubria; PhD School in Biological and Medical Sciences; University of Insubria (FAR); Centro Interuniversitario di Biotecnologie; Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	"Centro Grandi Attrezzature per la Ricerca Biomedica" Universita degli Studi dell'Insubria; PhD School in Biological and Medical Sciences; University of Insubria (FAR); Centro Interuniversitario di Biotecnologie; Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	This work was supported by the "Centro Grandi Attrezzature per la Ricerca Biomedica" Universita degli Studi dell'Insubria and the PhD School in Biological and Medical Sciences fellowships (to M. R., M. C., and S. D.). This work was also supported by grants from the University of Insubria (FAR) (to D. V., A. P., and G. D. L.), Centro Interuniversitario di Biotecnologie (to A. P.), Fondazione Comunitaria del Varesotto-ONLUS (to D. V.), and a young researcher award from Centro Insubre di Biotecnologie per la Salute Umana (to D.V.).	Chiu Roland K., 1999, Neoplasia (New York), V1, P446, DOI 10.1038/sj.neo.7900045; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gorman AM, 1997, CYTOMETRY, V29, P97; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P162, DOI 10.1023/A:1009470206468; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Onoda M, 2009, HEMATOLOGY, V14, P213, DOI 10.1179/102453309X426236; Pauloin T, 2009, MOL VIS, V15, P577; Perfettini JL, 2004, NAT CELL BIOL, V6, P386, DOI 10.1038/ncb0504-386; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tawada A, 2002, GLYCOBIOLOGY, V12, P421, DOI 10.1093/glycob/cwf048; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2003, MATRIX BIOL, V22, P511, DOI 10.1016/S0945-053X(03)00082-9; Vigetti D, 2008, CELL PHYSIOL BIOCHEM, V22, P137, DOI 10.1159/000149791; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Viola M, 2006, J PHARMACEUT BIOMED, V41, P36, DOI 10.1016/j.jpba.2005.10.010; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200; Yang TB, 2002, CANCER RES, V62, P2583; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	50	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34497	34503		10.1074/jbc.M111.266312	http://dx.doi.org/10.1074/jbc.M111.266312			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768115	Green Published, hybrid			2022-12-27	WOS:000295406300003
J	Tzatsos, A; Paskaleva, P; Lymperi, S; Contino, G; Stoykova, S; Chen, Z; Wong, KK; Bardeesy, N				Tzatsos, Alexandros; Paskaleva, Polina; Lymperi, Stephania; Contino, Gianmarco; Stoykova, Svetlana; Chen, Zhao; Wong, Kwok-Kin; Bardeesy, Nabeel			Lysine-specific Demethylase 2B (KDM2B)-let-7-Enhancer of Zester Homolog 2 (EZH2) Pathway Regulates Cell Cycle Progression and Senescence in Primary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP; TUMOR-SUPPRESSOR; SKELETAL-MUSCLE; NASOPHARYNGEAL CARCINOMA; EMBRYONIC FIBROBLASTS; MICRORNA EXPRESSION; SELF-RENEWAL; P16(INK4A); MIR-26A; PROLIFERATION	Sustained expression of the histone demethylase, KDM2B (Ndy1/FBXL10/JHDM1B), bypasses cellular senescence in primary mouse embryonic fibroblasts (MEFs). Here, we show that KDM2B is a conserved regulator of lifespan in multiple primary cell types and defines a program in which this chromatin-modifying enzyme counteracts the senescence-associated down-regulation of the EZH2 histone methyltransferase. Senescence in MEFs epigenetically silences KDM2B and induces the tumor suppressor miRNAs let-7b and miR-101, which target EZH2. Forced expression of KDM2B promotes immortalization by silencing these miRNAs through locus-specific histone H3 K36me2 demethylation, leading to EZH2 up-regulation. Overexpression of let-7b down-regulates EZH2, induces premature senescence, and counteracts immortalization of MEFs driven by KDM2B. The KDM2B-let-7-EZH2 pathway also contributes to the proliferation of immortal Ink4a/Arf null fibroblasts suggesting that, beyond its anti-senescence role in primary cells, this histone-modifying enzyme functions more broadly in the regulation of cellular proliferation.	[Tzatsos, Alexandros; Paskaleva, Polina; Contino, Gianmarco; Stoykova, Svetlana; Bardeesy, Nabeel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lymperi, Stephania] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Chen, Zhao; Wong, Kwok-Kin] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chen, Zhao; Wong, Kwok-Kin] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Tzatsos, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, CPZN4216,185 Cambridge St, Boston, MA 02114 USA.	atzatsos@partners.org; nelbardeesy@partners.org		Contino, Gianmarco/0000-0001-5874-0405; wong, kwok kin/0000-0001-6323-235X	National Institutes of Health, NCI/Harvard GI SPORE [P50 CA127003, R01 CA133557-01]; Waxman Foundation; Andrew Warshaw Institute; Nestora fund; NATIONAL CANCER INSTITUTE [P01CA117969, R01CA133557, R01CA122794, P50CA127003] Funding Source: NIH RePORTER	National Institutes of Health, NCI/Harvard GI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Waxman Foundation; Andrew Warshaw Institute; Nestora fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health, NCI/Harvard GI SPORE Grant (P50 CA127003 and R01 CA133557-01). This work was also supported by grants from the Waxman Foundation, the Andrew Warshaw Institute (to N. B.), and from the Nestora fund (to A. T.).	Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Tzatsos A, 2008, CELL STEM CELL, V3, P469, DOI 10.1016/j.stem.2008.10.008; Tzatsos A, 2009, J BIOL CHEM, V284, P22525, DOI 10.1074/jbc.M109.027748; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	38	94	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33061	33069		10.1074/jbc.M111.257667	http://dx.doi.org/10.1074/jbc.M111.257667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757686	hybrid, Green Published			2022-12-27	WOS:000294968800025
J	Hickey, JM; Lovell, S; Battaile, KP; Hu, L; Middaugh, CR; Hefty, PS				Hickey, John M.; Lovell, Scott; Battaile, Kevin P.; Hu, Lei; Middaugh, C. Russell; Hefty, P. Scott			The Atypical Response Regulator Protein ChxR Has Structural Characteristics and Dimer Interface Interactions That Are Unique within the OmpR/PhoB Subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; RECEIVER DOMAIN; DEVELOPMENTAL CYCLE; PHOP; DIMERIZATION; ACTIVATION; AUTOREGULATION; MECHANISM; ROLES	Typically as a result of phosphorylation, OmpR/PhoB response regulators form homodimers through a receiver domain as an integral step in transcriptional activation. Phosphorylation stabilizes the ionic and hydrophobic interactions between monomers. Recent studies have shown that some response regulators retain functional activity in the absence of phosphorylation and are termed atypical response regulators. The two currently available receiver domain structures of atypical response regulators are very similar to their phospho-accepting homologs, and their propensity to form homodimers is generally retained. An atypical response regulator, ChxR, from Chlamydia trachomatis, was previously reported to form homodimers; however, the residues critical to this interaction have not been elucidated. We hypothesize that the intra-and intermolecular interactions involved in forming a transcriptionally competent ChxR are distinct from the canonical phosphorylation (activation) paradigm in the OmpR/PhoB response regulator subfamily. To test this hypothesis, structural and functional studies were performed on the receiver domain of ChxR. Two crystal structures of the receiver domain were solved with the recently developed method using triiodo compound I3C. These structures revealed many characteristics unique to OmpR/PhoB subfamily members: typical or atypical. Included was the absence of two alpha-helices present in all other OmpR/PhoB response regulators. Functional studies on various dimer interface residues demonstrated that ChxR forms relatively stable homodimers through hydrophobic interactions, and disruption of these can be accomplished with the introduction of a charged residue within the dimer interface. A gel shift study with monomeric ChxR supports that dimerization through the receiver domain is critical for interaction with DNA.	[Hickey, John M.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Hu, Lei; Middaugh, C. Russell] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Argonne Natl Lab, Adv Photon Source, IMCA CAT, Hauptman Woodward Med Res Inst, Argonne, IL 60439 USA	University of Kansas; University of Kansas; University of Kansas; Hauptman Woodward Medical Research Institute; United States Department of Energy (DOE); Argonne National Laboratory	Hefty, PS (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	pshefty@ku.edu	Hu, Lei/M-5340-2013	Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [P20RR17708, AI079083]; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Department of Energy Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program [P41RR001209]; NIGMS; National Institutes of Health, National Center for Research Resources [P20 RR-17708]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR17708 and AI079083 (to J. M. H. and P. S. H.).; Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209) and the NIGMS. Use of the KU COBRE Protein Structure Laboratory was supported by National Institutes of Health Grant P20 RR-17708 from the National Center for Research Resources. We thank Drs. Liang Tang and Haiyan Zhao for the recombinant YycF. We are extremely appreciative of critical comments and suggestions provided by Dr. Audrey Lamb.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Delany I, 2002, MOL MICROBIOL, V46, P1107, DOI 10.1046/j.1365-2958.2002.03227.x; Delany I, 2002, J BACTERIOL, V184, P4800, DOI 10.1128/JB.184.17.4800-4810.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hickey J. M., 2010, CHLAM INF P 12 INT S, P313; Hickey JM, 2011, J BACTERIOL, V193, P389, DOI 10.1128/JB.00833-10; Hickey JM, 2009, ACTA CRYSTALLOGR F, V65, P791, DOI 10.1107/S1744309109025184; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Kato H, 2008, BIOSCI BIOTECH BIOCH, V72, P1072, DOI 10.1271/bbb.70816; Koo IC, 2006, P NATL ACAD SCI USA, V103, P750, DOI 10.1073/pnas.0509690103; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; O'Connor TJ, 2005, J MOL BIOL, V351, P1030, DOI 10.1016/j.jmb.2005.06.053; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Sandhu KS, 2007, PROTEINS, V68, P109, DOI 10.1002/prot.21328; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sippel KH, 2008, ACTA CRYSTALLOGR D, V64, P1172, DOI 10.1107/S0907444908030175; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696	51	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32606	32616		10.1074/jbc.M111.220574	http://dx.doi.org/10.1074/jbc.M111.220574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775428	Green Published, hybrid			2022-12-27	WOS:000294726800070
J	Leichner, GS; Avner, R; Harats, D; Roitelman, J				Leichner, Gil S.; Avner, Rachel; Harats, Dror; Roitelman, Joseph			Metabolically Regulated Endoplasmic Reticulum-associated Degradation of 3-Hydroxy-3-methylglutaryl-CoA Reductase EVIDENCE FOR REQUIREMENT OF A GERANYLGERANYLATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; INSIG-DEPENDENT UBIQUITINATION; LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL-SYNTHESIS; IN-VIVO; POLYISOPRENYL PHOSPHATES; ACCELERATES DEGRADATION; FEEDBACK-REGULATION; MEVALONATE PATHWAY; ENZYME DEGRADATION	In mammalian cells, the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), which catalyzes the rate-limiting step in the mevalonate pathway, is ubiquitylated and degraded by the 26 S proteasome when mevalonate-derived metabolites accumulate, representing a case of metabolically regulated endoplasmic reticulum-associated degradation (ERAD). Here, we studied which mevalonate-derived metabolites signal for HMGR degradation and the ERAD step(s) in which these metabolites are required. In HMGR-deficient UT-2 cells that stably express HMGal, a chimeric protein between beta-galactosidase and the membrane region of HMGR, which is necessary and sufficient for the regulated ERAD, we tested inhibitors specific to different steps in the mevalonate pathway. We found that metabolites downstream of farnesyl pyrophosphate but upstream to lanosterol were highly effective in initiating ubiquitylation, dislocation, and degradation of HMGal. Similar results were observed for endogenous HMGR in cells that express this protein. Ubiquitylation, dislocation, and proteasomal degradation of HMGal were severely hampered when production of geranylgeranyl pyrophosphate was inhibited. Importantly, inhibition of protein geranylgeranylation markedly attenuated ubiquitylation and dislocation, implicating for the first time a geranylgeranylated protein(s) in the metabolically regulated ERAD of HMGR.	[Leichner, Gil S.; Avner, Rachel; Harats, Dror; Roitelman, Joseph] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Biochem, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Roitelman, J (corresponding author), Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-52621 Tel Hashomer, Israel.	roitelma@post.tau.ac.il			Israel Ministry of Health	Israel Ministry of Health	This work was supported in part by a grant from the Chief Scientist of the Israel Ministry of Health.	Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Baron RA, 2009, J BIOL CHEM, V284, P6861, DOI 10.1074/jbc.M806952200; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Berkhout TA, 1996, J BIOL CHEM, V271, P14376, DOI 10.1074/jbc.271.24.14376; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BRADFUTE DL, 1994, J BIOL CHEM, V269, P6645; BROWN DA, 1984, P NATL ACAD SCI-BIOL, V81, P1674, DOI 10.1073/pnas.81.6.1674; BROWN MS, 1980, J LIPID RES, V21, P505; Cheng HH, 1999, J BIOL CHEM, V274, P17171, DOI 10.1074/jbc.274.24.17171; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; CORRELL CC, 1994, J BIOL CHEM, V269, P17390; Coxon FP, 2005, BONE, V37, P349, DOI 10.1016/j.bone.2005.04.021; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Elkabetz Y, 2003, J BIOL CHEM, V278, P18922, DOI 10.1074/jbc.M208730200; Engfelt WH, 1998, J LIPID RES, V39, P2182; Engfelt WH, 1997, J BIOL CHEM, V272, P24579, DOI 10.1074/jbc.272.39.24579; FAUST J, 1987, J BIOL CHEM, V262, P1996; FAUST JR, 1988, BIOL CHOLESTEROL, P19; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; GIRON MD, 1994, P NATL ACAD SCI USA, V91, P6398, DOI 10.1073/pnas.91.14.6398; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; KIM CM, 1992, J BIOL CHEM, V267, P23113; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Levy BD, 2002, CELL MOL LIFE SCI, V59, P729, DOI 10.1007/s00018-002-8462-2; Levy BD, 1997, NATURE, V389, P985, DOI 10.1038/40180; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; LISCUM L, 1985, J BIOL CHEM, V260, P522; MAYER RJ, 1991, J BIOL CHEM, V266, P20070; McGuire TF, 1996, J BIOL CHEM, V271, P27402, DOI 10.1074/jbc.271.44.27402; Meigs TE, 1997, ARCH BIOCHEM BIOPHYS, V345, P1, DOI 10.1006/abbi.1997.0200; Morand OH, 1997, J LIPID RES, V38, P373; MOSLEY ST, 1983, J BIOL CHEM, V258, P3875; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Ownby SE, 2003, LIPIDS, V38, P751, DOI 10.1007/s11745-003-1123-8; Ravid T, 1999, J BIOL CHEM, V274, P29341, DOI 10.1074/jbc.274.41.29341; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Roitelman J, 2004, J BIOL CHEM, V279, P6465, DOI 10.1074/jbc.M308094200; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; SCHROEPFER GJ, 1981, ANNU REV BIOCHEM, V50, P585, DOI 10.1146/annurev.bi.50.070181.003101; Sebti SM, 2000, METHOD ENZYMOL, V325, P381; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shen YX, 2007, BIOCHEM BIOPH RES CO, V352, P919, DOI 10.1016/j.bbrc.2006.11.121; Shmueli A, 2009, BIOCHEM BIOPH RES CO, V390, P758, DOI 10.1016/j.bbrc.2009.10.045; SIPERSTEIN MD, 1960, J CLIN INVEST, V39, P642, DOI 10.1172/JCI104079; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wiemer AJ, 2007, BIOCHEM BIOPH RES CO, V353, P921, DOI 10.1016/j.bbrc.2006.12.094; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002	68	14	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32150	32161		10.1074/jbc.M111.278036	http://dx.doi.org/10.1074/jbc.M111.278036			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778231	hybrid, Green Published			2022-12-27	WOS:000294726800025
J	Yoshida, S; Hong, SK; Suzuki, T; Nada, S; Mannan, AM; Wang, JY; Okada, M; Guan, KL; Inoki, K				Yoshida, Sei; Hong, Sungki; Suzuki, Tsukasa; Nada, Shigeyuki; Mannan, Aristotle M.; Wang, Junying; Okada, Masato; Guan, Kun-Liang; Inoki, Ken			Redox Regulates Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity by Modulating the TSC1/TSC2-Rheb GTPase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; AMINO-ACID SUFFICIENCY; TSC2 GAP ACTIVITY; CELL-GROWTH; AFFINITY-CHROMATOGRAPHY; PROTEIN-KINASE; PHENYLARSINE OXIDE; GENE-PRODUCTS; RAG GTPASES; S6 KINASE	Mammalian target of rapamycin (mTOR) is a kinase that plays a key role in a wide array of cellular processes and exists in two distinct functional complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Although mTORC2 is primarily activated by growth factors, mTORC1 is regulated by numerous extracellular and intracellular signals such as nutrients, growth factors, and cellular redox. Previous study has shown that cysteine oxidants sufficiently activate mTORC1 activity under amino acid-depleted conditions and that a reducing agent effectively suppresses amino acid-induced mTORC1 activity, thereby raising the possibility that redox-sensitive mechanisms underlie amino acid-dependent mTORC1 regulation. However, the molecular mechanism by which redox regulates mTORC1 activity is not well understood. In this study, we show that the redox-sensitive regulation of mTORC1 occurs via Rheb but not the Rag small GTPase. Enhancing cellular redox potential with cysteine oxidants significantly increases Rheb GTP levels. Importantly, modulation of the cellular redox potential with a cysteine oxidant or reducing agent failed to alter mTORC1 activity in TSC1(-/-) or TSC2(-/-) mouse embryonic fibroblast cells. Furthermore, a cysteine oxidant has little effect on mTOR localization but sufficiently activates mTORC1 activity in both p18(-/-) and control mouse embryonic fibroblast cells, suggesting that the redox-sensitive regulation of mTORC1 occurs independent of the Ragulator.Rag complex. Taken together, our results suggest that the TSC complex plays an important role in redox-sensitive mTORC1 regulation and argues for the activation of mTORC1 in places other than the lysosome upon inhibition of the TSC complex.	[Yoshida, Sei; Hong, Sungki; Suzuki, Tsukasa; Mannan, Aristotle M.; Wang, Junying; Inoki, Ken] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nada, Shigeyuki; Okada, Masato] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Osaka University; University of California System; University of California San Diego	Inoki, K (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	inokik@umich.edu	Guan, Kun-Liang/ADK-7088-2022	Yoshida, Sei/0000-0002-4771-3900	National Institutes of Health [DK083491]; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK083491 (to K. I.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bogumil R, 2002, METHOD ENZYMOL, V348, P271, DOI 10.1016/S0076-6879(02)48645-4; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; FROST SC, 1990, BIOCHEM J, V269, P589, DOI 10.1042/bj2690589; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P361, DOI 10.1196/annals.1354.051; HOFFMAN RD, 1992, J BIOL CHEM, V267, P14005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; KALEF E, 1994, METHOD ENZYMOL, V233, P395; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Urano J, 2001, METHOD ENZYMOL, V333, P217; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	109	112	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32651	32660		10.1074/jbc.M111.238014	http://dx.doi.org/10.1074/jbc.M111.238014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784859	Green Published, hybrid			2022-12-27	WOS:000294726800074
J	Danesh, SM; Kundu, P; Lu, R; Stefani, E; Toro, L				Danesh, Shahab M.; Kundu, Pallob; Lu, Rong; Stefani, Enrico; Toro, Ligia			Distinct Transcriptional Regulation of Human Large Conductance Voltage- and Calcium-activated K+ Channel Gene (hSlo1) by Activated Estrogen Receptor alpha and c-Src Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; SMOOTH-MUSCLE; BETA-SUBUNIT; EXPRESSION; ESTRADIOL; PATHWAY; BINDING; PP60C-SRC; PROMOTERS; TARGETS	Estrogen receptor alpha (ER alpha) regulates gene transcription via "genomic" (binding directly or indirectly, typically via Sp1 or AP-1 sites, to target genes) and/or "nongenomic" (signaling) mechanisms. ER alpha activation by estrogen up-regulates the murine Ca2+-activated K+ channel alpha subunit gene (mSlo1) via genomic mechanisms. Here, we investigated whether ER alpha also drives transcription of the human (hSlo1) gene. Consistent with this view, estrogen increased hSlo1 transcript levels in primary human smooth muscle cells. Promoter studies revealed that estrogen/hER alpha-mediated hSlo1 transcription was nearly 6-fold more efficient than for mSlo1 (EC50, 0.07 versus 0.4 nM). Unlike the genomic transcriptional mechanism employed by mSlo1, hSlo1 exhibits a nongenomic hER alpha-mediated regulatory mechanism. This is supported by the following: 1) efficient hSlo1 transcription after disruption of the DNA-binding domain of hER alpha or knockdown of Sp1, and 2) lack of AP-1 sites in the hSlo1 promoter. Three nongenomic signaling pathways were explored: Src, Rho, and PI3K. Inhibition of Src with 10 mu M PP2, and reported downstream ERK with 25 mu M PD98059 did not prevent estrogen action but caused an increase in hSlo1 basal transcription; conversely, constitutively active c-Src (Y527F) decreased hSlo1 basal transcription even preventing its estrogen/hER alpha-mediated transcriptional activation. Rho inhibition by coexpressed Clostridium botulinum C3 transferase did not alter estrogen action. In contrast, inhibition of PI3K activity with 10 mu M LY294002 decreased estrogen-stimulated hSlo1 transcription by similar to 40%. These results indicate that the nongenomic PI3K signaling pathway plays a role in estrogen/hER alpha-stimulated hSlo1 gene expression; whereas c-Src activity leads to hSlo1 gene tonic repression independently of estrogen, likely through ERK activation.	[Danesh, Shahab M.; Kundu, Pallob; Lu, Rong; Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Toro, L (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Div Mol Med, BH 528,CHS Box 957115, Los Angeles, CA 90095 USA.	ltoro@ucla.edu			National Institutes of Health [HL54970, HL088640];  [NS 007101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054970, R01HL088640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54970 (to L. T.), HL088640 (to E. S.), and Postdoctoral Fellowship NS 007101 (to S. M. D.).	Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Bjornstrom L, 2002, MOL ENDOCRINOL, V16, P2202, DOI 10.1210/me.2002-0072; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; Dhulipala PDK, 1999, BBA-GENE STRUCT EXPR, V1444, P254, DOI 10.1016/S0167-4781(98)00276-0; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; Eichhorn B, 2007, N-S ARCH PHARMACOL, V376, P145, DOI 10.1007/s00210-007-0193-3; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jamali K, 2003, ENDOCRINE, V20, P227, DOI 10.1385/ENDO:20:3:227; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kundu P, 2007, J BIOL CHEM, V282, P27478, DOI 10.1074/jbc.M704777200; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Marijic J, 2001, CIRC RES, V88, P210; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Segars JH, 2002, TRENDS ENDOCRIN MET, V13, P349, DOI 10.1016/S1043-2760(02)00633-1; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; Tanaka Yoshio, 2004, Journal of Smooth Muscle Research, V40, P125, DOI 10.1540/jsmr.40.125; Wade CNB, 2003, ENDOCRINOLOGY, V144, P832, DOI 10.1210/en.2002-220899; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; WUPENG XS, 1992, MOL ENDOCRINOL, V6, P231, DOI 10.1210/me.6.2.231; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279	38	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31064	31071		10.1074/jbc.M111.235457	http://dx.doi.org/10.1074/jbc.M111.235457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757754	Green Published, hybrid			2022-12-27	WOS:000294487500001
J	Yokota, S; Hirayama, T; Hirano, K; Kaneko, R; Toyoda, S; Kawamura, Y; Hirabayashi, M; Hirabayashi, T; Yagi, T				Yokota, Shinnichi; Hirayama, Teruyoshi; Hirano, Keizo; Kaneko, Ryosuke; Toyoda, Shunsuke; Kawamura, Yoshimi; Hirabayashi, Masumi; Hirabayashi, Takahiro; Yagi, Takeshi			Identification of the Cluster Control Region for the Protocadherin-beta Genes Located beyond the Protocadherin-gamma Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ODORANT RECEPTOR GENES; LOCUS-CONTROL REGION; GLOBIN GENE; PROTEIN CTCF; ALPHA FAMILY; HUMAN GENOME; EXPRESSION; MOUSE; MICE; NEURONS	The clustered protocadherins (Pcdhs), Pcdh-alpha, -beta, and -gamma, are transmembrane proteins constituting a subgroup of the cadherin superfamily. Each Pcdh cluster is arranged in tandem on the same chromosome. Each of the three Pcdh clusters shows stochastic and combinatorial expression in individual neurons, thus generating a hugely diverse set of possible cell surface molecules. Therefore, the clustered Pcdhs are candidates for determining neuronal molecular diversity. Here, we showed that the targeted deletion of DNase I hypersensitive (HS) site HS5-1, previously identified as a Pcdh-alpha regulatory element in vitro, affects especially the expression of specific Pcdh-alpha isoforms in vivo. We also identified a Pcdh-beta cluster control region (CCR) containing six HS sites (HS16, 17, 17', 18, 19, and 20) downstream of the Pcdh-gamma cluster. This CCR comprehensively activates the expression of the Pcdh-beta gene cluster in cis, and its deletion dramatically decreases their expression levels. Deleting the CCR non-uniformly down-regulates some Pcdh-gamma isoforms and does not affect Pcdh-alpha expression. Thus, the CCR effect extends beyond the 320-kb region containing the Pcdh-gamma cluster to activate the upstream Pcdh-beta genes. Thus, we concluded that the CCR is a highly specific regulatory unit for Pcdh-beta expression on the clustered Pcdh genomic locus. These findings suggest that each Pcdh cluster is controlled by distinct regulatory elements that activate their expression and that the stochastic gene regulation of the clustered Pcdhs is controlled by the complex chromatin architecture of the clustered Pcdh locus.	[Yokota, Shinnichi; Hirayama, Teruyoshi; Hirano, Keizo; Toyoda, Shunsuke; Hirabayashi, Takahiro; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; [Kaneko, Ryosuke] Gunma Univ, Grad Sch Med, Inst Expt Anim Res, Gunma 3718511, Japan; [Kawamura, Yoshimi] Keio Univ, Sch Med, Dept Physiol, Shinjyuku Ku, Tokyo 1608582, Japan; [Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Mammalian Transgenesis, Okazaki, Aichi 4448787, Japan	Osaka University; Gunma University; Keio University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Yagi, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kawamura, Yoshimi/L-1289-2013; Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Toyoda, Shunsuke/0000-0002-5291-7422; Kawamura, Yoshimi/0000-0002-9864-7974	Ministry of Education, Science, Sports, and Culture of Japan; National Institute for Physiological Sciences, Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences, Japan	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (to T. Y.) and by a grant from the Co-operative Study Program of National Institute for Physiological Sciences, Japan (to M. H.).	Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Hu X, 2006, BLOOD, V107, P821, DOI 10.1182/blood-2005-06-2308; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Junghans D, 2008, EUR J NEUROSCI, V27, P559, DOI 10.1111/j.1460-9568.2008.06052.x; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Noguchi Y, 2009, J BIOL CHEM, V284, P32002, DOI 10.1074/jbc.M109.046938; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Takei Y, 2001, GENOMICS, V72, P321, DOI 10.1006/geno.2000.6468; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	37	60	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31885	31895		10.1074/jbc.M111.245605	http://dx.doi.org/10.1074/jbc.M111.245605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771796	Green Published, hybrid			2022-12-27	WOS:000294487500081
J	Lalo, U; Roberts, JA; Evans, RJ				Lalo, Ulyana; Roberts, Jonathan A.; Evans, Richard J.			Identification of Human P2X1 Receptor-interacting Proteins Reveals a Role of the Cytoskeleton in Receptor Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; P2X(1) RECEPTORS; ION CHANNELS; FUNCTIONAL EVIDENCE; PLATELET-FUNCTIONS; EXTRACELLULAR ATP; LATERAL MOBILITY; SMOOTH-MUSCLE; ACTIN; ACTIVATION	P2X1 receptors are ATP-gated ion channels expressed by smooth muscle and blood cells. Carboxyl-terminally His-FLAG-tagged human P2X1 receptors were stably expressed in HEK293 cells and co-purified with cytoskeletal proteins including actin. Disruption of the actin cytoskeleton with cytochalasin D inhibited P2X1 receptor currents with no effect on the time course of the response or surface expression of the receptor. Stabilization of the cytoskeleton with jasplakinolide had no effect on P2X1 receptor currents but decreased receptor mobility. P2X2 receptor currents were unaffected by cytochalasin, and P2X1/2 receptor chimeras were used to identify the molecular basis of actin sensitivity. These studies showed that the intracellular amino terminus accounts for the inhibitory effects of cytoskeletal disruption similar to that shown for lipid raft/cholesterol sensitivity. Stabilization of the cytoskeleton with jasplakinolide abolished the inhibitory effects of cholesterol depletion on P2X1 receptor currents, suggesting that lipid rafts may regulate the receptor through stabilization of the cytoskeleton. These studies show that the cytoskeleton plays an important role in P2X1 receptor regulation.	[Lalo, Ulyana; Roberts, Jonathan A.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Roberts, Jon/A-6771-2012		Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allsopp RC, 2010, J BIOL CHEM, V285, P32770, DOI 10.1074/jbc.M110.148940; Ase AR, 2005, J PHARMACOL EXP THER, V315, P144, DOI 10.1124/jpet.105.089045; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Chaumont S, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162329; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, BIOCHEM BIOPH RES CO, V291, P611, DOI 10.1006/bbrc.2002.6488; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Gendreau S, 2003, J CHROMATOGR B, V786, P311, DOI 10.1016/S1570-0232(02)00743-2; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hering H, 2003, J NEUROSCI, V23, P3262; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kotnis S, 2010, MOL PHARMACOL, V77, P953, DOI 10.1124/mol.110.063636; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Parker KE, 1998, J PHYSIOL-LONDON, V510, P19, DOI 10.1111/j.1469-7793.1998.019bz.x; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Vial C, 2002, MOL PHARMACOL, V62, P1438, DOI 10.1124/mol.62.6.1438; Wareham K, 2009, BRIT J PHARMACOL, V157, P1215, DOI 10.1111/j.1476-5381.2009.00287.x; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707	41	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30591	30599		10.1074/jbc.M111.253153	http://dx.doi.org/10.1074/jbc.M111.253153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757694	Green Published, hybrid			2022-12-27	WOS:000294283600038
J	Alboresi, A; Gerotto, C; Cazzaniga, S; Bassi, R; Morosinotto, T				Alboresi, Alessandro; Gerotto, Caterina; Cazzaniga, Stefano; Bassi, Roberto; Morosinotto, Tomas			A Red-shifted Antenna Protein Associated with Photosystem II in Physcomitrella patens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING ANTENNA; CHARGE-TRANSFER STATE; PIGMENT-BINDING; CHLAMYDOMONAS-REINHARDTII; MAXIMUM-LIKELIHOOD; CRYSTAL-STRUCTURE; COMPLEX; PLANTS; PHOTOSYNTHESIS; LHCA4	Antenna systems of plants and green algae are made up of pigment-protein complexes belonging to the light-harvesting complex (LHC) multigene family. LHCs increase the light-harvesting cross-section of photosystems I and II and catalyze photoprotective reactions that prevent light-induced damage in an oxygenic environment. The genome of the moss Physcomitrella patens contains two genes encoding LHCb9, a new antenna protein that bears an overall sequence similarity to photosystem II antenna proteins but carries a specific motif typical of photosystem I antenna proteins. This consists of the presence of an asparagine residue as a ligand for Chl 603 (A5) chromophore rather than a histidine, the common ligand in all other LHCbs. Asparagine as a Chl 603 (A5) ligand generates red-shifted spectral forms associated with photosystem I rather than with photosystem II, suggesting that in P. patens, the energy landscape of photosystem II might be different with respect to that of most green algae and plants. In this work, we show that the in vitro refolded LHCb9-pigment complexes carry a red-shifted fluorescence emission peak, different from all other known photosystem II antenna proteins. By using a specific antibody, we localized LHCb9 within PSII supercomplexes in the thylakoid membranes. This is the first report of red-shifted spectral forms in a PSII antenna system, suggesting that this biophysical feature might have a special role either in optimization of light use efficiency or in photoprotection in the specific environmental conditions experienced by this moss.	[Alboresi, Alessandro; Cazzaniga, Stefano; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Gerotto, Caterina; Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy; [Bassi, Roberto] Phytosphare Forschungszentrum Julich, ICG 3, D-52425 Julich, Germany	University of Verona; University of Padua; Helmholtz Association; Research Center Julich	Bassi, R (corresponding author), Univ Verona, Dipartimento Biotecnol, Str Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Cazzaniga, Stefano/ABG-3898-2021; Morosinotto, Tomas/AAC-3188-2019; Alboresi, Alessandro/Z-1220-2019	Cazzaniga, Stefano/0000-0002-2824-7916; Morosinotto, Tomas/0000-0002-0803-7591; Alboresi, Alessandro/0000-0003-4818-7778; bassi, roberto/0000-0002-4140-8446; Gerotto, Caterina/0000-0001-7142-3535	Cassa di Risparmio di Padova e Rovigo (CaRiPaRo) Foundation, Universita di Padova [CPDA089403]; EEC Project Harvest; Fondo per gli Investimenti della Ricerca di Base-Parallelomics [RBIP06CTBR]	Cassa di Risparmio di Padova e Rovigo (CaRiPaRo) Foundation, Universita di Padova(Fondazione Cariparo); EEC Project Harvest; Fondo per gli Investimenti della Ricerca di Base-Parallelomics	This work was supported by the Cassa di Risparmio di Padova e Rovigo (CaRiPaRo) Foundation, Universita di Padova Grant CPDA089403, EEC Project Harvest and Fondo per gli Investimenti della Ricerca di Base-Parallelomics Grant RBIP06CTBR.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Alboresi A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-71; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2007, BIOPHYS J, V93, P2418, DOI 10.1529/biophysj.107.106955; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; Gerotto C, 2011, PLANT CELL ENVIRON, V34, P922, DOI 10.1111/j.1365-3040.2011.02294.x; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Klimmek F, 2006, PLANT PHYSIOL, V140, P793, DOI 10.1104/pp.105.073304; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Matsubara S, 2007, PLANT PHYSIOL, V144, P926, DOI 10.1104/pp.107.099077; MELIS A, 1989, PHILOS T ROY SOC B, V323, P397, DOI 10.1098/rstb.1989.0019; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Romero E, 2009, BIOPHYS J, V96, pL35, DOI 10.1016/j.bpj.2008.11.043; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; TRISSL HW, 1993, PHOTOSYNTH RES, V35, P247, DOI 10.1007/BF00016556; Trouiller B, 2006, NUCLEIC ACIDS RES, V34, P232, DOI 10.1093/nar/gkj423; Watling JR, 1997, AUST J PLANT PHYSIOL, V24, P17, DOI 10.1071/PP96074; Zhang H, 1997, PLANT PHYSIOL, V115, P1525, DOI 10.1104/pp.115.4.1525	58	21	21	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28978	28987		10.1074/jbc.M111.226126	http://dx.doi.org/10.1074/jbc.M111.226126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705318	Green Published, hybrid			2022-12-27	WOS:000293837000034
J	Hannun, YA; Obeid, LM				Hannun, Yusuf A.; Obeid, Lina M.			Many Ceramides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NECROSIS-FACTOR-ALPHA; RADIATION-INDUCED APOPTOSIS; LONGEVITY ASSURANCE GENE-1; TANDEM MASS-SPECTROMETRY; SPHINGOLIPID METABOLISM; SPHINGOSINE 1-PHOSPHATE; SYNTHASE 6; NEUTRAL SPHINGOMYELINASE-2; ALKALINE CERAMIDASE; CELLULAR-RESPONSES	Intensive research over the past 2 decades has implicated ceramide in the regulation of several cell responses. However, emerging evidence points to dramatic complexities in ceramide metabolism and structure that defy the prevailing unifying hypothesis on ceramide function that is based on the understanding of ceramide as a single entity. Here, we develop the concept that "ceramide" constitutes a family of closely related molecules, subject to metabolism by >28 enzymes and with >200 structurally distinct mammalian ceramides distinguished by specific structural modifications. These ceramides are synthesized in a combinatorial fashion with distinct enzymes responsible for the specific modifications. These multiple pathways of ceramide generation led to the hypothesis that individual ceramide molecular species are regulated by specific biochemical pathways in distinct subcellular compartments and execute distinct functions. In this minireview, we describe the "many ceramides" paradigm, along with the rationale, supporting evidence, and implications for our understanding of bioactive sphingolipids and approaches for unraveling these pathways.	[Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	hannun@musc.edu; obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [R01AG016583, R01GM062887]; NCI [R01GM43825, R01GM63265, P01CA097132]; Office of Research and Development, Department of Veterans Affairs; Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC); NATIONAL CANCER INSTITUTE [P01CA097132, R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063265, R01GM043825, R01GM062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was support, in whole or in part, by National Institutes of Health Grants R01AG016583 and R01GM062887 (to L. M. O.) and R01GM43825, R01GM63265, and P01CA097132 from NCI (to Y. A. H.) and in part by a MERIT Award (to L. M. O.) from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC). This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Beckham TH, 2010, EXPERT OPIN THER TAR, V14, P529, DOI 10.1517/14728221003752768; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.3; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; Fyrst H, 2008, J LIPID RES, V49, P597, DOI 10.1194/jlr.M700414-JLR200; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Huang WC, 2011, J LIPIDS, V2011, DOI 10.1155/2011/565316; Kawamori T, 2010, ADV EXP MED BIOL, V688, P109; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Kruer MC, 2010, ANN NEUROL, V68, P611, DOI 10.1002/ana.22122; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; Lopez-Montero I, 2005, J BIOL CHEM, V280, P25811, DOI 10.1074/jbc.M412052200; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Mao ZH, 2010, J BIOL CHEM, V285, P29078, DOI 10.1074/jbc.M110.105296; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Modrak DE, 2006, MOL CANCER THER, V5, P200, DOI 10.1158/1535-7163.MCT-05-0420; Momin AA, 2011, J LIPID RES, V52, P1073, DOI 10.1194/jlr.M010454; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; OLDFIELD E, 1972, FEBS LETT, V21, P303, DOI 10.1016/0014-5793(72)80189-3; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Perrotta C, 2010, PHYSIOLOGY, V25, P64, DOI 10.1152/physiol.00048.2009; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Riboni L, 2010, ADV EXP MED BIOL, V688, P24; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Schiffmann S, 2010, BIOCHEM PHARMACOL, V80, P1632, DOI 10.1016/j.bcp.2010.08.012; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Watts JD, 1999, CELL DEATH DIFFER, V6, P105, DOI 10.1038/sj.cdd.4400472; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Yacoub A, 2010, CANCER RES, V70, P1120, DOI 10.1158/0008-5472.CAN-09-4043; Yang Q, 2010, CELL MOL LIFE SCI, V67, P1477, DOI 10.1007/s00018-010-0260-7; Zhang Y, 2011, J LIPID RES, V52, P771, DOI 10.1194/jlr.M012880; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	96	397	404	0	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27855	27862		10.1074/jbc.R111.254359	http://dx.doi.org/10.1074/jbc.R111.254359			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693702	Green Published, hybrid			2022-12-27	WOS:000293557800002
J	Xie, P; Kondeti, VK; Lin, S; Haruna, Y; Raparia, K; Kanwar, YS				Xie, Ping; Kondeti, Vinay K.; Lin, Sun; Haruna, Yoshisuke; Raparia, Kirtee; Kanwar, Yashpal S.			RETRACTED: Role of Extracellular Matrix Renal Tubulo-interstitial Nephritis Antigen (TINag) in Cell Survival Utilizing Integrin alpha v beta 3/Focal Adhesion Kinase (FAK)/Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B-Serine/Threonine Kinase (AKT) Signaling Pathway (Retracted article. See vol. 294, pg. 10379, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							IV COLLAGEN; APOPTOSIS; FAK; ALPHA(V)BETA(3); DISEASE; KIDNEY; DIFFERENTIATION; ORGANIZATION; DISRUPTION; MECHANISMS	Tubulo-interstitial nephritis antigen (TINag) is an extracellular matrix protein expressed in tubular basement membranes. Combined mutations in TINag and nephrocystin-1 genes lead to nephronophthisis with reduced cell survival. Because certain extracellular matrix proteins are known to modulate cell survival, studies were initiated in Lewis rats lacking TINag to assess if they are more susceptible to cisplatin-induced injury. Cisplatin induced a higher degree of tubular cell damage and apoptosis in regions where TINag is expressed in a parental Wistar strain. This was accompanied by an accentuated increase in serum creatinine and Kim-1RNAand renal expression of Bax, p53, and its nuclear accumulation, mtDNA fragmentation, and a decrease of Bcl-2. Cisplatin induced fulminant apoptosis of HK-2 cells with increased caspase3/7 activity, mtDNA fragmentation, and a reduced cell survival. These effects were partially reversed in cells maintained on TINag substratum. Far Western/solid phase assays established TINag binding with integrin alpha v beta 3 comparable with vitronectin. Transfection of cells with alpha v-siRNA accentuated cisplatin-induced apoptosis, aberrant translocation of cytochrome c and Bax, and reduced cell survival. The alpha v-siRNA decreased expression of integrin-recruited focal adhesion kinase (FAK) and p-FAK, while increasing the expression of p53 and p-p53. Similarly, p-AKT was reduced although ILK was unaffected. Inhibition of PI3K had similar adverse cellular effects. These effects were ameliorated in cells on TINag substratum. In vivo, a higher degree of decrease in the expression of p-FAK and pAKT was observed in Lewis rats following cisplatin treatment. These in vivo and in vitro studies demonstrate an essential role of TINag in cellular survival to maintain proper tubular homeostasis utilizing integrin alpha v beta 3 and downstream effectors.	[Xie, Ping; Kondeti, Vinay K.; Raparia, Kirtee; Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Xie, Ping; Kondeti, Vinay K.; Raparia, Kirtee; Kanwar, Yashpal S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Lin, Sun] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China; [Haruna, Yoshisuke] Kawasaki Med Sch, Dept Med, Okayama 7010192, Japan	Northwestern University; Northwestern University; Central South University; Kawasaki Medical School	Kanwar, YS (corresponding author), Northwestern Univ, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu	kondeti, vinay kumar/C-3171-2012		National Institutes of Health [DK60635]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60635.	ABRAHAMSON DR, 1991, KIDNEY INT, V39, P382, DOI 10.1038/ki.1991.50; BERGSTEIN J, 1975, NEW ENGL J MED, V292, P874, DOI 10.1056/NEJM197504242921701; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Bijian K, 2004, AM J PHYSIOL-RENAL, V286, pF255, DOI 10.1152/ajprenal.00259.2003; Bromme NC, 2000, BIOCHEM BIOPH RES CO, V271, P474, DOI 10.1006/bbrc.2000.2639; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BUTKOWSKI RJ, 1990, J BIOL CHEM, V265, P21091; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; Chen Y, 1996, KIDNEY INT, V49, P153, DOI 10.1038/ki.1996.20; COHEN AH, 1986, LAB INVEST, V55, P564; Cooke MJ, 2010, J BIOMED MATER RES A, V93A, P824, DOI 10.1002/jbm.a.32585; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; EDDY AA, 1994, J AM SOC NEPHROL, V5, P1273; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; HAY ED, 1989, AM J MED GENET, V34, P14, DOI 10.1002/ajmg.1320340107; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Huang Q, 2006, CANCER RES, V66, P5807, DOI 10.1158/0008-5472.CAN-06-0077; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Iliae D., 1998, J CELL BIOL, V143, P547; KALFA TA, 1994, J BIOL CHEM, V269, P1654; Kanwar YS, 2007, AM J PATHOL, V171, P9, DOI 10.2353/ajpath.2007.070356; Kanwar YS, 1999, P NATL ACAD SCI USA, V96, P11323, DOI 10.1073/pnas.96.20.11323; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; KELLY CJ, 2004, BRENNER RECTORS KIDN, P1483; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kruidering M, 1998, CELL DEATH DIFFER, V5, P601, DOI 10.1038/sj.cdd.4400392; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Makino H., 2000, KIDNEY INT S, V77, P67; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Naryzhny SN, 2010, FEBS LETT, V584, P4292, DOI 10.1016/j.febslet.2010.09.021; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Nelson TR, 1997, CONNECT TISSUE RES, V36, P223, DOI 10.3109/03008209709160222; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PICHLER R, 1995, MINER ELECTROL METAB, V21, P317; Pozzi A, 2003, NEPHRON EXP NEPHROL, V94, pE77, DOI 10.1159/000072025; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Su C., 2007, CANC INVEST, V18, P1; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sugimoto K., 2011, NEPHROLOGY, V10, P1440; Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336; Takemura Y, 2010, PEDIATR NEPHROL, V25, P1349, DOI 10.1007/s00467-010-1463-8; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; van de Water B, 1999, J BIOL CHEM, V274, P13328, DOI 10.1074/jbc.274.19.13328; van de Water B, 2001, J BIOL CHEM, V276, P36183, DOI 10.1074/jbc.M102091200; Wang ZP, 2010, J BIOL CHEM, V285, P20806, DOI 10.1074/jbc.M110.118521; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xie P, 2009, J AM SOC NEPHROL, V20, P807, DOI 10.1681/ASN.2008091007; YOSHIDA H, 1990, KIDNEY INT, V37, P1286, DOI 10.1038/ki.1990.113; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	60	20	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34131	34146		10.1074/jbc.M111.241778	http://dx.doi.org/10.1074/jbc.M111.241778			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795690	Green Published, hybrid			2022-12-27	WOS:000295159200044
J	Danielsson, J; Kurnik, M; Lang, L; Oliveberg, M				Danielsson, Jens; Kurnik, Martin; Lang, Lisa; Oliveberg, Mikael			Cutting Off Functional Loops from Homodimeric Enzyme Superoxide Dismutase 1 (SOD1) Leaves Monomeric beta-Barrels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PANCREATIC TRYPSIN-INHIBITOR; MAGNETIC-RESONANCE RELAXATION; ISOTOPE EXCHANGE KINETICS; PULSED-FIELD GRADIENTS; MODEL-FREE APPROACH; HYDROGEN-EXCHANGE; NMR-SPECTROSCOPY; POSTTRANSLATIONAL MODIFICATIONS; CU,ZN-SUPEROXIDE DISMUTASE	Demetallation of the homodimeric enzyme Cu/Zn-superoxide dismutase (SOD1) is known to unleash pronounced dynamic motions in the long active-site loops that comprise almost a third of the folded structure. The resulting apo species, which shows increased propensity to aggregate, stands out as the prime disease precursor in amyotrophic lateral sclerosis (ALS). Even so, the detailed structural properties of the apoSOD1 framework have remained elusive and controversial. In this study, we examine the structural interplay between the central apoSOD1 barrel and the active-site loops by simply cutting them off; loops IV and VII were substituted with short Gly-Ala-Gly linkers. The results show that loop removal breaks the dimer interface and leads to soluble, monomeric beta-barrels with high structural integrity. NMR-detected nuclear Overhauser effects are found between all of the constituent beta-strands, confirming ordered interactions across the whole barrel. Moreover, the breathing motions of the SOD1 barrel are overall insensitive to loop removal and yield hydrogen/deuterium protection factors typical for cooperatively folded proteins (i.e. the active-site loops act as a "bolt-on" domain with little dynamic influence on its structural foundation). The sole exceptions are the relatively low protection factors in beta-strand 5 and the turn around Gly-93, a hot spot for ALS-provoking mutations, which decrease even further upon loop removal. Taken together, these data suggest that the cytotoxic function of apoSOD1 does not emerge from its folded ground state but from a high energy intermediate or even from the denatured ensemble.	[Danielsson, Jens; Kurnik, Martin; Lang, Lisa; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden	Stockholm University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se	Danielsson, Jens/AAG-6915-2021; Kurnik, Martin/AFZ-2568-2022	Kurnik, Martin/0000-0001-9255-9730; Danielsson, Jens/0000-0002-6048-6896	Swedish Research Council; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation; Hjarnfonden; EC (EU-NMR) [RII3-026145]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation; Hjarnfonden; EC (EU-NMR)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, and Hjarnfonden. This work was also supported by the Access to Research Infrastructures Activity in the 6th Framework Program of the EC (Contract RII3-026145, EU-NMR) for conducting the research at CERM.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Daggett V, 2009, PROTEIN ENG DES SEL, V22, P445, DOI 10.1093/protein/gzp049; Danielsson J, 2002, MAGN RESON CHEM, V40, pS89, DOI 10.1002/mrc.1132; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Ferraro DM, 2004, BIOCHEMISTRY-US, V43, P587, DOI 10.1021/bi035943y; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; FUSHMAN D, 1994, J BIOMOL STRUCT DYN, V11, P1377, DOI 10.1080/07391102.1994.10508074; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Haglund E, 2009, P NATL ACAD SCI USA, V106, P21619, DOI 10.1073/pnas.0907665106; Hamill SJ, 2000, J MOL BIOL, V297, P165, DOI 10.1006/jmbi.2000.3517; HILTON BD, 1979, BIOCHEMISTRY-US, V18, P5834, DOI 10.1021/bi00593a013; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jaswal SS, 2007, PROTEIN SCI, V16, P2378, DOI 10.1110/ps.072994207; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lynch SM, 2004, BIOCHEMISTRY-US, V43, P16525, DOI 10.1021/bi048831v; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; Museth AK, 2009, BIOCHEMISTRY-US, V48, P8817, DOI 10.1021/bi900703v; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Oliveberg M, 2001, CURR OPIN STRUC BIOL, V11, P94, DOI 10.1016/S0959-440X(00)00171-8; Oliveberg M, 2010, NAT METHODS, V7, P187, DOI 10.1038/nmeth0310-187; Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PEDERSEN TG, 1993, J MOL BIOL, V230, P651, DOI 10.1006/jmbi.1993.1176; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; RODER H, 1985, BIOCHEMISTRY-US, V24, P7396, DOI 10.1021/bi00346a055; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WOODWARD CK, 1980, BIOPHYS J, V32, P561, DOI 10.1016/S0006-3495(80)84990-3; Wright CF, 2004, PROTEIN ENG DES SEL, V17, P443, DOI 10.1093/protein/gzh052; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	78	47	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33070	33083		10.1074/jbc.M111.251223	http://dx.doi.org/10.1074/jbc.M111.251223			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21700707	Green Published, hybrid			2022-12-27	WOS:000294968800026
J	Szymanski, MR; Jezewska, MJ; Bujalowski, PJ; Bussetta, C; Ye, MY; Choi, KH; Bujalowski, W				Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bussetta, Cecile; Ye, Mengyi; Choi, Kyung H.; Bujalowski, Wlodzimierz			Full-length Dengue Virus RNA-dependent RNA Polymerase-RNA/DNA Complexes STOICHIOMETRIES, INTRINSIC AFFINITIES, COOPERATIVITIES, BASE, AND CONFORMATIONAL SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE DNAB PROTEIN; SINGLE-STRANDED-DNA; SWINE-FEVER VIRUS; DE-NOVO SYNTHESIS; NUCLEIC-ACID; QUANTITATIVE-ANALYSIS; SSDNA INTERACTIONS; LARGE LIGANDS; NONCOOPERATIVE BINDING; FUNCTIONAL STRUCTURE	Fundamental aspects of interactions of the Dengue virus type 3 full-length polymerase with the single-stranded and double-stranded RNA and DNA have been quantitatively addressed. The polymerase exists as a monomer with an elongated shape in solution. In the absence of magnesium, the total site size of the polymerase-ssRNA complex is 26 +/- 2 nucleotides. In the presence of Mg2+, the site size increases to 29 +/- 2 nucleotides, indicating that magnesium affects the enzyme global conformation. The enzyme shows a preference for the homopyrimidine ssRNAs. Positive cooperativity in the binding to homopurine ssRNAs indicates that the type of nucleic acid base dramatically affects the enzyme orientation in the complex. Both the intrinsic affinity and the cooperative interactions are accompanied by a net ion release. The polymerase binds the dsDNA with an affinity comparable with the ssRNAs affinity, indicating that the binding site has an open conformation in solution. The lack of detectable dsRNA or dsRNA-DNA hybrid affinities indicates that the entry to the binding site is specific for the sugar-phosphate backbone and/or conformation of the duplex.	[Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bussetta, Cecile; Ye, Mengyi; Choi, Kyung H.; Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bussetta, Cecile; Ye, Mengyi; Choi, Kyung H.; Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	wbujalow@utmb.edu		Szymanski, Michal/0000-0001-9452-8508	National Institutes of Health [GM-58565, AI-087856]; Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-58565 (to W. B.) and AI-087856. This work was also supported by a Sealy Memorial Endowment Fund research pilot grant (to K. C.).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; BAKER BM, 1978, BIOPOLYMERS, V17, P1361, DOI 10.1002/bip.1978.360170519; BLOK J, 1985, J GEN VIROL, V66, P1323, DOI 10.1099/0022-1317-66-6-1323; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; BULL HB, 1968, ARCH BIOCHEM BIOPHYS, V128, P497, DOI 10.1016/0003-9861(68)90056-8; Cantor R. C., 1980, BIOPHYSICAL CHEM, VII, P591; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Choi KH, 2006, STRUCTURE, V14, P1107, DOI 10.1016/j.str.2006.05.020; Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015; Correia JJ, 2001, BIOCHEMISTRY-US, V40, P1473, DOI 10.1021/bi0019343; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; EISENBERG H, 1967, J MOL BIOL, V30, P17, DOI 10.1016/0022-2836(67)90240-9; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; Galletto R, 2004, BIOCHEMISTRY-US, V43, P10988, DOI 10.1021/bi049377y; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; Jezewska MJ, 2007, BIOCHEMISTRY-US, V46, P12909, DOI 10.1021/bi700677j; Jezewska MJ, 2007, J MOL BIOL, V373, P75, DOI 10.1016/j.jmb.2007.06.054; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 2006, J MOL BIOL, V356, P121, DOI 10.1016/j.jmb.2005.10.061; Jezewska MJ, 2004, J MOL BIOL, V343, P115, DOI 10.1016/j.jmb.2004.08.021; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P11864, DOI 10.1021/bi030111l; Jezewska MJ, 2003, CELL BIOCHEM BIOPHYS, V38, P125, DOI 10.1385/CBB:38:2:125; Jezewska MJ, 2001, J MOL BIOL, V313, P977, DOI 10.1006/jmbi.2001.5042; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KRAKAUER H, 1971, BIOPOLYMERS, V10, P2459, DOI 10.1002/bip.360101209; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; LEDNEVA RK, 1978, NUCLEIC ACIDS RES, V5, P4225, DOI 10.1093/nar/5.11.4225; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Marcinowicz A, 2008, J MOL BIOL, V375, P386, DOI 10.1016/j.jmb.2007.06.051; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Rajendran S, 2001, BIOCHEMISTRY-US, V40, P11794, DOI 10.1021/bi011173j; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Roychowdhury A, 2009, BIOCHEMISTRY-US, V48, P6712, DOI 10.1021/bi900050x; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Szymanski MR, 2010, J MOL BIOL, V398, P8, DOI 10.1016/j.jmb.2010.02.009; TOLMAN GL, 1974, BIOCHEMISTRY-US, V13, P4869, DOI 10.1021/bi00721a001; WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06	59	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33095	33108		10.1074/jbc.M111.255034	http://dx.doi.org/10.1074/jbc.M111.255034			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21725087	Green Published, hybrid			2022-12-27	WOS:000294968800028
J	Kissner, TL; Moisan, L; Mann, E; Alam, S; Ruthel, G; Ulrich, RG; Rebek, M; Rebek, J; Saikh, KU				Kissner, Teri L.; Moisan, Lionel; Mann, Enrique; Alam, Shahabuddin; Ruthel, Gordon; Ulrich, Robert G.; Rebek, Mitra; Rebek, Julius, Jr.; Saikh, Kamal U.			A Small Molecule That Mimics the BB-loop in the Toll Interleukin-1 (IL-1) Receptor Domain of MyD88 Attenuates Staphylococcal Enterotoxin B-induced Pro-inflammatory Cytokine Production and Toxicity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; MHC CLASS-II; INTENSIVE-CARE UNITS; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; DENDRITIC CELLS; SHOCK-SYNDROME; LETHAL SHOCK; T-CELLS; SUPERANTIGEN	Toxic shock syndrome (TSS) is a clinical consequence of the profound amplification of host pro-inflammatory cytokine signaling that results from staphylococcal enterotoxin (SE) exposure. We recently reported that MyD88(-/-) mice were resistant to SEA or SEB toxic shock and displayed reduced levels of pro-inflammatory cytokines in their serum. Here we report that SEB stimulation of total mononuclear cells up-regulated MyD88 in monocytes and T cells. Further, MyD88 gene silencing in primary human cells using siRNA prevented SEB or SEB plus lipopolysaccharide (LPS) induction of interleukin-1 beta (IL-1 beta) transcriptional activation, suggesting that MyD88-mediated signaling is an essential component of SEB toxicity. We synthesized small molecules that mimic the conserved BB-loop in the Toll/IL-1 receptor (TIR) domain of MyD88. In primary human cells, these mimetics attenuated SEB-induced pro-inflammatory cytokine production. SEB stimulation of primary cells with mimetic affected newly synthesized MyD88 and downstream signaling components. Furthermore, LPS-induced MyD88 signaling was likewise inhibited in a cell-based reporter assay. More importantly, administration of mimetic reduced cytokine responses and increased survivability in a murine SEB challenge model. Collectively, these results suggest that MyD88 BB-loop mimetics interfere with SEB-induced pro-inflammatory signaling and toxicity, thus offering a potential approach in the therapy of toxic shock.	[Kissner, Teri L.; Alam, Shahabuddin; Ruthel, Gordon; Ulrich, Robert G.; Saikh, Kamal U.] USA, Dept Immunol, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Moisan, Lionel; Mann, Enrique; Rebek, Mitra; Rebek, Julius, Jr.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Moisan, Lionel; Mann, Enrique; Rebek, Mitra; Rebek, Julius, Jr.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Saikh, KU (corresponding author), 1425 Porter St, Frederick, MD 21702 USA.	kamal.saikh@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022; Mann, Enrique/K-6594-2014	Mann, Enrique/0000-0002-2050-4295; Ruthel, Gordon/0000-0001-9193-5589	Defense Threat Reduction Agency; Skaggs Institute; Spanish Ministerio de Educacion y Ciencia	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Skaggs Institute; Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by the Defense Threat Reduction Agency (to K. U. S.) and the Skaggs Institute.; Supported by a Spanish Ministerio de Educacion y Ciencia fellowship.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Beno DWA, 2001, AM J PHYSIOL-GASTR L, V280, pG866, DOI 10.1152/ajpgi.2001.280.5.G866; Blank C, 1997, EUR J IMMUNOL, V27, P825, DOI 10.1002/eji.1830270405; Buatois V, 2003, J IMMUNOL, V171, P5812, DOI 10.4049/jimmunol.171.11.5812; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; DUNNE A, 2003, SCI STKE, V3, P171; FAASSEN AE, 1995, J IMMUNOL, V155, P1737; Han KJ, 2010, J BIOL CHEM, V285, P12543, DOI 10.1074/jbc.M109.072231; Hassan GS, 2011, NAT IMMUNOL, V12, P375, DOI 10.1038/ni.2023; HAUSCHILDT S, 1993, EUR J IMMUNOL, V23, P2988, DOI 10.1002/eji.1830231139; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Kissner TL, 2010, IMMUNOLOGY, V130, P516, DOI 10.1111/j.1365-2567.2010.03249.x; KISSNER TL, INNATE IMMUN-LONDON, DOI DOI 10.1177/1753425910374092; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MIETHKE T, 1993, EUR J IMMUNOL, V23, P1494, DOI 10.1002/eji.1830230715; Mills Kingston H G, 2009, Nat Med, V15, P1363, DOI 10.1038/nm1209-1363; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Saikh KU, 2004, J IMMUNOL, V173, P7426, DOI 10.4049/jimmunol.173.12.7426; Saikh KU, 2001, CLIN EXP IMMUNOL, V126, P447, DOI 10.1046/j.1365-2249.2001.01672.x; SCHOLL P, 1989, P NATL ACAD SCI USA, V86, P4210, DOI 10.1073/pnas.86.11.4210; SPERTINI F, 1992, J IMMUNOL, V149, P65; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Ulrich RG, 1995, TRENDS MICROBIOL, V3, P463, DOI 10.1016/S0966-842X(00)89011-3; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	34	29	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31385	31396		10.1074/jbc.M110.204982	http://dx.doi.org/10.1074/jbc.M110.204982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21693701	Green Published, hybrid			2022-12-27	WOS:000294487500033
J	Lemmon, CRM; Woo, JH; Tully, E; Wilsbach, K; Gabrielson, E				Lemmon, Colleen R. M.; Woo, Ju-Hyung; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward			Nuclear Factor-kappa B (NF-kappa B) Mediates a Protective Response in Cancer Cells Treated with Inhibitors of Fatty Acid Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PACLITAXEL-INDUCED APOPTOSIS; LUNG-CANCER; MULTIPLE-MYELOMA; TUMOR-CELLS; ACTIVATION; PATHWAY; THERAPY; DEATH; PHOSPHORYLATION	The efficacy of drugs used to treat cancer can be significantly attenuated by adaptive responses of neoplastic cells to drug-induced stress. To determine how cancer cells respond to inhibition of the enzyme fatty acid synthase (FAS), we focused on NF-kappa B-mediated pathways, which can be activated by various cellular stresses. Treating lung cancer cells with C93, a pharmacological inhibitor of FAS, results in changes indicative of a rapid initiation of NF-kappa B signaling, including translocation of RelA/p65 NF-kappa B to the nucleus, activation of a transfected NF-kappa B-luciferase reporter, and increased expression of NF-kappa B dependent transcripts, IL-6, IL-8, and COX-2. Verifying that these responses to C93 are specifically related to inhibition of FAS, we confirmed that levels of these same transcripts increase in response to siRNA targeting FAS. Inhibiting this NF-kappa B response (either by transfecting a mutant I kappa B alpha or treating with bortezomib) resulted in increased cell killing by C93, indicating that the NF-kappa B response is protective in this setting. Because inhibiting FAS leads to accumulation of intermediate metabolites of fatty acid biosynthesis, we then questioned whether protein kinase C (PKC) is involved in this response to metabolic stress. Immunofluorescence microscopy revealed that C93 treatment results in cellular translocation of PKC alpha and PKC beta isoforms and increased PKC alpha-dependent phosphorylation of the I kappa B alpha subunit of NF-kappa B. Furthermore, inhibiting PKC activity with RO-31-8220 or PKC alpha isoform-specific siRNA attenuates C93-induced I kappa B alpha phosphorylation and NF-kappa B activation and also potentiates C93-induced cell killing. These results suggest a link between PKC and NF-kappa B in protecting cancer cells from metabolic stress induced by inhibiting FAS.	Johns Hopkins Univ, Sch Med, Johns Hopkins Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gabrielson, E (corresponding author), Johns Hopkins Canc Ctr CRB2,Room 304,1550 E Orlea, Baltimore, MD 21231 USA.	egabriel@jhmi.edu			National Institutes of Health, NCI [P50 CA058184, R01 CA101232]; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [P50CA058184, R01CA101232] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants P50 CA058184 and R01 CA101232. This work was also supported by the Flight Attendant Medical Research Institute.	Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Csiki I, 2005, CLIN CANCER RES, V11, P6634, DOI 10.1158/1078-0432.CCR-05-0436; Cusack JC, 2001, CANCER RES, V61, P3535; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Edelman Martin J, 2005, Clin Lung Cancer, V7 Suppl 2, pS64, DOI 10.3816/CLC.2005.s.011; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Huang Y, 2000, CANCER RES, V60, P4426; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Lee JM, 2008, CRIT REV ONCOL HEMAT, V66, P208, DOI 10.1016/j.critrevonc.2008.01.004; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Menendez JA, 2004, INT J ONCOL, V24, P591; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Strozyk E, 2006, ONCOGENE, V25, P6239, DOI 10.1038/sj.onc.1209655; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Woo JH, 2007, CANCER BIOL THER, V6, P2005, DOI 10.4161/cbt.6.12.5168; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	35	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31457	31465		10.1074/jbc.M111.274308	http://dx.doi.org/10.1074/jbc.M111.274308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768098	Green Published, hybrid			2022-12-27	WOS:000294487500040
J	Maqbool, A; Levdikov, VM; Blagova, EV; Herve, M; Horler, RSP; Wilkinson, AJ; Thomas, GH				Maqbool, Abbas; Levdikov, Vladimir M.; Blagova, Elena V.; Herve, Mireille; Horler, Richard S. P.; Wilkinson, Anthony J.; Thomas, Gavin H.			Compensating Stereochemical Changes Allow Murein Tripeptide to Be Accommodated in a Conventional Peptide-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; GLUTAMYL-MESO-DIAMINOPIMELATE; L-ALANINE AMIDASE; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; OPPA PROTEIN; TRANSPORT; SPECIFICITY; CRYSTALLIZATION	The oligopeptide permease (Opp) of Escherichia coli is an ATP-binding cassette transporter that uses the substrate-binding protein (SBP) OppA to bind peptides and deliver them to the membrane components (OppBCDF) for transport. OppA binds conventional peptides 2-5 residues in length regardless of their sequence, but does not facilitate transport of the cell wall component murein tripeptide (Mtp, L-Ala-gamma-D-Glu-meso-Dap), which contains a D-amino acid and a gamma-peptide linkage. Instead, MppA, a homologous substrate-binding protein, forms a functional transporter with OppBCDF for uptake of this unusual tripeptide. Here we have purified MppA and demonstrated biochemically that it binds Mtp with high affinity (K-D similar to 250 nM). The crystal structure of MppA in complex with Mtp has revealed that Mtp is bound in a relatively extended conformation with its three carboxylates projecting from one side of the molecule and its two amino groups projecting from the opposite face. Specificity for Mtp is conferred by charge-charge and dipole-charge interactions with ionic and polar residues of MppA. Comparison of the structure of MppA-Mtp with structures of conventional tripeptides bound to OppA, reveals that the peptide ligands superimpose remarkably closely given the profound differences in their structures. Strikingly, the effect of the D-stereochemistry, which projects the side chain of the D-Glu residue at position 2 in the direction of the main chain in a conventional tripeptide, is compensated by the formation of a gamma-linkage to the amino group of diaminopimelic acid, mimicking the peptide bond between residues 2 and 3 of a conventional tripeptide.	[Levdikov, Vladimir M.; Blagova, Elena V.; Wilkinson, Anthony J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Maqbool, Abbas; Horler, Richard S. P.; Thomas, Gavin H.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Herve, Mireille] Univ Paris 11, Lab Enveloppes Bacteriennes & Antibiot, IBBMC, UMR8619, F-91450 Orsay, France; [Herve, Mireille] CNRS, F-91405 Orsay, France	University of York - UK; University of York - UK; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Wilkinson, AJ (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	ajw@ysbl.york.ac.uk; ght2@york.ac.uk	Thomas, Gavin H/E-5753-2011; Maqbool, Abbas/AAA-9052-2020; Levdikov, Vladimir/AAA-6139-2022; Maqbool, Abbas/G-3191-2016	Thomas, Gavin H/0000-0002-9763-1313; Levdikov, Vladimir/0000-0003-3041-1049; Maqbool, Abbas/0000-0002-6189-5560; Wilkinson, Anthony/0000-0003-4577-9479; Horler, Richard/0000-0002-9908-2469	Higher Education Commission Pakistan; Wellcome Trust [082829/Z/07/Z]; European Commission [LSHG-CT-2006-031220, BASYSBIO LSHG-CT-2006-037469]	Higher Education Commission Pakistan(Higher Education Commission of Pakistan); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a Higher Education Commission Pakistan studentship (to A. M.), Wellcome Trust Grant 082829/Z/07/Z (to V. L.), and European Commission SPINE2-COMPLEXES project Grants LSHG-CT-2006-031220 and BASYSBIO LSHG-CT-2006-037469 (to E. B.).	Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brzozowski AM, 2001, J APPL CRYSTALLOGR, V34, P97, DOI 10.1107/S0021889800017362; Cuneo MJ, 2009, J BIOL CHEM, V284, P33217, DOI 10.1074/jbc.M109.041624; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; Doeven MK, 2005, MOL MICROBIOL, V57, P640, DOI 10.1111/j.1365-2958.2005.04698.x; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; Herve M, 2007, J BACTERIOL, V189, P3987, DOI 10.1128/JB.00087-07; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Lanfermeijer FC, 1999, BIOCHEMISTRY-US, V38, P14440, DOI 10.1021/bi9914715; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Lessard IAD, 1998, CHEM BIOL, V5, P489, DOI 10.1016/S1074-5521(98)90005-9; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanavati DA, 2006, APPL ENVIRON MICROB, V72, P1336, DOI 10.1128/AEM.72.2.1336-1345.2006; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Park JT, 1998, J BACTERIOL, V180, P1215, DOI 10.1128/JB.180.5.1215-1223.1998; PAYNE JW, 1971, BIOCHEM J, V123, P245, DOI 10.1042/bj1230245; Pennartz A, 2009, ANTIMICROB AGENTS CH, V53, P2991, DOI 10.1128/AAC.01520-07; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Sleigh SH, 1997, BIOCHEMISTRY-US, V36, P9747, DOI 10.1021/bi970457u; Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Williams WA, 2004, BIOCHEMISTRY-US, V43, P16193, DOI 10.1021/bi048877o; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	39	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31512	31521		10.1074/jbc.M111.267179	http://dx.doi.org/10.1074/jbc.M111.267179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21705338	hybrid, Green Published			2022-12-27	WOS:000294487500046
J	Olucha, J; Meneely, KM; Chilton, AS; Lamb, AL				Olucha, Jose; Meneely, Kathleen M.; Chilton, Annemarie S.; Lamb, Audrey L.			Two Structures of an N-Hydroxylating Flavoprotein Monooxygenase ORNITHINE HYDROXYLASE FROM PSEUDOMONAS AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; P-HYDROXYBENZOATE HYDROXYLASE; CONTAINING MONO-OXYGENASE; BIOCHEMICAL-CHARACTERIZATION; CYCLOHEXANONE MONOOXYGENASE; REACTION-MECHANISM; COFACTOR	The ornithine hydroxylase from Pseudomonas aeruginosa (PvdA) catalyzes the FAD-dependent hydroxylation of the side chain amine of ornithine, which is subsequently formylated to generate the iron-chelating hydroxamates of the siderophore pyoverdin. PvdA belongs to the class B flavoprotein monooxygenases, which catalyze the oxidation of substrates using NADPH as the electron donor and molecular oxygen. Class B enzymes include the well studied flavin-containing monooxygenases and Baeyer-Villiger monooxygenases. The first two structures of a class B N-hydroxylating monooxygenase were determined with FAD in oxidized (1.9 angstrom resolution) and reduced (3.03 angstrom resolution) states. PvdA has the two expected Ross-mann-like dinucleotide-binding domains for FAD and NADPH and also a substrate-binding domain, with the active site at the interface between the three domains. The structures have NADP(H) and (hydroxy) ornithine bound in a solvent-exposed active site, providing structural evidence for substrate and co-substrate specificity and the inability of PvdA to bind FAD tightly. Structural and biochemical evidence indicates that NADP(+) remains bound throughout the oxidative half-reaction, which is proposed to shelter the flavin intermediates from solvent and thereby prevent uncoupling of NADPH oxidation from hydroxylated product formation.	[Olucha, Jose; Meneely, Kathleen M.; Chilton, Annemarie S.; Lamb, Audrey L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Lamb, AL (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	lamb@ku.edu		Lamb, Audrey/0000-0002-2352-2130	Office of Biological and Environmental Research, United States Department of Energy; National Center for Research Resources Biomedical Technology, National Institutes of Health; NIGMS [T32 GM08545]; Stanford Synchrotron Radiation Lightsource; IDeA Networks of Biomedical Research Excellence of the National Center for Research Resources [P20 RR016475]; NIAID [K02 AI093675]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008545] Funding Source: NIH RePORTER	Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources Biomedical Technology, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stanford Synchrotron Radiation Lightsource; IDeA Networks of Biomedical Research Excellence of the National Center for Research Resources; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. G. R. Moran for insightful discussions and critically reading this manuscript. Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the Office of Basic Energy Sciences, United States Department of Energy. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Office of Biological and Environmental Research, United States Department of Energy; by the National Center for Research Resources Biomedical Technology Program, National Institutes of Health; and by NIGMS. We thank the staff at the Stanford Synchrotron Radiation Lightsource for support and assistance.; This work was supported, in whole or in part, by National Institutes of Health Graduate Training Program in Dynamic Aspects of Chemical Biology Grant T32 GM08545 from NIGMS (to J. O. and K. M. M.) and by National Institutes of Health Grant P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources and Grant K02 AI093675 from NIAID (to A. L. L.).	ADAMS PD, 2010, ACTA CRYSTALLOGR D 2, V66, P213, DOI DOI 10.1107/S0907444909052925; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Cho HJ, 2011, J STRUCT BIOL, V175, P39, DOI 10.1016/j.jsb.2011.04.007; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; DeLano W.L, PYMOL MOL GRAPHICS S; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Ge L, 2006, J BACTERIOL, V188, P7205, DOI 10.1128/JB.00949-06; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamerbeek NM, 2004, EUR J BIOCHEM, V271, P2107, DOI 10.1111/j.1432-1033.2004.04126.x; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Moran GR, 1996, BIOCHEMISTRY-US, V35, P9278, DOI 10.1021/bi960360s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; THARIATH A, 1993, J BACTERIOL, V175, P589, DOI 10.1128/JB.175.3.589-596.1993; THARIATH AM, 1993, BIOCHIM BIOPHYS ACTA, V1203, P27, DOI 10.1016/0167-4838(93)90032-M; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012	36	50	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31789	31798		10.1074/jbc.M111.265876	http://dx.doi.org/10.1074/jbc.M111.265876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757711	Green Published, hybrid			2022-12-27	WOS:000294487500072
J	So, BR; An, S; Kumar, S; Das, M; Turner, DA; Hadad, CM; Musier-Forsyth, K				So, Byung Ran; An, Songon; Kumar, Sandeep; Das, Mom; Turner, Daniel A.; Hadad, Christopher M.; Musier-Forsyth, Karin			Substrate-mediated Fidelity Mechanism Ensures Accurate Decoding of Proline Codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; TRANSLATIONAL QUALITY-CONTROL; HAEMOPHILUS-INFLUENZAE YBAK; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; EDITING DOMAIN; AMINO-ACIDS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	Aminoacyl-tRNA synthetases attach specific amino acids to cognate tRNAs. Prolyl-tRNA synthetases are known to mischarge tRNA(Pro) with the smaller amino acid alanine and with cysteine, which is the same size as proline. Quality control in proline codon translation is partly ensured by an editing domain (INS) present in most bacterial prolyl-tRNA synthetases that hydrolyzes smaller Ala-tRNA(Pro) and excludes Pro-tRNA(Pro). In contrast, Cys-tRNA(Pro) is cleared by a freestanding INS domain homolog, YbaK. Here, we have investigated the molecular mechanism of catalysis and substrate recognition by Hemophilus influenzae YbaK using site-directed mutagenesis, enzymatic assays of isosteric substrates and functional group analogs, and computational modeling. These studies together with mass spectrometric characterization of the YbaK-catalyzed reaction products support a novel substrate-assisted mechanism of Cys-tRNA(Pro) deacylation that prevents nonspecific Pro-tRNA(Pro) hydrolysis. Collectively, we propose that the INS and YbaK domains co-evolved distinct mechanisms involving steric exclusion and thiol-specific chemistry, respectively, to ensure accurate decoding of proline codons.	[So, Byung Ran; Kumar, Sandeep; Das, Mom; Turner, Daniel A.; Hadad, Christopher M.; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [So, Byung Ran; Kumar, Sandeep; Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [An, Songon] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Das, Mom/0000-0002-9436-6809; Hadad, Christopher/0000-0003-1211-4315; An, Songon/0000-0003-2189-7374	National Institutes of Health [GM049928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049928, R55GM049928, R01GM049928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049928.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CASE DA, 2006, AMBER 9 U CAL SAN FR; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; CREIGHTON TE, 1996, PROTEINS STRUCTURE M; Crepin T, 2006, STRUCTURE, V14, P1511, DOI 10.1016/j.str.2006.08.007; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Fersht AR., 1977, ENZYME STRUCTURE MEC; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Hagiwara Y, 2009, FEBS LETT, V583, P1901, DOI 10.1016/j.febslet.2009.05.026; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IGLOI GL, 1977, BIOCHEMISTRY-US, V16, P1696, DOI 10.1021/bi00627a027; JAKUBOWSKI H, 1994, NUCLEIC ACIDS RES, V22, P1155, DOI 10.1093/nar/22.7.1155; Jakubowski H, 1999, BIOCHEMISTRY-US, V38, P8088, DOI 10.1021/bi990629i; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1990, P NATL ACAD SCI USA, V87, P4504, DOI 10.1073/pnas.87.12.4504; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamtekar S, 2003, P NATL ACAD SCI USA, V100, P1673, DOI 10.1073/pnas.0437911100; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lim K, 2003, J BIOL CHEM, V278, P13496, DOI 10.1074/jbc.M213150200; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling J, 2007, P NATL ACAD SCI USA, V104, P72, DOI 10.1073/pnas.0606272104; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Mascarenhas A. P., 2008, PROTEIN ENG, P153; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Murayama K, 2005, ACTA CRYSTALLOGR F, V61, P26, DOI 10.1107/S1744309104032555; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Shitivelband S, 2005, J MOL BIOL, V348, P513, DOI 10.1016/j.jmb.2005.02.023; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Wolf YI, 1999, GENOME RES, V9, P689; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Yadavalli SS, 2008, P NATL ACAD SCI USA, V105, P19031, DOI 10.1073/pnas.0810781106; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	65	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31810	31820		10.1074/jbc.M111.232611	http://dx.doi.org/10.1074/jbc.M111.232611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768119	hybrid, Green Published			2022-12-27	WOS:000294487500074
J	Hurlimann, HC; Laloo, B; Simon-Kayser, B; Saint-Marc, C; Coulpier, F; Lemoine, S; Daignan-Fornier, B; Pinson, B				Huerlimann, Hans C.; Laloo, Benoit; Simon-Kayser, Barbara; Saint-Marc, Christelle; Coulpier, Fanny; Lemoine, Sophie; Daignan-Fornier, Bertrand; Pinson, Benoit			Physiological and Toxic Effects of Purine Intermediate 5-Amino-4-imidazolecarboxamide Ribonucleotide (AICAR) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; GENE-EXPRESSION; IN-VITRO; BIOSYNTHESIS; INHIBITION; MUTANTS; COREGULATION; PHOSPHATE	5-Amino-4-imidazolecarboxamide ribonucleotide 5'-phosphate (AICAR) is a monophosphate metabolic intermediate of the de novo purine synthesis pathway that has highly promising metabolic and antiproliferative properties. Yeast mutants unable to metabolize AICAR are auxotroph for histidine. A screening for suppressors of this phenotype identified recessive and dominant mutants that result in lowering the intracellular AICAR concentration. The recessive mutants affect the adenosine kinase, which is shown here to catalyze the phosphorylation of AICAR riboside in yeast. The dominant mutants strongly enhance the capacity of the alkaline phosphatase Pho13 to dephosphorylate 5-amino-4-imidazole N-succinocarboxamide ribonucleotide 5'-phosphate(SAICAR) into its non-toxic riboside form. By combining these mutants with transcriptomics and metabolomics analyses, we establish that in yeast responses to AICAR and SAICAR are clearly linked to the concentration of the monophosphate forms, whereas the derived nucleoside moieties have no effect even at high intracellular concentration. Finally, we show that AICAR/SAICAR concentrations vary under physiological conditions known to modulate transcription of the purine and phosphate pathway genes.	[Huerlimann, Hans C.; Laloo, Benoit; Simon-Kayser, Barbara; Saint-Marc, Christelle; Daignan-Fornier, Bertrand; Pinson, Benoit] Univ Segalen, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Huerlimann, Hans C.; Laloo, Benoit; Simon-Kayser, Barbara; Saint-Marc, Christelle; Daignan-Fornier, Bertrand; Pinson, Benoit] CNRS, IBGC, UMR 5095, F-33077 Bordeaux, France; [Coulpier, Fanny; Lemoine, Sophie] ENS, IBENS, Inst Biol ENS, F-75005 Paris, France; [Coulpier, Fanny; Lemoine, Sophie] INSERM, U1024, F-75005 Paris, France; [Coulpier, Fanny; Lemoine, Sophie] CNRS, UMR 8197, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Daignan-Fornier, B (corresponding author), Univ Segalen, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue C St Saens, F-33077 Bordeaux, France.	b.daignan-fornier@ibgc.cnrs.fr		Pinson, Benoit/0000-0003-2936-9058	Association Francaise contre les Myopathies; Conseil Regional d'Aquitaine; Universite Bordeaux; Ligue Contre le Cancer	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Universite Bordeaux; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by grants from the Association Francaise contre les Myopathies, Conseil Regional d'Aquitaine, and Universite Bordeaux 2.; Supported by Ligue Contre le Cancer fellowships.	Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Guetsova ML, 1997, GENETICS, V147, P383; Hanko Valoran P, 2004, J Biomol Tech, V15, P317; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; KANEKO Y, 1989, MOL GEN GENET, V220, P133, DOI 10.1007/BF00260867; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Lecoq K, 2001, YEAST, V18, P335, DOI 10.1002/1097-0061(20010315)18:4<335::AID-YEA674>3.0.CO;2-X; Lecoq K, 2000, GENETICS, V156, P953; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; Mizunuma M, 2004, P NATL ACAD SCI USA, V101, P6086, DOI 10.1073/pnas.0308314101; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ndubuisil MI, 2002, BIOCHEMISTRY-US, V41, P7841, DOI 10.1021/bi0255064; Pinson B, 1998, NUCLEIC ACIDS RES, V26, P3977, DOI 10.1093/nar/26.17.3977; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; SABINA RL, 1985, J BIOL CHEM, V260, P6107; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tibbetts AS, 2000, J BIOL CHEM, V275, P20920, DOI 10.1074/jbc.M909851199	30	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30994	31002		10.1074/jbc.M111.262659	http://dx.doi.org/10.1074/jbc.M111.262659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757731	Green Published, hybrid			2022-12-27	WOS:000294283600077
J	O'Hara, SP; Splinter, PL; Trussoni, CE; Gajdos, GB; Lineswala, PN; LaRusso, NF				O'Hara, Steven P.; Splinter, Patrick L.; Trussoni, Christy E.; Gajdos, Gabriella B.; Lineswala, Pooja N.; LaRusso, Nicholas F.			Cholangiocyte N-Ras Protein Mediates Lipopolysaccharide-induced Interleukin 6 Secretion and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY EPITHELIAL-CELLS; CRYPTOSPORIDIUM-PARVUM; IMMUNE RECOGNITION; INNATE IMMUNITY; NUCLEAR-FACTOR; EXPRESSION; HELICOBACTER; RESPONSES; BETA-DEFENSIN-2; CYTOMEGALOVIRUS	Cholangiocytes, the epithelial cells lining the bile ducts in the liver, are periodically exposed to potentially injurious microbes and/or microbial products. As a result, cholangiocytes actively participate in microbe-associated, hepatic proinflammatory responses. We previously showed that infection of cultured human cholangiocytes with the protozoan parasite, Cryptosporidium parvum, or treatment with Gram-negative bacteria-derived LPS, activates NF kappa B in a myeloid differentiation 88 (MyD88)-dependent manner. Here, we describe a novel signaling pathway initiated by Toll-like receptors (TLRs) involving the small GTPase, Ras, that mediates cholangiocyte proinflammatory cytokine production and induction of cholangiocyte proliferation. Using cultured human cholangiocytes and a Ras activation assay, we found that agonists of plasma membrane TLRs (TLR 1, 2, 4, 5, and 6) rapidly (< 10 min) activated N-Ras, but not other p21 Ras isoforms, resulting in the rapid (< 15 min) phosphorylation of the downstream Ras effector, ERK1/2. RNA interference-induced depletion of TRAF6, a downstream effector of MyD88 and known activator of MAPK signaling, had no effect on N-Ras activation. Following N-Ras activation the proinflammatory cytokine, IL6, is rapidly secreted. Using a luciferase reporter, we demonstrated that LPS treatment induced IL6 promoter-driven luciferase which was suppressed using MEK/ERK pharmacologic inhibitors (PD98059 or U0126) and RNAi-induced depletion of N-Ras. Finally, we showed that LPS increased cholangiocyte proliferation (1.5-fold), which was inhibited by depletion of N-Ras; TLR agonist-induced proliferation was also inhibited following pretreatment with an IL6 receptor-blocking antibody. Together, our results support a novel signaling axis involving microbial activation of N-Ras likely involved in the cholangiocyte pathogen-induced proinflammatory response.	[O'Hara, Steven P.; Splinter, Patrick L.; Trussoni, Christy E.; Gajdos, Gabriella B.; LaRusso, Nicholas F.] Mayo Clin, Div Gastroenterol & Hepatol, Ctr Digest Dis, Rochester, MN 55905 USA; [Lineswala, Pooja N.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	O'Hara, SP (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Ctr Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	ohara.steven@mayo.edu		Trussoni, Christy/0000-0002-4247-076X	National Institutes of Health [AI089713, DK57993]; American Gastroenterological Association; Genetics Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK057993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; Genetics Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI089713 (to S. P. O.) and DK57993 (to N. F. L.). This work was also supported by an American Gastroenterological Association summer research fellowship (to P. N. L.) and the Genetics Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Carratelli CR, 2009, FEMS IMMUNOL MED MIC, V57, P116, DOI 10.1111/j.1574-695X.2009.00586.x; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Chen XM, 2002, SEMIN LIVER DIS, V22, P277, DOI 10.1055/s-2002-34505; Chen XM, 2001, GASTROENTEROLOGY, V120, P1774, DOI 10.1053/gast.2001.24850; Cruickshank SM, 1998, J HEPATOL, V29, P550, DOI 10.1016/S0168-8278(98)80149-9; Domiati-Saad R, 2000, PEDIATR DEVEL PATHOL, V3, P367, DOI 10.1007/s100240010045; Fischler B, 2009, ACTA PAEDIATR, V98, P1600, DOI 10.1111/j.1651-2227.2009.01416.x; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Hamada T, 2009, HELICOBACTER, V14, P545, DOI 10.1111/j.1523-5378.2009.00729.x; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harada K, 2004, HEPATOLOGY, V40, P925, DOI 10.1002/hep.20379; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Harada K, 2001, J PATHOL, V193, P218, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH776&gt;3.0.CO;2-H; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Jafri M, 2009, J PEDIATR SURG, V44, P500, DOI 10.1016/j.jpedsurg.2008.07.007; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karrar A, 2007, GASTROENTEROLOGY, V132, P1504, DOI 10.1053/j.gastro.2007.01.039; Kosaka T, 2010, BRIT J SURG, V97, P544, DOI 10.1002/bjs.6907; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; MORITA M, 1994, HEPATOLOGY, V19, P426; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; O'Hara SP, 2009, J INFECT DIS, V199, P1195, DOI 10.1086/597387; Park J, 1999, HEPATOLOGY, V29, P1037, DOI 10.1002/hep.510290423; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Prior IA, 2001, J CELL SCI, V114, P1603; Rauschenfels S, 2009, EUR J PEDIATR, V168, P469, DOI 10.1007/s00431-008-0774-2; Scholz M, 1997, TISSUE ANTIGENS, V49, P640, DOI 10.1111/j.1399-0039.1997.tb02813.x; Silva CP, 2003, J CLIN MICROBIOL, V41, P5615, DOI 10.1128/JCM.41.12.5615-5618.2003; Sripa B, 2000, INT J PARASITOL, V30, P735, DOI 10.1016/S0020-7519(00)00054-0; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Takayama S, 2010, DIGEST DIS SCI, V55, P1905, DOI 10.1007/s10620-009-0946-6; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Triantafilou M, 2002, J CELL SCI, V115, P2603; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wu MH, 2009, J IMMUNOL, V183, P8054, DOI 10.4049/jimmunol.0902140; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x	41	49	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30352	30360		10.1074/jbc.M111.269464	http://dx.doi.org/10.1074/jbc.M111.269464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757746	Green Published, hybrid			2022-12-27	WOS:000294283600013
J	Behrendorff, N; Dolai, S; Hong, WJ; Gaisano, HY; Thorn, P				Behrendorff, Natasha; Dolai, Subhankar; Hong, Wanjin; Gaisano, Herbert Y.; Thorn, Peter			Vesicle-associated Membrane Protein 8 (VAMP8) Is a SNARE (Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor) Selectively Required for Sequential Granule-to-granule Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; REGULATED EXOCYTOSIS; ZYMOGEN GRANULES; COMPOUND EXOCYTOSIS; MAST-CELLS; V-SNARE; RELEASE; SECRETION; DISTINCT; ENDOBREVIN/VAMP-8	Compound exocytosis is found in many cell types and is the major form of regulated secretion in acinar and mast cells. Its key characteristic is the homotypic fusion of secretory granules. These then secrete their combined output through a single fusion pore to the outside. The control of compound exocytosis remains poorly understood. Although soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) such as syntaxin 2, SNAP23 (synaptosome-associated protein of 23 kDa), and SNAP25 have been suggested to play a role, none has been proven. Vesicle-associated membrane protein 8 (VAMP8) is a SNARE first associated with endocytic processes but more recently has been suggested as an R-SNARE in regulated exocytosis. Secretion in acinar cells is reduced when VAMP8 function is inhibited and is less in VAMP8 knock-out mice. Based on electron microscopy experiments, it was suggested that VAMP8 may be involved in compound exocytosis. Here we have tested the hypothesis that VAMP8 controls homotypic granule-to-granule fusion during sequential compound exocytosis. We use a new assay to distinguish primary fusion events (fusion with the cell membrane) from secondary fusion events (granule-granule fusion). Our data show the pancreatic acinar cells from VAMP8 knock-out animals have a specific reduction in secondary granule fusion but that primary granule fusion is unaffected. Furthermore, immunoprecipitation experiments show syntaxin 2 association with VAMP2, whereas syntaxin 3 associates with VAMP8. Taken together our data indicate that granule-to-granule fusion is regulated by VAMP8 containing SNARE complexes distinct from those that regulate primary granule fusion.	[Behrendorff, Natasha; Thorn, Peter] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Dolai, Subhankar; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Hong, Wanjin] Inst Mol & Cellular Biol, Singapore 138673, Singapore	University of Queensland; University of Toronto; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Thorn, P (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	p.thorn@uq.edu.au	Behrendorff, Natasha/B-4908-2010; Thorn, Peter/F-7030-2010; HONG, Wanjin/E-9927-2010	Thorn, Peter/0000-0002-3228-770X; 	Australian Research Council [DP110100642]; National Health and Medical Research Council [APP1002520]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DP110100642 (to P. T.) and National Health and Medical Research Council Grant APP1002520 (to P. T. and H. Y. G.).	Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Behrendorff N, 2010, GASTROENTEROLOGY, V139, P1711, DOI 10.1053/j.gastro.2010.07.051; BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; FALKOWSKI MA, 2011, AM J PHYSL; Falkowski MA, 2010, J BIOL CHEM, V285, P35558, DOI 10.1074/jbc.M110.146597; Freedman SD, 1998, EUR J CELL BIOL, V75, P163, DOI 10.1016/S0171-9335(98)80058-7; Gaisano HY, 1996, GASTROENTEROLOGY, V111, P1661, DOI 10.1016/S0016-5085(96)70030-6; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; ICHIKAWA A, 1965, J CELL BIOL, V24, P369, DOI 10.1083/jcb.24.3.369; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Larina O, 2007, MOL BIOL CELL, V18, P3502, DOI 10.1091/mbc.E07-01-0024; Lippert U, 2007, FEBS LETT, V581, P3479, DOI 10.1016/j.febslet.2007.06.057; Loo LS, 2009, EUR J IMMUNOL, V39, P3520, DOI 10.1002/eji.200939378; Low JT, 2010, J CELL SCI, V123, P3201, DOI 10.1242/jcs.071225; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Pickett JA, 2005, J BIOL CHEM, V280, P1506, DOI 10.1074/jbc.M411967200; Polgar J, 2002, BLOOD, V100, P1081, DOI 10.1182/blood.V100.3.1081; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Steegmaier M, 2000, TRAFFIC, V1, P553, DOI 10.1034/j.1600-0854.2000.010705.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Thorn P, 1996, CELL CALCIUM, V20, P203, DOI 10.1016/S0143-4160(96)90107-4; Thorn P, 2004, P NATL ACAD SCI USA, V101, P6774, DOI 10.1073/pnas.0400336101; Turvey MR, 2004, PFLUG ARCH EUR J PHY, V448, P552, DOI 10.1007/s00424-004-1288-z; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang CC, 2010, MOL CELL BIOL, V30, P333, DOI 10.1128/MCB.00814-09; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549	43	58	58	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29627	29634		10.1074/jbc.M111.265199	http://dx.doi.org/10.1074/jbc.M111.265199			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733851	Green Published, hybrid			2022-12-27	WOS:000294046600021
J	Chaya, T; Shibata, S; Tokuhara, Y; Yamaguchi, W; Matsumoto, H; Kawahara, I; Kogo, M; Ohoka, Y; Inagaki, S				Chaya, Taro; Shibata, Satoshi; Tokuhara, Yasunori; Yamaguchi, Wataru; Matsumoto, Hiroshi; Kawahara, Ichiro; Kogo, Mikihiko; Ohoka, Yoshiharu; Inagaki, Shinobu			Identification of a Negative Regulatory Region for the Exchange Activity and Characterization of T332I Mutant of Rho Guanine Nucleotide Exchange Factor 10 (ARHGEF10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL MIGRATION; PERIPHERAL NERVOUS-SYSTEM; ACTIN STRESS FIBERS; ACTIVATION; PROTEIN; GTPASES; KINASE; AUTOINHIBITION; CDC42; RAC1	The T332I mutation in Rho guanine nucleotide exchange factor 10 (ARHGEF10) was previously found in persons with slowed nerve conduction velocities and thin myelination of peripheral nerves. However, the molecular and cellular basis of the T332I mutant is not understood. Here, we show that ARHGEF10 has a negative regulatory region in the N terminus, in which residue 332 is located, and the T332I mutant is constitutively active. An N-terminal truncated ARHGEF10 mutant, ARHGEF10 Delta N (lacking amino acids 1-332), induced cell contraction that was inhibited by a Rho kinase inhibitor Y27632 and had higher GEF activity for RhoA than the wild type. The T332I mutant also showed the phenotype similar to the N-terminal truncated mutant. These data suggest that the ARHGEF10 T332I mutation-associated phenotype observed in the peripheral nerves is due to activated GEF activity of the ARHGEF10 T332I mutant.	[Chaya, Taro; Shibata, Satoshi; Tokuhara, Yasunori; Yamaguchi, Wataru; Matsumoto, Hiroshi; Kawahara, Ichiro; Ohoka, Yoshiharu; Inagaki, Shinobu] Osaka Univ, Grad Sch Med, Div Hlth Sci, Neurobiol Grp, Suita, Osaka 5650871, Japan; [Matsumoto, Hiroshi; Kawahara, Ichiro; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Div Pathogenesis & Control Oral Dis, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Shibata, S (corresponding author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Neurobiol Grp, Yamadaoka 1-7, Suita, Osaka 5650871, Japan.	sshibata@sahs.med.osaka-u.ac.jp; inagaki@sahs.med.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020	Kogo, Mikihiko/0000-0002-4556-2491; Yamaguchi, Wataru/0000-0002-7840-4609; Tokuhara, Yasunori/0000-0002-8322-2543	Japan Ministry of Education, Culture, Sports, Science, and Technology	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for general scientific research from the Japan Ministry of Education, Culture, Sports, Science, and Technology (to S.I.).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aoki T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-56; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Mohl M, 2006, N-S ARCH PHARMACOL, V373, P333, DOI 10.1007/s00210-006-0083-0; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200	40	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29511	29520		10.1074/jbc.M111.236810	http://dx.doi.org/10.1074/jbc.M111.236810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719701	Green Published, hybrid			2022-12-27	WOS:000294046600008
J	Grasse, N; Mamedov, F; Becker, K; Styring, S; Rogner, M; Nowaczyk, MM				Grasse, Nicole; Mamedov, Fikret; Becker, Kristin; Styring, Stenbjorn; Roegner, Matthias; Nowaczyk, Marc M.			Role of Novel Dimeric Photosystem II (PSII)-Psb27 Protein Complex in PSII Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; D1 PROTEIN; PSB27 PROTEIN; THERMOSYNECHOCOCCUS-ELONGATUS; THERMOPHILIC CYANOBACTERIUM; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANE; MANGANESE CLUSTER; PHOTOINHIBITION; STRESS	The multisubunit membrane protein complex Photosystem II (PSII) catalyzes one of the key reactions in photosynthesis: the light-driven oxidation of water. Here, we focus on the role of the Psb27 assembly factor, which is involved in biogenesis and repair after light-induced damage of the complex. Weshow that Psb27 is essential for the survival of cyanobacterial cells grown under stress conditions. The combination of cold stress (30 degrees C) and high light stress (1000 mu mol of photons x m(-2) x s(-1)) led to complete inhibition of growth in a Delta psb27 mutant strain of the thermophilic cyanobacterium Thermosynechococcus elongatus, whereas wild-type cells continued to grow. Moreover, Psb27-containing PSII complexes became the predominant PSII species in preparations from wild-type cells grown under cold stress. Two different PSII-Psb27 complexes were isolated and characterized in this study. The first complex represents the known monomeric PSII-Psb27 species, which is involved in the assembly of PSII. Additionally, a novel dimeric PSII-Psb27 complex could be allocated in the repair cycle, i.e. in processes after inactivation of PSII, by N-15 pulse-label experiments followed by mass spectrometry analysis. Comparison with the corresponding PSII species from Delta psb27 mutant cells showed that Psb27 prevented the release of manganese from the previously inactivated complex. These results indicate a more complex role of the Psb27 protein within the life cycle of PSII, especially under stress conditions.	[Grasse, Nicole; Becker, Kristin; Roegner, Matthias; Nowaczyk, Marc M.] Ruhr Univ Bochum, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Mamedov, Fikret; Styring, Stenbjorn] Uppsala Univ, Angstrom Lab, Dept Chem, SE-75120 Uppsala, Sweden	Ruhr University Bochum; Uppsala University	Nowaczyk, MM (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, ND3-126,Univ Str 150, D-44780 Bochum, Germany.	marc.m.nowaczyk@rub.de	Nowaczyk, Marc/D-4214-2014; Mamedov, Fikret/A-1761-2016; Styring, Stenbjörn/L-8414-2016	Nowaczyk, Marc/0000-0002-9269-0672; Mamedov, Fikret/0000-0002-6218-3039; Styring, Stenbjörn/0000-0002-2803-9244	Deutsche Forschungsgemeinschaft [SFB 480, C1]; Protein Research Department of the Ruhr-Universitat Bochum; European Union; Swedish Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Protein Research Department of the Ruhr-Universitat Bochum; European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 480, Project C1; to N. G., M. M. N., and M. R.), the Protein Research Department of the Ruhr-Universitat Bochum (to M. M. N. and M. R.), and the European Union (SOLAR-H2) and by the Swedish Research Council (to F. M. and S. S.).	Albaum SP, 2009, BIOINFORMATICS, V25, P3128, DOI 10.1093/bioinformatics/btp568; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; AWRAMIK SM, 1992, PHOTOSYNTH RES, V33, P75, DOI 10.1007/BF00039172; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Danielsson R, 2006, J BIOL CHEM, V281, P14241, DOI 10.1074/jbc.M600634200; Goussias C, 2002, PHILOS T R SOC B, V357, P1369, DOI 10.1098/rstb.2002.1134; GOUSSIAS C, 2002, PHILOS T R SOC LON B, V357, P1419; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Hongsthong A, 2008, FEMS MICROBIOL LETT, V288, P92, DOI 10.1111/j.1574-6968.2008.01330.x; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P171, DOI 10.1093/pcp/pch015; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Laczko-Dobos H, 2009, BIOCHEMISTRY-US, V48, P10120, DOI 10.1021/bi9011034; Liu HJ, 2011, J BIOL CHEM, V286, P24865, DOI 10.1074/jbc.M111.246231; Los Dmitry A., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P221; Mabbitt PD, 2009, BIOCHEMISTRY-US, V48, P8771, DOI 10.1021/bi901309c; Mamedov F, 2007, PHYSIOL PLANTARUM, V131, P41, DOI 10.1111/j.1399-3054.2007.00938.x; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; Nowaczyk MM, 2010, EUR J CELL BIOL, V89, P974, DOI 10.1016/j.ejcb.2010.08.008; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Rexroth S, 2004, BBA-BIOENERGETICS, V1658, P202, DOI 10.1016/j.bbabio.2004.05.014; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Rutherford AW, 2004, SCIENCE, V303, P1782, DOI 10.1126/science.1096767; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zhang LX, 2000, PLANT CELL, V12, P1769, DOI 10.1105/tpc.12.9.1769	45	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29548	29555		10.1074/jbc.M111.238394	http://dx.doi.org/10.1074/jbc.M111.238394			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737447	hybrid, Green Published			2022-12-27	WOS:000294046600012
J	Roy, K; Kansal, R; Bartels, SR; Hamilton, DJ; Shaaban, S; Fleckenstein, JM				Roy, Koushik; Kansal, Rita; Bartels, Scott R.; Hamilton, David J.; Shaaban, Salwa; Fleckenstein, James M.			Adhesin Degradation Accelerates Delivery of Heat-labile Toxin by Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-CULTURE CELLS; COLONIZATION FACTOR; MOLECULAR CHARACTERIZATION; ENHANCED TOXICITY; EPITHELIAL-CELLS; OUTER-MEMBRANE; PROTEASE; SECRETION; STRAINS; IDENTIFICATION	Many enteric pathogens, including enterotoxigenic Escherichia coli (ETEC), produce one or more serine proteases that are secreted via the autotransporter (or type V) bacterial secretion pathway. These molecules have collectively been referred to as SPATE proteins (serine protease autotransporter of the Enterobacteriaceae). EatA, an autotransporter previously identified in ETEC, possesses a functional serine protease motif within its secreted amino-terminal passenger domain. Although this protein is expressed by many ETEC strains and is highly immunogenic, its precise function is unknown. Here, we demonstrate that EatA degrades a recently characterized adhesin, EtpA, resulting in modulation of bacterial adhesion and accelerated delivery of the heat-labile toxin, a principal ETEC virulence determinant. Antibodies raised against the passenger domain of EatA impair ETEC delivery of labile toxin to epithelial cells suggesting that EatA may be an effective target for vaccine development.	[Roy, Koushik; Bartels, Scott R.; Fleckenstein, James M.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Hamilton, David J.] Univ Tennessee, Hlth Sci Ctr, Dept Comparat Med, Memphis, TN 38163 USA; [Fleckenstein, James M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Shaaban, Salwa] Beni Sueif Univ, Fac Pharm, Beni Sueif 62514, Egypt; [Fleckenstein, James M.] Vet Affairs Med Ctr, Med Serv, Memphis, TN 38104 USA; [Kansal, Rita] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Beni Suef University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Fleckenstein, JM (corresponding author), 1030 Jefferson Ave, Memphis, TN 38104 USA.	jflecke1@tennessee.edu	Fleckenstein, James M./P-6242-2019	Fleckenstein, James M./0000-0002-1148-697X	National Institutes of Health [R01 AI089894-01]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089894] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI089894-01 (to J. M. F.). This work was also supported by Merit Review Program funding from the Department of Veterans Affairs (to J. M. F.).	Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; CLEMENTS JD, 1990, INFECT IMMUN, V58, P1159, DOI 10.1128/IAI.58.5.1159-1166.1990; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Coster TS, 2007, INFECT IMMUN, V75, P252, DOI 10.1128/IAI.01131-06; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; ELSINGHORST EA, 1994, INFECT IMMUN, V62, P3463, DOI 10.1128/IAI.62.8.3463-3471.1994; EVANS DG, 1978, INFECT IMMUN, V19, P727, DOI 10.1128/IAI.19.2.727-736.1978; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; EVANS DJ, 1973, INFECT IMMUN, V8, P322, DOI 10.1128/IAI.8.3.322-328.1973; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Fleckenstein JM, 2009, NAT PROTOC, V4, P1083, DOI 10.1038/nprot.2009.87; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Fleckenstein JM, 1996, INFECT IMMUN, V64, P2256, DOI 10.1128/IAI.64.6.2256-2265.1996; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; HARLOW E, 1999, USING ANTIBODIES LAB, P77; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Maroncle NM, 2006, INFECT IMMUN, V74, P6124, DOI 10.1128/IAI.01086-06; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nooh MM, 2006, J BIOL CHEM, V281, P35281, DOI 10.1074/jbc.M605544200; OFEK I, 1990, INFECT IMMUN, V58, P3737, DOI 10.1128/IAI.58.11.3737-3742.1990; Patel SK, 2004, INFECT IMMUN, V72, P1786, DOI 10.1128/IAI.72.3.1786-1794.2004; Pilonieta MC, 2007, J BACTERIOL, V189, P5060, DOI 10.1128/JB.00131-07; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Roy K, 2010, INFECT IMMUN, V78, P3027, DOI 10.1128/IAI.00264-10; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; SATTERWHITE TK, 1978, LANCET, V2, P181; Shames SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001057; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; ZAFRIRI D, 1987, J CLIN INVEST, V79, P1210, DOI 10.1172/JCI112939	44	36	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29771	29779		10.1074/jbc.M111.251546	http://dx.doi.org/10.1074/jbc.M111.251546			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757737	hybrid, Green Published			2022-12-27	WOS:000294046600036
J	Shen, W; Gorelick, RJ; Bambara, RA				Shen, Wen; Gorelick, Robert J.; Bambara, Robert A.			HIV-1 Nucleocapsid Protein Increases Strand Transfer Recombination by Promoting Dimeric G-quartet Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COPY-CHOICE RECOMBINATION; REVERSE TRANSCRIPTION; DNA-SYNTHESIS; GENOMIC RNA; RETROVIRAL RECOMBINATION; TRANSFER MECHANISM; G-QUADRUPLEXES; TELOMERIC DNA; BINDING-SITE	A preferred site for HIV-1 recombination was identified in vivo and in vitro surrounding the beginning of the HIV-1 gag gene. This G-rich gag hotspot for recombination contains three evenly spaced G-runs that stalled reverse transcriptase. Disruption of the G-runs suppressed both the associated pausing and strand transfer in vitro. Significantly, this same gag sequence was able to fold into a G-quartet monomer, dimer, and tetramer, depending on the cations employed. The pause band at the G-run (nucleotide (nt) 405-409), which was predicted to be involved in forming a G-quartet monomer, diminished with increased HIV-1 nucleocapsid (NC) protein. More NC induced stronger pauses at other G-runs (nt 363-367 and nt 382-384), a region that forms a G-quartet dimer, adhering the two RNA templates. We hypothesized that NC induces the unfolding of the monomeric G-quartet but stabilizes the dimeric interaction. We tested this by inserting a known G-quartet formation sequence, 5'-(UGGGGU)(4)-3', into a relatively structure-free template from the HIV-1 pol gene. Strand transfer assays were performed with cations that either encourage (K+) or discourage (Li+) G-quartet formation with or without NC. Strikingly, a G-quartet monomer was observed without NC, whereas a G-quartet dimer was observed with NC, both only in the presence of K+. Moreover, the transfer efficiency of the dimerized template (with K+ and NC) reached about 90%, approximately 2.5-fold of that of the non-dimerized template. Evidently, template dimerization induced by NC creates a proximity effect, leading to the unique high peak of transfer at the gag recombination hotspot.	[Shen, Wen; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Shen, Wen; Bambara, Robert A.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Gorelick, Robert J.] Inc NCI Frederick, SAIC Frederick, AIDS & Canc Virus Program, Frederick, MD 21702 USA	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM049573]; NCI, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049573 (to R. A. B.) and by federal funds from the NCI, National Institutes of Health, under contract HHSN261200800001E.	ALLAIN B, 1994, EMBO J, V13, P973, DOI 10.1002/j.1460-2075.1994.tb06342.x; Auxilien S, 1999, J BIOL CHEM, V274, P4412, DOI 10.1074/jbc.274.7.4412; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Berglund JA, 1997, NUCLEIC ACIDS RES, V25, P1042, DOI 10.1093/nar/25.5.1042; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; CHEONG CJ, 1992, BIOCHEMISTRY-US, V31, P8406, DOI 10.1021/bi00151a003; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P5380, DOI 10.1073/pnas.0500729102; DUESBERG PH, 1968, P NATL ACAD SCI USA, V60, P1511, DOI 10.1073/pnas.60.4.1511; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GREEN LM, 1990, P NATL ACAD SCI USA, V87, P6403, DOI 10.1073/pnas.87.16.6403; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kankia BI, 2005, NUCLEIC ACIDS RES, V33, P4395, DOI 10.1093/nar/gki741; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lee R, 1998, BIOCHEMISTRY-US, V37, P900, DOI 10.1021/bi972197m; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lyonnais S, 2003, NUCLEIC ACIDS RES, V31, P5754, DOI 10.1093/nar/gkg716; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; MONCHAUD D, 2010, J NUCL ACIDS; Moumen A, 2001, NUCLEIC ACIDS RES, V29, P3814, DOI 10.1093/nar/29.18.3814; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Roda RH, 2002, J BIOL CHEM, V277, P46900, DOI 10.1074/jbc.M208638200; Rong LW, 1998, J VIROL, V72, P9353, DOI 10.1128/JVI.72.11.9353-9358.1998; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wu WX, 1996, J VIROL, V70, P7132, DOI 10.1128/JVI.70.10.7132-7142.1996	52	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29838	29847		10.1074/jbc.M111.262352	http://dx.doi.org/10.1074/jbc.M111.262352			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737842	Green Published, hybrid			2022-12-27	WOS:000294046600043
J	White, CD; Li, ZG; Dillon, DA; Sacks, DB				White, Colin D.; Li, Zhigang; Dillon, Deborah A.; Sacks, David B.			IQGAP1 Protein Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DEPENDENT KINASE INHIBITOR; ERBB RECEPTORS; METASTATIC BREAST; SYNERGISTICALLY INHIBIT; MONOCLONAL-ANTIBODY; SIGNALING PATHWAYS; SCAFFOLD PROTEINS; NEU ONCOGENE; PROLIFERATION	Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20-25% of breast cancers. Increased HER2 expression is an adverse prognostic factor and correlates with decreased patient survival. HER2-positive (HER2(+)) breast cancer is treated with trastuzumab. Unfortunately, some patients are intrinsically refractory to therapy, and many who do respond initially become resistant within 1 year. Understanding the molecular mechanisms underlying HER2 signaling and trastuzumab resistance is essential to reduce breast cancer mortality. IQGAP1 is a ubiquitously expressed scaffold protein that contains multiple protein interaction domains. By regulating its binding partners IQGAP1 integrates signaling pathways, several of which contribute to breast tumorigenesis. We show here that IQGAP1 is overexpressed in HER2(+) breast cancer tissue and binds directly to HER2. Knockdown of IQGAP1 decreases HER2 expression, phosphorylation, signaling, and HER2-stimulated cell proliferation, effects that are all reversed by reconstituting cells with IQGAP1. Reducing IQGAP1 up-regulates p27, and blocking this increase attenuates the growth inhibitory effects of IQGAP1 knockdown. Importantly, IQGAP1 is overexpressed in trastuzumab-resistant breast epithelial cells, and reducing IQGAP1 both augments the inhibitory effects of trastuzumab and restores trastuzumab sensitivity to trastuzumab-resistant SkBR3 cells. These data suggest that inhibiting IQGAP1 function may represent a rational strategy for treating HER2(+) breast carcinoma.	[White, Colin D.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [White, Colin D.; Li, Zhigang; Dillon, Deborah A.; Sacks, David B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [White, Colin D.; Li, Zhigang; Dillon, Deborah A.; Sacks, David B.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Li, Zhigang; Sacks, David B.] NIH, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA	White, CD (corresponding author), Beth Israel Deaconess Med Ctr, 3 Blackfan Circle, Boston, MA 02115 USA.	cdwhite@bidmc.harvard.edu		Sacks, David/0000-0003-3100-0735	National Institutes of Health [R01CA075205-09]; Department of Defense [BC087504]; NATIONAL CANCER INSTITUTE [R01CA075205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA075205-09 (to D. B. S.). This work was also funded by the Department of Defense Breast Cancer Research Program (BC087504; to C. D. W.).	BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2004, CELL CYCLE, V3, P51; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Com E, 2007, MOL CELL PROTEOMICS, V6, P1842, DOI 10.1074/mcp.M700119-MCP200; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Dokmanovic M, 2009, MOL CANCER THER, V8, P1557, DOI 10.1158/1535-7163.MCT-09-0140; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Le XF, 2003, J BIOL CHEM, V278, P23441, DOI 10.1074/jbc.M300848200; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nahta R, 2004, CANCER CHEMOTH PHARM, V53, P186, DOI 10.1007/s00280-003-0728-3; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schaefer G, 1999, J BIOL CHEM, V274, P859, DOI 10.1074/jbc.274.2.859; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Walch A, 2008, MODERN PATHOL, V21, P544, DOI 10.1038/modpathol.2008.3; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu KM, 2002, MOL CANCER THER, V1, P695; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200; Yang HY, 2001, ONCOGENE, V20, P3695, DOI 10.1038/sj.onc.1204472; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou RX, 2000, DIFFERENTIATION, V66, P165, DOI 10.1046/j.1432-0436.2000.660402.x	70	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29734	29747		10.1074/jbc.M111.220939	http://dx.doi.org/10.1074/jbc.M111.220939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724847	Green Published, hybrid			2022-12-27	WOS:000294046600033
J	Yan, KL; Cao, Q; Reilly, CM; Young, NL; Garcia, BA; Mishra, N				Yan, Kailin; Cao, Qiang; Reilly, Christopher M.; Young, Nicolas L.; Garcia, Benjamin A.; Mishra, Nilamadhab			Histone Deacetylase 9 Deficiency Protects against Effector T Cell-mediated Systemic Autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; MRL-LPR/LPR MOUSE; MRL/LPR MICE; INDUCIBLE COSTIMULATOR; INTERFERON-GAMMA; RENAL-DISEASE; MURINE LUPUS; EXPRESSION; INHIBITION; RESPONSES	Co-repressor histone deacetylase 9 (HDAC9) plays a key role in the development and differentiation of many types of cells, including regulatory T cells. However, the biological function of HDAC9 in T effector cells is unknown. Systemic autoimmune diseases like lupus, diabetes, and rheumatoid arthritis have dysfunctional effector T cells. To determine the role of HDAC9 in systemic autoimmunity, we created MRL/lpr mice with HDAC9 deficiency that have aberrant effector T cell function. HDAC9 deficiency led to decreased lympho-proliferation, inflammation, autoantibody production, and increased survival in MRL/lpr mice. HDAC9-deficient mice manifested Th2 polarization, decreased T effector follicular cells positive for inducible co-stimulator, and activated T cells in vivo compared with HDAC9-intact MRL/lpr mice. HDAC9 deficiency also resulted in increased GATA3 and roquin and decreased BCL6 gene expression. HDAC9 deficiency was associated with increased site-specific lysine histone acetylation at H3 (H3K9, H3K14, and H3K18) globally that was localized to IL-4, roquin, and peroxisome proliferator-activated receptor-gamma promoters with increased gene expression, respectively. In kidney and spleen, HDAC9 deficiency decreased inflammation and cytokine and chemokine production due to peroxisome proliferator-activated receptor gamma overexpression. These findings suggest that HDAC9 acts as an epigenetic switch in effector T cell-mediated systemic autoimmunity.	[Yan, Kailin; Cao, Qiang; Mishra, Nilamadhab] Wake Forest Univ, Bowman Gray Sch Med, Sect Rheumatol & Immunol, Dept Internal Med, Winston Salem, NC 27157 USA; [Reilly, Christopher M.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24060 USA; [Reilly, Christopher M.] Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA; [Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University; Princeton University	Mishra, N (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Sect Rheumatol & Immunol, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	nmishra@wfubmc.edu	Young, Nicolas/AAI-5242-2020	Young, Nicolas/0000-0002-3323-2815; Reilly, Chris/0000-0003-4787-7750	National Institutes of Health [RO1-HL 084592, RO1-HL084592 S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL 084592 and RO1-HL084592 S1 (to N. M.).	Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Crosby MB, 2006, CLIN IMMUNOL, V118, P276, DOI 10.1016/j.clim.2005.09.018; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Fairhurst AM, 2009, J IMMUNOL, V183, P6831, DOI 10.4049/jimmunol.0900742; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hill GS, 2000, KIDNEY INT, V58, P1160, DOI 10.1046/j.1523-1755.2000.00272.x; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu XD, 2008, J BIOL CHEM, V283, P13825, DOI 10.1074/jbc.M801275200; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Mishra N, 2001, P NATL ACAD SCI USA, V98, P2628, DOI 10.1073/pnas.051507098; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Odegard JM, 2009, J IMMUNOL, V182, P4076, DOI 10.4049/jimmunol.0800758; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Parietti V, 2008, ARTHRITIS RHEUM-US, V58, P1751, DOI 10.1002/art.23464; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Reilly CM, 2008, J AUTOIMMUN, V31, P123, DOI 10.1016/j.jaut.2008.04.020; Reilly CM, 2004, J IMMUNOL, V173, P4171, DOI 10.4049/jimmunol.173.6.4171; Reilly CM, 2001, CLIN IMMUNOL, V98, P337, DOI 10.1006/clim.2000.4985; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Tada Y, 2006, CLIN IMMUNOL, V120, P179, DOI 10.1016/j.clim.2006.02.009; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zeller GC, 2006, J AM SOC NEPHROL, V17, P122, DOI 10.1681/ASN.2005080802; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	50	69	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28833	28843		10.1074/jbc.M111.233932	http://dx.doi.org/10.1074/jbc.M111.233932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708950	hybrid, Green Published			2022-12-27	WOS:000293837000021
J	Haga, Y; Ishii, K; Suzuki, T				Haga, Yoshimi; Ishii, Kumiko; Suzuki, Tadashi			N-Glycosylation Is Critical for the Stability and Intracellular Trafficking of Glucose Transporter GLUT4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; PLASMA-MEMBRANE; LINKED GLYCANS; INSULIN ACTION; PROTEIN; VESICLES; CELLS; TRANSLOCATION; GLUCOSE-TRANSPORTER-4; GLYCOPROTEIN	The facilitative glucose transporter GLUT4 plays a key role in regulating whole body glucose homeostasis. GLUT4 dramatically changes its distribution upon insulin stimulation, and insulin-resistant diabetes is often linked with compromised translocation of GLUT4 under insulin stimulation. To elucidate the functional significance of the sole N-glycan chain on GLUT4, wild-type GLUT4 and a GLUT4 glycosylation mutant conjugated with enhanced GFP were stably expressed in HeLa cells. The N-glycan contributed to the overall stability of newly synthesized GLUT4. Moreover, cell surface expression of wildtype GLUT4 in HeLa cells was elevated upon insulin treatment, whereas the glycosylation mutant lost the ability to respond to insulin. Subcellular distribution of the mutant was distinct from that of wild-type GLUT4, implying that the subcellular localization required for insulin-mediated translocation was impaired in the mutant protein. Interestingly, kifunensine-treated cells also lost sensitivity to insulin, suggesting the functional importance of the N-glycan structure for GLUT4 trafficking. The Km or turnover rates of wild-type and mutant GLUT4, however, were similar, suggesting that the N-glycan had little effect on transporter activity. These findings underscore the critical roles of the N-glycan chain in quality control as well as intracellular trafficking of GLUT4.	[Haga, Yoshimi; Ishii, Kumiko; Suzuki, Tadashi] RIKEN, Adv Sci Inst, Glycometabolome Team, Wako, Saitama 3510198, Japan	RIKEN	Suzuki, T (corresponding author), RIKEN, Adv Sci Inst, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014	Suzuki, Tadashi/0000-0003-1030-7631; Haga, Yoshimi/0000-0001-7861-617X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22570148] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. S.) and a grant-in-aid for Japan Society for the Promotion of Science postdoctoral fellow (to Y.H.).	AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; ASANO T, 1991, J BIOL CHEM, V266, P24632; ASANO T, 1993, FEBS LETT, V324, P258, DOI 10.1016/0014-5793(93)80129-I; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; BLAKER GJ, 1971, J CELL SCI, V9, P529; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; FEUGEAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P60, DOI 10.1016/0005-2736(90)90238-J; FEUGEAS JP, 1991, BIOCHIM BIOPHYS ACTA, V1066, P59, DOI 10.1016/0005-2736(91)90250-C; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ing BL, 1996, BIOCHEM BIOPH RES CO, V218, P76, DOI 10.1006/bbrc.1996.0015; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; KITAGAWA T, 1995, J CELL SCI, V108, P3735; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Lampson MA, 2000, J CELL SCI, V113, P4065; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Li J, 2007, ARCH BIOCHEM BIOPHYS, V463, P102, DOI 10.1016/j.abb.2007.03.005; Lin ZX, 2011, J PROTEOME RES, V10, P2602, DOI 10.1021/pr200102h; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Rodriguez-Enriquez S, 2009, J CELL PHYSIOL, V221, P552, DOI 10.1002/jcp.21885; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Xiong WY, 2010, MOL BIOL CELL, V21, P1375, DOI 10.1091/mbc.E09-08-0751; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504	46	50	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31320	31327		10.1074/jbc.M111.253955	http://dx.doi.org/10.1074/jbc.M111.253955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757715	Green Published, hybrid			2022-12-27	WOS:000294487500027
J	Stefan, M; Jacobson, EM; Huber, AK; Greenberg, DA; Li, CW; Skrabanek, L; Conception, E; Fadlalla, M; Ho, K; Tomer, Y				Stefan, Mihaela; Jacobson, Eric M.; Huber, Amanda K.; Greenberg, David A.; Li, Cheuk Wun; Skrabanek, Luce; Conception, Erlinda; Fadlalla, Mohammed; Ho, Kenneth; Tomer, Yaron			Novel Variant of Thyroglobulin Promoter Triggers Thyroid Autoimmunity through an Epigenetic Interferon alpha-modulated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GENOME; HASHIMOTOS-THYROIDITIS; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; DISEASE; TRANSCRIPTION; ASSOCIATION; GRAVES; IDENTIFICATION; METHYLATIONS	Autoimmune thyroid diseases (AITD) arise from complex interactions between genetic, epigenetic, and environmental factors. Whole genome linkage scans and association studies have established thyroglobulin (TG) as a major AITD susceptibility gene. However, the causative TG variants and the pathogenic mechanisms are unknown. Here, we describe a genetic/epigenetic mechanism by which a newly identified TG promoter single-nucleotide polymorphism (SNP) variant predisposes to AITD. Sequencing analyses followed by case control and family-based association studies identified an SNP (-1623A -> G) that was associated with AITD in the Caucasian population (p = 0.006). We show that the nucleotide substitution introduced by SNP (-1623A/G) modified a binding site for interferon regulatory factor-1 (IRF-1), a major interferon-induced transcription factor. Using chromatin immunoprecipitation, we demonstrated that IRF-1 binds to the 5' TG promoter motif, and the transcription factor binding correlates with active chromatin structure and is marked by enrichment of mono-methylated Lys-4 residue of histone H3, a signature of active transcriptional enhancers. Using reporter mutations and siRNA approaches, we demonstrate that the disease-associated allele (G) conferred increased TG promoter activity through IRF-1 binding. Finally, treatment of thyroid cells with interferon alpha, a known trigger of AITD, increased TG promoter activity only when it interacted with the disease-associated variant through IRF-1 binding. These results reveal a new mechanism of interaction between environmental (IFN alpha) and genetic (TG) factors to trigger AITD.	[Stefan, Mihaela; Huber, Amanda K.; Conception, Erlinda; Ho, Kenneth; Tomer, Yaron] Mt Sinai Med Ctr, Dept Med, Div Endocrinol, New York, NY 10029 USA; [Jacobson, Eric M.; Li, Cheuk Wun; Fadlalla, Mohammed] Univ Cincinnati, Div Endocrinol, Cincinnati, OH 45267 USA; [Greenberg, David A.] Columbia Univ, Div Stat Genet, New York, NY 10032 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Stefan, Mihaela; Tomer, Yaron] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati; Columbia University; Cornell University; Cornell University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Stefan, M (corresponding author), Mt Sinai Med Ctr, Dept Med, Div Endocrinol, New York, NY 10029 USA.	mihaela.stefan@mssm.edu; yaron.tomer@mssm.edu	Tomer, Yaron/GWU-8933-2022	Huber, Amanda/0000-0003-0375-8709	National Institutes of Health [DK61659, DK067555, DK073681, MH48858, NS27941]; Veterans Affairs merit award; American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067555, R01DK073681, T35DK060444, R01DK061659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK61659, DK067555, and DK073681 (to Y. T.) and Grants MH48858 and NS27941 (to D. A. G.). This work was also supported by a Veterans Affairs merit award (to Y. T.).; Supported by a grant from the American Thyroid Association.	Akeno N, 2011, J IMMUNOL, V186, P4693, DOI 10.4049/jimmunol.1002631; Akeno N, 2008, J AUTOIMMUN, V31, P339, DOI 10.1016/j.jaut.2008.08.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban Y, 2004, CLIN ENDOCRINOL, V61, P263, DOI 10.1111/j.1365-2265.2004.02096.x; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berg V, 1996, BBA-GENE STRUCT EXPR, V1307, P35, DOI 10.1016/0167-4781(96)00044-9; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brown RS, 2009, CURR OPIN PEDIATR, V21, P523, DOI 10.1097/MOP.0b013e32832cf824; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caputo M, 2010, ENDOCRINE, V37, P389, DOI 10.1007/s12020-010-9317-5; Carayanniotis G, 2007, THYROID, V17, P963, DOI 10.1089/thy.2007.0199; Carella C, 2004, J CLIN ENDOCR METAB, V89, P3656, DOI 10.1210/jc.2004-0627; Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; Christophe D, 1987, Horm Metab Res Suppl, V17, P70; CHRISTOPHE D, 1985, NUCLEIC ACIDS RES, V13, P5127, DOI 10.1093/nar/13.14.5127; Collins JE, 2003, J CLIN ENDOCR METAB, V88, P5039, DOI 10.1210/jc.2003-030093; DONDA A, 1993, MOL CELL ENDOCRINOL, V90, pR23, DOI 10.1016/0303-7207(93)90162-D; ESCHLER DC, 2011, CLIN REV AL IN PRESS; Espinoza CR, 2001, J MOL ENDOCRINOL, V27, P59, DOI 10.1677/jme.0.0270059; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hsiao JY, 2008, CLIN EXP MED, V8, P17, DOI 10.1007/s10238-008-0151-5; Hsiao JY, 2007, J CLIN ENDOCR METAB, V92, P3197, DOI 10.1210/jc.2007-0675; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Jacobson EM, 2007, J AUTOIMMUN, V28, P85, DOI 10.1016/j.jaut.2007.02.006; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Menconi F, 2011, J ENDOCRINOL INVEST, V34, P78, DOI [10.1007/BF03346699, 10.3275/7499]; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Rose NR, 2000, APPL BIOCHEM BIOTECH, V83, P245, DOI 10.1385/ABAB:83:1-3:245; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schonberger J, 2000, J MOL MED, V78, P102, DOI 10.1007/s001090000085; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 2007, ENDOCRIN METAB CLIN, V36, P1051, DOI 10.1016/j.ecl.2007.07.001; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tomer Y, 2010, J AUTOIMMUN, V34, pJ322, DOI 10.1016/j.jaut.2009.11.008; Varela V, 2010, ENDOCRINE, V38, P320, DOI 10.1007/s12020-010-9398-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	50	51	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31168	31179		10.1074/jbc.M111.247510	http://dx.doi.org/10.1074/jbc.M111.247510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757724	Green Published, hybrid			2022-12-27	WOS:000294487500012
J	Tang, J; Pecka, JL; Tan, XD; Beisel, KW; He, DZZ				Tang, Jie; Pecka, Jason L.; Tan, Xiaodong; Beisel, Kirk W.; He, David Z. Z.			Engineered Pendrin Protein, an Anion Transporter and Molecular Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; PLASMA-MEMBRANE; NONLINEAR CAPACITANCE; GENE PDS; PRESTIN; ELECTROMOTILITY; MOTILITY; SALICYLATE; LOCALIZATION	Pendrin and prestin both belong to a distinct anion transporter family called solute carrier protein 26A, or SLC26A. Pendrin (SLC26A4) is a chloride-iodide transporter that is found at the luminal membrane of follicular cells in the thyroid gland as well as in the endolymphatic duct and sac of the inner ear, whereas prestin (SLC26A5) is expressed in the plasma membrane of cochlear outer hair cells and functions as a unique voltage-dependent motor. We recently identified a motif that is critical for the motor function of prestin. We questioned whether it was possible to create a chimeric pendrin protein with motor capability by integrating this motility motif from prestin. The chimeric pendrin was constructed by substituting residues 160-179 in human pendrin with residues 156-169 from gerbil prestin. Non-linear capacitance and somatic motility, two hallmarks representing prestin function, were measured from chimeric pendrin-transfected human embryonic kidney 293 cells using the voltage clamp technique and photodiode-based displacement measurement system. We showed that this 14-amino acid substitution from prestin was able to confer pendrin with voltage-dependent motor capability despite the amino acid sequence disparity between pendrin and prestin. The molecular mechanism that facilitates motor function appeared to be the same as prestin because the motor activity depended on the concentration of intracellular chloride and was blocked by salicylate treatment. Radioisotope-labeled formate uptake measurements showed that the chimeric pendrin protein retained the capability to transport formate, suggesting that the gain of motor function was not at the expense of its inherent transport capability. Thus, the engineered pendrin was capable of both transporting anions and generating force.	[Tang, Jie; Pecka, Jason L.; Tan, Xiaodong; Beisel, Kirk W.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Creighton University	He, DZZ (corresponding author), 2500 Calif Plaza, Omaha, NE 68178 USA.	hed@creighton.edu	Tang, Jie/GNW-2318-2022	Tan, Xiaodong/0000-0003-0251-2774; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Tang, Jie/0000-0001-7882-4462	National Institutes of Health NIH [R01 DC008649]; NIDCD [R01 DC004696]; NCRR, National Institutes of Health [RR17417-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696, R01DC008649] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health NIH Grants R01 DC008649 ( to K. B.) and R01 DC004696 (to D. H.) from the NIDCD. The Integrated Biological Imaging Facility, supported by the Creighton University Medical School, was constructed with support from C06 Grant RR17417-01 from the NCRR, National Institutes of Health.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Ashmore J. F., 1989, COCHLEAR MECH, P107; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Choi BY, 2009, J MED GENET, V46, P856, DOI 10.1136/jmg.2009.067892; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; He DZZ, 2006, J MEMBRANE BIOL, V209, P119, DOI 10.1007/s00232-005-0833-9; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; He DZZ, 2003, J NEUROSCI, V23, P9089; He DZZ, 1997, J NEUROSCI, V17, P3634; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; Kakehata S, 1996, J NEUROSCI, V16, P4881; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Okoruwa OE, 2008, EVOL DEV, V10, P300, DOI 10.1111/j.1525-142X.2008.00239.x; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Pendrin V., 1896, LANCET, V148, P532; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, HEARING RES, V159, P69, DOI 10.1016/S0378-5955(01)00321-5; Sarojini V, 2010, J PEPT SCI, V16, P430, DOI 10.1002/psc.1259; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Seymour M. L., 2011, 34 M ASS RES OT BALT; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032	44	18	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31014	31021		10.1074/jbc.M111.259564	http://dx.doi.org/10.1074/jbc.M111.259564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757707	Green Published, hybrid			2022-12-27	WOS:000294283600079
J	Tomlinson, CG; Syson, K; Sengerova, B; Atack, JM; Sayers, JR; Swanson, L; Tainer, JA; Williams, NH; Grasby, JA				Tomlinson, Christopher G.; Syson, Karl; Sengerova, Blanka; Atack, John M.; Sayers, Jon R.; Swanson, Linda; Tainer, John A.; Williams, Nicholas H.; Grasby, Jane A.			Neutralizing Mutations of Carboxylates That Bind Metal 2 in T5 Flap Endonuclease Result in an Enzyme That Still Requires Two Metal Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 RNASE-H; DNA-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; WILD-TYPE; RESTRICTION-ENDONUCLEASE; SUBSTRATE-SPECIFICITY; CATALYTIC PARAMETERS; THERMUS-AQUATICUS; STRUCTURAL BASIS	Flap endonucleases (FENs) are divalent metal ion-dependent phosphodiesterases. Metallonucleases are often assigned a "two-metal ion mechanism" where both metals contact the scissile phosphate diester. The spacing of the two metal ions observed in T5FEN structures appears to preclude this mechanism. However, the overall reaction catalyzed by wild type (WT) T5FEN requires three Mg2+ ions, implying that a third ion is needed during catalysis, and so a two-metal ion mechanism remains possible. To investigate the positions of the ions required for chemistry, a mutant T5FEN was studied where metal 2 (M2) ligands are altered to eliminate this binding site. In contrast to WT T5FEN, the overall reaction catalyzed by D201I/D204S required two ions, but over the concentration range of Mg2+ tested, maximal rate data were fitted to a single binding isotherm. Calcium ions do not support FEN catalysis and inhibit the reactions supported by viable metal cofactors. To establish participation of ions in stabilization of enzyme-substrate complexes, dissociation constants of WT and D201I/D204S-substrate complexes were studied as a function of [Ca2+]. At pH 9.3 (maximal rate conditions), Ca2+ substantially stabilized both complexes. Inhibition of viable cofactor supported reactions of WT, and D201I/D204S T5FENs was biphasic with respect to Ca2+ and ultimately dependent on 1/[Ca2+](2). By varying the concentration of viable metal cofactor, Ca2+ ions were shown to inhibit competitively displacing two catalytic ions. Combined analyses imply that M2 is not involved in chemical catalysis but plays a role in substrate binding, and thus a two-metal ion mechanism is plausible.	[Tomlinson, Christopher G.; Syson, Karl; Sengerova, Blanka; Atack, John M.; Swanson, Linda; Williams, Nicholas H.; Grasby, Jane A.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England; [Sayers, Jon R.] Univ Sheffield, Sch Med & Biomed Sci, Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Sheffield; University of Sheffield; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk	Sayers, Jon R/AAP-6179-2020; Tainer, John/GWQ-4878-2022; Collis, Blanka/ABB-6858-2020; Atack, John/B-7961-2015; Sayers, Jon R/I-8974-2012	Sayers, Jon R/0000-0002-5082-1443; Tainer, John/0000-0003-1659-2429; Atack, John/0000-0002-7994-6995; Sayers, Jon R/0000-0002-5082-1443; Williams, Nicholas/0000-0002-4457-4220	Biotechnology and Biological Sciences Research Council [F0147321]; National Institutes of Health [CA081967]; BBSRC [BB/F014732/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA081967] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant F0147321. This work was also supported by National Institutes of Health Grant CA081967 (to J.A.T.).	Allen LM, 2009, BIOCHEM J, V418, P285, DOI 10.1042/BJ20081637; Bastock JA, 2007, J MOL BIOL, V368, P421, DOI 10.1016/j.jmb.2007.01.083; Bhagwat M, 1997, J BIOL CHEM, V272, P28531, DOI 10.1074/jbc.272.45.28531; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Dupureur CM, 2010, METALLOMICS, V2, P609, DOI 10.1039/c0mt00013b; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Gangisetty O, 2005, J BIOL CHEM, V280, P12876, DOI 10.1074/jbc.M414025200; Hohl M, 2003, J BIOL CHEM, V278, P19500, DOI 10.1074/jbc.M213155200; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Lagunavicius A, 1997, BIOCHEMISTRY-US, V36, P11093, DOI 10.1021/bi963126a; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Pickering TJ, 1999, J BIOL CHEM, V274, P17711, DOI 10.1074/jbc.274.25.17711; Pickering TJ, 1999, NUCLEIC ACIDS RES, V27, P730, DOI 10.1093/nar/27.3.730; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s	41	12	12	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30878	30887		10.1074/jbc.M111.230391	http://dx.doi.org/10.1074/jbc.M111.230391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21734257	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000294283600067
J	Vinnakota, KC; Dash, RK; Beard, DA				Vinnakota, Kalyan C.; Dash, Ranjan K.; Beard, Daniel A.			Stimulatory Effects of Calcium on Respiration and NAD(P)H Synthesis in Intact Rat Heart Mitochondria Utilizing Physiological Substrates Cannot Explain Respiratory Control in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; OXIDATIVE-PHOSPHORYLATION; METABOLITE CONCENTRATIONS; PHOSPHATE METABOLITE; MAMMALIAN HEART; CA2+; INVIVO	Mitochondrial TCA cycle dehydrogenase enzymes have been shown to be stimulated by Ca2+ under various substrate and ADP incubation conditions in an attempt to determine and understand the role of Ca2+ in maintaining energy homeostasis in working hearts. In this study, we tested the hypothesis that, at physiological temperature and 1 mM extramitochondrial free magnesium, Ca2+ can stimulate the overall mitochondrial NAD(P)H generation flux in rat heart mitochondria utilizing pyruvate and malate as substrates at both subsaturating and saturating concentrations. In both cases, we found that, in the physiological regime of mitochondrial oxygen consumption observed in the intact animal and in the physiological range of cytosolic Ca2+ concentration averaged per beat, Ca2+ had no observable stimulatory effect. A modest apparent stimulatory effect (22-27%) was observable at supraphysiological maximal ADP-stimulated respiration at 2.5 mM initial phosphate. The stimulatory effects observed over the physiological Ca2+ range are not sufficient to make a significant contribution to the control of oxidative phosphorylation in the heart in vivo.	Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Beard, DA (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53222 USA.	dbeard@mcw.edu	Vinnakota, Kalyan/G-4706-2010	Vinnakota, Kalyan/0000-0003-2185-2213	National Institutes of Health [R01 HL094317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL094317 (to D.A.B.).	BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Baniene R, 2006, IEE P SYST BIOL, V153, P350, DOI 10.1049/ip-syb:20060009; Beard DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000459; BISHOP PD, 1984, ARCH BIOCHEM BIOPHYS, V230, P335, DOI 10.1016/0003-9861(84)90116-4; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANCE B, 1955, J BIOL CHEM, V217, P409; Dibb KM, 2007, J PHYSIOL-LONDON, V585, P579, DOI 10.1113/jphysiol.2007.141473; HANSFORD RG, 1981, BIOCHEM J, V198, P525, DOI 10.1042/bj1980525; KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265; LANDAW EM, 1984, AM J PHYSIOL, V246, pR665, DOI 10.1152/ajpregu.1984.246.5.R665; Mildaziene V, 1996, BIOCHEM J, V320, P329, DOI 10.1042/bj3200329; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Okere IC, 2006, J APPL PHYSIOL, V100, P76, DOI 10.1152/japplphysiol.00255.2005; Panov AV, 1996, AM J PHYSIOL-HEART C, V270, pH1398, DOI 10.1152/ajpheart.1996.270.4.H1398; SCADUTO RC, 1994, EUR J BIOCHEM, V223, P751, DOI 10.1111/j.1432-1033.1994.tb19049.x; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tune JD, 2000, AM J PHYSIOL-HEART C, V278, pH74, DOI 10.1152/ajpheart.2000.278.1.H74; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; WAN B, 1989, J BIOL CHEM, V264, P13430; Ward ML, 2003, J PHYSIOL-LONDON, V546, P537, DOI 10.1113/jphysiol.2002.029132; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732	23	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30816	30822		10.1074/jbc.M111.242529	http://dx.doi.org/10.1074/jbc.M111.242529			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757763	hybrid, Green Published			2022-12-27	WOS:000294283600061
J	Yu, E; Zhai, DY; Jin, CF; Gerlic, M; Reed, JC; Liddington, R				Yu, Eric; Zhai, Dayong; Jin, Chaofang; Gerlic, Motti; Reed, John C.; Liddington, Robert			Structural Determinants of Caspase-9 Inhibition by the Vaccinia Virus Protein, F1L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; CRYSTAL-STRUCTURE; CELL-DEATH; APOPTOTIC PROTEIN; BACULOVIRUS P35; WEB SERVER; ACTIVATION; BCL-2; XIAP; APOPTOSOME	In multicellular organisms, apoptosis is a powerful method of host defense against viral infection. Apoptosis is mediated by a cascade of caspase-family proteases that commit infected cells to a form of programmed cell death. Therefore, to replicate within host cells, viruses have developed various strategies to inhibit caspase activation. In the mitochondrial cell-death pathway, release of cytochrome c from mitochondria into the cytosol triggers assembly of the oligomeric apoptosome, resulting in dimerization and activation of the apical caspase-9 (C9), and in turn its downstream effector caspases, leading to apoptosis. We previously showed that the vaccinia virus-encoded Bcl-2-like protein, F1L, which suppresses cytochrome c release by binding Bcl-2 family proteins, is also a C9 inhibitor. Here, we identify a novel motif within the flexible N-terminal region of F1L that is necessary and sufficient for interaction with and inhibition of C9. Based on functional studies and mutagenesis, we developed an atomic model of the complex in which F1L inhibits C9 by engaging the active site in the reverse orientation with respect to substrate peptides, in a manner analogous to that of XIAP-mediated inhibition of caspases-3 and -7. These studies offer new insights into the mechanism of apoptosome inhibition by F1L as well as novel probes to understand the molecular bases of apoptosome regulation and turnover. They also suggest how the two distinct functionalities of F1L (inhibition of C9 and suppression of pro-apoptotic Bcl-2 family proteins) may operate in a cellular setting.	[Yu, Eric; Zhai, Dayong; Jin, Chaofang; Gerlic, Motti; Reed, John C.; Liddington, Robert] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Liddington, R (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org	gerlic, Motti/I-5492-2019; Gerlic, Motti/U-3484-2017	gerlic, Motti/0000-0001-9518-1833; Gerlic, Motti/0000-0001-9518-1833; Yu, Eric/0000-0001-7026-7008	National Institutes of Health [AI056324, AI091967]; Department of Defense [W81XWH-10-1-0093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967, R01AI056324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI056324 and AI091967. This work was also supported by Department of Defense Grant W81XWH-10-1-0093).	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Campbell S, 2010, J BIOL CHEM, V285, P4695, DOI 10.1074/jbc.M109.053769; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; dela Cruz WP, 2001, J BIOL CHEM, V276, P32933, DOI 10.1074/jbc.M103930200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Huang QL, 2003, J MOL BIOL, V332, P1123, DOI 10.1016/j.jmb.2003.08.007; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, BIOCHEMISTRY-US, V40, P13274, DOI 10.1021/bi010574w; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rost B, 1996, METHOD ENZYMOL, V266, P525; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhai DY, 2010, J BIOL CHEM, V285, P5569, DOI 10.1074/jbc.M109.078113; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	52	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30748	30758		10.1074/jbc.M111.280149	http://dx.doi.org/10.1074/jbc.M111.280149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757755	hybrid, Green Published			2022-12-27	WOS:000294283600055
J	Olzmann, JA; Kopito, RR				Olzmann, James A.; Kopito, Ron R.			Lipid Droplet Formation Is Dispensable for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; UBIQUITIN-LIGASE; ER LUMEN; YEAST; DISLOCATION; CYTOSOL; RETROTRANSLOCATION; PEROXISOMES; HRD1P	Proteins that fail to fold or assemble in the endoplasmic reticulum (ER) are destroyed by cytoplasmic proteasomes through a process known as ER-associated degradation. Substrates of this pathway are initially sequestered within the ER lumen and must therefore be dislocated across the ER membrane to be degraded. It has been proposed that generation of bicellar structures during lipid droplet formation may provide an "escape hatch" through which misfolded proteins, toxins, and viruses can exit the ER. We have directly tested this hypothesis by exploiting yeast strains defective in lipid droplet formation. Our data demonstrate that lipid droplet formation is dispensable for the dislocation of a plant toxin and the degradation of both soluble and integral membrane glycoproteins.	[Olzmann, James A.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), 337 Campus Dr, Stanford, CA 94305 USA.	kopito@stanford.edu		Olzmann, James/0000-0001-7751-8316	National Institutes of Health [GM074874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074874, F32GM086026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074874 (to R. R. K.).	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	31	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27872	27874		10.1074/jbc.C111.266452	http://dx.doi.org/10.1074/jbc.C111.266452			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693705	Green Published, hybrid			2022-12-27	WOS:000293557800005
J	Shi, XJ; Sun, XO; Liu, M; Li, DW; Aneja, R; Zhou, J				Shi, Xingjuan; Sun, Xiaoou; Liu, Min; Li, Dengwen; Aneja, Ritu; Zhou, Jun			CEP70 Protein Interacts with gamma-Tubulin to Localize at the Centrosome and Is Critical for Mitotic Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CYLD; CHROMOSOMAL INSTABILITY; MICROTUBULE DYNAMICS; MECHANISMS; DISEASE; CANCER; CELL; MISORIENTATION; ORIENTATION; MOTOR	Deregulation of the mitotic spindle has been implicated in genomic instability, an important aspect of tumorigenesis and malignant transformation. To ensure the fidelity of chromosome transmission, the mitotic spindle is assembled by exquisite mechanisms and orchestrated by centrosomes in animal cells. Centrosomal proteins especially are thought to act coordinately to ensure accurate spindle formation, but the molecular details remain to be investigated. In this study, we report the molecular characterization and functional analysis of a novel centrosomal protein, Cep70. Our data show that Cep70 localizes to the centrosome throughout the cell cycle and binds to the key centrosomal component, gamma-tubulin, through the peptide fragments that contain the coiled-coil domains. Our data further reveal that the centrosomal localization pattern of Cep70 is dependent on its interaction with gamma-tubulin. Strikingly, Cep70 plays a significant role in the organization of both preexisting and nascent microtubules in interphase cells. In addition, Cep70 is necessary for the organization and orientation of the bipolar spindle during mitosis. These results thus report for the first time the identification of Cep70 as an important centrosomal protein that interacts with gamma-tubulin and underscore its critical role in the regulation of mitotic spindle assembly.	[Shi, Xingjuan; Sun, Xiaoou; Li, Dengwen; Zhou, Jun] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Dept Biochem, Key Lab Immune Microenvironm & Dis, Minist Educ,Basic Med Coll, Tianjin 300070, Peoples R China; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Nankai University; Tianjin Medical University; University System of Georgia; Georgia State University	Zhou, J (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin Key Lab Prot Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260	National Natural Science Foundation of China [30825022, 90913021, 30801407]; National Basic Research Program of China [2007CB914503, 2010CB912204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30825022, 90913021, and 30801407 and National Basic Research Program of China Grants 2007CB914503 and 2010CB912204.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200	23	30	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33401	33408		10.1074/jbc.M111.252262	http://dx.doi.org/10.1074/jbc.M111.252262			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795687	hybrid, Green Published			2022-12-27	WOS:000294968800058
J	Blum, AP; Gleitsman, KR; Lester, HA; Dougherty, DA				Blum, Angela P.; Gleitsman, Kristin Rule; Lester, Henry A.; Dougherty, Dennis A.			Evidence for an Extended Hydrogen Bond Network in the Binding Site of the Nicotinic Receptor ROLE OF THE VICINAL DISULFIDE OF THE alpha 1 SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID MUTAGENESIS; CYSTEINYL-L-CYSTEINE; N-METHYL PEPTIDES; ACETYLCHOLINE-RECEPTOR; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; DELTA-SUBUNIT; DEPENDENT CONTRIBUTIONS; TORPEDO-CALIFORNICA; ANGSTROM RESOLUTION	The defining feature of the alpha subunits of the family of nicotinic acetylcholine receptors is a vicinal disulfide between Cys-192 and Cys-193. Although this structure has played a pivotal role in a number of pioneering studies of nicotinic receptors, its functional role in native receptors remains uncertain. Using mutant cycle analysis and unnatural residue mutagenesis, including backbone mutagenesis of the peptide bond of the vicinal disulfide, we have established the presence of a network of hydrogen bonds that extends from that peptide NH, across a beta turn to another backbone hydrogen bond, and then across the subunit interface to the side chain of a functionally important Asp residue in the non-alpha subunit. We propose that the role of the vicinal disulfide is to distort the beta turn and thereby properly position a backbone NH for intersubunit hydrogen bonding to the key Asp.	[Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS 34407, NS 11756]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R37NS034407, R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 34407 (to D.A.D.) and NS 11756 (to H.A.L.).	Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; AUBRY A, 1981, INT J PEPT PROT RES, V18, P195; Avizonis DZ, 1996, J AM CHEM SOC, V118, P13031, DOI 10.1021/ja962005v; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Beligere GS, 2000, J AM CHEM SOC, V122, P12079, DOI 10.1021/ja001648e; Blankenship JW, 2002, BIOCHEMISTRY-US, V41, P15676, DOI 10.1021/bi026862p; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CAPASSO S, 1977, ACTA CRYSTALLOGR B, V33, P2080, DOI 10.1107/S0567740877007778; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; CHABALA LD, 1986, J PHYSIOL-LONDON, V379, P83, DOI 10.1113/jphysiol.1986.sp016242; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Creighton CJ, 2001, J AM CHEM SOC, V123, P12664, DOI 10.1021/ja016505m; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; Deechongkit S, 2004, J AM CHEM SOC, V126, P16762, DOI 10.1021/ja045934s; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Deechongkit S, 2004, ORG LETT, V6, P497, DOI 10.1021/ol036102m; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Frisch M.J., 2016, GAUSSIAN16 REV B01; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Gleitsman K. R, 2010, THESIS CALTECH PASAD; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; HATA Y, 1977, ACTA CRYSTALLOGR B, V33, P3561, DOI 10.1107/S0567740877011480; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Hudaky I, 2004, PROTEINS, V55, P152, DOI 10.1002/prot.10581; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KARLIN A, 1966, BIOCHIM BIOPHYS ACTA, V126, P525, DOI 10.1016/0926-6585(66)90010-0; Karlin A., 1969, J GEN PHYSIOL, V54, P245; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Nakhle BM, 2000, J AM CHEM SOC, V122, P8105, DOI 10.1021/ja0006090; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Park JD, 2002, J MED CHEM, V45, P911, DOI 10.1021/jm010272s; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Ruggles EL, 2009, TETRAHEDRON, V65, P1257, DOI 10.1016/j.tet.2008.11.085; SILMAN I, 1969, SCIENCE, V164, P1420, DOI 10.1126/science.164.3886.1420; Silverman S. K, 1998, THESIS CALTECH PASAD; Sine SM, 2002, J GEN PHYSIOL, V120, P483, DOI 10.1085/jgp.20028568; Sohn CH, 2009, J AM CHEM SOC, V131, P5444, DOI 10.1021/ja806534r; SPARTAN, SPARTAN; Torrice M. M, 2009, THESIS CALTECH PASAD; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VITOUX B, 1981, INT J PEPT PROT RES, V17, P469; WALKER JW, 1981, BIOCHEMISTRY-US, V20, P2191, DOI 10.1021/bi00511a018; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	60	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32251	32258		10.1074/jbc.M111.254235	http://dx.doi.org/10.1074/jbc.M111.254235			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757705	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000294726800035
J	Boysen, KE; Matuschewski, K				Boysen, Katja E.; Matuschewski, Kai			Arrested Oocyst Maturation in Plasmodium Parasites Lacking Type II NADH:Ubiquinone Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM DIHYDROOROTATE DEHYDROGENASE; MITOCHONDRIAL ELECTRON-TRANSPORT; ALTERNATIVE NADH DEHYDROGENASE; HIGH-AFFINITY INHIBITOR; MALARIA-PARASITE; QUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; DRUG TARGETS; LIFE-CYCLE; COMPLEX-I	The Plasmodium mitochondrial electron transport chain has received considerable attention as a potential target for new antimalarial drugs. Atovaquone, a potent inhibitor of Plasmodium cytochrome bc(1), in combination with proguanil is recommended for chemoprophylaxis and treatment of malaria. The type II NADH: ubiquinone oxidoreductase (NDH2) is considered an attractive drug target, as its inhibition is thought to lead to the arrest of the mitochondrial electron transport chain and, as a consequence, pyrimidine biosynthesis, an essential pathway for the parasite. Using the rodent malaria parasite Plasmodium berghei as an in vivo infection model, we studied the role of NDH2 during Plasmodium life cycle progression. NDH2 can be deleted by targeted gene disruption and, thus, is dispensable for the pathogenic asexual blood stages, disproving the candidacy for an anti-malarial drug target. After transmission to the insect vector, NDH2-deficient ookinetes display an intact mitochondrial membrane potential. However, ndh2(-) parasites fail to develop into mature oocysts in the mosquito midgut. We propose that Plasmodium blood stage parasites rely on glycolysis as the main ATP generating process, whereas in the invertebrate vector, a glucose-deprived environment, the malaria parasite is dependent on an intact mitochondrial respiratory chain.	[Boysen, Katja E.; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany	Max Planck Society	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Charitepl 1, D-10117 Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de		Matuschewski, Kai/0000-0001-6147-8591	Max Planck Society; EviMalar network of excellence [34]	Max Planck Society(Max Planck Society); EviMalar network of excellence	This work was supported by the Max Planck Society and partly by grants from the EviMalar network of excellence (#34).	Aikawa M, 1974, P1; Bajohr LL, 2010, ANTIMICROB AGENTS CH, V54, P517, DOI 10.1128/AAC.01001-09; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Biagini GA, 2006, ANTIMICROB AGENTS CH, V50, P1841, DOI 10.1128/AAC.50.5.1841-1851.2006; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; CANNING EU, 1973, PARASITOLOGY, V67, P29, DOI 10.1017/S0031182000046266; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Dong CK, 2009, BIOORG MED CHEM LETT, V19, P972, DOI 10.1016/j.bmcl.2008.11.071; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; Fisher N, 2008, TRENDS PARASITOL, V24, P9, DOI 10.1016/j.pt.2007.10.001; Fisher N, 2007, TRENDS PARASITOL, V23, P305, DOI 10.1016/j.pt.2007.04.014; Fisher N, 2009, METHOD ENZYMOL, V456, P303, DOI 10.1016/S0076-6879(08)04417-0; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; HATEFI Y, 1962, J BIOL CHEM, V237, P1676; HEYMANN H, 1948, J BIOL CHEM, V176, P1359; Hirai M, 2010, ACTA TROP, V114, P157, DOI 10.1016/j.actatropica.2009.08.005; Hochachka PW, 1984, BIOCH ADAPTATION, P145; HOWELLS RE, 1969, MIL MED, V134, P893; HOWELLS RE, 1970, ANN TROP MED PARASIT, V64, P181, DOI 10.1080/00034983.1970.11686680; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Kawahara K, 2009, J BIOCHEM, V145, P229, DOI 10.1093/jb/mvn161; Kerscher SJ, 2000, BBA-BIOENERGETICS, V1459, P274, DOI 10.1016/S0005-2728(00)00162-6; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Krungkrai J, 2002, EXP PARASITOL, V100, P54, DOI 10.1006/expr.2001.4674; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mather MW, 2008, J BIOENERG BIOMEMBR, V40, P425, DOI 10.1007/s10863-008-9176-4; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mogi T, 2009, FEMS MICROBIOL LETT, V291, P157, DOI 10.1111/j.1574-6968.2008.01451.x; Mogi T, 2009, MITOCHONDRION, V9, P443, DOI 10.1016/j.mito.2009.08.004; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Phillips Margaret A., 2010, Infectious Disorders - Drug Targets, V10, P226; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Raine JD, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030030; Rodrigues T, 2010, CURR MED CHEM, V17, P929, DOI 10.2174/092986710790820660; Saleh A, 2007, ANTIMICROB AGENTS CH, V51, P1217, DOI 10.1128/AAC.00895-06; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Sinden R. E., 1997, The molecular biology of insect disease vectors: a methods manual., P67; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Suraveratum N, 2000, MOL BIOCHEM PARASIT, V105, P215, DOI 10.1016/S0166-6851(99)00180-2; TERZAKIS JA, 1967, J CELL BIOL, V34, P311, DOI 10.1083/jcb.34.1.311; TERZAKIS JA, 1974, J PROTOZOOL, V21, P251, DOI 10.1111/j.1550-7408.1974.tb03649.x; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vaidya Akhil B., 1998, P355; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vontas J, 2005, MOL BIOCHEM PARASIT, V139, P1, DOI 10.1016/j.molbiopara.2004.03.003; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2020, GLOB REP ANT DRUG EF	66	60	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32661	32671		10.1074/jbc.M111.269399	http://dx.doi.org/10.1074/jbc.M111.269399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771793	Green Published, hybrid			2022-12-27	WOS:000294726800075
J	Salinas, RK; Bruschweiler-Li, L; Johnson, E; Bruschweiler, R				Salinas, Roberto K.; Bruschweiler-Li, Lei; Johnson, Eric; Brueschweiler, Rafael			Ca2+ Binding Alters the Interdomain Flexibility between the Two Cytoplasmic Calcium-binding Domains in the Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; NA+-CA2+ EXCHANGER; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; C-2 DOMAINS; RELAXATION; ALIGNMENT; PROTEINS	The Na+/Ca2+ exchanger (NCX) is a membrane protein, which catalyzes the counter transport of Na+ and Ca2+ ions across the plasma membrane, playing a key role in the maintenance of the intracellular Ca2+ homeostasis in various cell types. NCX consists of a transmembrane part and a large intracellular loop. The activation of the NCX transport function requires the binding of Ca2+ to two tandem C2 domains, CBD1 and CBD2, which are an integral part of the exchanger's intracellular loop. Although high-resolution structures of individual CBD1 and CBD2 are available, their interdomain structure and dynamics and the atomic level mechanism of allosteric Ca2+-regulation remains unknown. Here, we use solution NMR spectroscopy to study the interdomain dynamics of CBD12, a 32 kDa construct that contains both the CBD1 and CBD2 domains connected by a short linker. Analysis of NMR residual dipolar couplings shows that CBD12 assumes on average an elongated shape both in the absence and in the presence of Ca2+. NMR N-15 relaxation data of the Apo state indicate that the two domains sample a wide range of relative arrangements on the nanosecond time scale. These arrangements comprise significantly non-linear interdomain orientations. Binding of Ca2+ to CBD1 significantly restricts the interdomain flexibility, stabilizing a more rigid elongated conformation. These findings suggest a molecular mechanism for the role of CBD12 in the function of NCX.	[Salinas, Roberto K.; Bruschweiler-Li, Lei; Johnson, Eric; Brueschweiler, Rafael] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Salinas, Roberto K.; Bruschweiler-Li, Lei; Johnson, Eric; Brueschweiler, Rafael] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bruschweiler, R (corresponding author), Florida State Univ, Dept Chem & Biochem, 95 Chieftan Way,Rm 118 DLC, Tallahassee, FL 32306 USA.	bruschweiler@magnet.fsu.edu	Bruschweiler, Rafael/F-6624-2015; Complexos, INCT Fluidos/H-9172-2013; Salinas, Roberto Kopke/C-2036-2012	Salinas, Roberto Kopke/0000-0003-1032-7683; Johnson, Eric/0000-0001-8735-8184	National Science Foundation [MCB-0918362]; American Heart Association	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by Grant MCB-0918362 of the National Science Foundation.; Recipient of postdoctoral fellowship from the American Heart Association.	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Hus JC, 2008, J AM CHEM SOC, V130, P15927, DOI 10.1021/ja804274s; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reeves JP, 2008, CHANNELS, V2, P322, DOI 10.4161/chan.2.5.6897; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	43	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32123	32131		10.1074/jbc.M111.249268	http://dx.doi.org/10.1074/jbc.M111.249268			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778234	Green Published, hybrid			2022-12-27	WOS:000294726800022
J	Wang, H; Ishizaki, R; Kobayashi, E; Fujiwara, T; Akagawa, K; Izumi, T				Wang, Hao; Ishizaki, Ray; Kobayashi, Eri; Fujiwara, Tomonori; Akagawa, Kimio; Izumi, Tetsuro			Loss of Granuphilin and Loss of Syntaxin-1A Cause Differential Effects on Insulin Granule Docking and Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; SECRETORY GRANULES; EXOCYTOSIS; INTERACTS; VESICLES; PROMOTES; MUNC-18; COMPLEX; RAB27B; MICE	The Rab27 effector granuphilin/Slp4 is essential for the stable attachment (docking) of secretory granules to the plasma membrane, and it also inhibits subsequent fusion. Granuphilin is thought to mediate these processes through interactions with Rab27 on the granule membrane and with syntaxin-1a on the plasma membrane and its binding partner Munc18-1. Consistent with this hypothesis, both syntaxin-1a-and Munc18-1-deficient secretory cells, as well as granuphilin null cells, have been observed to have a deficit of docked granules. However, to date there has been no direct comparative analysis of the docking defects in those mutant cells. In this study, we morphometrically compared granule-docking states between granuphilin null and syntaxin-1a null pancreatic beta cells derived from mice having the same genetic background. We found that loss of syntaxin-1a does not cause a significant granule-docking defect, in contrast to granuphilin deficiency. Furthermore, we newly generated granuphilin/syntaxin-1a double knock-out mice, characterized their phenotypes, and found that the double mutant mice represent a phenocopy of granuphilin null mice and do not represent phenotypes of syntaxin-1a null mice, including their granule-docking behavior. Because granuphilin binds to syntaxin-2 and syntaxin-3 as well as syntaxin-1a, it likely mediates granule docking through interactions with those multiple syntaxins on the plasma membrane.	[Wang, Hao; Ishizaki, Ray; Kobayashi, Eri; Izumi, Tetsuro] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol Med, Gunma 3718512, Japan; [Fujiwara, Tomonori; Akagawa, Kimio] Kyorin Univ, Sch Med, Dept Cell Physiol, Tokyo 1818611, Japan	Gunma University; Kyorin University	Izumi, T (corresponding author), 3-39-15 Showa Machi, Gunma 3718512, Japan.	tizumi@showa.gunma-u.ac.jp			Global COE from Ministry of Education, Culture, Sports, Science and Technology of Japan; Mitsubishi Foundation; Novo Nordisk insulin study award; Grants-in-Aid for Scientific Research [20113005] Funding Source: KAKEN	Global COE from Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Novo Nordisk insulin study award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants in aid for scientific research (to T.I. and R.I.), a Global COE program grant from Ministry of Education, Culture, Sports, Science and Technology of Japan, and in part by grants from the Mitsubishi Foundation and a Novo Nordisk insulin study award (to T.I.).	Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Fukuda M, 2005, J BIOL CHEM, V280, P39175, DOI 10.1074/jbc.M505759200; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; Izumi T, 2007, DIABETES OBES METAB, V9, P109, DOI 10.1111/j.1463-1326.2007.00789.x; Izumi T, 2011, FRONT BIOSCI-LANDMRK, V16, P360, DOI 10.2741/3692; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Torii S, 2004, J BIOL CHEM, V279, P22532, DOI 10.1074/jbc.M400600200; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Yu M, 2007, MOL BIOL CELL, V18, P688, DOI 10.1091/mbc.E06-10-0914; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	31	17	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32244	32250		10.1074/jbc.M111.268631	http://dx.doi.org/10.1074/jbc.M111.268631			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768089	hybrid, Green Published			2022-12-27	WOS:000294726800034
J	Suzuki, T; Yoshinaga, N; Tanabe, S				Suzuki, Takuya; Yoshinaga, Naho; Tanabe, Soichi			Interleukin-6 (IL-6) Regulates Claudin-2 Expression and Tight Junction Permeability in Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER FUNCTION; EXPERIMENTAL COLITIS; SELECTIVE CHANNELS; CROHNS-DISEASE; CELLS; ACTIVATION; OCCLUDIN; KINASE; APOPTOSIS; PKC	In inflammatory bowel diseases (IBD), intestinal barrier function is impaired as a result of deteriorations in epithelial tight junction (TJ) structure. IL-6, a pleiotropic cytokine, is elevated in IBD patients, although the role of IL-6 in barrier function remains unknown. We present evidence that IL-6 increases TJ permeability by stimulating the expression of channel-forming claudin-2, which is required for increased caudal-related homeobox (Cdx) 2 through the MEK/ERK and PI3K pathways in intestinal epithelial cells. IL-6 increases the cation-selective TJ permeability without any changes to uncharged dextran flux or cell viability in Caco-2 cells. IL-6 markedly induces claudin-2 expression, which is associated with increased TJ permeability. The colonic mucosa of mice injected with IL-6 also exhibits an increase in claudin-2 expression. The claudin-2 expression and TJ permeability induced by IL-6 are sensitive to the inhibition of gp130, MEK, and PI3K. Furthermore, expression of WT-MEK1 induces claudin-2 expression in Caco-2 cells. Claudin-2 promoter activity is increased by IL-6 in a MEK/ERK and PI3K-dependent manner, and deletion of Cdx binding sites in the promoter sequence results in a loss of IL-6-induced promoter activity. IL-6 increases Cdx2 protein expression, which is suppressed by the inhibition of MEK and PI3K. These observations may reveal an important mechanism by which IL-6 can undermine the integrity of the intestinal barrier.	[Suzuki, Takuya; Yoshinaga, Naho; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, Higashihiroshima 7398528, Japan	Hiroshima University	Suzuki, T (corresponding author), 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	takuya@hiroshima-u.ac.jp	Tanabe, Soichi/R-6229-2019; Suzuki, Takuya/H-3750-2019	Suzuki, Takuya/0000-0003-3709-543X	Japan Society for the Promotion of Science [21780117]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B) 21780117.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; KUSUGAMI K, 1995, DIGEST DIS SCI, V40, P949, DOI 10.1007/BF02064182; Louis E, 1997, EUR J GASTROEN HEPAT, V9, P939, DOI 10.1097/00042737-199710000-00004; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Reinisch W, 1999, AM J GASTROENTEROL, V94, P2156; Sakamoto H, 2010, SCAND J GASTROENTERO, V45, P1273, DOI 10.3109/00365521.2010.501522; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang LX, 2007, J BIOL CHEM, V282, P8219, DOI 10.1074/jbc.M604068200; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003	40	334	349	4	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31263	31271		10.1074/jbc.M111.238147	http://dx.doi.org/10.1074/jbc.M111.238147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771795	hybrid, Green Published			2022-12-27	WOS:000294487500021
J	Bowden, KL; Bilbey, NJ; Bilawchuk, LM; Boadu, E; Sidhu, R; Ory, DS; Du, H; Chan, T; Francis, GA				Bowden, Kristin L.; Bilbey, Nicolas J.; Bilawchuk, Leanne M.; Boadu, Emmanuel; Sidhu, Rohini; Ory, Daniel S.; Du, Hong; Chan, Teddy; Francis, Gordon A.			Lysosomal Acid Lipase Deficiency Impairs Regulation of ABCA1 Gene and Formation of High Density Lipoproteins in Cholesteryl Ester Storage Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; NIEMANN-PICK DISEASE; PLASMA HDL CHOLESTEROL; PARTICLE FORMATION; HUMAN FIBROBLASTS; LIPID EFFLUX; AGONIST; HYPOALPHALIPOPROTEINEMIA; 27-HYDROXYCHOLESTEROL; ESTERIFICATION	ATP-binding cassette transporter A1 (ABCA1) mediates the rate-limiting step in high density lipoprotein (HDL) particle formation, and its expression is regulated primarily by oxysterol-dependent activation of liver X receptors. We previously reported that ABCA1 expression and HDL formation are impaired in the lysosomal cholesterol storage disorder Niemann-Pick disease type C1 and that plasma HDL-C is low in the majority of Niemann-Pick disease type C patients. Here, we show that ABCA1 regulation and activity are also impaired in cholesteryl ester storage disease (CESD), caused by mutations in the LIPA gene that result in less than 5% of normal lysosomal acid lipase (LAL) activity. Fibroblasts from patients with CESD showed impaired up-regulation of ABCA1 in response to low density lipoprotein (LDL) loading, reduced phospholipid and cholesterol efflux to apolipoprotein A-I, and reduced alpha-HDL particle formation. Treatment of normal fibroblasts with chloroquine to inhibit LAL activity reduced ABCA1 expression and activity, similar to that of CESD cells. Liver X receptor agonist treatment of CESD cells corrected ABCA1 expression but failed to correct LDL cholesteryl ester hydrolysis and cholesterol efflux to apoA-I. LDL-induced production of 27-hydroxycholesterol was reduced in CESD compared with normal fibroblasts. Treatment with conditioned medium containing LAL from normal fibroblasts or with recombinant human LAL rescued ABCA1 expression, apoA-I-mediated cholesterol efflux, HDL particle formation, and production of 27-hydroxycholesterol by CESD cells. These results provide further evidence that the rate of release of cholesterol from late endosomes/lysosomes is a critical regulator of ABCA1 expression and activity, and an explanation for the hypoalphalipoproteinemia seen in CESD patients.	[Bowden, Kristin L.; Bilbey, Nicolas J.; Bilawchuk, Leanne M.; Boadu, Emmanuel; Chan, Teddy; Francis, Gordon A.] St Pauls Hosp, Inst Heart & Lung Hlth, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Sidhu, Rohini; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Du, Hong] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	St. Paul's Hospital; University of Saskatchewan; Washington University (WUSTL); University System of Ohio; University of Cincinnati	Francis, GA (corresponding author), St Pauls Hosp, Inst Heart & Lung Hlth, Dept Med, Rm 166,Burrard Bldg,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	gordon.francis@hli.ubc.ca	应, 宁宁/G-9472-2011; Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167	Canadian Institutes of Health Research [MOP-79532]; National Institutes of Health [HL067773, HL087001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, R01HL087001] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grant MOP-79532 (to G. A. F.). This work was also supported by National Institutes of Health Grants HL067773 (to D. S. O.) and HL087001 (to H. D.).	Anderson RA, 1999, MOL GENET METAB, V68, P333, DOI 10.1006/mgme.1999.2904; Aravindhan K, 2006, J LIPID RES, V47, P1250, DOI 10.1194/jlr.M500512-JLR200; Assmann G, 2001, METABOLIC MOL BASES, P3551; AXELSON M, 1995, J BIOL CHEM, V270, P15102, DOI 10.1074/jbc.270.25.15102; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boadu E, 2006, J BIOL CHEM, V281, P37081, DOI 10.1074/jbc.M606890200; BROWN MS, 1974, J BIOL CHEM, V249, P789; BROWN MS, 1976, J BIOL CHEM, V251, P3277; BROWN MS, 1975, P NATL ACAD SCI USA, V72, P2925, DOI 10.1073/pnas.72.8.2925; Brunham LR, 2006, CIRC RES, V99, P672, DOI 10.1161/01.RES.0000244014.19589.8e; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; CHUNG BH, 1980, J LIPID RES, V21, P284; Du H, 1998, MOL GENET METAB, V64, P126, DOI 10.1006/mgme.1998.2707; Du H, 2001, J LIPID RES, V42, P489; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis GA, 1996, BIOCHEMISTRY-US, V35, P15188, DOI 10.1021/bi9618169; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Garver WS, 2010, J LIPID RES, V51, P406, DOI 10.1194/jlr.P000331; GINSBERG HN, 1987, J CLIN INVEST, V80, P1692, DOI 10.1172/JCI113259; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GUARDIOLA F, 1995, J CHROMATOGR A, V705, P289, DOI 10.1016/0021-9673(95)00034-K; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Menke JG, 2002, ENDOCRINOLOGY, V143, P2548, DOI 10.1210/en.143.7.2548; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1986, J BIOL CHEM, V261, P6775; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; SANDO GN, 1985, J BIOL CHEM, V260, P5186; SANDO GN, 1982, J LIPID RES, V23, P114; SATTLER W, 1993, BIOCHEM J, V294, P771, DOI 10.1042/bj2940771; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Tang WQ, 2008, ARTERIOSCL THROM VAS, V28, P448, DOI 10.1161/ATVBAHA.107.160465; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Waddington EI, 2005, METHODS, V36, P196, DOI 10.1016/j.ymeth.2004.12.002; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	50	65	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30624	30635		10.1074/jbc.M111.274381	http://dx.doi.org/10.1074/jbc.M111.274381			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757691	Green Published, hybrid			2022-12-27	WOS:000294283600042
J	Fernandes, RJ; Farnand, AW; Traeger, GR; Weis, MA; Eyre, DR				Fernandes, Russell J.; Farnand, Alex W.; Traeger, Geoffrey R.; Weis, Mary Ann; Eyre, David R.			A Role for Prolyl 3-Hydroxylase 2 in Post-translational Modification of Fibril-forming Collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; 3-HYDROXYPROLINE RESIDUES; LYSYL HYDROXYLASE; PROCOLLAGEN-II; AMINO-ACID; CELL-LINE; IN-VITRO; FAMILY; MUTATIONS; LEPRECAN	The fibrillar collagen types I, II, and V/XI have recently been shown to have partially 3-hydroxylated proline (3Hyp) residues at sites other than the established primary Pro-986 site in the collagen triple helical domain. These sites showed tissue specificity in degree of hydroxylation and a pattern of D-periodic spacing. This suggested a contributory role in fibril supramolecular assembly. The sites in clade A fibrillar alpha 1(II), alpha 2(V), and alpha 1(I) collagen chains share common features with known prolyl 3-hydroxylase 2 (P3H2) substrate sites in alpha 1(IV) chains implying a role for this enzyme. We pursued this possibility using the Swarm rat chondrosarcoma cell line (RCS-LTC) found to express high levels of P3H2 mRNA. Mass spectrometry determined that all the additional candidate 3Hyp substrate sites in the pN type II collagen made by these cells were highly hydroxylated. In RNA interference experiments, P3H2 protein synthesis was suppressed coordinately with prolyl 3-hydroxylation at Pro-944, Pro-707, and the C-terminal GPP repeat of the pN alpha 1(II) chain, but Pro-986 remained fully hydroxylated. Furthermore, when P3H2 expression was turned off, as seen naturally in cultured SAOS-2 osteosarcoma cells, full 3Hyp occupancy at Pro-986 in alpha 1(I) chains was unaffected, whereas 3-hydroxylation of residue Pro-944 in the alpha 2(V) chain was largely lost, and 3-hydroxylation of Pro-707 in alpha 2(V) and alpha 2(I) chains were sharply reduced. The results imply that P3H2 has preferred substrate sequences among the classes of 3Hyp sites in clade A collagen chains.	[Fernandes, Russell J.; Farnand, Alex W.; Traeger, Geoffrey R.; Weis, Mary Ann; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Orthopaed Res Labs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fernandes, RJ (corresponding author), 1959 NE Pacific St,HSB BB1010,Box 356500, Seattle, WA 98195 USA.	rjf@u.washington.edu			National Institutes of Health, NIAMS [AR057025, AR036794, AR037318]; National Center for Research Resources [TL1 RR025016]; University of Washington; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R01AR037318, R37AR036794, R01AR057025, R37AR037318] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Washington(University of Washington); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS Grants AR057025 (to R. J. F.) and AR036794 and AR037318 (to D. R. E.). This work was also supported by National Center for Research Resources Grant TL1 RR025016 (to A. W. F.) and the Ernest M. Burgess Endowed Chair research program at the University of Washington.	Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; BISHOP PN, 1994, BIOCHEM BIOPH RES CO, V203, P289, DOI 10.1006/bbrc.1994.2180; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; Fernandes RJ, 2003, EUR J BIOCHEM, V270, P3243, DOI 10.1046/j.1432-1033.2003.03711.x; Fernandes RJ, 1997, EUR J BIOCHEM, V247, P620, DOI 10.1111/j.1432-1033.1997.00620.x; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; Fernandes RJ, 2007, BONE, V40, P1343, DOI 10.1016/j.bone.2007.01.011; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; HOLMES DF, 1993, J BIOL CHEM, V268, P15758; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; KADLER KE, 1993, INT J EXP PATHOL, V74, P319; KIVIRIKKO KI, 1973, BIOCHEMISTRY-US, V12, P4966, DOI 10.1021/bi00748a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miller AD, 2006, OSTEOARTHR CARTILAGE, V14, P1315, DOI 10.1016/j.joca.2006.08.004; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MOULD AP, 1987, J MOL BIOL, V195, P543, DOI 10.1016/0022-2836(87)90182-3; MYLLYLA R, 1981, BIOCHEM J, V196, P683, DOI 10.1042/bj1960683; OGLE JD, 1962, J BIOL CHEM, V237, P3667; OLSEN BR, 1973, EUR J BIOCHEM, V35, P135, DOI 10.1111/j.1432-1033.1973.tb02819.x; RISTELI J, 1974, BIOCHEM J, V144, P115, DOI 10.1042/bj1440115; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; Shah R, 2009, BRIT J CANCER, V100, P1687, DOI 10.1038/sj.bjc.6605042; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729	37	27	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30662	30669		10.1074/jbc.M111.267906	http://dx.doi.org/10.1074/jbc.M111.267906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757687	Green Published, hybrid			2022-12-27	WOS:000294283600046
J	Henry, LK; Iwamoto, H; Field, JR; Kaufmann, K; Dawson, ES; Jacobs, MT; Adams, C; Felts, B; Zdravkovic, I; Armstrong, V; Combs, S; Solis, E; Rudnick, G; Noskov, SY; DeFelice, LJ; Meiler, J; Blakely, RD				Henry, L. Keith; Iwamoto, Hideki; Field, Julie R.; Kaufmann, Kristian; Dawson, Eric S.; Jacobs, Miriam T.; Adams, Chelsea; Felts, Bruce; Zdravkovic, Igor; Armstrong, Vanessa; Combs, Steven; Solis, Ernesto; Rudnick, Gary; Noskov, Sergei Y.; DeFelice, Louis J.; Meiler, Jens; Blakely, Randy D.			A Conserved Asparagine Residue in Transmembrane Segment 1 (TM1) of Serotonin Transporter Dictates Chloride-coupled Neurotransmitter Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; DOPAMINE TRANSPORTER; DOMAIN-I; MOLECULAR-MECHANISM; ALTERNATING ACCESS; SIDE-CHAIN; RAT-BRAIN; SUBSTRATE RECOGNITION; SCANNING MUTAGENESIS; PERMEATION PATHWAY	Na+- and Cl--dependent uptake of neurotransmitters via transporters of the SLC6 family, including the human serotonin transporter (SLC6A4), is critical for efficient synaptic transmission. Although residues in the human serotonin transporter involved in direct Cl- coordination of human serotonin transport have been identified, the role of Cl- in the transport mechanism remains unclear. Through a combination of mutagenesis, chemical modification, substrate and charge flux measurements, and molecular modeling studies, we reveal an unexpected role for the highly conserved transmembrane segment 1 residue Asn-101 in coupling Cl- binding to concentrative neurotransmitter uptake.	[Henry, L. Keith] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Zdravkovic, Igor; Noskov, Sergei Y.] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Jacobs, Miriam T.; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Henry, L. Keith; Iwamoto, Hideki; Field, Julie R.; Solis, Ernesto; DeFelice, Louis J.; Meiler, Jens; Blakely, Randy D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Kaufmann, Kristian; Combs, Steven; Meiler, Jens] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Dawson, Eric S.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Blakely, Randy D.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37232 USA; [DeFelice, Louis J.; Blakely, Randy D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Henry, L. Keith; Dawson, Eric S.; Meiler, Jens] Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA; [Dawson, Eric S.] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA	University of North Dakota Grand Forks; University of Calgary; Yale University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Henry, LK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Ste 3700,501 N Columbia Rd, Grand Forks, ND 58203 USA.	keith.henry@med.und.edu; randy.blakely@vanderbilt.edu		De Felice, Louis/0000-0002-4594-3171; Solis, Jr., Ernesto/0000-0001-9406-9540; Meiler, Jens/0000-0001-8945-193X; Noskov, Sergei/0000-0001-7769-335X; Jacobs, Miriam/0000-0002-8831-7592	NIDA; NINDS; NIGMS; NARSAD; Center for Structural Biology at Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NARSAD(NARSAD); Center for Structural Biology at Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants from NIDA (to L.K.H., G.R., and R.D.B.), NINDS (to H.I. and L.J.D.), and NIGMS (to J.M.). This work was also supported by NARSAD (to L.K.H.) and the Center for Structural Biology at Vanderbilt University.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Anisimov VM, 2005, J CHEM THEORY COMPUT, V1, P153, DOI 10.1021/ct049930p; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Barker Eric L., 1995, P321; BAYLY CI, 1994, J AM CHEM SOC, V116, P697, DOI 10.1021/ja00081a034; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cao YW, 1998, J NEUROSCI, V18, P7739; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chang AS, 1998, J PHYSIOL-LONDON, V510, P903, DOI 10.1111/j.1469-7793.1998.903bj.x; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Field JR, 2010, J BIOL CHEM, V285, P11270, DOI 10.1074/jbc.M109.093658; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foloppe N, 2007, J MOL BIOL, V372, P798, DOI 10.1016/j.jmb.2007.05.101; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; HOFFMAN BJ, 1989, FEBS LETT, V247, P453, DOI 10.1016/0014-5793(89)81390-0; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Jang IS, 2001, J NEUROSCI, V21, P5962, DOI 10.1523/JNEUROSCI.21-16-05962.2001; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Li LB, 2008, J PHYS CHEM B, V112, P9574, DOI 10.1021/jp7114912; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; LINGJAERDE O, 1971, ACTA PHYSIOL SCAND, V81, P75, DOI 10.1111/j.1748-1716.1971.tb04878.x; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mager S, 1998, METHOD ENZYMOL, V296, P551; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; NELSON MT, 1982, J MEMBRANE BIOL, V69, P213, DOI 10.1007/BF01870400; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Ni YS, 2001, J BIOL CHEM, V276, P27329, DOI 10.1074/jbc.M102258200; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ramsey IS, 2002, J BIOL CHEM, V277, P14475, DOI 10.1074/jbc.M110783200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; Schroeter S, 1996, ANN NY ACAD SCI, V801, P239, DOI 10.1111/j.1749-6632.1996.tb17446.x; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simonson T, 2004, J AM CHEM SOC, V126, P4167, DOI 10.1021/ja039788m; Sonders MS, 1997, J NEUROSCI, V17, P960; Sung U, 2007, MOL CELL NEUROSCI, V34, P251, DOI 10.1016/j.mcn.2006.11.007; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	76	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30823	30836		10.1074/jbc.M111.250308	http://dx.doi.org/10.1074/jbc.M111.250308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730057	hybrid, Green Published			2022-12-27	WOS:000294283600062
J	Li, L; Wang, DL; Jiang, YA; Sun, JF; Zhang, SY; Chen, YY; Wang, XQ				Li, Liang; Wang, Dongli; Jiang, Yinan; Sun, Jianfeng; Zhang, Senyan; Chen, Yuanyuan; Wang, Xinquan			Crystal Structure of Human ISG15 Protein in Complex with Influenza B Virus NS1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MOLECULE; STIMULATED GENE-15; A VIRUS; UBIQUITIN; DOMAIN; INTERFERONS; RESPONSES; SOFTWARE; BINDING	ISG15 (interferon-stimulated gene 15), the first ubiquitin-like protein (UBL) identified, has emerged as an important cellular antiviral factor. It consists of two UBL domains with a short linker between them. The covalent attachment of ISG15 to host and viral proteins to modify their functions, similar to ubiquitylation, is named ISGylation. Influenza B virus NS1B protein antagonizes human but not mouse ISGylation because NS1B exhibits species specificity; it only binds human and non-human primate ISG15. Previous studies have demonstrated that the N-terminal UBL domain and linker of ISG15 are required for the binding by NS1B and that the linker plays a large role in the species specificity, but the structural basis for them has not been elucidated. Here we report the crystal structure of human ISG15 in complex with NS1B at a resolution of 2.0 angstrom. A loop in the ISG15 N-terminal UBL domain inserts into a pocket in the NS1B dimer, forming a high affinity binding site. The nonspecific van der Waals contacts around the ISG15 linker form a low affinity site for NS1B binding. However, sequence alignment reveals that residues in the high affinity site are highly conserved in primate and non-primate ISG15. We propose that the low affinity binding around the ISG15 linker is important for the initial contact with NS1B and that the stable complex formation is largely contributed by the following high affinity interactions between ISG15 N-terminal UBL domain and NS1B. This provides a structural basis for the species-specific binding of ISG15 by the NS1B protein.	[Li, Liang; Wang, Dongli; Jiang, Yinan; Sun, Jianfeng; Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Chen, Yuanyuan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, XQ (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Med Sci Bldg C226, Beijing 100084, Peoples R China.	xinquanwang@mail.tsinghua.edu.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; zhang, sen/GXH-3513-2022; Chen, Yuanyuan/GXG-2130-2022		Ministry of Science and Technology [2011CB910502, 2010CB912402]; Ministry of Education of China [20090002120036, 20100002110001]; Tsinghua University; Fok Ying Tung Education Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education of China(Ministry of Education, China); Tsinghua University; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by grants from the Ministry of Science and Technology (Grants 2011CB910502 and 2010CB912402), the Ministry of Education of China (Grants 20090002120036 and 20100002110001), the Tsinghua University 985 Phase II fund, and the Fok Ying Tung Education Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Sridharan H, 2010, J BIOL CHEM, V285, P7852, DOI 10.1074/jbc.C109.095703; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Yuan WM, 2002, VIROLOGY, V304, P291, DOI 10.1006/viro.2002.1663; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	26	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30258	30262		10.1074/jbc.C111.257899	http://dx.doi.org/10.1074/jbc.C111.257899			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757684	Green Published, hybrid			2022-12-27	WOS:000294283600003
J	Mavaro, A; Abts, A; Bakkes, PJ; Moll, GN; Driessen, AJM; Smits, SHJ; Schmitt, L				Mavaro, Antonino; Abts, Andre; Bakkes, Patrick J.; Moll, Gert N.; Driessen, Arnold J. M.; Smits, Sander H. J.; Schmitt, Lutz			Substrate Recognition and Specificity of the NisB Protein, the Lantibiotic Dehydratase Involved in Nisin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; LEADER PEPTIDE; KINETIC-ANALYSIS; LIPID-II; MECHANISM; TRANSPORT; IMMUNITY; EXPRESSION; PRECURSOR; PRENISIN	Nisin is a posttranslationally modified antimicrobial peptide containing the cyclic thioether amino acids lanthionine and methyllanthionine. Although much is known about its antimicrobial activity and mode of action, knowledge about the nisin modification process is still rather limited. The dehydratase NisB is believed to be the initial interaction partner in modification. NisB dehydrates specific serine and threonine residues in prenisin, whereas the cyclase NisC catalyzes the (methyl) lanthionine formation. The fully modified prenisin is exported and the leader peptide is cleaved off by the extracellular protease NisP. Light scattering analysis demonstrated that purified NisB is a dimer in solution. Using size exclusion chromatography and surface plasmon resonance, the interaction of NisB and prenisin, including several of its modified derivatives, was studied. Unmodified prenisin binds to NisB with an affinity of 1.05 +/- 0.25 mu M, whereas the dehydrated and the fully modified derivatives bind with respective affinities of 0.31 +/- 0.07 and 10.5 +/- 1.7 mu M. The much lower affinity for the fully modified prenisin was related to a > 20-fold higher off-rate. For all three peptides the stoichiometry of binding was 1:1. Active nisin, which is the equivalent of fully modified prenisin lacking the leader peptide did not bind to NisB, nor did prenisin in which the highly conserved FNLD box within the leader peptide was mutated to AAAA. Taken together our data indicate that the leader peptide is essential for initial recognition and binding of prenisin to NisB.	[Mavaro, Antonino; Abts, Andre; Bakkes, Patrick J.; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Moll, Gert N.] BiOMaDe Technol Fdn, NL-9747 AG Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Kluyver Ctr Genom Ind Microorganisms, NL-9747 AG Groningen, Netherlands	Heinrich Heine University Dusseldorf; University of Groningen; University of Groningen	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@hhu.de	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Bakkes, Patrick/0000-0003-1876-7384; Driessen, Arnold J.M./0000-0001-9258-9104	Deutsche Forschungsgemeinschaft [SCHM 1279/10-1]; Heinrich Heine University of Duesseldorf	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinrich Heine University of Duesseldorf	This work was supported by Deutsche Forschungsgemeinschaft SCHM 1279/10-1 and a grant from the Heinrich Heine University of Duesseldorf (to L. S.).	Abts A., 2011, INT J PEPTI IN PRESS; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; HANSEN JN, 1993, ANNU REV MICROBIOL, V47, P535, DOI 10.1146/annurev.micro.47.1.535; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hesse M., 1987, SPEKTROSKOPISCHE MET, V4; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Kiesau P, 1997, J BACTERIOL, V179, P1475, DOI 10.1128/jb.179.5.1475-1481.1997; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Kuipers A, 2008, APPL ENVIRON MICROB, V74, P6591, DOI 10.1128/AEM.01334-08; Kuipers A, 2006, APPL ENVIRON MICROB, V72, P7626, DOI 10.1128/AEM.01802-06; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Mistrik P, 2004, ANAL BIOCHEM, V327, P271, DOI 10.1016/j.ab.2004.01.022; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007; Qiao M, 1996, J APPL BACTERIOL, V80, P626, DOI 10.1111/j.1365-2672.1996.tb03267.x; Qiao MQ, 1996, FEMS MICROBIOL LETT, V144, P89, DOI 10.1111/j.1574-6968.1996.tb08513.x; Ra SR, 1996, MICROBIOL-SGM, V142, P1281, DOI 10.1099/13500872-142-5-1281; Rew Y, 2002, J MED CHEM, V45, P3746, DOI 10.1021/jm020108k; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, BIOCHEMISTRY-US, V46, P13179, DOI 10.1021/bi700106z; Rink R, 2007, APPL ENVIRON MICROB, V73, P1792, DOI 10.1128/AEM.02350-06; Sen AK, 1999, EUR J BIOCHEM, V261, P524, DOI 10.1046/j.1432-1327.1999.00303.x; Shioya K, 2010, APPL MICROBIOL BIOT, V86, P891, DOI 10.1007/s00253-009-2334-8; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; SIEZEN RJ, 1995, PROTEIN ENG, V8, P117, DOI 10.1093/protein/8.2.117; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Sun ZZ, 2009, ANTIMICROB AGENTS CH, V53, P1964, DOI 10.1128/AAC.01382-08; van Saparoea HBV, 2008, APPL ENVIRON MICROB, V74, P5541, DOI 10.1128/AEM.00342-08; VANDERMEER JR, 1994, J BIOL CHEM, V269, P3555; Xie LL, 2002, BIOCHEM BIOPH RES CO, V295, P952, DOI 10.1016/S0006-291X(02)00783-0	41	44	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30552	30560		10.1074/jbc.M111.263210	http://dx.doi.org/10.1074/jbc.M111.263210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757717	Green Published, hybrid			2022-12-27	WOS:000294283600034
J	Oshikawa, G; Nagao, T; Wu, N; Kurosu, T; Miura, O				Oshikawa, Gaku; Nagao, Toshikage; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu			c-Cbl and Cbl-b Ligases Mediate 17-Allylaminodemethoxygeldanamycin-induced Degradation of Autophosphorylated Flt3 Kinase with Internal Tandem Duplication through the Ubiquitin Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MOLECULAR CHAPERONE; INHIBITOR PKC412; HSP90 INHIBITORS; TYROSINE KINASES; DOMAIN MUTATIONS; MUTANT FLT-3; AML CELLS; TRANSFORMATION	The class III receptor-tyrosine kinase Flt3 regulates normal hematopoiesis. Aninternal tandem duplication (ITD) in the juxtamembrane domain of Flt3 (Flt3-ITD) contributes to transformation and is associated with poor prognosis in acute myeloid leukemia. Here, we demonstrate that, as compared with wildtype Flt3 (Flt3-WT), Flt3-ITD more rapidly undergoes degradation through the proteasomal and lysosomal pathways in model hematopoietic 32D cells and in human leukemic MV4-11 cells. The Hsp90 inhibitor 17-allylaminodemethoxygeldanamycin (17-AAG) preferentially induced the polyubiquitination and proteasomal degradation of Flt3-ITD autophosphorylated on Tyr-591 in these cells. The E3 ubiquitin ligases c-Cbl and to a lesser extent Cbl-b facilitated at least partly Lys-48-linked polyubiquitination of autophosphorylated Flt3-ITD when coexpressed in 293T cells. Moreover, c-Cbl and Cbl-b facilitated degradation of Flt3-ITD in 293T cells and significantly enhanced the 17-AAG-induced decline in autophosphorylated Flt3-ITD. The enhancement of Flt3-ITD degradation was also observed in 32D cells inducibly overexpressing c-Cbl or Cbl-b. Furthermore, overexpression of loss-of-function mutants of both c-Cbl (c-Cbl-R420Q) and Cbl-b (Cbl-b-C373A) together in 32D cells retarded the degradation of autophosphorylated Flt3-ITD and significantly inhibited the 17-AAG-induced degradation of Flt3-ITD to confer the resistance to cytotoxicity of 17-AAG on these cells. These results suggest that c-Cbl as well as Cbl-b may play important roles in Hsp90 inhibitor-induced degradation of Flt3-ITD through the ubiquitin proteasome system and in regulation of the basal expression level of Flt3-ITD in leukemic cells.	[Oshikawa, Gaku; Nagao, Toshikage; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Miura, O (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Bali P, 2004, CLIN CANCER RES, V10, P4991, DOI 10.1158/1078-0432.CCR-04-0210; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; George P, 2004, CANCER RES, V64, P3645, DOI 10.1158/0008-5472.CAN-04-0006; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; MIURA O, 1993, MOL CELL BIOL, V13, P1788, DOI 10.1128/MCB.13.3.1788; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Padron D, 2007, CANCER RES, V67, P7695, DOI 10.1158/0008-5472.CAN-07-0484; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Robinson LJ, 2005, EXP HEMATOL, V33, P469, DOI 10.1016/j.exphem.2005.01.004; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Tsirigotis M, 2001, BIOTECHNIQUES, V31, P120, DOI 10.2144/01311rr03; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yao Q, 2005, LEUKEMIA, V19, P1605, DOI 10.1038/sj.leu.2403881; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Yao Q, 2007, CLIN CANCER RES, V13, P1591, DOI 10.1158/1078-0432.CCR-06-1750; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328	46	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30263	30273		10.1074/jbc.M111.232348	http://dx.doi.org/10.1074/jbc.M111.232348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21768087	Green Published, hybrid			2022-12-27	WOS:000294283600004
J	Samant, GV; Schupp, MO; Francois, M; Moleri, S; Kothinti, RK; Chun, CZ; Sinha, I; Sellars, S; Leigh, N; Pramanik, K; Horswill, MA; Remadevi, I; Li, KG; Wilkinson, GA; Tabatabai, NM; Beltrame, M; Koopman, P; Ramchandran, R				Samant, Ganesh V.; Schupp, Marcus O.; Francois, Mathias; Moleri, Silvia; Kothinti, Rajendra K.; Chun, Chang Zoon; Sinha, Indranil; Sellars, Suzanna; Leigh, Noah; Pramanik, Kallal; Horswill, Mark A.; Remadevi, Indulekha; Li, Keguo; Wilkinson, George A.; Tabatabai, Niloofar M.; Beltrame, Monica; Koopman, Peter; Ramchandran, Ramani			Sox Factors Transcriptionally Regulate ROBO4 Gene Expression in Developing Vasculature in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUNDANT ROLES; LYMPHATIC VASCULATURE; NEURAL CREST; IN-VIVO; PROMOTER; BINDING; MICE; MUTATIONS; RECEPTOR; CADMIUM	Despite their importance as members of the Roundabout (Robo) family in the control of axonal and vascular patterning, the transcriptional regulation of these genes is poorly understood. In this study, we show that members of the Sry-related high mobility box (Sox) transcription factor family as being transcriptional regulators of roundabout4 (robo4), a Robo gene family member that participates in sprouting angiogenesis in vivo, in zebrafish. Double whole mount in situ hybridization analysis in zebrafish embryos revealed co-localization of the vascular relevant Sox factors sox7 or sox18 mRNA with robo4 transcripts in developing intersomitic vessels. A 3-kb human ROBO4 promoter element was able to drive reporter expression in zebrafish to recapitulate the endogenous temporal intersomitic vessel expression pattern of robo4. EMSA analysis confirmed binding of Sox18 to a canonical Sox binding site (from -1170 bp to -1176 bp) in the ROBO4 promoter (3 kb), and mutation analysis indicated that this site was partially responsible for ROBO4 promoter activity in ECs. A combination of gain-and loss-of-function analysis identified Sox7 and Sox18 co-regulation of robo4 but not fli1a transcripts in zebrafish. Finally, Sox-mediated robo4 transcriptional regulation is conserved across evolution. These studies imply Sox-mediated transcriptional regulation of Robo4 in the developing embryonic vasculature.	[Samant, Ganesh V.; Schupp, Marcus O.; Chun, Chang Zoon; Sinha, Indranil; Sellars, Suzanna; Leigh, Noah; Horswill, Mark A.; Remadevi, Indulekha; Li, Keguo; Wilkinson, George A.; Ramchandran, Ramani] Med Coll Wisconsin, Div Dev Biol, Dev Vasc Biol Program, Dept Pediat,Childrens Res Inst, Milwaukee, WI 53226 USA; [Francois, Mathias; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Pramanik, Kallal] Prescient Life Sci, New Delhi 122002, India; [Moleri, Silvia; Beltrame, Monica] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-2620133 Milan, Italy; [Kothinti, Rajendra K.; Tabatabai, Niloofar M.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Kothinti, Rajendra K.; Tabatabai, Niloofar M.] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; University of Queensland; University of Milan; Medical College of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu	moleri, silvia/AAA-8523-2020; Koopman, Peter A/C-9416-2009; Beltrame, Monica/D-8093-2017; francois, mathias/A-9604-2014	Koopman, Peter A/0000-0001-6939-0914; francois, mathias/0000-0002-9846-6882; Beltrame, Monica/0000-0001-5094-3494; MOLERI, SILVIA/0000-0003-2277-1378	National Institutes of Health [HL090712]; Advancing Healthier Wisconsin grant; Children's Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing Healthier Wisconsin grant; Children's Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL090712 and an administrative supplement to HL090712 (to R.R.). This work was also supported by an Advancing Healthier Wisconsin grant and Children's Research Institute seed funds (to R.R.).	Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kothinti RK, 2010, TOXICOL APPL PHARM, V244, P254, DOI 10.1016/j.taap.2009.12.038; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Tabatabai NA, 2005, TOXICOLOGY, V207, P369, DOI 10.1016/j.tox.2004.10.007; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299	25	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30740	30747		10.1074/jbc.M111.220665	http://dx.doi.org/10.1074/jbc.M111.220665			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730073	Green Published, hybrid			2022-12-27	WOS:000294283600054
J	Sakurai, A; Jian, XY; Lee, CJ; Manavski, Y; Chavakis, E; Donaldson, J; Randazzo, PA; Gutkind, JS				Sakurai, Atsuko; Jian, Xiaoying; Lee, Charity J.; Manavski, Yosif; Chavakis, Emmanouil; Donaldson, Julie; Randazzo, Paul A.; Gutkind, J. Silvio			Phosphatidylinositol-4-phosphate 5-Kinase and GEP100/Brag2 Protein Mediate Antiangiogenic Signaling by Semaphorin 3E-Plexin-D1 through Arf6 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; POSTSYNAPTIC DENSITY; ACTIN CYTOSKELETON; TUMOR ANGIOGENESIS; CELL-ADHESION; MEMBRANE; DOMAIN; ALPHA; 4,5-BISPHOSPHATE; ENDOCYTOSIS	The semaphorins are a family of secreted or membrane-bound proteins that are known to guide axons in the developing nervous system. Genetic evidence revealed that a class III semaphorin, semaphorin 3E (Sema3E), and its receptor Plexin-D1 also control the vascular patterning during development. At the molecular level, we have recently shown that Sema3E acts on Plexin-D1 expressed in endothelial cells, thus initiating a novel antiangiogenic signaling pathway that results in the retraction of filopodia in endothelial tip cells. Sema3E induces the rapid disassembly of integrin-mediated adhesive structures, thereby inhibiting endothelial cell adhesion to the extracellular matrix. This process requires the activation of small GTPase Arf6 (ADP-ribosylation factor 6), which regulates intracellular trafficking of beta 1 integrin. However, the molecular mechanisms by which Sema3E-Plexin-D1 activates Arf6 remained to be identified. Here we show that GEP100 (guanine nucleotide exchange protein 100)/Brag2, a guanine nucleotide exchange factor for Arf6, mediates Sema3E-induced Arf6 activation in endothelial cells. We provide evidence that upon activation by Sema3E, Plexin-D1 recruits phosphatidylinositol-4-phosphate 5-kinase, and its enzymatic lipid product, phosphatidylinositol 4,5-bisphosphate, binds to the pleckstrin homology domain of GEP100. Phosphatidylinositol 4,5-bisphosphate binding to GEP100 enhances its guanine nucleotide exchange factor activity toward Arf6, thus resulting in the disassembly of integrin-mediated focal adhesions and endothelial cell collapse. Our present study reveals a novel phospholipid-regulated antiangiogenic signaling pathway whereby Sema3E activates Arf6 through Plexin-D1 and consequently controls integrin-mediated endothelial cell attachment to the extracellular matrix and migration.	[Sakurai, Atsuko; Lee, Charity J.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Manavski, Yosif; Chavakis, Emmanouil] Goethe Univ, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany; [Chavakis, Emmanouil] Goethe Univ Frankfurt, Dept Internal Med 3, D-6000 Frankfurt, Germany; [Donaldson, Julie] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	National Institute of Dental and Craniofacial Research; Japan Society for the Promotion of Science; Deutsche Forschungsgemeinschaft [TR-SFB23, A2]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a National Institutes of the extracellular matrix and causing the retraction of filopodia Health grant from Intramural Research Program of the National Institute of Dental and Craniofacial Research.; Supported by Japan Society for the Promotion of Science postdoctoral fellowships for research abroad.; Supported by Deutsche Forschungsgemeinschaft Grant TR-SFB23, Project A2.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Bhatt A, 2002, J CELL SCI, V115, P3415; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Derrien V, 2002, J CELL SCI, V115, P2867; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gay CM, 2011, DEV BIOL, V349, P1, DOI 10.1016/j.ydbio.2010.09.008; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Inaba Y, 2004, J NEUROCHEM, V89, P1347, DOI 10.1111/j.1471-4159.2004.02440.x; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2010, J BIOL CHEM, V285, P30698, DOI 10.1074/jbc.M110.107458; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	45	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34335	34345		10.1074/jbc.M111.259499	http://dx.doi.org/10.1074/jbc.M111.259499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795701	hybrid, Green Published			2022-12-27	WOS:000295159200062
J	Fauquant, C; Redeker, V; Landrieu, I; Wieruszeski, JM; Verdegem, D; Laprevote, O; Lippens, G; Gigant, B; Knossow, M				Fauquant, Caroline; Redeker, Virginie; Landrieu, Isabelle; Wieruszeski, Jean-Michel; Verdegem, Dries; Laprevote, Olivier; Lippens, Guy; Gigant, Benoit; Knossow, Marcel			Systematic Identification of Tubulin-interacting Fragments of the Microtubule-associated Protein Tau Leads to a Highly Efficient Promoter of Microtubule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATHMIN-LIKE DOMAIN; DYNAMIC INSTABILITY; PROJECTION DOMAIN; BINDING DOMAINS; COMPLEX; PHOSPHORYLATION; TAUOPATHIES; ISOFORMS; DISEASE; REGIONS	Tau is a microtubule-associated protein that stabilizes microtubules and stimulates their assembly. Current descriptions of the tubulin-interacting regions of Tau involve microtubules as the target and result mainly from deletions of Tau domains based on sequence analysis and from NMR spectros-copy experiments. Here, instead of microtubules, we use the complex of two tubulin heterodimers with the stathmin-like domain of the RB3 protein (T2R) to identify interacting Tau fragments generated by limited proteolysis. We show that fragments in the proline-rich region and in the microtubule-binding repeats domain each interact on their own not only with T2R but also with microtubules, albeit with moderate affinity. NMR analysis of the interaction with T2R of constructs in these two regions leads to a fragment, composed of adjacent parts of the microtubule-binding repeat domain and of the proline-rich region, that binds tightly to stabilized microtubules. This demonstrates the synergy of the two Tau regions we identified in the Tau-microtubule interaction. Moreover, we show that this fragment, which binds to two tubulin heterodimers, stimulates efficiently microtubule assembly.	[Fauquant, Caroline; Redeker, Virginie; Gigant, Benoit; Knossow, Marcel] CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Landrieu, Isabelle; Wieruszeski, Jean-Michel; Verdegem, Dries; Lippens, Guy] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, UMR CNRS 8576, IFR 147, F-59655 Villeneuve Dascq, France; [Laprevote, Olivier] CNRS, Lab Spectrometrie Masse, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Gigant, B (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr; knossow@lebs.cnrs-gif.fr	Landrieu, Isabelle/AAF-8495-2019; Redeker, Virginie/L-8929-2018	Landrieu, Isabelle/0000-0002-4883-2637; Redeker, Virginie/0000-0003-2694-8388; Gigant, Benoit/0000-0002-5946-6759; Lippens, Guy/0000-0002-8236-0901	CNRS; Agence Nationale pour la Recherche [ANR-05-Blanc-6320-01]; Equipments RMN THC [Fr3050]; Fondation pour la Recherche Medicale [DEQ20081213979]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Equipments RMN THC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS, Agence Nationale pour la Recherche Grant ANR-05-Blanc-6320-01, Tres Grands Equipments RMN THC Fr3050, and Fondation pour la Recherche Medicale Grant DEQ20081213979.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Avila J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00049; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Black MM, 1996, J NEUROSCI, V16, P3601; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRANDT R, 1993, J BIOL CHEM, V268, P3414; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cao BR, 2009, BIOMACROMOLECULES, V10, P555, DOI 10.1021/bm801224q; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2002, FEBS LETT, V529, P341, DOI 10.1016/S0014-5793(02)03421-X; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; Dehmelt L, 2005, GENOME BIOL, V6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; Mukhopadhyay R, 2001, FEBS LETT, V505, P374, DOI 10.1016/S0014-5793(01)02844-7; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Preuss U, 1997, J CELL SCI, V110, P789; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x	47	43	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33358	33368		10.1074/jbc.M111.223545	http://dx.doi.org/10.1074/jbc.M111.223545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757739	Green Published, hybrid			2022-12-27	WOS:000294968800054
J	Fan, ACY; Kozlov, G; Hoegl, A; Marcellus, RC; Wong, MJH; Gehring, K; Young, JC				Fan, Anna C. Y.; Kozlov, Guennadi; Hoegl, Annabelle; Marcellus, Richard C.; Wong, Michael J. H.; Gehring, Kalle; Young, Jason C.			Interaction between the Human Mitochondrial Import Receptors Tom20 and Tom70 in Vitro Suggests a Chaperone Displacement Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; OUTER-MEMBRANE; PREPROTEIN TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; ADP/ATP CARRIER; COMPLEX; PRESEQUENCE; RECOGNITION; DOMAIN	The mitochondrial import receptor Tom70 contains a tetratricopeptide repeat (TPR) clamp domain, which allows the receptor to interact with the molecular chaperones, Hsc70/Hsp70 and Hsp90. Preprotein recognition by Tom70, a critical step to initiate import, is dependent on these cytosolic chaperones. Preproteins are subsequently released from the receptor for translocation across the outer membrane, yet the mechanism of this step is unknown. Here, we report that Tom20 interacts with the TPR clamp domain of Tom70 via a conserved C-terminal DDVE motif. This interaction was observed by cross-linking endogenous proteins on the outer membrane of mitochondria from HeLa cells and in co-precipitation and NMR titrations with purified proteins. Upon mutation of the TPR clamp domain or deletion of the DDVE motif, the interaction was impaired. In co-precipitation experiments, the Tom20-Tom70 interaction was inhibited by C-terminal peptides from Tom20, as well as from Hsc70 and Hsp90. The Hsp90-Tom70 interaction was measured with surface plasmon resonance, and the same peptides inhibited the interaction. Thus, Tom20 competes with the chaperones for Tom70 binding. Interestingly, antibody blocking of Tom20 did not increase the efficiency of Tom70-dependent preprotein import; instead, it impaired the Tom70 import pathway in addition to the Tom20 pathway. The functional interaction between Tom20 and Tom70 may be required at a later step of the Tom70-mediated import, after chaperone docking. We suggest a novel model in which Tom20 binds Tom70 to facilitate preprotein release from the chaperones by competition.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Young, JC (corresponding author), 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	jason.young2@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The work was supported by the Canadian Institutes of Health Research and the Canadian Foundation for Innovation.	Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chewawiwat N, 1999, J BIOCHEM, V125, P721, DOI 10.1093/oxfordjournals.jbchem.a022342; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Fan ACY, 2010, BIOCHEM J, V429, P553, DOI 10.1042/BJ20091855; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Haucke V, 1996, EMBO J, V15, P1231, DOI 10.1002/j.1460-2075.1996.tb00464.x; Igura M, 2005, ACTA CRYSTALLOGR F, V61, P514, DOI 10.1107/S1744309105011577; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; Truscott KN, 2002, MOL CELL BIOL, V22, P7780, DOI 10.1128/MCB.22.22.7780-7789.2002; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Yang CS, 2002, ARCH BIOCHEM BIOPHYS, V400, P105, DOI 10.1006/abbi.2002.2778; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; ZARA V, 1992, J BIOL CHEM, V267, P12077	48	34	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32208	32219		10.1074/jbc.M111.280446	http://dx.doi.org/10.1074/jbc.M111.280446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771790	hybrid, Green Published			2022-12-27	WOS:000294726800031
J	Bahudhanapati, H; Zhang, YN; Sidhu, SS; Brew, K				Bahudhanapati, Harinath; Zhang, Yingnan; Sidhu, Sachdev S.; Brew, Keith			Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) IDENTIFICATION OF SELECTIVE INHIBITORS OF COLLAGENASE-1 (METALLOPROTEINASE 1 (MMP-1))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KUNITZ DOMAIN INHIBITORS; ALPHA-CONVERTING-ENZYME; FACTOR-FACTOR VIIA; MATRIX-METALLOPROTEINASES; CRYSTAL-STRUCTURE; ITERATIVE OPTIMIZATION; CATALYTIC DOMAIN; POTENT INHIBITOR; BREAST-CANCER; SWISS-MODEL	Tissue inhibitor of metalloproteinases-2 (TIMP-2) is a broad spectrum inhibitor of the matrix metalloproteinases (MMPs), which function in extracellular matrix catabolism. Here, phage display was used to identify variants of human TIMP-2 that are selective inhibitors of human MMP-1, a collagenase whose unregulated action is linked to cancer, arthritis, and fibrosis. Using hard randomization of residues 2, 4, 5, and 6 (L1) and soft randomization of residues 34-40 (L2) and 67-70 (L3), a library was generated containing 2 x 10(10) variants of TIMP-2. Five clones were isolated after five rounds of selection with MMP-1, using MMP-3 as a competitor. The enriched phages selectively bound MMP-1 relative to MMP-3 and contained mutations only in L1. The most selective variant (TM8) was used to generate a second library in which residues Cys(1)-Gln(9) were soft-randomized. Four additional clones, selected from this library, showed a similar affinity for MMP-1 as wild-type TIMP-2 but reduced affinity for MMP-3. Variants of the N-terminal domain of TIMP-2 (N-TIMP-2) with the sequences of the most selective clones were expressed and characterized for inhibitory activity against eight MMPs. All were effective inhibitors of MMP-1 with nanomolar K-i values, but TM8, containing Ser(2) to Asp and Ser(4) to Ala substitutions, was the most selective having a nanomolar K-i value for MMP-1 but no detectable inhibitory activity toward MMP-3 and MMP-14 up to 10 mu M. This study suggests that phage display and selection with other MMPs may be an effective method for discovering tissue inhibitor of metalloproteinase variants that discriminate between specified MMPs as targets.	[Bahudhanapati, Harinath; Brew, Keith] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Basic Sci, Boca Raton, FL 33431 USA; [Zhang, Yingnan; Sidhu, Sachdev S.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	State University System of Florida; Florida Atlantic University; Roche Holding; Genentech	Brew, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Izal, María/B-7398-2011; Brew, Keith/W-1643-2019; Brew, Keith/A-6746-2009	Brew, Keith/0000-0003-1306-1032	National Institutes of Health [R01 AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR40994 (to K. B.).	Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; DENNIS MS, 1994, J BIOL CHEM, V269, P22129; DENNIS MS, 1994, J BIOL CHEM, V269, P22137; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gardsvoll H, 1998, FEBS LETT, V431, P170, DOI 10.1016/S0014-5793(98)00742-X; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Markland W, 1996, BIOCHEMISTRY-US, V35, P8058, DOI 10.1021/bi952629y; Markland W, 1996, BIOCHEMISTRY-US, V35, P8045, DOI 10.1021/bi9526286; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Van Doren SR, 2008, BIOPOLYMERS, V89, P960, DOI 10.1002/bip.21043; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang CI, 1996, METHOD ENZYMOL, V267, P52; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Welch AR, 1996, BIOCHEMISTRY-US, V35, P10103, DOI 10.1021/bi9601969; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; WITTY JP, 1995, CANCER RES, V55, P1401; Wu Y, 2011, J BIOL CHEM, V286, P16891, DOI 10.1074/jbc.M111.222307; Zhang JP, 2005, BIOTECHNOL PROGR, V21, P1220, DOI 10.1021/bp0500359	41	28	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31761	31770		10.1074/jbc.M111.253328	http://dx.doi.org/10.1074/jbc.M111.253328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21715326	Green Published, hybrid			2022-12-27	WOS:000294487500069
J	Candela, T; Maes, E; Garenaux, E; Rombouts, Y; Krzewinski, F; Gohar, M; Guerardel, Y				Candela, Thomas; Maes, Emmanuel; Garenaux, Estelle; Rombouts, Yoann; Krzewinski, Frederic; Gohar, Michel; Guerardel, Yann			Environmental and Biofilm-dependent Changes in a Bacillus cereus Secondary Cell Wall Polysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DNA; NMR-SPECTROSCOPY; ANTHRACIS; PROTEINS; SUBTILIS; STRAINS; STAPHYLOCOCCUS; PEPTIDOGLYCAN; THURINGIENSIS; SPORULATION	Bacterial species from the Bacillus genus, including Bacillus cereus and Bacillus anthracis, synthesize secondary cell wall polymers (SCWP) covalently associated to the peptidoglycan through a phospho-diester linkage. Although such components were observed in a wide panel of B. cereus and B. anthracis strains, the effect of culture conditions or of bacterial growth state on their synthesis has never been addressed. Herein we show that B. cereus ATCC 14579 can synthesize not only one, as previously reported, but two structurally unrelated secondary cell wall polymers (SCWP) polysaccharides. The first of these SCWP, -> 4)[GlcNAc(beta 1-3)]GlcNAc(beta 1-6)[Glc(beta 1-3)][ManNAc(alpha 1-4)]GalNAc(alpha 1-4) ManNAc(beta 1 ->, although presenting an original sequence, fits to the already described the canonical sequence motif of SCWP. In contrast, the second polysaccharide was made up by a totally original sequence, -> 6)-Gal(alpha 1-2)(2-R-hydroxyglutar-5-ylamido) Fuc2NAc4N(alpha 1-6) GlcNAc(beta 1 ->, which no equivalent has ever been identified in the Bacillus genus. In addition, we established that the syntheses of these two polysaccharides were differently regulated. The first one is constantly expressed at the surface of the bacteria, whereas the expression of the second is tightly regulated by culture conditions and growth states, planktonic, or biofilm.	[Maes, Emmanuel; Garenaux, Estelle; Rombouts, Yoann; Krzewinski, Frederic; Guerardel, Yann] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Maes, Emmanuel; Garenaux, Estelle; Rombouts, Yoann; Krzewinski, Frederic; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Candela, Thomas; Gohar, Michel] INRA, UMR1319, F-78352 Jouy En Josas, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guerardel, Y (corresponding author), Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France.	yann.guerardel@univ-lille1.fr	Candela, Thomas/ABA-6367-2021; Candela, Thomas/AAC-9583-2021	GOHAR, Michel/0000-0001-8341-3297; Guerardel, Yann/0000-0003-4967-9512; Krzewinski, Frederic/0000-0003-1491-6899; Candela, thomas/0000-0002-4686-2533; Rombouts, Yoann/0000-0003-4482-2199	Conseil Regional Nord-Pas de Calais ARCir; Ministere de l'Enseignement Superieur; Region Ile de France; TGE RMN THC [Fr3050]; Region Nord-Pas de Calais; European Union; Ministere Francais de la Recherche; Universite Lille1-Sciences and Technologies; CNRS; Centre Commun de Mesure RMN de l'Universite de Lille1	Conseil Regional Nord-Pas de Calais ARCir(Region Hauts-de-FranceRegion Ile-de-France); Ministere de l'Enseignement Superieur; Region Ile de France(Region Ile-de-France); TGE RMN THC; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); European Union(European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Universite Lille1-Sciences and Technologies; CNRS(Centre National de la Recherche Scientifique (CNRS)); Centre Commun de Mesure RMN de l'Universite de Lille1	This work was supported by the Conseil Regional Nord-Pas de Calais ARCir (to Y. G.), the Ministere de l'Enseignement Superieur (to Y. R.), and the Region Ile de France (to T. C.). Research on the 800 and 900 MHz spectrometers was supported by the TGE RMN THC Fr3050.; We thank I. G. Boneca from the Institut Pasteur for the analysis of peptidoglycans by HPLC, B. Coddeville from Unite de Glycobiologie Structurale et Fonctionnelle for helping in the MS/MS analysis of polysaccharides, and Prof. A. Dell for providing access to mass spectrometry facility (Division of Molecular Biosciences, Faculty of Natural Sciences, Imperial College London). The 800- and 900-MHz spectrometers were funded by Region Nord-Pas de Calais, European Union (FEDER), Ministere Francais de la Recherche, Universite Lille1-Sciences and Technologies, and CNRS. The 400 MHz facility was funded by the Centre Commun de Mesure RMN de l'Universite de Lille1.	Antikainen J, 2002, MOL MICROBIOL, V46, P381, DOI 10.1046/j.1365-2958.2002.03180.x; Archibald A. R., 1993, P381; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BRADBURY JH, 1984, CARBOHYD RES, V126, P125, DOI 10.1016/0008-6215(84)85131-9; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Chitlaru T, 2004, PROTEOMICS, V4, P677, DOI 10.1002/pmic.200300575; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Forsberg LS, 2011, GLYCOBIOLOGY, V21, P934, DOI 10.1093/glycob/cwr026; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guerardel Y, 2004, J BIOL CHEM, V279, P15591, DOI 10.1074/jbc.M308928200; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; KOERNER TAW, 1987, METHOD ENZYMOL, V138, P38; Kolter R, 2005, TRENDS MICROBIOL, V13, P1, DOI 10.1016/j.tim.2004.11.003; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; LANG WK, 1982, J BACTERIOL, V151, P367, DOI 10.1128/JB.151.1.367-375.1982; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; LECADET MM, 1980, J GEN MICROBIOL, V121, P203; Lee K, 2007, MICROBIOL-SGM, V153, P1693, DOI 10.1099/mic.0.2006/003376-0; Lee REB, 2005, GLYCOBIOLOGY, V15, P139, DOI 10.1093/glycob/cwh150; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Leoff C, 2009, GLYCOBIOLOGY, V19, P665, DOI 10.1093/glycob/cwp036; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Maes E, 2009, J BIOCHEM, V145, P413, DOI 10.1093/jb/mvp008; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Peng JS, 2002, INT J FOOD MICROBIOL, V77, P11, DOI 10.1016/S0168-1605(02)00060-0; Ren DC, 2004, BIOTECHNOL BIOENG, V86, P344, DOI 10.1002/bit.20053; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Vinogradov E, 2003, EUR J BIOCHEM, V270, P1810, DOI 10.1046/j.1432-1033.2003.03543.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	45	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31250	31262		10.1074/jbc.M111.249821	http://dx.doi.org/10.1074/jbc.M111.249821			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784857	Green Published, hybrid			2022-12-27	WOS:000294487500020
J	Carrasco-Lopez, C; Rojas-Altuve, A; Zhang, WL; Hesek, D; Lee, M; Barbe, S; Andre, I; Ferrer, P; Silva-Martin, N; Castro, GR; Martinez-Ripoll, M; Mobashery, S; Hermoso, JA				Carrasco-Lopez, Cesar; Rojas-Altuve, Alzoray; Zhang, Weilie; Hesek, Dusan; Lee, Mijoon; Barbe, Sophie; Andre, Isabelle; Ferrer, Pilar; Silva-Martin, Noella; Castro, German R.; Martinez-Ripoll, Martin; Mobashery, Shahriar; Hermoso, Juan A.			Crystal Structures of Bacterial Peptidoglycan Amidase AmpD and an Unprecedented Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITROBACTER-FREUNDII AMPD; GRAM-NEGATIVE BACTERIA; RECOGNITION PROTEIN-S; L-ALANINE AMIDASE; PATTERN-RECOGNITION; ESCHERICHIA-COLI; DROSOPHILA-MELANOGASTER; MOLECULAR-DYNAMICS; FORCE-FIELD; BINDING	AmpD is a cytoplasmic peptidoglycan (PG) amidase involved in bacterial cell-wall recycling and in induction of beta-lactamase, a key enzyme of beta-lactam antibiotic resistance. AmpD belongs to the amidase_2 family that includes zinc-dependent amidases and the peptidoglycan-recognition proteins (PGRPs), highly conserved pattern-recognition molecules of the immune system. Crystal structures of Citrobacter freundii AmpD were solved in this study for the apoenzyme, for the holoenzyme at two different pH values, and for the complex with the reaction products, providing insights into the PG recognition and the catalytic process. These structures are significantly different compared with the previously reported NMR structure for the same protein. The NMR structure does not possess an accessible active site and shows the protein in what is proposed herein as an inactive "closed" conformation. The transition of the protein from this inactive conformation to the active "open" conformation, as seen in the x-ray structures, was studied by targeted molecular dynamics simulations, which revealed large conformational rearrangements (as much as 17 angstrom) in four specific regions representing one-third of the entire protein. It is proposed that the large conformational change that would take the inactive NMR structure to the active x-ray structure represents an unprecedented mechanism for activation of AmpD. Analysis is presented to argue that this activation mechanism might be representative of a regulatory process for other intracellular members of the bacterial amidase_2 family of enzymes.	[Carrasco-Lopez, Cesar; Rojas-Altuve, Alzoray; Silva-Martin, Noella; Martinez-Ripoll, Martin; Hermoso, Juan A.] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, E-28006 Madrid, Spain; [Zhang, Weilie; Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Barbe, Sophie; Andre, Isabelle] LISBP, INP, UPS, INSA, F-31077 Toulouse, France; [Barbe, Sophie; Andre, Isabelle] CNRS, UMR5504, F-31400 Toulouse, France; [Barbe, Sophie; Andre, Isabelle] Univ Toulouse, INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Ferrer, Pilar; Castro, German R.] European Synchrotron Radiat Facil, SpLine Spanish CRG Beamline, F-38043 Grenoble, France; [Ferrer, Pilar; Castro, German R.] CSIC, ICMM, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Notre Dame; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Mobashery, S (corresponding author), Serrano 119, Madrid 28006, Spain.	mobashery@nd.edu; xjuan@iqfr.csic.es	Hermoso, Juan/J-3433-2012; Castro, German/AAG-7411-2020; Castro, German R/H-6679-2015; Lee, Mijoon/AFK-1543-2022; Martinez-Ripoll, Martin/A-8313-2012; Ferrer, Pilar/E-7836-2014; Barbe, Sophie/ABD-9530-2020	Hermoso, Juan/0000-0002-1862-8950; Castro, German/0000-0003-4251-3245; Castro, German R/0000-0003-4251-3245; Lee, Mijoon/0000-0001-7432-0427; Martinez-Ripoll, Martin/0000-0002-4019-0529; Ferrer, Pilar/0000-0001-9807-7679; Carrasco-Lopez, Cesar/0000-0002-3853-8776; Barbe, Sophie/0000-0003-2581-5022	National Institutes of Health; Spanish Ministry of Science and Technology [BFU2008-01711]; European Union [EU-CP223111]; COMBACT program [S-BIO-0260/2006]; Spanish Ministerio de Ciencia e Innovacion [PI201060E013]; Consejo Superior de Investigaciones Cientificas	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); COMBACT program; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by grants from the Spanish Ministry of Science and Technology (BFU2008-01711), EU-CP223111 (CARE-PNEUMO, European Union), and the COMBACT program (S-BIO-0260/2006). We acknowledge the Spanish Ministerio de Ciencia e Innovacion (PI201060E013) and Consejo Superior de Investigaciones Cientificas for financial support and for provision of synchrotron radiation facilities.	ADAMS PD, 2010, ACTA CRYSTALLOGR D 2, V66, P213, DOI DOI 10.1107/S0907444909052925; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro GR, 1998, J SYNCHROTRON RADIAT, V5, P657, DOI 10.1107/S0909049597019079; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COWTAN K, 1994, JOINT CCP4 ESF EACBM, P31; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; DELEON JM, 1991, PHYS REV B, V44, P4146, DOI 10.1103/PhysRevB.44.4146; Doyle R.J., 2001, MOL MED MICROBIOLOGY, P137; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS P, 1993, CCP4 DARESBURY STUDY, P114; Genereux C, 2004, BIOCHEM J, V377, P111, DOI 10.1042/BJ20030862; GROCHULSKI P, 1994, PROTEIN SCI, V3, P82; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hesek D, 2009, J AM CHEM SOC, V131, P5187, DOI 10.1021/ja808498m; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Liepinsh E, 2003, J MOL BIOL, V327, P833, DOI 10.1016/S0022-2836(03)00185-2; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrosino JF, 2002, ANTIMICROB AGENTS CH, V46, P1535, DOI 10.1128/AAC.46.5.1535-1539.2002; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wiedemann B, 1998, DRUG RESIST UPDATE, V1, P223, DOI 10.1016/S1368-7646(98)80002-2; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	54	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31714	31722		10.1074/jbc.M111.264366	http://dx.doi.org/10.1074/jbc.M111.264366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775432	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000294487500064
J	Sharma, P; Dube, D; Sinha, M; Mishra, B; Dey, S; Mal, G; Pathak, KML; Kaur, P; Sharma, S; Singh, TP				Sharma, Pradeep; Dube, Divya; Sinha, Mau; Mishra, Biswajit; Dey, Sharmistha; Mal, Gorakh; Pathak, Krishan M. L.; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Multiligand Specificity of Pathogen-associated Molecular Pattern-binding Site in Peptidoglycan Recognition Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EXPRESSION; FAMILY; GENE; PGRP	The peptidoglycan recognition protein PGRP-S is an innate immunity molecule that specifically interacts with microbial peptidoglycans and other pathogen-associated molecular patterns. We report here two structures of the unique tetrameric camel PGRP-S (CPGRP-S) complexed with (i) muramyl dipeptide (MDP) at 2.5 angstrom resolution and (ii) GlcNAc and beta-maltose at 1.7 angstrom resolution. The binding studies carried out using surface plasmon resonance indicated that CPGRP-S binds to MDP with a dissociation constant of 10(-7) M, whereas the binding affinities for GlcNAc and beta-maltose separately are in the range of 10(-4) M to 10(-5) M, whereas the dissociation constant for the mixture of GlcNAc and maltose was estimated to be 10(-6) M. The data from bacterial suspension culture experiments showed a significant inhibition of the growth of Staphylococcus aureus cells when CPGRP-S was added to culture medium. The ELISA experiment showed that the amount of MDP-induced production of TNF-alpha and IL-6 decreased considerably after the introduction of CPGRP-S. The crystal structure determinations of (i) a binary complex with MDP and (ii) a ternary complex with GlcNAc and beta-maltose revealed that MDP, GlcNAc, and beta-maltose bound to CPGRP-S in the ligand binding cleft, which is situated at the interface of molecules C and D of the homotetramer formed by four protein molecules A, B, C, and D. In the binary complex, the muramyl moiety of MDP is observed at the C-D interface, whereas the peptide chain protrudes into the center of tetramer. In the ternary complex, GlcNAc and beta-maltose occupy distinct non-overlapping positions belonging to different subsites.	[Sharma, Pradeep; Dube, Divya; Sinha, Mau; Mishra, Biswajit; Dey, Sharmistha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Mal, Gorakh; Pathak, Krishan M. L.] Natl Res Ctr Camel, Bikaner 334001, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Camel	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160	Departments of Science and Technology; Department of Biotechnology, Ministry of Science and Technology (government of India, New Delhi); Council of Scientific and Industrial Research, New Delhi	Departments of Science and Technology; Department of Biotechnology, Ministry of Science and Technology (government of India, New Delhi)(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Departments of Science and Technology and Department of Biotechnology, Ministry of Science and Technology (government of India, New Delhi) and the Council of Scientific and Industrial Research, New Delhi (to P. S. and M. S.).	BAO ZZ, 1992, J BIOL CHEM, V267, P4974; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Xu XN, 2002, J IMMUNOL METHODS, V268, P21, DOI 10.1016/S0022-1759(02)00196-5	24	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31723	31730		10.1074/jbc.M111.264374	http://dx.doi.org/10.1074/jbc.M111.264374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784863	Green Published, hybrid			2022-12-27	WOS:000294487500065
J	Nam, KH; Kurinov, I; Ke, AL				Ki Hyun Nam; Kurinov, Igor; Ke, Ailong			Crystal Structure of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated Csn2 Protein Revealed Ca2+-dependent Double-stranded DNA Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; IMMUNE-SYSTEM; SMALL RNA; CRISPR; BACTERIA; SEQUENCE; DEFENSE; CONSERVATION	Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated protein genes (cas genes) are widespread in bacteria and archaea. They form a line of RNA-based immunity to eradicate invading bacteriophages and malicious plasmids. A key molecular event during this process is the acquisition of new spacers into the CRISPR loci to guide the selective degradation of the matching foreign genetic elements. Csn2 is a Nmeni subtype-specific cas gene required for new spacer acquisition. Here we characterize the Enterococcus faecalis Csn2 protein as a double-stranded (ds-) DNA-binding protein and report its 2.7 angstrom tetrameric ring structure. The inner circle of the Csn2 tetrameric ring is similar to 26 angstrom wide and populated with conserved lysine residues poised for nonspecific interactions with ds-DNA. Each Csn2 protomer contains an alpha/beta domain and an alpha-helical domain; significant hinge motion was observed between these two domains. Ca2+ was located at strategic positions in the oligomerization interface. We further showed that removal of Ca2+ ions altered the oligomerization state of Csn2, which in turn severely decreased its affinity for ds-DNA. In summary, our results provided the first insight into the function of the Csn2 protein in CRISPR adaptation by revealing that it is a ds-DNA-binding protein functioning at the quaternary structure level and regulated by Ca2+ ions.	[Ki Hyun Nam; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Kurinov, Igor] Cornell Univ, NE CAT, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Cornell University; Cornell University	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ak425@cornell.edu	Nam, Ki Hyun/N-6812-2019	Nam, Ki Hyun/0000-0003-3268-354X	National Institutes of Health [GM-086766, GM-059604]; Korean Ministry of Education, Science and Technology [NRF-2010-357-C00106]; National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102543, R01GM059604, R01GM086766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-086766 and GM-059604 throughout the Public Health Service (to A.K.). This work was also supported by the National Research Foundation of Korea Grant NRF-2010-357-C00106 from the Korean Ministry of Education, Science and Technology (to K.H.N.).; We thank the beam line staff at Advanced Photon Source ID24 and Macromolecular Diffraction at Cornell High Energy Synchrotron Source for assistance in data collection and Matthew Bratkowski for helpful discussions and comments on the manuscript. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beam lines, which are supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (U.S. DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	38	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30759	30768		10.1074/jbc.M111.256263	http://dx.doi.org/10.1074/jbc.M111.256263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21697083	Green Published, hybrid			2022-12-27	WOS:000294283600056
J	Melton, EM; Cerny, RL; Watkins, PA; Dirusso, CC; Black, PN				Melton, Elaina M.; Cerny, Ronald L.; Watkins, Paul A.; Dirusso, Concetta C.; Black, Paul N.			Human Fatty Acid Transport Protein 2a/Very Long Chain Acyl-CoA Synthetase 1 (FATP2a/Acsvl1) Has a Preference in Mediating the Channeling of Exogenous n-3 Fatty Acids into Phosphatidylinositol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; COENZYME-A; VECTORIAL ACYLATION; CELLULAR UPTAKE; HEPG2 CELLS; METABOLISM; SYSTEM; COMPONENTS; MUTATIONS	The trafficking of fatty acids across the membrane and into downstream metabolic pathways requires their activation to CoA thioesters. Members of the fatty acid transport protein/very long chain acyl-CoA synthetase (FATP/Acsvl) family are emerging as key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. We have expressed two naturally occurring splice variants of human FATP2 (Acsvl1) in yeast and 293T-REx cells and addressed their roles in fatty acid transport, activation, and intracellular trafficking. Although both forms (FATP2a (M-r 70,000) and FATP2b (M-r 65,000 and lacking exon3, which encodes part of the ATP binding site)) were functional in fatty acid import, only FATP2a had acyl-CoA synthetase activity, with an apparent preference toward very long chain fatty acids. To further address the roles of FATP2a or FATP2b in fatty acid uptake and activation, LC-MS/MS was used to separate and quantify different acyl-CoA species (C14-C24) and to monitor the trafficking of different classes of exogenous fatty acids into intracellular acyl-CoA pools in 293T-REx cells expressing either isoform. The use of stable isotopically labeled fatty acids demonstrated FATP2a is involved in the uptake and activation of exogenous fatty acids, with a preference toward n-3 fatty acids (C18:3 and C22:6). Using the same cells expressing FATP2a or FATP2b, electrospray ionization/MS was used to follow the trafficking of stable isotopically labeled n-3 fatty acids into phosphatidylcholine and phosphatidylinositol. The expression of FATP2a resulted in the trafficking of C18:3-CoA and C22:6-CoA into both phosphatidylcholine and phosphatidylinositol but with a distinct preference for phosphatidylinositol. Collectively these data demonstrate FATP2a functions in fatty acid transport and activation and provides specificity toward n-3 fatty acids in which the corresponding n-3 acyl-CoAs are preferentially trafficked into acyl-CoA pools destined for phosphatidylinositol incorporation.	[Black, Paul N.] Univ Nebraska, Dept Biochem, George W Beadle Ctr N200, Lincoln, NE 68588 USA; [Cerny, Ronald L.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Melton, Elaina M.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Watkins, Paul A.] Kennedy Krieger Res Inst, Baltimore, MD 21205 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Albany Medical College; Kennedy Krieger Institute	Black, PN (corresponding author), Univ Nebraska, Dept Biochem, George W Beadle Ctr N200, Lincoln, NE 68588 USA.	pblack2@unl.edu	DiRusso, Concetta C/M-1884-2014	Black, Paul/0000-0002-6272-6881; DiRusso, Concetta/0000-0001-7388-9152; Watkins, Paul A./0000-0002-3246-1405; Melton, Elaina/0000-0002-4030-7766	National Institutes of Health [RO1-DK07076, RO1-GM56850, 1F31DK085961]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK085961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK07076 and RO1-GM56850 (to P. N. B. and C. C. D.) and 1F31DK085961 (to E. M. M.).	Alderson NL, 2005, J LIPID RES, V46, P1569, DOI 10.1194/jlr.D500013-JLR200; Arias-Barrau E, 2009, METHODS MOL BIOL, V580, P233, DOI 10.1007/978-1-60761-325-1_13; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; Black Paul N, 2007, Novartis Found Symp, V286, P127; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Black PN, 2000, J NUTR, V130, p305S, DOI 10.1093/jn/130.2.305S; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DiRusso CC, 2000, EUR J BIOCHEM, V267, P4422, DOI 10.1046/j.1432-1327.2000.01489.x; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Dirusso CC, 2008, BBA-MOL CELL BIOL L, V1781, P135, DOI 10.1016/j.bbalip.2008.01.002; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; Faergeman NJ, 1997, J BIOL CHEM, V272, P8531, DOI 10.1074/jbc.272.13.8531; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Kaiser C., 1994, YEAST GENETICS; Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539; Li H, 2007, BBA-MOL CELL BIOL L, V1771, P1246, DOI 10.1016/j.bbalip.2007.05.009; Liebisch G, 1999, J LIPID RES, V40, P1539; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Marszalek JR, 2005, J BIOL CHEM, V280, P10817, DOI 10.1074/jbc.M411750200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Rizzo C, 2003, PEDIATR RES, V53, P1013, DOI 10.1203/01.PDR.0000064902.59052.0F; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Steinberg SJ, 1999, MOL GENET METAB, V68, P32, DOI 10.1006/mgme.1999.2883; Steinberg SJ, 2000, J BIOL CHEM, V275, P15605, DOI 10.1074/jbc.C000015200; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2; Stuhlsatz-Krouper SM, 1999, PROSTAG LEUKOTR ESS, V60, P285, DOI 10.1016/S0952-3278(99)80001-5; Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642; Sun D, 2006, ANAL BIOCHEM, V349, P87, DOI 10.1016/j.ab.2005.10.006; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Yee JK, 2008, J LIPID RES, V49, P2124, DOI 10.1194/jlr.M700600-JLR200; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	57	42	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30670	30679		10.1074/jbc.M111.226316	http://dx.doi.org/10.1074/jbc.M111.226316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21768100	Green Published, hybrid			2022-12-27	WOS:000294283600047
J	Ovadia, H; Haim, Y; Nov, O; Almog, O; Kovsan, J; Bashan, N; Benhar, M; Rudich, A				Ovadia, Hilla; Haim, Yulia; Nov, Ori; Almog, Orna; Kovsan, Julia; Bashan, Nava; Benhar, Moran; Rudich, Assaf			Increased Adipocyte S-Nitrosylation Targets Anti-lipolytic Action of Insulin RELEVANCE TO ADIPOSE TISSUE DYSFUNCTION IN OBESITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-B/AKT; RECEPTOR SUBSTRATE-1; MACROPHAGE INFILTRATION; PHOSPHODIESTERASE 3B; DIABETES-MELLITUS; OXIDATIVE STRESS; REACTIVE OXYGEN; FAT TISSUE	Protein S-nitrosylation is a reversible protein modification implicated in both physiological and pathophysiological regulation of protein function. In obesity, skeletal muscle insulin resistance is associated with increased S-nitrosylation of insulin-signaling proteins. However, whether adipose tissue is similarly affected in obesity and, if so, what are the causes and functional consequences of increased S-nitrosylation in this tissue are unknown. Total protein S-nitrosylation was increased in intra-abdominal adipose tissue of obese humans and in high fat-fed or leptin-deficient ob/ob mice. Both the insulin receptor beta-subunit and Akt were S-nitrosylated, correlating with body weight. Elevated protein and RNA xpression of inducible NO synthase and decreased protein levels of thioredoxin reductase were associated with increased adipose tissue S-nitrosylation. Cultured differentiated pre-adipocyte cell lines exposed to the NO donors S-nitrosoglutathione (GSNO) or S-nitroso-N-acetylpenicillamine exhibited diminished insulin-stimulated phosphorylation of Akt but not of GSK3 nor of insulin-stimulated glucose uptake. Yet the anti-lipolytic action of insulin was markedly impaired in both cultured adipocytes and in mice injected with GSNO prior to administration of insulin. In cells, impaired ability of insulin to diminish phosphorylated PKA substrates in response to isoproterenol suggested impaired insulin-induced activation of PDE3B. Consistently, increased S-nitrosylation of PDE3B was detected in adipose tissue of high fat-fed obese mice. Site-directed mutagenesis revealed that Cys-768 and Cys-1040, two putative sites for S-nitrosylation adjacent to the substrate-binding site of PDE3B, accounted for similar to 50% of its GSNO-induced S-nitrosylation. Collectively, PDE3B and the anti-lipolytic action of insulin may constitute novel targets for increased S-nitrosylation of adipose tissue in obesity.	[Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel; [Benhar, Moran] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84103 Beer Sheva, Israel	Ben Gurion University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ben Gurion University	Rudich, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel.	rudich@bgu.ac.il	Benhar, Moran/AAV-5764-2020	Benhar, Moran/0000-0002-7094-3456; Rudich, Assaf/0000-0002-1366-1444	Israel Science Foundation [118-06, 1103-09]; Israeli Ministry of Health [3/5067]; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Health; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	This work was supported in part by Israel Science Foundation Grants 118-06 and 1103-09 (to A. R. and N. B.), Israeli Ministry of Health Grant 3/5067, and by the Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education.	Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Bashan N, 2007, ENDOCRINOLOGY, V148, P2955, DOI 10.1210/en.2006-1369; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; Brune B, 1996, REV PHYSIOL BIOCH P, V127, P1, DOI 10.1007/BFb0048263; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Elizalde M, 2000, J LIPID RES, V41, P1244; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Kovsan J, 2009, AM J PHYSIOL-ENDOC M, V296, pE315, DOI 10.1152/ajpendo.90486.2008; LANE P, 2001, SCI STKE, pRE1; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LOTEN EG, 1991, INT J BIOCHEM, V23, P649, DOI 10.1016/0020-711X(91)90033-J; MANGANIELLO VC, 1995, ARCH BIOCHEM BIOPHYS, V322, P1, DOI 10.1006/abbi.1995.1429; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Nishikawa T, 2003, DIABETES CARE, V26, P1507, DOI 10.2337/diacare.26.5.1507; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Rehman A, 1999, FEBS LETT, V448, P120, DOI 10.1016/S0014-5793(99)00339-7; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; WEINBERG JB, 1995, BLOOD, V86, P1184; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	47	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30433	30443		10.1074/jbc.M111.235945	http://dx.doi.org/10.1074/jbc.M111.235945			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21724851	hybrid, Green Published			2022-12-27	WOS:000294283600022
J	Botte, CY; Yamaryo-Botte, Y; Janouskovec, J; Rupasinghe, T; Keeling, PJ; Crellin, P; Coppel, RL; Marechal, E; McConville, MJ; McFadden, GI				Botte, Cyrille Y.; Yamaryo-Botte, Yoshiki; Janouskovec, Jan; Rupasinghe, Thusita; Keeling, Patrick J.; Crellin, Paul; Coppel, Ross L.; Marechal, Eric; McConville, Malcolm J.; McFadden, Geoffrey I.			Identification of Plant-like Galactolipids in Chromera velia, a Photosynthetic Relative of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; APICOMPLEXAN PARASITES; TOXOPLASMA-GONDII; DIGALACTOSYL-DIACYLGLYCEROL; PLASMODIUM-FALCIPARUM; PHOSPHATE DEPRIVATION; PLASMA-MEMBRANE; PHOTOSYSTEM-I; FATTY-ACIDS; CHLOROPLAST	Apicomplexa are protist parasites that include Plasmodium spp., the causative agents of malaria, and Toxoplasma gondii, responsible for toxoplasmosis. Most Apicomplexa possess a relict plastid, the apicoplast, which was acquired by secondary endosymbiosis of a red alga. Despite being nonphotosynthetic, the apicoplast is otherwise metabolically similar to algal and plant plastids and is essential for parasite survival. Previous studies of Toxoplasma gondii identified membrane lipids with some structural features of plastid galactolipids, the major plastid lipid class. However, direct evidence for the plant-like enzymes responsible for galactolipid synthesis in Apicomplexan parasites has not been obtained. Chromera velia is an Apicomplexan relative recently discovered in Australian corals. C. velia retains a photosynthetic plastid, providing a unique model to study the evolution of the apicoplast. Here, we report the unambiguous presence of plant-like monogalactosyldiacylglycerol and digalactosyldiacylglycerol in C. velia and localize digalactosyldiacylglycerol to the plastid. We also provide evidence for a plant-like biosynthesis pathway and identify candidate galactosyltran-ferases responsible for galactolipid synthesis. Our study provides new insights in the evolution of these important enzymes in plastid-containing eukaryotes and will help reconstruct the evolution of glycerolipid metabolism in important parasites such as Plasmodium and Toxoplasma.	[Botte, Cyrille Y.; McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia; [Botte, Cyrille Y.; Marechal, Eric] Univ Grenoble 1, UMR 5168, CNRS,Inst Rech & Technol Sci Vivant, Commissariat Energie Atom,Inst Natl Rech Agron, F-38054 Grenoble, France; [Yamaryo-Botte, Yoshiki; Crellin, Paul; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Yamaryo-Botte, Yoshiki; Rupasinghe, Thusita; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Janouskovec, Jan; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Monash University; University of Melbourne; University of British Columbia	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia.	gim@unimelb.edu.au	Janouškovec, Jan/ABA-2568-2021; Coppel, Ross L/A-6626-2008; Botte, Cyrille/G-1972-2014; McFadden, Geoffrey McFadden I/F-7667-2014	Janouškovec, Jan/0000-0001-6547-749X; Coppel, Ross L/0000-0002-4476-9124; Botte, Cyrille/0000-0002-2245-536X; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Crellin, Paul K/0000-0002-2017-4935; Keeling, Patrick/0000-0002-7644-0745; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411	European Research Council; National Health and Medical Research Council of Australia; CNRS; Agence Nationale de la Recherche	European Research Council(European Research Council (ERC)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by European Research Council FP7 Marie Curie Actions via an International Outgoing Fellowship Marie Curie fellowship (to C. Y. B.), National Health and Medical Research Council of Australia, CNRS, and Agence Nationale de la Recherche ReGal grant (to E. M.).	Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bisanz C, 2006, BIOCHEM J, V394, P197, DOI 10.1042/BJ20050609; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; Botte C, 2008, J LIPID RES, V49, P746, DOI 10.1194/jlr.M700476-JLR200; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Guo JK, 2005, FEBS LETT, V579, P3619, DOI 10.1016/j.febslet.2005.05.049; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Ivanov AG, 2006, PLANT CELL PHYSIOL, V47, P1146, DOI 10.1093/pcp/pcj089; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Joyard J, 1998, PLANT PHYSIOL, V118, P715, DOI 10.1104/pp.118.3.715; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kelly AA, 2002, J BIOL CHEM, V277, P1166, DOI 10.1074/jbc.M110066200; KNUDSEN E, 1982, ARCH MICROBIOL, V132, P149, DOI 10.1007/BF00508721; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Leblond JD, 2000, J PHYCOL, V36, P1103, DOI 10.1046/j.1529-8817.2000.00018.x; Leblond JD, 2010, EUR J PHYCOL, V45, P13, DOI 10.1080/09670260903171650; LIVERMORE BP, 1974, J BACTERIOL, V120, P1268, DOI 10.1128/JB.120.3.1268-1273.1974; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Steffen R, 2005, BIOCHEMISTRY-US, V44, P3123, DOI 10.1021/bi0484668; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993	39	38	38	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29893	29903		10.1074/jbc.M111.254979	http://dx.doi.org/10.1074/jbc.M111.254979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712377	hybrid, Green Published			2022-12-27	WOS:000294046600048
J	Cornelius, F; Mahmmoud, YA; Toyoshima, C				Cornelius, Flemming; Mahmmoud, Yasser A.; Toyoshima, Chikashi			Metal Fluoride Complexes of Na,K-ATPase CHARACTERIZATION OF FLUORIDE-STABILIZED PHOSPHOENZYME ANALOGUES AND THEIR INTERACTION WITH CARDIOTONIC STEROIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; SODIUM-POTASSIUM PUMP; DISSOCIATION RATE CONSTANTS; CALCIUM-PUMP; CRYSTAL-STRUCTURE; PHOSPHORYL TRANSFER; RECTAL GLANDS; PROTEINASE-K; BINDING SITE; ATPASE	The Na,K-ATPase belongs to the P-type ATPase family of primary active cation pumps. Metal fluorides like magnesium-, beryllium-, and aluminum fluoride act as phosphate analogues and inhibit P-type ATPases by interacting with the phosphorylation site, stabilizing conformations that are analogous to specific phosphoenzyme intermediates. Cardiotonic steroids like ouabain used in the treatment of congestive heart failure and arrhythmias specifically inhibit the Na,K-ATPase, and the detailed structure of the highly conserved binding site has recently been described by the crystal structure of the shark Na,K-ATPase in a state analogous to E2 center dot 2K(+)center dot P-1 with ouabain bound with apparently low affinity (1). In the present work inhibition, and subsequent reactivation by high Na+, after treatment of shark Na,K-ATPase with various metal fluorides are characterized. Half-maximal inhibition of Na,K-ATPase activity by metal fluorides is in the micromolar range. The binding of cardiotonic steroids to the metal fluoride-stabilized enzyme forms was investigated using the fluorescent ouabain derivative 9-anthroyl ouabain and compared with binding to phosphorylated enzyme. The fastest binding was to the Be-fluoride stabilized enzyme suggesting a preformed ouabain binding cavity, in accord with results for Ca-ATPase where Be-fluoride stabilizes the E2-P ground state with an open luminal ion access pathway, which in Na,K-ATPase could be a passage for ouabain. The Be-fluoride stabilized enzyme conformation closely resembles the E2-P ground state according to proteinase K cleavage. Ouabain, but not its aglycone ouabagenin, prevented reactivation of this metal fluoride form by high Na+ demonstrating the pivotal role of the sugar moiety in closing the extracellular cation pathway.	[Cornelius, Flemming; Mahmmoud, Yasser A.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Aarhus University; University of Tokyo	Cornelius, F (corresponding author), Univ Aarhus, Dept Biomed, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	fc@biophys.au.dk	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by The Danish Medical Research Foundation and by an FI/Danish-Japanese cooperation program from The Danish Agency for Science Technology and Innovation (to F. C.) and by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a Strategic Japanese-Danish Cooperative Program Grant from Japan Science and Technology Agency (to C. T.).	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORTES PAG, 1977, BIOCHEMISTRY-US, V16, P531, DOI 10.1021/bi00622a030; GOLDSTEIN G, 1964, ANAL CHEM, V36, P243, DOI 10.1021/ac60207a074; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; MINTZ E, 1990, J BIOL CHEM, V265, P18762; MISSIAEN L, 1988, BIOCHEM J, V253, P827, DOI 10.1042/bj2530827; MOCZYDLOWSKI EG, 1980, BIOCHEMISTRY-US, V19, P969, DOI 10.1021/bi00546a022; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; MURPHY AJ, 1992, J BIOL CHEM, V267, P16990; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; ROBINSON JD, 1982, J BIOENERG BIOMEMBR, V14, P319, DOI 10.1007/BF00743061; ROBINSON JD, 1986, J BIOENERG BIOMEMBR, V18, P521, DOI 10.1007/BF00743148; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Schlichting I, 1999, NAT STRUCT BIOL, V6, P721, DOI 10.1038/11485; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1982, BIOCHIM BIOPHYS ACTA, V688, P369, DOI 10.1016/0005-2736(82)90348-0; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YODA A, 1982, MOL PHARMACOL, V22, P700; YODA A, 1977, MOL PHARMACOL, V13, P352; YODA A, 1974, ANN NY ACAD SCI, V242, P598, DOI 10.1111/j.1749-6632.1974.tb19120.x	41	32	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29882	29892		10.1074/jbc.M111.259663	http://dx.doi.org/10.1074/jbc.M111.259663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21708939	hybrid, Green Published			2022-12-27	WOS:000294046600047
J	Szczepanek, K; Chen, Q; Derecka, M; Salloum, FN; Zhang, QF; Szelag, M; Cichy, J; Kukreja, RC; Dulak, J; Lesnefsky, EJ; Larner, AC				Szczepanek, Karol; Chen, Qun; Derecka, Marta; Salloum, Fadi N.; Zhang, Qifang; Szelag, Magdalena; Cichy, Joanna; Kukreja, Rakesh C.; Dulak, Jozef; Lesnefsky, Edward J.; Larner, Andrew C.			Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; COMPLEX-III; SUBSARCOLEMMAL MITOCHONDRIA; HEART-MITOCHONDRIA; GENE-EXPRESSION; MOUSE HEART; INJURY; PHOSPHORYLATION; CARDIOMYOPATHY	Expression of the STAT3 transcription factor in the heart is cardioprotective and decreases the levels of reactive oxygen species. Recent studies indicate that a pool of STAT3 resides in the mitochondria where it is necessary for the maximal activity of complexes I and II of the electron transport chain. However, it has not been explored whether mitochondrial STAT3 modulates cardiac function under conditions of stress. Transgenic mice with cardiomyocyte-specific overexpression of mitochondria-targeted STAT3 with a mutation in the DNA-binding domain (MLS-STAT3E) were generated. We evaluated the role of mitochondrial STAT3 in the preservation of mitochondrial function during ischemia. Under conditions of ischemia heart mitochondria expressing MLS-STAT3E exhibited modest decreases in basal activities of complexes I and II of the electron transport chain. In contrast to WThearts, complex I-dependent respiratory rates were protected against ischemic damage in MLS-STAT3E hearts. MLS-STAT3E prevented the release of cytochrome c into the cytosol during ischemia. In contrast to WT mitochondria, ischemia did not augment reactive oxygen species production in MLS-STAT3E mitochondria likely due to an MLS-STAT3E-mediated partial blockade of electron transport through complex I. Given the caveat of STAT3 overexpression, these results suggest a novel protective mechanism mediated by mitochondrial STAT3 that is independent of its canonical activity as a nuclear transcription factor.	[Szczepanek, Karol; Derecka, Marta; Zhang, Qifang; Szelag, Magdalena; Lesnefsky, Edward J.; Larner, Andrew C.] Virginia Commonwealth Univ, Div Cardiol, Pauley Heart Ctr, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Szczepanek, Karol; Chen, Qun; Salloum, Fadi N.; Kukreja, Rakesh C.; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Div Cardiol, Pauley Heart Ctr, Dept Internal Med, Richmond, VA 23298 USA; [Szczepanek, Karol; Szelag, Magdalena; Dulak, Jozef] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, PL-30387 Krakow, Poland; [Derecka, Marta; Cichy, Joanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Immunol, PL-30387 Krakow, Poland; [Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Med Serv, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University; Jagiellonian University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Larner, AC (corresponding author), Virginia Commonwealth Univ, Div Cardiol, Pauley Heart Ctr, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu	Salloum, Fadi N/C-2391-2008; zhang, qifang/H-5691-2013; zhang, qifang/F-9857-2013; Chen, Qun/HGD-0868-2022	Salloum, Fadi N/0000-0002-8947-9315; Cichy, Joanna/0000-0002-0552-8344; Derecka, Marta/0000-0001-6265-9781	National Institutes of Health [CA098924, 2PO1AG15885]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA098924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098924 (to A. C. L.) and 2PO1AG15885 (to E. J. L.) and a grant from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (to E. J. L.).	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Butler KL, 2006, AM J PHYSIOL-HEART C, V291, pH797, DOI 10.1152/ajpheart.01334.2005; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2009, J INVEST MED, V57, P558; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAS DK, 1995, J MOL CELL CARDIOL, V27, P181, DOI 10.1016/S0022-2828(08)80017-X; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xiong Y, 2006, FREE RADICAL BIO MED, V41, P46, DOI 10.1016/j.freeradbiomed.2006.02.024; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	45	165	170	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29610	29620		10.1074/jbc.M111.226209	http://dx.doi.org/10.1074/jbc.M111.226209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715323	Green Published, hybrid			2022-12-27	WOS:000294046600019
J	Dhamija, S; Kuehne, N; Winzen, R; Doerrie, A; Dittrich-Breiholz, O; Thakur, BK; Kracht, M; Holtmann, H				Dhamija, Sonam; Kuehne, Nancy; Winzen, Reinhard; Doerrie, Anneke; Dittrich-Breiholz, Oliver; Thakur, Basant Kumar; Kracht, Michael; Holtmann, Helmut			Interleukin-1 Activates Synthesis of Interleukin-6 by Interfering with a KH-type Splicing Regulatory Protein (KSRP)-dependent Translational Silencing Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENTS; MESSENGER-RNA; POSTTRANSCRIPTIONAL CONTROL; KINASE 2; KSRP; EXPRESSION; IDENTIFICATION; STABILIZATION	Post-transcriptional mechanisms play an important role in the control of inflammatory gene expression. The heterogeneous nuclear ribonucleoprotein K homology (KH)-type splicing regulatory protein (KSRP) triggers rapid degradation of mRNAs for various cytokines, chemokines, and other inflammation-related proteins by interacting with AU-rich elements (AREs) in the 3'-untranslated mRNA regions. In addition to destabilizing mRNAs, AU-rich elements can restrict their translation. Evidence that KSRP also participates in translational silencing was obtained in a screen comparing the polysome profiles of cells with siRNA-mediated depletion of KSRP with that of control cells. Among the group of mRNAs showing increased polysome association upon KSRP depletion are those of interleukin (IL)-6 and IL-1 alpha as well as other ARE-containing transcripts. Redistribution of IL-6 mRNA to polysomes was associated with increased IL-6 protein secretion by the KSRP-depleted cells. Silencing of IL-6 and IL-1 alpha mRNAs depended on their 3'-untranslated regions. The sequence essential for translational control of IL-6 mRNA and its interaction with KSRP was located to an ARE. KSRP-dependent silencing was reversed by IL-1, a strong inducer of IL-6 mRNA and protein expression. The results identify KSRP as a protein involved in ARE-mediated translational silencing. They suggest that KSRP restricts inflammatory gene expression not only by enhancing degradation of mRNAs but also by inhibiting translation, both functions that are counteracted by the proinflammatory cytokine IL-1.	[Dhamija, Sonam; Kuehne, Nancy; Winzen, Reinhard; Doerrie, Anneke; Dittrich-Breiholz, Oliver; Thakur, Basant Kumar; Holtmann, Helmut] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Holtmann, H (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	holtmann.helmut@mh-hannover.de	Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kracht, Michael/0000-0002-8501-043X; Kuhne, Nancy/0000-0002-9418-7296; Thakur, Barun Kumar/0000-0002-1713-9186	Deutsche Forschungsgemeinschaft [SFB 566/A10, SFB 566/Z2, Ho 1116/5]; Niedersachsen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsen Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 566/A10, SFB 566/Z2, and Ho 1116/5 and by a grant from the Niedersachsen Foundation.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CONTENT J, 1985, EUR J BIOCHEM, V152, P253, DOI 10.1111/j.1432-1033.1985.tb09191.x; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; Gau BH, 2011, NUCLEIC ACIDS RES, V39, P3582, DOI 10.1093/nar/gkq1295; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; HAEGEMAN G, 1986, EUR J BIOCHEM, V159, P625, DOI 10.1111/j.1432-1033.1986.tb09931.x; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; KOHASE M, 1986, CELL, V45, P659, DOI 10.1016/0092-8674(86)90780-4; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; PRICHETT W, 1995, J INFLAMM, V45, P97; Rothe F, 2006, BIOCHEM BIOPH RES CO, V343, P57, DOI 10.1016/j.bbrc.2006.02.112; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; TONOUCHI N, 1992, J BIOTECHNOL, V22, P283, DOI 10.1016/0168-1656(92)90146-Z; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; ZILBERSTEIN A, 1986, EMBO J, V5, P2529, DOI 10.1002/j.1460-2075.1986.tb04531.x	43	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33279	33288		10.1074/jbc.M111.264754	http://dx.doi.org/10.1074/jbc.M111.264754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795706	Green Published, hybrid			2022-12-27	WOS:000294968800047
J	Dupuis-Coronas, S; Lagarrigue, F; Ramel, D; Chicanne, G; Saland, E; Gaits-Iacovoni, F; Payrastre, B; Tronchere, H				Dupuis-Coronas, Sophie; Lagarrigue, Frederic; Ramel, Damien; Chicanne, Gaetan; Saland, Estelle; Gaits-Iacovoni, Frederique; Payrastre, Bernard; Tronchere, Helene			The Nucleophosmin-Anaplastic Lymphoma Kinase Oncogene Interacts, Activates, and Uses the Kinase PIKfyve to Increase Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-CELL LYMPHOMA; PHOSPHATIDYLINOSITOL 5-PHOSPHATE; NPM-ALK; EXTRACELLULAR-MATRIX; TYROSINE KINASE; PHOSPHOINOSITIDE; PATHWAY; INSULIN; PTDINS5P; METALLOPROTEINASES	NPM-ALK is a chimeric tyrosine kinase detected in most anaplastic large cell lymphomas that results from the reciprocal translocation t(2,5)(p23; q35) that fuses the N-terminal domain of nucleophosmin (NPM) to the catalytic domain of the anaplastic lymphoma kinase (ALK) receptor. The constitutive activity of the kinase is responsible for its oncogenicity through the stimulation of several downstream signaling pathways, leading to cell proliferation, migration, and survival. We demonstrated previously that the high level of phosphatidylinositol 5-phosphate measured in NPM-ALK-expressing cells is controlled by the phosphoinositide kinase PIKfyve, a lipid kinase known for its role in vesicular trafficking. Here, we show that PIKfyve associates with NPM-ALK and that the interaction involves the 181300 region of the oncogene. Moreover, we demonstrate that the tyrosine kinase activity of the oncogene controls PIKfyve lipid kinase activity but is dispensable for the formation of the complex. Silencing or inhibition of PIKfyve using siRNA or the PIKfyve inhibitor YM201636 have no effect on NPM-ALK-mediated proliferation and migration but strongly reduce invasive capacities of NPM-ALK-expressing cells and their capacity to degrade the extracellular matrix. Accordingly, immunofluorescence studies confirm a perturbation of matrix metalloproteinase 9 localization at the cell surface and defect in maturation. Altogether, these results suggest a role for PIKfyve in NPM-ALK-mediated invasion.	[Dupuis-Coronas, Sophie; Lagarrigue, Frederic; Ramel, Damien; Chicanne, Gaetan; Saland, Estelle; Gaits-Iacovoni, Frederique; Payrastre, Bernard; Tronchere, Helene] Univ Toulouse 3, Ctr Hosp Univ Toulouse, INSERM, U1048,I2MC, F-31432 Toulouse 4, France; [Payrastre, Bernard] CHU Toulouse, Hematol Lab, F-31432 Toulouse 4, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Tronchere, H (corresponding author), CHU Rangueil, INSERM, U1048, I2MC, F-31432 Toulouse 4, France.	helene.tronchere@inserm.fr	SALAND, Estelle/W-7996-2019; Chicanne, Gaëtan/M-5260-2014; TRONCHERE, Helene/M-5631-2014; Payrastre, Bernard/M-5295-2014	Chicanne, Gaetan/0000-0002-7081-2595; , Bernard/0000-0002-8693-0190; Lagarrigue, Frederic/0000-0002-4660-8666; Gaits-Iacovoni, Frederique/0000-0002-9853-0442; RAMEL, Damien/0000-0002-9089-1497	Ministere de l'Education Nationale de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer; Agence Nationale de la Recherche (ANR) eRare; ANR Blanc; Pole de Competitivite Cancer-Bio Sante/Fonds Uniques Interministeriels des Poles de Competitivite	Ministere de l'Education Nationale de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR) eRare(French National Research Agency (ANR)); ANR Blanc(French National Research Agency (ANR)); Pole de Competitivite Cancer-Bio Sante/Fonds Uniques Interministeriels des Poles de Competitivite	This work is supported by grants from Ministere de l'Education Nationale de la Recherche et de la Technologie, Association pour la Recherche contre le Cancer, Agence Nationale de la Recherche (ANR) eRare, ANR Blanc, and Pole de Competitivite Cancer-Bio Sante/Fonds Uniques Interministeriels des Poles de Competitivite.	Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bonvini P, 2002, CANCER RES, V62, P1559; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Coronas S, 2008, BIOCHEM BIOPH RES CO, V372, P351, DOI 10.1016/j.bbrc.2008.05.062; Coronas S, 2007, BIOCHEM SOC SYMP, V74, P117, DOI 10.1042/BSS2007c11; Cussac D, 2004, BLOOD, V103, P1464; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fiorani C, 2001, CLIN LYMPHOMA, V2, P29, DOI 10.3816/CLM.2001.n.009; Gehring EM, 2009, CELL PHYSIOL BIOCHEM, V24, P361, DOI 10.1159/000257428; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Hubinger G, 1999, EXP HEMATOL, V27, P1796, DOI 10.1016/S0301-472X(99)00116-2; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Klaus F, 2009, BIOCHEM BIOPH RES CO, V381, P407, DOI 10.1016/j.bbrc.2009.02.053; Lamant L, 2004, LEUKEMIA, V18, P1693, DOI 10.1038/sj.leu.2403464; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Meijer HJG, 2001, BIOCHEM J, V360, P491, DOI 10.1042/0264-6021:3600491; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Osborne SL, 2008, J BIOL CHEM, V283, P2804, DOI 10.1074/jbc.M704856200; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Prakobwong S, 2011, INT J CANCER, V129, P88, DOI 10.1002/ijc.25656; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Sbrissa D, 2001, MOL CELL ENDOCRINOL, V181, P35, DOI 10.1016/S0303-7207(01)00539-1; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shojaiefard M, 2007, BIOCHEM BIOPH RES CO, V359, P843, DOI 10.1016/j.bbrc.2007.05.111; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; Slupianek A, 2001, CANCER RES, V61, P2194; Sopjani M, 2010, J MEMBRANE BIOL, V233, P35, DOI 10.1007/s00232-009-9222-0; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Strutz-Seebohm N, 2007, CELL PHYSIOL BIOCHEM, V20, P729, DOI 10.1159/000110433; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Zou J, 2007, P NATL ACAD SCI USA, V104, P16834, DOI 10.1073/pnas.0708189104	57	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32105	32114		10.1074/jbc.M111.227512	http://dx.doi.org/10.1074/jbc.M111.227512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21737449	hybrid, Green Published			2022-12-27	WOS:000294726800020
J	Stewart, AP; Haerteis, S; Diakov, A; Korbmacher, C; Edwardson, JM				Stewart, Andrew P.; Haerteis, Silke; Diakov, Alexei; Korbmacher, Christoph; Edwardson, J. Michael			Atomic Force Microscopy Reveals the Architecture of the Epithelial Sodium Channel (ENaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; SUBUNIT STOICHIOMETRY; ACTIVATION; RECEPTORS; MUTATION	The epithelial sodium channel (ENaC) is a member of the ENaC/degenerin superfamily. ENaC is a heteromultimer containing three homologous subunits (alpha, beta, and gamma); however, the subunit stoichiometry is still controversial. Here, we addressed this issue using atomic force microscopy imaging of complexes between isolated ENaC and antibodies/Fab fragments directed against specific epitope tags on the alpha-, beta- and gamma-subunits. We show that for alpha-, beta- and gamma-ENaC alone, pairs of antibodies decorate the channel at an angle of 120 degrees, indicating that the individual subunits assemble as homotrimers. A similar approach demonstrates that alpha beta gamma-ENaC assembles as a heterotrimer containing one copy of each subunit. Intriguingly, all four subunit combinations also produce higher-order structures containing two or three individual trimers. The trimer-of-trimers organization would account for earlier reports that ENaC contains eight to nine subunits.	[Stewart, Andrew P.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Haerteis, Silke; Diakov, Alexei; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Cambridge; University of Erlangen Nuremberg	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk	Haerteis, Silke/AGS-5314-2022	Haerteis, Silke/0000-0002-9440-3307	Jean Shanks Foundation; James Baird Fund; IZKF (Interdisciplinary Centre of Clinical Research); Friedrich-Alexander-Universitat Erlangen-Nurnberg; Bayerische Forschungsstiftung; Deutsche Forschungsgemeinschaft [SFB 423, A12]; Kidney Research UK; Kidney Research UK [RP11/2009] Funding Source: researchfish	Jean Shanks Foundation; James Baird Fund; IZKF (Interdisciplinary Centre of Clinical Research); Friedrich-Alexander-Universitat Erlangen-Nurnberg; Bayerische Forschungsstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kidney Research UK(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK))	Member of the University of Cambridge MB/PhD Programme and supported by the Jean Shanks Foundation and the James Baird Fund.; Supported by a young investigator grant from the IZKF (Interdisciplinary Centre of Clinical Research) and the Erlanger Leistungsbezogene Anschub-finanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg and recipient of a travel grant from the Bayerische Forschungsstiftung.; Supported by the Deutsche Forschungsgemeinschaft (SFB 423, Project A12).; Supported by Kidney Research UK. To whom correspondence should be addressed: Dept. of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom. Tel.: 44-1223-334014; Fax: 44-1223-334100; E-mail: jme1000@cam.ac.uk.	Anantharam A, 2007, J GEN PHYSIOL, V130, P55, DOI 10.1085/jgp.200609716; Barrera NP, 2008, PFLUG ARCH EUR J PHY, V456, P199, DOI 10.1007/s00424-007-0381-5; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dijkink L, 2002, PFLUG ARCH EUR J PHY, V444, P549, DOI 10.1007/s00424-002-0855-4; Eskandari S, 1999, J BIOL CHEM, V274, P27281, DOI 10.1074/jbc.274.38.27281; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Huber R, 2010, CELL PHYSIOL BIOCHEM, V25, P145, DOI 10.1159/000272059; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Zhou Y, 2003, J NEUROSCI, V23, P9004	34	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31944	31952		10.1074/jbc.M111.275289	http://dx.doi.org/10.1074/jbc.M111.275289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775436	Green Published, hybrid			2022-12-27	WOS:000294726800003
J	Wong, WT; Chan, KC; So, PK; Yap, HK; Chung, WH; Leung, YC; Wong, KY; Zhao, YX				Wong, Wai-Ting; Chan, Kwok-Chu; So, Pui-Kin; Yap, Hong-Kin; Chung, Wai-Hong; Leung, Yun-Chung; Wong, Kwok-Yin; Zhao, Yanxiang			Increased Structural Flexibility at the Active Site of a Fluorophore-conjugated beta-Lactamase Distinctively Impacts Its Binding toward Diverse Cephalosporin Antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE FLUORESCENCE; CONFORMATIONAL DYNAMICS; ACYL-ENZYME; AMINO-ACID; 3 DECADES; PROTEIN; BIOSENSOR; BENZYLPENICILLIN; INTERMEDIATE; SPECTROSCOPY	The Omega-loop at the active site of beta-lactamases exerts significant impact on the kinetics and substrate profile of these enzymes by forming part of the substrate binding site and posing as steric hindrance toward bulky substrates. Mutating certain residues on the Omega-loop has been a general strategy for molecular evolution of beta-lactamases to expand their hydrolytic activity toward extended-spectrum antibiotics through a mechanism believed to involve enhanced structural flexibility of the Omega-loop. Yet no structural information is available that demonstrates such flexibility or its relation to substrate profile and enzyme kinetics. Here we report an engineered beta-lactamase that contains an environment-sensitive fluorophore conjugated near its active site to probe the structural dynamics of the Omega-loop and to detect the binding of diverse substrates. Our results show that this engineered beta-lactamase has improved binding kinetics and positive fluorescence signal toward oxyimino-cephalosporins, but shows little such effect to non-oxyimino-cephalosporins. Structural studies reveal that the Omega-loop adopts a less stabilized structure, and readily undergoes conformational change to accommodate the binding of bulky oxyimino-cephalosporins while no such change is observed for non-oxyimino-cephalosporins. Mutational studies further confirm that this substrate-induced structural change is directly responsible for the positive fluorescence signal specific to oxyimino-cephalosporins. Our data provide mechanistic evidence to support the long-standing model that the evolutionary strategy of mutating the Omega-loop leads to increased structural flexibility of this region, which in turn facilitates the binding of extended spectrum beta-lactam antibiotics. The oxyimino-cephalosporin-specific fluorescence profile of our engineered beta-lactamase also demonstrates the possibility of designing substrate-selective biosensing systems.	[Wong, Wai-Ting; Chan, Kwok-Chu; So, Pui-Kin; Yap, Hong-Kin; Chung, Wai-Hong; Leung, Yun-Chung; Wong, Kwok-Yin; Zhao, Yanxiang] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Leung, YC (corresponding author), Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	bctleung@inet.polyu.edu.hk; bckywong@inet.polyu.edu.hk; bcyxzhao@inet.polyu.edu.hk	Wong, Kwok-Yin/O-5948-2014; Wong, Wai Ting/E-5731-2014	Wong, Kwok-Yin/0000-0003-4984-7109; Wong, Wai Ting/0000-0002-9401-2752; Leung, Yun-chung/0000-0003-3590-7027; Zhao, Yanxiang/0000-0002-9408-9979	Research Grants Council [PolyU 5463/05M, PolyU 5380/04M, PolyU 5017/06P, PolyU 5641/08M, PolyU 5639/09M]; University Grants Committee [AoE/P-10/01]; Research Committee of the Hong Kong Polytechnic University	Research Grants Council(Hong Kong Research Grants Council); University Grants Committee; Research Committee of the Hong Kong Polytechnic University	This work was supported by the Research Grants Council (PolyU 5463/05M, PolyU 5380/04M, PolyU 5017/06P, PolyU 5641/08M, and PolyU 5639/09M), the Area of Excellence Fund of the University Grants Committee (AoE/P-10/01), and the Research Committee of the Hong Kong Polytechnic University.	Caselli E, 2001, CHEM BIOL, V8, P17, DOI 10.1016/S1074-5521(00)00052-1; Chan PH, 2008, J AM CHEM SOC, V130, P6351, DOI 10.1021/ja076111g; Chan PH, 2005, ANAL CHEM, V77, P5268, DOI 10.1021/ac0502605; Chan PH, 2004, J AM CHEM SOC, V126, P4074, DOI 10.1021/ja038409m; Chen CCH, 2001, BIOCHEMISTRY-US, V40, P2351, DOI 10.1021/bi002277h; Cohen BE, 2002, SCIENCE, V296, P1700, DOI 10.1126/science.1069346; Cohen BE, 2005, P NATL ACAD SCI USA, V102, P965, DOI 10.1073/pnas.0409469102; Crichlow GV, 2001, BIOCHEMISTRY-US, V40, P6233, DOI 10.1021/bi010131s; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Koehorst RBM, 2008, BIOPHYS J, V94, P3945, DOI 10.1529/biophysj.107.125807; Koehorst RBM, 2010, EUR BIOPHYS J BIOPHY, V39, P647, DOI 10.1007/s00249-009-0538-6; Loving G, 2008, J AM CHEM SOC, V130, P13630, DOI 10.1021/ja804754y; Loving G, 2009, BIOCONJUGATE CHEM, V20, P2133, DOI 10.1021/bc900319z; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Powers RA, 2001, BIOCHEMISTRY-US, V40, P9207, DOI 10.1021/bi0109358; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Vazquez ME, 2005, J AM CHEM SOC, V127, P1300, DOI 10.1021/ja0449168; Venkatraman P, 2007, NAT CHEM BIOL, V3, P222, DOI 10.1038/nchembio868; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941	23	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31771	31780		10.1074/jbc.M110.198895	http://dx.doi.org/10.1074/jbc.M110.198895			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21705325	Green Published, hybrid			2022-12-27	WOS:000294487500070
J	Xu, XJ; Pan, C; Zhang, LN; Ashida, H				Xu, Xiaojuan; Pan, Chen; Zhang, Lina; Ashida, Hitoshi			Immunomodulatory beta-Glucan from Lentinus edodes Activates Mitogen-activated Protein Kinases and Nuclear Factor-kappa B in Murine RAW 264.7 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; ANTIFUNGAL IMMUNITY; FRUIT BODIES; TUMOR-CELLS; ANTITUMOR; LIPOPOLYSACCHARIDE; PATHWAY; CANCER	Lentinan, a cell wall beta-glucan from the fruiting bodies of Lentinus edodes, is well known to be a biological defense modifier, but the signal transduction pathway(s) induced by Lentinan have not been elucidated. In this study, we extracted Lentinan (LNT-S) by ultrasonication from Lentinus edodes and report that, in murine RAW 264.7 macrophages, LNT-S glucan activated NF-kappa B p65 and triggered its nuclear translocation as determined by Western blotting. Moreover, LNT-S enhanced NF-kappa B-luciferase activity in the Dual-Luciferase gene system assay. Its upstream signaling molecules, MAPKs such as ERK1/2 and JNK1/2, were shown to be activated by assessing the level of phosphorylation in a time- and concentration-dependent manner, but its downstream proinflammatory enzyme, inducible NOS, was not observed. The data evaluated using a TNF-alpha ELISA kit and Griess reagent further demonstrated that no proinflammatory mediators such as TNF-alpha and NO were produced by LNT-S stimulation in RAW 264.7 cells. In contrast, LPS significantly induced inducible NOS expression and increased NO and TNF-alpha production, which are associated with activation of the NF-kappa B p65/p50 heterodimer complex. It is possible that LNT-S did not activate NF-kappa B p65/p50, and the activation of NF-kappa B p65 was not sufficient to stimulate cytokine production. These data demonstrate that LNT-S glucan carries out its immunomodulating activity by activating MAPK signaling pathways without secretion of TNF-alpha and NO.	[Xu, Xiaojuan; Pan, Chen; Zhang, Lina] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China; [Xu, Xiaojuan; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan	Wuhan University; Kobe University	Xu, XJ (corresponding author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.	xuxj626@263.net	Zhang, Li/GWM-7501-2022; Wei, Qin/AAF-3325-2019	Chen, Pan/0000-0003-3794-717X; Xu, Xiaojuan/0000-0002-1404-5088	Japan Society for the Promotion of Science [20.08431]; National Natural Science Foundation [20874078]; Youth Technology Chenguang Project of Wuhan [200950431193]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Technology Chenguang Project of Wuhan	This work was supported by Japan Society for the Promotion of Science Postdoctoral Fellowship 20.08431 (to X. X.), National Natural Science Foundation Grant 20874078, and Youth Technology Chenguang Project of Wuhan 200950431193.	ABEL G, 1989, INT J IMMUNOPHARMACO, V11, P615, DOI 10.1016/0192-0561(89)90146-X; Adams DS, 1997, J LEUKOCYTE BIOL, V62, P865, DOI 10.1002/jlb.62.6.865; AKIYAMA T, 1987, MANIPULATION HOST DE, P227; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Cleary JA, 1999, IMMUNOL CELL BIOL, V77, P395, DOI 10.1046/j.1440-1711.1999.00848.x; Fang NB, 2006, J ALTERN COMPLEM MED, V12, P125, DOI 10.1089/acm.2006.12.125; FRUEHAUF JP, 1982, IMMUNOPHARMACOLOGY, V5, P65, DOI 10.1016/0162-3109(82)90037-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HERLYN D, 1985, JPN J CANCER RES, V76, P37; Herre J, 2004, CRIT REV IMMUNOL, V24, P193, DOI 10.1615/CritRevImmunol.v24.i3.30; Kerekgyarto C, 1996, INT J IMMUNOPHARMACO, V18, P347, DOI 10.1016/S0192-0561(96)00038-0; Kim JW, 2005, BIOCHEM PHARMACOL, V70, P1352, DOI 10.1016/j.bcp.2005.08.006; Kournikakis Bill, 2003, MedGenMed, V5, P1; Kupfahl C, 2006, INT IMMUNOPHARMACOL, V6, P686, DOI 10.1016/j.intimp.2005.10.008; LADANYI A, 1993, CANCER IMMUNOL IMMUN, V36, P123, DOI 10.1007/BF01754412; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li B, 2007, CLIN IMMUNOL, V124, P170, DOI 10.1016/j.clim.2007.05.002; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Liu F, 1999, LIFE SCI, V64, P1005, DOI 10.1016/S0024-3205(99)00027-2; Lo HC, 2006, LIFE SCI, V78, P1957, DOI 10.1016/j.lfs.2005.08.033; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Markova N, 2005, PHARMAZIE, V60, P42; Markova N, 2003, INT IMMUNOPHARMACOL, V3, P1557, DOI 10.1016/S1567-5769(03)00178-4; Masihi KN, 1997, INT J IMMUNOPHARMACO, V19, P463; Mayell M, 2001, Altern Med Rev, V6, P48; NANBA H, 1987, CHEM PHARM BULL, V35, P2453; NANBA H, 1987, CHEM PHARM BULL, V35, P2459; Nicolosi R, 1999, AM J CLIN NUTR, V70, P208; OKAMURA K, 1986, CANCER, V58, P865, DOI 10.1002/1097-0142(19860815)58:4<865::AID-CNCR2820580411>3.0.CO;2-S; PETER G, 1988, IMMUNOPHARM IMMUNOT, V10, P157; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Ruan Z, 2005, INT IMMUNOPHARMACOL, V5, P811, DOI 10.1016/j.intimp.2004.11.011; Sevag MG, 1934, BIOCHEM Z, V273, P419; Shimojoh M, 2010, BIOMACROMOLECULES, V11, P1212, DOI 10.1021/bm9013793; SUGA T, 1984, CANCER RES, V44, P5132; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Taguchi T., 1986, HOST DEFENSE MECHANI, P221; TEBO JM, 1994, J IMMUNOL, V153, P4713; Vetvicka V, 2004, INT IMMUNOPHARMACOL, V4, P721, DOI 10.1016/j.intimp.2004.02.007; Vetvicka V, 2008, BIOMED PHARMACOTHER, V62, P283, DOI 10.1016/j.biopha.2007.05.011; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; XIE QW, 1994, J BIOL CHEM, V269, P4705; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200	49	46	52	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31194	31198		10.1074/jbc.M111.246470	http://dx.doi.org/10.1074/jbc.M111.246470			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775433	Green Published, hybrid			2022-12-27	WOS:000294487500014
J	Koutsoupakis, C; Kolaj-Robin, O; Soulimane, T; Varotsis, C				Koutsoupakis, Constantinos; Kolaj-Robin, Olga; Soulimane, Tewfik; Varotsis, Constantinos			Probing Protonation/Deprotonation of Tyrosine Residues in Cytochrome ba(3) Oxidase from Thermus thermophilus by Time-resolved Step-scan Fourier Transform Infrared Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; B-CO COMPLEX; ACTIVE-SITE; PARACOCCUS-DENITRIFICANS; PROTON TRANSLOCATION; ELECTRON-TRANSFER; CARBON-MONOXIDE; CROSS-LINK; HIS-TYR; HISTIDINE	Elucidating the properties of the heme Fe-Cu-B binuclear center and the dynamics of the protein response in cytochrome c oxidase is crucial to understanding not only the dioxygen activation and bond cleavage by the enzyme but also the events related to the release of the produced water molecules. The time-resolved step-scan FTIR difference spectra show the nu 7a(CO) of the protonated form of Tyr residues at 1247 cm(-1) and that of the deprotonated form at 1301 cm(-1). By monitoring the intensity changes of the 1247 and 1301 cm(-1) modes as a function of pH, we measured a pK(a) of 7.8 for the observed tyrosine. The FTIR spectral changes associated with the tyrosine do not belong to Tyr-237 but are attributed to the highly conserved in heme-copper oxidases Tyr-136 and/or Tyr-133 residue (Koutsoupakis, K., Stavrakis, S., Pinakoulaki, E., Soulimane, T., and Varotsis, C. (2002) J. Biol. Chem. 277, 32860-32866). The oxygenation of CO by the mixed-valence form of the enzyme revealed the formation of the similar to 607 nm P (Fe(IV) = O) species in the pH 6-9 range and the return to the oxidized form without the formation of the 580 nm F form. The data indicate that Tyr-237 is not involved in the proton transfer pathway in the oxygenation of CO by the mixed-valence form of the enzyme. The implication of these results with respect to the role of Tyr-136 and Tyr-133 in proton transfer/gating along with heme a(3) ring D propionate-H2O-ring A propionate-Asp-372 site to the exit/output proton channel (H2O pool) is discussed.	[Koutsoupakis, Constantinos; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus; [Kolaj-Robin, Olga; Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Limerick, Ireland; [Kolaj-Robin, Olga; Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	Cyprus University of Technology; University of Limerick; University of Limerick	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus.	c.varotsis@cut.ac.cy	Ng, Kwan Hoong/D-2231-2009	Varotsis, Constantinos/0000-0003-2771-8891	Cyprus University of Technology; Science Foundation Ireland [BICF865]	Cyprus University of Technology; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by research funds from the Cyprus University of Technology (to C. V.) and the Science Foundation Ireland Grant BICF865 (to T. S.).	Aki M, 2002, J PHYS CHEM A, V106, P3436, DOI 10.1021/jp012492n; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Cappuccio JA, 2002, J AM CHEM SOC, V124, P1750, DOI 10.1021/ja011852h; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Daskalakis V, 2007, J PHYS CHEM B, V111, P10502, DOI 10.1021/jp0718597; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fern W. O., 1932, AM J PHYSIOL, V102, P379; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; HAN SH, 1990, J AM CHEM SOC, V112, P9445, DOI 10.1021/ja00182a001; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P9116, DOI 10.1021/bi012056r; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kannt A, 1998, BIOPHYS J, V74, P708, DOI 10.1016/S0006-3495(98)73996-7; Kim Y, 2001, J AM CHEM SOC, V123, P757, DOI 10.1021/ja0027867; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; Koutsoupakis C, 2004, BIOPHYS J, V86, P2438, DOI 10.1016/S0006-3495(04)74300-3; Koutsoupakis C, 2003, J AM CHEM SOC, V125, P14728, DOI 10.1021/ja036107e; Koutsoupakis K, 2003, J BIOL CHEM, V278, P14893, DOI 10.1074/jbc.M210293200; Koutsoupakis K, 2002, J BIOL CHEM, V277, P32860, DOI 10.1074/jbc.M204943200; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; McCauley KM, 2000, J AM CHEM SOC, V122, P2403, DOI 10.1021/ja993774s; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Pinakoulaki E, 2003, J BIOL CHEM, V278, P18761, DOI 10.1074/jbc.M211925200; Pinakoulaki E, 2002, J BIOL CHEM, V277, P32867, DOI 10.1074/jbc.M205568200; Pinakoulaki E, 2002, J BIOL CHEM, V277, P13563, DOI 10.1074/jbc.M112200200; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Smirnova IA, 2008, J BIOENERG BIOMEMBR, V40, P281, DOI 10.1007/s10863-008-9157-7; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Stavrakis S, 2002, J AM CHEM SOC, V124, P3814, DOI 10.1021/ja0169825; Szundi I, 2010, P NATL ACAD SCI USA, V107, P21010, DOI 10.1073/pnas.1008603107; Tomson F, 2002, BIOCHEMISTRY-US, V41, P14383, DOI 10.1021/bi026370c; VAROTSIS C, 1990, J BIOL CHEM, V265, P11131; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; WOODRUFF WH, 1993, J BIOENERG BIOMEMBR, V25, P177, DOI 10.1007/BF00762859; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; YOUNG LJ, 1986, BIOCHEMISTRY-US, V25, P152, DOI 10.1021/bi00349a022	37	19	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30600	30605		10.1074/jbc.M111.252213	http://dx.doi.org/10.1074/jbc.M111.252213			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757723	Green Published, hybrid			2022-12-27	WOS:000294283600039
J	Oh, HM; Yu, CR; Golestaneh, N; Amadi-Obi, A; Lee, YS; Eseonu, A; Mahdi, RM; Egwuagu, CE				Oh, Hyun-Mee; Yu, Cheng-Rong; Golestaneh, Nady; Amadi-Obi, Ahjoku; Lee, Yun Sang; Eseonu, Amarachi; Mahdi, Rashid M.; Egwuagu, Charles E.			STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; DNA-BINDING; ACTIVATION; PROLIFERATION; SUPPRESSORS; EXPRESSION; CONTRIBUTE; GENES; IL-2	Much is known about the role of STAT3 in regulating differentiation of interleukin-17-producing Th17 cells, but its function in other lymphocyte subsets is not well understood. In this report, we reveal wide-ranging functions of STAT3 in T-cells and provide evidence that STAT3 is convergence point for mechanisms that regulate lymphocyte quiescence and those controlling T-cell activation and survival. We show here that STAT3 inhibits T-lymphocyte proliferation by up-regulating the expression of Class-O Forkhead transcription factors, which play essential roles in maintaining T-cells in quiescent state. We further show that STAT3 binds directly to FoxO1 or FoxO3a promoter and that STAT3-deficiency resulted in down-regulation of the expression of FoxO1, FoxO3a and FoxO-target genes (I kappa B and p27Kip1). Compared with wild-type T-cells, STAT3-deficient T-cells produced more IL-2, due in part, to marked decrease in I kappa B-mediated sequestration of NF-kappa B in the cytoplasm and resultant enhancement of NF-kappa B activation. However, the high level of IL-2 production by STAT3-deficient T-cells was partially restored to normal levels by overexpressing FoxO1. It is notable that their exaggerated increase in IL-2 production rendered STAT3-deficient lymphocytes more susceptible to activation-induced cell death, suggesting that STAT3 might protect T-cells from apoptosis by limiting their production of IL-2 through up-regulation of FoxO1/FoxO3a expression. Moreover, we found that STAT3 enhanced survival of activated T-cells by up-regulating OX-40 and Bcl-2 while down-regulating FasL and Bad expression, suggesting that similar to role of FoxOs in regulating the lifespan of worms, STAT3 and FoxO pathways converge to regulate lifespan of T-lymphocytes.	[Oh, Hyun-Mee; Yu, Cheng-Rong; Amadi-Obi, Ahjoku; Lee, Yun Sang; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Golestaneh, Nady] Georgetown Univ, Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Eseonu, Amarachi] Harvard Univ, Harvard Coll, Dept Biomed Engn, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University; Harvard University	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, Immunol Lab, NIH, 10-10N116,10 Ctr Dr, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov		Yu, Cheng-Rong/0000-0001-7246-0362	NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000315] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health Intramural Research Programs.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li WM, 1999, DEV BIOL, V210, P44, DOI 10.1006/dbio.1999.9267; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu Jun O, 2005, Sci STKE, V2005, pre1; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	31	71	71	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30888	30897		10.1074/jbc.M111.253500	http://dx.doi.org/10.1074/jbc.M111.253500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730069	Green Published, hybrid			2022-12-27	WOS:000294283600068
J	Schollmeier, Y; Krause, JM; Kreye, S; Malsam, J; Sollner, TH				Schollmeier, Yvette; Krause, Jean Michel; Kreye, Susanne; Malsam, Joerg; Soellner, Thomas H.			Resolving the Function of Distinct Munc18-1/SNARE Protein Interaction Modes in a Reconstituted Membrane Fusion Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE FUSION; NEURONAL SNARE COMPLEX; SYNTAXIN 1A; N-PEPTIDE; CA2+-TRIGGERED EXOCYTOSIS; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SWITCH; SEC1/MUNC18 PROTEINS; GENERAL SECRETION; TERMINAL DOMAIN	Sec1p/Munc18 proteins and SNAP receptors (SNAREs) are key components of the intracellular membrane fusion machinery. Compartment-specific v-SNAREs on a transport vesicle pair with their cognate t-SNAREs on the target membrane and drive lipid bilayer fusion. In a reconstituted assay that dissects the sequential assembly of t-SNARE (syntaxin 1.SNAP-25) and v-/t-SNARE (VAMP2.syntaxin 1.SNAP-25) complexes, and finally measures lipid bilayer merger, we resolved the inhibitory and stimulatory functions of the Sec1p/Munc18 protein Munc18-1 at the molecular level. Inhibition of membrane fusion by Munc18-1 requires a closed conformation of syntaxin 1. Remarkably, the concurrent preincubation of Munc18-1-inhibited syntaxin 1 liposomes with both VAMP2 liposomes and SNAP-25 at low temperature releases the inhibition and effectively stimulates membrane fusion. VAMP8 liposomes can neither release the inhibition nor exert the stimulatory effect, demonstrating the need for a specific Munc18-1/VAMP2 interaction. In addition, Munc18-1 binds to the N-terminal peptide of syntaxin 1, which is obligatory for a robust stimulation of membrane fusion. In contrast, this interaction is neither required for the inhibitory function of Munc18-1 nor for the release of this block. These results indicate that Munc18-1 and the neuronal SNAREs already have the inherent capability to function as a basic stage-specific off/on switch to control membrane fusion.	[Schollmeier, Yvette; Krause, Jean Michel; Kreye, Susanne; Malsam, Joerg; Soellner, Thomas H.] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sollner, TH (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	thomas.soellner@bzh.uni-heidelberg.de			National Institutes of Health [NS0443391]; German Research Foundation [GRK1188, SFB/TRR83]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grant NS0443391 (to T. H. S.). This work was also supported by German Research Foundation Grants GRK1188 and SFB/TRR83 (to Y. S. and T. H. S.).	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Halachmi N, 1996, J NEUROCHEM, V66, P889; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; MacDonald C, 2010, BIOCHEM SOC T, V38, P209, DOI 10.1042/BST0380209; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson Mary, 2009, Biochem J, V418, pe1, DOI 10.1042/BJ20082389; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Sassa T, 1999, J NEUROSCI, V19, P4772; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	78	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30582	30590		10.1074/jbc.M111.269886	http://dx.doi.org/10.1074/jbc.M111.269886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730064	Green Published, hybrid			2022-12-27	WOS:000294283600037
J	Tatum, D; Li, WT; Placer, M; Li, SS				Tatum, Danielle; Li, Wentao; Placer, Margaret; Li, Shisheng			Diverse Roles of RNA Polymerase II-associated Factor 1 Complex in Different Subpathways of Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; DNA-DAMAGE CHECKPOINT; GLOBAL GENOMIC REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; HISTONE H2B UBIQUITYLATION; NUCLEOSOME CORE PARTICLE; SACCHAROMYCES-CEREVISIAE; PAF1 COMPLEX; NONTRANSCRIBED STRAND; ELONGATION-FACTORS	Transcription-coupled repair (TCR) and global genomic repair (GGR) are two pathways of nucleotide excision repair (NER). In Saccharomyces cerevisiae, Rad26 is important but not absolutely required for TCR. Rpb4, a nonessential RNA polymerase II (Pol II) subunit that forms a subcomplex with Rpb7, and the Spt4-Spt5 complex, a transcription elongation factor, have been shown to suppress Rad26-independent TCR. The Pol II-associated factor 1 complex (Paf1C) has been shown to function in transcription elongation, 3'-processing of mRNAs, and posttranslational modification of histones. Here we show that Paf1C plays a marginal role in facilitating Rad26-dependent TCR but significantly suppresses Rad26-independent TCR. The suppression of Rad26-independent TCR is achieved by cooperating with Spt4-Spt5. Wepropose a model that, in the absence of Rad26, a lesion is "locked" in the active center of a Pol II elongation complex, which is stabilized by the coordinated interactions of Rpb4-Rpb7, Spt4-Spt5, and Paf1C with each other and with the core Pol II. We also found that Paf1C facilitates GGR, especially in internucleosomal linker regions. The facilitation of GGR is achieved through enabling monoubiquitination of histone H2B lysine 123 by Bre1, which in turn permits di- and trimethylation of histone H3 lysine 79 by Dot1. To our best knowledge, among the NER-modulating factors documented so far, Paf1C appears to have the most diverse functions in different NER pathways or subpathways.	[Tatum, Danielle; Li, Wentao; Placer, Margaret; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Li, Wentao/AAU-1637-2020	Li, Wentao/0000-0003-2313-6384; Tatum, Danielle/0000-0002-3281-3853	National Science Foundation [MCB-0745229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0745229.	Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Brueckner F, 2007, FEBS LETT, V581, P2757, DOI 10.1016/j.febslet.2007.05.014; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P227; Gaillard H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000364; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; LeJeune D, 2009, DNA REPAIR, V8, P40, DOI 10.1016/j.dnarep.2008.08.010; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Li SS, 2007, DNA REPAIR, V6, P1596, DOI 10.1016/j.dnarep.2007.05.005; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Li SH, 2006, J BIOL CHEM, V281, P36643, DOI 10.1074/jbc.M604885200; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 1997, J MOL BIOL, V271, P31, DOI 10.1006/jmbi.1997.1154; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Teng Y, 2008, EMBO REP, V9, P97, DOI 10.1038/sj.embor.7401112; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Waters R, 2009, DNA REPAIR, V8, P146, DOI 10.1016/j.dnarep.2008.11.001; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	67	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30304	30313		10.1074/jbc.M111.252981	http://dx.doi.org/10.1074/jbc.M111.252981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737840	Green Published, hybrid			2022-12-27	WOS:000294283600008
J	Yu, X; Chen, M; Zhang, S; Yu, ZH; Sun, JP; Wang, LN; Liu, SJ; Imasaki, T; Takagi, Y; Zhang, ZY				Yu, Xiao; Chen, Ming; Zhang, Sheng; Yu, Zhi-Hong; Sun, Jin-Peng; Wang, Lina; Liu, Sijiu; Imasaki, Tsuyoshi; Takagi, Yuichiro; Zhang, Zhong-Yin			Substrate Specificity of Lymphoid-specific Tyrosine Phosphatase (Lyp) and Identification of Src Kinase-associated Protein of 55 kDa Homolog (SKAP-HOM) as a Lyp Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; GENETIC-VARIATION; PTPN22; VARIANT; POLYMORPHISM; INHIBITOR; ADHESION; COMPLEX; CLONING	A missense single-nucleotide polymorphism in the gene encoding the lymphoid-specific tyrosine phosphatase (Lyp) has been identified as a causal factor in a wide spectrum of autoimmune diseases. Interestingly, the autoimmune-predisposing variant of Lyp appears to represent a gain-of-function mutation, implicating Lyp as an attractive target for the development of effective strategies for the treatment of many autoimmune disorders. Unfortunately, the precise biological functions of Lyp in signaling cascades and cellular physiology are poorly understood. Identification and characterization of Lyp substrates will help define the chain of molecular events coupling Lyp dysfunction to diseases. In the current study, we identified consensus sequence motifs for Lyp substrate recognition using an "inverse alanine scanning" combinatorial library approach. The intrinsic sequence specificity data led to the discovery and characterization of SKAP-HOM, a cytosolic adaptor protein required for proper activation of the immune system, as a bona fide Lyp substrate. To determine the molecular basis for Lyp substrate recognition, we solved crystal structures of Lyp in complex with the consensus peptide as well as the phosphopeptide derived from SKAP-HOM. Together with the biochemical data, the structures define the molecular determinants for Lyp substrate specificity and provide a solid foundation upon which novel therapeutics targeting Lyp can be developed for multiple autoimmune diseases.	[Yu, Xiao; Chen, Ming; Zhang, Sheng; Yu, Zhi-Hong; Sun, Jin-Peng; Wang, Lina; Liu, Sijiu; Imasaki, Tsuyoshi; Takagi, Yuichiro; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu	SUN, JINPENG/F-9551-2013; sun, Jinpeng/AAR-9196-2020	Imasaki, Tsuyoshi/0000-0001-5462-1820; Yu, Xiao/0000-0003-1119-8334	National Institutes of Health [CA69202, CA126937]; NATIONAL CANCER INSTITUTE [R01CA069202, R01CA126937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69202 and CA126937.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Cheung YW, 1997, J AM CHEM SOC, V119, P9568, DOI 10.1021/ja971825k; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Curtis DJ, 2000, EXP HEMATOL, V28, P1250, DOI 10.1016/S0301-472X(00)00537-3; Espanel X, 2005, METHODS, V35, P64, DOI 10.1016/j.ymeth.2004.07.009; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huyer G, 1998, ANAL BIOCHEM, V258, P19, DOI 10.1006/abio.1997.2541; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V252, P738, DOI 10.1006/bbrc.1998.9637; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini MC, 1998, BIOCHEMISTRY-US, V37, P15598, DOI 10.1021/bi981427+; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Stanford SM, 2010, SEMIN IMMUNOPATHOL, V32, P127, DOI 10.1007/s00281-010-0201-4; Sun HY, 2009, CHEM COMMUN, P677, DOI 10.1039/b817853d; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Swanson KD, 2008, MOL CELL, V32, P564, DOI 10.1016/j.molcel.2008.09.022; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	48	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30526	30534		10.1074/jbc.M111.254722	http://dx.doi.org/10.1074/jbc.M111.254722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21719704	Green Published, hybrid			2022-12-27	WOS:000294283600031
J	Mazier, S; Quick, M; Shi, L				Mazier, Sonia; Quick, Matthias; Shi, Lei			Conserved Tyrosine in the First Transmembrane Segment of Solute:Sodium Symporters Is Involved in Na+-coupled Substrate Co-transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NA+/PROLINE TRANSPORTER; MOLECULAR CHARACTERIZATION; NA+/GLUCOSE COTRANSPORTER; CRYSTAL-STRUCTURE; ACID TRANSPORTER; PROLINE UPTAKE; SODIUM; BINDING; PROTEIN	Solute: sodium symporters (SSSs) transport vital molecules across the plasma membrane of all living organisms. vSGLT, the Na+/galactose transporter of Vibrio parahemeolyticus, is the only SSS for which high resolution structural information is available, revealing a LeuT-like fold and a Na+-binding site analogous to the Na2 site of LeuT. Whereas the core transmembrane segments (TMs) of SSSs share high structural similarity with other transporters of LeuT-like fold, TM1 does not correspond to any TM in those structural homologs and was only resolved for the backbone atoms in the initial vSGLT structure (Protein Data Bank code 3DH4). To assess the role of TM1 in Na+-coupled substrate symport by the SSSs, here we have studied the role of a conserved residue in TM1 by computational modeling in conjunction with radiotracer transport and binding studies. Based on our sequence alignment and much topological data for homologous PutP, the Na+/proline transporter, we have simulated a series of vSGLT models with shifted TM1 residue assignments. We show that in two converged vSGLT models that retained the original TM1 backbone conformation, a conserved residue, Tyr-19, is associated with the Na(+)binding interaction network. In silico and in vitro mutagenesis of homologous Tyr-14 in PutP revealed the involvement of this conserved residue in Na+-dependent substrate binding and transport. Thus, our combined computational and experimental data provide the first clues about the importance of a conserved residue in TM1, a unique TM in the proteins with LeuT-like fold, in the Na+-coupled symport mechanism of SSSs.	[Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Mazier, Sonia; Shi, Lei] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Shi, Lei] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; Cornell University; Cornell University; New York State Psychiatry Institute	Quick, M (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 650 W 168th St,BB1119, New York, NY 10032 USA.	mq2102@columbia.edu; les2007@med.cornell.edu	Shi, Lei/AAV-1321-2020	Shi, Lei/0000-0002-4137-096X	National Institutes of Health [P30ES09089, DA023694]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023694, K99DA023694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants P30ES09089 (to Joseph H. Graziano) and DA023694 (to L. S.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Choe S, 2010, BIOPHYS J, V99, pL56, DOI 10.1016/j.bpj.2010.08.055; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MYERS RS, 1988, MOL MICROBIOL, V2, P749, DOI 10.1111/j.1365-2958.1988.tb00086.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Reed-Tsur MD, 2008, ENDOCRINOLOGY, V149, P3077, DOI 10.1210/en.2008-0027; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Smirnova I, 2009, BIOCHEMISTRY-US, V48, P8852, DOI 10.1021/bi9011918; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; VALLARI DS, 1985, J BACTERIOL, V162, P1156, DOI 10.1128/JB.162.3.1156-1161.1985; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xie ZY, 2000, J BIOL CHEM, V275, P25959, DOI 10.1074/jbc.M002687200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2010, MOL BIOSYST, V6, P1040, DOI 10.1039/b927492h	42	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29347	29355		10.1074/jbc.M111.263327	http://dx.doi.org/10.1074/jbc.M111.263327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705334	Green Published, hybrid			2022-12-27	WOS:000293837000069
J	Tsubakiyama, R; Mizunuma, M; Gengyo, A; Yamamoto, J; Kume, K; Miyakawa, T; Hirata, D				Tsubakiyama, Ryohei; Mizunuma, Masaki; Gengyo, Anri; Yamamoto, Josuke; Kume, Kazunori; Miyakawa, Tokichi; Hirata, Dai			Implication of Ca2+ in the Regulation of Replicative Life Span of Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; PROTEIN PHOSPHATASE; CALORIE RESTRICTION; SECRETORY PATHWAY; RIBOSOMAL DNA; CALCINEURIN; SIR2; GENES	In eukaryotic cells, Ca2+-triggered signaling pathways are used to regulate a wide variety of cellular processes. Calcineurin, a highly conserved Ca2+/calmodulin-dependent protein phosphatase, plays key roles in the regulation of diverse biological processes in organisms ranging from yeast to humans. We isolated a mutant of the SIR3 gene, implicated in the regulation of life span, as a suppressor of the Ca2+ sensitivity of zds1 Delta cells in the budding yeast Saccharomyces cerevisiae. Therefore, we investigated a relationship between Ca2+ signaling and life span in yeast. Here we show that Ca2+ affected the replicative life span (RLS) of yeast. Increased external and intracellular Ca2+ levels caused a reduction in their RLS. Consistently, the increase in calcineurin activity by either the zds1 deletion or the constitutively activated calcineurin reduced RLS. Indeed, the shortened RLS of zds1 Delta cells was suppressed by the calcineurin deletion. Further, the calcineurin deletion per se promoted aging without impairing the gene silencing typically observed in short-lived sir mutants, indicating that calcineurin plays an important role in a regulation of RLS even under normal growth condition. Thus, our results indicate that Ca2+ homeostasis/Ca2+ signaling are required to regulate longevity in budding yeast.	[Tsubakiyama, Ryohei; Mizunuma, Masaki; Gengyo, Anri; Yamamoto, Josuke; Kume, Kazunori; Miyakawa, Tokichi; Hirata, Dai] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan	Hiroshima University	Mizunuma, M (corresponding author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan.	mmizu49120@hiroshima-u.ac.jp	Kume, Kazunori/T-4061-2018; Mizunuma, Masaki/V-2941-2017	Kume, Kazunori/0000-0002-0613-8081; Mizunuma, Masaki/0000-0002-1531-1763	Japan Society for the Promotion of Science [18688004, 21780095]; Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [21780095] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science for Young Scientists (A) and (B) 18688004 and 21780095 (to M. M.), and by Ministry of Education, Science, and Culture of Japan (to D. H.).	ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Austriaco NR, 1997, P NATL ACAD SCI USA, V94, P9768, DOI 10.1073/pnas.94.18.9768; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Defossez PA, 2001, BIOESSAYS, V23, P327, DOI 10.1002/bies.1047; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; FARCASANU IC, 1995, EUR J BIOCHEM, V232, P712, DOI 10.1111/j.1432-1033.1995.tb20865.x; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Ma XJ, 1996, GENE DEV, V10, P1327, DOI 10.1101/gad.10.11.1327; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; Mizunuma M, 2005, J CELL SCI, V118, P4219, DOI 10.1242/jcs.02535; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Nakamura T, 1996, MOL GEN GENET, V251, P211; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; RINE J, 1987, GENETICS, V116, P9; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yokoyama H, 2006, EMBO REP, V7, P519, DOI 10.1038/sj.embor.7400647; Yu YX, 1996, MOL CELL BIOL, V16, P5254; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082	58	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28681	28687		10.1074/jbc.M111.231415	http://dx.doi.org/10.1074/jbc.M111.231415			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712379	Green Published, hybrid			2022-12-27	WOS:000293837000005
J	Chanda, D; Kim, DK; Li, TG; Kim, YH; Koo, SH; Lee, CH; Chiang, JYL; Choi, HS				Chanda, Dipanjan; Kim, Don-Kyu; Li, Tiangang; Kim, Yong-Hoon; Koo, Seung-Hoi; Lee, Chul-Ho; Chiang, John Y. L.; Choi, Hueng-Sik			Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCANNABINOID SYSTEM; RISK-FACTORS; ER STRESS; OVERWEIGHT PATIENTS; ACTIVATION; RIMONABANT; DYSREGULATION; ANTAGONIST; INSULIN; BLOCKER	Activated cannabinoid 1 receptor (CB1R) signaling has been implicated in the development of phenotypes associated with fatty liver, insulin resistance, and impaired suppression of hepatic glucose output. Endoplasmic reticulum stress-associated liver-specific transcription factor CREBH is emerging as a critical player in various hepatic metabolic pathways and regulates hepatic gluconeogenesis in diet-induced obese settings. In this study, we elucidated the critical role of CREBH in mediating CB1R signaling to regulate glucose homeostasis in primary rat and human hepatocytes. mRNA and protein levels and glucose production were analyzed in primary rat and human hepatocytes. ChIP assays were performed together with various transcriptional analyses using standard techniques. CB1R activation by 2-arachidonoylglycerol (2-AG) specifically induced CREBH gene expression via phosphorylation of the JNK signaling pathway and c-Jun binding to the AP-1 binding site in the CREBH gene promoter. 2-AG treatment significantly induced hepatic gluconeogenic gene expression and glucose production in primary hepatocytes, and we demonstrated that the CREBH binding site mutant significantly attenuated 2-AG-mediated activation of the gluconeogenic gene promoter. Endogenous knockdown of CREBH led to ablation of 2-AG-induced gluconeogenic gene expression and glucose production, and the CB1R antagonist AM251 or insulin exhibited repression of CREBH gene induction and subsequently inhibited gluconeogenesis in both rat and human primary hepatocytes. These results demonstrate a novel mechanism of action of activated CB1R signaling to induce hepatic gluconeogenesis via direct activation of CREBH, thereby contributing to a better understanding of the endocannabinoid signaling mechanism involved in regulating the hepatic glucose metabolism.	[Chanda, Dipanjan; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Li, Tiangang; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea	Chonnam National University; Chonnam National University; Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Koo, Seung-Hoi/E-2763-2015; Chanda, Dipanjan/AAU-3996-2021	Chiang, John Y. L./0000-0001-9360-7650; Koo, Seung-Hoi/0000-0001-8769-2879; Chanda, Dipanjan/0000-0003-0685-187X	National Institutes of Health [DK44442, DK58379]; Ministry of Education, Science, and Technology [2010-0019512]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100588]; Korean Ministry of Education, Science and Technology [20110018305]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058379, R37DK058379, R01DK044442, R56DK044442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44442 and DK58379 (to J. Y. L. C.). This work was also supported by Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology Grant 2010-0019512 (to H.-S. C.); by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant A100588 (to H.-S. C.); and by National Creative Research Initiatives Grant 20110018305 funded by the Korean Ministry of Education, Science and Technology (to H.-S. C.).	Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Irwin N, 2008, EUR J PHARMACOL, V581, P226, DOI 10.1016/j.ejphar.2007.12.003; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang D, 2006, ENDOCRINOLOGY, V147, P350, DOI 10.1210/en.2005-1014; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	29	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27971	27979		10.1074/jbc.M111.224352	http://dx.doi.org/10.1074/jbc.M111.224352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693703	hybrid, Green Published			2022-12-27	WOS:000293557800015
J	Pelikan-Conchaudron, A; Le Clainche, C; Didry, D; Carlier, MF				Pelikan-Conchaudron, Andrea; Le Clainche, Christophe; Didry, Dominique; Carlier, Marie-France			The IQGAP1 Protein Is a Calmodulin-regulated Barbed End Capper of Actin Filaments POSSIBLE IMPLICATIONS IN ITS FUNCTION IN CELL MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; N-WASP; CRYSTAL-STRUCTURE; INTEGRATES CA2+/CALMODULIN; PEDESTAL FORMATION; SHIGELLA-FLEXNERI; STRUCTURAL BASIS; HOMOLOGY DOMAIN; ACTOMYOSIN RING; F-ACTIN	IQGAP1 is a large modular protein that displays multiple partnership and is thought to act as a scaffold in coupling cell signaling to the actin and microtubule cytoskeletons in cell migration, adhesion, and cytokinesis. However the molecular mechanisms underlying the activities of IQGAP1 are poorly understood in part because of its large size, poor solubility and lack of functional assays to challenge biochemical properties in various contexts. We have purified bacterially expressed recombinant human IQGAP1. The protein binds Cdc42, Rac1, and the CRIB domain of N-WASP in a calmodulin-sensitive fashion. We further show that in addition to bundling of filaments via a single N-terminal calponin-homology domain, IQGAP1 actually regulates actin assembly. It caps barbed ends, with a higher affinity for ADP-bound terminal subunits (K-B = 4 nM). The barbed end capping activity is inhibited by calmodulin, consistent with calmodulin binding to IQGAP1 with a K-C of 40 nM, both in the absence and presence of Ca2+ ions. The barbed end capping activity resides in the C-terminal half of IQGAP1. It is possible that the capping activity of IQGAP1 accounts for its stimulation of cell migration. We further find that bacterially expressed recombinant IQGAP1 fragments easily co-purify with nucleic acids that turn out to activate N-WASP protein to branch filaments with Arp2/3 complex. The present results open perspectives for tackling the function of IQGAP1 in more complex reconstituted systems.	[Pelikan-Conchaudron, Andrea; Le Clainche, Christophe; Didry, Dominique; Carlier, Marie-France] CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3289, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Carlier, MF (corresponding author), CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3289, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr	Le Clainche, Christophe/A-4782-2015	Le Clainche, Christophe/0000-0001-5659-677X	ANR-PCV; ERC; Ligue Nationale contre le Cancer (MFC is equipe labellisee Ligue); European Community [241548]; French Minister of Research; EU [241548]	ANR-PCV(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Ligue Nationale contre le Cancer (MFC is equipe labellisee Ligue)(Institut National du Cancer (INCA) France); European Community(European Commission); French Minister of Research; EU(European Commission)	This work was supported in part by ANR-PCV 2006, an ERC advanced grant (2009) (to M.-F.C.), the Ligue Nationale contre le Cancer (MFC is equipe labellisee Ligue), and the European Community's Seventh Framework Programme [FP7/2007-2013] under Grant agreement n<SUP>o</SUP> 241548.; Supported by a fellowship from the French Minister of Research and by EU FP7 Grant 241548.	Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Eng K, 1998, CURR BIOL, V8, P611, DOI 10.1016/S0960-9822(98)70248-9; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Heil A, 2011, J BIOL CHEM, V286, P7227, DOI 10.1074/jbc.M110.135095; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Husson C, 2010, ANN NY ACAD SCI, V1194, P44, DOI 10.1111/j.1749-6632.2010.05473.x; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kim T, 2010, J MOL BIOL, V404, P794, DOI 10.1016/j.jmb.2010.10.017; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Morrison EE, 2009, ADV EXP MED BIOL, V656, P41, DOI 10.1007/978-1-4419-1145-2_4; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Shannon KB, 1999, MOL BIOL CELL, V10, P283, DOI 10.1091/mbc.10.2.283; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Umemoto R, 2010, J BIOMOL NMR, V48, P59, DOI 10.1007/s10858-010-9434-8; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167	58	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35119	35128		10.1074/jbc.M111.258772	http://dx.doi.org/10.1074/jbc.M111.258772			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21730051	hybrid, Green Published			2022-12-27	WOS:000295406300065
J	Griffiths, HH; Whitehouse, IJ; Baybutt, H; Brown, D; Kellett, KAB; Jackson, CD; Turner, AJ; Piccardo, P; Manson, JC; Hooper, NM				Griffiths, Heledd H.; Whitehouse, Isobel J.; Baybutt, Herbert; Brown, Debbie; Kellett, Katherine A. B.; Jackson, Carolyn D.; Turner, Anthony J.; Piccardo, Pedro; Manson, Jean C.; Hooper, Nigel M.			Prion Protein Interacts with BACE1 Protein and Differentially Regulates Its Activity toward Wild Type and Swedish Mutant Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; PLAQUE-FORMATION; CLEAVING ENZYME; MUTATION; APP; PATHOGENESIS; OLIGOMERS; BRAIN; MICE	In Alzheimer disease amyloid-beta (A beta) peptides derived from the amyloid precursor protein (APP) accumulate in the brain. Cleavage of APP by the beta-secretase BACE1 is the rate-limiting step in the production of A beta. We have reported previously that the cellular prion protein (PrPC) inhibited the action of BACE1 toward human wild type APP (APP(WT)) in cellular models and that the levels of endogenous murine A beta were significantly increased in PrPC-null mouse brain. Here we investigated the molecular and cellular mechanisms underlying this observation. PrPC interacted directly with the prodomain of the immature Golgi-localized form of BACE1. This interaction decreased BACE1 at the cell surface and in endosomes where it preferentially cleaves APP(WT) but increased it in the Golgi where it preferentially cleaves APP with the Swedish mutation (APP(Swe)). In transgenic mice expressing human APP with the Swedish and Indiana familial mutations (APP(Swe,Ind)), PrPC deletion had no influence on APP proteolytic processing, A beta plaque deposition, or levels of soluble A beta or A beta oligomers. In cells, although PrPC inhibited the action of BACE1 on APP(WT), it did not inhibit BACE1 activity toward APP(Swe). The differential subcellular location of the BACE1 cleavage of APP(Swe) relative to APP(WT) provides an explanation for the failure of PrPC deletion to affect A beta accumulation in APP(Swe,Ind) mice. Thus, although PrPC exerts no control on cleavage of APP(Swe) by BACE1, it has a profound influence on the cleavage of APP(WT), suggesting that PrPC may be a key protective player against sporadic Alzheimer disease.	[Griffiths, Heledd H.; Whitehouse, Isobel J.; Kellett, Katherine A. B.; Jackson, Carolyn D.; Turner, Anthony J.; Hooper, Nigel M.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Baybutt, Herbert; Brown, Debbie; Piccardo, Pedro; Manson, Jean C.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Baybutt, Herbert; Brown, Debbie; Piccardo, Pedro; Manson, Jean C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Piccardo, Pedro] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	University of Leeds; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; US Food & Drug Administration (FDA)	Hooper, NM (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk		Kellett, Katherine/0000-0002-2802-0615; Jarosz-Griffiths, Heledd/0000-0001-5154-4815; manson, jean/0000-0002-0175-9890; Hooper, Nigel/0000-0002-5811-3484	NIAID [Y1-AI-4893-02]; Medical Research Council of Great Britain [G9824728, G0802189]; Alzheimer's Research Trust of Great Britain [PG2008/2]; Food and Drug Administration Agreement [224-05-1307]; MRC [G9824728, G0802189] Funding Source: UKRI; Alzheimers Research UK [ART-PG2010-2, ART-PG2008-2] Funding Source: researchfish; Medical Research Council [G9824728, G0802189] Funding Source: researchfish	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust of Great Britain; Food and Drug Administration Agreement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Agreement Y1-AI-4893-02 from the NIAID. This work was also supported by Medical Research Council of Great Britain Grants G9824728 and G0802189, Alzheimer's Research Trust of Great Britain Grant PG2008/2, and Food and Drug Administration Agreement 224-05-1307.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0; Hooper NM, 2008, TRENDS BIOCHEM SCI, V33, P151, DOI 10.1016/j.tibs.2008.01.004; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Whitehouse IJ, 2010, J ALZHEIMERS DIS, V22, P1023, DOI 10.3233/JAD-2010-101071; Yamakawa H, 2010, J BIOL CHEM, V285, P1634, DOI 10.1074/jbc.M109.066753; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	40	50	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33489	33500		10.1074/jbc.M111.278556	http://dx.doi.org/10.1074/jbc.M111.278556			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795680	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000294968800066
J	Maric, D; McGwire, BS; Buchanan, KT; Olson, CL; Emmer, BT; Epting, CL; Engman, DM				Maric, Danijela; McGwire, Bradford S.; Buchanan, Kathryn T.; Olson, Cheryl L.; Emmer, Brian T.; Epting, Conrad L.; Engman, David M.			Molecular Determinants of Ciliary Membrane Localization of Trypanosoma cruzi Flagellar Calcium-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYRISTOYL-ELECTROSTATIC SWITCH; ACIDIC PHOSPHOLIPIDS; LIPID MODIFICATIONS; TARGETING PROTEINS; PLASMA-MEMBRANE; GENE-EXPRESSION; BLOOD-STREAM; BRUCEI; LEISHMANIA; FAMILY	The flagellar calcium-binding protein (FCaBP) of Trypanosoma cruzi is localized to the flagellar membrane in all life cycle stages of the parasite. Myristoylation and palmitoylation of the N terminus of FCaBP are necessary for flagellar membrane targeting. Not all dually acylated proteins in T. cruzi are flagellar, however. Other determinants of FCaBP therefore likely contribute to flagellar specificity. We generated T. cruzi transfectants expressing the N-terminal 24 or 12 amino acids of FCaBP fused to GFP. Analysis of these mutants revealed that although amino acids 1-12 are sufficient for dual acylation and membrane binding, amino acids 13-24 are required for flagellar specificity and lipid raft association. Mutagenesis of several conserved lysine residues in the latter peptide demonstrated that these residues are essential for flagellar targeting and lipid raft association. Finally, FCaBP was expressed in the protozoan Leishmania amazonensis, which lacks FCaBP. The flagellar localization and membrane association of FCaBP in L. amazonensis suggest that the mechanisms for flagellar targeting, including a specific palmitoyl acyltransferase, are conserved in this organism.	[Maric, Danijela; McGwire, Bradford S.; Buchanan, Kathryn T.; Olson, Cheryl L.; Emmer, Brian T.; Epting, Conrad L.; Engman, David M.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Maric, Danijela; McGwire, Bradford S.; Buchanan, Kathryn T.; Olson, Cheryl L.; Emmer, Brian T.; Engman, David M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Epting, Conrad L.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Engman, DM (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	d-engman@northwestern.edu	Engman, David/T-6747-2018	Engman, David/0000-0001-5869-9844; Emmer, Brian T./0000-0001-7365-1021	National Institutes of Health [R01 AI46781, K12 HD047349]; American Heart Association [0910101G, 0020652Z, 0010187Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 AI46781. This work was also supported by American Heart Association Fellowships 0910101G, 0020652Z, and 0010187Z (to D. M., B. S. M., and K. T. B.), respectively.; Supported by National Institutes of Health Pediatric Critical Care Scientist Development Award K12 HD047349.	ALLAND L, 1994, J BIOL CHEM, V269, P16701; BANGS JD, 1993, J CELL SCI, V105, P1101; BARNES DA, 1990, MOL BIOCHEM PARASIT, V41, P101, DOI 10.1016/0166-6851(90)90101-Q; BLOODGOOD RA, 1995, PROTOPLASMA, V185, P123, DOI 10.1007/BF01272852; CHAILLEY B, 1985, J HISTOCHEM CYTOCHEM, V33, P1, DOI 10.1177/33.1.3965567; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Godsel L. M, 1997, IMMUNOLOGY MICROBIAL, P180; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; GODSEL LM, 1995, J EUKARYOT MICROBIOL, V42, P320, DOI 10.1111/j.1550-7408.1995.tb01587.x; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; HALLAK H, 1994, J BIOL CHEM, V269, P4571; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Kaneshiro E.S., 1990, P241; KANESHIRO ES, 1984, J LIPID RES, V25, P369; KAWULA TH, 1994, J BACTERIOL, V176, P610, DOI 10.1128/jb.176.3.610-619.1994; KAYA K, 1984, J BIOL CHEM, V259, P3548; KIRCHHOFF LV, 1985, JAMA-J AM MED ASSOC, V254, P3058, DOI 10.1001/jama.254.21.3058; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Landfear SM, 2001, MOL BIOCHEM PARASIT, V115, P1, DOI 10.1016/S0166-6851(01)00262-6; LIU X, 1992, P NATL ACAD SCI USA, V89, P4991, DOI 10.1073/pnas.89.11.4991; Maldonado RA, 1997, EXP PARASITOL, V86, P200, DOI 10.1006/expr.1997.4159; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Okura M, 2005, J BIOL CHEM, V280, P16235, DOI 10.1074/jbc.M414535200; OLSON CL, 1994, J BIOL CHEM, V269, P3868; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Porcel BM, 1996, EXP PARASITOL, V84, P387, DOI 10.1006/expr.1996.0127; RESH MD, 1993, BIOCHIM BIOPHYS ACTA, V1155, P307, DOI 10.1016/0304-419X(93)90012-2; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385, DOI 10.1128/MCB.13.10.6385; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Snapp EL, 1997, J CELL BIOL, V139, P1775, DOI 10.1083/jcb.139.7.1775; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; TETLEY L, 1986, ACTA TROP, V43, P307; TIBBETS RS, 1994, INFECT IMMUN, V62, P2499, DOI 10.1128/IAI.62.6.2499-2507.1994; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200; WU YM, 1992, BIOCHEM J, V287, P187, DOI 10.1042/bj2870187; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	58	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33109	33117		10.1074/jbc.M111.240895	http://dx.doi.org/10.1074/jbc.M111.240895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784841	hybrid, Green Published			2022-12-27	WOS:000294968800029
J	Vitvitsky, V; Garg, SK; Banerjee, R				Vitvitsky, Victor; Garg, Sanjay K.; Banerjee, Ruma			Taurine Biosynthesis by Neurons and Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISETHIONIC ACID; ORGANIC OSMOLYTES; RAT-BRAIN; HYPOTAURINE; METABOLISM; CYSTEINE; OXIDATION; CELLS; IDENTIFICATION; DECARBOXYLASE	The physiological roles of taurine, a product of cysteine degradation and one of the most abundant amino acids in the body, remain elusive. Taurine deficiency leads to heart dysfunction, brain development abnormalities, retinal degradation, and other pathologies. The taurine synthetic pathway is proposed to be incomplete in astrocytes and neurons, and metabolic cooperation between these cell types is reportedly needed to complete the pathway. In this study, we analyzed taurine synthesis capability as reported by incorporation of radioactivity from [S-35]cysteine into taurine, in primary murine astrocytes and neurons, and in several transformed cell lines (human (SH-SY5Y) and murine (N1E-115) neuroblastoma, human astrocytoma (U-87MG and 1321 N1), and rat glioma (C6)). Extensive incorporation of radioactivity from [S-35]cysteine into taurine was observed in rat glioma cells as well as in primary mouse astrocytes and neurons, establishing the presence of an intact taurine synthesis pathway in these cells. Interestingly, exposure of cells to cysteine or cysteamine resulted in elevated intracellular hypotaurine without a corresponding increase in taurine levels, suggesting that oxidation of hypotaurine limits taurine synthesis in cells. Consistent with its role as an organic osmolyte, taurine synthesis was stimulated under hypertonic conditions in neurons.	[Vitvitsky, Victor; Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Vitvitsky, Victor/ABA-2967-2021	Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [DK64959]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK64959.	Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Banerjee R, 2008, TRENDS BIOCHEM SCI, V33, P413, DOI 10.1016/j.tibs.2008.06.006; Beetsch JW, 1998, AM J PHYSIOL-CELL PH, V274, pC866, DOI 10.1152/ajpcell.1998.274.4.C866; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Bothwell JH, 2001, J NEUROCHEM, V77, P1632, DOI 10.1046/j.1471-4159.2001.00403.x; Brand A, 1997, CELL MOL BIOL, V43, P645; Brand A, 1998, J NEUROCHEM, V71, P827; Dominy J, 2004, NEUROCHEM RES, V29, P97, DOI 10.1023/B:NERE.0000010437.81860.d5; Dominy JE, 2007, AM J PHYSIOL-ENDOC M, V293, pE62, DOI 10.1152/ajpendo.00053.2007; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Fellman J H, 1987, Adv Exp Med Biol, V217, P39; FIORI A, 1969, Acta Vitaminologica et Enzymologica, V23, P204; Fisher SK, 2008, J NEUROCHEM, V106, P1998, DOI 10.1111/j.1471-4159.2008.05510.x; Foster DJ, 2009, J NEUROCHEM, V108, P437, DOI 10.1111/j.1471-4159.2008.05773.x; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Garg SK, 2010, METHODS IN REDOX SIGNALING, P7; Garg SK, 2009, J NEUROCHEM, V108, P1155, DOI 10.1111/j.1471-4159.2009.05872.x; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hussy N, 2000, ADV EXP MED BIOL, V483, P227; HUXTABLE R, 1972, J NUTR, V102, P805, DOI 10.1093/jn/102.7.805; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Kimelberg H K, 1987, Cent Nerv Syst Trauma, V4, P3; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; Morales I, 2007, AM J PHYSIOL-CELL PH, V292, pC1934, DOI 10.1152/ajpcell.00593.2006; Nakamura H, 2006, AMINO ACIDS, V31, P27, DOI 10.1007/s00726-005-0277-7; OJA SS, 1981, BIOCHIM BIOPHYS ACTA, V677, P350, DOI 10.1016/0304-4165(81)90246-4; PECK EJ, 1967, BIOCHIM BIOPHYS ACTA, V141, P499, DOI 10.1016/0304-4165(67)90178-X; PERRY TL, 1973, J NEUROCHEM, V21, P1009, DOI 10.1111/j.1471-4159.1973.tb07547.x; READ WO, 1962, J BIOL CHEM, V237, P1521; RICCI G, 1978, PHYSIOL CHEM PHYS M, V10, P435; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; SUMIZU K, 1962, BIOCHIM BIOPHYS ACTA, V63, P210, DOI 10.1016/0006-3002(62)90357-8; TAPPAZ M, 1994, ADV EXP MED BIOL, V359, P257; Tuz K, 2001, J NEUROCHEM, V79, P143, DOI 10.1046/j.1471-4159.2001.00546.x; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WORDEN JA, 1985, COMP BIOCHEM PHYS B, V82, P233, DOI 10.1016/0305-0491(85)90232-9	41	83	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32002	32010		10.1074/jbc.M111.253344	http://dx.doi.org/10.1074/jbc.M111.253344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778230	Green Published, hybrid			2022-12-27	WOS:000294726800009
J	Autry, JM; Rubin, JE; Pietrini, SD; Winters, DL; Robia, SL; Thomas, DD				Autry, Joseph M.; Rubin, John E.; Pietrini, Sean D.; Winters, Deborah L.; Robia, Seth L.; Thomas, David D.			Oligomeric Interactions of Sarcolipin and the Ca-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; MUSCLE SARCOPLASMIC-RETICULUM; FLUORESCENCE ENERGY-TRANSFER; SOLID-STATE NMR; CALCIUM-TRANSPORT; SKELETAL-MUSCLE; PHOSPHOLAMBAN OLIGOMERIZATION; ENDOPLASMIC-RETICULUM; ANTIMICROBIAL PEPTIDE; ATRIAL-FIBRILLATION	We have detected directly the interactions of sarcolipin (SLN) and the sarcoplasmic reticulum Ca-ATPase (SERCA) by measuring fluorescence resonance energy transfer (FRET) between fusion proteins labeled with cyan fluorescent protein (donor) and yellow fluorescent protein (acceptor). SLN is a membrane protein that helps control contractility by regulating SERCA activity in fast-twitch and atrial muscle. Here we used FRET microscopy and spectroscopy with baculovirus expression in insect cells to provide direct evidence for: 1) oligomerization of SLN and 2) regulatory complex formation between SLN and the fast-twitch muscle Ca-ATPase (SERCA1a isoform). FRET experiments demonstrated that SLN monomers self-associate into dimers and higher order oligomers in the absence of SERCA, and that SLN monomers also bind to SERCA monomers in a 1:1 binary complex when the two proteins are coexpressed. FRET experiments further demonstrated that the binding affinity of SLN for itself is similar to that for SERCA. Mutating SLN residue isoleucine-17 to alanine (I17A) decreased the binding affinity of SLN self-association and converted higher order oligomers into monomers and dimers. The I17A mutation also decreased SLN binding affinity for SERCA but maintained 1:1 stoichiometry in the regulatory complex. Thus, isoleucine-17 plays dual roles in determining the distribution of SLN homooligomers and stabilizing the formation of SERCA-SLN heterodimers. FRET results for SLN self-association were supported by the effects of SLN expression in bacterial cells. We propose that SLN exists as multiple molecular species in muscle, including SERCA-free (monomer, dimer, oligomer) and SERCA-bound (heterodimer), with transmembrane zipper residues of SLN serving to stabilize oligomeric interactions.	[Autry, Joseph M.; Rubin, John E.; Pietrini, Sean D.; Winters, Deborah L.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Robia, Seth L.] Loyola Univ, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	University of Minnesota System; University of Minnesota Twin Cities; Loyola University Chicago	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall, Minneapolis, MN 55455 USA.	ddt@umn.edu	Thomas, David D/B-4257-2012; Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [GM27906]; Lillehei Heart Institute; University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lillehei Heart Institute; University of Minnesota(University of Minnesota System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant GM27906 from the National Institutes of Health (to D. D. T.).; Supported by a grant from the Lillehei Heart Institute.; Supported by two grants from the Undergraduate Research Opportunities Program at the University of Minnesota.	Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Aly A, 2001, BIOPHYS J, V80, p26A; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Becucci L, 2007, BIOPHYS J, V93, P2678, DOI 10.1529/biophysj.107.109280; Becucci L, 2009, BIOPHYS J, V97, P2693, DOI 10.1016/j.bpj.2009.08.035; Becucci L, 2009, BIOPHYS J, V96, pL60, DOI 10.1016/j.bpj.2009.03.013; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Buffy JJ, 2006, BIOCHEMISTRY-US, V45, P10939, DOI 10.1021/bi060728d; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; COOK EA, 1989, BIOCHEM J, V264, P533, DOI 10.1042/bj2640533; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Espagne A, 2011, BIOCHEMISTRY-US, V50, P437, DOI 10.1021/bi1015875; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; Glaves JP, 2009, BIOPHYS J, V96, p211A, DOI 10.1016/j.bpj.2008.12.1866; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; JONA I, 1989, ACTA PHYSIOL HUNG, V74, P215; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan D H, 1974, Methods Enzymol, V32, P291; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Pandey BK, 2011, BIOCHEM J, V436, P609, DOI 10.1042/BJ20110056; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Remppis Andrew, 2002, Basic Research in Cardiology, V97; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SKERJANC IS, 1993, J BIOL CHEM, V268, P15944; Smeazzetto S, 2010, BIOPHYS J, V98, p327A; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Thomas DD, 1998, ANN NY ACAD SCI, V853, P186, DOI 10.1111/j.1749-6632.1998.tb08266.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Uemura N, 2004, EUR J CLIN INVEST, V34, P723, DOI 10.1111/j.1365-2362.2004.01422.x; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Vittorini S, 2007, MOL MED, V13, P105, DOI 10.2119/2006-00054.Vittorini; Waggoner JR, 2004, PROTEIN EXPRES PURIF, V34, P56, DOI 10.1016/j.pep.2003.11.005; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	65	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31697	31706		10.1074/jbc.M111.246843	http://dx.doi.org/10.1074/jbc.M111.246843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21737843	hybrid, Green Published			2022-12-27	WOS:000294487500062
J	Dorjbal, B; Derse, D; Lloyd, P; Soheilian, F; Nagashima, K; Heidecker, G				Dorjbal, Batsukh; Derse, David; Lloyd, Patricia; Soheilian, Ferri; Nagashima, Kunio; Heidecker, Gisela			The Role of ITCH Protein in Human T-cell Leukemia Virus Type 1 Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE-BUDDING DOMAINS; NEDD4-LIKE UBIQUITIN LIGASE; INFECTIOUS-ANEMIA VIRUS; IMMUNODEFICIENCY-VIRUS; MULTIVESICULAR BODY; PARTICLE RELEASE; ESCRT MACHINERY; SORTING PATHWAY; MATRIX PROTEIN; HOST PROTEINS	Human T-cell leukemia virus type 1 (HTLV-1) has two late domain (LD) motifs, PPPY and PTAP, which are important for viral budding. Mutations in the PPPY motif are more deleterious for viral release than changes in the PTAP motif. Several reports have shown that the interaction of PPPY with the WW domains of a Nedd4 (neuronal precursor cell-expressed developmentally down-regulated-4) family ubiquitin ligase (UL) is a critical event in virus release. We tested nine members of the Nedd4 family ULs and found that ITCH is the main contributor to HTLV-1 budding. ITCH overexpression strongly inhibited release and infectivity of wild-type (wt) HTLV-1, but rescued the release of infectious virions with certain mutations in the PPPY motif. Electron microscopy showed either fewer or misshapen virus particles when wt HTLV-1 was produced in the presence of overexpressed ITCH, whereas mutants with changes in the PPPY motif yielded normal looking particles at wt level. The other ULs had significantly weaker or no effects on HTLV-1 release and infectivity except for SMURF-1, which caused enhanced release of wt and all PPPY- mutant particles. These particles were poorly infectious and showed abnormal morphology by electron microscopy. Budding and infectivity defects due to overexpression of ITCH and SMURF-1 were correlated with higher than normal ubiquitination of Gag. Only silencing of ITCH, but not of WWP1, WWP2, and Nedd4, resulted in a reduction of HTLV-1 budding from 293T cells. The binding efficiencies between the HTLV-1 LD and WW domains of different ULs as measured by mammalian two-hybrid interaction did not correlate with the strength of their effect on HTLV-1 budding.	[Dorjbal, Batsukh; Derse, David; Heidecker, Gisela] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Lloyd, Patricia] SAIC, Basic Res Program, Frederick, MD 21702 USA; [Soheilian, Ferri; Nagashima, Kunio] SAIC, Image Anal Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick	Heidecker, G (corresponding author), NCI, HIV Drug Resistance Program, POB B,Bldg 535,Rm 111, Frederick, MD 21702 USA.	heidecke@mail.nih.gov			National Institutes of Health, NCI, Center for Cancer Research	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Chen K, 2008, BIOCHEMISTRY-US, V47, P1928, DOI 10.1021/bi701984h; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Gottwein E, 2006, J VIROL, V80, P6267, DOI 10.1128/JVI.02177-05; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Heidecker G, 2004, J VIROL, V78, P6636, DOI 10.1128/JVI.78.12.6636-6648.2004; Heidecker G, 2007, J VIROL, V81, P9769, DOI 10.1128/JVI.00642-07; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Joshi A, 2008, TRAFFIC, V9, P1972, DOI 10.1111/j.1600-0854.2008.00817.x; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Le Blanc I, 2002, J VIROL, V76, P10024, DOI 10.1128/JVI.76.19.10024-10029.2002; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; Mitchell MS, 2007, J VIROL, V81, P4422, DOI 10.1128/JVI.02660-06; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Ott DE, 2002, J VIROL, V76, P3038, DOI 10.1128/JVI.76.6.3038-3044.2002; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; PUTTERMAN D, 1990, VIROLOGY, V176, P633, DOI 10.1016/0042-6822(90)90035-P; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Urata S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-66; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Wang HT, 2004, J VIROL, V78, P1503, DOI 10.1128/JVI.78.3.1503-1512.2004; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; WORLK T, 2007, CELL DIV, V2, P11; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zhadina M, 2007, P NATL ACAD SCI USA, V104, P20031, DOI 10.1073/pnas.0708002104; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	64	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31092	31104		10.1074/jbc.M111.259945	http://dx.doi.org/10.1074/jbc.M111.259945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21724848	Green Published, hybrid			2022-12-27	WOS:000294487500004
J	Yang, R; Fredman, G; Krishnamoorthy, S; Agrawal, N; Irimia, D; Piomelli, D; Serhan, CN				Yang, Rong; Fredman, Gabrielle; Krishnamoorthy, Sriram; Agrawal, Nitin; Irimia, Daniel; Piomelli, Daniele; Serhan, Charles N.			Decoding Functional Metabolomics with Docosahexaenoyl Ethanolamide (DHEA) Identifies Novel Bioactive Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID RECEPTOR; WHOLE-BLOOD; FATTY-ACIDS; ANANDAMIDE; ENDOCANNABINOIDS; PLATELETS; INJURY; BINDS; D1; INFLAMMATION	Neuroinflammation and traumatic brain injury involve activation of inflammatory cells and production of local pro-inflammatory mediators that can amplify tissue damage. Using LC-UV-MS-MS-based lipidomics in tandem with functional screening at the single-cell level in microfluidic chambers, we identified a series of novel bioactive oxygenated docosahexaenoyl ethanolamide( DHEA) derived products that regulated leukocyte motility. These included 10,17-dihydroxydocosahexaenoyl ethanolamide (10,17-diHDHEA) and 15-hydroxy-16(17)-epoxy-docosapentaenoyl ethanolamide (15-HEDPEA), each of which was an agonist of recombinant CB2 receptors with EC50 3.9 X 10(-10) and 1.0 X 10(-10)M. In human whole blood, 10,17-diHDHEA and 15-HEDPEA at concentrations as low as 10 pM each prevented formation of platelet-leukocyte aggregates involving either platelet-monocyte or platelet-polymorphonuclear leukocyte. In vivo, 15-HEDPEA was organ-protective in mouse reperfusion second organ injury. Together these results indicate that DHEA oxidative metabolism produces potent novel molecules with anti-inflammatory and organ-protective properties.	[Yang, Rong; Fredman, Gabrielle; Krishnamoorthy, Sriram; Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Yang, Rong; Fredman, Gabrielle; Krishnamoorthy, Sriram; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Agrawal, Nitin; Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, Ctr Engn Med & Surg Serv, BioMEMS Resource Ctr, Boston, MA 02129 USA; [Agrawal, Nitin; Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92617 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92617 USA; [Piomelli, Daniele] Italian Inst Technol, I-16163 Genoa, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Serhan, CN (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 829,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Yang, Rong/ABA-7587-2021; Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Yang, Rong/0000-0001-8837-0089	National Institutes of Health [R01NS067686, RC2AT005909, R01DE019938]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [RC2AT005909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS067686 (to C. N. S.), RC2AT005909 (to C. N. S.), and R01DE019938 (to C. N. S. and D. I.).	Arnason BG, 2010, NEUROIMMUNE, V9, P1; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Calder PC, 2010, P NUTR SOC, V69, P565, DOI 10.1017/S0029665110000157; De Petrocellis L, 2000, CHEM PHYS LIPIDS, V108, P191, DOI 10.1016/S0009-3084(00)00196-1; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Franklin A, 2003, J NEUROSCI, V23, P7767; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; KILGORE KS, 1999, REPERFUSION INJURY; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kozak KR, 2002, PROSTAG LEUKOTR ESS, V66, P211, DOI 10.1054/plef.2001.0359; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kumar V., 2004, ROBBINS COTRAN PATHO; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Nishiura H, 1996, J BIOL CHEM, V271, P878, DOI 10.1074/jbc.271.2.878; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Pace-Asciak CR, 1999, ADV EXP MED BIOL, V447, P123; Pavlopoulos S, 2006, CURR PHARM DESIGN, V12, P1751, DOI 10.2174/138161206776873743; PREISSNER WC, 1983, BRIT J DERMATOL, V109, P1, DOI 10.1111/j.1365-2133.1983.tb03984.x; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; RINDER HM, 1991, BLOOD, V78, P1730; ROWLEY FA, 1998, EICOSANOIDS; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; UEDA N, 1995, BBA-LIPID LIPID MET, V1254, P127, DOI 10.1016/0005-2760(94)00170-4; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; YANG R, 2011, CURR PR S94 IN PRESS; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	42	69	72	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31532	31541		10.1074/jbc.M111.237990	http://dx.doi.org/10.1074/jbc.M111.237990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757729	Green Published, hybrid			2022-12-27	WOS:000294487500048
J	Razani, B; Zhang, HX; Schulze, PC; Schilling, JD; Verbsky, J; Lodhi, IJ; Topkara, VK; Feng, C; Coleman, T; Kovacs, A; Kelly, DP; Saffitz, JE; Dorn, GW; Nichols, CG; Semenkovich, CF				Razani, Babak; Zhang, Haixia; Schulze, P. Christian; Schilling, Joel D.; Verbsky, John; Lodhi, Irfan J.; Topkara, Veli K.; Feng, Chu; Coleman, Trey; Kovacs, Attila; Kelly, Daniel P.; Saffitz, Jeffrey E.; Dorn, Gerald W., II; Nichols, Colin G.; Semenkovich, Clay F.			Fatty Acid Synthase Modulates Homeostatic Responses to Myocardial Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; ACTIVATES PPAR-ALPHA; SARCOLEMMAL K-ATP; CARDIAC-HYPERTROPHY; HEART-FAILURE; IN-VIVO; PRESSURE-OVERLOAD; DIABETIC CARDIOMYOPATHY; CALMODULIN KINASE; GENE-EXPRESSION	Fatty acid synthase (FAS) promotes energy storage through de novo lipogenesis and participates in signaling by the nuclear receptor PPAR alpha in noncardiac tissues. To determine if de novo lipogenesis is relevant to cardiac physiology, we generated and characterized FAS knockout in the myocardium (FASKard) mice. FASKard mice develop normally, manifest normal resting heart function, and have normal cardiac PPAR alpha signaling as well as fatty acid oxidation. However, they decompensate with stress. Most die within 1 h of transverse aortic constriction, probably due to arrhythmia. Voltage clamp measurements of FASKard cardiomyocytes show hyperactivation of L-type calcium channel current that could not be reversed with palmitate supplementation. Of the classic regulators of this current, Ca2+/calmodulin-dependent protein kinase II (CaMKII) but not protein kinase A signaling is activated in FASKard hearts, and knockdown of FAS in cultured cells activates CaMKII. In addition to being intolerant of the stress of acute pressure, FASKard hearts were also intolerant of the stress of aging, reflected as persistent CaMKII hyperactivation, progression to dilatation, and premature death by similar to 1 year of age. CaMKII signaling appears to be pathogenic in FASKard hearts because inhibition of its signaling in vivo rescues mice from early mortality after transverse aortic constriction. FAS was also increased in two mechanistically distinct mouse models of heart failure and in the hearts of humans with end stage cardiomyopathy. These data implicate a novel relationship between FAS and calcium signaling in the heart and suggest that FAS induction in stressed myocardium represents a compensatory response to protect cardiomyocytes from pathological calcium flux.	[Razani, Babak; Lodhi, Irfan J.; Feng, Chu; Coleman, Trey; Semenkovich, Clay F.] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Razani, Babak; Schilling, Joel D.; Topkara, Veli K.; Kovacs, Attila] Washington Univ, Div Cardiol, St Louis, MO 63110 USA; [Zhang, Haixia; Verbsky, John; Nichols, Colin G.; Semenkovich, Clay F.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, St Louis, MO 63110 USA; [Schulze, P. Christian] Columbia Univ, Div Cardiol, New York, NY 10032 USA; [Kelly, Daniel P.] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA; [Saffitz, Jeffrey E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Columbia University; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Semenkovich, CF (corresponding author), Washington Univ, Div Endocrinol Metab & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Nichols, Colin/D-6336-2012; Kelly, Daniel/ABG-2056-2021; Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Semenkovich, Clay/0000-0003-1163-1871; Topkara, Veli/0000-0002-2236-2008; Razani, Babak/0000-0002-7172-9240; Lodhi, Irfan/0000-0002-6246-9862	National Institutes of Health [P50 HL083762, DK076729, HL95010, DK088083, DK20579, DK56341, F32 DK083895, K08 HL098559]; Washington University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098373, R01HL059888, R01HL058493, K08HL098559, R01HL095010, P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088083, P60DK020579, R01DK076729, P30DK056341, F32DK083895, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 HL083762, DK076729, HL95010, DK088083, DK20579, DK56341, F32 DK083895, and K08 HL098559. This work was also supported by the Physician Scientist Training Program and Cardiovascular Training Grant at Washington University.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anderson ME, 2009, J CLIN INVEST, V119, P1082, DOI 10.1172/JCI39262; Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BALLARD FB, 1960, J CLIN INVEST, V39, P717, DOI 10.1172/JCI104088; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Burchfield JS, 2010, CIRC-HEART FAIL, V3, P157, DOI 10.1161/CIRCHEARTFAILURE.109.899732; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chen YJ, 2003, PHYSIOL GENOMICS, V14, P251, DOI 10.1152/physiolgenomics.00022.2003; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; DORN GW, 1994, AM J PHYSIOL, V267, pH400, DOI 10.1152/ajpheart.1994.267.1.H400; Du F, 2006, BIOCHEM BIOPH RES CO, V347, P814, DOI 10.1016/j.bbrc.2006.06.162; EVANS JR, 1964, CIRC RES, V15, P96; FEIN FS, 1994, CARDIOVASC DRUG THER, V8, P65, DOI 10.1007/BF00877091; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Flagg TP, 2005, J MOL CELL CARDIOL, V39, P647, DOI 10.1016/j.yjmcc.2005.06.003; Flagg TP, 2004, AM J PHYSIOL-HEART C, V286, pH1361, DOI 10.1152/ajpheart.00676.2003; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528, DOI 10.1152/ajpendo.1983.244.6.E528; Giarratana Nadia, 2007, Methods Mol Biol, V380, P285; Gilbertson J. R., 1977, LIPID METABOLISM MAM, V1, P367; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Haim TE, 2010, J MOL CELL CARDIOL, V48, P395, DOI 10.1016/j.yjmcc.2009.10.004; Hellerstein MK, 1999, EUR J CLIN NUTR, V53, pS53, DOI 10.1038/sj.ejcn.1600744; Hoch B, 1998, J CELL BIOCHEM, V68, P259, DOI 10.1002/(SICI)1097-4644(19980201)68:2<259::AID-JCB12>3.0.CO;2-A; HOIT BD, 1995, CIRC RES, V77, P632, DOI 10.1161/01.RES.77.3.632; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Ikeda Y, 2008, PHYSIOLOGY, V23, P6, DOI 10.1152/physiol.00033.2007; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kedzierski RM, 2003, MOL CELL BIOL, V23, P8226, DOI 10.1128/MCB.23.22.8226-8232.2003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kittleson MM, 2004, CIRCULATION, V110, P3444, DOI 10.1161/01.CIR.0000148178.19465.11; Kraichely RE, 2009, AM J PHYSIOL-GASTR L, V296, pG833, DOI 10.1152/ajpgi.90610.2008; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Liao RL, 2005, CIRCULATION, V111, P2416, DOI 10.1161/01.CIR.0000167557.59069.D9; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Nakamura A, 2001, AM J PHYSIOL-HEART C, V281, pH1104, DOI 10.1152/ajpheart.2001.281.3.H1104; ORAM JF, 1973, J BIOL CHEM, V248, P5299; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; PetitJacques J, 1996, J PHYSIOL-LONDON, V493, P67, DOI 10.1113/jphysiol.1996.sp021365; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sakata Y, 1998, CIRCULATION, V97, P1488; Schneider JG, 2010, J BIOL CHEM, V285, P23396, DOI 10.1074/jbc.M110.100321; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; SHIMADA T, 1992, J GEN PHYSIOL, V100, P27, DOI 10.1085/jgp.100.1.27; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Tavi P, 2001, TRENDS PHARMACOL SCI, V22, P254, DOI 10.1016/S0165-6147(00)01679-5; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; Topkara VK, 2009, CIRCULATION, V120, pS857; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Tucker SJ, 2008, J GEN PHYSIOL, V131, P431, DOI 10.1085/jgp.200709936; Ueno K, 2000, GENES CELLS, V5, P859, DOI 10.1046/j.1365-2443.2000.00369.x; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Weis MT, 2004, CARDIOVASC RES, V63, P338, DOI 10.1016/j.cardiores.2004.04.025; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; Yamada S, 2006, J PHYSIOL-LONDON, V577, P1053, DOI 10.1113/jphysiol.2006.119511; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	86	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30949	30961		10.1074/jbc.M111.230508	http://dx.doi.org/10.1074/jbc.M111.230508			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757749	Green Published, hybrid			2022-12-27	WOS:000294283600073
J	Sharma, NR; Mateu, G; Dreux, M; Grakoui, A; Cosset, FL; Melikyan, GB				Sharma, Nishi R.; Mateu, Guaniri; Dreux, Marlene; Grakoui, Arash; Cosset, Francois-Loic; Melikyan, Gregory B.			Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CELL ENTRY; STRUCTURAL-CHANGES; TRANSMEMBRANE DOMAINS; TARGET MEMBRANES; PORE FORMATION; GLYCOPROTEIN; RECEPTOR	Hepatitis C virus (HCV) entry into permissive cells is a complex process that involves interactions with at least four co-factors followed by endocytosis and low pH-dependent fusion with endosomes. The precise sequence of receptor engagement and their roles in promoting HCV E1E2 glycoprotein-mediated fusion are poorly characterized. Because cell-free HCV tolerates an acidic environment, we hypothesized that binding to one or more receptors on the cell surface renders E1E2 competent to undergo low pH-induced conformational changes and promote fusion with endosomes. To test this hypothesis, we examined the effects of low pH and of the second extracellular loop (ECL2) of CD81, one of the four entry factors, on HCV infectivity. Pretreatment with an acidic buffer or with ECL2 enhanced infection through changing the E1E2 conformation, as evidenced by the altered reactivity of these proteins with conformation-specific antibodies and stable association with liposomes. However, neither of the two treatments alone permitted direct fusion with the cell plasma membrane. Sequential HCV preincubation with ECL2 and acidic buffer in the absence of target cells resulted in a marked loss of infectivity, implying that the receptor-bound HCV is primed for low pH-dependent conformational changes. Indeed, soluble receptor-pretreated HCV fused with the cell plasma membrane at low pH under conditions blocking an endocytic entry pathway. These findings suggest that CD81 primes HCV for low pH-dependent fusion early in the entry process. The simple triggering paradigm and intermediate conformations of E1E2 identified in this study could help guide future vaccine and therapeutic efforts to block HCV infection.	[Sharma, Nishi R.; Melikyan, Gregory B.] Emory Univ, Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon, UCB Lyon 1, IFR128, F-69007 Lyon, France; [Mateu, Guaniri; Grakoui, Arash] Dept Med, Div Infect Dis, F-69007 Lyon, France; [Dreux, Marlene; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France; [Dreux, Marlene; Cosset, Francois-Loic] INSERM, U758, F-69364 Lyon, France; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Childrens Ctr, Div Pediat Infect Dis, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Dreux, Marlene/M-7295-2014; Cosset, François-Loïc/M-5862-2019	Dreux, Marlene/0000-0002-6607-4796; Cosset, François-Loïc/0000-0001-8842-3726	National Institutes of Health [DK083356, AI070101]; USPHS; American Recovery and Reinvestment [R21 AI079714]; Agence Nationale pour la Recherche Contre le SIDA et les Hepatites Virales; European Research Council [ERC-2008-AdG-233130-HEPCENT]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070101, R21AI079714, R01AI070101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); American Recovery and Reinvestment; Agence Nationale pour la Recherche Contre le SIDA et les Hepatites Virales(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083356 and AI070101 from USPHS (to A. G.). This work was also supported by American Recovery and Reinvestment Act Grant R21 AI079714 (to G. M.), Agence Nationale pour la Recherche Contre le SIDA et les Hepatites Virales, and European Research Council Grant ERC-2008-AdG-233130-HEPCENT (to F.-L. C.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; Campbell JN, 2004, BIOMACROMOLECULES, V5, P1728, DOI 10.1021/bm049878z; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Earp LJ, 2003, J VIROL, V77, P3058, DOI 10.1128/JVI.77.5.3058-3066.2003; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Heo TH, 2006, VIRUS RES, V121, P58, DOI 10.1016/j.virusres.2006.04.002; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Markosyan RM, 2007, J VIROL, V81, P11218, DOI 10.1128/JVI.01256-07; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Nakajima H, 2005, BIOCHEM BIOPH RES CO, V328, P1091, DOI 10.1016/j.bbrc.2005.01.056; Perrault M, 2009, BIOCHEM J, V423, P303, DOI 10.1042/BJ20091000; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Tan YJ, 2003, VIROLOGY, V308, P250, DOI 10.1016/S0042-6822(02)00136-8; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Whitbeck JC, 2006, J VIROL, V80, P3773, DOI 10.1128/JVI.80.8.3773-3780.2006; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	81	72	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30361	30376		10.1074/jbc.M111.263350	http://dx.doi.org/10.1074/jbc.M111.263350			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737455	Green Published, hybrid			2022-12-27	WOS:000294283600014
J	Tanabe, Y; Maruyama, J; Yamaoka, S; Yahagi, D; Matsuo, I; Tsutsumi, N; Kitamoto, K				Tanabe, Yasuko; Maruyama, Jun-ichi; Yamaoka, Shohei; Yahagi, Daiki; Matsuo, Ichiro; Tsutsumi, Nobuhiro; Kitamoto, Katsuhiko			Peroxisomes Are Involved in Biotin Biosynthesis in Aspergillus and Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID SYNTHESIS; SACCHAROMYCES-CEREVISIAE; COLLETOTRICHUM-LAGENARIUM; PODOSPORA-ANSERINA; EMBRYO DEVELOPMENT; METABOLIC FUNCTION; PLANT PEROXISOMES; PROTEIN-TRANSPORT; GENE	Among the eukaryotes only plants and a number of fungi are able to synthesize biotin. Although initial events leading to the biosynthesis of biotin remain largely unknown, the final steps are known to occur in the mitochondria. Here we deleted the Aopex5 and Aopex7 genes encoding the receptors for peroxisomal targeting signals PTS1 and PTS2, respectively, in the filamentous fungus Aspergillus oryzae. In addition to exhibiting defects in the peroxisomal targeting of either PTS1 or PTS2 proteins, the deletion strains also displayed growth defects on minimal medium containing oleic acid as the sole carbon source. Unexpectedly, these peroxisomal transport-deficient strains also exhibited growth defects on minimal medium containing glucose as the sole carbon source that were remediated by the addition of biotin and its precursors, including 7-keto-8-aminopelargonic acid (KAPA). Genome database searches in fungi and plants revealed that BioF protein/KAPA synthase, one of the biotin biosynthetic enzymes, has a PTS1 sequence at the C terminus. Fungal Delta bioF strains expressing the fungal and plant BioF proteins lacking PTS1 still exhibited growth defects in the absence of biotin, indicating that peroxisomal targeting of KAPA synthase is crucial for the biotin biosynthesis. Furthermore, in the plant Arabidopsis thaliana, AtBioF localized to the peroxisomes through recognition of its PTS1 sequence, suggesting involvement of peroxisomes in biotin biosynthesis in plants. Taken together we demonstrate a novel role for peroxisomes in biotin biosynthesis and suggest the presence of as yet unidentified peroxisomal proteins that function in the earlier steps of biotin biosynthesis.	[Tanabe, Yasuko; Maruyama, Jun-ichi; Yahagi, Daiki; Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; [Yamaoka, Shohei; Tsutsumi, Nobuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Yamaoka, Shohei] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Matsuo, Ichiro] Gunma Univ, Dept Chem & Chem Biol, Gunma 3768515, Japan	University of Tokyo; University of Tokyo; Kyoto University; Gunma University	Maruyama, J (corresponding author), Bunkyo Ku, Tokyo 1138657, Japan.	amarujun@mail.ecc.u-tokyo.ac.jp	Tsutsumi, Nobuhiro/C-6051-2016	Tsutsumi, Nobuhiro/0000-0002-2610-6837	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23770043] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientist (to J. M. and S. Y.) and Research Fellowship for Young Scientist (to S. Y.) from the Japan Society for the Promotion of Science.	Al-Feel W, 2003, P NATL ACAD SCI USA, V100, P3095, DOI 10.1073/pnas.0538069100; Arnal N, 2006, PLANT MOL BIOL, V62, P471, DOI 10.1007/s11103-006-9034-x; Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; BAILEY A, 1995, MOL GEN GENET, V249, P191, DOI 10.1007/BF00290366; Baud S, 2003, PLANT J, V33, P75, DOI 10.1046/j.1365-313X.2003.016010.x; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; BOWER S, 1995, J BACTERIOL, V177, P2572, DOI 10.1128/jb.177.9.2572-2575.1995; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Fan JL, 2005, PLANT PHYSIOL, V139, P231, DOI 10.1104/pp.105.066811; Girzalsky W, 2009, BIOL CHEM, V390, P745, DOI 10.1515/BC.2009.104; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hu JP, 2002, SCIENCE, V297, P405, DOI 10.1126/science.1073633; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Liu FF, 2008, J CELL BIOL, V180, P325, DOI 10.1083/jcb.200705049; Mano S, 2005, VITAM HORM, V72, P111, DOI 10.1016/S0083-6729(05)72004-5; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Muralla R, 2008, PLANT PHYSIOL, V146, P60, DOI 10.1104/pp.107.107409; OHSUGI M, 1988, J NUTR SCI VITAMINOL, V34, P343, DOI 10.3177/jnsv.34.343; Peraza-Reyes L, 2008, TRAFFIC, V9, P1998, DOI 10.1111/j.1600-0854.2008.00812.x; Pinon V, 2005, PLANT PHYSIOL, V139, P1666, DOI 10.1104/pp.105.070144; PLOUX O, 1992, BIOCHEM J, V283, P327, DOI 10.1042/bj2830327; Rebeille F, 2007, PHOTOSYNTH RES, V92, P149, DOI 10.1007/s11120-007-9167-z; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; ROPER JA, 1950, NATURE, V166, P956, DOI 10.1038/166956b0; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Schneiter R, 2000, MOL CELL BIOL, V20, P2984, DOI 10.1128/MCB.20.9.2984-2995.2000; Schumann U, 2003, P NATL ACAD SCI USA, V100, P9626, DOI 10.1073/pnas.1633697100; Sparkes IA, 2003, PLANT PHYSIOL, V133, P1809, DOI 10.1104/pp.103.031252; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724	51	44	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30455	30461		10.1074/jbc.M111.247338	http://dx.doi.org/10.1074/jbc.M111.247338			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730067	hybrid, Green Published			2022-12-27	WOS:000294283600024
J	Valapala, M; Vishwanatha, JK				Valapala, Mallika; Vishwanatha, Jamboor K.			Lipid Raft Endocytosis and Exosomal Transport Facilitate Extracellular Trafficking of Annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; CELL-SURFACE; ENDOSOME BIOGENESIS; APICAL MEMBRANE; ESCRT COMPLEXES; K562 CELLS; CALCIUM; DOMAINS; DYNAMICS; CAVEOLAE	Annexin A2 (AnxA2), a Ca2+-dependent phospholipid-binding protein, is known to associate with the plasma membrane and the endosomal system. Within the plasma membrane, AnxA2 associates in a Ca2+ dependent manner with cholesterol-rich lipid raft microdomains. Here, we show that the association of AnxA2 with the lipid rafts is influenced not only by intracellular levels of Ca2+ but also by N-terminal phosphorylation at tyrosine 23. Binding of AnxA2 to the lipid rafts is followed by the transport along the endocytic pathway to be associated with the intralumenal vesicles of the multivesicular endosomes. AnxA2-containing multivesicular endosomes fuse directly with the plasma membrane resulting in the release of the intralumenal vesicles into the extracellular environment, which facilitates the exogenous transfer of AnxA2 from one cell to another. Treatment with Ca2+ ionophore triggers the association of AnxA2 with the specialized microdomains in the exosomal membrane that possess raft-like characteristics. Phosphorylation at Tyr-23 is also important for the localization of AnxA2 to the exosomal membranes. These results suggest that AnxA2 is trafficked from the plasma membrane rafts and is selectively incorporated into the lumenal membranes of the endosomes to escape the endosomal degradation pathway. The Ca2+-dependent exosomal transport constitutes a novel pathway of extracellular transport of AnxA2.	[Valapala, Mallika; Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX 76107 USA; [Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Vishwanatha, JK (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	Jamboor.vishwanatha@unthsc.edu		Vishwanatha, Jamboor/0000-0002-0266-6020	National Center on Minority Health and Health Disparities [MD001633]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by National Center on Minority Health and Health Disparities Grant MD001633.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Barwise JL, 1996, J CELL SCI, V109, P247; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brown Deborah A, 2002, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1110s51; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; Danielsen EM, 2003, BIOCHEMISTRY-US, V42, P14670, DOI 10.1021/bi0355239; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Foster Leonard J., 2007, V43, P35, DOI 10.1007/978-1-4020-5943-8_4; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hayes MJ, 2009, BBA-MOL CELL RES, V1793, P1086, DOI 10.1016/j.bbamcr.2008.10.007; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Koga K, 2005, ANTICANCER RES, V25, P3703; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; MacDonald PE, 2005, J CELL SCI, V118, P5911, DOI 10.1242/jcs.02685; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nelson WJ, 2004, NAT CELL BIOL, V6, P282, DOI 10.1038/ncb0404-282; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2004, DEV CELL, V7, P458, DOI 10.1016/j.devcel.2004.09.009; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pfeffer SR, 2001, NAT CELL BIOL, V3, pE108, DOI 10.1038/35074625; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rubin D, 2003, AM J PHYSIOL-CELL PH, V285, pC377, DOI 10.1152/ajpcell.00060.2003; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Savina A, 2002, J CELL SCI, V115, P2505; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Turpin E, 1998, BBA-MOL CELL RES, V1402, P115, DOI 10.1016/S0167-4889(97)00151-1; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zeuschner D, 2001, EUR J CELL BIOL, V80, P499, DOI 10.1078/0171-9335-00184; Zhuang LY, 2002, CANCER RES, V62, P2227	64	128	131	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30911	30925		10.1074/jbc.M111.271155	http://dx.doi.org/10.1074/jbc.M111.271155			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737841	Green Published, hybrid			2022-12-27	WOS:000294283600070
J	Tan, JQ; Zhang, TM; Jiang, L; Chi, JW; Hu, DS; Pan, Q; Wang, DL; Zhang, ZH				Tan, Jieqiong; Zhang, Tongmei; Jiang, Li; Chi, Jingwei; Hu, Dongshen; Pan, Qian; Wang, Danling; Zhang, Zhuohua			Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALLIDO-PYRAMIDAL DEGENERATION; SUPRANUCLEAR UPGAZE PARESIS; ONSET PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; IRON TRANSPORT; BRAIN; MUTATIONS; DEMENTIA; APOPTOSIS; TOXICITY	Mutations in the ATP13A2 gene are associated with Kufor-Rakeb syndrome (KRS) and are found also in patients with various other types of parkinsonism. ATP13A2 encodes a predicted lysosomal P5-type ATPase that plays important roles in regulating cation homeostasis. Disturbance of cation homeostasis in brains is indicated in Parkinson disease pathogenesis. In this study, we explored the biological function of ATP13A2 as well as the pathogenic mechanism of KRS pathogenic ATP13A2 mutants. The results revealed that wild-type ATP13A2, but not the KRS pathogenic ATP13A2 mutants, protected cells from Mn2+-induced cell death in mammalian cell lines and primary rat neuronal cultures. In addition, wild-type ATP13A2 reduced intracellular manganese concentrations and prevented cytochrome c release from mitochondria compared with the pathogenic mutants. Furthermore, endogenous ATP13A2 was up-regulated upon Mn2+ treatment. Our results suggest that ATP13A2 plays important roles in protecting cells against manganese cytotoxicity via regulating intracellular manganese homeostasis. The study provides a potential mechanism of KRS and parkinsonism pathogenesis.	[Tan, Jieqiong; Zhang, Tongmei; Chi, Jingwei; Pan, Qian; Wang, Danling; Zhang, Zhuohua] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Jiang, Li; Hu, Dongshen] Nanhai Entry Exit Inspect & Quarantine Bur, Foshan 528200, Peoples R China; [Zhang, Zhuohua] Burnham Inst Med Res, La Jolla, CA 92037 USA	Central South University; Sanford Burnham Prebys Medical Discovery Institute	Zhang, ZH (corresponding author), Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn			National Institutes of Health [R01 NS057289, P01 ES016738]; Chinese National 973 Projects [2011CB510000]; Natural Science Foundation of China [30730052, 30971469, 30800586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National 973 Projects(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS057289 and P01 ES016738 (to Z. Z.). This work was also supported by Chinese National 973 Projects Grant 2011CB510000 (to Z. Z.) and Natural Science Foundation of China Grants 30730052 (to Z. Z.) and 30971469 and 30800586 (to D. W.).	ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Behrens MI, 2010, MOVEMENT DISORD, V25, P1929, DOI 10.1002/mds.22996; CAI T, BRAIN RES, V1359, P201; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; DEXTER DT, 1987, LANCET, V2, P1219; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Djarmati A, 2009, MOVEMENT DISORD, V24, P2104, DOI 10.1002/mds.22728; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Furune T, 2008, GENES GENET SYST, V83, P373, DOI 10.1266/ggs.83.373; GAVIN CE, 1990, BIOCHEM J, V266, P329, DOI 10.1042/bj2660329; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hampshire DJ, 2001, J MED GENET, V38, P680, DOI 10.1136/jmg.38.10.680; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Jabalquinto AM, 1999, J PROTEIN CHEM, V18, P659, DOI 10.1023/A:1020602222808; Johnson NA, 2009, ARCH BIOCHEM BIOPHYS, V481, P157, DOI 10.1016/j.abb.2008.11.010; KINNETT DG, 1982, INT J BIOCHEM, V14, P977, DOI 10.1016/0020-711X(82)90058-1; Lees AJ, 2007, NEUROLOGY, V68, P1553, DOI 10.1212/01.wnl.0000265228.66664.f4; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li Y, 2010, BRAIN RES BULL, V81, P428, DOI 10.1016/j.brainresbull.2009.11.007; Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68; Logroscino G, 1998, MOVEMENT DISORD, V13, P13; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Malecki EA, 1999, J NEUROSCI RES, V56, P113; Mao XY, 2010, PARKINSONISM RELAT D, V16, P235, DOI 10.1016/j.parkreldis.2009.11.010; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Ning YP, 2008, NEUROLOGY, V70, P1491, DOI 10.1212/01.wnl.0000310427.72236.68; Oikawa S, 2006, FREE RADICAL BIO MED, V41, P748, DOI 10.1016/j.freeradbiomed.2006.05.018; Prabhakaran K, 2009, NEUROTOXICOLOGY, V30, P414, DOI 10.1016/j.neuro.2009.02.012; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tamm C, 2008, TOXICOL SCI, V101, P310, DOI 10.1093/toxsci/kfm267; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Yokel RA, 2002, ENVIRON HEALTH PERSP, V110, P699, DOI 10.1289/ehp.02110s5699; Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223; ZHANG P, 1994, NEUROSCIENCE, V61, P317, DOI 10.1016/0306-4522(94)90234-8; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	51	113	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29654	29662		10.1074/jbc.M111.233874	http://dx.doi.org/10.1074/jbc.M111.233874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724849	Green Published, hybrid			2022-12-27	WOS:000294046600024
J	Kanagawa, M; Satoh, T; Ikeda, A; Adachi, Y; Ohno, N; Yamaguchi, Y				Kanagawa, Mayumi; Satoh, Tadashi; Ikeda, Akemi; Adachi, Yoshiyuki; Ohno, Naohito; Yamaguchi, Yoshiki			Structural Insights into Recognition of Triple-helical beta-Glucans by an Insect Fungal Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PROTEIN; BETA-1,3-GLUCAN; CONFORMATION; DECTIN-1; LECTIN; DOMAIN; SPECTROSCOPY; INFECTIONS; DROSOPHILA	The innate ability to detect pathogens is achieved by pattern recognition receptors, which recognize non-self-components such as beta 1,3-glucan. beta 1,3-Glucans form a triple-helical structure stabilized by interchain hydrogen bonds. beta 1,3-Glucan recognition protein (beta GRP)/Gram-negative bacteria-binding protein 3 (GNBP3), one of the pattern recognition receptors, binds to long, structured beta 1,3-glucan to initiate innate immune response. However, binding details and how specificity is achieved in such receptors remain important unresolved issues. We solved the crystal structures of the N-terminal beta 1,3-glucan recognition domain of beta GRP/GNBP3 (beta GRP-N) in complex with the beta 1,3-linked glucose hexamer, laminarihexaose. In the crystals, three structured laminarihexaoses simultaneously interact through six glucose residues (two from each chain) with one beta GRP-N. The spatial arrangement of the laminarihexaoses bound to beta GRP-N is almost identical to that of a beta 1,3-glucan triple-helical structure. Therefore, our crystallographic structures together with site-directed mutagenesis data provide a structural basis for the unique recognition by such receptors of the triple-helical structure of beta 1,3-glucan.	[Kanagawa, Mayumi; Satoh, Tadashi; Ikeda, Akemi; Yamaguchi, Yoshiki] RIKEN, Adv Sci Inst, Dept Biol Chem, Struct Glycobiol Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Adachi, Yoshiyuki; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Sch Pharm, Tokyo 1920392, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences	Yamaguchi, Y (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yyoshiki@riken.jp	Yamaguchi, Yoshiki/N-5246-2015; Satoh, Tadashi/M-5157-2017	Yamaguchi, Yoshiki/0000-0003-0100-5439; Satoh, Tadashi/0000-0002-4493-4978	National Synchroton Radiation Research Center (NSRRC) (Taiwan)	National Synchroton Radiation Research Center (NSRRC) (Taiwan)	We thank Drs. Akihiro Miyanoshita and Taro Imamura (National Food Research Institute) for kindly providing P. interpunctella and Masaki Ishii for isolation of the P. interpunctella beta GRP gene. We also thank Drs. Yukishige Ito, Yoichi Takeda (RIKEN/ERATO), Shinya Hanashima (RIKEN), and Yasutoshi Sakoda and Yasushi Sakaguchi (DKSH Japan) for ITC measurements and for helpful discussions. We thank the beamline staff of Photon Factory (PF) High Energy Accelerator Research Organization (KEK) (Japan), SPring-8 (Japan), and National Synchroton Radiation Research Center (NSRRC) (Taiwan) for providing data collection facilities and support.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; ATKINS E, 1986, INT J BIOL MACROMOL, V8, P323, DOI 10.1016/0141-8130(86)90050-4; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUAH CT, 1983, MACROMOLECULES, V16, P1375, DOI 10.1021/ma00242a020; DILUZIO NR, 1979, INT J CANCER, V24, P773, DOI 10.1002/ijc.2910240613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Kulicke WM, 1997, CARBOHYD RES, V297, P135, DOI 10.1016/S0008-6215(96)00273-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee H, 2009, BMB REP, V42, P506, DOI 10.5483/BMBRep.2009.42.8.506; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Okobira T, 2008, BIOMACROMOLECULES, V9, P783, DOI 10.1021/bm700511d; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SH, 2011, J BIOL CHEM, V286, P1567, DOI 10.1074/jbc.M110.144006; Pazos C, 2005, J CLIN MICROBIOL, V43, P299, DOI 10.1128/JCM.43.1.299-305.2005; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Sletmoen M, 2008, BIOPOLYMERS, V89, P310, DOI 10.1002/bip.20920; Takahasi K, 2009, P NATL ACAD SCI USA, V106, P11679, DOI 10.1073/pnas.0901671106; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; YOSHIOKA Y, 1992, CHEM PHARM BULL, V40, P1221; Young SH, 2000, J BIOL CHEM, V275, P11874, DOI 10.1074/jbc.275.16.11874	37	42	44	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29158	29165		10.1074/jbc.M111.256701	http://dx.doi.org/10.1074/jbc.M111.256701			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697086	hybrid, Green Published			2022-12-27	WOS:000293837000052
J	Nam, EA; Zhao, RX; Glick, GG; Bansbach, CE; Friedman, DB; Cortez, D				Nam, Edward A.; Zhao, Runxiang; Glick, Gloria G.; Bansbach, Carol E.; Friedman, David B.; Cortez, David			Thr-1989 Phosphorylation Is a Marker of Active Ataxia Telangiectasia-mutated and Rad3-related (ATR) Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; EARLY EMBRYONIC LETHALITY; DOUBLE-STRAND BREAKS; DNA-DAMAGE; CATALYTIC SUBUNIT; MRE11-RAD50-NBS1 COMPLEX; CHECKPOINT RESPONSE; CELL-CYCLE; IN-VITRO; ACTIVATION	The DNA damage response kinases ataxia telangiectasia-mutated (ATM), DNA-dependent protein kinase (DNA-PK), and ataxia telangiectasia-mutated and Rad3-related (ATR) signal through multiple pathways to promote genome maintenance. These related kinases share similar methods of regulation, including recruitment to specific nucleic acid structures and association with protein activators. ATM and DNA-PK also are regulated via phosphorylation, which provides a convenient biomarker for their activity. Whether phosphorylation regulates ATR is unknown. Here we identify ATR Thr-1989 as a DNA damage-regulated phosphorylation site. Selective inhibition of ATR prevents Thr-1989 phosphorylation, and phosphorylation requires ATR activation. Cells engineered to express only a non-phosphorylatable T1989A mutant exhibit a modest ATR functional defect. Our results suggest that, like ATM and DNA-PK, phosphorylation regulates ATR, and phospho-peptide specific antibodies to Thr-1989 provide a proximal marker of ATR activation.	[Zhao, Runxiang; Glick, Gloria G.; Bansbach, Carol E.; Friedman, David B.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Nam, Edward A.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 613 Light Hall, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			National Institutes of Health [R01CA102729]; Vanderbilt-Ingram Cancer Center from the NCI, National Institutes of Health [CA06485]; Vanderbilt Center in Molecular Toxicology from the NIEHS, National Institutes of Health [P30ES000267]; NATIONAL CANCER INSTITUTE [R01CA102729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center from the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Vanderbilt Center in Molecular Toxicology from the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA102729 (to D.C.). This work was also supported by Vanderbilt-Ingram Cancer Center Grant CA06485 from the NCI, National Institutes of Health, and Vanderbilt Center in Molecular Toxicology Grant P30ES000267 from the NIEHS, National Institutes of Health.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lewis KA, 2007, GENE CHROMOSOME CANC, V46, P1061, DOI 10.1002/gcc.20486; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zighelboim I, 2009, J CLIN ONCOL, V27, P3091, DOI 10.1200/JCO.2008.19.9802; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	52	83	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28707	28714		10.1074/jbc.M111.248914	http://dx.doi.org/10.1074/jbc.M111.248914			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705319	hybrid, Green Published			2022-12-27	WOS:000293837000008
J	Sarri, E; Sicart, A; Lazaro-Dieguez, F; Egea, G				Sarri, Elisabet; Sicart, Adria; Lazaro-Dieguez, Francisco; Egea, Gustavo			Phospholipid Synthesis Participates in the Regulation of Diacylglycerol Required for Membrane Trafficking at the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PLASMA-MEMBRANE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PROTEIN-TRANSPORT; LIPID-METABOLISM; STIMULATED HUMAN; MAMMALIAN-CELLS; RAT-LIVER; RECEPTOR	The lipid metabolite diacylglycerol (DAG) is required for transport carrier biogenesis at the Golgi, although how cells regulate its levels is not well understood. Phospholipid synthesis involves highly regulated pathways that consume DAG and can contribute to its regulation. Here we altered phosphatidylcholine (PC) and phosphatidylinositol synthesis for a short period of time in CHO cells to evaluate the changes in DAG and its effects in membrane trafficking at the Golgi. We found that cellular DAG rapidly increased when PC synthesis was inhibited at the non-permissive temperature for the rate-limiting step of PC synthesis in CHO-MT58 cells. DAG also increased when choline and inositol were not supplied. The major phospholipid classes and triacylglycerol remained unaltered for both experimental approaches. The analysis of Golgi ultrastructure and membrane trafficking showed that 1) the accumulation of the budding vesicular profiles induced by propanolol was prevented by inhibition of PC synthesis, 2) the density of KDEL receptor-containing punctated structures at the endoplasmic reticulum-Golgi interface correlated with the amount of DAG, and 3) the post-Golgi transport of the yellow fluorescent temperature-sensitive G protein of stomatitis virus and the secretion of a secretory form of HRP were both reduced when DAG was lowered. We confirmed that DAG-consuming reactions of lipid synthesis were present in Golgi-enriched fractions. We conclude that phospholipid synthesis pathways play a significant role to regulate the DAG required in Golgi-dependent membrane trafficking.	[Sarri, Elisabet] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Fac Med, E-08036 Barcelona, Spain; Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, E-08036 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sarri, E (corresponding author), Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Fac Med, C Casanova 143, E-08036 Barcelona, Spain.	elisabet.sarri@ub.edu	Sarri, Elisabet/AHA-6911-2022; Egea, Gustavo/I-2394-2014; Lázaro-Diéguez, Francisco/J-3491-2015	Sarri, Elisabet/0000-0002-2435-399X; Egea, Gustavo/0000-0001-5242-150X; Lázaro-Diéguez, Francisco/0000-0002-4970-8128	Ministerio de Ciencia e Innovacion [BFU2009-07186]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by Ministerio de Ciencia e Innovacion Grant BFU2009-07186.	Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Caviglia JM, 2004, J LIPID RES, V45, P1500, DOI 10.1194/jlr.M400079-JLR200; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Gasull T, 2003, J NEUROSCI, V23, P4100; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hui N, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P46; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KENNEDY ED, 1990, BIOCHEM J, V267, P781, DOI 10.1042/bj2670781; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KTISTAKIS NT, 1995, P NATL ACAD SCI USA, V92, P4952, DOI 10.1073/pnas.92.11.4952; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; MATOZAKI T, 1991, J BIOL CHEM, V266, P22246; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; PREISS J, 1986, J BIOL CHEM, V261, P8597; RAGAN CI, 1988, BIOCHEM J, V249, P143, DOI 10.1042/bj2490143; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sarri E, 2006, BIOCHEM J, V394, P325, DOI 10.1042/BJ20050834; Sarri E, 2003, BIOCHEM J, V369, P319, DOI 10.1042/BJ20021347; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Testerink N, 2009, J LIPID RES, V50, P2182, DOI 10.1194/jlr.M800660-JLR200; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; van der Sanden MHM, 2004, BBA-MOL CELL BIOL L, V1636, P99, DOI 10.1016/j.bbalip.2003.08.008; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; VOZIYAN PA, 1993, BIOCHEM J, V295, P757, DOI 10.1042/bj2950757; WANG E, 1991, J BIOL CHEM, V266, P14486; Weibel ER, 1979, PRACTICAL METHODS BI, V1; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774	47	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28632	28643		10.1074/jbc.M111.267534	http://dx.doi.org/10.1074/jbc.M111.267534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700701	hybrid, Green Published			2022-12-27	WOS:000293557800077
J	Bossuyt, J; Chang, CW; Helmstadter, K; Kunkel, MT; Newton, AC; Campbell, KS; Martin, JL; Bossuyt, S; Robia, SL; Bers, DM				Bossuyt, Julie; Chang, Chia-Wei; Helmstadter, Kathryn; Kunkel, Maya T.; Newton, Alexandra C.; Campbell, Kenneth S.; Martin, Jody L.; Bossuyt, Sven; Robia, Seth L.; Bers, Donald M.			Spatiotemporally Distinct Protein Kinase D Activation in Adult Cardiomyocytes in Response to Phenylephrine and Endothelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CARDIAC-HYPERTROPHY; HISTONE DEACETYLASE-5; HEART-FAILURE; PRESSURE-OVERLOAD; MOLECULAR-CLONING; LOOP SER(744); LIVING CELLS; IN-VIVO; PKC-MU	Protein kinase D (PKD) is a nodal point in cardiac hypertrophic signaling. It triggers nuclear export of class II histone deacetylase (HDAC) and regulates transcription. Although this pathway is thought to be critical in cardiac hypertrophy and heart failure, little is known about spatiotemporal aspects of PKD activation at the myocyte level. Here, we demonstrate that in adult cardiomyocytes two important neurohumoral stimuli that induce hypertrophy, endothelin-1 (ET1) and phenylephrine (PE), trigger comparable global PKD activation and HDAC5 nuclear export, but via divergent spatiotemporal PKD signals. PE-induced HDAC5 export is entirely PKD-dependent, involving fleeting sarcolemmal PKD translocation (for activation) and very rapid subsequent nuclear import. In contrast, ET1 recruits and activates PKD that remains predominantly sarcolemmal. This explains why PE-induced nuclear HDAC5 export in myocytes is totally PKD-dependent, whereas ET1-induced HDAC5 export depends more prominently on InsP(3) and CaMKII signaling. Thus alpha-adrenergic and ET-1 receptor signaling via PKD in adult myocytes feature dramatic differences in cellular localization and translocation in mediating hypertrophic signaling. This raises new opportunities for targeted therapeutic intervention into distinct limbs of this hypertrophic signaling pathway.	[Bossuyt, Julie; Chang, Chia-Wei; Helmstadter, Kathryn; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Chang, Chia-Wei; Martin, Jody L.; Robia, Seth L.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA; [Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Campbell, Kenneth S.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Bossuyt, Sven] Aalto Univ, Dept Engn Design & Prod, Sch Sci & Technol, FI-02015 Helsinki, Finland	University of California System; University of California Davis; Loyola University Chicago; University of California System; University of California San Diego; University of Kentucky; Aalto University	Bossuyt, J (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	jbossuyt@ucdavis.edu; dmbers@ucdavis.edu	Bossuyt, Sven/H-5660-2012; Bers, Donald M/C-4507-2012; Campbell, Kenneth/C-3285-2008	Bossuyt, Sven/0000-0002-9223-735X; Bossuyt, Julie/0000-0001-8874-4765; Campbell, Kenneth/0000-0001-5615-5958; Bers, Donald/0000-0002-2237-9483	National Institutes of Health Grants [R01HL103933, P01-HL80101, P01-DK5441, T32HL86350]; American Heart Association [SDG 0835312N]; predoctoral fellowship; FWO-Vlaanderen and Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, R01HL103933, T32HL086350, P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); predoctoral fellowship; FWO-Vlaanderen and Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL103933 (to J. B.), P01-HL80101 (to D. M. B.), P01-DK5441 (to A. C. N.), and T32HL86350 (to K. H.), American Heart Association Grant SDG 0835312N (to J. B.) and a predoctoral fellowship (to C. W. C.), and a grant from the FWO-Vlaanderen and Academy of Finland (to S. B.).	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Beumer JH, 2010, CURR CLIN PHARMACOL, V5, P196, DOI 10.2174/157488410791498770; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu F, 2008, J MOL CELL CARDIOL, V45, P715, DOI 10.1016/j.yjmcc.2008.08.015; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Trauzold A, 2003, ONCOGENE, V22, P8939, DOI 10.1038/sj.onc.1207001; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	49	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33390	33400		10.1074/jbc.M111.246447	http://dx.doi.org/10.1074/jbc.M111.246447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795686	hybrid, Green Published			2022-12-27	WOS:000294968800057
J	Saini, V; Staren, DM; Ziarek, JJ; Nashaat, ZN; Campbell, EM; Volkman, BF; Marchese, A; Majetschak, M				Saini, Vikas; Staren, Daniel M.; Ziarek, Joshua J.; Nashaat, Zayd N.; Campbell, Edward M.; Volkman, Brian F.; Marchese, Adriano; Majetschak, Matthias			The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-derived Factor-1 alpha Function through Distinct Receptor Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR-PATTERN MOLECULES; EXTRACELLULAR UBIQUITIN; EXOGENOUS UBIQUITIN; FACTOR-I; LYMPHOCYTE CHEMOATTRACTANT; ARRESTIN-2 INTERACTS; T-LYMPHOCYTES; BINDING; INJURY	Recently, we identified extracellular ubiquitin as an endogenous CXC chemokine receptor (CXCR) 4 agonist. However, the receptor selectivity and molecular basis of the CXCR4 agonist activity of ubiquitin are unknown, and functional consequences of CXCR4 activation with ubiquitin are poorly defined. Here, we provide evidence that ubiquitin and the cognate CXCR4 ligand stromal cell-derived factor (SDF)-1 alpha do not share CXCR7 as a receptor. We further demonstrate that ubiquitin does not utilize the typical two-site binding mechanism of chemokine-receptor interactions, in which the receptor N terminus is important for ligand binding. CXCR4 activation with ubiquitin and SDF-1 alpha lead to similar G alpha(1)-iresponses and to a comparable magnitude of phosphorylation of ERK-1/2, p90 ribosomal S6 kinase-l and Akt, although phosphorylations occur more transiently after activation with ubiquitin. Despite the similarity of signal transduction events after activation of CXCR4 with both ligands, ubiquitin possesses weaker chemotactic activity than SDF-l alpha in cell migration assays and does not interfere with productive entry of HIV-1 into P4.R5 multinuclear activation of galactosidase indicator cells. Unlike SDF-1 alpha, ubiquitin lacks interactions with an N-terminal CXCR4 peptide in NMR spectroscopy experiments. Binding and signaling studies in the presence of antibodies against the N terminus and extracellular loops 2/3 of CXCR4 confirm that the ubiquitin CXCR4 interaction is independent of the N-terminal receptor domain, whereas blockade of extracellular loops 2/3 prevents receptor binding and activation. Our findings define ubiquitin as a CXCR4 agonist, which does not interfere with productive cellular entry of HIV-1, and provide new mechanistic insights into interactions between CXCR4 and its natural ligands.	[Saini, Vikas; Staren, Daniel M.; Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Burn & Shock Trauma Inst, Dept Surg, Maywood, IL 60153 USA; [Nashaat, Zayd N.; Campbell, Edward M.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Marchese, Adriano; Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ziarek, Joshua J.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Medical College of Wisconsin	Majetschak, M (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	mmajetschak@lumc.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Ziarek, Joshua/0000-0002-3740-9999	U.S. Army Medical Research and Materiel Command (USAMRMC); Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH1020122]; National Institutes of Health [GM075159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant that was awarded and administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD, under Contract Number W81XWH1020122 (to M. M.). This work was also supported in part by National Institutes of Health Grant GM075159 (to A. M.). The therapeutic use of ubiquitin has been patented (US patent # 7,262,162) and M. M. is an inventor. M. M. has not received any income related to the patent.	Ahn HC, 2009, EXP NEUROL, V220, P120, DOI 10.1016/j.expneurol.2009.07.031; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cai DQ, 2004, ARCH BIOCHEM BIOPHYS, V425, P42, DOI 10.1016/j.abb.2004.02.027; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Di Salvo J, 2000, EUR J PHARMACOL, V409, P143, DOI 10.1016/S0014-2999(00)00846-3; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Earle SA, 2006, TRANSPLANTATION, V82, P1544, DOI 10.1097/01.tp.0000236057.56721.d0; Ethier MF, 1996, AM J PHYSIOL-LUNG C, V270, pL199, DOI 10.1152/ajplung.1996.270.2.L199; FAN H, 2011, INFLAMMATION; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kuritzkes DR, 2009, CURR OPIN HIV AIDS, V4, P82, DOI 10.1097/COH.0b013e328322402e; Lee Y, 2002, BLOOD, V99, P4307, DOI 10.1182/blood.V99.12.4307; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li MC, 2010, CELL REPROGRAM, V12, P405, DOI 10.1089/cell.2009.0088; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Majetschak M, 2006, IMMUNOL CELL BIOL, V84, P59, DOI 10.1111/j.1440-1711.2005.01399.x; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2008, J TRAUMA, V64, P586, DOI 10.1097/TA.0b013e3181641bc5; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; O'Hayre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011716; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Saini Vikas, 2010, Commun Integr Biol, V3, P608, DOI 10.4161/cib.3.6.13375; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Steen A, 2009, MINI-REV MED CHEM, V9, P1605, DOI 10.2174/138955709791012265; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2010, J AM CHEM SOC, V132, P7242, DOI 10.1021/ja1002263; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	70	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33466	33477		10.1074/jbc.M111.233742	http://dx.doi.org/10.1074/jbc.M111.233742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757744	Green Published, hybrid			2022-12-27	WOS:000294968800064
J	Heidler, J; Al-Furoukh, N; Kukat, C; Salwig, I; Ingelmann, ME; Seibel, P; Kruger, M; Holtz, J; Wittig, I; Braun, T; Szibor, M				Heidler, Juliana; Al-Furoukh, Natalie; Kukat, Christian; Salwig, Isabelle; Ingelmann, Marie-Elisabeth; Seibel, Peter; Krueger, Marcus; Holtz, Juergen; Wittig, Ilka; Braun, Thomas; Szibor, Marten			Nitric Oxide-associated Protein 1 (NOA1) Is Necessary for Oxygen-dependent Regulation of Mitochondrial Respiratory Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CHAIN SUPERCOMPLEXES; ELECTRON-TRANSPORT; HEART-MITOCHONDRIA; APOPTOSIS; HYPOXIA; METABOLISM; SYNTHASE; PHOSPHORYLATION; ORGANIZATION	In eukaryotic cells, maintenance of cellular ATP stores depends mainly on mitochondrial oxidative phosphorylation (OXPHOS), which in turn requires sufficient cellular oxygenation. The crucial role of proper oxygenation for cellular viability is reflected by involvement of several mechanisms, which sense hypoxia and regulate activities of respiratory complexes according to available oxygen concentrations. Here, we focus on mouse nitric oxide-associated protein 1 (mNOA1), which has been identified as an important component of the machinery that adjusts OXPHOS activity to oxygen concentrations. mNOA1 is an evolutionary conserved GTP-binding protein that is involved in the regulation of mitochondrial protein translation and respiration. We found that mNOA1 is located mostly in the mitochondrial matrix from where it interacts with several high molecular mass complexes, most notably with the complex IV of the respiratory chain and the prohibitin complex. Knockdown of mNOA1 impaired enzyme activity I+III, resulting in oxidative stress and eventually cell death. mNOA1 is transcriptionally regulated in an oxygen-sensitive manner. We propose that oxygen-dependent regulation of mNOA1 is instrumental to adjusting OXPHOS activity to oxygen availability, thereby controlling mitochondrial metabolism.	[Heidler, Juliana; Al-Furoukh, Natalie; Salwig, Isabelle; Ingelmann, Marie-Elisabeth; Krueger, Marcus; Braun, Thomas; Szibor, Marten] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Heidler, Juliana] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany; [Kukat, Christian] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Seibel, Peter] Univ Leipzig, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Zentrum Biol Chem, D-60590 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Max Planck Society; Leipzig University; Goethe University Frankfurt	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de; marten.szibor@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Kukat, Christian/AAW-1268-2020	Kukat, Christian/0000-0003-1508-0229; Schindler, Natalie/0000-0001-7281-4597; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society; Deutsche Forschungsgemeinschaft [Br1416]; Excellence Initiative "Cardiopulmonary System"; University of Giessen-Marburg Lung Center; Deutsche Forschungsgemeinschaft, Sonderforschungsbereich [815, Z1]	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative "Cardiopulmonary System"; University of Giessen-Marburg Lung Center; Deutsche Forschungsgemeinschaft, Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by the Max-Planck-Society, the Deutsche Forschungsgemeinschaft Grant Br1416, the Excellence Initiative "Cardiopulmonary System," and the University of Giessen-Marburg Lung Center (to T. B.), and the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815 (Redox-Proteomics), Project Z1 (to I. W.).	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parihar MS, 2008, BBA-GEN SUBJECTS, V1780, P921, DOI 10.1016/j.bbagen.2008.02.006; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; Schild L, 2001, FASEB J, V15, P565; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Taylor SW, 2002, J PROTEOME RES, V1, P451, DOI 10.1021/pr025533g; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Tyc J, 2010, INT J PARASITOL, V40, P73, DOI 10.1016/j.ijpara.2009.07.008; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200	47	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32086	32093		10.1074/jbc.M111.221986	http://dx.doi.org/10.1074/jbc.M111.221986			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771794	Green Published, hybrid			2022-12-27	WOS:000294726800018
J	Kao, LY; Kurtz, LM; Shao, XS; Papadopoulos, MC; Liu, L; Bok, D; Nusinowitz, S; Chen, B; Stella, SL; Andre, M; Weinreb, J; Luong, SS; Piri, N; Kwong, JMK; Newman, D; Kurtz, I				Kao, Liyo; Kurtz, Lisa M.; Shao, Xuesi; Papadopoulos, Marios C.; Liu, Li; Bok, Dean; Nusinowitz, Steven; Chen, Bryan; Stella, Salvatore L.; Andre, Mark; Weinreb, Josh; Luong, Serena S.; Piri, Natik; Kwong, Jacky M. K.; Newman, Debra; Kurtz, Ira			Severe Neurologic Impairment in Mice with Targeted Disruption of the Electrogenic Sodium Bicarbonate Cotransporter NBCe2 (Slc4a5 Gene)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GANGLION-CELLS; MOUSE CHOROID-PLEXUS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; EPITHELIAL-CELLS; BRAIN VENTRICLES; INNER-EAR; RAT; EXPRESSION; PROTEIN	The choroid plexus lining the four ventricles in the brain is where the majority of cerebrospinal fluid (CSF) is produced. The secretory function of the choroid plexus is mediated by specific transport systems that allow the directional flux of nutrients and ions into the CSF and the removal of toxins. Normal CSF dynamics and chemistry ensure that the environment for neural function is optimal. Here, we report that targeted disruption of the Slc4a5 gene encoding the electrogenic sodium bicarbonate cotransporter NBCe2 results in significant remodeling of choroid plexus epithelial cells, including abnormal mitochondrial distribution, cytoskeletal protein expression, and ion transporter polarity. These changes are accompanied by very significant abnormalities in intracerebral ventricle volume, intracranial pressure, and CSF electrolyte levels. The Slc4a5(-/-) mice are significantly more resistant to induction of seizure behavior than wild-type controls. In the retina of Slc4a5(-/-) mice, loss of photoreceptors, ganglion cells, and retinal detachment results in visual impairment assessed by abnormal electroretinogram waveforms. Our findings are the first demonstration of the fundamental importance of NBCe2 in the biology of the nervous system.	[Kao, Liyo; Andre, Mark; Weinreb, Josh; Newman, Debra; Kurtz, Ira] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Kurtz, Lisa M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shao, Xuesi; Bok, Dean; Luong, Serena S.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Papadopoulos, Marios C.] St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England; [Liu, Li] Columbia Univ Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bok, Dean; Nusinowitz, Steven; Chen, Bryan; Piri, Natik; Kwong, Jacky M. K.] Univ Calif Los Angeles, Dept Ophthalmol, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bok, Dean; Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stella, Salvatore L.] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA	University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California Los Angeles; St Georges University London; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Missouri System; University of Missouri Kansas City	Kurtz, I (corresponding author), Univ Calif Los Angeles, Dept Med, Rm 7-155,Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu		Papadopoulos, Marios/0000-0001-9174-4176; Stella Jr., Salvatore/0000-0003-1971-2537	National Institutes of Health [DK077162, DK058563]; NATIONAL EYE INSTITUTE [R01EY018644, P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK058563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563 (to I. K.).	Abuin A, 2007, Handb Exp Pharmacol, P129; Abuladze N, 2004, AM J PHYSIOL-CELL PH, V287, pC781, DOI 10.1152/ajpcell.00590.2003; Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bouzinova EV, 2005, AM J PHYSIOL-CELL PH, V289, pC1448, DOI 10.1152/ajpcell.00313.2005; Chen LM, 2008, NEUROSCIENCE, V151, P374, DOI 10.1016/j.neuroscience.2007.10.015; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2009, AM J PHYSIOL-CELL PH, V296, pC1291, DOI 10.1152/ajpcell.00062.2009; DeLellis Stephen M, 2010, J Spec Oper Med, V10, P38; Foldvary-Schaefer N, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.6_suppl_2.S2; Gao P, 1999, J HISTOCHEM CYTOCHEM, V47, P1255, DOI 10.1177/002215549904701005; GONZALEZMARTINEZ LM, 1994, BIOL CELL, V81, P215, DOI 10.1016/0248-4900(94)90003-5; Ishii Y, 2003, INVEST OPHTH VIS SCI, V44, P1982, DOI 10.1167/iovs.02-0912; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Kong WC, 1999, LIFE SCI, V64, P1773, DOI 10.1016/S0024-3205(99)00115-0; Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; LINDSEY AE, 1990, P NATL ACAD SCI USA, V87, P5278, DOI 10.1073/pnas.87.14.5278; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Majumdar D, 2010, NEUROSCIENCE, V171, P951, DOI 10.1016/j.neuroscience.2010.09.037; Marek KW, 2010, NAT NEUROSCI, V13, P944, DOI 10.1038/nn.2582; Merves M, 2003, JARO-J ASSOC RES OTO, V4, P264, DOI 10.1007/s10162-002-3033-7; Millar ID, 2008, BIOCHEM BIOPH RES CO, V373, P550, DOI 10.1016/j.bbrc.2008.06.053; Newton PN, 2002, CLIN INFECT DIS, V35, P769, DOI 10.1086/342299; Nielsen S, 1997, J NEUROSCI, V17, P171; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PARTON RG, 1991, J CELL BIOL, V113, P261, DOI 10.1083/jcb.113.2.261; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; PEDLEY TA, 1969, EXP NEUROL, V25, P207, DOI 10.1016/0014-4886(69)90045-4; Poca MA, 2005, EXPERT OPIN PHARMACO, V6, P1525, DOI 10.1517/14656566.6.9.1525; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Pratico D, 2004, J ALZHEIMERS DIS, V6, P385; Preston JE, 2001, MICROSC RES TECHNIQ, V52, P31, DOI 10.1002/1097-0029(20010101)52:1<31::AID-JEMT5>3.3.CO;2-K; Pushkin A, 2000, BBA-GENE STRUCT EXPR, V1493, P215, DOI 10.1016/S0167-4781(00)00149-4; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; REED DJ, 1967, EXP BRAIN RES, V3, P212; Reiss WG, 1996, ANN PHARMACOTHER, V30, P514, DOI 10.1177/106002809603000515; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; SAITO Y, 1982, J PHYSIOL-LONDON, V328, P229, DOI 10.1113/jphysiol.1982.sp014261; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; Shao XM, 2007, J NEUROSCI METH, V159, P108, DOI 10.1016/j.jneumeth.2006.07.001; Shu XD, 2003, DEVELOPMENT, V130, P6165, DOI 10.1242/dev.00844; Shuvaev VV, 2001, NEUROBIOL AGING, V22, P397, DOI 10.1016/S0197-4580(00)00253-0; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Trapp S, 1996, NEUROREPORT, V7, P2000, DOI 10.1097/00001756-199608120-00029; VOGH BP, 1975, AM J PHYSIOL, V228, P673, DOI 10.1152/ajplegacy.1975.228.3.673; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Wu XH, 2006, NEUROSCI LETT, V400, P146, DOI 10.1016/j.neulet.2006.02.031; Xiong ZQ, 2000, J NEUROSCI, V20, P1290	63	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32563	32574		10.1074/jbc.M111.249961	http://dx.doi.org/10.1074/jbc.M111.249961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21705333	Green Published, hybrid			2022-12-27	WOS:000294726800066
J	Kim, SY; Lee, JH; Huh, JW; Ro, JY; Oh, YM; Lee, SD; An, S; Lee, YS				Kim, Sun-Yong; Lee, Ji-Hyun; Huh, Jin Won; Ro, Jai Youl; Oh, Yeon-Mock; Lee, Sang-Do; An, Sungkwan; Lee, Yun-Song			Cigarette Smoke Induces Akt Protein Degradation by the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG FIBROBLASTS; SIGNAL-REGULATING KINASE-1; OXIDATIVE STRESS; CELLULAR SENESCENCE; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; DOWN-REGULATION; ACTIVATION; EMPHYSEMA; MECHANISMS	Emphysema is one of the characteristic features of chronic obstructive pulmonary disease, which is caused mainly by cigarette smoking. Recent data have suggested that apoptosis and cell cycle arrest may contribute to the development of emphysema. In this study, we addressed the question of whether and how cigarette smoke affected Akt, which plays a critical role in cell survival and proliferation. In normal human lung fibroblasts, cigarette smoke extract (CSE) caused cell death, accompanying degradation of total and phosphorylated Akt (p-Akt), which was inhibited by MG132. CSE exposure resulted in preferential ubiquitination of the active Akt (myristoylated), rather than the inactive (T308A/S473A double mutant) Akt. Consistent with cytotoxicity, CSE induced a progressive decrease of phosphorylated human homolog of mouse double minute homolog 2 (p-HDM2) and phosphorylated apoptosis signal regulating kinase 1 (p-ASK1) with concomitant elevation of p53, p21, and phosphorylated p38 MAPK. Forced expression of the active Akt reduced both CSE-induced cytotoxicity and alteration in HDM2/p53/p21 and ASK1/p38 MAPK, compared with the inactive Akt. Of note, CSE induced expression of the tetratricopeptide repeat domain 3 (TTC3), known as a ubiquitin ligase for active Akt. TTC3 siRNAs suppressed not only CSE-induced Akt degradation but also CSE-induced cytotoxicity. Accordingly, rat lungs exposed to cigarette smoke for 3 months showed elevated TTC3 expression and reduced Akt and p-Akt. Taken together, these data suggest that cigarette smoke induces cytotoxicity, partly through Akt degradation via the ubiquitin-proteasome system, in which TTC3 acts as a ubiquitin ligase for active Akt.	[Kim, Sun-Yong; Ro, Jai Youl; Lee, Yun-Song] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol, Suwon 440746, South Korea; [Lee, Ji-Hyun] Pochon CHA Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Songnam 463712, South Korea; [Huh, Jin Won; Oh, Yeon-Mock; Lee, Sang-Do] Univ Ulsan, Coll Med, Asthma Ctr, Dept Pulm & Crit Care Med, Seoul 138736, South Korea; [Huh, Jin Won; Oh, Yeon-Mock; Lee, Sang-Do] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Res Ctr Chron Obstruct Airway Dis, Seoul 138736, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea	Sungkyunkwan University (SKKU); Pochon Cha University; University of Ulsan; University of Ulsan; Asan Medical Center; Konkuk University	Lee, YS (corresponding author), 300 Chunchun Dong, Suwon 440746, South Korea.	yslee@skku.edu			National Research Foundation of Korea [2010-0007209]; Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Welfare & Family Affairs Project, Republic of Korea [A084753]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Welfare & Family Affairs Project, Republic of Korea	This research was supported by Grant 2010-0007209 from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology and by Grant A084753 from the Korea Healthcare Technology R&D Welfare & Family Affairs Project, Republic of Korea.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Carnevali S, 1998, AM J PHYSIOL-LUNG C, V274, pL591, DOI 10.1152/ajplung.1998.274.4.L591; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; COONEY TP, 1982, NEW ENGL J MED, V307, P1170, DOI 10.1056/NEJM198211043071902; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Huh J. W., 2011, AM J PHYSL IN PRESS; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marwick JA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-11; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Osoata GO, 2009, BIOCHEM BIOPH RES CO, V384, P366, DOI 10.1016/j.bbrc.2009.04.128; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ricupero DA, 2001, AM J PHYSIOL-CELL PH, V281, pC99, DOI 10.1152/ajpcell.2001.281.1.C99; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tsukahara F, 1996, J BIOCHEM-TOKYO, V120, P820; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	49	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31932	31943		10.1074/jbc.M111.267633	http://dx.doi.org/10.1074/jbc.M111.267633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778238	Green Published, hybrid			2022-12-27	WOS:000294726800002
J	Singhal, E; Kumar, P; Sen, P				Singhal, Eshu; Kumar, Prakash; Sen, Pradip			A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; X-LINKED AGAMMAGLOBULINEMIA; SCATTER FACTOR-RECEPTOR; MULTIPLE-MYELOMA; ANTIGEN RECEPTOR; BINDING-PROTEIN; DOCKING SITE; T-CELLS; C-MET; BTK	The limited success of dendritic cell (DC)-based immunotherapy in multiple myeloma is partly due to hepatocyte growth factor (HGF)-induced DC dysfunction. From a therapeutic standpoint, it is important to understand the molecular events involved in inhibition of DC activation/maturation by HGF. Because Bruton's tyrosine kinase (Btk) negatively regulates maturation and immunostimulatory function of DCs, a role for Btk in HGF-induced inhibition of both murine and human DCs was investigated. We demonstrate that Btk is a novel proximal component of HGF-induced c-MET (HGF receptor) signaling. Following HGF treatment, Btk binds to c-MET and becomes activated. Btk activation in turn blocks the NF-kappa B pathway and subsequent DC activation via the c-Src-PI3K-AKT-mammalian target of rapamycin (mTOR) pathway. Notably, Btk activation is necessary for HGF-induced association of c-Src and PI3K with c-MET. Furthermore, we provide the first evidence that HGF inhibits DC activation by inducing autocrine interleukin (IL)-10 secretion, which requires activation of Btk. Blocking activation of Btk and its downstream the c-Src-PI3K-AKT-mTOR pathway prevents HGF-induced IL-10 secretion by DCs. In addition, neutralization of IL-10 secretion from DCs impaired the inhibitory effect of HGF on DCs. Thus, our study identifies a novel role for Btk in HGF-induced DC inhibition.	[Singhal, Eshu; Sen, Pradip] CSIR, Inst Microbial Technol, Div Cell Biol & Immunol, Chandigarh 160036, India; [Kumar, Prakash] CSIR, Inst Microbial Technol, Div Prot Sci & Engn, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sen, P (corresponding author), CSIR, Inst Microbial Technol, Div Cell Biol & Immunol, Sect 39A, Chandigarh 160036, India.	psen@imtech.res.in	Sinha, Prakash Kumar/K-6048-2013; Sen, Pradip/AAA-8832-2022; Sinha, Eshu Singhal/D-9051-2013	Sinha, Prakash Kumar/0000-0002-2067-5676; Sinha, Eshu Singhal/0000-0001-6048-050X	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a grant from the Department of Biotechnology, Government of India and an intramural grant from the Council of Scientific and Industrial Research, Government of India (to P. S.).	ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; Afar DEH, 1996, MOL CELL BIOL, V16, P3465; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Beilmann M, 2000, BLOOD, V95, P3964; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Gagliardi MC, 2003, CLIN EXP IMMUNOL, V133, P115, DOI 10.1046/j.1365-2249.2003.t01-1-02178.x; Galimi F, 2001, J IMMUNOL, V166, P1241, DOI 10.4049/jimmunol.166.2.1241; Glassford J, 2003, ONCOGENE, V22, P2248, DOI 10.1038/sj.onc.1206425; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Iwama A, 2002, J EXP MED, V195, P547, DOI 10.1084/jem.20011465; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Kurz SM, 2002, EUR J IMMUNOL, V32, P1832, DOI 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2; Mine S, 1998, LAB INVEST, V78, P1395; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Niemann C, 1998, J CELL BIOL, V143, P533, DOI 10.1083/jcb.143.2.533; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Singhal E, 2011, INT J BIOCHEM CELL B, V43, P1134, DOI 10.1016/j.biocel.2011.04.006; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Tzeng SR, 2000, PROTEIN SCI, V9, P2377, DOI 10.1110/ps.9.12.2377; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; van der Voort R, 2000, J EXP MED, V192, P1115, DOI 10.1084/jem.192.8.1115; Weaver DJ, 2001, J IMMUNOL, V167, P1461, DOI 10.4049/jimmunol.167.3.1461; Yamaura K, 2004, CIRCULATION, V110, P1650, DOI 10.1161/01.CIR.0000143052.45956.71; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	47	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32054	32063		10.1074/jbc.M111.271247	http://dx.doi.org/10.1074/jbc.M111.271247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784852	Green Published, hybrid			2022-12-27	WOS:000294726800015
J	Kizuka, Y; Kitazume, S; Yoshida, M; Taniguchi, N				Kizuka, Yasuhiko; Kitazume, Shinobu; Yoshida, Minoru; Taniguchi, Naoyuki			Brain-specific Expression of N-Acetylglucosaminyltransferase IX (GnT-IX) Is Regulated by Epigenetic Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BLOCKING ACTIVITY; SYNAPTIC PLASTICITY; MOLECULAR-CLONING; POLYSIALIC ACID; NERVOUS-SYSTEM; MICE DEFICIENT; PROTEIN CTCF; GLYCOSYLATION; PROMOTER; DIFFERENTIATION	It is well known that biosynthesis of glycans takes place in organ-and tissue-specific manners and glycan expression is controlled by various factors including glycosyltransferases. The expression mechanism of glycosyltransferases, however, is poorly understood. Here we investigated the expression mechanism of a brain-specific glycosyltransferase, GnT-IX (N-acetyl-glucosaminyltransferase IX, also designated as GnT-Vb), which synthesizes branched O-mannose glycan. Using an epigenetic approach, we revealed that the genomic region around the transcriptional start site of the GnT-IX gene was highly associated with active chromatin histone marks in a neural cell-specific manner, indicating that brain-specific GnT-IX expression is under control of an epigenetic "histone code." By EMSA and ChIP analyses we identified two regulatory proteins, NeuroD1 and CTCF that bind to and activate the GnT-IX promoter. We also revealed that GnT-IX expression was suppressed in CTCF-and NeuroD1-depleted cells, indicating that a NeuroD1- and CTCF-dependent epigenetic mechanism governs brain-specific GnT-IX expression. Several other neural glycosyltransferase genes are also found to be regulated by epigenetic histone modifications. This is the first report demonstrating a molecular mechanism at the chromatin level underlying tissue-specific glycan expression.	[Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genom Res Grp, Wako, Saitama 3510198, Japan; [Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, RIKEN Osaka Univ Alliance Lab, Osaka 5670047, Japan	RIKEN; RIKEN; Osaka University; RIKEN	Taniguchi, N (corresponding author), 2-1 Hirosawa, Wako, Saitama, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016; Yoshida, Minoru/C-8049-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Yoshida, Minoru/0000-0002-4376-5674; Kizuka, Yasuhiko/0000-0002-3181-9743	Systems Glycobiology Research project; RIKEN ASI; Osaka University; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23770163] Funding Source: KAKEN	Systems Glycobiology Research project; RIKEN ASI; Osaka University; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Systems Glycobiology Research project (to N. T.), a Grant for the Strategic programs for R&D of RIKEN ASI, Global COE Program of Osaka University, and Grants-in-Aid for Scientific Research (A) (to N. T.) and for Young Scientists (B) (to Y. K.) from the Japan Society for the Promotion of Science (JSPS).	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Granovsky M, 2000, NAT MED, V6, P306; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Ko JH, 1999, J BIOL CHEM, V274, P22941, DOI 10.1074/jbc.274.33.22941; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee I, 2006, J NEUROCHEM, V97, P947, DOI 10.1111/j.1471-4159.2006.03785.x; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rajput B, 1996, J BIOL CHEM, V271, P5131, DOI 10.1074/jbc.271.9.5131; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Takashima S, 1998, J BIOL CHEM, V273, P7675, DOI 10.1074/jbc.273.13.7675; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamamoto S, 2002, J BIOCHEM, V131, P337, DOI 10.1093/oxfordjournals.jbchem.a003108; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	42	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31875	31884		10.1074/jbc.M111.251173	http://dx.doi.org/10.1074/jbc.M111.251173			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771782	Green Published, hybrid			2022-12-27	WOS:000294487500080
J	Nagano, M; Hoshino, D; Koshiba, S; Shuo, T; Koshikawa, N; Tomizawa, T; Hayashi, F; Tochio, N; Harada, T; Akizawa, T; Watanabe, S; Handa, N; Shirouzu, M; Kigawa, T; Yokoyama, S; Seiki, M				Nagano, Makoto; Hoshino, Daisuke; Koshiba, Seizo; Shuo, Takuya; Koshikawa, Naohiko; Tomizawa, Tadashi; Hayashi, Fumiaki; Tochio, Naoya; Harada, Takushi; Akizawa, Toshifumi; Watanabe, Satoru; Handa, Noriko; Shirouzu, Mikako; Kigawa, Takanori; Yokoyama, Shigeyuki; Seiki, Motoharu			ZF21 Protein, a Regulator of the Disassembly of Focal Adhesions and Cancer Metastasis, Contains a Novel Noncanonical Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MOTILITY; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CYTOPLASMIC TAIL; NMR STRUCTURE; FYVE DOMAIN; BINDING; INTEGRINS; MIGRATION; DYNAMICS; KINASE	Directional migration of adherent cells on an extracellular matrix requires repeated formation and disassembly of focal adhesions (FAs). Directional migration of adherent cells We have identified ZF21 as a regulator of disassembly of FAs and cell migration, and increased expression of the gene has been linked to metastatic colon cancer. ZF21 is a member of a protein family characterized by the presence of the FYVE domain, which is conserved among Fab1p, YOPB, Vps27p, and EEA1 proteins, and has been shown to mediate the binding of such proteins to phosphoinositides in the lipid layers of cell membranes. ZF21 binds multiple factors that promote disassembly of FAs such as FAK, beta-tubulin, m-calpain, and SHP-2. ZF21 does not contain any other known protein motifs other than the FYVE domain, but a region of the protein C-terminal to the FYVE domain is sufficient to mediate binding to beta-tubulin. In this study, we demonstrate that the C-terminal region is important for the ability of ZF21 to induce disassembly of FAs and cell migration, and to promote an early step of experimental metastasis to the lung in mice. In light of the importance of the C-terminal region, we analyzed its ternary structure using NMR spectroscopy. We demonstrate that this region exhibits a structure similar to that of a canonical pleckstrin homology domain, but that it lacks a positively charged interface to bind phosphatidylinositol phosphate. Thus, ZF21 contains a novel noncanonical PH-like domain that is a possible target to develop a therapeutic strategy to treat metastatic cancer.	[Nagano, Makoto; Hoshino, Daisuke; Shuo, Takuya; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan; [Nagano, Makoto; Akizawa, Toshifumi] Setsunan Univ, Fac Pharmaceut Sci, Hirakata Osaka 5730101, Japan; [Koshiba, Seizo; Tomizawa, Tadashi; Hayashi, Fumiaki; Tochio, Naoya; Harada, Takushi; Watanabe, Satoru; Handa, Noriko; Shirouzu, Mikako; Kigawa, Takanori; Yokoyama, Shigeyuki] Yokohama Inst, RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Koshiba, Seizo] Yokohama City Univ, Int Grad Sch Arts & Sci, Dept Supramol Biol, Yokohama, Kanagawa 2300045, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; RIKEN; Yokohama City University; Tokyo Institute of Technology; University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Nagano, Makoto/J-7050-2015; watanabe, satoru s/E-9501-2012; Shirouzu, Mikako/A-6521-2016; Tochio, Naoya/E-9495-2012; Koshikawa, Naohiko/S-7306-2017; Seiki, Motoharu/K-9443-2015; Kigawa, Takanori/A-7679-2010	Yokoyama, Shigeyuki/0000-0003-3133-7338; Nagano, Makoto/0000-0002-1948-1591; watanabe, satoru s/0000-0001-5329-9278; Koshikawa, Naohiko/0000-0002-4539-888X; Kigawa, Takanori/0000-0003-0146-9719	Core Research for Evolutional Science and Technology (CREST); RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22591762] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (S) and Core Research for Evolutional Science and Technology (CREST) (to M. S.), the RIKEN Structural Genomics/Proteomics Initiative (RSGI), and the National Project on Protein Structural and Functional Analyses (to S. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Baron CB, 1999, BIOCHEM J, V341, P805, DOI 10.1042/0264-6021:3410805; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Li H, 2008, J BIOL CHEM, V283, P27165, DOI 10.1074/jbc.M803892200; Liu SC, 2000, J CELL SCI, V113, P3563; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; NAGANO M, 2010, CELL ADH MIGR, V5, P23; Nagano M, 2010, J BIOL CHEM, V285, P21013, DOI 10.1074/jbc.M110.106443; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niiya D, 2009, J BIOL CHEM, V284, P27360, DOI 10.1074/jbc.M109.029124; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Takeuchi H, 1998, BIOCHEM J, V334, P211, DOI 10.1042/bj3340211; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Truong H, 2009, CELL ADHES MIGR, V3, P179, DOI 10.4161/cam.3.2.8036; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	58	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31598	31609		10.1074/jbc.M110.199430	http://dx.doi.org/10.1074/jbc.M110.199430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768110	Green Published, hybrid			2022-12-27	WOS:000294487500054
J	Kowalczyk, C; Dunkel, N; Willen, L; Casal, ML; Mauldin, EA; Gaide, O; Tardivel, A; Badic, G; Etter, AL; Favre, M; Jefferson, DM; Headon, DJ; Demotz, S; Schneider, P				Kowalczyk, Christine; Dunkel, Nathalie; Willen, Laure; Casal, Margret L.; Mauldin, Elizabeth A.; Gaide, Olivier; Tardivel, Aubry; Badic, Giovanna; Etter, Anne-Lise; Favre, Manuel; Jefferson, Douglas M.; Headon, Denis J.; Demotz, Stephane; Schneider, Pascal			Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; TUMOR-NECROSIS-FACTOR; RECOMBINANT ECTODYSPLASIN; TNF SUPERFAMILY; TRANSGENIC MICE; GENE; MOUSE; MUTATIONS; INDUCTION; APOPTOSIS	The TNF family ligand ectodysplasin A (EDA) and its receptor EDAR are required for proper development of skin appendages such as hair, teeth, and eccrine sweat glands. Loss of function mutations in the Eda gene cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition that can be ameliorated in mice and dogs by timely administration of recombinant EDA. In this study, several agonist anti-EDAR monoclonal antibodies were generated that cross-react with the extracellular domains of human, dog, rat, mouse, and chicken EDAR. Their half-life in adult mice was about 11 days. They induced tail hair and sweat gland formation when administered to newborn EDA-deficient Tabby mice, with an EC50 of 0.1 to 0.7 mg/kg. Divalency was necessary and sufficient for this therapeutic activity. Only some antibodies were also agonists in an in vitro surrogate activity assay based on the activation of the apoptotic Fas pathway. Activity in this assay correlated with small dissociation constants. When administered in utero in mice or at birth in dogs, agonist antibodies reverted several ectodermal dysplasia features, including tooth morphology. These antibodies are therefore predicted to efficiently trigger EDAR signaling in many vertebrate species and will be particularly suited for long term treatments.	[Kowalczyk, Christine; Dunkel, Nathalie; Willen, Laure; Tardivel, Aubry; Badic, Giovanna; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Casal, Margret L.; Mauldin, Elizabeth A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Gaide, Olivier] Univ Geneva, Dept Dermatol, CH-1211 Geneva, Switzerland; [Etter, Anne-Lise; Favre, Manuel; Demotz, Stephane] Apoxis SA, CH-1004 Lausanne, Switzerland; [Jefferson, Douglas M.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Jefferson, Douglas M.] Cell Essential, Boston, MA 02116 USA; [Headon, Denis J.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Headon, Denis J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Demotz, Stephane] Edimer Biotech, CH-1066 Epalinges, Switzerland	University of Lausanne; University of Pennsylvania; University of Geneva; Tufts University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch		Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; National Institutes of Health [RR02512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Swiss National Science Foundation (to P. S.) and by National Institutes of Health Grant RR02512 (to M.L.C.). P.S., M.L.C., O.G., and S.D. are shareholders of EdimerPharma.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahrer K, 2003, J CHROMATOGR A, V1009, P89, DOI 10.1016/S0021-9673(03)00433-3; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Casal ML, 2005, MAMM GENOME, V16, P524, DOI 10.1007/s00335-004-2463-4; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; DHEIN J, 1992, J IMMUNOL, V149, P3166; Fadeel B, 1997, INT IMMUNOL, V9, P201, DOI 10.1093/intimm/9.2.201; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; NAKATA M, 1980, AM J HUM GENET, V32, P908; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; PINHEIRO M, 1979, AM J MED GENET, V4, P113, DOI 10.1002/ajmg.1320040202; Rawlins EL, 2005, DEV DYNAM, V233, P1378, DOI 10.1002/dvdy.20461; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SHAWLOT W, 1989, MOL BIOL MED, V6, P299; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Zankl A, 2001, EUR J PEDIATR, V160, P296, DOI 10.1007/s004310100738	32	29	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30769	30779		10.1074/jbc.M111.267997	http://dx.doi.org/10.1074/jbc.M111.267997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730053	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000294283600057
J	Philp, A; Chen, A; Lan, D; Meyer, GA; Murphy, AN; Knapp, AE; Olfert, IM; McCurdy, CE; Marcotte, GR; Hogan, MC; Baar, K; Schenk, S				Philp, Andrew; Chen, Ai; Lan, Debin; Meyer, Gretchen A.; Murphy, Anne N.; Knapp, Amy E.; Olfert, I. Mark; McCurdy, Carrie E.; Marcotte, George R.; Hogan, Michael C.; Baar, Keith; Schenk, Simon			Sirtuin 1 (SIRT1) Deacetylase Activity Is Not Required for Mitochondrial Biogenesis or Peroxisome Proliferator-activated Receptor-gamma Coactivator-1 alpha (PGC-1 alpha) Deacetylation following Endurance Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE ACTIVATION; ENERGY-METABOLISM; ENZYME-ACTIVITY; ACETYLATION; INCREASES; RAT; EXPRESSION; AMPK; TRANSCRIPTION	The protein deacetylase, sirtuin 1 (SIRT1), is a proposed master regulator of exercise-induced mitochondrial biogenesis in skeletal muscle, primarily via its ability to deacetylate and activate peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha). To investigate regulation of mitochondrial biogenesis by SIRT1 in vivo, we generated mice lacking SIRT1 deacetylase activity in skeletal muscle (mKO). We hypothesized that deacetylation of PGC-1 alpha and mitochondrial biogenesis in sedentary mice and after endurance exercise would be impaired in mKO mice. Skeletal muscle contractile characteristics were determined in extensor digitorum longus muscle ex vivo. Mitochondrial biogenesis was assessed after 20 days of voluntary wheel running by measuring electron transport chain protein content, enzyme activity, and mitochondrial DNA expression. PGC-1 alpha expression, nuclear localization, acetylation, and interacting protein association were determined following an acute bout of treadmill exercise (AEX) using co-immunoprecipitation and immunoblotting. Contrary to our hypothesis, skeletal muscle endurance, electron transport chain activity, and voluntary wheel running-induced mitochondrial biogenesis were not impaired in mKO versus wild-type (WT) mice. Moreover, PGC-1 alpha expression, nuclear translocation, activity, and deacetylation after AEX were similar in mKO versus WT mice. Alternatively, we made the novel observation that deacetylation of PGC-1 alpha after AEX occurs in parallel with reduced nuclear abundance of the acetyltransferase, general control of amino-acid synthesis 5 (GCN5), as well as reduced association between GCN5 and nuclear PGC-1 alpha. These findings demonstrate that SIRT1 deacetylase activity is not required for exercise-induced deacetylation of PGC-1 alpha or mitochondrial biogenesis in skeletal muscle and suggest that changes in GCN5 acetyltransferase activity may be an important regulator of PGC-1 alpha activity after exercise.	[Lan, Debin; Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Chen, Ai] Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Meyer, Gretchen A.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Knapp, Amy E.; Hogan, Michael C.] Univ Calif San Diego, Div Physiol, La Jolla, CA 92093 USA; [Philp, Andrew; Marcotte, George R.; Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Olfert, I. Mark] W Virginia Univ, Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA; [McCurdy, Carrie E.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [McCurdy, Carrie E.] Univ Colorado, Charles C Gates Regenerat Med & Stem Cell Biol Pr, Aurora, CO 80045 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; West Virginia University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Schenk, S (corresponding author), Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA.	sschenk@ucsd.edu	; Murphy, Anne N/H-3217-2016	Baar, Keith/0000-0001-9337-6186; Schenk, Simon/0000-0002-8224-3203; Murphy, Anne N/0000-0002-5222-9902; Marcotte, George/0000-0002-9162-135X; Philp, Andrew/0000-0003-3860-4136; Meyer, Gretchen/0000-0001-9268-3993	National Institutes of Health [P30 AR058878-02, K12 HD057022]; National Skeletal Muscle Research Center [R24 HD050837]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837, K12HD057022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040155, P30AR058878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Skeletal Muscle Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 AR058878-02 and K12 HD057022. This work was also supported by National Skeletal Muscle Research Center Grant R24 HD050837.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; CONSTABLE SH, 1987, AM J PHYSIOL, V253, pC316, DOI 10.1152/ajpcell.1987.253.2.C316; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Hamilton DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011624; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hawley JA, 2009, NUTR REV, V67, P172, DOI 10.1111/j.1753-4887.2009.00185.x; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Philp A, 2010, AM J PHYSIOL-CELL PH, V299, pC240, DOI 10.1152/ajpcell.00438.2009; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250, DOI 10.1152/jappl.1996.80.6.2250; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	45	137	141	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30561	30570		10.1074/jbc.M111.261685	http://dx.doi.org/10.1074/jbc.M111.261685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757760	Green Published, hybrid			2022-12-27	WOS:000294283600035
J	Wang, LM; Guo, DG; Xing, BW; Zhang, JL; Shu, HB; Guo, L; Huang, XY				Wang, Limin; Guo, Dagang; Xing, Bowen; Zhang, Jillian; Shu, Hong-Bing; Guo, Lin; Huang, Xin-Yun			Resistance to Inhibitors of Cholinesterase-8A (Ric-8A) Is Critical for Growth Factor Receptor-induced Actin Cytoskeletal Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ASYMMETRIC CELL-DIVISION; CAENORHABDITIS-ELEGANS EMBRYOS; PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; G-ALPHA; C-ELEGANS; SIGNAL-TRANSDUCTION; MITOTIC SPINDLE; CORTICAL LOCALIZATION	Heterotrimeric G proteins are critical transducers of cellular signaling. In addition to their classic roles in relaying signals from G protein-coupled receptors (GPCRs), heterotrimeric G proteins also mediate physiological functions from non-GPCRs. Previously, we have shown that G alpha(13), a member of the heterotrimeric G proteins, is essential for growth factor receptor-induced actin cytoskeletal reorganization such as dynamic dorsal ruffle turnover and cell migration. These G alpha(13)-mediated dorsal ruffle turnover and cell migration by growth factors acting on their receptor tyrosine kinases (RTKs) are independent of GPCRs. However, the mechanism by which RTKs signal to G alpha(13) is not known. Here, we show that cholinesterase-8A (Ric-8A), a nonreceptor guanine nucleotide exchange factor for some heterotrimeric G proteins, is critical for coupling RTKs to G alpha(13). Down-regulation of Ric-8A protein levels in cells by RNA interference slowed down platelet-derived growth factor (PDGF)-induced dorsal ruffle turnover and inhibited PDGF-initiated cell migration. PDGF was able to increase the activity of Ric-8A in cells. Furthermore, purified Ric-8A proteins interact directly with purified G alpha(13) protein in a nucleotide-dependent manner. Deficiency of Ric-8A prevented the translocation of G alpha(13) to the cell cortex. Hence, Ric-8A is critical for growth factor receptor-induced actin cytoskeletal reorganization.	[Wang, Limin; Xing, Bowen; Shu, Hong-Bing; Guo, Lin; Huang, Xin-Yun] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Guo, Dagang; Zhang, Jillian] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA	Wuhan University; Cornell University	Huang, XY (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	xyhuang@med.cornell.edu	Wang, Limin/AAX-4273-2020	Wang, Limin/0000-0001-5998-2609	National Institutes of Health [HL91525]; 111 Project of China [B06018]; National Science Foundation of China [31028015, 30921001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL91525. This work was also supported by the 111 Project of China Grant B06018 and the National Science Foundation of China Grants 31028015 and 30921001.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; DHANASEKARAN DN, 2006, SCI STKE, pPE31; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; MANNING DR, 2003, SCI STKE, pPE35; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Sun H, 1997, J BIOL CHEM, V272, P5413, DOI 10.1074/jbc.272.9.5413; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; WARN R, 1993, SYM SOC EXP BIOL, V47, P325; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Waters C, 2003, J BIOL CHEM, V278, P6282, DOI 10.1074/jbc.M208560200; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	59	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31055	31061		10.1074/jbc.M111.253427	http://dx.doi.org/10.1074/jbc.M111.253427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21771786	Green Published, hybrid			2022-12-27	WOS:000294283600083
J	Chung, YW; Kim, HK; Kim, IY; Yim, MB; Chock, PB				Chung, Youn Wook; Kim, Ha Kun; Kim, Ick Young; Yim, Moon B.; Chock, P. Boon			Dual Function of Protein Kinase C (PKC) in 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced Manganese Superoxide Dismutase (MnSOD) Expression ACTIVATION OF CREB AND FOXO3a BY PKC-alpha PHOSPHORYLATION AND BY PKC-MEDIATED INACTIVATION OF Akt, RESPECTIVELY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTOR; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; PROMOTER REVEAL; PHORBOL ESTER; CANCER-CELLS; FACTOR-ALPHA	12-O-tetradecanoylphorbol-13-acetate (TPA) has been shown to induce transcriptional activation of human manganese superoxide dismutase (MnSOD) mRNA in human lung carcinoma cells, A549, mediated by a protein kinase C (PKC)-dependent activation of cAMP-responsive element-binding protein (CREB)-1/ATF-1-like factors. In this study, we showed that MnSOD protein expression was elevated in response to TPA or TNF-alpha, but not to hydrogen peroxide treatment. TPA-induced generation of reactive oxygen species (ROS) was blocked by pretreatment of the PKC inhibitor BIM and NADPH oxidase inhibitor DPI. Small interfering RNA (siRNA) experiments indicated that knocking down the NADPH oxidase components e.g. Rac1, p22(phox), p67(phox), and NOXO1 in A549 cells impaired TPA-induced MnSOD expression. To identify the PKC isozyme involved, we used a sod2 gene response reporter plasmid, pSODLUC-3340-I2E-C, capable of sensing the effect of TNF-alpha and TPA, to monitor the effects of PKC isozyme-specific inhibitors and siRNA-induced knockdown of specific PKC isozyme. Our data indicate that TPA-induced MnSOD expression was independent of p53 and most likely mediated by PKC-alpha-, and -epsilon-dependent signaling pathways. Furthermore, siRNA-induced knock-down of CREB and Forkhead box class O (FOXO) 3a led to a reduction in TPA-induced MnSOD gene expression. Together, our results revealed that TPA up-regulates, in part, two PKC-dependent transcriptional pathways to induce MnSOD expression. One pathway involves PKC-alpha catalyzed phosphorylation of CREB and the other involves a PKC-mediated the PP2A catalyzed dephosphorylation of Akt at Ser(473) which in turn leads to FOXO3a Ser(253) dephosphorylation and its activation.	[Chung, Youn Wook; Kim, Ha Kun; Yim, Moon B.; Chock, P. Boon] NHLBI, Biochim Lab, NIH, Bethesda, MD 20892 USA; [Kim, Ick Young] Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, Seoul 136701, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Korea University	Yim, MB (corresponding author), NHLBI, Biochim Lab, NIH, Bldg 50,Room 2134,MSC 8012, Bethesda, MD 20892 USA.	bchock@nih.gov		Chung, Youn Wook/0000-0002-4382-1410	NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of NHLBI, National Institutes of Health.	AKASHI M, 1995, J BIOL CHEM, V270, P15864, DOI 10.1074/jbc.270.26.15864; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Chung YW, 2002, BIOCHEM BIOPH RES CO, V293, P1248; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; FUJII J, 1991, J BIOL CHEM, V266, P23142; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; HARRIS CA, 1991, J IMMUNOL, V147, P149; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jeong DW, 2002, J BIOL CHEM, V277, P17871, DOI 10.1074/jbc.M200808200; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kiningham KK, 2004, BIOCHEM J, V384, P543, DOI 10.1042/BJ20040714; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8; OBERLEY LW, 1979, CANCER RES, V39, P1141; Porntadavity S, 2001, DNA CELL BIOL, V20, P473, DOI 10.1089/104454901316976109; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Wen HC, 2003, CELL SIGNAL, V15, P37, DOI 10.1016/S0898-6568(02)00047-5; WHITSETT JA, 1992, AM J PHYSIOL, V262, pL688, DOI 10.1152/ajplung.1992.262.6.L688; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Xu Y, 2002, BIOCHEM J, V362, P401, DOI 10.1042/0264-6021:3620401; Xu Y, 1999, ONCOGENE, V18, P93, DOI 10.1038/sj.onc.1202265; Xu Y, 2008, MOL CANCER RES, V6, P1881, DOI 10.1158/1541-7786.MCR-08-0253; Yeh CC, 1998, DNA CELL BIOL, V17, P921, DOI 10.1089/dna.1998.17.921; Zhu CH, 2001, J BIOL CHEM, V276, P14407, DOI 10.1074/jbc.M009708200	55	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29681	29690		10.1074/jbc.M111.264945	http://dx.doi.org/10.1074/jbc.M111.264945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705328	hybrid, Green Published			2022-12-27	WOS:000294046600027
J	Rahman, P; Huysmans, RD; Wiradjaja, F; Gurung, R; Ooms, LM; Sheffield, DA; Dyson, JM; Layton, MJ; Sriratana, A; Takada, H; Tiganis, T; Mitchell, CA				Rahman, Parvin; Huysmans, Richard D.; Wiradjaja, Fenny; Gurung, Rajendra; Ooms, Lisa M.; Sheffield, David A.; Dyson, Jennifer M.; Layton, Meredith J.; Sriratana, Absorn; Takada, Hidetoshi; Tiganis, Tony; Mitchell, Christina A.			Silencer of Death Domains (SODD) Inhibits Skeletal Muscle and Kidney Enriched Inositol 5-Phosphatase (SKIP) and Regulates Phosphoinositide 3-Kinase (PI3K)/Akt Signaling to the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; POLYPHOSPHATE 5-PHOSPHATASES; PROTEIN-KINASE; CHAPERONE REGULATORS; PLASMA-MEMBRANE; ADAPTER PROTEIN; MOTILITY; AKT; PHOSPHORYLATION; RECEPTOR	Phosphoinositide 3-kinase (PI3K) regulates cell polarity and migration by generating phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) at the leading edge of migrating cells. The serine-threonine protein kinase Akt binds to PI(3,4,5)P-3, resulting in its activation. Active Akt promotes spatially regulated actin cytoskeletal remodeling and thereby directed cell migration. The inositol polyphosphate 5-phosphatases (5-ptases) degrade PI(3,4,5)P-3 to form PI(3,4)P-2, which leads to diminished Akt activation. Several 5-ptases, including SKIP and SHIP2, inhibit actin cytoskeletal reorganization by opposing PI3K/Akt signaling. In this current study, we identify a molecular co-chaperone termed silencer of death domains (SODD/BAG4) that forms a complex with several 5-ptase family members, including SKIP, SHIP1, and SHIP2. The interaction between SODD and SKIP exerts an inhibitory effect on SKIP PI(3,4,5)P-3 5-ptase catalytic activity and consequently enhances the recruitment of PI(3,4,5)P-3-effectors to the plasma membrane. In contrast, SODD-/- mouse embryonic fibroblasts exhibit reduced Akt-Ser(473) and -Thr(308) phosphorylation following EGF stimulation, associated with increased SKIP PI(3,4,5)P-3-5-ptase activity. SODD-/- mouse embryonic fibroblasts exhibit decreased EGF-stimulated F-actin stress fibers, lamellipodia, and focal adhesion complexity, a phenotype that is rescued by the expression of constitutively active Akt1. Furthermore, reduced cell migration was observed in SODD-/- macrophages, which express the three 5-ptases shown to interact with SODD (SKIP, SHIP1, and SHIP2). Therefore, this study identifies SODD as a novel regulator of PI3K/Akt signaling to the actin cytoskeleton.	[Rahman, Parvin; Huysmans, Richard D.; Wiradjaja, Fenny; Gurung, Rajendra; Ooms, Lisa M.; Sheffield, David A.; Dyson, Jennifer M.; Layton, Meredith J.; Sriratana, Absorn; Tiganis, Tony; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Takada, Hidetoshi] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2C1, Canada; [Takada, Hidetoshi] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada	Monash University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tiganis, Tony/AAV-3495-2020; Ooms, Lisa/AGZ-7420-2022	Tiganis, Tony/0000-0002-8065-9942; Mitchell, Christina A/0000-0001-9372-3192; Ooms, Lisa Michelle/0000-0002-8918-9932	National Health and Medical Research Council (NHMRC) Australia [1010368, 384137]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Australia Grants 1010368 and 384137.	Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Al-Lamki RS, 2003, AM J PATHOL, V163, P401, DOI 10.1016/S0002-9440(10)63670-X; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Antoku K, 2001, BIOCHEM BIOPH RES CO, V286, P1003, DOI 10.1006/bbrc.2001.5512; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bondar VM, 2002, MOL CANCER THER, V1, P989; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cheng HL, 2000, MOL CELL ENDOCRINOL, V170, P211, DOI 10.1016/S0303-7207(00)00324-5; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; Cross M, 2005, PROTEOMICS, V5, P4754, DOI 10.1002/pmic.200500058; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Endres R, 2003, MOL CELL BIOL, V23, P6609, DOI 10.1128/MCB.23.18.6609-6617.2003; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Hawthorne VS, 2004, CANCER BIOL THER, V3, P776, DOI 10.4161/cbt.3.8.1031; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; McKenna LB, 2007, CELL MOL LIFE SCI, V64, P2723, DOI 10.1007/s00018-007-7247-z; Mitchell CA, 2002, IUBMB LIFE, V53, P25, DOI 10.1080/15216540210815; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Onnockx S, 2008, J CELL PHYSIOL, V214, P260, DOI 10.1002/jcp.21193; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Ozawa F, 2000, BIOCHEM BIOPH RES CO, V271, P409, DOI 10.1006/bbrc.2000.2610; Paez Juan, 2003, Cancer Treat Res, V115, P145; Prasad N, 2002, J CELL SCI, V115, P3807, DOI 10.1242/jcs.00070; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takada H, 2003, MOL CELL BIOL, V23, P4026, DOI 10.1128/MCB.23.11.4026-4033.2003; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tao HF, 2007, J HUAZHONG U SCI-MED, V27, P326, DOI 10.1007/s11596-007-0328-2; Todd I, 2004, IMMUNOLOGY, V113, P65, DOI 10.1111/j.1365-2567.2004.01942.x; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	61	10	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29758	29770		10.1074/jbc.M111.263103	http://dx.doi.org/10.1074/jbc.M111.263103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712384	hybrid, Green Published			2022-12-27	WOS:000294046600035
J	Peng, AM; Wang, L; Fisher, LA				Peng, Aimin; Wang, Ling; Fisher, Laura A.			Greatwall and Polo-like Kinase 1 Coordinate to Promote Checkpoint Recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; PROTEIN PHOSPHATASE 2A; XENOPUS EGG EXTRACTS; AURORA-A; DEPENDENT DEGRADATION; MAMMALIAN-CELLS; MITOTIC ENTRY; ACTIVATION; MITOSIS; CLASPIN	Checkpoint recovery upon completion of DNA repair allows the cell to return to normal cell cycle progression and is thus a crucial process that determines cell fate after DNA damage. We previously studied this process in Xenopus egg extracts and established Greatwall (Gwl) as an important regulator. Here we show that preactivated Gwl kinase can promote checkpoint recovery independently of cyclin-dependent kinase 1 (Cdk1) or Plx1 (Xenopus polo-like kinase 1), whereas depletion of Gwl from extracts exhibits no synergy with that of Plx1 in delaying checkpoint recovery, suggesting a distinct but related relationship between Gwl and Plx1. In further revealing their functional relationship, we found mutual dependence for activation of Gwl and Plx1 during checkpoint recovery, as well as their direct association. We characterized the protein association in detail and recapitulated it in vitro with purified proteins, which suggests direct interaction. Interestingly, Gwl interaction with Plx1 and its phosphorylation by Plx1 both increase at the stage of checkpoint recovery. More importantly, Plx1-mediated phosphorylation renders Gwl more efficient in promoting checkpoint recovery, suggesting a functional involvement of such regulation in the recovery process. Finally, we report an indirect regulatory mechanism involving Aurora A that may account for Gwl-dependent regulation of Plx1 during checkpoint recovery. Our results thus reveal novel mechanisms underlying the involvement of Gwl in checkpoint recovery, in particular, its functional relationship with Plx1, a well characterized regulator of checkpoint recovery. Coordinated interplays between Plx1 and Gwl are required for reactivation of these kinases from the G(2)/M DNA damage checkpoint and efficient checkpoint recovery.	[Peng, Aimin; Wang, Ling; Fisher, Laura A.] Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Peng, AM (corresponding author), Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA.	Aimin.Peng@UNMC.edu			National Institutes of Health [P20 RR018759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported, in whole or in part, by National Institutes of Health Grant P20 RR018759 (to A. P.).	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Goldberg ML, 2010, P NATL ACAD SCI USA, V107, P12409, DOI 10.1073/pnas.1006046107; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guo ZJ, 2000, MOL BIOL CELL, V11, P1535, DOI 10.1091/mbc.11.5.1535; Jackson PK, 2006, MOL CELL, V22, P156, DOI 10.1016/j.molcel.2006.04.005; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Lorca T, 2010, J CELL SCI, V123, P2281, DOI 10.1242/jcs.064527; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lupardus PJ, 2007, METHODS, V41, P222, DOI 10.1016/j.ymeth.2006.07.024; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Maton G, 2003, J BIOL CHEM, V278, P21439, DOI 10.1074/jbc.M300811200; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; Peng AM, 2010, CELL CYCLE, V9, P4364, DOI 10.4161/cc.9.21.13632; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; van Vugt MATM, 2004, CELL CYCLE, V3, P1383, DOI 10.4161/cc.3.11.1248; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vigneron S, 2011, MOL CELL BIOL, V31, P2262, DOI 10.1128/MCB.00753-10; Virshup DM, 2010, SCIENCE, V330, P1638, DOI 10.1126/science.1199898; WANG L, 2011, HYBRIDOMA IN PRESS; Yong Z, 2008, MOL BIOL CELL, V19, P1317, DOI 10.1091/mbc.E07-11-1099; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022; Yu JT, 2004, J CELL BIOL, V164, P487, DOI 10.1083/JCB.200310059; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	43	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28996	29004		10.1074/jbc.M111.257121	http://dx.doi.org/10.1074/jbc.M111.257121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708943	Green Published, hybrid			2022-12-27	WOS:000293837000036
J	Shimozu, Y; Hirano, K; Shibata, T; Shibata, N; Uchida, K				Shimozu, Yuuki; Hirano, Keita; Shibata, Takahiro; Shibata, Noriyuki; Uchida, Koji			4-Hydroperoxy-2-nonenal Is Not Just an Intermediate but a Reactive Molecule That Covalently Modifies Proteins to Generate Unique Intramolecular Oxidation Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; 9-AND 13-HYDROPEROXIDES; LINOLENIC ACIDS; ALDEHYDES; ATHEROSCLEROSIS; HYDROPEROXIDES; TRANSFORMATION; DECOMPOSITION; MALONALDEHYDE; MECHANISMS	alpha,beta-Unsaturated aldehydes generated during lipid peroxidation, such as 4-oxoalkenals and 4-hydroxyalkenals, can give rise to protein degeneration in a variety of pathological states. Although the covalent modification of proteins by these end products has been well studied, the reactivity of unstable intermediates possessing a hydroperoxy group, such as 4-hydroperoxy-2-nonenal (HPNE), with protein has received little attention. We have now established a unique protein modification in which the 4-hydroperoxy group of HPNE is involved in the formation of structurally unusual lysine adducts. In addition, we showed that one of the HPNE-specific lysine adducts constitutes the epitope of a monoclonal antibody raised against the HPNE-modified protein. Upon incubation with bovine serum albumin, HPNE preferentially reacted with the lysine residues. By employing N-alpha-benzoylglycyl-lysine, we detected two major products containing one HPNE molecule per peptide. Based on the chemical and spectroscopic evidence, the products were identified to be the N-alpha-benzoylglycyl derivatives of N-epsilon-4-hydroxynonanoic acid-lysine and N-epsilon-4-hydroxy-(2Z)-nonenoyllysine, both of which are suggested to be formed through mechanisms in which the initial HPNE-lysine adducts undergo Baeyer-Villiger-like reactions proceeding through an intramolecular oxidation catalyzed by the hydroperoxy group. On the other hand, using an HPNE-modified protein as the immunogen, we raised a monoclonal antibody against the HPNE-modified protein and identified one of the HPNE-specific lysine adducts, N-epsilon-4-hydroxynonanoic acid-lysine, as an intrinsic epitope of the monoclonal antibody. Furthermore, we demonstrated that the HPNE-specific epitopes were produced not only in the oxidized low density lipoprotein in vitro but also in the atherosclerotic lesions. These results indicated that HPNE is not just an intermediate but also a reactive molecule that could covalently modify proteins in biological systems.	[Shimozu, Yuuki; Hirano, Keita; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan	Nagoya University; Tokyo Women's Medical University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Shimozu, Yuuki/AAW-1504-2021; Shibata, Takahiro/I-6872-2014	Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X				CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GARDNER HW, 1993, J BIOL CHEM, V268, P6971; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GREIN B, 1993, J AGR FOOD CHEM, V41, P2385, DOI 10.1021/jf00036a032; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Ishino K, 2010, J BIOL CHEM, V285, P15302, DOI 10.1074/jbc.M109.068023; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; PATAI S, 1964, CHEM ALKENES, P565; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Schneider C, 2005, LIPIDS, V40, P1155, DOI 10.1007/s11745-005-1480-3; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; SZWEDA LI, 1993, J BIOL CHEM, V268, P3342; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchida K, 1997, ARCH BIOCHEM BIOPHYS, V346, P45, DOI 10.1006/abbi.1997.0266; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; Xu GZ, 1998, CHEM RES TOXICOL, V11, P247, DOI 10.1021/tx980003d; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j	30	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29313	29324		10.1074/jbc.M111.255737	http://dx.doi.org/10.1074/jbc.M111.255737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690609	hybrid, Green Published			2022-12-27	WOS:000293837000066
J	Baltanas, FC; Casafont, I; Lafarga, V; Weruaga, E; Alonso, JR; Berciano, MT; Lafarga, M				Baltanas, Fernando C.; Casafont, Inigo; Lafarga, Vanesa; Weruaga, Eduardo; Alonso, Jose R.; Berciano, Maria T.; Lafarga, Miguel			Purkinje Cell Degeneration in pcd Mice Reveals Large Scale Chromatin Reorganization and Gene Silencing Linked to Defective DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CEREBELLAR CORTEX; MUTANT MICE; NUCLEAR ARCHITECTURE; NEURON LOSS; MAMMALIAN-CELLS; MOLECULAR-BASIS; STRAND BREAKS; CAJAL BODIES; DAMAGE; ORGANIZATION	DNArepair protects neurons against spontaneous or disease-associated DNA damage. Dysfunctions of this mechanism underlie a growing list of neurodegenerative disorders. The Purkinje cell (PC) degeneration mutation causes the loss of nna1 expression and is associated with the postnatal degeneration of PCs. This PC degeneration dramatically affects nuclear architecture and provides an excellent model to elucidate the nuclear mechanisms involved in a whole array of neurodegenerative disorders. We used immunocytochemistry for histone variants and components of the DNA damage response, an in situ transcription assay, and in situ hybridization for telomeres to analyze changes in chromatin architecture and function. We demonstrate that the phosphorylation of H2AX, a DNA damage signal, and the trimethylation of the histone H4K20, a repressive mark, in extensive domains of genome are epigenetic hallmarks of chromatin in degenerating PCs. These histone modifications are associated with a large scale reorganization of chromatin, telomere clustering, and heterochromatin-induced gene silencing, all of them key factors in PC degeneration. Furthermore, ataxia telangiectasia mutated and 53BP1, two components of the DNA repair pathway, fail to be concentrated in the damaged chromatin compartments, even though the expression levels of their coding genes were slightly up-regulated. Although the mechanism by which Nna1 loss of function leads to PC neuro-degeneration is undefined, the progressive accumulation of DNA damage in chromosome territories irreversibly compromises global gene transcription and seems to trigger PC degeneration and death.	[Lafarga, Miguel] Univ Cantabria, Fac Med, Dept Anat & Cell Biol, Inst Formac & Invest Marques Valdecilla, E-39011 Santander, Spain; [Baltanas, Fernando C.; Weruaga, Eduardo; Alonso, Jose R.] Univ Salamanca, Lab Neural Plast & Neurorepair, Inst Neurosci Castilla & Leon, E-37007 Salamanca, Spain; [Casafont, Inigo; Berciano, Maria T.; Lafarga, Miguel] Univ Cantabria, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Anat & Cell Biol, Inst Formac & Invest Marques de Valdecilla, E-39011 Santander, Spain; [Lafarga, Vanesa] Autonomous Univ Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Alonso, Jose R.] Univ Tarapaca, Inst Alta Invest, Arica 1520, Chile	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Salamanca; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Tarapaca	Lafarga, M (corresponding author), Univ Cantabria, Fac Med, Dept Anat & Cell Biol, Inst Formac & Invest Marques Valdecilla, Avd Cardenal Herrera Oria S-N, E-39011 Santander, Spain.	lafargam@unican.es	Baltanas, Fernando C./D-4756-2018; Baltanas, Fernando C./AAU-7451-2021; Weruaga, Eduardo/C-3102-2012; Lafarga, Miguel/K-3733-2014; Lafarga, Vanesa/ABF-9934-2021; Alonso, J. R./B-2523-2017	Baltanas, Fernando C./0000-0001-8110-0991; Baltanas, Fernando C./0000-0001-8110-0991; Weruaga, Eduardo/0000-0003-2887-5506; Alonso, J. R./0000-0001-5235-7616; CASAFONT, INIGO/0000-0001-5691-6841; Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	Direccion General de Investigacion [BFU2008-00175]; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas [CB06/05/0037]; Instituto de Salud Carlos III, Ministerio de Ciencia y Tecnologa [BFU2010-18284]; Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Instituto de Formacion e Investigacion Marques de Valdecilla [FMV/UC09-02]; Junta de Castilla y Leon; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon	Direccion General de Investigacion(Spanish Government); Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas; Instituto de Salud Carlos III, Ministerio de Ciencia y Tecnologa(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Instituto de Formacion e Investigacion Marques de Valdecilla(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon	This work was supported by Direccion General de Investigacion Grant BFU2008-00175, Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas Grant CB06/05/0037 from Instituto de Salud Carlos III, Ministerio de Ciencia y Tecnologa Grant BFU2010-18284, Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Instituto de Formacion e Investigacion Marques de Valdecilla Grant FMV/UC09-02, Junta de Castilla y Leon, and Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Baltanas FC, 2011, BRAIN PATHOL, V21, P374, DOI 10.1111/j.1750-3639.2010.00461.x; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Caldecott KW, 2004, DNA REPAIR, V3, P875, DOI 10.1016/j.dnarep.2004.04.011; Casafont I, 2006, NEUROSCIENCE, V140, P453, DOI 10.1016/j.neuroscience.2006.02.030; CHAKRABARTI L, 2009, BRAIN, V2, P24; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dar I, 2011, J BIOL CHEM, V286, P15361, DOI 10.1074/jbc.M110.204172; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Dellaire G, 2009, CELL CYCLE, V8, P3750, DOI 10.4161/cc.8.22.10065; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dusart I, 2006, CEREBELLUM, V5, P163, DOI 10.1080/14734220600699373; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; GARCIASEGURA LM, 1989, J COMP NEUROL, V290, P440, DOI 10.1002/cne.902900311; GILLARDON F, 1995, NEUROREPORT, V6, P1766, DOI 10.1097/00001756-199509000-00014; GILLARDON F, 1995, J NEUROSCI RES, V41, P708, DOI 10.1002/jnr.490410517; Gonzalez-Suarez I, 2009, CELL CYCLE, V8, P3860, DOI 10.4161/cc.8.23.10092; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hetman M, 2010, J NEUROCHEM, V114, P1537, DOI 10.1111/j.1471-4159.2010.06859.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kong LJ, 2006, MOL CELL, V22, P63, DOI 10.1016/j.molcel.2006.02.016; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LAFARGA M, 1991, J NEUROCYTOL, V20, P533, DOI 10.1007/BF01215262; Lafarga M, 1997, CELL TISSUE RES, V289, P25, DOI 10.1007/s004410050849; Lafarga M, 2009, CHROMOSOMA, V118, P437, DOI 10.1007/s00412-009-0212-x; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Lee Y, 2000, GENE DEV, V14, P2576, DOI 10.1101/gad.837100; Li GY, 2009, EXP EYE RES, V89, P581, DOI 10.1016/j.exer.2009.06.004; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Martou G, 2000, EXP CELL RES, V256, P131, DOI 10.1006/excr.1999.4793; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; PALAY SL, 1974, CYTOLOGY ORG; Paulson HL, 2005, NEURON, V46, P845, DOI 10.1016/j.neuron.2005.05.025; Pena E, 2001, J COMP NEUROL, V430, P250, DOI 10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rutten BPF, 2007, NEUROBIOL AGING, V28, P91, DOI 10.1016/j.neurobiolaging.2005.10.019; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Solovei I, 2004, CYTOGENET GENOME RES, V105, P302, DOI 10.1159/000078202; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wang XY, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-4; WeruagaPrieto E, 1996, GLIA, V16, P117, DOI 10.1002/(SICI)1098-1136(199602)16:2<117::AID-GLIA4>3.0.CO;2-0; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V233, P96, DOI 10.1006/bbrc.1997.6411	75	39	39	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28287	28302		10.1074/jbc.M111.246041	http://dx.doi.org/10.1074/jbc.M111.246041			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700704	Green Published, hybrid			2022-12-27	WOS:000293557800046
J	Roschzttardtz, H; Grillet, L; Isaure, MP; Conejero, G; Ortega, R; Curie, C; Mari, S				Roschzttardtz, Hannetz; Grillet, Louis; Isaure, Marie-Pierre; Conejero, Genevieve; Ortega, Richard; Curie, Catherine; Mari, Stephane			Plant Cell Nucleolus as a Hot Spot for Iron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-FLUORESCENCE; LOCALIZATION; METABOLISM; MICROSCOPY; PROTEINS; FERRITIN; DISEASE; STORAGE	Many central metabolic processes require iron as a cofactor and take place in specific subcellular compartments such as the mitochondrion or the chloroplast. Proper iron allocation in the different organelles is thus critical to maintain cell function and integrity. To study the dynamics of iron distribution in plant cells, we have sought to identify the different intracellular iron pools by combining three complementary imaging approaches, histochemistry, micro particle-induced x-ray emission, and synchrotron radiation micro X-ray fluorescence. Pea (Pisum sativum) embryo was used as a model in this study because of its large cell size and high iron content. Histochemical staining with ferrocyanide and diaminobenzidine (Perls/diaminobenzidine) strongly labeled a unique structure in each cell, which co-labeled with the DNA fluorescent stain DAPI, thus corresponding to the nucleus. The unexpected presence of iron in the nucleus was confirmed by elemental imaging using micro particle-induced x-ray emission. X-ray fluorescence on cryo-sectioned embryos further established that, quantitatively, the iron concentration found in the nucleus was higher than in the expected iron-rich organelles such as plastids or vacuoles. Moreover, within the nucleus, iron was particularly accumulated in a subcompartment that was identified as the nucleolus as it was shown to transiently disassemble during cell division. Taken together, our data uncover an as yet unidentified although abundant iron pool in the cell, which is located in the nuclei of healthy, actively dividing plant tissues. This result paves the way for the discovery of a novel cellular function for iron related to nucleus/nucleolus-associated processes.	[Roschzttardtz, Hannetz; Grillet, Louis; Conejero, Genevieve; Curie, Catherine; Mari, Stephane] Univ Montpellier 2, Lab Biochim & Physiol Mol Plantes, Inst Biol Integrat Plantes, Ecole Natl Super Agron,INRA,CNRS,UMR5004, F-34060 Montpellier 2, France; [Isaure, Marie-Pierre] Univ Pau & Pays Adour, CNRS, Inst Pluridisciplinaire Rech Environm & Mat, Lab Chim Analyt Bioinorgan & Environm,UMR5254, F-64063 Pau 9, France; [Ortega, Richard] Univ Bordeaux, Ctr Etud Nucl Bordeaux Gradignan, CNRS, UMR5797, F-33175 Gradignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Agrocampus Ouest; Montpellier SupAgro; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux	Mari, S (corresponding author), Univ Montpellier 2, Lab Biochim & Physiol Mol Plantes, Inst Biol Integrat Plantes, Ecole Natl Super Agron,INRA,CNRS,UMR5004, F-34060 Montpellier 2, France.	mari@supagro.inra.fr	Grillet, Louis/AFV-6693-2022	Grillet, Louis/0000-0002-2914-9023; ISAURE, Marie-Pierre/0000-0002-6557-5759; Ortega, Richard/0000-0003-1692-5406	Centre National de la Recherche Scientifique; l'Institut National de la Recherche Agronomique; Circulation of Iron within the Plant and Delivery to the Seed (CIDS) [23643]; Agence Nationale pour la Recherche [07-3-18-8-87 DISTRIMET]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); l'Institut National de la Recherche Agronomique; Circulation of Iron within the Plant and Delivery to the Seed (CIDS); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique, l'Institut National de la Recherche Agronomique, and by Grant 23643 (Circulation of Iron within the Plant and Delivery to the Seed (CIDS)).; Supported by a postdoctoral fellowship from the Agence Nationale pour la Recherche (Program 07-3-18-8-87 DISTRIMET). Present address: Dept. of Botany, University of Wisconsin-Madison, B122 Birge Hall, 430 Lincoln Dr., Madison, WI 53706.	Berens C, 1998, CHEM BIOL, V5, P163, DOI 10.1016/S1074-5521(98)90061-8; Carmona A, 2008, ANAL BIOANAL CHEM, V390, P1585, DOI 10.1007/s00216-008-1866-6; Carmona A, 2008, J ANAL ATOM SPECTROM, V23, P1083, DOI 10.1039/b802242a; Gordon N, 2000, BRAIN DEV-JPN, V22, P465, DOI 10.1016/S0387-7604(00)00175-3; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jeong J, 2008, P NATL ACAD SCI USA, V105, P10619, DOI 10.1073/pnas.0708367105; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Matsuyama S, 2010, X-RAY SPECTROM, V39, P260, DOI 10.1002/xrs.1256; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Quintana C, 2006, J STRUCT BIOL, V153, P42, DOI 10.1016/j.jsb.2005.11.001; Roschzttardtz H, 2009, PLANT PHYSIOL, V151, P1329, DOI 10.1104/pp.109.144444; Schroder JM, 2005, ACTA NEUROPATHOL, V109, P109, DOI 10.1007/s00401-004-0949-5; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Witting PK, 2006, BIOCHEMISTRY-US, V45, P12500, DOI 10.1021/bi0604375; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	19	60	64	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27863	27866		10.1074/jbc.C111.269720	http://dx.doi.org/10.1074/jbc.C111.269720			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21719700	Green Published, hybrid			2022-12-27	WOS:000293557800003
J	Seo, J; Tsakem, EL; Breitman, M; Gurevich, VV				Seo, Jungwon; Tsakem, Elviche L.; Breitman, Maya; Gurevich, Vsevolod V.			Identification of Arrestin-3-specific Residues Necessary for JNK3 Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEAR EXPORT SIGNAL; CRYSTAL-STRUCTURE; BETA-ARRESTIN; NONVISUAL ARRESTINS; CLATHRIN ADAPTER; VISUAL ARRESTIN; CONE ARRESTIN; WILD-TYPE; BINDING	Arrestins bind active phosphorylated G protein-coupled receptors, blocking G protein activation and channeling the signaling to G protein-independent pathways. Free arrestin-3 and receptor-bound arrestin-3 scaffold the ASK1-MKK4-JNK3 module, promoting JNK3 phosphorylation, whereas highly homologous arrestin-2 does not. Here, we used arrestin-2/3 chimeras and mutants to identify key residues of arrestin-3 responsible for its ability to facilitate JNK3 activation. Our data demonstrate that both arrestin domains are involved in JNK3 activation, with the C-terminal domain being more important than the N-terminal domain. We found that Val-343 is the key contributor to this function, whereas Leu-278, Ser-280, His-350, Asp-351, His-352, and Ile-353 play supporting roles. We also show that the arrestin-3-specific difference in the arrangement of the beta-strands in the C-terminal domain that underlies its lower selectivity for active phosphoreceptors does not play an appreciable role in its ability to enhance JNK3 activation. Importantly, the strength of the binding of ASK1 or JNK3, as revealed by the efficiency of co-immunoprecipitation, does not correlate with the ability of arrestin proteins to promote ASK1-dependent JNK3 phosphorylation. Thus, multiple residues on the non-receptor-binding side of arrestin-3 are crucial for JNK3 activation, and this function and the receptor-binding characteristics of arrestin can be manipulated independently by targeted mutagenesis.	[Seo, Jungwon; Tsakem, Elviche L.; Breitman, Maya; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [GM077561, GM081756, EY011500]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM077561, GM081756, and EY011500 (to V. V. G.).	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	38	40	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27894	27901		10.1074/jbc.M111.260448	http://dx.doi.org/10.1074/jbc.M111.260448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21715332	Green Published, hybrid			2022-12-27	WOS:000293557800008
J	Diguet, N; Mallat, Y; Ladouce, R; Clodic, G; Prola, A; Tritsch, E; Blanc, J; Larcher, JC; Delcayre, C; Samuel, JL; Friguet, B; Bolbach, G; Li, ZL; Mericskay, M				Diguet, Nicolas; Mallat, Youssef; Ladouce, Romain; Clodic, Gilles; Prola, Alexandre; Tritsch, Eva; Blanc, Jocelyne; Larcher, Jean-Christophe; Delcayre, Claude; Samuel, Jane-Lise; Friguet, Bertrand; Bolbach, Gerard; Li, Zhenlin; Mericskay, Mathias			Muscle Creatine Kinase Deficiency Triggers Both Actin Depolymerization and Desmin Disorganization by Advanced Glycation End Products in Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; SERUM RESPONSE FACTOR; HEART-FAILURE; IN-VIVO; PROTEIN; GENE; SRF; CYTOSKELETON; DYSFUNCTION; MYOPATHY	Alterations in the balance of cytoskeleton as well as energetic proteins are involved in the cardiac remodeling occurring in dilated cardiomyopathy (DCM). We used two-dimensional DIGE proteomics as a discovery approach to identify key molecular changes taking place in a temporally controlled model of DCM triggered by cardiomyocyte-specific serum response factor (SRF) knock-out in mice. We identified muscle creatine kinase (MCK) as the primary down-regulated protein followed by alpha-actin and alpha-tropomyosin down-regulation leading to a decrease of polymerized F-actin. The early response to these defects was an increase in the amount of desmin intermediate filaments and phosphorylation of the alpha B-crystallin chaperone. We found that alpha B-crystallin and desmin progressively lose their striated pattern and accumulate at the intercalated disk and the sarcolemma, respectively. We further show that desmin is a preferential target of advanced glycation end products (AGE) in mouse and human DCM. Inhibition of CK in cultured cardiomyocytes is sufficient to recapitulate both the actin depolymerization defect and the modification of desmin by AGE. Treatment with either cytochalasin D or glyoxal, a cellular AGE, indicated that both actin depolymerization and AGE contribute to desmin disorganization. Heat shock-induced phosphorylation of alpha B-crystallin provides a transient protection of desmin against glyoxal in a p38 MAPK-dependent manner. Our results show that the strong down-regulation of MCK activity contributes to F-actin instability and induces post-translational modification of alpha B-crystallin and desmin. Our results suggest that AGE may play an important role in DCM because they alter the organization of desmin filaments that normally support stress response and mitochondrial functions in cardiomyocytes.	[Mericskay, Mathias] Univ Paris 06, UR4 Vieillissement, UPMC, Dept Aging Stress & Inflammat, F-75005 Paris, France; [Clodic, Gilles; Bolbach, Gerard] Univ Paris 06, Mass Spectrometry Facil IFR83, UPMC, F-75005 Paris, France; [Larcher, Jean-Christophe] Univ Paris 06, CNRS Dev Biol UMR7622, UPMC, F-75005 Paris, France; [Prola, Alexandre] Univ Paris 11, LabEx LERMIT, INSERM, UMR S 769, F-92296 Chatenay Malabry, France; [Delcayre, Claude; Samuel, Jane-Lise] Univ Paris 07, INSERM Biomarkers & Heart Dis U942, F-75010 Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mericskay, M (corresponding author), Univ Paris 06, UR4 Vieillissement, UPMC, Dept Aging Stress & Inflammat, Inflammat 7,BP 256, F-75005 Paris, France.	mathias.mericskay@upmc.fr	Li, Zhenlin/E-3937-2016; Prola, Alexandre/ABG-1623-2021; Diguet, Nicolas/H-3876-2017; MERICSKAY, Mathias/M-3477-2018	Diguet, Nicolas/0000-0001-9963-7623; Samuel, Jane-Lise/0000-0002-7346-2404; LI, Zhenlin/0000-0002-3706-4505; Prola, Alexandre/0000-0001-6667-7653; MERICSKAY, Mathias/0000-0002-6779-092X; Friguet, Bertrand/0000-0001-8085-1961	Agence Nationale pour la Recherche [ANR-05-PCOD-003, ANR-08-GENOPAT-038]; "Association Francaise contre les Myopathies" (AFM); French Ministry of Research	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by "Agence Nationale pour la Recherche" Grants ANR-05-PCOD-003 and ANR-08-GENOPAT-038 and the "Association Francaise contre les Myopathies" (AFM).; Supported by a Ph.D. fellowship from the French Ministry of Research and AFM.	Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x; Balasubramanian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011470; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; Camors E, 2006, J MOL CELL CARDIOL, V40, P47, DOI 10.1016/j.yjmcc.2005.08.009; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Caron A, 1999, MUSCLE NERVE, V22, P1122, DOI 10.1002/(SICI)1097-4598(199908)22:8<1122::AID-MUS17>3.0.CO;2-T; Chang J, 2003, CIRCULATION, V108, P407, DOI 10.1161/01.CIR.0000084502.02147.83; Davis FJ, 2002, AM J PHYSIOL-HEART C, V282, pH1521, DOI 10.1152/ajpheart.00844.2001; Gary-Bobo G, 2008, EUR J HEART FAIL, V10, P635, DOI 10.1016/j.ejheart.2008.04.014; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Ghelis T, 2008, PLANT PHYSIOL, V148, P1668, DOI 10.1104/pp.108.124594; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6; KueperO T, 2007, J BIOL CHEM, V282, P23427, DOI 10.1074/jbc.M701586200; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Little WC, 2005, J CARD FAIL, V11, P191, DOI 10.1016/j.cardfail.2004.09.010; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; O'Connor RS, 2008, J PHYSIOL-LONDON, V586, P2841, DOI 10.1113/jphysiol.2008.151027; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohtakara K, 2000, BIOCHEM BIOPH RES CO, V272, P712, DOI 10.1006/bbrc.2000.2854; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Poggioli S, 2002, EXP GERONTOL, V37, P1207, DOI 10.1016/S0531-5565(02)00145-6; RAPPAPORT L, 1988, FEBS LETT, V231, P421, DOI 10.1016/0014-5793(88)80863-9; Saupe KW, 1998, CIRC RES, V82, P898; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Szweda LI, 2000, METHOD ENZYMOL, V319, P562; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Ventura-Clapier R, 2004, MOL CELL BIOCHEM, V256, P29, DOI 10.1023/B:MCBI.0000009857.69730.97; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Verbeke P, 1997, J HISTOCHEM CYTOCHEM, V45, P1059, DOI 10.1177/002215549704500804; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Voziyan PA, 2005, CELL MOL LIFE SCI, V62, P1671, DOI 10.1007/s00018-005-5082-7; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32	47	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35007	35019		10.1074/jbc.M111.252395	http://dx.doi.org/10.1074/jbc.M111.252395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768101	Green Published, hybrid			2022-12-27	WOS:000295406300054
J	Chew, KCM; Ang, ET; Tai, YK; Tsang, F; Lo, SQ; Ong, E; Ong, WY; Shen, HM; Lim, KL; Dawson, VL; Dawson, TM; Soong, TW				Chew, Katherine C. M.; Ang, Eng-Tat; Tai, Yee Kit; Tsang, Fai; Lo, Shun Qiang; Ong, Elijah; Ong, Wei-Yi; Shen, Han-Ming; Lim, Kah-Leong; Dawson, Valina L.; Dawson, Ted M.; Soong, Tuck Wah			Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T alpha-Synuclein IMPLICATIONS FOR NEURONAL CELL DEATH IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; DOUBLE-EDGED-SWORD; LEWY BODY; SUBSTANTIA-NIGRA; OXIDATIVE DAMAGE; NEURODEGENERATION; MUTATION; BRAIN; TRANSPORTER; PROTEIN	Parkinson disease (PD), a prevalent neurodegenerative motor disorder, is characterized by the rather selective loss of dopaminergic neurons and the presence of alpha-synuclein-enriched Lewy body inclusions in the substantia nigra of the midbrain. Although the etiology of PD remains incompletely understood, emerging evidence suggests that dysregulated iron homeostasis may be involved. Notably, nigral dopaminergic neurons are enriched in iron, the uptake of which is facilitated by the divalent metal ion transporter DMT1. To clarify the role of iron in PD, we generated SH-SY5Y cells stably expressing DMT1 either singly or in combination with wild type or mutant alpha-synuclein. We found that DMT1 overexpression dramatically enhances Fe2+ uptake, which concomitantly promotes cell death. This Fe2+-mediated toxicity is aggravated by the presence of mutant alpha-synuclein expression, resulting in increased oxidative stress and DNA damage. Curiously, Fe2+-mediated cell death does not appear to involve apoptosis. Instead, the phenomenon seems to occur as a result of excessive autophagic activity. Accordingly, pharmacological inhibition of autophagy reverses cell death mediated by Fe2+ overloading. Taken together, our results suggest a role for iron in PD pathogenesis and provide a mechanism underlying Fe2+-mediated cell death.	[Soong, Tuck Wah] Natl Univ Singapore, Ion Channel & Transporter Lab, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Ang, Eng-Tat; Ong, Wei-Yi] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Shen, Han-Ming] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Lim, Kah-Leong; Soong, Tuck Wah] Natl Inst Neurosci, Singapore 308443, Singapore; [Lim, Kah-Leong] Duke Natl Univ Singapore Neurosci Res Partnership, Agcy Sci Technol & Res A STAR, Singapore 169857, Singapore; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA	National University of Singapore; National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR); Johns Hopkins University	Soong, TW (corresponding author), Natl Univ Singapore, Ion Channel & Transporter Lab, Dept Physiol, Yong Loo Lin Sch Med, Block MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Lim, Kah/L-5426-2019; Ang, Eng-Tat/AAV-2294-2020; Tai, Yee Kit/AHB-6200-2022; Tai, Yee Kit/HCH-5864-2022; SHEN, Han-Ming/B-5942-2011; Lim, Kah-Leong/AAY-3308-2020; Dawson, Valina/Y-9757-2019; Tai, Yee Kit/AAC-9347-2020	SHEN, Han-Ming/0000-0001-7369-5227; Tai, Yee Kit/0000-0003-0798-3575; Dawson, Valina/0000-0002-2915-3970; Lim, Kah-Leong/0000-0002-5440-2588; Ang, Eng-Tat/0000-0003-1770-2482	Biomedical Research Council (BMRC) [R-185-000-093-305]; BMRC [0813319580]; National Medical Research Council Exploratory/Developmental Singapore [10nov065]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); BMRC(Agency for Science Technology & Research (A*STAR)); National Medical Research Council Exploratory/Developmental Singapore(National Medical Research Council, Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Biomedical Research Council (BMRC) Grant R-185-000-093-305 (to T. W. S.), BMRC Grant 0813319580, and National Medical Research Council Exploratory/Developmental Grant 10nov065 (to K.-L. L.), Singapore.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Arawaka S, 1998, NEUROLOGY, V51, P887, DOI 10.1212/WNL.51.3.887; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; CRUZORIVE LM, 1987, J MICROSC-OXFORD, V145, P121; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Low GKM, 2008, INT J BIOCHEM CELL B, V40, P2583, DOI 10.1016/j.biocel.2008.05.009; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Matsuzaki M, 2004, BRAIN RES, V1004, P83, DOI 10.1016/j.brainres.2004.01.017; Mitchell RM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-6; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sherer TB, 2005, ANTIOXID REDOX SIGN, V7, P627, DOI 10.1089/ars.2005.7.627; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singleton A, 2004, BRAIN, V127, P768, DOI 10.1093/brain/awh081; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tan JMM, 2009, ANTIOXID REDOX SIGN, V11, P2119, DOI 10.1089/ARS.2009.2490; Tsang F, 2003, IUBMB LIFE, V55, P323, DOI 10.1080/1521654031000153058; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Ye FQ, 1996, MOVEMENT DISORD, V11, P243, DOI 10.1002/mds.870110305; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang L, 2000, BIOCHEM J, V349, P289, DOI 10.1042/0264-6021:3490289	45	67	67	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33380	33389		10.1074/jbc.M111.268409	http://dx.doi.org/10.1074/jbc.M111.268409			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795716	hybrid, Green Published			2022-12-27	WOS:000294968800056
J	Poll, F; Doll, C; Schulz, S				Poell, Florian; Doll, Christian; Schulz, Stefan			Rapid Dephosphorylation of G Protein-coupled Receptors by Protein Phosphatase 1 beta Is Required for Termination of beta-Arrestin-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATOSTATIN; PHOSPHORYLATION; OCTREOTIDE; DESENSITIZATION; SUBTYPES; SST(2A); HETERODIMERIZATION; INTERNALIZATION; RESENSITIZATION; TRAFFICKING	Termination of signaling of activated G protein-coupled receptors (GPCRs) is essential for maintenance of cellular homeostasis. It is well established that beta-arrestin redistributes to phosphorylated GPCRs and thereby facilitates desensitization of classical G protein-dependent signaling. beta-Arrestin in turn serves as a scaffold to initiate a second wave of signaling. Here, we report a molecular mechanism that regulates the termination of unconventional beta-arrestin-dependent GPCR signaling. We identify protein phosphatase 1 beta (PP1 beta) as a phosphatase for the cluster of phosphorylated threonines ((353)TTETQRT(359)) within the sst(2A) somatostatin receptor carboxyl terminus that mediates beta-arrestin binding using siRNA knock-down screening. We show that PP1 beta-mediated sst(2A) dephosphorylation is initiated directly after receptor activation at or near the plasma membrane. As a functional consequence of diminished PP1 beta activity, we find that somatostatin-and substance P-induced but not epidermal growth factor-induced ERK activation was aberrantly enhanced and prolonged. Thus, we demonstrate a novel mechanism for fine tuning unconventional beta-arrestin-dependent GPCR signaling in that recruitment of PP1 beta to activated GPCRs facilitates GPCR dephosphorylation and, hence, leads to disruption of the beta-arrestin-GPCR complex.	[Poell, Florian; Doll, Christian; Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp, D-07747 Jena, Germany	Friedrich Schiller University of Jena	Schulz, S (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp, Drackendorfer Str 1, D-07747 Jena, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885	Deutsche Forschungsgemeinschaft [SCHU924/10-3]; Deutsche Krebshilfe [108036]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU924/10-3 and Deutsche Krebshilfe Grant 108036.	BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fischer T, 2008, J CLIN ENDOCR METAB, V93, P4519, DOI 10.1210/jc.2008-1063; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Ghosh M, 2011, J BIOL CHEM, V286, P13561, DOI 10.1074/jbc.M110.215723; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Innamorati G, 1998, J BIOL CHEM, V273, P7155, DOI 10.1074/jbc.273.12.7155; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lesche S, 2009, J CLIN ENDOCR METAB, V94, P654, DOI 10.1210/jc.2008-1919; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mundschenk J, 2003, J CLIN ENDOCR METAB, V88, P5150, DOI 10.1210/jc.2003-030262; Nagel F, 2011, MOL ENDOCRINOL, V25, P859, DOI 10.1210/me.2010-0407; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Plockinger U, 2008, J CLIN ENDOCR METAB, V93, P1203, DOI 10.1210/jc.2007-1986; Poll F, 2010, MOL ENDOCRINOL, V24, P436, DOI 10.1210/me.2009-0315; Schulz S, 2000, CLIN CANCER RES, V6, P1865; Spurney RF, 2001, J PHARMACOL EXP THER, V296, P592; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015	32	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32931	32936		10.1074/jbc.M111.224899	http://dx.doi.org/10.1074/jbc.M111.224899			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795688	Green Published, hybrid			2022-12-27	WOS:000294968800011
J	De Marchi, U; Castelbou, C; Demaurex, N				De Marchi, Umberto; Castelbou, Cyril; Demaurex, Nicolas			Uncoupling Protein 3 (UCP3) Modulates the Activity of Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) by Decreasing Mitochondrial ATP Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; OXYGEN SPECIES PRODUCTION; PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM; CA2+ HOMEOSTASIS; CALCIUM SIGNALS; CELL-DEATH; INDICATORS; LETM1; GENE	The uncoupling proteins UCP2 and UCP3 have been postulated to catalyze Ca2+ entry across the inner membrane of mitochondria, but this proposal is disputed, and other, unrelated proteins have since been identified as the mitochondrial Ca2+ uniporter. To clarify the role of UCPs in mitochondrial Ca2+ handling, we down-regulated the expression of the only uncoupling protein of HeLa cells, UCP3, and measured Ca2+ and ATP levels in the cytosol and in organelles with genetically encoded probes. UCP3 silencing did not alter mitochondrial Ca2+ uptake in permeabilized cells. In intact cells, however, UCP3 depletion increased mitochondrial ATP production and strongly reduced the cytosolic and mitochondrial Ca2+ elevations evoked by histamine. The reduced Ca2+ elevations were due to inhibition of store-operated Ca2+ entry and reduced depletion of endoplasmic reticulum (ER) Ca2+ stores. UCP3 depletion accelerated the ER Ca2+ refilling kinetics, indicating that the activity of sarco/endoplasmic reticulum Ca2+ (SERCA) pumps was increased. Accordingly, SERCA inhibitors reversed the effects of UCP3 depletion on cytosolic, ER, and mitochondrial Ca2+ responses. Our results indicate that UCP3 is not a mitochondrial Ca2+ uniporter and that it instead negatively modulates the activity of SERCA by limiting mitochondrial ATP production. The effects of UCP3 on mitochondrial Ca2+ thus reflect metabolic alterations that impact on cellular Ca2+ homeostasis. The sensitivity of SERCA to mitochondrial ATP production suggests that mitochondria control the local ATP availability at ER Ca2+ uptake and release sites.	[De Marchi, Umberto; Castelbou, Cyril; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	Nicolas.Demaurex@unige.ch		De Marchi, Umberto/0000-0002-6011-5446; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [31-068317]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation Grant 31-068317 (to N. D.).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Baughman J. M., 2011, NATURE IN PRESS; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Stefani D., 2011, NATURE IN PRESS; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jousset H, 2008, CELL CALCIUM, V43, P83, DOI 10.1016/j.ceca.2007.04.006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; Prakriya M, 2009, IMMUNOL REV, V231, P88, DOI 10.1111/j.1600-065X.2009.00820.x; Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449; Rosado JA, 2006, MINI-REV MED CHEM, V6, P409, DOI 10.2174/138955706776361466; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	51	59	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32533	32541		10.1074/jbc.M110.216044	http://dx.doi.org/10.1074/jbc.M110.216044			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775425	Green Published, hybrid			2022-12-27	WOS:000294726800063
J	Kirschner, R; Hubmacher, D; Iyengar, G; Kaur, J; Fagotto-Kaufmann, C; Bromme, D; Bartels, R; Reinhardt, DP				Kirschner, Ryan; Hubmacher, Dirk; Iyengar, Garud; Kaur, Jasvir; Fagotto-Kaufmann, Christine; Broemme, Dieter; Bartels, Rainer; Reinhardt, Dieter P.			Classical and Neonatal Marfan Syndrome Mutations in Fibrillin-1 Cause Differential Protease Susceptibilities and Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR MODULES; CBEGF DOMAIN PAIR; CALCIUM-BINDING; CATHEPSIN-K; MATRIX METALLOPROTEINASES; SECONDARY STRUCTURE; BACKBONE DYNAMICS; FBN1 MUTATIONS; EXPRESSION; MICROFIBRILS	Mutations in fibrillin-1 give rise to Marfan syndrome (MFS) characterized by vascular, skeletal, and ocular abnormalities. Fibrillins form the backbone of extracellular matrix microfibrils in tissues including blood vessels, bone, and skin. They are crucial for regulating elastic fiber biogenesis and growth factor bioavailability. To compare the molecular consequences of mutations causing the severe neonatal MFS with mutations causing the milder classical MFS, we introduced representative point mutations from each group in a recombinant human fibrillin-1 fragment. Structural effects were analyzed by circular dichroism spectroscopy and analytical gel filtration chromatography. Proteolytic susceptibility was probed with non-physiological and physiological proteases, including plasmin, thrombin, matrix metalloproteinases, and cathepsins. All mutant proteins showed a similar gross secondary structure and no differences in heat stability as compared with the wild-type protein. Proteins harboring neonatal mutations were typically more susceptible to proteolytic cleavage compared with those with classical mutations and the wild-type protein. Proteolytic neo-cleavage sites were found both in close proximity and distant to the mutations, indicating small but significant structural changes exposing cryptic cleavage sites. We also report for the first time that cathepsin K and V cleave non-mutated fibrillin-1 at several domain boundaries. Compared with the classical mutations and the wild type, the group of neonatal mutations more severely affected the ability of fibrillin-1 to interact with heparin/heparan sulfate, which plays a role in microfibril assembly. These results suggest differential molecular pathogenetic concepts for neonatal and classical MFS including enhanced proteolytic susceptibility for physiologically relevant enzymes and loss of function for heparin binding.	[Hubmacher, Dirk; Iyengar, Garud; Kaur, Jasvir; Fagotto-Kaufmann, Christine; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ H3A 2B2, Canada; [Kirschner, Ryan; Reinhardt, Dieter P.] McGill Univ, Fac Dent, Div Biomed Sci, Montreal, PQ H3A 2B2, Canada; [Broemme, Dieter] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada; [Bartels, Rainer] Res Ctr Borstel, D-23845 Borstel, Germany	McGill University; McGill University; University of British Columbia; Forschungszentrum Borstel	Reinhardt, DP (corresponding author), McGill Univ, Dept Anat & Cell Biol, Fac Med, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	dieter.reinhardt@mcgill.ca	Hubmacher, Dirk/AAE-1875-2020; Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Hubmacher, Dirk/0000-0003-1569-9451	Canadian Institutes of Health Research [IMH-102821, MOP-106494]; Canadian Marfan Association; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Marfan Association; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the Canadian Institutes of Health Research Grants IMH-102821 and MOP-106494, the Canadian Marfan Association, and the Canada Foundation for Innovation.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; Buhling F, 2000, ADV EXP MED BIOL, V477, P281; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Faivre L, 2009, EUR J HUM GENET, V17, P491, DOI 10.1038/ejhg.2008.207; Fleischer KJ, 1997, ANN THORAC SURG, V63, P1012, DOI 10.1016/S0003-4975(97)00061-1; HALME T, 1985, EXP MOL PATHOL, V43, P1, DOI 10.1016/0014-4800(85)90050-4; HANDFORD P, 1995, J BIOL CHEM, V270, P6751, DOI 10.1074/jbc.270.12.6751; HAYWARD C, 1994, HUM MOL GENET, V3, P373, DOI 10.1093/hmg/3.2.373; Hindson VJ, 1999, FEBS LETT, V452, P195, DOI 10.1016/S0014-5793(99)00623-7; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; KIELTY CM, 1994, MATRIX BIOL, V14, P191, DOI 10.1016/0945-053X(94)90008-6; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; Mellody KT, 2006, J BIOL CHEM, V281, P31854, DOI 10.1074/jbc.M602743200; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng DK, 1999, J PAEDIATR CHILD H, V35, P321, DOI 10.1046/j.1440-1754.1999.00355.x; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Perez A B, 1999, Hum Mutat, V13, P84, DOI 10.1002/(SICI)1098-1004(1999)13:1<84::AID-HUMU15>3.0.CO;2-U; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; RAGHUNATH M, 1994, BIOCHEM J, V302, P889, DOI 10.1042/bj3020889; RAGHUNATH M, 1993, HUM GENET, V90, P511; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Samokhin AO, 2008, ATHEROSCLEROSIS, V200, P58, DOI 10.1016/j.atherosclerosis.2007.12.047; Segura AM, 1998, CIRCULATION, V98, pII331; Shang J, 2005, METHODS, V35, P390, DOI 10.1016/j.ymeth.2004.10.012; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Smallridge RS, 1999, J MOL BIOL, V286, P661, DOI 10.1006/jmbi.1998.2536; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; TSUJI T, 1986, J CUTAN PATHOL, V13, P144, DOI 10.1111/j.1600-0560.1986.tb01515.x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Whiteman P, 2001, J BIOL CHEM, V276, P17156, DOI 10.1074/jbc.M006547200; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200; Yuan XM, 2002, J MOL BIOL, V316, P113, DOI 10.1006/jmbi.2001.5329; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659	67	38	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32810	32823		10.1074/jbc.M111.221804	http://dx.doi.org/10.1074/jbc.M111.221804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784848	Green Published, hybrid			2022-12-27	WOS:000294726800088
J	Li, ZC; Zhang, ZB; Xie, JX; Li, X; Tian, J; Cai, T; Cui, HJ; Ding, HF; Shapiro, JI; Xie, ZJ				Li, Zhichuan; Zhang, Zhongbing; Xie, Joe X.; Li, Xin; Tian, Jiang; Cai, Ting; Cui, Hongjuan; Ding, Hanfei; Shapiro, Joseph I.; Xie, Zijian			Na/K-ATPase Mimetic pNaKtide Peptide Inhibits the Growth of Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ANDROGEN RECEPTOR; K-ATPASE; EPITHELIAL-CELLS; BETA-SUBUNIT; C-SRC; NA,K-ATPASE; KINASE; ACTIVATION; EXPRESSION	Cells contain a large pool of nonpumping Na/K-ATPase that participates in signal transduction. Here, we show that the expression of alpha 1 Na/K-ATPase is significantly reduced in human prostate carcinoma as well as in several human cancer cell lines. This down-regulation impairs the ability of Na/K-ATPase to regulate Src-related signaling processes. A supplement of pNaKtide, a peptide derived from alpha 1 Na/K-ATPase, reduces the activities of Src and Src effectors. Consequently, these treatments stimulate apoptosis and inhibit growth in cultures of human cancer cells. Moreover, administration of pNaKtide inhibits angiogenesis and growth of tumor xenograft. Thus, the new findings demonstrate the in vivo effectiveness of pNaKtide and suggest that the defect in Na/K-ATPase-mediated signal transduction may be targeted for developing new anticancer therapeutics.	[Li, Zhichuan; Zhang, Zhongbing; Xie, Joe X.; Tian, Jiang; Cai, Ting; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Li, Xin] Univ Toledo, Coll Med, Dept Pathol, Toledo, OH 43614 USA; [Cui, Hongjuan; Ding, Hanfei] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Li, Zhichuan; Tian, Jiang; Shapiro, Joseph I.; Xie, Zijian] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-Jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017	Ding, Han-Fei/0000-0001-5702-3439	National Institutes of Health from the NHLBI [HL-36573]; National Institutes of Health from the NIGMS [GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 from the NHLBI and GM-78565 from the NIGMS.	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Contreras RG, 1999, J CELL SCI, V112, P4223; Desai SJ, 2006, CANCER RES, V66, P10449, DOI 10.1158/0008-5472.CAN-06-2582; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Lara PN, 2009, ANTI-CANCER DRUG, V20, P179, DOI 10.1097/CAD.0b013e328325a867; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Rabbani SA, 2010, MOL CANCER THER, V9, P1147, DOI 10.1158/1535-7163.MCT-09-0962; Rajasekaran AK, 2003, AM J PHYSIOL-RENAL, V285, pF388, DOI 10.1152/ajprenal.00439.2002; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; Sakai H, 2004, FEBS LETT, V563, P151, DOI 10.1016/S0014-5793(04)00292-3; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Seligson DB, 2008, J UROLOGY, V179, P338, DOI 10.1016/j.juro.2007.08.094; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Wang GM, 2007, PROSTATE, V67, P968, DOI 10.1002/pros.20582; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Yamanaka Y, 1989, Nihon Ika Daigaku Zasshi, V56, P579; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	47	70	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32394	32403		10.1074/jbc.M110.207597	http://dx.doi.org/10.1074/jbc.M110.207597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784855	Green Published, hybrid			2022-12-27	WOS:000294726800049
J	Wu, SJ; Eiben, CB; Carra, JH; Huang, I; Zong, D; Liu, PX; Wu, CT; Nivala, J; Dunbar, J; Huber, T; Senft, J; Schokman, R; Smith, MD; Mills, JH; Friedlander, AM; Baker, D; Siegel, JB				Wu, Sean J.; Eiben, Christopher B.; Carra, John H.; Huang, Ivan; Zong, David; Liu, Peixian; Wu, Cindy T.; Nivala, Jeff; Dunbar, Josef; Huber, Tomas; Senft, Jeffrey; Schokman, Rowena; Smith, Matthew D.; Mills, Jeremy H.; Friedlander, Arthur M.; Baker, David; Siegel, Justin B.			Improvement of a Potential Anthrax Therapeutic by Computational Protein Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-ANTHRACIS; CAPSULE; TRANSPEPTIDASE; SEQUENCES; PLASMID; CAPD	Past anthrax attacks in the United States have highlighted the need for improved measures against bioweapons. The virulence of anthrax stems from the shielding properties of the Bacillus anthracis poly-gamma-D-glutamic acid capsule. In the presence of excess CapD, a B. anthracis gamma-glutamyl transpeptidase, the protective capsule is degraded, and the immune system can successfully combat infection. Although CapD shows promise as a next generation protein therapeutic against anthrax, improvements in production, stability, and therapeutic formulation are needed. In this study, we addressed several of these problems through computational protein engineering techniques. We show that circular permutation of CapD improved production properties and dramatically increased kinetic thermostability. At 45 degrees C, CapD was completely inactive after 5 min, but circularly permuted CapD remained almost entirely active after 30 min. In addition, we identify an amino acid substitution that dramatically decreased transpeptidation activity but not hydrolysis. Subsequently, we show that this mutant had a diminished capsule degradation activity, suggesting that CapD catalyzes capsule degradation through a transpeptidation reaction with endogenous amino acids and peptides in serum rather than hydrolysis.	[Wu, Sean J.; Eiben, Christopher B.; Huang, Ivan; Zong, David; Liu, Peixian; Wu, Cindy T.; Nivala, Jeff; Dunbar, Josef; Huber, Tomas; Smith, Matthew D.; Mills, Jeremy H.; Baker, David; Siegel, Justin B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Carra, John H.; Senft, Jeffrey; Schokman, Rowena; Friedlander, Arthur M.] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Siegel, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	siegeljb@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Mills, Jeremy/0000-0003-2017-1846; Zong, David/0000-0002-8157-4780; Nivala, Jeff/0000-0002-8210-5417; Eiben, Christopher/0000-0002-2816-2277	Defense Advanced Research Projects Agency; Howard Hughes Medical Institute	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a grant from the Defense Advanced Research Projects Agency and the Howard Hughes Medical Institute.	Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Institute of Medicine (United States). Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, 2002, ANTHR VACC IS IT SAF; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lowther WT, 2000, BBA-PROTEIN STRUCT M, V1477, P157, DOI 10.1016/S0167-4838(99)00271-X; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Pomerantsev AP, 1997, VACCINE, V15, P1846, DOI 10.1016/S0264-410X(97)00132-1; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Scorpio A, 2010, MICROBIOL-SGM, V156, P1459, DOI 10.1099/mic.0.035857-0; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Stepanov AV, 1996, J BIOTECHNOL, V44, P155, DOI 10.1016/0168-1656(95)00092-5; TATE SS, 1981, MOL CELL BIOCHEM, V39, P357, DOI 10.1007/BF00232585; Wu RY, 2009, J BIOL CHEM, V284, P24406, DOI 10.1074/jbc.M109.019034; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zakharian TY, 2001, COMPUT CHEM, V25, P135, DOI 10.1016/S0097-8485(00)00075-9	21	10	15	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32586	32592		10.1074/jbc.M111.251041	http://dx.doi.org/10.1074/jbc.M111.251041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768086	Green Published, hybrid			2022-12-27	WOS:000294726800068
J	Yi, JX; Ma, CL; Li, Y; Weisleder, N; Rios, E; Ma, JJ; Zhou, JS				Yi, Jianxun; Ma, Changling; Li, Yan; Weisleder, Noah; Rios, Eduardo; Ma, Jianjie; Zhou, Jingsong			Mitochondrial Calcium Uptake Regulates Rapid Calcium Transients in Skeletal Muscle during Excitation-Contraction (E-C) Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CA2+ SIGNALS; MEMBRANE DEPOLARIZATION; FLUORESCENT INDICATORS; ENDOPLASMIC-RETICULUM; VENTRICULAR MYOCYTES; INTRACELLULAR CA2+; CARDIAC MYOCYTES; RELEASE; FIBERS	Defective coupling between sarcoplasmic reticulum and mitochondria during control of intracellular Ca2+ signaling has been implicated in the progression of neuromuscular diseases. Our previous study showed that skeletal muscles derived from an amyotrophic lateral sclerosis (ALS) mouse model displayed segmental loss of mitochondrial function that was coupled with elevated and uncontrolled sarcoplasmic reticulum Ca2+ release activity. The localized mitochondrial defect in the ALS muscle allows for examination of the mitochondrial contribution to Ca2+ removal during excitation-contraction coupling by comparing Ca2+ transients in regions with normal and defective mitochondria in the same muscle fiber. Here we show that Ca2+ transients elicited by membrane depolarization in fiber segments with defective mitochondria display an similar to 10% increased amplitude. These regional differences in Ca2+ transients were abolished by the application of 1,2-bis(O-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid, a fast Ca2+ chelator that reduces mitochondrial Ca2+ uptake. Using a mitochondria-targeted Ca2+ biosensor (mt11-YC3.6) expressed in ALS muscle fibers, we monitored the dynamic change of mitochondrial Ca2+ levels during voltage-induced Ca2+ release and detected a reduced Ca2+ uptake by mitochondria in the fiber segment with defective mitochondria, which mirrored the elevated Ca2+ transients in the cytosol. Our study constitutes a direct demonstration of the importance of mitochondria in shaping the cytosolic Ca2+ signaling in skeletal muscle during excitation-contraction coupling and establishes that malfunction of this mechanism may contribute to neuromuscular degeneration in ALS.	[Yi, Jianxun; Ma, Changling; Li, Yan; Rios, Eduardo; Zhou, Jingsong] Rush Univ Sch Med, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rush University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhou, JS (corresponding author), 1750 W Harrison St, Chicago, IL 60612 USA.	jingsong_zhou@rush.edu	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	Muscular Dystrophy Association [MDA-4351]; NIAMS/National Institutes of Health [AR057404, AR032808, AR049184, AG28614, AR054793]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032808, K99AR054793, R37AR032808, R00AR054793, R01AR057404, R01AR049184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was fully supported by Muscular Dystrophy Association Grant MDA-4351 and NIAMS/National Institutes of Health Grant AR057404 (to J. Z.) and partially supported by NIAMS/National Institutes of Health Grants AR032808 and AR049184 (to E. R.) AG28614 (to J. M.), and AR054793 (to N. W.).	Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bers DM, 2001, EXCITATION CONTRACTI; Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; Csernoch L, 2004, J PHYSIOL-LONDON, V557, P43, DOI 10.1113/jphysiol.2003.059154; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eisenberg B.R, 1983, QUANTITATIVE ULTRAST; GONZALEZ A, 1993, J GEN PHYSIOL, V102, P373, DOI 10.1085/jgp.102.3.373; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; ISENBERG G, 1993, CARDIOVASC RES, V27, P1800, DOI 10.1093/cvr/27.10.1800; Kavanagh NI, 2000, BBA-BIOENERGETICS, V1457, P57, DOI 10.1016/S0005-2728(00)00054-2; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lannergren J, 2001, J MUSCLE RES CELL M, V22, P265, DOI 10.1023/A:1012227009544; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MELZER W, 1984, BIOPHYS J, V45, P637, DOI 10.1016/S0006-3495(84)84203-4; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Pacher P, 2000, J PHYSIOL-LONDON, V529, P553, DOI 10.1111/j.1469-7793.2000.00553.x; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schuhmeier RP, 2004, J GEN PHYSIOL, V123, P33, DOI 10.1085/jgp.200308908; Sedova M, 2006, AM J PHYSIOL-CELL PH, V291, pC840, DOI 10.1152/ajpcell.00619.2005; Shirokova N, 1996, J GEN PHYSIOL, V107, P1, DOI 10.1085/jgp.107.1.1; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; ZAIDI NF, 1989, J BIOL CHEM, V264, P21725; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P379, DOI 10.1111/j.1469-7793.1998.379bt.x	46	63	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32436	32443		10.1074/jbc.M110.217711	http://dx.doi.org/10.1074/jbc.M110.217711			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795684	Green Published, hybrid			2022-12-27	WOS:000294726800053
J	Bergsmann, J; Derler, I; Muik, M; Frischauf, I; Fahrner, M; Pollheimer, P; Schwarzinger, C; Gruber, HJ; Groschner, K; Romanin, C				Bergsmann, Judith; Derler, Isabella; Muik, Martin; Frischauf, Irene; Fahrner, Marc; Pollheimer, Philipp; Schwarzinger, Clemens; Gruber, Hermann J.; Groschner, Klaus; Romanin, Christoph			Molecular Determinants within N Terminus of Orai3 Protein That Control Channel Activation and Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; OPERATED CA2+ ENTRY; CRAC CHANNELS; CALCIUM-CHANNELS; PLASMA-MEMBRANE; STIM1; DEPLETION; BORATE; CELLS; CALMODULIN	STIM1 and Orai represent the key components of Ca2+ release-activated Ca2+ channels. Activation of Orai channels requires coupling of the C terminus of STIM1 to the N and C termini of Orai. Although the latter appears to be central in the interaction with STIM1, the role of the N terminus and particularly of the conserved region close to the first transmembrane sequence is less well understood. Here, we investigated in detail the functional role of this conserved region in Orai3 by stepwise deletions. Molecular determinants were mapped for the two modes of Orai3 activation via STIM1 or 2-aminoethoxydiphenyl borate (2-APB) and for current gating characteristics. Increasing N-terminal truncations revealed a progressive decrease of the specific fast inactivation of Orai3 concomitant with diminished binding to calmodulin. STIM1-dependent activation of Orai3 was maintained as long as the second half of this conserved N-terminal domain was present. Further truncations abolished it, whereas Orai3 stimulation via 2-APB was partially retained. In aggregate, the N-terminal conserved region plays a multifaceted role in Orai3 current gating with distinct structural requirements for STIM1- and 2-APB-stimulated activation.	[Bergsmann, Judith; Derler, Isabella; Muik, Martin; Frischauf, Irene; Fahrner, Marc; Pollheimer, Philipp; Gruber, Hermann J.; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Schwarzinger, Clemens] Univ Linz, Inst Chem Technol Organ Mat, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharmaceut Sci Pharmacol & Toxicol, A-8010 Graz, Austria	Johannes Kepler University Linz; Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	christoph.romanin@jku.at	Fahrner, Marc/AAI-7927-2021; Schwarzinger, Clemens/AAA-4193-2022; Romanin, Christoph/D-5399-2009; Groschner, Klaus/A-2550-2010; Derler, Isabella/B-7871-2019; Frischauf, Irene/AAG-2007-2019	Romanin, Christoph/0000-0003-3756-4136; Groschner, Klaus/0000-0002-8659-377X; Derler, Isabella/0000-0002-4768-146X; Frischauf, Irene/0000-0003-0661-2932; Schwarzinger, Clemens/0000-0002-8421-9063; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Fund (FWF) [P211925, P22565]; Austrian Research Promotion Agency (FFG) Austrian Nanoscience Initiative, NSI-NABIOS [VO104-08-BI, 819703]; Hertha-Firnberg Scholarship [T466, T442]; Austrian Science Fund (FWF) [P 22565, P 21925] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG) Austrian Nanoscience Initiative, NSI-NABIOS; Hertha-Firnberg Scholarship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Fund (FWF) Projects P211925 (to K. G.) and P22565 (to C. R.) and Austrian Research Promotion Agency (FFG) Austrian Nanoscience Initiative VO104-08-BI Project 819703 NSI-NABIOS (to H. J. G.).; Supported by Hertha-Firnberg Scholarship T466. To whom correspondence may be addressed. E-mail: isabella. derler@jku.at.; Supported by Hertha-Firnberg Scholarship T442.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Frischauf I, 2011, J BIOL CHEM, V286, P8577, DOI 10.1074/jbc.M110.187179; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	35	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31565	31575		10.1074/jbc.M111.227546	http://dx.doi.org/10.1074/jbc.M111.227546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21724845	Green Published, hybrid			2022-12-27	WOS:000294487500051
J	Borbulevych, O; Kumarasiri, M; Wilson, B; Llarrull, LI; Lee, M; Hesek, D; Shi, QC; Peng, J; Baker, BM; Mobashery, S				Borbulevych, Oleg; Kumarasiri, Malika; Wilson, Brian; Llarrull, Leticia I.; Lee, Mijoon; Hesek, Dusan; Shi, Qicun; Peng, Jeffrey; Baker, Brian M.; Mobashery, Shahriar			Lysine N-zeta-Decarboxylation Switch and Activation of the beta-Lactam Sensor Domain of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR NMR-SPECTROSCOPY; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; CRYSTAL-STRUCTURE; SIGNALING PATHWAY; CROSS-CORRELATION; ANTIBIOTICS; MACROMOLECULES; INSIGHTS; PROGRAM	The integral membrane protein BlaR1 of methicillin-resistant Staphylococcus aureus senses the presence of beta-lactam antibiotics in the milieu and transduces the information to the cytoplasm, where the biochemical events that unleash induction of antibiotic resistance mechanisms take place. We report herein by two-dimensional and three-dimensional NMR experiments of the sensor domain of BlaR1 in solution and by determination of an x-ray structure for the apo protein that Lys-392 of the antibiotic-binding site is posttranslationally modified by N-zeta-carboxylation. Additional crystallographic and NMR data reveal that on acylation of Ser-389 by antibiotics, Lys-392 experiences N-zeta-decarboxylation. This unique process, termed the lysine N-zeta-decarboxylation switch, arrests the sensor domain in the activated ("on") state, necessary for signal transduction and all the subsequent biochemical processes. We present structural information on how this receptor activation process takes place, imparting longevity to the antibiotic-receptor complex that is needed for the induction of the antibiotic-resistant phenotype in methicillin-resistant S. aureus.	[Borbulevych, Oleg; Kumarasiri, Malika; Wilson, Brian; Llarrull, Leticia I.; Lee, Mijoon; Hesek, Dusan; Shi, Qicun; Peng, Jeffrey; Baker, Brian M.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Mobashery, S (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	mobashery@nd.edu	Lee, Mijoon/AFK-1543-2022; Baker, Brian/B-4584-2009	Lee, Mijoon/0000-0001-7432-0427; Baker, Brian/0000-0002-0864-0964	National Institutes of Health [AI33170, GM085109]; Pew Charitable Trusts; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI33170 (to S. M.) and GM085109 (to J. P.).; A Pew Latin American Fellow in the Biomedical Sciences, supported by The Pew Charitable Trusts.; Results shown in this study are derived from work performed at the Structural Biology Center and LS-CAT at the Advanced Photon Source of Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817).	Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P2167, DOI 10.1128/AAC.01517-09; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi D, 2000, J AM CHEM SOC, V122, P6132, DOI 10.1021/ja0013881; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Johnson JW, 2010, J AM CHEM SOC, V132, P2558, DOI 10.1021/ja9086374; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Llarrull LI, 2010, CURR OPIN MICROBIOL, V13, P551, DOI 10.1016/j.mib.2010.09.008; Llarrull LI, 2010, BIOCHEMISTRY-US, V49, P7975, DOI 10.1021/bi101177a; Llarrull LI, 2009, ANTIMICROB AGENTS CH, V53, P4051, DOI 10.1128/AAC.00084-09; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Maveyraud L, 2000, STRUCTURE, V8, P1289, DOI 10.1016/S0969-2126(00)00534-7; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PALMER AG, 1992, MOL PHYS, V75, P699, DOI 10.1080/00268979200100511; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; ROLINSON GN, 1961, BRIT MED J, V1, P125, DOI 10.1136/bmj.1.5219.125; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	43	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31466	31472		10.1074/jbc.M111.252189	http://dx.doi.org/10.1074/jbc.M111.252189			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775440	Green Published, hybrid			2022-12-27	WOS:000294487500041
J	Quinlan, CL; Gerencser, AA; Treberg, JR; Brand, MD				Quinlan, Casey L.; Gerencser, Akos A.; Treberg, Jason R.; Brand, Martin D.			The Mechanism of Superoxide Production by the Antimycin-inhibited Mitochondrial Q-cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; ELECTRON-TRANSFER CHAIN; STEADY-STATE KINETICS; PROTONMOTIVE Q-CYCLE; RHODOPSEUDOMONAS-SPHAEROIDES; RESPIRATORY-CHAIN; C REDUCTASE; Q(O) SITE; UBIQUINOL OXIDATION	Superoxide production from antimycin-inhibited complex III in isolated mitochondria first increased to a maximum then decreased as substrate supply was modulated in three different ways. In each case, superoxide production had a similar bell-shaped relationship to the reduction state of cytochrome b(566), suggesting that superoxide production peaks at intermediate Q-reduction state because it comes from a semiquinone in the outer quinone-binding site in complex III (Q(o)). Imposition of a membrane potential changed the relationships between superoxide production and b(566) reduction and between b(562) and b(566) redox states, suggesting that b(562) reduction also affects semiquinone concentration and superoxide production. To assess whether this behavior was consistent with the Q-cycle mechanism of complex III, we generated a kinetic model of the antimycin-inhibited Q(o) site. Using published rate constants (determined without antimycin), with unknown rate constants allowed to vary, the model failed to fit the data. However, when we allowed the rate constant for quinol oxidation to decrease 1000-fold and the rate constant for semiquinone oxidation by b(566) to depend on the b(562) redox state, the model fit the energized and de-energized data well. In such fits, quinol oxidation was much slower than literature values and slowed further when b(566) was reduced, and reduction of b(562) stabilized the semiquinone when b(566) was oxidized. Thus, superoxide production at Q(o) depends on the reduction states of b(566) and b(562) and fits the Q-cycle only if particular rate constants are altered when b oxidation is prevented by antimycin. These mechanisms limit superoxide production and short circuiting of the Q-cycle when electron transfer slows.	[Quinlan, Casey L.; Gerencser, Akos A.; Treberg, Jason R.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Quinlan, CL (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	cquinlan@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Quinlan, Casey/0000-0002-7808-8271; Treberg, Jason/0000-0001-5112-7325	National Institutes of Health [R01 AG033542, P01 AG025901, PL1 AG032118]; NATIONAL INSTITUTE ON AGING [PL1AG032118, P01AG025901, R01AG033542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG033542 (to C. L. Q., J. R. T., and M. D. B.), P01 AG025901 (to M. D. B.), and PL1 AG032118 (to A. A. G. and M. D. B.).	Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Cooley JW, 2009, BIOCHEMISTRY-US, V48, P1888, DOI 10.1021/bi802216h; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15791, DOI 10.1021/bi990961u; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DEVRIES S, 1983, BIOCHIM BIOPHYS ACTA, V723, P91, DOI 10.1016/0005-2728(83)90013-0; DEVRIES S, 1982, BIOCHIM BIOPHYS ACTA, V681, P41, DOI 10.1016/0005-2728(82)90276-6; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; ERECINSKA M, 1976, ARCH BIOCHEM BIOPHYS, V174, P143, DOI 10.1016/0003-9861(76)90333-7; ESPOSTI MD, 1982, BIOCHIM BIOPHYS ACTA, V682, P189, DOI 10.1016/0005-2728(82)90098-6; ESPOSTI MD, 1991, ARCH BIOCHEM BIOPHYS, V289, P303, DOI 10.1016/0003-9861(91)90415-F; FATO R, 1993, BIOCHEM J, V290, P225, DOI 10.1042/bj2900225; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Harman D, 1998, J Int Fed Clin Chem, V10, P24; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; LENAZ G, 1988, J MEMBRANE BIOL, V104, P193, DOI 10.1007/BF01872322; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; MEINHARDT SW, 1983, BIOCHIM BIOPHYS ACTA, V723, P219, DOI 10.1016/0005-2728(83)90121-4; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Mulkidjanian AY, 2005, BBA-BIOENERGETICS, V1709, P5, DOI 10.1016/j.bbabio.2005.03.009; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; PASQUALI P, 1985, J BIOENERG BIOMEMBR, V17, P283, DOI 10.1007/BF00751105; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sarewicz M, 2010, BBA-BIOENERGETICS, V1797, P1820, DOI 10.1016/j.bbabio.2010.07.005; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TRUMPOWER BL, 1976, BIOCHEM BIOPH RES CO, V70, P73, DOI 10.1016/0006-291X(76)91110-4; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Van Remmen H, 2001, EXP GERONTOL, V36, P957; VANDENBERG WH, 1979, J BIOL CHEM, V254, P8594; WEST IC, 1988, BIOCHIM BIOPHYS ACTA, V933, P35, DOI 10.1016/0005-2728(88)90053-9	52	129	133	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31361	31372		10.1074/jbc.M111.267898	http://dx.doi.org/10.1074/jbc.M111.267898			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21708945	hybrid, Green Published			2022-12-27	WOS:000294487500031
J	Su, YC; Miller, TN; Navaneetham, D; Schoonmaker, RT; Sinha, D; Walsh, PN				Su, Ya-Chi; Miller, Tara N.; Navaneetham, Duraiswamy; Schoonmaker, Robert T.; Sinha, Dipali; Walsh, Peter N.			The Role of Factor XIa (FXIa) Catalytic Domain Exosite Residues in Substrate Catalysis and Inhibition by the Kunitz Protease Inhibitor Domain of Protease Nexin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XIA; PLASMA THROMBOPLASTIN ANTECEDENT; X-ACTIVATING COMPLEX; FACTOR-IX; BLOOD-COAGULATION; SERINE PROTEASES; AUTOLYSIS LOOP; CRYSTAL-STRUCTURE; CHRISTMAS-FACTOR; BINDING-SITE	To select residues in coagulation factor XIa (FXIa) potentially important for substrate and inhibitor interactions, we examined the crystal structure of the complex between the catalytic domain of FXIa and the Kunitz protease inhibitor (KPI) domain of a physiologically relevant FXIa inhibitor, protease nexin 2 (PN2). Six FXIa catalytic domain residues (Glu(98), Tyr(143), Ile(151), Arg(3704), Lys(192), and Tyr(5901)) were subjected to mutational analysis to investigate the molecular interactions between FXIa and the small synthetic substrate (S-2366), the macromolecular substrate (factor IX (FIX)) and inhibitor PN2KPI. Analysis of all six Ala mutants demonstrated normal K-m values for S-2366 hydrolysis, indicating normal substrate binding compared with plasma FXIa; however, all except E98A and K192A had impaired values of k(cat) for S-2366 hydrolysis. All six Ala mutants displayed deficient k(cat) values for FIX hydrolysis, and all were inhibited by PN2KPI with normal values of K-i except for K192A, and Y5901A, which displayed increased values of K-i. The integrity of the S1 binding site residue, Asp(189), utilizing p-aminobenzamidine, was intact for all FXIa mutants. Thus, whereas all six residues are essential for catalysis of the macromolecular substrate (FIX), only four (Tyr(143), Ile(151), Arg(3704), and Tyr(5901)) are important for S-2366 hydrolysis; Glu(98) and Lys(192) are essential for FIX but not S-2366 hydrolysis; and Lys(192) and Tyr(5901) are required for both inhibitor and macromolecular substrate interactions.	[Su, Ya-Chi; Miller, Tara N.; Navaneetham, Duraiswamy; Schoonmaker, Robert T.; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Su, Ya-Chi; Miller, Tara N.; Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Walsh, PN (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3400 N Broad St, Philadelphia, PA 19140 USA.	pnw@temple.edu			National Institutes of Health [HL74124, HL46213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL046213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL74124 and HL46213 (to P. N. W.).	Adler M, 2000, BIOCHEMISTRY-US, V39, P12534, DOI 10.1021/bi001477q; Badellino KO, 2000, BIOCHEMISTRY-US, V39, P4769, DOI 10.1021/bi9925468; BAGLIA FA, 1991, J BIOL CHEM, V266, P24190; Blouse GE, 2009, J BIOL CHEM, V284, P4647, DOI 10.1074/jbc.M804922200; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; Coleman P L, 1976, Methods Enzymol, V45, P12; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Halfon S., 1998, HDB PROTEOLYTIC ENZY, P12; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Jin L, 2005, ACTA CRYSTALLOGR D, V61, P1418, DOI [10.1107/S0907444905024340, 10.1107/S090744905024340]; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; Krem MM, 2002, J BIOL CHEM, V277, P40260, DOI 10.1074/jbc.M206173200; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LEIBA H, 1965, BRIT J HAEMATOL, V11, P654, DOI 10.1111/j.1365-2141.1965.tb00114.x; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; NAITO K, 1991, J BIOL CHEM, V266, P7353; Narasimhan LS, 2000, J MED CHEM, V43, P361, DOI 10.1021/jm990216f; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; RAPAPORT SI, 1961, BLOOD, V18, P149, DOI 10.1182/blood.V18.2.149.149; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; Sandler B, 1998, J AM CHEM SOC, V120, P595, DOI 10.1021/ja972991v; Scandura JM, 1997, BIOCHEMISTRY-US, V36, P412, DOI 10.1021/bi9612576; Schmidt AE, 2004, J BIOL CHEM, V279, P29485, DOI 10.1074/jbc.M402971200; Shen L, 1999, THROMB HAEMOSTASIS, V82, P1078, DOI 10.1055/s-0037-1614332; SINHA D, 1985, J BIOL CHEM, V260, P714; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Wilkinson FH, 2002, J BIOL CHEM, V277, P5734, DOI 10.1074/jbc.M107753200; Wilkinson FH, 2002, J BIOL CHEM, V277, P5725, DOI 10.1074/jbc.M107027200; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200; Yang X, 2005, BIOCHEM J, V390, P157, DOI 10.1042/BJ20050029	51	4	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31904	31914		10.1074/jbc.M111.257527	http://dx.doi.org/10.1074/jbc.M111.257527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21778227	Green Published, hybrid			2022-12-27	WOS:000294487500083
J	Yoo, J; Ko, S; Kim, H; Sampson, H; Yun, JH; Choe, KM; Chang, I; Arrowsmith, CH; Krause, HM; Cho, HS; Lee, W				Yoo, Jiho; Ko, Sunggeon; Kim, Hyeyon; Sampson, Heidi; Yun, Ji-Hye; Choe, Kwang-Min; Chang, Iksoo; Arrowsmith, Cheryl H.; Krause, Henry M.; Cho, Hyun-Soo; Lee, Weontae			Crystal Structure of Fushi Tarazu Factor 1 Ligand Binding Domain/Fushi Tarazu Peptide Complex Identifies New Class of Nuclear Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROIDOGENIC FACTOR-I; FUNCTIONAL-CHARACTERIZATION; MACROMOLECULAR STRUCTURES; ESTROGEN-RECEPTOR; ORPHAN RECEPTORS; PROTEIN; GENE; EMBRYOGENESIS; SUPERFAMILY; LRH-1	The interaction between the orphan nuclear receptor FTZ-F1 (Fushi tarazu factor 1) and the segmentation gene protein FTZ is critical for specifying alternate parasegments in the Drosophila embryo. Here, we have determined the structure of the FTZ-F1 ligand-binding domain (LBD).FTZ peptide complex using x-ray crystallography. Strikingly, the ligand-binding pocket of the FTZ-F1LBD is completely occupied by helix 6 (H6) of the receptor, whereas the cofactor FTZ binds the co-activator cleft site of the FTZ-F1 LBD. Our findings suggest that H6 is essential for transcriptional activity of FTZ-F1; this is further supported by data from mutagenesis and activity assays. These data suggest that FTZ-F1 might belong to a novel class of ligand-independent nuclear receptors. Our findings are intriguing given that the highly homologous human steroidogenic factor-1 and liver receptor homolog-1 LBDs exhibit sizable ligand-binding pockets occupied by putative ligand molecules.	[Yoo, Jiho; Kim, Hyeyon; Choe, Kwang-Min; Cho, Hyun-Soo] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Ko, Sunggeon; Yun, Ji-Hye; Lee, Weontae] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Sampson, Heidi] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Chang, Iksoo] Pusan Natl Univ, Dept Phys, Creat Res Initiat Ctr Proteome Biophys, Pusan 609735, South Korea; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Krause, Henry M.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	Yonsei University; Yonsei University; McGill University; Pusan National University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Cho, HS (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seodaemun Gu 134, Seoul 120749, South Korea.	hscho8@yonsei.ac.kr; wlee@spin.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Yoo, Jiho/AAG-3529-2020	Yoo, Jiho/0000-0002-0864-2142; Lee, Weontae/0000-0003-2347-1262; Krause, Henry/0000-0002-6182-7074; Arrowsmith, Cheryl/0000-0002-4971-3250	World Class University [R33-2009-000-10123-0]; National Research Foundation/Ministry of Education, Science and Technology (MEST) of Korea [2008-0061984]; National Research Foundation (NRF) of Korea through the National Core Research Center [R15-2004-024-00000-0]; Korean government (MEST) [2009-0073145, 2009-0084897]; MEST [2011-0005000]	World Class University; National Research Foundation/Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation (NRF) of Korea through the National Core Research Center; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by World Class University Program R33-2009-000-10123-0 (to W. L.) and National Creative Research Initiatives Center for Proteome Biophysics Grant 2008-0061984 (to I. C.) from the National Research Foundation/Ministry of Education, Science and Technology (MEST) of Korea. This work was also supported by National Research Foundation (NRF) of Korea through the National Core Research Center Grant R15-2004-024-00000-0 and the Midcareer Researcher Program through an NRF grant funded by the Korean government (MEST) (2009-0073145 and 2009-0084897; to H.-S. C.) and by Basic Science Research Program through the NRF of Korea funded by MEST (to K.-M. C.) (Grant 2011-0005000).	Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Beato M, 1985, Haematol Blood Transfus, V29, P217; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARROLL SB, 1985, CELL, V43, P47, DOI 10.1016/0092-8674(85)90011-X; Chiang John Y L, 2005, Curr Opin Investig Drugs, V6, P994; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Mak HY, 1999, MOL CELL BIOL, V19, P3895; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHNO CK, 1993, MECH DEVELOP, V40, P13, DOI 10.1016/0925-4773(93)90084-B; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce KH, 2004, DRUG DISCOV TODAY, V9, P741, DOI 10.1016/S1359-6446(04)03201-5; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; WAKIMOTO BT, 1984, DEV BIOL, V102, P147, DOI 10.1016/0012-1606(84)90182-9; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; WOODARD CT, 1994, CELL, V79, P607, DOI 10.1016/0092-8674(94)90546-0	43	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31225	31231		10.1074/jbc.M111.252916	http://dx.doi.org/10.1074/jbc.M111.252916			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775434	Green Published, hybrid			2022-12-27	WOS:000294487500017
J	Deng, T; Sieglaff, DH; Zhang, AJ; Lyon, CJ; Ayers, SD; Cvoro, A; Gupte, AA; Xia, XF; Baxter, JD; Webb, P; Hsueh, WA				Deng, Tuo; Sieglaff, Douglas H.; Zhang, Aijun; Lyon, Christopher J.; Ayers, Steven D.; Cvoro, Aleksandra; Gupte, Anisha A.; Xia, Xuefeng; Baxter, John D.; Webb, Paul; Hsueh, Willa A.			A Peroxisome Proliferator-activated Receptor gamma (PPAR gamma)/PPAR gamma Coactivator 1 beta Autoregulatory Loop in Adipocyte Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; GENE-EXPRESSION; GLUCOSE-UPTAKE; GENOME-WIDE; OXIDATIVE-METABOLISM; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; FAT; DIFFERENTIATION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) activation induces adipogenesis and also enhances lipogenesis, mitochondrial activity, and insulin sensitivity in adipocytes. Whereas some studies implicate PPAR gamma coactivator 1 alpha (PGC-1 alpha) in the mitochondrial effect, the mechanisms involved in PPAR gamma regulation of adipocyte mitochondrial function are not resolved. PPAR gamma-activating ligands (thiazolidinediones (TZDs)) are important insulin sensitizers and were recently shown to indirectly induce PGC-1 beta transcription in osteoclasts. Here, we asked whether similar effects occur in adipocytes and show that TZDs also strongly induce PGC-1 beta in cultured 3T3-L1 cells. This effect, however, differs from the indirect effect proposed for bone and is rapid and direct and involves PPAR gamma interactions with an intronic PPAR gamma response element cluster in the PGC-1 beta locus. TZD treatment of cultured adipocytes results in up-regulation of mitochondrial marker genes, and increased mitochondrial activity and use of short interfering RNA confirms that these effects require PGC-1 beta. PGC-1 beta did not participate inPPAR gamma effects on adipogenesis or lipogenesis, and PGC-1 beta knockdown did not alter insulin-responsive glucose uptake into 3T3-L1 cells. Similar effects on PGC-1 beta and mitochondrial gene expression are seen in vivo; fractionation of obese mouse adipose tissue reveals that PPAR gamma and PGC-1 beta, but not PGC-1 alpha, are coordinately up-regulated in adipocytes relative to preadipocytes and that TZD treatment induces PGC-1 beta and mitochondrial marker genes in adipose tissue of obese mice. We propose that PPAR gamma directly induces PGC-1 beta expression in adipocytes and that this effect regulates adipocyte mitochondrial activity.	[Deng, Tuo; Sieglaff, Douglas H.; Zhang, Aijun; Lyon, Christopher J.; Ayers, Steven D.; Cvoro, Aleksandra; Gupte, Anisha A.; Xia, Xuefeng; Baxter, John D.; Webb, Paul; Hsueh, Willa A.] Methodist Hosp, Res Inst, Ctr Diabet Res, Weill Cornell Med Coll, Houston, TX 77030 USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Hsueh, WA (corresponding author), Methodist Hosp, Res Inst, Ctr Diabet Res, Weill Cornell Med Coll, 6565 Fannin,F8-045, Houston, TX 77030 USA.	wahsueh@tmhs.org	Gupte, Anisha/D-6756-2015; Deng, Tuo/M-3176-2015; Ayers, Stephen D/O-4535-2014	Gupte, Anisha/0000-0002-5173-1773; Ayers, Stephen D/0000-0003-1390-8969	National Institutes of Health [1R24DK087723-01, U01 GM094614]; American Diabetes Association [7-07-CVD-12]; MacDonald Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); MacDonald Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R24DK087723-01 (to W.A.H. and J.D.B.) and U01 GM094614 (to P.W.). This work was also supported by American Diabetes Association Fellowship 7-07-CVD-12 (to T.D.) and the MacDonald Foundation (to W.A.H.).	Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/j.amjmed.2003.09.005; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Halleux CM, 1999, J CLIN ENDOCR METAB, V84, P4097, DOI 10.1210/jc.84.11.4097; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hu X, 2007, DIABETOLOGIA, V50, P1048, DOI 10.1007/s00125-007-0622-3; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lebovitz HE, 2002, DIABETES-METAB RES, V18, pS23, DOI 10.1002/dmrr.252; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lopez-Solache I, 2002, ENDOCRINE, V19, P197, DOI 10.1385/ENDO:19:2:197; Mukherjee R, 2000, MOL ENDOCRINOL, V14, P1425, DOI 10.1210/me.14.9.1425; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Shah P, 2010, EXPERT OPIN DRUG SAF, V9, P347, DOI 10.1517/14740331003623218; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752	37	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30723	30731		10.1074/jbc.M111.251926	http://dx.doi.org/10.1074/jbc.M111.251926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21719705	Green Published, hybrid			2022-12-27	WOS:000294283600052
J	Illingworth, M; Ramsey, A; Zheng, ZD; Chen, LL				Illingworth, Melissa; Ramsey, Andrew; Zheng, Zhida; Chen, Lingling			Stimulating the Substrate Folding Activity of a Single Ring GroEL Variant by Modulating the Cochaperonin GroES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP HYDROLYSIS; OLIGOMERIC STRUCTURE; POLYPEPTIDE BINDING; IN-VIVO; CYCLE; MECHANISM	In mediating protein folding, chaperonin GroEL and cochaperonin GroES form an enclosed chamber for substrate proteins in an ATP-dependent manner. The essential role of the double ring assembly of GroEL is demonstrated by the functional deficiency of the single ring GroEL(SR). The GroEL(SR)-GroES is highly stable with minimal ATPase activity. To restore the ATP cycle and the turnover of the folding chamber, we sought to weaken the GroEL(SR)-GroES interaction systematically by concatenating seven copies of groES to generate groES(7). GroES Ile-25, Val-26, and Leu-27, residues on the GroEL-GroES interface, were substituted with Asp on different groES modules of groES(7). GroES(7) variants activate ATP activity of GroEL(SR), but only some restore the substrate folding function of GroEL(SR), indicating a direct role of GroES in facilitating substrate folding through its dynamics with GroEL. Active GroEL(SR)-GroES(7) systems may resemble mammalian mitochondrial chaperonin systems.	[Illingworth, Melissa; Ramsey, Andrew; Zheng, Zhida; Chen, Lingling] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Chen, LL (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, 212 S Hawthome Dr,Simon Hall 400A, Bloomington, IN 47405 USA.	linchen@indiana.edu	Chen, Ling-Ling/AAY-3547-2021		National Institutes of Health [R01GM065260, R01GM065260-05S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM065260 and R01GM065260-05S1 (to L. C.).	Ben-Zvi AP, 1998, P NATL ACAD SCI USA, V95, P15275, DOI 10.1073/pnas.95.26.15275; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; Chatellier J, 2000, J MOL BIOL, V304, P897, DOI 10.1006/jmbi.2000.4278; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Gupta Radhey S., 1996, P27, DOI 10.1016/B978-012237455-5/50003-8; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; Kovacs E, 2010, J MOL BIOL, V396, P1271, DOI 10.1016/j.jmb.2009.11.074; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li YL, 2010, J PEPT SCI, V16, P693, DOI 10.1002/psc.1288; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Lorimer G, 1997, NATURE, V388, P720, DOI 10.1038/41892; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; Miyazaki T, 2002, J BIOL CHEM, V277, P50621, DOI 10.1074/jbc.M209183200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; TODD MJ, 1995, BIOCHEMISTRY-US, V34, P14932, DOI 10.1021/bi00045a038; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30401	30408		10.1074/jbc.M111.255935	http://dx.doi.org/10.1074/jbc.M111.255935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757689	Green Published, hybrid			2022-12-27	WOS:000294283600018
J	Kim, JS; Park, YY; Park, SY; Cho, H; Kang, D; Cho, H				Kim, Jo-Sun; Park, Yong-Yea; Park, Sun-Yi; Cho, Hyeseon; Kang, Dongmin; Cho, Hyeseong			The Auto-ubiquitylation of E3 Ubiquitin-protein Ligase Chfr at G(2) Phase Is Required for Accumulation of Polo-like Kinase 1 and Mitotic Entry in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE SOMATIC-CELLS; CHECKPOINT GENE; EPIGENETIC INACTIVATION; DAMAGE CHECKPOINT; STRESS CHECKPOINT; LUNG-CANCER; DNA-DAMAGE; CENP-F; MITOSIS; HYPERMETHYLATION	The E3 ubiquitin-protein ligase Chfr is a mitotic stress checkpoint protein that delays mitotic entry in response to microtubule damage; however, the molecular mechanism by which Chfr accomplishes this remains elusive. Here, we show that Chfr levels are elevated in response to microtubule-damaging stress. Moreover, G(2)/M transition is associated with cell cycle-dependent turnover of Chfr accompanied by high autoubiquitylation activity, suggesting that regulation of Chfr levels and auto-ubiquitylation activity are functionally significant. To test this, we generated Chfr mutants Chfr-K2A and Chfr-K5A in which putative lysine target sites of auto-ubiquitylation were replaced with alanine. Chfr-K2A did not undergo cell cycle-dependent degradation, and its levels remained high during G(2)/M phase. The elevated levels of Chfr-K2A caused a significant reduction in phosphohistone H3 levels and cyclinB1/Cdk1 kinase activities, leading to mitotic entry delay. Notably, polo-like kinase 1 levels at G(2) phase, but not at S phase, were similar to 2-3-fold lower in cells expressing Chfr-K2A than in wild-type Chfr-expressing cells. Consistent with this, ubiquitylation of Plk1 at G(2) phase was accelerated in Chfr-K2A-expressing cells. In contrast, Aurora A levels remained constant, indicating that Plk1 is a major target of Chfr in controlling the timing of mitotic entry. Indeed, overexpression of Plk1 in Chfr-K2A-expressing cells restored cyclin B1/Cdk1 kinase activity and promoted mitotic entry. Collectively, these data indicate that Chfr auto-ubiquitylation is required to allow Plk1 to accumulate to levels necessary for activation of cyclin B1/Cdk1 kinase and mitotic entry. Our results provide the first evidence that Chfr auto-ubiquitylation and degradation are important for the G(2)/M transition.	[Kim, Jo-Sun; Park, Yong-Yea; Park, Sun-Yi; Cho, Hyeseong] Ajou Univ, Sch Med, Dept Biochem, Suwon 443721, South Korea; [Kim, Jo-Sun; Park, Yong-Yea; Park, Sun-Yi; Cho, Hyeseong] Ajou Univ, Grad Sch Mol Sci & Technol, Suwon 443721, South Korea; [Cho, Hyeseon] NIH, Cell Mol Immunol Sect B, Immunoregulat Lab, Bethesda, MD 20892 USA; [Kang, Dongmin] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kang, Dongmin] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ajou University; Ajou University; National Institutes of Health (NIH) - USA; Ewha Womans University; Ewha Womans University	Cho, H (corresponding author), Ajou Univ, Sch Med, Dept Biochem, 5 Wonchon Dong, Suwon 443721, South Korea.	hscho@ajou.ac.kr		Cho, Hyeseong/0000-0002-4672-8887; Kang, Dongmin/0000-0001-5997-625X	Ministry of Health and Welfare [0820060]; Ajon University	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ajon University	This work was supported by National R&D Program for Cancer Control (0820060), Ministry of Health and Welfare. Y. Park is supported by the grant of "The Ajon University Excellence Research Program in 2011."	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Banno K, 2007, INT J ONCOL, V31, P713; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Chaturvedi P, 2002, CANCER RES, V62, P1797; Corn PG, 2003, CARCINOGENESIS, V24, P47, DOI 10.1093/carcin/24.1.47; Erson AE, 2004, MOL CARCINOGEN, V39, P26, DOI 10.1002/mc.10161; Hussein D, 2002, J CELL SCI, V115, P3403; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kang Dongmin, 2004, Methods Mol Biol, V280, P229; Kwon YE, 2009, MOL CELLS, V27, P359, DOI 10.1007/s10059-009-0046-7; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Loring GL, 2008, CELL CYCLE, V7, P96, DOI 10.4161/cc.7.1.5113; Mariatos G, 2003, CANCER RES, V63, P7185; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rieder CL, 2000, COLD SPRING HARB SYM, V65, P369, DOI 10.1101/sqb.2000.65.369; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shtivelman E, 2003, MOL CANCER RES, V1, P959; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Yanokura M, 2007, ONCOL REP, V17, P41; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Yun C, 2004, MOL CANCER RES, V2, P159	31	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30615	30623		10.1074/jbc.M111.231803	http://dx.doi.org/10.1074/jbc.M111.231803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21768102	Green Published, hybrid			2022-12-27	WOS:000294283600041
J	Mazzaferro, S; Benallegue, N; Carbone, A; Gasparri, F; Vijayan, R; Biggin, PC; Moroni, M; Bermudez, I				Mazzaferro, Simone; Benallegue, Nail; Carbone, Anna; Gasparri, Federica; Vijayan, Ranjit; Biggin, Philip C.; Moroni, Mirko; Bermudez, Isabel			Additional Acetylcholine (ACh) Binding Site at alpha 4/alpha 4 Interface of (alpha 4 beta 2)(2)alpha 4 Nicotinic Receptor Influences Agonist Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ALTERNATE STOICHIOMETRIES; SUBUNIT INTERFACES; EXPRESSION; RESIDUES; CHANNELS; (ALPHA-4)(2)(BETA-2)(3); ANTAGONISTS	Nicotinic acetylcholine receptor (nAChR) alpha 4 and beta 2 subunits assemble in two alternate stoichiometries to produce (alpha 4 beta 2)(2)alpha 4 and (alpha 4 beta 2)(2)alpha 4, which display different agonist sensitivities. Functionally relevant agonist binding sites are thought to be located at alpha 4(+)/beta 2(-) subunit interfaces, but because these interfaces are present in both receptor isoforms, it is unlikely that they account for differences in agonist sensitivities. In contrast, incorporation of either alpha 4 or beta 2 as auxiliary subunits produces isoform-specific alpha 4(+)/alpha 4(-) or beta 2(+)/beta 2(-) interfaces. Using fully concatenated (alpha 4 beta 2)(2)alpha 4 nAChRs in conjunction with structural modeling, chimeric receptors, and functional mutagenesis, we have identified an additional site at the alpha 4(+)/alpha 4(-) interface that accounts for isoform-specific agonist sensitivity of the (alpha 4 beta 2)(2)alpha 4 nAChR. The additional site resides in a region that also contains a potentiating Zn2+ site but is engaged by agonists to contribute to receptor activation. By engineering alpha 4 subunits to provide a free cysteine in loop C at the alpha 4(+)alpha 4(-) interface, we demonstrated that the acetylcholine responses of the mutated receptors are attenuated or enhanced, respectively, following treatment with the sulfhydryl reagent [2-(trimethylammonium)ethyl] methanethiosulfonate or aminoethyl methanethiosulfonate. The findings suggest that agonist occupation of the site at the alpha 4(+)/(alpha 4(-) interface leads to channel gating through a coupling mechanism involving loop C. Overall, we propose that the additional agonist site at the alpha 4(+)/alpha 4(-) interface, when occupied by agonist, contributes to receptor activation and that this additional contribution underlies the agonist sensitivity signature of (alpha 4 beta 2)(2)alpha 4 nAChRs.	[Mazzaferro, Simone; Benallegue, Nail; Gasparri, Federica; Bermudez, Isabel] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England; [Carbone, Anna] Charite, Leibniz Inst Mol Pharmakol & Neurocure Initiat, D-13125 Berlin, Germany; [Vijayan, Ranjit; Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Moroni, Mirko] UCL, Dept Pharmacol, London WC1E 6BT, England	Oxford Brookes University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Oxford; University of London; University College London	Bermudez, I (corresponding author), Oxford Brookes Univ, Sch Life Sci, Gipsy Lane, Oxford OX3 0BP, England.	ibermudez@brookes.ac.uk	Vijayan, Ranjit/AAH-6015-2019; Vijayan, Ranjit/GXF-4345-2022; Moroni, Mirko/Q-1524-2018	Vijayan, Ranjit/0000-0002-3830-7409; Vijayan, Ranjit/0000-0002-3830-7409; Benallegue, Nail/0000-0002-8931-4393; Mazzaferro, Simone/0000-0003-4402-5325; Biggin, Philip/0000-0001-5100-8836; Bermudez, Isabel/0000-0001-7692-1509	Royal Society; Brookes University	Royal Society(Royal Society of London); Brookes University	This work was supported by grants from the Royal Society and Brookes University.	Akk G, 1999, BRIT J PHARMACOL, V128, P1467, DOI 10.1038/sj.bjp.0702941; Akk G, 2001, J PHYSIOL-LONDON, V535, P729, DOI 10.1111/j.1469-7793.2001.00729.x; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Bren N, 1997, J BIOL CHEM, V272, P30793, DOI 10.1074/jbc.272.49.30793; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; Gay EA, 2007, J PHYSIOL-LONDON, V584, P727, DOI 10.1113/jphysiol.2007.142554; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hsiao B, 2008, J NEUROPHYSIOL, V99, P999, DOI 10.1152/jn.01040.2007; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Perkins DI, 2009, J BIOL CHEM, V284, P27304, DOI 10.1074/jbc.M109.023598; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	35	99	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31043	31054		10.1074/jbc.M111.262014	http://dx.doi.org/10.1074/jbc.M111.262014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757735	hybrid, Green Published			2022-12-27	WOS:000294283600082
J	Auger, A; Beilhartz, GL; Zhu, SQ; Cauchon, E; Falgueyret, JP; Grobler, JA; Ehteshami, M; Gotte, M; Melnyk, RA				Auger, Anick; Beilhartz, Greg L.; Zhu, Siqi; Cauchon, Elizabeth; Falgueyret, Jean-Pierre; Grobler, Jay A.; Ehteshami, Maryam; Goette, Matthias; Melnyk, Roman A.			Impact of Primer-induced Conformational Dynamics of HIV-1 Reverse Transcriptase on Polymerase Translocation and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NONNUCLEOSIDE INHIBITORS; RIBONUCLEASE-H; DNA-POLYMERASE; POLYPURINE TRACT; ACTIVE-SITE; IN-VITRO; INITIATION; MECHANISM; MUTATIONS	The rapid emergence and the prevalence of resistance mutations in HIV-1 reverse transcriptase (RT) underscore the need to identify RT inhibitors with novel binding modes and mechanisms of inhibition. Recently, two structurally distinct inhibitors, phosphonoformic acid (foscarnet) and INDOPY-1 were shown to disrupt the translocational equilibrium of RT during polymerization through trapping of the enzyme in the pre- and the post-translocation states, respectively. Here, we show that foscarnet and INDOPY-1 additionally display a shared novel inhibitory preference with respect to substrate primer identity. In RT-catalyzed reactions using RNA-primed substrates, translocation inhibitors were markedly less potent at blocking DNA polymerization than in equivalent DNA-primed assays; i.e. the inverse pattern observed with marketed non-nucleoside inhibitors that bind the allosteric pocket of RT. This potency profile was shown to correspond with reduced binding on RNA.DNA primer/template substrates versus DNA.DNA substrates. Furthermore, using site-specific footprinting with chimeric RNA.DNA primers, we demonstrate that the negative impact of the RNA primer on translocation inhibitor potency is overcome after 18 deoxyribonucleotide incorporations, where RT transitions primarily into polymerization-competent binding mode. In addition to providing a simple means to identify similarly acting translocation inhibitors, these findings suggest a broader role for the primer-influenced binding mode on RT translocation equilibrium and inhibitor sensitivity.	[Auger, Anick; Zhu, Siqi; Cauchon, Elizabeth; Falgueyret, Jean-Pierre; Melnyk, Roman A.] Merck Frosst Ctr Therapeut Res, Kirkland, PQ H9H 3L1, Canada; [Beilhartz, Greg L.; Ehteshami, Maryam; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Grobler, Jay A.] Merck & Co Inc, West Point, PA 19486 USA	Merck & Company; McGill University; Merck & Company	Melnyk, RA (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	roman.melnyk@sickkids.ca	Melnyk, Roman/GQA-9908-2022		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (to M. G.).	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; ARNOLD E, 1992, NATURE, V357, P85, DOI 10.1038/357085a0; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P24295; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; FU TB, 1992, J VIROL, V66, P4271, DOI 10.1128/JVI.66.7.4271-4278.1992; FURFINE ES, 1991, J BIOL CHEM, V266, P406; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Grobler JA, 2007, J BIOL CHEM, V282, P8005, DOI 10.1074/jbc.M608274200; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Jones FD, 2007, VIROLOGY, V360, P341, DOI 10.1016/j.virol.2006.10.008; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Scarth B, 2011, J MOL BIOL, V405, P349, DOI 10.1016/j.jmb.2010.10.009; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; SMITH JK, 1984, J VIROL, V52, P314, DOI 10.1128/JVI.52.2.314-319.1984; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; WOHRL BM, 1990, BIOCHEMISTRY-US, V29, P10141, DOI 10.1021/bi00496a001; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	32	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29575	29583		10.1074/jbc.M111.268235	http://dx.doi.org/10.1074/jbc.M111.268235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737446	Green Published, hybrid			2022-12-27	WOS:000294046600015
J	Ben-David, O; Pewzner-Jung, Y; Brenner, O; Laviad, EL; Kogot-Levin, A; Weissberg, I; Biton, IE; Pienik, R; Wang, E; Kelly, S; Alroy, J; Raas-Rothschild, A; Friedman, A; Brugger, B; Merrill, AH; Futerman, AH				Ben-David, Oshrit; Pewzner-Jung, Yael; Brenner, Ori; Laviad, Elad L.; Kogot-Levin, Aviram; Weissberg, Itai; Biton, Inbal E.; Pienik, Reut; Wang, Elaine; Kelly, Samuel; Alroy, Joseph; Raas-Rothschild, Annick; Friedman, Alon; Bruegger, Britta; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Encephalopathy Caused by Ablation of Very Long Acyl Chain Ceramide Synthesis May Be Largely Due to Reduced Galactosylceramide Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; SYNTHASE 2; SUBSTRATE-SPECIFICITY; FAMILY-MEMBERS; UDP-GALACTOSE; MYELIN SHEATH; GROWTH-FACTOR; NON-HYDROXY	Sphingolipids (SLs) act as signaling molecules and as structural components in both neuronal cells and myelin. We now characterize the biochemical, histological, and behavioral abnormalities in the brain of a mouse lacking very long acyl (C22-C24) chain SLs. This mouse, which is defective in the ability to synthesize C22-C24-SLs due to ablation of ceramide synthase 2, has reduced levels of galactosylceramide (GalCer), a major component of myelin, and in particular reduced levels of non-hydroxy-C22-C24-GalCer and 2-hydroxy-C22-C24-GalCer. Noteworthy brain lesions develop with a time course consistent with a vital role for C22-C24-GalCer in myelin stability. Myelin degeneration and detachment was observed as was abnormal motor behavior originating from a subcortical region. Additional abnormalities included bilateral and symmetrical vacuolization and gliosis in specific brain areas, which corresponded to some extent to the pattern of ceramide synthase 2 expression, with astrogliosis considerably more pronounced than microglial activation. Unexpectedly, unidentified storage materials were detected in lysosomes of astrocytes, reminiscent of the accumulation that occurs in lysosomal storage disorders. Together, our data demonstrate a key role in the brain for SLs containing very long acyl chains and in particular GalCer with a reduction in their levels leading to distinctive morphological abnormalities in defined brain regions.	[Ben-David, Oshrit; Pewzner-Jung, Yael; Laviad, Elad L.; Pienik, Reut; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Brenner, Ori; Biton, Inbal E.] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Kogot-Levin, Aviram; Raas-Rothschild, Annick] Hadassah Hebrew Univ, Med Ctr, Dept Human Genet & Metab Dis, IL-91120 Jerusalem, Israel; [Weissberg, Itai; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Neurobiol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 01536 USA; [Alroy, Joseph] Tufts Univ, Sch Med, Sch Vet Med, Boston, MA 01536 USA; [Alroy, Joseph] Tufts Med Ctr, Boston, MA 01536 USA; [Bruegger, Britta] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Tufts University; Tufts University; Tufts Medical Center; Ruprecht Karls University Heidelberg	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Pewzner, Faivish/I-6225-2017; Weissberg, Itai/AGU-9930-2022	Pewzner, Faivish/0000-0002-7490-8121; Futerman, Anthony/0000-0003-0013-0115; Weissberg, Itai/0000-0002-5513-1599; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; Merck KGaA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Merck KGaA(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by Israel Science Foundation Grant 1404/07, the Minerva Foundation, and Merck KGaA.	Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Ben-David O, 2010, NEUROMOL MED, V12, P341, DOI 10.1007/s12017-010-8114-x; Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200; Brann AB, 1999, J NEUROSCI, V19, P8199; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; BURCK U, 1985, EUR J PEDIATR, V143, P203, DOI 10.1007/BF00442139; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Dupree JL, 1999, J NEUROCYTOL, V28, P271, DOI 10.1023/A:1007049310758; Dupree JL, 1998, MICROSC RES TECHNIQ, V41, P431, DOI 10.1002/(SICI)1097-0029(19980601)41:5<431::AID-JEMT9>3.0.CO;2-S; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUJIWAKI T, 1995, CLIN CHIM ACTA, V234, P23, DOI 10.1016/0009-8981(94)05970-4; FURUYA S, 1995, J NEUROCHEM, V65, P1551; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Ginzburg L, 2005, J NEUROCHEM, V95, P1619, DOI 10.1111/j.1471-4159.2005.03534.x; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jana A, 2010, NEUROMOL MED, V12, P351, DOI 10.1007/s12017-010-8128-4; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; LEDEEN RW, 1992, TRENDS GLYCOSCI GLYC, V4, P174; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455; Meixner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-22; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Muller G, 2001, VET PATHOL, V38, P281, DOI 10.1354/vp.38-3-281; Muse ED, 2001, J NEUROCHEM, V76, P77, DOI 10.1046/j.1471-4159.2001.00015.x; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; PETUSHKOVA NA, 1992, PRENATAL DIAG, V12, P835, DOI 10.1002/pd.1970121010; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Pitsch J, 2007, NEUROBIOL DIS, V26, P623, DOI 10.1016/j.nbd.2007.03.003; PRENCE EM, 1992, CLIN CHEM, V38, P501; RAUCH HJ, 1983, AM J DERMATOPATH, V5, P263, DOI 10.1097/00000372-198306000-00013; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P348; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; Schwarz A, 1997, J NEUROSCI, V17, P2929; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; STEWART RJ, 1993, BIOCHEMISTRY-US, V32, P10666, DOI 10.1021/bi00091a017; Summers B. A., 1995, VET NEUROPATHOLOGY, P208; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P455; Taniike M, 1998, J NEUROSCI RES, V51, P536, DOI 10.1002/(SICI)1097-4547(19980215)51:4<536::AID-JNR13>3.3.CO;2-F; van der Bijl P, 1996, BIOCHEM J, V317, P589, DOI 10.1042/bj3170589; van Zyl R, 2010, J NEUROCHEM, V112, P282, DOI 10.1111/j.1471-4159.2009.06458.x; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008; Zoller I, 2005, GLIA, V52, P190, DOI 10.1002/glia.20230	65	53	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30022	30033		10.1074/jbc.M111.261206	http://dx.doi.org/10.1074/jbc.M111.261206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705317	hybrid, Green Published			2022-12-27	WOS:000294046600061
J	Beliveau, F; Brule, C; Desilets, A; Zimmerman, B; Laporte, SA; Lavoie, CL; Leduc, R				Beliveau, Francois; Brule, Cedric; Desilets, Antoine; Zimmerman, Brandon; Laporte, Stephane A.; Lavoie, Christine L.; Leduc, Richard			Essential Role of Endocytosis of the Type II Transmembrane Serine Protease TMPRSS6 in Regulating Its Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-DEFICIENCY ANEMIA; CELL-SURFACE; HEPCIDIN EXPRESSION; MATRIPTASE-2; HEMOJUVELIN; ACTIVATION; MUTATIONS; IDENTIFICATION; PHOSPHORYLATION; TRAFFICKING	The type II transmembrane serine protease TMPRSS6 (also known as matriptase-2) controls iron homeostasis through its negative regulation of expression of hepcidin, a key hormone involved in iron metabolism. Upstream of the hepcidin-regulated signaling pathway, TMPRSS6 cleaves its target substrate hemojuvelin (HJV) at the plasma membrane, but the dynamics of the cell-surface expression of the protease have not been addressed. Here, we report that TMPRSS6 undergoes constitutive internalization in transfected HEK293 cells and in two human hepatic cell lines, HepG2 and primary hepatocytes, both of which express TMPRSS6 endogenously. Cell surface-labeled TMPRSS6 was internalized and was detected in clathrin-and AP-2-positive vesicles via a dynamin-dependent pathway. The endocytosed TMPRSS6 next transited in early endosomes and then to lysosomes. Internalization of TMPRSS6 is dependent on specific residues within its N-terminal cytoplasmic domain, as site-directed mutagenesis of these residues abrogated internalization and maintained the enzyme at the cell surface. Cells coexpressing these mutants and HJV produced significantly decreased levels of hepcidin compared with wild-type TMPRSS6 due to the sustained cleavage of HJV at the cell surface by TMPRSS6 mutants. Our results underscore for the first time the importance of TMPRSS6 trafficking at the plasma membrane in the regulation of hepcidin expression, an event that is essential for iron homeostasis.	[Beliveau, Francois; Brule, Cedric; Desilets, Antoine; Lavoie, Christine L.; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Zimmerman, Brandon; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3A 1A1, Canada; [Zimmerman, Brandon; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1A1, Canada	University of Sherbrooke; McGill University; McGill University	Leduc, R (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.	richard.leduc@usherbrooke.ca	Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; Beliveau, Francois/0000-0001-6324-2363; Desilets, Antoine/0000-0001-5081-5564	Canadian Institutes of Health Research; Banting and Best Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (to R. L. and C. L. L.).; Recipient of a Banting and Best Canadian Institutes of Health Research studentship award.	Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodeur J, 2009, TRAFFIC, V10, P1098, DOI 10.1111/j.1600-0854.2009.00933.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Fein E, 2007, PEPTIDES, V28, P951, DOI 10.1016/j.peptides.2007.01.016; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Parr C, 2007, CLIN CANCER RES, V13, P3568, DOI 10.1158/1078-0432.CCR-06-2357; Pierre SV, 2011, AM J PHYSIOL-CELL PH, V300, pC42, DOI 10.1152/ajpcell.00386.2010; Posner BI, 2010, PROG BRAIN RES, V181, P1, DOI 10.1016/S0079-6123(08)81001-1; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramsay AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P569, DOI 10.2741/2702; Ramsay AJ, 2009, HUM MOL GENET, V18, P3673, DOI 10.1093/hmg/ddp315; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Sanders AJ, 2008, J CELL PHYSIOL, V216, P780, DOI 10.1002/jcp.21460; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wickramasinghe RD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-58	38	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29035	29043		10.1074/jbc.M111.223461	http://dx.doi.org/10.1074/jbc.M111.223461			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21724843	Green Published, hybrid			2022-12-27	WOS:000293837000040
J	Terao, M; Ishikawa, A; Nakahara, S; Kimura, A; Kato, A; Moriwaki, K; Kamada, Y; Murota, H; Taniguchi, N; Katayama, I; Miyoshi, E				Terao, Mika; Ishikawa, Akiko; Nakahara, Susumu; Kimura, Akihiro; Kato, Arisa; Moriwaki, Kenta; Kamada, Yoshihiro; Murota, Hiroyuki; Taniguchi, Naoyuki; Katayama, Ichiro; Miyoshi, Eiji			Enhanced Epithelial-Mesenchymal Transition-like Phenotype in N-Acetylglucosaminyltransferase V Transgenic Mouse Skin Promotes Wound Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ASPARAGINE-LINKED OLIGOSACCHARIDES; NECROSIS-FACTOR-ALPHA; KERATINOCYTE MIGRATION; POOR-PROGNOSIS; E-CADHERIN; EXPRESSION; METASTASIS; CANCER; GLYCOSYLATION	N-Acetylglucosaminyltransferase V (GnT-V) catalyzes the beta 1,6 branching of N-acetylglucosamine on N-glycans. GnT-V expression is elevated during malignant transformation in various types of cancer. However, the mechanism by which GnT-V promotes cancer progression is unclear. Tocharacterize the biological significance of GnT-V, we established GnT-V transgenic (Tg) mice, in which GnT-V is regulated by a beta-actin promoter. No spontaneous cancer was detected in any organs of the GnT-V Tg mice. However, GnT-V expression was up-regulated in GnT-V Tg mouse skin, and cultured keratinocytes derived from these mice showed enhanced migration, which was associated with changes in E-cadherin localization and epithelial-mesenchymal transition (EMT). Further, EMT-associated factors snail, twist, and N-cadherin were up-regulated, and cutaneous wound healing was accelerated in vivo. We further investigated the detailed mechanisms of EMT by assessing EGF signaling and found up-regulated EGF receptor signaling in GnT-V Tg mouse keratinocytes. These findings indicate that GnT-V overexpression promotes EMT and keratinocyte migration in part through enhanced EGF receptor signaling.	[Terao, Mika; Ishikawa, Akiko; Kimura, Akihiro; Kato, Arisa; Moriwaki, Kenta; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Terao, Mika; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan; [Nakahara, Susumu; Taniguchi, Naoyuki; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp	Kamada, Yoshihiro/GQA-8854-2022; Kamada, Yoshihiro/AHC-1613-2022; Kamada, Yoshihiro/H-3309-2019; Terao, Mineko/AAA-6415-2020; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Kamada, Yoshihiro/0000-0001-5485-902X; Kamada, Yoshihiro/0000-0001-5485-902X; Terao, Mineko/0000-0002-9976-9869; Taniguchi, Naoyuki/0000-0001-5889-5968; Kimura, Akihiro/0000-0001-5614-8547; Moriwaki, Kenta/0000-0002-8724-4715	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [22791069, 21249038]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Global COE program of Osaka University funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-aid for Young Scientists (B) No. 22791069, and a Grant-in-aid for Scientific Research (A) No. 21249038 from the Japan Society for the Promotion of Science.	CHEN JD, 1995, J INVEST DERMATOL, V104, P729, DOI 10.1111/1523-1747.ep12606970; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1989, CANCER RES, V49, P945; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Dosaka-Akita H, 2004, CLIN CANCER RES, V10, P1773, DOI 10.1158/1078-0432.CCR-1047-3; Freytag J, 2010, J INVEST DERMATOL, V130, P2179, DOI 10.1038/jid.2010.106; Granovsky M, 2000, NAT MED, V6, P306; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Hardwicke J, 2008, SURG-J R COLL SURG E, V6, P172, DOI 10.1016/S1479-666X(08)80114-X; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; Ishimura H, 2006, CLIN CANCER RES, V12, P2506, DOI 10.1158/1078-0432.CCR-05-1938; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; MIYOSHI E, 1993, CANCER RES, V53, P3899; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Murata K, 2000, CLIN CANCER RES, V6, P1772; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; PINHO SS, 2011, CELL MOL LIFE SCI; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; Stoll S, 1997, J CLIN INVEST, V100, P1271, DOI 10.1172/JCI119641; Taniguchi N, 2001, GLYCOCONJUGATE J, V18, P859, DOI 10.1023/A:1022292223878; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wilkins-Port CE, 2007, CELLS TISSUES ORGANS, V185, P116, DOI 10.1159/000101312; Yamamoto E, 2007, BRIT J CANCER, V97, P1538, DOI 10.1038/sj.bjc.6604044; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	45	51	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28303	28311		10.1074/jbc.M111.220376	http://dx.doi.org/10.1074/jbc.M111.220376			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697088	Green Published, hybrid			2022-12-27	WOS:000293557800047
J	Chen, L; Qanie, D; Jafari, A; Taipaleenmaki, H; Jensen, CH; Saamanen, AM; Sanz, MLN; Laborda, J; Abdallah, BM; Kassem, M				Chen, Li; Qanie, Diyako; Jafari, Abbas; Taipaleenmaki, Hanna; Jensen, Charlotte H.; Saamanen, Anna-Marja; Nueda Sanz, Maria Luisa; Laborda, Jorge; Abdallah, Basem M.; Kassem, Moustapha			Delta-like 1/Fetal Antigen-1 (Dlk1/FA1) Is a Novel Regulator of Chondrogenic Cell Differentiation via Inhibition of the Akt Kinase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL UNIPARENTAL DISOMY; FOCAL ADHESION KINASE; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; 1 FA1; GROWTH; PROTEIN; PREF-1; FETAL	Delta-like 1 (Dlk1, also known as fetal antigen-1, FA1) is a member of Notch/Delta family that inhibits adipocyte and osteoblast differentiation; however, its role in chondrogenesis is still not clear. Thus, we overexpressed Dlk1/FA1 in mouse embryonic ATDC5 cells and tested its effects on chondrogenic differentiation. Dlk1/FA1 inhibited insulin-induced chondrogenic differentiation as evidenced by reduction of cartilage nodule formation and gene expression of aggrecan, collagen Type II and X. Similar effects were obtained either by using Dlk1/FA1-conditioned medium or by addition of a purified, secreted, form of Dlk1 (FA1) directly to the induction medium. The inhibitory effects of Dlk1/FA1 were dose-dependent and occurred irrespective of the chondrogenic differentiation stage: proliferation, differentiation, maturation, or hypertrophic conversion. Overexpression or addition of the Dlk1/FA1 protein to the medium strongly inhibited the activation of Akt, but not the ERK1/2, or p38 MAPK pathways, and the inhibition of Akt by Dlk1/FA1 was mediated through PI3K activation. Interestingly, inhibition of fibronectin expression by siRNA rescued the Dlk1/FA1-mediated inhibition of Akt, suggesting interaction of Dlk1/FA1 and fibronectin in chondrogenic cells. Our results identify Dlk1/FA1 as a novel regulator of chondrogenesis and suggest Dlk1/FA1 acts as an inhibitor of the PI3K/Akt pathways that leads to its inhibitory effects on chondrogenesis.	[Chen, Li; Qanie, Diyako; Jafari, Abbas; Abdallah, Basem M.; Kassem, Moustapha] Univ So Denmark, Odense Univ Hosp, Mol Endocrinol Lab, DK-5000 Odense, Denmark; [Taipaleenmaki, Hanna; Saamanen, Anna-Marja] Univ Turku, Dept Med Biochem, FI-20520 Turku, Finland; [Taipaleenmaki, Hanna; Saamanen, Anna-Marja] Univ Turku, Dept Genet, FI-20520 Turku, Finland; [Jensen, Charlotte H.] Univ So Denmark, Dept Immunol, DK-5020 Odense, Denmark; [Nueda Sanz, Maria Luisa; Laborda, Jorge] Univ Castilla La Mancha, Sch Med, Reg Ctr Biomed Res CRIB, Albacete 02006, Spain; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; University of Turku; University of Turku; University of Southern Denmark; Universidad de Castilla-La Mancha; King Saud University	Kassem, M (corresponding author), Kloevervaenget 6,4th Floor, DK-5000 Odense C, Denmark.	mkassem@health.sdu.dk	Chen, Li/AAN-7309-2020; Nueda, María-Luisa/L-3044-2014; Kassem, Moustapha/O-3819-2019; Jafari, Abbas/AAF-6256-2019; Jensen, Charlotte Harken/AAZ-1738-2020; Jafari Kermani, Abbas/I-5074-2015; Jensen, Charlotte Harken/P-4612-2014; Abdallah, Basem/G-5667-2017; Laborda, Jorge/L-5726-2014	Nueda, María-Luisa/0000-0002-5456-5045; Kassem, Moustapha/0000-0003-1557-0869; Jensen, Charlotte Harken/0000-0001-9683-8761; Jafari Kermani, Abbas/0000-0003-2443-6231; Jensen, Charlotte Harken/0000-0001-9683-8761; Abdallah, Basem/0000-0003-0324-8055; Laborda, Jorge/0000-0002-9210-838X; Chen, Li/0000-0001-5561-7612; Saamanen, Anna-Marja/0000-0003-3963-6324; Taipaleenmaki, Hanna/0000-0002-8254-9333	Karen Elise Jensen's Foundation; Novo Nordisk foundation; region of Southern Denmark, Denmark, King Abdulaziz City for Science and Technology [09-BIO740-20]	Karen Elise Jensen's Foundation; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); region of Southern Denmark, Denmark, King Abdulaziz City for Science and Technology	This work was supported by grants from the Karen Elise Jensen's Foundation, The Novo Nordisk foundation, and a local grant from the region of Southern Denmark, Denmark, King Abdulaziz City for Science and Technology (09-BIO740-20), KSA.	Abdallah BM, 2007, ENDOCRINOLOGY, V148, P3111, DOI 10.1210/en.2007-0171; Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Baladron V, 2002, BIOCHEM BIOPH RES CO, V291, P193, DOI 10.1006/bbrc.2002.6431; Berends MJW, 1999, AM J MED GENET, V84, P76, DOI 10.1002/(SICI)1096-8628(19990507)84:1<76::AID-AJMG16>3.0.CO;2-F; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; FAY TN, 1988, EUR J OBSTET GYN R B, V29, P73, DOI 10.1016/0028-2243(88)90167-0; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Harkness L, 2009, STEM CELL REV REP, V5, P353, DOI 10.1007/s12015-009-9099-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hordijk R, 1999, J MED GENET, V36, P782, DOI 10.1136/jmg.36.10.782; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Jensen CH, 1997, CLIN CHIM ACTA, V268, P1, DOI 10.1016/S0009-8981(97)00152-6; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lundholt BK, 2005, J BIOMOL SCREEN, V10, P20, DOI 10.1177/108705710429989; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Smas CM, 1996, INT J OBESITY, V20, pS65; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996; Sul H. S, 2009, MOL CELL BIOL, V23, P1717; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705	47	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32140	32149		10.1074/jbc.M111.230110	http://dx.doi.org/10.1074/jbc.M111.230110			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21724852	Green Published, hybrid			2022-12-27	WOS:000294726800024
J	Lok, CN; Sy, LK; Liu, FL; Che, CM				Lok, Chun-Nam; Sy, Lai-King; Liu, Fuli; Che, Chi-Ming			Activation of Autophagy of Aggregation-prone Ubiquitinated Proteins by Timosaponin A-III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEASOME SYSTEM; MULTIVESICULAR BODIES; CANCER-CELLS; SELECTIVE AUTOPHAGY; MAMMALIAN AUTOPHAGY; K562 CELLS; CALCIUM; DEGRADATION; MTOR	Chemical modulators of autophagy provide useful pharmacological tools for examination of autophagic processes, and also may lead to new therapeutic agents for diseases in which control of cellular sequestration and degradation capacity are beneficial. We have identified that timosaponin A-III (TAIII), a medicinal saponin reported to exhibit anticancer properties and improve brain function, is a pronounced activator of autophagy. In this work, the salient features and functional role of TAIII-induced autophagy were investigated. In TAIII-treated cells, autophagic flux with increased formation of autophagosomes and conversion into autolysosomes is induced in association with inhibition of mammalian target of rapamycin activity and elevation of cytosolic free calcium. The TAIII-induced autophagy is distinct from conventional induction by rapamycin, exhibiting large autophagic vacuoles that appear to contain significant contents of endosomal membranes and multivesicular bodies. Furthermore, TAIII stimulates biosynthesis of cholesterol, which is incorporated to the autophagic vacuole membranes. The TAIII-induced autophagic vacuoles capture ubiquitinated proteins, and in proteasome-inhibited cells TAIII promotes autophagy of aggregation-prone ubiquitinated proteins. Our studies demonstrate that TAIII induced a distinct form of autophagy, and one of its pharmacological actions is likely to enhance the cellular quality control capacity via autophagic clearance of otherwise accumulated ubiquitinated protein aggregates.	[Che, Chi-Ming] Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, State Key Lab Synthet Chem, Dept Chem, Pokfulam, Hong Kong, Peoples R China; Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, Open Lab Chem Biol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Che, CM (corresponding author), Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, State Key Lab Synthet Chem, Dept Chem, Pokfulam, Hong Kong, Peoples R China.	cmche@hku.hk	Che, Chi Ming/D-3055-2009	Che, Chi Ming/0000-0002-2554-7219	Area of Excellence Scheme under University Grants Committee [AoE/P10/01]; Department of Health of Hong Kong Special Administrative Region, People's Republic of China	Area of Excellence Scheme under University Grants Committee; Department of Health of Hong Kong Special Administrative Region, People's Republic of China	This work was supported by Area of Excellence Scheme AoE/P10/01, established under the University Grants Committee and Department of Health of Hong Kong Special Administrative Region, People's Republic of China.	Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; FAWCETT DW, 1981, CELL, P487; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fortun J, 2003, J NEUROSCI, V23, P10672; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014410; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; King FW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007283; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Lee B, 2009, PHARMACOL BIOCHEM BE, V93, P121, DOI 10.1016/j.pbb.2009.04.021; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; LENK SE, 1992, J CELL BIOL, V118, P301, DOI 10.1083/jcb.118.2.301; Li TJ, 2007, NEUROSCI LETT, V421, P147, DOI 10.1016/j.neulet.2007.04.082; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mitra S, 2009, AUTOPHAGY, V5, P1037, DOI 10.4161/auto.5.7.9291; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Salomons FA, 2009, MOL CELL BIOL, V29, P1774, DOI 10.1128/MCB.01485-08; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang GJ, 2002, LIFE SCI, V71, P1081, DOI 10.1016/S0024-3205(02)01794-0; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	64	22	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31684	31696		10.1074/jbc.M110.202531	http://dx.doi.org/10.1074/jbc.M110.202531			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757721	Green Published, hybrid			2022-12-27	WOS:000294487500061
J	Morgan, HP; McNae, IW; Nowicki, MW; Zhong, WH; Michels, PAM; Auld, DS; Fothergill-Gilmore, LA; Walkinshaw, MD				Morgan, Hugh P.; McNae, Iain W.; Nowicki, Matthew W.; Zhong, Wenhe; Michels, Paul A. M.; Auld, Douglas S.; Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.			The Trypanocidal Drug Suramin and Other Trypan Blue Mimetics Are Inhibitors of Pyruvate Kinases and Bind to the Adenosine Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-GRAPHICS; BRUCEI; DISCOVERY; ENZYMES; ANALOGS; GLUCOSE; INVIVO; MODEL	Ehrlich's pioneering chemotherapeutic experiments published in 1904 (Ehrlich, P., and Shiga, K. (1904) Berlin Klin. Wochenschrift 20, 329-362) described the efficacy of a series of dye molecules including trypan blue and trypan red to eliminate trypanosome infections in mice. The molecular structures of the dyes provided a starting point for the synthesis of suramin, which was developed and used as a trypanocidal drug in 1916 and is still in clinical use. Despite the biological importance of these dye-like molecules, the mode of action on trypanosomes has remained elusive. Here we present crystal structures of suramin and three related dyes in complex with pyruvate kinases from Leishmania mexicana or from Trypanosoma cruzi. The phenyl sulfonate groups of all four molecules (suramin, Ponceau S, acid blue 80, and benzothiazole-2,5-disulfonic acid) bind in the position of ADP/ATP at the active sites of the pyruvate kinases (PYKs). The binding positions in the two different trypanosomatid PYKs are nearly identical. We show that suramin competitively inhibits PYKs from humans (muscle, tumor, and liver isoenzymes, K-i = 1.1-17 mu M), T. cruzi (K-i = 108 mu M), and L. mexicana (K-i = 116 mu M), all of which have similar active sites. Synergistic effects were observed when examining suramin inhibition in the presence of an allosteric effector molecule, whereby IC50 values decreased up to 2-fold for both trypanosomatid and human PYKs. These kinetic and structural analyses provide insight into the promiscuous inhibition observed for suramin and into the mode of action of the dye-like molecules used in Ehrlich's original experiments.	[Morgan, Hugh P.; McNae, Iain W.; Nowicki, Matthew W.; Zhong, Wenhe; Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.] Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium; [Auld, Douglas S.] NHGRI, NIH, Chem Genom Ctr, Rockville, MD 20850 USA	University of Edinburgh; Universite Catholique Louvain; Universite Catholique Louvain; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI)	Walkinshaw, MD (corresponding author), Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	m.walkinshaw@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019; Michels, Paul A/A-5637-2009	Michels, Paul A/0000-0003-3726-6104; walkinshaw, malcolm/0000-0001-5955-9325; McNae, Iain/0000-0002-6312-7936	Medical Research Council; European Commission; Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council [G0600014] Funding Source: researchfish; MRC [G0600014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the Medical Research Council and by the European Commission through its International Cooperation with Developing Countries program.; We thank Professor Hee-won Park, Structural Genomics Consortium, University of Toronto, Canada for the gift of human PYK isoenzymes and Dr. J. Dornan for excellent advice and practical help. We also thank the staff at the synchrotron facilities at the European Synchrotron Radiation Facility (ESRF) and Diamond synchrotron radiation facility and also at the National Institutes of Health, Rockville, MD. The Centre for Translational and Chemical Biology and the Edinburgh Protein Production Facility were funded by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council (BBSRC).	AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Avliyakulov NK, 2000, EUR J BIOCHEM, V267, P1723, DOI 10.1046/j.1432-1327.2000.01169.x; Baghdiguian S, 1997, CANCER J - FRANCE, V10, P31; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Braga-Silva LA, 2007, FEMS IMMUNOL MED MIC, V51, P399, DOI 10.1111/j.1574-695X.2007.00321.x; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; De Clercq E, 2009, MED RES REV, V29, P571, DOI 10.1002/med.20149; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; EHRLICH P, 1904, BERLIN KLIN WOCHE 41, V20, P329; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FAIRLAMB AH, 1980, MOL BIOCHEM PARASIT, V1, P315, DOI 10.1016/0166-6851(80)90050-X; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Hannaert V, 2002, FEBS LETT, V514, P255, DOI 10.1016/S0014-5793(02)02374-8; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; Hsin KY, 2011, NUCLEIC ACIDS RES, V39, pD1042, DOI 10.1093/nar/gkq878; Huang SS, 1997, FEBS LETT, V416, P297, DOI 10.1016/S0014-5793(97)01213-1; Jagielski AK, 2006, EUR J PHARMACOL, V537, P205, DOI 10.1016/j.ejphar.2006.03.029; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; KLEINE F. K., 1922, Deutsche Medizinische Wochenschrift, V48, P1693, DOI 10.1055/s-0028-1136308; Klinger M, 1999, MOL PHARMACOL, V55, P462; LAROCCA RV, 1992, ANN ONCOL, V3, P571, DOI 10.1093/oxfordjournals.annonc.a058264; LAROCCA RV, 1990, J STEROID BIOCHEM, V37, P893, DOI 10.1016/0960-0760(90)90439-R; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; MAHONEY CW, 1990, J BIOL CHEM, V265, P5424; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; MISSET O, 1987, EUR J BIOCHEM, V162, P493, DOI 10.1111/j.1432-1033.1987.tb10667.x; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; Morgan HP, 2010, ACTA CRYSTALLOGR F, V66, P215, DOI 10.1107/S1744309109053494; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Pal A, 2002, MOL BIOCHEM PARASIT, V122, P217, DOI 10.1016/S0166-6851(02)00096-8; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; SUBRAMANIAN S, 1984, CRC CR REV BIOCH MOL, V16, P169, DOI 10.3109/10409238409102302; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; VANSCHAFTINGEN E, 1987, EUR J BIOCHEM, V166, P653; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VOOGD TE, 1993, PHARMACOL REV, V45, P177; WILLSON M, 1993, MOL BIOCHEM PARASIT, V59, P201, DOI 10.1016/0166-6851(93)90218-M	51	61	61	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31232	31240		10.1074/jbc.M110.212613	http://dx.doi.org/10.1074/jbc.M110.212613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733839	Green Published, hybrid			2022-12-27	WOS:000294487500018
J	Seidman, JS; Janssen, BD; Hayes, CS				Seidman, Jason S.; Janssen, Brian D.; Hayes, Christopher S.			Alternative Fates of Paused Ribosomes during Translation Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER RNA; ESCHERICHIA-COLI; PROTEIN L9; TRYPTOPHAN INDUCTION; AMINO-ACID; TRANS-TRANSLATION; OPERON EXPRESSION; NASCENT PEPTIDE; BINDING PROTEIN; TAGGING SYSTEM	The bacterial tmRNA.SmpB system facilitates recycling of stalled translational complexes in a process termed "ribosome rescue." During ribosome rescue, the nascent chain is tagged with the tmRNA-encoded ssrA peptide, which targets the tagged polypeptide for degradation. Translational pausing also induces a variety of recoding events such as frameshifts, ribosome hops, and stop codon readthrough. To examine the interplay between recoding and ribosome rescue, we determined the various fates of ribosomes that pause during translation termination. We expressed a model protein containing the C-terminal Asp-Pro nascent peptide motif (which interferes with translation termination) and quantified the protein chains produced by recoding and ssrA-peptide tagging. The nature and extent of translational recoding depended upon the codon for the C-terminal Pro residue, with CCU and CCC promoting efficient +1 frameshifting. In contrast, ssrA-peptide tagging was unaffected by C-terminal Pro coding. Moreover, +1 frameshifting was not suppressed by tmRNA.SmpB activity, suggesting that recoding and ribosome rescue are not competing events. However, cells lacking ribosomal protein L9 (Delta L9) exhibited a significant increase in recoding and a concomitant decrease in ssrA-peptide tagging. Pulse-chase analysis revealed that pre-termination ribosomes turn over more rapidly in Delta L9 cells, suggesting that increased recoding alleviates the translational arrest. Together, these results indicate that tmRNA.SmpB does not suppress transient ribosome pauses, but responds to prolonged translational arrest.	[Seidman, Jason S.; Janssen, Brian D.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Life Sci Technol Bldg,Room 3105, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu			National Institutes of Health [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health through Grant GM078634.	Adamski FM, 1996, J MOL BIOL, V261, P357, DOI 10.1006/jmbi.1996.0469; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Bjornsson A, 1996, NUCLEIC ACIDS RES, V24, P1753, DOI 10.1093/nar/24.9.1753; Bjornsson A, 1996, EMBO J, V15, P1696, DOI 10.1002/j.1460-2075.1996.tb00515.x; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Gong M, 2007, J BACTERIOL, V189, P3147, DOI 10.1128/JB.01868-06; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; Gurvich OL, 2011, NUCLEIC ACIDS RES, V39, P3079, DOI 10.1093/nar/gkq1272; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; HERBST KL, 1994, P NATL ACAD SCI USA, V91, P12525, DOI 10.1073/pnas.91.26.12525; Herr AJ, 2000, EMBO J, V19, P2671, DOI 10.1093/emboj/19.11.2671; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; HOFFMAN DW, 1994, EMBO J, V13, P205, DOI 10.1002/j.1460-2075.1994.tb06250.x; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Leipuviene R, 2007, J BACTERIOL, V189, P7024, DOI 10.1128/JB.00710-07; Lieberman KR, 2000, J MOL BIOL, V297, P1129, DOI 10.1006/jmbi.2000.3621; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Ruhe ZC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015207; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Trimble MJ, 2004, RNA, V10, P805, DOI 10.1261/rna.7010904	45	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31105	31112		10.1074/jbc.M111.268201	http://dx.doi.org/10.1074/jbc.M111.268201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757758	Green Published, hybrid			2022-12-27	WOS:000294487500005
J	Stark, BC; Wen, KK; Allingham, JS; Rubenstein, PA; Lord, M				Stark, Benjamin C.; Wen, Kuo-Kuang; Allingham, John S.; Rubenstein, Peter A.; Lord, Matthew			Functional Adaptation between Yeast Actin and Its Cognate Myosin Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; HEAVY-CHAIN; ACTOMYOSIN INTERACTIONS; DICTYOSTELIUM ACTIN; PROTEIN-STRUCTURE; CONTRACTILE RING; BUDDING YEAST; LIGHT-CHAIN; N-TERMINUS	We employed budding yeast and skeletal muscle actin to examine the contribution of the actin isoform to myosin motor function. While yeast and muscle actin are highly homologous, they exhibit different charge density at their N termini (a proposed myosin-binding interface). Muscle myosin-II actin-activated ATPase activity is significantly higher with muscle versus yeast actin. Whether this reflects inefficiency in the ability of yeast actin to activate myosin is not known. Here we optimized the isolation of two yeast myosins to assess actin function in a homogenous system. Yeast myosin-II (Myo1p) and myosin-V (Myo2p) accommodate the reduced N-terminal charge density of yeast actin, showing greater activity with yeast over muscle actin. Increasing the number of negative charges at the N terminus of yeast actin from two to four (as in muscle) had little effect on yeast myosin activity, while other substitutions of charged residues at the myosin interface of yeast actin reduced activity. Thus, yeast actin functions most effectively with its native myosins, which in part relies on associations mediated by its outer domain. Compared with yeast myosin-II and myosin-V, muscle myosin-II activity was very sensitive to salt. Collectively, our findings suggest differing degrees of reliance on electrostatic interactions during weak actomyosin binding in yeast versus muscle. Our study also highlights the importance of native actin isoforms when considering the function of myosins.	[Stark, Benjamin C.; Lord, Matthew] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Wen, Kuo-Kuang; Rubenstein, Peter A.] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Allingham, John S.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	University of Vermont; University of Iowa; Queens University - Canada	Lord, M (corresponding author), 149 Beaumont Ave,HSRF 108, Burlington, VT 05405 USA.	matthew.lord@uvm.edu	Stark, Benjamin/E-6095-2010; Allingham, John/AAW-9262-2020	Stark, Benjamin/0000-0002-1799-5361; Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; University of Vermont; American Heart Association [0835236N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Vermont; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 (to P. A. R.) and by a New Research Initiative Award (University of Vermont) and a Scientist Development Grant (0835236N) from the American Heart Association (to M. L.).	Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; BERTRAND R, 1988, BIOCHEMISTRY-US, V27, P5728, DOI 10.1021/bi00415a050; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1993, J BIOL CHEM, V268, P2410; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; DASGUPTA G, 1989, J MOL BIOL, V207, P833, DOI 10.1016/0022-2836(89)90249-0; DASGUPTA G, 1992, BIOCHEMISTRY-US, V31, P1836, DOI 10.1021/bi00121a036; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Fang XD, 2010, J CELL BIOL, V191, P1333, DOI 10.1083/jcb.201005134; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huckaba TM, 2006, J CELL BIOL, V175, P957, DOI 10.1083/jcb.200609155; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KARLSSON R, 1991, MOL CELL BIOL, V11, P213, DOI 10.1128/MCB.11.1.213; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lord M, 2008, P NATL ACAD SCI USA, V105, P8014, DOI 10.1073/pnas.0802874105; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MILLER CJ, 1995, BIOCHEMISTRY-US, V34, P2694, DOI 10.1021/bi00008a037; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rose MD., 1990, METHODS YEAST GENETI; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sellers J. R., 1999, MYOSINS; Sladewski TE, 2009, MOL BIOL CELL, V20, P3941, DOI 10.1091/mbc.E09-04-0346; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P4800, DOI 10.1021/bi00262a043; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; WATTS FZ, 1987, EMBO J, V6, P3499, DOI 10.1002/j.1460-2075.1987.tb02675.x; WATTS FZ, 1985, NATURE, V316, P83, DOI 10.1038/316083a0	50	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30384	30392		10.1074/jbc.M111.262899	http://dx.doi.org/10.1074/jbc.M111.262899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757693	hybrid, Green Published			2022-12-27	WOS:000294283600016
J	Van Rechem, C; Black, JC; Abbas, T; Allen, A; Rinehart, CA; Yuan, GC; Dutta, A; Whetstine, JR				Van Rechem, Capucine; Black, Joshua C.; Abbas, Tarek; Allen, Andrew; Rinehart, Claire A.; Yuan, Guo-Cheng; Dutta, Anindya; Whetstine, Johnathan R.			The SKP1-Cul1-F-box and Leucine-rich Repeat Protein 4 (SCF-FbxL4) Ubiquitin Ligase Regulates Lysine Demethylase 4A (KDM4A)/Jumonji Domain-containing 2A (JMJD2A) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN-CELLS; HISTONE METHYLTRANSFERASE; DYNAMIC REGULATION; GENE-EXPRESSION; S PHASE; DEGRADATION; REPLICATION; CHROMATIN; PR-SET7	Chromatin-modifying enzymes play a fundamental role in regulating chromatin structure so that DNA replication is spatially and temporally coordinated. For example, the lysine demethylase 4A/Jumonji domain-containing2A(KDM4A/JMJD2A) is tightly regulated during the cell cycle. Overexpression of JMJD2A leads to altered replication timing and faster S phase progression. In this study, we demonstrate that degradation of JMJD2A is regulated by the proteasome. JMJD2A turnover is coordinated through the SKP1-Cul1-F-box ubiquitin ligase complex that contains cullin 1 and the F-box and leucine-rich repeat protein 4 (FbxL4). This complex interacted with JMJD2A. Ubiquitin overexpression restored turnover and blocked the JMJD2A-dependent faster S phase progression in a cullin 1-dependent manner. Furthermore, increased ubiquitin levels decreased JMJD2A occupancy and BrdU incorporation at target sites. This study highlights a finely tuned mechanism for regulating histone demethylase levels and emphasizes the need to tightly regulate chromatin modifiers so that the cell cycle occurs properly.	[Van Rechem, Capucine; Black, Joshua C.; Allen, Andrew; Whetstine, Johnathan R.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Van Rechem, Capucine; Black, Joshua C.; Allen, Andrew; Whetstine, Johnathan R.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Abbas, Tarek; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rinehart, Claire A.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; University of Virginia; Western Kentucky University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Whetstine, JR (corresponding author), Harvard Univ, Sch Med, Dept Med, Bldg 149,13th St,Rm 7-213, Charlestown, MA 02129 USA.	jwhetstine@hms.harvard.edu	Black, Joshua/Q-2484-2015; Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Black, Joshua/0000-0002-2491-8815; Van Rechem, Capucine/0000-0002-5408-6124	Ellison Medical Foundation [CA059267]; National Institutes of Health [R01CA60499, R01HG005085]; Jane Coffin Childs Memorial Fund for Medical Research; NCI National Institutes of Health [KCA140774A]; NATIONAL CANCER INSTITUTE [K99CA140774, R01CA060499, R00CA140774, C06CA059267] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by the Ellison Medical Foundation, Howard Goodman Fellowship, and Grant CA059267 (to J. R. W.). This work was also supported by National Institutes of Health Grants R01CA60499 (to A. D.) and R01HG005085 (to G. C. Y.). This work has also been aided by grants from The Jane Coffin Childs Memorial Fund for Medical Research (to J. C. B.) and from NCI National Institutes of Health Grant KCA140774A (to T. A.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Mendez J, 2009, CRIT REV BIOCHEM MOL, V44, P343, DOI 10.1080/10409230903232618; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867	35	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30462	30470		10.1074/jbc.M111.273508	http://dx.doi.org/10.1074/jbc.M111.273508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757720	hybrid, Green Published			2022-12-27	WOS:000294283600025
J	Zhang, YX; Bonzo, JA; Gonzalez, FJ; Wang, L				Zhang, Yuxia; Bonzo, Jessica A.; Gonzalez, Frank J.; Wang, Li			Diurnal Regulation of the Early Growth Response 1 (Egr-1) Protein Expression by Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) and Small Heterodimer Partner (SHP) Cross-talk in Liver Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID BIOSYNTHESIS; RECEPTOR-SHP; GENE-EXPRESSION; TARGET GENES; INJURY; CELLS; IDENTIFICATION; STIMULATION; FIBROBLASTS; METABOLISM	Early growth response 1 (Egr-1) protein is a critical regulator of genes contributing to liver fibrosis; however, little is known about the upstream transcriptional factors that control its expression. Here we show that Egr-1 expression is tightly regulated by nuclear receptor signaling. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) activated the Egr-1 promoter through three DR1 response elements as identified by trans-activation assays. Deletion of these response elements or knockdown of HNF4 alpha using siRNA largely abrogated Egr-1 promoter activation. HNF4 alpha activity, as well as its enrichment on the Egr-1 promoter, were markedly repressed by small heterodimer partner (SHP) co-expression. Egr-1 mRNA and protein were transiently induced by HNF4 alpha. On the contrary, HNF4 alpha siRNA reduced Egr-1 expression at both the mRNA and protein levels, and overexpression of SHP reversed these effects. Conversely, knockdown of SHP by siRNA elevated Egr-1 protein. Interestingly, Egr-1 mRNA exhibited diurnal fluctuation, which was synchronized to the cyclic expression of SHP and HNF4 alpha after cells were released from serum shock. Unexpectedly, the levels of Egr-1 mRNA and protein were highly up-regulated in Hnf4 alpha(-/-) mice. Both HNF4 alpha and Egr-1 expression were dramatically increased in SHP-/- mice with bile duct ligation and in human cirrhotic livers, which was inversely correlated with diminished SHP expression. In conclusion, our study revealed control network for Egr-1 expression through a feedback loop between SHP and HNF4 alpha.	[Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA; [Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Bonzo, Jessica A.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, L (corresponding author), 30 North 1900 East,SOM 3C310, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu		Bonzo, Jessica/0000-0003-2403-9981	National Institutes of Health [DK080440, N01-DK-7-0004/HHSN267200700004C]; Multidisciplinary Cancer Research Training Program [T32CA092347]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multidisciplinary Cancer Research Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080440 (to L. W.).; Supported by Multidisciplinary Cancer Research Training Program Grant T32CA092347.; We thank Dr. Scott Friedman for the LX2 cells and Drs. Frances Sladek and Akiyoshi Fukamizu for the HNF4 alpha constructs. Normal human liver and cirrhotic liver specimens were obtained through the Liver Tissue Cell Distribution System (Minneapolis, MN), which is funded by National Institutes of Health Contract N01-DK-7-0004/HHSN267200700004C.	ALLEN K, TOXICOL APPL PHARM, V243, P63; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brady LM, 1996, BIOCHEM J, V316, P765, DOI 10.1042/bj3160765; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; DeLigio JT, 2009, CANCER BIOL THER, V8, P1889, DOI 10.4161/cbt.8.20.9804; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Humphries A, 2004, BIOCHEM BIOPH RES CO, V320, P551, DOI 10.1016/j.bbrc.2004.06.006; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; Nakamura H, 2002, GENE THER, V9, P495, DOI 10.1038/sj.gt.3301681; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Tabbi-Anneni I, 2010, AM J PHYSIOL-ENDOC M, V298, pE961, DOI 10.1152/ajpendo.00655.2009; Tan FK, 2005, ARTHRITIS RHEUM-US, V52, P865, DOI 10.1002/art.20871; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yasuoka H, 2009, AM J PATHOL, V175, P605, DOI 10.2353/ajpath.2009.080991; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	40	27	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29635	29643		10.1074/jbc.M111.253039	http://dx.doi.org/10.1074/jbc.M111.253039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21725089	Green Published, hybrid			2022-12-27	WOS:000294046600022
J	Kim, B; Huang, G; Ho, WB; Greenspan, DS				Kim, Byoungjae; Huang, Guorui; Ho, Wen-Bin; Greenspan, Daniel S.			Bone Morphogenetic Protein-1 Processes Insulin-like Growth Factor-binding Protein 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; BREAST-CANCER CELLS; MESSENGER-RNAS; FUNCTIONALLY REDUNDANT; CELLULAR-LOCALIZATION; FIBROBLAST-GROWTH; DORSOVENTRAL AXIS; GENE-EXPRESSION; FACTORS IGFS; TGF-BETA	The bone morphogenetic protein-1 (BMP1)-like metalloproteinases play key roles in extracellular matrix formation, by converting precursors into mature functional proteins involved in forming the extracellular matrix. The BMP1-like proteinases also play roles in activating growth factors, such as BMP2/4, myostatin, growth differentiation factor 11, and transforming growth factor beta 1, by cleaving extracellular antagonists. The extracellular insulin-like growth factor-binding proteins (IGFBPs) are involved in regulating the effects of insulin-like growth factors (IGFs) on growth, development, and metabolism. Of the six IGFBPs, IGFBP3 has the greatest interaction with the large pool of circulating IGFs. It is also produced locally in tissues and is itself regulated by proteolytic processing. Here, we show that BMP1 cleaves human and mouse IGFBP3 at a single conserved site, resulting in markedly reduced ability of cleaved IGFBP3 to bind IGF-I or to block IGF-I-induced cell signaling. In contrast, such cleavage is shown to result in enhanced IGF-I-independent ability of cleaved IGFBP3 to block FGF-induced proliferation and to induce Smad phosphorylation. Consistent with in vivo roles for such cleavage, it is shown that, whereas wild type mouse embryo fibroblasts (MEFs) produce cleaved IGFBP3, MEFs doubly null for the Bmp1 gene and for the Tll1 gene, which encodes the related metalloproteinase mammalian Tolloid-like 1 (mTLL1), produce only unprocessed IGFBP3, thus demonstrating endogenous BMP1-related proteinases to be responsible for IGFBP3-processing activity in MEFs. Similarly, in zebrafish embryos, overexpression of Bmp1a is shown to reverse an Igfbp3-induced phenotype, consistent with the ability of BMP1-like proteinases to cleave IGFBP3 in vivo.	[Kim, Byoungjae; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Kim, Byoungjae; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Ho, Wen-Bin] FibroGen Inc, San Francisco, CA 94158 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; FibroGen	Greenspan, DS (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, 600 Highland Ave, Madison, WI 53792 USA.	dsgreens@wisc.edu	Huang, Guorui/M-9641-2013	Greenspan, Daniel/0000-0001-8096-7446	National Institutes of Health [AR53815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053815, R01AR047746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR53815 (to D. S. G.).	BATEMAN JF, 1986, J BIOL CHEM, V261, P4198; Beattie J, 2009, BIOCHEM BIOPH RES CO, V381, P572, DOI 10.1016/j.bbrc.2009.02.088; BLAT C, 1994, EXP CELL RES, V215, P114, DOI 10.1006/excr.1994.1322; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Braulke T, 1996, GROWTH REGULAT, V6, P55; CERRO JA, 1993, REGUL PEPTIDES, V48, P189, DOI 10.1016/0167-0115(93)90347-B; Chau P, 2007, BIOCHEMISTRY-US, V46, P8445, DOI 10.1021/bi700028u; Chen JY, 2004, MAR BIOTECHNOL, V6, P1, DOI 10.1007/s10126-002-0115-9; Coverley JA, 1997, MOL CELL ENDOCRINOL, V128, P1, DOI 10.1016/S0303-7207(97)04032-X; Coverley JA, 2000, ENDOCRINOLOGY, V141, P564, DOI 10.1210/en.141.2.564; de los Rios P, 1999, CAN J PHYSIOL PHARM, V77, P235, DOI 10.1139/cjpp-77-4-235; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Fanayan S, 2000, J BIOL CHEM, V275, P39146, DOI 10.1074/jbc.M006964200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Grgurevic L, 2011, J AM SOC NEPHROL, V22, P681, DOI 10.1681/ASN.2010070722; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; Han VKM, 1996, HORM RES, V45, P160, DOI 10.1159/000184780; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jasuja R, 2006, MECH DEVELOP, V123, P548, DOI 10.1016/j.mod.2006.05.004; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee CI, 2001, PEDIATR RES, V49, P379, DOI 10.1203/00006450-200103000-00012; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li Y, 2005, J BIOL CHEM, V280, P3613, DOI 10.1074/jbc.M411479200; LindenberghKortleve DJ, 1997, MOL CELL ENDOCRINOL, V132, P81, DOI 10.1016/S0303-7207(97)00123-8; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Mochizuki S, 2004, BIOCHEM BIOPH RES CO, V315, P79, DOI 10.1016/j.bbrc.2004.01.022; Mullins MC, 1996, DEVELOPMENT, V123, P81; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; RetschBogart GZ, 1996, AM J RESP CELL MOL, V14, P61, DOI 10.1165/ajrcmb.14.1.8534487; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Xu QJ, 2004, J BIOL CHEM, V279, P4269, DOI 10.1074/jbc.M311586200; Zadeh SM, 1997, ENDOCRINOLOGY, V138, P3069, DOI 10.1210/en.138.7.3069	54	19	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29014	29025		10.1074/jbc.M111.252585	http://dx.doi.org/10.1074/jbc.M111.252585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697095	hybrid, Green Published			2022-12-27	WOS:000293837000038
J	Mendez, M; Gross, KW; Glenn, ST; Garvin, JL; Carretero, OA				Mendez, Mariela; Gross, Kenneth W.; Glenn, Sean T.; Garvin, Jeffrey L.; Carretero, Oscar A.			Vesicle-associated Membrane Protein-2 (VAMP2) Mediates cAMP-stimulated Renin Release in Mouse Juxtaglomerular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; COLLECTING DUCT CELLS; IN-VITRO; TETANUS TOXIN; RAT-KIDNEY; REGULATED EXOCYTOSIS; GLUT4 TRAFFICKING; ADENYLYL-CYCLASE; SNARE COMPLEX; MACULA DENSA	Renin is essential for blood pressure control. Renin is stored in granules in juxtaglomerular (JG) cells, located in the pole of the renal afferent arterioles. The second messenger cAMP stimulates renin release. However, it is unclear whether fusion and exocytosis of renin-containing granules is involved. In addition, the role of the fusion proteins, SNAREs (soluble N-ethylmaleimide-sensitive factor attachment proteins), in renin release from JG cells has not been studied. The vesicle SNARE proteins VAMP2 (vesicle associated membrane protein 2) and VAMP3 mediate cAMP-stimulated exocytosis in other endocrine cells. Thus, we hypothesized that VAMP2 and/or -3 mediate cAMP-stimulated renin release from JG cells. By fluorescence-activated cell sorting, we isolated JG cells expressing green fluorescent protein and compared the relative abundance of VAMP2/3 in JG cells versus total mouse kidney mRNA by quantitative PCR. We found that VAMP2 and VAMP3 mRNA are expressed and enriched in JG cells. Confocal imaging of primary cultures of JG cells showed that VAMP2 (but not VAMP3) co-localized with renin-containing granules. Cleavage of VAMP2 and VAMP3 with tetanus toxin blocked cAMP-stimulated renin release from JG cells by similar to 50% and impaired cAMP-stimulated exocytosis by similar to 50%, as monitored with FM1-43. Then we specifically knocked down VAMP2 or VAMP3 by adenoviral-mediated delivery of short hairpin silencing RNA. We found that silencing VAMP2 blocked cAMP-induced renin release by similar to 50%. In contrast, silencing VAMP3 had no effect on basal or cAMP-stimulated renin release. We conclude that VAMP2 and VAMP3 are expressed in JG cells, but only VAMP2 is targeted to renin-containing granules and mediates the stimulatory effect of cAMP on renin exocytosis.	[Mendez, Mariela; Garvin, Jeffrey L.; Carretero, Oscar A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Garvin, Jeffrey L.] Wayne State Univ, Dept Physiol, Detroit, MI 48201 USA; [Gross, Kenneth W.; Glenn, Sean T.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Roswell Park Cancer Institute	Mendez, M (corresponding author), 2799 W Grand Blvd,E&R 7063, Detroit, MI 48202 USA.	mmendez1@hfhs.org	Mendez, Mariela/D-7033-2019	Mendez, Mariela/0000-0002-2537-7272	National Institutes of Health, National Research Service [F32 HL096346-01, 5R01HL48459-17]; National Kidney Foundation; NCI, National Institutes of Health [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048459, F32HL096346] Funding Source: NIH RePORTER	National Institutes of Health, National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant National Research Service Awards F32 HL096346-01 (to M. M.) and 5R01HL48459-17 (to K. W. G.). This work also supported by a National Kidney Foundation fellowship grant.; We thank Craig Jones, MaryKay Ellsworth, and the Flow and Image Cytometry Resource at Roswell Park Cancer Institute, which is supported by NCI, National Institutes of Health-funded Cancer Center Support Grant CA016056. We also thank Dr. Pablo Ortiz for reading of the manuscript and suggestions.	Alexander EA, 1997, AM J PHYSIOL-RENAL, V273, pF1054, DOI 10.1152/ajprenal.1997.273.6.F1054; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Beierwaltes WH, 2010, AM J PHYSIOL-RENAL, V298, pF1, DOI 10.1152/ajprenal.00143.2009; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Cabaniols JP, 1999, MOL BIOL CELL, V10, P4033, DOI 10.1091/mbc.10.12.4033; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Chieregatti E, 2004, MOL BIOL CELL, V15, P1918, DOI 10.1091/mbc.E03-09-0684; CHU WN, 1990, MOL ENDOCRINOL, V4, P1905, DOI 10.1210/mend-4-12-1905; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cosen-Binker LI, 2008, WORLD J GASTROENTERO, V14, P2314, DOI 10.3748/wjg.14.2314; DEJONG W, 1969, P SOC EXP BIOL MED, V130, P85; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Friis UG, 1999, CIRC RES, V84, P929; Fujita-Yoshigaki J, 1998, EUR J MORPHOL, V36, P46; FujitaYoshigaki J, 1996, J BIOL CHEM, V271, P13130, DOI 10.1074/jbc.271.22.13130; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GENEST J, 1973, CAN MED ASSOC J, V109, P475; Gil C, 2005, BIOCHEM BIOPH RES CO, V329, P117, DOI 10.1016/j.bbrc.2005.01.111; Glenn ST, 2008, PHYSIOL GENOMICS, V35, P243, DOI 10.1152/physiolgenomics.00017.2008; Gomez RA, 1997, MICROSC RES TECHNIQ, V39, P254, DOI 10.1002/(SICI)1097-0029(19971101)39:3<254::AID-JEMT5>3.0.CO;2-K; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; HACKENTHAL E, 1983, CLIN EXP HYPERTENS A, V5, P975, DOI 10.3109/10641968309048836; HACKENTHAL E, 1986, MOL CELL ENDOCRINOL, V47, P1, DOI 10.1016/0303-7207(86)90010-9; Hajduch E, 1997, BIOCHEM J, V321, P233, DOI 10.1042/bj3210233; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Huang XH, 2001, PANCREAS, V23, P125, DOI 10.1097/00006676-200108000-00002; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Inoue T, 1998, AM J PHYSIOL-RENAL, V275, pF752, DOI 10.1152/ajprenal.1998.275.5.F752; ITOH S, 1985, KIDNEY INT, V27, P762, DOI 10.1038/ki.1985.77; ITOH S, 1985, HYPERTENSION, V7, pI49, DOI 10.1161/01.HYP.7.3_Pt_2.I49; ITOH S, 1985, J CLIN INVEST, V76, P1412, DOI 10.1172/JCI112118; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jensen BL, 1996, AM J PHYSIOL-RENAL, V271, pF659, DOI 10.1152/ajprenal.1996.271.3.F659; JO IH, 1995, P NATL ACAD SCI USA, V92, P1876, DOI 10.1073/pnas.92.6.1876; Jutras I, 1999, FEBS LETT, V443, P48, DOI 10.1016/S0014-5793(98)01672-X; Kurtz A., 1991, CELL PHYSIOL BIOCHEM, V1, P98, DOI 10.1159/000154598; Lacombe MJ, 2005, J BIOL CHEM, V280, P4803, DOI 10.1074/jbc.M408658200; LARAGH JH, 1975, JOHNS HOPKINS MED J, V137, P184; Li GM, 2003, J BIOL CHEM, V278, P19791, DOI 10.1074/jbc.M212250200; Lopez MLSS, 2003, METH MOLEC MED, V86, P193; Lopez MLSS, 2004, DEV CELL, V6, P719; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Mandon B, 1997, AM J PHYSIOL-RENAL, V273, pF718, DOI 10.1152/ajprenal.1997.273.5.F718; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MATSUDA M, 1994, ANN NY ACAD SCI, V710, P94, DOI 10.1111/j.1749-6632.1994.tb26617.x; Methot D, 2001, Curr Hypertens Rep, V3, P68, DOI 10.1007/s11906-001-0083-x; NIELSEN S, 1995, J CLIN INVEST, V96, P1834, DOI 10.1172/JCI118229; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P162, DOI 10.1161/01.HYP.0000250708.04205.d4; PARK CS, 1978, AM J PHYSIOL, V234, pF506, DOI 10.1152/ajprenal.1978.234.6.F506; Pellizzari R, 1998, TOXICOL LETT, V103, P191, DOI 10.1016/S0378-4274(98)00306-3; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Peti-Peterdi J, 2004, AM J PHYSIOL-RENAL, V287, pF329, DOI 10.1152/ajprenal.00420.2003; Reudelhuber TL, 1998, ADV EXP MED BIOL, V436, P229; REUDELHUBER TL, 1994, KIDNEY INT, V46, P1522, DOI 10.1038/ki.1994.435; SCHRICKER K, 1995, AM J PHYSIOL-RENAL, V269, pF64, DOI 10.1152/ajprenal.1995.269.1.F64; Sterling H, 2003, AM J PHYSIOL-RENAL, V284, pF510, DOI 10.1152/ajprenal.00309.2002; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; TAUGNER R, 1984, CELL TISSUE RES, V237, P459; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Verderio C, 1999, J NEUROCHEM, V73, P372, DOI 10.1046/j.1471-4159.1999.0730372.x; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449	76	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28608	28618		10.1074/jbc.M111.225839	http://dx.doi.org/10.1074/jbc.M111.225839			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21708949	hybrid, Green Published			2022-12-27	WOS:000293557800075
J	Remen, KMR; Henning, P; Lerner, UH; Gustafsson, JA; Andersson, G				Remen, Kirsten M. Robertson; Henning, Petra; Lerner, Ulf H.; Gustafsson, Jan-Ake; Andersson, Goran			Activation of Liver X Receptor (LXR) Inhibits Receptor Activator of Nuclear Factor kappa B Ligand (RANKL)-induced Osteoclast Differentiation in an LXR beta-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; RESISTANT ACID-PHOSPHATASE; COLLAGEN-INDUCED ARTHRITIS; T-CELLS C1; GENE-EXPRESSION; BONE-RESORPTION; CATHEPSIN-K; DC-STAMP; TERMINAL DIFFERENTIATION; DEFICIENT MICE	Bone destruction is the major pathological process in many bone metabolic diseases and is a result of increased osteoclast formation and bone resorption. The liver X receptors (alpha, beta), important regulators of cholesterol metabolism and inflammatory signaling, have recently been observed to play a role in both physiological and pathological bone turnover. However, the relationship between liver X receptors (LXR) and osteoclast differentiation/formation remains unknown. Here, we report that the LXR ligand GW3965 is able to clearly and potently inhibit the formation of mature osteoclasts from receptor activator of nuclear factor kappa B ligand (RANKL)-stimulated human and murine osteoclast precursors. This results in a significant inhibition of bone resorption. We observed that GW3965 significantly inhibited expression of the osteoclast markers tartrate-resistant acid phosphatase, cathepsin K, osteoclast-associated receptor (OSCAR), and calcitonin receptor, appearing to act in an NFATc1/p38/microphthalmia-associated transcription factor (MITF)-dependent mechanism, independently of receptor activator of nuclear factor kappa B or c-Fos and not directly involving the NF kappa B pathways. GW3965 was less effective in RAW264.7 monocyte/macrophage cells, which are more committed into the osteoclast lineage. Also, GW3965 seemed to act differently depending on the source of the progenitor cells as it had no effect on calvarial osteoclasts, compared with marrow or blood-derived monocytes. As these effects were abolished in osteoclast precursors derived from LXR beta(-/-) mice, we suggest that GW3965 acts via an LXR beta-dependent mechanism. Taken together, our results suggest that the LXR can act as an important inhibitor of RANKL-mediated osteoclast differentiation.	[Remen, Kirsten M. Robertson; Gustafsson, Jan-Ake] Karolinska Inst, Novum, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Henning, Petra; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, S-41345 Gothenburg, Sweden; [Lerner, Ulf H.] Umea Univ, S-90187 Umea, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Andersson, Goran] Karolinska Univ Hosp, Karolinska Inst, Div Pathol, Dept Lab Med, S-14186 Huddinge, Sweden	Karolinska Institutet; University of Gothenburg; Umea University; University of Houston System; University of Houston; Karolinska Institutet; Karolinska University Hospital	Remen, KMR (corresponding author), Karolinska Inst, Novum, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.	kirsten.remen@ki.se		Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council [K209-52X-10363-17-3, 2006-17820-42007-12]; Robert A. Welch Foundation; Karolinska Institute Foundation for Geriatric Diseases; Karolinska Institute Research Foundation; Apotekare Hedbergs Fund for Medical Research; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V	Swedish Research Council(Swedish Research CouncilEuropean Commission); Robert A. Welch Foundation(The Welch Foundation); Karolinska Institute Foundation for Geriatric Diseases; Karolinska Institute Research Foundation(Karolinska Institutet); Apotekare Hedbergs Fund for Medical Research; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V	This work was supported by the Swedish Research Council Grants K209-52X-10363-17-3 and 2006-17820-42007-12, the Robert A. Welch Foundation, the Karolinska Institute Foundation for Geriatric Diseases, the Karolinska Institute Research Foundation, the Apotekare Hedbergs Fund for Medical Research, the Swedish Rheumatism Association, and the Royal 80 Year Fund of King Gustav V.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bandyopadhyay S, 2006, BIOCHEM PHARMACOL, V72, P184, DOI 10.1016/j.bcp.2006.04.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chintalacharuvu SR, 2007, ARTHRITIS RHEUM, V56, P1365, DOI 10.1002/art.22528; Conaway H. H., 2011, J BIOL CHEM     0629, DOI [10.1074/jbc.M111247734, DOI 10.1074/JBC.M111247734]; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Everts V, 2009, BBA-MOL BASIS DIS, V1792, P757, DOI 10.1016/j.bbadis.2009.05.004; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kawase Y, 2003, J BONE MINER RES, V18, P975, DOI 10.1359/jbmr.2003.18.6.975; Kim JH, 2008, J MOL BIOL, V383, P502, DOI 10.1016/j.jmb.2008.08.036; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Kinser S, 2005, J NUTR BIOCHEM, V16, P88, DOI 10.1016/j.jnutbio.2004.10.003; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lerner UH, 1997, ACTA PHYSIOL SCAND, V161, P81, DOI 10.1046/j.1365-201X.1997.d01-1933.x; LERNER UH, 1987, J BONE MINER RES, V2, P375; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Liu Y, 2003, J BIOL CHEM, V278, P20603, DOI 10.1074/jbc.M212093200; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Lu SY, 2010, MOL BIOL CELL, V21, P1763, DOI 10.1091/mbc.E09-07-0584; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P304; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128; Prawitt J, 2011, BONE, V48, P339, DOI 10.1016/j.bone.2010.08.018; Robertson KM, 2006, J BONE MINER RES, V21, P1276, DOI 10.1359/JBMR.060503; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Schuster GU, 2002, CIRCULATION, V106, P1147, DOI 10.1161/01.CIR.0000026802.79202.96; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Treuter E, 2007, MOL CELL, V25, P178, DOI 10.1016/j.molcel.2007.01.009; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaza T, 1998, BONE, V23, P499, DOI 10.1016/S8756-3282(98)00138-0; Zenger S, 2010, BIOCHEM BIOPH RES CO, V394, P743, DOI 10.1016/j.bbrc.2010.03.063	59	36	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33084	33094		10.1074/jbc.M111.235937	http://dx.doi.org/10.1074/jbc.M111.235937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784849	hybrid, Green Published			2022-12-27	WOS:000294968800027
J	Lonetti, A; Szijgyarto, Z; Bosch, D; Loss, O; Azevedo, C; Saiardi, A				Lonetti, Annalisa; Szijgyarto, Zsolt; Bosch, Daniel; Loss, Omar; Azevedo, Cristina; Saiardi, Adolfo			Identification of an Evolutionarily Conserved Family of Inorganic Polyphosphate Endopolyphosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL HEXAKISPHOSPHATE KINASE; YEAST SACCHAROMYCES-CEREVISIAE; DIPHOSPHOINOSITOL POLYPHOSPHATES; BUDDING YEAST; PYROPHOSPHATES; METABOLISM; SURVIVAL; CELLS; GENE; PHOSPHOHYDROLASE	Inorganic polyphosphate (poly-P) consists of just a chain of phosphate groups linked by high energy bonds. It is found in every organism and is implicated in a wide variety of cellular processes (e.g. phosphate storage, blood coagulation, and pathogenicity). Its metabolism has been studied mainly in bacteria while remaining largely uncharacterized in eukaryotes. It has recently been suggested that poly-P metabolism is connected to that of highly phosphorylated inositol species (inositol pyrophosphates). Inositol pyrophosphates are molecules in which phosphate groups outnumber carbon atoms. Like poly-P they contain high energy bonds and play important roles in cell signaling. Here, we show that budding yeast mutants unable to produce inositol pyrophosphates have undetectable levels of poly-P. Our results suggest a prominent metabolic parallel between these two highly phosphorylated molecules. More importantly, we demonstrate that DDP1, encoding diadenosine and diphosphoinositol phosphohydrolase, possesses a robust poly-P endopolyphosphohydrolase activity. In addition, we prove that this is an evolutionarily conserved feature because mammalian Nudix hydrolase family members, the three Ddp1 homologues in human cells (DIPP1, DIPP2, and DIPP3), are also capable of degrading poly-P.	[Saiardi, Adolfo] UCL, Dept Cell & Dev Biol, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Cell & Dev Biol, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Saiardi, A (corresponding author), UCL, Dept Cell & Dev Biol, MRC, Cell Biol Unit, Gower St, London WC1E 6BT, England.	dmcbado@ucl.ac.uk	Lonetti, Annalisa/AAB-3647-2019; Azevedo, Cristina/Y-4296-2019	Lonetti, Annalisa/0000-0002-3944-3090; Azevedo, Cristina/0000-0002-6997-1265	Medical Research Council; Human Frontier Science Program [RGP0048/2009-C]; Medical Research Council [MC_U122680443] Funding Source: researchfish; MRC [MC_U122680443] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council funding to the Cell Biology Unit and by Human Frontier Science Program Grant RGP0048/2009-C.	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Azevedo C, 2010, METHODS MOL BIOL, V645, P73, DOI 10.1007/978-1-60327-175-2_5; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; CAMESELLE JC, 1982, BIOCHEM J, V201, P405, DOI 10.1042/bj2010405; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Fisher DI, 2002, J BIOL CHEM, V277, P47313, DOI 10.1074/jbc.M209795200; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gomez-Garcia MR, 2004, P NATL ACAD SCI USA, V101, P15876, DOI 10.1073/pnas.0406923101; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulaev I. S., 2004, BIOCH INORGANIC POLY, P15; Kulaev IS, 2000, BIOCHEMISTRY-MOSCOW+, V65, P271; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lichko LP, 2008, BIOCHEMISTRY-MOSCOW+, V73, P985, DOI 10.1134/S0006297908090046; Lichko LP, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1404, DOI 10.1134/S0006297910110131; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Loss O., 2011, J VIS EXP IN PRESS; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Norbis F, 1997, J MEMBRANE BIOL, V156, P19, DOI 10.1007/s002329900183; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; Shi XB, 2005, FEBS LETT, V579, P2014, DOI 10.1016/j.febslet.2005.02.032; Trilisenko LV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P577, DOI 10.1023/A:1023963927976; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104	54	133	144	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31966	31974		10.1074/jbc.M111.266320	http://dx.doi.org/10.1074/jbc.M111.266320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775424	hybrid, Green Published			2022-12-27	WOS:000294726800005
J	Ahn, SY; Jamshidi, N; Mo, ML; Wu, W; Eraly, SA; Dnyanmote, A; Bush, KT; Gallegos, TF; Sweet, DH; Palsson, BO; Nigam, SK				Ahn, Sun-Young; Jamshidi, Neema; Mo, Monica L.; Wu, Wei; Eraly, Satish A.; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Sweet, Douglas H.; Palsson, Bernhard O.; Nigam, Sanjay K.			Linkage of Organic Anion Transporter-1 to Metabolic Pathways through Integrated "Omics"-driven Network and Functional Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; MOLECULAR PHYSIOLOGY; ESCHERICHIA-COLI; OLFACTORY MUCOSA; URATE TRANSPORT; URIC-ACID; KIDNEY; CELLS; OAT1; RAT	The main kidney transporter of many commonly prescribed drugs (e. g. penicillins, diuretics, antivirals, methotrexate, and non-steroidal anti-inflammatory drugs) is organic anion transporter-1 (OAT1), originally identified as NKT (Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) J. Biol. Chem. 272, 6471-6478). Targeted metabolomics in knockouts have shown that OAT1 mediates the secretion or reabsorption of many important metabolites, including intermediates in carbohydrate, fatty acid, and amino acid metabolism. This observation raises the possibility that OAT1 helps regulate broader metabolic activities. We therefore examined the potential roles of OAT1 in metabolic pathways using Recon 1, a functionally tested genome-scale reconstruction of human metabolism. A computational approach was used to analyze in vivo metabolomic as well as transcriptomic data from wild-type and OAT1 knock-out animals, resulting in the implication of several metabolic pathways, including the citric acid cycle, polyamine, and fatty acid metabolism. Validation by in vitro and ex vivo analysis using Xenopus oocyte, cell culture, and kidney tissue assays demonstrated interactions between OAT1 and key intermediates in these metabolic pathways, including previously unknown substrates, such as polyamines (e. g. spermine and spermidine). A genome-scale metabolic network reconstruction generated some experimentally supported predictions for metabolic pathways linked to OAT1-related transport. The data support the possibility that the SLC22 and other families of transporters, known to be expressed in many tissues and primarily known for drug and toxin clearance, are integral to a number of endogenous pathways and may be involved in a larger remote sensing and signaling system (Ahn, S. Y., and Nigam, S. K. (2009) Mol. Pharmacol. 76, 481-490, and Wu, W., Dnyanmote, A. V., and Nigam, S. K.(2011) Mol. Pharmacol. 79, 795-805). Drugs may alter metabolism by competing for OAT1 binding of metabolites.	[Wu, Wei; Eraly, Satish A.; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, La Jolla, CA 92093 USA; [Ahn, Sun-Young; Wu, Wei; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jamshidi, Neema; Mo, Monica L.; Palsson, Bernhard O.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wu, Wei; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sweet, Douglas H.] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA 23298 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Virginia Commonwealth University	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu	Sweet, Douglas H/H-7914-2013	Sweet, Douglas H/0000-0002-8911-9184; Palsson, Bernhard/0000-0003-2357-6785; Jamshidi, Neema/0000-0003-3857-9735; Ahn, Sun-Young/0000-0001-5571-6901	National Institutes of Health [3RO1GM088824, 5RO1DK079784, R01HL094728]; Society of Toxicology; Colgate Palmolive Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Toxicology; Colgate Palmolive Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 3RO1GM088824 and 5RO1DK079784 (to S. K. N.) and R01HL094728 (to S. A. E.).; Supported by a postdoctoral fellowship sponsored by the Society of Toxicology and Colgate Palmolive Inc.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Beery E, 2003, ENDOCRINOLOGY, V144, P4519, DOI 10.1210/en.2002-221001; BRENNER BM, 2004, BRENNER RECTORS KIDN, P231; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Enomoto A, 2007, THER APHER DIAL, V11, pS27, DOI 10.1111/j.1744-9987.2007.00515.x; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, PHYSIOL GENOMICS, V18, P12, DOI 10.1152/physiolgenomics.00014.2004; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Hasegawa M, 2003, J PHARMACOL EXP THER, V305, P1087, DOI 10.1124/jpet.102.046847; Ichida K, 2003, KIDNEY INT, V63, P143, DOI 10.1046/j.1523-1755.2003.00710.x; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; KETTELER M, 1994, AM J PHYSIOL, V267, pF197, DOI 10.1152/ajprenal.1994.267.2.F197; Kumar VS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000308; Levillain O, 2004, AM J PHYSIOL-RENAL, V286, pF727, DOI 10.1152/ajprenal.00315.2003; Levillain O, 1998, AM J PHYSIOL-RENAL, V274, pF1020, DOI 10.1152/ajprenal.1998.274.6.F1020; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Mount DB, 2005, CURR OPIN NEPHROL HY, V14, P460, DOI 10.1097/01.mnh.0000170749.10785.04; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2007, NAT CLIN PRACT NEPHR, V3, P443, DOI 10.1038/ncpneph0558; Nii-Kono T, 2007, KIDNEY INT, V71, P738, DOI 10.1038/sj.ki.5002097; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Sato M, 2008, PHARM RES-DORDR, V25, P639, DOI 10.1007/s11095-007-9401-6; SILVA P, 1990, SEMIN NEPHROL, V10, P432; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; Sugiyama D, 2001, J PHARMACOL EXP THER, V298, P316; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; Wang J., 2006, P 1 WORKSH LARG SCAL, P169; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; You GF, 2002, MED RES REV, V22, P602, DOI 10.1002/med.10019; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006	50	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31522	31531		10.1074/jbc.M111.272534	http://dx.doi.org/10.1074/jbc.M111.272534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757732	Green Published, hybrid			2022-12-27	WOS:000294487500047
J	Isogai, S; Morimoto, D; Arita, K; Unzai, S; Tenno, T; Hasegawa, J; Sou, Y; Komatsu, M; Tanaka, K; Shirakawa, M; Tochio, H				Isogai, Shin; Morimoto, Daichi; Arita, Kyohei; Unzai, Satoru; Tenno, Takeshi; Hasegawa, Jun; Sou, Yu-shin; Komatsu, Masaaki; Tanaka, Keiji; Shirakawa, Masahiro; Tochio, Hidehito			Crystal Structure of the Ubiquitin-associated (UBA) Domain of p62 and Its Interaction with Ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; SELECTIVE AUTOPHAGY; RECOGNITION; SOFTWARE; PROTEINS; DEGRADATION; P62/SQSTM1; MECHANISM; DIMERIZATION; REFINEMENT	p62/SQSTM1/A170 is a multimodular protein that is found in ubiquitin-positive inclusions associated with neurodegenerative diseases. Recent findings indicate that p62 mediates the interaction between ubiquitinated proteins and autophagosomes, leading these proteins to be degraded via the autophagy-lysosomal pathway. This ubiquitin-mediated selective autophagy is thought to begin with recognition of the ubiquitinated proteins by the C-terminal ubiquitin-associated (UBA) domain of p62. We present here the crystal structure of the UBA domain of mouse p62 and the solution structure of its ubiquitin-bound form. The p62 UBA domain adopts a novel dimeric structure in crystals, which is distinctive from those of other UBA domains. NMR analyses reveal that in solution the domain exists in equilibrium between the dimer and monomer forms, and binding ubiquitin shifts the equilibrium toward the monomer to form a 1: 1 complex between the UBA domain and ubiquitin. The dimer-to-monomer transition is associated with a structural change of the very C-terminal end of the p62 UBA domain, although the UBA fold itself is essentially maintained. Our data illustrate that dimerization and ubiquitin binding of the p62 UBA domain are incompatible with each other. These observations reveal an autoinhibitory mechanism in the p62 UBA domain and suggest that autoinhibition plays a role in the function of p62.	[Isogai, Shin; Morimoto, Daichi; Arita, Kyohei; Shirakawa, Masahiro; Tochio, Hidehito] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan; [Tenno, Takeshi] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Unzai, Satoru] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hasegawa, Jun; Sou, Yu-shin; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan	Kyoto University; Kobe University; Yokohama City University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp; tochio@moleng.kyoto-u.ac.jp	Arita, Kyohei/AAJ-6402-2020; Komatsu, Masaaki/B-8321-2011; Tochio, Hidehito/F-6109-2011; Tochio, Hidehito/GWV-0429-2022	Arita, Kyohei/0000-0002-9762-8405; Komatsu, Masaaki/0000-0001-7672-7722; Tochio, Hidehito/0000-0003-3843-3330; Morimoto, Daichi/0000-0002-7672-2136; Sou, Yu-shin/0000-0002-7219-9106; Isogai, Shin/0000-0002-3768-6427	Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [22113511] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research and the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, and Culture of Japan.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Rochus K., 2004, COMPUTER AIDED RESON; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	42	85	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31864	31874		10.1074/jbc.M111.259630	http://dx.doi.org/10.1074/jbc.M111.259630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21715324	Green Published, hybrid			2022-12-27	WOS:000294487500079
J	Lubkowska, L; Maharjan, AS; Komissarova, N				Lubkowska, Lucyna; Maharjan, Anu S.; Komissarova, Natalia			RNA Folding in Transcription Elongation Complex IMPLICATION FOR TRANSCRIPTION TERMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ESCHERICHIA-COLI; NASCENT RNA; DNA HYBRID; IN-VIVO; TRANSLATIONAL CONTROL; SECONDARY STRUCTURE; STEM-LOOP; 3 END; POLYMERASE	Intrinsic transcription termination signal in DNA consists of a short inverted repeat followed by a T-rich stretch. Transcription of this sequence by RNA polymerase (RNAP) results in formation of a "termination hairpin" (TH) in the nascent RNA and in rapid dissociation of the transcription elongation complex (EC) at termination points located 7-8 nt downstream of the base of TH stem. RNAP envelops 15 nt of the RNA following RNA growing 3'-end, suggesting that folding of the TH is impeded by a tight protein environment when RNAP reaches the termination points. To monitor TH folding under this constraint, we halted Escherichia coli ECs at various distances downstream from a TH and treated them with single-strand specific RNase T1. The EC interfered with TH formation when halted at 6, 7, and 8, but not 9, nt downstream from the base of the potential stem. Thus, immediately before termination, the downstream arm of the TH is protected from complementary interactions with the upstream arm. This protection makes TH folding extremely sensitive to the sequence context, because the upstream arm easily engages in competing interactions with the rest of the nascent RNA. We demonstrate that by de-synchronizing TH formation and transcription of the termination points, this subtle competition significantly affects the efficiency of transcription termination. This finding can explain previous puzzling observations that sequences far upstream of the TH or point mutations in the terminator that preserve TH stability affect termination. These results can help understand other time sensitive co-transcriptional processes in pro- and eukaryotes.	[Lubkowska, Lucyna; Komissarova, Natalia] NCI, Ctr Canc Res, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Maharjan, Anu S.; Komissarova, Natalia] NICHD, Program Genom & Differentiat, NIH, Bethesda, MD 20892 USA; [Maharjan, Anu S.] Smith Coll, Northampton, MA 01063 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Smith College	Komissarova, N (corresponding author), NCI, 37 Convent Dr, Bethesda, MD 20892 USA.	komissar@mail.nih.gov			National Cancer Institute, Center for Cancer Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Balzer M, 1998, J MOL BIOL, V276, P547, DOI 10.1006/jmbi.1997.1556; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besancon W, 1999, NUCLEIC ACIDS RES, V27, P4353, DOI 10.1093/nar/27.22.4353; Breaker RR, 2009, FUTURE MICROBIOL, V4, P771, DOI 10.2217/FMB.09.46; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CESARENI G, 1985, TRENDS BIOCHEM SCI, V10, P303, DOI 10.1016/0968-0004(85)90168-9; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; CHAO MY, 1995, NUCLEIC ACIDS RES, V23, P1691, DOI 10.1093/nar/23.10.1691; CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Geissmann T, 2009, RNA BIOL, V6, P153, DOI 10.4161/rna.6.2.8047; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GOLIGER JA, 1989, J MOL BIOL, V205, P331, DOI 10.1016/0022-2836(89)90344-6; GROENEVELD H, 1995, RNA, V1, P79; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Kashlev M, 2002, J BIOL CHEM, V277, P14501, DOI 10.1074/jbc.M200215200; King RA, 1996, CELL, V87, P893, DOI 10.1016/S0092-8674(00)81996-0; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KROGER M, 1982, GENE, V20, P25, DOI 10.1016/0378-1119(82)90084-1; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; LEWICKI BTU, 1993, J MOL BIOL, V231, P581, DOI 10.1006/jmbi.1993.1311; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Potrykus K, 2010, NUCLEIC ACIDS RES, V38, P1636, DOI 10.1093/nar/gkp1150; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Spirin Alexander S, 2004, RNA Biol, V1, P3; TELESNITSKY APW, 1989, J MOL BIOL, V205, P315, DOI 10.1016/0022-2836(89)90343-4; TOMIZAWA J, 1982, CELL, V31, P575, DOI 10.1016/0092-8674(82)90313-0; Toulme F, 2005, J MOL BIOL, V351, P39, DOI 10.1016/j.jmb.2005.05.052; VONHIPPEL PH, 1987, ESCHERICHIA COLI SAL; Wee KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001844; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Woodson SA, 2000, CELL MOL LIFE SCI, V57, P796, DOI 10.1007/s000180050042; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31576	31585		10.1074/jbc.M111.249359	http://dx.doi.org/10.1074/jbc.M111.249359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21730066	Green Published, hybrid			2022-12-27	WOS:000294487500052
J	Vilcaes, AA; Demichelis, VT; Daniotti, JL				Vilcaes, Aldo A.; Torres Demichelis, Vanina; Daniotti, Jose L.			Trans-activity of Plasma Membrane-associated Ganglioside Sialyltransferase in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; GOLGI-COMPLEX; GD3 SYNTHASE; MEDIATED APOPTOSIS; BREFELDIN-A; GROWTH; GLYCOSPHINGOLIPIDS; EXPRESSION; PROTEIN; PHOSPHORYLATION	Gangliosides are acidic glycosphingolipids that contain sialic acid residues and are expressed in nearly all vertebrate cells. They are synthesized at the Golgi complex by a combination of glycosyltransferase activities followed by vesicular delivery to the plasma membrane, where they participate in a variety of physiological as well as pathological processes. Recently, a number of enzymes of ganglioside anabolism and catabolism have been shown to be associated with the plasma membrane. In particular, it was observed that CMP-NeuAc:GM3 sialyltransferase (Sial-T2) is able to sialylate GM3 at the plasma membrane (cis-catalytic activity). In this work, we demonstrated that plasma membrane-integrated ecto-Sial-T2 also displays a trans-catalytic activity at the cell surface of epithelial and melanoma cells. By using a highly sensitive enzyme-linked immunosorbent assay combined with confocal fluorescence microscopy, we observed that ecto-Sial-T2 was able to sialylate hydrophobically or covalently immobilized GM3 onto a solid surface. More interestingly, we observed that ecto-Sial-T2 was able to sialylate GM3 exposed on the membrane of neighboring cells by using both the exogenous and endogenous donor substrate (CMP-N-acetylneuraminic acid) available at the extracellular milieu. In addition, the trans-activity of ecto-Sial-T2 was considerably reduced when the expression of the acceptor substrate was inhibited by using a specific inhibitor of biosynthesis of glycolipids, indicating the lipidic nature of the acceptor. Our findings provide the first direct evidence that an ecto-sialyltransferase is able to trans-sialylate substrates exposed in the plasma membrane from mammalian cells, which represents a novel insight into the molecular events that regulate the local glycosphingolipid composition.	[Vilcaes, Aldo A.; Torres Demichelis, Vanina; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC UNC CONICET, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC UNC CONICET, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar			Secretaria de Ciencia y Tecnologia (SECyT); Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina; CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by grants from Secretaria de Ciencia y Tecnologia (SECyT), Universidad Nacional de Cordoba (UNC), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina.; A recipient of CONICET (Argentina) fellowship.	Colell A, 2002, FEBS LETT, V526, P135, DOI 10.1016/S0014-5793(02)03140-X; Crespo PM, 2010, J BIOL CHEM, V285, P29179, DOI 10.1074/jbc.M110.123422; Crespo PM, 2004, J BIOL CHEM, V279, P47610, DOI 10.1074/jbc.M407181200; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; DANIOTTI JL, 1992, J NEUROCHEM, V59, P107, DOI 10.1111/j.1471-4159.1992.tb08881.x; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Handa Y, 2005, PAIN, V117, P271, DOI 10.1016/j.pain.2005.06.016; HARAGUCHI M, 1995, BIOCHEM J, V312, P273, DOI 10.1042/bj3120273; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kim JK, 2010, J KOREAN MED SCI, V25, P1492, DOI 10.3346/jkms.2010.25.10.1492; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; KOPITZ J, 1994, BIOCHEM BIOPH RES CO, V199, P1188, DOI 10.1006/bbrc.1994.1356; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; Maccioni HJF, 2007, J NEUROCHEM, V103, P81, DOI 10.1111/j.1471-4159.2007.04717.x; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; MILJAN EA, 2002, SCI STKE, pRE15; Ohkawa Y, 2008, BIOCHEM BIOPH RES CO, V373, P14, DOI 10.1016/j.bbrc.2008.05.149; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Prinetti A, 2007, J NEUROCHEM, V103, P113, DOI 10.1111/j.1471-4159.2007.04714.x; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; Sonnino S, 2010, FEBS LETT, V584, P1914, DOI 10.1016/j.febslet.2009.11.020; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Tajima O, 2010, BEHAV BRAIN RES, V206, P101, DOI 10.1016/j.bbr.2009.09.005; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Yuyama K, 2011, J NEUROCHEM, V116, P845, DOI 10.1111/j.1471-4159.2010.07071.x; Zurita AR, 2001, BIOCHEM J, V355, P465, DOI 10.1042/0264-6021:3550465	39	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31437	31446		10.1074/jbc.M111.257196	http://dx.doi.org/10.1074/jbc.M111.257196			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768099	Green Published, hybrid			2022-12-27	WOS:000294487500038
J	Chowdhury, S; Howell, GM; Teggart, CA; Chowdhury, A; Person, JJ; Bowers, DM; Brattain, MG				Chowdhury, Sanjib; Howell, Gillian M.; Teggart, Carol A.; Chowdhury, Aparajita; Person, Jonathan J.; Bowers, Dawn M.; Brattain, Michael G.			Histone Deacetylase Inhibitor Belinostat Represses Survivin Expression through Reactivation of Transforming Growth Factor beta ( TGF beta) Receptor II Leading to Cancer Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; DEPENDENT PROTEIN-KINASE; PANCREATIC-CANCER; INDUCED APOPTOSIS; TRANSCRIPTIONAL REPRESSION; PROTEASOME FUNCTION; COLORECTAL-CANCER; EPIGENETIC EVENTS; PROSTATE-CANCER; DOWN-REGULATION	Survivin is a cancer-associated gene that functions to promote cell survival, cell division, and angiogenesis and is a marker of poor prognosis. Histone deacetylase inhibitors induce apoptosis and re-expression of epigenetically silenced tumor suppressor genes in cancer cells. In association with increased expression of the tumor suppressor gene transforming growth factor beta receptor II (TGF beta RII) induced by the histone deacetylase inhibitor belinostat, we observed repressed survivin expression. We investigated the molecular mechanisms involved in survivin down-regulation by belinostat downstream of reactivation of TGF beta signaling. We identified two mechanisms. At early time points, survivin protein half-life was decreased with its proteasomal degradation. We observed that belinostat activated protein kinase A at early time points in a TGF beta signaling-dependent mechanism. After longer times (48 h), survivin mRNA was also decreased by belinostat. We made the novel observation that belinostat mediated cell death through the TGF beta/protein kinase A signaling pathway. Induction of TGF beta RII with concomitant survivin repression may represent a significant mechanism in the anticancer effects of this drug. Therefore, patient populations exhibiting high survivin expression with epigenetically silenced TGF beta RII might potentially benefit from the use of this histone deacetylase inhibitor.	[Chowdhury, Sanjib; Howell, Gillian M.; Teggart, Carol A.; Chowdhury, Aparajita; Person, Jonathan J.; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Bowers, Dawn M.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Brattain, MG (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	mbrattain@unmc.edu			National Institutes of Health [CA72001, CA38173]; NATIONAL CANCER INSTITUTE [R37CA038173, R01CA038173, R01CA072001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA72001 and CA38173 (to M.G.B.).	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P32854, DOI 10.1074/jbc.M103951200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P3348, DOI 10.1074/jbc.M002462200; Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Chiou SK, 2007, BIOCHEM PHARMACOL, V74, P1485, DOI 10.1016/j.bcp.2007.07.024; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Fandy TE, 2005, NEOPLASIA, V7, P646, DOI 10.1593/neo.04655; Fotheringham S, 2009, CANCER CELL, V15, P57, DOI 10.1016/j.ccr.2008.12.001; Gobbi H, 2000, HISTOPATHOLOGY, V36, P168; Grady WM, 2005, BIOCHEM SOC T, V33, P684, DOI 10.1042/BST0330684; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Heider U, 2008, EUR J HAEMATOL, V80, P133, DOI 10.1111/j.1600-0609.2007.00995.x; Hitomi T, 2003, FEBS LETT, V554, P347, DOI 10.1016/S0014-5793(03)01186-4; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Jiang SJ, 2007, GYNECOL ONCOL, V105, P493, DOI 10.1016/j.ygyno.2007.01.012; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kang SH, 1999, ONCOGENE, V18, P7280, DOI 10.1038/sj.onc.1203146; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G; Lehmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-395; Li FZ, 2005, ONCOGENE, V24, P1385, DOI 10.1038/sj.onc.1208330; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; Matsushita M, 1999, BRIT J CANCER, V80, P194, DOI 10.1038/sj.bjc.6690339; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Monks A, 2009, ANTI-CANCER DRUG, V20, P682, DOI 10.1097/CAD.0b013e32832e14e1; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Okabe S, 2007, STEM CELLS DEV, V16, P503, DOI 10.1089/scd.2007.9994; Osada H, 2001, CANCER RES, V61, P8331; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; PEREIRA ME, 1990, ARCH BIOCHEM BIOPHYS, V283, P68, DOI 10.1016/0003-9861(90)90613-4; Periyasamy S, 2000, ONCOGENE, V19, P4660, DOI 10.1038/sj.onc.1203822; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Taghiyev AF, 2006, CANCER BIOL THER, V5, P1199, DOI 10.4161/cbt.5.9.3168; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Ye SC, 1999, CANCER RES, V59, P4725; Zhang FX, 2007, PHYSIOLOGY, V22, P373, DOI 10.1152/physiol.00026.2007; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhao J, 2000, J CELL SCI, V113, P4363; Zhou YF, 2005, CANCER RES, V65, P5848, DOI 10.1158/0008-5472.CAN-04-3509; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	63	28	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30937	30948		10.1074/jbc.M110.212035	http://dx.doi.org/10.1074/jbc.M110.212035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757750	Green Published, hybrid			2022-12-27	WOS:000294283600072
J	Goncalves, AMD; de Sanctis, D; McSweeney, SM				Goncalves, Ana Maria D.; de Sanctis, Daniele; McSweeney, Sean M.			Structural and Functional Insights into DR2231 Protein, the MazG-like Nucleoside Triphosphate Pyrophosphohydrolase from Deinococcus radiodurans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NUCLEIC-ACIDS; RADIATION; DUTPASE; PYROPHOSPHATASE; PERSPECTIVE; MECHANISM; DEATH; ASSAY	Deinococcus radiodurans is among the very few bacterial species extremely resistant to ionizing radiation, UV light, oxidizing agents, and cycles of prolonged desiccation. The proteome of D. radiodurans reflects the evolutionary pressure exerted by chronic exposure to (nonradioactive) forms of DNA and protein damage. A clear example of this adaptation is the overrepresentation of protein families involved in the removal of non-canonical nucleoside triphosphates (NTPs) whose incorporation into nascent DNA would promote mutagenesis and DNA damage. The three-dimensional structure of the DR2231 protein has been solved at 1.80A resolution. This protein had been classified as an all-alpha-helical MazG-like protein. The present study confirms that it holds the basic structural module characteristic of the MazG superfamily; two helices form a rigid domain, and two helices form a mobile domain and connecting loops. Contrary to what is known of MazG proteins, DR2231 protein shows a functional affinity with dUTPases. Enzymatic and isothermal calorimetry assays have demonstrated high specificity toward dUTP but an inability to hydrolyze dTTP, a typical feature of dUTPases. Co-crystallization with the product of hydrolysis, dUMP, in the presence of magnesium or manganese cations, suggests similarities with the dUTP/dUDP hydrolysis mechanism reported for dimeric dUTPases. The genome of D. radiodurans encodes for all enzymes required for dTTP synthesis from dCMP, thus bypassing the need of a dUTPase. We postulate that DR2231 protein is not essential to D. radiodurans and rather performs "house-cleaning" functions within the framework of oxidative stress response. We further propose DR2231 protein as an evolutionary precursor of dimeric dUTPases.	[Goncalves, Ana Maria D.; de Sanctis, Daniele; McSweeney, Sean M.] European Synchrotron Radiat Facil, Macromol Crystallog Grp, F-38043 Grenoble, France	European Synchrotron Radiation Facility (ESRF)	de Sanctis, D (corresponding author), European Synchrotron Radiat Facil, Macromol Crystallog Grp, Rue Jules Horowitz 6, F-38043 Grenoble, France.	daniele.de_sanctis@esrf.fr; seanmcs@esrf.fr	Domingues Gonçalves, Ana Maria/D-4542-2012	Domingues Gonçalves, Ana Maria/0000-0002-8714-8934	"Fundacao para a Ciencia e Tecnologia," Portugal [SFRH/BEST/15939/2005]; ESRF Structural Biology group at the ESRF beamlines	"Fundacao para a Ciencia e Tecnologia," Portugal(Portuguese Foundation for Science and Technology); ESRF Structural Biology group at the ESRF beamlines	Supported by "Fundacao para a Ciencia e Tecnologia," Portugal, Research Grant SFRH/BEST/15939/2005.; We acknowledge the High Throughput Crystallization (HTX) Laboratory (EMBL Grenoble, France) for access to the Cartesian PixSys and the support provided by the ESRF Structural Biology group at the ESRF beamlines and in the laboratory housed in the Carl-Ivar Branden building.	ALBAKRI GH, 1985, GENE, V33, P305, DOI 10.1016/0378-1119(85)90238-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bernier-Villamor V, 2002, FEBS LETT, V526, P147, DOI 10.1016/S0014-5793(02)03158-7; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; Koonin EV, 2000, BACTERIAL STRESS RESPONSES, P417; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova KS, 2000, GENETICA, V108, P25, DOI 10.1023/A:1004035424657; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moroz OV, 2004, J MOL BIOL, V342, P1583, DOI 10.1016/j.jmb.2004.07.050; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musso-Buendia JA, 2009, J ENZYM INHIB MED CH, V24, P111, DOI 10.1080/14756360801915476 ; Nyman PO, 2001, CURR PROTEIN PEPT SC, V2, P277, DOI 10.2174/1389203013381071; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Quesada-Soriano I, 2008, BBA-PROTEINS PROTEOM, V1784, P1347, DOI 10.1016/j.bbapap.2008.05.014; Ranatunga W, 2004, J MOL BIOL, V339, P103, DOI 10.1016/j.jmb.2004.01.065; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Tellez-Sanz R, 2007, BIOCHIMIE, V89, P972, DOI 10.1016/j.biochi.2007.03.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zhang JJ, 2003, J BIOL CHEM, V278, P21408, DOI 10.1074/jbc.M213294200	58	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30691	30705		10.1074/jbc.M111.247999	http://dx.doi.org/10.1074/jbc.M111.247999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733847	Green Published, hybrid			2022-12-27	WOS:000294283600049
J	Purushothaman, A; Hurst, DR; Pisano, C; Mizumoto, S; Sugahara, K; Sanderson, RD				Purushothaman, Anurag; Hurst, Douglas R.; Pisano, Claudio; Mizumoto, Shuji; Sugahara, Kazuyuki; Sanderson, Ralph D.			Heparanase-mediated Loss of Nuclear Syndecan-1 Enhances Histone Acetyltransferase (HAT) Activity to Promote Expression of Genes That Drive an Aggressive Tumor Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I ACTIVITY; FIBROBLAST-GROWTH-FACTOR; MULTIPLE-MYELOMA; SULFATE PROTEOGLYCANS; ACETYLATION; LOCALIZATION; CHROMATIN; METASTASIS; HEPARIN; CANCER	Heparanase acts as a master regulator of the aggressive tumor phenotype in part by enhancing expression of proteins known to drive tumor progression (e. g. VEGF, MMP-9, hepatocyte growth factor (HGF), and RANKL). However, the mechanism whereby this enzyme regulates gene expression remains unknown. We previously reported that elevation of heparanase levels in myeloma cells causes a dramatic reduction in the amount of syndecan-1 in the nucleus. Because syndecan-1 has heparan sulfate chains and because exogenous heparan sulfate has been shown to inhibit the activity of histone acetyltransferase (HAT) enzymes in vitro, we hypothesized that the reduction in nuclear syndecan-1 in cells expressing high levels of heparanase would result in increased HAT activity leading to stimulation of protein transcription. We found that myeloma cells or tumors expressing high levels of heparanase and low levels of nuclear syndecan-1 had significantly higher levels of HAT activity when compared with cells or tumors expressing low levels of heparanase. High levels of HAT activity in heparanase-high cells were blocked by SST0001, an inhibitor of heparanase. Restoration of high syndecan-1 levels in heparanase-high cells diminished nuclear HAT activity, establishing syndecan-1 as a potent inhibitor of HAT. Exposure of heparanase-high cells to anacardic acid, an inhibitor of HAT activity, significantly suppressed their expression of VEGF and MMP-9, two genes known to be up-regulated following elevation of heparanase. These results reveal a novel mechanistic pathway driven by heparanase expression, which leads to decreased nuclear syndecan-1, increased HAT activity, and up-regulation of transcription of multiple genes that drive an aggressive tumor phenotype.	[Hurst, Douglas R.; Sanderson, Ralph D.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Hurst, Douglas R.; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Pisano, Claudio] Sigma Tau Ind Farmaceut Riunite SpA, I-00040 Pomezia, Italy; [Mizumoto, Shuji; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Hokkaido University	Sanderson, RD (corresponding author), 1530 3rd Ave S,SHEL 814, Birmingham, AL 35294 USA.	sanderson@uab.edu	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505; pisano, claudio/0000-0001-8624-2980; Hurst, Douglas/0000-0002-1296-2210	National Institutes of Health [CA135075, CA138340]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); NATIONAL CANCER INSTITUTE [R01CA138340, R01CA135075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.). This work was also supported by the Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to K. S.). Dr. Claudio Pisano is an employee of sigma-tau Industrie Farmaceutiche Riunite S. p. A.; this company is developing SST0001 for clinical use.	Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Isharwal S, 2008, PROSTATE, V68, P1097, DOI 10.1002/pros.20772; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; Kelly T, 2003, CANCER RES, V63, P8749; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; LOIDL P, 1994, CHROMOSOMA, V103, P441; Mahlknecht U, 2000, MOL MED, V6, P623, DOI 10.1007/BF03402044; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Nilsson U, 2010, CANCER RES, V70, P3771, DOI 10.1158/0008-5472.CAN-09-4331; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Richardson TP, 2001, J CELL SCI, V114, P1613; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schubert SY, 2004, LAB INVEST, V84, P535, DOI 10.1038/labinvest.3700084; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; VILLEPONTEAU B, 1992, BIOCHEM J, V288, P953, DOI 10.1042/bj2880953; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhang LX, 2010, MOL CANCER RES, V8, P278, DOI 10.1158/1541-7786.MCR-09-0375; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	42	88	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30377	30383		10.1074/jbc.M111.254789	http://dx.doi.org/10.1074/jbc.M111.254789			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757697	hybrid, Green Published			2022-12-27	WOS:000294283600015
J	Tsutsumi, K; Matsuda, M; Kotani, M; Mizokami, A; Murakami, A; Takahashi, I; Terada, Y; Kanematsu, T; Fukami, K; Takenawa, T; Jimi, E; Hirata, M				Tsutsumi, Koshiro; Matsuda, Miho; Kotani, Miho; Mizokami, Akiko; Murakami, Ayako; Takahashi, Ichiro; Terada, Yoshihiro; Kanematsu, Takashi; Fukami, Kiyoko; Takenawa, Tadaomi; Jimi, Eijiro; Hirata, Masato			Involvement of PRIP, Phospholipase C-related, but Catalytically Inactive Protein, in Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INS(1,4,5)P-3 BINDING-PROTEIN; GABA(A) RECEPTOR; OSTEOBLAST DIFFERENTIATION; RAT-BRAIN; OSTEOCLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-SURFACE; P130	PRIP (phospholipase C-related, but catalytically inactive protein) is a novel protein isolated in this laboratory. PRIP-deficient mice showed increased serum gonadotropins, but decreased gonadal steroid hormones. This imbalance was similar to that for the cause of bone disease, such as osteoporosis. In the present study, therefore, we analyzed mutant mice with special reference to the bone property. We first performed three-dimensional analysis of the femur of female mice. The bone mineral density and trabecular bone volume were higher in mutant mice. We further performed histomorphometrical assay of bone formation parameters: bone formation rate, mineral apposition rate, osteoid thickness, and osteoblast number were up-regulated in the mutant, indicating that increased bone mass is caused by the enhancement of bone formation ability. We then cultured primary cells isolated from calvaria prepared from both genotypes. In mutant mice, osteoblast differentiation, as assessed by alkaline phosphatase activity and the expression of osteoblast differentiation marker genes, was enhanced. Moreover, we analyzed the phosphorylation of Smad1/5/8 in response to bone morphogenetic protein, with longer phosphorylation in the mutant. These results indicate that PRIP is implicated in the negative regulation of bone formation.	[Tsutsumi, Koshiro; Matsuda, Miho; Kotani, Miho; Mizokami, Akiko; Kanematsu, Takashi; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Tsutsumi, Koshiro; Terada, Yoshihiro] Kyushu Univ, Fac Dent Sci, Div Fixed Prosthodont, Fukuoka 8128582, Japan; [Kotani, Miho; Murakami, Ayako; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Orthodont, Fukuoka 8128582, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Jimi, Eijiro] Kyushu Dent Coll, Dept Mol Signaling & Biochem, Kitakyushu, Fukuoka 8038580, Japan	Kyushu University; Kyushu University; Kyushu University; Tokyo University of Pharmacy & Life Sciences; Kobe University; Kyushu Dental University	Hirata, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan.	hirata1@dent.kyushu-u.ac.jp	Mizokami, Akiko/ABC-5448-2021; Mizokami, Akiko/AAY-2193-2020	Mizokami, Akiko/0000-0002-7490-5190	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Kyushu University; Grants-in-Aid for Scientific Research [22659376] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to K. T., M. M., A. M., and M. H.), and by Kyushu University P&P program (to M. M.).	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Hashiguchi D, 2011, J DENT RES, V90, P912, DOI 10.1177/0022034511407335; Hirata S, 2010, J CELL BIOCHEM, V111, P1445, DOI 10.1002/jcb.22872; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri Takenobu, 2008, Clin Calcium, V18, P194, DOI CliCa0802194201; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuda M, 1998, NEUROSCI LETT, V257, P97, DOI 10.1016/S0304-3940(98)00810-6; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mizokami A, 2010, J NEUROCHEM, V114, P302, DOI 10.1111/j.1471-4159.2010.06754.x; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Passeri G, 2008, EXP GERONTOL, V43, P79, DOI 10.1016/j.exger.2007.06.013; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Yamane H, 2009, BONE, V44, P1055, DOI 10.1016/j.bone.2008.05.010; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]	48	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31032	31042		10.1074/jbc.M111.235903	http://dx.doi.org/10.1074/jbc.M111.235903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757756	Green Published, hybrid			2022-12-27	WOS:000294283600081
J	Vu, TT; Stafford, AR; Leslie, BA; Kim, PY; Fredenburgh, JC; Weitz, JI				Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.			Histidine-rich Glycoprotein Binds Fibrin(ogen) with High Affinity and Competes with Thrombin for Binding to the gamma '-Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOT-BOUND THROMBIN; HUMAN-FIBRINOGEN; FACTOR-XIII; ZINC CONCENTRATIONS; PLASMA-PROTEIN; CELL-SURFACE; ALPHA; IDENTIFICATION; FIBRINOLYSIS; PLASMINOGEN	Histidine-rich glycoprotein (HRG) is an abundant protein that binds fibrinogen and other plasma proteins in a Zn2(+)-dependent fashion but whose function is unclear. HRG has antimicrobial activity, and its incorporation into fibrin clots facilitates bacterial entrapment and killing and promotes inflammation. Although these findings suggest that HRG contributes to innate immunity and inflammation, little is known about the HRG-fibrin(ogen) interaction. By immunoassay, HRG-fibrinogen complexes were detected in Zn2(+)-supplemented human plasma, a finding consistent with a high affinity interaction. Surface plasmon resonance determinations support this concept and show that in the presence of Zn2(+), HRG binds the predominant gamma(A)/gamma'-fibrinogen and the gamma-chain elongated isoform, gamma(A)/gamma'-fibrinogen, with K-d values of 9 nM. Likewise, I-125-labeled HRG binds gamma(A)/gamma(A)-or gamma(A)/gamma'-fibrin clots with similar K-d values when Zn2(+) is present. There are multiple HRG binding sites on fibrin(ogen) because HRG binds immobilized fibrinogen fragment D or E and gamma'-peptide, an analog of the COOH terminus of the gamma'-chain that mediates the high affinity interaction of thrombin with gamma(A)/gamma'-fibrin. Thrombin competes with HRG for gamma'-peptide binding and displaces I-125-HRG from gamma(A)/gamma'-fibrin clots and vice versa. Taken together, these data suggest that (a) HRG circulates in complex with fibrinogen and that the complex persists upon fibrin formation, and (b) by competing with thrombin for gamma(A)/gamma'-fibrin binding, HRG may modulate coagulation. Therefore, the HRG-fibrin interaction may provide a novel link between coagulation, innate immunity, and inflammation.	[Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Vu, Trang T.; Weitz, Jeffrey I.] McMaster Univ, Dept Med Sci, Hamilton, ON L8L 2X2, Canada; [Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), McMaster Univ, Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Kim, Paul/GYV-3258-2022	Weitz, Jeffrey/0000-0002-1092-7550; Kim, Paul/0000-0003-0943-4924	Canadian Institutes of Health Research [MOP 3992, MOP 102735, CTP 79846]; Heart and Stroke Foundation of Ontario [T4792, T4730]; Heart and Stroke Foundation of Canada; Ontario Research and Development Challenge Fund; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Research and Development Challenge Fund(General Electric); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported in part by the Canadian Institutes of Health Research (MOP 3992, MOP 102735, and CTP 79846), the Heart and Stroke Foundation of Ontario (T4792 and T4730), the Heart and Stroke Foundation of Canada (a Novel and Exploratory Research Fund grant), and the Ontario Research and Development Challenge Fund.; Supported by a Heart and Stroke Foundation of Ontario Graduate Student Award.	Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Bosshart H, 2003, FEBS LETT, V553, P135, DOI 10.1016/S0014-5793(03)00997-9; CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033; FOOTE JW, 1984, J CLIN PATHOL, V37, P1050, DOI 10.1136/jcp.37.9.1050; FORNACE AJ, 1984, J BIOL CHEM, V259, P2826; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 2001, J BIOL CHEM, V276, P44828, DOI 10.1074/jbc.M108710200; Gorgani NN, 1999, IMMUNOLOGY, V98, P456, DOI 10.1046/j.1365-2567.1999.00885.x; Guo F, 2009, BIOCHEM BIOPH RES CO, V390, P942, DOI 10.1016/j.bbrc.2009.10.082; HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x; JACKMAN MP, 1992, J BIOL CHEM, V267, P15375; Jancso A, 2009, J INORG BIOCHEM, V103, P1634, DOI 10.1016/j.jinorgbio.2009.09.002; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Jones AL, 2004, J BIOL CHEM, V279, P38267, DOI 10.1074/jbc.M406027200; Jones AL, 2004, J BIOL CHEM, V279, P30114, DOI 10.1074/jbc.M401996200; KACZMAREK E, 1988, J BIOL CHEM, V263, P13896; Kretz CA, 2006, J BIOL CHEM, V281, P37477, DOI 10.1074/jbc.M607359200; KUMAR R, 1995, THROMB HAEMOSTASIS, V74, P962; LAKOMAA EL, 1982, TOXICOL APPL PHARM, V65, P286, DOI 10.1016/0041-008X(82)90011-4; Lamanna JC, 1996, ADV EXP MED BIOL, V388, P283; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LEUNG LLK, 1983, BLOOD, V62, P1016; LIJNEN HR, 1980, J BIOL CHEM, V255, P214; LIU LW, 1991, J BIOL CHEM, V266, P16977; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Lu PP, 2011, LIFE SCI, V88, P839, DOI 10.1016/j.lfs.2011.03.003; MacQuarrie JL, 2011, BLOOD, V117, P4134, DOI 10.1182/blood-2010-07-290551; MARDER VJ, 1969, J BIOL CHEM, V244, P2111; Maret W, 2004, J ANAL ATOM SPECTROM, V19, P15, DOI 10.1039/b307540k; MARX G, 1993, J CELL PHYSIOL, V156, P437, DOI 10.1002/jcp.1041560302; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; MORGAN WT, 1978, BIOCHIM BIOPHYS ACTA, V535, P319, DOI 10.1016/0005-2795(78)90098-3; Mutch NJ, 2001, THROMB HAEMOSTASIS, V86, P1028; NIKULA TK, 1995, MOL IMMUNOL, V32, P865, DOI 10.1016/0161-5890(95)00052-G; Olman MA, 1998, PROTEIN EXPRES PURIF, V14, P71, DOI 10.1006/prep.1998.0911; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Stewart AJ, 2009, BIOCHIMIE, V91, P1518, DOI 10.1016/j.biochi.2009.08.002; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; TURCOTTE A, 1992, ANTIMICROB AGENTS CH, V36, P2211, DOI 10.1128/AAC.36.10.2211; van den Herik EG, 2011, THROMB HAEMOSTASIS, V105, P430, DOI 10.1160/TH10-09-0569; Weitz Jeffrey I, 2003, Cardiovasc Toxicol, V3, P13, DOI 10.1385/CT:3:1:13; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036	53	29	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30314	30323		10.1074/jbc.M111.253831	http://dx.doi.org/10.1074/jbc.M111.253831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757718	Green Published, hybrid			2022-12-27	WOS:000294283600009
J	Wohlschlager, T; Butschi, A; Zurfluh, K; Vonesch, SC; Keller, UAD; Gehrig, P; Bleuler-Martinez, S; Hengartner, MO; Aebi, M; Kunzler, M				Wohlschlager, Therese; Butschi, Alex; Zurfluh, Katrin; Vonesch, Sibylle C.; Keller, Ulrich Auf Dem; Gehrig, Peter; Bleuler-Martinez, Silvia; Hengartner, Michael O.; Aebi, Markus; Kuenzler, Markus			Nematotoxicity of Marasmius oreades Agglutinin (MOA) Depends on Glycolipid Binding and Cysteine Protease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSHROOM POLYPORUS-SQUAMOSUS; NEMATODE CAENORHABDITIS-ELEGANS; HIGH-AFFINITY LECTIN; ENDOPLASMIC-RETICULUM; PERITROPHIC MATRIX; FRUITING BODY; RESISTANCE; TOXIN; GAL-ALPHA-1,3GAL; IDENTIFICATION	Fruiting body lectins have been proposed to act as effector proteins in the defense of fungi against parasites and predators. The Marasmius oreades agglutinin (MOA) is a Gal alpha 1,3Gal/GalNAc-specific lectin from the fairy ring mushroom that consists of an N-terminal ricin B-type lectin domain and a C-terminal dimerization domain. The latter domain shows structural similarity to catalytically active proteins, suggesting that, in addition to its carbohydrate-binding activity, MOA has an enzymatic function. Here, we demonstrate toxicity of MOA toward the model nematode Caenorhabditis elegans. This toxicity depends on binding of MOA to glycosphingolipids of the worm via its lectin domain. We show further that MOA has cysteine protease activity and demonstrate a critical role of this catalytic function in MOA-mediated nematotoxicity. The proteolytic activity of MOA was dependent on high Ca2+ concentrations and favored by slightly alkaline pH, suggesting that these conditions trigger activation of the toxin at the target location. Our results suggest that MOA is a fungal toxin with intriguing similarities to bacterial binary toxins and has a protective function against fungivorous soil nematodes.	[Wohlschlager, Therese; Zurfluh, Katrin; Bleuler-Martinez, Silvia; Aebi, Markus; Kuenzler, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Keller, Ulrich Auf Dem] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Butschi, Alex; Vonesch, Sibylle C.; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Gehrig, Peter] Univ Zurich, Funct Genom Ctr, CH-8057 Zurich, Switzerland; [Gehrig, Peter] ETH, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kunzler, M (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10,HCI F413, CH-8093 Zurich, Switzerland.	markus.kuenzler@micro.biol.ethz.ch	Keller, Ulrich auf dem/G-6004-2012; Hengartner, Michael O/E-6235-2011; Wohlschlager, Therese/G-4622-2016; Keller, Ulrich auf dem/X-2710-2019	Keller, Ulrich auf dem/0000-0002-3431-7415; Wohlschlager, Therese/0000-0001-9359-6744; Keller, Ulrich auf dem/0000-0002-3431-7415; Zurfluh, Katrin/0000-0002-8760-4768; Vonesch, Sibylle/0000-0003-2485-1048; Kunzler, Markus/0000-0003-1275-0629; Hengartner, Michael/0000-0002-7584-596X	European Commission; Swiss National Science Foundation [31003A-130671]; ETH Zurich	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by the European Commission Marie Curie Program (EuroGlycoArrays ITN), Swiss National Science Foundation Grant 31003A-130671 (to M. K., M.O.H., and M. A.), and ETH Zurich.	Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; Barrows BD, 2007, J INVERTEBR PATHOL, V95, P198, DOI 10.1016/j.jip.2007.04.002; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Goldstein I. J., 2007, MUSHROOM LECTINS; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; Hamshou M, 2010, INSECT BIOCHEM MOLEC, V40, P883, DOI 10.1016/j.ibmb.2010.08.008; Ideo H, 2009, J BIOL CHEM, V284, P26493, DOI 10.1074/jbc.M109.038257; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kruger RP, 2002, J BIOL CHEM, V277, P15002, DOI 10.1074/jbc.M200165200; Kunzler M, 2010, METHOD ENZYMOL, V480, P141, DOI 10.1016/S0076-6879(10)80007-2; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Marroquin LD, 2000, GENETICS, V155, P1693; McGhee James D, 2007, WormBook, P1; Mo HQ, 2000, J BIOL CHEM, V275, P10623, DOI 10.1074/jbc.275.14.10623; Mohan S, 2006, J INSECT PHYSIOL, V52, P21, DOI 10.1016/j.jinsphys.2005.08.011; Mohan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001786; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Suzuki T, 2005, METHODS, V35, P360, DOI 10.1016/j.ymeth.2004.10.008; Tateno H, 2004, BIOCHEM J, V382, P667, DOI 10.1042/BJ20040391; Tateno H, 2004, ARCH BIOCHEM BIOPHYS, V427, P101, DOI 10.1016/j.abb.2004.04.013; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Trigueros V, 2003, BBA-GEN SUBJECTS, V1621, P292, DOI 10.1016/S0304-4165(03)00098-9; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; Varki A., 2009, ESSENTIALS GLYCOBIOL, P37; Warner RL, 2004, EXP MOL PATHOL, V77, P77, DOI 10.1016/j.yexmp.2004.04.003; Winter HC, 2002, J BIOL CHEM, V277, P14996, DOI 10.1074/jbc.M200161200; Zhang BY, 2001, GLYCOBIOLOGY, V11, P141, DOI 10.1093/glycob/11.2.141	39	33	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30337	30343		10.1074/jbc.M111.258202	http://dx.doi.org/10.1074/jbc.M111.258202			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757752	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000294283600011
J	Naseem, S; Gunasekera, A; Araya, E; Konopka, JB				Naseem, Shamoon; Gunasekera, Angelo; Araya, Esteban; Konopka, James B.			N-Acetylglucosamine (GlcNAc) Induction of Hyphal Morphogenesis and Transcriptional Responses in Candida albicans Are Not Dependent on Its Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GLUCOSAMINE; ESCHERICHIA-COLI; CATABOLIC PATHWAY; PROTEIN-KINASE; GENE; VIRULENCE; IDENTIFICATION; EXPRESSION; MUTANTS; YEAST	N-Acetylglucosamine (GlcNAc) stimulates important signaling pathways in a wide range of organisms. In the human fungal pathogen Candida albicans, GlcNAc stimulates hyphal cell morphogenesis, virulence genes, and the genes needed to catabolize GlcNAc. Previous studies on the GlcNAc transporter (NGT1) indicated that GlcNAc has to be internalized to induce signaling. Therefore, the role of GlcNAc catabolism was examined by deleting the genes required to phosphorylate, deacetylate, and deaminate GlcNAc to convert it to fructose-6-PO4 (HXK1, NAG1, and DAC1). As expected, the mutants failed to utilize GlcNAc. Surprisingly, GlcNAc inhibited the growth of the nag1 Delta and dac1 Delta mutants in the presence of other sugars, suggesting that excess GlcNAc-6-PO4 is deleterious. Interestingly, both hxk1 Delta and an hxk1 Delta nag1 Delta dac1 Delta triple mutant could be efficiently stimulated by GlcNAc to form hyphae. These mutants could also be stimulated to express GlcNAc-regulated genes. Because GlcNAc must be phosphorylated by Hxk1 to be catabolized, and also for it to enter the anabolic pathways that form chitin, N-linked glycosylation, and glycosyl-phosphatidylinositol anchors, the mutant phenotypes indicate that GlcNAc metabolism is not needed to induce signaling in C. albicans. Thus, these studies in C. albicans reveal a novel role for GlcNAc in cell signaling that may also regulate critical pathways in other organisms.	[Naseem, Shamoon; Gunasekera, Angelo; Araya, Esteban; Konopka, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Konopka, JB (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	jkonopka@ms.cc.sunysb.edu		Konopka, James/0000-0001-5989-4086	National Institutes of Health from USPHS [RO1 GM087368]; National Institutes of Health from the NCI [T32 CA009176]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087368] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM087368 from USPHS (to J.B.K.).; Supported by a National Institutes of Health Training Grant T32 CA009176 from the NCI.	Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Barnhart MM, 2006, J BACTERIOL, V188, P5212, DOI 10.1128/JB.00234-06; BERNHEIM NJ, 1970, J BACTERIOL, V101, P384, DOI 10.1128/JB.101.2.384-391.1970; Brown V, 2009, CURR BIOL, V19, P436, DOI 10.1016/j.cub.2009.01.056; Castilla R, 1998, CELL SIGNAL, V10, P713, DOI 10.1016/S0898-6568(98)00015-1; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; DOUGLAS HC, 1954, J BACTERIOL, V68, P662, DOI 10.1128/JB.68.6.662-670.1954; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gunasekera A, 2010, EUKARYOT CELL, V9, P1476, DOI 10.1128/EC.00178-10; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Naderer T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001245; NATARAJAN K, 1993, J BIOL CHEM, V268, P9206; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Perez-Campo FM, 2001, CURR MICROBIOL, V43, P429, DOI 10.1007/s002840010333; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIMONETTI N, 1974, NATURE, V250, P344, DOI 10.1038/250344a0; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Singh V, 2007, FUNGAL GENET BIOL, V44, P563, DOI 10.1016/j.fgb.2006.11.006; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Wendland J, 2006, J BASIC MICROB, V46, P513, DOI 10.1002/jobm.200610167; Wendland J, 2009, APPL ENVIRON MICROB, V75, P5840, DOI 10.1128/AEM.00053-09; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; Whiteway M, 2004, CURR OPIN MICROBIOL, V7, P350, DOI 10.1016/j.mib.2004.06.005; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09	40	60	72	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28671	28680		10.1074/jbc.M111.249854	http://dx.doi.org/10.1074/jbc.M111.249854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700702	Green Published, hybrid			2022-12-27	WOS:000293837000004
J	Mul, JD; Nadra, K; Jagalur, NB; Nijman, IJ; Toonen, PW; Medard, JJ; Gres, S; de Bruin, A; Han, GS; Brouwers, JF; Carman, GM; Saulnier-Blache, JS; Meijer, D; Chrast, R; Cuppen, E				Mul, Joram D.; Nadra, Karim; Jagalur, Noorjahan B.; Nijman, Isaac J.; Toonen, Pim W.; Medard, Jean-Jacques; Gres, Sandra; de Bruin, Alain; Han, Gil-Soo; Brouwers, Jos F.; Carman, George M.; Saulnier-Blache, Jean-Sebastien; Meijer, Dies; Chrast, Roman; Cuppen, Edwin			A Hypomorphic Mutation in Lpin1 Induces Progressively Improving Neuropathy and Lipodystrophy in the Rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; SCHWANN-CELL DIFFERENTIATION; PERIPHERAL NEUROPATHY; SUBCELLULAR-LOCALIZATION; QUANTITATIVE-ANALYSIS; EXPRESSION; LIPIN; GENE; PROTEIN; MYOGLOBINURIA	The Lpin1 gene encodes the phosphatidate phosphatase (PAP1) enzyme Lipin 1, which plays a critical role in lipid metabolism. In this study we describe the identification and characterization of a rat model with a mutated Lpin1 gene (Lpin1(1Hubr)), generated by N-ethyl-N-nitrosourea mutagenesis. Lpin1(1Hubr) rats are characterized by hindlimb paralysis and mild lipodystrophy that are detectable from the second postnatal week. Sequencing of Lpin1 identified a point mutation in the 5'-end splice site of intron 18 resulting in missplicing, a reading frameshift, and a premature stop codon. As this mutation does not induce nonsense-mediated decay, it allows the production of a truncated Lipin 1 protein lacking PAP1 activity. Lpin1(1Hubr) rats developed hypomyelination and mild lipodystrophy rather than the pronounced demyelination and adipocyte defects characteristic of Lpin1(fld/fld) mice, which carry a null allele for Lpin1. Furthermore, biochemical, histological, and molecular analyses revealed that these lesions improve in older Lpin1(1Hubr) rats as compared with young Lpin1(1Hubr) rats and Lpin1(fld/fld) mice. We observed activation of compensatory biochemical pathways substituting for missing PAP1 activity that, in combination with a possible non-enzymatic Lipin 1 function residing outside of its PAP1 domain, may contribute to the less severe phenotypes observed in Lpin1(1Hubr) rats as compared with Lpin1(fld/fld) mice. Although we are cautious in making a direct parallel between the presented rodent model and human disease, our data may provide new insight into the pathogenicity of recently identified human LPIN1 mutations.	[Nadra, Karim; Medard, Jean-Jacques; Chrast, Roman] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Mul, Joram D.; Nijman, Isaac J.; Toonen, Pim W.; Cuppen, Edwin] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Mul, Joram D.; Nijman, Isaac J.; Toonen, Pim W.; Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Jagalur, Noorjahan B.; Meijer, Dies] Erasmus MC Univ Med Ctr, Dept Cell Biol & Genet, NL-3015 GE Rotterdam, Netherlands; [Gres, Sandra; Saulnier-Blache, Jean-Sebastien] Univ Toulouse 3, Inst Malad Metab & Cardiovasc I2MC, INSERM U1048, F-31432 Toulouse 4, France; [de Bruin, Alain] Univ Utrecht, Dutch Mol Pathol Ctr, Fac Vet Med, NL-3584 CL Utrecht, Netherlands; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Brouwers, Jos F.] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Med, NL-3508 TC Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands	University of Lausanne; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Utrecht University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Utrecht University; Utrecht University; Utrecht University Medical Center	Nadra, K (corresponding author), Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland.	Karim.Nadra@unil.ch; Roman.Chrast@unil.ch	Meijer, Dies/C-7786-2012; Saulnier-Blache, Jean Sebastien/X-7729-2018; Cuppen, Edwin/F-5696-2011; Brouwers, Jos F/AAH-1444-2019; de Bruin, Alain/AAL-9195-2020; Cuppen, Edwin/H-2389-2016; Mul, Joram/C-3125-2011	Meijer, Dies/0000-0002-8461-6341; Cuppen, Edwin/0000-0002-0400-9542; Brouwers, Jos F/0000-0003-2924-3279; Cuppen, Edwin/0000-0002-0400-9542; de Bruin, Alain/0000-0001-8579-2649; Chrast, Roman/0000-0003-4189-3514; Mul, Joram/0000-0003-0453-2568; Nijman, Isaac/0000-0002-1840-1158; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723	National Institutes of Health [GM-28140]; Swiss National Science Foundation [PP00P3_124833/1]; INSERM; Fondation de la Recherche Medicale [DRM20101220459]; European Science Foundation EURYI; Dutch government; European community [NWO 918.66.616, FP7/2007-2013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); European Science Foundation EURYI(European Science Foundation (ESF)); Dutch government; European community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.), Swiss National Science Foundation Grant PP00P3_124833/1 (to R. C.), INSERM and Fondation de la Recherche Medicale Grant DRM20101220459 (to J. S. S. B.), a grant from the European Science Foundation EURYI (to E. C.), and Dutch government and European community Grants NWO 918.66.616 and FP7/2007-2013 (to D. M.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brouwers J. F., 2011, BIOL REPROD IN PRESS; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; de Preux AS, 2007, MOL CELL NEUROSCI, V35, P525, DOI 10.1016/j.mcn.2007.04.010; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Douglas DS, 2009, J NEUROSCI, V29, P12089, DOI 10.1523/JNEUROSCI.2029-09.2009; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833, DOI 10.1177/33.8.4020099; Frio TR, 2009, HUM MUTAT, V30, P1340, DOI 10.1002/humu.21071; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Mul JD, 2010, AM J PHYSIOL-ENDOC M, V298, pE477, DOI 10.1152/ajpendo.00154.2009; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Nijman IJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-95; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Roberts RZ, 2000, BBA-MOL CELL BIOL L, V1487, P33, DOI 10.1016/S1388-1981(00)00081-0; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Spiekerkoetter U, 2004, MUSCLE NERVE, V29, P66, DOI 10.1002/mus.10500; van Boxtel R, 2008, CARCINOGENESIS, V29, P1290, DOI 10.1093/carcin/bgn094; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	39	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26781	26793		10.1074/jbc.M110.197947	http://dx.doi.org/10.1074/jbc.M110.197947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21715287	Green Published, hybrid			2022-12-27	WOS:000293078200054
J	Guo, YD; Zhang, WL; Giroux, C; Cai, YL; Ekambaram, P; Dilly, AK; Hsu, A; Zhou, SL; Maddipati, KR; Liu, JJ; Joshi, S; Tucker, SC; Lee, MJ; Honn, KV				Guo, Yande; Zhang, Wenliang; Giroux, Craig; Cai, Yinlong; Ekambaram, Prasanna; Dilly, Ashok-kumar; Hsu, Andrew; Zhou, Senlin; Maddipati, Krishna Rao; Liu, Jingjing; Joshi, Sangeeta; Tucker, Stephanie C.; Lee, Menq-Jer; Honn, Kenneth V.			Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-TYPE 12-LIPOXYGENASE; TUMOR-CELL ADHESION; KINASE-C; 12(S)-HYDROXYEICOSATETRAENOIC ACID; LIPOXYGENASE METABOLITE; PROSTATE-CANCER; EXPRESSION; ACTIVATION; 12(S)-HETE; ANGIOGENESIS	Hydroxy fatty acids are critical lipid mediators involved in various pathophysiologic functions. We cloned and identified GPR31, a plasma membrane orphan G protein-coupled receptor that displays high affinity for the human 12-lipoxygenase-derived product 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE). Thus, GPR31 is named 12-(S)-HETE receptor (12-HETER) in this study. The cloned 12-HETER demonstrated high affinity binding for 12-(S)-[H-3]HETE (K-d = 4.8 +/- 0.12 nM). Also, 12-(S)-HETE efficiently and selectively stimulated GTP gamma S coupling in the membranes of 12-HETER-transfected cells (EC50 = 0.28 +/- 1.26 nM). Activating GTP gamma S coupling with 12-(S)-HETE proved to be both regio- and stereospecific. Also, 12-(S)-HETE/12-HETER interactions lead to activation of ERK1/2, MEK, and NF kappa B. Moreover, knocking down 12-HRTER specifically inhibited 12-(S)-HETE-stimulated cell invasion. Thus, 12-HETER represents the first identified high affinity receptor for the 12-(S)-HETE hydroxyl fatty acids.	[Guo, Yande; Zhang, Wenliang; Cai, Yinlong; Ekambaram, Prasanna; Dilly, Ashok-kumar; Hsu, Andrew; Zhou, Senlin; Maddipati, Krishna Rao; Liu, Jingjing; Joshi, Sangeeta; Tucker, Stephanie C.; Lee, Menq-Jer; Honn, Kenneth V.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48202 USA; [Giroux, Craig] Wayne State Univ, Sch Med, Dept Chem, Detroit, MI 48202 USA; [Honn, Kenneth V.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48202 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Honn, KV (corresponding author), 5101 Cass Ave,431 Chem Bldg, Detroit, MI 48202 USA.	k.v.honn@wayne.edu	Ekambaram, Prasanna/I-5309-2019; Joshi, Sudhanshu/L-2284-2019; Maddipati, Krishna Rao/G-1859-2011; Maddipati, Krishna Rao/H-3569-2019; zhang, wenliang/A-7525-2011	Joshi, Sudhanshu/0000-0003-4748-5001; Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; 	National Institutes of Health [CA029997, DoD W81XWH-06-1-0226, HL071071]; NATIONAL CANCER INSTITUTE [R01CA029997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA029997, DoD W81XWH-06-1-0226 (to K. V. H.), and HL071071 (to M. J. L.).	ARENBERGER P, 1992, EUR J IMMUNOL, V22, P2469, DOI 10.1002/eji.1830220944; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; CHOPRA H, 1991, INT J CANCER, V49, P774, DOI 10.1002/ijc.2910490524; GROSSI IM, 1989, CANCER RES, V49, P1029; Hampson AJ, 2002, J NEUROSCI, V22, P257, DOI 10.1523/JNEUROSCI.22-01-00257.2002; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Herbertsson H, 1999, ARCH BIOCHEM BIOPHYS, V367, P33, DOI 10.1006/abbi.1999.1233; Herbertsson H, 1998, J LIPID RES, V39, P237; HERBERTSSON H, 1995, BBA-GEN SUBJECTS, V1244, P191, DOI 10.1016/0304-4165(94)00223-K; HONN KV, 1994, CANCER METAST REV, V13, P365, DOI 10.1007/BF00666105; HONN KV, 1994, EXP CELL RES, V214, P120, DOI 10.1006/excr.1994.1240; HONN KV, 1994, CANCER RES, V54, P565; HONN KV, 1992, CANCER METAST REV, V11, P325, DOI 10.1007/BF01307186; HONN KV, 1992, PROSTAGLANDINS, V44, P413, DOI 10.1016/0090-6980(92)90137-I; Kandouz M, 2003, PROSTAG OTH LIPID M, V71, P189, DOI 10.1016/S1098-8823(03)00042-X; Kurahashi Y, 2000, P NATL ACAD SCI USA, V97, P5779, DOI 10.1073/pnas.97.11.5779; LIU B, 1991, CELL REGUL, V2, P1045, DOI 10.1091/mbc.2.12.1045; LIU B, 1995, P NATL ACAD SCI USA, V92, P9323, DOI 10.1073/pnas.92.20.9323; Liu XH, 1996, CLIN EXP METASTAS, V14, P145, DOI 10.1007/BF00121211; Matsuyama M, 2004, INT J ONCOL, V24, P821; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; Nie D, 1998, CANCER RES, V58, P4047; Nie DT, 2006, J BIOL CHEM, V281, P18601, DOI 10.1074/jbc.M601887200; Pidgeon GP, 2003, CANCER RES, V63, P4258; Shappell SB, 2003, CANCER RES, V63, P2256; Szekeres CK, 2000, J BIOL CHEM, V275, P38831, DOI 10.1074/jbc.M002673200; Tang DG, 1997, ADV EXP MED BIOL, V400, P349; TANG DG, 1995, J CELL SCI, V108, P2629; TIMAR J, 1993, INT J CANCER, V55, P1003, DOI 10.1002/ijc.2910550621; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zingoni A, 1997, GENOMICS, V42, P519, DOI 10.1006/geno.1997.4754	33	128	136	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33832	33840		10.1074/jbc.M110.216564	http://dx.doi.org/10.1074/jbc.M110.216564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21712392	Green Published, hybrid			2022-12-27	WOS:000295159200014
J	Berlin, S; Tsemakhovich, VA; Castel, R; Ivanina, T; Dessauer, CW; Keren-Raifman, T; Dascal, N				Berlin, Shai; Tsemakhovich, Vladimir A.; Castel, Ruth; Ivanina, Tatiana; Dessauer, Carmen W.; Keren-Raifman, Tal; Dascal, Nathan			Two Distinct Aspects of Coupling between G alpha(i) Protein and G Protein-activated K+ Channel (GIRK) Revealed by Fluorescently Labeled G alpha(i3) Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; HETEROTRIMERIC G-PROTEINS; RECTIFYING POTASSIUM CHANNELS; C-TERMINAL DOMAIN; PERTUSSIS-TOXIN; ALPHA-SUBUNITS; XENOPUS OOCYTES; LIVING CELLS; KIR3 CHANNELS; RECEPTOR	G protein-activated K+ channels (Kir3 or GIRK) are activated by direct interaction with G beta gamma. G alpha is essential for specific signaling and regulates basal activity of GIRK (I-basal) and kinetics of the response elicited by activation by G protein-coupled receptors (I-evoked). These regulations are believed to occur within a GIRK-G alpha-G beta gamma signaling complex. Fluorescent energy resonance transfer (FRET) studies showed strong GIRK-G beta gamma interactions but yielded controversial results regarding the GIRK-G alpha(i/o) interaction. We investigated the mechanisms of regulation of GIRK by G alpha(i/o) using wild-type G alpha(i3) (G alpha i3WT) and G alpha(i3) labeled at three different positions with fluorescent proteins, CFP or YFP (xFP). G alpha(i3)xFP proteins bound the cytosolic domain of GIRK1 and interacted with G beta gamma in a guanine nucleotide-dependent manner. However, only an N-terminally labeled, myristoylated G alpha(i3)xFP (G alpha i3NT) closely mimicked all aspects of G alpha i3WT regulation except for a weaker regulation of I-basal. G alpha(i3) labeled with YFP within the G alpha helical domain preserved regulation of I-basal but failed to restore fast I-evoked. Titrated expression of G alpha i3NT and G alpha(i3) WT confirmed that regulation of I-basal and of the kinetics of I-evoked of GIRK1/2 are independent functions of G alpha(i). FRET and direct biochemical measurements indicated much stronger interaction between GIRK1 and G beta gamma than between GIRK1 and G alpha(i3). Thus, G alpha(i/o)beta gamma heterotrimer may be attached to GIRK primarily via G beta gamma within the signaling complex. Our findings support the notion that G alpha(i/o) actively regulates GIRK. Although regulation of I-basal is a function of G alpha(GDP)(i), our new findings indicate that regulation of kinetics of I-evoked is mediated by G alpha(GTP)(i).	[Berlin, Shai; Tsemakhovich, Vladimir A.; Castel, Ruth; Ivanina, Tatiana; Keren-Raifman, Tal; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dascaln@post.tau.ac.il	Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280; Berlin, shai/0000-0002-5153-4876	National Institutes of Health [GM60419]; United States Israel Binational Science Foundation [2009255]; Israel Science Foundation [1396/05, 49/08, 386/09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60419 (to C. W. D.). This work was also supported by United States Israel Binational Science Foundation Grant 2009255 (to N. D. and C. W. D.) and Israel Science Foundation Grants 1396/05 and 49/08 (to N. D.) and 386/09 (to T. I.).	Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Corey S, 2001, J BIOL CHEM, V276, P11409, DOI 10.1074/jbc.M100058200; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Ivanina T, 2000, FEBS LETT, V466, P327, DOI 10.1016/S0014-5793(99)01738-X; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Mirshahi T, 2004, J BIOL CHEM, V279, P11890, DOI 10.1074/jbc.M313322200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Rishal I, 2003, J BIOL CHEM, V278, P3840, DOI 10.1074/jbc.C200605200; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Singer-Lahat D, 2000, PFLUG ARCH EUR J PHY, V440, P627, DOI 10.1007/s004240000341; SUNYER T, 1989, MOL ENDOCRINOL, V3, P1115, DOI 10.1210/mend-3-7-1115; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; Waldhoer M, 1999, J BIOL CHEM, V274, P30571, DOI 10.1074/jbc.274.43.30571; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; WEST RE, 1985, J BIOL CHEM, V260, P4428; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; YAMADA M, 1993, J BIOL CHEM, V268, P24551; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yevenes GE, 2010, J BIOL CHEM, V285, P30203, DOI 10.1074/jbc.M110.134676; Zheng J, 2003, J NEUROSCI, V23, P8167; ZHENG J, 2003, SCI STKE, pPL7; Zylbergold P, 2010, CHANNELS, V4, P411, DOI 10.4161/chan.4.5.13327	62	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33223	33235		10.1074/jbc.M111.271056	http://dx.doi.org/10.1074/jbc.M111.271056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795707	Green Published, hybrid			2022-12-27	WOS:000294968800041
J	Zhu, CF; Luong, R; Zhuo, M; Johnson, DT; McKenney, JK; Cunha, GR; Sun, ZJ				Zhu, Chunfang; Luong, Richard; Zhuo, Ming; Johnson, Daniel T.; McKenney, Jesse K.; Cunha, Gerald R.; Sun, Zijie			Conditional Expression of the Androgen Receptor Induces Oncogenic Transformation of the Mouse Prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIAS-LIKE PROTEIN; CANCER PROGRESSION; THERAPY FAILURE; GENE; MICE; MUTATION; MODELS; CASTRATION; GENERATION; TRANSGENE	The androgen signaling pathway, mediated through the androgen receptor (AR), is critical in prostate tumorigenesis. However, the precise role of AR in prostate cancer development and progression still remains largely unknown. Specifically, it is unclear whether overexpression of AR is sufficient to induce prostate tumor formation in vivo. Here, we inserted the human AR transgene with a LoxP-stop-loxP (LSL) cassette into the mouse ROSA26 locus, permitting "conditionally" activated AR transgene expression through Cre recombinase-mediated removal of the LSL cassette. By crossing this AR floxed strain with Osr1-Cre (odd skipped related) mice, in which the Osr1 promoter activates at embryonic day 11.5 in urogenital sinus epithelium, we generated a conditional transgenic line, R26hAR(loxP):Osr1-Cre+. Expression of transgenic AR was detected in both prostatic luminal and basal epithelial cells and is resistant to castration. Approximately one-half of the transgenic mice displayed mouse prostatic intraepithelial neoplasia (mPIN) lesions. Intriguingly, four mice (10%) developed prostatic adenocarcinomas, with two demonstrating invasive diseases. Positive immunostaining of transgenic AR protein was observed in the majority of atypical and tumor cells in the mPIN and prostatic adenocarcinomas, providing a link between transgenic AR expression and oncogenic transformation. An increase in Ki67-positive cells appeared in all mPIN and prostatic adenocarcinoma lesions of the mice. Thus, we demonstrated for the first time that conditional activation of transgenic AR expression by Osr1 promoter induces prostate tumor formation in mice. This new AR transgenic mouse line mimics the human disease and can be used for study of prostate tumorigenesis and drug development.	[Zhu, Chunfang; Zhuo, Ming; Johnson, Daniel T.; Sun, Zijie] Stanford Univ, Dept Urol & Genet, Sch Med, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Dept Comparat Med, Sch Med, Stanford, CA 94305 USA; [McKenney, Jesse K.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Urol, Sch Med, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco	Sun, ZJ (corresponding author), Stanford Univ, Dept Urol, Sch Med, S287 Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	National Cancer Institute [CA-070297]; NATIONAL CANCER INSTITUTE [R01CA070297, R29CA070297] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grant CA-070297 from the National Cancer Institute.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen C, 2006, CLIN CANCER RES, V12, P5274, DOI 10.1158/1078-0432.CCR-06-0500; Bruchovsky N, 1975, Vitam Horm, V33, P61; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gao H, 2006, CANCER RES, V66, P7929, DOI 10.1158/0008-5472.CAN-06-1637; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; Koivisto P, 1997, CANCER RES, V57, P314; Koivisto P, 1998, AM J PATHOL, V152, P1; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Salinas CA, 2005, PROSTATE, V65, P58, DOI 10.1002/pros.20230; Shaneyfelt T, 2000, J CLIN ONCOL, V18, P847, DOI 10.1200/JCO.2000.18.4.847; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Stanford JL, 1997, CANCER RES, V57, P1194; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weinstein MH, 2002, MODERN PATHOL, V15, P1302, DOI 10.1097/01.MP.0000038460.95912.6E; Winter SF, 2003, PROSTATE CANCER P D, V6, P204, DOI 10.1038/sj.pcan.4500655; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843	48	34	36	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33478	33488		10.1074/jbc.M111.269894	http://dx.doi.org/10.1074/jbc.M111.269894			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795710	Green Published, hybrid			2022-12-27	WOS:000294968800065
J	Chen, SW; Bellew, C; Yao, X; Stefkova, J; Dipp, S; Saifudeen, Z; Bachvarov, D; El-Dahr, SS				Chen, Shaowei; Bellew, Christine; Yao, Xiao; Stefkova, Jana; Dipp, Susana; Saifudeen, Zubaida; Bachvarov, Dimcho; El-Dahr, Samir S.			Histone Deacetylase (HDAC) Activity Is Critical for Embryonic Kidney Gene Expression, Growth, and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHING MORPHOGENESIS; URETERAL BUD; TRANSCRIPTIONAL REPRESSION; MICE; ROLES; CELL; CATENIN; BIOLOGY; INHIBITORS; EPITHELIUM	Histone deacetylases (HDACs) regulate fundamental biological processes such as cellular proliferation, differentiation, and survival via genomic and nongenomic effects. This study examined the importance of HDAC activity in the regulation of gene expression and differentiation of the developing mouse kidney. Class I HDAC1-3 and class II HDAC4, -7, and -9 genes are developmentally regulated. Moreover, HDAC1-3 are highly expressed in nephron precursors. Short term treatment of cultured mouse embryonic kidneys with HDAC inhibitors (HDACi) induced global histone H3 and H4 hyperacetylation and H3K4 hypermethylation. However, genome-wide profiling revealed that the HDAC-regulated transcriptome is restricted and encompasses regulators of the cell cycle, Wnt/beta-catenin, TGF-beta/Smad, and PI3K-AKT pathways. Further analysis demonstrated that base-line expression of key developmental renal regulators, including Osr1, Eya1, Pax2/8, WT1, Gdnf, Wnt9b, Sfrp1/2, and Emx2, is dependent on intact HDAC activity. Treatment of cultured embryonic kidney cells with HDACi recapitulated these gene expression changes, and chromatin immunoprecipitation assays revealed that HDACi is associated with histone hyperacetylation of Pax2/Pax8, Gdnf, Sfrp1, and p21. Gene knockdown studies demonstrated that HDAC1 and HDAC2 play a redundant role in regulation of Pax2/8 and Sfrp1 but not Gdnf. Long term treatment of embryonic kidneys with HDACi impairs the ureteric bud branching morphogenesis program and provokes growth arrest and apoptosis. We conclude that HDAC activity is critical for normal embryonic kidney homeostasis, and we implicate class I HDACs in the regulation of early nephron gene expression, differentiation, and survival.	[Chen, Shaowei; Bellew, Christine; Yao, Xiao; Stefkova, Jana; Dipp, Susana; Saifudeen, Zubaida; El-Dahr, Samir S.] Tulane Univ, Hlth Sci Ctr, Sect Pediat Nephrol, Dept Pediat, New Orleans, LA 70112 USA; [Chen, Shaowei] Tulane Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Bachvarov, Dimcho] Univ Laval, Dept Mol Med, Quebec City, PQ G1R 2J6, Canada	Tulane University; Tulane University; Laval University	El-Dahr, SS (corresponding author), 1430 Tulane Ave,SL-37, New Orleans, LA 70112 USA.	seldahr@tulane.edu		Kauffman, Christine/0000-0002-2496-1987; Bachvarov, Dimcho/0000-0001-6509-9599	National Institutes of Health [DK-079886, DK-62550, DK56264]; National Kidney Foundation; Centers of Biomedical Research Excellence [1P20 RR-017659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079886, R43DK062550, R01DK056264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-079886, DK-62550, and DK56264 (to S. S. E.-D.).; Supported by a fellowship grant from the National Kidney Foundation.; Supported by Grant 1P20 RR-017659 from Centers of Biomedical Research Excellence.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bouchard M, 2004, DIFFERENTIATION, V72, P295, DOI 10.1111/j.1432-0436.2004.07207001.x; Boyle S, 2006, AM J PHYSIOL-RENAL, V291, pF1, DOI 10.1152/ajprenal.00447.2005; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Godin RE, 1999, INT J DEV BIOL, V43, P405; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hains D, 2008, PEDIATR RES, V64, P592, DOI 10.1203/PDR.0b013e318187cc12; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kopan R, 2007, J AM SOC NEPHROL, V18, P2014, DOI 10.1681/ASN.2007040453; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Partanen M, 1999, INT J DEV BIOL, V43, P487; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Reidy KJ, 2009, DEVELOPMENT, V136, P3979, DOI 10.1242/dev.037267; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; Rosenblum ND, 2008, SEMIN FETAL NEONAT M, V13, P125, DOI 10.1016/j.siny.2007.10.005; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Saifudeen Z, 2009, J AM SOC NEPHROL, V20, P2328, DOI 10.1681/ASN.2008121224; Sajithlal G, 2005, DEV BIOL, V284, P323, DOI 10.1016/j.ydbio.2005.05.029; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Sakurai H, 2003, SEMIN CELL DEV BIOL, V14, P217, DOI 10.1016/S1084-9521(03)00024-7; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schanstra JP, 2007, KIDNEY INT, V72, P442, DOI 10.1038/sj.ki.5002172; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sharma M, 2009, GENE, V439, P87, DOI 10.1016/j.gene.2009.03.014; Shen B, 2007, J AM SOC NEPHROL, V18, P1140, DOI 10.1681/ASN.2006101127; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Srinivas S, 1999, DEV GENET, V24, P241; Torres M, 1995, DEVELOPMENT, V121, P4057; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; VanLint C, 1996, GENE EXPRESSION, V5, P245; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yu J, 2004, CURR OPIN GENET DEV, V14, P550, DOI 10.1016/j.gde.2004.07.009; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	77	66	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32775	32789		10.1074/jbc.M111.248278	http://dx.doi.org/10.1074/jbc.M111.248278			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778236	Green Published, hybrid			2022-12-27	WOS:000294726800085
J	Hara, T; Mimura, K; Abe, T; Shioi, G; Seiki, M; Sakamoto, T				Hara, Toshiro; Mimura, Kouhei; Abe, Takaya; Shioi, Go; Seiki, Motoharu; Sakamoto, Takeharu			Deletion of the Mint3/Apba3 Gene in Mice Abrogates Macrophage Functions and Increases Resistance to Lipopolysaccharide-induced Septic Shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MT1-MMP; HYPOXIA; HIF-1-ALPHA; PROMOTES; PROTEIN; INTERACTS; FIH-1; CELLS	Two major metabolic systems are usually used to generate ATP: oxidative phosphorylation (OXPHOS) in the mitochondria and glycolysis. Most types of cells employ OXPHOS for ATP production during normoxia but then shift energy production from OXPHOS to glycolysis when exposed to hypoxia. Hypoxia-inducible factor-1 (HIF-1) is the master transcription factor regulating this metabolic shift. On the other hand, macrophages are unique in making use of glycolysis for ATP generation constitutively even during normoxia. We recently proposed that in macrophages, Mint3/APBA3 inhibits factor inhibiting HIF-1 (FIH-1) during normoxia, which in turn releases the suppression of HIF-1 activity by FIH-1. To demonstrate the physiological function of APBA3 in macrophages, we established Apba3(-/-) mice. The mutant mice presented no apparent gross phenotype but exhibited significant resistance against LPS-induced septic shock. The level of ATP in macrophages obtained from the mutant mice was reduced to 60% of the level observed in wild type cells, which in turn led to reduced ATP-dependent activities such as glycolysis, cytokine production, and motility. We also generated mutant mice with the Apba3 gene deleted specifically from cells of the myeloid lineage and confirmed that LPS-induced septic shock is mitigated significantly. Thus, we show cell type-specific regulation of energy production by APBA3 in macrophages using genetically manipulated mice. The specific function of APBA3 in macrophages might allow us to develop therapeutics to regulate aberrant macrophage function during infection and diseases.	[Hara, Toshiro; Mimura, Kouhei; Seiki, Motoharu; Sakamoto, Takeharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan; [Abe, Takaya; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuou Ku, Kobe, Hyogo, Japan	University of Tokyo; RIKEN	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. S.), by Grant-in-Aid for Japan Society for the Promotion of Science Fellows from Japan Society for the Promotion of Science (to T. H.), and by a Grant-in-Aid for Scientific Research (S) and on Priority Areas, i.e. the "Integrative Research toward the Conquest of Cancer", from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. S.).	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; OZMEN L, 1994, J EXP MED, V180, P907, DOI 10.1084/jem.180.3.907; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761	33	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32542	32551		10.1074/jbc.M111.271726	http://dx.doi.org/10.1074/jbc.M111.271726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778228	Green Published, hybrid			2022-12-27	WOS:000294726800064
J	Koyanagi, S; Hamdan, AM; Horiguchi, M; Kusunose, N; Okamoto, A; Matsunaga, N; Ohdo, S				Koyanagi, Satoru; Hamdan, Ahmed M.; Horiguchi, Michiko; Kusunose, Naoki; Okamoto, Akinori; Matsunaga, Naoya; Ohdo, Shigehiro			cAMP-response Element (CRE)-mediated Transcription by Activating Transcription Factor-4 (ATF4) Is Essential for Circadian Expression of the Period2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; NERVOUS-SYSTEM; MOUSE-LIVER; CLOCK; PROTEIN; BINDING; OSTEOBLASTS; METABOLISM; STRESS; CELLS	Activating transcription factor (ATF)/cAMP-response element (CRE)-binding (CREB) proteins induce the CRE-mediated gene transcription depending on the cAMP stimulation. cAMP-dependent signaling oscillates in a circadian manner, which in turn also sustains core oscillation machinery of the circadian clock. Here, we show that among the ATF/CREB family proteins, ATF4 is essential for the circadian expression of the Period2 (Per2) gene, a key component of the circadian clock. Transcription of the Atf4 gene was regulated by core components of the circadian clock, and its expression exhibited circadian oscillation in mouse tissues as well as embryonic fibroblasts. ATF4 bound to the CRE of the Per2 promoter in a circadian time-dependent manner and periodically activated the transcription of the Per2 gene. Consequently, the oscillation of the Per2 expression was attenuated in embryonic cells prepared from Atf4-null mice. Furthermore, the loss of ATF4 also disrupted the rhythms in the expression of other clock genes. These results suggest that ATF4 is a component responsible for sustaining circadian oscillation of CRE-mediated gene expression and also constitute a molecular link connecting cAMP-dependent signaling to the circadian clock.	[Koyanagi, Satoru; Hamdan, Ahmed M.; Horiguchi, Michiko; Kusunose, Naoki; Okamoto, Akinori; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan	Kyushu University	Ohdo, S (corresponding author), Kyushu Univ, Dept Pharmaceut, Grad Sch Pharmaceut Sci, 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020; Hamdan, Ahmed M/H-3794-2018	Hamdan, Ahmed M/0000-0003-4930-792X; Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Ministry of Education, Culture, Sport, Science, and Technology [20014016]; Japan Society for the Promotion of Science [21659041];  [21390047]	Ministry of Education, Culture, Sport, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid for Scientific Research on Priority Areas (Cancer) 20014016 (to S. O.) from the Ministry of Education, Culture, Sport, Science, and Technology, Grant-in-aid for Scientific Research (B) 21390047 (to S. O.), and Grant-in-aid for Challenging Exploratory Research 21659041 (to S. O.) from the Japan Society for the Promotion of Science.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Kato Y, 1999, MOL CELL ENDOCRINOL, V154, P151, DOI 10.1016/S0303-7207(99)00078-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; LIN YS, 1989, P NATL ACAD SCI USA, V86, P109, DOI 10.1073/pnas.86.1.109; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Shimamura M, 2003, BIOCHEM BIOPH RES CO, V300, P464, DOI 10.1016/S0006-291X(02)02807-3; Sowa H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P326; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; TAN Y, 1994, MOL CELL BIOL, V14, P7546, DOI 10.1128/MCB.14.11.7546; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888	33	64	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32416	32423		10.1074/jbc.M111.258970	http://dx.doi.org/10.1074/jbc.M111.258970			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768648	Green Published, hybrid			2022-12-27	WOS:000294726800051
J	Mangala, LS; Zhang, Y; He, ZH; Emami, K; Ramesh, GT; Story, M; Rohde, LH; Wu, HL				Mangala, Lingegowda S.; Zhang, Ye; He, Zhenhua; Emami, Kamal; Ramesh, Govindarajan T.; Story, Michael; Rohde, Larry H.; Wu, Honglu			Effects of Simulated Microgravity on Expression Profile of MicroRNA in Human Lymphoblastoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; MODELED MICROGRAVITY; HUMAN FIBROBLASTS; BREAST-CANCER; T-CELLS; TRANSCRIPTION; STRESS; SPACE; DIFFERENTIATION	This study explores the changes in expression of microRNA (miRNA) and related genes under simulated microgravity conditions. In comparison with static 1 x g, microgravity has been shown to alter global gene expression patterns and protein levels in cultured cells or animals. miRNA has recently emerged as an important regulator of gene expression, possibly regulating as many as one-third of all human genes. However, very little is known about the effect of altered gravity on miRNA expression. To test the hypothesis that the miRNA expression profile would be altered in zero gravity resulting in altered regulation of gene expression leading to metabolic or functional changes in cells, we cultured TK6 human lymphoblastoid cells in a high aspect ratio vessel (bioreactor) for 72 h either in the rotating condition to model microgravity in space or in the static condition as a control. Expression of several miRNAs was changed significantly in the simulated microgravity condition including miR150, miR-34a, miR-423-5p, miR-22, miR-141, miR-618, and miR-222. To confirm whether this altered miRNA expression correlates with gene expression and functional changes of the cells, we performed DNA microarray and validated the related genes using quantitative RT-PCR. Expression of several transcription factors including EGR2, ETS1, and c-REL was altered in simulated microgravity conditions. Taken together, the results reported here indicate that simulated microgravity alters the expression of miRNAs and genes in TK6 cells. To our knowledge, this study is the first to report the effects of simulated microgravity on the expression of miRNA and related genes.	[Mangala, Lingegowda S.; Zhang, Ye; Emami, Kamal; Wu, Honglu] NASA Johnson Space Ctr, Radiat Biophys Lab, Houston, TX 77058 USA; [Mangala, Lingegowda S.; He, Zhenhua; Rohde, Larry H.] Univ Houston Clear Lake, Dept Biol Sci, Houston, TX 77058 USA; [Zhang, Ye] Wyle Integrated Sci & Engn Grp, Houston, TX 77058 USA; [Ramesh, Govindarajan T.] Norfolk State Univ, Mol Toxicol Lab, Norfolk, VA 23504 USA; [Story, Michael] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Houston System; University of Houston; University of Houston Clear Lake; Norfolk State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mangala, LS (corresponding author), NASA Johnson Space Ctr, Radiat Biophys Lab, 2101 NASA Pkwy, Houston, TX 77058 USA.	lingegowda.s.mangala@nasa.gov	Story, Michael/AAX-2864-2021	Story, Michael/0000-0001-6522-4169	University of Houston Institute for Space Systems Operations	University of Houston Institute for Space Systems Operations	This work was supported in part by the University of Houston Institute for Space Systems Operations Program.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Barr YR, 2007, AVIAT SPACE ENVIR MD, V78, pA26; Boo LN, 2005, CANCER RES, V65, P6622, DOI 10.1158/0008-5472.CAN-05-0086; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Clement Jade Q., 2008, Genomics Proteomics & Bioinformatics, V6, P8, DOI 10.1016/S1672-0229(08)60017-0; Clement JQ., 2007, J GRAVIT PHYSL, V14, P121; Cooper D, 2001, IN VITRO CELL DEV-AN, V37, P63; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; GRILLI M, 1993, INT REV CYTOL, V143, P1; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; LEACH CS, 1990, ACTA ASTRONAUT, V21, P659, DOI 10.1016/0094-5765(90)90077-X; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Mackley JR, 2006, BIOCHEM J, V396, P307, DOI 10.1042/BJ20060057; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Molnar G, 1997, IN VITRO CELL DEV-AN, V33, P386; Nakatsuka H, 2006, AM J PHYSIOL-GASTR L, V291, pG26, DOI 10.1152/ajpgi.00467.2005; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; Pietrzyk RA, 2007, AVIAT SPACE ENVIR MD, V78, pA9; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Semov A, 2002, FASEB J, V16, P899, DOI 10.1096/fj.01-1002fje; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Wang YG, 2010, BLOOD CELL MOL DIS, V44, P191, DOI 10.1016/j.bcmd.2009.12.010; Ward NE, 2006, J CELL BIOCHEM, V99, P1187, DOI 10.1002/jcb.20988; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	46	43	54	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32483	32490		10.1074/jbc.M111.267765	http://dx.doi.org/10.1074/jbc.M111.267765			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775437	Green Published, hybrid			2022-12-27	WOS:000294726800058
J	Pingali, SV; O'Neill, HM; McGaughey, J; Urban, VS; Rempe, CS; Petridis, L; Smith, JC; Evans, BR; Heller, WT				Pingali, Sai Venkatesh; O'Neill, Hugh M.; McGaughey, Joseph; Urban, Volker S.; Rempe, Caroline S.; Petridis, Loukas; Smith, Jeremy C.; Evans, Barbara R.; Heller, William T.			Small Angle Neutron Scattering Reveals pH-dependent Conformational Changes in Trichoderma reesei Cellobiohydrolase I IMPLICATIONS FOR ENZYMATIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; FACTORS INFLUENCING GLYCOSYLATION; STRUCTURAL-CHARACTERIZATION; PROTEIN DENATURATION; N-GLYCOSYLATION; CORE PROTEIN; CELLULASE; CEL7A; MUTANT; MACROMOLECULES	Cellobiohydrolase I (Cel7A) of the fungus Trichoderma reesei (now classified as an anamorph of Hypocrea jecorina) hydrolyzes crystalline cellulose to soluble sugars, making it of key interest for producing fermentable sugars from biomass for biofuel production. The activity of the enzyme is pH-dependent, with its highest activity occurring at pH 4-5. To probe the response of the solution structure of Cel7A to changes in pH, we measured small angle neutron scattering of it in a series of solutions having pH values of 7.0, 6.0, 5.3, and 4.2. As the pH decreases from 7.0 to 5.3, the enzyme structure remains well defined, possessing a spatial differentiation between the cellulose binding domain and the catalytic core that only changes subtly. At pH 4.2, the solution conformation of the enzyme changes to a structure that is intermediate between a properly folded enzyme and a denatured, unfolded state, yet the secondary structure of the enzyme is essentially unaltered. The results indicate that at the pH of optimal activity, the catalytic core of the enzyme adopts a structure in which the compact packing typical of a fully folded polypeptide chain is disrupted and suggest that the increased range of structures afforded by this disordered state plays an important role in the increased activity of Cel7A through conformational selection.	[Pingali, Sai Venkatesh; O'Neill, Hugh M.; McGaughey, Joseph; Urban, Volker S.; Rempe, Caroline S.; Evans, Barbara R.; Heller, William T.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [Pingali, Sai Venkatesh; O'Neill, Hugh M.; Urban, Volker S.; Heller, William T.] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA; [O'Neill, Hugh M.; Urban, Volker S.; Heller, William T.] Oak Ridge Natl Lab, Neutron Scattering Sci Div, Oak Ridge, TN 37831 USA; [Petridis, Loukas; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Evans, BR (corresponding author), Oak Ridge Natl Lab, Div Chem Sci, POB 2008,MS-6194, Oak Ridge, TN 37831 USA.	evansb@ornl.gov; hellerwt@ornl.gov	Petridis, Loukas/B-3457-2009; smith, jeremy c/B-7287-2012; Heller, William/ABE-1104-2020; Urban, Volker S/N-5361-2015	Petridis, Loukas/0000-0001-8569-060X; smith, jeremy c/0000-0002-2978-3227; Heller, William/0000-0001-6456-2975; Urban, Volker S/0000-0002-7962-3408; Pingali, Sai Venkatesh/0000-0001-7961-4176; O'Neill, Hugh/0000-0003-2966-5527; Rempe, Caroline/0000-0002-8326-6423	Office of Biological and Environmental Research, U.S. Department of Energy [FWP ERKP752]; Office of Biological and Environmental Research [FWP ERKP291]; U.S. Department of Energy [DE-AC05-00OR22725]; Department of Energy Science Undergraduate Laboratory	Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy(United States Department of Energy (DOE)); Department of Energy Science Undergraduate Laboratory	This work was supported by the Genomic Science Program, Office of Biological and Environmental Research, U.S. Department of Energy, under Contract FWP ERKP752. The research at Oak Ridge National Laboratory Center for Structural Molecular Biology (CSMB) was supported by the Office of Biological and Environmental Research under Contract FWP ERKP291, using facilities supported by the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle, LLC for the U.S. Department of Energy under Contract DE-AC05-00OR22725.; Supported by a Department of Energy Science Undergraduate Laboratory internship and Higher Education Research Experience internship managed by Oak Ridge Institute of Science and Education.	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; Baker GA, 2009, CHEM ENG J, V147, P6, DOI 10.1016/j.cej.2008.11.033; Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Boer H, 2000, BIOTECHNOL BIOENG, V69, P486, DOI 10.1002/1097-0290(20000905)69:5<486::AID-BIT3>3.0.CO;2-N; CALMETTES P, 1994, BIOPHYS CHEM, V53, P105, DOI 10.1016/0301-4622(94)00081-6; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Das A, 2004, PRAMANA-J PHYS, V63, P363, DOI 10.1007/BF02704999; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; EVANS BR, 1994, ARCH BIOCHEM BIOPHYS, V312, P459, DOI 10.1006/abbi.1994.1332; FAGERSTAM LG, 1984, FEBS LETT, V167, P309, DOI 10.1016/0014-5793(84)80148-9; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guinier A., 1955, SMALL ANGLE SCATTERI; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Heller WT, 2005, ACTA CRYSTALLOGR D, V61, P33, DOI 10.1107/S0907444904025855; Heller WT, 2003, BIOCHEMISTRY-US, V42, P10579, DOI 10.1021/bi0348664; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Kirste R.G., 1982, SMALL ANGLE XRAY SCA, P387; Klarskov K, 1997, CARBOHYD RES, V304, P143, DOI 10.1016/S0008-6215(97)00215-2; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee HJ, 1997, J BIOTECHNOL, V57, P127, DOI 10.1016/S0168-1656(97)00111-9; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Porod V. G., 1951, KOLLOID Z, V124, P83; Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200; SCHMUCK M, 1986, BIOTECHNOL LETT, V8, P397, DOI 10.1007/BF01026739; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SHOEMAKER S, 1983, BIO-TECHNOL, V1, P691, DOI 10.1038/nbt1083-691; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WOODWARD J, 1994, BIOTECHNOL APPL BIOC, V19, P141; Zhong L, 2008, CELLULOSE, V15, P261, DOI 10.1007/s10570-007-9186-0; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005	45	25	25	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32801	32809		10.1074/jbc.M111.263004	http://dx.doi.org/10.1074/jbc.M111.263004			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784865	hybrid, Green Published			2022-12-27	WOS:000294726800087
J	Chiluiza, D; Bargo, S; Callahan, R; Rhoads, RE				Chiluiza, David; Bargo, Sharon; Callahan, Robert; Rhoads, Robert E.			Expression of Truncated Eukaryotic Initiation Factor 3e (eIF3e) Resulting from Integration of Mouse Mammary Tumor Virus (MMTV) Causes a Shift from Cap-dependent to Cap-independent Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; PROTEIN-SYNTHESIS; MESSENGER-RNAS; MALIGNANT-TRANSFORMATION; CELL-DEATH; GENE; REVEALS; PATHWAYS; OVEREXPRESSION; INHIBITOR	Integration of mouse mammary tumor virus (MMTV) at the common integration site Int6 occurs in the gene encoding eIF3e, the p48 subunit of translation initiation factor eIF3. Integration is at any of several introns of the Eif3e gene and causes the expression of truncated Eif3e mRNAs. Ectopic expression of the truncated eIF3e protein resulting from integration at intron 5 (3e5) induces malignant transformation, but by an unknown mechanism. Because eIF3e makes up at least part of the binding site for eIF4G, we examined the effects of 3e5 expression on protein synthesis. We developed an NIH3T3 cell line that contains a single copy of the 3e5 sequence at a predetermined genomic site. Co-immunoprecipitation indicated diminished binding of eIF3 to eIF4G, signifying a reduction in recruitment of the mRNA-unwinding machinery to the 43 S preinitiation complex. Cell growth and overall protein synthesis were decreased. Translation driven by the eIF4G-independent hepatitis C virus internal ribosome entry sequence (HCV IRES) in a bicistronic mRNA was increased relative to cap-dependent translation. Endogenous mRNAs encoding XIAP, c-Myc, CYR61, and Pim-1, which are translated in a cap-independent manner, were shifted to heavier polysomes whereas mRNAs encoding GAPDH, actin, L32, and L34, which are translated in a cap-dependent manner, were shifted to lighter polysomes. We propose that expression of 3e5 diminishes eIF4G interaction with eIF3 and causes abnormal gene expression at the translational level. The correlation between up-regulation of cap-independent translation and MMTV-induced tumorigenesis contrasts with the well established model for malignant transformation involving up-regulation of highly cap-dependent translation.	[Chiluiza, David; Rhoads, Robert E.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71106 USA; [Bargo, Sharon; Callahan, Robert] NCI, Mammary Biol & Tumorigenesis Lab, NIH, Bethesda, MD 20892 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rhoads, RE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.	rrhoad@lsuhsc.edu			NIGMS, National Institutes of Health [R01GM20818]; NATIONAL CANCER INSTITUTE [ZIABC005148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01GM20818 from the NIGMS, National Institutes of Health.	Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Baranick BT, 2008, P NATL ACAD SCI USA, V105, P4733, DOI 10.1073/pnas.0710650105; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Byrd MP, 2002, MOL CELL BIOL, V22, P4499, DOI 10.1128/MCB.22.13.4499-4511.2002; CALLAHAN R, 1976, P NATL ACAD SCI USA, V73, P3579, DOI 10.1073/pnas.73.10.3579; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P269, DOI 10.1007/s10911-008-9094-4; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Diella F, 1997, DNA CELL BIOL, V16, P839, DOI 10.1089/dna.1997.16.839; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Grudzien E, 2006, J BIOL CHEM, V281, P1857, DOI 10.1074/jbc.M509121200; Grzmil M, 2010, ONCOGENE, V29, P4080, DOI 10.1038/onc.2010.152; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; HOAREAU AK, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jin Y, 2004, CELL MOL NEUROBIOL, V24, P853, DOI 10.1007/s10571-004-6924-9; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Jopling CL, 2004, RNA, V10, P287, DOI 10.1261/rna.5138804; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Kindich R, 2005, CLIN CHEM, V51, P649, DOI 10.1373/clinchem.2004.045013; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Maquat LE, 2009, BIOCHEM SOC T, V37, P1287, DOI 10.1042/BST0371287; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Raafat A, 2009, ONCOGENE, V28, P219, DOI 10.1038/onc.2008.379; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Tekmal R.R., 1997, FRONT BIOSCI, V2, P519; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; YAN RQ, 1992, J BIOL CHEM, V267, P23226; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	57	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31288	31296		10.1074/jbc.M111.267294	http://dx.doi.org/10.1074/jbc.M111.267294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21737453	Green Published, hybrid			2022-12-27	WOS:000294487500024
J	Egeler, EL; Urner, LM; Rakhit, R; Liu, CW; Wandless, TJ				Egeler, Emily L.; Urner, Lorenz M.; Rakhit, Rishi; Liu, Corey W.; Wandless, Thomas J.			Ligand-switchable Substrates for a Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-QUALITY CONTROL; PLASMODIUM-FALCIPARUM; TRANSITION-STATE; SMALL MOLECULES; DEGRADATION; STABILITY; CHAPERONE; FKBP12; IDENTIFICATION; RECOGNITION	Cellular maintenance of protein homeostasis is essential for normal cellular function. The ubiquitin-proteasome system (UPS) plays a central role in processing cellular proteins destined for degradation, but little is currently known about how misfolded cytosolic proteins are recognized by protein quality control machinery and targeted to the UPS for degradation in mammalian cells. Destabilizing domains (DDs) are small protein domains that are unstable and degraded in the absence of ligand, but whose stability is rescued by binding to a high affinity cell-permeable ligand. In the work presented here, we investigate the biophysical properties and cellular fates of a panel of FKBP12 mutants displaying a range of stabilities when expressed in mammalian cells. Our findings correlate observed cellular instability to both the propensity of the protein domain to unfold in vitro and the extent of ubiquitination of the protein in the non-permissive (ligand-free) state. We propose a model in which removal of stabilizing ligand causes the DD to unfold and be rapidly ubiquitinated by the UPS for degradation at the proteasome. The conditional nature of DD stability allows a rapid and non-perturbing switch from stable protein to unstable UPS substrate unlike other methods currently used to interrogate protein quality control, providing tunable control of degradation rates.	[Egeler, Emily L.; Urner, Lorenz M.; Rakhit, Rishi; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Wandless, TJ (corresponding author), 318 Campus Dr,Clark Ctr W350A, Stanford, CA 94305 USA.	wandless@stanford.edu			National Institutes of Health [GM068589]; Canadian Institutes of Health Research; Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046, R01GM068589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM068589.; Supported by a postdoctoral fellowship from the Canadian Institutes of Health Research.; Supported in part by the Stanford University School of Medicine.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fulton KF, 1999, J MOL BIOL, V291, P445, DOI 10.1006/jmbi.1999.2942; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Perng YC, 2011, J VIROL, V85, P4841, DOI 10.1128/JVI.02344-10; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; ROSEN MK, 1991, BIOCHEMISTRY-US, V30, P4774, DOI 10.1021/bi00233a020; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sambrook J., 1989, MOL CLONING, pA1; Schoeber JPH, 2009, AM J PHYSIOL-RENAL, V296, pF204, DOI 10.1152/ajprenal.90473.2008; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Xu Q, 2004, MOL CANCER THER, V3, P1263; Yano M, 2004, BIOMACROMOLECULES, V5, P1465, DOI 10.1021/bm049957a; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	48	41	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31328	31336		10.1074/jbc.M111.264101	http://dx.doi.org/10.1074/jbc.M111.264101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768107	Green Published, hybrid			2022-12-27	WOS:000294487500028
J	Hu, YZ; Mivechi, NF				Hu, Yanzhong; Mivechi, Nahid F.			Promotion of Heat Shock Factor Hsf1 Degradation via Adaptor Protein Filamin A-interacting Protein 1-Like (FILIP-1L)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; MOLECULAR CHAPERONES; TARGETED DISRUPTION; SUMO MODIFICATION; LENS DEVELOPMENT; FACTOR-II; STRESS; PHOSPHORYLATION; BINDING; DIFFERENTIATION	Heat shock factor Hsf1 is involved in the regulation of a variety of cellular processes including heat shock response, development and differentiation, aging, and tumorigenesis. Hsf1 transcriptional activity is tightly controlled through phosphorylation, sumoylation, and acetylation, and through association with a number of regulatory proteins. However, regulation of Hsf1 protein stability or turnover remains unknown. We have identified a novel Hsf1-interacting protein, FILIP-1L, that was found to bind to Hsf1 through yeast two-hybrid screening. FILIP-1L encodes multiple isoforms spanning from 711 to 1135 amino acid residues. FILIP-1L contains four coiled-coil and two N-terminal leucine zipper domains. Ectopic expression of FILIP-1L reduces the expression of the Hsf1 protein because FILIP-1L promotes Hsf1 ubiquitination and degradation through the ubiquitin-proteasome system, leading to a reduction in Hsf1-mediated transcription. FILIP-1L, Hsf1, and the ubiquitin-binding domain of HhR23A, a receptor that transports polyubiquitinated proteins to the 19 S proteasome subunit targeting them for degradation, are found in a complex. This indicates that FILIP-1L is a potential adaptor that is involved in the Hsf1 degradation pathway. Taken together, our results indicate that FILIP-1L interacts with Hsf1, controlling its stability and thus modulating the heat shock response. These data indicate a novel function for FILIP-1L and a pathway for Hsf1 degradation through the ubiquitin-proteasome system.	[Hu, Yanzhong; Mivechi, Nahid F.] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA 30912 USA; [Mivechi, Nahid F.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA; [Mivechi, Nahid F.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mivechi, NF (corresponding author), 1410 Laney Walker Blvd,CN-3141, Augusta, GA 30912 USA.	nmivechi@georgiahealth.edu			National Institutes of Health [CA062130, CA132640]; Veterans Affairs Award [1I01BX000161]; NATIONAL CANCER INSTITUTE [R01CA132640, R01CA062130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA062130 and CA132640 (to N. F. M.).; Recipient of Veterans Affairs Award 1I01BX000161. To whom correspondence should be addressed: 1410 Laney Walker Blvd., CN-3141, Augusta, GA 30912. Tel.: 706-721-8759; E-mail: nmivechi@georgiahealth.edu.	Ahlskog JK, 2010, MOL CELL BIOL, V30, P5608, DOI 10.1128/MCB.01506-09; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dai RJ, 2000, J BIOL CHEM, V275, P18210, DOI 10.1074/jbc.M000958200; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Homma S, 2007, J NEUROSCI, V27, P7974, DOI 10.1523/JNEUROSCI.0006-07.2007; Hu YZ, 2003, J BIOL CHEM, V278, P17299, DOI 10.1074/jbc.M300788200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; Kwon M, 2008, CANCER RES, V68, P7332, DOI 10.1158/0008-5472.CAN-08-1087; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Tandle AT, 2005, CYTOKINE, V30, P347, DOI 10.1016/j.cyto.2005.01.020; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	36	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31397	31408		10.1074/jbc.M111.255851	http://dx.doi.org/10.1074/jbc.M111.255851			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784850	hybrid, Green Published			2022-12-27	WOS:000294487500034
J	Rana, NA; Nita-Lazar, A; Takeuchi, H; Kakuda, S; Luther, KB; Haltiwanger, RS				Rana, Nadia A.; Nita-Lazar, Aleksandra; Takeuchi, Hideyuki; Kakuda, Shinako; Luther, Kelvin B.; Haltiwanger, Robert S.			O-Glucose Trisaccharide Is Present at High but Variable Stoichiometry at Multiple Sites on Mouse Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; FACTOR-LIKE REPEATS; HAMSTER OVARY CELLS; FACTOR-LIKE MODULES; FACTOR-LIKE DOMAIN; LIGAND-BINDING; LUNATIC-FRINGE; FUCOSYL-TRANSFERASE; LINKED FUCOSE; FACTOR-IX	Notch activity is regulated by both O-fucosylation and O-glucosylation, and Notch receptors contain multiple predicted sites for both. Here we examine the occupancy of the predicted O-glucose sites on mouse Notch1 (mN1) using the consensus sequence (CXSXPC2)-X-1. We show that all of the predicted sites are modified, although the efficiency of modifying O-glucose sites is site- and cell type-dependent. For instance, although most sites are modified at high stoichiometries, the site at EGF 27 is only partially glucosylated, and the occupancy of the site at EGF 4 varies with cell type. O-Glucose is also found at a novel, non-traditional consensus site at EGF 9. Based on this finding, we propose a revision of the consensus sequence for O-glucosylation to allow alanine N-terminal to cysteine 2: (CXSX)-X-1(A/P)C-2. We also show through biochemical and mass spectral analyses that serine is the only hydroxyamino acid that is modified with O-glucose on EGF repeats. The O-glucose at all sites is efficiently elongated to the trisaccharide Xyl-Xyl-Glc. To establish the functional importance of individual O-glucose sites in mN1, we used a cell-based signaling assay. Elimination of most individual sites shows little or no effect on mN1 activation, suggesting that the major effects of O-glucose are mediated by modification of multiple sites. Interestingly, elimination of the site in EGF 28, found in the Abruptex region of Notch, does significantly reduce activity. These results demonstrate that, like O-fucose, the O-glucose modifications of EGF repeats occur extensively on mN1, and they play important roles in Notch function.	[Rana, Nadia A.; Nita-Lazar, Aleksandra; Takeuchi, Hideyuki; Kakuda, Shinako; Luther, Kelvin B.; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.	rhaltiwanger@ms.cc.sunysb.edu	Takeuchi, Hideyuki/AAZ-9210-2020; Nita-Lazar, Aleksandra/N-3740-2018	Nita-Lazar, Aleksandra/0000-0002-8523-605X; Luther, Kelvin/0000-0001-9438-9675	National Institutes of Health [GM61126]; NCI [T32 CA009176]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001085, ZIAAI001084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61126 and NCI T32 CA009176.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chapman G, 2008, ADV EXP MED BIOL, V638, P95; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; de Celis JF, 2000, DEVELOPMENT, V127, P1291; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hiruma-Shimizu K, 2010, J AM CHEM SOC, V132, P14857, DOI 10.1021/ja105216u; IASCONE M, 2011, CLIN GENET IN PRESS; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krogh TN, 1997, EUR J BIOCHEM, V244, P334, DOI 10.1111/j.1432-1033.1997.00334.x; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; Louvi A, 2006, DEV NEUROSCI-BASEL, V28, P5, DOI 10.1159/000090748; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moran JL, 1999, MAMM GENOME, V10, P535, DOI 10.1007/s003359901039; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; NISHIMURA H, 1992, J BIOCHEM-TOKYO, V111, P460, DOI 10.1093/oxfordjournals.jbchem.a123780; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; Stanley P, 2009, IMMUNOL REV, V230, P201, DOI 10.1111/j.1600-065X.2009.00791.x; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; Wiweger MI, 2011, J PATHOL, V223, P531, DOI 10.1002/path.2824; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	65	68	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31623	31637		10.1074/jbc.M111.268243	http://dx.doi.org/10.1074/jbc.M111.268243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757702	hybrid, Green Published			2022-12-27	WOS:000294487500056
J	Ben-Ami, I; Yao, Z; Naor, Z; Seger, R				Ben-Ami, Ido; Yao, Zhong; Naor, Zvi; Seger, Rony			RETRACTED: G(q) Protein-induced Apoptosis Is Mediated by AKT Kinase Inhibition That Leads to Protein Kinase C-induced c-Jun N-terminal Kinase Activation (Retracted article. See vol. 292, pg. 8848, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							GONADOTROPIN-RELEASING-HORMONE; G-ALPHA-Q; GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER CELLS; COUPLED RECEPTORS; SIGNALING PATHWAYS; CARDIAC-HYPERTROPHY; NEGATIVE REGULATION; HELA-CELLS; IN-VITRO	G(q) protein-coupled receptors (G(q)PCRs) regulate various cellular processes, including mainly proliferation and differentiation. In a previous study we found that in prostate cancer cells, the G(q)PCR of gonadotropin-releasing hormone (GnRH) induces apoptosis by reducing the PKC-dependent AKT activity and elevating JNK phosphorylation. Because it was thought that GqPCRs mainly induce activation of AKT, we first undertook to examine how general this phenomenon is. In a screen of 21 cell lines we found that PKC activation results in the reduction of AKT activity, which correlates nicely with JNK activation and in some cases with apoptosis. To understand further the signaling pathways involved in this stimulation, we studied in detail SVOG-4O and alpha T3-1 cells. We found that prostaglandin F2 alpha and GnRH agonist (GnRH-a) indeed induce significant G(q) and PKC-dependent apoptosis in these cells. This is mediated by two signaling branches downstream of PKC, which converge at the level of MLK3 upstream of JNK. One branch consists of c-Src activation of the JNK cascade, and the second involves reduction of AKT activity that alleviates its inhibitory effect on MLK3 to allow the flow of the c-Src signal to JNK. At the MAPKK level, we found that the signal is transmitted by MKK7 and not MKK4. Our results present a general mechanism that mediates a G(q)PCR-induced, death receptor-independent, apoptosis in physiological, as well as cancer-related systems.	[Ben-Ami, Ido; Yao, Zhong; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Ben-Ami, Ido] Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Obstet & Gynecol, IL-69978 Ramat Aviv, Israel; [Naor, Zvi] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel	Weizmann Institute of Science; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Seger, R (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	rony.seger@weizmann.ac.il			European Union [LSHC CT-2006-037731]; Israel Science Foundation	European Union(European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported by a grants from the European Union Sixth Framework Program (GROWTHSTOP, LSHC CT-2006-037731) and from the Israel Science Foundation.	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Benard O, 2001, J BIOL CHEM, V276, P4554, DOI 10.1074/jbc.M006995200; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; Cigola E, 1997, EXP CELL RES, V231, P363, DOI 10.1006/excr.1997.3477; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dobkin-Bekman M, 2009, MOL ENDOCRINOL, V23, P1850, DOI 10.1210/me.2008-0260; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kim HG, 2008, NEUROSIGNALS, V16, P165, DOI 10.1159/000111561; Kraus S, 2006, CANCER LETT, V234, P109, DOI 10.1016/j.canlet.2005.02.038; Kraus S, 2004, CANCER RES, V64, P5736, DOI 10.1158/0008-5472.CAN-04-1156; Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luttrell LM, 2002, J CELL SCI, V115, P455; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsubara H, 2000, J CLIN ENDOCR METAB, V85, P1620, DOI 10.1210/jc.85.4.1620; Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; New DC, 2007, FEBS J, V274, P6025, DOI 10.1111/j.1742-4658.2007.06116.x; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rose A, 2004, J BIOL CHEM, V279, P52500, DOI 10.1074/jbc.M404571200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; RUEDA BR, 1995, BIOL REPROD, V52, P305, DOI 10.1095/biolreprod52.2.305; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Ueda H, 2004, EXP CELL RES, V298, P207, DOI 10.1016/j.yexcr.2004.04.015; Ueda H, 2001, J BIOL CHEM, V276, P42527, DOI 10.1074/jbc.M102529200; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wu EHT, 2006, FEBS J, V273, P2388, DOI 10.1111/j.1742-4658.2006.05245.x; Wu J, 2002, BBA-MOL CELL BIOL L, V1582, P100, DOI 10.1016/S1388-1981(02)00143-9	45	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31022	31031		10.1074/jbc.M111.247726	http://dx.doi.org/10.1074/jbc.M111.247726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757743	Green Published, hybrid			2022-12-27	WOS:000294283600080
J	Koutmos, M; Gherasim, C; Smith, JL; Banerjee, R				Koutmos, Markos; Gherasim, Carmen; Smith, Janet L.; Banerjee, Ruma			Structural Basis of Multifunctionality in a Vitamin B-12-processing Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE TRANSFERASES; METHYLMALONIC ACIDURIA; IDENTIFICATION; PROTEINS; LIGAND	An early step in the intracellular processing of vitamin B-12 involves CblC, which exhibits dual reactivity, catalyzing the reductive decyanation of cyanocobalamin (vitamin B-12), and the dealkylation of alkylcobalamins (e.g. methylcobalamin; MeCbl). Insights into how the CblC scaffold supports this chemical dichotomy have been unavailable despite it being the most common locus of patient mutations associated with inherited cobalamin disorders that manifest in both severe homocystinuria and methylmalonic aciduria. Herein, we report structures of human CblC, with and without bound MeCbl, which provide novel biochemical insights into its mechanism of action. Our results reveal that CblC is the most divergent member of the NADPH-dependent flavin reductase family and can use FMN or FAD as a prosthetic group to catalyze reductive decyanation. Further-more, CblC is the first example of an enzyme with glutathione transferase activity that has a sequence and structure unrelated to the GST superfamily. CblC thus represents an example of evolutionary adaptation of a common structural platform to perform diverse chemistries. The CblC structure allows us to rationalize the biochemical basis of a number of pathological mutations associated with severe clinical phenotypes.	[Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48106 USA; Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48106 USA.	rbanerje@umich.edu		Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [DK45776, GM024908]; National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024908, R01GM024908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45776 (to R. B.) and GM024908 (to Rowena G. Matthews).; We thank Rowena G. Matthews for critical discussions and for input on the manuscript. We acknowledge the General Medicine and Cancer Collaborative Access Team, supported by the National Institute of General Medical Sciences (Y1-GM-1104) and the National Cancer Institute (Y1-CO-1020), for beam time and assistance at the Advanced Photon Source. We thank W. C. Brown and J. Delproposto (Life Sciences Institute, University of Michigan, Ann Arbor, MI) for cloning CblC in one of the expression plasmids (construct 3).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BROWN KL, 1984, J AM CHEM SOC, V106, P7894, DOI 10.1021/ja00337a043; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froese DS, 2009, MOL GENET METAB, V98, P338, DOI 10.1016/j.ymgme.2009.07.014; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Kim P, 2005, NUCLEIC ACIDS RES, V33, pD75, DOI 10.1093/nar/gki118; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; MASSEY V, 1977, J BIOL CHEM, V252, P5612; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEZACKA EH, 1993, BIOCHIM BIOPHYS ACTA, V1157, P167, DOI 10.1016/0304-4165(93)90061-C; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458	26	60	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29780	29787		10.1074/jbc.M111.261370	http://dx.doi.org/10.1074/jbc.M111.261370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697092	Green Published, hybrid			2022-12-27	WOS:000294046600037
J	Nagashima, Y; Kowa, H; Tsuji, S; Iwata, A				Nagashima, Yu; Kowa, Hisatomo; Tsuji, Shoji; Iwata, Atsushi			FAT10 Protein Binds to Polyglutamine Proteins and Modulates Their Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HUNTINGTONS-DISEASE; DEGRADATION; GENE; NEURODEGENERATION; PATHWAYS; IDENTIFICATION; AGGREGATION; DEATH; SUMO	Expansion of polyglutamine (pQ) chain by expanded CAG repeat causes dominantly inherited neurodegeneration such as Huntington disease, dentatorubral-pallidoluysian atrophy (DRPLA), and numbers of other spinocerebellar ataxias. Expanded pQ disrupts the stability of the pQ-harboring protein and increases its susceptibility to aggregation. Aggregated pQ protein is recognized by the ubiquitin proteasome system, and the enzyme ubiquitin ligase covalently attaches ubiquitin, which serves as a degradation signal by the proteasome. However, accumulation of the aggregated proteins in the diseased brain suggests insufficient degradation machinery. Ubiquitin has several functionally related proteins that are similarly attached to target proteins through its C terminus glycine residue. They are called ubiquitin-like molecules, and some of them are similarly related to the protein degradation pathway. One of the ubiquitin- like molecules, FAT10, is known to accelerate protein degradation through a ubiquitin-independent manner, but its role in pQ aggregate degradation is completely unknown. Thus we investigated its role in a Huntington disease cellular model and found that FAT10 molecules were covalently attached to huntingtin through their C terminus glycine. FAT10 binds preferably to huntingtin with a short pQ chain and completely aggregated huntingtin was FAT10-negative. In addition, ataxin-1,3 and DRPLA proteins were both positive for FAT10, and aggregation enhancement was observed upon FAT10 knockdown. These findings were similar to those for huntingtin. Our new finding will provide a new role for FAT10 in the pathogenesis of polyglutamine diseases.	[Iwata, Atsushi] Univ Tokyo, Dept Mol Neurosci Neurodegenerat, Tokyo 1138655, Japan; [Nagashima, Yu; Tsuji, Shoji; Iwata, Atsushi] Univ Tokyo, Dept Neurol, Tokyo 1138655, Japan; [Iwata, Atsushi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kowa, Hisatomo] Kobe Univ, Dept Neurol, Kobe, Hyogo 6500017, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kobe University	Iwata, A (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	iwata-tky@umin.ac.jp	Iwata, Atsushi/A-9598-2013; Iwata, Atsushi/AAH-8924-2019	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	Japan Society for the Promotion of Science; Japan Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation; Janssen Pharmaceuticals	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by Kakenhi from the Japan Society for the Promotion of Science, the Japan Ministry of Education, Culture, Sports, Science and Technology; PRESTO from the Japan Science and Technology Agency, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Brain Science Foundation, the Cell Science Research Foundation, and Janssen Pharmaceuticals.	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Herrmann J, 2004, CARDIOVASC RES, V61, P11, DOI 10.1016/j.cardiores.2003.09.033; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; ONODERA O, 1995, AM J HUM GENET, V57, P1050; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang DW, 2006, ONCOGENE, V25, P2318, DOI 10.1038/sj.onc.1209220; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	31	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29594	29600		10.1074/jbc.M111.261032	http://dx.doi.org/10.1074/jbc.M111.261032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757738	Green Published, hybrid			2022-12-27	WOS:000294046600017
J	Bos, MP; Tommassen, J				Bos, Martine P.; Tommassen, Jan			The LptD Chaperone LptE Is Not Directly Involved in Lipopolysaccharide Transport in Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; CELL-ENVELOPE BIOGENESIS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; INNER-MEMBRANE; LIPID-A; FUNCTIONAL-ANALYSIS; EXPORT PATHWAY; PROTEIN; BIOSYNTHESIS	The biosynthesis of lipopolysaccharide (LPS) in Gram-negative bacteria is well understood, in contrast to the transport to its destination, the outer leaflet of the outer membrane. In Escherichia coli, synthesis and transport of LPS are essential processes. Neisseria meningitidis, conversely, can survive without LPS and tolerates inactivation of genes involved in LPS synthesis and transport. Here, we analyzed whether the LptA, LptB, LptC, LptE, LptF, and LptG proteins, recently implicated in LPS transport in E. coli, function similarly in N. meningitidis. None of the analyzed proteins was essential in N. meningitidis, consistent with their expected roles in LPS transport and additionally demonstrating that they are not required for an essential process such as phospholipid transport. As expected, the absence of most of the Lpt proteins resulted in a severe defect in LPS transport. However, the absence of LptE did not disturb transport of LPS to the cell surface. LptE was found to be associated with LptD, and its absence affected total levels of LptD, suggesting a chaperone-like role for LptE in LptD biogenesis. The absence of a direct role of LptE in LPS transport was substantiated by bioinformatic analyses showing a low conservation of LptE in LPS-producing bacteria. Apparently, the role of LptE in N. meningitidis deviates from that in E. coli, suggesting that the Lpt system does not function in a completely conserved manner in all Gram-negative bacteria.	[Bos, Martine P.] Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Bos, MP (corresponding author), Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.	M.Bos@uu.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945	Netherlands Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research	Netherlands Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research	This work was supported by the Netherlands Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research.	Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Bowyer A, 2011, BIOCHEM BIOPH RES CO, V404, P1093, DOI 10.1016/j.bbrc.2010.12.121; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Haarmann R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454124; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steeghs L, 2002, CELL MICROBIOL, V4, P599, DOI 10.1046/j.1462-5822.2002.00214.x; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Tefsen B, 2005, J BIOL CHEM, V280, P35961, DOI 10.1074/jbc.M509026200; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	46	34	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28688	28696		10.1074/jbc.M111.239673	http://dx.doi.org/10.1074/jbc.M111.239673			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705335	hybrid, Green Published			2022-12-27	WOS:000293837000006
J	Wang, SY; Thibault, G; Ng, DTW				Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.			Routing Misfolded Proteins through the Multivesicular Body (MVB) Pathway Protects against Proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; RETICULUM-ASSOCIATED DEGRADATION; DOA4 DEUBIQUITINATING ENZYME; AMINO-ACID PERMEASE; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; YEAST VACUOLE; ESCRT-I; SORTING COMPLEX	The secretory pathway maintains multiple quality control checkpoints. Initially, endoplasmic reticulum-associated degradation pathways monitor protein folding to retain and eliminate aberrant products. Despite its broad client range, some molecules escape detection and traffic to Golgi membranes. There, a poorly understood mechanism termed Golgi quality control routes aberrant proteins for lysosomal/vacuolar degradation. To better understand Golgi quality control, we examined the processing of the obligate substrate Wsc1p. Misfolded Wsc1p does not use routes of typical vacuolar membrane proteins. Instead, it partitions into intralumenal vesicles of the multivesicular body (MVB) pathway, mediated by the E3 ubiquitin ligase Rsp5p. Its subsequent transport to the vacuolar lumen is essential for complete molecule breakdown. Surprisingly, the transport mode plays a second crucial function in neutralizing potential substrate toxicity. Eliminating the MVB sorting signal diverted molecules to the vacuolar limiting membrane, resulting in the generation of toxic by-products. These data demonstrate a new role of the MVB pathway in protein quality control.	[Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Wang, Songyu; Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Ng, DTW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.	davis@tll.org.sg	Thibault, Guillaume/J-9730-2013	Thibault, Guillaume/0000-0002-7926-4812	Temasek Trust; Singapore Millennium Foundation	Temasek Trust; Singapore Millennium Foundation	This work was supported by funds from the Temasek Trust and by grants from the Singapore Millennium Foundation (predoctoral fellowship (to S. W.) and postdoctoral fellowship (to G. T.)).	Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Jakob CA, 2001, EMBO REP, V2, P423; Jenness DD, 1997, MOL CELL BIOL, V17, P6236, DOI 10.1128/MCB.17.11.6236; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jorgensen MU, 1999, EUR J BIOCHEM, V260, P461, DOI 10.1046/j.1432-1327.1999.00176.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Sambrook J., 2002, MOL CLONING LAB MANU; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang SY, 2010, MOL BIOL CELL, V21, P1153, DOI 10.1091/mbc.E09-10-0910; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0	91	41	42	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29376	29387		10.1074/jbc.M111.233346	http://dx.doi.org/10.1074/jbc.M111.233346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708947	Green Published, hybrid			2022-12-27	WOS:000293837000072
J	Bedia, C; Casas, J; Andrieu-Abadie, N; Fabrias, G; Levade, T				Bedia, Carmen; Casas, Josefina; Andrieu-Abadie, Nathalie; Fabrias, Gemma; Levade, Thierry			Acid Ceramidase Expression Modulates the Sensitivity of A375 Melanoma Cells to Dacarbazine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; MALIGNANT GLIOMA-CELLS; PROSTATE-CANCER; TUMOR-GROWTH; INDUCED CYTOTOXICITY; INDUCED AUTOPHAGY; UP-REGULATION; SPHINGOLIPIDS; DEATH; INHIBITION	Dacarbazine (DTIC) is the treatment of choice for metastatic melanoma, but its response in patients remains very poor. Ceramide has been shown to be a death effector and to play an important role in regulating cancer cell growth upon chemotherapy. Among ceramidases, the enzymes that catabolize ceramide, acid ceramidase (aCDase) has been implicated in cancer progression. Here we show that DTIC elicits a time-and dose-dependent decrease of aCDase activity and an increase of intracellular ceramide levels in human A375 melanoma cells. The loss of enzyme activity occurred as a consequence of reactive oxygen species-dependent activation of cathepsin B-mediated degradation of aCDase. These events preceded autophagic features and loss of cell viability. Down-regulation of acid but not neutral or alkaline ceramidase 2 resulted in elevated levels of ceramide and sensitization to the toxic effects of DTIC. Conversely, inducible overexpression of acid but not neutral ceramidase reduced ceramide levels and conferred resistance to DTIC. In conclusion, we report that increased levels of ceramide, due to enhanced degradation of aCDase, are in part responsible for the cell death effects of DTIC. These results suggest that down-regulation of aCDase alone or in combination with DTIC may represent a useful tool in the treatment of metastatic melanoma.	[Levade, Thierry] CHU Rangueil, Ctr Rech Cancerol Toulouse, Equipe 4, INSERM,UMR1037, F-31432 Toulouse 4, France; [Bedia, Carmen; Andrieu-Abadie, Nathalie; Levade, Thierry] Univ Toulouse 3, Ctr Rech Cancerol Toulouse, F-31062 Toulouse, France; [Casas, Josefina; Fabrias, Gemma] CSIC, Inst Quim Avancada Catalunya, Dept Biomed Chem, ES-08034 Barcelona, Spain; [Levade, Thierry] Hop Purpan, Inst Federatif Biol, Lab Biochim Metab, F-31059 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); CHU de Toulouse	Levade, T (corresponding author), CHU Rangueil, Ctr Rech Cancerol Toulouse, Equipe 4, INSERM,UMR1037, BP 84225, F-31432 Toulouse 4, France.	thierry.levade@inserm.fr	Casas, Josefina/L-7934-2014; Andrieu-Abadie, Nathalie/N-6793-2013; Bedia, Carmen/H-9185-2015; Bedia, Carmen/D-3827-2013; Levade, Thierry/O-8948-2014	Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Bedia, Carmen/0000-0003-4584-5843; Fabrias, Gemma/0000-0001-7162-3772	INSERM, Universite Paul Sabatier the Vaincre les Maladies Lysosomales Foundation; Spanish Ministry of Science and Innovation [SAF2008-00706]; Generalitat de Catalunya [2009-SGR-1072]; Obra Social La Caixa; Agencia de Gestio d Ajuts Universitaris i de Recerca [2007-BP-A00129]	INSERM, Universite Paul Sabatier the Vaincre les Maladies Lysosomales Foundation(Institut National de la Sante et de la Recherche Medicale (Inserm)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Obra Social La Caixa(La Caixa Foundation); Agencia de Gestio d Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported in part by INSERM, Universite Paul Sabatier the Vaincre les Maladies Lysosomales Foundation, the Spanish Ministry of Science and Innovation (Grant SAF2008-00706), and the Generalitat de Catalunya (Grant 2009-SGR-1072).; Supported by the Obra Social La Caixa and Agencia de Gestio d Ajuts Universitaris i de Recerca (Grant 2007-BP-A00129), Generalitat de Catalunya. Present address: Dept. of Biomedicinal Chemistry, Institut de Quimica Avancada de Catalunya, CSIC, 08034 Barcelona, Spain.	Bedia C, 2010, J LIPID RES, V51, P3542, DOI 10.1194/jlr.D010033; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauvier D, 2002, INT J ONCOL, V20, P855; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Djavaheri-Mergny M, 2007, CELL RES, V17, P576, DOI 10.1038/cr.2007.58; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; Musumarra G, 2003, BIOL CHEM, V384, P321, DOI 10.1515/BC.2003.037; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pourahmad J, 2009, CANCER CHEMOTH PHARM, V65, P89, DOI 10.1007/s00280-009-1007-8; Raisova M, 2002, FEBS LETT, V516, P47, DOI 10.1016/S0014-5793(02)02472-9; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Selzner M, 2001, CANCER RES, V61, P1233; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; WENGER DA, 1991, TECHNIQUES DIAGNOSTI, P587	39	62	69	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28200	28209		10.1074/jbc.M110.216382	http://dx.doi.org/10.1074/jbc.M110.216382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700700	Green Published, hybrid			2022-12-27	WOS:000293557800038
J	Gandotra, S; Lim, K; Girousse, A; Saudek, V; O'Rahilly, S; Savage, DB				Gandotra, Sheetal; Lim, Koini; Girousse, Amandine; Saudek, Vladimir; O'Rahilly, Stephen; Savage, David B.			Human Frame Shift Mutations Affecting the Carboxyl Terminus of Perilipin Increase Lipolysis by Failing to Sequester the Adipose Triglyceride Lipase (ATGL) Coactivator AB-hydrolase-containing 5 (ABHD5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLETS; STIMULATED LIPOLYSIS; ADIPOCYTE LIPOLYSIS; PROTEIN; CGI-58; TRANSLOCATION; ACTIVATION; EXPRESSION; RESISTANCE	Perilipin (PLIN1) is a constitutive adipocyte lipid droplet coat protein. N-terminal amphipathic helices and central hydrophobic stretches are thought to anchor it on the lipid droplet, where it appears to function as a scaffold protein regulating lipase activity. We recently identified two different C-terminal PLIN1 frame shift mutations (Leu-404fs and Val-398fs) in patients with a novel subtype of partial lipodystrophy, hypertriglyceridemia, severe insulin resistance, and type 2 diabetes (Gandotra, S., Le Dour, C., Bottomley, W., Cervera, P., Giral, P., Reznik, Y., Charpentier, G., Auclair, M., Delepine, M., Barroso, I., Semple, R. K., Lathrop, M., Lascols, O., Capeau, J., O'Rahilly, S., Magre, J., Savage, D. B., and Vigouroux, C. (2011) N. Engl. J. Med. 364, 740-748.) When overexpressed in preadipocytes, both mutants fail to inhibit basal lipolysis. Here we used bimolecular fluorescence complementation assays to show that the mutants fail to bind ABHD5, permitting its constitutive coactivation of ATGL, resulting in increased basal lipolysis. siRNA-mediated knockdown of either ABHD5 or ATGL expression in the stably transfected cells expressing mutant PLIN1 reduced basal lipolysis. These insights from naturally occurring human variants suggest that the C terminus sequesters ABHD5 and thus inhibits basal ATGL activity. The data also suggest that pharmacological inhibition of ATGL could have therapeutic potential in patients with this rare but metabolically serious disorder.	[Gandotra, Sheetal] Univ Cambridge, Addenbrookes Hosp, IMS MRL, Cambridge CB2 0QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gandotra, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, IMS MRL, Hills Rd,,Box 289,Level 4, Cambridge CB2 0QQ, England.	gandotrasheetal@gmail.com; dbs23@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; girousse, amandine/GYD-3740-2022	O'Rahilly, Stephen/0000-0003-2199-4449; girousse, amandine/0000-0001-6142-4710; Savage, David Bousfield/0000-0002-7857-7032	Wellcome Trust; United Kingdom National Institute for Health Research Cambridge Biomedical Research Centre; Medical Research Council Centre for Obesity and Related Metabolic Disease; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council Centre for Obesity and Related Metabolic Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust (to S. G., S. O., and D. B. S.), the United Kingdom National Institute for Health Research Cambridge Biomedical Research Centre, and the Medical Research Council Centre for Obesity and Related Metabolic Disease.	Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Chong BM, 2011, J BIOL CHEM, V286, P23254, DOI 10.1074/jbc.M110.217091; Clifford GM, 1997, BIOCHEM SOC T, V25, pS672, DOI 10.1042/bst025s672; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Garcia A, 2004, J BIOL CHEM, V279, P8409, DOI 10.1074/jbc.M311198200; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hall AM, 2010, J LIPID RES, V51, P554, DOI 10.1194/jlr.M000976; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	32	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34998	35006		10.1074/jbc.M111.278853	http://dx.doi.org/10.1074/jbc.M111.278853			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21757733	Green Published, hybrid			2022-12-27	WOS:000295406300053
J	Dobierzewska, A; Giltiay, NV; Sabapathi, S; Karakashian, AA; Nikolova-Karakashian, MN				Dobierzewska, Aneta; Giltiay, Natalia V.; Sabapathi, Sathish; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.			Protein Phosphatase 2A and Neutral Sphingomyelinase 2 Regulate IRAK-1 Protein Ubiquitination and Degradation in Response to Interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CYTOCHROME-P450 2C11 CYP2C11; IL-1 SIGNALING PATHWAY; FACTOR-ALPHA; TERMINAL KINASE; LYS63-LINKED POLYUBIQUITINATION; DIFFERENTIAL REGULATION; INDUCED APOPTOSIS	The IL-1 beta signaling cascade is initiated by the phosphorylation of IL-1 beta receptor-associated kinase-1 (IRAK-1), followed by its ubiquitination and degradation. This paper investigates the regulation of IRAK-1 degradation in primary hepatocytes and in HEK cells overexpressing the IL-1 beta receptor. We provide evidence that protein phosphatase 2A (PP2A) is a negative regulator of the phosphorylation, Lys(48)-linked ubiquitination, and degradation of IRAK-1. PP2A catalytic activity increased within 30 min of stimulation with IL-1 beta. siRNA against PP2A catalytic subunit (PP2Ac) or treatment with pharmacological inhibitor, okadaic acid, enhanced IRAK-1 Lys(48)-linked ubiquitination and degradation. Direct interaction between PP2Ac and IRAK-1 was observed, suggesting that IRAK-1 might be a PP2A substrate. The mechanisms of PP2A activation by IL-1 beta involved neutral sphingomyelinase-2 (NSMase-2) and an accumulation of ceramide. Overexpression of NSMase-2 delayed IRAK-1 degradation in a PP2A-dependent manner, whereas NSMase-2 silencing had the opposite effect. The addition of sphingomyelinase, ceramide, or a proteasome inhibitor all led to retention of IRAK-1 at the cell membrane and to increased JNK phosphorylation. This study suggests that NSMase-2- and PP2A-dependent regulation of IRAK-1 degradation is a novel mechanism to fine tune the magnitude of IL-1 beta response.	[Nikolova-Karakashian, Mariana N.] Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, Lexington, KY 40536 USA	University of Kentucky	Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu	Giltiay, Natalia V./H-8655-2019; Giltiay, Natalia/AAH-2130-2019	Giltiay, Natalia/0000-0001-7284-514X	National Institutes of Health [AG 026711]; NATIONAL INSTITUTE ON AGING [R01AG019223, R56AG019223, R01AG026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG 026711 (to M. N.-K.).	Adib-Conquy M, 2002, J BIOL CHEM, V277, P27927, DOI 10.1074/jbc.M200705200; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Henmi T, 2009, BIOCHEM J, V423, P71, DOI 10.1042/BJ20090208; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim WH, 2000, BIOCHEM CELL BIOL, V78, P127, DOI 10.1139/bcb-78-2-127; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Krueger KM, 1997, J BIOL CHEM, V272, P5; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Liu W, 2003, BIOORG MED CHEM LETT, V13, P1597, DOI 10.1016/S0960-894X(03)00105-7; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Neumann D, 2008, J LEUKOCYTE BIOL, V84, P807, DOI 10.1189/jlb.0507290; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Peiser M, 2008, J LEUKOCYTE BIOL, V83, P1118, DOI 10.1189/jlb.0807567; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777; Rutkute K, 2007, BIOCHEM BIOPH RES CO, V361, P263, DOI 10.1016/j.bbrc.2007.06.079; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; SCHUTZE S, 1994, J LEUKOCYTE BIOL, V56, P533, DOI 10.1002/jlb.56.5.533; Shanley TP, 2002, CRIT CARE MED, V30, pS80, DOI 10.1097/00003246-200201001-00011; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Zhao B, 2008, SHOCK, V29, P181, DOI 10.1097/shk.0b013e318070c840	75	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32064	32073		10.1074/jbc.M111.238030	http://dx.doi.org/10.1074/jbc.M111.238030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21708940	Green Published, hybrid			2022-12-27	WOS:000294726800016
J	Lamberto, GR; Torres-Monserrat, V; Bertoncini, CW; Salvatella, X; Zweckstetter, M; Griesinger, C; Fernandez, CO				Lamberto, Gonzalo R.; Torres-Monserrat, Valentina; Bertoncini, Carlos W.; Salvatella, Xavier; Zweckstetter, Markus; Griesinger, Christian; Fernandez, Claudio O.			Toward the Discovery of Effective Polycyclic Inhibitors of alpha-Synuclein Amyloid Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; PARKINSONS-DISEASE; FIBRIL FORMATION; PHOTODYNAMIC THERAPY; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VITRO; AGGREGATION; PHTHALOCYANINE; MECHANISM	The fibrillation of amyloidogenic proteins is a critical step in the etiology of neurodegenerative disorders such as Alzheimer and Parkinson diseases. There is major interest in the therapeutic intervention on such aberrant aggregation phenomena, and the utilization of polyaromatic scaffolds has lately received considerable attention. In this regard, the molecular and structural basis of the anti-amyloidogenicity of polyaromatic compounds, required to evolve this molecular scaffold toward therapeutic drugs, is not known in detail. We present here biophysical and biochemical studies that have enabled us to characterize the interaction of metal-substituted, tetrasulfonated phthalocyanines (PcTS) with alpha-synuclein (AS), the major protein component of amyloid-like deposits in Parkinson disease. The inhibitory activity of the assayed compounds on AS amyloid fibril formation decreases in the order PcTS[Ni(II)] similar to PcTS > PcTS[Zn(II)] >> PcTS[Al(III)] approximate to 0. Using NMR and electronic absorption spectroscopies we demonstrated conclusively that the differences in binding capacity and anti-amyloid activity of phthalocyanines on AS are attributed to their relative ability to self-stack through pi-pi interactions, modulated by the nature of the metal ion bound at the molecule. Low order stacked aggregates of phthalocyanines were identified as the active amyloid inhibitory species, whose effects are mediated by residue specific interactions. Such sequence-specific anti-amyloid behavior of self-stacked phthalocyanines contrasts strongly with promiscuous amyloid inhibitors with self-association capabilities that act via nonspecific sequestration of AS molecules. The new findings reported here constitute an important contribution for future drug discovery efforts targeting amyloid formation.	[Lamberto, Gonzalo R.; Torres-Monserrat, Valentina; Fernandez, Claudio O.] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Bertoncini, Carlos W.; Salvatella, Xavier] Inst Res Biomed, Barcelona 08029, Spain; [Fernandez, Claudio O.] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Partner Grp, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Deutsch Forsch Gemeinschaft Ctr Mol Physiol Brain, D-37077 Gottingen, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Max Planck Society	Fernandez, CO (corresponding author), Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario, Suipacha 531,S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.	cfernan@gwdg.de	Salvatella, Xavier/C-7337-2008	Salvatella, Xavier/0000-0002-8371-4185; Fernandez, Claudio Oscar/0000-0003-0454-7735; Zweckstetter, Markus/0000-0002-2536-6581; Bertoncini, Carlos/0000-0001-7695-2882	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; Fundacion Antorchas; Max Planck Society; Alexander von Humboldt Foundation; Fundacion Josefina Prats; Government of Santa Fe; ANPCyT [PME2003-2006]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET); CONICET in Argentina; Framework Programme 7 Marie Curie Intra-European Fellowship; Institucio Catalana de Recerca i Estudis Avancats; Institute for Research in Biomedicine, Barcelona, Spain; Ministerio de Ciencia e Innovacion de Espana [CTQ2009-08850-BQU]; Max Planck Society, Federal Ministry of Education and Research, Germany [NGFN-Plus 01GS08190]; Deutsche Forschungsgemeinschaft [ZW 71/2-2, 3-2]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Fundacion Antorchas; Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fundacion Josefina Prats; Government of Santa Fe; ANPCyT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET in Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Framework Programme 7 Marie Curie Intra-European Fellowship; Institucio Catalana de Recerca i Estudis Avancats(ICREA); Institute for Research in Biomedicine, Barcelona, Spain; Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Max Planck Society, Federal Ministry of Education and Research, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, Fundacion Antorchas, Max Planck Society, Alexander von Humboldt Foundation, Fundacion Josefina Prats, and the Government of Santa Fe. The Bruker Avance II 600 MHz NMR spectrometer used in this work was purchased with funds from ANPCyT (PME2003-2006) and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET).; Recipient of a fellowship from CONICET in Argentina and Fundacion Josefina Prats.; Recipient of a Framework Programme 7 Marie Curie Intra-European Fellowship grant.; Supported by Institucio Catalana de Recerca i Estudis Avancats, Institute for Research in Biomedicine, Barcelona, Spain, and Ministerio de Ciencia e Innovacion de Espana Grant CTQ2009-08850-BQU.; Supported by the Max Planck Society, Federal Ministry of Education and Research, Germany, Grant NGFN-Plus 01GS08190, and Deutsche Forschungsgemeinschaft Heisenberg Scholarships ZW 71/2-2 and 3-2.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Bertini I, 1996, COORDIN CHEM REV, V150, pR7; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Boyle RW, 1996, PHOTOCHEM PHOTOBIOL, V64, P469, DOI 10.1111/j.1751-1097.1996.tb03093.x; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Caughey WS, 2007, ANTIMICROB AGENTS CH, V51, P3887, DOI 10.1128/AAC.01599-06; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hill JS, 1995, P NATL ACAD SCI USA, V92, P12126, DOI 10.1073/pnas.92.26.12126; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Laia CAT, 2008, J PHYS CHEM B, V112, P4276, DOI 10.1021/jp076100+; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Rao JN, 2008, BIOCHEMISTRY-US, V47, P4651, DOI 10.1021/bi8002378; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STYLLI SS, 1995, J CLIN NEUROSCI, V2, P64, DOI 10.1016/0967-5868(95)90033-0; STYLLI SS, 1995, J CLIN NEUROSCI, V2, P146, DOI 10.1016/0967-5868(95)90008-X; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	49	38	40	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32036	32044		10.1074/jbc.M111.242958	http://dx.doi.org/10.1074/jbc.M111.242958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795682	Green Published, hybrid			2022-12-27	WOS:000294726800013
J	Fujita-Sato, S; Ito, S; Isobe, T; Ohyama, T; Wakabayashi, K; Morishita, K; Ando, O; Isono, F				Fujita-Sato, Saori; Ito, Shuichiro; Isobe, Takashi; Ohyama, Takao; Wakabayashi, Kenji; Morishita, Kaoru; Ando, Osamu; Isono, Fujio			Structural Basis of Digoxin That Antagonizes ROR gamma t Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; GROWTH-FACTOR-BETA; NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; IL-17; LINEAGE; ALPHA; AUTOIMMUNITY; MODULATION; DISTINCT	The retinoic acid-related orphan nuclear receptor gamma t (ROR gamma t)/ROR gamma 2 is well known as a master regulator of interleukin 17 (IL-17)-producing helper T (Th17) cell development. To develop a therapeutic agent against Th17-mediated autoimmune diseases, we screened chemical compounds and successfully found that digoxin inhibited IL-17 production. Further studies revealed that digoxin bound to the ligand binding domain of ROR gamma t and suppressed Th17 differentiation without affecting Th1 differentiation. To better understand the structural basis for the inhibitory activity of digoxin, we determined the crystal structure of the ROR gamma t ligand-binding domain in complex with digoxin at 2.2 angstrom resolution. The structure reveals that digoxin binds to the ligand-binding pocket protruding between helices H3 and H11 from the pocket. In addition, digoxin disrupts the key interaction important for the agonistic activity, resulting in preventing the positioning of helix H12 in the active conformation, thus antagonizing coactivator interaction. Functional studies demonstrated that digoxin inhibited ROR gamma t activity and decreased IL-17 production but not ROR alpha activity. Digoxin inhibited IL-17 production in CD4(+) T cells from experimental autoimmune encephalomyelitis mice. Our data indicates that ROR gamma t is a promising therapeutic target for Th17-derived autoimmune diseases and our structural data will help to design novel ROR gamma t antagonists.	[Isobe, Takashi; Isono, Fujio] Daiichi Sankyo Co Ltd, R&D Div, Frontier Res Labs, Tokyo 1348630, Japan; [Fujita-Sato, Saori; Ando, Osamu] Daiichi Sankyo Co Ltd, R&D Div, Oncol Res Labs, Tokyo 1348630, Japan; [Ito, Shuichiro] Daiichi Sankyo Co Ltd, R&D Div, Lead Discovery & Optimizat Res Labs 2, Tokyo 1348630, Japan; [Ohyama, Takao; Morishita, Kaoru] Daiichi Sankyo Co Ltd, R&D Div, Biol Res Labs, Tokyo 1348630, Japan; [Wakabayashi, Kenji] Daiichi Sankyo RD Associe Co Ltd, Res Dept 3, Edogawa Ku, Tokyo 1348630, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Isono, F (corresponding author), Daiichi Sankyo Co Ltd, R&D Div, Frontier Res Labs, Tokyo 1348630, Japan.	isono.fujio.vd@daiichisankyo.co.jp						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Crome SQ, 2009, EUR J IMMUNOL, V39, P1480, DOI 10.1002/eji.200838908; DeLano W.L, PYMOL MOL GRAPHICS S; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; MAEDA H, 1994, JPN J CANCER RES, V85, P1137, DOI 10.1111/j.1349-7006.1994.tb02919.x; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Unutmaz D, 2009, EUR J IMMUNOL, V39, P1452, DOI 10.1002/eji.200939540; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	48	99	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31409	31417		10.1074/jbc.M111.254003	http://dx.doi.org/10.1074/jbc.M111.254003			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733845	hybrid, Green Published			2022-12-27	WOS:000294487500035
J	Murai, MJ; Chruszcz, M; Reddy, G; Grembecka, J; Cierpicki, T				Murai, Marcelo J.; Chruszcz, Maksymilian; Reddy, Gireesh; Grembecka, Jolanta; Cierpicki, Tomasz			Crystal Structure of Menin Reveals Binding Site for Mixed Lineage Leukemia (MLL) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE-NEOPLASIA TYPE-1; X-RAY-DIFFRACTION; GENE; MODEL; INTERACTS; PRODUCT; JUND	Menin is a tumor suppressor protein that is encoded by the MEN1 (multiple endocrine neoplasia 1) gene and controls cell growth in endocrine tissues. Importantly, menin also serves as a critical oncogenic cofactor of MLL (mixed lineage leukemia) fusion proteins in acute leukemias. Direct association of menin with MLL fusion proteins is required for MLL fusion protein-mediated leukemogenesis in vivo, and this interaction has been validated as a new potential therapeutic target for development of novel anti-leukemia agents. Here, we report the first crystal structure of menin homolog from Nematostella vectensis. Due to a very high sequence similarity, the Nematostella menin is a close homolog of human menin, and these two proteins likely have very similar structures. Menin is predominantly an alpha-helical protein with the protein core comprising three tetratricopeptide motifs that are flanked by two alpha-helical bundles and covered by a beta-sheet motif. A very interesting feature of menin structure is the presence of a large central cavity that is highly conserved between Nematostella and human menin. By employing site-directed mutagenesis, we have demonstrated that this cavity constitutes the binding site for MLL. Our data provide a structural basis for understanding the role of menin as a tumor suppressor protein and as an oncogenic co-factor of MLL fusion proteins. It also provides essential structural information for development of inhibitors targeting the menin-MLL interaction as a novel therapeutic strategy in MLL-related leukemias.	[Murai, Marcelo J.; Reddy, Gireesh; Grembecka, Jolanta; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chruszcz, Maksymilian] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Michigan System; University of Michigan; University of Virginia	Cierpicki, T (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr,MSRB1,Room 4510, Ann Arbor, MI 48109 USA.	tomaszc@umich.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485	American Chemical Society [RSG-11-082-01-DMC]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA160467] Funding Source: NIH RePORTER	American Chemical Society(American Chemical Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Research Scholar Grant RSG-11-082-01-DMC from the American Chemical Society (to T. C.) and a Leukemia and Lymphoma Society Translational Research Program grant (to J. G.).	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balogh K, 2010, MOL CELL ENDOCRINOL, V326, P80, DOI 10.1016/j.mce.2010.04.011; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kim H, 2003, CANCER RES, V63, P6135; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; MacConaill LE, 2006, MOL CANCER RES, V4, P793, DOI 10.1158/1541-7786.MCR-06-0123; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Veeramalai M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-358; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	48	68	70	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31742	31748		10.1074/jbc.M111.258186	http://dx.doi.org/10.1074/jbc.M111.258186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757704	hybrid, Green Published			2022-12-27	WOS:000294487500067
J	Lu, M; Wang, J; Ives, HE; Pearce, D				Lu, Ming; Wang, Jian; Ives, Harlan E.; Pearce, David			mSIN1 Protein Mediates SGK1 Protein Interaction with mTORC2 Protein Complex and Is Required for Selective Activation of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER PROTEIN; VACUOLAR H+-ATPASE; NA+ CHANNEL; KINASE; PHOSPHORYLATION; SERUM; TOR; TRANSPORT; RAPTOR; AKT	The mammalian target of rapamycin (mTOR) plays a central role in the regulation of a number of cellular processes including growth, metabolism, and ion transport. mTOR is found in two multiprotein complexes, mTORC1 and mTORC2, which phosphorylate distinct substrates and regulate distinct cellular processes. SGK1 is an mTORC2 substrate, which is a key regulator of epithelial Na+ transport mediated by the epithelial sodium channel. Although it is known that SGK1 physically interacts with mTORC2, it is unknown which mTORC2 component mediates this interaction or whether this interaction plays a physiologically relevant role in specific activation of SGK1. Here we identify mSIN1 as the mTORC2 component that mediates interaction with SGK1 and demonstrate that this interaction is required for SGK1 phosphorylation and epithelial sodium channel activation. We used the yeast two-hybrid system coupled with random mutagenesis to identify a mutant mSIN1 (mSIN1/Q68H), which does not interact with SGK1. Expression of this mutant does not restore SGK1 phosphorylation to wild-type levels in mSIN1-deficient murine embryo fibroblasts. Furthermore, in kidney epithelial cells, mSIN1/Q68H has a dominant-negative effect on SGK1 phosphorylation and on SGK1-dependent Na+ transport. Interestingly, this interaction appears to be specific in that another mTORC2 substrate, Akt, does not interact with mSIN1, and its phosphorylation and activity are unaffected by the Q68H mutation. These data support the conclusion that mTORC2 uses distinct strategies to phosphorylate different substrates and suggest a mechanism for mTORC2 specificity in the regulation of diverse cellular processes.	[Lu, Ming; Wang, Jian; Ives, Harlan E.; Pearce, David] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Pearce, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pearce, D (corresponding author), 600 16th St, San Francisco, CA 94107 USA.	david.pearce@ucsf.edu			National Institutes of Health [DK056695, DK085101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085101, R01DK056695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK056695 and DK085101 (to D. P.).	Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LinGoerke JL, 1997, BIOTECHNIQUES, V23, P409, DOI 10.2144/97233bm12; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	39	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30647	30654		10.1074/jbc.M111.257592	http://dx.doi.org/10.1074/jbc.M111.257592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757730	Green Published, hybrid			2022-12-27	WOS:000294283600044
J	Valentine, WJ; Godwin, VI; Osborne, DA; Liu, JX; Fujiwara, Y; Van Brocklyn, J; Bittman, R; Parrill, AL; Tigyi, G				Valentine, William J.; Godwin, Virginia I.; Osborne, Daniel A.; Liu, Jianxiong; Fujiwara, Yuko; Van Brocklyn, James; Bittman, Robert; Parrill, Abby L.; Tigyi, Gabor			FTY720 (Gilenya) Phosphate Selectivity of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P(1)) G Protein-coupled Receptor Requires Motifs in Intracellular Loop 1 and Transmembrane Domain 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; IMMUNOSUPPRESSIVE AGENT FTY720; DIFFERENTIATION GENE FAMILY; MULTIPLE-SCLEROSIS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; RECOGNITION; RESIDUES; PERMEABILITY; ANTAGONIST	FTY720 phosphate (FTY720P) is a high potency agonist for all the endothelial differentiation gene family sphingosine 1-phosphate (S1P) receptors except S1P receptor subtype 2 (S1P(2)). To map the distinguishing features of S1P(2) ligand recognition, we applied a computational modeling-guided mutagenesis strategy that was based on the high degree of sequence homology between S1P(1) and S1P(2). S1P(2) point mutants of the ligand-binding pocket were characterized. The head group-interacting residues Arg3.28, Glu3.29, and Lys7.34 were essential for activation. Mutation of residues Ala3.32, Leu3.36, Val5.41, Phe6.44, Trp6.48, Ser7.42, and Ser7.46, predicted to interact with the S1P hydrophobic tail, impaired activation by S1P. Replacing individual or multiple residues in the ligand-binding pocket of S1P(2) with S1P(1) sequence did not impart activation by FTY720P. Chimeric S1P(1)/S1P(2) receptors were generated and characterized for activation by S1P or FTY720P. The S1P(2) chimera with S1P(1) sequence from the N terminus to transmembrane domain 2 (TM2) was activated by FTY720P, and the S1P(2)(IC1-TM2)(S1P1) domain insertion chimera showed S1P(1)-like activation. Twelve residues in this domain, distributed in four motifs a-d, differ between S1P(1) and S1P(2). Insertion of (RPMYY)-R-78 in motif b alone or simultaneous swapping of five other residues in motifs c and d from S1P(1) into S1P(2) introduced FTY720P responsiveness. Molecular dynamics calculations indicate that FTY720P binding selectivity is a function of the entropic contribution to the binding free energy rather than enthalpic contributions and that preferred agonists retain substantial flexibility when bound. After exposure to FTY720P, the S1P(2)(IC1-TM2) S1P(1) receptor recycled to the plasma membrane, indicating that additional structural elements are required for the selective degradative trafficking of S1P(1).	[Valentine, William J.; Osborne, Daniel A.; Liu, Jianxiong; Fujiwara, Yuko; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, Memphis, TN 38163 USA; [Godwin, Virginia I.; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Dept Chem, Memphis, TN 38152 USA; [Van Brocklyn, James] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University System of Ohio; Ohio State University; City University of New York (CUNY) System; Queens College NY (CUNY)	Tigyi, G (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, 894 Union Ave, Memphis, TN 38163 USA.	gtigyi@uthsc.edu		Parrill, Abby/0000-0003-1658-8497	National Institutes of Health [CA-092160, HL-083187]; Van Vleet Oncology Research Endowment; National Science Foundation [CHE-0851880]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Vleet Oncology Research Endowment; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-092160 (to G. T.) and HL-083187 (to R. B.). This work was also supported by the Van Vleet Oncology Research Endowment and National Science Foundation Grant CHE-0851880 (to A. P.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Hohlfeld R, 2011, NEUROLOGY, V76, pS28, DOI 10.1212/WNL.0b013e31820db40f; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mehling M, 2011, NEUROLOGY, V76, pS20, DOI 10.1212/WNL.0b013e31820db341; Ohmori T, 2003, CARDIOVASC RES, V58, P170, DOI 10.1016/S0008-6363(03)00260-8; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Parrill AL, 2004, SEMIN CELL DEV BIOL, V15, P467, DOI 10.1016/j.semcdb.2004.05.006; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Pham TCT, 2008, J MOL GRAPH MODEL, V26, P1189, DOI 10.1016/j.jmgm.2007.11.001; Ratnala VRP, 2009, METHODS MOL BIOL, V552, P67, DOI 10.1007/978-1-60327-317-6_5; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sensken SC, 2008, CELL SIGNAL, V20, P1125, DOI 10.1016/j.cellsig.2008.01.019; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Takuwa Y, 2008, BBA-MOL CELL BIOL L, V1781, P483, DOI 10.1016/j.bbalip.2008.04.003; Valentine WJ, 2008, J BIOL CHEM, V283, P12175, DOI 10.1074/jbc.M708847200; Valentine WJ, 2010, CELL SIGNAL, V22, P1543, DOI 10.1016/j.cellsig.2010.05.023; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	36	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30513	30525		10.1074/jbc.M111.263442	http://dx.doi.org/10.1074/jbc.M111.263442			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21719706	Green Published, hybrid			2022-12-27	WOS:000294283600030
J	Rinehart, J; Vazquez, N; Kahle, KT; Hodson, CA; Ring, AM; Gulcicek, EE; Louvi, A; Bobadilla, NA; Gamba, G; Lifton, RP				Rinehart, Jesse; Vazquez, Norma; Kahle, Kristopher T.; Hodson, Caleb A.; Ring, Aaron M.; Gulcicek, Erol E.; Louvi, Angeliki; Bobadilla, Norma A.; Gamba, Gerardo; Lifton, Richard P.			WNK2 Kinase Is a Novel Regulator of Essential Neuronal Cation-Chloride Cotransporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; ALANINE-RICH KINASE; PROTEIN-KINASE; CELL-VOLUME; NA+-K+-2CL(-) COTRANSPORTER; INHERITED HYPERTENSION; NERVOUS-SYSTEM; BLOOD-PRESSURE; SPAK; EXPRESSION	NKCC1 and KCC2, related cation-chloride cotransporters (CCC), regulate cell volume and gamma-aminobutyric acid (GABA)-ergic neurotranmission by modulating the intracellular concentration of chloride [Cl-]. These CCCs are oppositely regulated by serine-threonine phosphorylation, which activates NKCC1 but inhibits KCC2. The kinase(s) that performs this function in the nervous system are not known with certainty. WNK1 and WNK4, members of the WNK(with no lysine [(K) under bar]) kinase family, either directly or via the downstream SPAK/OSR1 Ste 20-type kinases, regulate the furosemide-sensitive NKCC2 and the thiazide-sensitive NCC, kidney-specific CCCs. What role the novel WNK2 kinase plays in this regulatory cascade, if any, is unknown. Here, we show that WNK2, unlike other WNKs, is not expressed in kidney; rather, it is a neuron-enriched kinase primarily expressed in neocortical pyramidal cells, thalamic relay cells, and cerebellar granule and Purkinje cells in both the developing and adult brain. Bumetanide-sensitive and Cl--dependent Rb-86(+) uptake assays in Xenopus laevis oocytes revealed that WNK2 promotes Cl- accumulation by reciprocally activating NKCC1 and inhibiting KCC2 in a kinase-dependent manner, effectively bypassing normal tonicity requirements for cotransporter regulation. TiO2 enrichment and tandem mass spectrometry studies demonstrate WNK2 forms a protein complex in the mammalian brain with SPAK, a known phosphoregulator of NKCC1. In this complex, SPAK is phosphorylated at Ser-383, a consensus WNK recognition site. These findings suggest a role for WNK2 in the regulation of CCCs in the mammalian brain, with implications for both cell volume regulation and/or GABAergic signaling.	[Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Rinehart, Jesse; Hodson, Caleb A.; Ring, Aaron M.; Louvi, Angeliki; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Inst Nacl Cardiol Ignacio Chavez, Mexico City 14000, DF, Mexico; [Kahle, Kristopher T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Kahle, Kristopher T.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Gulcicek, Erol E.] Yale Univ, Keck Biotechnol Resource Lab, New Haven, CT 06510 USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Howard Hughes Medical Institute; Yale University; National Institute of Cardiology - Mexico; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University	Gamba, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico.	gamba@biomedicas.unam.mx; richard.lifton@yale.edu	; Gamba, Gerardo/P-4873-2016	Ring, Aaron/0000-0003-3699-2446; Gamba, Gerardo/0000-0002-4378-9043	NIDA, National Institutes of Health [2P30DA018343]; Leducq Foundation Transatlantic Network on Hypertension; el Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico) [59992]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Leducq Foundation Transatlantic Network on Hypertension(Leducq Foundation); el Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by NIDA, National Institutes of Health Grant 2P30DA018343 (to J. R., E. E. G., and R. P. L.), the Leducq Foundation Transatlantic Network on Hypertension (to G. G. and R. P. L.), and el Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico) Grant 59992 (to G. G.).	ARROYO JP, 2011, J AM SOC NE IN PRESS, V22; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; BREITWIESER GE, 1990, AM J PHYSIOL, V258, pC749, DOI 10.1152/ajpcell.1990.258.4.C749; Byun N, 2007, NEUROBIOL DIS, V28, P39, DOI 10.1016/j.nbd.2007.06.014; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Garzon-Muvdi T, 2007, AM J PHYSIOL-RENAL, V292, pF1197, DOI 10.1152/ajprenal.00335.2006; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Jun P, 2009, NEURO-ONCOLOGY, V11, P414, DOI 10.1215/15228517-2008-096; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Louvi A, 2000, DEVELOPMENT, V127, P4061; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Marty A, 2005, TRENDS NEUROSCI, V28, P284, DOI 10.1016/j.tins.2005.04.003; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rudnik-Schoneborn S, 2009, NEUROPEDIATRICS, V40, P129, DOI 10.1055/s-0029-1234084; Schomberg SL, 2003, J NEUROPHYSIOL, V89, P159, DOI 10.1152/jn.00229.2002; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; TOLE S, 1995, J NEUROSCI, V15, P970; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	64	65	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30171	30180		10.1074/jbc.M111.222893	http://dx.doi.org/10.1074/jbc.M111.222893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733846	Green Published, hybrid			2022-12-27	WOS:000294046600074
J	Yoon, MS; Sun, YT; Arauz, E; Jiang, Y; Chen, J				Yoon, Mee-Sup; Sun, Yuting; Arauz, Edwin; Jiang, Yu; Chen, Jie			Phosphatidic Acid Activates Mammalian Target of Rapamycin Complex 1 (mTORC1) Kinase by Displacing FK506 Binding Protein 38 (FKBP38) and Exerting an Allosteric Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; PHOSPHOLIPASE-D; CELL-GROWTH; PATHWAY; RHEB; TOR; INHIBITOR; NUTRIENT; PLD; PROGRESSION	Phosphatidic acid (PA) is a critical mediator of mitogenic activation of mammalian target of rapamycin complex 1 (mTORC1) signaling, a master regulator of mammalian cell growth and proliferation. The mechanism by which PA activates mTORC1 signaling has remained unknown. Here, we report that PA selectively stimulates mTORC1 but not mTORC2 kinase activity in cells and in vitro. Furthermore, we show that PA competes with the mTORC1 inhibitor, FK506 binding protein 38 (FKBP38), for mTOR binding at a site encompassing the rapamycin-FKBP12 binding domain. This leads to PA antagonizing FKBP38 inhibition of mTORC1 kinase activity in vitro and rescuing mTORC1 signaling from FKBP38 in cells. Phospholipase D 1, a PA-generating enzyme that is an established upstream regulator of mTORC1, is found to negatively affect mTOR-FKBP38 interaction, confirming the role of endogenous PA in this regulation. Interestingly, removal of FKBP38 alone is insufficient to activate mTORC1 kinase and signaling, which require PA even when the FKBP38 level is drastically reduced by RNAi. In conclusion, we propose a dual mechanism for PA activation of mTORC1: PA displaces FKBP38 from mTOR and allosterically stimulates the catalytic activity of mTORC1.	[Yoon, Mee-Sup; Sun, Yuting; Arauz, Edwin; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Jiang, Yu] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, J (corresponding author), 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@illinois.edu	Sun, Yuting/C-7906-2012; Diaz, Edwin Arauz/AAI-5457-2021	Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914, CA129821]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832, R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant AR048914 (to J. C.) CA129821 (to Y. J.).	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Billon-Denis E, 2008, J LIPID RES, V49, P295, DOI 10.1194/jlr.M700171-JLR200; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566	35	93	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29568	29574		10.1074/jbc.M111.262816	http://dx.doi.org/10.1074/jbc.M111.262816			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737445	Green Published, hybrid			2022-12-27	WOS:000294046600014
J	Gui, SY; Wooderchak, WL; Daly, MP; Porter, PJ; Johnson, SJ; Hevel, JM				Gui, Shanying; Wooderchak, Whitney L.; Daly, Michael P.; Porter, Paula J.; Johnson, Sean J.; Hevel, Joan M.			Investigation of the Molecular Origins of Protein-arginine Methyltransferase I (PRMT1) Product Specificity Reveals a Role for Two Conserved Methionine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; LYSINE METHYLTRANSFERASES; HISTONE METHYLATION; STRUCTURAL BASIS; PHE/TYR SWITCH; DOMAIN; VIVO; MECHANISM; SOFTWARE; BINDING	Protein-arginine methyltransferases aid in the regulation of many biological processes by methylating specific arginyl groups within targeted proteins. The varied nature of the response to methylation is due in part to the diverse product specificity displayed by the protein-arginine methyltransferases. In addition to site location within a protein, biological response is also determined by the degree (mono-/dimethylation) and type of arginine dimethylation (asymmetric/symmetric). Here, we have identified two strictly conserved methionine residues in the PRMT1 active site that are not only important for activity but also control substrate specificity. Mutation of Met-155 or Met-48 results in a loss in activity and a change in distribution of mono-and dimethylated products. The altered substrate specificity of M155A and M48L mutants is also evidenced by automethylation. Investigation into the mechanistic basis of altered substrate recognition led us to consider each methyl transfer step separately. Single turnover experiments reveal that the rate of transfer of the second methyl group is much slower than transfer of the first methyl group in M48L, especially for arginine residues located in the center of the peptide substrate where turnover of the monomethylated species is negligible. Thus, altered product specificity in M48L originates from the differential effect of the mutation on the two rates. Characterization of the two active-site methionines provides the first insight into how the PRMT1 active site is engineered to control product specificity.	[Gui, Shanying; Wooderchak, Whitney L.; Porter, Paula J.; Johnson, Sean J.; Hevel, Joan M.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Daly, Michael P.] Waters Corp, Beverly, MA 01915 USA	Utah System of Higher Education; Utah State University; Waters Corporation	Hevel, JM (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84322 USA.	Joanie.Hevel@usu.edu	Gui, Shanying/AAM-8633-2021; Johnson, Sean/G-8191-2012	Johnson, Sean/0000-0001-7992-2494; Hevel, Joan/0000-0002-9559-4635	Herman Frasch Foundation [657-HF07]; National Science Foundation [0920776]; American Recovery and Reinvestment Act; American Heart Association; Div Of Molecular and Cellular Bioscience [0920776] Funding Source: National Science Foundation	Herman Frasch Foundation; National Science Foundation(National Science Foundation (NSF)); American Recovery and Reinvestment Act; American Heart Association(American Heart Association); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Herman Frasch Foundation Award 657-HF07 (to J. M. H.), National Science Foundation Award 0920776 (to J. M. H.) funded through the American Recovery and Reinvestment Act, and an American Heart Association undergraduate research fellowship (to P. J. P.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balakrishnan L, 2010, CRIT REV BIOCHEM MOL, V45, P440, DOI 10.3109/10409238.2010.504700; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Coward J. K., 1977, BIOCH ADENOSYLMETHIO, P127; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Lakowski TM, 2010, ACS CHEM BIOL, V5, P1053, DOI 10.1021/cb100161u; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Levine T.B., 2006, METABOLIC SYNDROME C; Markowski P, 2007, ANAL CHIM ACTA, V605, P205, DOI 10.1016/j.aca.2007.10.033; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olsen J, 1979, TRANSMETHYLATION; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; *RIG CORP, 2006, CRYSTALCLEAR INT PRO; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Segel IH, 1975, ENZYME KINETICS BEHA; Suh-Lailam BB, 2010, ANAL BIOCHEM, V398, P218, DOI 10.1016/j.ab.2009.09.005; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; ZAPPIA V, 1980, J CHROMATOGR, V189, P399, DOI 10.1016/S0021-9673(00)80319-2; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	45	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29118	29126		10.1074/jbc.M111.224097	http://dx.doi.org/10.1074/jbc.M111.224097			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697082	hybrid, Green Published			2022-12-27	WOS:000293837000048
J	Niture, SK; Jain, AK; Shelton, PM; Jaiswal, AK				Niture, Suryakant K.; Jain, Abhinav K.; Shelton, Phillip M.; Jaiswal, Anil K.			RETRACTED: Src Subfamily Kinases Regulate Nuclear Export and Degradation of Transcription Factor Nrf2 to Switch Off Nrf2-mediated Antioxidant Activation of Cytoprotective Gene Expression (Publication with Expression of Concern. See vol. 191, pg. 1199, 2016) (Retracted article. See vol. 292, pg. 2048, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							OXIDATIVE STRESS; PHOSPHORYLATION; PATHWAY; PROTEIN; IDENTIFICATION; ELECTROPHILE; INFLAMMATION; SENSITIVITY; DISRUPTION; PROTECTION	Nrf2 (NF-E2-related factor 2) is a nuclear transcription factor that in response to chemical and radiation stress regulates coordinated induction of a battery of cytoprotective gene expressions leading to cellular protection. In this study, we investigated the role of Src kinases in the regulation of Nrf2 and downstream signaling. siRNA-mediated inhibition of Fyn, Src, Yes, and Fgr, but not Lyn, in mouse hepatoma Hepa-1 cells, led to nuclear accumulation of Nrf2 and up-regulation of Nrf2 downstream gene expression. Mouse embryonic fibroblasts with combined deficiency of Fyn/Src/Yes/Fgr supported results from siRNA. In addition, steady-state overexpression of Fyn, Src, and Yes phosphorylated Nrf2Tyr568 that triggered nuclear export and degradation of Nrf2 and down-regulation of Nrf2 downstream gene expression. Exposure of cells to antioxidant, oxidant, or UV radiation increased nuclear import of Fyn, Src, and Yes kinases, which phosphorylated Nrf2Tyr568 resulting in nuclear export and degradation of Nrf2. Further analysis revealed that stress-activated GSK3 beta acted upstream to the Src kinases and phosphorylated the Src kinases, leading to their nuclear localization and Nrf2 phosphorylation. The overexpression of Src kinases in Hepa-1 cells led to decreased Nrf2, increased apoptosis, and decreased cell survival. Mouse embryonic fibroblasts deficient in Src kinases showed nuclear accumulation of Nrf2, induction of Nrf2 and downstream gene expression, reduced apoptosis, and increased cell survival. The studies together demonstrate that Src kinases play a critical role in nuclear export and degradation of Nrf2, thereby providing a negative feedback mechanism to switch off Nrf2 activation and restore normal cellular homeostasis.	[Niture, Suryakant K.; Jain, Abhinav K.; Shelton, Phillip M.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu	Jain, Abhinav K/A-2540-2013	Niture, Suryakant/0000-0003-0613-9399	National Institutes of Health [RO1 GM047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM047466.	Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Rojo AI, 2008, MOL CELL NEUROSCI, V39, P125, DOI 10.1016/j.mcn.2008.06.007; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sun Z, 2011, MOL CELL BIOL, V31, P1800, DOI 10.1128/MCB.05036-11; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Yadav V, 2011, MOL CARCINOGEN, V50, P346, DOI 10.1002/mc.20716; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	35	66	67	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28821	28832		10.1074/jbc.M111.255042	http://dx.doi.org/10.1074/jbc.M111.255042			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690096	Green Published, hybrid			2022-12-27	WOS:000293837000020
J	Nakano, C; Horinouchi, S; Ohnishi, Y				Nakano, Chiaki; Horinouchi, Sueharu; Ohnishi, Yasuo			Characterization of a Novel Sesquiterpene Cyclase Involved in (+)-Caryolan-1-ol Biosynthesis in Streptomyces griseus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL OIL COMPOSITION; FACTOR REGULATORY CASCADE; A-FACTOR; MORPHOLOGICAL DEVELOPMENT; SECONDARY METABOLISM; MOLECULAR-CLONING; GERMACRADIENOL SYNTHASE; GEOSMIN BIOSYNTHESIS; BIOLOGICAL-ACTIVITY; GENE	Most terpenoids have been isolated from plants and fungi and only a few from bacteria. However, an increasing number of genome sequences indicate that bacteria possess a variety of terpenoid cyclase genes. We characterized a sesquiterpene cyclase gene (SGR2079, named gcoA) found in Streptomyces griseus. When expressed in Streptomyces lividans, gcoA directed production of a sesquiterpene, isolated and determined to be (+)-caryolan-1-ol using spectroscopic analyses. (+)-Caryolan-1-ol was also detected in the crude cell lysate of wild-type S. griseus but not in a gcoA knockout mutant, indicating that GcoA is a genuine (+)-caryolan-1-ol synthase. Enzymatic properties were characterized using N-terminally histidine-tagged GcoA, produced in Escherichia coli. As expected, incubation of the recombinant GcoA protein with farnesyl diphosphate yielded (+)-caryolan-1-ol. However, a small amount of another sesquiterpene was also detected. This was identified as the bicyclic sesquiterpene hydrocarbon (+)-beta-caryophyllene by comparison with an authentic sample using GC-MS. Incorporation of a deuterium atom into the C-9 methylene of (+)-caryolan-1-ol in an in vitro GcoA reaction in deuterium oxide indicated that (+)-caryolan-1-ol was synthesized by a proton attack on the C-8/C-9 double bond of (+)-beta-caryophyllene. Several beta-caryophyllene synthases have been identified from plants, but these cannot synthesize caryolan-1-ol. Although caryolan-1-ol has been isolated previously from several plants, the enzyme responsible for its biosynthesis has not been identified previously. GcoA is thus the first known caryolan-1-ol synthase. Isolation of caryolan-1-ol from microorganisms is unprecedented.	[Nakano, Chiaki; Horinouchi, Sueharu; Ohnishi, Yasuo] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138567, Japan	University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138567, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp		Ohnishi, Yasuo/0000-0001-7633-9236	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	This work was supported in part by the Targeted Proteins Research Program (TPRP) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Funding Program for Next Generation World-Leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan.	Abel C, 2009, PLANTA, V230, P1, DOI 10.1007/s00425-009-0921-7; Agger SA, 2008, J BACTERIOL, V190, P6084, DOI 10.1128/JB.00759-08; Akanuma G, 2009, MOL MICROBIOL, V73, P898, DOI 10.1111/j.1365-2958.2009.06814.x; BARTON DHR, 1952, J CHEM SOC, P2210, DOI 10.1039/jr9520002210; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; Cane DE, 2006, J ANTIBIOT, V59, P471, DOI 10.1038/ja.2006.66; Cane DE, 2003, P NATL ACAD SCI USA, V100, P1547, DOI 10.1073/pnas.0337625100; CANE DE, 1994, BIOCHEMISTRY-US, V33, P5846, DOI 10.1021/bi00185a024; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chou WKW, 2010, J AM CHEM SOC, V132, P8850, DOI 10.1021/ja103087w; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Rocha KAD, 2010, APPL CATAL A-GEN, V374, P87, DOI 10.1016/j.apcata.2009.11.032; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dickschat JS, 2005, CHEM BIODIVERS, V2, P318, DOI 10.1002/cbdv.200590014; FITJER L, 1995, J AM CHEM SOC, V117, P9180, DOI 10.1021/ja00141a009; FRICKE C, 1995, PHYTOCHEMISTRY, V39, P1119, DOI 10.1016/0031-9422(95)00184-9; Ghimire GP, 2008, J MICROBIOL BIOTECHN, V18, P1216; Giglio S, 2008, ENVIRON SCI TECHNOL, V42, P8027, DOI 10.1021/es801465w; Hara H, 2009, MICROBIOL-SGM, V155, P2197, DOI 10.1099/mic.0.027862-0; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Hu YF, 2011, CHEM BIOL, V18, P32, DOI 10.1016/j.chembiol.2010.11.008; Jayaprakasha GK, 2003, J AGR FOOD CHEM, V51, P4344, DOI 10.1021/jf034169i; Kamatou GPP, 2008, S AFR J BOT, V74, P230, DOI 10.1016/j.sajb.2007.08.002; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Keszei A, 2010, PHYTOCHEMISTRY, V71, P844, DOI 10.1016/j.phytochem.2010.03.013; Kopke D, 2008, PLANTA, V228, P427, DOI 10.1007/s00425-008-0747-8; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Konig WA, 1996, PHYTOCHEMISTRY, V43, P629, DOI 10.1016/0031-9422(96)00354-8; Lin X, 2006, J AM CHEM SOC, V128, P6022, DOI 10.1021/ja061292s; Lourens ACU, 2004, J ETHNOPHARMACOL, V95, P253, DOI 10.1016/j.jep.2004.07.027; Meekijjaroenroj A, 2007, FLAVOUR FRAG J, V22, P300, DOI 10.1002/ffj.1797; MISRA R, 1979, TETRAHEDRON, V35, P2301, DOI 10.1016/0040-4020(79)80125-8; Mockute D, 2001, PHYTOCHEMISTRY, V57, P65, DOI 10.1016/S0031-9422(00)00474-X; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Orav A, 2004, J AGR FOOD CHEM, V52, P2582, DOI 10.1021/jf030635s; Schilmiller AL, 2010, PLANT PHYSIOL, V153, P1212, DOI 10.1104/pp.110.157214; Takamatsu S, 2011, MICROB BIOTECHNOL, V4, P184, DOI 10.1111/j.1751-7915.2010.00209.x; Tetzlaff CN, 2006, BIOCHEMISTRY-US, V45, P6179, DOI 10.1021/bi060419n; TRESSL R, 1983, J AGR FOOD CHEM, V31, P892, DOI 10.1021/jf00118a056	41	49	53	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27980	27987		10.1074/jbc.M111.265652	http://dx.doi.org/10.1074/jbc.M111.265652			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693706	hybrid, Green Published			2022-12-27	WOS:000293557800016
J	Zarrabi, K; Dufour, A; Li, J; Kuscu, C; Pulkoski-Gross, A; Zhi, JZ; Hu, YJ; Sampson, NS; Zucker, S; Cao, J				Zarrabi, Kevin; Dufour, Antoine; Li, Jian; Kuscu, Cem; Pulkoski-Gross, Ashleigh; Zhi, Jizu; Hu, Youjun; Sampson, Nicole S.; Zucker, Stanley; Cao, Jian			Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPEXIN-LIKE DOMAIN; BREAST-CANCER; 1-MATRIX METALLOPROTEINASE; TRANSMEMBRANE DOMAIN; PROMMP-2 ACTIVATION; PROSTATE-CANCER; CD44 CLEAVAGE; TUMOR-GROWTH; MT1-MMP; INVASION	Matrix metalloproteinases (MMPs) have been shown to be key players in both extracellular matrix remodeling and cell migration during cancer metastasis. MMP-14, a membrane-anchored MMP, in particular, is closely associated with these processes. The hemopexin (PEX) domain of MMP-14 has been proposed as the modulating region involved in the molecular cross-talk that initiates cell migration through homodimerization of MMP-14 as well as heterodimerization with the cell surface adhesion molecule CD44. In this study, minimal regions required for function within the PEX domain were investigated through a series of substitution mutations. Blades I and IV were found to be involved in cell migration. We found that blade IV is necessary for MMP-14 homodimerization and that blade I is required for CD44 MMP-14 heterodimerization. Cross-talk between MMP-14 and CD44 results in phosphorylation of EGF receptor and downstream activation of the MAPK and PI3K signaling pathways involved in cell migration. Based on these mutagenesis analyses, peptides mimicking the essential outermost strand motifs within the PEX domain of MMP-14 were designed. These synthetic peptides inhibit MMP-14-enhanced cell migration in a dose-dependent manner but have no effect on the function of other MMPs. Furthermore, these peptides interfere with cancer metastasis without affecting primary tumor growth. Thus, targeting the MMP-14 hemopexin domain represents a novel approach to inhibit MMP-14-mediated cancer dissemination.	[Zarrabi, Kevin; Li, Jian; Kuscu, Cem; Pulkoski-Gross, Ashleigh; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Dufour, Antoine; Sampson, Nicole S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zhi, Jizu] SUNY Stony Brook, Bioinformat Facil, Stony Brook, NY 11794 USA; [Hu, Youjun; Cao, Jian] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zucker, Stanley] SUNY Stony Brook, Dept Hematol & Oncol, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cao, J (corresponding author), Room 004,Life Sci Bldg, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu	Sampson, Nicole/C-4598-2014; Dufour, Antoine/AAB-7886-2019; Zarrabi, Kevin/AHH-3952-2022	Sampson, Nicole/0000-0002-2835-7760; KUSCU, CEM/0000-0001-7154-6762	National Institutes of Health [5R01CA113553]; Carol Baldwin Breast Cancer Foundation; New York State Foundation for Science, Technology, and Innovation [C040076]; Veterans Affairs Merit Review grant; NATIONAL CANCER INSTITUTE [R01CA113553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM092714, T32GM007518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Breast Cancer Foundation; New York State Foundation for Science, Technology, and Innovation; Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant 5R01CA113553 (to J. C. and N. S. S.). This work was also supported by a Carol Baldwin Breast Cancer Foundation grant (to J. C.), by New York State Foundation for Science, Technology, and Innovation Faculty Development Program Grant C040076 (to N. S.), by a Veterans Affairs Merit Review grant, and by a Carol Baldwin Breast Cancer Foundation grant (to S. Z.).	Anderegg U, 2009, J INVEST DERMATOL, V129, P1471, DOI 10.1038/jid.2008.323; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Cao J, 2005, THROMB HAEMOSTASIS, V93, P770, DOI 10.1160/TH04-08-0555; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Khaldoyanidi SK, 2003, J BIOL CHEM, V278, P4127, DOI 10.1074/jbc.M209590200; Kirsch M, 2004, CANC TREAT, V117, P285; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Magenta G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-47; Marrero-Diaz R, 2009, CELL MOTIL CYTOSKEL, V66, P48, DOI 10.1002/cm.20325; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Pavlaki M, 2002, J BIOL CHEM, V277, P2740, DOI 10.1074/jbc.M108987200; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Seraj MJ, 2000, CANCER RES, V60, P2764; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	53	150	161	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33167	33177		10.1074/jbc.M111.256644	http://dx.doi.org/10.1074/jbc.M111.256644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795678	Green Published, hybrid			2022-12-27	WOS:000294968800036
J	Ferreira-Gomes, MS; Gonzalez-Lebrero, RM; de la Fuente, MC; Strehler, EE; Rossi, RC; Rossi, JPFC				Ferreira-Gomes, Mariela S.; Gonzalez-Lebrero, Rodolfo M.; de la Fuente, Maria C.; Strehler, Emanuel E.; Rossi, Rolando C.; Rossi, Juan Pablo F. C.			Calcium Occlusion in Plasma Membrane Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-DEPENDENT ATPASE; NA+/K+-ATPASE; PUMP; INHIBITION; MECHANISM; TRANSPORT; CA2+; PHOSPHOENZYME; STOICHIOMETRY; ACTIVATION	In this work, we set out to identify and characterize the calcium occluded intermediate(s) of the plasma membrane Ca2+-ATPase (PMCA) to study the mechanism of calcium transport. To this end, we developed a procedure for measuring the occlusion of Ca2+ in microsomes containing PMCA. This involves a system for overexpression of the PMCA and the use of a rapid mixing device combined with a filtration chamber, allowing the isolation of the enzyme and quantification of retained calcium. Measurements of retained calcium as a function of the Ca2+ concentration in steady state showed a hyperbolic dependence with an apparent dissociation constant of 12 +/- 2.2 mu M, which agrees with the value found through measurements of PMCA activity in the absence of calmodulin. When enzyme phosphorylation and the retained calcium were studied as a function of time in the presence of La-III (inducing accumulation of phosphoenzyme in the E1P state), we obtained apparent rate constants not significantly different from each other. Quantification of EP and retained calcium in steady state yield a stoichiometry of one mole of occluded calcium per mole of phosphoenzyme. These results demonstrate for the first time that one calcium ion becomes occluded in the E1P-phosphorylated intermediate of the PMCA.	[Rossi, Rolando C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Rossi, RC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fis Quim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	rcr@qb.ffyb.uba.ar; jprossi@qb.ffyb.uba.ar		Rossi, Juan Pablo/0000-0001-7087-844X; Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270	National Institutes of Health, Fogarty International Center [R03TW006837]; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires, Ciencia y Tecnica from Argentina; FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Ciencia y Tecnica from Argentina(University of Buenos Aires); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health, Fogarty International Center Grant R03TW006837. This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires, Ciencia y Tecnica from Argentina.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSEN JP, 1985, P NATL ACAD SCI USA, V82, P4573, DOI 10.1073/pnas.82.14.4573; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Caride AJ, 2001, CELL CALCIUM, V30, P49, DOI 10.1054/ceca.2001.0212; CLARK A, 1983, CELL CALCIUM, V4, P83, DOI 10.1016/0143-4160(83)90037-4; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; GARRAHAN PJ, 1978, BIOCHIM BIOPHYS ACTA, V513, P59, DOI 10.1016/0005-2736(78)90111-6; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; Kaufman SB, 1999, J BIOL CHEM, V274, P20779, DOI 10.1074/jbc.274.30.20779; KRATJE RB, 1983, BIOCHIM BIOPHYS ACTA, V731, P40, DOI 10.1016/0005-2736(83)90395-4; LARSEN FL, 1978, J MEMBRANE BIOL, V41, P361, DOI 10.1007/BF01872000; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; Montes MR, 2011, BBA-BIOMEMBRANES, V1808, P316, DOI 10.1016/j.bbamem.2010.08.022; Moreira OC, 2005, BBA-BIOENERGETICS, V1708, P411, DOI 10.1016/j.bbabio.2005.05.010; Rega A. F., 1986, CA2 PUMP PLASMA MEMB; RITOV VB, 1993, BIOCHIM BIOPHYS ACTA, V1148, P257, DOI 10.1016/0005-2736(93)90137-O; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SCHATZMANN HJ, 1973, J PHYSIOL-LONDON, V235, P551, DOI 10.1113/jphysiol.1973.sp010403; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; SUMIDA M, 1974, J BIOCHEM-TOKYO, V75, P283, DOI 10.1093/oxfordjournals.jbchem.a130396; TAKISAWA H, 1983, J BIOL CHEM, V258, P2986; Verma AK, 1996, J BIOL CHEM, V271, P3714; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013	28	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32018	32025		10.1074/jbc.M111.266650	http://dx.doi.org/10.1074/jbc.M111.266650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795697	Green Published, hybrid			2022-12-27	WOS:000294726800011
J	Qi, YP; Tsuda, K; Nguyen, LV; Wang, X; Lin, JS; Murphy, AS; Glazebrook, J; Thordal-Christensen, H; Katagiri, F				Qi, Yiping; Tsuda, Kenichi; Nguyen, Le V.; Wang, Xia; Lin, Jinshan; Murphy, Angus S.; Glazebrook, Jane; Thordal-Christensen, Hans; Katagiri, Fumiaki			Physical Association of Arabidopsis Hypersensitive Induced Reaction Proteins (HIRs) with the Immune Receptor RPS2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; PLANT-PATHOGEN INTERACTIONS; RPS2-MEDIATED DISEASE RESISTANCE; DOWNY MILDEW RESISTANCE; PROGRAMMED CELL-DEATH; RICH REPEAT DOMAIN; LIPID RAFTS; PLASMA-MEMBRANE; SPFH DOMAIN; FLAGELLIN PERCEPTION	Arabidopsis RPS2 is a typical nucleotide-binding leucine-rich repeat resistance protein, which indirectly recognizes the bacterial effector protein AvrRpt2 and thereby activates effector-triggered immunity (ETI). Previously, we identified two hypersensitive induced reaction (AtHIR) proteins, AtHIR1 (At1g09840) and AtHIR2 (At3g01290), as potential RPS2 complex components. AtHIR proteins contain the stomatin/prohibitin/flotillin/HflK/C domain (also known as the prohibitin domain or band 7 domain). In this study, we confirmed that AtHIR1 and AtHIR2 form complexes with RPS2 in Arabidopsis and Nicotiana benthamiana using a pulldown assay and fluorescence resonance energy transfer (FRET) analysis. Arabidopsis has four HIR family genes (AtHIR1-4). All AtHIR proteins could form homo- and hetero-oligomers in vivo and were enriched in membrane microdomains of the plasma membrane. The mRNA levels of all except AtHIR4 were significantly induced by microbe-associated molecular patterns, such as the bacterial flagellin fragment flg22. Athir2-1 and Athir3-1 mutants allowed more growth of Pto DC3000 AvrRpt2, but not Pto DC3000, indicating that these mutations reduce RPS2-mediated ETI but do not affect basal resistance to the virulent strain. Overexpression of AtHIR1 and AtHIR2 reduced growth of Pto DC3000. Taken together, the results show that the AtHIR proteins are physically associated with RPS2, are localized in membrane microdomains, and quantitatively contribute to RPS2-mediated ETI.	[Qi, Yiping; Tsuda, Kenichi; Nguyen, Le V.; Glazebrook, Jane; Katagiri, Fumiaki] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Wang, Xia; Lin, Jinshan; Murphy, Angus S.] Purdue Univ, Dept Hort, W Lafayette, IN 47907 USA; [Thordal-Christensen, Hans] Univ Copenhagen, Fac Life Sci, Dept Agr & Ecol, DK-1871 Frederiksberg C, Denmark	University of Minnesota System; University of Minnesota Twin Cities; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Copenhagen	Katagiri, F (corresponding author), Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, 1500 Gortner Ave, St Paul, MN 55108 USA.	katagiri@umn.edu	Qi, Yiping/AAZ-3976-2020; Thordal-Christensen, Hans/F-6281-2014; Tsuda, Kenichi/A-2453-2009	Qi, Yiping/0000-0002-9556-6706; Thordal-Christensen, Hans/0000-0001-8813-0157; Tsuda, Kenichi/0000-0001-7074-0731; Glazebrook, Jane/0000-0001-5167-736X; Katagiri, Fumiaki/0000-0001-6893-3788	National Science Foundation [IOS-0419648, MCB-0918908]; University of Minnesota	National Science Foundation(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	This work was supported by Grants IOS-0419648 (Arabidopsis 2010 Program) and MCB-0918908 from the National Science Foundation (to F. K.).; Supported by a Hamm Memorial Graduate Student fellowship and a PBS doctoral dissertation fellowship from the University of Minnesota.	Ahn CS, 2006, PLANT J, V46, P658, DOI 10.1111/j.1365-313X.2006.02726.x; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Banerjee D, 2001, GENETICS, V158, P439; Bassham DC, 2008, PLANT PHYSIOL, V147, P1504, DOI 10.1104/pp.108.121129; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bhat RA, 2005, PLANTA, V223, P5, DOI 10.1007/s00425-005-0096-9; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Desveaux D, 2006, CURR OPIN PLANT BIOL, V9, P376, DOI 10.1016/j.pbi.2006.05.005; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Glazebrook J, 1997, GENETICS, V146, P381; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Grennan AK, 2007, PLANT PHYSIOL, V143, P1083, DOI 10.1104/pp.104.900218; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; Hink MA, 2002, PLANT MOL BIOL, V50, P871, DOI 10.1023/A:1021282619035; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2008, PLANTA, V227, P409, DOI 10.1007/s00425-007-0628-6; Jung HW, 2007, MOL PLANT PATHOL, V8, P503, DOI 10.1111/J.1364-3703.2007.00410.X; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Karrer EE, 1998, PLANT MOL BIOL, V36, P681, DOI 10.1023/A:1005949304445; Keinath NF, 2010, J BIOL CHEM, V285, P39140, DOI 10.1074/jbc.M110.160531; Kwon C, 2008, TRENDS IMMUNOL, V29, P159, DOI 10.1016/j.it.2008.01.004; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Magee AI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-234; Martin SW, 2005, TRENDS PLANT SCI, V10, P263, DOI 10.1016/j.tplants.2005.04.004; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Morel J, 2006, MOL CELL PROTEOMICS, V5, P1396, DOI 10.1074/mcp.M600044-MCP200; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nadimpalli R, 2000, J BIOL CHEM, V275, P29579, DOI 10.1074/jbc.M002339200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Qi YP, 2011, MOL PLANT PATHOL, V12, P702, DOI 10.1111/J.1364-3703.2010.00704.X; Qi YP, 2010, MOL PLANT MICROBE IN, V23, P1573, DOI 10.1094/MPMI-05-10-0106; Qi YP, 2009, PLANT J, V57, P932, DOI 10.1111/j.1365-313X.2008.03736.x; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rostoks N, 2003, THEOR APPL GENET, V107, P1094, DOI 10.1007/s00122-003-1351-8; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shahollari B, 2007, PLANT J, V50, P1, DOI 10.1111/j.1365-313X.2007.03028.x; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Wang Y, 2010, PLANT CELL, V22, P249, DOI 10.1105/tpc.109.072066; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yu XM, 2008, GENE, V407, P193, DOI 10.1016/j.gene.2007.10.010; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zhang ZG, 2008, MOL PLANT, V1, P510, DOI 10.1093/mp/ssn011; Zhang ZG, 2007, PLANT J, V49, P302, DOI 10.1111/j.1365-313X.2006.02961.x; Zhou LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-290; Zhou L, 2009, PLANT CELL ENVIRON, V32, P1804, DOI 10.1111/j.1365-3040.2009.02039.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	95	75	83	7	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31297	31307		10.1074/jbc.M110.211615	http://dx.doi.org/10.1074/jbc.M110.211615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757708	Green Published, hybrid			2022-12-27	WOS:000294487500025
J	Fang, HL; Wu, YF; Huang, XH; Wang, WY; Ang, B; Cao, XT; Wan, T				Fang, Hongliang; Wu, Yanfeng; Huang, Xiaohui; Wang, Wenying; Ang, Bing; Cao, Xuetao; Wan, Tao			Toll-like Receptor 4 (TLR4) Is Essential for Hsp70-like Protein 1 (HSP70L1) to Activate Dendritic Cells and Induce Th1 Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; CANCER CELLS; VACCINE; ADJUVANT; PATHWAY; INNATE; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE; IDENTIFICATION; INTERFERON	Toll-like receptors (TLRs) play important roles in initiation of innate and adaptive immune responses. Emerging evidence suggests that TLR agonists can serve as potential adjuvant for vaccination. Heat shock proteins (HSPs), functionally serving as TLR4 agonists, have been proposed to act as Th1 adjuvant. We have identified a novel Hsp70 family member, termed Hsp70-like protein 1 (Hsp70L1), shown that Hsp70L1 is a potent T helper cell (Th1) polarizing adjuvant that contributes to antitumor immune responses. However, the underlying mechanism for how Hsp70L1 exerts its Th1 adjuvant activity remains to be elucidated. In this study, we found that Hsp70L1 binds directly to TLR4 on the surface of DCs, activates MAPK and NF-kappa B pathways, up-regulates I-a(b), CD40, CD80, and CD86 expression and promotes production of TNF-alpha, IL-1 beta, and IL-12p70. Hsp70L1 failed to induce such phenotypic maturation and cytokine production in TLR4-deficient DCs, indicating a role for TLR4 in mediating Hsp70L1-induced DC activation. Furthermore, more efficient induction of carcinoembryonic antigen (CEA)-specific Th1 immune response was observed in mice immunized by wild-type DCs pulsed with Hsp70L1-CEA(576-669) fusion protein as compared with TLR4-deficient DCs pulsed with same fusion protein. In addition, TLR4 antagonist impaired induction of CEA-specific human Th1 immune response in a coculture system of peripheral blood lymphocytes (PBLs) from HLAA2.1(+) healthy donors and autologous DCs pulsed with Hsp70L1-CEA(576- 669) in vitro. Taken together, these results demonstrate that TLR4 is a key receptor mediating the interaction of Hsp70L1 with DCs and subsequently enhancing the induction of Th1 immune response by Hsp70L1/antigen fusion protein.	[Fang, Hongliang; Wu, Yanfeng; Huang, Xiaohui; Wang, Wenying; Ang, Bing; Cao, Xuetao; Wan, Tao] Second Mil Med Univ, Natl Key Lab Med Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Fang, Hongliang; Wu, Yanfeng; Huang, Xiaohui; Wang, Wenying; Ang, Bing; Cao, Xuetao; Wan, Tao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	caoxt@immunol.org; taowan@immunol.org			National Natural Science Foundation of China [30872296, 30772205]; National High Technology Research, Development Program of China [2007AA021105, 2009AA02Z102]; Shanghai Science and Technology Major Project [10DZ1910300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research, Development Program of China(National High Technology Research and Development Program of China); Shanghai Science and Technology Major Project	This work was supported by grants from the National Natural Science Foundation of China (30872296, 30772205), National High Technology Research, Development Program of China (2007AA021105 and 2009AA02Z102), and Shanghai Science and Technology Major Project (10DZ1910300).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Capsoni F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2827; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hoshino K, 1999, J IMMUNOL, V162, P3749; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Liu SX, 2008, MOL IMMUNOL, V46, P242, DOI 10.1016/j.molimm.2008.08.279; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Murata M, 2008, CANCER SCI, V99, P1435, DOI 10.1111/j.1349-7006.2008.00832.x; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rhee EG, 2010, J VIROL, V84, P10413, DOI 10.1128/JVI.00928-10; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wood C, 2008, LANCET, V372, P145, DOI 10.1016/S0140-6736(08)60697-2; Wu YF, 2005, CANCER RES, V65, P4947, DOI 10.1158/0008-5472.CAN-04-3912; Zhang T, 2009, BLOOD, V114, P4081, DOI 10.1182/blood-2009-05-219881	33	73	82	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30393	30400		10.1074/jbc.M111.266528	http://dx.doi.org/10.1074/jbc.M111.266528			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730052	hybrid, Green Published			2022-12-27	WOS:000294283600017
J	Xue, Z; He, Y; Ye, KX; Gu, ZL; Mao, YX; Qi, L				Xue, Zhen; He, Yin; Ye, Kaixiong; Gu, Zhenglong; Mao, Yuxin; Qi, Ling			A Conserved Structural Determinant Located at the Interdomain Region of Mammalian Inositol-requiring Enzyme 1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSCRIPTION FACTOR; DIMERIZATION DOMAIN; IRE1; IRE1-ALPHA; KINASE; SIGNALS; XBP1	Inositol-requiring enzyme 1 alpha (IRE1 alpha), an endoplasmic reticulum-resident sensor for mammalian unfolded protein response, is a bifunctional enzyme containing kinase and RNase domains critical for trans-autophosphorylation and Xbp1 mRNA splicing, respectively, in response to endoplasmic reticulum stress. However, the amino acid residues important for its function and activation remain largely unexplored. Here, through analysis of IRE1 alpha mutants associated with human somatic cancers, we have identified a highly conserved proline residue at position 830 (Pro(830)) that is critical for its structural integrity and hence, the activation of both kinase and RNase domains. Structural analysis revealed that Pro(830) may form a highly conserved structural linker with adjacent tryptophan and tyrosine residues at positions 833 and 945 (Trp(833) and Tyr(945)), thereby bridging the kinase and RNase domains. Indeed, mutation of Pro(830) to leucine (P830L) completely abolished the kinase and RNase activities, significantly decreased protein stability, and prevented oligomerization of IRE1 alpha upon ER stress; similar observations were made for mutations of Trp(833) to alanine (W833A) and to a lesser extent for Y945A. Our finding may facilitate the identification of small molecules to compromise IRE1 alpha function specifically.	[Xue, Zhen; Ye, Kaixiong; Gu, Zhenglong; Qi, Ling] Cornell Univ, Grad Program Nutr, Ithaca, NY 14853 USA; [He, Yin; Gu, Zhenglong; Qi, Ling] Cornell Univ, Grad Program Genet & Dev, Ithaca, NY 14853 USA; [Xue, Zhen; Ye, Kaixiong; Gu, Zhenglong; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Mao, Yuxin] Cornell Univ, Weill Inst Mol & Cell Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Qi, L (corresponding author), Cornell Univ, Grad Program Nutr, Ithaca, NY 14853 USA.	lq35@cornell.edu	Ye, Kaixiong/C-2297-2017	Ye, Kaixiong/0000-0003-4658-7292; Qi, Ling/0000-0001-8229-0184; Mao, Yuxin/0000-0002-5064-1397	NIDDK, National Institutes of Health [R01DK082582]; American Diabetes Association [7-08-JF-47]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant R01DK082582 (to L.Q.). This work was also supported by Cornell startup packages (to L.Q., Z.G., and Y.M.) American Diabetes Association Grant 7-08-JF-47 (to L.Q.).	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	26	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30859	30866		10.1074/jbc.M111.273714	http://dx.doi.org/10.1074/jbc.M111.273714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757700	Green Published, hybrid			2022-12-27	WOS:000294283600065
J	Cochran, R; Kalisiak, J; Kucukkilinc, T; Radic, Z; Garcia, E; Zhang, LM; Ho, KY; Amitai, G; Kovarik, Z; Fokin, VV; Sharpless, KB; Taylor, P				Cochran, Rory; Kalisiak, Jaroslaw; Kuecuekkilinc, Tuba; Radic, Zoran; Garcia, Edzna; Zhang, Limin; Ho, Kwok-Yiu; Amitai, Gabriel; Kovarik, Zrinka; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer			Oxime-assisted Acetylcholinesterase Catalytic Scavengers of Organophosphates That Resist Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE; ACTIVE-CENTER; CHOLINESTERASES; BIOSCAVENGER; REACTIVATION; TOXICITY; RESIDUES; PROTECTION; INHIBITOR; MUTATIONS	The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophosphates (OPs). Exposure to OPs can lead to serious cardiovascular complications, respiratory compromise, and death. Current therapy to combat OP poisoning involves an oxime reactivator (2-PAM, obidoxime, TMB4, or HI-6) combined with atropine and on occasion an anticonvulsant. Butyrylcholinesterase, administered in the plasma compartment as a bio-scavenger, has also shown efficacy but is limited by its strict stoichiometric scavenging, slow reactivation, and a propensity for aging. Here, we characterize 10 human (h) AChE mutants that, when coupled with an oxime, give rise to catalytic reactivation and aging resistance of the soman conjugate. With the most efficient human AChE mutant Y337A/F338A, we show enhanced reactivation rates for several OP-hAChE conjugates compared with wild-type hAChE when reactivated with HI-6 (1-(2'-hydroxyiminomethyl-1'-pyridinium)-3-(4'-carbamoyl-1-pyridinium)). In addition, we interrogated an 840-member novel oxime library for reactivation of Y337A/F338A hAChE-OP conjugates to delineate the most efficient oxime-mutant enzyme pairs for catalytic bio-scavenging. Combining the increased accessibility of the Y337A mutation to oximes within the space-impacted active center gorge with the aging resistance of the F338A mutation provides increased substrate diversity in scavenging potential for aging-prone alkyl phosphate inhibitors.	[Cochran, Rory; Kuecuekkilinc, Tuba; Radic, Zoran; Garcia, Edzna; Zhang, Limin; Ho, Kwok-Yiu; Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kalisiak, Jaroslaw; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kalisiak, Jaroslaw; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Amitai, Gabriel] Israel Inst Biol Res, Div Med Chem, IL-74100 Ness Ziona, Israel; [Kovarik, Zrinka] Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Institute for Medical Research & Occupational Health (IMROH)	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu	KUCUKKILINC, ZEKIYE TUBA TUYLU/I-8426-2013	KUCUKKILINC, ZEKIYE TUBA TUYLU/0000-0003-1566-0717; Cochran, Rory/0000-0001-9123-4010	National Institutes of Health, NINDS [U01 NS 058046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058046] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 NS 058046 from USPHS CounterAct Program through the NINDS.	ALDRIDGE WN, 1972, ENZYME INHIBITORS SU, P1; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; [Anonymous], ENZYMES 3E; ASHANI Y, 1995, J BIOL CHEM, V270, P6370, DOI 10.1074/jbc.270.11.6370; Cerasoli DM, 2005, CHEM-BIOL INTERACT, V157, P363, DOI 10.1016/j.cbi.2005.10.052; CRODDY E, 2005, WEAPONS MASS DESTRUC, P1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FLEISHER JH, 1965, BIOCHEM PHARMACOL, V14, P641, DOI 10.1016/0006-2952(65)90082-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang YJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-50; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; Kovarik Z, 2003, BIOCHEM J, V373, P33, DOI 10.1042/BJ20021862; Kovarik Z, 2007, TOXICOLOGY, V233, P79, DOI 10.1016/j.tox.2006.08.032; Kucukkilinc T, 2010, CHEM-BIOL INTERACT, V187, P238, DOI 10.1016/j.cbi.2010.03.050; Mazor O, 2008, MOL PHARMACOL, V74, P755, DOI 10.1124/mol.108.047449; MCDONOUGH JH, 2007, CHEM WARFARE AGENTS, P71; Ordentlich A, 1999, BIOCHEMISTRY-US, V38, P3055, DOI 10.1021/bi982261f; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Raveh L, 1997, TOXICOL APPL PHARM, V145, P43, DOI 10.1006/taap.1997.8160; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P2465, DOI 10.1016/0006-2952(93)90228-O; Rosenberg YJ, 2010, CHEM-BIOL INTERACT, V187, P279, DOI 10.1016/j.cbi.2010.02.042; Saxena A, 1997, BIOCHEM PHARMACOL, V54, P269, DOI 10.1016/S0006-2952(97)00180-9; SAXENA A, 1993, BIOCHEM BIOPH RES CO, V197, P343, DOI 10.1006/bbrc.1993.2481; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; Taylor P., 2011, GOODMAN GILMANS PHAR, V12th ed, P239; Taylor Palmer, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P339, DOI 10.2478/v10004-007-0027-1; Taylor P, 2007, TOXICOLOGY, V233, P70, DOI 10.1016/j.tox.2006.11.061; Valle AM, 2011, J PHARMACOL EXP THER, V338, P125, DOI 10.1124/jpet.111.180091; WOLFE AD, 1992, TOXICOL APPL PHARM, V117, P189, DOI 10.1016/0041-008X(92)90236-L	31	48	49	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29718	29724		10.1074/jbc.M111.264739	http://dx.doi.org/10.1074/jbc.M111.264739			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730071	Green Published, hybrid			2022-12-27	WOS:000294046600031
J	Long, XC; Miano, JM				Long, Xiaochun; Miano, Joseph M.			Transforming Growth Factor-beta 1 (TGF-beta 1) Utilizes Distinct Pathways for the Transcriptional Activation of MicroRNA 143/145 in Human Coronary Artery Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SERUM RESPONSE FACTOR; NEOINTIMAL LESION FORMATION; EMBRYONIC STEM-CELLS; P38 MAP KINASE; GENE-EXPRESSION; TGF-BETA; MESENCHYMAL TRANSITION; PHENOTYPIC MODULATION; CONTRACTILE PHENOTYPE	MicroRNA 143/145 (miR143/145) is restricted to adult smooth muscle cell (SMC) lineages and mediates, in part, the expression of several SMC contractile genes. Although the function of miR143/145 has begun to be elucidated, its transcriptional regulation in response to various signaling inputs is poorly understood. In an effort to define a miR signature for SMC differentiation, we screened human coronary artery SMCs for miRs modulated by TGF-beta 1, a known stimulus for SMC differentiation. Array analysis revealed a number of TGF-beta 1-induced miRs, including miR143/145. Validation studies showed that TGF-beta 1 stimulated miR143/145 expression in a dose-and time-dependent manner. We utilized several chemical inhibitors and found that SB203580, a specific inhibitor of p38MAPK, significantly decreased TGF-beta 1-induced miR143/145 expression. siRNA studies demonstrated that the effect of TGF-beta 1 on miR143/145 was dependent upon the myocardin and serum response factor transcriptional switch as well as SMAD4. TGF-beta 1 stimulated a 580-bp human miR143/145 enhancer, and mutagenesis studies revealed a critical role for both a known CArG box and an adjacent SMAD-binding element for full TGF-beta 1-dependent activation of the enhancer. Chromatin immunoprecipitation assays documented TGF-beta 1-mediated enrichment of SMAD3 and SMAD4 binding over the enhancer region containing the SMAD-binding element. Pre-miR145 strongly promoted SMC differentiation, whereas an anti-miR145 partially blocked TGF-beta 1-induced SMC differentiation. These results demonstrate a dual pathway for TGF-beta 1-induced transcription of miR143/145, thus revealing a novel mechanism underlying TGF-beta 1-induced human vascular SMC differentiation.	[Long, Xiaochun] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Dept Med, Rochester, NY 14642 USA	University of Rochester	Long, XC (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Dept Med, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	xiaochun_long@urmc.rochester.edu; j.m.miano@rochester.edu	; Miano, Joseph/L-5634-2018	Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [HL62572, HL091168]; American Heart Association [10SDG3670036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62572 and HL091168 (to J. M. M.). This work was also supported by American Heart Association Scientist Development Grant 10SDG3670036 (to X. L.).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; La Rocca G, 2011, J CELL PHYSIOL, V226, P602, DOI 10.1002/jcp.22368; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	61	102	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30119	30129		10.1074/jbc.M111.258814	http://dx.doi.org/10.1074/jbc.M111.258814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712382	hybrid, Green Published			2022-12-27	WOS:000294046600069
J	Markowska, AI; Jefferies, KC; Panjwani, N				Markowska, Anna I.; Jefferies, Kevin C.; Panjwani, Noorjahan			Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL NEOVASCULARIZATION; BINDING LECTIN; VEGF-A; ANGIOGENESIS; CARCINOMA; MICE; GLYCOSYLATION; MEMBRANE; CANCER	Angiogenesis is heavily influenced by VEGF-A and its family of receptors, particularly VEGF receptor 2 (VEGF-R2). Like most cell surface proteins, VEGF-R2 is glycosylated, although the function of VEGF-R2 with respect to its glycosylation pattern is poorly characterized. Galectin-3, a glycan binding protein, interacts with the EGF and TGF beta receptors, retaining them on the plasma membrane and altering their signal transduction. Because VEGF-R2 is glycosylated and both galectin-3 and VEGF-R2 are involved with angiogenesis, we hypothesized that galectin-3 binds VEGF-R2 and modulates its signal transduction as well. Employing a Western blot analysis approach, we found that galectin-3 induces phosphorylation of VEGF-R2 in endothelial cells. Knockdown of galectin-3 and Mgat5, an enzyme that synthesizes high-affinity glycan ligands of galectin-3, reduced VEGF-A mediated angiogenesis in vitro. A direct interaction on the plasma membrane was detected between galectin-3 and VEGF-R2, and this interaction was dependent on the expression of Mgat5. Using immunofluorescence and cell surface labeling, we found an increase in the level of internalized VEGF-R2 in both Mgat5 and galectin-3 knockdown cells, suggesting that galectin-3 retains the receptor on the plasma membrane. Finally, we observed reduced suture-induced neovascularization in the corneas of Gal3(-/-) and Mgat5(-/-) mice. These findings are consistent with the hypothesis that, like its role with the EGF and TGF beta receptors, galectin-3 contributes to the plasma membrane retention and proangiogenic function of VEGF-R2.	[Markowska, Anna I.] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Biochem, Boston, MA 02111 USA; [Markowska, Anna I.; Jefferies, Kevin C.; Panjwani, Noorjahan] Tufts Univ, Dept Ophthalmol, Sch Med, Boston, MA 02111 USA; [Markowska, Anna I.; Panjwani, Noorjahan] Tufts Univ, Dept Biochem, Sch Med, Boston, MA 02111 USA; [Panjwani, Noorjahan] New England Eye Ctr, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Panjwani, N (corresponding author), 136 Harrison Ave,SC704, Boston, MA 02111 USA.	noorjahan.panjwani@tufts.edu			National Eye Institute [EY07088]; National Institutes of Health [P30 N5047243]; New England Corneal Transplant Fund; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007088, F32EY007088, T35EY007088] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Corneal Transplant Fund; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute Grant EY07088 and by National Institutes of Health Grant P30 N5047243 for confocal microscopy performed at the Tufts Center for Neuroscience Research. This work was also supported, in part, by The New England Corneal Transplant Fund, the Massachusetts Lions Eye Research Fund, and an unrestricted grant from Research to Prevent Blindness to the New England Eye Center.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gan LS, 2004, ACTA OPHTHALMOL SCAN, V82, P557, DOI 10.1111/j.1600-0420.2004.00312.x; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gillenwater A, 1996, HEAD NECK-J SCI SPEC, V18, P422, DOI 10.1002/(SICI)1097-0347(199609/10)18:5<422::AID-HED5>3.3.CO;2-S; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Granovsky M, 2000, NAT MED, V6, P306; Hosseini H, 2007, MED HYPOTHESES, V68, P799, DOI 10.1016/j.mehy.2006.06.063; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.0.CO;2-0; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; IRIMURA T, 1991, CANCER RES, V51, P387; JOOEKO J, 2000, MED SCI MONITOR, V6, P1047; Korff T, 1999, J CELL SCI, V112, P3249; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pluda JM, 1997, SEMIN ONCOL, V24, P203; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Streilein JW, 1996, INVEST OPHTH VIS SCI, V37, P413; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; XU XC, 1995, AM J PATHOL, V147, P815	38	154	160	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29913	29921		10.1074/jbc.M111.226423	http://dx.doi.org/10.1074/jbc.M111.226423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715322	Green Published, hybrid			2022-12-27	WOS:000294046600050
J	Mora-Santos, M; Limon-Mortes, MC; Giraldez, S; Herrero-Ruiz, J; Saez, C; Japon, MA; Tortolero, M; Romero, F				Mora-Santos, Mar; Cristina Limon-Mortes, M.; Giraldez, Servando; Herrero-Ruiz, Joaquin; Saez, Carmen; Japon, Miguela A.; Tortolero, Maria; Romero, Francisco			Glycogen Synthase Kinase-3 beta (GSK3 beta) Negatively Regulates PTTG1/Human Securin Protein Stability, and GSK3 beta Inactivation Correlates with Securin Accumulation in Breast Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID SEPARATION; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; TRANSFORMING GENE; BETA-CATENIN/TCF; UBIQUITIN LIGASE; XENOPUS EMBRYOS; PHOSPHORYLATION; PROTEOLYSIS; DEGRADATION	PTTG1, also known as securin, is an inactivating partner of separase, the major effector for chromosome segregation during mitosis. At the metaphase-to-anaphase transition, securin is targeted for proteasomal destruction by the anaphase-promoting complex or cyclosome, allowing activation of separase. In addition, securin is overexpressed in metastatic or genomically instable tumors, suggesting a relevant role for securin in tumor progression. Stability of securin is regulated by phosphorylation; some phosphorylated forms are degraded out of mitosis, by the action of the SKP1-CUL1-F-box protein (SCF) complex. The kinases targeting securin for proteolysis have not been identified, and mechanistic insight into the cause of securin accumulation in human cancers is lacking. Here, we demonstrate that glycogen synthase kinase-3 beta (GSK3 beta) phosphorylates securin to promote its proteolysis via SCF beta TrCP E3 ubiquitin ligase. Importantly, a strong correlation between securin accumulation and GSK3 beta inactivation was observed in breast cancer tissues, indicating that GSK3 beta inactivation may account for securin accumulation in breast cancers.	[Mora-Santos, Mar; Cristina Limon-Mortes, M.; Giraldez, Servando; Herrero-Ruiz, Joaquin; Tortolero, Maria; Romero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, E-41080 Seville, Spain; [Saez, Carmen; Japon, Miguela A.] Univ Seville, CSIC, IBIS, Hosp Univ Virgen del Rocio, Seville 41013, Spain; [Saez, Carmen; Japon, Miguela A.] Hosp Univ Virgen del Rocio, Dept Anat Patol, Seville 41013, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Romero, F (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Apartado Correos 1095, E-41080 Seville, Spain.	frport@us.es	del Mar Mora-Santos, Maria/V-3495-2017; IBIS, TUMORIGENESIS/P-3506-2015; Tortolero, Maria/K-5744-2014; Sáez, Carmen/B-9468-2015; Japón, Miguel A/L-2555-2017; GIRALDEZ, SERVANDO/K-3927-2014; Ruiz, Joaquin Herrero/AAP-5598-2020; Romero, Francisco/K-2101-2014; Limon-Mortes, M Cristina/K-4397-2014	del Mar Mora-Santos, Maria/0000-0002-8042-0886; Tortolero, Maria/0000-0003-1797-9940; Sáez, Carmen/0000-0002-8600-0508; Japón, Miguel A/0000-0002-5980-5044; GIRALDEZ, SERVANDO/0000-0001-9543-9347; Ruiz, Joaquin Herrero/0000-0002-4120-139X; Romero, Francisco/0000-0002-9588-6881; Limon-Mortes, M Cristina/0000-0003-3720-814X	Ministerio de Ciencia e Innovacion, Spain [SAF2008-03095, SAF2008-05046]; Ministerio de Sanidad, Spain [ISCIII-RETIC-RD06/0020-FEDER]; Direccion General de Investigacion, Tecnologia y Empresa, Junta de Andalucia [P08-CVI-03603, PI09-0589]; Ministerio de Ciencia e Innovacion (MICINN); Junta de Andalucia; Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (FIS); Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad, Spain(Spanish Government); Direccion General de Investigacion, Tecnologia y Empresa, Junta de Andalucia(Junta de AndaluciaSpanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from Ministerio de Ciencia e Innovacion, Spain (Grants SAF2008-03095 and SAF2008-05046), Ministerio de Sanidad, Spain (Grant ISCIII-RETIC-RD06/0020-FEDER), and Direccion General de Investigacion, Tecnologia y Empresa, Junta de Andalucia (Grants P08-CVI-03603 and PI09-0589).; Supported by a fellowship from Ministerio de Ciencia e Innovacio'n (MICINN).; Supported by a fellowship from Junta de Andalucia.; Supported by a contract from Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (FIS) and Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Romero F, 1998, J BIOL CHEM, V273, P5923, DOI 10.1074/jbc.273.10.5923; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Saez C, 2006, J CLIN ENDOCR METAB, V91, P1404, DOI 10.1210/jc.2005-2532; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Saez C, 2002, ONCOGENE, V21, P8173, DOI 10.1038/sj.onc.1205954; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou CQ, 2005, INT J CANCER, V113, P891, DOI 10.1002/ijc.20642; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	47	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30047	30056		10.1074/jbc.M111.232330	http://dx.doi.org/10.1074/jbc.M111.232330			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757741	hybrid, Green Published			2022-12-27	WOS:000294046600063
J	Mutig, K; Kahl, T; Saritas, T; Godes, M; Persson, P; Bates, J; Raffi, H; Rampoldi, L; Uchida, S; Hille, C; Dosche, C; Kumar, S; Castaneda-Bueno, M; Gamba, G; Bachmann, S				Mutig, Kerim; Kahl, Thomas; Saritas, Turgay; Godes, Michael; Persson, Pontus; Bates, James; Raffi, Hajamohideen; Rampoldi, Luca; Uchida, Shinichi; Hille, Carsten; Dosche, Carsten; Kumar, Satish; Castaneda-Bueno, Maria; Gamba, Gerardo; Bachmann, Sebastian			Activation of the Bumetanide-sensitive Na+, K+,2Cl(-) Cotransporter (NKCC2) Is Facilitated by Tamm-Horsfall Protein in a Chloride-sensitive Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; DISTAL CONVOLUTED TUBULE; SHORT-TERM STIMULATION; CL-COTRANSPORTER; ULTRASTRUCTURAL-LOCALIZATION; NA-K-2CL COTRANSPORTER; CAMP INCREASES; MACULA DENSA; MOUSE MODEL; UMOD GENE	Active transport of NaCl across thick ascending limb (TAL) epithelium is accomplished by Na+, K+,2Cl(-) cotransporter (NKCC2). The activity of NKCC2 is determined by vasopressin (AVP) or intracellular chloride concentration and includes its amino-terminal phosphorylation. Co-expressed Tamm-Horsfall protein (THP) has been proposed to interact with NKCC2. We hypothesized that THP modulates NKCC2 activity in TAL. THP-deficient mice (THP-/-) showed an increased abundance of intracellular NKCC2 located in subapical vesicles (+47% compared with wild type (WT) mice), whereas base-line phosphorylation of NKCC2 was significantly decreased (-49% compared with WT mice), suggesting reduced activity of the transporter in the absence of THP. Cultured TAL cells with low endogenous THP levels and low base-line phosphorylation of NKCC2 displayed sharp increases in NKCC2 phosphorylation (+38%) along with a significant change of intracellular chloride concentration upon transfection with THP. In NKCC2-expressing frog oocytes, co-injection with THP cRNA significantly enhanced the activation of NKCC2 under low chloride hypotonic stress (+112% versus +235%). Short term (30 min) stimulation of the vasopressin V2 receptor pathway by V2 receptor agonist (deamino-cis-D-Arg vasopressin) resulted in enhanced NKCC2 phosphorylation in WT mice and cultured TAL cells transfected with THP, whereas in the absence of THP, NKCC2 phosphorylation upon deamino-cis-D-Arg vasopressin was blunted in both systems. Attenuated effects of furosemide along with functional and structural adaptation of the distal convoluted tubule in THP-/- mice supported the notion that NaCl reabsorption was impaired in TAL lacking THP. In summary, these results are compatible with a permissive role for THP in the modulation of NKCC2-dependent TAL salt reabsorptive function.	[Mutig, Kerim; Kahl, Thomas; Saritas, Turgay; Bachmann, Sebastian] Charite, Dept Anat, D-10115 Berlin, Germany; [Godes, Michael; Persson, Pontus] Charite, Dept Physiol, D-10115 Berlin, Germany; [Bates, James; Raffi, Hajamohideen; Kumar, Satish] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Rampoldi, Luca] Ist Sci San Raffaele, Dulbecco Telethon Inst, Mol Genet Renal Disorders Unit Dibit, I-20132 Milan, Italy; [Uchida, Shinichi] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo 1138519, Japan; [Hille, Carsten; Dosche, Carsten] Univ Potsdam, Dept Phys Chem, D-14476 Potsdam, Germany; [Castaneda-Bueno, Maria; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Inst Invest Biomed, Mexico City 14000, DF, Mexico; [Castaneda-Bueno, Maria; Gamba, Gerardo] Inst Nacl Cardiol Ignacio Chavez, Mexico City 14000, DF, Mexico	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oklahoma System; University of Oklahoma Health Sciences Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Tokyo Medical & Dental University (TMDU); University of Potsdam; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Gamba, G (corresponding author), IIB INNSZ INCICH, Vasco Quiroga 15,Colonia Secc 16, Mexico City 14000, DF, Mexico.	gamba@biomedicas.unam.mx; sbachm@charite.de	Uchida, Shinichi/D-1111-2013; Mutig, Kerim/L-9010-2017; Rampoldi, Luca/L-3639-2018; Rampoldi, Luca/AAN-6228-2020; Turgay, Saritas/AAH-5127-2020; CASTANEDA-BUENO, MARIA/GYR-1202-2022; Gamba, Gerardo/P-4873-2016	Mutig, Kerim/0000-0001-9006-5112; Rampoldi, Luca/0000-0002-0544-7042; Rampoldi, Luca/0000-0002-0544-7042; Turgay, Saritas/0000-0002-6691-9218; Hille, Carsten/0000-0003-3454-8077; Gamba, Gerardo/0000-0002-4378-9043; Castaneda-Bueno, Maria/0000-0002-5801-3504; Persson, Pontus/0000-0003-0926-2878	Deutsche Forschungsgemeinschaft [FOR 667]; Leducq Foundation; Consejo Nacional de Ciencia y Tecnologia [59992]; Fondazione Telethon Funding Source: Custom	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leducq Foundation(Leducq Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondazione Telethon(Fondazione Telethon)	This work was supported by the Deutsche Forschungsgemeinschaft (FOR 667) and Leducq Foundation and Consejo Nacional de Ciencia y Tecnologia Grant 59992 (to G.G.).	Abdallah JG, 2001, J AM SOC NEPHROL, V12, P1335, DOI 10.1681/ASN.V1271335; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; Bachmann S, 1999, ANAT EMBRYOL, V200, P447, DOI 10.1007/s004290050294; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; BACHMANN S, 1985, HISTOCHEMISTRY, V83, P531, DOI 10.1007/BF00492456; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; Hille C, 2009, PHOTOCH PHOTOBIO SCI, V8, P319, DOI 10.1039/b813797h; KAISSLING B, 1985, AM J PHYSIOL, V248, pF374, DOI 10.1152/ajprenal.1985.248.3.F374; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mutig K, 2007, AM J PHYSIOL-RENAL, V293, pF1166, DOI 10.1152/ajprenal.00196.2007; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Na KY, 2003, AM J PHYSIOL-RENAL, V284, pF133, DOI 10.1152/ajprenal.00227.2002; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Reinalter SC, 2004, ACTA PHYSIOL SCAND, V181, P513, DOI 10.1111/j.1365-201X.2004.01325.x; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Sachs AN, 2008, AM J PHYSIOL-RENAL, V295, pF1799, DOI 10.1152/ajprenal.90510.2008; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; SCHLATTER E, 1985, PFLUG ARCH EUR J PHY, V405, P367, DOI 10.1007/BF00595690; Schnermann J, 1998, AM J PHYSIOL-REG I, V274, pR263, DOI 10.1152/ajpregu.1998.274.2.R263; SCHROTER J, 1993, KIDNEY INT, V44, P401, DOI 10.1038/ki.1993.258; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574	45	118	126	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30200	30210		10.1074/jbc.M111.222968	http://dx.doi.org/10.1074/jbc.M111.222968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737451	Green Published, hybrid			2022-12-27	WOS:000294046600077
J	Rosano, GL; Bruch, EM; Ceccarelli, EA				Rosano, German L.; Bruch, Eduardo M.; Ceccarelli, Eduardo A.			Insights into the CLP/HSP100 Chaperone System from Chloroplasts of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CLP PROTEASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; IN-VIVO; PROTEINS; IMPORT; ATP; STRESS; TRANSLOCATION; DEGRADATION	HSP100 proteins are molecular chaperones involved in protein quality control. They assist in protein (un)folding, prevent aggregation, and are thought to participate in precursor translocation across membranes. Caseinolytic proteins ClpC and ClpD from plant chloroplasts belong to the HSP100 family. Their role has hitherto been investigated by means of physiological studies and reverse genetics. In the present work, we employed an in vitro approach to delve into the structural and functional characteristics of ClpC2 and ClpD from Arabidopsis thaliana (AtClpC2 and AtClpD). They were expressed in Escherichia coli and purified to near-homogeneity. The proteins were detected mainly as dimers in solution, and, upon addition of ATP, the formation of hexamers was observed. Both proteins exhibited basal ATPase activity (K-m, 1.42 mM, V-max, 0.62 nmol/(min x mu g) for AtClpC2 and K-m similar to 19.80 mM, V-max similar to 0.19 nmol/(min x mu g) for AtClpD). They were able to reactivate the activity of heat-denatured luciferase (similar to 40% for AtClpC2 and similar to 20% for AtClpD). The Clp proteins tightly bound a fusion protein containing a model transit peptide. This interaction was detected by binding assays, where the chaperones were selectively trapped by the transit peptide-containing fusion, immobilized on glutathione-agarose beads. Association of HSP100 proteins to import complexes with a bound transit peptide-containing fusion was also observed in intact chloroplasts. The presented data are useful to understand protein quality control and protein import into chloroplasts in plants.	[Rosano, German L.; Bruch, Eduardo M.; Ceccarelli, Eduardo A.] Univ Nacl Rosario, CONICET, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR,Fac Ciencias, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Ceccarelli, EA (corresponding author), Suipacha 531,S2002LRK, Rosario, Argentina.	ceccarelli@ibr.gov.ar	Ceccarelli, Eduardo A./M-8699-2014; Rosano, Germán/I-6429-2019; Ceccarelli, Eduardo A./V-2600-2019	Ceccarelli, Eduardo A./0000-0001-5776-3306; Rosano, Germán/0000-0002-8313-6813; Ceccarelli, Eduardo A./0000-0001-5776-3306	CONICET; Agencia de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT)	This study was supported by grants from CONICET and Agencia de Promocion Cientifica y Tecnologica (ANPCyT, Argentina).	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; HARPER S, 2008, CURR PROTOC PROTEIN; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Maglica Z, 2008, J MOL BIOL, V384, P503, DOI 10.1016/j.jmb.2008.09.046; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Rial DV, 2003, J BIOL CHEM, V278, P46473, DOI 10.1074/jbc.M306684200; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Sjogren LLE, 2004, PLANT PHYSIOL, V136, P4114, DOI 10.1104/pp.104.053835; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Weaver LM, 1999, PLANT PHYSIOL, V119, P1209, DOI 10.1104/pp.119.4.1209; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zheng B, 2002, PHYSIOL PLANTARUM, V114, P92, DOI 10.1034/j.1399-3054.2002.1140113.x	54	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29671	29680		10.1074/jbc.M110.211946	http://dx.doi.org/10.1074/jbc.M110.211946			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737456	Green Published, hybrid			2022-12-27	WOS:000294046600026
J	Gogada, R; Prabhu, V; Amadori, M; Scott, R; Hashmi, S; Chandra, D				Gogada, Raghu; Prabhu, Varun; Amadori, Michael; Scott, Rachael; Hashmi, Sana; Chandra, Dhyan			Resveratrol Induces p53-independent, X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Bax Protein Oligomerization on Mitochondria to Initiate Cytochrome c Release and Caspase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; BCL-2 FAMILY PROTEINS; COLON-CANCER CELLS; S-PHASE ARREST; CHEMOPREVENTIVE AGENT; PROAPOPTOTIC FUNCTION; ANTICANCER DRUGS; APOCYTOCHROME-C; LEUKEMIA CELLS; IN-VIVO	Resveratrol, a naturally occurring phytoalexin, is known to induce apoptosis in multiple cancer cell types, but the underlying molecular mechanisms remain unclear. Here, we show that resveratrol induced p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated translocation of Bax to mitochondria where it underwent oligomerization to initiate apoptosis. Resveratrol treatment promoted interaction between Bax and XIAP in the cytosol and on mitochondria, suggesting that XIAP plays a critical role in the activation and translocation of Bax to mitochondria. This process did not involve p53 but required accumulation of Bim and t-Bid on mitochondria. Bax primarily underwent homo-oligomerization on mitochondria and played a major role in release of cytochrome c to the cytosol. Bak, another key protein that regulates the mitochondrial membrane permeabilization, did not interact with p53 but continued to associate with Bcl-xL. Thus, the proapoptotic function of Bak remained suppressed during resveratrol-induced apoptosis. Caspase-9 silencing inhibited resveratrol-induced caspase activation, whereas caspase-8 knockdown did not affect caspase activity, suggesting that resveratrol induces caspase-9-dependent apoptosis. Together, our findings characterize the molecular mechanisms of resveratrol-induced caspase activation and subsequent apoptosis in cancer cells.	[Gogada, Raghu; Prabhu, Varun; Amadori, Michael; Scott, Rachael; Hashmi, Sana; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Chandra, D (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org	Gogada, Raghu/AAG-6624-2019	Gogada, Raghu/0000-0003-0933-7999; Chandra, Dhyan/0000-0001-7272-9384	National Institutes of Health [CA123142]; NCI Center [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, K01CA123142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health K01 Award CA123142 (to D. C.) and NCI Center Support Grant CA016056 (to the Roswell Park Cancer Institute).	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chow HHS, 2010, CANCER PREV RES, V3, P1168, DOI 10.1158/1940-6207.CAPR-09-0155; Chow SE, 2010, CANCER GENE THER, V17, P872, DOI 10.1038/cgt.2010.44; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Di X, 2010, BREAST CANCER RES TR, V124, P349, DOI 10.1007/s10549-010-0765-7; Dorrie J, 2001, CANCER RES, V61, P4731; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FORRESTER K, 1995, ONCOGENE, V10, P2103; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Guha P, 2011, J PHARMACOL EXP THER, V336, P206, DOI 10.1124/jpet.110.171983; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Honda T, 2004, CANCER GENE THER, V11, P249, DOI 10.1038/sj.cgt.7700684; Hsieh TC, 1999, CANCER RES, V59, P2596; Huang TT, 2011, J CELL PHYSIOL, V226, P720, DOI 10.1002/jcp.22391; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Joe AK, 2002, CLIN CANCER RES, V8, P893; Joshi B, 1999, CANCER RES, V59, P4343; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim MY, 2009, ANTICANCER RES, V29, P3733; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Mahyar-Roemer M, 2004, ONCOGENE, V23, P6226, DOI 10.1038/sj.onc.1207637; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mohan J, 2006, J BIOL CHEM, V281, P17599, DOI 10.1074/jbc.M602641200; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niles RM, 2003, CANCER LETT, V190, P157, DOI 10.1016/S0304-3835(02)00676-6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Owens TW, 2010, J BIOL CHEM, V285, P1081, DOI 10.1074/jbc.M109.072322; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Pavet V, 2010, CANCER RES, V70, P1101, DOI 10.1158/0008-5472.CAN-09-2889; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Rushworth SA, 2009, BRIT J PHARMACOL, V157, P1186, DOI 10.1111/j.1476-5381.2009.00266.x; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Sanchez-Alcazar JA, 2001, CANCER RES, V61, P1038; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; She QB, 2001, CANCER RES, V61, P1604; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; STUART RA, 1990, CELL, V60, P31, DOI 10.1016/0092-8674(90)90713-O; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; Tinhofer I, 2001, FASEB J, V15, P1613, DOI 10.1096/fj.00-0675fje; Van Ginkel PR, 2007, CLIN CANCER RES, V13, P5162, DOI 10.1158/1078-0432.CCR-07-0347; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	91	63	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28749	28760		10.1074/jbc.M110.202440	http://dx.doi.org/10.1074/jbc.M110.202440			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712378	Green Published, hybrid			2022-12-27	WOS:000293837000013
J	Kumar, VP; West, AH; Cook, PF				Kumar, Vidya Prasanna; West, Ann H.; Cook, Paul F.			Kinetic and Chemical Mechanisms of Homocitrate Synthase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FEEDBACK INHIBITION; CRYSTAL-STRUCTURE; LYSINE; ENZYME; CELLS; IONS	The homocitrate synthase from Thermus thermophilus (TtHCS) is a metal-activated enzyme with either Mg2+ or Mn2+ capable of serving as the divalent cation. The enzyme exhibits a sequential kinetic mechanism. The mechanism is steady state ordered with alpha-ketoglutarate (alpha-Kg) binding prior to acetyl-CoA (AcCoA) with Mn2+, whereas it is steady state random with Mg2+, suggesting a difference in the competence of the E.Mn.alpha-Kg.AcCoA and E.Mg.alpha-Kg.AcCoA complexes. The mechanism is supported by product and dead-end inhibition studies. The primary isotope effect obtained with deuterioacetylCoA (AcCoA-d(3)) in the presence of Mg2+ is unity (value 1.0) at low concentrations of AcCoA, whereas it is 2 at high concentrations of AcCoA. Data suggest the presence of a slow conformational change induced by binding of AcCoA that accompanies deprotonation of the methyl group of AcCoA. The solvent kinetic deuterium isotope effect is also unity at low AcCoA, but is 1.7 at high AcCoA, consistent with the proposed slow conformational change. The maximum rate is pH independent with either Mg2+ or Mn2+ as the divalent metal ion, whereas V/K alpha-Kg (with Mn2+) decreases at low and high pH giving pK values of about 6.5 and 8.0. Lysine is a competitive inhibitor that binds to the active site of TtHCS, and shares some of the same binding determinants as alpha-Kg. Lysine binding exhibits negative cooperativity, indicating cross-talk between the two monomers of the TtHCS dimer. Data are discussed in terms of the overall mechanism of TtHCS.	[Kumar, Vidya Prasanna; West, Ann H.; Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	pcook@ou.edu	Kumar, Vidya/ABH-9877-2020		Grayce B. Kerr endowment	Grayce B. Kerr endowment	This work was supported by a grant from the Grayce B. Kerr endowment to the University of Oklahoma (to P. F. C.).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; Andi B, 2004, ARCH BIOCHEM BIOPHYS, V421, P243, DOI 10.1016/j.abb.2003.11.005; BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019; Bulfer SL, 2010, J BIOL CHEM, V285, P10446, DOI 10.1074/jbc.M109.094383; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; Cleland W W, 1979, Methods Enzymol, V63, P103; Cook P. F., 2007, ENZYME KINETICS MECH, P121; Feller A, 1997, YEAST, V13, P1337, DOI 10.1002/(SICI)1097-0061(199711)13:14<1337::AID-YEA186>3.0.CO;2-O; Giuseppin MLF, 2000, METAB ENG, V2, P14, DOI 10.1006/mben.1999.0134; GRAY GS, 1976, CAN J MICROBIOL, V22, P1664, DOI 10.1139/m76-246; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hans MA, 2001, APPL MICROBIOL BIOT, V56, P776, DOI 10.1007/s002530100708; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; Jiang YM, 2007, NEUROTOXICOLOGY, V28, P126, DOI 10.1016/j.neuro.2006.08.005; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Lin Y, 2008, BIOCHEMISTRY-US, V47, P10809, DOI 10.1021/bi801370h; Okada T, 2010, J BIOL CHEM, V285, P4195, DOI 10.1074/jbc.M109.086330; QIAN J, 2008, THESIS U OKLAHOMA; Qian JH, 2008, BIOCHEMISTRY-US, V47, P6851, DOI 10.1021/bi800087k; Qian JH, 2006, BIOCHEMISTRY-US, V45, P12136, DOI 10.1021/bi060889h; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; TERSCHURE EG, 1995, J BACTERIOL, V177, P6672, DOI 10.1128/jb.177.22.6672-6675.1995; THOLEY G, 1988, NEUROCHEM RES, V13, P45, DOI 10.1007/BF00971853; TUCCI AF, 1972, ARCH BIOCHEM BIOPHYS, V153, P742, DOI 10.1016/0003-9861(72)90393-1; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6	29	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29428	29439		10.1074/jbc.M111.246355	http://dx.doi.org/10.1074/jbc.M111.246355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21733842	Green Published, hybrid			2022-12-27	WOS:000293837000077
J	Schwan, C; Nolke, T; Kruppke, AS; Schubert, DM; Lang, AE; Aktories, K				Schwan, Carsten; Noelke, Thilo; Kruppke, Anna S.; Schubert, Daniel M.; Lang, Alexander E.; Aktories, Klaus			Cholesterol- and Sphingolipid-rich Microdomains Are Essential for Microtubule-based Membrane Protrusions Induced by Clostridium difficile Transferase (CDT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM C2 TOXIN; CLATHRIN-INDEPENDENT ENDOCYTOSIS; LIPID RAFTS; PLASMA-MEMBRANE; BACTERIAL TOXINS; CELLS; ACTIN; CYCLODEXTRINS; MECHANISMS; CURVATURE	Clostridium difficile toxin (CDT) is a binary actin-ADP-ribosylating toxin that causes depolymerization of the actin cytoskeleton and formation of microtubule-based membrane protrusions, which are suggested to be involved in enhanced bacterial adhesion and colonization of hypervirulent C.difficile strains. Here, we studied the involvement of membrane lipid components of human colon adenocarcinoma (Caco-2) cells in formation of membrane protrusions. Depletion of cholesterol by methyl-beta-cyclodextrin inhibited protrusion formation in a concentration-dependent manner but had no major effect on the toxin-catalyzed modification of actin in target cells. Repletion of cholesterol reconstituted formation of protrusions and increased velocity and total amount of protrusion formation. Methyl-beta-cyclodextrin had no effect on the CDT-induced changes in the dynamics of microtubules. Formation of membrane protrusions was also inhibited by the cholesterol-binding polyene antibiotic nystatin. Degradation or inhibition of synthesis of sphingolipids by sphingomyelinase and myriocin, respectively, blocked CDT-induced protrusion formation. Benzyl alcohol, which increases membrane fluidity, prevented protrusion formation. CDT-induced membrane protrusions were stained by flotillin-2 and by the fluorescent-labeled lipid raft marker cholera toxin subunit B, which selectively interacts with GM1 ganglioside mainly located in lipid microdomains. The data suggest that formation and especially the initiation of CDT-induced microtubule-based membrane protrusions depend on cholesterol-and sphingolipid-rich lipid microdomains.	[Schwan, Carsten; Noelke, Thilo; Kruppke, Anna S.; Schubert, Daniel M.; Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Schwan, Carsten/0000-0003-3876-8739	Deutsche Forschungsgemeinschaft [AK 6-20/1]; BIOSS Program, Freiburg, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BIOSS Program, Freiburg, Germany	This work was supported by Deutsche Forschungsgemeinschaft Grant AK 6-20/1 and the BIOSS Program, Freiburg, Germany.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BASSE F, 1992, EUR J BIOCHEM, V205, P155, DOI 10.1111/j.1432-1033.1992.tb16763.x; Christian AE, 1997, J LIPID RES, V38, P2264; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Gibert M, 2011, CELL MICROBIOL, V13, P154, DOI 10.1111/j.1462-5822.2010.01527.x; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Grimmer S, 2006, TRAFFIC, V7, P1243, DOI 10.1111/j.1600-0854.2006.00456.x; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; IKEZAWA H, 1978, BIOCHIM BIOPHYS ACTA, V528, P247; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kelly CP, 2008, NEW ENGL J MED, V359; Larive RM, 2010, BBA-BIOMEMBRANES, V1798, P389, DOI 10.1016/j.bbamem.2009.11.016; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Poole K, 2004, FEBS LETT, V565, P53, DOI 10.1016/j.febslet.2004.03.095; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Safouane M, 2010, TRAFFIC, V11, P1519, DOI 10.1111/j.1600-0854.2010.01116.x; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon S, 2002, IMMUNOBIOLOGY, V205, P108, DOI 10.1078/0171-2985-00114; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Stepanova T, 2003, J NEUROSCI, V23, P2655; Sterthoff C, 2010, INFECT IMMUN, V78, P1468, DOI 10.1128/IAI.01351-09; Uemstsu Y, 2007, BIOL CELL, V99, P141, DOI 10.1042/BC20060089; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29356	29365		10.1074/jbc.M111.261925	http://dx.doi.org/10.1074/jbc.M111.261925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705797	Green Published, hybrid			2022-12-27	WOS:000293837000070
J	Pan, CG; Cai, LF; Lu, H; Lu, L; Jiang, SB				Pan, Chungen; Cai, Lifeng; Lu, Hong; Lu, Lu; Jiang, Shibo			A Novel Chimeric Protein-based HIV-1 Fusion Inhibitor Targeting gp41 Glycoprotein with High Potency and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-HELIX BUNDLE FORMATION; ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; MEMBRANE-FUSION; COILED-COIL; TYPE-1 GP41; INFECTION; PEPTIDE; ENFUVIRTIDE; DOMAIN	T20 (enfuvirtide, Fuzeon) is the first generation HIV-1 fusion inhibitor approved for salvage therapy of HIV-1-infected patients refractory to current antiretroviral drugs. However, its application is limited by the high cost of peptide synthesis, rapid proteolysis, and poor efficacy against emerging drug-resistant strains. Here we reported the design of a novel chimera protein-based fusion inhibitor targeting gp41, TLT35, that uses a flexible 35-mer linker to couple T20 and T1144, the first and next generation HIV-1 fusion inhibitors, respectively. TLT35, which was expressed in Escherichia coli with good yield, showed low nM activity against HIV-1-mediated cell-cell fusion and infection by laboratory-adapted HIV-1 strains (X4 or R5), including T20-resistant variants and primary HIV-1 isolates of clades A to G and group O (R5 or X4R5). TLT35 was stable in human sera and in peripheral blood mononuclear cell culture and was more resistant to proteolysis than either T20 or T1144 alone. Circular dichroism spectra showed that TLT35 folded into a thermally stable conformation with high alpha-helical content and T-m value in aqueous solution. It formed a highly stable complex with gp41 N-terminal heptad repeat peptide and blocked formation of the gp41 six-helix-bundle core. These merits combined with an anticipated low production cost for expression of TLT35 in E. coli make this novel protein-based fusion inhibitor a promising candidate for further development as an anti-HIV-1 microbicide or therapeutic for the prevention and treatment of HIV-1 infection.	[Pan, Chungen; Cai, Lifeng; Lu, Hong; Lu, Lu; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth,Minist Educ, Shanghai 200032, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Pan, Chungen] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Inst Human Virol,Minist Educ, Guangzhou 510080, Guangdong, Peoples R China; [Cai, Lifeng] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China	New York Blood Center; Fudan University; Fudan University; Sun Yat Sen University; Academy of Military Medical Sciences - China	Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.	sjiang@nybloodcenter.org	lu, lu/HII-7530-2022; Jiang, Shibo/L-4500-2014; Lu, Lu/K-7070-2014; lu, lu/HGA-0894-2022	Jiang, Shibo/0000-0001-8283-7135; Lu, Lu/0000-0002-2255-0391; Pan, Chungen/0000-0003-0359-533X	National Institutes of Health [AI046221]; Guangdong Recruitment Program of Creative Research Groups; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guangdong Recruitment Program of Creative Research Groups; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI046221 (to S. J.). This work was also supported by the Guangdong Recruitment Program of Creative Research Groups (to C. P.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; DELMEDICO M, 2006, 13 C RETR OPP INF FE; Dervillez X, 2006, CHEMMEDCHEM, V1, P330, DOI 10.1002/cmdc.200500062; Dimitrov AS, 2001, J BIOL CHEM, V276, P30335, DOI 10.1074/jbc.M103788200; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Dwyer JJ, 2003, BIOCHEMISTRY-US, V42, P4945, DOI 10.1021/bi027283n; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; Hong LA, 2003, J VIROL METHODS, V107, P155, DOI 10.1016/S0166-0934(02)00213-6; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; JIANG S, 2004, DRUG DISCOV TODAY, V1, P497; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; Ni L, 2005, BIOCHEM BIOPH RES CO, V332, P831, DOI 10.1016/j.bbrc.2005.05.037; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Pang W, 2008, VIROLOGY, V377, P80, DOI 10.1016/j.virol.2008.04.013; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	35	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28425	28434		10.1074/jbc.M111.241992	http://dx.doi.org/10.1074/jbc.M111.241992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690094	hybrid, Green Published			2022-12-27	WOS:000293557800058
J	Araki, K; Nagata, K				Araki, Kazutaka; Nagata, Kazuhiro			Functional in Vitro Analysis of the ERO1 Protein and Protein-disulfide Isomerase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BOND FORMATION; PH-DEPENDENCE; ACTIVE-SITE; OXIDATIVE ACTIVITY; QUALITY-CONTROL; ERO1-ALPHA; SUBSTRATE; FAMILY; PDI	Oxidative protein folding in the endoplasmic reticulum is supported by efficient electron relays driven by enzymatic reactions centering on the ERO1-protein-disulfide isomerase (PDI) pathway. A controlled in vitro oxygen consumption assay was carried out to analyze the ERO1-PDI reaction. The results showed the pH-dependent oxidation of PDI by ERO1 alpha. Among several possible disulfide bonds regulating ERO1 alpha activity, Cys(94)-Cys(131) and Cys(99)-Cys(104) disulfide bonds are dominant regulators by excluding the involvement of the Cys(85)-Cys(391) disulfide in the regulation. The fine-tuned species specificity of the ERO1-PDI pathway was demonstrated by functional in vitro complementation assays using yeast and mammalian oxidoreductases. Finally, the results provide experimental evidence for the intramolecular electron transfer from the a domain to the a' domain within PDI during its oxidation by ERO1 alpha.	[Araki, Kazutaka; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kita Ku, Kyoto 8038555, Japan; [Araki, Kazutaka] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan	Kyoto Sangyo University; Kyoto University	Nagata, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kita Ku, Kyoto 8038555, Japan.	nagata@cc.kyoto-su.ac.jp	Araki, Kazutaka/L-6296-2018	Araki, Kazutaka/0000-0003-2901-2454	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19G0314, 19058008]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Creative Scientific Research (19G0314) and for Scientific Research on Priority Area (19058008) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to K. N.) and by a fellowship from the Japan Society for the Promotion of Science (to K. A.).	Alanen HI, 2006, ANTIOXID REDOX SIGN, V8, P283, DOI 10.1089/ars.2006.8.283; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Berntsson M, 1997, ANAL CHIM ACTA, V355, P43, DOI 10.1016/S0003-2670(97)81610-8; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189; Dempsey JL, 2010, CHEM REV, V110, P7024, DOI 10.1021/cr100182b; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Heldman N, 2010, PROTEIN SCI, V19, P1863, DOI 10.1002/pro.473; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mossner E, 1998, PROTEIN SCI, V7, P1233; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang YH, 2008, PROTEIN J, V27, P181, DOI 10.1007/s10930-007-9121-0	37	59	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32705	32712		10.1074/jbc.M111.227181	http://dx.doi.org/10.1074/jbc.M111.227181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757736	Green Published, hybrid			2022-12-27	WOS:000294726800079
J	Cavanaugh, NA; Beard, WA; Batra, VK; Perera, L; Pedersen, LG; Wilson, SH				Cavanaugh, Nisha A.; Beard, William A.; Batra, Vinod K.; Perera, Lalith; Pedersen, Lee G.; Wilson, Samuel H.			Molecular Insights into DNA Polymerase Deterrents for Ribonucleotide Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; RNA-POLYMERASE; TRIGGER LOOP; BETA; SUBSTRATE; SUGAR; DISCRIMINATION; PYRIMIDINES	DNA polymerases can misinsert ribonucleotides that lead to genomic instability. DNA polymerase beta discourages ribonucleotide insertion with the backbone carbonyl of Tyr-271; alanine substitution of Tyr-271, but not Phe-272, resulted in a > 10-fold loss in discrimination. The Y271A mutant also inserted ribonucleotides more efficiently than wild type on a variety of ribonucleoside (rNMP)-containing DNA substrates. Substituting Mn2+ for Mg2+ decreased sugar discrimination for both wild-type and mutant enzymes primarily by increasing the affinity for rCTP. This facilitated crystallization of ternary substrate complexes of both the wild-type and Y271A mutant enzymes. Crystallographic structures of Y271A- and wild type-substrate complexes indicated that rCTP is well accommodated in the active site but that O2' of rCTP and the carbonyl oxygen of Tyr-271 or Ala-271 are unusually close (similar to 2.5 and 2.6 angstrom, respectively). Structure-based modeling indicates that the local energetic cost of positioning these closely spaced oxygens is similar to 2.2 kcal/mol for the wild-type enzyme. Because the side chain of Tyr-271 also hydrogen bonds with the primer terminus, loss of this interaction affects its catalytic positioning. Our results support a model where DNA polymerase beta utilizes two strategies, steric and geometric, with a single protein residue to deter ribonucleotide insertion.	[Cavanaugh, Nisha A.; Beard, William A.; Batra, Vinod K.; Perera, Lalith; Pedersen, Lee G.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Pedersen, Lee G.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Perera, Lalith/ABB-9995-2021; perera, Lalith/B-6879-2012; Wilson, Samuel H/E-6644-2019; Pedersen, Lee G/E-3405-2013	perera, Lalith/0000-0003-0823-1631; Wilson, Samuel H/0000-0002-1702-5293; Pedersen, Lee G/0000-0003-1262-9861	National Institutes of Health [P41 RR-01081, Z01-ES0500158, Z01-ES050161]; NIEHS [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA105010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES043010, ZIAES050158, Z01ES050161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. R. E. London and B. D. Freudenthal for critical reading of this manuscript and E. W. Hou for purification of the F272A mutant. Molecular graphics images were produced using the Chimera package (20) from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).; This work was supported, in whole or in part, by National Institutes of Health Research Project Grants Z01-ES0500158 and Z01-ES050161 (to S. H. W.) from the Intramural Research Program, NIEHS, in association with Grant 1U19CA105010.	ADAMS PD, 2010, ACTA CRYSTALLOGR D 2, V66, P213, DOI DOI 10.1107/S0907444909052925; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; CASE DA, 2008, AMBER 10 U CAL SAN F; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gardner AF, 2004, J BIOL CHEM, V279, P11834, DOI 10.1074/jbc.M308286200; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kirouac KN, 2011, J MOL BIOL, V407, P382, DOI 10.1016/j.jmb.2011.01.037; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2000, J BIOL CHEM, V275, P40266, DOI 10.1074/jbc.M005757200; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Schutz M, 1997, J CHEM PHYS, V107, P4597, DOI 10.1063/1.474820; Sherrer SM, 2010, BIOCHEMISTRY-US, V49, P10179, DOI 10.1021/bi101465n; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	47	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31650	31660		10.1074/jbc.M111.253401	http://dx.doi.org/10.1074/jbc.M111.253401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733843	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000294487500058
J	Richards, CI; Srinivasan, R; Xiao, C; Mackey, EDW; Miwa, JM; Lester, HA				Richards, Christopher I.; Srinivasan, Rahul; Xiao, Cheng; Mackey, Elisha D. W.; Miwa, Julie M.; Lester, Henry A.			Trafficking of alpha 4* Nicotinic Receptors Revealed by Superecliptic Phluorinn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACETYLCHOLINE-RECEPTORS; PHARMACOLOGICAL CHAPERONE; SUBUNIT STOICHIOMETRY; MIDBRAIN; INHIBITION; EXPRESSION; INSERTION; EXPOSURE; BINDING	We employed a pH-sensitive GFP analog, superecliptic phluorin, to observe aspects of nicotinic acetylcholine receptor (nAChR) trafficking to the plasma membrane (PM) in cultured mouse cortical neurons. The experiments exploit differences in the pH among endoplasmic reticulum (ER), trafficking vesicles, and the extracellular solution. The data confirm that few alpha 4 beta 4 nAChRs, but many alpha 4 beta 2 nAChRs, remain in neutral intracellular compartments, mostly the ER. We observed fusion events between nAChR-containing vesicles and PM; these could be quantified in the dendritic processes. We also studied the beta 4R348C polymorphism, linked to amyotrophic lateral sclerosis (ALS). This mutation depressed fusion rates of alpha 4 beta 4 receptor-containing vesicles with the PM by similar to 2-fold, with only a small decrease in the number of nAChRs per vesicle. The mutation also decreased the number of ER exit sites, showing that the reduced receptor insertion results from a change at an early stage in trafficking. We confirm the previous report that the mutation leads to reduced agonist-induced currents; in the cortical neurons studied, the reduction amounts to 2-3-fold. Therefore, the reduced agonist-induced currents are caused by the reduced number of alpha 4 beta 4-containing vesicles reaching the membrane. Chronic nicotine exposure (0.2 mu M) did not alter the PM insertion frequency or trafficking behavior of alpha 4 beta 4-laden vesicles. In contrast, chronic nicotine substantially increased the number of alpha 4 beta 2-containing vesicle fusions at the PM; this stage in alpha 4 beta 2 nAChR up-regulation is presumably downstream from increased ER exit. Superecliptic phluorin provides a tool to monitor trafficking dynamics of nAChRs in disease and addiction.	[Richards, Christopher I.; Srinivasan, Rahul; Xiao, Cheng; Mackey, Elisha D. W.; Miwa, Julie M.; Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Lester, HA (corresponding author), CALTECH, Div Biol, MC 156-29, Pasadena, CA 91125 USA.	lester@caltech.edu	Srinivasan, Rahul/H-3065-2012; Xiao, Cheng/O-5696-2015	Srinivasan, Rahul/0000-0003-0237-6602; Xiao, Cheng/0000-0001-9649-7450; Miwa, Julie/0000-0002-4418-3756	National Institutes of Health [AG033954, DA17279, NS11756]; California Tobacco-related Disease Research Program [19KT-0032]; National Institutes of Health Kirschstein NRSA [DA030877]; Beckman Institute; Tobacco-related Disease Research Program [18FT-0066]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279, F32DA030877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-related Disease Research Program(University of California System); National Institutes of Health Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute; Tobacco-related Disease Research Program(University of California System); Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG033954, DA17279, and NS11756. This work was also supported by the California Tobacco-related Disease Research Program Grant 19KT-0032 and by a gift from Louis and Janet Fletcher.; Supported by National Institutes of Health Kirschstein NRSA DA030877 and a Beckman Institute fellowship.; Supported by a Tobacco-related Disease Research Program Postdoctoral Fellowship 18FT-0066 and by a Rapid Response grant from the Michael J. Fox Foundation.	Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Asokan A, 2002, J PHARM SCI-US, V91, P903, DOI 10.1002/jps.10095; Bueno OF, 1998, MOL BRAIN RES, V59, P165, DOI 10.1016/S0169-328X(98)00129-6; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Connor JX, 1998, J BIOL CHEM, V273, P28906, DOI 10.1074/jbc.273.44.28906; David-Watine B, 1999, NEUROPHARMACOLOGY, V38, P785, DOI 10.1016/S0028-3908(99)00015-5; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Fucile S, 2002, P NATL ACAD SCI USA, V99, P3956, DOI 10.1073/pnas.052699599; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Graham AJ, 2003, J CHEM NEUROANAT, V25, P97, DOI 10.1016/S0891-0618(02)00100-X; Grailhe R, 2004, EUR J NEUROSCI, V19, P855, DOI 10.1111/j.1460-9568.2004.03153.x; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Mani M, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.003.2009; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moriconi C, 2011, PFLUG ARCH EUR J PHY, V461, P225, DOI 10.1007/s00424-010-0905-2; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Sabatelli M, 2009, HUM MOL GENET, V18, P3997, DOI 10.1093/hmg/ddp339; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Simpson CL, 2006, BBA-MOL BASIS DIS, V1762, P973, DOI 10.1016/j.bbadis.2006.08.001; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Stephens DJ, 2000, J CELL SCI, V113, P2177; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Thorns J, 2010, EXP NEUROL, V224, P389, DOI 10.1016/j.expneurol.2010.04.014; Wu J, 2004, J PHARMACOL EXP THER, V311, P80, DOI 10.1124/jpet.104.070417; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	44	44	45	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31241	31249		10.1074/jbc.M111.256024	http://dx.doi.org/10.1074/jbc.M111.256024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768117	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000294487500019
J	Bamberger, M; Santos, AM; Goncalves, CM; Oliveira, MI; James, JR; Moreira, A; Lozano, F; Davis, SJ; Carmo, AM				Bamberger, Martina; Santos, Ana Mafalda; Goncalves, Carine M.; Oliveira, Marta I.; James, John R.; Moreira, Alexandra; Lozano, Franscisco; Davis, Simon J.; Carmo, Alexandre M.			A New Pathway of CD5 Glycoprotein-mediated T Cell Inhibition Dependent on Inhibitory Phosphorylation of Fyn Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-TYROSINE-PHOSPHATASE; TERMINAL SRC KINASE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; LIPID RAFTS; B-CELLS; TRANSMEMBRANE ADAPTER; MONOCLONAL-ANTIBODIES	Triggering of the T cell receptor initiates a signaling cascade resulting in the activation of the T cell. These signals are integrated alongside those resulting from the triggering of other receptors whose function is to modulate the overall response. CD5 is an immunotyrosine-based inhibition motif-bearing receptor that antagonizes the overt T cell receptor activation response by recruiting inhibitory intracellular mediators such as SHP-1, RasGAP, or Cbl. We now propose that the inhibitory effects of CD5 are also mediated by a parallel pathway that functions at the level of inhibition of Fyn, a kinase generally associated with T cell receptor-mediated activation. After CD5 ligation, phosphorylation of the negative regulatory tyrosine (Tyr(531)) of Fyn increases, and this correlates with a substantial reduction in the kinase activity of Fyn and a profound inhibition of ZAP-70 activation. The effect requires the last 23 amino acids of the cytoplasmic domain of the receptor, strongly implying the involvement of a new CD5-interacting signaling or adaptor protein. Furthermore, we show that upon CD5 ligation there is a profound shift in its distribution from the bulk fluid phase to the lipid raft environment, where it associates with Fyn, Lck, and PAG. We suggest that the relocation of CD5, which we also show is capable of forming homodimers, to the proximity of raft-resident molecules enables CD5 to inhibit membrane proximal signaling by controlling the phosphorylation and activity of Fyn, possibly by interfering with the disassembly of C-terminal Src kinase (Csk)-PAG-Fyn complexes during T cell activation.	[Bamberger, Martina; Santos, Ana Mafalda; Goncalves, Carine M.; Oliveira, Marta I.; Moreira, Alexandra; Carmo, Alexandre M.] Univ Porto, Inst Biol Mol & Celular, Grp Cell Activat & Gene Express, P-4150180 Oporto, Portugal; [Bamberger, Martina; Santos, Ana Mafalda; Goncalves, Carine M.; Oliveira, Marta I.; Carmo, Alexandre M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal; [James, John R.; Davis, Simon J.] Univ Oxford, Nuffield Dept Clin Med, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Lozano, Franscisco] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin Barcelona, Dept Immunol, E-08036 Barcelona, Spain; [Lozano, Franscisco] Univ Barcelona, Fac Med, Dept Cell Biol Immunol & Neurosci, Barcelona 08036, Spain	Universidade do Porto; Universidade do Porto; University of Oxford; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Carmo, AM (corresponding author), Univ Porto, Inst Biol Mol & Celular, Grp Cell Activat & Gene Express, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	acarmo@ibmc.up.pt	Lozano-Soto, Francisco/AAB-7930-2019; Carmo, Alexandre/B-5191-2011; Moreira, Alexandra/B-4803-2011; LOZANO, FRANCISCO/AAB-7888-2019; James, John R/B-5547-2008; Oliveira, Marta I A/M-9386-2013; James, John/AAP-3607-2021	Lozano-Soto, Francisco/0000-0003-3714-2304; Carmo, Alexandre/0000-0002-2508-9799; Moreira, Alexandra/0000-0001-9853-7575; LOZANO, FRANCISCO/0000-0003-1119-4368; James, John R/0000-0003-1452-7578; Oliveira, Marta I A/0000-0002-0578-9202; James, John/0000-0003-1452-7578; Santos, Ana Mafalda/0000-0002-0015-5286; Goncalves, Carine/0000-0002-4512-6147	European Regional Development Fund (FEDER); Portuguese government [SAU-MII/98041/2008]; Federation of European Biochemical Societies, Boehringer Ingelheim Fonds; American Portuguese Biomedical Research Fund; Fundacao para a Ciencia e a Tecnologia; Wellcome Trust; Spanish Ministry of Education and Science [SAF2007-62193]	European Regional Development Fund (FEDER)(European Commission); Portuguese government(Portuguese Foundation for Science and Technology); Federation of European Biochemical Societies, Boehringer Ingelheim Fonds(Boehringer Ingelheim); American Portuguese Biomedical Research Fund; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Spanish Ministry of Education and Science(Spanish Government)	This work is supported by the European Regional Development Fund (FEDER) through Programa Operacional Factores de Competitividade-COMPETE, and by the Portuguese government through FCT-Fundacao para a Ciencia e a Tecnologia, project SAU-MII/98041/2008. Additional support was from the Federation of European Biochemical Societies, Boehringer Ingelheim Fonds, and the American Portuguese Biomedical Research Fund.; Recipients of studentships from Fundacao para a Ciencia e a Tecnologia.; Funded by the Wellcome Trust.; Supported by Spanish Ministry of Education and Science Grant SAF2007-62193.	ANTIN JH, 1986, J IMMUNOL, V136, P505; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Baumgartner M, 2003, BLOOD, V101, P1874, DOI 10.1182/blood-2002-02-0456; Biancone L, 1996, J EXP MED, V184, P811, DOI 10.1084/jem.184.3.811; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Brossard U, 2003, J IMMUNOL, V170, P4623, DOI 10.4049/jimmunol.170.9.4623; Brown MH, 2010, J IMMUNOL, V185, P6068, DOI 10.4049/jimmunol.0903823; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; Calvo J, 1999, EUR J IMMUNOL, V29, P2119, DOI 10.1002/(SICI)1521-4141(199907)29:07<2119::AID-IMMU2119>3.3.CO;2-6; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; Carmo AM, 1999, J IMMUNOL, V163, P4238; Castro MAA, 2003, J LEUKOCYTE BIOL, V73, P183, DOI 10.1189/jlb.0902437; Castro MAA, 2002, EUR J IMMUNOL, V32, P1509, DOI 10.1002/1521-4141(200205)32:5<1509::AID-IMMU1509>3.0.CO;2-T; CEUPPENS JL, 1986, J IMMUNOL, V137, P1816; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Dennehy KM, 1998, EUR J IMMUNOL, V28, P1617, DOI 10.1002/(SICI)1521-4141(199805)28:05<1617::AID-IMMU1617>3.0.CO;2-7; Dennehy KM, 1997, EUR J IMMUNOL, V27, P679, DOI 10.1002/eji.1830270316; Dennehy KM, 2001, INT IMMUNOL, V13, P149, DOI 10.1093/intimm/13.2.149; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; Gary-Gouy H, 2000, J BIOL CHEM, V275, P548, DOI 10.1074/jbc.275.1.548; Gary-Gouy H, 2002, J IMMUNOL, V168, P232, DOI 10.4049/jimmunol.168.1.232; Giurisato E, 2003, J BIOL CHEM, V278, P6771, DOI 10.1074/jbc.M210758200; Goncalves CM, 2009, MOL IMMUNOL, V46, P2585, DOI 10.1016/j.molimm.2009.05.006; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; JUNE CH, 1987, J IMMUNOL, V138, P2782; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nunes RJ, 2008, J IMMUNOL, V180, P988, DOI 10.4049/jimmunol.180.2.988; Nunes RJ, 2006, ADV EXP MED BIOL, V584, P127; OKADA M, 1991, J BIOL CHEM, V266, P24249; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Pospisil R, 2000, LEUKEMIA LYMPHOMA, V36, P353, DOI 10.3109/10428190009148857; RAAB M, 1994, MOL CELL BIOL, V14, P2862, DOI 10.1128/MCB.14.5.2862; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Schade AE, 2002, J IMMUNOL, V168, P2233, DOI 10.4049/jimmunol.168.5.2233; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Simarro M, 1997, J IMMUNOL, V159, P4307; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; THOMAS Y, 1984, J IMMUNOL, V133, P724; Timson, 1992, MOL CELL BIOL, V12, P5438; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VAN DE VELDE H, 1991, NATURE, V351, P662; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Vila JM, 2001, EUR J IMMUNOL, V31, P1191, DOI 10.1002/1521-4141(200104)31:4<1191::AID-IMMU1191>3.3.CO;2-8; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	67	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30324	30336		10.1074/jbc.M111.230102	http://dx.doi.org/10.1074/jbc.M111.230102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757751	Green Published, hybrid			2022-12-27	WOS:000294283600010
J	Bhardwaj, A; Molineux, IJ; Casjens, SR; Cingolani, G				Bhardwaj, Anshul; Molineux, Ian J.; Casjens, Sherwood R.; Cingolani, Gino			Atomic Structure of Bacteriophage Sf6 Tail Needle Knob	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS PHAGES; RECEPTOR-BINDING PROTEIN; 3-DIMENSIONAL STRUCTURE; DNA; REVEALS; EVOLUTION; BACTERIAL; COMMON; IDENTIFICATION; STABILIZATION	Podoviridae are double-stranded DNA bacteriophages that use short, non-contractile tails to adsorb to the host cell surface. Within the tail apparatus of P22-like phages, a dedicated fiber known as the "tail needle" likely functions as a cell envelope-penetrating device to promote ejection of viral DNA inside the host. In Sf6, a P22-like phage that infects Shigella flexneri, the tail needle presents a C-terminal globular knob. This knob, absent in phage P22 but shared in other members of the P22-like genus, represents the outermost exposed tip of the virion that contacts the host cell surface. Here, we report a crystal structure of the Sf6 tail needle knob determined at 1.0 angstrom resolution. The structure reveals a trimeric globular domain of the TNF fold structurally superimposable with that of the tail-less phage PRD1 spike protein P5 and the adenovirus knob, domains that in both viruses function in receptor binding. However, P22-like phages are not known to utilize a protein receptor and are thought to directly penetrate the host surface. At 1.0 angstrom resolution, we identified three equivalents of L-glutamic acid (L-Glu) bound to each subunit interface. Although intimately bound to the protein, L-Glu does not increase the structural stability of the trimer nor it affects its ability to self-trimerize in vitro. In analogy to P22 gp26, we suggest the tail needle of phage Sf6 is ejected through the bacterial cell envelope during infection and its C-terminal knob is threaded through peptidoglycan pores formed by glycan strands.	[Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Molineux, Ian J.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA	Jefferson University; University of Texas System; University of Texas Austin; Utah System of Higher Education; University of Utah	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu		Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [1R56AI076509-01A1, AI074825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076509, R01AI074825, R56AI074825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R56AI076509-01A1 (to G.C.) and AI074825 (to S.R.C.).	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Andrews D, 2005, J BIOL CHEM, V280, P5929, DOI 10.1074/jbc.C400513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; CHELVANAYAGAM G, 1992, J MOL BIOL, V228, P220, DOI 10.1016/0022-2836(92)90502-B; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Chua JEH, 1999, MICROBIOL-UK, V145, P1649, DOI 10.1099/13500872-145-7-1649; DeLano W.L, PYMOL MOL GRAPHICS S; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x	49	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30867	30877		10.1074/jbc.M111.260877	http://dx.doi.org/10.1074/jbc.M111.260877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21705802	Green Published, hybrid			2022-12-27	WOS:000294283600066
J	Guntermann, S; Foley, E				Guntermann, Silvia; Foley, Edan			Protein Dredd Is an Essential Component of the c-Jun N-terminal Kinase Pathway in the Drosophila Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; ANTIBACTERIAL DEFENSE; INNATE IMMUNITY; DEFICIENCY IMD; NUCLEAR IMPORT; ACTIVATION; RELISH; GENE; JNK; PEPTIDOGLYCAN	The Drosophila immune deficiency (IMD) pathway mobilizes c-Jun N-terminal kinase (JNK), caspase, and nuclear factor-kappa B (NF-kappa B) modules to counter infection with Gram-negative bacteria. Dredd is an essential caspase in the IMD pathway, and it is widely established that NF-kappa B activation depends on Dredd. More recent cell culture studies suggested a role for Dredd in the activation of dJNK (Drosophila JNK). However, there are no epistatic or mechanistic data on the involvement of Dredd in dJNK activation. More importantly, there is no in vivo evidence to demonstrate a physiological requirement for Dredd in the IMD/dJNK pathway. We performed a comprehensive analysis of the role of Dredd in the IMD/dJNK pathway, and we demonstrated that Dredd is essential for the activation of IMD/dJNK in cell culture. We positioned Dredd activity at an early point of the IMD/dJNK pathway and uncovered a series of interactions between Dredd and additional proximal IMD pathway molecules. Mechanistically, we showed that the caspase activity inhibitor p35 blocked dJNK activation and the induction of dJNK-dependent genes in cell culture and in vivo. Most importantly, we demonstrated that dredd mutant flies are completely inhibited in their ability to activate dJNK or express dJNK-responsive target genes after bacterial infection in vivo. In conclusion, we established Dredd as an essential component of the IMD pathway required for the full activation of IMD/dJNK in cell culture and in vivo. Our data enhance our appreciation of Dredd-dependent IMD signal transduction events.	[Guntermann, Silvia; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			Natural Sciences and Engineering Research Council [RGPIN 371188]; Canada Foundation for Innovation; Alberta Science and Research Investment Program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program	This work was supported by Natural Sciences and Engineering Research Council Grant RGPIN 371188 (to E. F.).; p35 DNA was provided by Pascal Meier. Bruno Lemaitre and Jean Marc Reichhart provided the dredd<SUP>B118</SUP> and yolk-GAL4 fly stocks, respectively. Relish antibodies were provided by Neal Silverman. David Bond generated the pMT-HAdTAK1<SUP>CA</SUP> expression plasmid. Rejish Thomas assisted with the generation of expression plasmids. cDNA was obtained from Drosophila Genomics Resource Center, and flies were provided by the Bloomington Drosophila Stock Center. We are grateful to David Bond and Brendon Parsons for critical reading of the manuscript. Infrastructure funds were provided by the Canada Foundation for Innovation and the Alberta Science and Research Investment Program.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Bond D, 2008, BIOL PROCED ONLINE, V10, P20, DOI 10.1251/bpo139; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Riedl SJ, 2001, BIOCHEMISTRY-US, V40, P13274, DOI 10.1021/bi010574w; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhuang ZH, 2006, CELL SIGNAL, V18, P964, DOI 10.1016/j.cellsig.2005.08.020	62	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30284	30294		10.1074/jbc.M111.220285	http://dx.doi.org/10.1074/jbc.M111.220285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730059	hybrid, Green Published			2022-12-27	WOS:000294283600006
J	Lamsoul, I; Burande, CF; Razinia, Z; Houles, TC; Menoret, D; Baldassarre, M; Erard, M; Moog-Lutz, C; Calderwood, DA; Lutz, PG				Lamsoul, Isabelle; Burande, Clara F.; Razinia, Ziba; Houles, Thibault C.; Menoret, Delphine; Baldassarre, Massimiliano; Erard, Monique; Moog-Lutz, Christel; Calderwood, David A.; Lutz, Pierre G.			Functional and Structural Insights into ASB2 alpha, a Novel Regulator of Integrin-dependent Adhesion of Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; BONE-MARROW; PROTEASOMAL DEGRADATION; TRANSGENIC MICE; FILAMIN BINDING; DIFFERENTIATION; FIBRONECTIN	By providing contacts between hematopoietic cells and the bone marrow microenvironment, integrins are implicated in cell adhesion and thereby in control of cell fate of normal and leukemia cells. The ASB2 gene, initially identified as a retinoic acid responsive gene and a target of the promyelocytic leukemia retinoic acid receptor alpha oncoprotein in acute promyelocytic leukemia cells, encodes two isoforms, a hematopoietic-type (ASB2 alpha) and a muscle-type (ASB2 alpha) that are involved in hematopoietic and myogenic differentiation, respectively. ASB2 alpha is the specificity subunit of an E3 ubiquitin ligase complex that targets filamins to proteasomal degradation. To examine the relationship of the ASB2 alpha structure to E3 ubiquitin ligase function, functional assays and molecular modeling were performed. We show that ASB2 alpha, through filamin A degradation, enhances adhesion of hematopoietic cells to fibronectin, the main ligand of beta 1 integrins. Furthermore, we demonstrate that a short N-terminal region specific to ASB2 alpha, together with ankyrin repeats 1 to 10, is necessary for association of ASB2 alpha with filamin A. Importantly, the ASB2 alpha N-terminal region comprises a 9-residue segment with predicted structural homology to the filamin-binding motifs of migfilin and beta integrins. Together, these data provide new insights into the molecular mechanisms of ASB2 alpha binding to filamin.	[Lutz, Pierre G.] CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [Lamsoul, Isabelle; Burande, Clara F.; Houles, Thibault C.; Menoret, Delphine; Erard, Monique; Moog-Lutz, Christel; Lutz, Pierre G.] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Razinia, Ziba; Baldassarre, Massimiliano; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Razinia, Ziba; Baldassarre, Massimiliano; Calderwood, David A.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplanta, New Haven, CT 06520 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Yale University; Yale University	Lutz, PG (corresponding author), CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	Pierre.Lutz@ipbs.fr	Calderwood, David A/AAC-6954-2019; Baldassarre, Massimiliano/AAI-6581-2021; Baldassarre, Massimiliano/E-6236-2011; Lutz, Pierre/B-8822-2009	Calderwood, David A/0000-0002-0791-4142; Baldassarre, Massimiliano/0000-0002-2498-4767; Baldassarre, Massimiliano/0000-0002-2498-4767; Lamsoul, Isabelle/0000-0002-7769-5627; Lutz, Pierre/0000-0003-0590-9101; /0000-0001-9299-744X	National Institutes of Health [GM068600]; Centre National de la Recherche Scientifique; Universite Paul Sabatier; Comite Leucemie de la Fondation de France; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Comite Leucemie de la Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (Grant GM068600 to D. A. C.), and by grants from the Centre National de la Recherche Scientifique, the Universite Paul Sabatier, the Comite Leucemie de la Fondation de France and the Association pour la Recherche sur le Cancer (to P. G. L.).	Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Becker PS, 2009, BLOOD, V113, P866, DOI 10.1182/blood-2007-12-124818; Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Bendall LJ, 1998, LEUKEMIA, V12, P1375, DOI 10.1038/sj.leu.2401136; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Denis FM, 2005, J BIOL CHEM, V280, P9043, DOI 10.1074/jbc.M413564200; Fernandez-Vidal A, 2006, CANCER RES, V66, P7128, DOI 10.1158/0008-5472.CAN-05-2552; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014	42	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30571	30581		10.1074/jbc.M111.220921	http://dx.doi.org/10.1074/jbc.M111.220921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737450	Green Published, hybrid			2022-12-27	WOS:000294283600036
J	Waardenberg, AJ; Bernardo, BC; Ng, DCH; Shepherd, PR; Cemerlang, N; Sbroggio, M; Wells, CA; Dalrymple, BP; Brancaccio, M; Lin, RCY; McMullen, JR				Waardenberg, Ashley J.; Bernardo, Bianca C.; Ng, Dominic C. H.; Shepherd, Peter R.; Cemerlang, Nelly; Sbroggio, Mauro; Wells, Christine A.; Dalrymple, Brian P.; Brancaccio, Mara; Lin, Ruby C. Y.; McMullen, Julie R.			Phosphoinositide 3-Kinase (PI3K(p110 alpha)) Directly Regulates Key Components of the Z-disc and Cardiac Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; SEVERE FORM; MUSCLE; EXPRESSION; PROTEIN; MELUSIN; FAMILY; GROWTH; P110-ALPHA; INSULIN-LIKE-GROWTH-FACTOR-1	Maintenance of cardiac structure and Z-disc signaling are key factors responsible for protecting the heart in a setting of stress, but how these processes are regulated is not well defined. We recently demonstrated that PI3K(p110 alpha) protects the heart against myocardial infarction. The aim of this study was to determine whether PI3K(p110 alpha) directly regulates components of the Z-disc and cardiac structure. To address this question, a unique three-dimensional virtual muscle model was applied to gene expression data from transgenic mice with increased or decreased PI3K(p110 alpha) activity under basal conditions (sham) and in a setting of myocardial infarction to display the location of structural proteins. Key findings from this analysis were then validated experimentally. The three-dimensional virtual muscle model visually highlighted reciprocally regulated transcripts associated with PI3K activation that encoded key components of the Z-disc and costamere, including melusin. Studies were performed to assess whether PI3K and melusin interact in the heart. Here, we identify a novel melusin-PI3K interaction that generates lipid kinase activity. The direct impact of PI3K(p110 alpha) on myocyte structure was assessed by treating neonatal rat ventricular myocytes with PI3K(p110 alpha) inhibitors and examining the myofiber morphology of hearts from PI3K transgenic mice. Results demonstrate that PI3K is critical for myofiber maturation and Z-disc alignment. In summary, PI3K regulates the expression of genes essential for cardiac structure and Z-disc signaling, interacts with melusin, and is critical for Z-disc alignment.	[Bernardo, Bianca C.; Cemerlang, Nelly; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 8008, Australia; [Waardenberg, Ashley J.; Wells, Christine A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Waardenberg, Ashley J.; Dalrymple, Brian P.] CSIRO, Food Futures Flagship, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Ng, Dominic C. H.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic 3010, Australia; [Shepherd, Peter R.] Univ Auckland, Dept Mol Med, Auckland 1142, New Zealand; [Shepherd, Peter R.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Sbroggio, Mauro; Brancaccio, Mara] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Baker Heart and Diabetes Institute; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; University of Auckland; University of Auckland; University of Turin; University of Queensland; University of New South Wales Sydney; University of New South Wales Sydney	McMullen, JR (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 8008, Australia.	julie.mcmullen@bakeridi.edu.au	Lin, Ruby CY/A-1636-2009; Ng, Dominic/C-7291-2015; Dalrymple, Brian P/F-8721-2010; Waardenberg, Ashley/D-2595-2012; Wells, Christine A/A-5071-2010	Lin, Ruby CY/0000-0003-4163-511X; Ng, Dominic/0000-0003-4657-159X; Dalrymple, Brian P/0000-0003-3891-5233; Wells, Christine A/0000-0003-3133-3628; Sbroggio, Mauro/0000-0002-8266-661X; Bernardo, Bianca Christine/0000-0002-4534-0549; Waardenberg, Ashley/0000-0002-9382-7490	Griffith University; Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship; National Health and Medical Research Council (NHMRC) [367600, 586604, 351012]; Victorian Government; Australian Research Council [FT0001657]; University of New South Wales; University of Melbourne	Griffith University(Griffith University); Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Australian Research Council(Australian Research Council); University of New South Wales; University of Melbourne(University of Melbourne)	This work was supported by postgraduate scholarships from Griffith University and the Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship (to A.J.W.) and by National Health and Medical Research Council (NHMRC) Project Grant 367600 (to J.R.M.). This work was supported in part by the Victorian Government Operational Infrastructure Support Program. This work was also supported by Australian Research Council Future Fellowship FT0001657 (to J.R.M.), Honorary NHMRC Senior Research Fellowship 586604 (to J.R.M.), NHMRC Peter Doherty Fellowship 351012 (to R.C.Y.L.), University of New South Wales Vice Chancellor Research Fellowship (to R.C.Y.L.), and by an University of Melbourne Roper fellowship (to D.C.H.N.).	Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; De Acetis M, 2005, CIRC RES, V96, P1087, DOI 10.1161/01.RES.0000168028.36081.e0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; McMullen JR, 2008, CLIN EXP PHARMACOL P, V35, P349, DOI 10.1111/j.1440-1681.2007.04873.x; McMullen JR, 2007, CELL CYCLE, V6, P910, DOI 10.4161/cc.6.8.4124; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Murray JT, 2004, BIOCHEM J, V384, P489, DOI 10.1042/BJ20041058; Ng DCH, 2008, CELL MOTIL CYTOSKEL, V65, P40, DOI 10.1002/cm.20242; Ng DCH, 2011, J BIOL CHEM, V286, P1576, DOI 10.1074/jbc.M110.128157; Nishiyama A, 1998, CARDIOVASC RES, V40, P343, DOI 10.1016/S0008-6363(98)00135-7; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sbroggio M, 2008, FEBS LETT, V582, P1788, DOI 10.1016/j.febslet.2008.04.058; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Waardenberg AJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-88; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30837	30846		10.1074/jbc.M111.271684	http://dx.doi.org/10.1074/jbc.M111.271684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757757	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000294283600063
J	Lee, AS; Xu, D; Plews, JR; Nguyen, PK; Nag, D; Lyons, JK; Han, L; Hu, SJ; Lan, F; Liu, JW; Huang, M; Narsinh, KH; Long, CT; de Almeida, PE; Levi, B; Kooreman, N; Bangs, C; Pacharinsak, C; Ikeno, F; Yeung, AC; Gambhir, SS; Robbins, RC; Longaker, MT; Wu, JC				Lee, Andrew S.; Xu, Dan; Plews, Jordan R.; Nguyen, Patricia K.; Nag, Divya; Lyons, Jennifer K.; Han, Leng; Hu, Shijun; Lan, Feng; Liu, Junwei; Huang, Mei; Narsinh, Kazim H.; Long, Charles T.; de Almeida, Patricia E.; Levi, Benjamin; Kooreman, Nigel; Bangs, Charles; Pacharinsak, Cholawat; Ikeno, Fumiaki; Yeung, Alan C.; Gambhir, Sanjiv S.; Robbins, Robert C.; Longaker, Michael T.; Wu, Joseph C.			Preclinical Derivation and Imaging of Autologously Transplanted Canine Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; LINES; DIFFERENTIATION; EXPRESSION; SURVIVAL; GENE	Derivation of patient-specific induced pluripotent stem cells (iPSCs) opens a new avenue for future applications of regenerative medicine. However, before iPSCs can be used in a clinical setting, it is critical to validate their in vivo fate following autologous transplantation. Thus far, preclinical studies have been limited to small animals and have yet to be conducted in large animals that are physiologically more similar to humans. In this study, we report the first autologous transplantation of iPSCs in a large animal model through the generation of canine iPSCs (ciPSCs) from the canine adipose stromal cells and canine fibroblasts of adult mongrel dogs. We confirmed pluripotency of ciPSCs using the following techniques: (i) immunostaining and quantitative PCR for the presence of pluripotent and germ layer-specific markers in differentiated ciPSCs; (ii) microarray analysis that demonstrates similar gene expression profiles between ciPSCs and canine embryonic stem cells; (iii) teratoma formation assays; and (iv) karyotyping for genomic stability. Fate of ciPSCs autologously transplanted to the canine heart was tracked in vivo using clinical positron emission tomography, computed tomography, and magnetic resonance imaging. To demonstrate clinical potential of ciPSCs to treat models of injury, we generated endothelial cells (ciPSC-ECs) and used these cells to treat immunodeficient murine models of myocardial infarction and hindlimb ischemia.	[Lee, Andrew S.; Xu, Dan; Plews, Jordan R.; Nag, Divya; Han, Leng; Hu, Shijun; Lan, Feng; Liu, Junwei; Huang, Mei; Narsinh, Kazim H.; de Almeida, Patricia E.; Kooreman, Nigel; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Radiol, Stanford, CA 94305 USA; [Lee, Andrew S.; Xu, Dan; Plews, Jordan R.; Nguyen, Patricia K.; Nag, Divya; Han, Leng; Hu, Shijun; Lan, Feng; Liu, Junwei; Huang, Mei; Narsinh, Kazim H.; de Almeida, Patricia E.; Ikeno, Fumiaki; Yeung, Alan C.; Wu, Joseph C.] Stanford Univ, Sch Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA; [Lyons, Jennifer K.; Long, Charles T.; Pacharinsak, Cholawat] Stanford Univ, Sch Med, Dept Vet Med, Stanford, CA 94305 USA; [Levi, Benjamin; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Plast Surg, Stanford, CA 94305 USA; [Bangs, Charles] Stanford Univ, Sch Med, Dept Pathol Cytogenet, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Longaker, Michael T.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Longaker, MT (corresponding author), 257 Campus Dr, Stanford, CA 94305 USA.	longaker@stanford.edu; joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Han, Leng/G-5093-2012; Hu, Shijun/I-5818-2012; Lan, Feng/I-2023-2012; Wu, Joseph/H-1067-2013	Lan, Feng/0000-0002-9038-4014; IKENO, FUMIAKI/0000-0003-2905-0311; Wu, Joseph/0000-0002-6068-8041; Han, Leng/0000-0002-7380-2640; Hu, Shijun/0000-0002-0068-8429	National Institutes of Health [DP2OD004437, HL089027, HL099117, EB009689, HL100490, HL099776]; Mallinckrodt Foundation; Howard Hughes Medical Institute; Radiological Society of North America; Stanford Bio-X Program; California Institute for Regenerative Medicine (CIRM) [T1-00001, CIRM RL1-00662-1]; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776, R21HL089027, RC1HL099117, R33HL089027, RC1HL100490, T32HL098049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009689] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Radiological Society of North America; Stanford Bio-X Program; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DP2OD004437, HL089027, HL099117, and EB009689 (to J. C. W.), HL100490 (to M. T. L.), and HL099776 (to R. C. R.). This work was also supported by the Mallinckrodt Foundation (to J. C. W.), the Howard Hughes Medical Institute (to A. S. L. and K. H. N.), the Radiological Society of North America (to A. S. L. and K. H. N.), the Stanford Bio-X Program (to A. S. L.), the California Institute for Regenerative Medicine (CIRM) T1-00001, CIRM RL1-00662-1, and and the Oak Foundation and the Hagey Laboratory for Pediatric Regenerative Medicine (to M. T. L.).	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayes B, 2008, STEM CELLS, V26, P465, DOI 10.1634/stemcells.2007-0640; Huang Ngan F, 2009, J Vis Exp, DOI 10.3791/1034; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li Z., 2011, STEM CELLS IN PRESS; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008443; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Luo J., 2011, STEM CELLS IN PRESS; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vaags AK, 2009, STEM CELLS, V27, P329, DOI 10.1634/stemcells.2008-0433; Wilcox JT, 2009, STEM CELLS DEV, V18, P1167, DOI 10.1089/scd.2008.0336; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	30	73	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32697	32704		10.1074/jbc.M111.235739	http://dx.doi.org/10.1074/jbc.M111.235739			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21719696	Green Published, hybrid			2022-12-27	WOS:000294726800078
J	Mandal, MNA; Moiseyev, GP; Elliott, MH; Kasus-Jacobi, A; Li, XM; Chen, H; Zheng, LX; Nikolaeva, O; Floyd, RA; Ma, JX; Anderson, RE				Mandal, Md Nawajes A.; Moiseyev, Gennadiy P.; Elliott, Michael H.; Kasus-Jacobi, Anne; Li, Xiaoman; Chen, Hui; Zheng, Lixin; Nikolaeva, Olga; Floyd, Robert A.; Ma, Jian-Xing; Anderson, Robert E.			alpha-Phenyl-N-tert-butylnitrone (PBN) Prevents Light-induced Degeneration of the Retina by Inhibiting RPE65 Protein Isomerohydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; SPIN-TRAPPING AGENT; VISUAL CYCLE; MACULAR DEGENERATION; RAT RETINA; IN-VIVO; CONGENITAL AMAUROSIS; LIPID-PEROXIDATION; BUTYL NITRONE; VITAMIN-A	alpha-Phenyl-N-tert-butylnitrone (PBN), a free radical spin trap, has been shown previously to protect retinas against light-induced neurodegeneration, but the mechanism of protection is not known. Here we report that PBN-mediated retinal protection probably occurs by slowing down the rate of rhodopsin regeneration by inhibiting RPE65 activity. PBN (50 mg/kg) protected albino Sprague-Dawley rat retinas when injected 0.5-12 h before exposure to damaging light at 2,700 lux intensity for 6 h but had no effect when administered after the exposure. PBN injection significantly inhibited in vivo recovery of rod photoresponses and the rate of recovery of functional rhodopsin photopigment. Assays for visual cycle enzyme activities indicated that PBN inhibited one of the key enzymes of the visual cycle, RPE65, with an IC50 = 0.1 mM. The inhibition type for RPE65 was found to be uncompetitive with K-i = 53 mu M. PBN had no effect on the activity of other visual cycle enzymes, lecithin retinol acyltransferase and retinol dehydrogenases. Interestingly, a more soluble form of PBN, N-tert-butyl-alpha-(2-sulfophenyl) nitrone, which has similar free radical trapping activity, did not protect the retina or inhibit RPE65 activity, providing some insight into the mechanism of PBN specificity and action. Slowing down the visual cycle is considered a treatment strategy for retinal diseases, such as Stargardt disease and dry age-related macular degeneration, in which toxic byproducts of the visual cycle accumulate in retinal cells. Thus, PBN inhibition of RPE65 catalytic action may provide therapeutic benefit for such retinal diseases.	[Mandal, Md Nawajes A.] Univ Oklahoma Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Mandal, Md Nawajes A.; Moiseyev, Gennadiy P.; Elliott, Michael H.; Kasus-Jacobi, Anne; Nikolaeva, Olga; Ma, Jian-Xing] Univ Oklahoma Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Floyd, Robert A.] Univ Oklahoma Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA; [Anderson, Robert E.] Univ Oklahoma Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.; Nikolaeva, Olga; Ma, Jian-Xing] Univ Oklahoma Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK 73104 USA; [Floyd, Robert A.] Oklahoma Med Res Fdn, Expt Therapeut Res Lab, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Mandal, MNA (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, 608 SL Young Blvd, Oklahoma City, OK 73104 USA.	mmandal@ouhsc.edu	KASUS-JACOBI, Anne/V-7799-2019; du, zhao jiang/F-6229-2011	KASUS-JACOBI, Anne/0000-0003-3844-0450; hui, chen/0000-0001-5276-2515	National Institutes of Health (NIH), NEI [EY 012190, EY 04149, EY 019494, EY 012231, EY 00871]; NIH, NCRR [RR 17703]; Foundation Fighting Blindness, USA; Research to Prevent Blindness, Inc., USA; University of Oklahoma College of Medicine Alumni Association	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Foundation Fighting Blindness, USA; Research to Prevent Blindness, Inc., USA(Research to Prevent Blindness (RPB)); University of Oklahoma College of Medicine Alumni Association	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI Grants EY 012190, EY 04149, EY 019494, EY 012231, and EY 00871 and NIH, NCRR, Grant RR 17703. This work was also supported by the Foundation Fighting Blindness, USA, Research to Prevent Blindness, Inc., USA, and the University of Oklahoma College of Medicine Alumni Association.	CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; DELAPAZ MA, 1992, INVEST OPHTH VIS SCI, V33, P2091; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fersht A, 1985, ENZYME STRUCTURE MEC, P108; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; HAMBURGER SA, 1989, CIRC SHOCK, V29, P329; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kasus-Jacobi A, 2005, J BIOL CHEM, V280, P20413, DOI 10.1074/jbc.M413789200; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Konovalova TA, 2000, FREE RADICAL BIO MED, V28, P1030, DOI 10.1016/S0891-5849(00)00192-1; Kotake Y, 1998, BBA-MOL CELL RES, V1448, P77, DOI 10.1016/S0167-4889(98)00126-8; Kubota R., 2011, RETINA IN PRESS; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; MIYAJIMA T, 1995, BIOCHEM BIOPH RES CO, V215, P114, DOI 10.1006/bbrc.1995.2440; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Moiseyev G, 2008, J BIOL CHEM, V283, P8110, DOI 10.1074/jbc.M703654200; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Noell W K, 1966, Invest Ophthalmol, V5, P450; NOELL WK, 1971, SCIENCE, V172, P76, DOI 10.1126/science.172.3978.76; NOELL WK, 1971, SCIENCE, V172, P72, DOI 10.1126/science.172.3978.72; Novelli G P, 1986, Free Radic Res Commun, V1, P321, DOI 10.3109/10715768609080971; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1992, INVEST OPHTH VIS SCI, V33, P1599; ORGANISCIAK DT, 1985, INVEST OPHTH VIS SCI, V26, P1580; PHILLIS JW, 1990, NEUROSCI LETT, V116, P315, DOI 10.1016/0304-3940(90)90093-O; Poliakov E, 2011, BIOCHEMISTRY-US, V50, P6739, DOI 10.1021/bi200532m; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sack CA, 1996, NEUROSCI LETT, V205, P181, DOI 10.1016/0304-3940(96)12417-4; Saito K, 1998, BIOSCI BIOTECH BIOCH, V62, P792, DOI 10.1271/bbb.62.792; Sang H, 1999, ARCH BIOCHEM BIOPHYS, V363, P341, DOI 10.1006/abbi.1998.1086; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Sugawara T, 1998, INVEST OPHTH VIS SCI, V39, P2458; Tabatabaie T, 1997, FEBS LETT, V407, P148, DOI 10.1016/S0014-5793(97)00327-X; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, INVEST OPHTH VIS SCI, V42, P1653; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Williams HE, 2007, FREE RADICAL RES, V41, P1047, DOI 10.1080/10715760701557161; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Znoiko SL, 2002, INVEST OPHTH VIS SCI, V43, P1604	65	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32491	32501		10.1074/jbc.M111.255877	http://dx.doi.org/10.1074/jbc.M111.255877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21785167	Green Published, hybrid			2022-12-27	WOS:000294726800059
J	Okunishi, K; Sisson, TH; Huang, SK; Hogaboam, CM; Simon, RH; Peters-Golden, M				Okunishi, Katsuhide; Sisson, Thomas H.; Huang, Steven K.; Hogaboam, Cory M.; Simon, Richard H.; Peters-Golden, Marc			Plasmin Overcomes Resistance to Prostaglandin E-2 in Fibrotic Lung Fibroblasts by Reorganizing Protein Kinase A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INDUCTION; SCAFFOLDING PROTEIN; PULMONARY-FIBROSIS; ACTIVATION; INHIBITION; RECEPTOR; PROLIFERATION; MACROPHAGES; MECHANISMS; EXPRESSION	Collagen deposition by fibroblasts contributes to scarring in fibrotic diseases. Activation of protein kinase A (PKA) by cAMP represents a pivotal brake on fibroblast activation, and the lipid mediator prostaglandin E-2 (PGE(2)) exerts its well known anti-fibrotic actions through cAMP signaling. However, fibrotic fibroblasts from the lungs of patients with idiopathic pulmonary fibrosis, or of mice with bleomycin-induced fibrosis, are resistant to the normal collagen-inhibiting action of PGE(2). In this study, we demonstrate that plasminogen activation to plasmin restores PGE(2) sensitivity in fibrotic lung fibroblasts from human and mouse. This involves amplified PKA signaling resulting from the promotion of new interactions between AKAP9 and PKA regulatory subunit II in the perinuclear region as well as from the inhibition of protein phosphatase 2A. This is the first report to show that an extracellular mediator can dramatically reorganize and amplify the intracellular PKA-A-kinase anchoring protein signaling network and suggests a new strategy to control collagen deposition by fibrotic fibroblasts.	[Okunishi, Katsuhide; Sisson, Thomas H.; Huang, Steven K.; Simon, Richard H.; Peters-Golden, Marc] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hogaboam, Cory M.] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	Hogaboam, Cory M./AAI-1433-2021; hogaboam, cory/M-3578-2014	Hogaboam, Cory M./0000-0003-3366-4850; 	National Institutes of Health [HL094311, HL078871, HL094657]; American Lung Association; Uehara Memorial Foundation; Parker B. Francis fellowship; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078871, K08HL094657, R01HL094311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Uehara Memorial Foundation(Uehara Memorial Foundation); Parker B. Francis fellowship; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094311 (to M.P.-G.), HL078871 (to T.H.S.), and HL094657 (to S.K.H.). This work was also supported by an American Lung Association senior research training fellowship (to K.O.), a Uehara Memorial Foundation research fellowship (to K.O.), a Parker B. Francis fellowship (to S.K.H.), and an American Thoracic Society career development award (to S.K.H.).	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; CHAPMAN HA, 1986, AM REV RESPIR DIS, V133, P437; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; Christensen JG, 2003, CANCER RES, V63, P7345; Day JRS, 2004, CIRCULATION, V110, P2597, DOI 10.1161/01.CIR.0000138027.80056.31; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; El Homasany BSED, 2005, J IMMUNOL, V175, P7811, DOI 10.4049/jimmunol.175.12.7811; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Hattori N, 2004, AM J PATHOL, V164, P1091, DOI 10.1016/S0002-9440(10)63196-3; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Liu XQ, 2005, J PHARMACOL EXP THER, V315, P678, DOI 10.1124/jpet.105.090324; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; OGREID D, 1989, EUR J BIOCHEM, V181, P19; Quesnel C, 2010, EUR RESPIR J, V35, P1312, DOI 10.1183/09031936.00074709; Rhim JH, 2006, AGING CELL, V5, P451, DOI 10.1111/j.1474-9726.2006.00239.x; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Singh T, 2010, ARCH OTOLARYNGOL, V136, P163, DOI 10.1001/archoto.2009.175; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; TASKEN KA, 1991, MOL ENDOCRINOL, V5, P21, DOI 10.1210/mend-5-1-21; Ugland H, 2008, MOL BIOL CELL, V19, P5082, DOI 10.1091/mbc.E08-01-0094; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	46	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32231	32243		10.1074/jbc.M111.235606	http://dx.doi.org/10.1074/jbc.M111.235606			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795691	hybrid, Green Published			2022-12-27	WOS:000294726800033
J	Xu, XQ; Oliveira, F; Chang, BW; Collin, N; Gomes, R; Teixeira, C; Reynoso, D; Pham, VM; Elnaiem, DE; Kamhawi, S; Ribeiro, JMC; Valenzuela, JG; Andersen, JF				Xu, Xueqing; Oliveira, Fabiano; Chang, Bianca W.; Collin, Nicolas; Gomes, Regis; Teixeira, Clarissa; Reynoso, David; Pham, Van My; Elnaiem, Dia-Eldin; Kamhawi, Shaden; Ribeiro, Jose M. C.; Valenzuela, Jesus G.; Andersen, John F.			Structure and Function of a "Yellow" Protein from Saliva of the Sand Fly Lutzomyia longipalpis That Confers Protective Immunity against Leishmania major Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; BINDING; EVOLUTION; VECTOR; MODEL; HYPERSENSITIVITY; IDENTIFICATION; TRANSCRIPTOME; PHAGOCYTOSIS; MECHANISM	LJM11, an abundant salivary protein from the sand fly Lutzomyia longipalpis, belongs to the insect "yellow" family of proteins. In this study, we immunized mice with 17 plasmids encoding L. longiplapis salivary proteins and demonstrated that LJM11 confers protective immunity against Leishmania major infection. This protection correlates with a strong induction of a delayed type hypersensitivity (DTH) response following exposure to L. longipalpis saliva. Additionally, splenocytes of exposed mice produce IFN-gamma upon stimulation with LJM11, demonstrating the systemic induction of Th1 immunity by this protein. In contrast to LJM11, LJM111, another yellow protein from L. longipalpis saliva, does not produce a DTH response in these mice, suggesting that structural or functional features specific to LJM11 are important for the induction of a robust DTH response. To examine these features, we used calorimetric analysis to probe a possible ligand binding function for the salivary yellow proteins. LJM11, LJM111, and LJM17 all acted as high affinity binders of prohemostatic and proinflammatory biogenic amines, particularly serotonin, catecholamines, and histamine. We also determined the crystal structure of LJM11, revealing a six-bladed beta-propeller fold with a single ligand binding pocket located in the central part of the propeller structure on one face of the molecule. A hypothetical model of LJM11 suggests a positive electrostatic potential on the face containing entry to the ligand binding pocket, whereas LJM111 is negative to neutral over its entire surface. This may be the reason for differences in antigenicity between the two proteins.	[Xu, Xueqing; Oliveira, Fabiano; Chang, Bianca W.; Collin, Nicolas; Gomes, Regis; Teixeira, Clarissa; Reynoso, David; Pham, Van My; Elnaiem, Dia-Eldin; Kamhawi, Shaden; Ribeiro, Jose M. C.; Valenzuela, Jesus G.; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Collin, Nicolas] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Elnaiem, Dia-Eldin] Univ Maryland Eastern Shore, Dept Nat Sci, Princess Anne, MD 21853 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Lausanne; University System of Maryland; University of Maryland Eastern Shore	Andersen, JF (corresponding author), 12735 Twinbrook Pkwy, Rockville, MD 20852 USA.	jandersen@niaid.nih.gov	Gomes, Regis Bernardo Brandim Regis/AAJ-1471-2021; Reynoso, David/AAM-4476-2021; Oliveira, Fabiano/AAG-5388-2019	Gomes, Regis Bernardo Brandim Regis/0000-0001-7603-5101; Reynoso, David/0000-0002-2639-4197; Oliveira, Fabiano/0000-0002-7924-8038; Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health, NIAID; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000932, ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program. Use of the Advanced Photon Source beamlines was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belkaid Y, 2000, P NATL ACAD SCI USA, V97, P6704, DOI 10.1073/pnas.97.12.6704; Bethony JM, 2011, IMMUNOL REV, V239, P237, DOI 10.1111/j.1600-065X.2010.00976.x; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang JM, 2002, BIOCHEM BIOPH RES CO, V290, P287, DOI 10.1006/bbrc.2001.6200; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gudderra NP, 2005, J BIOL CHEM, V280, P25022, DOI 10.1074/jbc.M504386200; Han D, 2002, BIOCHEM J, V368, P333; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kamhawi S, 2000, MICROBES INFECT, V2, P1765, DOI 10.1016/S1286-4579(00)01331-9; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Oliveira MCG, 2007, NEUROSCIENCE, V145, P708, DOI 10.1016/j.neuroscience.2006.12.021; RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Thiakaki M, 2005, MICROBES INFECT, V7, P760, DOI 10.1016/j.micinf.2005.01.013; Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; Xanthos DN, 2008, PAIN, V137, P640, DOI 10.1016/j.pain.2007.10.031	44	87	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32383	32393		10.1074/jbc.M111.268904	http://dx.doi.org/10.1074/jbc.M111.268904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795673	hybrid, Green Published			2022-12-27	WOS:000294726800048
J	Bodoor, K; Lontay, B; Safi, R; Weitzel, DH; Loiselle, D; Wei, ZZ; Lengyel, S; McDonnell, DP; Haystead, TA				Bodoor, Khaldon; Lontay, Beata; Safi, Rachid; Weitzel, Douglas H.; Loiselle, David; Wei, Zhengzheng; Lengyel, Szabolcs; McDonnell, Donald P.; Haystead, Timothy A.			Smoothelin-like 1 Protein Is a Bifunctional Regulator of the Progesterone Receptor during Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; METABOLIZING ENZYME CYP26A1; MYOSIN PHOSPHATASE; RAT MYOMETRIUM; CONTRACTILE FP; MICE LACKING; EXPRESSION; ESTROGEN; ACTIVATION; BINDING	During pregnancy, uterine smooth muscle (USM) coordinately adapts its contractile phenotype in order to accommodate the developing fetus and then prepare for delivery. Herein we show that SMTNL1 plays a major role in pregnancy to promote adaptive responses in USM and that this process is specifically mediated through interactions of SMTNL1 with the steroid hormone receptor PR-B. In vitro and in vivo SMTNL1 selectively binds PR and not other steroid hormone receptors. The physiological relationship between the two proteins was also established in global gene expression and transcriptional reporter studies in pregnant smtnl1(-/-) mice and by RNA interference in progesterone-sensitive cell lines. We show that the contraction-associated and progestin-sensitive genes (oxytocin receptor, connexin 43, and cyclooxygenase-2) and prolactins are down-regulated in pregnant smtnl1(-/-) mice. We suggest that SMTNL1 is a bifunctional co-regulator of PR-B signaling and thus provides a molecular mechanism whereby PR-B is targeted to alter gene expression patterns within USM cells to coordinately promote alterations in USM function during pregnancy.	[Haystead, Timothy A.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC, Durham, NC 27710 USA; [Wei, Zhengzheng] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Lontay, Beata] Univ Debrecen, Dept Med Chem, H-4032 Debrecen, Hungary; [Lengyel, Szabolcs] Univ Debrecen, Dept Ecol, H-4032 Debrecen, Hungary	Duke University; Duke University; University of Debrecen; University of Debrecen	Haystead, TA (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC, Res Dr,C119,Box 3, Durham, NC 27710 USA.	hayst001@mc.duke.edu	Safi, Rachid/A-5909-2010; Lengyel, Szabolcs/A-3483-2011	Lengyel, Szabolcs/0000-0002-7049-0100	National Institutes of Health [R56DK065954-05]; King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; J. Bolyai Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048807, R56DK065954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; J. Bolyai Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56DK065954-05 (to T. A. J. H.).; Supported by a postdoctoral fellowship from the King Hussein Institute for Biotechnology and Cancer, Amman, Jordan. Currently on a sabbatical leave from the Department of Applied Biology-Faculty of Science and Arts at the Jordan University of Science and Technology, Irbid 21110, Jordan.; Supported by the J. Bolyai Fellowship.	Aleman G, 2005, AM J PHYSIOL-ENDOC M, V289, pE172, DOI 10.1152/ajpendo.00584.2004; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Brodt-Eppley J, 1998, BIOL REPROD, V59, P878, DOI 10.1095/biolreprod59.4.878; CHALLIS JRG, 1986, OXFORD REV REPROD B, V8, P61; Chappell PE, 1999, ENDOCRINOLOGY, V140, P3653, DOI 10.1210/en.140.8.3653; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fang X, 1997, ENDOCRINOLOGY, V138, P2763, DOI 10.1210/en.138.7.2763; Fritzsche B, 2007, MOL REPROD DEV, V74, P258, DOI 10.1002/mrd.20526; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Han BC, 2010, J CELL PHYSIOL, V223, P471, DOI 10.1002/jcp.22056; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HENDRIX EM, 1995, BIOL REPROD, V52, P547, DOI 10.1095/biolreprod52.3.547; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Ishida H, 2008, J BIOL CHEM, V283, P20569, DOI 10.1074/jbc.M800627200; Jaffer S, 2009, ENDOCRINOLOGY, V150, P4672, DOI 10.1210/en.2009-0419; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim J, 2006, YONSEI MED J, V47, P558, DOI 10.3349/ymj.2006.47.4.558; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Lontay B, 2010, J BIOL CHEM, V285, P29357, DOI 10.1074/jbc.M110.143966; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mesiano S, 2007, SEMIN CELL DEV BIOL, V18, P321, DOI 10.1016/j.semcdb.2007.05.003; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Ogren L, 1988, Int Rev Cytol, V112, P1; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Ou CW, 2000, AM J OBSTET GYNECOL, V182, P919, DOI 10.1016/S0002-9378(00)70347-4; Patel FA, 2003, J CLIN ENDOCR METAB, V88, P2922, DOI 10.1210/jc.2002-021710; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Shynlova O, 2007, BIOL REPROD, V76, P571, DOI 10.1095/biolreprod.106.056929; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Soares Michael J, 2004, Reprod Biol Endocrinol, V2, P51, DOI 10.1186/1477-7827-2-51; Somlyo AV, 2007, CIRC RES, V101, P645, DOI 10.1161/CIRCRESAHA.107.161893; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Tsuboi K, 2000, ENDOCRINOLOGY, V141, P315, DOI 10.1210/en.141.1.315; Ulke-Lemee A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-10; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Ward RM, 2003, BJOG-INT J OBSTET GY, V110, P8, DOI 10.1016/S1470-0328(03)00012-0; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Xia HF, 2010, HUM REPROD, V25, P2985, DOI 10.1093/humrep/deq268; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; Zhao K, 1996, BIOL REPROD, V54, P607, DOI 10.1095/biolreprod54.3.607	67	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31839	31851		10.1074/jbc.M111.270397	http://dx.doi.org/10.1074/jbc.M111.270397			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771785	hybrid, Green Published			2022-12-27	WOS:000294487500077
J	Popa, I; Fernandez, JM; Garcia-Manyes, S				Popa, Ionel; Fernandez, Julio M.; Garcia-Manyes, Sergi			Direct Quantification of the Attempt Frequency Determining the Mechanical Unfolding of Ubiquitin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; SINGLE-DOMAIN PROTEINS; NON-ARRHENIUS KINETICS; SPEED LIMIT; CLAMP SPECTROSCOPY; FOLDING KINETICS; TRANSITION-STATE; IMMUNOGLOBULIN DOMAINS; TEMPERATURE-DEPENDENCE; BIMOLECULAR REACTIONS	Understanding protein dynamics requires a comprehensive knowledge of the underlying potential energy surface that governs the motion of each individual protein molecule. Single molecule mechanical studies have provided the unprecedented opportunity to study the individual unfolding pathways along a well defined coordinate, the end-to-end length of the protein. In these experiments, unfolding requires surmounting an energy barrier that separates the native from the extended state. The calculation of the absolute value of the barrier height has traditionally relied on the assumption of an attempt frequency, upsilon*. Here we used single molecule force-clamp spectroscopy to directly determine the value of upsilon* for mechanical unfolding by measuring the unfolding rate of the small protein ubiquitin at varying temperatures. Our experiments demonstrate a significant effect of the temperature on the mechanical rate of unfolding. By extrapolating the unfolding rate in the absence of force for different temperatures, varying within the range spanning from 5 to 45 degrees C, we measured a value for the activation barrier of Delta G* = 71 +/- 5 kJ/mol and an exponential prefactor upsilon* similar to 4 x 10(9) s(-1). Although the measured prefactor value is 3 orders of magnitude smaller than the value predicted by the transition state theory (similar to 6 x 10(12) s(-1)), it is 400-fold higher than that encountered in analogous experiments studying the effect of temperature on the reactivity of a protein-embedded disulfide bond (similar to 10(7) M-1 s(-1)). This approach will allow quantitative characterization of the complete energy landscape of a folding polypeptide from highly extended states, of capital importance for proteins with elastic function.	[Popa, Ionel; Fernandez, Julio M.; Garcia-Manyes, Sergi] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	jfernandez@columbia.edu; sergi.garcia-manes@kcl.ac.uk	Popa, Ionel/P-4739-2016; Popa, Ionel/N-1428-2014	Popa, Ionel/0000-0003-3111-4716; Popa, Ionel/0000-0003-3111-4716; Garcia-Manyes, Sergi/0000-0001-5140-2606	Swiss National Science Foundation; Fundacion IberCaja; National Institutes of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228, R01HL066030] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fundacion IberCaja; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swiss National Science Foundation through a postdoctoral fellowship (to I. P.), by the Fundacion IberCaja (to S. G. M.), and by National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.).	Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P6479, DOI 10.1021/ja800180u; Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P18961, DOI 10.1074/jbc.R109.011932; Banachewicz W, 2011, P NATL ACAD SCI USA, V108, P569, DOI 10.1073/pnas.1017832108; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERKOVICH R, 2010, BIOPHYS J, V2692, P2701; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Botello E, 2009, J PHYS CHEM B, V113, P10845, DOI 10.1021/jp9002356; Brujic J, 2006, NAT PHYS, V2, P282, DOI 10.1038/nphys269; Brujic J, 2007, BIOPHYS J, V92, P2896, DOI 10.1529/biophysj.106.099481; Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; CARRION V, 2007, P NATL ACAD SCI USA, V163, P245; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Chung HS, 2008, PROTEINS, V72, P474, DOI 10.1002/prot.22043; Collet O, 2003, J AM CHEM SOC, V125, P6573, DOI 10.1021/ja029075o; Dougan L, 2008, P NATL ACAD SCI USA, V105, P3185, DOI 10.1073/pnas.0706075105; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Estape D, 1999, J BIOL CHEM, V274, P34083, DOI 10.1074/jbc.274.48.34083; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FERNANDEZ JM, 2009, SINGLE MOL SPECTROSC, P317; Fernandez-Ramos A, 2006, CHEM REV, V106, P4518, DOI 10.1021/cr050205w; Ferrer S, 2006, J AM CHEM SOC, V128, P16851, DOI 10.1021/ja0653977; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Garcia-Manyes S, 2011, J AM CHEM SOC, V133, P3104, DOI 10.1021/ja109865z; Garcia-Manyes S, 2009, NAT CHEM, V1, P236, DOI [10.1038/NCHEM.207, 10.1038/nchem.207]; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HERSCHBACH DR, 1956, J CHEM PHYS, V25, P736, DOI 10.1063/1.1743039; Hyeon CB, 2003, P NATL ACAD SCI USA, V100, P10249, DOI 10.1073/pnas.1833310100; Irback A, 2005, P NATL ACAD SCI USA, V102, P13427, DOI 10.1073/pnas.0501581102; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kuo TL, 2010, P NATL ACAD SCI USA, V107, P11336, DOI 10.1073/pnas.1006517107; Law R, 2003, BIOPHYS J, V85, P3286, DOI 10.1016/S0006-3495(03)74747-X; Lednev IK, 1999, J AM CHEM SOC, V121, P8074, DOI 10.1021/ja991382f; Li JY, 2010, P NATL ACAD SCI USA, V107, P19284, DOI 10.1073/pnas.1013159107; Li MS, 2004, POLYMER, V45, P573, DOI 10.1016/j.polymer.2003.10.066; Liang J, 2011, J AM CHEM SOC, V133, P3528, DOI 10.1021/ja109684q; Liu RC, 2009, BIOPHYS J, V96, P3810, DOI 10.1016/j.bpj.2009.01.043; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Matagne A, 2000, J MOL BIOL, V297, P193, DOI 10.1006/jmbi.2000.3540; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Noronha M, 2010, J PHYS CHEM B, V114, P9912, DOI 10.1021/jp104167h; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554; Pollak E, 2005, CHAOS, V15, DOI 10.1063/1.1858782; Pu JZ, 2006, CHEM REV, V106, P3140, DOI 10.1021/cr050308e; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636; Schlierf M, 2005, J MOL BIOL, V354, P497, DOI 10.1016/j.jmb.2005.09.070; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schlierf M, 2010, BIOPHYS J, V99, P1620, DOI 10.1016/j.bpj.2010.06.039; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Taniguchi Y, 2008, BIOPHYS J, V95, P5296, DOI 10.1529/biophysj.108.141275; TRUHLAR DG, 1983, J PHYS CHEM-US, V87, P2664, DOI 10.1021/j100238a003; Walther KA, 2007, P NATL ACAD SCI USA, V104, P7916, DOI 10.1073/pnas.0702179104; West DK, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2185100; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Yew ZT, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031923; Zaman MH, 2003, PHYS CHEM CHEM PHYS, V5, P2589, DOI 10.1039/b212671k	75	43	44	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31072	31079		10.1074/jbc.M111.264093	http://dx.doi.org/10.1074/jbc.M111.264093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768096	Green Published, hybrid			2022-12-27	WOS:000294487500002
J	Sharma, A; Sharma, A				Sharma, Ashwani; Sharma, Amit			Fatty Acid Induced Remodeling within the Human Liver Fatty Acid-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; HIGH-AFFINITY; LONG-CHAIN; EXPRESSION; RECEPTORS; COMPLEX; HEART	We crystallized human liver fatty acid-binding protein (LFABP) in apo, holo, and intermediate states of palmitic acid engagement. Structural snapshots of fatty acid recognition, entry, and docking within LFABP support a heads-in mechanism for ligand entry. Apo-LFABP undergoes structural remodeling, where the first palmitate ingress creates the atomic environment for placement of the second palmitate. These new mechanistic insights will facilitate development of pharmacological agents against LFABP.	[Sharma, Ashwani; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com			University Grants Commission, Government of India; EU, DBT (Govt. of India)	University Grants Commission, Government of India(University Grants Commission, India); EU, DBT (Govt. of India)(Department of Biotechnology (DBT) India)	This work was supported, in whole or in part, by University Grants Commission, Government of India (to Ashwani Sharma) and grants from EU, DBT (Govt. of India, to Amit Sharma).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; De Geronimo E, 2010, BBA-MOL CELL BIOL L, V1801, P1082, DOI 10.1016/j.bbalip.2010.05.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engels W, 1999, MOL CELL BIOCHEM, V192, P53, DOI 10.1023/A:1006855214237; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; HONMA Y, 1994, J BIOCHEM, V116, P1025, DOI 10.1093/oxfordjournals.jbchem.a124623; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; JAMISON RS, 1994, BIOCHEMISTRY-US, V33, P2873, DOI 10.1021/bi00176a017; Kamijo-Ikemori A, 2009, NEPHROL DIAL TRANSPL, V24, P788, DOI 10.1093/ndt/gfn573; Lucke C, 1999, MOL CELL BIOCHEM, V192, P109, DOI 10.1023/A:1006834708786; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Martin GG, 2009, AM J PHYSIOL-GASTR L, V297, pG1053, DOI 10.1152/ajpgi.00116.2009; Newberry EP, 2008, AM J PHYSIOL-GASTR L, V294, pG307, DOI 10.1152/ajpgi.00377.2007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rolf B, 1995, BBA-LIPID LIPID MET, V1259, P245, DOI 10.1016/0005-2760(95)00170-0; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Sharma A, 2008, J BIOL CHEM, V283, P24077, DOI 10.1074/jbc.M801946200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; TREVASKIS NL, 2011, PHARM RES IN PRESS; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velkov T, 2008, J CHROMATOGR B, V867, P238, DOI 10.1016/j.jchromb.2008.04.011; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	32	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31924	31928		10.1074/jbc.M111.270165	http://dx.doi.org/10.1074/jbc.M111.270165			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757748	hybrid, Green Published			2022-12-27	WOS:000294487500085
J	Akha, AAS; Harper, JM; Salmon, AB; Schroeder, BA; Tyra, HM; Rutkowski, DT; Miller, RA				Akha, Amir A. Sadighi; Harper, James M.; Salmon, Adam B.; Schroeder, Bethany A.; Tyra, Heather M.; Rutkowski, D. Thomas; Miller, Richard A.			Heightened Induction of Proapoptotic Signals in Response to Endoplasmic Reticulum Stress in Primary Fibroblasts from a Mouse Model of Longevity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; LIFE-SPAN EXTENSION; ER STRESS; CELL-DEATH; TRANSCRIPTION FACTOR; MULTIPLE FORMS; MESSENGER-RNA; DWARF MICE; RESISTANCE; XBP1	Previous work from our laboratory has shown that primary fibroblasts from long-lived Snell dwarf mice display a higher sensitivity to the lethal effects of endoplasmic reticulum (ER) stressors, such as thapsigargin, than cells from normal mice. Here we show that thapsigargin induces higher expression of CHOP, enhanced cleavage of caspase-12, higher caspase-3 activity, and increased phosphorylation of c-JUN, all indicators of enhanced apoptosis, in dwarf fibroblasts. Dwarf and normal fibroblasts show no genotypic difference in up-regulating BiP, GRP94, and ERp72 proteins after exposure to thapsigargin. However, dwarf fibroblasts express lower basal levels of a number of putative XBP1 target genes including Armet, Edem1, Erdj3, p58(IPK) and Sec61a1, as well as Ire1 alpha itself. Furthermore, when exposed to thapsigargin, dwarf fibroblasts display attenuated splicing of Xbp1, but similar phosphorylation of eIF2 alpha, in comparison to normal fibroblasts. These data support the notion that IRE1/XBP1 signaling is set at a lower level in dwarf fibroblasts. Diminished Xbp1 splicing in dwarf-derived fibroblasts may tilt the balance between prosurvival and proapoptotic signals in favor of apoptosis, thereby leading to higher induction of proapoptotic signals in these cells and ultimately their increased sensitivity to ER stressors. These results, together with recent findings in Caenorhabditis elegans daf-2 mutants, point to a potential interplay between insulin/IGF-1 signals and unfolded protein response signaling.	[Akha, Amir A. Sadighi; Harper, James M.; Salmon, Adam B.; Schroeder, Bethany A.; Miller, Richard A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Sch Med, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA; [Tyra, Heather M.; Rutkowski, D. Thomas] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Iowa	Akha, AAS (corresponding author), 6240 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	asadighi@umich.edu		Rutkowski, Thomas/0000-0001-6586-4449; Harper, James/0000-0003-0765-8828	National Institutes of Health [AG031736, AG024824, AG019899, DK084058]; Carver Trust Medical Research Initiative; University of Michigan Nathan Shock Center; University of Michigan Claude Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824, R01AG019899, P01AG031736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Trust Medical Research Initiative; University of Michigan Nathan Shock Center; University of Michigan Claude Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG031736, AG024824, AG019899 (to R. A. M.), and DK084058 and a Carver Trust Medical Research Initiative award (to D. T. R.), a University of Michigan Nathan Shock Center Pilot grant (to J. M. H.), and a University of Michigan Claude Pepper Older Americans Independence Center RCDC Junior faculty award (to A. A. S. A.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Leiser SF, 2006, MECH AGEING DEV, V127, P821, DOI 10.1016/j.mad.2006.08.003; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; Miller RA, 2011, AGEING RES REV, V10, P181, DOI 10.1016/j.arr.2010.01.002; Miller RA, 2009, J GERONTOL A-BIOL, V64, P179, DOI 10.1093/gerona/gln072; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sierra F, 2006, J GERONTOL A-BIOL, V61, P557, DOI 10.1093/gerona/61.6.557; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	47	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30344	30351		10.1074/jbc.M111.220541	http://dx.doi.org/10.1074/jbc.M111.220541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757703	hybrid, Green Published			2022-12-27	WOS:000294283600012
J	Wang, D; Zetterstrom, CE; Gabrielsen, M; Beckham, KSH; Tree, JJ; Macdonald, SE; Byron, O; Mitchell, TJ; Gally, DL; Herzyk, P; Mahajan, A; Uvell, H; Burchmore, R; Smith, BO; Elofsson, M; Roe, AJ				Wang, Dai; Zetterstrom, Caroline E.; Gabrielsen, Mads; Beckham, Katherine S. H.; Tree, Jai J.; Macdonald, Sarah E.; Byron, Olwyn; Mitchell, Tim J.; Gally, David L.; Herzyk, Pawel; Mahajan, Arvind; Uvell, Hanna; Burchmore, Richard; Smith, Brian O.; Elofsson, Mikael; Roe, Andrew J.			Identification of Bacterial Target Proteins for the Salicylidene Acylhydrazide Class of Virulence-blocking Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; III SECRETION INHIBITORS; CHLAMYDIA-TRACHOMATIS; THIOL PEROXIDASE; DRUG DISCOVERY; YERSINIA; EXPRESSION; STRATEGIES	A class of anti-virulence compounds, the salicylidene acylhydrazides, has been widely reported to block the function of the type three secretion system of several Gram-negative pathogens by a previously unknown mechanism. In this work we provide the first identification of bacterial proteins that are targeted by this group of compounds. We provide evidence that their mode of action is likely to result from a synergistic effect arising from a perturbation of the function of several conserved proteins. We also examine the contribution of selected target proteins to the pathogenicity of Yersinia pseudotuberculosis and to expression of virulence genes in Escherichia coli O157.	[Zetterstrom, Caroline E.; Elofsson, Mikael] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Wang, Dai; Gabrielsen, Mads; Beckham, Katherine S. H.; Macdonald, Sarah E.; Mitchell, Tim J.; Burchmore, Richard; Roe, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Byron, Olwyn; Smith, Brian O.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel; Smith, Brian O.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Uvell, Hanna; Elofsson, Mikael] Umea Univ, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; [Uvell, Hanna; Elofsson, Mikael] Umea Univ, Labs Mol Infect Med Sweden, SE-90187 Umea, Sweden; [Elofsson, Mikael] Umea Univ, Labs Chem Biol Umea, Dept Chem, SE-90187 Umea, Sweden; [Tree, Jai J.; Gally, David L.; Mahajan, Arvind] Univ Edinburgh, Zoonot & Anim Pathogens Res Lab, Immun & Infect Div, Roslin Inst, Edinburgh EH16 4SB, Midlothian, Scotland; [Tree, Jai J.; Gally, David L.; Mahajan, Arvind] Univ Edinburgh, R D SVS, Edinburgh EH16 4SB, Midlothian, Scotland	Umea University; University of Glasgow; University of Glasgow; University of Glasgow; Umea University; Umea University; Umea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Elofsson, M (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	Mikael.Elofsson@chem.umu.se; andrew.roe@glasgow.ac.uk	Smith, Brian O/J-1899-2015; Smith, Brian/AAJ-9393-2020; Burchmore, Richard/A-1896-2011	Smith, Brian O/0000-0003-3363-4168; Smith, Brian/0000-0003-3363-4168; Elofsson, Mikael/0000-0002-3219-4669; Tree, Jai/0000-0001-8233-0975; Mitchell, Timothy/0000-0002-8309-5556; Gabrielsen, Mads/0000-0002-9848-2276; Beckham, Kate/0000-0002-4929-6119; roe, andrew/0000-0003-3698-6134; Gally, David/0000-0002-2566-0844; Burchmore, Richard/0000-0003-1663-9004; Byron, Olwyn/0000-0001-7857-4520	Medical Research Scotland [223 ORG]; Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) [BB/G011389/1]; Swedish Research Council; Wellcome Trust; Knut and Alice Wallenberg Foundation; Vinnova; BBSRC [BB/G011389/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011389/1] Funding Source: researchfish	Medical Research Scotland; Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vinnova(Vinnova); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was generously supported by Medical Research Scotland Grant 223 ORG (to D. W., A. J. R. and R. B.) and Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) Grant BB/G011389/1 (to A. J. R. and M. G.).; Supported by the Swedish Research Council.; Supported by the Wellcome Trust.; Supported by the Knut and Alice Wallenberg Foundation and Vinnova.	Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Barker JJ, 2006, DRUG DISCOV TODAY, V11, P391, DOI 10.1016/j.drudis.2006.03.001; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chu H, 2010, INT J ANTIMICROB AG, V36, P145, DOI 10.1016/j.ijantimicag.2010.03.018; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; Dahlgren MK, 2010, MOLECULES, V15, P4423, DOI 10.3390/molecules15064423; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Gabrielsen M, 2010, ACTA CRYSTALLOGR F, V66, P1606, DOI 10.1107/S1744309110039679; Guiffant Damien, 2007, Biotechnology Journal, V2, P68, DOI 10.1002/biot.200600223; Hall A, 2009, J MOL BIOL, V393, P867, DOI 10.1016/j.jmb.2009.08.040; Hillgren JM, 2010, MOLECULES, V15, P6019, DOI 10.3390/molecules15096019; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Hudson DL, 2007, ANTIMICROB AGENTS CH, V51, P2631, DOI 10.1128/AAC.01492-06; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hung DT, 2006, CURR OPIN CHEM BIOL, V10, P321, DOI 10.1016/j.cbpa.2006.06.016; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kauppi AM, 2007, BIOORGAN MED CHEM, V15, P6994, DOI 10.1016/j.bmc.2007.07.047; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Linusson A, 2010, CURR MED CHEM, V17, P2001, DOI 10.2174/092986710791233661; Lynch SV, 2008, CURR OPIN CRIT CARE, V14, P593, DOI 10.1097/MCC.0b013e32830f1dd5; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Morphy R, 2009, CURR PHARM DESIGN, V15, P587, DOI 10.2174/138161209787315594; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Ploom T, 1999, STRUCT FOLD DES, V7, P509, DOI 10.1016/S0969-2126(99)80067-7; Puri AW, 2009, ACS CHEM BIOL, V4, P603, DOI 10.1021/cb9001409; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Roe AJ, 2003, BIOCHEM SOC T, V31, P98, DOI 10.1042/bst0310098; Roe AJ, 2007, MICROBIOL-SGM, V153, P1350, DOI 10.1099/mic.0.2006/003707-0; Sambrook S, 1989, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simmons KJ, 2010, NAT REV MICROBIOL, V8, P501, DOI 10.1038/nrmicro2349; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	56	73	75	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29922	29931		10.1074/jbc.M111.233858	http://dx.doi.org/10.1074/jbc.M111.233858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724850	Green Published, hybrid			2022-12-27	WOS:000294046600051
J	Wolf-Ringwall, AL; Winter, PW; Liu, JJ; Van Orden, AK; Roess, DA; Barisas, G				Wolf-Ringwall, Amber L.; Winter, Peter W.; Liu, Jingjing; Van Orden, Alan K.; Roess, Deborah A.; Barisas, George			Restricted Lateral Diffusion of Luteinizing Hormone Receptors in Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN CHORIONIC-GONADOTROPIN; RESONANCE ENERGY-TRANSFER; SINGLE-PARTICLE TRACKING; PHOTON-COUNTING HISTOGRAM; HUMAN LUTROPIN RECEPTOR; CELL PLASMA-MEMBRANE; LH RECEPTORS; CYTOCHALASIN-D; LUTEAL CELLS	Single particle tracking was used to evaluate lateral motions of individual FLAG-tagged human luteinizing hormone (LH) receptors expressed on CHO cells and native LH receptors on both KGN human granulosa-derived tumor cells and M17 human neuroblastoma cells before and after exposure to human chorionic gonadotropin (hCG). Compared with LH receptors on untreated cells, LH receptors on cells treated with 100 nM hCG exhibit restricted lateral diffusion and are confined in small, nanometer-scale, membrane compartments. Similar to LH receptors labeled with Au-hCG, LH receptors labeled with gold-deglycosylated hCG, an hCG antagonist, also exhibit restricted lateral diffusion and are confined in nanoscale membrane compartments on KGN cells treated with 100 nM hCG. LH receptor point mutants lacking potential palmitoylation sites remain in large compartments despite treatment with 100 nM hCG as do LH receptors on cells treated with cytochalasin D. Finally, both polarization homotransfer fluorescence resonance energy transfer imaging and photon counting histogram analysis indicate that treatment with hCG induces aggregation of YFP-coupled LH receptors stably expressed on CHO cells. Taken together, our results demonstrate that binding of hCG induces aggregation of LH receptors within nanoscale, cell surface membrane compartments, that hCG binding also affects the lateral motions of antagonist binding LH receptors, and that receptor surface densities must be considered in evaluating the extent of hormone-dependent receptor aggregation.	[Van Orden, Alan K.; Barisas, George] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Wolf-Ringwall, Amber L.; Roess, Deborah A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Winter, Peter W.; Roess, Deborah A.; Barisas, George] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA; [Liu, Jingjing] Tufts Med Ctr, Boston, MA 02111 USA	Colorado State University; Colorado State University; Colorado State University; Tufts Medical Center	Barisas, G (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	barisas@lamar.colostate.edu	Van Orden, Alan K/N-4219-2015		National Institutes of Health [HD41980]; U.S. Department of Agriculture Animal Health and Disease at Colorado State University; National Science Foundation [MCB-1024669, CHE-0628260]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD041980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture Animal Health and Disease at Colorado State University; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health Grant HD41980 (to D. A. R.), the U.S. Department of Agriculture Animal Health and Disease Program at Colorado State University (to D. A. R.), and National Science Foundation Grants MCB-1024669 (to B. G. B.) and CHE-0628260.	AMSTERDAM A, 1980, P NATL ACAD SCI-BIOL, V77, P3440, DOI 10.1073/pnas.77.6.3440; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Barisas BG, 2007, BIOPHYS CHEM, V126, P209, DOI 10.1016/j.bpc.2006.05.026; Barron AM, 2010, ENDOCRINOLOGY, V151, P5380, DOI 10.1210/en.2009-1168; Bowen RL, 2004, J BIOL CHEM, V279, P20539, DOI 10.1074/jbc.M311993200; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chen Y, 2009, CHEM-EUR J, V15, P5327, DOI 10.1002/chem.200802305; Chu YW, 1999, CYTOMETRY, V36, P333, DOI 10.1002/(SICI)1097-0320(19990801)36:4<333::AID-CYTO8>3.0.CO;2-F; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; DRAGSTEN P, 1979, P NATL ACAD SCI USA, V76, P5163, DOI 10.1073/pnas.76.10.5163; DUNKEL L, 1993, ENDOCRINOLOGY, V132, P763, DOI 10.1210/en.132.2.763; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Horvat RD, 1999, BIOCHEM BIOPH RES CO, V255, P382, DOI 10.1006/bbrc.1999.0185; Hunzicker-Dunn M, 2003, J BIOL CHEM, V278, P42744, DOI 10.1074/jbc.M306133200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Jin H, 1997, EUR J PHARMACOL, V324, P109, DOI 10.1016/S0014-2999(97)00059-9; Jung JY, 2006, J AM CHEM SOC, V128, P1240, DOI 10.1021/ja0560736; KAWATE N, 1994, J BIOL CHEM, V269, P30651; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Lei Y, 2005, BIOCHEM BIOPH RES CO, V337, P430, DOI 10.1016/j.bbrc.2005.09.066; Lei Y, 2007, MOL CELL ENDOCRINOL, V260, P65, DOI 10.1016/j.mce.2005.11.046; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; LUBORSKY JL, 1984, ENDOCRINOLOGY, V115, P2217, DOI 10.1210/endo-115-6-2217; LUBORSKY JL, 1979, MOL CELL ENDOCRINOL, V15, P61, DOI 10.1016/0303-7207(79)90008-X; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; NISWENDER GD, 1985, ENDOCRINOLOGY, V116, P164, DOI 10.1210/endo-116-1-164; Perroud TD, 2003, CHEMPHYSCHEM, V4, P1121, DOI 10.1002/cphc.200300824; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Puett D, 1996, MOL CELL ENDOCRINOL, V125, P55, DOI 10.1016/S0303-7207(96)03954-8; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Ries J, 2008, PHYS CHEM CHEM PHYS, V10, P3487, DOI 10.1039/b718132a; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; ROESS DA, 1988, ENDOCRINOLOGY, V122, P261, DOI 10.1210/endo-122-1-261; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; ROESS DA, 1992, BIOCHIM BIOPHYS ACTA, V1137, P309, DOI 10.1016/0167-4889(92)90151-Z; Roess DA, 1997, BBA-MOL CELL RES, V1357, P98, DOI 10.1016/S0167-4889(97)00019-0; Roess DA, 2000, BBA-BIOMEMBRANES, V1464, P242, DOI 10.1016/S0005-2736(00)00159-0; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Ruan QQ, 2002, BIOPHYS J, V83, P3177, DOI 10.1016/S0006-3495(02)75320-4; SAIRAM MR, 1983, J BIOL CHEM, V258, P445; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schulze C, 2009, CELL MOTIL CYTOSKEL, V66, P193, DOI 10.1002/cm.20341; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Smith SML, 2006, ENDOCRINOLOGY, V147, P1789, DOI 10.1210/en.2005-1046; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200	61	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29818	29827		10.1074/jbc.M111.250969	http://dx.doi.org/10.1074/jbc.M111.250969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21690095	Green Published, hybrid			2022-12-27	WOS:000294046600041
J	Gould, CM; Antal, CE; Reyes, G; Kunkel, MT; Adams, RA; Ziyar, A; Riveros, T; Newton, AC				Gould, Christine M.; Antal, Corina E.; Reyes, Gloria; Kunkel, Maya T.; Adams, Ryan A.; Ziyar, Ahdad; Riveros, Tania; Newton, Alexandra C.			Active Site Inhibitors Protect Protein Kinase C from Dephosphorylation and Stabilize Its Mature Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; CRYSTAL-STRUCTURE; IN-VIVO; BETA-II; PKC; PHOSPHORYLATION; ALPHA; AKT; AUTOPHOSPHORYLATION; ACTIVATION	Conformational changes acutely control protein kinase C (PKC). We have previously shown that the autoinhibitory pseudosubstrate must be removed from the active site in order for 1) PKC to be phosphorylated by its upstream kinase phosphoinositide-dependent kinase 1 (PDK-1), 2) the mature enzyme to bind and phosphorylate substrates, and 3) the mature enzyme to be dephosphorylated by phosphatases. Here we show an additional level of conformational control; binding of active site inhibitors locks PKC in a conformation in which the priming phosphorylation sites are resistant to dephosphorylation. Using homogeneously pure PKC, we show that the active site inhibitor Go 6983 prevents the dephosphorylation by pure protein phosphatase 1 (PP1) or the hydrophobic motif phosphatase, pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP). Consistent with results using pure proteins, treatment of cells with the competitive inhibitors Go 6983 or bisindolylmaleimide I, but not the uncompetitive inhibitor bisindolylmaleimide IV, prevents the dephosphorylation and down-regulation of PKC induced by phorbol esters. Pulse-chase analyses reveal that active site inhibitors do not affect the net rate of priming phosphorylations of PKC; rather, they inhibit the dephosphorylation triggered by phorbol esters. These data provide a molecular explanation for the recent studies showing that active site inhibitors stabilize the phosphorylation state of protein kinases B/Akt and C.	[Gould, Christine M.; Antal, Corina E.; Reyes, Gloria; Kunkel, Maya T.; Adams, Ryan A.; Ziyar, Ahdad; Riveros, Tania; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Gould, Christine M.; Antal, Corina E.; Riveros, Tania] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [R01 GM43154]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM43154 (to A.C.N.).	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Narayana N, 1999, BIOCHEMISTRY-US, V38, P2367, DOI 10.1021/bi9820659; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639	40	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28922	28930		10.1074/jbc.M111.272526	http://dx.doi.org/10.1074/jbc.M111.272526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715334	Green Published, hybrid			2022-12-27	WOS:000293837000029
J	Keyamura, K; Katayama, T				Keyamura, Kenji; Katayama, Tsutomu			DnaA Protein DNA-binding Domain Binds to Hda Protein to Promote Inter-AAA plus Domain Interaction Involved in Regulatory Inactivation of DnaA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; REPLICATION INITIATION; CHROMOSOMAL REPLICATION; ATP HYDROLYSIS; SLIDING CLAMP; E. COLI; BACILLUS-SUBTILIS; STRUCTURAL BASIS; RNA-POLYMERASE; ADP-DNAA	Chromosomal replication is initiated from the replication origin oriC in Escherichia coli by the active ATP-bound form of DnaA protein. The regulatory inactivation of DnaA (RIDA) system, a complex of the ADP-bound Hda and the DNA-loaded replicase clamp, represses extra initiations by facilitating DnaA-bound ATP hydrolysis, yielding the inactive ADP-bound form of DnaA. However, the mechanisms involved in promoting the DnaA-Hda interaction have not been determined except for the involvement of an interaction between the AAA+ domains of the two. This study revealed that DnaA Leu-422 and Pro-423 residues within DnaA domain IV, including a typical DNA-binding HTH motif, are specifically required for RIDA-dependent ATP hydrolysis in vitro and that these residues support efficient interaction with the DNA-loaded clamp.Hda complex and with Hda in vitro. Consistently, substitutions of these residues caused accumulation of ATP-bound DnaA in vivo and oriC-dependent inhibition of cell growth. Leu-422 plays a more important role in these activities than Pro-423. By contrast, neither of these residues is crucial for DNA replication from oriC, although they are highly conserved in DnaA orthologues. Structural analysis of a DnaA.Hda complex model suggested that these residues make contact with residues in the vicinity of the Hda AAA+ sensor I that participates in formation of a nucleotide-interacting surface. Together, the results show that functional DnaA-Hda interactions require a second interaction site within DnaA domain IV in addition to the AAA+ domain and suggest that these interactions are crucial for the formation of RIDA complexes that are active for DnaA-ATP hydrolysis.	[Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Technology and Science of Japan	Ministry of Education, Culture, Sports, Technology and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from Ministry of Education, Culture, Sports, Technology and Science of Japan.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Asklund M, 2005, J MOL BIOL, V345, P717, DOI 10.1016/j.jmb.2004.10.092; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Collier J, 2009, J BACTERIOL, V191, P5706, DOI 10.1128/JB.00525-09; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; De Felice M, 2004, BIOCHEM J, V381, P645, DOI 10.1042/BJ20040280; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Felczak MM, 2009, MOL MICROBIOL, V72, P1348, DOI 10.1111/j.1365-2958.2009.06724.x; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Kurz M, 2004, J BACTERIOL, V186, P3508, DOI 10.1128/JB.186.11.3508-3515.2004; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Riber L, 2005, J BACTERIOL, V187, P5605, DOI 10.1128/JB.187.16.5605-5613.2005; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2004, GENES CELLS, V9, P509, DOI 10.1111/j.1356-9597.2004.00741.x; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; THEISEN PW, 1993, MOL MICROBIOL, V10, P575, DOI 10.1111/j.1365-2958.1993.tb00929.x; Waldminghaus T, 2009, PLASMID, V61, P141, DOI 10.1016/j.plasmid.2009.02.004; Xu QP, 2009, J MOL BIOL, V385, P368, DOI 10.1016/j.jmb.2008.10.059; Yoshida Y, 2003, CELL MOL LIFE SCI, V60, P1998, DOI 10.1007/s00018-003-3176-7; YOSHIKAWA H, 1991, MOL MICROBIOL, V5, P2589, DOI 10.1111/j.1365-2958.1991.tb01967.x; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x	65	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29336	29346		10.1074/jbc.M111.233403	http://dx.doi.org/10.1074/jbc.M111.233403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708944	hybrid, Green Published			2022-12-27	WOS:000293837000068
J	Sun, XW; Essalmani, R; Susan-Resiga, D; Prat, A; Seidah, NG				Sun, Xiaowei; Essalmani, Rachid; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.			Latent Transforming Growth Factor beta-Binding Proteins-2 and-3 Inhibit the Proprotein Convertase 5/6A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PROHORMONE CONVERTASE; EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; CDNA STRUCTURE; 7B2; FURIN; CELLS; MOUSE; DIFFERENTIATION	The basic amino acid-specific proprotein convertase 5/6 (PC5/6) is an essential secretory protease, as knock-out mice die at birth and exhibit multiple homeotic transformation defects, including impaired bone morphogenesis and lung structure. Some of the observed defects were attributed to impaired processing of the TGF beta-like growth differentiating factor 11 precursor (proGdf11). In this work we present evidence that the latent TGF beta-binding proteins 2 and 3 (LTBP-2 and -3) inhibit the extracellular processing of proGdf11 by PC5/6A. This is partly due to the binding of LTBPs in the endoplasmic reticulum to the zymogen proPC5/6A, thus allowing the complex to exit the endoplasmic reticulum and be sequestered as an inactive zymogen in the extracellular matrix but not at the cell surface. This results in lower levels of PC5/6A in the media, without affecting those of PACE4, Furin, or a soluble form of PC7. The secreted soluble protease-specific activity of PC5/6A or a variant lacking the C-terminal Cys-rich domain (PC5/6-Delta CRD) is significantly decreased when co-expressed with LTBPs in cells. A similar enzymatic inhibition seems to apply to PACE4 and Furin. In situ hybridization analyses revealed extensive co-localization of PC5/6 and LTBP-3 mRNAs in mice at embryonic day 15.5 and post partum day 1. In conclusion, this is the first time that a zymogen of the proprotein convertases was shown to exit the endoplasmic reticulum in the presence of LTBPs, representing a potential novel mechanism for the regulation of PC5/6A activity, e. g. in tissues such as bone and lung where LTBP-3 and PC5/6 co-localize.	[Sun, Xiaowei; Essalmani, Rachid; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X	Canadian Institutes of Health Research [MOP-44363]; Strauss Foundation; Canada Chair [216684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This work was supported by Canadian Institutes of Health Research Grant MOP-44363, a Strauss Foundation grant, and Canada Chair Grant 216684.	Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BEAUBIEN G, 1995, CELL TISSUE RES, V279, P539; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Bernot D, 2011, J CELL SCI, V124, P1224, DOI 10.1242/jcs.079889; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Ho DM, 2010, MECH DEVELOP, V127, P485, DOI 10.1016/j.mod.2010.08.004; Hyytiainen M, 1998, J BIOL CHEM, V273, P20669, DOI 10.1074/jbc.273.32.20669; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Koli K, 2005, EXP CELL RES, V310, P370, DOI 10.1016/j.yexcr.2005.08.008; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MBIKAY M, 1989, INT J PEPT PROT RES, V33, P39; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Parsi MK, 2010, MATRIX BIOL, V29, P393, DOI 10.1016/j.matbio.2010.03.005; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; SEIDAH NG, 1983, ARCH BIOCHEM BIOPHYS, V225, P525, DOI 10.1016/0003-9861(83)90063-2; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Yuasa K, 2009, J BIOCHEM, V146, P407, DOI 10.1093/jb/mvp090; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	48	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29063	29073		10.1074/jbc.M111.242479	http://dx.doi.org/10.1074/jbc.M111.242479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700711	hybrid, Green Published			2022-12-27	WOS:000293837000043
J	Tisserand, J; Khetchoumian, K; Thibault, C; Dembele, D; Chambon, P; Losson, R				Tisserand, Johan; Khetchoumian, Konstantin; Thibault, Christelle; Dembele, Doulaye; Chambon, Pierre; Losson, Regine			Tripartite Motif 24 (Trim24/Tif1 alpha) Tumor Suppressor Protein Is a Novel Negative Regulator of Interferon (IFN)/Signal Transducers and Activators of Transcription (STAT) Signaling Pathway Acting through Retinoic Acid Receptor alpha (Rar alpha) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; NUCLEAR RECEPTORS; UP-REGULATION; ARGININE METHYLTRANSFERASE-1; TRIM24 TIF1-ALPHA; TIF1 FAMILY; HEPATITIS-C; GROWTH; LIVER	Recent genetic studies in mice have established that the nuclear receptor coregulator Trim24/Tif1 alpha suppresses hepatocarcinogenesis by inhibiting retinoic acid receptor alpha (Rara)-dependent transcription and cell proliferation. However, Rara targets regulated by Trim24 remain unknown. We report that the loss of Trim24 resulted in interferon (IFN)/STAT pathway overactivation soon after birth (week 5). Despite a transient attenuation of this pathway by the induction of several IFN/STAT pathway repressors later in the disease, this phenomenon became more pronounced in tumors. Remarkably, Rara haplo-deficiency, which suppresses tumorigenesis in Trim24(-/-) mice, prevented IFN/STAT overactivation. Moreover, together with Rara, Trim24 bound to the retinoic acid-responsive element of the Stat1 promoter and repressed its retinoic acid-induced transcription. Altogether, these results identify Trim24 as a novel negative regulator of the IFN/STAT pathway and suggest that this repression through Rara inhibition may prevent liver cancer.	[Tisserand, Johan; Khetchoumian, Konstantin; Thibault, Christelle; Dembele, Doulaye; Chambon, Pierre; Losson, Regine] Univ Strasbourg 1, Dept Funct Genom, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,INSERM, F-67404 Illkirch Graffenstaden, Communaute Urba, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg 1, Dept Funct Genom, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,INSERM, BP 10142, F-67404 Illkirch Graffenstaden, Communaute Urba, France.	chambon@igbmc.fr	Dembélé, Doulaye/O-6513-2017	Dembélé, Doulaye/0000-0003-3879-6940; Thibault-Carpentier, Christelle/0000-0003-1562-1451	CNRS; INSERM; Agence Nationale de la Recherche [ANR06-BLAN-0377]; Association pour la Recherche contre le Cancer (ARC); Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa); ARTOn; Ministere de la Recherche et des Technologies; ARC; INCa; ARI (Agence Regionale de l'Innovation)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); ARTOn; Ministere de la Recherche et des Technologies; ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); ARI (Agence Regionale de l'Innovation)	This work was supported in part by the CNRS, INSERM, Agence Nationale de la Recherche Grant ANR06-BLAN-0377, Association pour la Recherche contre le Cancer (ARC), Ligue Nationale Contre le Cancer, and the Institut National du Cancer (INCa; Project ARTOn).; Supported by fellowships from the Ministere de la Recherche et des Technologies, ARC, INCa, and ARI (Agence Regionale de l'Innovation).	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Breuhahn K, 2004, CANCER RES, V64, P6058, DOI 10.1158/0008-5472.CAN-04-0292; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chelbi-Alix MK, 1999, LEUKEMIA, V13, P1167, DOI 10.1038/sj.leu.2401469; Chen L., 2011, INT J BIOCH IN PRESS; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Desmet VJ, 2009, HEPATOLOGY, V49, P355, DOI 10.1002/hep.22681; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Huynh H, 2010, BIOCHEM PHARMACOL, V80, P550, DOI 10.1016/j.bcp.2010.03.034; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Khetchoumian K, 2008, CELL CYCLE, V7, P3647, DOI 10.4161/cc.7.23.7123; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Kolla V, 1996, J BIOL CHEM, V271, P10508, DOI 10.1074/jbc.271.18.10508; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Lehner F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013344; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Matsuda M, 2005, LAB INVEST, V85, P655, DOI 10.1038/labinvest.3700257; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Onitsuka A, 1996, SURG TODAY, V26, P126, DOI 10.1007/BF00311777; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; RESAR LMS, 1993, MOL CELL BIOL, V13, P1130, DOI 10.1128/MCB.13.2.1130; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugawara I, 2004, TOHOKU J EXP MED, V202, P41, DOI 10.1620/tjem.202.41; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Xiao WH, 1997, J BIOL CHEM, V272, P9742, DOI 10.1074/jbc.272.15.9742; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	56	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33369	33379		10.1074/jbc.M111.225680	http://dx.doi.org/10.1074/jbc.M111.225680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21768647	Green Published, hybrid			2022-12-27	WOS:000294968800055
J	Brown, NG; Chow, DC; Sankaran, B; Zwart, P; Prasad, BVV; Palzkill, T				Brown, Nicholas G.; Chow, Dar-Chone; Sankaran, Banumathi; Zwart, Peter; Prasad, B. V. Venkataram; Palzkill, Timothy			Analysis of the Binding Forces Driving the Tight Interactions between beta-Lactamase Inhibitory Protein-II (BLIP-II) and Class A beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS PC1; SITE-DIRECTED MUTAGENESIS; ACYL-ENZYME INTERMEDIATE; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC STRUCTURE; MODULAR ARCHITECTURE; PHAGE DISPLAY; COMPLEX; INTERFACE; TEM-1	beta-Lactamases hydrolyze beta-lactam antibiotics to provide drug resistance to bacteria. beta-Lactamase inhibitory protein-II (BLIP-II) is a potent proteinaceous inhibitor that exhibits low picomolar affinity for class A beta-lactamases. This study examines the driving forces for binding between BLIP-II and beta-lactamases using a combination of presteady state kinetics, isothermal titration calorimetry, and x-ray crystallography. The measured dissociation rate constants for BLIP-II and various beta-lactamases ranged from 10(-4) to 10(-7) s(-1) and are comparable with those found in some of the tightest known protein-protein interactions. The crystal structures of BLIP-II alone and in complex with Bacillus anthracis Bla1 beta-lactamase revealed no significant side-chain movement in BLIP-II in the complex versus the monomer. The structural rigidity of BLIP-II minimizes the loss of the entropy upon complex formation and, as indicated by thermodynamics experiments, may be a key determinant of the observed potent inhibition of beta-lactamases.	[Brown, Nicholas G.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Brown, Nicholas G.; Chow, Dar-Chone; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Sankaran, Banumathi; Zwart, Peter] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Palzkill, T (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.tmc.edu	Zwart, Peter/F-7123-2013	Brown, Nicholas/0000-0002-6141-0164; Prasad, B.V.Venkataram/0000-0002-1172-2071	National Institutes of Health from the Keck Center Biomedical Discovery [T90 DA 022885];  [AI32956];  [AI092963]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R37AI032956, R01AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	National Institutes of Health from the Keck Center Biomedical Discovery(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T90 DA 022885 (a training fellowship from the Keck Center Biomedical Discovery from the Large Scale Data Sets Training Program of the Gulf Coast Consortia) and AI32956 and AI092963 (to T. P.).	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albeck S, 1999, BIOCHEMISTRY-US, V38, P11, DOI 10.1021/bi981772z; Ali Shah A, 2004, RES MICROBIOL, V155, P409, DOI 10.1016/j.resmic.2004.02.009; Andujar-Sanchez M, 2004, BIOPHYS CHEM, V111, P183, DOI 10.1016/j.bpc.2004.05.011; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P3345, DOI 10.1093/nar/gkg528; Bai HJ, 2011, PROTEINS, V79, P720, DOI 10.1002/prot.22904; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Brown NG, 2010, PROTEIN ENG DES SEL, V23, P469, DOI 10.1093/protein/gzq017; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Castro MJM, 1996, BIOCHEMISTRY-US, V35, P11435, DOI 10.1021/bi960515w; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; DeLano W.L, PYMOL MOL GRAPHICS S; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Drawz SM, 2009, BIOCHEMISTRY-US, V48, P4557, DOI 10.1021/bi9003292; Durchschlag H, 2003, RADIAT PHYS CHEM, V67, P479, DOI 10.1016/S0969-806X(03)00089-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Guharoy M, 2010, PROTEINS, V78, P3219, DOI 10.1002/prot.22821; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; Huang WZ, 1998, ANTIMICROB AGENTS CH, V42, P2893, DOI 10.1128/AAC.42.11.2893; Huang WZ, 2000, J BIOL CHEM, V275, P14964, DOI 10.1074/jbc.M001285200; JELESAROV I, 1994, BIOCHEMISTRY-US, V33, P13321, DOI 10.1021/bi00249a019; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Materon IC, 2003, ANTIMICROB AGENTS CH, V47, P2040, DOI 10.1128/AAC.47.6.2040-2042.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page M. I., 1999, CURR PHARM DESIGN, V5, P915; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paoli M, 2001, PROG BIOPHYS MOL BIO, V76, P103, DOI 10.1016/S0079-6107(01)00007-4; Park HU, 1998, MICROBIOL-SGM, V144, P2161, DOI 10.1099/00221287-144-8-2161; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pons T, 2003, CURR MED CHEM, V10, P505, DOI 10.2174/0929867033368204; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Ruvinsky AM, 2011, J MOL BIOL, V408, P356, DOI 10.1016/j.jmb.2011.02.030; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Shaul Y, 2005, PROTEINS, V60, P341, DOI 10.1002/prot.20489; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13751, DOI 10.1021/bi00042a005; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; Wang JH, 2009, J BIOL CHEM, V284, P595, DOI 10.1074/jbc.M804089200; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Yuan J, 2009, J MOL BIOL, V389, P401, DOI 10.1016/j.jmb.2009.04.028; Zawadzke LE, 1995, PROTEIN ENG, V8, P1275, DOI 10.1093/protein/8.12.1275; Zhang Z, 2004, J BIOL CHEM, V279, P42860, DOI 10.1074/jbc.M406157200; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	94	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32723	32735		10.1074/jbc.M111.265058	http://dx.doi.org/10.1074/jbc.M111.265058			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775426	Green Published, hybrid			2022-12-27	WOS:000294726800081
J	Hodson, C; Cole, AR; Lewis, LPC; Miles, JA; Purkiss, A; Walden, H				Hodson, Charlotte; Cole, Ambrose R.; Lewis, Laurence P. C.; Miles, Jennifer A.; Purkiss, Andrew; Walden, Helen			Structural Analysis of Human FANCL, the E3 Ligase in the Fanconi Anemia Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; PROTEINS; COMPLEX; GENE; CLONING; DOMAIN; UBE2T; E2	The Fanconi anemia (FA) pathway is essential for the repair of DNA interstrand cross-links. At the heart of this pathway is the monoubiquitination of the FANCI-FANCD2 (ID) complex by the multiprotein "core complex" containing the E3 ubiquitin ligase FANCL. Vertebrate organisms have the eight-protein core complex, whereas invertebrates apparently do not. We report here the structure of the central domain of human FANCL in comparison with the recently solved Drosophila melanogaster FANCL. Our data represent the first structural detail into the catalytic core of the human system and reveal that the central fold of FANCL is conserved between species. However, there are macromolecular differences between the FANCL proteins that may account for the apparent distinctions in core complex requirements between the vertebrate and invertebrate FA pathways. In addition, we characterize the binding of human FANCL with its partners, Ube2t, FANCD2, and FANCI. Mutational analysis reveals which residues are required for substrate binding, and we also show the domain required for E2 binding.	[Hodson, Charlotte; Cole, Ambrose R.; Lewis, Laurence P. C.; Miles, Jennifer A.; Purkiss, Andrew; Walden, Helen] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, London WC2A 3LY, England	Cancer Research UK	Walden, H (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	Helen.Walden@cancer.org.uk		Miles, Jennifer/0000-0001-8839-9201	Protein Structure and Function laboratory; Cancer Research UK	Protein Structure and Function laboratory; Cancer Research UK(Cancer Research UK)	We thank Michael Way for discussions and criticisms on the manuscript and members of the Protein Structure and Function laboratory for suggestions and support. We also thank K. J. Patel for the plasmid for HIS-FANCD2 and P. Knipscheer and J. C. Walter for the FLAG-FANCI plasmid. We thank the protein production facility for generating the viruses for the insect cell protein expression.; This work was supported by a grant from Cancer Research UK.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 1999, BLOOD, V93, P1430, DOI 10.1182/blood.V93.4.1430.404a36a_1430_1432; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; GERMAN J, 1987, BLOOD, V69, P1637; Gurtan AM, 2006, J BIOL CHEM, V281, P10896, DOI 10.1074/jbc.M511411200; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Marek LR, 2006, DNA REPAIR, V5, P1317, DOI 10.1016/j.dnarep.2006.05.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mcvey M, 2010, ENVIRON MOL MUTAGEN, V51, P646, DOI 10.1002/em.20551; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Titus TA, 2006, GENE, V371, P211, DOI 10.1016/j.gene.2005.11.038; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	39	37	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32628	32637		10.1074/jbc.M111.244632	http://dx.doi.org/10.1074/jbc.M111.244632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775430	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000294726800072
J	McVicker, G; Sun, L; Sohanpal, BK; Gashi, K; Williamson, RA; Plumbridge, J; Blomfield, IC				McVicker, Gareth; Sun, Lei; Sohanpal, Baljinder K.; Gashi, Krishna; Williamson, Richard A.; Plumbridge, Jacqueline; Blomfield, Ian C.			SlyA Protein Activates fimB Gene Expression and Type 1 Fimbriation in Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-NS; PHASE VARIATION; SALMONELLA-ENTERICA; ACQUIRED GENES; URINARY-TRACT; SIALIC-ACID; VIRULENCE; DNA; TRANSCRIPTION; TYPHIMURIUM	We have demonstrated that SlyA activates fimB expression and hence type 1 fimbriation, a virulence factor in Escherichia coli. SlyA is shown to bind to two operator sites (O-SA1 and O-SA2), situated between 194 and 167 base pairs upstream of the fimB transcriptional start site. fimB expression is derepressed in an hns mutant and diminished by a slyA mutation in the presence of H-NS only. H-NS binds to multiple sites in the promoter region, including two sites (H-NS2 and H-NS3) that overlap O-SA1 and O-SA2, respectively. Mutations that disrupt either O-SA1 or O-SA2 eliminate or reduce the activating effect of SlyA but have different effects on the level of expression. We interpret these results as reflecting the relative competition between SlyA and H-NS binding. Moreover we show that SlyA is capable of displacing H-NS from its binding sites in vitro. We suggest SlyA binding prevents H-NS binding to H-NS2 and H-NS3 and the subsequent oligomerization of H-NS necessary for full inhibition of fimB expression. In addition, we show that SlyA activates fimB expression independently of two other known regulators of fimB expression, NanR and NagC. It is demonstrated that the rarely used UUG initiation codon limits slyA expression and that low SlyA levels limit fimB expression. Furthermore, Western blot analysis shows that cells grown in rich-defined medium contain similar to 1000 SlyA dimers per cell whereas those grown in minimal medium contain >20% more SlyA. This study extends our understanding of the role that SlyA plays in the host-bacterial relationship.	[McVicker, Gareth; Sun, Lei; Sohanpal, Baljinder K.; Gashi, Krishna; Williamson, Richard A.; Blomfield, Ian C.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Plumbridge, Jacqueline] CNRS, Inst Biol Physicochim, Unite Propre Rech 9073, F-75005 Paris, France	University of Kent; Centre National de la Recherche Scientifique (CNRS)	Blomfield, IC (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	i.c.blomfield@kent.ac.uk		McVicker, Gareth/0000-0002-6967-5968	Wellcome Trust [GR076360/Z/05/Z, 085931/Z/08/Z]; CNRS [UPR9073]	Wellcome Trust(Wellcome Trust); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Grants GR076360/Z/05/Z and 085931/Z/08/Z from the Wellcome Trust. The work in Paris was supported by funds from the CNRS (UPR9073).	Aberg A, 2006, MOL MICROBIOL, V60, P1520, DOI 10.1111/j.1365-2958.2006.05191.x; ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Barnich N, 2007, WORLD J GASTROENTERO, V13, P5571, DOI 10.3748/wjg.v13.i42.5571; BLOMFIELD IC, 1991, J BACTERIOL, V173, P5298, DOI 10.1128/jb.173.17.5298-5307.1991; BLOMFIELD IC, 1993, J BACTERIOL, V175, P27, DOI 10.1128/JB.175.1.27-36.1993; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Bremer H, 1996, ESCHERICHIA COLI SAL; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Corbett D, 2007, J BIOL CHEM, V282, P33326, DOI 10.1074/jbc.M703465200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhakal BK, 2008, EUR J CLIN INVEST, V38, P2, DOI 10.1111/j.1365-2362.2008.01986.x; Donato GM, 1997, J BACTERIOL, V179, P6618, DOI 10.1128/jb.179.21.6618-6625.1997; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; El-Labany S, 2003, MOL MICROBIOL, V49, P1109, DOI 10.1046/j.1365-2958.2003.03624.x; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; GALLY DL, 1993, J BACTERIOL, V175, P6186, DOI 10.1128/JB.175.19.6186-6193.1993; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Haider F, 2009, INT MICROBIOL, V11, P245, DOI 10.2436/20.1501.01.68; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Kawakami T, 1999, MICROBIOL IMMUNOL, V43, P351, DOI 10.1111/j.1348-0421.1999.tb02415.x; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lahooti M, 2005, J BACTERIOL, V187, P6273, DOI 10.1128/JB.187.18.6273-6280.2005; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; MCCLAIN MS, 1993, J BACTERIOL, V175, P4335, DOI 10.1128/JB.175.14.4335-4344.1993; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Oscarsson J, 1996, MOL MICROBIOL, V20, P191, DOI 10.1111/j.1365-2958.1996.tb02500.x; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Silhavy T. J., 1984, EXPT GENE FUSIONS; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Sohanpal B. K., 2007, MOL MICROBIOL, V101, P16322; Sohanpal BK, 2004, P NATL ACAD SCI USA, V101, P16322, DOI 10.1073/pnas.0405821101; Song HW, 2008, J BIOL CHEM, V283, P28158, DOI 10.1074/jbc.M801058200; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Xie Y, 2006, INFECT IMMUN, V74, P4039, DOI 10.1128/IAI.02058-05; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	61	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32026	32035		10.1074/jbc.M111.266619	http://dx.doi.org/10.1074/jbc.M111.266619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768111	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000294726800012
J	Zhang, L; Chen, XJ; Lu, HB; Xie, ZP; Staehelin, C				Zhang, Ling; Chen, Xue-Jiao; Lu, Huang-Bin; Xie, Zhi-Ping; Staehelin, Christian			Functional Analysis of the Type 3 Effector Nodulation Outer Protein L (NopL) from Rhizobium sp NGR234 SYMBIOTIC EFFECTS, PHOSPHORYLATION, AND INTERFERENCE WITH MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN NGR234; HOST-SPECIFICITY; ARABIDOPSIS; SYSTEM; BIOSYNTHESIS; RESPONSES; LEGUMES; AVRPTOB; FAMILY; CELLS	Pathogenic bacteria use type 3 secretion systems to deliver virulence factors (type 3 effector proteins) directly into eukaryotic host cells. Similarly, type 3 effectors of certain nitrogen-fixing rhizobial strains affect nodule formation in the symbiosis with host legumes. Nodulation outer protein L (NopL) of Rhizobium sp. strain NGR234 is a Rhizobium-specific type 3 effector. Nodulation tests and microscopic analysis showed that distinct necrotic areas were rapidly formed in ineffective nodules of Phaseolus vulgaris (cv. Tendergreen) induced by strain NGR Omega nopL (NGR234 mutated in nopL), indicating that NopL antagonized nodule senescence. Further experiments revealed that NopL interfered with mitogen-activated protein kinase (MAPK) signaling in yeast and plant cells (Nicotiana tabacum). Expression of nopL in yeast disrupted the mating pheromone (alpha-factor) response pathway, whereas nopL expression in N. tabacum suppressed cell death induced either by overexpression of the MAPK gene SIPK (salicylic acid-induced protein kinase) or by SIPKDD (mutation in the TXY motif resulting in constitutive MAPK activity). These data indicate that NopL impaired function of MAPK proteins or MAPK substrates. Furthermore, we demonstrate that NopL was multiply phosphorylated either in yeast or N. tabacum cells that expressed nopL. Four phosphorylated serines were confirmed by mass spectrometry. All four phosphorylation sites exhibit a Ser-Pro pattern, a typical motif in MAPK substrates. Taken together, data suggest that NopL mimics a MAPK substrate and that NopL suppresses premature nodule senescence by impairing MAPK signaling in host cells.	[Zhang, Ling; Chen, Xue-Jiao; Lu, Huang-Bin; Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China	Sun Yat Sen University	Xie, ZP (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China.	xiez@mail.sysu.edu.cn; cst@mail.sysu.edu.cn			National Basic Research Program of China (973 program) [2010CB126501]; National Natural Science Foundation of China [30771150]; Science Foundation of the Key Laboratory of Biocontrol [SKLBC09B05]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Key Laboratory of Biocontrol	This work was supported by the National Basic Research Program of China (973 program) Grant 2010CB126501, National Natural Science Foundation of China Grant 30771150, and Science Foundation of the Key Laboratory of Biocontrol Grant SKLBC09B05.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Ausmees N, 2004, J BACTERIOL, V186, P4774, DOI 10.1128/JB.186.14.4774-4780.2004; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; Bartsev AV, 2003, FEBS LETT, V554, P271, DOI 10.1016/S0014-5793(03)01145-1; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Chaudhuri B, 1997, GENETICS, V145, P75; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; Fauvart M, 2008, FEMS MICROBIOL LETT, V285, P1, DOI 10.1111/j.1574-6968.2008.01254.x; Fernandez-Pascual M, 2006, J EXP BOT, V57, P2735, DOI 10.1093/jxb/erl038; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Kambara K, 2009, MOL MICROBIOL, V71, P92, DOI 10.1111/j.1365-2958.2008.06507.x; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Minic Z, 2007, J EXP BOT, V58, P2503, DOI 10.1093/jxb/erm082; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Munkvold KR, 2009, MOL PLANT PATHOL, V10, P777, DOI 10.1111/j.1364-3703.2009.00586.x; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Schechter LM, 2010, APPL ENVIRON MICROB, V76, P3758, DOI 10.1128/AEM.03122-09; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Skorpil P, 2005, MOL MICROBIOL, V57, P1304, DOI 10.1111/j.1365-2958.2005.04768.x; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Wenzel M, 2010, MOL PLANT MICROBE IN, V23, P124, DOI 10.1094/MPMI-23-1-0124; Xiao F, 2007, J BIOL CHEM, V282, P30737, DOI 10.1074/jbc.M705565200; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Zhang SQ, 2001, PLANT CELL, V13, P1877, DOI 10.1105/tpc.13.8.1877; Zhou JM, 2008, CURR OPIN MICROBIOL, V11, P179, DOI 10.1016/j.mib.2008.02.004	40	51	53	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32178	32187		10.1074/jbc.M111.265942	http://dx.doi.org/10.1074/jbc.M111.265942			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775427	hybrid, Green Published			2022-12-27	WOS:000294726800028
J	Zhou, YF; Zhou, Y; Shingu, T; Feng, L; Chen, Z; Ogasawara, M; Keating, MJ; Kondo, S; Huang, P				Zhou, Yunfei; Zhou, Yan; Shingu, Takashi; Feng, Li; Chen, Zhao; Ogasawara, Marcia; Keating, Michael J.; Kondo, Seiji; Huang, Peng			Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells PREFERENCE FOR HYPOXIA AND HIGH DEPENDENCY ON GLYCOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR STEM-CELLS; CANCER-CELLS; BRAIN-TUMORS; IN-VIVO; PHENOTYPE; DIFFERENTIATION; IDENTIFICATION; NICHE; EGF	Recent studies suggest that a small subpopulation of malignant cells with stem-like properties is resistant to chemotherapy and may be responsible for the existence of residual cancer after treatment. We have isolated highly tumorigenic cancer cells with 100-fold increase in tumor initiating capacity from the tumor xenografts of human glioblastoma U87 cells in mice. These cells exhibit stem-like properties and show unique energy metabolic characteristics including low mitochondrial respiration, increased glycolysis for ATP generation, and preference for hypoxia to maintain their stemness and tumor forming capacity. Mechanistically, mitochondrial depression in the highly tumorigenic cells occurs mainly at complex II of the electron transport chain with a down-regulation of the succinate dehydrogenase subunit B, leading to deregulation of hypoxia-inducible factors. Under hypoxia, the stem-like cancer cells are resistant to conventional anticancer agents but are sensitive to glycolytic inhibition. Furthermore, combination of glycolytic inhibition with standard therapeutic agents is effective in killing the tumor-initiating cells in vitro and inhibits tumor formation in vivo. Our study suggests that stem-like cancer cells prefer a low oxygen microenvironment and actively utilize the glycolytic pathway for ATP generation. Inhibition of glycolysis may be an effective strategy to eradicate residual cancer stem cells that are otherwise resistant to chemotherapeutic agents in their hypoxic niches.	[Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Shingu, Takashi; Kondo, Seiji] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Huang, P (corresponding author), Unit 951,1515 Holcombe Blvd, Houston, TX 77030 USA.	phuang@mdanderson.org	Shingu, Takashi/AAS-4820-2021		National Institutes of Health [CA085563, CA100428, CA109041, CA16672]; Houston Endowment; Odyssey Fellowship; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA109041, R01CA100428, R01CA085563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston Endowment; Odyssey Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA085563, CA100428, CA109041, and CA16672. This work was also supported by an Odyssey Fellowship sponsored by the Houston Endowment.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; HOLZER T, 1993, J COMPUT ASSIST TOMO, V17, P681; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Moppett IK, 2007, ANESTH ANALG, V105, P1094, DOI 10.1213/01.ane.0000284620.37846.e5; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Singh SK, 2003, CANCER RES, V63, P5821; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	39	164	170	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32843	32853		10.1074/jbc.M111.260935	http://dx.doi.org/10.1074/jbc.M111.260935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795717	hybrid, Green Published			2022-12-27	WOS:000294726800091
J	Jin, LH; Lin, SC; Rong, H; Zheng, SY; Jin, SK; Wang, R; Li, Y				Jin, Lihua; Lin, Shengchen; Rong, Hui; Zheng, Songyang; Jin, Shikan; Wang, Rui; Li, Yong			Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor alpha/delta Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABLE PROSTACYCLIN ANALOG; FATTY-ACIDS; DIFFERENTIAL ACTIVATION; PULMONARY-HYPERTENSION; PLATELET-AGGREGATION; UP-REGULATION; PPAR; ANGIOGENESIS; EICOSANOIDS; LIGANDS	Iloprost is a prostacyclin analog that has been used to treat many vascular conditions. Peroxisome proliferator-activated receptors (PPARs) are ligand-regulated transcription factors with various important biological effects such as metabolic and cardiovascular physiology. Here, we report the crystal structures of the PPAR alpha ligand-binding domain and PPAR delta ligand-binding domain bound to iloprost, thus providing unambiguous evidence for the direct interaction between iloprost and PPARs and a structural basis for the recognition of PPAR alpha/delta by this prostacyclin analog. In addition to conserved contacts for all PPAR alpha ligands, iloprost also initiates several specific interactions with PPARs using its unique structural groups. Structural and functional studies of receptor-ligand interactions reveal strong functional correlations of the iloprost-PPAR alpha/delta interactions as well as the molecular basis of PPAR subtype selectivity toward iloprost ligand. As such, the structural mechanism may provide a more rational template for designing novel compounds targeting PPARs with more favorable pharmacologic impact based on existing iloprost drugs.	[Jin, Lihua; Lin, Shengchen; Jin, Shikan; Wang, Rui; Li, Yong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China; [Lin, Shengchen; Rong, Hui; Zheng, Songyang; Li, Yong] Univ Pittsburgh, Ctr Pharmacogenet, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	Xiamen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, Y (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China.	yongli@ymail.com	Lin, Shengchen/T-3529-2018; Jin, Lihua/AAN-5177-2020	Lin, Shengchen/0000-0003-1488-8680; Jin, Lihua/0000-0002-2685-6048	National Institutes of Health [DK081757]; American Heart Association; Fundamental Research Funds for the Central Universities [2010121083, 2011121029]; Science Planning Program of Fujian Province [2009J1010]; Office of Science of the United States Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science Planning Program of Fujian Province; Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081757. This work was also supported by an award from the American Heart Association, the Fundamental Research Funds for the Central Universities Grants 2010121083 and 2011121029, and Grant 2009J1010 from the Science Planning Program of Fujian Province.; We thank E. Kondrashkina and Z. Wawrzak for assistance in data collection at sector 21 (LS-CAT) of the Advance Photo Source and staff at BL17U of Shanghai Synchrotron Radiation Source for help. Use of the Advanced Photon Source was supported by the Office of Science of the United States Department of Energy.	Barger PM, 2002, J MOL CELL CARDIOL, V34, P713, DOI 10.1006/jmcc.2002.2029; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Biscetti F, 2008, CIRC RES, V103, P7, DOI 10.1161/CIRCRESAHA.108.180224; Biscetti F, 2009, J VASC RES, V46, P103, DOI 10.1159/000143793; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Hertz R, 1996, EUR J BIOCHEM, V235, P242, DOI 10.1111/j.1432-1033.1996.00242.x; Hoeper MM, 2000, NEW ENGL J MED, V342, P1866, DOI 10.1056/NEJM200006223422503; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; MONCADA S, 1977, LANCET, V1, P18; NAMBA T, 1994, J BIOL CHEM, V269, P9986; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pola R, 2004, J MOL CELL CARDIOL, V36, P363, DOI 10.1016/j.yjmcc.2003.10.016; Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x; STURZEBECHER S, 1986, PROSTAGLANDINS, V31, P95, DOI 10.1016/0090-6980(86)90228-5; TOWN MH, 1982, PROSTAG OTH LIPID M, V24, P61, DOI 10.1016/0090-6980(82)90177-0; WHITTLE BJR, 1980, PROSTAGLANDINS, V19, P605, DOI 10.1016/S0090-6980(80)80010-4; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	29	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31473	31479		10.1074/jbc.M111.266023	http://dx.doi.org/10.1074/jbc.M111.266023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775429	hybrid, Green Published			2022-12-27	WOS:000294487500042
J	Levet-Paulo, M; Lazzaroni, JC; Gilbert, C; Atlan, D; Doublet, P; Vianney, A				Levet-Paulo, Melanie; Lazzaroni, Jean-Claude; Gilbert, Christophe; Atlan, Daniele; Doublet, Patricia; Vianney, Anne			The Atypical Two-component Sensor Kinase Lpl0330 from Legionella pneumophila Controls the Bifunctional Diguanylate Cyclase-Phosphodiesterase Lpl0329 to Modulate Bis-(3 '-5 ')-cyclic Dimeric GMP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-DI-GMP; BIOFILM FORMATION; HISTIDINE KINASE; SYSTEM; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; DETERMINANTS; TURNOVER; PROTEINS	A significant part of bacterial two-component system response regulators contains effector domains predicted to be involved in metabolism of bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP), a second messenger that plays a key role in many physiological processes. The intracellular level of c-di-GMP is controlled by diguanylate cyclase and phosphodiesterases activities associated with GGDEF and EAL domains, respectively. The Legionella pneumophila Lens genome displays 22 GGDEF/EAL domain-encoding genes. One of them, lpl0329, encodes a protein containing a two-component system receiver domain and both GGDEF and EAL domains. Here, we demonstrated that the GGDEF and EAL domains of Lpl0329 are both functional and lead to simultaneous synthesis and hydrolysis of c-di-GMP. Moreover, these two opposite activities are finely regulated by Lpl0329 phosphorylation due to the atypical histidine kinase Lpl0330. Indeed, Lpl0330 was found to autophosphorylate on a histidine residue in an atypical H box, which is conserved in various bacteria species and thus defines a new histidine kinase subfamily. Lpl0330 also catalyzes the phosphotranfer to Lpl0329, which results in a diguanylate cyclase activity decrease whereas phosphodiesterase activity remains efficient. Altogether, these data present (i) a new histidine kinase subfamily based on the conservation of an original H box that we named HGN H box, and (ii) the first example of a bifunctional enzyme that modulates synthesis and turnover of c-di-GMP in response to phosphorylation of its receiver domain.	[Levet-Paulo, Melanie; Lazzaroni, Jean-Claude; Gilbert, Christophe; Atlan, Daniele; Doublet, Patricia; Vianney, Anne] Univ Lyon 1, CNRS, Microbiol Adaptat & Pathogenie UMR5240, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vianney, A (corresponding author), UMR 5240, Bat Lwoff R 3,10 Rue Dubois, F-69622 Villeurbanne, France.	anne.vianney@univ-lyon1.fr	Vianney, Anne/L-9544-2014; Doublet, Patricia/L-9480-2014; Gilbert, Christophe/M-6005-2014	Doublet, Patricia/0000-0001-5848-4317; Gilbert, Christophe/0000-0003-3021-7350	Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council)	Supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barakat M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-315; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Bordeleau E, 2010, ENVIRON MICROBIOL, V12, P510, DOI 10.1111/j.1462-2920.2009.02094.x; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Galperin MY, 2007, METHOD ENZYMOL, V422, P47, DOI 10.1016/S0076-6879(06)22003-2; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gilles-Gonzalez MA, 2008, METHOD ENZYMOL, V437, P173, DOI 10.1016/S0076-6879(07)37010-9; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kenney LJ, 2010, CURR OPIN MICROBIOL, V13, P168, DOI 10.1016/j.mib.2010.01.013; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Lai TH, 2009, J BACTERIOL, V191, P693, DOI 10.1128/JB.01218-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez-Wilson HF, 2008, J BACTERIOL, V190, P6439, DOI 10.1128/JB.00541-08; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Wolanin PM, 2002, GENOME BIOL, V3	45	30	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31136	31144		10.1074/jbc.M111.231340	http://dx.doi.org/10.1074/jbc.M111.231340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757706	Green Published, hybrid			2022-12-27	WOS:000294487500008
J	O'Leary, H; Liu, WH; Rorabaugh, JM; Coultrap, SJ; Bayer, KU				O'Leary, Heather; Liu, Wallace H.; Rorabaugh, Jacki M.; Coultrap, Steven J.; Bayer, K. Ulrich			Nucleotides and Phosphorylation Bi-directionally Modulate Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Binding to the N-Methyl-D-aspartate (NMDA) Receptor Subunit GluN2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RATE-DETERMINING STEP; NR2B SUBUNIT; SYNAPTIC PLASTICITY; SELF-ASSOCIATION; INHIBITORY AUTOPHOSPHORYLATION; CATALYTIC SUBUNIT; DENDRITIC SPINES; MOLECULAR MEMORY; ALPHA-ACTININ	The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and the NMDA-type glutamate receptor are key regulators of synaptic plasticity underlying learning and memory. Direct binding of CaMKII to the NMDA receptor subunit GluN2B (formerly known as NR2B) (i) is induced by Ca2+/CaM but outlasts this initial Ca2+-stimulus, (ii) mediates CaMKII translocation to synapses, and (iii) regulates synaptic strength. CaMKII binds to GluN2B around S1303, the major CaMKII phosphorylation site on GluN2B. We show here that a phosphomimetic S1303D mutation inhibited CaM-induced CaMKII binding to GluN2B in vitro, presenting a conundrum how binding can occur within cells, where high ATP concentration should promote S1303 phosphorylation. Surprisingly, addition of ATP actually enhanced the binding. Mutational analysis revealed that this positive net effect was caused by four modulatory effects of ATP, two positive (direct nucleotide binding and CaMKII T286 autophosphorylation) and two negative (GluN2B S1303 phosphorylation and CaMKII T305/6 autophosphorylation). Imaging showed positive regulation by nucleotide binding also within transfected HEK cells and neurons. In fact, nucleotide binding was a requirement for efficient CaMKII interaction with GluN2B in cells, while T286 autophosphorylation was not. Kinetic considerations support a model in which positive regulation by nucleotide binding and T286 autophosphorylation occurs faster than negative modulation by GluN2B S1303 and CaMKII T305/6 phosphorylation, allowing efficient CaMKII binding to GluN2B despite the inhibitory effects of the two slower reactions.	[O'Leary, Heather; Liu, Wallace H.; Rorabaugh, Jacki M.; Coultrap, Steven J.; Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu			National Institutes of Health [T32GM007635, R01NS052644]; National Institutes of Health (UCD Center) [P30NS048154]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154, R01NS052644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (UCD Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported, in whole or in part, by National Institutes of Health Grants T32GM007635 (to H. O'L., W. H. L., and J. M. R.), P30NS048154 (UCD Center Grant), and R01NS052644 (to K. U. B.).	Aubol BE, 2003, BIOCHEMISTRY-US, V42, P12813, DOI 10.1021/bi035200c; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BHATNAGAR D, 1983, BIOCHEMISTRY-US, V22, P6310, DOI 10.1021/bi00295a042; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Cheriyan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016495; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; KITAMURA Y, 1993, J NEUROCHEM, V61, P100, DOI 10.1111/j.1471-4159.1993.tb03542.x; KOLAJ M, 1994, J NEUROPHYSIOL, V72, P2525, DOI 10.1152/jn.1994.72.5.2525; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Vest RS, 2009, FEBS LETT, V583, P3577, DOI 10.1016/j.febslet.2009.10.028; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	63	47	48	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31272	31281		10.1074/jbc.M111.233668	http://dx.doi.org/10.1074/jbc.M111.233668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768120	Green Published, hybrid			2022-12-27	WOS:000294487500022
J	Pamren, A; Wanngren, J; Tjernberg, LO; Winblad, B; Bhat, R; Naslund, J; Karlstrom, H				Pamren, Annelie; Wanngren, Johanna; Tjernberg, Lars O.; Winblad, Bengt; Bhat, Ratan; Naslund, Jan; Karlstrom, Helena			Mutations in Nicastrin Protein Differentially Affect Amyloid beta-Peptide Production and Notch Protein Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; INTRAMEMBRANE PROTEOLYSIS; PRECURSOR PROTEIN; ALZHEIMER-DISEASE; PRESENILIN; COMPLEX; PEN-2; IDENTIFICATION; TRAFFICKING; MECHANISM	The gamma-secretase complex is responsible for intramembrane processing of over 60 substrates and is involved in Notch signaling as well as in the generation of the amyloid beta-peptide (A beta). Aggregated forms of A beta have a pathogenic role in Alzheimer disease and, thus, reducing the A beta levels by inhibiting gamma-secretase is a possible treatment strategy for Alzheimer disease. Regrettably, clinical trials have shown that inhibition of gamma-secretase results in Notch-related side effects. Therefore, it is of great importance to find ways to inhibit amyloid precursor protein (APP) processing without disturbing vital signaling pathways such as Notch. Nicastrin (Nct) is part of the gamma-secretase complex and has been proposed to be involved in substrate recognition and selection. We have investigated how the four evenly spaced and conserved cysteine residues in the Nct ectodomain affect APP and Notch processing. We mutated these cysteines to serines and analyzed them in cells lacking endogenous Nct. We found that two mutants, C213S (C2) and C230S (C3), differentially affected APP and Notch processing. Both the formation of A beta and the intracellular domain of amyloid precursor protein (AICD) were reduced, whereas the production of Notch intracellular domain (NICD) was maintained on a high level, although C230S (C3) showed impaired complex assembly. Our data demonstrate that single residues in a gamma-secretase component besides presenilin are able to differentially affect APP and Notch processing.	[Pamren, Annelie; Wanngren, Johanna; Tjernberg, Lars O.; Winblad, Bengt; Karlstrom, Helena] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Novum, Alzheimer Dis Res Ctr, SE-14186 Stockholm, Sweden; [Bhat, Ratan; Naslund, Jan] AstraZeneca CNS, Pain Res Area, SE-15185 Sodertalje, Sweden	Karolinska Institutet; AstraZeneca	Karlstrom, H (corresponding author), Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Novum, 5th Fl, SE-14157 Stockholm, Sweden.	Helena.Karlstrom@ki.se		Karlstrom, Helena/0000-0002-0498-2473	Swedish Brain Power; Wallenberg's Foundation; Loo och Hans Ostermans Stiftelse; Stiftelsen Gamla Tjanarinnor; KI stiftelsen for aldersforskning; Swedish Medical Society; Gun och Bertil Stohnes Stiftelse; Strategic Research Area: Neuroscience [2009-1077]	Swedish Brain Power; Wallenberg's Foundation; Loo och Hans Ostermans Stiftelse; Stiftelsen Gamla Tjanarinnor; KI stiftelsen for aldersforskning; Swedish Medical Society; Gun och Bertil Stohnes Stiftelse; Strategic Research Area: Neuroscience	This work was supported by grants from Swedish Brain Power, Wallenberg's Foundation, Loo och Hans Ostermans Stiftelse, Stiftelsen Gamla Tjanarinnor, KI stiftelsen for aldersforskning, Swedish Medical Society, Gun och Bertil Stohnes Stiftelse, and Strategic Research Area: Neuroscience (Regulation Number 2009-1077).	Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Franberg J, 2011, BIOCHEM BIOPH RES CO, V404, P564, DOI 10.1016/j.bbrc.2010.12.029; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li T, 2003, J NEUROSCI, V23, P3272; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Morais VA, 2008, FEBS LETT, V582, P427, DOI 10.1016/j.febslet.2008.01.003; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Teranishi Y, 2010, J CELL MOL MED, V14, P2675, DOI 10.1111/j.1582-4934.2009.00907.x; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	33	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31153	31158		10.1074/jbc.C111.235267	http://dx.doi.org/10.1074/jbc.C111.235267			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768095	hybrid, Green Published			2022-12-27	WOS:000294487500010
J	Wang, Y; Huang, YX; Xue, CL; He, Y; He, ZG				Wang, Yi; Huang, Yuanxia; Xue, Chaolun; He, Yang; He, Zheng-Guo			ClpR Protein-like Regulator Specifically Recognizes RecA Protein-independent Promoter Motif and Broadly Regulates Expression of DNA Damage-inducible Genes in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM-GLUTAMICUM; FACTOR SIGMA(H); TUBERCULOSIS; CLGR; TRANSCRIPTION; IDENTIFICATION; NETWORKS; SURVIVAL; SYSTEM; REPAIR	The RecA-dependent DNA damage response pathway (SOS response) appears to be the major DNA repair mechanism in most bacteria, but it has been suggested that a RecA-independent mechanism is responsible for controlling expression of most damage-inducible DNA repair genes in Mycobacterium tuberculosis. The specific reparative responses and molecular mediators involved in the DNA repair mechanism remain largely unclear in this pathogen and its related species. In this study, a mycobacterial ClpR-like regulator, corresponding to Rv2745c in M. tuberculosis and to Ms2694 in M. smegmatis mc(2)155, was found to interact with the promoter regions of multiple damage-inducible DNA repair genes. Specific binding of the ClpR-like factor to the conserved RecA-independent promoter RecA-NDp motif was then confirmed using in vitro electrophoretic mobility shift assays as well as in vivo chromatin immunoprecipitation experiments. The ClpR knock-out experiments, in combination with quantitative real time PCR assays, demonstrated that the expression of these RecA-independent genes were significantly down-regulated in the mutant strain of M. smegmatis in response to a DNA-damaging agent compared with the wild type strain. Furthermore, the ClpR-like factor was shown to contribute to mycobacterial genomic stability. These results enhance our understanding of the function of the ClpR regulator and the regulatory mechanism of RecA-independent DNA repair in mycobacteria.	[Wang, Yi; Huang, Yuanxia; Xue, Chaolun; He, Yang; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014		National Natural Science Foundation of China [30930003, 31025002]; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Chutian Scholar Program	This work was supported by the National Natural Science Foundation of China (Grants 30930003 and 31025002) and the Hubei Chutian Scholar Program (to Z.-G. H.).	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Baumbach J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-24; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Brooks PC, 2006, J BACTERIOL, V188, P6034, DOI 10.1128/JB.00340-06; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; Dawson LF, 2010, J BACTERIOL, V192, P599, DOI 10.1128/JB.01066-09; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Krawczyk J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp453; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1982, BIOCHIMIE, V64, P585, DOI 10.1016/S0300-9084(82)80092-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rauch PJG, 1996, MICROBIOL-UK, V142, P1025, DOI 10.1099/00221287-142-4-1025; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; World Health Organization, 2010, GLOB TUB CONTR REP 2; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672	36	36	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31159	31167		10.1074/jbc.M111.241802	http://dx.doi.org/10.1074/jbc.M111.241802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771781	Green Published, hybrid			2022-12-27	WOS:000294487500011
J	Alvarez, D; Briassouli, P; Clancy, RM; Zavadil, J; Reed, JH; Abellar, RG; Halushka, M; Fox-Talbot, K; Barrat, FJ; Buyon, JP				Alvarez, David; Briassouli, Paraskevi; Clancy, Robert M.; Zavadil, Jiri; Reed, Joanne H.; Abellar, Rosanna G.; Halushka, Marc; Fox-Talbot, Karen; Barrat, Franck J.; Buyon, Jill P.			A Novel Role of Endothelin-1 in Linking Toll-like Receptor 7-mediated Inflammation to Fibrosis in Congenital Heart Block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC FIBROBLAST PROLIFERATION; GROWTH-FACTOR BETA-1; PROTEIN-KINASE-C; TGF-BETA; MYOCARDIAL-INFARCTION; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; MATURE PEPTIDE; SSA/RO-SSB/LA; ANTI-SSA/RO	Autoimmune associated congenital heart block (CHB) may result from pathogenic cross-talk between inflammatory and profibrosing pathways. Incubation of macrophages with immune complexes (IC) composed of Ro60, a target of the pathologic maternal autoantibodies necessary for CHB, hY3 ssRNA, and affinity-purified anti-Ro60 antibody induces the Toll-like receptor 7 (TLR7)-dependent generation of supernatants that provoke a fibrosing phenotype in human fetal cardiac fibroblasts. We show herein that these cells are a major source of TGF beta and that endothelin-1 (ET-1) is one of the key components responsible for the profibrosing effects generated by stimulated macrophages. Supernatants from macrophages incubated with IC induced the fibroblast secretion of TGF beta, which was inhibited by treating the macrophages with an antagonist of TLR7. Under the same conditions, the induced fibroblast secretion of TGF beta was decreased by inhibitors of the ET-1 receptors ETa or ETb or by an anti-ET-1 antibody but not by an isotype control. Exogenous ET-1 induced a profibrosing phenotype, whereas fibroblasts transfected with either ETa or ETb siRNA were unresponsive to the profibrosing effects of the IC-generated macrophage supernatants. Immunohistochemistry of the hearts from two fetuses dying with CHB revealed the presence of ET-1-producing mononuclear cells in the septal region in areas of calcification and fibrosis. In conclusion, these data support a novel role of ET-1 in linking TLR7 inflammatory signaling to subsequent fibrosis and provide new insight in considering therapeutics for CHB.	[Alvarez, David; Briassouli, Paraskevi; Clancy, Robert M.; Zavadil, Jiri; Reed, Joanne H.; Buyon, Jill P.] NYU, Med Ctr, New York, NY 10016 USA; [Abellar, Rosanna G.] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Barrat, Franck J.] Dynavax Technol, Berkeley, CA 94710 USA; [Halushka, Marc; Fox-Talbot, Karen] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	New York University; Columbia University; Johns Hopkins University; Johns Hopkins Medicine	Buyon, JP (corresponding author), 560 1st Ave,TH-407, New York, NY 10016 USA.	Jill.Buyon@nyumc.org	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Halushka, Marc/0000-0002-7112-7389; Reed, Joanne/0000-0002-7585-7848; Buyon, Jill/0000-0002-3852-7129	National Institutes of Health [AR-42455, N01-AR-4-2271]; Mary Kirkland Center for Lupus Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042455, R37AR042455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Kirkland Center for Lupus Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-42455 and N01-AR-4-2271 and a grant from the Mary Kirkland Center for Lupus Research.	Asano K, 2002, J MOL CELL CARDIOL, V34, P833, DOI 10.1006/jmcc.2002.2022; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C; Buyon JP, 2005, AUTOIMMUN REV, V4, P1, DOI 10.1016/j.autrev.2004.04.003; Buyon JP, 2007, DUBOIS LUPUS ERYTHEM, P1058; Cambiaggi C, 2001, CYTOKINE, V14, P230, DOI 10.1006/cyto.2001.0865; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Clancy RM, 2004, ARTHRITIS RHEUM, V50, P173, DOI 10.1002/art.11430; Clancy RM, 2003, J IMMUNOL, V171, P3253, DOI 10.4049/jimmunol.171.6.3253; Clancy RM, 2002, J IMMUNOL, V169, P2156, DOI 10.4049/jimmunol.169.4.2156; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; Clancy RM, 2010, J IMMUNOL, V184, P2148, DOI 10.4049/jimmunol.0902248; Divino JN, 2010, VET IMMUNOL IMMUNOP, V136, P127, DOI 10.1016/j.vetimm.2010.02.006; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; GRUSCHWITZ M, 1990, J INVEST DERMATOL, V94, P197, DOI 10.1111/1523-1747.ep12874503; GUARDA E, 1993, CARDIOVASC RES, V27, P2130, DOI 10.1093/cvr/27.12.2130; Hafizi S, 2004, CELL PHYSIOL BIOCHEM, V14, P285, DOI 10.1159/000080338; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Katwa LC, 2003, AM J PHYSIOL-HEART C, V285, pH1132, DOI 10.1152/ajpheart.01141.2002; Kuruvilla L, 2007, CELL BIOCHEM BIOPHYS, V47, P65, DOI 10.1385/CBB:47:1:65; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; Massai L, 2003, AM J PHYSIOL-GASTR L, V284, pG340, DOI 10.1152/ajpgi.00262.2002; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Miranda-Carus ME, 1998, J IMMUNOL, V161, P5886; Nield LE, 2002, J AM COLL CARDIOL, V40, P796, DOI 10.1016/S0735-1097(02)02004-1; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Ogata T, 2004, J CARDIOVASC PHARM, V44, pS279, DOI 10.1097/01.fjc.0000166274.24797.0e; PELTONEN J, 1990, J INVEST DERMATOL, V94, P365, DOI 10.1111/1523-1747.ep12874491; Piacentini L, 2000, J MOL CELL CARDIOL, V32, P565, DOI 10.1006/jmcc.2000.1109; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Spirig R, 2009, MOL IMMUNOL, V46, P3178, DOI 10.1016/j.molimm.2009.05.179; Teder P, 2000, AM J RESP CELL MOL, V23, P7, DOI 10.1165/ajrcmb.23.1.f192; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Xu SW, 2001, J INVEST DERMATOL, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x; Zolk O, 1999, CIRCULATION, V99, P2118, DOI 10.1161/01.CIR.99.16.2118	45	43	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30444	30454		10.1074/jbc.M111.263657	http://dx.doi.org/10.1074/jbc.M111.263657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730058	Green Published, hybrid			2022-12-27	WOS:000294283600023
J	Isakov, E; Stanhill, A				Isakov, Elada; Stanhill, Ariel			Stalled Proteasomes Are Directly Relieved by P97 Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; AAA-ATPASE CDC48/P97; 26 S PROTEASOME; ASSEMBLY PATHWAY; DEGRADATION; RECOGNITION; PARTICLE; COMPLEX; PROTEOTOXICITY; IDENTIFICATION	The 26 S proteasome is the eukaryotic protease responsible for the degradation of most cellular proteins. As such it accommodates the ability to function under diverse conditions that the cell may encounter. This function is supported by various adaptors that modulate various aspects in protein degradation, these include regulation of substrate delivery, deubiquitination, unfolding, and 20 S gate dilation. Here we show a new functional complex between the P97 and the proteasome that is assembled in response to proteasomal impairment. This entails P97 binding to the 26 S proteasome via the 19 S particle thereby forming an additional hexameric ATPase ring to relieve repression. P97-bound proteasomes showed selective binding toward the Npl4-ufd1 P97 co-factors, indicating a unique cellular role for P97 binding to proteasomes. P97-bound proteasomes display enhanced activity, showing a relief in proteolysis impairment. Our findings place P97 directly in non-ERAD proteasomal functions and establish a new checkpoint in UPS impairment. The ability to modulate proteasome activity and properly respond to protein misfolding, is of great importance in cellular regulation.	[Isakov, Elada; Stanhill, Ariel] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Stanhill, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	stanhill@tx.technion.ac.il		stanhill, ariel/0000-0002-0318-2212	Israeli Science Foundation [ISF 497/08]; ERC; Brain Power for Israel Foundation	Israeli Science Foundation(Israel Science Foundation); ERC(European Research Council (ERC)European Commission); Brain Power for Israel Foundation	This work was supported by the Israeli Science Foundation (ISF 497/08), ERC-FP7-IRG (to A. S.), and the Brain Power for Israel Foundation (to E. I.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Baumeister W, 1997, CURR OPIN STRUC BIOL, V7, P273, DOI 10.1016/S0959-440X(97)80036-X; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; MA CP, 1992, J BIOL CHEM, V267, P10515; Macario AJL, 2007, FRONT BIOSCI-LANDMRK, V12, P2588, DOI 10.2741/2257; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Meyer H, 2010, BIOCHEM CELL BIOL, V88, P23, DOI [10.1139/o09-119, 10.1139/O09-119]; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wilk S, 2000, ARCH BIOCHEM BIOPHYS, V383, P265, DOI 10.1006/abbi.2000.2086; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	48	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30274	30283		10.1074/jbc.M111.240309	http://dx.doi.org/10.1074/jbc.M111.240309			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733848	Green Published, hybrid			2022-12-27	WOS:000294283600005
J	Kireeva, ML; Domecq, C; Coulombe, B; Burton, ZF; Kashlev, M				Kireeva, Maria L.; Domecq, Celine; Coulombe, Benoit; Burton, Zachary F.; Kashlev, Mikhail			Interaction of RNA Polymerase II Fork Loop 2 with Downstream Non-template DNA Regulates Transcription Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NTP-DRIVEN TRANSLOCATION; STRUCTURAL BASIS; ACTIVE-SITE; NUCLEOSIDE TRIPHOSPHATES; ALLOSTERIC BINDING; COMPLEX; RESOLUTION; MECHANISM; CATALYSIS; DYNAMICS	Fork loop 2 is a small semiconservative segment of the larger fork domain in the second largest Rpb2 subunit of RNA polymerase II (Pol II). This flexible loop, juxtaposed at the leading edge of transcription bubble, has been proposed to participate in DNA strand separation, translocation along DNA, and NTP loading to Pol II during elongation. Here we show that the Rpb2 mutant carrying a deletion of the flexible part of the loop is not lethal in yeast. The mutation exhibits no defects in DNA melting and translocation in vitro but confers a moderate decrease of the catalytic activity of the enzyme caused by the impaired sequestration of the NTP substrate in the active center prior to catalysis. In the structural model of the Pol II elongation complex, fork loop 2 directly interacts with an unpaired DNA residue in the non-template DNA strand one nucleotide ahead from the active center (the i + 2 position). We showed that elimination of this putative interaction by replacement of the i + 2 residue with an abasic site inhibits Pol II activity to the same degree as the deletion of fork loop 2. This replacement has no detectable effect on the activity of the mutant enzyme. We provide direct evidence that interaction of fork loop 2 with the non-template DNA strand facilitates NTP sequestration through interaction with the adjacent segment of the fork domain involved in the active center of Pol II.	[Kireeva, Maria L.; Kashlev, Mikhail] NCI Frederick, NIH, Ctr Canc Res, Frederick, MD 21702 USA; [Domecq, Celine; Coulombe, Benoit] Univ Montreal, Gene Transcript & Prote Lab, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Domecq, Celine; Coulombe, Benoit] Univ Montreal, Dept Biochem, Montreal, PQ H2W 1R7, Canada; [Burton, Zachary F.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Michigan State University	Kashlev, M (corresponding author), NCI Frederick, NIH, Ctr Canc Res, Frederick, MD 21702 USA.	kashlevm@mail.nih.gov	Kireeva, Maria/B-4391-2018	Kireeva, Maria/0000-0003-0527-3182	National Institutes of Health [R01 GM 092949]; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 092949 (to Z.F.B.).	Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burton ZF, 2005, BIOCHEM CELL BIOL, V83, P486, DOI 10.1139/O05-059; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Domecq C, 2010, PROTEIN EXPRES PURIF, V69, P83, DOI 10.1016/j.pep.2009.06.016; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Erie DA, 2009, CURR OPIN STRUC BIOL, V19, P708, DOI 10.1016/j.sbi.2009.10.008; Feig M, 2010, BIOPHYS J, V99, P2577, DOI 10.1016/j.bpj.2010.08.010; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Fujita T, 2010, J RECEPT SIG TRANSD, V30, P31, DOI 10.3109/10799890903517921; Garland CS, 1999, BIOCHEMISTRY-US, V38, P3421, DOI 10.1021/bi9820098; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Jovanovic M, 2011, J BIOL CHEM, V286, P14469, DOI 10.1074/jbc.M110.212902; Kashkina E, 2007, J BIOL CHEM, V282, P21578, DOI 10.1074/jbc.C700098200; Kennedy SR, 2011, P NATL ACAD SCI USA, V108, P6079, DOI 10.1073/pnas.1011274108; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva M, 2009, METHODS, V48, P333, DOI 10.1016/j.ymeth.2009.04.008; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Langelier MF, 2005, NUCLEIC ACIDS RES, V33, P2629, DOI 10.1093/nar/gki570; Meyer PA, 2009, J BIOL CHEM, V284, P12933, DOI 10.1074/jbc.M809199200; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Palangat M, 2004, J MOL BIOL, V341, P429, DOI 10.1016/j.jmb.2004.06.009; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Seibold SA, 2010, BBA-GENE REGUL MECH, V1799, P575, DOI 10.1016/j.bbagrm.2010.05.002; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; TELESNITSKY A, 1989, BIOCHEMISTRY-US, V28, P5210, DOI 10.1021/bi00438a044; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070	44	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30898	30910		10.1074/jbc.M111.260844	http://dx.doi.org/10.1074/jbc.M111.260844			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730074	hybrid, Green Published			2022-12-27	WOS:000294283600069
J	Xue, J; Graham, ME; Novelle, AE; Sue, N; Gray, N; McNiven, MA; Smillie, KJ; Cousin, MA; Robinson, PJ				Xue, Jing; Graham, Mark E.; Novelle, Aimee E.; Sue, Nancy; Gray, Noah; McNiven, Mark A.; Smillie, Karen J.; Cousin, Michael A.; Robinson, Phillip J.			Calcineurin Selectively Docks with the Dynamin Ixb Splice Variant to Regulate Activity-dependent Bulk Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; ACTIVATED T-CELLS; NERVE-TERMINALS; PHOSPHATASE-ACTIVITY; CHROMAFFIN CELLS; CENTRAL SYNAPSES; BINDING PROTEIN; NUCLEAR FACTOR; PHOSPHORYLATION; CALCIUM	Depolarization of nerve terminals stimulates rapid dephosphorylation of two isoforms of dynamin I (dynI), mediated by the calcium-dependent phosphatase calcineurin (CaN). Dephosphorylation at the major phosphorylation sites Ser-774/778 promotes a dynI-syndapin I interaction for a specific mode of synaptic vesicle endocytosis called activity-dependent bulk endocytosis (ADBE). DynI has two main splice variants at its extreme C terminus, long or short (dynIxa and dynIxb) varying only by 20 (xa) or 7 (xb) residues. Recombinant GST fusion proteins of dynIxa and dynIxb proline-rich domains (PRDs) were used to pull down interacting proteins from rat brain nerve terminals. Both bound equally to syndapin, but dynIxb PRD exclusively bound to the catalytic subunit of CaNA, which recruited CaNB. Binding of CaN was increased in the presence of calcium and was accompanied by further recruitment of calmodulin. Point mutations showed that the entire C terminus of dynIxb is a CaN docking site related to a conserved CaN docking motif (PXIXI(T/S)). This sequence is unique to dynIxb among all other dynamin variants or genes. Peptide mimetics of the dynIxb tail blocked CaN binding in vitro and selectively inhibited depolarization-evoked dynI dephosphorylation in nerve terminals but not of other dephosphins. Therefore, docking to dynIxb is required for the regulation of both dynI splice variants, yet it does not regulate the phosphorylation cycle of other dephosphins. The peptide blocked ADBE, but not clathrin-mediated endocytosis of synaptic vesicles. Our results indicate that Ca2+ influx regulates assembly of a fully active CaN-calmodulin complex selectively on the tail of dynIxb and that the complex is recruited to sites of ADBE in nerve terminals.	[Xue, Jing; Graham, Mark E.; Novelle, Aimee E.; Sue, Nancy; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia; [Gray, Noah; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Smillie, Karen J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Membrane Biol Grp, Edinburgh EH8 9XD, Midlothian, Scotland	Children's Medical Research Institute - Australia; University of Sydney; Mayo Clinic; University of Edinburgh	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.	probinson@cmri.org.au	Robinson, Phillip J/G-4008-2011; Graham, Mark E/A-6480-2014	Robinson, Phillip J/0000-0002-7878-0313; Graham, Mark E/0000-0002-7290-1217; Gray, Noah/0000-0002-4672-7403; Smillie, Karen/0000-0003-4369-0470; Cousin, Michael/0000-0002-1762-160X	NHMRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank Alan Prescott and John James for help with the electron microscopy analysis and the NHMRC for financial support.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V., 2009, ENCY NEUROSCIENCE; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Chan SA, 2003, PFLUG ARCH EUR J PHY, V445, P540, DOI 10.1007/s00424-002-0966-y; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Cheung G, 2010, J NEUROSCI, V30, P8151, DOI 10.1523/JNEUROSCI.0293-10.2010; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; LAPOINTE MC, 1990, HYPERTENSION, V15, P20, DOI 10.1161/01.HYP.15.1.20; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; ROBINSON PJ, 1985, J NEUROCHEM, V44, P338, DOI 10.1111/j.1471-4159.1985.tb05422.x; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Ruiz-Velasco V, 1998, CIRC RES, V82, P557, DOI 10.1161/01.RES.82.5.557; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Song HO, 2010, MOL CELLS, V30, P255, DOI 10.1007/s10059-010-0116-x; Stemmer P, 1991, Curr Opin Neurobiol, V1, P53, DOI 10.1016/0959-4388(91)90010-5; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	58	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30295	30303		10.1074/jbc.M111.273110	http://dx.doi.org/10.1074/jbc.M111.273110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730063	Green Published, hybrid			2022-12-27	WOS:000294283600007
J	Ewen, EP; Snyder, CM; Wilson, M; Desjardins, D; Naya, FJ				Ewen, Elizabeth P.; Snyder, Christine M.; Wilson, Megan; Desjardins, Danielle; Naya, Francisco J.			The Mef2A Transcription Factor Coordinately Regulates a Costamere Gene Program in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; STRIATED-MUSCLE; C-JUN; TARGET; EXPRESSION; ENHANCER; ANOIKIS; PROTEIN; MICE; CARDIOMYOCYTES	The Mef2 family of transcription factors regulates muscle differentiation, but the specific gene programs controlled by each member remain unknown. Characterization of Mef2A knockout mice has revealed severe myofibrillar defects in cardiac muscle indicating a requirement for Mef2A in cytoarchitectural integrity. Through comprehensive expression analysis of Mef2A-deficient hearts, we identified a cohort of dysregulated genes whose products localize to the peripheral Z-disc/costamere region. Many of these genes are essential for costamere integrity and function. Here we demonstrate that these genes are directly regulated by Mef2A, establishing a mechanism by which Mef2A controls the costamere. In an independent model system, acute knockdown of Mef2A in primary neonatal cardiomyocytes resulted in profound malformations of myofibrils and focal adhesions accompanied by adhesion-dependent programmed cell death. These findings indicate a role for Mef2A in cardiomyocyte survival through regulation of costamere integrity. Finally, bioinformatics analysis identified over-represented transcription factor-binding sites in this network of costamere promoters that may provide insight into the mechanism by which costamere genes are regulated by Mef2A. The global control of costamere gene expression adds another dimension by which this essential macromolecular complex may be regulated in health and disease.	[Ewen, Elizabeth P.; Snyder, Christine M.; Wilson, Megan; Desjardins, Danielle; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 24 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health Grant (to F. J. N.).	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Klamut HJ, 1997, NUCLEIC ACIDS RES, V25, P1618, DOI 10.1093/nar/25.8.1618; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068	37	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29644	29653		10.1074/jbc.M111.268094	http://dx.doi.org/10.1074/jbc.M111.268094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724844	Green Published, hybrid			2022-12-27	WOS:000294046600023
J	Friedman, EJ; Wang, HX; Jiang, K; Perovic, I; Deshpande, A; Pochapsky, TC; Temple, BRS; Hicks, SN; Harden, TK; Jones, AM				Friedman, Erin J.; Wang, Helen X.; Jiang, Kun; Perovic, Iva; Deshpande, Aditi; Pochapsky, Thomas C.; Temple, Brenda R. S.; Hicks, Stephanie N.; Harden, T. Kendall; Jones, Alan M.			Acireductone Dioxygenase 1 (ARD1) Is an Effector of the Heterotrimeric G Protein beta Subunit in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SALVAGE PATHWAY; KLEBSIELLA-PNEUMONIAE; MOLECULAR-BASIS; GAMMA-SUBUNITS; CELL-DIVISION; EXPRESSION; IDENTIFICATION; RESISTANCE; THALIANA; ENZYMES	Heterotrimeric G protein complexes are conserved from plants to mammals, but the complexity of each system varies. Arabidopsis thaliana contains one G alpha, one G beta (AGB1), and at least three G gamma subunits, allowing it to form three versions of the heterotrimer. This plant model is ideal for genetic studies because mammalian systems contain hundreds of unique heterotrimers. The activation of these complexes promotes interactions between both the G alpha subunit and the G beta gamma dimer with enzymes and scaffolds to propagate signaling to the cytoplasm. However, although effectors of G alpha and G beta are known in mammals, no G beta effectors were previously known in plants. Toward identifying AGB1 effectors, we genetically screened for dominant mutations that suppress G beta-null mutant (agb1-2) phenotypes. We found that overexpression of acireductone dioxygenase 1 (ARD1) suppresses the 2-day-old etiolated phenotype of agb1-2. ARD1 is homologous to prokaryotic and eukaryotic ARD proteins; one function of ARDs is to operate in the methionine salvage pathway. We show here that ARD1 is an active metalloenzyme, and AGB1 and ARD1 both control embryonic hypocotyl length by modulating cell division; they also may contribute to the production of ethylene, a product of the methionine salvage pathway. ARD1 physically interacts with AGB1, and ARD enzymatic activity is stimulated by AGB1 in vitro. The binding interface on AGB1 was deduced using a comparative evolutionary approach and tested using recombinant AGB1 mutants. A possible mechanism for AGB1 activation of ARD1 activity was tested using directed mutations in a loop near the substrate-binding site.	[Friedman, Erin J.; Wang, Helen X.; Jiang, Kun; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hicks, Stephanie N.; Harden, T. Kendall; Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Harden, T. Kendall] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perovic, Iva; Pochapsky, Thomas C.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Deshpande, Aditi] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Wang, Helen X.] SmileNature Corp, San Diego, CA 92129 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Brandeis University; Brandeis University	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu		Pochapsky, Thomas/0000-0001-8995-1088	National Institutes of Health from NIGMS [R01GM065989, R01-GM44191]; Department of Energy [DE-FG02-05er15671]; National Science Foundation [MCB-0723515, MCB -0718202]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044191, R01GM065989] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM065989 from NIGMS (to the A.M.J. laboratory) and Grant R01-GM44191 (to the T. C. P. laboratory). This work was also supported by Department of Energy Grant DE-FG02-05er15671 and National Science Foundation Grants MCB-0723515 and MCB -0718202.	Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Burstenbinder K, 2010, PLANT J, V62, P977, DOI 10.1111/j.1365-313X.2010.04211.x; Chai SC, 2008, BIOCHEMISTRY-US, V47, P2428, DOI 10.1021/bi7004152; CHAKRAVORTY D, 2011, PLANT J IN PRESS; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; Dai Y, 2001, BIOCHEMISTRY-US, V40, P6379, DOI 10.1021/bi010110y; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gotoh I, 2007, GENES CELLS, V12, P105, DOI 10.1111/j.1365-2443.2006.01035.x; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Ju TT, 2006, J MOL BIOL, V363, P823, DOI 10.1016/j.jmb.2006.08.060; Kim JH, 2008, PLANT CELL PHYSIOL, V49, P1627, DOI 10.1093/pcp/pcn115; Lin T, 2005, GENE, V360, P27, DOI 10.1016/j.gene.2005.07.017; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Oram SW, 2007, NEOPLASIA, V9, P643, DOI 10.1593/neo.07415; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Pochapsky TC, 2006, J BIOMOL NMR, V34, P117, DOI 10.1007/s10858-005-5735-8; Pochapsky TC, 2002, NAT STRUCT BIOL, V9, P966, DOI 10.1038/nsb863; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sauter M, 2005, PLANT J, V44, P718, DOI 10.1111/j.1365-313X.2005.02564.x; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sundin AM, 2002, J CHROMATOGR B, V766, P115, DOI 10.1016/S0378-4347(01)00460-1; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Woeste K, 1998, PHILOS T ROY SOC B, V353, P1431, DOI 10.1098/rstb.1998.0298; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147; Xu QP, 2006, PROTEINS, V64, P808, DOI 10.1002/prot.20947; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang LG, 2008, DEV BIOL, V324, P68, DOI 10.1016/j.ydbio.2008.09.008; Zhang YL, 2004, BIOORGAN MED CHEM, V12, P3847, DOI 10.1016/j.bmc.2004.05.002	40	92	94	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30107	30118		10.1074/jbc.M111.227256	http://dx.doi.org/10.1074/jbc.M111.227256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712381	hybrid, Green Published			2022-12-27	WOS:000294046600068
J	Matoba, Y; Bando, N; Oda, K; Noda, M; Higashikawa, F; Kumagai, T; Sugiyama, M				Matoba, Yasuyuki; Bando, Naohiko; Oda, Kosuke; Noda, Masafumi; Higashikawa, Fumiko; Kumagai, Takanori; Sugiyama, Masanori			A Molecular Mechanism for Copper Transportation to Tyrosinase That Is Assisted by a Metallochaperone, Caddie Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; STREPTOMYCES-CASTANEOGLOBISPORUS; HEMOCYANIN; RESOLUTION; GENE; INHIBITORS; BIOLOGY; MODEL	The Cu(II)-soaked crystal structure of tyrosinase that is present in a complex with a protein, designated "caddie," which we previously determined, possesses two copper ions at its catalytic center. We had identified two copper-binding sites in the caddie protein and speculated that copper bound to caddie may be transported to the tyrosinase catalytic center. In our present study, at a 1.16-1.58 angstrom resolution, we determined the crystal structures of tyrosinase complexed with caddie prepared by altering the soaking time of the copper ion and the structures of tyrosinase complexed with different caddie mutants that display little or no capacity to activate tyrosinase. Based on these structures, we propose a molecular mechanism by which two copper ions are transported to the tyrosinase catalytic center with the assistance of caddie acting as a metallochaperone.	[Matoba, Yasuyuki; Bando, Naohiko; Oda, Kosuke; Noda, Masafumi; Higashikawa, Fumiko; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University	Sugiyama, M (corresponding author), Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp	ODA, KOSUKE/ABD-2610-2021; Johnson, Michael D. L./B-4352-2012		National Project on Protein Structural and Functional Analyses, Japan; Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [22790068] Funding Source: KAKEN	National Project on Protein Structural and Functional Analyses, Japan; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Project on Protein Structural and Functional Analyses, Japan (to M.S.) and a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan (to M.S. and Y.M.).	BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bubacco L, 2007, ARCH BIOCHEM BIOPHYS, V465, P320, DOI 10.1016/j.abb.2007.07.008; CHEN LY, 1992, J BIOL CHEM, V267, P20100; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Decker H, 2006, ANGEW CHEM INT EDIT, V45, P4546, DOI 10.1002/anie.200601255; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; HAZES B, 1993, PROTEIN SCI, V2, P597; Ikeda K, 1996, APPL MICROBIOL BIOT, V45, P80, DOI 10.1007/s002530050652; Jeon HJ, 2006, J AGR FOOD CHEM, V54, P9827, DOI 10.1021/jf062315p; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kohashi PY, 2004, PROTEIN EXPRES PURIF, V34, P202, DOI 10.1016/j.pep.2003.11.015; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; LEE YHW, 1988, GENE, V65, P71, DOI 10.1016/0378-1119(88)90418-0; Low C, 2010, J MOL BIOL, V398, P375, DOI 10.1016/j.jmb.2010.03.014; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Remaut H, 2001, J BIOL CHEM, V276, P49365, DOI 10.1074/jbc.M108304200; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; WOOLERY GL, 1984, BIOCHIM BIOPHYS ACTA, V788, P155, DOI 10.1016/0167-4838(84)90257-7	30	36	37	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30219	30231		10.1074/jbc.M111.256818	http://dx.doi.org/10.1074/jbc.M111.256818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730070	Green Published, hybrid			2022-12-27	WOS:000294046600079
J	Samak, G; Narayanan, D; Jaggar, JH; Rao, R				Samak, Geetha; Narayanan, Damodaran; Jaggar, Jonathan H.; Rao, RadhaKrishna			Ca(v)1.3 Channels and Intracellular Calcium Mediate Osmotic Stress-induced N-terminal c-Jun Kinase Activation and Disruption of Tight Junctions in Caco-2 Cell Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY BOWEL-DISEASE; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; PHOSPHOLIPASE-C; ACETALDEHYDE; MECHANISM; OCCLUDIN; PERMEABILITY; INTESTINE	We investigated the role of a Ca2+ channel and intracellular calcium concentration ([Ca2+](i)) in osmotic stress-induced JNK activation and tight junction disruption in Caco-2 cell monolayers. Osmotic stress-induced tight junction disruption was attenuated by 1,2-bis(2-aminophenoxyl) ethane-N, N,N',N'-tetraacetic acid (BAPTA)-mediated intracellular Ca2+ depletion. Depletion of extracellular Ca2+ at the apical surface, but not basolateral surface, also prevented tight junction disruption. Similarly, thapsigargin-mediated endoplasmic reticulum (ER) Ca2+ depletion attenuated tight junction disruption. Thapsigargin or extracellular Ca2+ depletion partially reduced osmotic stress-induced rise in [Ca2+](i), whereas thapsigargin and extracellular Ca2+ depletion together resulted in almost complete loss of rise in [Ca2+](i). L-type Ca2+ channel blockers (isradipine and diltiazem) or knockdown of the Ca(v)1.3 channel abrogated [Ca2+](i) rise and disruption of tight junction. Osmotic stress-induced JNK2 activation was abolished by BAPTA and isradipine, and partially reduced by extracellular Ca2+ depletion, thapsigargin, or Ca(v)1.3 knockdown. Osmotic stress rapidly induced c-Src activation, which was significantly attenuated by BAPTA, isradipine, or extracellular Ca2+ depletion. Tight junction disruption by osmotic stress was blocked by tyrosine kinase inhibitors (genistein and PP2) or siRNA-mediated knockdown of c-Src. Osmotic stress induced a robust increase in tyrosine phosphorylation of occludin, which was attenuated by BAPTA, SP600125 (JNK inhibitor), or PP2. These results demonstrate that Ca(v)1.3 and rise in [Ca2+](i) play a role in the mechanism of osmotic stress-induced tight junction disruption in an intestinal epithelial monolayer. [Ca2+](i) mediate osmotic stress-induced JNK activation and subsequent c-Src activation and tyrosine phosphorylation of tight junction proteins. Additionally, inositol 1,4,5-trisphosphate receptor-mediated release of ER Ca2+ also contributes to osmotic stress-induced tight junction disruption.	[Samak, Geetha; Narayanan, Damodaran; Jaggar, Jonathan H.; Rao, RadhaKrishna] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, R (corresponding author), 894 Union Ave, Memphis, TN 38163 USA.	rrao2@uthsc.edu			National Institutes of Health [R01-DK55532, R01-AA12307, HL067061, HL094378]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067061, R01HL094378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK55532 (to R.K.R.), R01-AA12307 (to R.K.R.), HL067061 (to J.H.J.), and HL094378 (to J.H.J.).	Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; BALDA MS, 1991, J MEMBRANE BIOL, V122, P193, DOI 10.1007/BF01871420; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CHEROMCHA DP, 1988, DIGEST DIS SCI, V33, pS78, DOI 10.1007/BF01538135; Haorah J, 2007, J NEUROCHEM, V100, P324, DOI 10.1111/j.1471-4159.2006.04245.x; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Ma TY, 2000, MICROSC RES TECHNIQ, V51, P156, DOI 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J; Mace OJ, 2007, J PHYSIOL-LONDON, V580, P605, DOI 10.1113/jphysiol.2006.124784; MADARA JL, 1983, J CELL BIOL, V97, P125, DOI 10.1083/jcb.97.1.125; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Nakkrasae LI, 2010, J PHYSIOL SCI, V60, P9, DOI 10.1007/s12576-009-0068-0; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; SCHILLI R, 1982, GUT, V23, P326, DOI 10.1136/gut.23.4.326; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; Vikstrom E, 2010, EUR J CELL BIOL, V89, P584, DOI 10.1016/j.ejcb.2010.03.002; Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524	31	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30232	30243		10.1074/jbc.M111.240358	http://dx.doi.org/10.1074/jbc.M111.240358			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737448	Green Published, hybrid			2022-12-27	WOS:000294046600080
J	Suzuki, M; Kiga, K; Kersulyte, D; Cok, J; Hooper, CC; Mimuro, H; Sanada, T; Suzuki, S; Oyama, M; Kozuka-Hata, H; Kamiya, S; Zou, QM; Gilman, RH; Berg, DE; Sasakawa, C				Suzuki, Masato; Kiga, Kotaro; Kersulyte, Dangeruta; Cok, Jaime; Hooper, Catherine C.; Mimuro, Hitomi; Sanada, Takahito; Suzuki, Shiho; Oyama, Masaaki; Kozuka-Hata, Hiroko; Kamiya, Shigeru; Zou, Quan-Ming; Gilman, Robert H.; Berg, Douglas E.; Sasakawa, Chihiro			Attenuated CagA Oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; KINASE; HOST; MECHANISMS; INFECTION; POLARITY; STOMACH; TARGETS; HUMANS; CANCER	Population genetic analyses of bacterial genes whose products interact with host tissues can give new understanding of infection and disease processes. Here we show that strains of the genetically diverse gastric pathogen Helicobacter pylori from Amerindians from the remote Peruvian Amazon contain novel alleles of cagA, a major virulence gene, and reveal distinctive properties of their encoded CagA proteins. CagA is injected into the gastric epithelium where it hijacks pleiotropic signaling pathways, helps Hp exploit its special gastric mucosal niche, and affects the risk that infection will result in overt gastroduodenal diseases including gastric cancer. The Amerindian CagA proteins contain unusual but functional tyrosine phosphorylation motifs and attenuated CRPIA motifs, which affect gastric epithelial proliferation, inflammation, and bacterial pathogenesis. Amerindian CagA proteins induced less production of IL-8 and cancer-associated Mucin 2 than did those of prototype Western or East Asian strains and behaved as dominant negative inhibitors of action of prototype CagA during mixed infection of Mongolian gerbils. We suggest that Amerindian cagA is of relatively low virulence, that this may have been selected in ancestral strains during infection of the people who migrated from Asia into the Americas many thousands of years ago, and that such attenuated CagA proteins could be useful therapeutically.	[Kersulyte, Dangeruta; Berg, Douglas E.] Washington Univ, Sch Med, Dept Med Microbiol, St Louis, MO 63110 USA; [Suzuki, Masato; Kiga, Kotaro; Mimuro, Hitomi; Sanada, Takahito; Suzuki, Shiho; Sasakawa, Chihiro] Univ Tokyo, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Med Prote Lab, Inst Med Sci, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Cok, Jaime; Hooper, Catherine C.; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Fac Med, Dept Microbiol, Lima 31, Peru; [Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Tokyo 1818611, Japan; [Zou, Quan-Ming] Third Mil Med Univ, Coll Med Lab Sci, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Washington University (WUSTL); University of Tokyo; University of Tokyo; University of Tokyo; Washington University (WUSTL); Washington University (WUSTL); Universidad Peruana Cayetano Heredia; Kyorin University; Army Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Berg, DE (corresponding author), Washington Univ, Sch Med, Dept Med Microbiol, St Louis, MO 63110 USA.	berg@borcim.wustl.edu; sasakawa@ims.u-tokyo.ac.jp	Suzuki, Masato/B-7568-2013; Suzuki, Shiho/Z-4458-2019	Suzuki, Masato/0000-0001-8975-2193; Oyama, Masaaki/0000-0001-6478-3735; Suzuki, Shiho/0000-0003-3168-1729; Kozuka-Hata, Hiroko/0000-0002-9286-6594	National Institutes of Health [RO1 DK63041, R21 AI078237, R21 AI088337, T53 1007646, D43TW006581]; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology) [23000012, 20229006, 23390102, 18073003]; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23590518] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK63041, R21 AI078237, R21 AI088337, T53 1007646, and D43TW006581. This work was also supported by grants for Specially Promoted Research (23000012), Scientific Research (S) (20229006), Scientific Research (B) (23390102), and Scientific Research on Priority Areas (18073003) from the Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology).	Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; HIERRO SHP, 1998, LIBERATION LAND RIGH; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mimuro H, 2008, BIOESSAYS, V30, P515, DOI 10.1002/bies.20768; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Pelz C, 2011, J BIOL CHEM, V286, P8999, DOI 10.1074/jbc.M110.166504; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; WERNER L, 2001, DIARY POLL WATCHER P; Yamaoka Y, 2000, EPIDEMIOL INFECT, V124, P91, DOI 10.1017/S0950268899003209; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	40	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29964	29972		10.1074/jbc.M111.263715	http://dx.doi.org/10.1074/jbc.M111.263715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757722	Green Published, hybrid			2022-12-27	WOS:000294046600055
J	Rosell, FI; Kuo, HH; Mauk, AG				Rosell, Federico I.; Kuo, Hsin H.; Mauk, A. Grant			NADH Oxidase Activity of Indoleamine 2,3-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDES; NATURAL CIRCULAR-DICHROISM; L-TRYPTOPHAN; AUTOMATED DOCKING; DIFFERENT PEROXIDASES; MOLECULAR SIMULATION; HYDROGEN-PEROXIDE; SUBSTRATE-BINDING; SUPEROXIDE ANION; HUMAN-HEMOGLOBIN	The heme enzyme indoleamine 2,3-dioxygenase (IDO) was found to oxidize NADH under aerobic conditions in the absence of other enzymes or reactants. This reaction led to the formation of the dioxygen adduct of IDO and supported the oxidation of Trp to N-formylkynurenine. Formation of the dioxygen adduct and oxidation of Trp were accelerated by the addition of small amounts of hydrogen peroxide, and both processes were inhibited in the presence of either superoxide dismutase or catalase. Anaerobic reaction of IDO with NADH proceeded only in the presence of a mediator ( e. g. methylene blue) and resulted in formation of the ferrous form of the enzyme. We propose that trace amounts of peroxide previously proposed to occur in NADH solutions as well as solid NADH activate IDO and lead to aerobic formation of superoxide and the reactive dioxygen adduct of the enzyme.	[Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Mauk, AG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mauk@interchange.ubc.ca			Canadian Cancer Society; University of British Columbia; Canadian Foundation for Innovation; Centre for Blood Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); University of British Columbia; Canadian Foundation for Innovation(Canada Foundation for Innovation); Centre for Blood Research	This work was supported in part by a grant from the Canadian Cancer Society.; Supported in part by a University of British Columbia university graduate fellowship.; Recipient of a Canada research chair. To whom correspondence should be addressed. Tel.: 604-822-3719; Fax: 604-822-6860; E-mail: mauk@interchange.ubc.ca.; We thank Dr. Marcia R. Mauk for developing the original IDO purification protocol, Dr. David S. Waugh for providing the polyHis-tagged TEV protease expression system, Drs. Susanne Ludwiczek and Tomoko Misono for expressing and purifying the TEV protease used, and Dr. Wei Chen for analysis of recombinant IDO by electrospray mass spectrometry. The Cary spectrophotometers and Applied Biosystems Q-Star mass spectrometers were obtained through grants from the Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics and the Centre for Blood Research.	Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; BERNOFSKY C, 1982, J BIOL CHEM, V257, P6809; BERNOFSKY C, 1987, PYRIDINE NUCLEOTID B, P105; Brasen JC, 2004, ARCH BIOCHEM BIOPHYS, V431, P55, DOI 10.1016/j.abb.2004.07.019; BROWN WD, 1969, J BIOL CHEM, V244, P6702; Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x; CASHON R, 1986, J BIOL CHEM, V261, P2700; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w; DOLIN MI, 1962, BIOCHIM BIOPHYS ACTA, V63, P219, DOI 10.1016/0006-3002(62)90361-X; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; ESWAR N, 2006, CURRENT PROTOCOLS BI, V15; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; HALLIWELL B, 1978, PHOTOCHEM PHOTOBIOL, V28, P757, DOI 10.1111/j.1751-1097.1978.tb07013.x; HAYAISHI O, 1977, J BIOL CHEM, V252, P3548; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIRATA F, 1977, J BIOL CHEM, V252, P4637; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; Hultquist D E, 1981, Prog Clin Biol Res, V55, P291; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; Irimia A, 2004, EMBO J, V23, P1234, DOI 10.1038/sj.emboj.7600147; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; KAJITA A, 1970, BIOCHEM BIOPH RES CO, V39, P1199, DOI 10.1016/0006-291X(70)90688-1; Kirkor ES, 2000, ANAL CHEM, V72, P1381, DOI 10.1021/ac990957o; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KOSOWER EM, 1978, J AM CHEM SOC, V100, P5185, DOI 10.1021/ja00484a047; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Kummer U, 1996, BBA-GEN SUBJECTS, V1289, P397, DOI 10.1016/0304-4165(95)00176-X; LAND EJ, 1971, BIOCHIM BIOPHYS ACTA, V234, P34, DOI 10.1016/0005-2728(71)90126-5; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LIVINGSTON DJ, 1985, J BIOL CHEM, V260, P5699; Lu CY, 2011, J BIOL CHEM, V286, P21220, DOI 10.1074/jbc.M111.221507; Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Maghzal GJ, 2008, J BIOL CHEM, V283, P12014, DOI 10.1074/jbc.M710266200; MARMORSTEIN RQ, 1987, J BIOL CHEM, V262, P4922; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCCOMB RB, 1976, CLIN CHEM, V22, P141; MCDONALD G, 1972, BIOCHEMISTRY-US, V11, P1920, DOI 10.1021/bi00760a029; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; NAKAMURA S, 1969, NATURE, V222, P794, DOI 10.1038/222794a0; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; NISHIZUKA Y, 1963, J BIOL CHEM, V238, pP483; OGO S, 1989, J BIOL CHEM, V264, P11302; Olek RA, 2002, CLIN CHIM ACTA, V324, P129, DOI 10.1016/S0009-8981(02)00242-5; Oshima R, 2004, J MOL BIOL, V342, P207, DOI 10.1016/j.jmb.2004.07.009; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; PEARSON JT, BIOCHEMISTRY, V49, P2647; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANNES LJ, 1979, BIOCHEM BIOPH RES CO, V91, P1309, DOI 10.1016/0006-291X(79)91209-9; SARMA RH, 1970, BIOCHEMISTRY-US, V9, P539, DOI 10.1021/bi00805a013; Scheeline A, 1997, CHEM REV, V97, P739, DOI 10.1021/cr960081a; Schenkman JB, 1999, DRUG METAB REV, V31, P351, DOI 10.1081/DMR-100101923; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; SONO M, 1986, BIOCHEMISTRY-US, V25, P6089, DOI 10.1021/bi00368a038; SONO M, 1984, BIOCHIM BIOPHYS ACTA, V789, P170, DOI 10.1016/0167-4838(84)90202-4; STELLWAGEN E, 1977, ACCOUNTS CHEM RES, V10, P92, DOI 10.1021/ar50111a004; STELLWAGEN E, 1990, METHOD ENZYMOL, V182, P343; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; SUTTON HC, 1976, BIOCHEM J, V155, P503, DOI 10.1042/bj1550503; SUZUKI T, 1992, J MOL BIOL, V228, P698, DOI 10.1016/0022-2836(92)90854-D; Suzuki T, 1996, BBA-GENE STRUCT EXPR, V1308, P41, DOI 10.1016/0167-4781(96)00059-0; Suzuki T, 2003, GENE, V308, P89, DOI 10.1016/S0378-1119(03)00467-0; Suzuki T, 1998, COMP BIOCHEM PHYS B, V121, P117, DOI 10.1016/S0305-0491(98)10086-X; SUZUKI T, 1994, J PROTEIN CHEM, V13, P9, DOI 10.1007/BF01891987; TANIGUCHI T, 1979, J BIOL CHEM, V254, P3288; UCHIDA K, 1983, J BIOL CHEM, V258, P2519; Valeur KR, 1996, BBA-GEN SUBJECTS, V1289, P377, DOI 10.1016/0304-4165(95)00174-3; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VELICK SF, 1961, S LIGHT LIFE, P108; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; Vottero E, 2006, FEBS LETT, V580, P2265, DOI 10.1016/j.febslet.2006.03.034; VOTTERO ER, 2007, THESIS U BRIT COLUMB; WEBER G, 1957, NATURE, V180, P1409, DOI 10.1038/1801409a0; YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260; YAMAZAKI I, 1967, BIOCHIM BIOPHYS ACTA, V132, P310, DOI 10.1016/0005-2744(67)90150-7; YAMAZAKI I, 1965, BIOCHEM BIOPH RES CO, V19, P249, DOI 10.1016/0006-291X(65)90513-9; Yanagisawa S, 2011, FARADAY DISCUSS, V148, P239, DOI 10.1039/c004552g; YOKOTA K, 1965, BIOCHIM BIOPHYS ACTA, V105, P301, DOI 10.1016/S0926-6593(65)80154-0	93	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29273	29283		10.1074/jbc.M111.262139	http://dx.doi.org/10.1074/jbc.M111.262139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690092	Green Published, hybrid			2022-12-27	WOS:000293837000062
J	Zhu, B; Lee, SJ; Richardson, CC				Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.			Bypass of a Nick by the Replisome of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION FORK; GENE 4 PROTEIN; STRAND-DISPLACEMENT; ESCHERICHIA-COLI; PRIMASE DOMAINS; BINDING PROTEIN; DEOXYRIBONUCLEIC-ACID; POLYMERASE-ACTIVITY; HELICASE ACTIVITY; SINGLE-MOLECULE	DNA polymerase and DNA helicase are essential components of DNA replication. The helicase unwinds duplex DNA to provide single-stranded templates for DNA synthesis by the DNA polymerase. In bacteriophage T7, movement of either the DNA helicase or the DNA polymerase alone terminates upon encountering a nick in duplex DNA. Using a minicircular DNA, we show that the helicase.polymerase complex can bypass a nick, albeit at reduced efficiency of 7%, on the non-template strand to continue rolling circle DNA synthesis. A gap in the non-template strand cannot be bypassed. The efficiency of bypass synthesis depends on the DNA sequence downstream of the nick. A nick on the template strand cannot be bypassed. Addition of T7 single-stranded DNA-binding protein to the complex stimulates nick bypass 2-fold. We propose that the association of helicase with the polymerase prevents dissociation of the helicase upon encountering a nick, allowing the helicase to continue unwinding of the duplex downstream of the nick.	[Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	zhang, huidong/B-5667-2011		National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; CHA TA, 1989, J BIOL CHEM, V264, P12220; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; MASAMUNE Y, 1971, J BIOL CHEM, V246, P2692; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; MOK M, 1987, J BIOL CHEM, V262, P16644; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rezende LF, 2003, J BIOL CHEM, V278, P29098, DOI 10.1074/jbc.M303374200; Rezende LF, 2002, J BIOL CHEM, V277, P50643, DOI 10.1074/jbc.M207359200; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1987, J BIOL CHEM, V262, P16212; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	44	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28488	28497		10.1074/jbc.M111.252023	http://dx.doi.org/10.1074/jbc.M111.252023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21701044	Green Published, hybrid			2022-12-27	WOS:000293557800064
J	Huang, SH; Long, M; Wu, CH; Kwon-Chung, KJ; Chang, YC; Chi, F; Lee, S; Jong, A				Huang, Sheng-He; Long, Min; Wu, Chun-Hua; Kwon-Chung, Kyung J.; Chang, Yun C.; Chi, Feng; Lee, Susan; Jong, Ambrose			Invasion of Cryptococcus neoformans into Human Brain Microvascular Endothelial Cells Is Mediated through the Lipid Rafts-Endocytic Pathway via the Dual Specificity Tyrosine Phosphorylation-regulated Kinase 3 (DYRK3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; INTRACELLULAR TRAFFICKING; DEPENDENT ENDOCYTOSIS; CHOLERA-TOXIN; CYTOSKELETON; ACTIVATION; CAVEOLAE; PROTEIN; MEMBRANE; SURVIVAL	Cryptococcus neoformans is a neurotropic fungal pathogen, which provokes the onset of devastating meningoencephalitis. Weused human brain microvascular endothelial cells (HBMEC) as the in vitro model to investigate how C. neoformans traverses across the blood-brain barrier. In this study, we present several lines of evidence indicating that C. neoformans invasion is mediated through the endocytic pathway via lipid rafts. Human CD44 molecules from lipid rafts can directly interact with hyaluronic acid, the C. neoformans ligand. Bikunin, which perturbs CD44 function in the lipid raft, can block C. neoformans adhesion and invasion of HBMEC. The lipid raft marker, ganglioside GM1, co-localizes with CD44 on the plasma membrane, and C. neoformans cells can adhere to the host cell in areas where GM1 is enriched. These findings suggest that C. neoformans entry takes place on the lipid rafts. Upon C. neoformans engagement, GM1 is internalized through vesicular structures to the nuclear membrane. This endocytic redistribution process is abolished by cytochalasin D, nocodazole, or anti-DYRK3 (dual specificity tyrosine-phosphorylation-regulated kinase 3) siRNA. Concomitantly, the knockdown of DYRK3 significantly reduces C. neoformans invasion across the HBMEC monolayer in vitro. Our data demonstrate that the lipid raft-dependent endocytosis process mediates C. neoformans internalization into HBMEC and that the CD44 protein of the hosts, cytoskeleton, and intracellular kinase-DYRK3 are involved in this process.	[Huang, Sheng-He; Long, Min; Wu, Chun-Hua; Chi, Feng; Jong, Ambrose] Univ So Calif, Saban Res Inst, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Lee, Susan] Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90027 USA; [Kwon-Chung, Kyung J.; Chang, Yun C.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jong, A (corresponding author), Childrens Hosp, Div Hematol Oncol, Mailstop 57,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	ajong@chla.usc.edu	Chi, Feng/H-5895-2012		National Institutes of Health from USPHS [R01-NS047599, R01-AI40635]; National Institutes of Health from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000057, R01AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS047599 (to A.J.) and R01-AI40635 from USPHS (to S.H.H.).; Supported by National Institutes of Health grants from the intramural program of NIAID.	Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bogacheva O, 2008, J BIOL CHEM, V283, P36665, DOI 10.1074/jbc.M807844200; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Chang YC, 2006, INFECT IMMUN, V74, P3930, DOI 10.1128/IAI.00089-06; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2005, CURR OPIN MICROBIOL, V8, P331, DOI 10.1016/j.mib.2005.02.018; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Wakahara K, 2005, J CELL BIOCHEM, V94, P995, DOI 10.1002/jcb.20364; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; Yavlovich A, 2004, FEMS MICROBIOL LETT, V233, P241, DOI 10.1016/j.femsle.2004.02.016; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021	47	49	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34761	34769		10.1074/jbc.M111.219378	http://dx.doi.org/10.1074/jbc.M111.219378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21693704	Green Published, hybrid			2022-12-27	WOS:000295406300030
J	Koinuma, D; Shinozaki, M; Nagano, Y; Ikushima, H; Horiguchi, K; Goto, K; Chano, T; Saitoh, M; Imamura, T; Miyazono, K; Miyazawa, K				Koinuma, Daizo; Shinozaki, Masahiko; Nagano, Yoshiko; Ikushima, Hiroaki; Horiguchi, Kana; Goto, Kouichiro; Chano, Tokuhiro; Saitoh, Masao; Imamura, Takeshi; Miyazono, Kohei; Miyazawa, Keiji			RB1CC1 Protein Positively Regulates Transforming Growth Factor-beta Signaling through the Modulation of Arkadia E3 Ubiquitin Ligase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; TGF-BETA; C-SKI; DEPENDENT DEGRADATION; MEDIATED DEGRADATION; NEGATIVE REGULATION; CELL-MEMBRANE; HECT DOMAIN; I RECEPTOR; SMAD7	Transforming growth factor-beta (TGF-beta) signaling is controlled by a variety of regulators, of which Smad7, c-Ski, and SnoN play a pivotal role in its negative regulation. Arkadia is a RING-type E3 ubiquitin ligase that targets these negative regulators for degradation to enhance TGF-beta signaling. In the present study we identified a candidate human tumor suppressor gene product RB1CC1/FIP200 as a novel positive regulator of TGF-beta signaling that functions as a substrate-selective cofactor of Arkadia. Overexpression of RB1CC1 enhanced TGF-beta signaling, and knockdown of endogenous RB1CC1 attenuated TGF-beta beta-induced expression of target genes as well as TGF-beta-induced cytostasis. RB1CC1 down-regulated the protein levels of c-Ski but not SnoN by enhancing the activity of Arkadia E3 ligase toward c-Ski. Substrate selectivity is primarily attributable to the physical interaction of RB1CC1 with substrates, suggesting its role as a scaffold protein. RB1CC1 thus appears to play a unique role as a modulator of TGF-beta signaling by restricting substrate specificity of Arkadia.	[Koinuma, Daizo; Shinozaki, Masahiko; Nagano, Yoshiko; Ikushima, Hiroaki; Horiguchi, Kana; Goto, Kouichiro; Saitoh, Masao; Miyazono, Kohei; Miyazawa, Keiji] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Koinuma, Daizo; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan; [Chano, Tokuhiro] Shiga Univ Med Sci, Dept Clin Lab Med, Shiga 5202192, Japan; [Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan; [Imamura, Takeshi] Ehime Univ, Dept Mol Med Pathogenesis, Grad Sch Med, Toon, Ehime 7910295, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Shiga University of Medical Science; University of Yamanashi; Ehime University	Miyazono, K (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Koinuma, Daizo/Y-8716-2018; Chano, Tokuhiro/F-5816-2018	Koinuma, Daizo/0000-0001-5611-2122; Chano, Tokuhiro/0000-0002-9959-1183	KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22112002, 22390052] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan).	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Chano T, 2002, GENE, V291, P29, DOI 10.1016/S0378-1119(02)00585-1; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ibarrola N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-2; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2011, J BIOCHEM, V149, P1, DOI 10.1093/jb/mvq133; Mizutani A, 2010, J BIOCHEM, V148, P733, DOI 10.1093/jb/mvq127; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Piek E, 2001, ADV CANCER RES, V83, P1, DOI 10.1016/S0065-230X(01)83001-3; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yuzawa H, 2009, BONE, V44, P53, DOI 10.1016/j.bone.2008.09.013; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	66	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32502	32512		10.1074/jbc.M111.227561	http://dx.doi.org/10.1074/jbc.M111.227561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795712	Green Published, hybrid			2022-12-27	WOS:000294726800060
J	Ma, HP				Ma, He-Ping			Hydrogen Peroxide Stimulates the Epithelial Sodium Channel through a Phosphatidylinositide 3-Kinase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; NITRIC-OXIDE; SUPEROXIDE-PRODUCTION; INDUCED HYPERTENSION; OXIDATIVE STRESS; APICAL MEMBRANE; NADPH OXIDASE; RENAL MEDULLA; H2O2; ENAC	Recent studies indicate that oxidative stress mediates salt-sensitive hypertension. To test the hypothesis that the renal epithelial sodium channel (ENaC) is a target of oxidative stress, patch clamp techniques were used to determine whether ENaC in A6 distal nephron cells is regulated by hydrogen peroxide (H2O2). In the cell-attached configuration, H2O2 significantly increased ENaC open probability (P-o) and single-channel current amplitude but not the unit conductance. High concentrations of exogenous H2O2 are required to elevate intracellular H2O2, probably because catalase, the enzyme that promotes the decomposition of H2O2 to H2O and O-2, is highly expressed in A6 cells. The effect of H2O2 on ENaC P-o was enhanced by 3-aminotriazole, a catalase inhibitor, and abolished by overexpression of catalase, indicating that intracellular H2O2 levels are critical to produce the effect. However, H2O2 did not directly activate ENaC in inside-out patches. The effects of H2O2 on ENaC P-o and amiloride-sensitive Na+ current were abolished by inhibition of phosphatidylinositide 3-kinase (PI3K). Confocal microscopy data showed that H2O2 elevated phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) in the apical membrane by stimulating PI3K. Because ENaC is stimulated by PI(3,4,5) P-3, these data suggest that H2O2 stimulates ENaC via PI3K-mediated increases in apical PI(3,4,5) P-3.	Emory Univ Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Ma, HP (corresponding author), Emory Univ Sch Med, Dept Physiol, 615 Michael St,Suite 601, Atlanta, GA 30322 USA.	heping.ma@emory.edu			National Institutes of Health [5R01-DK067110]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-DK067110 (to H.-P. M.).	Abe M, 2006, AM J PHYSIOL-RENAL, V291, pF350, DOI 10.1152/ajprenal.00407.2005; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Barlow RS, 2000, AM J PHYSIOL-HEART C, V279, pH475, DOI 10.1152/ajpheart.2000.279.2.H475; Bettowski J, 2006, PEPTIDES, V27, P3234, DOI 10.1016/j.peptides.2006.08.010; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Blazer-Yost BL, 2004, AM J PHYSIOL-CELL PH, V287, pC1569, DOI 10.1152/ajpcell.00226.2004; Chen YF, 2003, AM J PHYSIOL-REG I, V285, pR827, DOI 10.1152/ajpregu.00636.2002; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Lin MJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1598, DOI 10.1152/ajplung.00323.2006; Ma HP, 2007, PFLUG ARCH EUR J PHY, V455, P169, DOI 10.1007/s00424-007-0294-3; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Taylor NE, 2005, AM J PHYSIOL-REG I, V289, pR1573, DOI 10.1152/ajpregu.00525.2005; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang J, 2009, AM J PHYSIOL-RENAL, V296, pF284, DOI 10.1152/ajprenal.90647.2008; Warnock D G, 1999, Curr Hypertens Rep, V1, P158, DOI 10.1007/s11906-999-0013-x; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Williams SS, 2007, CURR OPIN PEDIATR, V19, P192, DOI 10.1097/MOP.0b013e32801e217c; Yu L, 2008, AM J PHYSIOL-RENAL, V295, pF1519, DOI 10.1152/ajprenal.00605.2007; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006; Zhang Y, 2005, HYPERTENSION, V46, P732, DOI 10.1161/01.HYP.0000182660.74266.6d; Zhang ZR, 2010, PFLUG ARCH EUR J PHY, V459, P377, DOI 10.1007/s00424-009-0733-4	38	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32444	32453		10.1074/jbc.M111.254102	http://dx.doi.org/10.1074/jbc.M111.254102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795700	Green Published, hybrid			2022-12-27	WOS:000294726800054
J	Gatei, M; Jakob, B; Chen, P; Kijas, AW; Becherel, OJ; Gueven, N; Birrell, G; Lee, JH; Paull, TT; Lerenthal, Y; Fazry, S; Taucher-Scholz, G; Kalb, R; Schindler, D; Waltes, R; Dork, T; Lavin, MF				Gatei, Magtouf; Jakob, Burkhard; Chen, Philip; Kijas, Amanda W.; Becherel, Olivier J.; Gueven, Nuri; Birrell, Geoff; Lee, Ji-Hoon; Paull, Tanya T.; Lerenthal, Yaniv; Fazry, Shazrul; Taucher-Scholz, Gisela; Kalb, Reinhard; Schindler, Detlev; Waltes, Regina; Doerk, Thilo; Lavin, Martin F.			ATM Protein-dependent Phosphorylation of Rad50 Protein Regulates DNA Repair and Cell Cycle Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; MRN COMPLEX; S-PHASE; AUTOPHOSPHORYLATION SITES; MRE11 COMPLEX; NBS1; DAMAGE; ACTIVATION	The Mre11/Rad50/NBN complex plays a central role in coordinating the cellular response to DNA double-strand breaks. The importance of Rad50 in that response is evident from the recent description of a patient with Rad50 deficiency characterized by chromosomal instability and defective ATM-dependent signaling. We report here that ATM (defective in ataxia-telangiectasia) phosphorylates Rad50 at a single site (Ser-635) that plays an important adaptor role in signaling for cell cycle control and DNA repair. Although a Rad50 phosphosite-specific mutant (S635G) supported normal activation of ATM in Rad50-deficient cells, it was defective in correcting DNA damage-induced signaling through the ATM-dependent substrate SMC1. This mutant also failed to correct radiosensitivity, DNA double-strand break repair, and an S-phase checkpoint defect in Rad50-deficient cells. This was not due to disruption of the Mre11/Rad50/NBN complex revealing for the first time that phosphorylation of Rad50 plays a key regulatory role as an adaptor for specific ATM-dependent downstream signaling through SMC1 for DNA repair and cell cycle checkpoint control in the maintenance of genome integrity.	[Gatei, Magtouf; Chen, Philip; Kijas, Amanda W.; Becherel, Olivier J.; Gueven, Nuri; Birrell, Geoff; Fazry, Shazrul; Lavin, Martin F.] Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4029, Australia; [Jakob, Burkhard; Taucher-Scholz, Gisela] Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany; [Becherel, Olivier J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Lee, Ji-Hoon; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Lee, Ji-Hoon; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Lerenthal, Yaniv] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Kalb, Reinhard; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Waltes, Regina] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Dept Gynecol, D-30625 Hannover, Germany; [Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; University of Queensland; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Tel Aviv University; Sackler Faculty of Medicine; University of Wurzburg; Hannover Medical School; Hannover Medical School; University of Queensland	Lavin, MF (corresponding author), Queensland Inst Med Res, 300 Herston Rd, Herston, Qld 4006, Australia.	martin.lavin@qimr.edu.au	Kalb, Reinhard/AAR-3249-2021; Dörk, Thilo/J-8620-2012; Lavin, Martin F/F-5961-2014; Lee, Jihoon/AAK-3497-2021; Jakob, Burkhard/D-2047-2013	Kalb, Reinhard/0000-0003-3906-6907; Dörk, Thilo/0000-0002-9458-0282; Lavin, Martin F/0000-0002-5940-4769; Lee, Jihoon/0000-0001-7387-935X; Jakob, Burkhard/0000-0003-2404-377X; Fazry, Shazrul/0000-0002-7072-8609; Paull, Tanya/0000-0002-2991-651X; Kijas, Amanda/0000-0001-8538-7766; Guven, Nuri/0000-0003-3782-767X	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australian National Health and Medical Research Council.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BARBI G, 1991, AM J MED GENET, V40, P44, DOI 10.1002/ajmg.1320400109; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Di Virgilio M, 2005, J CELL BIOL, V171, P765, DOI 10.1083/jcb.200506029; Di Virgilio M, 2009, DNA REPAIR, V8, P1311, DOI 10.1016/j.dnarep.2009.07.006; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Dzikiewicz-Krawczyk A, 2008, MUTAT RES-REV MUTAT, V659, P262, DOI 10.1016/j.mrrev.2008.05.005; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Huang JR, 2002, NUCLEIC ACIDS RES, V30, P667, DOI 10.1093/nar/30.3.667; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2003, MOL CANCER RES, V1, P674; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Quennet V, 2011, NUCLEIC ACIDS RES, V39, P2144, DOI 10.1093/nar/gkq1175; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	81	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31542	31556		10.1074/jbc.M111.258152	http://dx.doi.org/10.1074/jbc.M111.258152			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757780	Green Published, hybrid			2022-12-27	WOS:000294487500049
J	Lawrence, SA; Hackett, JC; Moran, RG				Lawrence, Scott A.; Hackett, John C.; Moran, Richard G.			Tetrahydrofolate Recognition by the Mitochondrial Folate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; GAMMA-GLUTAMATE SYNTHETASE; SUBSTRATE-BINDING SITE; ADP/ATP CARRIER; OXOGLUTARATE CARRIER; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; PROTEIN; IDENTIFICATION; DENSITY	A mitochondrial carrier family (MCF) of transport proteins facilitates the transfer of charged small molecules across the inner mitochondrial membrane. The human genome has similar to 50 genes corresponding to members of this family. All MCF proteins contain three repeats of a characteristic and conserved PX(D/E)XX(K/R) motif thought to be central to the mechanism of these transporters. The mammalian mitochondrial folate transporter (MFT) is one of a few MCF members, known as the P(I/L) W subfamily, that have evolved a tryptophan residue in place of the (D/E) in the second conserved motif; the function of this substitution (Trp-142) is unclear. Molecular dynamics simulations of the MFT in its explicit membrane environment identified this tryptophan, as well as several other residues lining the transport cavity, to be involved in a series of sequential interactions that coordinated the movement of the tetrahydrofolate substrate within the transport cavity. We probed the function of these residues by mutagenesis. The mutation of every residue identified by molecular dynamics to interact with tetrahydrofolate during simulated transit into the aqueous channel severely impaired folate transport. Mutation of the subfamily-defining tryptophan residue in the MFT to match the MCF consensus at this position (W142D) was incompatible with cell survival. These studies indicate that MFT Trp-142, as well as other residues lining the transporter interior, coordinate tetrahydrofolate descent and positioning of the substrate in the transporter basin. Overall, we identified residues in the walls and at the base of the transport cavity that are involved in substrate recognition by the MFT.	[Lawrence, Scott A.; Moran, Richard G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Hackett, John C.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Hackett, John C.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Moran, Richard G.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Moran, RG (corresponding author), 401 Coll St,POB 980035, Richmond, VA 23298 USA.	rmoran@vcu.edu	Hackett, John/J-3871-2019	Hackett, John/0000-0002-4923-2668	National Institutes of Health [R01-CA104279]; NATIONAL CANCER INSTITUTE [R01CA104279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA104279 (to R. G. M.).	Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Della Rocca BM, 2005, MOL MEMBR BIOL, V22, P443, DOI 10.1080/09687860500269335; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Falconi M, 2006, PROTEINS, V65, P681, DOI 10.1002/prot.21102; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FREEMANTLE SJ, 1995, J BIOL CHEM, V270, P9579, DOI 10.1074/jbc.270.16.9579; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnston JM, 2008, MOL MEMBR BIOL, V25, P506, DOI 10.1080/09687680802459271; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LIN BF, 1993, J BIOL CHEM, V268, P21674; Ma CL, 2007, J BIOL CHEM, V282, P17210, DOI 10.1074/jbc.M611268200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Perchiniak E, 2007, BIOCHEMISTRY-US, V46, P1557, DOI 10.1021/bi062191+; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; SANBROOK J, 2001, MOL CLONING LAB MANU, P3; Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014; Stipani V, 2001, BIOCHEMISTRY-US, V40, P15805, DOI 10.1021/bi011616j; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Tonazzi A, 2005, BBA-BIOMEMBRANES, V1718, P53, DOI 10.1016/j.bbamem.2005.10.007; *TRIP INT, 2008, SYB 8 0 ORCHESTRAR; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; Walters DE, 2004, BIOPHYS J, V87, P907, DOI 10.1529/biophysj.104.042127; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105	46	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31480	31489		10.1074/jbc.M111.272187	http://dx.doi.org/10.1074/jbc.M111.272187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768094	hybrid, Green Published			2022-12-27	WOS:000294487500043
J	Misztal, K; Wisniewska, MB; Ambrozkiewicz, M; Nagalski, A; Kuznicki, J				Misztal, Katarzyna; Wisniewska, Marta B.; Ambrozkiewicz, Mateusz; Nagalski, Andrzej; Kuznicki, Jacek			WNT Protein-independent Constitutive Nuclear Localization of beta-Catenin Protein and Its Low Degradation Rate in Thalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE THALAMUS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; CORTEX; CELLS; BRAIN; MICE; TELENCEPHALON; GASTRULATION	Nuclear localization of beta-catenin is a hallmark of canonical Wnt signaling, a pathway that plays a crucial role in brain development and the neurogenesis of the adult brain. We recently showed that beta-catenin accumulates specifically in mature thalamic neurons, where it regulates the expression of the Ca(v)3.1 voltage-gated calcium channel gene. Here, we investigated the mechanisms underlying beta-catenin accumulation in thalamic neurons. Wereport that a lack of soluble factors produced either by glia or cortical neurons does not impair nuclear beta-catenin accumulation in thalamic neurons. We next found that the number of thalamic neurons with beta-catenin nuclear localization did not change when the Wnt/Dishevelled signaling pathway was inhibited by Dickkopf1 or a dominant negative mutant of Dishevelled3. These results suggest a WNT-independent cell-autonomous mechanism. We found that the protein levels of APC, AXIN1, and GSK3 beta, components of the beta-catenin degradation complex, were lower in the thalamus than in the cortex of the adult rat brain. Reduced levels of these proteins were also observed in cultured thalamic neurons compared with cortical cultures. Finally, pulse-chase experiments confirmed that cytoplasmic beta-catenin turnover was slower in thalamic neurons than in cortical neurons. Altogether, our data indicate that the nuclear localization of beta-catenin in thalamic neurons is their cell-intrinsic feature, which was WNT-independent but associated with low levels of proteins involved in beta-catenin labeling for ubiquitination and subsequent degradation.	[Misztal, Katarzyna; Wisniewska, Marta B.; Ambrozkiewicz, Mateusz; Nagalski, Andrzej; Kuznicki, Jacek] Int Inst Mol & Cell Biol, Lab Neurodegenerat, PL-02109 Warsaw, Poland; [Kuznicki, Jacek] Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Kuznicki, J (corresponding author), Int Inst Mol & Cell Biol, Lab Neurodegenerat, 4 Ks Trojdena St, PL-02109 Warsaw, Poland.	jacek.kuznicki@iimcb.gov.pl	Ambrozkiewicz, Mateusz/O-9547-2019; Kuznicki, Jacek/AAW-9239-2020; Nagalski, Andrzej/AAH-3366-2019; Nagalski, Andrzej/O-3173-2015; Wisniewska, Marta B./A-6691-2009	Kuznicki, Jacek/0000-0001-6486-0657; Nagalski, Andrzej/0000-0002-4864-5604; Nagalski, Andrzej/0000-0002-4864-5604; Wisniewska, Marta B./0000-0002-1593-0361; Misztal, Katarzyna/0000-0001-6575-2500; Ambrozkiewicz, Mateusz/0000-0001-5225-5230	European Community [229676]; Polish Ministry of Science and Higher Education [4245/B/P01/2010/38, 1917/B/P01/2010/39]	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the European Community Seventh Framework Programme FP7/2007-2013 under Grant Agreement 229676 and Polish Ministry of Science and Higher Education Grants 4245/B/P01/2010/38 and 1917/B/P01/2010/39.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Asavaritikrai P, 2003, EXP NEUROL, V181, P39, DOI 10.1016/S0014-4886(03)00025-6; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bluske KK, 2009, DEV DYNAM, V238, P3297, DOI 10.1002/dvdy.22167; Boulos S, 2006, BRAIN RES, V1102, P27, DOI 10.1016/j.brainres.2006.04.089; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Galceran J, 2000, DEVELOPMENT, V127, P469; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Imura T, 2010, STEM CELLS, V28, P2053, DOI 10.1002/stem.524; Jones EG, 2004, J COMP NEUROL, V477, P55, DOI 10.1002/cne.20234; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kohler EM, 2010, ONCOGENE, V29, P1663, DOI 10.1038/onc.2009.447; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lee S, 2009, J COMP NEUROL, V517, P925, DOI 10.1002/cne.22199; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Louvi A, 2007, J COMP NEUROL, V504, P550, DOI 10.1002/cne.21461; Lucas JJ, 1999, NEUROREPORT, V10, P2699, DOI 10.1097/00001756-199909090-00002; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Sousa KM, 2010, J BIOL CHEM, V285, P7246, DOI 10.1074/jbc.M109.079822; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wisniewska MB, 2010, J NEUROSCI, V30, P4957, DOI 10.1523/JNEUROSCI.1425-09.2010; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007; Zhou CJ, 2004, J NEUROSCI, V24, P7632, DOI 10.1523/JNEUROSCI.2123-04.2004	51	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31781	31788		10.1074/jbc.M111.229666	http://dx.doi.org/10.1074/jbc.M111.229666			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757747	Green Published, hybrid			2022-12-27	WOS:000294487500071
J	Denda, K; Nakao-Wakabayashi, K; Okamoto, N; Kitamura, N; Ryu, JY; Tagawa, Y; Ichisaka, T; Yamanaka, S; Komada, M				Denda, Kimitoshi; Nakao-Wakabayashi, Kanako; Okamoto, Naoki; Kitamura, Naomi; Ryu, Je-Young; Tagawa, Yoh-ichi; Ichisaka, Tomoko; Yamanaka, Shinya; Komada, Masayuki			Nrk, an X-linked Protein Kinase in the Germinal Center Kinase Family, Is Required for Placental Development and Fetoplacental Induction of Labor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTURITION; MOUSE; MICE; CHROMOSOME; FETAL; EXPRESSION; APOPTOSIS; HORMONE; GROWTH; INACTIVATION	The complete mechanism of labor induction in eutherian mammals remains unclear. Although important roles for the fetus and placenta in triggering labor have been proposed, no gene has been shown to be required in the fetus/placenta for labor induction. Here we show that Nrk, an X-linked gene encoding a Ser/Thr kinase of the germinal center kinase family, is essential in the fetus/placenta for labor in mice. Nrk was specifically expressed in the spongiotrophoblast layer, a fetus-derived region of the placenta, and Nrk disruption caused dysregulated overgrowth of the layer. Due to preferential inactivation of the paternally derived X chromosome in placenta, Nrk heterozygous mutant placentas exhibited a similar defect to that in Nrk-null tissues when the wild-type allele was paternally derived. However, the phenotype was weaker than in Nrk-null placentas due to leaky Nrk expression from the inactivated X chromosome. Crossing of Nrk-null females to wild-type and Nrk-null males, as well as uterine transfer of Nrk-null fetuses to wild-type females, revealed that pregnant mice exhibit a severe defect in delivery when all fetuses/placentas are Nrk-null. In addition, Nrk was not expressed in female reproductive tissues such as the uterus and ovary, as well as the fetal amnion and yolk sac, in pregnant mice. Progesterone and estrogen levels in the maternal circulation and placenta, which control the timing of labor, were unaffected upon Nrk disruption. We thus provide evidence for a novel labor-inducing fetoplacental signal that depends on the X chromosome and possibly arises from the placenta.	[Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ryu, Je-Young; Tagawa, Yoh-ichi] Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Kyoto University	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp	Tagawa, Yoh-ichi/F-7216-2011	Tagawa, Yoh-ichi/0000-0002-7673-6781	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21025011, 21113505]; Grants-in-Aid for Scientific Research [23657086] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants 21025011 and 21113505 to M. K.).	Arai S, 2010, STEROIDS, V75, P13, DOI 10.1016/j.steroids.2009.09.004; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hogan B, 1994, MANIPULATING MOUSE E; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Kakinuma H, 2005, CELL SIGNAL, V17, P1439, DOI 10.1016/j.cellsig.2005.03.004; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kutsukake N, 2009, AM J PRIMATOL, V71, P696, DOI 10.1002/ajp.20708; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; Mesiano S, 2007, SEMIN CELL DEV BIOL, V18, P321, DOI 10.1016/j.semcdb.2007.05.003; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nakano K, 2000, J BIOL CHEM, V275, P20533, DOI 10.1074/jbc.M001009200; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; Nathanielsz PW, 1996, AM SCI, V84, P562; Ratajczak CK, 2008, PEDIATR RES, V64, P581, DOI 10.1203/PDR.0b013e31818718d2; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Vidaeff AC, 2008, CURR MED CHEM, V15, P614, DOI 10.2174/092986708783769786; Zeng ZY, 2008, BIOL REPROD, V78, P1029, DOI 10.1095/biolreprod.107.065821	37	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28802	28810		10.1074/jbc.M111.258160	http://dx.doi.org/10.1074/jbc.M111.258160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715335	Green Published, hybrid			2022-12-27	WOS:000293837000018
J	Fox, AM; Ciziene, D; McLaughlin, SH; Stewart, M				Fox, Abigail M.; Ciziene, Danguole; McLaughlin, Stephen H.; Stewart, Murray			Electrostatic Interactions Involving the Extreme C Terminus of Nuclear Export Factor CRM1 Modulate Its Affinity for Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; STRUCTURAL BASIS; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; PORE COMPLEX; MECHANISM; SIGNALS; RANGTP; RECEPTOR; MUTANTS	The toroid-shaped nuclear protein export factor CRM1 is constructed from 21 tandem HEAT repeats, each of which contains an inner (B) and outer (A) alpha-helix joined by loops. Proteins targeted for export have a nuclear export signal (NES) that binds between the A-helices of HEAT repeats 11 and 12 on the outer surface of CRM1. RanGTP binding increases the affinity of CRM1 for NESs. In the absence of RanGTP, the CRM1 C-terminal helix, together with the HEAT repeat 9 loop, modulates its affinity for NESs. Here we show that there is an electrostatic interaction between acidic residues at the extreme distal tip of the C-terminal helix and basic residues on the HEAT repeat 12 B-helix that lies on the inner surface of CRM1 beneath the NES binding site. Small angle x-ray scattering indicates that the increased affinity for NESs generated by mutations in the C-terminal helix is not associated with large scale changes in CRM1 conformation, consistent with the modulation of NES affinity being mediated by a local change in CRM1 near the NES binding site. These data also suggest that in the absence of RanGTP, the C-terminal helix lies across the CRM1 toroid in a position similar to that seen in the CRM1-Snurportin crystal structure. By creating local changes that stabilize the NES binding site in its closed conformation and thereby reducing the affinity of CRM1 for NESs, the C-terminal helix and HEAT 9 loop facilitate release of NES-containing cargo in the cytoplasm and also inhibit their return to the nucleus.	[Fox, Abigail M.; Ciziene, Danguole; McLaughlin, Stephen H.; Stewart, Murray] MRC LMB, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC LMB, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk		McLaughlin, Stephen/0000-0001-9135-6253	Wellcome Trust; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Wellcome Trust programme grant (to M. S.).	Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Sokolova AV, 2003, J APPL CRYSTALLOGR, V36, P865, DOI 10.1107/S0021889803000220; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	28	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29325	29335		10.1074/jbc.M111.245092	http://dx.doi.org/10.1074/jbc.M111.245092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708948	Green Published, hybrid			2022-12-27	WOS:000293837000067
J	Lira, A; Kulczycki, J; Slack, R; Anisman, H; Park, DS				Lira, Arman; Kulczycki, Jerzy; Slack, Ruth; Anisman, Hymie; Park, David S.			Involvement of the Fc gamma Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; MICROGLIAL ACTIVATION; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; NITRIC-OXIDE; REACTIVE MICROGLIA; OXIDATIVE STRESS; NEURODEGENERATION; NEURONS; DEGENERATION	Although there is growing evidence for a role of the innate immune response in Parkinson's disease, the nature of any humoral response in dopaminergic degeneration is uncertain. Here we report on a protracted N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of dopaminergic death that potentially allows a more full adaptive humoral response to develop. Rag2 mutant mice that lack the full adaptive response (deficient in both T and B cells) are resistant to dopaminergic death and behavioral deficiencies in this model. These mice are resensitized after reconstitution with WT splenocytes. To more directly provide evidence for humoral/IgG involvement, we show that deficiency of Fc gamma receptors, which are critical for activation of macrophages/microglia by binding to IgGs, is also protective in this protracted model. Fc gamma R-deficient mice display improved behavior and impaired microglial activation. Interestingly, however, Rag2 mutant but not Fc gamma R-deficient mice are resistant to a more standard N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine paradigm where death is more rapid. Taken together, these data indicate that, provided sufficient time, the humoral arm of the adaptive immune system can play a critical functional role in modulating the microglial response to dopaminergic degeneration and suggest that this humoral component may participate in degeneration in Parkinson's disease.	[Lira, Arman; Slack, Ruth; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Kulczycki, Jerzy; Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada; [Park, David S.] Pusan Natl Univ, Dept Cogno Mechatron Engn, Pusan, South Korea	University of Ottawa; Carleton University; Pusan National University	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca		Park, David/0000-0002-4490-3784; Slack, Ruth/0000-0002-1552-2835	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario (HSFO); Parkinson's Disease Foundation (PDF); Parkinson's Society of Canada (PSC); Michael J. Fox Foundation; Neuroscience Canada; Centre for Stroke Recovery (CSR) Canadian Stroke Network; Ministry of Education, Science and Technology, South Korea [R31-2008-000-20004-0]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Parkinson's Disease Foundation (PDF); Parkinson's Society of Canada (PSC); Michael J. Fox Foundation; Neuroscience Canada; Centre for Stroke Recovery (CSR) Canadian Stroke Network; Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), the Heart and Stroke Foundation of Ontario (HSFO), the Parkinson's Disease Foundation (PDF), the Parkinson's Society of Canada (PSC), Michael J. Fox Foundation, Neuroscience Canada, the Centre for Stroke Recovery (CSR) Canadian Stroke Network, and World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea Grant R31-2008-000-20004-0.	Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Arai H, 2004, J BIOL CHEM, V279, P51647, DOI 10.1074/jbc.M407328200; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cao SW, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-42; CARVEY PM, 1991, NEUROLOGY, V41, P53, DOI 10.1212/WNL.41.5_Suppl_2.53; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; De Pablos RM, 2004, FASEB J, V18, P407, DOI 10.1096/fj.04-2153fje; Doucet JP, 1996, EUR J NEUROSCI, V8, P365, DOI 10.1111/j.1460-9568.1996.tb01220.x; DRAGUNOW M, 1995, MOL BRAIN RES, V30, P393, DOI 10.1016/0169-328X(95)00037-S; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Fasano S., 2002, Current Molecular Medicine (Hilversum), V2, P649, DOI 10.2174/1566524023362005; Fiszer U, 1996, J NEUROL SCI, V139, P66, DOI 10.1016/S0022-510X(96)00002-0; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; He Y, 2002, EXP NEUROL, V176, P322, DOI 10.1006/exnr.2002.7946; Hunot S, 1999, J NEUROSCI, V19, P3440; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kurkowska-Jastrzebska I, 1999, ACTA NEUROBIOL EXP, V59, P1; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liberatore GT, 1999, NAT MED, V5, P1403; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Neff F, 2008, AUTOIMMUN REV, V7, P501, DOI 10.1016/j.autrev.2008.04.010; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Petiniot LK, 2000, P NATL ACAD SCI USA, V97, P6664, DOI 10.1073/pnas.97.12.6664; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; Serra Pier Andrea, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS189, DOI 10.1016/j.parkreldis.2008.04.029; Stone DK, 2009, ANTIOXID REDOX SIGN, V11, P2151, DOI [10.1089/ars.2009.2460, 10.1089/ARS.2009.2460]; Storch A, 2004, J NEURAL TRANSM, V111, P1267, DOI 10.1007/s00702-004-0203-2; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; ULVESTAD E, 1994, J NEUROL SCI, V121, P125, DOI 10.1016/0022-510X(94)90340-9; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yokoyama H, 2008, NEUROL SCI, V29, P293, DOI 10.1007/s10072-008-0986-2; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118	43	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28783	28793		10.1074/jbc.M111.244830	http://dx.doi.org/10.1074/jbc.M111.244830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21693708	hybrid, Green Published			2022-12-27	WOS:000293837000016
J	Fontaine, F; Fuchs, RT; Storz, G				Fontaine, Fanette; Fuchs, Ryan T.; Storz, Gisela			Membrane Localization of Small Proteins in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CYTOPLASMIC MEMBRANE; SIGNAL RECOGNITION PARTICLE; F1F0 ATP SYNTHASE; SUBUNIT-C; TOPOLOGY PREDICTION; YIDC; INNER; INSERTION; TRANSLOCASE; PATHWAY	Escherichia coli synthesize over 60 poorly understood small proteins of less than 50 amino acids. A striking feature of these proteins is that 65% contain a predicted alpha-helical transmembrane (TM) domain. This prompted us to examine the localization, topology, and membrane insertion of the small proteins. Biochemical fractionation showed that, consistent with the predicted TM helix, the small proteins generally are most abundant in the inner membrane fraction. Examples of both N-in-C-out and N-out-C-in orientations were found in assays of topology-reporter fusions to representative small TM proteins. Interestingly, however, three of nine tested proteins display dual topology. Positive residues close to the transmembrane domains are conserved, and mutational analysis of one small protein, YohP, showed that the positive inside rule applies for single transmembrane domain proteins as has been observed for larger proteins. Finally, fractionation analysis of small protein localization in strains depleted of the Sec or YidC membrane insertion pathways uncovered differential requirements. Some small proteins appear to be affected by both Sec and YidC depletion, others showed more dependence on one or the other insertion pathway, whereas one protein was not affected by depletion of either Sec or YidC. Thus, despite their diminutive size, small proteins display considerable diversity in topology, biochemical features, and insertion pathways.	[Fontaine, Fanette; Fuchs, Ryan T.; Storz, Gisela] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Storz, G (corresponding author), 18 Lib Dr, Bethesda, MD 20892 USA.	storz@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008855] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Facey SJ, 2003, EUR J BIOCHEM, V270, P1724, DOI 10.1046/j.1432-1033.2003.03531.x; Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059; Gassel M, 1999, J BIOL CHEM, V274, P37901, DOI 10.1074/jbc.274.53.37901; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hobbs EC, 2011, CURR OPIN MICROBIOL, V14, P167, DOI 10.1016/j.mib.2011.01.007; Ikeda Masami, 2002, In Silico Biology, V2, P19; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Lippa AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000788; MANOIL C, 1991, METHOD CELL BIOL, V34, P61; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; RHOADS DB, 1984, J BACTERIOL, V159, P63, DOI 10.1128/JB.159.1.63-70.1984; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Thomason L., 2007, CURRENT PROTOCOLS MO, V79, P1171; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	38	52	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32464	32474		10.1074/jbc.M111.245696	http://dx.doi.org/10.1074/jbc.M111.245696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778229	hybrid, Green Published			2022-12-27	WOS:000294726800056
J	Chen, SC; Chang, LY; Wang, YW; Chen, YC; Weng, KF; Shih, SR; Shih, HM				Chen, Shu-Chuan; Chang, Luan-Yin; Wang, Yi-Wei; Chen, Yi-Chun; Weng, Kuo-Feng; Shih, Shin-Ru; Shih, Hsiu-Ming			Sumoylation-promoted Enterovirus 71 3C Degradation Correlates with a Reduction in Viral Replication and Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO PATHWAY; IN-VIVO; PROTEIN; PML; CLEAVAGE; BINDING; VIRUS; INFECTION; DISEASE; TARGETS	Enterovirus 71 (EV71), a member of the Picornaviridae family, may cause serious clinical manifestations associated with the central nervous system. Enterovirus 3C protease is required for virus replication and can trigger host cell apoptosis via cleaving viral polyprotein precursor and cellular proteins, respectively. Although the role of the 3C protease in processing viral and cellular proteins has been established, very little is known about the modulation of EV71 3C function by host cellular factors. Here, we show that sumoylation promotes EV71 3C protein ubiquitination for degradation, correlating with a decrease of EV71 in virus replication and cell apoptosis. SUMO E2-conjugating enzyme Ubc9 was identified as an EV71 3C-interacting protein. Further studies revealed that EV71 3C can be SUMO (small ubiquitin-like modifier)-modified at residue Lys-52. Sumoylation down-regulated 3C protease activity in vitro and also 3C protein stability in cells, in agreement with data suggesting 3C K52R protein induced greater substrate cleavage and apoptosis in cells. More importantly, the recombinant EV71 3C K52R virus infection conferred more apoptotic phenotype and increased virus levels in culture cells, which also correlated with a mouse model showing increased levels of viral VP1 protein in intestine and neuron loss in the spinal cord with EV71 3C K52R recombinant viral infection. Finally, we show that EV71 3C amino acid residues 45-52 involved in Ubc9 interaction determined the extent of 3C sumoylation and protein stability. Our results uncover a previously undescribed cellular regulatory event against EV71 virus replication and host cell apoptosis by sumoylation at 3C protease.	[Chen, Shu-Chuan; Wang, Yi-Wei; Chen, Yi-Chun; Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chen, Shu-Chuan; Wang, Yi-Wei; Shih, Hsiu-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11529, Taiwan; [Chang, Luan-Yin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Taipei 11529, Taiwan; [Weng, Kuo-Feng; Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan 33302, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital; Chang Gung University	Shih, HM (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	hmshih@ibms.sinica.edu.tw	Shih, Hsiu-Ming/S-7023-2018; Shih, Shin-Ru/M-9711-2016	CHANG, LUAN-YIN/0000-0003-2632-1956; Shih, Shin-Ru/0000-0003-4874-401X; Chen, Yi-Chun/0000-0001-6031-8414	National Science Council [NSC99-2321-B-002-025]; Frontier [NSC99-2321-B-001-007]; Academia Sinica Investigator Award	National Science Council(Ministry of Science and Technology, Taiwan); Frontier; Academia Sinica Investigator Award(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC99-2321-B-002-025, Frontier Grant NSC99-2321-B-001-007, and an Academia Sinica Investigator Award (to H.-M. S.).	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Calandria C, 2004, VIRUS RES, V104, P39, DOI 10.1016/j.virusres.2004.02.042; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chiocca S, 2007, BIOCHEM SOC T, V35, P1419, DOI 10.1042/BST0351419; CLARK ME, 1993, MOL CELL BIOL, V13, P1232, DOI 10.1128/MCB.13.2.1232; DOWNLOADED F, THOMSON; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; JOACHIMS M, 1995, VIROLOGY, V211, P451, DOI 10.1006/viro.1995.1427; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li Z, 2004, CANCER RES, V64, P9080, DOI 10.1158/0008-5472.CAN-04-2419; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; LIU JH, 1995, J EXP MED, V181, P1965, DOI 10.1084/jem.181.6.1965; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Muller S, 1999, J VIROL, V73, P5137; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; RUBINSTEIN SJ, 1992, J VIROL, V66, P3062, DOI 10.1128/JVI.66.5.3062-3068.1992; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shih SR, 2008, J NEUROVIROL, V14, P53, DOI 10.1080/13550280701798980; Shih SR, 2004, ANTIMICROB AGENTS CH, V48, P3523, DOI 10.1128/AAC.48.9.3523-3529.2004; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; Spengler ML, 2002, J VIROL, V76, P2990, DOI 10.1128/JVI.76.6.2990-2996.2002; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Votteler J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-11; Wang HY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-294; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wong TW, 2010, J ANTIMICROB CHEMOTH, V65, P2176, DOI 10.1093/jac/dkq301; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Yalamanchili P, 1997, J VIROL, V71, P1220, DOI 10.1128/JVI.71.2.1220-1226.1997; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	55	38	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31373	31384		10.1074/jbc.M111.254896	http://dx.doi.org/10.1074/jbc.M111.254896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784861	Green Published, hybrid			2022-12-27	WOS:000294487500032
J	Christensen, QH; Hagar, JA; O'Riordan, MXD; Cronan, JE				Christensen, Quin H.; Hagar, Jon A.; O'Riordan, Mary X. D.; Cronan, John E.			A Complex Lipoate Utilization Pathway in Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOIC ACID SYNTHESIS; INTRACELLULAR GROWTH; ESCHERICHIA-COLI; FATTY-ACIDS; CLONING; LPLA; METABOLISM; ATTACHMENT; EXPRESSION; FAMILY	Although a complete pathway of lipoic acid metabolism has been established in Escherichia coli, lipoic acid metabolism in other bacteria is more complex and incompletely understood. Listeria monocytogenes has been shown to utilize two lipoate-protein ligases for lipoic acid scavenging, whereas only one of the ligases can function in utilization of host-derived lipoic acid-modified peptides. We report that lipoic acid scavenging requires not only ligation of lipoic acid but also a lipoyl relay pathway in which an amidotransferase transfers lipoyl groups to the enzyme complexes that require the cofactor for activity. In addition, we provide evidence for a new lipoamidase activity that could allow utilization of lipoyl peptides by lipoate-protein ligase. These data support a model of an expanded, three-enzyme pathway for lipoic acid scavenging that seems widespread in the Firmicutes phylum of bacteria.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Christensen, Quin H.; Cronan, John E.] Univ Illinois, Chem Biol Interface Training Program, Urbana, IL 61801 USA; [Hagar, Jon A.; O'Riordan, Mary X. D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab, B103,601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019	O'Riordan, Mary/0000-0001-6014-4637	National Institutes of Health Ruth L. Kirschstein National Research Service [5 T32 GM070421 (NIGMS)]; NIAID [AI15650, AI064540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064540, R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award 5 T32 GM070421 (NIGMS) and Grants AI15650 (NIAID, to J. E. C.) and AI064540 (NIAID, to M. X. D. O.).	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Dowd GC, 2011, INFECT IMMUN, V79, P369, DOI 10.1128/IAI.00330-10; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; GOLOLOBOV MY, 1989, J THEOR BIOL, V140, P193, DOI 10.1016/S0022-5193(89)80128-6; Hassan BH, 2011, J BIOL CHEM, V286, P8263, DOI 10.1074/jbc.M110.194191; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; Keeney K, 2009, J BACTERIOL, V191, P2187, DOI 10.1128/JB.01179-08; Keeney KM, 2007, MOL MICROBIOL, V66, P758, DOI 10.1111/j.1365-2958.2007.05956.x; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; KUKSIS A, 1976, ANAL BIOCHEM, V70, P302, DOI 10.1016/0003-2697(76)90451-6; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LIU SJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P926, DOI 10.1006/abbi.1995.1124; Martin N, 2011, MOL MICROBIOL, V80, P335, DOI 10.1111/j.1365-2958.2011.07597.x; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; PRATT KJ, 1989, BIOCHEM J, V258, P749, DOI 10.1042/bj2580749; Sambrook J., 2001, MOL CLONING LAB MANU; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; SUZUKI K, 1963, J BIOL CHEM, V238, P4021; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	29	21	24	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31447	31456		10.1074/jbc.M111.273607	http://dx.doi.org/10.1074/jbc.M111.273607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768091	hybrid, Green Published			2022-12-27	WOS:000294487500039
J	Ghorpade, DS; Kaveri, SV; Bayry, J; Balaji, KN				Ghorpade, Devram Sampat; Kaveri, Srini V.; Bayry, Jagadeesh; Balaji, Kithiganahalli Narayanaswamy			RETRACTED: Cooperative Regulation of NOTCH1 Protein-Phosphatidylinositol 3-Kinase (PI3K) Signaling by NOD1, NOD2, and TLR2 Receptors Renders Enhanced Refractoriness to Transforming Growth Factor-beta (TGF-beta)- or Cytotoxic T-lymphocyte Antigen 4 (CTLA-4)-mediated Impairment of Human Dendritic Cell Maturation (Retracted article. See vol. 294, pg. 19449, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							MYCOBACTERIUM-TUBERCULOSIS; TGF-BETA; SOCS3 EXPRESSION; INNATE IMMUNITY; UP-REGULATION; CTLA-4; STIMULATION; DOMAIN; RECOGNITION; INFECTION	Dendritic cells (DCs) as sentinels of the immune system are important for eliciting both primary and secondary immune responses to a plethora of microbial pathogens. Cooperative stimulation of a complex set of pattern-recognition receptors, including TLR2 and nucleotide-binding oligomerization domain (NOD)-like receptors on DCs, acts as a rate-limiting factor in determining the initiation and mounting of the robust immune response. It underscores the need for "decoding" these multiple receptor interactions. In this study, we demonstrate that TLR2 and NOD receptors cooperatively regulate functional maturation of human DCs. Intriguingly, synergistic stimulation of TLR2 and NOD receptors renders enhanced refractoriness to TGF-beta- or CTLA-4-mediated impairment of human DC maturation. Signaling perturbation data suggest that NOTCH1-PI3K signaling dynamics assume critical importance in TLR2- and NOD receptor-mediated surmounting of CTLA-4- and TGF-beta -suppressed maturation of human DCs. Interestingly, the NOTCH1-PI3K signaling axis holds the capacity to regulate DC functions by virtue of PKC delta-MAPK-dependent activation of NF-kappa B. This study provides mechanistic and functional insights into TLR2-and NOD receptor-mediated regulation of DC functions and unravels NOTCH1-PI3K as a signaling cohort for TLR2 and NOD receptors. These findings serve in building a conceptual foundation for the design of improved strategies for adjuvants and immunotherapies against infectious diseases.	[Ghorpade, Devram Sampat; Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, U872, F-75006 Paris, France; [Ghorpade, Devram Sampat; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, Ctr Rech Cordeliers, Unite Mixte Rech Sante 872, Equipe Immunopathol & Therapeut Immunointervent 1, F-75006 Paris, France; [Kaveri, Srini V.] Univ Paris 05, Unite Mixte Rech Sante 872, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bayry, J (corresponding author), INSERM, U872, F-75006 Paris, France.	jagadeesh.bayry@crc.jussieu.fr; balaji@mcbl.iisc.ernet.in	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053	Indian Institute of Science; Departments of Biotechnology and Science and Technology; Council for Scientific and Industrial Research; VINNOVA, Sweden; Department of Biotechnology, India; INSERM; CNRS; Universite Pierre et Marie Curie; Universite Paris Descartes, France; INSERM-ICMR-AO; INSERM-ICMR	Indian Institute of Science; Departments of Biotechnology and Science and Technology; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); VINNOVA, Sweden(Vinnova); Department of Biotechnology, India(Department of Biotechnology (DBT) India); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; Universite Paris Descartes, France; INSERM-ICMR-AO; INSERM-ICMR	This work was supported by funds from Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, a collaborative grant for Indian Institute of Science and Karolinska Institute from VINNOVA, Sweden, and Department of Biotechnology, India (to K. N. B.), INSERM, CNRS, Universite Pierre et Marie Curie, Universite Paris Descartes, France (to S. V. K. and J. B.), and Cooperation INSERM-ICMR-AO 2009/2010 (to K. N. B. and J. B.).; Recipient of fellowships from INSERM-ICMR and Council for Scientific and Industrial Research.	Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Bayry J, 2009, NAT REV RHEUMATOL, V5, P244, DOI 10.1038/nrrheum.2009.77; Boisleve F, 2005, TOXICOLOGY, V206, P233, DOI 10.1016/j.tox.2004.08.015; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chang MX, 2011, FISH SHELLFISH IMMUN, V30, P118, DOI 10.1016/j.fsi.2010.09.014; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Elrefaei M, 2010, AIDS RES HUM RETROV, V26, P329, DOI 10.1089/aid.2009.0149; Elrefaei M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008194; Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Geissmann F, 1999, J IMMUNOL, V162, P4567; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P886, DOI 10.1016/j.dci.2011.01.008; Henckaerts L, 2007, INFLAMM BOWEL DIS, V13, P235, DOI 10.1002/ibd.20066; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim SG, 2004, ARCH PHARM RES, V27, P757, DOI 10.1007/BF02980145; Leng QB, 2006, INT IMMUNOL, V18, P637, DOI 10.1093/intimm/dxh375; Li JF, 1999, J IMMUNOL, V163, P6386; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; McKinsey TA, 2000, MOL IMMUNOL, V37, P783, DOI 10.1016/S0161-5890(00)00099-7; Melendez AJ, 1999, IMMUNOLOGY, V98, P1; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2009, MOL IMMUNOL, V46, P2947, DOI 10.1016/j.molimm.2009.06.019; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ohtani T, 2009, IMMUNOLOGY, V126, P485, DOI 10.1111/j.1365-2567.2008.02919.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Reuter MA, 2010, J VIROL, V84, P8549, DOI 10.1128/JVI.02303-09; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sousa CRE, 2001, IMMUNITY, V14, P495; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	62	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31347	31360		10.1074/jbc.M111.232413	http://dx.doi.org/10.1074/jbc.M111.232413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768114	hybrid, Green Published			2022-12-27	WOS:000294487500030
J	Spinnler, K; Frohlich, T; Arnold, GJ; Kunz, L; Mayerhofer, A				Spinnler, Katrin; Froehlich, Thomas; Arnold, Georg J.; Kunz, Lars; Mayerhofer, Artur			Human Tryptase Cleaves Pro-Nerve Growth Factor (Pro-NGF) HINTS OF LOCAL, MAST CELL-DEPENDENT REGULATION OF NGF/PRO-NGF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTICULAR PERITUBULAR CELLS; PRECURSOR PROTEIN EXPRESSION; HUMAN GRANULOSA-CELLS; MALE-INFERTILITY; HUMAN TESTIS; RECEPTORS; DEGRADATION; ACTIVATION; TRKA; P75	Several factors regulate nerve growth factor (NGF), which is formed from pro-NGF by intracellular and extracellular enzymatic cleavage. The close proximity between mast cells expressing the protease tryptase and NGF-producing smooth muscle-like peritubular cells in the testes of infertile patients led us to examine whether tryptase is among those factors. Human peritubular cells express functional tryptase receptors (PAR-2). Recombinant enzymatically active beta-tryptase increased NGF levels in the culture medium of primary human peritubular cells, but the peptide agonist for PAR-2 (SLIGKV) did not. Neither tryptase nor the peptide increased NGF mRNA levels. To test whether the increase in NGF is due to enzymatic activity of tryptase acting on pro-NGF, supernatants of peritubular cells and synthetic pro-NGF were treated with tryptase. Results of Western blot studies indicate enzymatic cleavage of pro-NGF by active tryptase. Heat-inactivated tryptase or SLIGKV was not effective. Mass spectrometry analysis of in vitro cleavage products from recombinant tryptase and synthetic pro-NGF revealed multiple cleavage sites within the pro-NGF sequence. The results also indicate the generation of mature NGF and smaller NGF fragments as a result of tryptase action. Thus, tryptase-secreting mast cells in the vicinity of pro-NGF/NGF-secreting cells in any human tissue are likely able to alter the ratios of pro-NGF/NGF. As NGF and pro-NGF have different affinities for their receptors, this indicates a novel way by which mast cells, via tryptase, can modify the microenvironment in human tissues with regard to neurotrophin actions.	[Spinnler, Katrin; Mayerhofer, Artur] Univ Munich, Inst Cell Biol & Anat, D-80802 Munich, Germany; [Froehlich, Thomas; Arnold, Georg J.] Univ Munich, Gene Ctr, Lab Funct Genome Anal, D-81377 Munich, Germany; [Kunz, Lars] Univ Munich, Dept Biol 2, Div Neurobiol, D-82152 Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich	Mayerhofer, A (corresponding author), Univ Munich, Inst Cell Biol & Anat, Biedersteiner Str 29, D-80802 Munich, Germany.	mayerhofer@lrz.uni-muenchen.de	Fröhlich, Thomas/C-6735-2011	Fröhlich, Thomas/0000-0002-4709-3211; Mayerhofer, Artur/0000-0002-9388-4639	Deutsche Forschungsgemeinschaft (DFG) [MA 1080/16-3, MA 1080/17-3, MA 1080/20-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant MA 1080/16-3 and in part by DFG Grants MA 1080/17-3 and MA 1080/20-1.	ADAM M, 2011, HUM REPROD IN PRESS; Albrecht M, 2006, J CLIN ENDOCR METAB, V91, P1956, DOI 10.1210/jc.2005-2169; Aloe L, 2001, Arch Physiol Biochem, V109, P354, DOI 10.1076/apab.109.3.354.9339; Anaf V, 2006, FERTIL STERIL, V86, P1336, DOI 10.1016/j.fertnstert.2006.03.057; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Bose Chinmoy K, 2009, J Stem Cells, V4, P217, DOI jsc.2010.4.4.217; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Caroleo MC, 2001, J NEUROIMMUNOL, V113, P193, DOI 10.1016/S0165-5728(00)00441-0; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; Chen Y, 1997, MOL CELL ENDOCRINOL, V127, P129, DOI 10.1016/S0303-7207(96)04001-4; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Delsite R, 1999, PROSTATE, V41, P39, DOI 10.1002/(SICI)1097-0045(19990915)41:1<39::AID-PROS6>3.0.CO;2-E; DISSEN GA, 1995, ENDOCRINOLOGY, V136, P4681, DOI 10.1210/en.136.10.4681; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fajardo I, 2003, BIOCHEM J, V369, P603, DOI 10.1042/BJ20021418; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Frungieri MB, 2002, FERTIL STERIL, V78, P298, DOI 10.1016/S0015-0282(02)03206-5; FURUKAWA S, 1987, BIOCHEM BIOPH RES CO, V147, P1048, DOI 10.1016/S0006-291X(87)80176-6; Girard BM, 2011, AM J PHYSIOL-RENAL, V300, pF345, DOI 10.1152/ajprenal.00515.2010; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Hayashi K, 2007, EUR J ORAL SCI, V115, P344, DOI 10.1111/j.1600-0722.2007.00480.x; Heider U, 2001, FERTIL STERIL, V75, P1141, DOI 10.1016/S0015-0282(01)01805-2; Imamura T, 1996, LAB INVEST, V74, P861; Julio-Pieper M, 2009, J CLIN ENDOCR METAB, V94, P3065, DOI 10.1210/jc.2009-0542; Kaminska R, 1999, J INVEST DERMATOL, V113, P567, DOI 10.1046/j.1523-1747.1999.00738.x; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li XD, 2006, ENDOCRINOLOGY, V147, P1271, DOI 10.1210/en.2005-0654; Lipnik-Stangelj M, 2006, BIOCHEM PHARMACOL, V72, P1375, DOI 10.1016/j.bcp.2006.06.028; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Mayerhofer A, 1996, ENDOCRINOLOGY, V137, P5662, DOI 10.1210/en.137.12.5662; Mayerhofer A, 1999, J ANDROL, V20, P341; Meineke V, 2000, FERTIL STERIL, V74, P239, DOI 10.1016/S0015-0282(00)00626-9; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Palardini A, 2008, NEUROPEPTIDES, V42, P205, DOI 10.1016/j.npep.2007.11.004; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Rauter I, 2008, J ALLERGY CLIN IMMUN, V121, P197, DOI 10.1016/j.jaci.2007.08.015; Reinshagen M, 2000, J NEUROCHEM, V74, P2127, DOI 10.1046/j.1471-4159.2000.0742127.x; Rey-Ares V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-40; Saller S, 2010, HUM REPROD, V25, P969, DOI 10.1093/humrep/dep467; Schell C, 2010, ENDOCRINOLOGY, V151, P1257, DOI 10.1210/en.2009-1325; Schell C, 2008, ENDOCRINOLOGY, V149, P1678, DOI 10.1210/en.2007-1064; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; Strauss L, 2009, ENDOCRINOLOGY, V150, P2865, DOI 10.1210/en.2008-1311; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; TAM EK, 1990, AM J RESP CELL MOL, V3, P27, DOI 10.1165/ajrcmb/3.1.27; Welker P, 2000, IMMUNOLOGY, V99, P418, DOI 10.1046/j.1365-2567.2000.00984.x; Yardley G, 2000, EXP DERMATOL, V9, P283, DOI 10.1034/j.1600-0625.2000.009004283.x; Yoon SO, 1998, J NEUROSCI, V18, P3273	61	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31707	31713		10.1074/jbc.M111.233486	http://dx.doi.org/10.1074/jbc.M111.233486			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768088	Green Published, hybrid			2022-12-27	WOS:000294487500063
J	Wu, XN; Wang, XK; Wu, SQ; Lu, JW; Zheng, M; Wang, YH; Zhou, HM; Zhang, HB; Han, JH				Wu, Xiao-Nan; Wang, Xue-Kun; Wu, Su-Qin; Lu, Jiawei; Zheng, Min; Wang, Yan-Hai; Zhou, Huamin; Zhang, Hongbing; Han, Jiahuai			Phosphorylation of Raptor by p38 beta Participates in Arsenite-induced Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP-KINASES; PROTEIN-KINASES; TUBEROUS SCLEROSIS; IMMUNE-RESPONSE; CELL-GROWTH; RAG GTPASES; S6 KINASE; TSC2; PATHWAY; STRESS	Cell growth is influenced by environmental stress. Mammalian target of rapamycin (mTOR), the central regulator of cell growth, can be positively or negatively regulated by various stresses through different mechanisms. The p38 MAP kinase pathway is essential in cellular stress responses. Activation of MK2, a downstream kinase of p38 alpha, enhances mTOR complex 1 (mTORC1) activity by preventing TSC2 from inhibiting mTOR activation. The p38 beta-PRAK cascade targets Rheb to inhibit mTORC1 activity upon glucose depletion. Here we show the activation of p38 beta participates in activation of mTOR complex 1 (mTORC1) induced by arsenite but not insulin, nutrients, anisomycin, or H2O2. Arsenite treatment of cells activates p38 beta and induces interaction between p38 beta and Raptor, a regulatory component of mTORC1, resulting in phosphorylation of Raptor on Ser(863) and Ser(771). The phosphorylation of Raptor on these sites enhances mTORC1 activity, and contributes largely to arsenite-induced mTORC1 activation. Our results shown here and in previous work demonstrate that the p38 pathway can regulate different components of the mTORC1 pathway, and that p38 beta can target different substrates to either positively or negatively regulate mTORC1 activation when a cell encounters different environmental stresses.	[Wu, Xiao-Nan; Wang, Xue-Kun; Wu, Su-Qin; Zheng, Min; Wang, Yan-Hai; Zhou, Huamin; Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Wu, Xiao-Nan; Wang, Xue-Kun; Wu, Su-Qin; Zheng, Min; Wang, Yan-Hai; Zhou, Huamin; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Lu, Jiawei] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Hongbing] Peking Union Med Coll, Beijing 100005, Peoples R China	Xiamen University; Xiamen University; Scripps Research Institute; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Han, JH (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	Han, J/G-4671-2010		National Institutes of Health [AI41637, AI68896]; NSF China [30830092, 30921005, 30828219, 31070688]; Fujian Provincial Department of Science Technology [2010J01228]; Science Planning Program of Fujian Province, 973 program [2009J1010, 2009CB522200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068896, R01AI041637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science Technology; Science Planning Program of Fujian Province, 973 program(National Basic Research Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants National Institutes of Health AI41637 and AI68896, and NSF China Grant 30830092, 30921005, 30828219, and 31070688, Fujian Provincial Department of Science & Technology Grant 2010J01228, and Science Planning Program of Fujian Province Grant 2009J1010, 973 program 2009CB522200.	BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gaestel M, 2008, FRONT BIOSCI, V13, P6050, DOI 10.2741/3136; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	42	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31501	31511		10.1074/jbc.M111.233122	http://dx.doi.org/10.1074/jbc.M111.233122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757713	Green Published, hybrid			2022-12-27	WOS:000294487500045
J	Sarkis, J; Hubert, JF; Legrand, B; Robert, E; Cheron, A; Jardin, J; Hitti, E; Le Rumeur, E; Vie, V				Sarkis, Joe; Hubert, Jean-Francois; Legrand, Baptiste; Robert, Estelle; Cheron, Angelique; Jardin, Julien; Hitti, Eric; Le Rumeur, Elisabeth; Vie, Veronique			Spectrin-like Repeats 11-15 of Human Dystrophin Show Adaptations to a Lipidic Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; AIR-WATER-INTERFACE; ROD DOMAIN; PROTEIN STRUCTURES; STABILITY PROPERTIES; IR SPECTROSCOPY; SKELETAL-MUSCLE; ATOMIC-FORCE; MONOLAYERS; MEMBRANE	Dystrophin is essential to skeletal muscle function and confers resistance to the sarcolemma by interacting with cytoskeleton and membrane. In the present work, we characterized the behavior of dystrophin 11-15 (DYS R11-15), five spectrin-like repeats from the central domain of human dystrophin, with lipids. DYSR11-15 displays an amphiphilic character at the liquid/air interface while maintaining its secondary alpha-helical structure. The interaction of DYS R11-15 with small unilamellar vesicles (SUVs) depends on the lipid nature, which is not the case with large unilamellar vesicles (LUVs). In addition, switching from anionic SUVs to anionic LUVs suggests the lipid packing as a crucial factor for the interaction of protein and lipid. The monolayer model and the modulation of surface pressure aim to mimic the muscle at work (i.e. dynamic changes of muscle membrane during contraction and relaxation) (high and low surface pressure). Strikingly, the lateral pressure modifies the protein organization. Increasing the lateral pressure leads the proteins to be organized in a regular network. Nevertheless, a different protein conformation after its binding to monolayer is revealed by trypsin proteolysis. Label-free quantification by nano-LC/MS/MS allowed identification of the helices in repeats 12 and 13 involved in the interaction with anionic SUVs. These results, combined with our previous studies, indicate that DYS R11-15 constitutes the only part of dystrophin that interacts with anionic as well as zwitterionic lipids and adapts its interaction and organization depending on lipid packing and lipid nature. We provide strong experimental evidence for a physiological role of the central domain of dystrophin in sarcolemma scaffolding through modulation of lipid-protein interactions.	[Vie, Veronique] Univ Rennes 1, CNRS, Inst Phys Rennes, UMR 6251, F-35042 Rennes, France; [Sarkis, Joe; Hubert, Jean-Francois; Legrand, Baptiste; Robert, Estelle; Cheron, Angelique; Jardin, Julien; Hitti, Eric; Le Rumeur, Elisabeth; Vie, Veronique] Univ Europeenne Bretagne, F-35000 Rennes, France; [Sarkis, Joe; Hubert, Jean-Francois; Legrand, Baptiste; Cheron, Angelique; Le Rumeur, Elisabeth] CNRS, Equipe RMN Interact Lipides Prot, Fac Med, UMR 6026,IFR 140,CS 34317, F-35043 Rennes, France; [Jardin, Julien] INRA, AGROCAMPUS OUEST, UMR Sci & Technol Lait & Oeuf 1253, F-35042 Rennes, France; [Hitti, Eric] INSERM 642, LTSI, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; Agrocampus Ouest; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vie, V (corresponding author), Univ Rennes 1, CNRS, Inst Phys Rennes, UMR 6251, 263 Av Gen Leclerc,Bat 11A, F-35042 Rennes, France.	veronique.vie@univ-rennes1.fr	HITTI, Eric/ABC-7717-2020; Legrand, Baptiste/ABB-2552-2021; JARDIN, Julien/A-3241-2012	JARDIN, Julien/0000-0003-0520-9391; Legrand, Baptiste/0000-0001-8931-7757; Sarkis, Joe/0000-0002-9342-7198	Association Francaise contre les Myopathies; RTR-BRESMAT (Universite Europeenne de Bretagne)	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); RTR-BRESMAT (Universite Europeenne de Bretagne)	This work was supported by the "Association Francaise contre les Myopathies" and by RTR-BRESMAT (Universite Europeenne de Bretagne).	Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ, P340; Baker RD, 2001, LIFETIME DATA ANAL, V7, P65, DOI 10.1023/A:1009677227030; BERGE B, 1993, EUROPHYS LETT, V21, P773, DOI 10.1209/0295-5075/21/7/010; BLAUDEZ D, 1993, APPL SPECTROSC, V47, P869, DOI 10.1366/0003702934415273; Blaudez D, 1996, J CHEM SOC FARADAY T, V92, P525, DOI 10.1039/ft9969200525; Bottier C, 2008, LANGMUIR, V24, P10901, DOI 10.1021/la800697s; Boutrou R, 2008, J AGR FOOD CHEM, V56, P8166, DOI 10.1021/jf801140d; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHI LF, 1993, SCIENCE, V259, P213, DOI 10.1126/science.259.5092.213; Chieze L, 2011, J MOL BIOL, V410, P60, DOI 10.1016/j.jmb.2011.04.006; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; DEMEL RA, 1987, BIOCHEMISTRY-US, V26, P8659, DOI 10.1021/bi00400a025; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; FIEHN W, 1971, J BIOL CHEM, V246, P5617; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kearney P, 2003, J Bioinform Comput Biol, V1, P183, DOI 10.1142/S021972000300023X; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Krieger CC, 2010, CYTOSKELETON, V67, P796, DOI 10.1002/cm.20489; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larios C, 2006, J PHYS CHEM B, V110, P23292, DOI 10.1021/jp0628582; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lavoie H, 2002, BIOPHYS J, V83, P3558, DOI 10.1016/S0006-3495(02)75356-3; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Legardinier S, 2008, BBA-PROTEINS PROTEOM, V1784, P672, DOI 10.1016/j.bbapap.2007.12.014; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MIKRUT JM, 1993, PHYS REV B, V48, P14479, DOI 10.1103/PhysRevB.48.14479; PEREZ JA, 1995, ANAL CHIM ACTA, V303, P65, DOI 10.1016/0003-2670(94)00570-C; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PONS F, 1990, P NATL ACAD SCI USA, V87, P7851, DOI 10.1073/pnas.87.20.7851; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Sospedra P, 1999, LANGMUIR, V15, P5111, DOI 10.1021/la981305i; Vie V, 2010, BBA-BIOMEMBRANES, V1798, P1503, DOI 10.1016/j.bbamem.2010.04.005; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S	57	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30481	30491		10.1074/jbc.M111.243881	http://dx.doi.org/10.1074/jbc.M111.243881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21712383	Green Published, hybrid			2022-12-27	WOS:000294283600027
J	Zeth, K; Pechlivanis, M; Samol, A; Pleiser, S; Vonrhein, C; Kerkhoff, E				Zeth, Kornelius; Pechlivanis, Markos; Samol, Annette; Pleiser, Sandra; Vonrhein, Clemens; Kerkhoff, Eugen			Molecular Basis of Actin Nucleation Factor Cooperativity CRYSTAL STRUCTURE OF THE SPIR-1 KINASE NON-CATALYTIC C-LOBE DOMAIN (KIND).FORMIN-2 FORMIN SPIR INTERACTION MOTIF (FSI) COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; VERY-KIND; DENDRITE GROWTH; EXCHANGE FACTOR; MICROTUBULE; CAPPUCCINO; ACTIVATION; SUBUNIT; GTPASES; OOCYTE	The distinct actin nucleation factors of the Spir and formin subgroup families cooperate in actin nucleation. The Spir/formin cooperativity has been identified to direct two essential steps in mammalian oocyte maturation, the asymmetric spindle positioning and polar body extrusion during meiosis. Understanding the nature and regulation of the Spir/Fmn cooperation is an important requirement to comprehend mammalian reproduction. Recently we dissected the structural elements of the Spir and Fmn family proteins, which physically link the two actin nucleation factors. The trans-regulatory interaction is mediated by the Spir kinase non-catalytic C-lobe domain (KIND) and the C-terminal formin Spir interaction motif (FSI). The interaction inhibits formin nucleation activity and enhances the Spir activity. To get insights into the molecular mechanism of the Spir/Fmn interaction, we determined the crystal structure of the KIND domain alone and in complex with the C-terminal Fmn-2 FSI peptide. Together they confirm the proposed structural homology of the KIND domain to the protein kinase fold and reveal the basis of the Spir/formin interaction. The complex structure showed a large interface with conserved and positively charged residues of the Fmn FSI peptide mediating major contacts to an acidic groove on the surface of KIND. Protein interaction studies verified the electrostatic nature of the interaction. The data presented here provide the molecular basis of the Spir/formin interaction and give a first structural view into the mechanisms of actin nucleation factor cooperativity.	[Pechlivanis, Markos; Samol, Annette; Pleiser, Sandra; Kerkhoff, Eugen] Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Bavarian Genome Res Network BayGene, D-93053 Regensburg, Germany; [Vonrhein, Clemens] Global Phasing Ltd, Cambridge CB3 0AX, England; [Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	University of Regensburg; Global Phasing Limited; Max Planck Society	Kerkhoff, E (corresponding author), Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Bavarian Genome Res Network BayGene, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	eugen.kerkhoff@klinik.uni-regensburg.de			Bavarian Genome Research Network (BayGene); German Research Foundation (DFG) [SPP 1135, SPP 1464]; Max Planck Society	Bavarian Genome Research Network (BayGene); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by the Bavarian Genome Research Network (BayGene) and the German Research Foundation (DFG SPP 1135, SPP 1464) (to E.K.) and DFG SPP 1464 and the Max Planck Society (to K.Z.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ciccarelli FD, 2003, TRENDS BIOCHEM SCI, V28, P349, DOI 10.1016/S0968-0004(03)00116-6; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dominguez R, 2010, CURR OPIN STRUC BIOL, V20, P217, DOI 10.1016/j.sbi.2009.12.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huang JH, 2011, FEBS J, V278, P1651, DOI 10.1111/j.1742-4658.2011.08085.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keegan RM, 2011, ACTA CRYSTALLOGR D, V67, P313, DOI 10.1107/S0907444911007530; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Mees A, 2005, GENE EXPR PATTERNS, V6, P79, DOI 10.1016/j.modgep.2005.04.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2008, NAT CELL BIOL, V10, P13, DOI 10.1038/ncb0108-13; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Stenzel N, 2009, J CELL SCI, V122, P3374, DOI 10.1242/jcs.046854; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wellington A, 1999, DEVELOPMENT, V126, P5267; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	32	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30732	30739		10.1074/jbc.M111.257782	http://dx.doi.org/10.1074/jbc.M111.257782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21705804	Green Published, hybrid			2022-12-27	WOS:000294283600053
J	Das, S; Kelschenbach, J; Charboneau, R; Barke, RA; Roy, S				Das, Subhas; Kelschenbach, Jennifer; Charboneau, Richard; Barke, Roderick A.; Roy, Sabita			Morphine Withdrawal Stress Modulates Lipopolysaccharide-induced Interleukin 12 p40 (IL-12p40) Expression by Activating Extracellular Signal-regulated Kinase 1/2, Which Is Further Potentiated by Glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALOXONE-PRECIPITATED WITHDRAWAL; MESSENGER-RNA EXPRESSION; HUMAN MONOCYTIC CELLS; DEPENDENT RATS; TRANSCRIPTION FACTORS; CYTOKINE PATTERNS; IMMUNE FUNCTION; NEURAL SYSTEM; NITRIC-OXIDE; MICE	Withdrawal stress is a common occurrence in opioid users, yet very few studies have examined the effects of morphine withdrawal (MW) on immune functioning or the role of glucocorticoids in MW-induced immunomodulation. This study investigated for the first time the role of glucocorticoids in MW modulation of LPS-induced IL-12p40, a key cytokine playing a pivotal role in immunoprotection. Using WT and mu-opioid receptor knock-out mice, we show that MW in vivo significantly attenuated LPS-induced IL-12p40 mRNA and protein expression. The role of glucocorticoids in MW modulation of IL-12p40 was investigated using a murine macrophage cell line, CRL2019, in an in vitro MW model. Interestingly, MW alone in the absence of glucocorticoids resulted in a significant reduction in IL-12p40 promoter activity and mRNA and protein expression. EMSA revealed a concurrent decrease in consensus binding to transcription factors NF kappa B, Activator Protein-1, and CCAAT/enhancer-binding protein and Western blot analysis demonstrated a significant activation of LPS-induced ERK1/2 phosphorylation. Interestingly, although glucocorticoid treatment alone also modulated these transcription factors and ERK1/2 activation, the addition of glucocorticoids to MW samples resulted in a greater than additive reduction in the transcription factors and significant hyperactivation of LPS-induced ERK1/2 phosphorylation. ERK inhibitors reversed MW and MW plus corticosterone inhibition of LPS-induced IL-12p40. The potentiating effects of glucocorticoids were non-genomic because nuclear translocation of glucocorticoid receptor was not significantly different between MW and corticosterone treatment. This study demonstrates for the first time that MW and glucocorticoids independently modulate IL-12p40 production through a mechanism involving ERK1/2 hyperactivation and that glucocorticoids can significantly augment MW-induced inhibition of IL-12p40.	[Das, Subhas; Barke, Roderick A.; Roy, Sabita] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kelschenbach, Jennifer; Roy, Sabita] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Charboneau, Richard; Barke, Roderick A.] Vet Affairs Med Ctr, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Mayo Mail Code 195,420 Delaware St SE, Minneapolis, MN 55455 USA.	royxx002@umn.edu	Das, Subhas/AAA-4568-2022		National Institutes of Health [RO1 DA 12104, RO1 DA 022935, KO2 DA 015349, P50 DA11806]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022935, R01DA031202, T32DA007097, P50DA011806, K02DA015349, R01DA012104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA 12104, RO1 DA 022935, KO2 DA 015349, and P50 DA11806 (to S. R.).	BHARGAVA HN, 1994, BRAIN RES, V642, P1, DOI 10.1016/0006-8993(94)90899-0; Boucher JG, 2010, VIRAL IMMUNOL, V23, P17, DOI 10.1089/vim.2009.0054; BRYANT HU, 1988, BIOCHEM PHARMACOL, V37, P3777, DOI 10.1016/0006-2952(88)90415-7; BRYANT HU, 1988, PSYCHOSOM MED, V50, P576, DOI 10.1097/00006842-198811000-00003; Cao JL, 2005, PAIN, V118, P336, DOI 10.1016/j.pain.2005.09.006; Cao JL, 2006, NEUROPHARMACOLOGY, V51, P315, DOI 10.1016/j.neuropharm.2006.03.028; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Casar B, 2009, CELL CYCLE, V8, P1007, DOI 10.4161/cc.8.7.8078; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Eisenstein TK, 2006, J NEUROIMMUNE PHARM, V1, P237, DOI 10.1007/s11481-006-9019-1; Feng P, 2005, INFECT IMMUN, V73, P7953, DOI 10.1128/IAI.73.12.7953-7959.2005; Feng P, 2005, J NEUROIMMUNOL, V164, P57, DOI 10.1016/j.jneuroim.2005.03.017; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Kelschenbach J, 2005, J IMMUNOL, V175, P2655, DOI 10.4049/jimmunol.175.4.2655; KISHIOKA S, 1994, JPN J PHARMACOL, V66, P257, DOI 10.1254/jjp.66.257; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Makara GB, 2001, PROG NEUROBIOL, V65, P367, DOI 10.1016/S0301-0082(01)00012-0; Milanes MV, 2002, NEUROSCI LETT, V334, P58, DOI 10.1016/S0304-3940(02)01036-4; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rahim RT, 2005, J LEUKOCYTE BIOL, V78, P1185, DOI 10.1189/jlb.0304123; Rahim RT, 2004, J NEUROIMMUNOL, V147, P114, DOI 10.1016/j.jneuroim.2003.10.024; Rahim RT, 2003, J NEUROIMMUNOL, V144, P16, DOI 10.1016/S0165-5728(03)00273-X; Rahim TR, 2002, J NEUROIMMUNOL, V127, P88, DOI 10.1016/S0165-5728(02)00103-0; Roy S, 2001, J NEUROIMMUNOL, V116, P147, DOI 10.1016/S0165-5728(01)00299-5; Roy S, 2006, J NEUROIMMUNE PHARM, V1, P77, DOI 10.1007/s11481-005-9009-8; Sacerdote Paola, 2008, Curr Opin Support Palliat Care, V2, P14, DOI 10.1097/SPC.0b013e3282f5272e; Seder RA, 1996, J IMMUNOL, V157, P2745; SIELING PA, 1994, IMMUNOBIOLOGY, V191, P378, DOI 10.1016/S0171-2985(11)80443-2; Stewart J, 2003, AM J ADDICTION, V12, P1, DOI 10.1080/10550490390143330; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; WAY EL, 1968, SCIENCE, V162, P1290, DOI 10.1126/science.162.3859.1290; Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5; ZHANG M, 1994, J CLIN INVEST, V93, P1733, DOI 10.1172/JCI117157; Zhang Y, 2010, J IMMUNOL, V184, P3866, DOI 10.4049/jimmunol.0903417; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	42	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29806	29817		10.1074/jbc.M111.271460	http://dx.doi.org/10.1074/jbc.M111.271460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730055	hybrid, Green Published			2022-12-27	WOS:000294046600040
J	Heuts, DPHM; Gummadova, JO; Pang, JY; Rigby, SEJ; Scrutton, NS				Heuts, Dominic P. H. M.; Gummadova, Jennet O.; Pang, Jiayun; Rigby, Stephen E. J.; Scrutton, Nigel S.			Reaction of Vascular Adhesion Protein-1 (VAP-1) with Primary Amines MECHANISTIC INSIGHTS FROM ISOTOPE EFFECTS AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; OXIDASE SSAO; DEHYDROGENASE; BINDING; SURFACE; ENZYME; PLASMA; PHENYLHYDRAZINE; STEREOCHEMISTRY; INHIBITORS	Human vascular adhesion protein-1 (VAP-1) is an endothelial copper-dependent amine oxidase involved in the recruitment and extravasation of leukocytes at sites of inflammation. VAP-1 is an important therapeutic target for several pathological conditions. We expressed soluble VAP-1 in HEK293 EBNA1 cells at levels suitable for detailed mechanistic studies with model substrates. Using the model substrate benzylamine, we analyzed the steady-state kinetic parameters of VAP-1 as a function of solution pH. We found two macroscopic pK(a) values that defined a bell-shaped plot of turnover number k(cat,app) as a function of pH, representing ionizable groups in the enzyme-substrate complex. The dependence of (k(cat)/K-m)(app) onpHrevealed a single pK(a) value (similar to 9) that we assigned to ionization of the amine group in free benzylamine substrate. A kinetic isotope effect (KIE) of 6 to 7.6 on (k(cat)/K-m)(app) over the pH range of 6 to 10 was observed with d2-benzylamine. Over the same pH range, the KIE on k(cat) was found to be close to unity. The unusual KIE values on (k(cat)/K-m)(app) were rationalized using a mechanistic scheme that includes the possibility of multiple isotopically sensitive steps. We also report the analysis of quantitative structure-activity relationships (QSAR) using para-substituted protiated and deuterated phenylethylamines. With phenylethylamines we observed a large KIE on k(cat, app) (8.01 +/- 0.28 with phenylethylamine), indicating that C-H bond breakage is limiting for 2,4,5-trihydroxyphenylalanine quinone reduction. Poor correlations were observed between steady-state rate constants and QSAR parameters. We show the importance of combining KIE, QSAR, and structural studies to gain insight into the complexity of the VAP-1 steady-state mechanism.	[Heuts, Dominic P. H. M.; Gummadova, Jennet O.; Rigby, Stephen E. J.; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Pang, Jiayun] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk	Pang, Jiayun/B-4274-2012	Pang, Jiayun/0000-0003-0689-8440	Ramsay Memorial Foundation Trust; BBSRC [BB/D01963X/1, BB/E013007/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, BB/D01963X/1] Funding Source: researchfish	Ramsay Memorial Foundation Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the Ramsay Memorial Foundation Trust.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; ALTON G, 1995, ARCH BIOCHEM BIOPHYS, V316, P353, DOI 10.1006/abbi.1995.1047; BARY Y, 1979, J CHEM SOC PERK T 2, P938, DOI 10.1039/p29790000938; Basran J, 2001, J BIOL CHEM, V276, P42887, DOI 10.1074/jbc.M108296200; Bonaiuto E, 2010, BIOCHIMIE, V92, P858, DOI 10.1016/j.biochi.2010.03.006; Boomsma F, 2005, MED SCI MONITOR, V11, pRA122; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dalfo E, 2003, BBA-MOL BASIS DIS, V1638, P278, DOI 10.1016/S0925-4439(03)00094-2; DuBois JL, 2006, BIOCHEMISTRY-US, V45, P3178, DOI 10.1021/bi052025m; DuBois JL, 2004, METHOD ENZYMOL, V378, P17; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; Enrique-Tarancon G, 1998, J BIOL CHEM, V273, P8025, DOI 10.1074/jbc.273.14.8025; Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515; FALK MC, 1983, BIOCHEMISTRY-US, V22, P3740, DOI 10.1021/bi00285a004; Federico R, 1997, BIOCHEM BIOPH RES CO, V240, P150, DOI 10.1006/bbrc.1997.7630; Gokturk C, 2007, AM J HYPERTENS, V20, P743, DOI 10.1016/j.amjhyper.2007.02.011; Hansch C, 1979, SUBSTITUENT CONSTANT, P1; Holt A, 2007, J NEURAL TRANSM, V114, P733, DOI 10.1007/s00702-007-0680-1; Hothi P, 2007, BIOCHEMISTRY-US, V46, P9250, DOI 10.1021/bi7007239; Hothi P, 2008, CHEMBIOCHEM, V9, P2839, DOI 10.1002/cbic.200800408; HYUN YL, 1995, BBA-PROTEIN STRUCT M, V1251, P198, DOI 10.1016/0167-4838(95)00117-D; HYUN YL, 1995, BIOCHEMISTRY-US, V34, P816, DOI 10.1021/bi00003a015; Jaakkola K, 1999, AM J PATHOL, V155, P1953, DOI 10.1016/S0002-9440(10)65514-9; Jakobsson E, 2005, ACTA CRYSTALLOGR D, V61, P1550, DOI 10.1107/S0907444905028805; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Kemik O, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-83; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kubinyi H, 1993, QSAR HANSCH ANAL REL; LINDSTROM A, 1976, EUR J BIOCHEM, V64, P321, DOI 10.1111/j.1432-1033.1976.tb10304.x; Macdonald PR, 2006, J BIOL CHEM, V281, P28408, DOI 10.1074/jbc.M605219200; MISRA HP, 1976, BIOCHEMISTRY-US, V15, P681, DOI 10.1021/bi00648a036; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Ohman J, 2006, PROTEIN EXPRES PURIF, V46, P321, DOI 10.1016/j.pep.2005.10.027; Olivieri A, 2010, BBA-PROTEINS PROTEOM, V1804, P941, DOI 10.1016/j.bbapap.2010.01.003; Pang JY, 2010, CHEM COMMUN, V46, P3104, DOI 10.1039/c003107k; Perrin CL, 2005, J AM CHEM SOC, V127, P9641, DOI 10.1021/ja0511927; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; PRECIOUS E, 1988, BIOCHEM PHARMACOL, V37, P707, DOI 10.1016/0006-2952(88)90145-1; Ruszczycky MW, 2006, J THEOR BIOL, V243, P328, DOI 10.1016/j.jtbi.2006.06.022; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Schramm VL, 2007, CURR OPIN CHEM BIOL, V11, P529, DOI 10.1016/j.cbpa.2007.07.013; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Stolen CM, 2004, FASEB J, V18, P702, DOI 10.1096/fj.03-0562fje; Swaroop A, 1988, GENOMICS, V2, P37, DOI 10.1016/0888-7543(88)90107-3; Wang EY, 2006, J MED CHEM, V49, P2166, DOI 10.1021/jm050538l; YANG CS, 1991, CHEM RES TOXICOL, V4, P408, DOI 10.1021/tx00022a002; Yraola F, 2009, CHEMMEDCHEM, V4, P495, DOI 10.1002/cmdc.200800393	49	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29584	29593		10.1074/jbc.M111.232850	http://dx.doi.org/10.1074/jbc.M111.232850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737458	Green Published, hybrid			2022-12-27	WOS:000294046600016
J	Ilghari, D; Lightbody, KL; Veverka, V; Waters, LC; Muskett, FW; Renshaw, PS; Carr, MD				Ilghari, Dariush; Lightbody, Kirsty L.; Veverka, Vaclav; Waters, Lorna C.; Muskett, Frederick W.; Renshaw, Philip S.; Carr, Mark D.			Solution Structure of the Mycobacterium tuberculosis EsxG.EsxH Complex FUNCTIONAL IMPLICATIONS AND COMPARISONS WITH OTHER M. TUBERCULOSIS Esx FAMILY COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; ESAT-6-CFP-10 COMPLEX; SECRETION SYSTEM; VII SECRETION; ESAT-6; CFP-10/ESAT-6; RECOGNITION; PROTEINS; PROGRAM; MARINUM	Mycobacterium tuberculosis encodes five type VII secretion systems that are responsible for exporting a number of proteins, including members of the Esx family, which have been linked to tuberculosis pathogenesis and survival within host cells. The gene cluster encoding ESX-3 is regulated by the availability of iron and zinc, and secreted protein products such as the EsxG.EsxH complex have been associated with metal ion acquisition. EsxG and EsxH have previously been shown to form a stable 1:1 heterodimeric complex, and here we report the solution structure of the complex, which features a core four-helix bundle decorated at both ends by long, highly flexible, N- and C-terminal arms that contain a number of highly conserved residues. Despite clear similarities in the overall backbone fold to the EsxA.EsxB complex, the structure reveals some striking differences in surface features, including a potential protein interaction site on the surface of the EsxG.EsxH complex. EsxG.EsxH was also found to contain a specific Zn2+ binding site formed from a cluster of histidine residues on EsxH, which are conserved across obligate mycobacterial pathogens including M. tuberculosis and Mycobacterium leprae. This site may reflect an essential role in zinc ion acquisition or point to Zn2+-dependent regulation of its interaction with functional partner proteins. Overall, the surface features of both the EsxG.EsxH and the EsxA.EsxB complexes suggest functions mediated via interactions with one or more target protein partners.	[Ilghari, Dariush; Lightbody, Kirsty L.; Veverka, Vaclav; Waters, Lorna C.; Muskett, Frederick W.; Renshaw, Philip S.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester	Lightbody, KL (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	kll18@le.ac.uk; mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	Wellcome Trust [080085, 083629]; Iran Ministry of Health and Medical Education; UCB Celltech	Wellcome Trust(Wellcome TrustEuropean Commission); Iran Ministry of Health and Medical Education; UCB Celltech(UCB Pharma SA)	This work was supported by program and project grants from the Wellcome Trust (Grants 080085 and 083629, respectively).; Funded by a PhD student grant awarded by the Iran Ministry of Health and Medical Education. Present Address: Dept. of Pharmacology, School of Medicine, New York University Medical Center, New York, NY 10016.; Supported by UCB Celltech.	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Arbing MA, 2010, PROTEIN SCI, V19, P1692, DOI 10.1002/pro.451; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Ebert JC, 2008, PROTEIN SCI, V17, P54, DOI 10.1110/ps.073138508; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Ilghari D, 2009, BIOMOL NMR ASSIGN, V3, P171, DOI 10.1007/s12104-009-9167-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; Lightbody KL, 2004, FEMS MICROBIOL LETT, V238, P255, DOI 10.1016/j.femsle.2004.07.043; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Okkels LM, 2004, J BACTERIOL, V186, P2487, DOI 10.1128/JB.186.8.2487-2491.2004; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; San Roman SA, 2010, MICROBIOL-SGM, V156, P1719, DOI 10.1099/mic.0.037069-0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; SNOW GA, 1965, BIOCHEM J, V97, P166, DOI 10.1042/bj0970166; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; WHO, 2009, WHOHTMTB2009411; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009	44	58	62	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29993	30002		10.1074/jbc.M111.248732	http://dx.doi.org/10.1074/jbc.M111.248732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730061	Green Published, hybrid			2022-12-27	WOS:000294046600058
J	Bermudez, VP; Farina, A; Raghavan, V; Tappin, I; Hurwitz, J				Bermudez, Vladimir P.; Farina, Andrea; Raghavan, Vineetha; Tappin, Inger; Hurwitz, Jerard			Studies on Human DNA Polymerase epsilon and GINS Complex and Their Role in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; XENOPUS EGG EXTRACTS; SACCHAROMYCES-CEREVISIAE; S-PHASE; CATALYTIC DOMAINS; CRYSTAL-STRUCTURE; DISTINCT ROLES; ALPHA-PRIMASE; BUDDING YEAST; POL EPSILON	In eukaryotic cells, DNA replication is carried out by the coordinated action of three DNA polymerases (Pols), Pol alpha, delta, and epsilon. In this report, we describe the reconstitution of the human four-subunit Pol epsilon and characterization of its catalytic properties in comparison with Pol alpha and Pol delta. Human Pol epsilon holoenzyme is a monomeric complex containing stoichiometric subunit levels of p261/Pol 2, p59, p17, and p12. We show that the Pol epsilon p261 N-terminal catalytic domain is solely responsible for its ability to catalyze DNA synthesis. Importantly, human Pol (hPol) epsilon was found more processive than hPol delta in supporting proliferating cell nuclear antigen-dependent elongation of DNA chains, which is in keeping with proposed roles for hPol epsilon and hPol delta in the replication of leading and lagging strands, respectively. Furthermore, GINS, a component of the replicative helicase complex that is composed of Sld5, Psf1, Psf2, and Psf3, was shown to interact weakly with all three replicative DNA Pols (alpha, delta, and epsilon) and to markedly stimulate the activities of Pol alpha and Pol epsilon. In vivo studies indicated that siRNA-targeted depletion of hPol delta and/or hPol epsilon reduced cell cycle progression and the rate of fork progression. Under the conditions used, we noted that depletion of Pol epsilon had a more pronounced inhibitory effect on cellular DNA replication than depletion of Pol delta. We suggest that reduction in the level of Pol delta may be less deleterious because of its collision-and-release role in lagging strand synthesis.	[Bermudez, Vladimir P.; Farina, Andrea; Raghavan, Vineetha; Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Hurwitz, J (corresponding author), 1275 York Ave, New York, NY 10021 USA.	j-hurwitz@ski.mskcc.org						Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Baker T. A., 2005, DNA REPLICATION; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Errico A, 2010, EMBO REP, V11, P270, DOI 10.1038/embor.2010.27; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kang HY, 2000, GENETICS, V155, P1055; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Langston LD, 2008, J BIOL CHEM, V283, P29522, DOI 10.1074/jbc.M804488200; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Shikata Koh, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-21; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Waga S, 2001, P NATL ACAD SCI USA, V98, P4978, DOI 10.1073/pnas.081088798; Wang JF, 2010, BIOCHEM BIOPH RES CO, V395, P336, DOI 10.1016/j.bbrc.2010.04.006; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	58	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28963	28977		10.1074/jbc.M111.256289	http://dx.doi.org/10.1074/jbc.M111.256289			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705323	Green Published, hybrid			2022-12-27	WOS:000293837000033
J	Chutkow, WA; Lee, RT				Chutkow, William A.; Lee, Richard T.			Thioredoxin Regulates Adipogenesis through Thioredoxin-interacting Protein (Txnip) Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; BETA-ARRESTINS; DEFICIENCY; MICE; METABOLISM; ACTIVATION; DISULFIDE; DELETION; LIGASE	Txnip (thioredoxin-interacting protein) is a critical mediator of metabolism and adipogenesis in vivo. The mechanisms of action of Txnip are believed to operate at least in part by inhibiting the redox signaling functions of thioredoxin. We tested here whether Txnip suppressed adipogenesis by inhibiting thioredoxin and discovered a reversal of roles; Txnip inhibits adipogenesis directly, and thioredoxin binding regulates Txnip by enhancing Txnip protein stability. Unlike Txnip, a Txnip mutant that cannot bind thioredoxin (C247S) did not prevent adipocyte differentiation, but was degraded more quickly by proteasomal targeting. Finding that endogenous Txnip protein is also rapidly degraded at the onset of adipogenesis suggested that Txnip degradation is required for adipocyte differentiation. Thioredoxin overexpression stabilized Txnip protein levels to inhibit adipogenesis, and adipogenic stimulants such as insulin promoted Txnip-thioredoxin dissociation to the more labile free Txnip state. As an alpha-arrestin protein, Txnip has two C-terminal tail PPXY motifs that mediate E3 ubiquitin ligase binding and Txnip protein stability. Mutating the PPXY motifs prevented Txnip degradation, even when thioredoxin binding was lost, and restored the ability of C247S Txnip to inhibit adipogenesis. These studies present a novel reconsideration of Txnip-thioredoxin signaling by showing that thioredoxin regulates the intrinsic function of Txnip as an inhibitor of adipogenesis through protein stabilization.	[Chutkow, William A.; Lee, Richard T.] Brigham & Womens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Chutkow, William A.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Chutkow, William A.] Vet Healthcare Syst, W Roxbury, MA 02132 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Chutkow, WA (corresponding author), 65 Landsdowne St,Rm 280, Cambridge, MA 02139 USA.	wchutkow@partners.org		Lee, Richard/0000-0003-4687-1381	National Institutes of Health [K08 HL088977, R01 HL048743, R01 HL103582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL103582, K08HL088977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HL088977 (to W. A. C.) and R01 HL048743 and R01 HL103582 (to R. T. L.).	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Blouet C, 2011, J NEUROSCI, V31, P6019, DOI 10.1523/JNEUROSCI.6498-10.2011; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P222, DOI 10.1016/j.intimp.2006.10.001; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Shao WJ, 2010, CELL SIGNAL, V22, P1240, DOI 10.1016/j.cellsig.2010.04.001; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	30	42	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29139	29145		10.1074/jbc.M111.267666	http://dx.doi.org/10.1074/jbc.M111.267666			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705327	hybrid, Green Published			2022-12-27	WOS:000293837000050
J	Orru, R; Dudek, HM; Martinoli, C; Pazmino, DET; Royant, A; Weik, M; Fraaije, MW; Mattevi, A				Orru, Roberto; Dudek, Hanna M.; Martinoli, Christian; Pazmino, Daniel E. Torres; Royant, Antoine; Weik, Martin; Fraaije, Marco W.; Mattevi, Andrea			Snapshots of Enzymatic Baeyer-Villiger Catalysis OXYGEN ACTIVATION AND INTERMEDIATE STABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLACETONE-MONOOXYGENASE; CYCLOHEXANONE MONOOXYGENASE; SPECIFICITY; MECHANISM; CRYSTALS; OXIDASE; REVEAL	Baeyer-Villiger monooxygenases catalyze the oxidation of carbonylic substrates to ester or lactone products using NADPH as electron donor and molecular oxygen as oxidative reactant. Using protein engineering, kinetics, microspectrophotometry, crystallography, and intermediate analogs, we have captured several snapshots along the catalytic cycle which highlight key features in enzyme catalysis. After acting as electron donor, the enzyme-bound NADP(H) forms an H-bond with the flavin cofactor. This interaction is critical for stabilizing the oxygen-activating flavin-peroxide intermediate that results from the reaction of the reduced cofactor with oxygen. An essential active-site arginine acts as anchoring element for proper binding of the ketone substrate. Its positively charged guanidinium group can enhance the propensity of the substrate to undergo a nucleophilic attack by the flavin-peroxide intermediate. Furthermore, the arginine side chain, together with the NADP(+) ribose group, forms the niche that hosts the negatively charged Criegee intermediate that is generated upon reaction of the substrate with the flavin-peroxide. The fascinating ability of Baeyer-Villiger monooxygenases to catalyze a complex multistep catalytic reaction originates from concerted action of this Arg-NADP(H) pair and the flavin subsequently to promote flavin reduction, oxygen activation, tetrahedral intermediate formation, and product synthesis and release. The emerging picture is that these enzymes are mainly oxygen-activating and "Criegee-stabilizing" catalysts that act on any chemically suitable substrate that can diffuse into the active site, emphasizing their potential value as toolboxes for biocatalytic applications.	[Dudek, Hanna M.; Pazmino, Daniel E. Torres; Fraaije, Marco W.] Univ Groningen, Lab Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Orru, Roberto; Martinoli, Christian; Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; [Royant, Antoine; Weik, Martin] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, CNRS Commissariat Energie Atom, F-38027 Grenoble, France; [Royant, Antoine; Weik, Martin] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Groningen; University of Pavia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Fraaije, MW (corresponding author), Univ Groningen, Lab Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl; andrea.mattevi@unipv.it	Mattevi, Andrea/R-4469-2019; Royant, Antoine/G-3684-2012; Fraaije, Marco/E-8421-2014; Orru, Roberto/E-9779-2013; mattevi, andrea/K-5464-2012; Weik, Martin/M-2770-2017	Mattevi, Andrea/0000-0002-9523-7128; Royant, Antoine/0000-0002-1919-8649; mattevi, andrea/0000-0002-9523-7128; Weik, Martin/0000-0001-9297-642X; Fraaije, Marco/0000-0001-6346-5014	European Union Project Oxygreen [212281]; Fondazione Cariplo Grant [2008.3148]	European Union Project Oxygreen; Fondazione Cariplo Grant(Fondazione Cariplo)	This work was supported by European Union Project Oxygreen 212281 and Fondazione Cariplo Grant 2008.3148.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CRIEGEE R, 1948, LIEBIGS ANN CHEM, V560, P127; de Gonzalo G, 2006, J MOL CATAL B-ENZYM, V39, P91, DOI 10.1016/j.molcatb.2006.01.010; de Gonzalo G, 2005, TETRAHEDRON-ASYMMETR, V16, P3077, DOI 10.1016/j.tetasy.2005.08.004; de Gonzalo G, 2010, CHEMBIOCHEM, V11, P2208, DOI 10.1002/cbic.201000395; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dudek HM, 2010, APPL MICROBIOL BIOT, V88, P1135, DOI 10.1007/s00253-010-2769-y; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Fraaije MW, 2005, APPL MICROBIOL BIOT, V66, P393, DOI 10.1007/s00253-004-1749-5; GHISLA S, 2009, FLAVIN COENZYMES; JONES KC, 1986, J BIOL CHEM, V261, P2553; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Mihovilovic MD, 2002, EUR J ORG CHEM, V2002, P3711; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Pazmino DET, 2008, ANGEW CHEM INT EDIT, V47, P2275, DOI 10.1002/anie.200704630; Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reetz MT, 2009, J AM CHEM SOC, V131, P15424, DOI 10.1021/ja906212k; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; Pazmino DET, 2007, ADV SYNTH CATAL, V349, P1361, DOI 10.1002/adsc.200700045; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van den Heuvel RHH, 2005, J BIOL CHEM, V280, P32115, DOI 10.1074/jbc.M503758200; Weik M, 2010, ACTA CRYSTALLOGR D, V66, P437, DOI 10.1107/S0907444910002702; Wu S, 2010, P NATL ACAD SCI USA, V107, P2775, DOI 10.1073/pnas.0911656107	40	110	111	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29284	29291		10.1074/jbc.M111.255075	http://dx.doi.org/10.1074/jbc.M111.255075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697090	hybrid, Green Published			2022-12-27	WOS:000293837000084
J	Volonte, D; Galbiati, F				Volonte, Daniela; Galbiati, Ferruccio			Polymerase I and Transcript Release Factor (PTRF)/Cavin-1 Is a Novel Regulator of Stress-induced Premature Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; CAVEOLAE; FIBROBLASTS; P53; COMPLEXES; PROTEINS; CULTURE; BIOLOGY; GENES; PTRF	According to the "free radical theory" of aging, premature senescence induced by oxidative stress contributes to organismal aging. Polymerase I and transcript release factor (PTRF)/cavin-1 is a structural protein component of caveolae, invaginations of the plasma membrane involved in signal transduction. We show that oxidative stress up-regulates PTRF/cavin-1 protein expression and promotes the interaction between PTRF/cavin-1 and caveolin-1, another structural protein component of caveolae. Consistent with these data, the number of caveolae is dramatically increased in cells subjected to oxidative stress. We demonstrate that down-regulation of PTRF/cavin-1 by shRNA significantly inhibits oxidative stress-induced premature senescence. Mechanistically, we found that PTRF/cavin-1 expression is necessary for the oxidant-induced sequestration of Mdm2, a negative regulator of p53, into caveolar membranes, away from p53, and activation of the p53/p21(Waf1/Cip1) pathway. Expression of a mutant form of PTRF/cavin-1, which fails to localize to caveolar membranes after oxidative stress, inhibits oxidative stress-induced activation of p53 and induction of premature senescence. Thus, PTRF/cavin-1 is a novel regulator of oxidative stress-induced premature senescence by acting as a link between free radicals and activation of the p53/p21(Waf1/Cip1) pathway.	[Volonte, Daniela; Galbiati, Ferruccio] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020		National Institutes of Health through the NIA [R01-AG022548, R01-AG030636]; UPMC Health System; NATIONAL INSTITUTE ON AGING [R01AG022548, R01AG030636] Funding Source: NIH RePORTER	National Institutes of Health through the NIA; UPMC Health System; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG022548 and R01-AG030636 (to F. G.) through the NIA and the Competitive Medical Research Fund of the UPMC Health System (to D.V.).	Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jin SK, 2001, J CELL SCI, V114, P4139; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Mason SW, 1997, EMBO J, V16, P163, DOI 10.1093/emboj/16.1.163; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	35	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28657	28661		10.1074/jbc.C111.235119	http://dx.doi.org/10.1074/jbc.C111.235119			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705337	hybrid, Green Published			2022-12-27	WOS:000293837000002
J	Chanroj, S; Lu, YX; Padmanaban, S; Nanatani, K; Uozumi, N; Rao, R; Sze, H				Chanroj, Salil; Lu, Yongxian; Padmanaban, Senthilkumar; Nanatani, Kei; Uozumi, Nobuyuki; Rao, Rajini; Sze, Heven			Plant-Specific Cation/H+ Exchanger 17 and Its Homologs Are Endomembrane K+ Transporters with Roles in Protein Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; RECTIFYING POTASSIUM CHANNEL; VACUOLAR H+-ATPASE; PLASMA-MEMBRANE; ESCHERICHIA-COLI; TRANSLOCATING ATPASES; EVOLUTIONARY ORIGINS; VESICLE TRAFFICKING; NA+/H+ ANTIPORTERS; ION HOMEOSTASIS	The complexity of intracellular compartments in eukaryotic cells evolved to provide distinct environments to regulate processes necessary for cell proliferation and survival. A large family of predicted cation/proton exchangers (CHX), represented by 28 genes in Arabidopsis thaliana, are associated with diverse endomembrane compartments and tissues in plants, although their roles are poorly understood. We expressed a phylogenetically related cluster of CHX genes, encoded by CHX15-CHX20, in yeast and bacterial cells engineered to lack multiple cation-handling mechanisms. Of these, CHX16-CHX20 were implicated in pH homeostasis because their expression rescued the alkaline pH-sensitive growth phenotype of the host yeast strain. A smaller subset, CHX17-CHX19, also conferred tolerance to hygromycin B. Further differences were observed in K+ - and low pH-dependent growth phenotypes. Although CHX17 did not alter cytoplasmic or vacuolar pH in yeast, CHX20 elicited acidification and alkalization of the cytosol and vacuole, respectively. Using heterologous expression in Escherichia coli strains lacking K+ uptake systems, we provide evidence for K+ (Rb-86) transport mediated by CHX17 and CHX20. Finally, we show that CHX17 and CHX20 affected protein sorting as measured by carboxypeptidase Y secretion in yeast mutants grown at alkaline pH. In plant cells, CHX20-RFP co-localized with an endoplasmic reticulum marker, whereas RFP-tagged CHX17-CHX19 co-localized with prevacuolar compartment and endosome markers. Together, these results suggest that in response to environmental cues, multiple CHX transporters differentially modulate K+ and pH homeostasis of distinct intracellular compartments, which alter membrane trafficking events likely to be critical for adaptation and survival.	[Chanroj, Salil; Lu, Yongxian; Padmanaban, Senthilkumar; Sze, Heven] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chanroj, Salil; Lu, Yongxian; Padmanaban, Senthilkumar; Sze, Heven] Univ Maryland, Maryland Agr Expt Stn, College Pk, MD 20742 USA; [Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Nanatani, Kei; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Tohoku University	Sze, H (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 0120 Biosci Res Bldg 413, College Pk, MD 20742 USA.	hsze@umd.edu	Lu, Yongxian/I-4286-2012; Uozumi, Nobuyuki/AAG-3252-2019	Uozumi, Nobuyuki/0000-0003-4268-1126	National Institutes of Health [R01DK054214]; National Science Foundation [IBN0209788]; United States Department of Energy [BES DEFG0207ER15883]; Japan Society for the Promotion of Science [22020002, 22380056]; Royal Thai Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23780073] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Thai Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK054214 (to R. R.). This work was also supported by National Science Foundation Grant IBN0209788 and United States Department of Energy Grant BES DEFG0207ER15883 (to H. S.), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 22020002 and 22380056 (to N. U.), and a Royal Thai Government Fellowship (to S. C.).	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Bock KW, 2006, PLANT PHYSIOL, V140, P1151, DOI 10.1104/pp.105.074708; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Flis K, 2005, BIOCHEM J, V390, P655, DOI 10.1042/BJ20050480; Fujisawa M, 2007, P NATL ACAD SCI USA, V104, P13289, DOI 10.1073/pnas.0703709104; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kanter U, 2010, J EXP BOT, V61, P3995, DOI 10.1093/jxb/erq213; Kinclova-Zimmermannova O, 2006, FEMS YEAST RES, V6, P792, DOI 10.1111/j.1567-1364.2006.00062.x; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Lu YX, 2011, PLANT CELL, V23, P81, DOI 10.1105/tpc.110.080499; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Maresova L, 2006, YEAST, V23, P1167, DOI 10.1002/yea.1424; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Rose JKC, 2010, PLANT PHYSIOL, V153, P433, DOI 10.1104/pp.110.154872; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Schulte A, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-7; Schumacher K, 2010, CURR OPIN PLANT BIOL, V13, P724, DOI 10.1016/j.pbi.2010.07.003; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; SZE H, 1985, ANNU REV PLANT PHYS, V36, P175, DOI 10.1146/annurev.pp.36.060185.001135; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; UOZUMI N, 1995, J BIOL CHEM, V270, P24276, DOI 10.1074/jbc.270.41.24276; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Uozumi N, 2001, AM J PHYSIOL-CELL PH, V281, pC733, DOI 10.1152/ajpcell.2001.281.3.C733; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Wagner MC, 2006, ANTIMICROB AGENTS CH, V50, P587, DOI 10.1128/AAC.50.2.587-595.2006; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; WEGNER LH, 1994, J MEMBRANE BIOL, V142, P363, DOI 10.1007/BF00233442; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	58	63	71	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33931	33941		10.1074/jbc.M111.252650	http://dx.doi.org/10.1074/jbc.M111.252650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795714	hybrid, Green Published			2022-12-27	WOS:000295159200025
J	Piganis, RAR; De Weerd, NA; Gould, JA; Schindler, CW; Mansell, A; Nicholson, SE; Hertzog, PJ				Piganis, Rebecca A. R.; De Weerd, Nicole A.; Gould, Jodee A.; Schindler, Christian W.; Mansell, Ashley; Nicholson, Sandra E.; Hertzog, Paul J.			Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon alpha Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX MOTIF; PROTEIN; ACTIVATION; DOMAIN; UBIQUITINATION; TRANSDUCTION; EXPRESSION; SUBUNIT-1; INTERACTS; COMPLEX	Type I IFNs are critical players in host innate and adaptive immunity. IFN signaling is tightly controlled to ensure appropriate immune responses as imbalance could result in uncontrolled inflammation or inadequate responses to infection. It is therefore important to understand how type I IFN signaling is regulated. Here we have investigated the mechanism by which suppressor of cytokine signaling 1 (SOCS1) inhibits type I IFN signaling. We have found that SOCS1 inhibits type I IFN signaling not via a direct interaction with the IFN alpha receptor 1 (IFNAR1) receptor component but through an interaction with the IFNAR1-associated kinase Tyk2. We have characterized the residues/regions involved in the interaction between SOCS1 and Tyk2 and found that SOCS1 associates via its SH2 domain with conserved phosphotyrosines 1054 and 1055 of Tyk2. The kinase inhibitory region of SOCS1 is also essential for its interaction with Tyk2 and inhibition of IFN signaling. We also found that Tyk2 is preferentially Lys-63 polyubiquitinated and that this activation reaction is inhibited by SOCS1. The consequent effect of SOCS1 inhibition of Tyk2 not only results in a reduced IFN response because of inhibition of Tyk2 kinase-mediated STAT signaling but also negatively impacts IFNAR1 surface expression, which is stabilized by Tyk2.	[Piganis, Rebecca A. R.; De Weerd, Nicole A.; Gould, Jodee A.; Mansell, Ashley; Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Schindler, Christian W.] Columbia Univ, Coll Phys & Surg, Hammer Hlth Sci Ctr, Dept Microbiol, New York, NY 10027 USA; [Schindler, Christian W.] Columbia Univ, Coll Phys & Surg, Hammer Hlth Sci Ctr, Dept Med, New York, NY 10027 USA; [Nicholson, Sandra E.] Walter & Elisa Hall Inst, Melbourne, Vic 3001, Australia	Monash University; Columbia University; Columbia University	Hertzog, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia.	Paul.Hertzog@monash.edu	de Weerd, Nicole/X-5886-2019; Hertzog, Paul J/G-6734-2013; Mansell, Ashley/B-9553-2008; Hertzog, Paul J/I-7053-2013	de Weerd, Nicole/0000-0002-7985-189X; Hertzog, Paul J/0000-0002-1373-8472; Mansell, Ashley/0000-0002-6540-1281; Hertzog, Paul J/0000-0002-1373-8472; Porritt, Rebecca/0000-0002-0973-5092; , Sandra/0000-0002-1314-2134	National Health and Medical Research Council; Victorian Government	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by funding from the National Health and Medical Research Council and the Victorian Government Infrastructure Support Program.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; BARBIERI G, 1994, EUR J BIOCHEM, V223, P427, DOI 10.1111/j.1432-1033.1994.tb19010.x; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Giordanetto F, 2003, PROTEIN ENG, V16, P115, DOI 10.1093/proeng/gzg015; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jin XJ, 2010, J BIOL CHEM, V285, P30539, DOI 10.1074/jbc.M110.129551; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Qing Y, 2005, J BIOL CHEM, V280, P1849, DOI 10.1074/jbc.M409863200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Russell-Harde D, 2000, J BIOL CHEM, V275, P23981, DOI 10.1074/jbc.M002518200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Trajanovska S, 2003, J INTERF CYTOK RES, V23, P351, DOI 10.1089/107999003322226005; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483	33	104	119	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33811	33818		10.1074/jbc.M111.270207	http://dx.doi.org/10.1074/jbc.M111.270207			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21757742	Green Published, hybrid			2022-12-27	WOS:000295159200012
J	Kasaikina, MV; Fomenko, DE; Labunskyy, VM; Lachke, SA; Qiu, WY; Moncaster, JA; Zhang, J; Wojnarowicz, MW; Natarajan, SK; Malinouski, M; Schweizer, U; Tsuji, PA; Carlson, BA; Maas, RL; Lou, MF; Goldstein, LE; Hatfield, DL; Gladyshev, VN				Kasaikina, Marina V.; Fomenko, Dmitri E.; Labunskyy, Vyacheslav M.; Lachke, Salil A.; Qiu, Wenya; Moncaster, Juliet A.; Zhang, Jie; Wojnarowicz, Mark W., Jr.; Natarajan, Sathish Kumar; Malinouski, Mikalai; Schweizer, Ulrich; Tsuji, Petra A.; Carlson, Bradley A.; Maas, Richard L.; Lou, Marjorie F.; Goldstein, Lee E.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Roles of the 15-kDa Selenoprotein (Sep15) in Redox Homeostasis and Cataract Development Revealed by the Analysis of Sep 15 Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; CELL-DEATH; SELENIUM; EXPRESSION; MUTATIONS; DISEASE; GENE; POLYMORPHISMS; SYSTEMS	The 15-kDa selenoprotein (Sep15) is a thioredoxin-like, endoplasmic reticulum-resident protein involved in the quality control of glycoprotein folding through its interaction with UDP-glucose: glycoprotein glucosyltransferase. Expression of Sep15 is regulated by dietary selenium and the unfolded protein response, but its specific function is not known. In this study, we developed and characterized Sep15 KO mice by targeted removal of exon 2 of the Sep15 gene coding for the cysteine-rich UDP-glucose: glycoprotein glucosyltransferase-binding domain. These KO mice synthesized a mutant mRNA, but the shortened protein product could be detected neither in tissues nor in Sep15 KO embryonic fibroblasts. Sep15 KO mice were viable and fertile, showed normal brain morphology, and did not activate endoplasmic reticulum stress pathways. However, parameters of oxidative stress were elevated in the livers of these mice. We found that Sep15 mRNA was enriched during lens development. Further phenotypic characterization of Sep15 KO mice revealed a prominent nuclear cataract that developed at an early age. These cataracts did not appear to be associated with severe oxidative stress or glucose dysregulation. We suggest that the cataracts resulted from an improper folding status of lens proteins caused by Sep15 deficiency.	[Kasaikina, Marina V.; Labunskyy, Vyacheslav M.; Lachke, Salil A.; Malinouski, Mikalai; Maas, Richard L.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kasaikina, Marina V.; Labunskyy, Vyacheslav M.; Lachke, Salil A.; Malinouski, Mikalai; Maas, Richard L.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kasaikina, Marina V.; Fomenko, Dmitri E.; Natarajan, Sathish Kumar; Malinouski, Mikalai] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Kasaikina, Marina V.; Fomenko, Dmitri E.; Natarajan, Sathish Kumar; Malinouski, Mikalai] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Qiu, Wenya; Lou, Marjorie F.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Moncaster, Juliet A.; Wojnarowicz, Mark W., Jr.; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Zhang, Jie; Schweizer, Ulrich] Charite Univ Med Berlin, Inst Expt Endokrinol, D-13353 Berlin, Germany; [Tsuji, Petra A.; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Delaware; University of Nebraska System; University of Nebraska Lincoln; Boston University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, New Res Bldg,Room 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Labunskyy, Vyacheslav/AAC-8489-2020; Schweizer, Ulrich/E-8105-2013; Gladyshev, Vadim N/J-6187-2013	Lachke, Salil/0000-0001-8845-010X; Schweizer, Ulrich/0000-0003-1380-4780; Goldstein, Lee/0000-0001-8419-9800; Gladyshev, Vadim/0000-0002-0372-7016; Labunskyy, Vyacheslav/0000-0001-9317-1076; Moncaster, Juliet/0000-0002-7849-4325	National Institutes of Health [CA080946]; Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005317, ZIABC010889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant CA080946 (to V. N. G.) and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (to D. L. H.).	Bahjat FR, 2000, J IMMUNOL, V165, P6559, DOI 10.4049/jimmunol.165.11.6559; Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Hu YJ, 2001, CANCER RES, V61, P2307; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Kumaraswamy E, 2002, METHOD ENZYMOL, V347, P187; Labunskyy VM, 2007, IUBMB LIFE, V59, P1, DOI 10.1080/15216540601126694; Labunskyy VM, 2009, BIOCHEMISTRY-US, V48, P8458, DOI 10.1021/bi900717p; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59; LESKE MC, 1988, ARCH OPHTHALMOL-CHIC, V106, P327; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Santhiya ST, 2010, MOL VIS, V16, P1837; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shinohara T, 2006, MED HYPOTHESES, V66, P365, DOI 10.1016/j.mehy.2005.08.044; Steinbrenner H, 2007, BIOL CHEM, V388, P1043, DOI 10.1515/BC.2007.136; TAYLOR HR, 1991, INVEST OPHTH VIS SCI, V32, P529; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	74	78	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33203	33212		10.1074/jbc.M111.259218	http://dx.doi.org/10.1074/jbc.M111.259218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21768092	Green Published, hybrid			2022-12-27	WOS:000294968800039
J	Miller, M; Shi, J; Zhu, YM; Kustov, M; Tian, JB; Stevens, A; Wu, M; Xu, J; Long, SY; Yang, P; Zholos, AV; Salovich, JM; Weaver, CD; Hopkins, CR; Lindsley, CW; McManus, O; Li, M; Zhu, MX				Miller, Melissa; Shi, Jie; Zhu, Yingmin; Kustov, Maksym; Tian, Jin-bin; Stevens, Amy; Wu, Meng; Xu, Jia; Long, Shunyou; Yang, Pu; Zholos, Alexander V.; Salovich, James M.; Weaver, C. David; Hopkins, Corey R.; Lindsley, Craig W.; McManus, Owen; Li, Min; Zhu, Michael X.			Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; CALCIUM-ENTRY; SMOOTH-MUSCLE; ESSENTIAL COMPONENT; TRPC5 CHANNELS; G-PROTEIN; ACTIVATION; CELLS; DIACYLGLYCEROL; EXPRESSION	Transient receptor potential canonical (TRPC) channels are Ca2+-permeable nonselective cation channels implicated in diverse physiological functions, including smooth muscle contractility and synaptic transmission. However, lack of potent selective pharmacological inhibitors for TRPC channels has limited delineation of the roles of these channels in physiological systems. Here we report the identification and characterization of ML204 as a novel, potent, and selective TRPC4 channel inhibitor. A high throughput fluorescent screen of 305,000 compounds of the Molecular Libraries Small Molecule Repository was performed for inhibitors that blocked intracellular Ca2+ rise in response to stimulation of mouse TRPC4 beta by mu-opioid receptors. ML204 inhibited TRPC4 beta-mediated intracellular Ca2+ rise with an IC50 value of 0.96 mu M and exhibited 19-fold selectivity against muscarinic receptor-coupled TRPC6 channel activation. In whole-cell patch clamp recordings, ML204 blocked TRPC4 beta currents activated through either mu-opioid receptor stimulation or intracellular dialysis of guanosine 5'-3-O-(thio)triphosphate (GTP gamma S), suggesting a direct interaction of ML204 with TRPC4 channels rather than any interference with the signal transduction pathways. Selectivity studies showed no appreciable block by 10-20 mu M ML204 of TRPV1, TRPV3, TRPA1, and TRPM8, as well as KCNQ2 and native voltage-gated sodium, potassium, and calcium channels in mouse dorsal root ganglion neurons. In isolated guinea pig ileal myocytes, ML204 blocked muscarinic cation currents activated by bath application of carbachol or intracellular infusion of GTP gamma S, demonstrating its effectiveness on native TRPC4 currents. Therefore, ML204 represents an excellent novel tool for investigation of TRPC4 channel function and may facilitate the development of therapeutics targeted to TRPC4.	[Salovich, James M.; Weaver, C. David; Hopkins, Corey R.; Lindsley, Craig W.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA; [Salovich, James M.; Hopkins, Corey R.; Lindsley, Craig W.] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA; [Salovich, James M.; Hopkins, Corey R.; Lindsley, Craig W.] Mol Lib Probe Prod Ctr Network, Dept Chem, Vanderbilt Specialized Chem Ctr Accelerated Probe, Nashville, TN 37232 USA; [Miller, Melissa; Shi, Jie; Stevens, Amy; Wu, Meng; Xu, Jia; Long, Shunyou; McManus, Owen; Li, Min] Johns Hopkins Univ, Dept Neurosci, High Throughput Biol Ctr, Sch Med, Baltimore, MD 21205 USA; [Miller, Melissa; Shi, Jie; Stevens, Amy; Wu, Meng; Xu, Jia; Long, Shunyou; McManus, Owen; Li, Min] Johns Hopkins Univ, Johns Hopkins Ion Channel Ctr, Sch Med, Baltimore, MD 21205 USA; [Zhu, Yingmin; Tian, Jin-bin; Yang, Pu; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Sch Med, Houston, TX 77030 USA; [Kustov, Maksym; Zholos, Alexander V.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Sch Med Dent & Biomed Sci, Belfast BT12 6BA, Antrim, North Ireland	Vanderbilt University; Vanderbilt University; Vanderbilt University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; Queens University Belfast	Hopkins, CR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA.	corey.r.hopkins@vanderbilt.edu; minli@jhmi.edu	tian, jinbin/L-6006-2019; Tian, JinBin/B-7001-2019; Wu, Meng/F-3958-2010; Zholos, Alexander/A-7017-2011	Tian, JinBin/0000-0002-5516-7778; Zholos, Alexander/0000-0002-4320-149X; Wu, Meng/0000-0003-2222-0736	National Institutes of Health; MLPCN;  [U54MH084691];  [U54MH084659];  [R21NS056942]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659, U54MH084691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MLPCN; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, MLPCN, Grants U54MH084691 (to M. L.), U54MH084659 (C. W. L.), and R21NS056942 (to M. X. Z.). Vanderbilt is a member of the MLPCN and houses the Vanderbilt Specialized Chemistry Center for Accelerated Probe Development. Johns Hopkins is a member of the MLPCN and houses the Johns Hopkins Ion Channel Center.	Beech DJ, 2004, J PHYSIOL-LONDON, V559, P685, DOI 10.1113/jphysiol.2004.068734; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hu HZ, 2010, PFLUG ARCH EUR J PHY, V459, P579, DOI 10.1007/s00424-009-0749-9; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; INOUE R, 1990, J PHYSIOL-LONDON, V424, P73, DOI 10.1113/jphysiol.1990.sp018056; Inoue Ryuji, 1998, Journal of Smooth Muscle Research, V34, P69; Jeon JP, 2008, BIOCHEM BIOPH RES CO, V377, P538, DOI 10.1016/j.bbrc.2008.10.012; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Lee KP, 2005, MOL CELLS, V20, P435; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miller M, 2011, TRP CHANNELS, P1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zholos AV, 2004, J GEN PHYSIOL, V123, P581, DOI 10.1085/jgp.200309002; Zholos AV, 1997, BRIT J PHARMACOL, V122, P885, DOI 10.1038/sj.bjp.0701438	39	154	161	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33436	33446		10.1074/jbc.M111.274167	http://dx.doi.org/10.1074/jbc.M111.274167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795696	Green Published, hybrid			2022-12-27	WOS:000294968800061
J	Vorontsov, II; Minasov, G; Kiryukhina, O; Brunzelle, JS; Shuvalova, L; Anderson, WF				Vorontsov, Ivan I.; Minasov, George; Kiryukhina, Olga; Brunzelle, Joseph S.; Shuvalova, Ludmilla; Anderson, Wayne F.			Characterization of the Deoxynucleotide Triphosphate Triphosphohydrolase (dNTPase) Activity of the EF1143 Protein from Enterococcus faecalis and Crystal Structure of the Activator-Substrate Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DEOXYGUANOSINE TRIPHOSPHATE; RIBONUCLEOTIDE REDUCTASE; DGTP TRIPHOSPHOHYDROLASE; GUANOSINE TRIPHOSPHATE; THERMUS-THERMOPHILUS; BACILLUS-SUBTILIS; HIGH-THROUGHPUT; DNA-DAMAGE; HYDROLYSIS	The EF1143 protein from Enterococcus faecalis is a distant homolog of deoxynucleotide triphosphate triphosphohydrolases (dNTPases) from Escherichia coli and Thermus thermophilus. These dNTPases are important components in the regulation of the dNTP pool in bacteria. Biochemical assays of the EF1143 dNTPase activity demonstrated nonspecific hydrolysis of all canonical dNTPs in the presence of Mn2+. In contrast, with Mg2+ hydrolysis required the presence of dGTP as an effector, activating the degradation of dATP and dCTP with dGTP also being consumed in the reaction with dATP. The crystal structure of EF1143 and dynamic light scattering measurements in solution revealed a tetrameric oligomer as the most probable biologically active unit. The tetramer contains four dGTP specific allosteric regulatory sites and four active sites. Examination of the active site with the dATP substrate suggests an in-line nucleophilic attack on the alpha-phosphate center as a possible mechanism of the hydrolysis and two highly conserved residues, His-129 and Glu-122, as an acid-base catalytic dyad. Structural differences between EF1143 apo and holo forms revealed mobility of the alpha 3 helix that can regulate the size of the active site binding pocket and could be stabilized in the open conformation upon formation of the tetramer and dGTP effector binding.	[Vorontsov, Ivan I.; Minasov, George; Kiryukhina, Olga; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Brunzelle, Joseph S.] Argonne Natl Lab, Adv Photon Source, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Northwestern University; Feinberg School of Medicine; United States Department of Energy (DOE); Argonne National Laboratory	Anderson, WF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Searle Bldg 8-459,303 E Chicago Ave, Chicago, IL 60611 USA.	wf-anderson@northwestern.edu		Minasov, George/0000-0001-5460-3462; Kiryukhina, Olga/0000-0001-5962-8423	National Institutes of Health for the Midwest Center for Structural Genomics [GM-62414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, P50GM062414] Funding Source: NIH RePORTER	National Institutes of Health for the Midwest Center for Structural Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM-62414 from the National Institutes of Health for the Midwest Center for Structural Genomics.	Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; DeLano W.L, PYMOL MOL GRAPHICS S; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fortelle E., 1997, METHOD ENZYMOL, P472; FREY PA, 1982, TETRAHEDRON, V38, P1541, DOI 10.1016/0040-4020(82)80130-0; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228; Grigorenko BL, 2005, PROTEINS, V60, P495, DOI 10.1002/prot.20472; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Huai Q, 2003, BIOCHEMISTRY-US, V42, P13220, DOI 10.1021/bi034653e; HUBER HE, 1988, J BIOL CHEM, V263, P13549; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; KREMMER T, 1989, J CHROMATOGR-BIOMED, V493, P45, DOI 10.1016/S0378-4347(00)82707-3; Letkiewicz S, 2009, FOLIA MICROBIOL, V54, P457, DOI 10.1007/s12223-009-0064-z; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mega R, 2009, FEBS J, V276, P3211, DOI 10.1111/j.1742-4658.2009.07035.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; QUIRK S, 1991, J BACTERIOL, V173, P6665, DOI 10.1128/jb.173.21.6665-6669.1991; Rajan SS, 2004, BIOCHEMISTRY-US, V43, P15472, DOI 10.1021/bi048665r; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; ROUSSEL A, 1991, TURBO FRODO SILICON; Salter EA, 2007, J PHYS CHEM B, V111, P4547, DOI 10.1021/jp066582+; SETO D, 1988, J BIOL CHEM, V263, P1494; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Xu HL, 2003, ACTA CRYSTALLOGR A, V59, P60, DOI 10.1107/S0108767302022304; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	47	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33158	33166		10.1074/jbc.M111.250456	http://dx.doi.org/10.1074/jbc.M111.250456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757692	Green Published, hybrid			2022-12-27	WOS:000294968800035
J	Wines, BD; Ramsland, PA; Trist, HM; Gardam, S; Brink, R; Fraser, JD; Hogarth, PM				Wines, Bruce D.; Ramsland, Paul A.; Trist, Halina M.; Gardam, Sandra; Brink, Robert; Fraser, John D.; Hogarth, P. Mark			Interaction of Human, Rat, and Mouse Immunoglobulin A (IgA) with Staphylococcal Superantigen-like 7 (SSL7) Decoy Protein and Leukocyte IgA Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-ALPHA-RI; SECRETORY COMPONENT; STRUCTURAL BASIS; COMPLEMENT C5; CD89; BINDING; NEUTROPHILS; IMMUNITY; IDENTIFICATION; DOMAIN	Host survival depends on an effective immune system and pathogen survival on the effectiveness of immune evasion mechanisms. Staphylococcus aureus utilizes a number of molecules to modulate host immunity, including the SSL family of which SSL7 binds IgA and inhibits Fc alpha receptor I (Fc alpha RI)-mediated function. Other Gram-positive bacterial pathogens produce IgA binding proteins, which, similar to SSL7, also bind the Fc at the CH2/CH3 interface (the junction between constant domains 2 and 3 of the heavy chain). The opposing activities of the host Fc alpha RI-IgA receptor ligand pair and the pathogen decoy proteins select for host and pathogen variants, which exert stronger protection or evasion, respectively. Curiously, mouse but not rat IgA contains a putative N-linked glycosylation site in the center of this host receptor and pathogen-binding site. Here, we demonstrate that this site is glycosylated and that the effect of amino acid changes and glycosylation of the CH2/CH3 interface inhibits interaction with the pathogen IgA binding protein SSL7, while maintaining binding of pIgR, essential to the biosynthesis and transport of SIgA.	[Wines, Bruce D.; Ramsland, Paul A.; Trist, Halina M.; Hogarth, P. Mark] Burnet Inst, Ctr Immunol, Melbourne, Vic 3004, Australia; [Gardam, Sandra; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW 2010, Australia; [Fraser, John D.] Univ Auckland, Maurice Wilkins Ctr, Auckland 1020, New Zealand; [Fraser, John D.] Univ Auckland, Sch Med Sci, Auckland 1020, New Zealand	Burnet Institute; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Auckland; University of Auckland	Hogarth, PM (corresponding author), Burnet Inst, Ctr Immunol, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	bwines@burnet.edu.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655; Hogarth, Mark/0000-0002-0360-7890; Ramsland, Paul/0000-0002-2107-2738	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council project grant.	Abi-Rached L, 2007, J IMMUNOL, V178, P7943, DOI 10.4049/jimmunol.178.12.7943; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; CHINTALACHARUVU KR, 1994, HEPATOLOGY, V19, P162, DOI 10.1016/0270-9139(94)90068-X; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; Hexham JM, 1999, J EXP MED, V189, P747, DOI 10.1084/jem.189.4.747; Kobayashi T, 2004, VACCINE, V23, P585, DOI 10.1016/j.vaccine.2004.07.015; Kragten EA, 1995, J MASS SPECTROM, V30, P1679, DOI 10.1002/jms.1190301207; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Lewis MJ, 2005, J IMMUNOL, V175, P6694, DOI 10.4049/jimmunol.175.10.6694; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; Maruoka T, 2004, IMMUNOGENETICS, V55, P712, DOI 10.1007/s00251-003-0626-1; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; Otten MA, 2005, J IMMUNOL, V174, P5472, DOI 10.4049/jimmunol.174.9.5472; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Pleass RJ, 1997, BIOCHEM SOC T, V25, pS327, DOI 10.1042/bst025327s; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Reljic R, 2004, IMMUNOL LETT, V93, P51, DOI 10.1016/j.imlet.2004.01.015; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SHEN L, 1992, IMMUNOL RES, V11, P273, DOI 10.1007/BF02919133; Stockmeyer B, 2000, J IMMUNOL, V165, P5954, DOI 10.4049/jimmunol.165.10.5954; van der Pol WL, 2000, J INFECT DIS, V182, P1139, DOI 10.1086/315825; van der Steen L, 2009, GASTROENTEROLOGY, V137, P2018, DOI 10.1053/j.gastro.2009.06.047; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; van Spriel AB, 1999, J INFECT DIS, V179, P661, DOI 10.1086/314643; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wines B. D., 2011, ADV EXP MED IN PRESS; Wines BD, 2006, J BIOL CHEM, V281, P1389, DOI 10.1074/jbc.M509334200; Wines BD, 1999, J IMMUNOL, V162, P2146; Wines BD, 2001, J IMMUNOL, V166, P1781, DOI 10.4049/jimmunol.166.3.1781; Wines BD, 2006, TISSUE ANTIGENS, V68, P103, DOI 10.1111/j.1399-0039.2006.00613.x; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	46	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33118	33124		10.1074/jbc.M111.272252	http://dx.doi.org/10.1074/jbc.M111.272252			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784854	Green Published, hybrid			2022-12-27	WOS:000294968800030
J	Chen, YJ; Fujita, T; Zhang, D; Doan, H; Pinkaew, D; Liu, ZH; Wu, JX; Koide, Y; Chiu, A; Lin, CCJ; Chang, JY; Ruan, KH; Fujise, K				Chen, Yanjie; Fujita, Takayuki; Zhang, Di; Doan, Hung; Pinkaew, Decha; Liu, Zhihe; Wu, Jiaxin; Koide, Yuichi; Chiu, Andrew; Lin, Curtis Chen-Jen; Chang, Jui-Yoa; Ruan, Ke-He; Fujise, Ken			Physical and Functional Antagonism between Tumor Suppressor Protein p53 and Fortilin, an Anti-apoptotic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; CALCIUM-BINDING; IN-VIVO; ANTIAPOPTOTIC PROTEIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESSENGER-RNA; MUTANT P53; MDM2; ACTIVATION	Tumor suppressor protein p53, our most critical defense against tumorigenesis, can be made powerless by mechanisms such as mutations and inhibitors. Fortilin, a 172-amino acid polypeptide with potent anti-apoptotic activity, is up-regulated in many human malignancies. However, the exact mechanism by which fortilin exerts its anti-apoptotic activity remains unknown. Here we present significant insight. Fortilin binds specifically to the sequence-specific DNA binding domain of p53. The interaction of fortilin with p53 blocks p53-induced transcriptional activation of Bax. In addition, fortilin, but not a double point mutant of fortilin lacking p53 binding, inhibits p53-dependent apoptosis. Furthermore, cells with wild-type p53 and fortilin, but not cells with wild-type p53 and the double point mutant of fortilin lacking p53 binding, fail to induce Bax gene and apoptosis, leading to the formation of large tumor in athymic mice. Our results suggest that fortilin is a novel p53-interacting molecule and p53 inhibitor and that it is a logical molecular target in cancer therapy.	[Chen, Yanjie; Doan, Hung; Pinkaew, Decha; Liu, Zhihe; Chiu, Andrew; Fujise, Ken] Univ Texas Med Branch, Div Cardiol, Dept Internal Med, Galveston, TX 77555 USA; [Fujise, Ken] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Fujita, Takayuki; Zhang, Di; Wu, Jiaxin; Koide, Yuichi; Lin, Curtis Chen-Jen; Chang, Jui-Yoa; Ruan, Ke-He; Fujise, Ken] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA; [Fujita, Takayuki; Koide, Yuichi] Yokohama City Univ, Dept Internal Med 2, Yokohama, Kanagawa 2360004, Japan; [Wu, Jiaxin; Ruan, Ke-He] Univ Houston, Coll Pharm, Houston, TX 77004 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; Yokohama City University; University of Houston System; University of Houston	Fujise, K (corresponding author), 301 Univ Blvd,Ste JSA5-106G, Galveston, TX 77555 USA.	Ken.Fujise@utmb.edu	Wu, Jiaxin/GVT-3486-2022; Lin, Curtis Chun-Jen/G-5571-2012; Pinkaew, Decha/AAD-3335-2022	Pinkaew, Decha/0000-0001-8334-1545	National Institutes of Health [HL68024]; National Heart, Blood, and Lung Institute; American Heart Association [0540054N]; MacDonald General Research Fund [04RDM013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); MacDonald General Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL68024 (to K. F.) from National Heart, Blood, and Lung Institute. This work was also supported by American Heart Association Grant 0540054N (to K. F.) and MacDonald General Research Fund Grant 04RDM013 (to K. F.).	Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; Chung S, 2000, CANCER LETT, V156, P185, DOI 10.1016/S0304-3835(00)00460-2; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; FRITSCHE M, 1993, ONCOGENE, V8, P307; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Graidist P, 2004, J BIOL CHEM, V279, P40868, DOI 10.1074/jbc.M401454200; Graidist P, 2007, BIOCHEM J, V408, P181, DOI 10.1042/BJ20070679; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; HAGHIGHAT NG, 1992, MOL BIOCHEM PARASIT, V51, P99, DOI 10.1016/0166-6851(92)90205-X; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hansen S, 1998, J MOL BIOL, V275, P575, DOI 10.1006/jmbi.1997.1507; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Koide Y, 2009, BBA-GEN SUBJECTS, V1790, P326, DOI 10.1016/j.bbagen.2009.01.012; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee JH, 2008, FEBS LETT, V582, P1210, DOI 10.1016/j.febslet.2008.01.066; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Lu BY, 2002, BIOCHEM J, V364, P81, DOI 10.1042/bj3640081; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; MIYASHITA T, 1995, CELL, V80, P293; Mnjoyan ZH, 2003, CIRCULATION, V108, P464, DOI 10.1161/01.CIR.0000080339.49212.49; Moll UM, 2001, BBA-REV CANCER, V1552, P47, DOI 10.1016/S0304-419X(01)00036-1; Monia BP, 1996, NAT MED, V2, P668, DOI 10.1038/nm0696-668; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Pellegrini M, 2001, EUR J BIOCHEM, V268, P3313, DOI 10.1046/j.1432-1327.2001.02235.x; Rao KVN, 2002, J BIOL CHEM, V277, P31207, DOI 10.1074/jbc.M204114200; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Salamanca S, 2005, BIOCHEMISTRY-US, V44, P744, DOI 10.1021/bi048182n; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; van Vlijmen BJM, 2001, CIRC RES, V88, P780, DOI 10.1161/hh0801.089261; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	69	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32575	32585		10.1074/jbc.M110.217836	http://dx.doi.org/10.1074/jbc.M110.217836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795694	Green Published, hybrid			2022-12-27	WOS:000294726800067
J	Leotoing, L; Chereau, F; Baron, S; Hube, F; Valencia, HJ; Bordereaux, D; Demmers, JA; Strouboulis, J; Baud, V				Leotoing, Laurent; Chereau, Fanny; Baron, Silvere; Hube, Florent; Valencia, Hugo J.; Bordereaux, Didier; Demmers, Jeroen A.; Strouboulis, John; Baud, Veronique			A20-binding Inhibitor of Nuclear Factor-kappa B (NF-kappa B)-2 (ABIN-2) Is an Activator of Inhibitor of NF-kappa B (I kappa B) Kinase alpha (IKK alpha)-mediated NF-kappa B Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-ALPHA; GENE-EXPRESSION; IMMUNE-SYSTEM; PHOSPHORYLATION; BETA; PATHWAY; COMPLEX; PROTEIN; SUBUNIT; CELLS	NF-kappa B transcription factors are pivotal players in controlling inflammatory and immune responses, as well as cell proliferation and apoptosis. Aberrant regulation of NF-kappa B and the signaling pathways that regulate its activity have been involved in various pathologies, particularly cancers, as well as inflammatory and autoimmune diseases. NF-kappa B activation is tightly regulated by the I kappa B kinase (IKK) complex, which is composed of two catalytic subunits IKK alpha and IKK beta, and a regulatory subunit IKK gamma/NEMO. Although IKK alpha and IKK beta share structural similarities, IKK alpha has been shown to have distinct biological functions. However, the molecular mechanisms that modulate IKK alpha activity have not yet been fully elucidated. To understand better the regulation of IKK alpha activity, we purified IKK alpha-associated proteins and identified ABIN-2. Here, we demonstrate that IKK alpha and IKK beta Both interact with ABIN-2 and impair its constitutive degradation by the proteasome. Nonetheless, ABIN-2 enhances IKK alpha- but not IKK beta-mediated NF-kappa B activation by specifically inducing IKK alpha autophosphorylation and kinase activity. Furthermore, we found that ABIN-2 serine 146 is critical for the ABIN-2-dependent IKK alpha transcriptional up-regulation of specific NF-kappa B target genes. These results imply that ABIN-2 acts as a positive regulator of NF-kappa B-dependent transcription by activating IKK alpha.	[Baud, Veronique] INSERM, U1016, Inst Cochin, Dept Immunol Hematol, F-75014 Paris, France; [Leotoing, Laurent; Chereau, Fanny; Valencia, Hugo J.; Bordereaux, Didier; Baud, Veronique] CNRS, UMR 8104, Paris, France; [Leotoing, Laurent; Chereau, Fanny; Valencia, Hugo J.; Bordereaux, Didier; Baud, Veronique] Univ Paris 05, Paris, France; [Baron, Silvere] Univ Clermont Ferrand, Clermont Univ, F-63000 Clermont Ferrand, France; [Baron, Silvere] GReD, CNRS, UMR 6247, F-63177 Aubiere, France; [Hube, Florent] Univ Paris 07, CNRS, UMR7216, Paris, France; [Demmers, Jeroen A.] Erasmus MC, Dept Biochem, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen A.] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Strouboulis, John] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Baud, V (corresponding author), INSERM, U1016, Inst Cochin, Dept Immunol Hematol, 123 Blvd Port Royal, F-75014 Paris, France.	veronique.baud@inserm.fr	Baud, Veronique/AAL-3950-2020; Valencia, Hugo/HHC-4835-2022; Demmers, Jeroen AA/F-4046-2016; Strouboulis, John/U-4459-2019; Baud, Veronique/F-7699-2013; HUBE, Florent/G-1174-2011	Baud, Veronique/0000-0002-4090-718X; Demmers, Jeroen AA/0000-0002-8757-9611; Baud, Veronique/0000-0002-4090-718X; HUBE, Florent/0000-0001-7560-2530; Chereau, Fanny/0000-0002-5651-9800; Strouboulis, John/0000-0002-6133-2872	Agence Nationale pour la Recherche; Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Canceropole Ile-de-France; Institut National du Cancer; Universite Paris Descartes; Agence Nationale de la Recherche; Ligue Nationale contre le Cancer; Ministere de la Recherche et des Technologies	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Universite Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministere de la Recherche et des Technologies	This work was supported by grants from the Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole, Canceropole Ile-de-France, Institut National du Cancer, and Universite Paris Descartes (to V.B.), postdoctoral funding from the Agence Nationale de la Recherche (to L.L.), grants from the Ligue Nationale contre le Cancer (to S.B. and F.H.), and a doctoral fellowship from the Ministere de la Recherche et des Technologies (to F.C.).	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Baud V, 2011, CURR TOP MICROBIOL, V349, P97, DOI 10.1007/82_2010_101; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chien CY, 2003, FEBS LETT, V543, P55, DOI 10.1016/S0014-5793(03)00401-0; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huang L, 2008, ONCOGENE, V27, P6131, DOI 10.1038/onc.2008.208; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; Luo JL, 2005, J CLIN IMMUNOL, V25, P541, DOI 10.1007/s10875-005-8217-6; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	55	26	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32277	32288		10.1074/jbc.M111.236448	http://dx.doi.org/10.1074/jbc.M111.236448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784860	hybrid, Green Published			2022-12-27	WOS:000294726800038
J	Mattoo, S; Durrant, E; Chen, MJ; Xiao, JY; Lazar, CS; Manning, G; Dixon, JE; Worby, CA				Mattoo, Seema; Durrant, Eric; Chen, Mark J.; Xiao, Junyu; Lazar, Cheri S.; Manning, Gerard; Dixon, Jack E.; Worby, Carolyn A.			Comparative Analysis of Histophilus somni Immunoglobulin-binding Protein A (IbpA) with Other Fic Domain-containing Enzymes Reveals Differences in Substrate and Nucleotide Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEINS; RHO GTPASES; ADENYLYLATION; AMPYLATION; DOC	A new family of adenylyltransferases, defined by the presence of a Fic domain, was recently discovered to catalyze the addition of adenosine monophosphate (AMP) to Rho GTPases (Yarbrough, M. L., Li, Y., Kinch, L. N., Grishin, N. V., Ball, H. L., and Orth, K. (2009) Science 323, 269-272; Worby, C. A., Mattoo, S., Kruger, R. P., Corbeil, L. B., Koller, A., Mendez, J. C., Zekarias, B., Lazar, C., and Dixon, J. E. (2009) Mol. Cell 34, 93-103). This adenylylation event inactivates Rho GTPases by preventing them from binding to their downstream effectors. We reported that the Fic domain(s) of the immunoglobulin-binding protein A (IbpA) from the pathogenic bacterium Histophilus somni adenylylates mammalian Rho GTPases, RhoA, Rac1, and Cdc42, thereby inducing host cytoskeletal collapse, which allows H. somni to breach alveolar barriers and cause septicemia. The IbpA-mediated adenylylation occurs on a functionally critical tyrosine in the switch 1 region of these GTPases. Here, we conduct a detailed characterization of the IbpA Fic2 domain and compare its activity with other known Fic adenylyltransferases, VopS (Vibrio outer protein S) from the bacterial pathogen Vibrio parahaemolyticus and the human protein HYPE (huntingtin yeast interacting protein E; also called FicD). We also included the Fic domains of the secreted protein, PfhB2, from the opportunistic pathogen Pasteurella multocida, in our analysis. PfhB2 shares a common domain architecture with IbpA and contains two Fic domains. We demonstrate that the PfhB2 Fic domains also possess adenylyltransferase activity that targets the switch 1 tyrosine of Rho GTPases. Comparative kinetic and phylogenetic analyses of IbpA-Fic2 with the Fic domains of PfhB2, VopS, and HYPE reveal important aspects of their specificities for Rho GTPases and nucleotide usage and offer mechanistic insights for determining nucleotide and substrate specificities for these enzymes. Finally, we compare the evolutionary lineages of Fic proteins with those of other known adenylyltransferases.	[Mattoo, Seema; Dixon, Jack E.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Mattoo, Seema; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Durrant, Eric; Xiao, Junyu; Lazar, Cheri S.; Dixon, Jack E.; Worby, Carolyn A.] Univ Calif San Diego, Dept Pharmacol Cellular & Mol Med, La Jolla, CA 92093 USA; [Durrant, Eric; Xiao, Junyu; Lazar, Cheri S.; Dixon, Jack E.; Worby, Carolyn A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Chen, Mark J.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Mattoo, S (corresponding author), 9500 Gilman Dr,MC 0721, La Jolla, CA 92093 USA.	smattoo@ucsd.edu; cworby@ucsd.edu	Manning, Gerard/C-8308-2009; Xiao, Junyu/ABE-2192-2020; Mattoo, Seema/ABD-5624-2021; Chen, Mark/O-3937-2014	Mattoo, Seema/0000-0003-3260-0046; Chen, Mark/0000-0003-1169-563X; Xiao, Junyu/0000-0003-1822-1701; Manning, Gerard/0000-0002-5087-9151	National Institutes of Health [GM090328, HG04016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM090328 (to J. E. D.) and HG04016 (to G. M.).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Pellegrin S., 2008, CURRENT PROTOCOLS CE, V38, P1481; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Tagawa Y, 2005, MICROB PATHOGENESIS, V39, P159, DOI 10.1016/j.micpath.2005.08.002; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zekarias B, 2010, INFECT IMMUN, V78, P1850, DOI 10.1128/IAI.01277-09; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	22	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32834	32842		10.1074/jbc.M111.227603	http://dx.doi.org/10.1074/jbc.M111.227603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795713	Green Published, hybrid			2022-12-27	WOS:000294726800090
J	Pedersen, JW; Bennett, EP; Schjoldager, KTBG; Meldal, M; Holmer, AP; Blixt, O; Clo, E; Levery, SB; Clausen, H; Wandall, HH				Pedersen, Johannes W.; Bennett, Eric P.; Schjoldager, Katrine T. -B. G.; Meldal, Morten; Holmer, Andreas P.; Blixt, Ola; Clo, Emiliano; Levery, Steven B.; Clausen, Henrik; Wandall, Hans H.			Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GALACTOSAMINE; N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; ELECTRON-TRANSFER DISSOCIATION; O-LINKED GLYCOSYLATION; UDP-GALNAC; CDNA CLONING; 3 MEMBERS; INITIATION; DROSOPHILA; IDENTIFICATION	UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferases (GalNAc-Ts) constitute a family of up to 20 transferases that initiate mucin-type O-glycosylation. The transferases are structurally composed of catalytic and lectin domains. Two modes have been identified for the selection of glycosylation sites by GalNAc-Ts: confined sequence recognition by the catalytic domain alone, and concerted recognition of acceptor sites and adjacent GalNAc-glycosylated sites by the catalytic and lectin domains, respectively. Thus far, only the catalytic domain has been shown to have peptide sequence specificity, whereas the primary function of the lectin domain is to increase affinity to previously glycosylated substrates. Whether the lectin domain also has peptide sequence selectivity has remained unclear. Using a glycopeptide array with a library of synthetic and recombinant glycopeptides based on sequences of mucins MUC1, MUC2, MUC4, MUC5AC, MUC6, and MUC7 as well as a random glycopeptide bead library, we examined the binding properties of four different lectin domains. The lectin domains of GalNAc-T1, -T2, -T3, and -T4 bound different subsets of small glycopeptides. These results indicate an additional level of complexity in the initiation step of O-glycosylation by GalNAc-Ts.	[Pedersen, Johannes W.; Schjoldager, Katrine T. -B. G.; Holmer, Andreas P.; Blixt, Ola; Clo, Emiliano; Levery, Steven B.; Clausen, Henrik; Wandall, Hans H.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Bennett, Eric P.] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark; [Meldal, Morten] Univ Copenhagen, Carlsberg Lab, DK-2100 Copenhagen, Denmark; [Meldal, Morten] Univ Copenhagen, Nano Sci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Wandall, HH (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hhw@sund.ku.dk	Meldal, Morten/B-7626-2016; Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021	Meldal, Morten/0000-0001-6114-9018; Bennett, Eric/0000-0002-4976-0647; Blixt, Ola/0000-0003-4143-6276; Clausen, Henrik/0000-0002-0915-5055; Wandall, Hans H./0000-0003-0240-9232	Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Research Foundation; Agnes and Poul Friis Foundation; Danish Cancer Society; University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Agnes and Poul Friis Foundation; Danish Cancer Society(Danish Cancer Society); University of Copenhagen	This work was supported by the Novo Nordisk Foundation, Danish Medical Research Council, Danish Cancer Research Foundation, Agnes and Poul Friis Foundation, Danish Cancer Society, and the University of Copenhagen (Program of Excellence).	Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Collins BE, 2002, GLYCOBIOLOGY, V12, P563, DOI 10.1093/glycob/cwf067; Dupont C, 1998, BIOCHEM J, V330, P41, DOI 10.1042/bj3300041; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Heise N, 2009, GLYCOBIOLOGY, V19, P918, DOI 10.1093/glycob/cwp068; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Imberty A, 1997, PROTEIN ENG, V10, P1353, DOI 10.1093/protein/10.12.1353; Iwasaki H, 2003, J BIOL CHEM, V278, P5613, DOI 10.1074/jbc.M211097200; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; McAlister GC, 2008, J PROTEOME RES, V7, P3127, DOI 10.1021/pr800264t; MELDAL M, 1992, TETRAHEDRON LETT, V33, P3077, DOI 10.1016/S0040-4039(00)79604-3; Meldal Morten, 1994, Methods (Orlando), V6, P417, DOI 10.1006/meth.1994.1044; Mirgorodskaya E, 1999, ANAL BIOCHEM, V269, P54, DOI 10.1006/abio.1998.3089; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Rottger S, 1998, J CELL SCI, V111, P45; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; SORENSEN T, 1995, J BIOL CHEM, V270, P24166, DOI 10.1074/jbc.270.41.24166; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tenno M, 2002, BIOCHEM BIOPH RES CO, V298, P755, DOI 10.1016/S0006-291X(02)02549-4; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Wojczyk BS, 2003, MOL BIOCHEM PARASIT, V131, P93, DOI 10.1016/S0166-6851(03)00196-8; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200; Zhang Y, 2009, J AM SOC MASS SPECTR, V20, P1425, DOI 10.1016/j.jasms.2009.03.019	56	46	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32684	32696		10.1074/jbc.M111.273722	http://dx.doi.org/10.1074/jbc.M111.273722			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768105	Green Published, hybrid			2022-12-27	WOS:000294726800077
J	Skipsey, M; Knight, KM; Brazier-Hicks, M; Dixon, DP; Steel, PG; Edwards, R				Skipsey, Mark; Knight, Kathryn M.; Brazier-Hicks, Melissa; Dixon, David P.; Steel, Patrick G.; Edwards, Robert			Xenobiotic Responsiveness of Arabidopsis thaliana to a Chemical Series Derived from a Herbicide Safener	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; REDOX REGULATION; PLANT DEFENSE; ACID; DETOXIFICATION; METABOLISM; IDENTIFICATION; EXPRESSION; INDUCTION; BINDING	Plants respond to synthetic chemicals by eliciting a xenobiotic response (XR) that enhances the expression of detoxifying enzymes such as glutathione transferases (GSTs). In agrochemistry, the ability of safeners to induce an XR is used to increase herbicide detoxification in cereal crops. Based on the responsiveness of the model plant Arabidopsis thaliana to the rice safener fenclorim (4,6-dichloro-2-phenylpyrimidine), a series of related derivatives was prepared and tested for the ability to induce GSTs in cell suspension cultures. The XR in Arabidopsis could be divided into rapid and slow types depending on subtle variations in the reactivity (electrophilicity) and chemical structure of the derivatives. In a comparative microarray study, Arabidopsis cultures were treated with closely related compounds that elicited rapid (fenclorim) and slow (4-chloro-6-methyl-2-phenylpyrimidine) XRs. Both chemicals induced major changes in gene expression, including a coordinated suppression in cell wall biosynthesis and an up-regulation in detoxification pathways, whereas only fenclorim selectively induced sulfur and phenolic metabolism. These transcriptome studies suggested several linkages between the XR and oxidative and oxylipin signaling. Confirming links with abiotic stress signaling, suppression of glutathione content enhanced GST induction by fenclorim, whereas fatty acid desaturase mutants, which were unable to synthesize oxylipins, showed an attenuated XR. Examining the significance of these studies to agrochemistry, only those fenclorim derivatives that elicited a rapid XR proved effective in increasing herbicide tolerance (safening) in rice.	[Skipsey, Mark; Brazier-Hicks, Melissa; Dixon, David P.; Edwards, Robert] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Knight, Kathryn M.; Steel, Patrick G.] Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University; Durham University	Edwards, R (corresponding author), Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England.	robert.edwards@fera.gsi.gov.uk	Dixon, David P/B-5413-2008; Steel, Patrick/G-3187-2012	Dixon, David P/0000-0003-4644-8399; Steel, Patrick/0000-0002-2493-5826; Brazier-Hicks, Melissa/0000-0001-5993-1940; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council [BBD0056201]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council Grant BBD0056201 and a Biotechnology and Biological Sciences Research Council research development fellowship (to R.E.).	Andersson MX, 2006, J BIOL CHEM, V281, P31528, DOI 10.1074/jbc.M604820200; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Brazier-Hicks M, 2008, J BIOL CHEM, V283, P21102, DOI 10.1074/jbc.M801998200; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; Cummins I, 2006, J MOL BIOL, V359, P422, DOI 10.1016/j.jmb.2006.03.048; Cummins I, 2009, PLANT BIOTECHNOL J, V7, P807, DOI 10.1111/j.1467-7652.2009.00445.x; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; Deng F, 2002, PESTIC BIOCHEM PHYS, V72, P24, DOI 10.1006/pest.2001.2579; DeRidder BP, 2006, PLANT PHYSIOL, V140, P167, DOI 10.1104/pp.105.067199; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Dixon DP, 2009, J BIOL CHEM, V284, P21249, DOI 10.1074/jbc.M109.020107; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Edwards R, 2005, Z NATURFORSCH C, V60, P307; Edwards R, 2005, ADV BOT RES, V42, P1, DOI 10.1016/S0065-2296(05)42001-7; Esch SW, 2007, J LIPID RES, V48, P235, DOI 10.1194/jlr.D600034-JLR200; FARAGO S, 1990, PLANT PHYSIOL, V94, P1808, DOI 10.1104/pp.94.4.1808; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; HARDEN DB, 1988, J ORG CHEM, V53, P4137, DOI 10.1021/jo00252a057; Lee HW, 2005, EUR J MED CHEM, V40, P862, DOI 10.1016/j.ejmech.2005.03.019; Liebeskind LS, 2002, ORG LETT, V4, P979, DOI 10.1021/ol0200091; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; Marcus Y, 2003, J BACTERIOL, V185, P1509, DOI 10.1128/JB.185.5.1509-1517.2003; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Ohkama-Ohtsu N, 2011, PLANT CELL PHYSIOL, V52, P205, DOI 10.1093/pcp/pcq181; Owen W.J., 2000, METABOLISM AGROCHEMI, P211; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; Rishi AS, 2004, PLANTA, V220, P296, DOI 10.1007/s00425-004-1356-9; Schaller F, 2004, J PLANT GROWTH REGUL, V23, P179, DOI 10.1007/s00344-004-0047-x; Schomaker JM, 2001, J ORG CHEM, V66, P7125, DOI 10.1021/jo010573+; Scott-Craig JS, 1998, PLANT PHYSIOL, V116, P1083, DOI 10.1104/pp.116.3.1083; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Thoma I, 2004, CHEM PHYS LIPIDS, V128, P135, DOI 10.1016/j.chemphyslip.2003.10.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang O, 2004, PROTEOMICS, V4, P2058, DOI 10.1002/pmic.200300733; Zhang Q, 2007, PROTEOMICS, V7, P1261, DOI 10.1002/pmic.200600423	45	41	42	0	42	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32268	32276		10.1074/jbc.M111.252726	http://dx.doi.org/10.1074/jbc.M111.252726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778235	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000294726800037
J	Wakita, Y; Kakimoto, T; Katoh, H; Negishi, M				Wakita, Yohei; Kakimoto, Tetsuhiro; Katoh, Hironori; Negishi, Manabu			The F-BAR Protein Rapostlin Regulates Dendritic Spine Formation in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE INVAGINATION; GTPASE-ACTIVATING PROTEIN; ALDRICH-SYNDROME PROTEIN; RAS GAP ACTIVITY; N-WASP; ACTIN CYTOSKELETON; R-RAS; RHO-FAMILY; ARP2/3 COMPLEX	Pombe Cdc15 homology proteins, characterized by Fer/CIP4 homology Bin-Amphiphysin-Rvs/extended Fer/CIP4 homology (F-BAR/EFC) domains with membrane invaginating property, play critical roles in a variety of membrane reorganization processes. Among them, Rapostlin/formin-binding protein 17 (FBP17) has attracted increasing attention as a critical coordinator of endocytosis. Here we found that Rapostlin was expressed in the developing rat brain, including the hippocampus, in late developmental stages when accelerated dendritic spine formation and maturation occur. In primary cultured rat hippocampal neurons, knockdown of Rapostlin by shRNA or overexpression of Rapostlin-QQ, an F-BAR domain mutant of Rapostlin that has no ability to induce membrane invagination, led to a significant decrease in spine density. Expression of shRNA-resistant wild-type Rapostlin effectively restored spine density in Rapostlin knockdown neurons, whereas expression of Rapostlin deletion mutants lacking the protein kinase C-related kinase homology region 1 (HR1) or Src homology 3 (SH3) domain did not. In addition, knockdown of Rapostlin or overexpression of Rapostlin-QQ reduced the uptake of transferrin in hippocampal neurons. Knockdown of Rnd2, which binds to the HR1 domain of Rapostlin, also reduced spine density and the transferrin uptake. These results suggest that Rapostlin and Rnd2 cooperatively regulate spine density. Indeed, Rnd2 enhanced the Rapostlin-induced tubular membrane invagination. We conclude that the F-BAR protein Rapostlin, whose activity is regulated by Rnd2, plays a key role in spine formation through the regulation of membrane dynamics.	[Wakita, Yohei; Kakimoto, Tetsuhiro; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp	kakimoto, tetsuhiro/W-1403-2019	Katoh, Hironori/0000-0002-8191-8117; Kakimoto, Tetsuhiro/0000-0003-1349-5690	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ishikawa Y, 2006, NEUROSCI LETT, V400, P218, DOI 10.1016/j.neulet.2006.02.064; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Kakimoto T, 2004, J BIOL CHEM, V279, P14104, DOI 10.1074/jbc.M312763200; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Katoh H, 2006, BRAIN RES, V1073, P103, DOI 10.1016/j.brainres.2005.12.085; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Koduru S, 2010, P NATL ACAD SCI USA, V107, P16252, DOI 10.1073/pnas.1002747107; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marie-Claire C, 2007, BRAIN RES, V1134, P12, DOI 10.1016/j.brainres.2006.11.065; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nakamura K, 2006, NEUROSCI RES, V54, P149, DOI 10.1016/j.neures.2005.10.008; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishi M, 1999, MOL BRAIN RES, V67, P74, DOI 10.1016/S0169-328X(99)00039-X; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shimomura A, 2009, J VET MED SCI, V71, P1591, DOI 10.1292/jvms.001591; Suetsugu S, 2010, J BIOCHEM, V148, P1, DOI 10.1093/jb/mvq049; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Tsuboi S, 2009, J BIOL CHEM, V284, P8548, DOI 10.1074/jbc.M805638200; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	71	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32672	32683		10.1074/jbc.M111.236265	http://dx.doi.org/10.1074/jbc.M111.236265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768103	hybrid, Green Published			2022-12-27	WOS:000294726800076
J	Li, Y; Si, R; Feng, Y; Chen, HH; Zou, L; Wang, E; Zhang, M; Warren, HS; Sosnovik, DE; Chao, W				Li, Yan; Si, Rui; Feng, Yan; Chen, Howard H.; Zou, Lin; Wang, E.; Zhang, Ming; Warren, H. Shaw; Sosnovik, David E.; Chao, Wei			Myocardial Ischemia Activates an Injurious Innate Immune Signaling via Cardiac Heat Shock Protein 60 and Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; NF-KAPPA-B; REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; SERUM DEPRIVATION; DEATH-DOMAIN; INFLAMMATION; TLR4; MACROPHAGES; PATHWAY	Innate immune response after transient ischemia is the most common cause of myocardial inflammation and may contribute to injury, yet the detailed signaling mechanisms leading to such a response are not well understood. Herein we tested the hypothesis that myocardial ischemia activates interleukin receptor-associated kinase-1 (IRAK-1), a kinase critical for the innate immune signaling such as that of Toll-like receptors (TLRs), via a mechanism that involves heat shock proteins (HSPs) and TLRs. Coronary artery occlusion induced a rapid myocardial IRAK-1 activation within 30 min in wild-type (WT), TLR2(-/-), or Trif(-/-) mice, but not in TLR4(def) or MyD88(-/-) mice. HSP60 protein was markedly increased in serum or in perfusate of isolated heart following ischemia/reperfusion (I/R). In vitro, recombinant HSP60 induced IRAK-1 activation in cells derived from WT, TLR2(-/-), or Trif(-/-) mice, but not from TLR4(def) or MyD88(-/-) mice. Both myocardial ischemia-and HSP60-induced IRAK-1 activation was abolished by anti-HSP60 antibody. Moreover, HSP60 treatment of cardiomyocytes (CMs) led to marked activation of caspase-8 and -3, but not -9. Expression of dominant-negative mutant of Fas-associated death domain protein or a caspase-8 inhibitor completely blocked HSP60-induced caspase-8 activation, suggesting that HSP60 likely activates an apoptotic program via the death-receptor pathway. In vivo, I/R-induced myocardial apoptosis and cytokine expression were significantly attenuated in TLR4def mice or in WT mice treated with anti-HSP60 antibody compared with WT controls. Taken together, the current study demonstrates that myocardial ischemia activates an innate immune signaling via HSP60 and TLR4, which plays an important role in mediating apoptosis and inflammation during I/R.	[Li, Yan; Si, Rui; Feng, Yan; Zou, Lin; Wang, E.; Zhang, Ming; Chao, Wei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA USA; [Chen, Howard H.; Sosnovik, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Martinos Ctr Biomed Imaging, Boston, MA USA; [Warren, H. Shaw] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Infect Dis Unit, Boston, MA USA; [Li, Yan] Huazhong Univ Sci & Technol, Union Hosp, Dept Pathol, Tongji Med Coll, Wuhan 430030, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Huazhong University of Science & Technology	Chao, W (corresponding author), Massachusetts Gen Hosp, Room 4-212,149 13th St, Charlestown, MA 02129 USA.	wchao@partners.org	Feng, Yan/H-5808-2012	Chao, Wei/0000-0002-2505-1360; Chen, Howard H./0000-0002-5145-0584	National Institutes of Health [R01GM080906, R01HL093038]; American Heart Association [0755890T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM080906 and R01HL093038. This work was also supported by American Heart Association Grant-in-Aid 0755890T.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BROWN JM, 1989, P NATL ACAD SCI USA, V86, P2516, DOI 10.1073/pnas.86.7.2516; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Chao W, 2005, AM J PHYSIOL-HEART C, V289, pH2073, DOI 10.1152/ajpheart.01216.2004; Chao W, 2005, J BIOL CHEM, V280, P21997, DOI 10.1074/jbc.M413676200; Chao W, 2002, J BIOL CHEM, V277, P31639, DOI 10.1074/jbc.M204104200; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chong AJ, 2004, J THORAC CARDIOV SUR, V128, P170, DOI 10.1016/j.jtcvs.2003.11.036; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kaczorowski DJ, 2009, TRANSPLANTATION, V87, P1455, DOI 10.1097/TP.0b013e3181a36e5e; Kajstura J, 1996, LAB INVEST, V74, P86; Katz M, 2003, BIOCHEM J, V375, P405, DOI 10.1042/BJ20030784; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim SC, 2009, CIRC RES, V105, P1186, DOI 10.1161/CIRCRESAHA.109.209643; KNOWLTON AA, 1991, J CLIN INVEST, V87, P139, DOI 10.1172/JCI114963; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Lin L, 2007, AM J PHYSIOL-HEART C, V293, pH2238, DOI 10.1152/ajpheart.00740.2007; MacLellan WR, 1997, CIRC RES, V81, P137, DOI 10.1161/01.RES.81.2.137; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meiler SE, 2002, J MOL CELL CARDIOL, V34, P349, DOI 10.1006/jmcc.2001.1519; NOVITSKY TJ, 1985, J CLIN MICROBIOL, V21, P211, DOI 10.1128/JCM.21.2.211-216.1985; Novo G, 2011, TRANSL RES, V157, P285, DOI 10.1016/j.trsl.2011.01.003; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sosnovik DE, 2008, NAT CLIN PRACT CARD, V5, pS63, DOI 10.1038/ncpcardio1115; Sosnovik DE, 2005, MAGNET RESON MED, V54, P718, DOI 10.1002/mrm.20617; Szerafin T, 2008, ANN THORAC SURG, V85, P80, DOI 10.1016/j.athoracsur.2007.06.049; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; Wang Y, 2010, J MOL CELL CARDIOL, V48, P360, DOI 10.1016/j.yjmcc.2009.11.009; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhu XS, 2006, AM J PHYSIOL-HEART C, V291, pH1900, DOI 10.1152/ajpheart.00112.2006	65	115	122	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31308	31319		10.1074/jbc.M111.246124	http://dx.doi.org/10.1074/jbc.M111.246124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775438	Green Published, hybrid			2022-12-27	WOS:000294487500026
J	Traver, MK; Henry, SC; Cantillana, V; Oliver, T; Hunn, JP; Howard, JC; Beer, S; Pfeffer, K; Coers, J; Taylor, GA				Traver, Maria K.; Henry, Stanley C.; Cantillana, Viviana; Oliver, Tim; Hunn, Julia P.; Howard, Jonathan C.; Beer, Sandra; Pfeffer, Klaus; Coers, Joern; Taylor, Gregory A.			Immunity-related GTPase M (IRGM) Proteins Influence the Localization of Guanylate-binding Protein 2 (GBP2) by Modulating Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLY EXPRESSED GTPASE; AUTOPHAGY-DEFICIENT MICE; P47 RESISTANCE GTPASES; INTERFERON-GAMMA; IFN-GAMMA; HOST-RESISTANCE; TOXOPLASMA-GONDII; CELLULAR-RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR PATHOGENS	The immunity-related GTPases (IRGs) are a family of proteins induced by interferon-gamma that play a crucial role in innate resistance to intracellular pathogens. The M subfamily of IRG proteins (IRGM) plays a profound role in this context, in part because of the ability of its members to regulate the localization and expression of other IRG proteins. We present here evidence that IRGM proteins affect the localization of the guanylate-binding proteins (GBPs), a second family of interferon-induced GTP-binding proteins that also function in innate immunity. Absence of Irgm1 or Irgm3 led to accumulation of Gbp2 in intracellular compartments that were positive for both the macroautophagy (hereafter referred to as autophagy) marker LC3 and the autophagic adapter molecule p62/Sqstm1. Gbp2 was similarly relocalized in cells in which autophagy was impaired because of the absence of Atg5. Both in Atg5- and IRGM-deficient cells, the IRG protein Irga6 relocalized to the same compartments as Gbp2, raising the possibility of a common regulatory mechanism. However, other data indicated that Irga6, but not Gbp2, was ubiquitinated in IRGM-deficient cells. Similarly, coimmunoprecipitation studies indicated that although Irgm3 did interact directly with Irgb6, it did not interact with Gbp2. Collectively, these data suggest that IRGM proteins indirectly modulate the localization of GBPs through a distinct mechanism from that through which they regulate IRG protein localization. Further, these results suggest that a core function of IRGM proteins is to regulate autophagic flux, which influences the localization of GBPs and possibly other factors that instruct cell-autonomous immune resistance.	[Traver, Maria K.; Coers, Joern; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Oliver, Tim] Duke Univ, Med Ctr, Div Geriatr, Durham, NC 27710 USA; [Cantillana, Viviana; Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Henry, Stanley C.; Taylor, Gregory A.] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27705 USA; [Hunn, Julia P.; Howard, Jonathan C.] Univ Cologne, Dept Cell Genet, Inst Genet, D-50674 Cologne, Germany; [Beer, Sandra; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Beer, Sandra; Pfeffer, Klaus] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany	Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Taylor, GA (corresponding author), 508 Fulton St,Rm N3008, Durham, NC 27705 USA.	gregory.taylor@duke.edu		Howard, Jonathan/0000-0003-2756-5143; Coers, Jorn/0000-0001-8707-4608; Pfeffer, Klaus/0000-0002-5652-6330	NIAID NIH HHS [R01 AI057831] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boehm U, 1998, J IMMUNOL, V161, P6715; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; de Souza AP, 2003, J PARASITOL, V89, P1237, DOI 10.1645/GE-3185RN; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; GUPTA SL, 1979, P NATL ACAD SCI USA, V76, P4817, DOI 10.1073/pnas.76.10.4817; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963; Henry SC, 2009, J LEUKOCYTE BIOL, V85, P877, DOI 10.1189/jlb.1008599; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	58	57	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30471	30480		10.1074/jbc.M111.251967	http://dx.doi.org/10.1074/jbc.M111.251967			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757726	Green Published, hybrid			2022-12-27	WOS:000294283600026
J	Crooks, RO; Rao, T; Mason, JM				Crooks, Richard O.; Rao, Tara; Mason, Jody M.			Truncation, Randomization, and Selection GENERATION OF A REDUCED LENGTH c-Jun ANTAGONIST THAT RETAINS HIGH INTERACTION STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED-COILS; OLIGOMERIZATION DOMAIN; EMPIRICAL PARAMETERS; PROTEIN-INTERACTION; FOLDING PROBLEM; ALPHA-HELICES; CHAIN-LENGTH; DNA-BINDING; IN-VIVO; PEPTIDES	The DNA binding activity of the transcriptional regulator activator protein-1 shows considerable promise as a target in cancer therapy. A number of different strategies have been employed to inhibit the function of this protein with promise having been demonstrated both in vitro and in vivo. Peptidebased therapeutics have received renewed interest in the last few years, and a number of 37-amino acid peptides capable of binding to the coiled coil dimerization domain of Jun and Fos have been derived. Here, we demonstrate how truncation and semirational library design, followed by protein-fragment complementation, can be used to produce a leucine zipper binding peptide by iterative means. To this end, we have implemented this strategy on the FosW peptide to produce 4hFosW. This peptide is truncated by four residues with comparably favorable binding properties and demonstrates the possibility to design progressively shorter peptides to serve as leucine zipper antagonists while retaining many of the key features of the parent peptide. Whether or not the necessity for low molecular weight antagonists is required from the perspective of druggability and efficacy is subject to debate. However, antagonists of reduced length are worthy of perusal from the point of view of synthetic cost as well as identifying the smallest functional unit that is required for binding.	[Crooks, Richard O.; Rao, Tara; Mason, Jody M.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Mason, JM (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	jmason@essex.ac.uk	Mason, Jody/W-8204-2019; Mason, Jody/A-9329-2011	Mason, Jody/0000-0002-4118-1958; Mason, Jody/0000-0002-4118-1958	Wellcome Trust [WT090184MA]; Department of Biological Sciences, University of Essex, RCIF; Cancer Research UK [11738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Biological Sciences, University of Essex, RCIF; Cancer Research UK(Cancer Research UK)	This work was supported in part by Wellcome Trust Grant WT090184MA.; We thank the Department of Biological Sciences, University of Essex, RCIF funding for the purchase of an Isothermal Titration Calorimeter. We thank Dr. Miao Yu for technical assistance.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; ELWELL ML, 1977, BIOCHIM BIOPHYS ACTA, V494, P367, DOI 10.1016/0005-2795(77)90166-0; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Kwok SC, 2004, BIOPOLYMERS, V76, P378, DOI 10.1002/bip.20141; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; LAU SYM, 1984, J BIOL CHEM, V259, P3253; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; Mason JM, 2007, J BIOL CHEM, V282, P23015, DOI 10.1074/jbc.M701828200; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; Mason JM, 2009, FEBS J, V276, P7305, DOI 10.1111/j.1742-4658.2009.07440.x; Mason JM, 2009, BIOCHEMISTRY-US, V48, P10380, DOI 10.1021/bi901401e; Mason JM, 2008, BIOCHEM SOC T, V36, P1442, DOI 10.1042/BST0361442; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Seldeen KL, 2008, ARCH BIOCHEM BIOPHYS, V473, P48, DOI 10.1016/j.abb.2008.02.024; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Worrall JAR, 2011, FEBS J, V278, P663, DOI 10.1111/j.1742-4658.2010.07988.x	49	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29470	29479		10.1074/jbc.M111.221267	http://dx.doi.org/10.1074/jbc.M111.221267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697091	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000294046600004
J	Demidenko, AA; Lee, J; Powers, TR; Nibert, ML				Demidenko, Aleksander A.; Lee, Jinkee; Powers, Thomas R.; Nibert, Max L.			Effects of Viscogens on RNA Transcription inside Reovirus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-CAPSID PROTEINS; DOUBLE-STRANDED DNA; CRYOELECTRON MICROSCOPY; IN-VITRO; IMAGE-RECONSTRUCTION; CORES; POLYMERASE; VISCOSITY; TRANSLOCATION; MOLECULE	The dsRNA genome of mammalian reovirus (MRV), like the dsDNA genomes of herpesviruses and many bacteriophages, is packed inside its icosahedral capsid in liquid-crystalline form, with concentrations near or more than 400 mg/ml. Viscosity in such environments must be high, but the relevance of viscosity for the macromolecular processes occurring there remains poorly characterized. Here, we describe the use of simple viscogens, glycerol and sucrose, to examine their effects on RNA transcription inside MRV core particles. Transcription inside MRV cores was strongly inhibited by these agents and to a greater extent than either predicted by theory or exhibited by a nonencapsidated transcriptase, suggesting that RNA transcription inside MRV cores is unusually sensitive to viscogen effects. The elongation phase of transcription was found to be a primary target of this inhibition. Similar results were obtained with particles of a second dsRNA virus, rhesus rotavirus, from a divergent taxonomic subfamily. Polymeric viscogens such as polyethylene glycol also inhibited RNA transcription inside MRV cores, but in a size-limited manner, suggesting that diffusion through channels in the MRV core is required for their activity. Modeling of the data suggested that the inherent intracapsid viscosity of both reo-and rotavirus is indeed high, two to three times the viscosity of water. The capacity for quantitative comparisons of intracapsid viscosity and effects of viscogens on macromolecular processes in confined spaces should be similarly informative in other systems.	[Demidenko, Aleksander A.; Nibert, Max L.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lee, Jinkee; Powers, Thomas R.] Brown Univ, Div Engn, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Brown University	Nibert, ML (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	mnibert@hms.harvard.edu	Powers, Thomas R/K-1451-2015	Powers, Thomas/0000-0003-3432-8226; Lee, Jinkee/0000-0001-5590-0549	National Institutes of Health [R01 AI47904]; National Science Foundation [CBET-0854108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01 AI47904 (to M. L. N.) and National Science Foundation Grant CBET-0854108 (to T. R. P.).	Allemand JF, 2009, FEMS MICROBIOL REV, V33, P593, DOI 10.1111/j.1574-6976.2009.00166.x; BANERJEE AK, 1970, J VIROL, V6, P1; BELLAMY AR, 1972, NATURE-NEW BIOL, V238, P49, DOI 10.1038/newbio238049a0; BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907; Bhattacharyya RP, 1999, BIOCHEMISTRY-US, V38, P2601, DOI 10.1021/bi982209j; Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2; Chandran K, 1999, J VIROL, V73, P3941, DOI 10.1128/JVI.73.5.3941-3950.1999; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; COOKE R, 1974, ANNU REV BIOPHYS BIO, V3, P95, DOI 10.1146/annurev.bb.03.060174.000523; DAVISON PF, 1967, BIOPOLYMERS, V5, P715, DOI 10.1002/bip.1967.360050805; Demidenko AA, 2009, J VIROL, V83, P5659, DOI 10.1128/JVI.02192-08; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Esmann M, 2008, BIOPHYS J, V94, P2767, DOI 10.1529/biophysj.106.101774; FARRELL JA, 1974, VIROLOGY, V62, P145, DOI 10.1016/0042-6822(74)90310-9; Farsetta DL, 2000, J BIOL CHEM, V275, P39693, DOI 10.1074/jbc.M004562200; Fologea D, 2005, NANO LETT, V5, P1734, DOI 10.1021/nl051063o; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; HARVEY JD, 1981, VIROLOGY, V112, P240, DOI 10.1016/0042-6822(81)90629-2; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Ivanovic T, 2007, J BIOL CHEM, V282, P12210, DOI 10.1074/jbc.M610258200; KAPULER AM, 1970, NATURE, V225, P1209, DOI 10.1038/2251209a0; KAWADE Y, 1956, BIOCHIM BIOPHYS ACTA, V19, P513, DOI 10.1016/0006-3002(56)90475-9; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lee H, 2008, BIOPHYS J, V95, P1590, DOI 10.1529/biophysj.108.133025; LEPAULT J, 1987, EMBO J, V6, P1507, DOI 10.1002/j.1460-2075.1987.tb02393.x; Mathlouthi M., 1995, SUCROSE PROPERTIES A, P137; Noble S, 1997, J VIROL, V71, P2182, DOI 10.1128/JVI.71.3.2182-2191.1997; RATTI G, 1978, NUCLEIC ACIDS RES, V5, P3843, DOI 10.1093/nar/5.10.3843; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; SKEHEL JJ, 1969, VIROLOGY, V39, P822, DOI 10.1016/0042-6822(69)90019-1; Spencer SM, 1997, J STRUCT BIOL, V120, P11, DOI 10.1006/jsbi.1997.3902; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Trask SD, 2006, J VIROL, V80, P11293, DOI 10.1128/JVI.01346-06; VANETTEN JL, 1980, J VIROL, V33, P769, DOI 10.1128/JVI.33.2.769-773.1980; YAMAKAWA M, 1981, J BIOL CHEM, V256, P6507; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009	43	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29521	29530		10.1074/jbc.M111.241703	http://dx.doi.org/10.1074/jbc.M111.241703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719697	Green Published, hybrid			2022-12-27	WOS:000294046600009
J	Tranter, M; Helsley, RN; Paulding, WR; McGuinness, M; Brokamp, C; Haar, L; Liu, Y; Ren, XP; Jones, WK				Tranter, Michael; Helsley, Robert N.; Paulding, Waltke R.; McGuinness, Michael; Brokamp, Cole; Haar, Lauren; Liu, Yong; Ren, Xiaoping; Jones, W. Keith			Coordinated Post-transcriptional Regulation of Hsp70.3 Gene Expression by MicroRNA and Alternative Polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA POLYADENYLATION; MYOCARDIAL-ISCHEMIA; STRESS-PROTEIN; HEAT-STRESS; INJURY; COX-2; TRANSCRIPTION; TRANSLATION; REPERFUSION	Heat shock protein 70 (Hsp70) is well documented to possess general cytoprotective properties in protecting the cell against stressful and noxious stimuli. We have recently shown that expression of the stress-inducible Hsp70.3 gene in the myocardium in response to ischemic preconditioning is NF-kappa B-dependent and necessary for the resulting late phase cardioprotection against a subsequent ischemia/reperfusion injury. Here we show that the Hsp70.3 gene product is subject to post-transcriptional regulation through parallel regulatory processes involving microRNAs and alternative polyadenylation of the mRNA transcript. First, we show that cardiac ischemic preconditioning of the in vivo mouse heart results in decreased levels of two Hsp70.3-targeting microRNAs: miR-378* and miR-711. Furthermore, an ischemic or heat shock stimulus induces alternative polyadenylation of the expressed Hsp70.3 transcript that results in the accumulation of transcripts with a shortened 3'-UTR. This shortening of the 3'-UTR results in the loss of the binding site for the suppressive miR-378* and thus renders the alternatively polyadenylated transcript insusceptible to miR-378*-mediated suppression. Results also suggest that the alternative polyadenylation-mediated shortening of the Hsp70.3 3'-UTR relieves translational suppression observed in the long 3'-UTR variant, allowing for a more robust increase in protein expression. These results demonstrate alternative polyadenylation of Hsp70.3 in parallel with ischemic or heat shock-induced up-regulation of mRNA levels and implicate the importance of this process in post-transcriptional control of Hsp70.3 expression.	[Tranter, Michael; Helsley, Robert N.; Paulding, Waltke R.; McGuinness, Michael; Brokamp, Cole; Haar, Lauren; Liu, Yong; Ren, Xiaoping; Jones, W. Keith] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Paulding, Waltke R.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA	University System of Ohio; University of Cincinnati; Xavier University	Jones, WK (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA.	joneswk@uc.edu	Helsley, Robert/AAQ-6032-2021	Helsley, Robert/0000-0001-5000-3187; Tranter, Michael/0000-0002-0609-3717; Brokamp, Cole/0000-0002-0289-3151	National Institutes of Health [HL63034, HL091478, T32 HL007382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL063034, R01HL091478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63034 and HL091478 (to W. K. J.).; Supported by National Institutes of Health Grant T32 HL007382 (to A. Schwartz).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; DONNELLY TJ, 1992, CIRCULATION, V85, P769, DOI 10.1161/01.CIR.85.2.769; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MESTRIL R, 1995, J MOL CELL CARDIOL, V27, P45, DOI 10.1016/S0022-2828(08)80006-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu XL, 2002, ARCH BIOCHEM BIOPHYS, V400, P233, DOI 10.1016/S0003-9861(02)00016-4; Ren XP, 2004, J SURG RES, V121, P120, DOI 10.1016/j.jss.2004.03.010; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tranter M, 2010, J MOL CELL CARDIOL, V49, P664, DOI 10.1016/j.yjmcc.2010.07.001; Wilhide ME, 2011, J MOL CELL CARDIOL, V51, P82, DOI 10.1016/j.yjmcc.2011.03.011; WURST W, 1993, GENE TARGETING PRACT, P36; Xing HY, 2004, J BIOL CHEM, V279, P10551, DOI 10.1074/jbc.M311719200; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Yu MY, 2006, BIOCHEM BIOPH RES CO, V345, P479, DOI 10.1016/j.bbrc.2006.04.113	28	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29828	29837		10.1074/jbc.M111.221796	http://dx.doi.org/10.1074/jbc.M111.221796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757701	Green Published, hybrid			2022-12-27	WOS:000294046600042
J	Kaufmann, M; Prosser, DE; Jones, G				Kaufmann, Martin; Prosser, David E.; Jones, Glenville			Bioengineering Anabolic Vitamin D-25-Hydroxylase Activity into the Human Vitamin D Catabolic Enzyme, Cytochrome P450 CYP24A1, by a V391L Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; 25-HYDROXYVITAMIN D-3; SUBSTRATE-BINDING; CALCITROIC ACID; METABOLISM; PATHWAY; ACTIVATION; KIDNEY; RAT; 1,25-DIHYDROXYVITAMIN-D3	CYP24A1 is a mitochondrial cytochrome P450 (CYP) that catabolizes 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25-(OH)(2)D-3) to different products: calcitroic acid or 1 alpha,25-(OH)(2)D-3-26,23-lactone via multistep pathways commencing with C24 and C23 hydroxylation, respectively. Despite the ability of CYP24A1 to catabolize a wide range of 25-hydroxylated analogs including 25-hydroxyvitamin D-3, the enzyme is unable to metabolize the synthetic prodrug, 1 alpha-hydroxyvitamin D-3 (1 alpha-OH-D-3), pre-sumably because it lacks a C25-hydroxyl. In the current study we show that a single V391L amino acid substitution in the beta 3a-strand of human CYP24A1 converts this enzyme from a catabolic 1 alpha,25-(OH)(2)D-3-24-hydroxylase into an anabolic 1 alpha-OH-D-3-25-hydroxylase, thereby forming the hormone, 1 alpha,25-(OH)(2)D-3. Furthermore, because the mutant enzyme retains its basal ability to catabolize 1 alpha,25-(OH)(2)D-3 via C24 hydroxylation, it can also make calcitroic acid. Previous work has shown that an A326G mutation is responsible for the regioselectivity differences observed between human (primarily C24-hydroxylating) and opossum (C23-hydroxylating) CYP24A1. When the V391L and A326G mutations were combined (V391L/A326G), the mutant enzyme continued to form 1 alpha,25-(OH)(2)D-3 from 1 alpha-OH-D-3, but this initial product was diverted via the C23 hydroxylation pathway into the 26,23-lactone. The relative position of Val-391 in the beta 3a-strand of a homology model and the crystal structure of rat CYP24A1 is consistent with hydrophobic contact of Val-391 and the substrate side chain near C21. We interpret that the substrate specificity of V391L-modified human CYP24A1 toward 1 alpha-OH-D-3 is enabled by an altered contact with the substrate side chain that optimally positions C25 of the 1 alpha-OH-D-3 above the heme for hydroxylation.	[Kaufmann, Martin; Prosser, David E.; Jones, Glenville] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Jones, Glenville] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Jones, G (corresponding author), Queens Univ, Dept Biochem, Botterell Hall Rm 650, Kingston, ON K7L 3N6, Canada.	gj1@queensu.ca			Canadian Institutes of Health Research [MA-9475, MMA-38116, MMA-69106]; Cytochroma Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cytochroma Inc.	This study was supported by Canadian Institutes of Health Research Grants MA-9475, MMA-38116, and MMA-69106 and a research grant from Cytochroma Inc.	AKIYOSHISHIBATA M, 1994, EUR J BIOCHEM, V224, P335, DOI 10.1111/j.1432-1033.1994.00335.x; Annalora A, 2004, ARCH BIOCHEM BIOPHYS, V425, P133, DOI 10.1016/j.abb.2004.01.025; Annalora AJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P262, DOI 10.1016/j.abb.2006.11.018; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Astecker N, 2004, ARCH BIOCHEM BIOPHYS, V431, P261, DOI 10.1016/j.abb.2004.08.023; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Bottner B, 1996, J BIOL CHEM, V271, P8028; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DELUCA HF, 1974, FED PROC, V33, P2211; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; GAMBHIR V, 2011, IMMUNOBIOLO IN PRESS; GUO YD, 1993, P NATL ACAD SCI USA, V90, P8668, DOI 10.1073/pnas.90.18.8668; Gupta RP, 2005, J CLIN ENDOCR METAB, V90, P1210, DOI 10.1210/jc.2004-0966; Hamamoto H, 2006, MOL PHARMACOL, V70, P120, DOI 10.1124/mol.106.023275; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hewison M, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1379; HOLICK MF, 1976, J BIOL CHEM, V251, P1020; HORIUCHI N, 1995, HORM METAB RES, V27, P83, DOI 10.1055/s-2007-979914; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Masuda S, 2006, BBA-MOL CELL BIOL L, V1761, P221, DOI 10.1016/j.bbalip.2006.01.004; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; PEDERSEN JI, 1988, BIOCHEM J, V250, P527, DOI 10.1042/bj2500527; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; QAW F, 1993, J BIOL CHEM, V268, P282; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; Sakaki T, 2000, EUR J BIOCHEM, V267, P6158, DOI 10.1046/j.1432-1327.2000.01680.x; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Swart AC, 2010, J STEROID BIOCHEM, V119, P112, DOI 10.1016/j.jsbmb.2009.12.014; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Yamada S, 1998, J MED CHEM, V41, P1467, DOI 10.1021/jm970761l	35	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28729	28737		10.1074/jbc.M111.236679	http://dx.doi.org/10.1074/jbc.M111.236679			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697097	Green Published, hybrid			2022-12-27	WOS:000293837000011
J	Wang, CC; Borchert, A; Ugun-Klusek, A; Tang, LY; Lui, WT; Chu, CY; Billett, E; Kuhn, H; Ufer, C				Wang, Chi Chiu; Borchert, Astrid; Ugun-Klusek, Aslihan; Tang, Ling Yin; Lui, Wai Ting; Chu, Ching Yan; Billett, Ellen; Kuhn, Hartmut; Ufer, Christoph			Monoamine Oxidase A Expression Is Vital for Embryonic Brain Development by Modulating Developmental Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-DEFICIENT MICE; KNOCK-OUT MICE; CELL-DEATH; C-MYC; MAO-A; PATHWAY; MOUSE; DIFFERENTIATION; INHIBITORS; DISORDERS	Monoamine oxidases (MAO-A, MAO-B) metabolize biogenic amines and have been implicated in neuronal apoptosis. Although apoptosis is an important process in embryo development, the role of MAO isoenzymes has not been investigated in detail. We found that expression of MAO-A and MAO-B can be detected early on during embryo development. Expression levels remained constant until around midgestation but then dropped to almost undetectable levels toward birth. Similar expression kinetics were observed in the brain. Isoform-specific expression silencing of MAO-A mediated by siRNA during in vitro embryogenesis induced developmental defects, as indicated by a reduction of the crown rump length and impaired cerebral development. These alterations were paralleled by elevated serotonin levels. Similar abnormalities were observed when embryos were cultured in the presence of the MAO-A inhibitor clorgyline or when the transcriptional inhibitor of MAO-A expression R1 was overexpressed. In contrast, no such alterations were detected when expression of MAO-B was knocked down. To explore the underlying mechanisms for the developmental abnormalities in MAO-A knockdown embryos, we quantified the degree of developmental apoptosis in the developing brain. MAO-A knockdown reduced the number of apoptotic cells in the neuroepithelium, which coincided with impaired activation of caspases 3 and 9. Moreover, we observed reduced cyclin D1 levels as an indicator of impaired cell proliferation in MAO-A knockdown embryos. This data highlights	[Borchert, Astrid; Kuhn, Hartmut; Ufer, Christoph] Univ Med Berlin Charite, Inst Biochem, D-13347 Berlin, Germany; [Wang, Chi Chiu; Tang, Ling Yin; Lui, Wai Ting; Chu, Ching Yan] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Inst Biomed Sci, Shatin, Hong Kong, Peoples R China; [Ugun-Klusek, Aslihan; Billett, Ellen; Ufer, Christoph] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Nottingham Trent University	Kuhn, H (corresponding author), Univ Med Berlin Charite, Inst Biochem, Oudenarder Str 16, D-13347 Berlin, Germany.	hartmut.kuehn@charite.de	Wang, Ronald/C-6541-2014	Wang, Ronald/0000-0002-3928-7278; Billett, Ellen/0000-0001-8245-6519; Ugun Klusek, Aslihan/0000-0002-0199-0275; Borchert, Astrid/0000-0003-3551-5592	European Commission [LSHM-CT-2004-0050333]; Li Ka Shing Institute of Health Sciences [6901988]; Leverhulme Trust;  [2008.1.052]	European Commission(European CommissionEuropean Commission Joint Research Centre); Li Ka Shing Institute of Health Sciences; Leverhulme Trust(Leverhulme Trust); 	This work was supported in part by European Commission Grants FP6 and LSHM-CT-2004-0050333 (to H. K.), by Direct Grant 2008.1.052 and Special Equipment Grant for High-performance Microscopic Platform for Live Genetics in 2008 and for Micromanipulation System for Transgenics in 2004 and Li Ka Shing Institute of Health Sciences 6901988 (to C. C. W.), and by a Leverhulme Trust grant (to E. E. B. and C. U.).	Alwan S, 2009, CNS DRUGS, V23, P493, DOI 10.2165/00023210-200923060-00004; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Beglopoulos V, 2004, NEUROMOL MED, V6, P13, DOI 10.1385/NMM:6:1:013; Billett EE, 2004, NEUROTOXICOLOGY, V25, P139, DOI 10.1016/S0161-813X(03)00094-9; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Borue X, 2007, INT J DEV NEUROSCI, V25, P341, DOI 10.1016/j.ijdevneu.2007.06.003; Burnet H, 2001, J NEUROSCI, V21, P5212, DOI 10.1523/JNEUROSCI.21-14-05212.2001; CASES O, 1995, SCIENCE, V268, P833; Cecconi F, 2008, CELL DEATH DIFFER, V15, P1170, DOI 10.1038/cdd.2008.64; Chen K, 2004, J BIOL CHEM, V279, P39645, DOI 10.1074/jbc.M405550200; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2004, NEUROTOXICOLOGY, V25, P31, DOI 10.1016/S0161-813X(03)00113-X; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Cheng AW, 2010, J NEUROSCI, V30, P10752, DOI 10.1523/JNEUROSCI.2037-10.2010; Chiou SH, 2006, BRIT J PHARMACOL, V148, P587, DOI 10.1038/sj.bjp.0706766; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Fitzgerald JC, 2007, J NEUROCHEM, V103, P2189, DOI 10.1111/j.1471-4159.2007.04921.x; Geha RM, 2001, J BIOL CHEM, V276, P9877, DOI 10.1074/jbc.M006972200; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Guo Y, 2005, ONCOGENE, V24, P2599, DOI 10.1038/sj.onc.1208326; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jahng JW, 1997, SYNAPSE, V25, P30; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Luo XY, 2003, DEV NEUROSCI-BASEL, V25, P173, DOI 10.1159/000072266; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Popova NK, 2006, PSYCHONEUROENDOCRINO, V31, P179, DOI 10.1016/j.psyneuen.2005.06.005; Santoni-Rugiu E, 1998, CANCER RES, V58, P123; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Senechal Y, 2006, NEURODEGENER DIS, V3, P134, DOI 10.1159/000094772; Shih JC, 2007, NEUROCHEM RES, V32, P1757, DOI 10.1007/s11064-007-9384-z; Stankovski L, 2007, J NEUROSCI, V27, P1315, DOI 10.1523/JNEUROSCI.4395-06.2007; Suarez-Merino B, 2001, Hum Mutat, V17, P523, DOI 10.1002/humu.1140; Syagailo YV, 2001, AM J MED GENET, V105, P168, DOI 10.1002/ajmg.1193; Ufer C, 2010, ANTIOXID REDOX SIGNA; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; VANMAELEFABRY G, 1990, TOXICOL IN VITRO, V4, P149, DOI 10.1016/0887-2333(90)90037-T; Vitalis T, 2002, J COMP NEUROL, V442, P331, DOI 10.1002/cne.10093; WANG CC, 2005, NEUROEMBRYOL AGING, V3, P78; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	46	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28322	28330		10.1074/jbc.M111.241422	http://dx.doi.org/10.1074/jbc.M111.241422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697081	hybrid, Green Published			2022-12-27	WOS:000293557800049
J	Morrison, C; Mancini, S; Cipollone, J; Kappelhoff, R; Roskelley, C; Overall, C				Morrison, Charlotte; Mancini, Stephanie; Cipollone, Jane; Kappelhoff, Reinhild; Roskelley, Calvin; Overall, Christopher			Microarray and Proteomic Analysis of Breast Cancer Cell and Osteoblast Co-cultures ROLE OF OSTEOBLAST MATRIX METALLOPROTEINASE (MMP)-13 IN BONE METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; C-TERMINAL DOMAIN; GELATINASE-A; COLLAGENASE-3 MMP-13; TUMOR MICROENVIRONMENT; 72-KDA GELATINASE; HUMAN FIBROBLASTS; TISSUE INHIBITOR; GENE-EXPRESSION; BONE METASTASES	Dynamic reciprocal interactions between a tumor and its microenvironment impact both the establishment and progression of metastases. These interactions are mediated, in part, through proteolytic sculpting of the microenvironment, particularly by the matrix metalloproteinases, with both tumors and stroma contributing to the proteolytic milieu. Because bone is one of the predominant sites of breast cancer metastases, we used a co-culture system in which a subpopulation of the highly invasive human breast cancer cell line MDA-MB-231, with increased propensity to metastasize to bone, was overlaid onto a monolayer of differentiated osteoblast MC3T3-E1 cells in a mineralized osteoid matrix. CLIP-CHIP (R) microarrays identified changes in the complete protease and inhibitor expression profile of the breast cancer and osteoblast cells that were induced upon co-culture. A large increase in osteoblast-derived MMP-13 mRNA and protein was observed. Affymetrix analysis and validation showed induction of MMP-13 was initiated by soluble factors produced by the breast tumor cells, including oncostatin M and the acute response apolipoprotein SAA3. Significant changes in the osteoblast secretomes upon addition of MMP-13 were identified by degradomics from which six novel MMP-13 substrates with the potential to functionally impact breast cancer metastasis to bone were identified and validated. These included inactivation of the chemokines CCL2 and CCL7, activation of platelet-derived growth factor-C, and cleavage of SAA3, osteoprotegerin, CutA, and antithrombin III. Hence, the influence of breast cancer metastases on the bone microenvironment that is executed via the induction of osteoblast MMP-13 with the potential to enhance metastases growth by generating a microenvironmental amplifying feedback loop is revealed.	[Overall, Christopher] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Morrison, Charlotte; Kappelhoff, Reinhild; Overall, Christopher] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Mancini, Stephanie; Cipollone, Jane; Roskelley, Calvin] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Overall, C (corresponding author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Roskelley, Calvin D/F-4630-2011		Canadian Institutes of Health Research; National Cancer Institute of Canada (Canadian Cancer Association); Canadian Breast Cancer Research Alliance Metastasis; Michael Smith Research Foundation; Canada Research Chair in Metalloproteinase Proteomics and Systems Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada (Canadian Cancer Association); Canadian Breast Cancer Research Alliance Metastasis; Michael Smith Research Foundation(Michael Smith Foundation for Health Research); Canada Research Chair in Metalloproteinase Proteomics and Systems Biology(Canada Research Chairs)	This work was supported in part by grants from the Canadian Institutes of Health Research, the National Cancer Institute of Canada (with funds raised by the Canadian Cancer Association), a Special Program Grant from the Canadian Breast Cancer Research Alliance Metastasis, and a Centre Grant from the Michael Smith Research Foundation to the University of British Columbia Centre of Blood Research.; Supported by a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology. To whom correspondence should be addressed: Centre for Blood Research, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada. E-mail: chris.overall@ubc.ca.	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Andarawewa KL, 2003, CANCER RES, V63, P5844; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bisson C, 2003, INT J CANCER, V105, P7, DOI 10.1002/ijc.11012; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler GS, 2010, METHODS MOL BIOL, V622, P451, DOI 10.1007/978-1-60327-299-5_26; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Cox Jennifer H., 2008, P519, DOI 10.1007/978-0-387-69057-5_26; D'Angelo M, 2001, J BONE MINER RES, V16, P2339, DOI 10.1359/jbmr.2001.16.12.2339; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Mabrouk M, 2007, BBA-MOL CELL RES, V1773, P309, DOI 10.1016/j.bbamcr.2006.11.018; Filanti C, 2000, J BONE MINER RES, V15, P2154, DOI 10.1359/jbmr.2000.15.11.2154; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Franchimont N, 1997, J BIOL CHEM, V272, P12144, DOI 10.1074/jbc.272.18.12144; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gonzalez LO, 2007, BRIT J CANCER, V97, P957, DOI 10.1038/sj.bjc.6603963; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kappelhoff R., 2009, CURRENT PROTOCOLS S, P1; Kappelhoff R, 2010, METHODS MOL BIOL, V622, P175, DOI 10.1007/978-1-60327-299-5_10; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Keller UAD, 2010, CANCER RES, V70, P7562, DOI 10.1158/0008-5472.CAN-10-1584; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lafleur MA, 2005, INT J CANCER, V114, P544, DOI 10.1002/ijc.20763; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Lee J, 2001, EUR J CANCER, V37, P106, DOI 10.1016/S0959-8049(00)00363-4; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Liang D, 2009, FEBS J, V276, P4473, DOI 10.1111/j.1742-4658.2009.07154.x; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; MAST AE, 1991, J BIOL CHEM, V266, P15810; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MITCHELL TI, 1993, BIOCHIM BIOPHYS ACTA, V1156, P245, DOI 10.1016/0304-4165(93)90038-A; Mizutani A, 2001, J BONE MINER RES, V16, P2043, DOI 10.1359/jbmr.2001.16.11.2043; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2042; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nakano Y, 2010, J CELL PHYSIOL, V223, P260, DOI 10.1002/jcp.22034; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Pendas AM, 2000, CLIN CHIM ACTA, V291, P137, DOI 10.1016/S0009-8981(99)00225-9; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P657, DOI 10.1097/00001721-200212000-00001; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rozanov DV, 2002, J BIOL CHEM, V277, P9318, DOI 10.1074/jbc.M110711200; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Schwarz E. M., 2007, ARTHRITIS RES THE S1, V9, P7; Selvamurugan N, 2000, J CELL BIOCHEM, V79, P182, DOI 10.1002/1097-4644(20001101)79:2<182::AID-JCB20>3.0.CO;2-0; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Terpos E, 2009, EXPERT OPIN BIOL TH, V9, P465, DOI [10.1517/14712590902845610, 10.1517/14712590902845610 ]; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Varghese S, 1999, AM J PHYSIOL-ENDOC M, V276, pE465, DOI 10.1152/ajpendo.1999.276.3.E465; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wagsater D, 2009, ATHEROSCLEROSIS, V202, P415, DOI 10.1016/j.atherosclerosis.2008.04.050; Yang CM, 2009, J BIOL CHEM, V284, P26040, DOI 10.1074/jbc.M109.040154; Yang JC, 2009, MOL BIOL REP, V36, P63, DOI 10.1007/s11033-007-9152-9; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zhang J, 2004, CANCER RES, V64, P6957, DOI 10.1158/0008-5472.CAN-04-0819; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	101	45	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34271	34285		10.1074/jbc.M111.222513	http://dx.doi.org/10.1074/jbc.M111.222513			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21784845	hybrid, Green Published			2022-12-27	WOS:000295159200057
J	Garcia-Perez, J; Rueda, P; Alcami, J; Rognan, D; Arenzana-Seisdedos, F; Lagane, B; Kellenberger, E				Garcia-Perez, Javier; Rueda, Patricia; Alcami, Jose; Rognan, Didier; Arenzana-Seisdedos, Fernando; Lagane, Bernard; Kellenberger, Esther			Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITOR; PROTEIN-LIGAND DOCKING; 2ND EXTRACELLULAR LOOP; MONOCLONAL-ANTIBODIES; TRANSMEMBRANE HELIX; HIGHLY POTENT; HIV-INFECTION; ENTRY; ANTAGONISTS	Maraviroc is a nonpeptidic small molecule human immunodeficiency virus type 1 (HIV-1) entry inhibitor that has just entered the therapeutic arsenal for the treatment of patients. We recently demonstrated that maraviroc binding to the HIV-1 coreceptor, CC chemokine receptor 5 (CCR5), prevents it from binding the chemokine CCL3 and the viral envelope glycoprotein gp120 by an allosteric mechanism. However, incomplete knowledge of ligand-binding sites and the lack of CCR5 crystal structures have hampered an in-depth molecular understanding of how the inhibitor works. Here, we addressed these issues by combining site-directed mutagenesis (SDM) with homology modeling and docking. Six crystal structures of G-protein-coupled receptors were compared for their suitability for CCR5 modeling. All CCR5 models had equally good geometry, but that built from the recently reported dimeric structure of the other HIV-1 coreceptor CXCR4 bound to the peptide CVX15 (Protein Data Bank code 3OE0) best agreed with the SDM data and discriminated CCR5 from non-CCR5 binders in a virtual screening approach. SDM and automated docking predicted that maraviroc inserts deeply in CCR5 transmembrane cavity where it can occupy three different binding sites, whereas CCL3 and gp120 lie on distinct yet overlapped regions of the CCR5 extracellular loop 2. Data suggesting that the transmembrane cavity remains accessible for maraviroc in CCL3-bound and gp120-bound CCR5 help explain our previous observation that the inhibitor enhances dissociation of preformed ligand-CCR5 complexes. Finally, we identified residues in the predicted CCR5 dimer interface that are mandatory for gp120 binding, suggesting that receptor dimerization might represent a target for new CCR5 entry inhibitors.	[Garcia-Perez, Javier; Rueda, Patricia; Arenzana-Seisdedos, Fernando; Lagane, Bernard] Inst Pasteur, INSERM U819, F-75724 Paris 15, France; [Garcia-Perez, Javier; Rueda, Patricia; Arenzana-Seisdedos, Fernando; Lagane, Bernard] Inst Pasteur, Unite Pathogenie Virale, F-75724 Paris 15, France; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, Madrid 28220, Spain; [Rognan, Didier; Kellenberger, Esther] Univ Strasbourg UMR7200, F-67400 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Instituto de Salud Carlos III; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Garcia-Perez, J (corresponding author), Inst Pasteur, INSERM U819, 25 Rue Dr Roux, F-75724 Paris 15, France.	bernard.lagane@pasteur.fr; ekellen@unistra.fr	Kellenberger, Esther/AFN-2081-2022; Rognan, Didier/B-9939-2014; Arenzana-Seisdedos, Fernando/E-5835-2016; Lagane, Bernard/AAA-2205-2019; García-Pérez, Javier/F-9248-2019; Lagane, Bernard/K-8446-2016; Alcami, Pepe/T-2242-2018	Kellenberger, Esther/0000-0002-9320-4840; Lagane, Bernard/0000-0002-3459-7867; García-Pérez, Javier/0000-0001-7551-7803; Alcami, Pepe/0000-0003-0023-7377; Rueda, Patricia/0000-0003-1553-0840	Instituto de Salud Carlos III; Spanish Ministry of Health [FIS PI080752]; AIDS Network ISCIII-RETIC [RD06/0006]; Agence Nationale de Recherche sur le SIDA (ANRS); FIPSE [36633/07]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AIDS Network ISCIII-RETIC; Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); FIPSE	This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Health Grant FIS PI080752, AIDS Network ISCIII-RETIC Grant RD06/0006, Agence Nationale de Recherche sur le SIDA (ANRS), and FIPSE Grant 36633/07.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Blanpain C, 1999, BLOOD, V94, P1899; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Kellenberger E, 2007, J MED CHEM, V50, P1294, DOI 10.1021/jm061389p; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kleinau G, 2010, FASEB J, V24, P2347, DOI 10.1096/fj.09-149146; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Labrecque J, 2011, VIROLOGY, V413, P231, DOI 10.1016/j.virol.2011.02.016; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Mazna P, 2005, BIOCHEM BIOPH RES CO, V332, P726, DOI 10.1016/j.bbrc.2005.05.017; Muniz-Medina VM, 2009, MOL PHARMACOL, V75, P490, DOI 10.1124/mol.108.052555; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Perez-Nueno VI, 2008, J CHEM INF MODEL, V48, P2146, DOI 10.1021/ci800257x; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Safarian D, 2006, VIROLOGY, V352, P477, DOI 10.1016/j.virol.2006.05.016; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Thompson DAD, 2002, J VIROL, V76, P3059, DOI 10.1128/JVI.76.6.3059-3064.2002; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wood A, 2005, PROGR MED CHEM, V43, P239, DOI 10.1016/S0079-6468(05)43007-6; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang J, 2007, ANTIMICROB AGENTS CH, V51, P1386, DOI 10.1128/AAC.01302-06	49	89	91	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33409	33421		10.1074/jbc.M111.279596	http://dx.doi.org/10.1074/jbc.M111.279596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21775441	hybrid, Green Published			2022-12-27	WOS:000294968800059
J	Sancar, F; Touroutine, D; Gao, SB; Oh, HJ; Gendrel, M; Bessereau, JL; Kim, H; Zhen, M; Richmond, JE				Sancar, Feyza; Touroutine, Denis; Gao, Shangbang; Oh, Hyun J.; Gendrel, Marie; Bessereau, Jean-Louis; Kim, Hongkyun; Zhen, Mei; Richmond, Janet E.			The Dystrophin-associated Protein Complex Maintains Muscle Excitability by Regulating Ca2+-dependent K+ (BK) Channel Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS DYSTROPHIN; GLYCOPROTEIN COMPLEX; POTASSIUM CHANNELS; GENETIC-EVIDENCE; SKELETAL-MUSCLE; DYSTROBREVIN; RECEPTOR; BLADDER; REPOLARIZATION; DYSTROGLYCAN	The dystrophin-associated protein complex (DAPC) consists of several transmembrane and intracellular scaffolding elements that have been implicated in maintaining the structure and morphology of the vertebrate neuromuscular junction (NMJ). Genetic linkage analysis has identified loss-of-function mutations in DAPC genes that give rise to degenerative muscular dystrophies. Although much is known about the involvement of the DAPC in maintaining muscle integrity, less is known about the precise contribution of the DAPC in cell signaling events. To better characterize the functional role of the DAPC at the NMJ, we used electrophysiology, immunohistochemistry, and fluorescent labeling to directly assess cholinergic synaptic transmission, ion channel localization, and muscle excitability in loss-of-function (lf) mutants of Caenorhabditis elegans DAPC homologues. We found that all DAPC mutants consistently display mislocalization of the Ca2+-gated K+ channel, SLO-1, in muscle cells, while ionotropic acetylcholine receptor (AChR) expression and localization at the NMJ remained unaltered. Synaptic cholinergic signaling was also not significantly impacted across DAPC(lf) mutants. Consistent with these findings and the postsynaptic mislocalization of SLO-1, we observed an increase in muscle excitability downstream of cholinergic signaling. Based on our results, we conclude that the DAPC is not involved in regulating AChR architecture at the NMJ, but rather functions to control muscle excitability, in an activity-dependent manner, through the proper localization of SLO-1 channels.	[Sancar, Feyza; Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Touroutine, Denis] Univ Massachusetts, Dept Neurobiol, Sch Med, Worcester, MA 01605 USA; [Gao, Shangbang; Zhen, Mei] Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Oh, Hyun J.; Kim, Hongkyun] Rosalind Franklin Univ Sci & Med, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Gendrel, Marie; Bessereau, Jean-Louis] Ecole Normale Super, Dept Biol, Inst Biol, F-75005 Paris, France; [Bessereau, Jean-Louis] INSERM, Unite 1024, F-75005 Paris, France; [Bessereau, Jean-Louis] Ctr Natl Rech Sci, Unit Mixte Rech 8197, F-75005 Paris, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Rosalind Franklin University Medical & Science; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Richmond, JE (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor St, Chicago, IL 60607 USA.	jer@uic.edu	Zhen, Mei/A-4967-2012; Bessereau, Jean-Louis/M-2988-2017	Zhen, Mei/0000-0003-0086-9622; Bessereau, Jean-Louis/0000-0002-3088-7621; Gao, Shangbang/0000-0001-5431-4628; Gendrel, Marie/0000-0002-0991-0479; Oh, Kelly/0000-0001-8203-5247; Kim, Hongkyun/0000-0002-4879-7122	National Institutes of Health [R01 MH073156, R01 NS058814]; Canadian Institute Health Research [MOP-93619, MOP-74530]; INSERM; Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute Health Research(Canadian Institutes of Health Research (CIHR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported, in whole or in part, by National Institutes of Health Grants R01 MH073156 (to J. E. R.), and R01 NS058814 (to H. K.); the Canadian Institute Health Research Grants (MOP-93619 and MOP-74530) (to M. Z.); and INSERM, the Fondation pour la Recherche Medicale and the Association Francaise contre les Myopathies (to J.-L. B.).	Abraham LS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001077; Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Allen DG, 2005, J PHYSIOL-LONDON, V567, P723, DOI 10.1113/jphysiol.2005.091694; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; Bingham JP, 2006, BIOCONJUGATE CHEM, V17, P689, DOI 10.1021/bc060002u; Carlson CG, 1998, NEUROBIOL DIS, V5, P3, DOI 10.1006/nbdi.1998.0188; Carre-Pierrat M, 2006, J MOL BIOL, V358, P387, DOI 10.1016/j.jmb.2006.02.037; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gieseler K, 1999, FEBS LETT, V461, P59, DOI 10.1016/S0014-5793(99)01421-0; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; Grisoni K, 2003, J MOL BIOL, V332, P1037, DOI 10.1016/j.jmb.2003.08.021; Hashitani H, 2003, BRIT J PHARMACOL, V140, P159, DOI 10.1038/sj.bjp.0705320; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; Hopf F. W., 2007, V45, P429; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kim H, 2004, NATURE, V430, P891, DOI 10.1038/nature02798; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Kong JM, 1999, BRAIN RES, V839, P298, DOI 10.1016/S0006-8993(99)01737-0; Lecroisey C, 2008, MOL BIOL CELL, V19, P785, DOI 10.1091/mbc.E07-05-0497; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; Meier T, 2000, NEWS PHYSIOL SCI, V15, P255; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Pilgram GSK, 2010, MOL NEUROBIOL, V41, P1, DOI 10.1007/s12035-009-8089-5; Richmond Janet, 2005, WormBook, P1; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Tricarico D, 2005, NEUROBIOL DIS, V20, P296, DOI 10.1016/j.nbd.2005.03.011; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Wang YJ, 2008, LIFE SCI, V82, P11, DOI 10.1016/j.lfs.2007.10.015; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4	49	18	23	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33501	33510		10.1074/jbc.M111.227678	http://dx.doi.org/10.1074/jbc.M111.227678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795674	hybrid, Green Published			2022-12-27	WOS:000294968800067
J	Mao, XC; Gluck, N; Chen, BZ; Starokadomskyy, P; Li, HY; Maine, GN; Burstein, E				Mao, Xicheng; Gluck, Nathan; Chen, Baozhi; Starokadomskyy, Petro; Li, Haiying; Maine, Gabriel N.; Burstein, Ezra			COMMD1 (Copper Metabolism MURR1 Domain-containing Protein 1) Regulates Cullin RING Ligases by Preventing CAND1 (Cullin-associated Nedd8-dissociated Protein 1) Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; GENE MURR1; COMPLEX; TOXICOSIS; SCF; PROTEOLYSIS; ACTIVATION; PROMOTES; DISEASE; CUL1	Cullin RING ligases (CRLs), the most prolific class of ubiquitin ligase enzymes, are multimeric complexes that regulate a wide range of cellular processes. CRL activity is regulated by CAND1 (Cullin-associated Nedd8-dissociated protein 1), an inhibitor that promotes the dissociation of substrate receptor components from the CRL. We demonstrate here that COMMD1 (copper metabolism MURR1 domain-containing 1), a factor previously found to promote ubiquitination of various substrates, regulates CRL activation by antagonizing CAND1 binding. We show that COMMD1 interacts with multiple Cullins, that the COMMD1-Cul2 complex cannot bind CAND1, and that, conversely, COMMD1 can actively displace CAND1 from CRLs. These findings highlight a novel mechanism of CRL activation and suggest that CRL regulation may underlie the pleiotropic activities of COMMD1.	[Mao, Xicheng; Chen, Baozhi; Starokadomskyy, Petro; Li, Haiying; Maine, Gabriel N.; Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gluck, Nathan; Burstein, Ezra] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gluck, Nathan] Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91120 Jerusalem, Israel; [Maine, Gabriel N.] William Beaumont Hosp, Dept Clin Pathol, Royal Oak, MI 48073 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; Hebrew University of Jerusalem; Beaumont Health	Burstein, E (corresponding author), 5323 Harry Hines Blvd,Rm J5-126, Dallas, TX 75390 USA.	ezra.burstein@utsouthwestern.edu	Li, Haiying/B-1879-2012; Burstein, Ezra/B-7247-2016	Burstein, Ezra/0000-0003-4341-6367	National Institutes of Health [R01 DK073639]; Crohn's and Colitis Foundation of America [SRA 2737]; University of Texas Southwestern Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; University of Texas Southwestern Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK073639. This work was also supported by Crohn's and Colitis Foundation of America Grant SRA 2737 and a University of Texas Southwestern Medical Center DOCS Award (to E.B.).	Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chua YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016071; Coronado VA, 2005, CLIN GENET, V68, P548, DOI 10.1111/j.1399-0004.2005.00524.x; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Li H., 2011, ONCOGENE IN PRESS; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine Gabriel N, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5318; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Stuehler B, 2004, J MOL MED, V82, P629, DOI 10.1007/s00109-004-0557-9; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson Caroline R. M., 2002, Trends in Cell Biology, V12, P545, DOI 10.1016/S0962-8924(02)02397-8; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	40	29	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32355	32365		10.1074/jbc.M111.278408	http://dx.doi.org/10.1074/jbc.M111.278408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778237	Green Published, hybrid			2022-12-27	WOS:000294726800045
J	Ortiz-Ramirez, C; Mora, SI; Trejo, J; Pantoja, O				Ortiz-Ramirez, Carlos; Mora, Silvia I.; Trejo, Jorge; Pantoja, Omar			PvAMT1;1, a Highly Selective Ammonium Transporter That Functions as H+/NH4+ Symporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; ION-TRANSPORT; RICE ROOTS; NH4+; PROTEINS; AMTB; ARABIDOPSIS; MECHANISMS	One of the main forms of nitrogen assimilated by microorganisms and plants is ammonium, despite its toxicity at low millimolar concentrations. Ammonium absorption has been demonstrated to be carried out by highly selective plasma membrane-located transporters of the AMT/MEP/Rh family and characterized by the presence of a well conserved hydrophobic pore through which ammonia is proposed to move. However, uncertainties exist regarding the exact chemical species transported by these membrane proteins, which can be in the form of either hydrophobic ammonia or charged ammonium. Here, we present the characterization of PvAMT1;1 from the common bean and demonstrate that it mediates the high affinity (micromolar), rapidly saturating (1 mM) electrogenic transport of ammonium. Activity of the transporter is enhanced by low extracellular pH, and associated with this acidic pH stimulation are changes in the reversal potential and cytoplasm acidification, indicating that PvAMT1; 1 functions as an H+/NH4+ symporter. Mutation analysis of a unique histidine present in PvAMT1; 1 (H125R) leads to the stimulation of ammonium transport by decreasing the K-m value by half and by increasing the V-max 3-fold, without affecting the pH dependence of the symporter. In contrast, mutation of the first conserved histidine within the channel modifies the properties of PvAMT1; 1, increasing its K-m and V-max values and transforming it into a pH-independent mechanism.	[Ortiz-Ramirez, Carlos; Mora, Silvia I.; Trejo, Jorge; Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Pantoja, O (corresponding author), Apdo Postal 510-3, Cuernavaca 62250, Mor, Mexico.	omar@ibt.unam.mx	Ortiz-Ramirez, Carlos/AAG-3118-2019; Pantoja, Omar/H-5981-2012	Pantoja, Omar/0000-0002-6538-9059; Ortiz-Ramirez, Carlos/0000-0002-5166-1955	Consejo Nacional de Ciencia y Tecnologia-Mexico [42664, 79191]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IN218308]; DGAPA-Universidad Nacional Autonoma de Mexico	Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); DGAPA-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported in part by Grants 42664 and 79191 from Consejo Nacional de Ciencia y Tecnologia-Mexico and Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Grant IN218308 (to O. P.).; Supported by a scholarship from Consejo Nacional de Ciencia y Tecnologia-Mexico.; Recipient of a postdoctoral fellowship from Consejo Nacional de Ciencia y Tecnologia-Mexico and DGAPA-Universidad Nacional Autonoma de Mexico.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boldt M, 2003, PFLUG ARCH EUR J PHY, V446, P652, DOI 10.1007/s00424-003-1122-z; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Demidchik V, 2002, PLANT PHYSIOL, V128, P379, DOI 10.1104/pp.010524; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; HILLE B, 1992, IONIC CHANNELS EXCIT, P1; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kronzucker HJ, 1997, NATURE, V385, P59, DOI 10.1038/385059a0; Lamoureux G, 2010, TRANSFUS CLIN BIOL, V17, P168, DOI 10.1016/j.tracli.2010.06.004; Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756; Lanquar V, 2009, PLANT CELL, V21, P3610, DOI 10.1105/tpc.109.068593; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Moroni A, 1998, J MEMBRANE BIOL, V163, P25, DOI 10.1007/s002329900367; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Sogaard R, 2009, PFLUG ARCH EUR J PHY, V458, P733, DOI 10.1007/s00424-009-0665-z; Uehlein N, 2007, PHYTOCHEMISTRY, V68, P122, DOI 10.1016/j.phytochem.2006.09.033; WANG MY, 1994, PLANT PHYSIOL, V104, P899, DOI 10.1104/pp.104.3.899; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; WIREN NV, 2004, TOP CURR GENET, V9, P1; Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	35	54	56	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31113	31122		10.1074/jbc.M111.261693	http://dx.doi.org/10.1074/jbc.M111.261693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757699	Green Published, hybrid			2022-12-27	WOS:000294487500006
J	Tanjore, H; Cheng, DS; Degryse, AL; Zoz, DF; Abdolrasulnia, R; Lawson, WE; Blackwell, TS				Tanjore, Harikrishna; Cheng, Dong-Sheng; Degryse, Amber L.; Zoz, Donald F.; Abdolrasulnia, Rasul; Lawson, William E.; Blackwell, Timothy S.			Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; PROTEIN TRANSLATION; PULMONARY-FIBROSIS; ALPHA-SUBUNIT; APOPTOSIS; KINASE; ACTIVATION; ER; EIF2-ALPHA; INDUCTION	Expression of mutant surfactant protein C (SFTPC) results in endoplasmic reticulum (ER) stress in type II alveolar epithelial cells (AECs). AECs have been implicated as a source of lung fibroblasts via epithelial-to-mesenchymal transition (EMT); therefore, we investigated whether ER stress contributes to EMT as a possible mechanism for fibrotic remodeling. ER stress was induced by tunicamyin administration or stable expression of mutant (L188Q) SFTPC in type II AEC lines. Both tunicamycin treatment and mutant SFTPC expression induced ER stress and the unfolded protein response. With tunicamycin or mutant SFTPC expression, phase contrast imaging revealed a change to a fibroblast-like appearance. During ER stress, expression of epithelial markers E-cadherin and Zonula occludens-1 decreased while expression of mesenchymal markers S100A4 and alpha-smooth muscle actin increased. Following induction of ER stress, we found activation of a number of pathways, including MAPK, Smad, beta-catenin, and Src kinase. Using specific inhibitors, the combination of a Smad2/3 inhibitor (SB431542) and a Src kinase inhibitor (PP2) blocked EMT with maintenance of epithelial appearance and epithelial marker expression. Similar results were noted with siRNA targeting Smad2 and Src kinase. Together, these studies reveal that induction of ER stress leads to EMT in lung epithelial cells, suggesting possible crosstalk between Smad and Src kinase pathways. Dissecting pathways involved in ER stress-induced EMT may lead to new treatment strategies to limit fibrosis.	[Tanjore, Harikrishna; Cheng, Dong-Sheng; Degryse, Amber L.; Zoz, Donald F.; Abdolrasulnia, Rasul; Lawson, William E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Lawson, William E.; Blackwell, Timothy S.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Tanjore, H (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, T-1218 MCN, Nashville, TN 37232 USA.	harikrishna.tanjore@vanderbilt.edu			National Institutes of Health, NHBLI [HL85317, HL92870, HL85406, HL87738]; Department of Veterans Affairs; American Lung Association; American Thoracic Society/Coalition of Pulmonary Fibrosis Research; Francis Families Foundation; IPFNet; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092870, R01HL085317, T32HL087738, K08HL085406] Funding Source: NIH RePORTER	National Institutes of Health, NHBLI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); American Lung Association; American Thoracic Society/Coalition of Pulmonary Fibrosis Research; Francis Families Foundation; IPFNet; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL85317 from the NHBLI (to T.S.B.), HL92870 (to T.S.B.), HL85406 (to W.E.L.), and HL87738 (to A.L.D.) and the Department of Veterans Affairs (to T.S.B. and W.E.L.). This work was also supported by American Lung Association Dalsemer Research Grant (to W.E.L.), American Thoracic Society/Coalition of Pulmonary Fibrosis Research Grant (to H.T.), Francis Families Foundation (to H.T.), IPFNet Cowlin Career Development Award (to A.L.D.).	Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Crossno PF, 2010, CHEST, V137, P969, DOI 10.1378/chest.09-0790; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	40	165	174	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30972	30980		10.1074/jbc.M110.181164	http://dx.doi.org/10.1074/jbc.M110.181164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757695	Green Published, hybrid			2022-12-27	WOS:000294283600075
J	Liu, Q; Su, SF; Blackwelder, AJ; Minges, JT; Wilson, EM				Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.			Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING-DOMAIN; COOH-TERMINAL INTERACTION; BULBAR MUSCULAR-ATROPHY; ACTIVATION FUNCTION 2; STRUCTURAL BASIS; PROSTATE-CANCER; INTERDOMAIN INTERACTION; PHOSPHORYLATION SITES; COREGULATOR MAGE-11; GENE-MUTATIONS	Male sex development and growth occur in response to high affinity androgen binding to the androgen receptor (AR). In contrast to complete amino acid sequence conservation in the AR DNA and ligand binding domains among mammals, a primate-specific difference in the AR NH2-terminal region that regulates the NH2- and carboxyl-terminal (N/C) interaction enables direct binding to melanoma antigen-A11 (MAGE-11), an AR coregulator that is also primate-specific. Human, mouse, and rat AR share the same NH2-terminal (23)FQNLF(27) sequence that mediates the androgen-dependent N/C interaction. However, the mouse and rat AR FXXLF motif is flanked by Ala(33) that evolved to Val(33) in primates. Human AR Val(33) was required to interact directly with MAGE-11 and for the inhibitory effect of the AR N/C interaction on activation function 2 that was relieved by MAGE-11. The functional importance of MAGE-11 was indicated by decreased human AR regulation of an androgen-dependent endogenous gene using lentivirus short hairpin RNAs and by the greater transcriptional strength of human compared with mouse AR. MAGE-11 increased progesterone and glucocorticoid receptor activity independently of binding an FXXLF motif by interacting with p300 and p160 coactivators. We conclude that the coevolution of the AR NH2-terminal sequence and MAGE-11 expression among primates provides increased regulatory control over activation domain dominance. Primate-specific expression of MAGE-11 results in greater steroid receptor transcriptional activity through direct interactions with the human AR FXXLF motif region and indirectly through steroid receptor-associated p300 and p160 coactivators.	[Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Liu, Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai Key Lab Mol Androl,Inst Biochem & Cell B, Shanghai 200031, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, Lineberger Comprehens Canc Ctr, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health [HD16910]; NICHD; NCI [P01-CA77739]; Fogarty International Center Training and Research in Population and Health [5D43-TW000627-15]; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers [U54-HD35041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R01HD016910, R37HD016910] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000627] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center Training and Research in Population and Health; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HD16910, United States Public Health Service grant from NICHD; Grant P01-CA77739 from the NCI; Grant 5D43-TW000627-15, a Fogarty International Center Training and Research in Population and Health grant; and Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research.	Albertelli MA, 2006, MOL ENDOCRINOL, V20, P1248, DOI 10.1210/me.2006-0021; Aprelikova O, 2009, CANCER RES, V69, P616, DOI 10.1158/0008-5472.CAN-08-0811; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Callewaert L, 2003, J BIOL CHEM, V278, P8212, DOI 10.1074/jbc.M210744200; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Choong CS, 1998, J MOL EVOL, V47, P334, DOI 10.1007/PL00006391; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; Delbridge Margaret L, 2007, Soc Reprod Fertil Suppl, V65, P1; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Ghadessy FJ, 1999, J CLIN INVEST, V103, P1517, DOI 10.1172/JCI4289; Ghali SA, 2003, J CLIN ENDOCR METAB, V88, P2185, DOI 10.1210/jc.2002-021324; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Irvine RA, 1999, IMMUNOGENETICS, V49, P585, DOI 10.1007/s002510050543; Jaaskelainen J, 2006, J MOL ENDOCRINOL, V36, P361, DOI 10.1677/jme.1.01885; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; KASPER S, 1994, J BIOL CHEM, V269, P31763; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Matsumoto K, 2001, GENE, V272, P173, DOI 10.1016/S0378-1119(01)00544-3; Orr CR, 2010, J BIOL CHEM, V285, P35567, DOI 10.1074/jbc.M110.146845; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605	59	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29951	29963		10.1074/jbc.M111.244715	http://dx.doi.org/10.1074/jbc.M111.244715			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730049	Green Published, hybrid			2022-12-27	WOS:000294046600054
J	Tsai, CY; Ngo, B; Tapadia, A; Hsu, PH; Wu, GK; Lee, WH				Tsai, Connie Y.; Ngo, Bryan; Tapadia, Anjali; Hsu, Pang-Hung; Wu, Guikai; Lee, Wen-Hwa			Aurora-A Phosphorylates Augmin Complex Component Hice1 Protein at an N-terminal Serine/Threonine Cluster to Modulate Its Microtubule Binding Activity during Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; MITOTIC SPINDLE; KINASE PEG2; HUMAN-CELLS; CENTROSOME; GRADIENT; CYCLE; IDENTIFICATION; AMPLIFICATION; DESTRUCTION	Proper assembly of mitotic spindles requires Hice1, a spindle-associated protein. Hice1 possesses direct microtubule binding activity at its N-terminal region and contributes to intraspindle microtubule nucleation as a subunit of the Augmin complex. However, whether microtubule binding activity of Hice1 is modulated by mitotic regulators remains unexplored. Here, we found that Aurora-A kinase, a major mitotic kinase, specifically binds to and phosphorylates Hice1. We identified four serine/threonine clusters on Hice1 that can be phosphorylated by Aurora-A in vitro. Of the four clusters, the Ser/Thr-17-21 cluster was the most critical for bipolar spindle assembly, whereas other phospho-deficient point mutants had a minimal effect on spindle assembly. Immunostaining with a phospho-Ser-19/20 phospho-specific antibody revealed that phosphorylated Hice1 primarily localizes to spindle poles during prophase to metaphase but gradually diminishes after anaphase. Consistently, the phospho-mimic 17-21E mutant reduced microtubule binding activity in vitro and diminished localization to spindles in vivo. Furthermore, expression of the 17-21E mutant led to decreased association of Fam29a, an Augmin component, with spindles. On the other hand, expression of the phospho-deficient 17-21A mutant permitted intraspindle nucleation but delayed the separation of early mitotic spindle poles and the timely mitotic progression. Taken together, these results suggest that Aurora-A modulates the microtubule binding activity of Hice1 in a spatiotemporal manner for proper bipolar spindle assembly.	[Wu, Guikai] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung 20224, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung 20224, Taiwan	University of California System; University of California Irvine; National Taiwan Ocean University; National Taiwan Ocean University	Wu, GK (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	gwu@uci.edu; whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014; Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434; Ngo, Bryan/0000-0002-7733-2658	National Institutes of Health [CA107568]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA107568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107568 (to W.-H. L.).; Supported by a Department of Defense Congressionally Directed Medical Research Program Predoctoral Fellowship.	Arlot-Bonnemains Y, 2001, FEBS LETT, V508, P149, DOI 10.1016/S0014-5793(01)03048-4; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2010, CURR OPIN CELL BIOL, V22, P44, DOI 10.1016/j.ceb.2009.11.012; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEALD R, 2009, KINETOCHORE, P1; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Jang CY, 2011, BIOCHEM BIOPH RES CO, V408, P174, DOI 10.1016/j.bbrc.2011.04.004; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Roghi C, 1998, J CELL SCI, V111, P557; Rome P, 2010, J CELL BIOL, V189, P651, DOI 10.1083/jcb.201001144; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Wainman A, 2009, GENE DEV, V23, P1876, DOI 10.1101/gad.532209; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Wu GK, 2009, MOL BIOL CELL, V20, P4686, DOI 10.1091/mbc.E08-11-1123; Zhu H, 2009, MOL CELLS, V27, P1, DOI 10.1007/s10059-009-0014-2; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046	40	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30097	30106		10.1074/jbc.M111.266767	http://dx.doi.org/10.1074/jbc.M111.266767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705324	hybrid, Green Published			2022-12-27	WOS:000294046600067
J	Pierantoni, GM; Esposito, F; Tornincasa, M; Rinaldo, C; Viglietto, G; Soddu, S; Fusco, A				Pierantoni, Giovanna Maria; Esposito, Francesco; Tornincasa, Mara; Rinaldo, Cinzia; Viglietto, Giuseppe; Soddu, Silvia; Fusco, Alfredo			Homeodomain-interacting Protein Kinase-2 Stabilizes p27(kip1) by Its Phosphorylation at Serine 10 and Contributes to Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; INHIBITOR P27(KIP1); GENE-EXPRESSION; CYTOPLASMIC RELOCALIZATION; TRANSCRIPTION FACTORS; POTENTIAL MEDIATOR; DNA-DAMAGE; IN-VITRO; HIPK2; P53	HIPK2 is a serine/threonine kinase that acts as a coregulator of an increasing number of factors involved in cell survival and proliferation during development and in response to different types of stress. Here we report on a novel target of HIPK2, the cyclin-dependent kinase inhibitor p27(kip1). HIPK2 phosphorylates p27(kip1) in vitro and in vivo at serine 10, an event that accounts for 80% of the total p27(kip1) phosphorylation and plays a crucial role in the stability of the protein. Indeed, HIPK2 depletion by transient or stable RNA interference in tumor cells of different origin was consistently associated with strong reduction of p27(kip1) phosphorylation at serine 10 and of p27(kip1) stability. An initial evaluation of the functional relevance of this HIPK2-mediated regulation of p27(kip1) revealed a contribution to cell motility, rather than to cell proliferation, but only in cells that do not express wild-type p53.	[Pierantoni, Giovanna Maria; Esposito, Francesco; Tornincasa, Mara; Viglietto, Giuseppe; Fusco, Alfredo] Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Cellulare & Mol, Fac Med Chirurg Napoli,Consiglio Nazl Ric, I-80131 Naples, Italy; [Rinaldo, Cinzia; Soddu, Silvia] Ist Nazl Tumori Regina Elena, Dipartimento Oncol Sperimentale, Lab Oncogenesi Mol, I-00158 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Fusco, A (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Via Pansini 5, I-80131 Naples, Italy.	afusco@napoli.com	Soddu, Silvia/ABH-6774-2020; Rinaldo, Cinzia/A-4252-2015; Pierantoni, Giovanna Maria/O-7527-2015; Viglietto, Giuseppe/AAC-2852-2019; Soddu, Silvia/K-2467-2018	Soddu, Silvia/0000-0001-8526-0044; Rinaldo, Cinzia/0000-0001-6124-762X; Pierantoni, Giovanna Maria/0000-0003-4078-8528; Viglietto, Giuseppe/0000-0003-2327-7515; Soddu, Silvia/0000-0001-8526-0044	Associazione Italiana Ricerca sul Cancro; Ministero della Salute; Fondazione Italiana per la Ricerca sul Cancro	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from the Associazione Italiana Ricerca sul Cancro and the Ministero della Salute.; Recipient of a Fondazione Italiana per la Ricerca sul Cancro fellowship.	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Baldassarre G, 1999, ONCOGENE, V18, P6241, DOI 10.1038/sj.onc.1203031; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Iacovelli S, 2009, CELL PROLIFERAT, V42, P373, DOI 10.1111/j.1365-2184.2009.00601.x; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pierantoni GM, 2006, CELL DEATH DIFFER, V13, P1554, DOI 10.1038/sj.cdd.4401839; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sicinski P, 2007, GENE DEV, V21, P1703, DOI 10.1101/gad.1583207; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Trapasso F, 2009, DNA CELL BIOL, V28, P161, DOI 10.1089/dna.2008.0778; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang D, 2011, NEOPLASMA, V58, P65, DOI 10.4149/neo_2011_01_65; Wee HJ, 2008, BLOOD, V112, P3777, DOI 10.1182/blood-2008-01-134122; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Yamada D, 2009, ONCOGENE, V28, P2535, DOI 10.1038/onc.2009.109; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	39	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29005	29013		10.1074/jbc.M111.230854	http://dx.doi.org/10.1074/jbc.M111.230854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715331	Green Published, hybrid			2022-12-27	WOS:000293837000037
J	West, MB; Wickham, S; Quinalty, LM; Pavlovicz, RE; Li, CL; Hanigan, MH				West, Matthew B.; Wickham, Stephanie; Quinalty, Leslie M.; Pavlovicz, Ryan E.; Li, Chenglong; Hanigan, Marie H.			Autocatalytic Cleavage of Human gamma-Glutamyl Transpeptidase Is Highly Dependent on N-Glycosylation at Asparagine 95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN TISSUE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; TRANSFERASE TRANSPEPTIDASE; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; INHIBITORS	gamma-Glutamyl transpeptidase (GGT) is a heterodimeric membrane enzyme that catalyzes the cleavage of extracellular glutathione and other gamma-glutamyl-containing compounds. GGT is synthesized as a single polypeptide (propeptide) that undergoes autocatalytic cleavage, which results in the formation of the large and small subunits that compose the mature enzyme. GGT is extensively N-glycosylated, yet the functional consequences of this modification are unclear. We investigated the effect of N-glycosylation on the kinetic behavior, stability, and functional maturation of GGT. Using site-directed mutagenesis, we confirmed that all seven N-glycosylation sites on human GGT are modified by N-glycans. Comparative enzyme kinetic analyses revealed that single substitutions are functionally tolerated, although the N95Q mutation resulted in a marked decrease in the cleavage efficiency of the propeptide. However, each of the single site mutants exhibited decreased thermal stability relative to wild-type GGT. Combined mutagenesis of all N-glycosylation sites resulted in the accumulation of the inactive propeptide form of the enzyme. Use of N-glycosylation inhibitors demonstrated that binding of the core N-glycans, not their subsequent processing, is the critical glycosylation event governing the autocleavage of GGT. Although N-glycosylation is necessary for maturation of the propeptide, enzymatic deglycosylation of the mature wild-type GGT does not substantially impact either the kinetic behavior or thermal stability of the fully processed human enzyme. These findings are the first to establish that co-translational N-glycosylation of human GGT is required for the proper folding and subsequent cleavage of the nascent propeptide, although retention of these N-glycans is not necessary for maintaining either the function or structural stability of the mature enzyme.	[West, Matthew B.; Wickham, Stephanie; Quinalty, Leslie M.; Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Pavlovicz, Ryan E.; Li, Chenglong] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Li, Chenglong] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43210 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hanigan, MH (corresponding author), Stanton L Young Biomed Res Ctr, Rm 264,975 NE 10th St, Oklahoma City, OK 73104 USA.	marie-hanigan@ouhsc.edu	Li, Chenglong/E-7182-2010; Driskill, Leslie/AAI-8748-2021	Li, Chenglong/0000-0003-3174-8719; Driskill, Leslie/0000-0003-3484-2794	National Institutes of Health [RO1 CA57530, R56 CA57530, F32 CA128338]; NATIONAL CANCER INSTITUTE [R01CA057530, F32CA128338, R56CA057530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA57530 and R56 CA57530 (to M. H. H.) and F32 CA128338 (to M. B. W.).	ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; ANGELE C, 1991, CLIN CHEM, V37, P662; BAROUKI R, 1984, J BIOL CHEM, V259, P7970; Bosques CJ, 2003, P NATL ACAD SCI USA, V100, P7593, DOI 10.1073/pnas.1232504100; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; ELCE JS, 1976, BIOCHEM J, V153, P223, DOI 10.1042/bj1530223; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSS V, 1986, BIOCHEM J, V236, P853, DOI 10.1042/bj2360853; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Hiramatsu K, 2007, ENDOCRINOLOGY, V148, P2708, DOI 10.1210/en.2007-0215; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; Keillor JW, 2005, METHOD ENZYMOL, V401, P449, DOI 10.1016/S0076-6879(05)01027-X; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; MEREDITH MJ, 1991, BIOCHEM INT, V25, P321; Nakajima M, 2010, BIOCHEM PHARMACOL, V79, P1165, DOI 10.1016/j.bcp.2009.11.020; NEMESANSZKY E, 1985, CLIN CHEM, V31, P797; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sener A, 2005, J BIOCHEM MOL BIOL, V38, P343; SHAW LM, 1978, CLIN CHEM, V24, P905; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; SMITH TK, 1994, FASEB J, V8, P661, DOI 10.1096/fasebj.8.9.7911768; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; THOMPSON GA, 1976, BIOCHEM BIOPH RES CO, V71, P32, DOI 10.1016/0006-291X(76)90245-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wada K, 2010, FEBS J, V277, P1000, DOI 10.1111/j.1742-4658.2009.07543.x; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856	48	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28876	28888		10.1074/jbc.M111.248823	http://dx.doi.org/10.1074/jbc.M111.248823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712391	Green Published, hybrid			2022-12-27	WOS:000293837000025
J	Wu, SR; Li, CF; Hung, LY; Huang, AM; Tseng, JT; Tsou, JH; Wang, JM				Wu, Sin-Rong; Li, Chien-Feng; Hung, Liang-Yi; Huang, A-Mei; Tseng, Joseph T.; Tsou, Jen-Hui; Wang, Ju-Ming			CCAAT/Enhancer-binding Protein delta Mediates Tumor Necrosis Factor alpha-induced Aurora Kinase C Transcription and Promotes Genomic Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER PROTEIN; CANCER-RELATED INFLAMMATION; B KINASE; CERVICAL-CANCER; C/EBP-DELTA; HISTONE H3; EXPRESSION; CELLS; GENE; LOCALIZATION	Epidemiologic and clinical research indicates that chronic inflammation increases the risk of certain cancers, possibly through chromosomal instability. However, the mechanism of inflammation-dependent chromosomal instability associated with tumorigenesis is not well characterized. The transcription factor CCAAT/enhancer-binding protein delta (C/EBP delta, CEBPD) is induced by tumor necrosis factor alpha (TNF alpha) and expressed in chronically inflamed tissue. In this study, we show that TNF alpha promotes aneuploidy. Loss of CEBPD attenuated TNF alpha-induced aneuploidy, and CEBPD caused centromere abnormality. Additionally, TNF alpha-induced CEBPD expression augmented anchorage-independent growth. We found that TNF alpha induced expression of aurora kinase C (AURKC) through CEBPD, and that AURKC also causes aneuploidy. Furthermore, high CEBPD expression correlated with AURKC expression in inflamed cervical tissue specimens. These data provide insight into a novel function for CEBPD in inducing genomic instability through the activation of AURKC expression in response to inflammatory signals.	[Wu, Sin-Rong; Hung, Liang-Yi; Tseng, Joseph T.; Tsou, Jen-Hui; Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Hung, Liang-Yi; Tseng, Joseph T.; Wang, Ju-Ming] Natl Cheng Kung Univ, Mol Inflammat Res Ctr, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Hung, Liang-Yi; Tseng, Joseph T.; Wang, Ju-Ming] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Coll Med, Tainan 701, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Wang, Ju-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ, Dept Med, Grad Inst Biochem, Kaohsiung 807, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; Taipei Medical University; Kaohsiung Medical University	Wang, JM (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan.	wwwjm4721@yahoo.com.tw	wang, ju-ming/A-1875-2011; Tseng, Joseph Ta-Chien/I-2850-2018; Hung, Liang-Yi/AAG-4174-2019	Tseng, Joseph Ta-Chien/0000-0002-3304-6086; , Liang-Yi/0000-0002-7284-2608; Huang, A-Mei/0000-0003-3723-0443	National Health Research Institutes [NHRI-EX99-9740NI]; National Cheng Kung University [C007]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); National Cheng Kung University	This work was supported, in whole or in part, by National Health Research Institutes Grant NHRI-EX99-9740NI and National Cheng Kung University landmark Grant C007.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahmad Aamir, 2009, Curr Aging Sci, V2, P174; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen JJ, 2005, MOL BIOL CELL, V16, P5579, DOI 10.1091/mbc.E05-08-0778; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Delhanty JDA, 2001, ANN HUM GENET, V65, P331, DOI 10.1017/S0003480001008739; HERRERO R, 1990, CANCER-AM CANCER SOC, V65, P380, DOI 10.1002/1097-0142(19900115)65:2<380::AID-CNCR2820650234>3.0.CO;2-9; Hour TC, 2010, BIOCHEM PHARMACOL, V80, P325, DOI 10.1016/j.bcp.2010.04.007; Hu HM, 2000, DNA CELL BIOL, V19, P679, DOI 10.1089/10445490050199063; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; JONES CJ, 1990, CANCER RES, V50, P3657; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu D, 2009, BIOCHEM SOC T, V37, P976, DOI 10.1042/BST0370976; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nguyen HG, 2009, FASEB J, V23, P2741, DOI 10.1096/fj.09-130963; Pan YC, 2010, CLIN CANCER RES, V16, P5770, DOI 10.1158/1078-0432.CCR-10-1025; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reddy KV, 2003, J BIOL CHEM, V278, P13810, DOI 10.1074/jbc.M211102200; Sasai K, 2004, CELL MOTIL CYTOSKEL, V59, P249, DOI 10.1002/cm.20039; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Tatsuka M, 1998, CANCER RES, V58, P4811; Ulisse S, 2006, INT J CANCER, V119, P275, DOI 10.1002/ijc.21842; Wang JM, 2006, NUCLEIC ACIDS RES, V34, P217, DOI 10.1093/nar/gkj422; Wang WL, 2008, NUCLEIC ACIDS RES, V36, P6066, DOI 10.1093/nar/gkn607; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x	44	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28662	28670		10.1074/jbc.M111.270710	http://dx.doi.org/10.1074/jbc.M111.270710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715338	Green Published, hybrid			2022-12-27	WOS:000293837000003
J	Yang, YQ; Groshong, JS; Matta, H; Gopalakrishnan, R; Yi, H; Chaudhary, PM				Yang, Yanqiang; Groshong, Jason S.; Matta, Hittu; Gopalakrishnan, Ramakrishnan; Yi, Han; Chaudhary, Preet M.			Constitutive NF-kappa B Activation Confers Interleukin 6 (IL6) Independence and Resistance to Dexamethasone and Janus Kinase Inhibitor INCB018424 in Murine Plasmacytoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; MULTIPLE-MYELOMA; IL-6 EXPRESSION; HERPESVIRUS; APOPTOSIS; K13; PATHWAYS; ONCOPROTEIN; MUTATIONS	Myeloma cells are dependent on IL6 for their survival and proliferation during the early stages of disease, and independence from IL6 is associated with disease progression. The role of the NF-kappa B pathway in the IL6-independent growth of myeloma cells has not been studied. Because human herpesvirus 8-encoded K13 selectively activates the NF-kappa B pathway, we have used it as a molecular tool to examine the ability of the NF-kappa B pathway to confer IL6 independence on murine plasmacytomas. We demonstrated that ectopic expression of K13, but not its NF-kappa B-defective mutant or a structural homolog, protected plasmacytomas against IL6 withdrawal-induced apoptosis and resulted in emergence of IL6-independent clones that could proliferate long-term in vitro in the absence of IL6 and form abdominal plasmacytomas with visceral involvement when injected intraperitoneally into syngeneic mice. These IL6-independent clones were dependent on NF-kappa B activity for their survival and proliferation but were resistant to dexamethasone and INCB018424, a selective Janus kinase 1/2 inhibitor. Ectopic expression of human T cell leukemia virus 1-encoded Tax protein, which resembles K13 in inducing constitutive NF-kappa B activation, similarly protected plasmacytoma cells against IL6 withdrawal-induced apoptosis. Although K13 is known to up-regulate IL6 gene expression, its protective effect was not due to induction of endogenous IL6 production but instead was associated with sustained expression of several antiapoptotic members of the Bcl2 family upon IL6 withdrawal. Collectively, these results demonstrate that NF-kappa B activation cannot only promote the emergence of IL6 independence during myeloma progression but can also confer resistance to dexamethasone and INCB018424.	[Matta, Hittu; Gopalakrishnan, Ramakrishnan; Yi, Han; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA; [Matta, Hittu; Gopalakrishnan, Ramakrishnan; Yi, Han; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA; [Yang, Yanqiang; Groshong, Jason S.; Matta, Hittu; Chaudhary, Preet M.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Inst Canc, Pittsburgh, PA 15213 USA	University of Southern California; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chaudhary, PM (corresponding author), Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Gopalakrishnan, Ramakrishnan/N-3454-2015; Chaudhary, Preet/E-1970-2018	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886; 	National Institutes of Health [CA85177, CA124621, CA139119]; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA124621, R01CA085177, R01CA139119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA85177, CA124621, and CA139119. This work was also supported by the Leukemia and Lymphoma Society and the Multiple Myeloma Research Foundation.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2000, BIOCHEM PHARMACOL, V60, P1033, DOI 10.1016/S0006-2952(00)00393-2; An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Billadeau D, 1997, CANCER RES, V57, P2268; BILLADEAU D, 1995, CANCER RES, V55, P3640; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Foehr ED, 2000, J BIOL CHEM, V275, P34021, DOI 10.1074/jbc.C000507200; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; Hu SM, 1997, J BIOL CHEM, V272, P9621; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Jijon H, 2004, CELL SIGNAL, V16, P1023, DOI 10.1016/j.cellsig.2004.02.005; Kastrinakis NG, 2000, ANN ONCOL, V11, P1217, DOI 10.1023/A:1008331714186; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keller SA, 2000, BLOOD, V96, P2537; Lattanzio G, 1997, AM J PATHOL, V151, P689; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Liu SQ, 2010, EUR J HAEMATOL, V84, P137, DOI 10.1111/j.1600-0609.2009.01365.x; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2003, CANCER BIOL THER, V2, P206, DOI 10.4161/cbt.2.2.348; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Ramakrishnan V, 2010, AM J HEMATOL, V85, P675, DOI 10.1002/ajh.21785; Rawat R, 2000, BLOOD, V96, P3514; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun SC, 2003, CANCER METAST REV, V22, P405, DOI 10.1023/A:1023733231406; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Trikha M, 2003, CLIN CANCER RES, V9, P4653; WEINBERG RA, 2007, BIOL CANC, P255; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	53	12	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27988	27997		10.1074/jbc.M110.213363	http://dx.doi.org/10.1074/jbc.M110.213363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21705340	hybrid, Green Published			2022-12-27	WOS:000293557800017
J	Zhang, JZ; Yarov-Yarovoy, V; Scheuer, T; Karbat, I; Cohen, L; Gordon, D; Gurevitz, M; Catterall, WA				Zhang, Joel Z.; Yarov-Yarovoy, Vladimir; Scheuer, Todd; Karbat, Izhar; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael; Catterall, William A.			Structure-Function Map of the Receptor Site for beta-Scorpion Toxins in Domain II of Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; PROTEIN-PROTEIN DOCKING; GATING MODIFIER; ALPHA-SUBUNIT; SENSOR; ACTIVATION; ROSETTA; BINDING; CONFORMATIONS; INACTIVATION	Voltage-gated sodium (Na-v) channels are the molecular targets of beta-scorpion toxins, which shift the voltage dependence of activation to more negative membrane potentials by a voltage sensor-trapping mechanism. Molecular determinants of beta-scorpion toxin (CssIV) binding and action on rat brain sodium channels are located in the S1-S2 (IIS1-S2) and S3-S4 (IIS3-S4) extracellular linkers of the voltage-sensing module in domain II. In IIS1-S2, mutations of two amino acid residues (Glu(779) and Pro(782)) significantly altered the toxin effect by reducing binding affinity. In IIS3-S4, six positions surrounding the key binding determinant, Gly(845), define a hot spot of high-impact residues. Two of these substitutions (A841N and L846A) reduced voltage sensor trapping. The other three substitutions (N842R, V843A, and E844N) increased voltage sensor trapping. These bidirectional effects suggest that the IIS3-S4 loop plays a primary role in determining both toxin affinity and efficacy. A high resolution molecular model constructed with the Rosetta-Membrane modeling system reveals interactions of amino acid residues in sodium channels that are crucial for toxin action with residues in CssIV that are required for its effects. In this model, the wedge-shaped CssIV inserts between the IIS1-S2 and IIS3-S4 loops of the voltage sensor, placing key amino acid residues in position to interact with binding partners in these extracellular loops. These results provide new molecular insights into the voltage sensor-trapping model of toxin action and further define the molecular requirements for the development of antagonists that can prevent or reverse toxicity of scorpion toxins.	[Zhang, Joel Z.; Yarov-Yarovoy, Vladimir; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Karbat, Izhar; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; Tel Aviv University	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	National Institutes of Health [U01 NS058039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 NS058039 (to W. A. C. and M. G.).	Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; COURAUD F, 1982, TOXICON, V20, P9, DOI 10.1016/0041-0101(82)90138-6; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Karbat I, 2010, J BIOL CHEM, V285, P30531, DOI 10.1074/jbc.M110.150888; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	43	61	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33641	33651		10.1074/jbc.M111.282509	http://dx.doi.org/10.1074/jbc.M111.282509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795675	hybrid, Green Published			2022-12-27	WOS:000294968800080
J	Hoffmann, BR; Annis, DS; Mosher, DF				Hoffmann, Brian R.; Annis, Douglas S.; Mosher, Deane F.			Reactivity of the N-terminal Region of Fibronectin Protein to Transglutaminase 2 and Factor XIIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA FIBRONECTIN; COAGULATION-FACTOR-XIIIA; COLD-INSOLUBLE GLOBULIN; GELATIN-BINDING DOMAIN; ACTIVATED FACTOR-XIII; BETA-SANDWICH DOMAIN; CROSS-LINKING; TISSUE TRANSGLUTAMINASE; CONFORMATIONAL-CHANGE; GLUTAMINE RESIDUES	Transglutaminase 2 (TG2) is secreted by a non-classical pathway into the extracellular space, where it has several activities pertinent to fibronectin (FN), including binding to the gelatin-binding domain of FN and acting as an integrin co-receptor. Glutamines in the N-terminal tail of FN are known to be susceptible to transamidation by both TG2 and activated blood coagulation factor XIII (FXIIIa). We used immunoblotting, limited proteolysis, and mass spectrometry to localize glutamines within FN that are subject to TG2-catalyzed incorporation of dansylcadaverine in comparison to residues modified by FXIIIa. Such analysis of plasma FN indicated that Gln-3, Gln-7, and Gln-9 in the N-terminal tail and Gln-246 of the linker between fifth and sixth type I modules ((5)F1 and (6)F1) are transamidated by both enzymes. Only minor incorporation of dansylcadaverine was detected elsewhere. Labeling of C-terminally truncated FN constructs revealed efficient TG2- or FXIIIa-catalyzed dansylcadaverine incorporation into the N-terminal residues of constructs as small as the 29-kDa fragment that includes (1-5)F1 and lacks modules from the adjacent gelatin-binding domain. However, when only (1-3)F1 were present, dansylcadaverine incorporation into the N-terminal residues of FN was lost and instead was in the enzymes, near the active site of TG2 and terminal domains of FXIIIa. Thus, these results demonstrate that FXIIIa and TG2 act similarly on glutamines at either end of (1-5)F1 and transamidation specificity of both enzymes is achieved through interactions with the intact 29K fragment.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 1300 Univ Ave,4285 MSC, Madison, WI 53706 USA.	dfmosher@wisc.edu			National Institutes of Health [R01HL021644, T32-HL007899, NCRR 1S10RR024601-1]; Wisconsin Partnership Fund for a Healthy Future and the Department of Chemistry; Northwestern University; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644, T32HL007899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership Fund for a Healthy Future and the Department of Chemistry; Northwestern University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL021644 (to D.F.M.) and T32-HL007899 (to B.R.H.).; We thank Dr. Prasanna Murthy for TG2, and the support and suggestions of Dr. Laszlo Lorand; both are at Northwestern University. The MS studies were performed on instruments of the University of Wisconsin-Madison Human Proteomics Program facility funded by the Wisconsin Partnership Fund for a Healthy Future and the Department of Chemistry Mass Spectrometry facility funded in part by National Institutes of Health NCRR 1S10RR024601-1. We gratefully acknowledge the advice and support of the facility directors, Drs. Ying Ge and Martha Vestling.	AESCHLIMANN D, 1995, J CELL BIOL, V129, P881, DOI 10.1083/jcb.129.3.881; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; Bark SJ, 2001, J AM CHEM SOC, V123, P1774, DOI 10.1021/ja002909n; Berry H, 1998, ANN NY ACAD SCI, V864, P198, DOI 10.1111/j.1749-6632.1998.tb10304.x; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Cleary DB, 2006, BBA-PROTEINS PROTEOM, V1764, P1207, DOI 10.1016/j.bbapap.2006.05.003; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Forsprecher J, 2009, AMINO ACIDS, V36, P747, DOI 10.1007/s00726-008-0125-7; Fox BA, 1999, J BIOL CHEM, V274, P4917, DOI 10.1074/jbc.274.8.4917; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GORMAN JJ, 1980, J BIOL CHEM, V255, P1175; GORMAN JJ, 1981, J BIOL CHEM, V256, P2712; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hevessy Z, 2000, THROMB RES, V99, P399, DOI 10.1016/S0049-3848(00)00261-9; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; HOHENADL C, 1995, J BIOL CHEM, V270, P23415, DOI 10.1074/jbc.270.40.23415; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; JEONG JM, 1995, J BIOL CHEM, V270, P5654, DOI 10.1074/jbc.270.10.5654; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Jones RA, 1997, J CELL SCI, V110, P2461; Karimi M, 2009, SEMIN THROMB HEMOST, V35, P426, DOI 10.1055/s-0029-1225765; KESKIOJA J, 1976, CELL, V9, P29, DOI 10.1016/0092-8674(76)90049-0; Lee KN, 2000, J BIOL CHEM, V275, P37382, DOI 10.1074/jbc.M003375200; Lee KN, 2001, ANN NY ACAD SCI, V936, P335; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Liu XY, 2003, MATRIX BIOL, V22, P393, DOI 10.1016/S0945-053X(03)00071-4; LORAND L, 1986, BIOCHEM BIOPH RES CO, V134, P685, DOI 10.1016/S0006-291X(86)80474-0; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorand L, 2007, FASEB J, V21, P1627, DOI 10.1096/fj.07-0602ufm; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsuka YV, 1997, J PROTEIN CHEM, V16, P739, DOI 10.1023/A:1026307731751; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; McDonagh J, 1987, HEMOSTASIS THROMBOSI, P289; MCDONAGH RP, 1981, FEBS LETT, V127, P174, DOI 10.1016/0014-5793(81)80198-6; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mitkevich OV, 1998, J BIOL CHEM, V273, P14387, DOI 10.1074/jbc.273.23.14387; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Murthy SNP, 1998, EXP EYE RES, V67, P273; MURTHY SNP, 1991, P NATL ACAD SCI USA, V88, P10601, DOI 10.1073/pnas.88.23.10601; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; Pastor MT, 1999, FEBS LETT, V451, P231, DOI 10.1016/S0014-5793(99)00572-4; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; POTTS JR, 1995, NAT STRUCT BIOL, V2, P946, DOI 10.1038/nsb1195-946; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Sarang Z, 2009, AMINO ACIDS, V36, P625, DOI 10.1007/s00726-008-0130-x; Sato H, 2000, ANAL BIOCHEM, V281, P68, DOI 10.1006/abio.2000.4551; SEKIGUCHI K, 1983, BIOCHEMISTRY-US, V22, P1415, DOI 10.1021/bi00275a015; SHAINOFF JR, 1991, J BIOL CHEM, V266, P6429; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Staunton David, 2009, V522, P73, DOI 10.1007/978-1-59745-413-1_5; STENBERG P, 1975, BIOCHEM J, V147, P155; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; WILLIAMS EC, 1983, J BIOL CHEM, V258, P5911; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	75	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32220	32230		10.1074/jbc.M111.255562	http://dx.doi.org/10.1074/jbc.M111.255562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757696	hybrid, Green Published			2022-12-27	WOS:000294726800032
J	Kishi, S; Abe, H; Akiyama, H; Tominaga, T; Murakami, T; Mima, A; Nagai, K; Kishi, F; Matsuura, M; Matsubara, T; Iehara, N; Ueda, O; Fukushima, N; Jishage, K; Doi, T				Kishi, Seiji; Abe, Hideharu; Akiyama, Haruhiko; Tominaga, Tatsuya; Murakami, Taichi; Mima, Akira; Nagai, Kojiro; Kishi, Fumi; Matsuura, Motokazu; Matsubara, Takeshi; Iehara, Noriyuki; Ueda, Otoya; Fukushima, Naoshi; Jishage, Kou-ichi; Doi, Toshio			SOX9 Protein Induces a Chondrogenic Phenotype of Mesangial Cells and Contributes to Advanced Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH MUSCLE ACTIN; LOW-OXYGEN TENSION; END-PRODUCTS; CHONDROCYTE DIFFERENTIATION; MATRIX EXPANSION; EXPRESSION; HYPOXIA; COLLAGEN; SMAD1; RAT	Diabetic nephropathy (DN) is the most important chronic kidney disease. We previously reported that Smad1 transcriptionally regulates the expression of extracellular matrix in DN. Phenotypic change in mesangial cells (MCs) is a key pathologic event in the progression of DN. The aim of this study is to investigate a novel mechanism underlying chondrogenic phenotypic change in MCs that results in the development of DN. MCs showed chondrogenic potential in a micromass culture, and BMP4 induced the expression of chondrocyte markers (SRY-related HMG Box 9 (SOX9) and type II collagen (COL2)). Advanced glycation end products induced the expression of chondrocyte marker proteins downstream from the BMP4-Smad1 signaling pathway in MCs. In addition, hypoxia also induced the expression of BMP4, hypoxia-inducible factor-1 alpha (HIF-1 alpha), and chondrocyte markers. Overexpression of SOX9 caused ectopic expression of proteoglycans and COL2 in MCs. Furthermore, forced expression of Smad1 induced chondrocyte markers as well. Dorsomorphin inhibited these inductions. Glomerular expressions of HIF-1 alpha, BMP4, and chondrocyte markers were observed in diabetic nephropathy mice. These positive stainings were observed in mesangial sclerotic lesions. SOX9 was partially colocalized with HIF-1 alpha and BMP4 in diabetic glomeruli. BMP4 knock-in transgenic mice showed not only similar pathological lesions to DN, but also the induction of chondrocyte markers in the sclerotic lesions. Here we demonstrate that HIF-1 alpha and BMP4 induce SOX9 expression and subsequent chondrogenic phenotype change in DN. The results suggested that the transdifferentiation of MCs into chondrocyte-like cells in chronic hypoxic stress may result in irreversible structural change in DN.	[Kishi, Seiji; Abe, Hideharu; Tominaga, Tatsuya; Murakami, Taichi; Mima, Akira; Nagai, Kojiro; Kishi, Fumi; Matsuura, Motokazu; Doi, Toshio] Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan; [Matsubara, Takeshi; Iehara, Noriyuki] Kyoto Univ, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068503, Japan; [Akiyama, Haruhiko] Kyoto Univ, Dept Nephrol, Sakyo Ku, Kyoto 6068503, Japan; [Ueda, Otoya; Jishage, Kou-ichi] Chugai Res Inst Med Sci Inc, Shizuoka 4128513, Japan; [Fukushima, Naoshi] Chugai Pharmaceut Co Ltd, Tokyo 1030092, Japan	Tokushima University; Kyoto University; Kyoto University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Abe, H (corresponding author), Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan.	abeabe@clin.med.tokushima-u.ac.jp			Japan Society for the Promotion of Science [21591033, 19590973]; Mitsui Sumitomo Welfare Foundation; Kidney Foundation, Japan [JKFB09-41]; Grants-in-Aid for Scientific Research [21591032] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsui Sumitomo Welfare Foundation; Kidney Foundation, Japan(Kidney Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (21591033 and 19590973), Mitsui Sumitomo Welfare Foundation, and The Kidney Foundation, Japan (JKFB09-41).	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Chen W, 2002, CHINESE MED J-PEKING, V115, P446; Cramer T, 2004, OSTEOARTHR CARTILAGE, V12, P433, DOI 10.1016/j.joca.2004.02.003; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Fornoni A, 2002, DIABETES, V51, P499, DOI 10.2337/diabetes.51.2.499; Garin G, 2003, AM J PATHOL, V163, P2485, DOI 10.1016/S0002-9440(10)63603-6; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Iehara N, 1996, KIDNEY INT, V50, P1166, DOI 10.1038/ki.1996.424; Isner JM, 2000, J CLIN INVEST, V106, P615, DOI 10.1172/JCI10961; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; JOHNSON RJ, 1994, KIDNEY INT, V45, P1769, DOI 10.1038/ki.1994.230; Lenz O, 1998, J AM SOC NEPHROL, V9, P2040; Lupia E, 1999, DIABETES, V48, P1638, DOI 10.2337/diabetes.48.8.1638; Makino H, 1995, J DIABETES COMPLICAT, V9, P282, DOI 10.1016/1056-8727(95)80022-7; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Naitoh M, 2005, GENES CELLS, V10, P1081, DOI 10.1111/j.1365-2443.2005.00902.x; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ohashi S, 2004, J BIOL CHEM, V279, P19816, DOI 10.1074/jbc.M310428200; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Tintut Y, 2003, CIRCULATION, V108, P2505, DOI 10.1161/01.CIR.0000096485.64373.C5; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704; Xia L, 2007, AM J PHYSIOL-ENDOC M, V293, pE1280, DOI 10.1152/ajpendo.00223.2007; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734	56	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32162	32169		10.1074/jbc.M111.244541	http://dx.doi.org/10.1074/jbc.M111.244541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795715	Green Published, hybrid			2022-12-27	WOS:000294726800026
J	Conaway, HH; Pirhayati, A; Persson, E; Pettersson, U; Svensson, O; Lindholm, C; Henning, P; Tuckermann, J; Lerner, UH				Conaway, H. Herschel; Pirhayati, Amir; Persson, Emma; Pettersson, Ulrika; Svensson, Olle; Lindholm, Catharina; Henning, Petra; Tuckermann, Jan; Lerner, Ulf H.			Retinoids Stimulate Periosteal Bone Resorption by Enhancing the Protein RANKL, a Response Inhibited by Monomeric Glucocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CALVARIAL BONES; KAPPA-B LIGAND; VITAMIN-A; DNA-BINDING; INDUCED OSTEOPOROSIS; PARATHYROID-HORMONE; MINERAL DENSITY; ACID RECEPTOR; CATHEPSIN K; DIFFERENTIATION	Increased vitamin A (retinol) intake has been suggested to increase bone fragility. In the present study, we investigated effects of retinoids on bone resorption in cultured neonatal mouse calvarial bones and their interaction with glucocorticoids (GC). All-trans-retinoic acid (ATRA), retinol, retinalaldehyde, and 9-cis-retinoic acid stimulated release of Ca-45 from calvarial bones. The resorptive effect of ATRA was characterized by mRNA expression of genes associated with osteoclast differentiation, enhanced osteoclast number, and bone matrix degradation. In addition, the RANKL/OPG ratio was increased by ATRA, release of Ca-45 stimulated by ATRA was blocked by exogenous OPG, and mRNA expression of genes associated with bone formation was decreased by ATRA. All retinoid acid receptors (RAR alpha/beta/gamma) were expressed in calvarial bones. Agonists with affinity to all receptor subtypes or specifically to RAR alpha enhanced the release of Ca-45 and mRNA expression of Rankl, whereas agonists with affinity to RAR beta/gamma or RAR gamma had no effects. Stimulation of Rankl mRNA by ATRA was competitively inhibited by the RAR alpha antagonist GR110. Exposure of calvarial bones to GC inhibited the stimulatory effects of ATRA on 45Ca release and Rankl mRNA and protein expression. This inhibitory effect was reversed by the glucocorticoid receptor (GR) antagonist RU 486. Increased Rankl mRNA stimulated by ATRA was also blocked by GC in calvarial bones from mice with a GR mutation that blocks dimerization (GR(dim) mice). The data suggest that ATRA enhances periosteal bone resorption by increasing the RANKL/OPG ratio via RAR alpha receptors, a response that can be inhibited by monomeric GR.	[Pirhayati, Amir; Persson, Emma; Lerner, Ulf H.] Umea Univ, Dept Mol Periodontol, SE-90187 Umea, Sweden; [Pettersson, Ulrika] Umea Univ, Dept Clin Pharmacol, SE-90187 Umea, Sweden; [Svensson, Olle] Umea Univ, Dept Orthoped Surg, SE-90187 Umea, Sweden; [Conaway, H. Herschel] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Lindholm, Catharina; Henning, Petra; Lerner, Ulf H.] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Ctr Bone & Arthrit Res, SE-41345 Gothenburg, Sweden; [Tuckermann, Jan] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Umea University; Umea University; Umea University; University of Arkansas System; University of Arkansas Medical Sciences; University of Gothenburg; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Lerner, UH (corresponding author), Umea Univ, Dept Mol Periodontol, SE-90187 Umea, Sweden.	Ulf.Lerner@odont.umu.se		Lerner, Ulf/0000-0002-3579-1960; Henning, Petra/0000-0002-9330-6265; Pettersson Kymmer, Ulrika/0000-0002-0557-9803	Swedish Research Council; Royal 80 Year Fund of King Gustav V; Swedish Rheumatism Association, Combine; Medical Faculty at Umea University; County Council of Vasterbotten; ALF/TUA at Sahlgrenska University Hospital; Deutsche Forschungsgemeinschaft [Tu220/6, FOR 1486]; Boehringer Stiftung	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal 80 Year Fund of King Gustav V; Swedish Rheumatism Association, Combine; Medical Faculty at Umea University; County Council of Vasterbotten; ALF/TUA at Sahlgrenska University Hospital; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Stiftung	This work was supported by grants from the Swedish Research Council, the Royal 80 Year Fund of King Gustav V, the Swedish Rheumatism Association, Combine, the Medical Faculty at Umea University, the County Council of Vasterbotten, ALF/TUA at Sahlgrenska University Hospital, Deutsche Forschungsgemeinschaft (Grant Tu220/6, FOR 1486 Immunobone; to J. T.), and the Boehringer Stiftung (to J. T.).	Ahlen J, 2002, BONE, V31, P242, DOI 10.1016/S8756-3282(02)00784-6; *APPL BIOS, 1997, US B, V2; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BRAND JS, 1972, ENDOCRINOLOGY, V90, P479, DOI 10.1210/endo-90-2-479; Caire-Juvera G, 2009, AM J CLIN NUTR, V89, P323, DOI 10.3945/ajcn.2008.26451; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; CARANO A, 1990, J CLIN INVEST, V85, P456, DOI 10.1172/JCI114459; Compston J, 2010, NAT REV RHEUMATOL, V6, P82, DOI 10.1038/nrrheum.2009.259; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Conaway HH, 1997, J ENDOCRINOL, V155, P513, DOI 10.1677/joe.0.1550513; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Fanjul AN, 1996, J BIOL CHEM, V271, P22441, DOI 10.1074/jbc.271.37.22441; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; GOLDMAN R, 1985, CANCER RES, V45, P3118; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hofbauer LC, 2009, MOL ENDOCRINOL, V23, P1525, DOI 10.1210/me.2009-0069; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Lerner UH, 1997, ACTA PHYSIOL SCAND, V161, P81, DOI 10.1046/j.1365-201X.1997.d01-1933.x; LERNER UH, 1987, J BONE MINER RES, V2, P375; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; NG KW, 1989, MOL ENDOCRINOL, V3, P2079, DOI 10.1210/mend-3-12-2079; NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536; OBERG KC, 1989, MOL ENDOCRINOL, V3, P915, DOI 10.1210/mend-3-6-915; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; PHILIBERT D, 1991, FRONT HORM RES, V19, P1; Pignatello MA, 1997, TOXICOL APPL PHARM, V142, P319, DOI 10.1006/taap.1996.8047; Pino-Lagos K, 2008, ANN NY ACAD SCI, V1143, P170, DOI 10.1196/annals.1443.017; Piu F, 2005, BIOCHEM PHARMACOL, V71, P156, DOI 10.1016/j.bcp.2005.10.025; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ribaya-Mercado JD, 2007, NUTR REV, V65, P425, DOI 10.1111/j.1753-4887.2007.tb00268.x; ROBERTS AB, 1984, CANCER RES, V44, P1635; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Schwab AM, 2005, ENDOCRINOLOGY, V146, P4349, DOI 10.1210/en.2005-0601; Swanson C, 2006, ENDOCRINOLOGY, V147, P3613, DOI 10.1210/en.2005-0717; Tanaka K, 2010, BONE, V47, P1006, DOI 10.1016/j.bone.2010.08.016; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teng M, 1996, J MED CHEM, V39, P3035, DOI 10.1021/jm9603532; Toma S, 1998, INT J CANCER, V78, P86, DOI 10.1002/(SICI)1097-0215(19980925)78:1<86::AID-IJC14>3.0.CO;2-3; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; VIOLETTE SM, 1989, J INVEST DERMATOL, V93, P165, DOI 10.1111/1523-1747.ep12277393; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WENER JA, 1972, ENDOCRINOLOGY, V90, P752, DOI 10.1210/endo-90-3-752; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010	61	40	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31425	31436		10.1074/jbc.M111.247734	http://dx.doi.org/10.1074/jbc.M111.247734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21715325	Green Published, hybrid			2022-12-27	WOS:000294487500037
J	Karunakaran, S; Ramachandran, S; Coothankandaswamy, V; Elangovan, S; Babu, E; Periyasamy-Thandavan, S; Gurav, A; Gnanaprakasam, JP; Singh, N; Schoenlein, PV; Prasad, PD; Thangaraju, M; Ganapathy, V				Karunakaran, Senthil; Ramachandran, Sabarish; Coothankandaswamy, Veena; Elangovan, Selvakumar; Babu, Ellappan; Periyasamy-Thandavan, Sudharsan; Gurav, Ashish; Gnanaprakasam, Jaya P.; Singh, Nagendra; Schoenlein, Patricia V.; Prasad, Puttur D.; Thangaraju, Muthusamy; Ganapathy, Vadivel			SLC6A14 (ATB(0,+)) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ACTIVE-TRANSPORT; ARGININE DEPRIVATION; UP-REGULATION; CELL-DEATH; EXPRESSION; NA+; TRYPTOPHAN; SYSTEM	SLC6A14, also known as ATB(0,+), is an amino acid transporter with unique characteristics. It transports 18 of the 20 proteinogenic amino acids. However, this transporter is expressed only at low levels in normal tissues. Here, we show that the transporter is up-regulated specifically in estrogen receptor (ER)-positive breast cancer, demonstrable with primary human breast cancer tissues and human breast cancer cell lines. SLC6A14 is an estrogen/ER target. The transport features of SLC6A14 include concentrative transport of leucine (an activator of mTOR), glutamine (an essential amino acid for nucleotide biosynthesis and substrate for glutaminolysis), and arginine (an essential amino acid for tumor cells), suggesting that ER-positive breast cancer cells up-regulate SLC6A14 to meet their increased demand for these amino acids. Consequently, treatment of ER-positive breast cancer cells in vitro with alpha-methyl-DL-tryptophan (alpha-MT), a selective blocker of SLC6A14, induces amino acid deprivation, inhibits mTOR, and activates autophagy. Prolongation of the treatment with alpha-MT causes apoptosis. Addition of an autophagy inhibitor (3-methyladenine) during alpha-MT treatment also induces apoptosis. These effects of alpha-MT are specific to ER-positive breast cancer cells, which express the transporter. The ability of alpha-MT to cause amino acid deprivation is significantly attenuated in MCF-7 cells, an ER-positive breast cancer cell line, when SLC6A14 is silenced with shRNA. In mouse xenograft studies, alpha-MT by itself is able to reduce the growth of the ER-positive ZR-75-1 breast cancer cells. These studies identify SLC6A14 as a novel and effective drug target for the treatment of ER-positive breast cancer.	[Karunakaran, Senthil; Ramachandran, Sabarish; Coothankandaswamy, Veena; Elangovan, Selvakumar; Babu, Ellappan; Periyasamy-Thandavan, Sudharsan; Gurav, Ashish; Gnanaprakasam, Jaya P.; Singh, Nagendra; Schoenlein, Patricia V.; Prasad, Puttur D.; Thangaraju, Muthusamy; Ganapathy, Vadivel] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Ganapathy, V (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	vganapat@georgiahealth.edu	Ramachandran, Sabarish/K-8146-2016; Periyasamy-Thandavan, Sudharsan/C-8406-2012; Elangovan, Selvakumar/ABB-9558-2021	Elangovan, Selvakumar/0000-0001-9906-5477; Gnana-Prakasam, Jaya P/0000-0003-2259-9213	National Institutes of Health [CA152396]; NATIONAL CANCER INSTITUTE [R21CA152396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA152396.	DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Ganapathy M. E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P357, DOI 10.2174/156800805774912953; GANAPATHY V, 2004, METABOLIC THERAPEUTI, P63; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gupta N, 2006, GYNECOL ONCOL, V100, P8, DOI 10.1016/j.ygyno.2005.08.016; Gupta N, 2005, BBA-MOL BASIS DIS, V1741, P215, DOI 10.1016/j.bbadis.2005.04.002; Hatanaka T, 2004, J PHARMACOL EXP THER, V308, P1138, DOI 10.1124/jpet.103.057109; Hatanaka T, 2002, BIOCHEM BIOPH RES CO, V291, P291, DOI 10.1006/bbrc.2002.6441; Hatanaka T, 2001, J CLIN INVEST, V107, P1035, DOI 10.1172/JCI12060; Karunakaran S, 2008, BIOCHEM J, V414, P343, DOI 10.1042/BJ20080622; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Laich A, 2002, CLIN CHEM, V48, P579; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; Periyasamy-Thandavan S, 2010, AUTOPHAGY, V6, P19, DOI 10.4161/auto.6.1.10323; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sloan JL, 1999, J BIOL CHEM, V274, P23740, DOI 10.1074/jbc.274.34.23740; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Umapathy NS, 2004, PHARM RES-DORDR, V21, P1303, DOI 10.1023/B:PHAM.0000033019.49737.28; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005	22	122	125	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31830	31838		10.1074/jbc.M111.229518	http://dx.doi.org/10.1074/jbc.M111.229518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771784	Green Published, hybrid			2022-12-27	WOS:000294487500076
J	Rahman, MA; Oomori, T; Worheide, G				Rahman, M. Azizur; Oomori, Tamotsu; Woerheide, Gert			Calcite Formation in Soft Coral Sclerites Is Determined by a Single Reactive Extracellular Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD INFRARED MICROSPECTROSCOPY; CARBONATE MINERALOGY; SPICULE FORMATION; SHELL PROTEINS; ORGANIC MATRIX; ARAGONITE; GROWTH; CHEMISTRY; MAGNESIUM; ANHYDRASE	Calcium carbonate exists in two main forms, calcite and aragonite, in the skeletons of marine organisms. The primary mineralogy of marine carbonates has changed over the history of the earth depending on the magnesium/calcium ratio in seawater during the periods of the so-called "calcite and aragonite seas." Organisms that prefer certain mineralogy appear to flourish when their preferred mineralogy is favored by seawater chemistry. However, this rule is not without exceptions. For example, some octocorals produce calcite despite living in an aragonite sea. Here, we address the unresolved question of how organisms such as soft corals are able to form calcitic skeletal elements in an aragonite sea. We show that an extracellular protein called ECMP-67 isolated from soft coral sclerites induces calcite formation in vitro even when the composition of the calcifying solution favors aragonite precipitation. Structural details of both the surface and the interior of single crystals generated upon interaction with ECMP-67 were analyzed with an apertureless-type near-field IR microscope with high spatial resolution. The results show that this protein is the main determining factor for driving the production of calcite instead of aragonite in the bio-calcification process and that -OH, secondary structures (e. g. alpha-helices and amides), and other necessary chemical groups are distributed over the center of the calcite crystals. Using an atomic force microscope, we also explored how this extracellular protein significantly affects the molecular-scale kinetics of crystal formation. We anticipate that a more thorough investigation of the proteinaceous skeleton content of different calcite-producing marine organisms will reveal similar components that determine the mineralogy of the organisms. These findings have significant implications for future models of the crystal structure of calcite in nature.	[Rahman, M. Azizur; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBioctr, D-80333 Munich, Germany; [Oomori, Tamotsu] Univ Ryukyus, Fac Sci, Dept Chem, Nishihara, Okinawa 9030213, Japan; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, D-80333 Munich, Germany	University of Munich; University of Munich; University of the Ryukyus	Rahman, MA (corresponding author), Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany.	a.rahman@lrz.uni-muenchen.de	Wörheide, Gert/C-1080-2008; Rahman, Dr. Azizur/A-9413-2018	Wörheide, Gert/0000-0002-6380-7421; Rahman, Dr. Azizur/0000-0002-7648-8642	Japan Society for the Promotion of Science (JSPS); Alexander von Humboldt Foundation; German Science Foundation (DFG)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) and the Alexander von Humboldt Foundation.; Supported by the German Science Foundation (DFG).	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Amos FF, 2010, CRYST GROWTH DES, V10, P4211, DOI 10.1021/cg100363m; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; D'Souza SM, 1999, NATURE, V398, P312, DOI 10.1038/18636; Dauphin Y, 2006, COMP BIOCHEM PHYS A, V145, P54, DOI 10.1016/j.cbpa.2006.04.029; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; GOLDBERG WM, 1987, B MAR SCI, V40, P287; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Kebukawa Y, 2009, CHEM LETT, V38, P22, DOI 10.1246/cl.2009.22; KINGSLEY RJ, 1982, CELL TISSUE RES, V223, P325, DOI 10.1007/BF01258493; Koga S, 2010, J MEMBRANE SCI, V355, P208, DOI 10.1016/j.memsci.2010.03.032; Kupka T, 2010, J RAMAN SPECTROSC, V41, P651, DOI 10.1002/jrs.2502; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Metzler RA, 2010, J AM CHEM SOC, V132, P6329, DOI 10.1021/ja909735y; NARITA Y, 2001, ANAL SCI           S, V17, pI685; Prange A, 1999, BBA-GEN SUBJECTS, V1428, P446, DOI 10.1016/S0304-4165(99)00095-1; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Rahman MA, 2005, PROTEOMICS, V5, P885, DOI 10.1002/pmic.200401130; Rivadeneyra MA, 2006, FOLIA MICROBIOL, V51, P445, DOI 10.1007/BF02931589; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Thompson JB, 2000, BIOPHYS J, V79, P3307, DOI 10.1016/S0006-3495(00)76562-3; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; WEBER JN, 1974, AM J SCI, V274, P84, DOI 10.2475/ajs.274.1.84; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; YANG SY, 1985, PLANT CELL PHYSIOL, V26, P25; Zhuravlev AY, 2008, GEOLOGY, V36, P923, DOI 10.1130/G25094A.1	33	26	26	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31638	31649		10.1074/jbc.M109.070185	http://dx.doi.org/10.1074/jbc.M109.070185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768106	Green Published, hybrid			2022-12-27	WOS:000294487500057
J	Seong, HA; Jung, H; Manoharan, R; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Manoharan, Ravi; Ha, Hyunjung			Positive Regulation of Apoptosis Signal-regulating Kinase 1 Signaling by ZPR9 Protein, a Zinc Finger Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; CELL-DEATH; NEGATIVE REGULATION; ASK1; PHOSPHORYLATION; STRESS; ACTIVATION; GROWTH; THIOREDOXIN; INHIBITOR	A zinc finger protein, ZPR9, has been identified as a physiological substrate of murine protein serine/threonine kinase 38 (MPK38), which is involved in various cellular responses, including the cell cycle, apoptosis, embryonic development, and oncogenesis. Here, ZPR9 was found to physically interact with apoptosis signal-regulating kinase 1 (ASK1) through a disulfide linkage involving Cys(1351) and Cys(1360) of ASK1 and Cys(305) and Cys(308) of ZPR9. ASK1 directly phosphorylated ZPR9 at Ser(314) and Thr(318), suggesting that ZPR9 can act as an ASK1 substrate. Ectopic expression of wild-type ZPR9, but not an S314A/T318A mutant, stimulated ASK1 kinase activity and positively regulated ASK1-mediated signaling to both JNK and p38 kinases by destabilizing complex formation between ASK1 and its negative regulators, Trx and 14-3-3, or by increasing complex formation between ASK1 and its substrate MKK3. ZPR9 functionally stimulated ASK1-induced AP-1 transcriptional activity as well as H2O2-mediated apoptosis in a phosphorylation-dependent manner. ASK1-mediated phosphorylation of ZPR9 at Ser(314) and Thr(318) was also responsible for ZPR9-induced apoptosis. Moreover, ZPR9 inhibited PDK1-mediated signaling through ASK1 activation. These results suggest that ZPR9 functions as a novel positive regulator of ASK1.	[Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea; [Jung, Haiyoung] Korea Res Inst Biosci & Biotechnol, Cell Therapy Res Ctr, Taejon 305806, South Korea	Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	National Research Foundation of Korea [R0A-2007-000-20006-0]; Chungbuk National University	National Research Foundation of Korea(National Research Foundation of Korea); Chungbuk National University	This work was supported by National Research Foundation of Korea Grant R0A-2007-000-20006-0 and in part by Chungbuk National University Grant 2010.	Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2003, J BIOL CHEM, V278, P9655, DOI 10.1074/jbc.M207478200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	27	12	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31123	31135		10.1074/jbc.M111.248674	http://dx.doi.org/10.1074/jbc.M111.248674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771788	Green Published, hybrid			2022-12-27	WOS:000294487500007
J	Wang, DY; Yuen, EY; Zhou, Y; Yan, Z; Xiang, YK				Wang, Dayong; Yuen, Eunice Y.; Zhou, Yuan; Yan, Zhen; Xiang, Yang K.			Amyloid beta Peptide-(1-42) Induces Internalization and Degradation of beta(2) Adrenergic Receptors in Prefrontal Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ALZHEIMERS-DISEASE; BETA(2)-ADRENERGIC RECEPTOR; LOCUS-CERULEUS; A-BETA; BETA-2-ADRENERGIC RECEPTOR; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; PLAQUE-FORMATION; TRANSGENIC MICE	Emerging evidence indicates that amyloid beta peptide (A beta) initially induces subtle alterations in synaptic function in Alzheimer disease. We have recently shown that A beta binds to beta(2) adrenergic receptor (beta(2)AR) and activates protein kinase A (PKA) signaling for glutamatergic regulation of synaptic activities. Here we show that in the cerebrums of mice expressing human familial mutant presenilin 1 and amyloid precursor protein genes, the levels of beta(2)AR are drastically reduced. Moreover, A beta induces internalization of transfected human beta(2)AR in fibroblasts and endogenous beta(2)AR in primary prefrontal cortical neurons. In fibroblasts, A beta treatment also induces transportation of beta(2)AR into lysosome, and prolonged A beta treatment causes beta(2)AR degradation. The A beta-induced beta(2)AR internalization requires the N terminus of the receptor containing the peptide binding sites and phosphorylation of beta(2)AR by G protein-coupled receptor kinase, not by PKA. However, the G protein-coupled receptor kinase phosphorylation of beta(2)AR and the receptor internalization are much slower than that induced by beta AR agonist isoproterenol. The A beta-induced beta(2)AR internalization is also dependent on adaptor protein arrestin 3 and GTPase dynamin, but not arrestin 2. Functionally, pretreatment of primary prefrontal cortical neurons with A beta induces desensitization of beta(2)AR, which leads to attenuated response to subsequent stimulation with isoproterenol, including decreased cAMP levels, PKA activities, PKA phosphorylation of serine 845 on alpha-amino-2,3-di-hydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor subunit 1 (GluR1), and AMPA receptor-mediated miniature excitatory postsynaptic currents. This study indicates that A beta induces beta(2)AR internalization and degradation leading to impairment of adrenergic and glutamatergic activities.	[Wang, Dayong; Zhou, Yuan; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiang, Yang K.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Xiang, YK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu		Wang, Dayong/0000-0002-2086-1663	National Institutes of Health [HL082846]; Alzheimer Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by the National Institutes of Health HL082846 (to Y. X.). This work was also supported by an Alzheimer Association New Investigator Research grant (to Y. X.).	ASANUMA M, 1991, NEUROCHEM RES, V16, P1253, DOI 10.1007/BF00966654; Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bondareff W, 1987, Alzheimer Dis Assoc Disord, V1, P256, DOI 10.1097/00002093-198701040-00005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chen CJ, 2003, J NEUROCHEM, V85, P443, DOI 10.1046/j.1471-4159.2003.01691.x; CSIKSZENTMIHALY.M, 1997, FINDING FLOW PSYCHOL, P1; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DOCHERTY K, 1979, BIOCHEM J, V178, P361, DOI 10.1042/bj1780361; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Englund H, 2007, DEMENT GERIATR COGN, V24, P369, DOI 10.1159/000109215; Feinstein DL, 1998, J NEUROCHEM, V70, P1484; Friedman JI, 1999, BIOL PSYCHIAT, V46, P1243, DOI 10.1016/S0006-3223(99)00232-2; Gallardo G, 2008, NAT NEUROSCI, V11, P301, DOI 10.1038/nn2058; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006; Henley JR, 1999, FASEB J, V13, pS243, DOI 10.1096/fasebj.13.9002.S243; Hichami A, 1996, MEDIAT INFLAMM, V5, P425, DOI 10.1155/S0962935196000580; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; HU XX, 1991, J NEUROIMMUNOL, V31, P35, DOI 10.1016/0165-5728(91)90084-K; HUANG HM, 1993, J BIOL CHEM, V268, P14616; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; Jadot M, 1997, EUR J BIOCHEM, V249, P862, DOI 10.1111/j.1432-1033.1997.t01-1-00862.x; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; Matthews KL, 2002, BIOL PSYCHIAT, V51, P407, DOI 10.1016/S0006-3223(01)01235-5; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramos BP, 2008, NEUROBIOL AGING, V29, P1060, DOI 10.1016/j.neurobiolaging.2007.02.003; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Raskind MA, 1999, BIOL PSYCHIAT, V46, P756, DOI 10.1016/S0006-3223(99)00008-6; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Satler C, 2007, ACTA NEUROL SCAND, V116, P355, DOI 10.1111/j.1600-0404.2007.00897.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Szot P, 2006, J NEUROSCI, V26, P467, DOI 10.1523/JNEUROSCI.4265-05.2006; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	60	60	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31852	31863		10.1074/jbc.M111.244335	http://dx.doi.org/10.1074/jbc.M111.244335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757762	hybrid, Green Published			2022-12-27	WOS:000294487500078
J	Huang, WR; Wang, YC; Chi, PI; Wang, L; Wang, CY; Lin, CH; Liu, HJ				Huang, Wei R.; Wang, Ying C.; Chi, Pei I.; Wang, Lai; Wang, Chi Y.; Lin, Chi H.; Liu, Hung J.			Cell Entry of Avian Reovirus Follows a Caveolin-1-mediated and Dynamin-2-dependent Endocytic Pathway That Requires Activation of p38 Mitogen-activated Protein Kinase (MAPK) and Src Signaling Pathways as Well as Microtubules and Small GTPase Rab5 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-C-PROTEIN; VIRUS ENTRY; RHO-GTPASES; MEDIATED ENDOCYTOSIS; EARLY ENDOSOMES; APOPTOSIS; CAVEOLAE; REPLICATION; INFLUENZA; P53	Very little is known about the mechanism of cell entry of avian reovirus (ARV). The aim of this study was to explore the mechanism of ARV entry and subsequent infection. Cholesterol mainly affected the early steps of the ARV life cycle, because the presence of cholesterol before and during viral adsorption greatly blocked ARV infectivity. Although we have demonstrated that ARV facilitating p38 MAPK is beneficial for virus replication, its mechanism remains unknown. Here, we show that ARV-induced phosphorylation of caveolin-1 (Tyr(14)), dynamin-2 expression, and Rac1 activation through activation of p38 MAPK and Src in the early stage of the virus life cycle is beneficial for virus entry and productive infection. The strong inhibition by dynasore, a specific inhibitor of dynamin-2, and depletion of endogenous caveolin-1 or dynamin-2 by siRNAs as well as the caveolin-1 colocalization study implicate caveolin-1-mediated and dynamin-2-dependent endocytosis as a significant avenue of ARV entry. By means of pharmacological inhibitors, dominant negative mutants, and siRNA of various cellular proteins and signaling molecules, phosphorylation of caveolin-1, dynamin-2 expression, and Rac1 activation were suppressed, suggesting that by orchestrating p38 MAPK, Src, and Rac1 signaling cascade in the target cells, ARV creates an appropriate intracellular environment facilitating virus entry and productive infection. Furthermore, disruption of microtubules, Rab5, or endosome acidification all inhibited ARV infection, suggesting that microtubules and small GTPase Rab5, which regulate transport to early endosome, are crucial for survival of ARV and that exposure of the virus to acidic pH is required for productive infection.	[Huang, Wei R.; Wang, Ying C.; Chi, Pei I.; Wang, Lai; Liu, Hung J.] Natl Chung Ching Univ, Inst Mol Biol, Taichung 402, Taiwan; [Wang, Ying C.; Chi, Pei I.] Natl Pingtung Univ Sci & Technol, Grad Inst Biotechnol, Pingtung 912, Taiwan; [Wang, Chi Y.] Natl Chung Ching Univ, Dept Vet Med, Taichung 402, Taiwan; [Lin, Chi H.] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan	National Pingtung University Science & Technology; National Yang Ming Chiao Tung University	Liu, HJ (corresponding author), Natl Chung Ching Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw		Liu, Hung-Jen/0000-0002-1460-1494; Huang, Wei-Ru/0000-0002-2508-8374	National Science Council of Taiwan [NSC99-2321-B-005-015-MY3, NSC97-2313-B-005-048-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grants NSC99-2321-B-005-015-MY3 and NSC97-2313-B-005-048-MY3.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Banerjee S, 2002, J VIROL, V76, P5937, DOI 10.1128/JVI.76.12.5937-5948.2002; Barnard RJO, 2003, CURR TOP MICROBIOL, V281, P107; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Bousarghin L, 2003, J VIROL, V77, P3846, DOI 10.1128/JVI.77.6.3846-3850.2003; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brindley MA, 2005, J VIROL, V79, P14482, DOI 10.1128/JVI.79.23.14482-14488.2005; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Candurra NA, 1999, J GEN VIROL, V80, P147, DOI 10.1099/0022-1317-80-1-147; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chulu JLC, 2007, BIOCHEM BIOPH RES CO, V356, P529, DOI 10.1016/j.bbrc.2007.02.164; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Drose S, 1997, J EXP BIOL, V200, P1; Duncan Roy, 1996, Virology, V219, P179; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grande A, 2000, VIROLOGY, V274, P367, DOI 10.1006/viro.2000.0473; Grande A, 2002, J GEN VIROL, V83, P131, DOI 10.1099/0022-1317-83-1-131; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hsu CJ, 2006, AVIAN PATHOL, V35, P320, DOI 10.1080/03079450600823386; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; KEEN JH, 1990, J CELL BIOL, V59, P404; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lin HY, 2007, AVIAN PATHOL, V36, P155, DOI 10.1080/03079450701261262; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2003, VIROLOGY, V314, P336, DOI 10.1016/S0042-6822(03)00415-X; Liu HJ, 2008, MOL CELLS, V26, P396; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; McLean TI, 1999, J VIROL, V73, P8415, DOI 10.1128/JVI.73.10.8415-8426.1999; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Nakatsue T, 1998, BIOCHEM BIOPH RES CO, V253, P59, DOI 10.1006/bbrc.1998.9724; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pietiainen VM, 2005, ANN MED, V37, P394, DOI 10.1080/07853890510011976; Rahaus M, 2004, J GEN VIROL, V85, P3529, DOI 10.1099/vir.0.80347-0; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Sieczkarski SB, 2005, ARCH VIROL, V150, P1783, DOI 10.1007/s00705-005-0558-1; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75	63	51	52	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30780	30794		10.1074/jbc.M111.257154	http://dx.doi.org/10.1074/jbc.M111.257154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21705803	Green Published, hybrid			2022-12-27	WOS:000294283600058
J	Gokey, NG; Lopez-Anido, C; Gillian-Daniel, AL; Svaren, J				Gokey, Nolan G.; Lopez-Anido, Camila; Gillian-Daniel, Anne Lynn; Svaren, John			Early Growth Response 1 (Egr1) Regulates Cholesterol Biosynthetic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; PERIPHERAL-NERVE MYELINATION; FATTY-ACID SYNTHESIS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; REDUCTASE PROMOTER; SQUALENE EPOXIDASE; DOWN-REGULATION; RECEPTOR GENE; C/EBP-BETA	The early growth response (EGR) family of transcription factors has been implicated in control of lipid biosynthetic genes. Egr1 is induced by insulin both in vitro and in vivo and is the most highly expressed family member in liver. In this study, we investigated whether Egr1 regulates cholesterol biosynthetic genes in liver. Using an insulin-sensitive liver cell line, we show that localization of Egr1 to cholesterol biosynthetic genes is induced by insulin treatment and that this localization precedes the induction of the genes. Reduction in Egr1 expression using targeted siRNA blunted the insulin-dependent induction of cholesterol genes. A similar reduction in squalene epoxidase expression was also observed in Egr1 null mice. In addition, application of chromatin immunoprecipitation (ChIP) samples to tiled gene microarrays revealed localization of Egr1 in promoter regions of many cholesterol gene loci. In vivo ChIP assays using liver tissue show that Egr1 localization to several cholesterol biosynthetic gene promoters is induced by feeding. Finally, analysis of plasma cholesterol in Egr1(-/-) mice indicated a significant decrease in serum cholesterol when compared with wild-type mice. Together these data point to Egr1 as a modulator of the cholesterol biosynthetic gene family in liver.	[Lopez-Anido, Camila; Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Gokey, Nolan G.] Univ Wisconsin, Comparat Biomed Sci Grad Program, Madison, WI 53705 USA; [Gillian-Daniel, Anne Lynn] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Svaren, John] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	jpsvaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Lopez-Anido, Camila/0000-0003-0601-3980	American Heart Association [0650102Z]; National Institutes of Health [DK59630]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, U2CDK059630] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant-in-aid 0650102Z from the American Heart Association.; We thank Anju Singh for assistance in the mouse liver perfusions and David Hui, Dana Lee, and Linda Keller at the Mouse Metabolic Phenotyping Center at the University of Cincinnati for performing assays and analysis of cholesterol levels. The MMPC is supported by National Institutes of Health Grant DK59630.	Barroso I, 1999, J BIOL CHEM, V274, P17997, DOI 10.1074/jbc.274.25.17997; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; Brand E, 2000, J MOL MED-JMM, V78, P81, DOI 10.1007/s001090000074; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Dooley KA, 1999, J BIOL CHEM, V274, P5285, DOI 10.1074/jbc.274.9.5285; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Flowers MT, 2006, J LIPID RES, V47, P2668, DOI 10.1194/jlr.M600203-JLR200; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jang SW, 2010, J NEUROCHEM, V115, P1409, DOI 10.1111/j.1471-4159.2010.07045.x; Jee S, 2007, INT J MOL MED, V20, P829; Jones EA, 2011, J NEUROSCI, V31, P4242, DOI 10.1523/JNEUROSCI.5893-10.2011; JUREVICS HA, 1994, J LIPID RES, V35, P112; Kang J, 1999, KIDNEY INT, V56, P452, DOI 10.1046/j.1523-1755.1999.00562.x; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Korn BS, 1998, J CLIN INVEST, V102, P2050, DOI 10.1172/JCI5341; Lagor WR, 2005, J BIOL CHEM, V280, P36601, DOI 10.1074/jbc.M504346200; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2005, J NEUROCHEM, V93, P737, DOI 10.1111/j.1471-4159.2005.03056.x; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Mayer SI, 2008, ENDOCRINOLOGY, V149, P6311, DOI 10.1210/en.2008-0251; McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065; Murphy C, 2006, BBA-MOL CELL BIOL L, V1761, P1213, DOI 10.1016/j.bbalip.2006.08.015; Nagai M, 2002, BIOCHEM BIOPH RES CO, V295, P74, DOI 10.1016/S0006-291X(02)00623-X; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Nakanishi M, 2008, NUCLEIC ACIDS RES, V36, P3443, DOI 10.1093/nar/gkn066; Osborne AR, 2004, BIOCHEM BIOPH RES CO, V318, P814, DOI 10.1016/j.bbrc.2004.04.105; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; Rae FK, 2004, ONCOGENE, V23, P3067, DOI 10.1038/sj.onc.1207360; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Seifert M, 2005, TRENDS GENET, V21, P553, DOI 10.1016/j.tig.2005.07.011; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Toews AD, 1997, MOL BRAIN RES, V49, P113, DOI 10.1016/S0169-328X(97)00132-0; Toews AD, 1996, J LIPID RES, V37, P2502; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wolfe MW, 1999, MOL ENDOCRINOL, V13, P752, DOI 10.1210/me.13.5.752; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200; Zhang F, 2002, J LIPID RES, V43, P1477, DOI 10.1194/jlr.M200126-JLR200; Zhou Y, 2006, BIOCHEM J, V397, P101, DOI 10.1042/BJ20060044	61	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29501	29510		10.1074/jbc.M111.263509	http://dx.doi.org/10.1074/jbc.M111.263509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712389	Green Published, hybrid			2022-12-27	WOS:000294046600007
J	Pietrosiuk, A; Lenherr, ED; Falk, S; Bonemann, G; Kopp, J; Zentgraf, H; Sinning, I; Mogk, A				Pietrosiuk, Aleksandra; Lenherr, Esther D.; Falk, Sebastian; Boenemann, Gabriele; Kopp, Juergen; Zentgraf, Hanswalter; Sinning, Irmgard; Mogk, Axel			Molecular Basis for the Unique Role of the AAA(+) Chaperone ClpV in Type VI Protein Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; N-DOMAIN; ADAPTER; DELIVERY; OLIGOMERIZATION; COMPLEXES; SYSTEM; SSPB	Ring-forming AAA(+) ATPases act in a plethora of cellular processes by remodeling macromolecules. The specificity of individual AAA(+) proteins is achieved by direct or adaptor-mediated association with substrates via distinct recognition domains. We investigated the molecular basis of substrate interaction for Vibrio cholerae ClpV, which disassembles tubular VipA/VipB complexes, an essential step of type VI protein secretion and bacterial virulence. We identified the ClpV recognition site within VipB, showed that productive ClpV-VipB interaction requires the oligomeric state of both proteins, solved the crystal structure of a ClpV N-domain-VipB peptide complex, and verified the interaction surface by mutant analysis. Our results show that the substrate is bound to a hydrophobic groove, which is formed by the addition of a single alpha-helix to the core N-domain. This helix is absent from homologous N-domains, explaining the unique substrate specificity of ClpV. A limited interaction surface between both proteins accounts for the dramatic increase in binding affinity upon ATP-driven ClpV hexamerization and VipA/VipB tubule assembly by coupling multiple weak interactions. This principle ensures ClpV selectivity toward the VipA/VipB macromolecular complex.	[Pietrosiuk, Aleksandra; Boenemann, Gabriele; Mogk, Axel] Heidelberg Univ, DKFZ ZMBH Alliance, ZMBH, D-69120 Heidelberg, Germany; [Lenherr, Esther D.; Falk, Sebastian; Kopp, Juergen; Sinning, Irmgard] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Kopp, Juergen] Excellenzcluster CellNetworks, D-69120 Heidelberg, Germany; [Zentgraf, Hanswalter] Deutsch Krebsforschungszentrum Angew Tumorvirol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Mogk, A (corresponding author), Heidelberg Univ, DKFZ ZMBH Alliance, ZMBH, INF282, D-69120 Heidelberg, Germany.	a.mogk@zmbh.uni-heidelberg.de	Falk, Sebastian/AAG-9706-2019; Falk, Sebastian/T-4796-2017	Falk, Sebastian/0000-0001-7848-4621; Falk, Sebastian/0000-0001-7848-4621; Kopp, Juergen/0000-0001-5633-7399	Deutsche Forschungsgemeinschaft [MO970/3-1, SFB 638]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, University of Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft Grants MO970/3-1 (to A. M.) and SFB 638 (to I. S.).; Supported by the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, University of Heidelberg.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Donatis GM, 2010, J BIOL CHEM, V285, P8771, DOI 10.1074/jbc.M109.053736; del Castillo U, 2010, FEBS LETT, V584, P929, DOI 10.1016/j.febslet.2010.01.029; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Effantin G, 2010, STRUCTURE, V18, P553, DOI 10.1016/j.str.2010.02.016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kojetin DJ, 2009, J MOL BIOL, V387, P639, DOI 10.1016/j.jmb.2009.01.046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schmidt R, 2009, RES MICROBIOL, V160, P629, DOI 10.1016/j.resmic.2009.08.018; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	44	79	83	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30010	30021		10.1074/jbc.M111.253377	http://dx.doi.org/10.1074/jbc.M111.253377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733841	hybrid, Green Published			2022-12-27	WOS:000294046600060
J	Saunders, LP; Cao, WX; Chang, WC; Albright, RA; Braddock, DT; De la Cruz, EM				Saunders, Lauren P.; Cao, Wenxiang; Chang, William C.; Albright, Ronald A.; Braddock, Demetrios T.; De La Cruz, Enrique M.			Kinetic Analysis of Autotaxin Reveals Substrate-specific Catalytic Pathways and a Mechanism for Lysophosphatidic Acid Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEUROPATHIC PAIN; LYSOPHOSPHOLIPASE-D; LPA; PHOSPHODIESTERASE; IDENTIFICATION; MOTILITY; SITE; MIGRATION; HELICASE; CANCER	Autotaxin (ATX) is a secreted lysophospholipase D that hydrolyzeslysophosphatidylcholine(LPC) intolysophosphatidic acid (LPA), initiating signaling cascades leading to cancer metastasis, wound healing, and angiogenesis. Knowledge of the pathway and kinetics of LPA synthesis by ATX is critical for developing quantitative physiological models of LPA signaling. We measured the individual rate constants and pathway of the LPA synthase cycle of ATX using the fluorescent lipid substrates FS-3 and 12-(N-methylN-(7-nitrobenz-2-oxa-1,3-diazol-4-yl))-LPC. FS-3 binds rapidly (k(1) >= 500 mu M-1 s(-1)) and is hydrolyzed slowly (k(2) = 0.024 s(-1)). Release of the first hydrolysis product is random and rapid (>= 1 s(-1)), whereas release of the second is slow and rate-limiting (0.005-0.007 s(-1)). Substrate binding and hydrolysis are slow and rate-limiting with LPC. Product release is sequential with choline preceding LPA. The catalytic pathway and kinetics depend strongly on the substrate, suggesting that ATX kinetics could vary for the various in vivo substrates. Slow catalysis with LPC reveals the potential for LPA signaling to spread to cells distal to the site of LPC substrate binding by ATX. An ATX mutant in which catalytic threonine at position 210 is replaced with alanine binds substrate weakly, favoring a role for Thr-210 in binding as well as catalysis. FTY720P, the bioactive form of a drug currently used to treat multiple sclerosis, inhibits ATX in an uncompetitive manner and slows the hydrolysis reaction, suggesting that ATX inhibition plays a significant role in lymphocyte immobilization in FTY720P-based therapeutics.	[Chang, William C.; Albright, Ronald A.; Braddock, Demetrios T.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Saunders, Lauren P.; Cao, Wenxiang; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Braddock, DT (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St, New Haven, CT 06510 USA.	demetrios.braddock@yale.edu; enrique.delacruz@yale.edu			National Institutes of Health [GM071688]; American Heart Association [09PRE2080041]; Bayer Health Care Pharmaceutical Inc.; National Science Foundation [MCB-0546353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Bayer Health Care Pharmaceutical Inc.; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071688 (to E. M. D. L. C.).; Supported in part by American Heart Association Predoctoral Fellowship Award 09PRE2080041.; Supported by a grant from Bayer Health Care Pharmaceutical Inc. To whom correspondence may be addressed: Dept. of Pathology, Yale University School of Medicine, 310 Cedar St., New Haven, CT 06510. Tel.: 203-737-1278; Fax: 203-785-6899; E-mail: demetrios.braddock@yale.edu.; American Heart Association Established Investigator 0940075N, recipient of National Science Foundation CAREER Award MCB-0546353, and a Hellman Family Fellow. To whom correspondence may be addressed: Dept. of Molecular Biophysics and Biochemistry, Yale University, P. O. Box 208114, New Haven, CT 06520-8114. Tel.: 203-432-5424; Fax: 203-432-1296; E-mail: enrique.delacruz@yale.edu.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Clair T, 2003, CANCER RES, V63, P5446; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Gijsbers R, 2003, FEBS LETT, V538, P60, DOI 10.1016/S0014-5793(03)00133-9; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Jeffery DR, 2011, EXPERT REV NEUROTHER, V11, P165, DOI 10.1586/ERN.10.193; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677; Koh E, 2003, CANCER RES, V63, P2042; Lee HY, 1996, J BIOL CHEM, V271, P24408, DOI 10.1074/jbc.271.40.24408; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Ma L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-64; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; OTTO MR, 1994, BIOPHYS J, V67, P2511, DOI 10.1016/S0006-3495(94)80741-6; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Reitan NK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982530; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Ueda H, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-11; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2008, CANCER LETT, V266, P203, DOI 10.1016/j.canlet.2008.02.052; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504	37	26	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30130	30141		10.1074/jbc.M111.246884	http://dx.doi.org/10.1074/jbc.M111.246884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719699	Green Published, hybrid			2022-12-27	WOS:000294046600070
J	Zaric, SS; Coulter, WA; Shelburne, CE; Fulton, CR; Zaric, MS; Scott, A; Lappin, MJ; Fitzgerald, DC; Irwin, CR; Taggart, CC				Zaric, Svetislav S.; Coulter, Wilson A.; Shelburne, Charles E.; Fulton, Catherine R.; Zaric, Marija S.; Scott, Aaron; Lappin, Mark J.; Fitzgerald, Denise C.; Irwin, Christopher R.; Taggart, Clifford C.			Altered Toll-like Receptor 2-mediated Endotoxin Tolerance Is Related to Diminished Interferon beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE; GENE-EXPRESSION; SUSTAINING INFLAMMATION; BACTEROIDES-FRAGILIS; HELICOBACTER-PYLORI; PERIODONTAL-DISEASE; MULTIPLE-SCLEROSIS; MURINE MACROPHAGES; INTERLEUKIN-8 GENE; TLR4 AGONISTS	Induction of endotoxin tolerance leads to a reduced inflammatory response after repeated challenge by LPS and is important for resolution of inflammation and prevention of tissue damage. Enterobacterial LPS is recognized by the TLR4 signaling complex, whereas LPS of some non-enterobacterial organisms is capable of signaling independently of TLR4 utilizing TLR2-mediated signal transduction instead. In this study we report that Porphyromonas gingivalis LPS, a TLR2 agonist, fails to induce a fully endotoxin tolerant state in a human monocytic cell line (THP-1) and mouse bone marrow-derived macrophages. In contrast to significantly decreased production of human IL-8 and TNF-alpha and, in mice, keratinocyte-derived cytokine (KC), macrophage inflammatory protein-2 (MIP-2), and TNF-alpha after repeated challenge with Escherichia coli LPS, cells repeatedly exposed to P. gingivalis LPS responded by producing less TNF-alpha but sustained elevated secretion of IL-8, KC, and MIP-2. Furthermore, in endotoxin-tolerant cells, production of IL-8 is controlled at the signaling level and correlates well with NF-kappa B activation, whereas TNF-alpha expression is blocked at the gene transcription level. Interferon beta plays an important role in attenuation of chemokine expression in endotoxin-tolerized cells as shown in interferon regulatory factor-3 knock-out mice. In addition, human gingival fibroblasts, commonly known not to display LPS tolerance, were found to be tolerant to repeated challenge by LPS if pretreated with interferon beta. The data suggest that the inability of the LPS-TLR2 complex to induce full endotoxin tolerance in monocytes/macrophages is related to diminished production of interferon beta and may partly explain the involvement of these LPS isoforms in the pathogenesis of chronic inflammatory diseases.	[Zaric, Svetislav S.; Fulton, Catherine R.; Zaric, Marija S.; Scott, Aaron; Fitzgerald, Denise C.; Taggart, Clifford C.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland; [Coulter, Wilson A.; Lappin, Mark J.; Irwin, Christopher R.] Queens Univ Belfast, Sch Dent, Belfast BT12 6BP, Antrim, North Ireland; [Shelburne, Charles E.] Univ Michigan, Sch Dent, Ann Arbor, MI 48108 USA	Queens University Belfast; Queens University Belfast; University of Michigan System; University of Michigan	Zaric, SS (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	szaric01@qub.ac.uk	Scott, Aaron/AAB-5203-2019; Taggart, Clifford C/G-4492-2014	Scott, Aaron/0000-0001-9325-5026; Taggart, Clifford/0000-0002-9930-2978; Zaric, Svetislav/0000-0003-4127-0253	Public Health Agency [COM/4275/10] Funding Source: researchfish	Public Health Agency		Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Albrecht V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-69; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Bendtzen K, 2010, J INTERF CYTOK RES, V30, P759, DOI 10.1089/jir.2010.0091; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Biswas SK, 2007, INT J BIOCHEM CELL B, V39, P1582, DOI 10.1016/j.biocel.2007.04.021; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chaniotou Z, 2010, GASTROENTEROLOGY, V139, P2083, DOI 10.1053/j.gastro.2010.08.024; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dieterle S, 2008, ANDROLOGIA, V40, P117, DOI 10.1111/j.1439-0272.2008.00833.x; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Freedman MS, 2006, EXPERT OPIN PHARMACO, V7, pS1, DOI 10.1517/14656566.7.1.S1; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim YJ, 2009, DNA CELL BIOL, V28, P185, DOI 10.1089/dna.2008.0816; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; LEPPER PM, 2011, MEDIATORS I IN PRESS; Lindgren A, 2011, INNATE IMMUN-LONDON, V17, P191, DOI 10.1177/1753425909357970; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Monneret G, 2010, EXPERT REV ANTI-INFE, V8, P1109, DOI [10.1586/eri.10.107, 10.1586/ERI.10.107]; Muthukuru M, 2005, INFECT IMMUN, V73, P687, DOI 10.1128/IAI.73.2.687-694.2005; Muthukuru M, 2008, INFECT IMMUN, V76, P477, DOI 10.1128/IAI.00100-07; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakayama K, 2004, J BIOL CHEM, V279, P6629, DOI 10.1074/jbc.M308620200; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sakuta T, 1998, J DENT RES, V77, P1597, DOI 10.1177/00220345980770080701; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shelburne CE, 2007, CELL MICROBIOL, V9, P1611, DOI 10.1111/j.1462-5822.2007.00897.x; TAKADA H, 1991, INFECT IMMUN, V59, P295, DOI 10.1128/IAI.59.1.295-301.1991; Toshchakov V, 2003, J ENDOTOXIN RES, V9, P169, DOI 10.1179/096805103125001577; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; YANG IV, 2010, AM J RESP C IN PRESS; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zaric S, 2009, J DENT RES, V88, P946, DOI 10.1177/0022034509344559; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10	54	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29492	29500		10.1074/jbc.M111.252791	http://dx.doi.org/10.1074/jbc.M111.252791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705332	Green Published, hybrid			2022-12-27	WOS:000294046600006
J	He, Y; Galant, A; Pang, QY; Strul, JM; Balogun, SF; Jez, JM; Chen, SX				He, Yan; Galant, Ashley; Pang, Qiuying; Strul, Johanna M.; Balogun, Sherifat F.; Jez, Joseph M.; Chen, Sixue			Structural and Functional Evolution of Isopropylmalate Dehydrogenases in the Leucine and Glucosinolate Pathways of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; 3-ISOPROPYLMALATE DEHYDROGENASE; CHAIN-ELONGATION; METHYLTHIOALKYLMALATE SYNTHASE; BIOSYNTHESIS; METABOLISM; RESOLUTION; GENE	The methionine chain-elongation pathway is required for aliphatic glucosinolate biosynthesis in plants and evolved from leucine biosynthesis. In Arabidopsis thaliana, three 3-isopropylmalate dehydrogenases (AtIPMDHs) play key roles in methionine chain-elongation for the synthesis of aliphatic glucosinolates (e. g. AtIPMDH1) and leucine (e. g. AtIPMDH2 and AtIPMDH3). Here we elucidate the molecular basis underlying the metabolic specialization of these enzymes. The 2.25 angstrom resolution crystal structure of AtIPMDH2 was solved to provide the first detailed molecular architecture of a plant IPMDH. Modeling of 3-isopropylmalate binding in the AtIPMDH2 active site and sequence comparisons of prokaryotic and eukaryotic IPMDH suggest that substitution of one active site residue may lead to altered substrate specificity and metabolic function. Site-directed mutagenesis of Phe-137 to a leucine in AtIPMDH1 (AtIPMDH1-F137L) reduced activity toward 3-(2'-methylthio)ethylmalate by 200-fold, but enhanced catalytic efficiency with 3-isopropylmalate to levels observed with AtIPMDH2 and AtIPMDH3. Conversely, the AtIPMDH2-L134F and AtIPMDH3-L133F mutants enhanced catalytic efficiency with 3-(2'-methylthio) ethylmalate similar to 100-fold and reduced activity for 3-isopropylmalate. Furthermore, the altered in vivo glucosinolate profile of an Arabidopsis ipmdh1 T-DNA knock-out mutant could be restored to wild-type levels by constructs expressing AtIPMDH1, AtIPMDH2-L134F, or AtIPMDH3-L133F, but not by AtIPMDH1-F137L. These results indicate that a single amino acid substitution results in functional divergence of IPMDH in planta to affect substrate specificity and contributes to the evolution of specialized glucosinolate biosynthesis from the ancestral leucine pathway.	[He, Yan; Pang, Qiuying; Strul, Johanna M.; Chen, Sixue] Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA; [Galant, Ashley; Balogun, Sherifat F.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	State University System of Florida; University of Florida; Washington University (WUSTL)	Chen, SX (corresponding author), Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA.	schen@ufl.edu	CHEN, SI/GZL-4800-2022		National Science Foundation [MCB-0845162, MCB-0904215]; Dept. of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; American Society of Plant Biologists; National Institutes of Health-MARC uSTAR	National Science Foundation(National Science Foundation (NSF)); Dept. of Energy Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); American Society of Plant Biologists; National Institutes of Health-MARC uSTAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (Grants MCB-0845162 (to S. C.) and MCB-0904215, to (J. M. J.)). Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center at the Advanced Photon Source, a national user facility operated by the University of Chicago for the Dept. of Energy Office of Biological and Environmental Research (DE-AC02-06CH11357).; Supported by an American Society of Plant Biologists Pioneer Hi-Bred Graduate Research Fellowship.; Recipient of an National Institutes of Health-MARC uSTAR Undergraduate Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; Bak S, 1998, PLANT MOL BIOL, V38, P725, DOI 10.1023/A:1006064202774; Bak Soren, 2006, Phytochemistry Reviews, V5, P309, DOI 10.1007/s11101-006-9033-1; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Chen S, 2001, PLANT PHYSIOL BIOCH, V39, P743, DOI 10.1016/S0981-9428(01)01301-8; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; de Kraker JW, 2011, PLANT CELL, V23, P38, DOI 10.1105/tpc.110.079269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Galant A, 2009, PLANT CELL, V21, P3450, DOI 10.1105/tpc.109.071183; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2010, PLANT CELL PHYSIOL, V51, P1480, DOI 10.1093/pcp/pcq113; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Imada K, 1998, STRUCTURE, V6, P971, DOI 10.1016/S0969-2126(98)00099-9; KADONO S, 1995, J BIOCHEM-TOKYO, V118, P745, DOI 10.1093/oxfordjournals.jbchem.a124975; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newton E, 2010, OECOLOGIA, V164, P689, DOI 10.1007/s00442-010-1702-5; Nozawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P806, DOI 10.1271/bbb.69.806; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sankoff D, 2001, CURR OPIN GENET DEV, V11, P681, DOI 10.1016/S0959-437X(00)00253-7; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Singh RK, 2005, J MOL BIOL, V346, P1, DOI 10.1016/j.jmb.2004.11.059; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7	33	28	28	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28794	28801		10.1074/jbc.M111.262519	http://dx.doi.org/10.1074/jbc.M111.262519			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697089	hybrid, Green Published			2022-12-27	WOS:000293837000017
J	Lomashvili, KA; Wang, XN; Wallin, R; O'Neill, WC				Lomashvili, Koba A.; Wang, Xiaonan; Wallin, Reidar; O'Neill, W. Charles			Matrix Gla Protein Metabolism in Vascular Smooth Muscle and Role in Uremic Vascular Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; AORTIC CALCIFICATION; ARTERY CALCIFICATION; POTENTIAL MECHANISM; CELL CALCIFICATION; KEUTEL-SYNDROME; RENAL-FAILURE; VITAMIN-K; IN-VITRO; PYROPHOSPHATE	Matrix Gla protein (MGP) is an inhibitor of vascular calcification but its mechanism of action and pathogenic role are unclear. This was examined in cultured rat aortas and in a model of vascular calcification in rats with renal failure. Both carboxylated (GlaMGP) and uncarboxylated (GluMGP) forms were present in aorta and disappeared during culture with warfarin. MGP was also released into the medium and removed by ultracentrifugation, and similarly affected by warfarin. In a high-phosphate medium, warfarin increased aortic calcification but only in the absence of pyrophosphate, another endogenous inhibitor of vascular calcification. Although GlaMGP binds and inactivates bone morphogenic protein (BMP)-2, a proposed mediator of vascular calcification through up-regulation of the osteogenic transcription factor runx2, neither warfarin, BMP-2, nor the BMP-2 antagonist noggin altered runx2 mRNA content in aortas, and noggin did not prevent warfarin-induced calcification. Aortic content of MGP mRNA was increased 5-fold in renal failure but did not differ between calcified and noncalcified aortas. Immunoblots showed increased GlaMGP in noncalcified (5-fold) and calcified (20-fold) aortas from rats with renal failure, with similar increases in GluMGP. We conclude that rat aortic smooth muscle produces both GlaMGP and GluMGP in tissue-bound and soluble, presumably vesicular, forms. MGP inhibits calcification independent of BMP-2-driven osteogenesis and only in the absence of pyrophosphate, consistent with direct inhibition of hydroxyapatite formation. Synthesis of MGP is increased in renal failure and deficiency of GlaMGP is not a primary cause of medial calcification in this condition.	[Lomashvili, Koba A.; Wang, Xiaonan; O'Neill, W. Charles] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Wallin, Reidar] Wake Forest Univ, Dept Med, Winston Salem, NC 27109 USA	Emory University; Wake Forest University	O'Neill, WC (corresponding author), WMB338,1639 Pierce Dr, Atlanta, GA 30322 USA.	woneill@emory.edu			National Institutes of Health [DK069681]; Amgen Junior Faculty Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Junior Faculty Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069681 (to W. C. O.) and an Amgen Junior Faculty Award (to K. A. L.).	Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Bro S, 2006, ARTERIOSCL THROM VAS, V26, P570, DOI 10.1161/01.ATV.0000201060.47945.cb; Brown MA, 2000, J BIOL CHEM, V275, P19795, DOI 10.1074/jbc.M002298200; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; FLEISCH H, 1965, NATURE, V207, P1300, DOI 10.1038/2071300b0; Hackeng TM, 2001, PROTEIN SCI, V10, P864, DOI 10.1110/ps.44701; HAO H, 1995, ARTERIOSCL THROM VAS, V15, P1474, DOI 10.1161/01.ATV.15.9.1474; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jiang GR, 2003, HYPERTENSION, V41, P1131, DOI 10.1161/01.HYP.0000066128.04083.CA; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; Lomashvili KA, 2009, KIDNEY INT, V75, P617, DOI 10.1038/ki.2008.646; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Moe SM, 2003, KIDNEY INT, V63, P1003, DOI 10.1046/j.1523-1755.2003.00820.x; MOOREHEAD WR, 1974, CLIN CHEM, V20, P1458; Mori K, 1998, FEBS LETT, V433, P19, DOI 10.1016/S0014-5793(98)00870-9; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Okada HKY, 1999, CLIN EXP NEPHROL, V3, P82; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Price PA, 2000, ARTERIOSCL THROM VAS, V20, P317, DOI 10.1161/01.ATV.20.2.317; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Roy ME, 2002, BONE, V31, P296, DOI 10.1016/S8756-3282(02)00821-9; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2007, BLOOD, V109, P2823, DOI 10.1182/blood-2006-07-035345; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Spronk HMH, 2001, BIOCHEM BIOPH RES CO, V289, P485, DOI 10.1006/bbrc.2001.5996; Sweatt A, 2003, J THROMB HAEMOST, V1, P178, DOI 10.1046/j.1538-7836.2003.00023.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669; ZHANG PM, 1994, BLOOD, V84, P169	47	66	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28715	28722		10.1074/jbc.M111.251462	http://dx.doi.org/10.1074/jbc.M111.251462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705322	Green Published, hybrid			2022-12-27	WOS:000293837000009
J	Cooper, J; Liu, L; Woodruff, EA; Taylor, HE; Goodwin, JS; D'Aquila, RT; Spearman, P; Hildreth, JEK; Dong, XH				Cooper, JoAnn; Liu, Ling; Woodruff, Elvin A.; Taylor, Harry E.; Goodwin, J. Shawn; D'Aquila, Richard T.; Spearman, Paul; Hildreth, James E. K.; Dong, Xinhong			Filamin A Protein Interacts with Human Immunodeficiency Virus Type 1 Gag Protein and Contributes to Productive Particle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; CALCIUM-SENSING RECEPTOR; HOST-CELL CYTOSKELETON; HIV-1 GAG; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; ACTIN-BINDING; SURFACE EXPRESSION; STRUCTURAL BASIS; DOMAIN	HIV-1 Gag precursor directs virus particle assembly and release. In a search for Gag-interacting proteins that are involved in late stages of the HIV-1 replication cycle, we performed yeast two-hybrid screening against a human cDNA library and identified the non-muscle actin filament cross-linking protein filamin A as a novel Gag binding partner. The 280-kDa filamin A regulates cortical actin network dynamics and participates in the anchoring of membrane proteins to the actin cytoskeleton. Recent studies have shown that filamin A facilitates HIV-1 cell-to-cell transmission by binding to HIV receptors and coreceptors and regulating their clustering on the target cell surface. Here we report a novel role for filamin A in HIV-1 Gag intracellular trafficking. We demonstrate that filamin A interacts with the capsid domain of HIV-1 Gag and that this interaction is involved in particle release in a productive manner. Disruption of this interaction eliminated Gag localization at the plasma membrane and induced Gag accumulation within internal compartments. Moreover, blocking clathrin-dependent endocytic pathways did not relieve the restriction to particle release induced by filamin A depletion. These results suggest that filamin A is involved in the distinct step of the Gag trafficking pathway. The discovery of the Gag-filamin A interaction may provide a new therapeutic target for the treatment of HIV infection.	[Cooper, JoAnn; Liu, Ling; Taylor, Harry E.; Hildreth, James E. K.; Dong, Xinhong] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Cooper, JoAnn; Liu, Ling; Dong, Xinhong] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Woodruff, Elvin A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [D'Aquila, Richard T.] Vanderbilt Univ, Dept Med, Div Infect Dis, Nashville, TN 37232 USA; [Spearman, Paul] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Vanderbilt University; Vanderbilt University; Emory University	Dong, XH (corresponding author), Meharry Med Coll, Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.	xdong@mmc.edu			National Institutes of Health [R21AI089330, U54RR019192, P30AI054999, U54RR026140]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497, G12RR003032, U54RR019192, U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089330, R01AI040338, P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI089330, U54RR019192, P30AI054999, and U54RR026140.	Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chan EY, 2009, J VIROL, V83, P9283, DOI 10.1128/JVI.00814-09; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kim EY, 2007, MOL PHARMACOL, V72, P622, DOI 10.1124/mol.107.038026; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Perotti ME, 1996, J VIROL, V70, P5916, DOI 10.1128/JVI.70.9.5916-5921.1996; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Resh MD, 2005, AIDS REV, V7, P84; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Votteler J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-12; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhang LJ, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-12; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	74	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28498	28510		10.1074/jbc.M111.239053	http://dx.doi.org/10.1074/jbc.M111.239053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21705339	hybrid, Green Published			2022-12-27	WOS:000293557800065
J	Zhuang, LN; Hu, WX; Xin, SM; Zhao, J; Pei, G				Zhuang, Le-nan; Hu, Wen-xiang; Xin, Shun-mei; Zhao, Jian; Pei, Gang			beta-Arrestin-1 Protein Represses Adipogenesis and Inflammatory Responses through Its Interaction with Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; TRANSCRIPTION; COMPLEX; DIFFERENTIATION; ARRESTIN; OBESITY; FAT; FIBROBLASTS; BEHAVIOR	One of the master regulators of adipogenesis and macrophage function is peroxisome proliferator-activated receptor-gamma (PPAR gamma). Here, we report that a deficiency of beta-arrestin-1 expression affects PPAR gamma-mediated expression of lipid metabolic genes and inflammatory genes. Further mechanistic studies revealed that beta-arrestin-1 interacts with PPAR gamma. beta-Arrestin-1 suppressed the formation of a complex between PPAR gamma and 9-cis-retinoic acid receptor-alpha through its direct interaction with PPAR gamma. The interaction of beta-arrestin-1 with PPAR gamma repressed PPAR gamma/9-cis-retinoic acid receptor-alpha function but promoted PPAR gamma/nuclear receptor corepressor function in PPAR gamma-mediated adipogenesis and inflammatory gene expression. Consistent with these results, a deficiency of beta-arrestin-1 binding to PPAR gamma abolished its suppression of PPAR gamma-dependent adipogenesis and inflammatory responses. These results indicate that the regulation of PPAR gamma by beta-arrestin-1 is critical. Furthermore, in vivo expression of beta-arrestin-1 (but not the binding-deficient mutant) significantly repressed adipogenesis, macrophage infiltration, and diet-induced obesity and improved glucose tolerance and systemic insulin sensitivity. Therefore, our findings not only reveal a molecular mechanism for the modulation of obesity by beta-arrestin-1 but also suggest a potential tactical approach against obesity and its associated metabolic disorders.	[Zhuang, Le-nan; Hu, Wen-xiang; Xin, Shun-mei; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Zhuang, Le-nan; Hu, Wen-xiang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Tongji University	Zhao, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jzhao@sibs.ac.cn; gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019; Hu, Wenxiang/W-3737-2017; Zhuang, Lenan/GZG-7254-2022	Zhao, Jian/0000-0002-8862-0591; Hu, Wenxiang/0000-0002-6754-5625; Zhuang, Lenan/0000-0001-9561-8396	Ministry of Science and Technology [2007CB947100, 2009CB940903, 2011CB910202]; National Natural Science Foundation of China [30871285, 90713047]; Chinese Academy of Sciences [XDA01010302]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This work was supported in part by Ministry of Science and Technology Grants 2007CB947100, 2009CB940903, and 2011CB910202; National Natural Science Foundation of China Grants 30871285 and 90713047; and Chinese Academy of Sciences Grant XDA01010302.; Supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program.	Auwerx J, 1999, CELL, V97, P161; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHOI JH, NATURE, V466, P451; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; REED BC, 1977, P NATL ACAD SCI USA, V74, P4876, DOI 10.1073/pnas.74.11.4876; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042; Zhuang LN, 2011, J BIOL CHEM, V286, P28396, DOI 10.1074/jbc.M111.223206	40	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28403	28413		10.1074/jbc.M111.256099	http://dx.doi.org/10.1074/jbc.M111.256099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700709	Green Published, hybrid			2022-12-27	WOS:000293557800056
J	Kanagasabai, R; Krishnamurthy, K; Druhan, LJ; Ilangovan, G				Kanagasabai, Ragu; Krishnamurthy, Karthikeyan; Druhan, Lawrence J.; Ilangovan, Govindasamy			Forced Expression of Heat Shock Protein 27 (Hsp27) Reverses P-Glycoprotein (ABCB1)-mediated Drug Efflux and MDR1 Gene Expression in Adriamycin-resistant Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TUMOR-SUPPRESSOR P53; MUTANT P53; MULTIDRUG-RESISTANCE; INDUCED APOPTOSIS; WILD-TYPE; TRANSCRIPTIONAL REPRESSION; ANTICANCER AGENTS; BINDING PROTEIN	Mutant p53 accumulation has been shown to induce the multidrug resistance gene (MDR1) and ATP binding cassette (ABC)-based drug efflux in human breast cancer cells. In the present work, we have found that transcriptional activation of the oxidative stress-responsive heat shock factor 1 (HSF-1) and expression of heat shock proteins, including Hsp27, which is normally known to augment proteasomal p53 degradation, are inhibited in Adriamycin (doxorubicin)-resistant MCF-7 cells (MCF-7/adr). Such an endogenous inhibition of HSF-1 and Hsp27 in turn results in p53 mutation with gain of function in its transcriptional activity and accumulation in MCF-7/adr. Also, lack of HSF-1 enhances nuclear factor kappa B (NF-kappa B) DNA binding activity together with mutant p53 and induces MDR1 gene and P-glycoprotein (P-gp, ABCB1), resulting in a multidrug-resistant phenotype. Ectopic expression of Hsp27, however, significantly depleted both mutant p53 and NF-kappa B (p65), reversed the drug resistance by inhibiting MDR1/P-gp expression in MCF-7/adr cells, and induced cell death by increased G(2)/M population and apoptosis. We conclude from these results that HSF-1 inhibition and depletion of Hsp27 is a trigger, at least in part, for the accumulation of transcriptionally active mutant p53, which can either directly or NF-kappa B-dependently induce an MDR1/P-gp phenotype in MCF-7 cells. Upon Hsp27 overexpression, this pathway is abrogated, and the acquired multidrug resistance is significantly abolished so that MCF-7/adr cells are sensitized to Dox. Thus, clinical alteration in Hsp27 or NF-kappa B level will be a potential approach to circumvent drug resistance in breast cancer.	[Kanagasabai, Ragu; Krishnamurthy, Karthikeyan; Ilangovan, Govindasamy] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA; [Druhan, Lawrence J.] Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Ilangovan, G (corresponding author), Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med, 392 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Govindasamy.Ilangovan@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [R21 HL094881, R01 HL078796-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078796, R21HL094881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL094881 and R01 HL078796-02.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bahr O, 2001, J CLIN INVEST, V107, P643, DOI 10.1172/JCI12415; Bradshaw TD, 2000, BRIT J CANCER, V83, P270; CIOCCA DR, 1992, CANCER RES, V52, P3648; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Deppert W, 1996, J CELL BIOCHEM, V62, P172, DOI 10.1002/(SICI)1097-4644(199608)62:2<172::AID-JCB5>3.0.CO;2-P; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Gao CL, 2000, INT J CANCER, V88, P191, DOI 10.1002/1097-0215(20001015)88:2<191::AID-IJC7>3.3.CO;2-1; Garrido C, 1996, EUR J BIOCHEM, V237, P653, DOI 10.1111/j.1432-1033.1996.0653p.x; Gulati AP, 2006, MOL CARCINOGEN, V45, P26, DOI 10.1002/mc.20149; Hansen RK, 1999, BREAST CANCER RES TR, V56, P187; Hansen RK, 2001, BIOCHEM BIOPH RES CO, V282, P186, DOI 10.1006/bbrc.2001.4548; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; HUOT J, 1991, CANCER RES, V51, P5245; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; KAMESAKI S, 1993, CANCER RES, V53, P4251; Kanagasabai R, 2010, MOL CANCER RES, V8, P1399, DOI 10.1158/1541-7786.MCR-10-0181; Kim E, 2007, ONCOGENE, V26, P2185, DOI 10.1038/sj.onc.1210312; Knowlton AA, 2006, CARDIOVASC RES, V69, P7, DOI 10.1016/j.cardiores.2005.10.009; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Ling YH, 1996, MOL PHARMACOL, V49, P832; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Morii T, 2010, ANTICANCER RES, V30, P3565; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; OESTERREICH S, 1993, CANCER RES, V53, P4443; Ogretmen B, 1997, ONCOGENE, V14, P499, DOI 10.1038/sj.onc.1200855; Ogretmen B, 1999, BIOCHEMISTRY-US, V38, P2189, DOI 10.1021/bi982236+; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Putt KS, 2005, CHEMBIOCHEM, V6, P53, DOI 10.1002/cbic.200400330; Richards EH, 1996, CANCER RES, V56, P2446; Robert J, 1998, BIOCHIMIE, V80, P247, DOI 10.1016/S0300-9084(98)80007-2; Ros JE, 2001, HEPATOLOGY, V33, P1425, DOI 10.1053/jhep.2001.24667; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Schett G, 1999, FASEB J, V13, P833, DOI 10.1096/fasebj.13.8.833; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schneider J, 1998, ANTICANCER RES, V18, P2967; Schwabedissen HEMZ, 2011, HANDB EXP PHARMACOL, V201, P325, DOI 10.1007/978-3-642-14541-4_9; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shabbits JA, 2002, MOL CANCER THER, V1, P205; Sigal A, 2000, CANCER RES, V60, P6788; Song MC, 2008, J CRIT CARE, V23, P406, DOI 10.1016/j.jcrc.2007.09.007; Srivastava SK, 2009, EXP EYE RES, V88, P2, DOI 10.1016/j.exer.2008.03.012; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tagashira M, 2000, CHEM PHARM BULL, V48, P575; Tchenio T, 2006, MOL CELL BIOL, V26, P580, DOI 10.1128/MCB.26.2.580-591.2006; Vedam K, 2010, AM J PHYSIOL-HEART C, V298, pH1832, DOI 10.1152/ajpheart.01047.2009; Vilaboa NE, 2000, J BIOL CHEM, V275, P24970, DOI 10.1074/jbc.M909136199; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wirth D, 2004, AM J PHYSIOL-LUNG C, V287, pL953, DOI 10.1152/ajplung.00184.2003; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; ZASTAWNY RL, 1993, ONCOGENE, V8, P1529	64	60	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33289	33300		10.1074/jbc.M111.249102	http://dx.doi.org/10.1074/jbc.M111.249102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784846	hybrid, Green Published			2022-12-27	WOS:000294968800048
J	Nagatoshi, M; Terasaka, K; Nagatsu, A; Mizukami, H				Nagatoshi, Mai; Terasaka, Kazuyoshi; Nagatsu, Akito; Mizukami, Hajime			Iridoid-specific Glucosyltransferase from Gardenia jasminoides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDICAGO-TRUNCATULA; CATHARANTHUS-ROSEUS; F GRANDIFLORA; GLUCOSIDES; GLYCOSYLTRANSFERASES; BIOSYNTHESIS; CULTURES; GLUCOSYLATION; SECOIRIDOIDS; METABOLISM	Iridoids are one of the most widely distributed secondary metabolites in higher plants. They are pharmacologically active principles in various medicinal plants and key intermediates in the biosynthesis of monoterpenoid indole alkaloids as well as quinoline alkaloids. Although most iridoids are present as 1-O-glucosides, the glucosylation step in the biosynthetic pathway has remained obscure. We isolated a cDNA coding for UDPglucose: iridoid glucosyltransferase (UGT85A24) from Gardenia jasminoides. UGT85A24 preferentially glucosylated the 1-O-hydroxyl group of 7-deoxyloganetin and genipin but exhibited only weak activity toward loganetin and no activity toward 7-deoxyloganetic acid. This suggests that, in the biosynthetic pathway of geniposide, a major iridoid compound in G. jasminoides, glucosylation occurs after methylation of 7-deoxyloganetic acid. UGT85A24 showed negligible activity toward any acceptor substrates other than iridoid aglycones. Thus, UGT85A24 has a remarkable specificity for iridoid aglycones. The mRNA level of UGT85A24 overlaps with the marked increase in genipin glucosylation activity in the methyl jasmonate-treated cell cultures of G. jasminoides and is related to iridoid accumulation in G. jasminoides fruits.	[Mizukami, Hajime] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Nagatsu, Akito] Kinjo Gakuin Univ, Sch Pharm, Nagoya, Aichi 4638521, Japan	Nagoya City University	Mizukami, H (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	hajimem@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22710218] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research and a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; CHAUDHURI RK, 1980, TETRAHEDRON, V36, P2317, DOI 10.1016/0040-4020(80)80128-1; Dinda B, 2007, CHEM PHARM BULL, V55, P689, DOI 10.1248/cpb.55.689; Dinda B, 2007, CHEM PHARM BULL, V55, P159, DOI 10.1248/cpb.55.159; El-Sayed Magdi, 2007, Phytochemistry Reviews, V6, P277, DOI 10.1007/s11101-006-9047-8; Franks TK, 2008, FUNCT PLANT BIOL, V35, P236, DOI 10.1071/FP07275; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Ghisalberti EL, 1998, PHYTOMEDICINE, V5, P147, DOI 10.1016/S0944-7113(98)80012-3; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Hasada K, 2010, J NAT MED-TOKYO, V64, P161, DOI 10.1007/s11418-010-0393-x; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; INOUE K, 1992, HETEROCYCLES, V33, P673; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Masada S, 2009, PLANT CELL PHYSIOL, V50, P1401, DOI 10.1093/pcp/pcp088; MEIJER AH, 1993, J PLANT RES, P145; Nakatsuka T, 2008, J EXP BOT, V59, P1241, DOI 10.1093/jxb/ern031; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; Noguchi A, 2008, PLANT J, V54, P415, DOI 10.1111/j.1365-313X.2008.03428.x; Noguchi A, 2009, PLANT CELL, V21, P1556, DOI 10.1105/tpc.108.063826; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Ono M, 2005, CHEM PHARM BULL, V53, P1342, DOI 10.1248/cpb.53.1342; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; UEDA S, 1981, PLANTA MED, V41, P186, DOI 10.1055/s-2007-971697; UESATO S, 1983, CHEM PHARM BULL, V31, P4185; UESATO S, 1984, TETRAHEDRON LETT, V25, P573, DOI 10.1016/S0040-4039(00)99941-6; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Yamamoto H., 2002, PLANT BIOTECHNOL-NAR, V19, P295; Yu Y, 2009, J NAT PROD, V72, P1459, DOI 10.1021/np900176q	33	54	67	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32866	32874		10.1074/jbc.M111.242586	http://dx.doi.org/10.1074/jbc.M111.242586			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799001	hybrid, Green Published			2022-12-27	WOS:000294726800093
J	Forshammar, J; Block, L; Lundborg, C; Biber, B; Hansson, E				Forshammar, Johan; Block, Linda; Lundborg, Christopher; Biber, Bjoern; Hansson, Elisabeth			Naloxone and Ouabain in Ultralow Concentrations Restore Na+/K+-ATPase and Cytoskeleton in Lipopolysaccharide-treated Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; PRIMARY CULTURES; HIPPOCAMPAL ASTROCYTES; NA+,K+-ATPASE ACTIVITY; CALCIUM OSCILLATIONS; ACTIN CYTOSKELETON; INFLAMMATORY PAIN	Astrocytes respond to inflammatory stimuli and may be important modulators of the inflammatory response in the nervous system. This study aimed first to assess how astrocytes in primary culture behave in response to inflammatory stimuli concerning intracellular Ca2+ responses, expression of Toll-like receptor 4 (TLR4), Na+/K+-ATPase, actin filament organization, and expression of cytokines. In a cell culture model with lipopolysaccharide (LPS), astrocyte response was assessed first in the acute phase and then after incubation with LPS for 1-48 h. The concentration curve for LPS-stimulated Ca2+ responses was bell-shaped, and the astrocytes expressed TLR4, which detects LPS and evokes intracellular Ca2+ transients. After a long incubation with LPS, TLR4 was up-regulated, LPS-evoked Ca2+ transients were expressed as oscillations, Na+/K+-ATPase was down-regulated, and the actin filaments were disorganized. Interleukin-1 beta(IL-1 beta) release was increased after 24 h in LPS. A second aim was to try to restore the LPS-induced changes in astrocytes with substances that may have dose-dependent anti-inflammatory properties. Naloxone and ouabain were tested separately in ultralow or high concentrations. Both substances evoked intracellular Ca2+ transients for all of the concentrations from 10(-15) up to 10(-4) M. Neither substance blocked the TLR4-evoked Ca2+ responses. Naloxone and ouabain prevented the LPS-induced down-regulation of Na+/K+-ATPase and restored the actin filaments. Ouabain, in addition, reduced the IL-1 beta release from reactive astrocytes. Notably, ultralow concentrations (10(-12) M) of naloxone and ouabain showed these qualities. Ouabain seems to be more potent in these effects of the two tested substances.	[Hansson, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, SE-41345 Gothenburg, Sweden; [Forshammar, Johan; Block, Linda; Lundborg, Christopher; Biber, Bjoern] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Anesthesiol & Intens Care Med, SE-41345 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hansson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14,1Tr, SE-41345 Gothenburg, Sweden.	elisabeth.hansson@neuro.gu.se		Block, Linda/0000-0002-7736-0093	Jacobson's Foundation; Arvid Carlsson's Foundation; Sahlgrenska University Hospital (LUA/ALF) (Gothenburg, Sweden) [GBG-11587]	Jacobson's Foundation; Arvid Carlsson's Foundation; Sahlgrenska University Hospital (LUA/ALF) (Gothenburg, Sweden)	This work was supported by Edit Jacobson's Foundation, Arvid Carlsson's Foundation, and the Sahlgrenska University Hospital (LUA/ALF GBG-11587) (Gothenburg, Sweden).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ABBOTT NJ, 1992, NEUROPATH APPL NEURO, V18, P424, DOI 10.1111/j.1365-2990.1992.tb00808.x; Allansson L, 2001, J NEUROCHEM, V76, P472, DOI 10.1046/j.1471-4159.2001.00097.x; Andersson AK, 2009, NEUROCHEM RES, V34, P556, DOI 10.1007/s11064-008-9819-1; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blomstrand F, 1999, NEUROSCIENCE, V88, P1241, DOI 10.1016/S0306-4522(98)00351-0; Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Cimen B, 2004, MOL CELL BIOCHEM, V259, P53, DOI 10.1023/B:MCBI.0000021344.64317.a2; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Delbro D, 2009, NEUROSCIENCE, V159, P770, DOI 10.1016/j.neuroscience.2009.01.005; Hansson E, 2008, NEUROSCIENCE, V155, P1237, DOI 10.1016/j.neuroscience.2008.04.027; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hansson E, 2006, ACTA PHYSIOL, V187, P321, DOI 10.1111/j.1748-1716.2006.01568.x; HANSSON E, 1984, BRAIN RES, V300, P9, DOI 10.1016/0006-8993(84)91335-0; HANSSON E, 2004, ADV MOL CEL, V31, P475; Hansson E, 2010, SCAND J PAIN, V1, P67, DOI 10.1016/j.sjpain.2010.01.002; Holthouser KA, 2010, AM J PHYSIOL-RENAL, V299, pF77, DOI 10.1152/ajprenal.00581.2009; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Liu X, 2008, J BIOL CHEM, V283, P11461, DOI 10.1074/jbc.M706942200; Liu XL, 2007, NEUROREPORT, V18, P597, DOI 10.1097/WNR.0b013e3280b07bc9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manunta P, 2010, BBA-MOL BASIS DIS, V1802, P1214, DOI 10.1016/j.bbadis.2010.03.001; Morita M, 2003, J NEUROSCI, V23, P10944; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; O'Shea RD, 2006, NEUROCHEM INT, V48, P604, DOI 10.1016/j.neuint.2005.12.028; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Qureshi N, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P687; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Sergeeva M, 2000, NEUROSCIENCE, V97, P765, DOI 10.1016/S0306-4522(00)00062-2; Seven I, 2005, MOL CELL BIOCHEM, V271, P107, DOI 10.1007/s11010-005-5616-1; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Simi A, 2007, NEUROPHARMACOLOGY, V52, P1563, DOI 10.1016/j.neuropharm.2007.02.011; Sowa G, 1997, IMMUNOPHARMACOLOGY, V36, P95, DOI 10.1016/S0162-3109(96)00159-2; Suzuki Y, 2005, INT J MOL MED, V15, P871; Takahashi S, 2000, EUR J PHARMACOL, V408, P127, DOI 10.1016/S0014-2999(00)00790-1; Tsai RY, 2009, NEUROSCIENCE, V159, P1244, DOI 10.1016/j.neuroscience.2009.01.058; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Yang L, 2010, EPILEPSIA, V51, P344, DOI 10.1111/j.1528-1167.2009.02250.x; Zhang LN, 2008, FUND CLIN PHARMACOL, V22, P615, DOI 10.1111/j.1472-8206.2008.00620.x	53	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31586	31597		10.1074/jbc.M111.247767	http://dx.doi.org/10.1074/jbc.M111.247767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757727	Green Published, hybrid			2022-12-27	WOS:000294487500053
J	Mulepati, S; Bailey, S				Mulepati, Sabin; Bailey, Scott			Structural and Biochemical Analysis of Nuclease Domain of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated Protein 3 (Cas3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL SHIFT ASSAYS; ESCHERICHIA-COLI; HD-DOMAIN; DNTP TRIPHOSPHOHYDROLASE; IMMUNE-SYSTEM; DNA; IDENTIFICATION; MODEL; BACTERIOPHAGE; SPECIFICITY	RNA transcribed from clustered regularly interspaced short palindromic repeats (CRISPRs) protects many pro-karyotes from invasion by foreign DNA such as viruses, conjugative plasmids, and transposable elements. Cas3 (CRISPR-associated protein 3) is essential for this CRISPR protection and is thought to mediate cleavage of the foreign DNA through its N-terminal histidine-aspartate (HD) domain. We report here the 1.8 angstrom crystal structure of the HD domain of Cas3 from Thermus thermophilus HB8. Structural and biochemical studies predict that this enzyme binds two metal ions at its active site. We also demonstrate that the single-stranded DNA endonuclease activity of this T. thermophilus domain is activated not by magnesium but by transition metal ions such as manganese and nickel. Structure-guided mutagenesis confirms the importance of the metal-binding residues for the nuclease activity and identifies other active site residues. Overall, these results provide a framework for understanding the role of Cas3 in the CRISPR system.	[Mulepati, Sabin; Bailey, Scott] Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [GM097330]; Department of Biochemistry and Molecular Biology; Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry and Molecular Biology; Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097330. This work was also supported by start-up funds provided by the Department of Biochemistry and Molecular Biology and the Johns Hopkins Malaria Research Institute.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; AN G, 1979, J BACTERIOL, V137, P1100, DOI 10.1128/JB.137.3.1100-1110.1979; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P771, DOI 10.1016/j.febslet.2009.01.024; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; SETO D, 1988, J BIOL CHEM, V263, P1494; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	41	87	94	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31896	31903		10.1074/jbc.M111.270017	http://dx.doi.org/10.1074/jbc.M111.270017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775431	Green Published, hybrid			2022-12-27	WOS:000294487500082
J	Acin-Perez, R; Russwurm, M; Gunnewig, K; Gertz, M; Zoidl, G; Ramos, L; Buck, J; Levin, LR; Rassow, J; Manfredi, G; Steegborn, C				Acin-Perez, Rebeca; Russwurm, Michael; Guennewig, Kathrin; Gertz, Melanie; Zoidl, Georg; Ramos, Lavoisier; Buck, Jochen; Levin, Lonny R.; Rassow, Joachim; Manfredi, Giovanni; Steegborn, Clemens			A Phosphodiesterase 2A Isoform Localized to Mitochondria Regulates Respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; GUANYLYL CYCLASE; RAT-BRAIN; STIMULATED PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; GAF DOMAINS; CAMP; PROTEIN; CGMP	Mitochondria are central organelles in cellular energy metabolism, apoptosis, and aging processes. A signaling network regulating these functions was recently shown to include soluble adenylyl cyclase as a local source of the second messenger cAMP in the mitochondrial matrix. However, a mitochondrial cAMP degrading phosphodiesterase (PDE) necessary for switching off this cAMP signal has not yet been identified. Here, we describe the identification and characterization of a PDE2A isoform in mitochondria from rodent liver and brain. We find that mitochondrial PDE2A is located in the matrix and that the unique N terminus of PDE2A isoform 2 specifically leads to mitochondrial localization of this isoform. Functional assays show that mitochondrial PDE2A forms a local signaling system with soluble adenylyl cyclase in the matrix, which regulates the activity of the respiratory chain. Our findings complete a cAMP signaling cascade in mitochondria and have implications for understanding the regulation of mitochondrial processes and for their pharmacological modulation.	[Gertz, Melanie; Rassow, Joachim; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95447 Bayreuth, Germany; [Acin-Perez, Rebeca; Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Zoidl, Georg] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44780 Bochum, Germany; [Russwurm, Michael] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany; [Guennewig, Kathrin; Gertz, Melanie] Ruhr Univ Bochum, Dept Physiol Chem, D-44780 Bochum, Germany; [Ramos, Lavoisier; Buck, Jochen; Levin, Lonny R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	University of Bayreuth; Cornell University; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Cornell University	Steegborn, C (corresponding author), Univ Bayreuth, Dept Biochem, Univ Str 30, D-95447 Bayreuth, Germany.	Clemens.Steegborn@uni-bayreuth.de	Acin-Perez, Rebeca/AAU-4913-2020; Acin-Perez, Rebeca/H-6160-2015	Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [R01 GM088999, R01 GM62328, NS552555]; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; Deutsche Forschungsgemeinschaft; Forschungsreferat Ruhr-Universitat Bochum Medizin [F630-2008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999, R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); United Mitochondrial Disease Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsreferat Ruhr-Universitat Bochum Medizin; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM088999 (to G. M.) and R01 GM62328 and NS552555 (to L. R. L. and J. B.). This work was also supported by grants from the Muscular Dystrophy Association (to G. M.), the United Mitochondrial Disease Foundation (to R. A.-P.), Deutsche Forschungsgemeinschaft (Grant Ko1157) (to M. R.), and Forschungsreferat Ruhr-Universitat Bochum Medizin (Grant F630-2008) (to M. R. and C. S.).	Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; AZILA N, 1989, BIOCHEM INT, V19, P1077; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BEAVO JA, 1971, J BIOL CHEM, V246, P3841; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bender AT, 2004, NEUROCHEM INT, V45, P853, DOI 10.1016/j.neuint.2004.03.015; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; BUNDEY RA, 2004, SCI STKE, pPE19; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; Domanska G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000878; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jager R, 2010, BRIT J PHARMACOL, V161, P1645, DOI 10.1111/j.1476-5381.2010.00977.x; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Lakshminarasimhan M, 2011, EXP GERONTOL, V46, P174, DOI 10.1016/j.exger.2010.08.024; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Middelhaufe S, 2007, BIOCHEM J, V407, P199, DOI 10.1042/BJ20070408; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Papatheodorou P, 2006, CELL MICROBIOL, V8, P677, DOI 10.1111/j.1462-5822.2005.00660.x; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; REPASKE DR, 1993, NEUROSCIENCE, V56, P673, DOI 10.1016/0306-4522(93)90364-L; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Sardanelli AM, 2006, FEBS LETT, V580, P5690, DOI 10.1016/j.febslet.2006.09.020; Schlicker C, 2009, J MOL BIOL, V385, P1207, DOI 10.1016/j.jmb.2008.11.037; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; SONNENBURG WK, 1991, J BIOL CHEM, V266, P17655; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YANG Q, 1994, BIOCHEM BIOPH RES CO, V205, P1850, DOI 10.1006/bbrc.1994.2886; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	68	97	97	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30423	30432		10.1074/jbc.M111.266379	http://dx.doi.org/10.1074/jbc.M111.266379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21724846	Green Published, hybrid			2022-12-27	WOS:000294283600021
J	Mizuguchi, H; Terao, T; Kitai, M; Ikeda, M; Yoshimura, Y; Das, AK; Kitamura, Y; Takeda, N; Fukui, H				Mizuguchi, Hiroyuki; Terao, Takuma; Kitai, Mika; Ikeda, Mitsuhiro; Yoshimura, Yoshiyuki; Das, Asish Kumar; Kitamura, Yoshiaki; Takeda, Noriaki; Fukui, Hiroyuki			Involvement of Protein Kinase C delta/Extracellular Signal-regulated Kinase/Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling Pathway in Histamine-induced Up-regulation of Histamine H-1 Receptor Gene Expression in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; NASAL EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; NUCLEAR-FACTOR; PKC-DELTA; POLY(ADP-RIBOSE) POLYMERASE-1; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS	The histamine H-1 receptor (H1R) gene is up-regulated in patients with allergic rhinitis. However, the mechanism and reason underlying this up-regulation are still unknown. Recently, we reported that the H1R expression level is strongly correlated with the severity of allergic symptoms. Therefore, understanding the mechanism of this up-regulation will help to develop new anti-allergic drugs targeted for H1R gene expression. Here we studied the molecular mechanism of H1R up-regulation in HeLa cells that express H1R endogenously in response to histamine and phorbol 12-myristate 13-acetate (PMA). In HeLa cells, histamine stimulation caused up-regulation of H1R gene expression. Rottlerin, a PKC delta-selective inhibitor, inhibited up-regulation of H1R gene expression, but Go6976, an inhibitor of Ca2+-dependent PKCs, did not. Histamine or PMA stimulation resulted in PKC delta phosphorylation at Tyr(311) and Thr(505). Activation of PKC delta by H2O2 resulted in H1R mRNA up-regulation. Overexpression of PKC delta enhanced up-regulation of H1R gene expression, and knockdown of the PKC delta gene suppressed this up-regulation. Histamine or PMA caused translocation PKC delta from the cytosol to the Golgi. U0126, an MEK inhibitor, and DPQ, a poly(ADP-ribose) polymerase-1 inhibitor, suppressed PMA-induced up-regulation of H1R gene expression. These results were confirmed by a luciferase assay using the H1R promoter. Phosphorylation of ERK and Raf-1 in response to PMA was also observed. However, real-time PCR analysis showed no inhibition of H1R mRNA up-regulation by a Raf-1 inhibitor. These results suggest the involvement of the PKC delta/ERK/poly(ADP-ribose) polymerase-1 signaling pathway in histamine-or PMA-induced up-regulation of H1R gene expression in HeLa cells.	[Mizuguchi, Hiroyuki; Terao, Takuma; Kitai, Mika; Ikeda, Mitsuhiro; Das, Asish Kumar; Fukui, Hiroyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Pharmacol, Tokushima 7708505, Japan; [Yoshimura, Yoshiyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 7708505, Japan; [Kitamura, Yoshiaki; Takeda, Noriaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Otolaryngol, Tokushima 7708505, Japan	Tokushima University; Tokushima University; Tokushima University	Fukui, H (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Pharmacol, 1-78-1 Shyomachi, Tokushima 7708505, Japan.	hfukui@ph.tokushima-u.ac.jp	Mizuguchi, Hiroyuki/B-5676-2013	Mizuguchi, Hiroyuki/0000-0001-7055-316X	Ministry of Health Labour and Welfare of Japan [10103185]; Japan Society for the Promotion of Science [22580132]; Osaka Medical Research Foundation for Incurable Diseases	Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation for Incurable Diseases	This work was supported by Grant-in-aid for Research on Allergic Disease and Immunology from the Ministry of Health Labour and Welfare of Japan 10103185 (to H. F.), Grant-in-aid for Scientific Research (C) from Japan Society for the Promotion of Science 22580132 (to H. M.), and by a grant from the Osaka Medical Research Foundation for Incurable Diseases.	Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; CHENG HF, 1995, J CLIN INVEST, V95, P2012, DOI 10.1172/JCI117886; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Das AK, 2007, J PHARMACOL SCI, V103, P374, DOI 10.1254/jphs.FP0061411; Das Asish Kumar, 2009, Allergology International, V58, P81, DOI 10.2332/allergolint.O-07-526; De Backer MD, 1998, BIOCHEM J, V335, P663, DOI 10.1042/bj3350663; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dev S, 2009, J PHARMACOL SCI, V109, P606, DOI 10.1254/jphs.09003FP; Devi S, 2008, J PHARMACOL SCI, V107, P159, DOI 10.1254/jphs.08028FP; Dinh QT, 2005, CLIN EXP ALLERGY, V35, P1443, DOI 10.1111/j.1365-2222.2005.02359.x; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hamano N, 1998, INT ARCH ALLERGY IMM, V115, P220, DOI 10.1159/000023904; Hao F, 2008, J BIOL CHEM, V283, P26928, DOI 10.1074/jbc.M803071200; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hermoso M, 2004, J BIOL CHEM, V279, P17681, DOI 10.1074/jbc.M304506200; Iriyoshi N, 1996, CLIN EXP ALLERGY, V26, P379, DOI 10.1111/j.1365-2222.1996.tb00553.x; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kajimoto T, 2001, MOL CELL BIOL, V21, P1769, DOI 10.1128/MCB.21.5.1769-1783.2001; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kitamura Y, 2004, ACTA OTO-LARYNGOL, V124, P1053, DOI 10.1080/00016480410022525; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Masaki T, 2011, MOL BIOL CELL, V22, P2144, DOI 10.1091/mbc.E10-11-0875; Matsubara M, 2006, INT ARCH ALLERGY IMM, V139, P279, DOI 10.1159/000091599; Matsubara M, 2005, BIOCHEM PHARMACOL, V69, P433, DOI 10.1016/j.bcp.2004.10.006; Matsushita C., 2008, Journal of Traditional Medicines, V25, P133; Megson AC, 2001, MOL PHARMACOL, V59, P1012, DOI 10.1124/mol.59.5.1012; Mizuguchi H, 2010, METHOD FIND EXP CLIN, V32, P745, DOI 10.1358/mf.2010.32.10.1533687; Mizuguchi H, 2008, J PHARMACOL SCI, V108, P480, DOI 10.1254/jphs.08222FP; Muscella A, 2004, J CELL PHYSIOL, V200, P428, DOI 10.1002/jcp.20033; Nakasaki T, 1999, PROSTAG OTH LIPID M, V58, P29, DOI 10.1016/S0090-6980(99)00021-0; Nie J, 1998, FEBS LETT, V424, P27, DOI 10.1016/S0014-5793(98)00131-8; Notcovich C, 2010, EXP CELL RES, V316, P401, DOI 10.1016/j.yexcr.2009.11.002; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; Ohuchi Y, 1998, INT J MOL MED, V1, P355; Rawling JM, 1997, BIOCHEM J, V324, P249, DOI 10.1042/bj3240249; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Shahriar M, 2009, J IMMUNOL, V183, P2133, DOI 10.4049/jimmunol.0901058; STARR S, 1995, J NEUROCHEM, V65, P569; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Terada N, 1999, CLIN EXP ALLERGY, V29, P52; THOMAS RF, 1992, P NATL ACAD SCI USA, V89, P4490, DOI 10.1073/pnas.89.10.4490; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027	58	41	42	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30542	30551		10.1074/jbc.M111.253104	http://dx.doi.org/10.1074/jbc.M111.253104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730054	Green Published, hybrid			2022-12-27	WOS:000294283600033
J	Pan, D; Kalfa, TA; Wang, D; Risinger, M; Crable, S; Ottlinger, A; Chandra, S; Mount, DB; Hubner, CA; Franco, RS; Joiner, CH				Pan, Dao; Kalfa, Theodosia A.; Wang, Daren; Risinger, Mary; Crable, Scott; Ottlinger, Anna; Chandra, Sharat; Mount, David B.; Huebner, Christian A.; Franco, Robert S.; Joiner, Clinton H.			K-Cl Cotransporter Gene Expression during Human and Murine Erythroid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SICKLE RETICULOCYTES; BONE-MARROW; MOLECULAR CHARACTERIZATION; VOLUME; CELLS; CLONING; CATION; KCC4; MICE; TRANSPORT	The K-Cl cotransporter (KCC) regulates red blood cell (RBC) volume, especially in reticulocytes. Western blot analysis of RBC membranes revealed KCC1, KCC3, and KCC4 proteins in mouse and human cells, with higher levels in reticulocytes. KCC content was higher in sickle versus normal RBC, but the correlation with reticulocyte count was poor, with inter-individual variability in KCC isoform ratios. Messenger RNA for each isoform was measured by real time RT-quantitative PCR. In human reticulocytes, KCC3a mRNA levels were consistently the highest, 1-7-fold higher than KCC4, the second most abundant species. Message levels for KCC1 and KCC3b were low. The ratios of KCC RNA levels varied among individuals but were similar in sickle and normal RBC. During in vivo maturation of human erythroblasts, KCC3a RNA was expressed consistently, whereas KCC1 and KCC3b levels declined, and KCC4 message first increased and then decreased. In mouse erythroblasts, a similar pattern for KCC3 and KCC1 expression during in vivo differentiation was observed, with low KCC4 RNA throughout despite the presence of KCC4 protein in mature RBC. During differentiation of mouse erythroleukemia cells, protein levels of KCCs paralleled increasing mRNA levels. Functional properties of KCCs expressed in HEK293 cells were similar to each other and to those in human RBC. However, the anion dependence of KCC in RBC resembled most closely that of KCC3. The results suggest that KCC3 is the dominant isoform in erythrocytes, with variable expression of KCC1 and KCC4 among individuals that could result in modulation of KCC activity.	[Pan, Dao; Wang, Daren] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Mol & Cell Therapy Program, Cincinnati, OH 45229 USA; [Kalfa, Theodosia A.; Risinger, Mary; Crable, Scott; Ottlinger, Anna; Chandra, Sharat; Franco, Robert S.; Joiner, Clinton H.] Cincinnati Childrens Hosp, Med Ctr, Canc & Blood Dis Inst, Div Hematol, Cincinnati, OH 45229 USA; [Pan, Dao; Kalfa, Theodosia A.; Chandra, Sharat; Joiner, Clinton H.] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH 45267 USA; [Franco, Robert S.] Univ Cincinnati, Sch Med, Dept Internal Med, Cincinnati, OH 45267 USA; [Mount, David B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst,Renal Div, Boston, MA 02115 USA; [Huebner, Christian A.] Univ Jena, Univ Hosp, Dept Clin Chem, D-07747 Jena, Germany	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Friedrich Schiller University of Jena	Pan, D (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Mol & Cell Therapy Program, Cincinnati, OH 45229 USA.	dao.pan@cchmc.org; clinton.joiner@cchmc.org	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943; Kalfa, Theodosia/0000-0002-0426-9686	National Institutes of Health [HL070871, NS064330, DK57708]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL070871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070871 (to C. H. J.), NS064330 (to D. P.), and DK57708 (to D. B. M.).	Armsby CC, 1996, AM J PHYSIOL-CELL PH, V270, pC866, DOI 10.1152/ajpcell.1996.270.3.C866; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Brugnara C, 2003, J PEDIAT HEMATOL ONC, V25, P927, DOI 10.1097/00043426-200312000-00004; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; BRUGNARA C, 1989, BLOOD, V74, P487; CANESSA M, 1986, FEBS LETT, V200, P197, DOI 10.1016/0014-5793(86)80538-5; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Crable SC, 2005, EXP HEMATOL, V33, P624, DOI 10.1016/j.exphem.2005.02.006; De Franceschi L, 2007, HAEMATOLOGICA, V92, P1319, DOI 10.3324/haematol.11556; DUNHAM PB, 1980, P NATL ACAD SCI-BIOL, V77, P1711, DOI 10.1073/pnas.77.3.1711; FRANCO RS, 1995, J CLIN INVEST, V95, P2573, DOI 10.1172/JCI117958; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Joiner CH, 2004, BLOOD, V104, P2954, DOI 10.1182/blood-2004-01-0112; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; KAJI D, 1986, J GEN PHYSIOL, V88, P719, DOI 10.1085/jgp.88.6.719; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Karadsheh MF, 2004, NEUROSCIENCE, V123, P381, DOI 10.1016/j.neuroscience.2003.10.004; Lauf PK, 2001, COMP BIOCHEM PHYS A, V130, P499, DOI 10.1016/S1095-6433(01)00421-4; LAUF PK, 1980, BIOCHEM BIOPH RES CO, V92, P1422, DOI 10.1016/0006-291X(80)90445-3; LOKEN MR, 1987, BLOOD, V69, P255; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Mercado A, 2001, AM J PHYSIOL-CELL PH, V281, pC670, DOI 10.1152/ajpcell.2001.281.2.C670; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Pellegrino CM, 1998, BLOOD CELL MOL DIS, V24, P31, DOI 10.1006/bcmd.1998.0168; Rinehart J, 2010, CURR OPIN HEMATOL, V17, P191, DOI 10.1097/MOH.0b013e32833800d0; Rust MB, 2007, J CLIN INVEST, V117, P1708, DOI 10.1172/JCI30630; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Su WF, 1999, AM J PHYSIOL-CELL PH, V277, pC899, DOI 10.1152/ajpcell.1999.277.5.C899; Wang DR, 2009, P NATL ACAD SCI USA, V106, P19958, DOI 10.1073/pnas.0908528106	41	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30492	30503		10.1074/jbc.M110.206516	http://dx.doi.org/10.1074/jbc.M110.206516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733850	Green Published, hybrid			2022-12-27	WOS:000294283600028
J	Runkle, EA; Sundstrom, JM; Runkle, KB; Liu, XW; Antonetti, DA				Runkle, E. Aaron; Sundstrom, Jeffrey M.; Runkle, Kristin B.; Liu, Xuwen; Antonetti, David A.			Occludin Localizes to Centrosomes and Modifies Mitotic Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEIN; EPITHELIAL-CELLS; BETA-CATENIN; PARACELLULAR PERMEABILITY; ENDOTHELIAL-CELLS; FACTOR ZONAB/DBPA; MEMBRANE-PROTEIN; EXPRESSION; GROWTH; ZO-1	Proper control of cell cycle progression and barrier function are essential processes to the maintenance of epithelial cell homeostasis. The contribution of tight junction proteins to barrier function is well established, whereas their contribution to cell cycle control is only beginning to be understood. Centrosomes are the principal microtubule organizing centers in eukaryotic cells and centrosome duplication and separation are linked to the cell cycle and mitotic entry. Here we demonstrate that occludin localizes with centrosomes in Madin-Darby canine kidney cells. Immunocytochemistry and biochemical fractionation studies reveal occludin localizes with centrosomes during interphase and occludin Ser-490 phosphorylation at centrosomes increases with mitotic entry. Stable expression of aspartic acid phosphomimetic (S490D) results in centrosomal localization of occludin and increases cell numbers. Furthermore, we provide evidence that occludin regulates centrosome separation and mitotic entry as the nonphosphorylatable alanine mutation (S490A) impedes centrosome separation, delays mitotic entry, and reduces proliferation. Collectively, these studies demonstrate a novel location and function for occludin in centrosome separation and mitosis.	[Liu, Xuwen; Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Sundstrom, Jeffrey M.] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA 17033 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Antonetti, DA (corresponding author), Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA.	dantonet@umich.edu	LIU, XUWEN/AAR-9250-2020	Sundstrom, Jeffrey/0000-0003-2738-2224; antonetti, david/0000-0003-1130-6577	National Institutes of Health [R01 EY012021]; American Heart Association (AHA) [0815468D]; NATIONAL EYE INSTITUTE [R01EY012021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY012021 (to D.A.A.), the Jules and Doris Stein Professorship (to D.A.A.), and American Heart Association (AHA) Great Rivers Affiliate Predoctoral Fellowship award 0815468D (to E.A.R.).	Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Hadjihannas MV, 2010, EMBO REP, V11, P317, DOI 10.1038/embor.2010.23; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hirase T, 1997, J CELL SCI, V110, P1603; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Oomen PHN, 2004, SCAND J CLIN LAB INV, V64, P119, DOI 10.1080/00365510410004704; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; Phillips BE, 2008, INVEST OPHTH VIS SCI, V49, P2568, DOI 10.1167/iovs.07-1204; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Tapia R, 2009, MOL BIOL CELL, V20, P1102, DOI 10.1091/mbc.E08-03-0277; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Tzelepi VN, 2008, MODERN PATHOL, V21, P22, DOI 10.1038/modpathol.3800959; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Wang Z, 2007, ONCOGENE, V26, P1222, DOI 10.1038/sj.onc.1209902; Wang ZL, 2005, ONCOGENE, V24, P4412, DOI 10.1038/sj.onc.1208634; Wittchen ES, 2000, J CELL BIOL, V151, P825, DOI 10.1083/jcb.151.4.825; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004	50	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30847	30858		10.1074/jbc.M111.262857	http://dx.doi.org/10.1074/jbc.M111.262857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757728	hybrid, Green Published			2022-12-27	WOS:000294283600064
J	Li, SQ; Zhu, F; Zykova, T; Kim, MO; Cho, YY; Bode, AM; Peng, C; Ma, WY; Carper, A; Langfald, A; Dong, ZG				Li, Shengqing; Zhu, Feng; Zykova, Tatyana; Kim, Myoung Ok; Cho, Yong Yeon; Bode, Ann M.; Peng, Cong; Ma, Weiya; Carper, Andria; Langfald, Alyssa; Dong, Zigang			T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of MKP1 Protein Prevents Solar Ultraviolet Light-induced Inflammation through Inhibition of the p38 Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATASE-MEDIATED CROSSTALK; COLORECTAL-CANCER CELLS; RPMI7951 MELANOMA-CELLS; MAP KINASE; INDUCED APOPTOSIS; BREAST-CANCER; P38-ALPHA; SKIN; MICE; PROLIFERATION	Solar UV radiation is a major environmental factor that causes DNA damage, inflammation, and even skin cancer. T-LAK cell-originated protein kinase (TOPK) is expressed widely in both normal and cancer cells and functions to inhibit apoptosis and promote carcinogenesis. However, its function in inflammation is not known. The p38 MAPK signaling pathway plays an important role in solar UVlight-induced inflammation. In this study, we found that TOPK negatively regulated the activity of p38 alpha by phosphorylating the p38 alpha-specific phosphatase MKP1 and enhancing the stability of MKP1. Notably, the absence of TOPK in mice resulted in a striking increase in skin inflammation. Therefore, we conclude that TOPK has a protective function in solar UV light-induced inflammation.	[Li, Shengqing; Zhu, Feng; Zykova, Tatyana; Kim, Myoung Ok; Cho, Yong Yeon; Bode, Ann M.; Peng, Cong; Ma, Weiya; Carper, Andria; Langfald, Alyssa; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Cho, Yong Yeon; Dong, Zigang] Catholic Univ Korea, Coll Pharm, Puchon, Gyeonggi Do, South Korea	University of Minnesota System; Catholic University of Korea	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; peng, cong/A-9454-2012; Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/C-1303-2010	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA120388, R37 CA081064, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA120388, R37 CA081064, and ES016548. This work was also supported by The Hormel Foundation.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; BODE AM, 2003, SCI STKE, pRE2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Cole N, 2010, INT ARCH ALLERGY IMM, V152, P87, DOI 10.1159/000265530; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Gambichler T, 2005, ARCH DERMATOL RES, V297, P218, DOI 10.1007/s00403-005-0604-6; Hildesheim J, 2004, J INVEST DERMATOL, V122, P497, DOI 10.1111/j.1523-1747.2004.22229.x; HRUZA LL, 1993, J INVEST DERMATOL, V100, pS35, DOI 10.1111/1523-1747.ep12355240; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jin XJ, 2010, J KOREAN MED SCI, V25, P930, DOI 10.3346/jkms.2010.25.6.930; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Lee EJ, 2010, FREE RADICAL BIO MED, V48, P1133, DOI 10.1016/j.freeradbiomed.2010.01.034; LEY RD, 1993, P NATL ACAD SCI USA, V90, P4337, DOI 10.1073/pnas.90.10.4337; Li G, 2006, ANN HEMATOL, V85, P583, DOI 10.1007/s00277-006-0137-x; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Mendoza RA, 2011, J ENDOCRINOL, V208, P11, DOI 10.1677/JOE-10-0237; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Sgambato A, 2010, EUR REV MED PHARMACO, V14, P263; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Vicentini FTMC, 2010, J PHARM PHARM SCI, V13, P274, DOI 10.18433/J3830G; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905; 1992, IARC MONOGR EVAL CAR, V55, P1	36	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29601	29609		10.1074/jbc.M111.225813	http://dx.doi.org/10.1074/jbc.M111.225813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715333	hybrid, Green Published			2022-12-27	WOS:000294046600018
J	Lin, WH; Martin, JL; Marsh, DJ; Jack, MM; Baxter, RC				Lin, Wen Hui; Martin, Janet L.; Marsh, Deborah J.; Jack, Michelle M.; Baxter, Robert C.			Involvement of Insulin-like Growth Factor-binding Protein-3 in the Effects of Histone Deacetylase Inhibitor MS-275 in Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; VIVO ANTITUMOR-ACTIVITY; BREAST-CANCER CELLS; IN-VIVO; SIGNALING PATHWAYS; PROSTATE-CANCER; GENE-EXPRESSION; LUNG-CANCER; IGFBP-3; INVASION	Insulin-like growth factor-binding protein-3 (IGFBP-3) expression is frequently suppressed in liver cancers and can be reactivated by histone deacetylase (HDAC) inhibition. This study examined the role of IGFBP-3 in mediating the effects of the HDAC inhibitor MS-275 in liver cancer cells and identified IGFBP-3-dependent proteins that regulate proliferation and migration. In HepG2 cells, MS-275 inhibited DNA synthesis, cell cycle activity, and cell viability concomitantly with increased binding of acetylated histone H3 to IGFBP-3 promoter sequences and induction of IGFBP-3 expression. IGFBP-3 down-regulation by siRNA significantly reversed the inhibition of cell viability and DNA synthesis by MS-275, indicating an intermediary role for IGFBP-3. Induction of the cyclin-dependent kinase inhibitor p21 by MS-275 was attenuated by IGFBP-3 down-regulation, providing an explanation for IGFBP-3-dependent effects of MS-275 on cell cycle activity. In contrast, MS-275 stimulated HepG2 cell migration, an effect also inhibited by IGFBP-3 down-regulation. Among genes whose induction by MS-275 was attenuated by IGFBP-3 down-regulation, LYVE1 and THBS2 (thrombospondin-2) were identified as mediators of IGFBP-3-dependent effects of MS-275. Silencing of either protein had no effect on the inhibition of HepG2 viability by MS-275 but reversed its stimulatory effect on cell migration. We conclude that among genes up-regulated by MS-275, IGFBP-3 is a key mediator of effects on hepatoma cell growth and migration, involving IGFBP-3-dependent proteins p21 (proliferation) and LYVE1 and THBS2 (migration). The enhanced cell motility that accompanies reactivation of IGFBP-3 expression in liver cancer by HDAC inhibition suggests the possibility of increased metastatic spread despite inhibited cell proliferation.	[Lin, Wen Hui; Martin, Janet L.; Marsh, Deborah J.; Baxter, Robert C.] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2065, Australia; [Jack, Michelle M.] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW 2065, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney	Baxter, RC (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia.	robert.baxter@sydney.edu.au	Marsh, Deborah J/I-1491-2014; Baxter, Robert C/F-3927-2012	Marsh, Deborah J/0000-0001-5899-4931; Baxter, Robert C/0000-0001-5061-2142				Aishima S, 2006, CANCER SCI, V97, P1182, DOI 10.1111/j.1349-7006.2006.00322.x; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Baradari V, 2007, WORLD J GASTROENTERO, V13, P4458; BAXTER RC, 1993, TRENDS ENDOCRIN MET, V4, P91, DOI 10.1016/1043-2760(93)90085-S; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; CHIN E, 1994, ENDOCRINOLOGY, V134, P2498, DOI 10.1210/en.134.6.2498; Choi HS, 2002, BIOCHEM BIOPH RES CO, V296, P1005, DOI 10.1016/S0006-291X(02)02001-6; Chuang ST, 2008, J UROLOGY, V179, P445, DOI 10.1016/j.juro.2007.09.106; Colombat M, 2003, J PATHOL, V201, P260, DOI 10.1002/path.1451; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Firth SM, 1999, PROTEIN EXPRES PURIF, V16, P202, DOI 10.1006/prep.1999.1075; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gahr S, 2008, ONCOL REP, V20, P1249, DOI 10.3892/or_00000137; Gong YW, 2000, MOL CELL BIOCHEM, V207, P101, DOI 10.1023/A:1007010818094; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; Hanafusa T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-9; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Huang SS, 2003, J BIOL CHEM, V278, P43855, DOI 10.1074/jbc.M306411200; Jaboin J, 2002, CANCER RES, V62, P6108; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Luo SM, 2005, WORLD J GASTROENTERO, V11, P4272; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; Massoner P, 2008, PROSTATE, V68, P1165, DOI 10.1002/pros.20785; Mattera D, 2003, CLIN ENDOCRINOL, V59, P699, DOI 10.1046/j.1365-2265.2003.01909.x; McElroy M, 2009, J SURG RES, V151, P68, DOI 10.1016/j.jss.2007.12.769; O'Han MK, 2009, GROWTH FACTORS, V27, P394, DOI 10.3109/08977190903185032; Oh SH, 2006, MOL CANCER THER, V5, P2685, DOI 10.1158/1535-7163.MCT-06-0142; Oh SH, 2006, CLIN CANCER RES, V12, P653, DOI 10.1158/1078-0432.CCR-05-1725; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Peng LH, 2008, INT J CANCER, V122, P558, DOI 10.1002/ijc.23100; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Riester D, 2007, APPL MICROBIOL BIOT, V75, P499, DOI 10.1007/s00253-007-0912-1; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Rosato RR, 2003, CANCER RES, V63, P3637; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; SCHARF JG, 1995, J HEPATOL, V23, P424, DOI 10.1016/0168-8278(95)80201-0; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Xi YG, 2006, MOL CANCER THER, V5, P3078, DOI 10.1158/1535-7163.MCT-06-0424; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yuan RH, 2011, J GASTROINTEST SURG, V15, P321, DOI 10.1007/s11605-010-1373-x; Yumoto E, 2005, INT J ONCOL, V27, P1223; Zhang YJ, 2006, INT J CANCER, V119, P985, DOI 10.1002/ijc.21699	53	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29540	29547		10.1074/jbc.M111.263111	http://dx.doi.org/10.1074/jbc.M111.263111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737444	Green Published, hybrid			2022-12-27	WOS:000294046600011
J	Mnatsakanyan, N; Kemboi, SK; Salas, J; Weber, J				Mnatsakanyan, Nelli; Kemboi, Silas K.; Salas, Jasmin; Weber, Joachim			The beta Subunit Loop That Couples Catalysis and Rotation in ATP Synthase Has a Critical Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; EPSILON-SUBUNIT; FOF1-ATP SYNTHASE; DELSEED MOTIF; F-1-ATPASE; RESOLUTION; HYDROLYSIS; MECHANISM	ATP synthase uses a unique rotational mechanism to convert chemical energy into mechanical energy and back into chemical energy. The helix-turn-helix structure in the C-terminal domain of the beta subunit containing the conserved DELSEED motif, termed "DELSEED-loop," was suggested to be involved in coupling between catalysis and rotation. If this is indeed the role of the loop, it must have a critical length, the minimum length required to sustain its function. Here, the critical length of the DELSEED-loop was determined by functional analysis of mutants of Bacillus PS3 ATP synthase that had 7-14 amino acids within the loop deleted. A 10 residue deletion lost the ability to catalyze ATP synthesis, but was still an active ATPase. Deletion of 14 residues abolished any enzymatic activity. Modeling indicated that in both deletion mutants the DELSEED-loop was shortened by similar to 10 angstrom; fluorescence resonance energy transfer experiments confirmed the modeling results. This appears to define the minimum length for DELSEED-loop required for coupling of catalysis and rotation. In addition, we could demonstrate that the loss of high-affinity binding to the catalytic site(s) that had been observed previously in two deletion mutants with 3-4 residues removed was not due to the loss of negative charged residues of the DELSEED motif in these mutants. An AALSAAA mutant in which all negative charges of the DELSEED motif were removed showed a normal pattern for MgATP binding to the catalytic sites, with a clearly present high-affinity site.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health [GM071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (including ARRA Administrative Supplement) (to J. W.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2003, METHOD ENZYMOL, V361, P211; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bulygin VV, 1998, J BIOL CHEM, V273, P31765, DOI 10.1074/jbc.273.48.31765; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Kobayashi M, 2010, J MOL BIOL, V398, P189, DOI 10.1016/j.jmb.2010.03.013; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; MATSUMOTO S, 1975, BIOCHEMISTRY-US, V14, P214, DOI 10.1021/bi00673a004; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; NOJI H, 2001, FEBS LETT, V276, P61; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020; Vinogradov AD, 2000, J EXP BIOL, V203, P41; WATANABE T, 1982, BIOCHEMISTRY-US, V21, P3245; Weber J, 2004, METHOD ENZYMOL, V380, P132; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2009, J BIOL CHEM, V284, P2374, DOI 10.1074/jbc.M808212200; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	48	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29788	29796		10.1074/jbc.M111.254730	http://dx.doi.org/10.1074/jbc.M111.254730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705326	hybrid, Green Published			2022-12-27	WOS:000294046600038
J	Ravichandran, P; Baluchamy, S; Gopikrishnan, R; Biradar, S; Ramesh, V; Goornavar, V; Thomas, R; Wilson, BL; Jeffers, R; Hall, JC; Ramesh, GT				Ravichandran, Prabakaran; Baluchamy, Sudhakar; Gopikrishnan, Ramya; Biradar, Santhoshkumar; Ramesh, Vani; Goornavar, Virupaxi; Thomas, Renard; Wilson, Bobby L.; Jeffers, Robert; Hall, Joseph C.; Ramesh, Govindarajan T.			Pulmonary Biocompatibility Assessment of Inhaled Single-wall and Multiwall Carbon Nanotubes in BALB/c Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; OXIDATIVE STRESS; TOXICITY; INFLAMMATION; INDUCTION; FIBROSIS	With the widespread application of carbon nanotubes (CNTs) in diverse commercial processes, scientists are now concerned about the potential health risk of occupational exposures. In this study, CNT-induced pulmonary toxicity was investigated by exposing BALB/c mice to aerosolized single-wall (SW) CNT and multiwall (MW) CNT (5 mu g/g of mice) for 7 consecutive days in a nose-only exposure system. Microscopic studies showed that inhaled CNTs were homogeneously distributed in the mouse lung. The total number of bronchoalveolar lavage polymorphonuclear leukocytes recovered from the mice exposed to SWCNT and MWCNT (1.2 x 10(6) +/- 0.52 and 9.87 x 10(5) +/- 1.45; respectively) was significantly greater than control mice (5.46 x 10(5) +/- 0.78). Rapid development of pulmonary fibrosis in mice that inhaled CNT was also confirmed by significant increases in the collagen level. The lactate dehydrogenase levels were increased nearly 2- and 2.4-fold in mice that inhaled SWCNT and MWCNT, respectively, as compared with control mice. In addition, exposure of CNTs to mice showed a significant (p < 0.05) reduction of antioxidants (glutathione, superoxide dismutase, and catalase) and induction of oxidants (myloperoxidase, oxidative stress, and lipid peroxidation) compared with control. Apoptosis-related proteins such as caspase-3 and -8 activities were also significantly increased in mice that inhaled CNT than in control mice. Together, this study shows that inhaled CNTs induce inflammation, fibrosis, alteration of oxidant and antioxidant levels, and induction of apoptosis-related proteins in the lung tissues to trigger cell death.	[Ravichandran, Prabakaran; Gopikrishnan, Ramya; Biradar, Santhoshkumar; Ramesh, Vani; Goornavar, Virupaxi; Jeffers, Robert; Hall, Joseph C.; Ramesh, Govindarajan T.] Norfolk State Univ, Dept Biol, Ctr Biotechnol & Biomed Sci, Mol Toxicol Lab, Norfolk, VA 23504 USA; [Baluchamy, Sudhakar] Pondicherry Univ, Dept Biotechnol, Pondicherry 605014, India; [Thomas, Renard; Wilson, Bobby L.] Texas So Univ, Dept Chem, Houston, TX 77004 USA	Norfolk State University; Pondicherry University; Texas Southern University	Ramesh, GT (corresponding author), Norfolk State Univ, Dept Biol, Ctr Biotechnol & Biomed Sci, Mol Toxicol Lab, Norfolk, VA 23504 USA.	gtramesh@nsu.edu			National Institutes of Health [1P20MD001822-1]; NASA [NNX08BA47A, NCC-1-02038,]; NSTI; NSF CREST; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NSTI; NSF CREST(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P20MD001822-1. This work was also supported by NASA Grants NNX08BA47A, NCC-1-02038, NSTI, and NSF CREST.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Baluchamy S, 2010, J BIOL CHEM, V285, P24769, DOI 10.1074/jbc.M110.138099; Cho WS, 2007, TOXICOL LETT, V175, P24, DOI 10.1016/j.toxlet.2007.09.008; Fahmy B, 2010, ENVIRON TOXICOL PHAR, V29, P173, DOI 10.1016/j.etap.2009.12.007; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P1227, DOI 10.1016/j.freeradbiomed.2005.11.010; Haegens A, 2005, CANCER RES, V65, P9670, DOI 10.1158/0008-5472.CAN-05-1751; Huczko A, 2001, FULLERENE SCI TECHN, V9, P251, DOI 10.1081/FST-100102973; Inoue K, 2010, FREE RADICAL BIO MED, V48, P924, DOI 10.1016/j.freeradbiomed.2010.01.013; JORIO A, 2008, CARBON NANOTUBES ADV, P13; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688; Miller FJ, 2000, INHAL TOXICOL, V12, P19, DOI 10.1080/089583700196536; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Periyakaruppan A, 2007, ARCH TOXICOL, V81, P389, DOI 10.1007/s00204-006-0167-0; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; PORTER DW, 2009, TOXICOLOGIST, V108, P457; Ravichandran P, 2010, APOPTOSIS, V15, P1507, DOI 10.1007/s10495-010-0532-6; Ravichandran P, 2009, J BIOCHEM MOL TOXIC, V23, P333, DOI 10.1002/jbt.20296; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Ryman-Rasmussen JP, 2009, AM J RESP CELL MOL, V40, P349, DOI 10.1165/rcmb.2008-0276OC; Sharma CS, 2007, J NANOSCI NANOTECHNO, V7, P2466, DOI 10.1166/jnn.2007.431; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Wang F, 2009, TOXICOL IN VITRO, V23, P808, DOI 10.1016/j.tiv.2009.04.009; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228	30	40	41	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29725	29733		10.1074/jbc.M111.251884	http://dx.doi.org/10.1074/jbc.M111.251884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705330	hybrid, Green Published			2022-12-27	WOS:000294046600032
J	Brailoiu, GC; Oprea, TI; Zhao, PW; Abood, ME; Brailoiu, E				Brailoiu, G. Cristina; Oprea, Tudor I.; Zhao, Pingwei; Abood, Mary E.; Brailoiu, Eugen			Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; MOBILIZES CALCIUM; CA2+ RELEASE; NAADP; CELLS; TRAFFICKING; STORES; ENDOCYTOSIS; MECHANISMS; ORGANELLES	Recent studies have demonstrated that the majority of endogenous cannabinoid type 1 (CB1) receptors do not reach the cell surface but are instead associated with endosomal and lysosomal compartments. Using calcium imaging and intracellular microinjection in CB1 receptor-transfected HEK293 cells and NG108-15 neuroblastoma x glioma cells, we provide evidence that anandamide acting on CB1 receptors increases intracellular calcium concentration when administered intracellularly but not extracellularly. The calcium-mobilizing effect of intracellular anandamide was dose-dependent and abolished by pretreatment with SR141716A, a CB1 receptor antagonist. The anandamide-induced calcium increase was reduced by blocking nicotinic acid-adenine dinucleotide phosphate-or inositol 1,4,5-trisphosphate-dependent calcium release and abolished when both lysosomal and endoplasmic reticulum calcium release pathways were blocked. Taken together, our results indicate that, in CB1 receptor-transfected HEK293 cells, intracellular CB1 receptors are functional; they are located in acid-filled calcium stores (endolysosomes). Activation of intracellular CB1 receptors releases calcium from endoplasmic reticulum and lysosomal calcium stores. In addition, our results support a novel role for nicotinic acid-adenine dinucleotide phosphate in cannabinoid-induced calcium signaling.	[Zhao, Pingwei; Abood, Mary E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Brailoiu, G. Cristina; Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Zhao, Pingwei; Abood, Mary E.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Oprea, Tudor I.] Univ New Mexico, Sch Med, Div Biocomp, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of New Mexico	Abood, ME (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA.	mabood@temple.edu; ebrailou@temple.edu	Oprea, Tudor I/A-5746-2011	Oprea, Tudor I/0000-0002-6195-6976; Abood, Mary/0000-0002-1744-2820	National Institutes of Health [HL90804, DA023204, DA05274]; Sunset Molecular Discovery (Santa Fe, NM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023204, P50DA005274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sunset Molecular Discovery (Santa Fe, NM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL90804 (to E. B.), and DA023204 and DA05274 (to M. E. A.). This work was also supported by a donation from Sunset Molecular Discovery (Santa Fe, NM).	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brailoiu E, 1999, BRIT J PHARMACOL, V126, P1133, DOI 10.1038/sj.bjp.0702421; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2001, MOL PHARMACOL, V60, P718; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; CAULFIELD MP, 1992, TEST, V106, P231; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FELDER CC, 1992, MOL PHARMACOL, V42, P838; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Ho BY, 1996, NEUROSCI LETT, V212, P123, DOI 10.1016/0304-3940(96)12792-0; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; McIntosh HH, 1998, MOL BRAIN RES, V53, P163, DOI 10.1016/S0169-328X(97)00294-5; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2011, TRAFFIC, V12, P12, DOI 10.1111/j.1600-0854.2010.01130.x; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Scavone JL, 2010, BRAIN RES, V1312, P18, DOI 10.1016/j.brainres.2009.11.023; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; STYRT B, 1988, BIOCHEM BIOPH RES CO, V154, P1308, DOI 10.1016/0006-291X(88)90282-3; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009	49	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29166	29174		10.1074/jbc.M110.217463	http://dx.doi.org/10.1074/jbc.M110.217463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21719698	Green Published, hybrid			2022-12-27	WOS:000293837000053
J	Li, J; Hoop, CL; Kodali, R; Sivanandam, VN; van der Wel, PCA				Li, Jun; Hoop, Cody L.; Kodali, Ravindra; Sivanandam, V. N.; van der Wel, Patrick C. A.			Amyloid-like Fibrils from a Domain-swapping Protein Feature a Parallel, in-Register Conformation without Native-like Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SHEET STRUCTURE; HUMAN PRION PROTEIN; HUMAN CYSTATIN-C; SOLID-STATE NMR; ANGLE-SPINNING NMR; CHEMICAL-SHIFTS; FORM PRIONS; BETA(2)-MICROGLOBULIN; GB1; DIMERIZATION	The formation of amyloid-like fibrils is characteristic of various diseases, but the underlying mechanism and the factors that determine whether, when, and how proteins form amyloid, remain uncertain. Certain mechanisms have been proposed based on the three-dimensional or runaway domain swapping, inspired by the fact that some proteins show an apparent correlation between the ability to form domain-swapped dimers and a tendency to form fibrillar aggregates. Intramolecular beta-sheet contacts present in the monomeric state could constitute intermolecular beta-sheets in the dimeric and fibrillar states. One example is an amyloid-forming mutant of the immunoglobulin binding domain B1 of streptococcal protein G, which in its native conformation consists of a four-stranded beta-sheet and one alpha-helix. Under native conditions this mutant adopts a domain-swapped dimer, and it also forms amyloid-like fibrils, seemingly in correlation to its domain-swapping ability. We employ magic angle spinning solid-state NMR and other methods to examine key structural features of these fibrils. Our results reveal a highly rigid fibril structure that lacks mobile domains and indicate a parallel in-register beta-sheet structure and a general loss of native conformation within the mature fibrils. This observation contrasts with predictions that native structure, and in particular intermolecular beta-strand interactions seen in the dimeric state, may be preserved in "domain-swapping" fibrils. We discuss these observations in light of recent work on related amyloid-forming proteins that have been argued to follow similar mechanisms and how this may have implications for the role of domain-swapping propensities for amyloid formation.	[Li, Jun; Hoop, Cody L.; Kodali, Ravindra; Sivanandam, V. N.; van der Wel, Patrick C. A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	van der Wel, PCA (corresponding author), 3501 5th Ave,BST3 2044, Pittsburgh, PA 15260 USA.	pvdwel@pitt.edu	li, jun/A-1197-2011; van der Wel, Patrick C.A./B-1428-2009	van der Wel, Patrick C.A./0000-0002-5390-3321; Hoop, Cody/0000-0003-4441-8321	National Center for Research Resources [UL1 RR024153]; University of Pittsburgh; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources (Grant UL1 RR024153) and startup funds from the University of Pittsburgh.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Alexandrescu AT, 2001, PAC S BIOCOMPUT, V6, P67; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Byeon IJL, 2004, J MOL BIOL, V340, P615, DOI 10.1016/j.jmb.2004.04.069; Byeon IJL, 2003, J MOL BIOL, V333, P141, DOI 10.1016/S0022-2836(03)00928-8; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eakin CM, 2005, BBA-PROTEINS PROTEOM, V1753, P92, DOI 10.1016/j.bbapap.2005.09.002; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Fandrich M, 2009, PRION, V3, P89; Franks WT, 2005, J AM CHEM SOC, V127, P12291, DOI 10.1021/ja044497e; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jee J, 2008, PROTEINS, V71, P1420, DOI 10.1002/prot.21831; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu G, 2010, J AM CHEM SOC, V132, P18223, DOI 10.1021/ja1069882; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Ramirez-Alvarado M, 2003, PROTEIN SCI, V12, P567, DOI 10.1110/ps.0227403; Ramirez-Alvarado M, 2002, J MOL BIOL, V323, P17, DOI 10.1016/S0022-2836(02)00840-9; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Robustelli P, 2008, STRUCTURE, V16, P1764, DOI 10.1016/j.str.2008.10.016; Rodziewicz-Motowidlo S, 2006, J STRUCT BIOL, V154, P68, DOI 10.1016/j.jsb.2005.11.015; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Rousseau F, 2006, J MOL BIOL, V363, P496, DOI 10.1016/j.jmb.2006.07.061; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Sicorello A, 2009, BIOPHYS J, V96, P2289, DOI 10.1016/j.bpj.2008.11.042; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Ventura S, 2002, J MOL BIOL, V322, P1147, DOI 10.1016/S0022-2836(02)00783-0; Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang JM, 2005, STRUCTURE, V13, P1279, DOI 10.1016/j.str.2005.06.010; Weingarth M, 2009, J AM CHEM SOC, V131, P13937, DOI 10.1021/ja9036143; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang SC, 2005, FASEB J, V19, P1778, DOI 10.1096/fj.05-4067hyp; ZHANG YZ, 1995, PROTEIN SCI, V4, P804	68	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28988	28995		10.1074/jbc.M111.261750	http://dx.doi.org/10.1074/jbc.M111.261750			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715337	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000293837000035
J	Morato-Marques, M; Campos, MR; Kane, S; Rangel, AP; Lewis, C; Ballinger, MN; Kim, SH; Peters-Golden, M; Jancar, S; Serezani, CH				Morato-Marques, Mariana; Campos, Marina R.; Kane, Steve; Rangel, Ana P.; Lewis, Casey; Ballinger, Megan N.; Kim, Sang-Hoon; Peters-Golden, Marc; Jancar, Sonia; Serezani, Carlos H.			Leukotrienes Target F-actin/Cofilin-1 to Enhance Alveolar Macrophage Anti-fungal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CASCADE; CANDIDA-ALBICANS; NADPH OXIDASE; HOST-DEFENSE; 5-LIPOXYGENASE METABOLISM; DEPENDENT PHAGOCYTOSIS; REGULATES PHAGOCYTOSIS; KLEBSIELLA-PNEUMONIAE; MURINE MACROPHAGES; BLOOD MONOCYTES	Candida albicans is the most common opportunistic fungal pathogen and causes local and systemic disease in immunocompromised patients. Alveolar macrophages (AMs) are pivotal for the clearance of C. albicans from the lung. Activated AMs secrete 5-lipoxygenase-derived leukotrienes (LTs), which in turn enhance phagocytosis and microbicidal activity against a diverse array of pathogens. Our aim was to investigate the role of LTB4 and LTD4 in AM antimicrobial functions against C. albicans and the signaling pathways involved. Pharmacologic and genetic inhibition of LT biosynthesis as well as receptor antagonism reduced phagocytosis of C. albicans when compared with untreated or WT controls. Conversely, exogenous LTs of both classes augmented base-line C. albicans phagocytosis by AMs. Although LTB4 enhanced mainly mannose receptor-dependent fungal ingestion, LTD4 enhanced mainly dectin-1 receptor-mediated phagocytosis. LT enhancement of yeast ingestion was dependent on protein kinase C-delta (PKC delta) and PI3K but not PKC alpha and MAPK activation. Both LTs reduced activation of cofilin-1, whereas they enhanced total cellular F-actin; however, LTB4 accomplished this through the activation of LIM kinases (LIMKs) 1 and 2, whereas LTD4 did so exclusively via LIMK-2. Finally, both exogenous LTB4 and LTD4 enhanced AM fungicidal activity in an NADPH oxidase-dependent manner. Our data identify LTB4 and LTD4 as key mediators of innate immunity against C. albicans, which act by both distinct and conserved signaling mechanisms to enhance multiple antimicrobial functions of AMs.	[Kane, Steve; Lewis, Casey; Ballinger, Megan N.; Peters-Golden, Marc; Serezani, Carlos H.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Sch Med, Ann Arbor, MI 48109 USA; [Morato-Marques, Mariana; Campos, Marina R.; Rangel, Ana P.; Jancar, Sonia] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Kim, Sang-Hoon] Eulji Univ, Sch Med, Dept Internal Med, Div Allergy & Resp Med, Seoul 139711, South Korea	University of Michigan System; University of Michigan; Universidade de Sao Paulo; Eulji University	Serezani, CH (corresponding author), Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Sch Med, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	cserezan@med.umich.edu	Connor, Toni R/C-6964-2012; Jancar, Sonia/C-5153-2012; serezani, C. Henrique/H-1675-2013	Jancar, Sonia/0000-0001-7983-3459; Ballinger, Megan/0000-0002-2202-3049; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health [HL-058897, HL-103777-01]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777, R56HL058897, R01HL058897, K99HL103777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-058897 (to M. P.-G.) and HL-103777-01 (C. H. S.). This work was also supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Adachi R, 2002, J BIOL CHEM, V277, P45566, DOI 10.1074/jbc.M207419200; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bailie MB, 1996, J IMMUNOL, V157, P5221; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; BALTER MS, 1989, J IMMUNOL, V142, P602; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Campos MRM, 2009, MOL IMMUNOL, V46, P1204, DOI 10.1016/j.molimm.2008.11.024; Canetti C, 2003, BLOOD, V102, P1877, DOI 10.1182/blood-2003-02-0534; Canetti C, 2007, J IMMUNOL, V179, P8350, DOI 10.4049/jimmunol.179.12.8350; Canetti C, 2006, J LEUKOCYTE BIOL, V79, P1234, DOI 10.1189/jlb.0705374; CASTRO M, 1994, INFECT IMMUN, V62, P3138, DOI 10.1128/IAI.62.8.3138-3145.1994; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chung J, 2008, J IMMUNOL, V181, P5501, DOI 10.4049/jimmunol.181.8.5501; Coffey MJ, 1998, J CLIN INVEST, V102, P663, DOI 10.1172/JCI2117; Coffey MJ, 1996, J IMMUNOL, V157, P393; Coffey MJ, 2004, PROSTAG LEUKOTR ESS, V71, P185, DOI 10.1016/j.plefa.2004.03.012; Coffey MJ, 1999, BLOOD, V94, P3897, DOI 10.1182/blood.V94.11.3897.423k12_3897_3905; Costa MFD, 2010, J LEUKOCYTE BIOL, V87, P323, DOI 10.1189/jlb.0809563; Dictar MO, 2000, MED MYCOL, V38, P251, DOI 10.1080/mmy.38.s1.251.258; Donini M, 2007, EUR J IMMUNOL, V37, P1194, DOI 10.1002/eji.200636532; Duarte-Escalante E, 2003, ARCH MED RES, V34, P176, DOI 10.1016/S0188-4409(03)00044-4; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Evans Scott E, 2010, Proc Am Thorac Soc, V7, P197, DOI 10.1513/pats.200907-075AL; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Gaudreault E, 2007, VIRAL IMMUNOL, V20, P407, DOI 10.1089/vim.2006.0099; Gillooly DJ, 2001, J CELL BIOL, V155, P15, DOI 10.1083/jcb.200109001; Giraldo E, 2010, MOL CELL BIOCHEM, V333, P115, DOI 10.1007/s11010-009-0211-5; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; HO NK, 1984, AUST PAEDIATR J, V20, P127; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Hu B, 2002, J LEUKOCYTE BIOL, V71, P881; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; JAKAB GJ, 1981, INFECT IMMUN, V34, P610, DOI 10.1128/IAI.34.2.610-622.1981; Kaposzta R, 1999, J CELL SCI, V112, P3237; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; KYRIAZIS AP, 1993, DIAGN CYTOPATHOL, V9, P487, DOI 10.1002/dc.2840090503; Lee C, 2005, J LEUKOCYTE BIOL, V78, P1016, DOI 10.1189/jlb.0105056; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Linden JR, 2010, MED MYCOL, V48, P355, DOI [10.1080/13693780903164566, 10.3109/13693780903164566]; Lynch KR, 1999, NATURE, V399, P789; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mancuso P, 2010, INFECT IMMUN, V78, P2264, DOI 10.1128/IAI.01323-09; Massoumi R, 1998, EUR J CELL BIOL, V76, P185, DOI 10.1016/S0171-9335(98)80033-2; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Monget P, 2002, DOMEST ANIM ENDOCRIN, V23, P139, DOI 10.1016/S0739-7240(02)00152-2; Morre DJ, 2002, ANTIOXID REDOX SIGN, V4, P207, DOI 10.1089/152308602753625960; Mugnai S, 1997, BRIT J PHARMACOL, V122, P1345, DOI 10.1038/sj.bjp.0701521; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; OMANN GM, 1987, J IMMUNOL, V138, P2626; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Peres CM, 2007, J IMMUNOL, V179, P5454, DOI 10.4049/jimmunol.179.8.5454; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; SAWYER RT, 1990, MYCOPATHOLOGIA, V109, P99, DOI 10.1007/BF00436790; Schindler B, 2008, MED MYCOL, V46, P251, DOI 10.1080/13693780701837157; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Serezani CHC, 2005, J LEUKOCYTE BIOL, V78, P976, DOI 10.1189/jlb.1004587; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; SKERRETT SJ, 1990, J IMMUNOL, V144, P1052; Smacchia C, 1997, HAEMATOLOGICA, V82, P526; Smallwood ND, 2005, AM J PHYSIOL-CELL PH, V288, pC906, DOI 10.1152/ajpcell.00484.2004; STENKE L, 1987, EXP HEMATOL, V15, P203; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Takao S, 1996, AM J PHYSIOL-CELL PH, V271, pC1278, DOI 10.1152/ajpcell.1996.271.4.C1278; THORSEN S, 1989, AIDS, V3, P651, DOI 10.1097/00002030-198910000-00006; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Virgili Annarosa, 2002, Am J Clin Dermatol, V3, P19, DOI 10.2165/00128071-200203010-00003; Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121; Yao ZR, 2006, CURR OPIN PULM MED, V12, P222, DOI 10.1097/01.mcp.0000219272.57933.01; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	81	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28902	28913		10.1074/jbc.M111.235309	http://dx.doi.org/10.1074/jbc.M111.235309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715328	Green Published, hybrid			2022-12-27	WOS:000293837000027
J	Yeh, YY; Shah, KH; Herman, PK				Yeh, Yuh-Ying; Shah, Khyati H.; Herman, Paul K.			An Atg13 Protein-mediated Self-association of the Atg1 Protein Kinase Is Important for the Induction of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP AUTOPHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; COMPLEX; YEAST; MACHINERY; MECHANISM; DISEASE; SITES; TOR	Autophagy pathways in eukaryotic cells mediate the turnover of a diverse set of cytoplasmic components, including damaged organelles and abnormal protein aggregates. Autophagy-mediated degradation is highly regulated, and defects in these pathways have been linked to a number of human disorders. The Atg1 protein kinase appears to be a key site of this control and is targeted by multiple signaling pathways to ensure the appropriate autophagic response to changing environmental conditions. Despite the importance of this kinase, relatively little is known about the molecular details of Atg1 activation. In this study we show that Atg13, an evolutionarily conserved regulator of Atg1, promotes the formation of a specific Atg1 self-interaction in the budding yeast, Saccharomyces cerevisiae. The appearance of this Atg1-Atg1 complex is correlated with the induction of autophagy, and conditions that disrupt this complex result in diminished levels of both autophagy and Atg1 kinase activity. Moreover, the addition of a heterologous dimerization domain to Atg1 resulted in elevated kinase activity both in vivo and in vitro. The formation of this complex appears to be an important prerequisite for the subsequent autophosphorylation of Thr-226 in the Atg1 activation loop. Previous work indicates that this modification is necessary and perhaps sufficient for Atg1 kinase activity. Interestingly, this Atg1 self-association does not require Atg17, suggesting that this second conserved regulator might activate Atg1 in a manner mechanistically distinct from that of Atg13. In all, this work suggests a model whereby this self-association stimulates the autophosphorylation of Atg1 within its activation loop.	[Yeh, Yuh-Ying; Shah, Khyati H.; Herman, Paul K.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Yeh, Yuh-Ying; Herman, Paul K.] Ohio State Univ, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; [Shah, Khyati H.; Herman, Paul K.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Herman, PK (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12th Ave,Rm 112, Columbus, OH 43210 USA.	herman.81@osu.edu			National Institutes of Health [GM65227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65227 (to P. K. H.).	Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chang YW, 2001, GENETICS, V157, P17; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kaiser C. S., 1994, METHODS YEAST GENETI, P207; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kijanska M, 2010, AUTOPHAGY, V6, P1168, DOI 10.4161/auto.6.8.13849; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Stephan JS, 2006, AUTOPHAGY, V2, P146, DOI 10.4161/auto.2.2.2485; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yeh YY, 2011, AUTOPHAGY, V7, P716, DOI 10.4161/auto.7.7.15155; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566	53	40	46	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28931	28939		10.1074/jbc.M111.250324	http://dx.doi.org/10.1074/jbc.M111.250324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712380	Green Published, hybrid			2022-12-27	WOS:000293837000030
J	Johansson, BB; Torsvik, J; Bjorkhaug, L; Vesterhus, M; Ragvin, A; Tjora, E; Fjeld, K; Hoem, D; Johansson, S; Raeder, H; Lindquist, S; Hernell, O; Cnop, M; Saraste, J; Flatmark, T; Molven, A; Njolstad, PR				Johansson, Bente B.; Torsvik, Janniche; Bjorkhaug, Lise; Vesterhus, Mette; Ragvin, Anja; Tjora, Erling; Fjeld, Karianne; Hoem, Dag; Johansson, Stefan; Raeder, Helge; Lindquist, Susanne; Hernell, Olle; Cnop, Miriam; Saraste, Jaakko; Flatmark, Torgeir; Molven, Anders; Njolstad, Pal R.			Diabetes and Pancreatic Exocrine Dysfunction Due to Mutations in the Carboxyl Ester Lipase Gene-Maturity Onset Diabetes of the Young (CEL-MODY) A PROTEIN MISFOLDING DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-DEPENDENT LIPASE; AMINO-ACID-SEQUENCES; STIMULATED LIPASE; HUMAN-MILK; ACTIVATED LIPASE; CDNA CLONING; INSULIN GENE; SECRETION; AGGREGATION; HYDROLASE	CEL-maturity onset diabetes of the young (MODY), diabetes with pancreatic lipomatosis and exocrine dysfunction, is due to dominant frameshift mutations in the acinar cell carboxyl ester lipase gene (CEL). As Cel knock-out mice do not express the phenotype and the mutant protein has an altered and intrinsically disordered tandem repeat domain, we hypothesized that the disease mechanism might involve a negative effect of the mutant protein. In silico analysis showed that the pI of the tandem repeat was markedly increased from pH 3.3 in wild-type (WT) to 11.8 in mutant (MUT) human CEL. By stably over-expressing CEL-WT and CEL-MUT in HEK293 cells, we found similar glycosylation, ubiquitination, constitutive secretion, and quality control of the two proteins. The CEL-MUT protein demonstrated, however, a high propensity to form aggregates found intracellularly and extracellularly. Different physicochemical properties of the intrinsically disordered tandem repeat domains of WT and MUT proteins may contribute to different short and long range interactions with the globular core domain and other macromolecules, including cell membranes. Thus, we propose that CEL-MODY is a protein misfolding disease caused by a negative gain-of-function effect of the mutant proteins in pancreatic tissues.	[Njolstad, Pal R.] Univ Bergen, Haukeland Univ Hosp, Sect Pediat, Dept Pediat, N-5021 Bergen, Norway; [Johansson, Bente B.; Torsvik, Janniche; Bjorkhaug, Lise; Vesterhus, Mette; Ragvin, Anja; Tjora, Erling; Fjeld, Karianne; Johansson, Stefan; Raeder, Helge; Njolstad, Pal R.] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Johansson, Bente B.; Torsvik, Janniche; Bjorkhaug, Lise; Ragvin, Anja; Fjeld, Karianne; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Hoem, Dag] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Hoem, Dag; Molven, Anders] Univ Bergen, Gade Inst, Sect Pathol, N-5021 Bergen, Norway; [Lindquist, Susanne; Hernell, Olle] Umea Univ, Dept Clin Sci, SE-90187 Umea, Sweden; [Cnop, Miriam] Univ Libre Brussels, Expt Med Lab, B-1070 Brussels, Belgium; [Cnop, Miriam] Erasmus Hosp, Div Endocrinol, B-1070 Brussels, Belgium; [Saraste, Jaakko; Flatmark, Torgeir] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Umea University; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Bergen; University of Bergen; Haukeland University Hospital	Njolstad, PR (corresponding author), Univ Bergen, Haukeland Univ Hosp, Sect Pediat, Dept Pediat, N-5021 Bergen, Norway.	pal.njolstad@uib.no	Raeder, Helge/AFQ-6279-2022; Johansson, Stefan/C-4394-2011; Johansson, Bente Berg/AAE-7666-2022; Raeder, Helge/ABE-3601-2020; Fjeld, Karianne/Q-7122-2018; Bjørkhaug, Lise/AAA-4356-2021; Vesterhus, Mette/AAX-8767-2020	Johansson, Stefan/0000-0002-2298-7008; Fjeld, Karianne/0000-0003-0441-1475; Bjørkhaug, Lise/0000-0002-9695-4559; Vesterhus, Mette/0000-0003-1493-2303; Johansson, Bente Berg/0000-0001-8893-1915; Cnop, Miriam/0000-0002-5112-1692	Bergen Medical Research Foundation; University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; Research Council of Norway; Fonds National de la Recherche Scientifique-Fonds de la Recherche Scientifique Medicale	Bergen Medical Research Foundation; University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; Research Council of Norway(Research Council of Norway); Fonds National de la Recherche Scientifique-Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	The work was supported by a grant from the Translational Fund of the Bergen Medical Research Foundation (to A. M. and P. R. N.), the University of Bergen, Haukeland University Hospital, Helse Vest, Innovest, the FUGE Program at the Research Council of Norway (to P. R. N.), and Fonds National de la Recherche Scientifique-Fonds de la Recherche Scientifique Medicale (to M. C.).	ABOUAKIL N, 1993, J BIOL CHEM, V268, P25755; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; BLACKBERG L, 1981, FEBS LETT, V136, P284, DOI 10.1016/0014-5793(81)80636-9; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Brown W. J., 1999, IMMUNOPEROXIDASE MET, V4.6.1-4.6.17; Bruneau N, 1998, J CELL SCI, V111, P2665; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Le Petit-Thevenin J, 2001, BBA-MOL CELL BIOL L, V1530, P184, DOI 10.1016/S1388-1981(00)00181-5; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; MARIANNE T, 1987, BIOCHEM J, V248, P189, DOI 10.1042/bj2480189; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pasqualini E, 2000, BIOCHEM J, V345, P121, DOI 10.1042/0264-6021:3450121; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; REUE K, 1991, J LIPID RES, V32, P267; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROSE MC, 1984, BIOCHEM J, V222, P371, DOI 10.1042/bj2220371; ROUDANI S, 1995, BBA-GENE STRUCT EXPR, V1264, P141, DOI 10.1016/0167-4781(95)00141-3; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Terzyan S, 2000, PROTEIN SCI, V9, P1783, DOI 10.1110/ps.9.9.1783; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Verine A, 2001, J BIOL CHEM, V276, P12356, DOI 10.1074/jbc.M008658200; Vesterhus M, 2008, DIABETES CARE, V31, P306, DOI 10.2337/dc07-1002; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039; Weise K, 2010, CHEMBIOCHEM, V11, P1280, DOI 10.1002/cbic.201000039; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797	48	60	70	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34593	34605		10.1074/jbc.M111.222679	http://dx.doi.org/10.1074/jbc.M111.222679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21784842	hybrid, Green Published			2022-12-27	WOS:000295406300014
J	Bai, HD; Baik, N; Kiosses, WB; Krajewski, S; Miles, LA; Parmer, RJ				Bai, Hongdong; Baik, Nagyung; Kiosses, William B.; Krajewski, Stan; Miles, Lindsey A.; Parmer, Robert J.			The Novel Plasminogen Receptor, Plasminogen Receptor(KT) (Plg-R-KT), Regulates Catecholamine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ACTIVATOR T-PA; CHROMOGRANIN-A; NEURONAL DEGENERATION; SYMPATHETIC AXONS; BINDING-SITES; CELL-DEATH; LATE-PHASE; SURFACE; SECRETION	Neurotransmitter release by catecholaminergic cells is negatively regulated by prohormone cleavage products formed from plasmin-mediated proteolysis. Here, we investigated the expression and subcellular localization of Plg-R-KT, a novel plasminogen receptor, and its role in catecholaminergic cell plasminogen activation and regulation of catecholamine release. Prominent staining with anti-Plg-R-KT mAb was observed in adrenal medullary chromaffin cells in murine and human tissue. In Western blotting, Plg-R-KT was highly expressed in bovine adrenomedullary chromaffin cells, human pheochromocytoma tissue, PC12 pheochromocytoma cells, and murine hippocampus. Expression of Plg-R-KT fused in-frame to GFP resulted in targeting of the GFP signal to the cell membrane. Phase partitioning, co-immunoprecipitation with urokinase-type plasminogen activator receptor (uPAR), and FACS analysis with antibody directed against the C terminus of Plg-R-KT were consistent with Plg-R-KT being an integral plasma membrane protein on the surface of catecholaminergic cells. Cells stably overexpressing Plg-R-KT exhibited substantial enhancement of plasminogen activation, and antibody blockade of non-transfected PC12 cells suppressed plasminogen activation. In functional secretion assays, nicotine-evoked [H-3] norepinephrine release from cells overexpressing Plg-R-KT was markedly decreased (by 51 +/- 2%, p < 0.001) when compared with control transfected cells, and anti-body blockade increased [H-3] norepinephrine release from non-transfected PC12 cells. In summary, Plg-R-KT is present on the surface of catecholaminergic cells and functions to stimulate plasminogen activation and modulate catecholamine release. Plg-R-KT thus represents a new mechanism and novel control point for regulating the interface between plasminogen activation and neurosecretory cell function.	[Bai, Hongdong; Parmer, Robert J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Bai, Hongdong; Parmer, Robert J.] Vet Adm San Diego Healthcare Syst, San Diego, CA 92161 USA; [Baik, Nagyung; Kiosses, William B.; Miles, Lindsey A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Krajewski, Stan] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Parmer, RJ (corresponding author), Univ Calif San Diego, Dept Med 9111H, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	rparmer@ucsd.edu			National Institutes of Health [HL050398, HL081046]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081046, R01HL050398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL050398 (to R. J. P.) and HL081046 (to L. A. M.). This work was also supported by a grant from the Department of Veterans Affairs (to R. J. P.).	Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Felez J, 1996, THROMB HAEMOSTASIS, V76, P577; Frey U, 1996, J NEUROSCI, V16, P2057; FRIEDMAN GC, 1995, J COMP NEUROL, V360, P658; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gualandris A, 1996, J NEUROSCI, V16, P2220; Gutierrez-Fernandez A, 2009, J NEUROSCI, V29, P12393, DOI 10.1523/JNEUROSCI.3553-09.2009; Hao ZF, 2006, BLOOD, V108, P200, DOI 10.1182/blood-2005-12-4884; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Jiang QJ, 2002, ANN NY ACAD SCI, V971, P445, DOI 10.1111/j.1749-6632.2002.tb04506.x; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; Jiang X, 2002, MICROVASC RES, V64, P438, DOI 10.1006/mvre.2002.2441; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; Miles LA, 2002, ANN NY ACAD SCI, V971, P454, DOI 10.1111/j.1749-6632.2002.tb04508.x; Miles LA, 2006, J NEUROSCI, V26, P13017, DOI 10.1523/JNEUROSCI.2070-06.2006; Odegaard JI, 2007, J LEUKOCYTE BIOL, V81, P711, DOI 10.1189/jlb.0906590; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; PARMER RJ, 1993, J CLIN INVEST, V92, P1042, DOI 10.1172/JCI116609; Parmer RJ, 2000, J CLIN INVEST, V106, P907, DOI 10.1172/JCI7394; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; Parmer RJ, 1998, TRENDS CARDIOVAS MED, V8, P306, DOI 10.1016/S1050-1738(98)00025-5; PITTMAN RN, 1995, J NEUROCHEM, V64, P566; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ranson M, 1998, BRIT J CANCER, V77, P1586, DOI 10.1038/bjc.1998.261; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Seeds NW, 2003, J NEUROSCI, V23, P7368; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Tsirka SE, 1997, J NEUROSCI, V17, P543; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang N, 2004, J THROMB HAEMOST, V2, P785, DOI 10.1111/j.1538-7836.2004.00694.x; Wang YF, 1998, J NEUROSCI RES, V53, P443, DOI 10.1002/(SICI)1097-4547(19980815)53:4<443::AID-JNR6>3.3.CO;2-L; Zhang L, 2002, THROMB HAEMOSTASIS, V87, P493	41	19	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33125	33133		10.1074/jbc.M111.218693	http://dx.doi.org/10.1074/jbc.M111.218693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795689	hybrid, Green Published			2022-12-27	WOS:000294968800031
J	de Groot, T; van der Hagen, EAE; Verkaart, S; Boekhorst, VAMT; Bindels, RJM; Hoenderop, JGJ				de Groot, Theun; van der Hagen, Eline A. E.; Verkaart, Sjoerd; Boekhorst, Veronika A. M. Te; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Role of the Transient Receptor Potential Vanilloid 5 (TRPV5) Protein N Terminus in Channel Activity, Tetramerization, and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT; MOLECULAR DETERMINANTS; ENDOPLASMIC-RETICULUM; CATION CHANNELS; PLASMA-MEMBRANE; KINASE DOMAIN; CELL-SURFACE; TRPM8; COLD; ARCHITECTURE	The epithelial Ca2+ channel transient receptor potential vanilloid 5 (TRPV5) constitutes the apical entry site for active Ca2+ reabsorption in the kidney. The TRPV5 channel is a member of the TRP family of cation channels, which are composed of four subunits together forming a central pore. Regulation of channel activity is tightly controlled by the intracellular N and C termini. The TRPV5 C terminus regulates channel activity by various mechanisms, but knowledge regarding the role of the N terminus remains scarce. To study the role of the N terminus in TRPV5 regulation, we generated different N-terminal deletion constructs. We found that deletion of the first 32 residues did not affect TRPV5-mediated Ca-45(2+) uptake, whereas deletion up to residue 34 and 75 abolished channel function. Immunocytochemistry demonstrated that these mutant channels were retained in the endoplasmic reticulum and in contrast to wildtype TRPV5 did not reach the Golgi apparatus, explaining the lack of complex glycosylation of the mutants. A limited amount of mutant channels escaped the endoplasmic reticulum and reached the plasma membrane, as shown by cell surface biotinylation. These channels did not internalize, explaining the reduced but significant amount of these mutant channels at the plasma membrane. Wild-type TRPV5 channels, despite significant plasma membrane internalization, showed higher plasma membrane levels compared with the mutant channels. The assembly into tetramers was not affected by the N-terminal deletions. Thus, the N-terminal residues 34-75 are critical in the formation of a functional TRPV5 channel because the deletion mutants were present at the plasma membrane as tetramers, but lacked channel activity.	[de Groot, Theun; van der Hagen, Eline A. E.; Verkaart, Sjoerd; Boekhorst, Veronika A. M. Te; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Bindels, René JM/B-9824-2013; Groot, Theun/A-2596-2015; Hoenderop, Joost G.J./H-8047-2014; te Boekhorst, Veronika/C-5430-2017	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; te Boekhorst, Veronika/0000-0002-9473-5926	Dutch Kidney Foundation [C03.6017, C06.2170]; Netherlands Organization for Scientific Research [NWO-ALW 814.02.001, NWO 819.02.012, NWO-CW 700.55.302]; European Young Investigator Award	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Young Investigator Award	This work was supported by Dutch Kidney Foundation Grants C03.6017 and C06.2170 and The Netherlands Organization for Scientific Research Grants NWO-ALW 814.02.001, NWO 819.02.012, and NWO-CW 700.55.302.; Supported by an European Young Investigator Award.	Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gaudet Rachelle, 2007, P349; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x	40	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32132	32139		10.1074/jbc.M111.226878	http://dx.doi.org/10.1074/jbc.M111.226878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795703	Green Published, hybrid			2022-12-27	WOS:000294726800023
J	Kasiviswanathan, R; Copeland, WC				Kasiviswanathan, Rajesh; Copeland, William C.			Ribonucleotide Discrimination and Reverse Transcription by the Human Mitochondrial DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; ESCHERICHIA-COLI; RNA-POLYMERASE; SIDE-CHAINS; GAMMA; REPLICATION; MUTATIONS; DEPLETION; FIDELITY; PURIFICATION	During DNA synthesis, DNA polymerases must select against ribonucleotides, present at much higher levels compared with deoxyribonucleotides. Most DNA polymerases are equipped to exclude ribonucleotides from their active site through a bulky side chain residue that can sterically block the 2'-hydroxyl group of the ribose ring. However, many nuclear replicative and repair DNA polymerases incorporate ribonucleotides into DNA, suggesting that the exclusion mechanism is not perfect. In this study, we show that the human mitochondrial DNA polymerase gamma discriminates ribonucleotides efficiently but differentially based on the base identity. Whereas UTP is discriminated by 77,000-fold compared with dTTP, the discrimination drops to 1,100-fold for GTP versus dGTP. In addition, the efficiency of the enzyme was reduced 3-14-fold, depending on the identity of the incoming nucleotide, when it extended from a primer containing a 3'-terminal ribonucleotide. DNA polymerase gamma is also proficient in performing single-nucleotide reverse transcription reactions from both DNA and RNA primer terminus, although its bypass efficiency is significantly diminished with increasing stretches of ribonucleotides in template DNA. Furthermore, we show that the E895A mutant enzyme is compromised in its ability to discriminate ribonucleotides, mainly due to its defects in deoxyribonucleoside triphosphate binding, and is also a poor reverse transcriptase. The potential biochemical defects of a patient harboring a disease mutation in the same amino acid (E895G) are discussed.	[Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019; Kasiviswanathan, Rajesh/D-2744-2012	Copeland, William/0000-0002-0359-0953; 	National Institutes of Health, NIEHS [ES 065078, ES 065080]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065078, ZIAES065080, Z01ES065080, ZIAES065078] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIEHS, Grants ES 065078 and ES 065080.	Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Boyer PL, 2000, P NATL ACAD SCI USA, V97, P3056, DOI 10.1073/pnas.97.7.3056; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; COPELAND WC, 1993, J BIOL CHEM, V268, P11041; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; GALLO RC, 1970, NATURE, V228, P927, DOI 10.1038/228927a0; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; KORNBERG A, 1992, DNA REPLICATION, P54; Lee HR, 2007, J BIOL CHEM, V282, P31982, DOI 10.1074/jbc.M705392200; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; MOSBAUGH DW, 1988, NUCLEIC ACIDS RES, V16, P5645, DOI 10.1093/nar/16.12.5645; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9	44	52	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31490	31500		10.1074/jbc.M111.252460	http://dx.doi.org/10.1074/jbc.M111.252460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21778232	hybrid, Green Published			2022-12-27	WOS:000294487500044
J	Wilson, CM; Magnaudeix, A; Yardin, C; Terro, F				Wilson, Cornelia M.; Magnaudeix, Amandine; Yardin, Catherine; Terro, Faraj			DC2 and Keratinocyte-associated Protein 2 (KCP2), Subunits of the Oligosaccharyltransferase Complex, Are Regulators of the gamma-Secretase-directed Processing of Amyloid Precursor Protein (APP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOPHORIN-I; ALZHEIMERS-DISEASE; BETA-SECRETASE; MAMMALIAN OLIGOSACCHARYLTRANSFERASE; SIGNALING PATHWAY; PRESENILIN-1; CELLS; PEN-2; NOTCH; ENDOPROTEOLYSIS	The oligosaccharyltransferase complex catalyzes the transfer of oligosaccharide from a dolichol pyrophosphate donor en bloc onto a free asparagine residue of a newly synthesized nascent chain during the translocation in the endoplasmic reticulum lumen. The role of the less known oligosaccharyltransferase (OST) subunits, DC2 and KCP2, recently identified still remains to be determined. Here, we have studied DC2 and KCP2, and we have established that DC2 and KCP2 are substrate-specific, affecting amyloid precursor protein (APP), indicating that they are not core components required for N-glycosylation and OST activity per se. We show for the first time that DC2 and KCP2 depletion affects APP processing, leading to an accumulation of C-terminal fragments, both C99 and C83, and a reduction in full-length mature APP. This reduction in mature APP levels was not due to a block in secretion because the levels of sAPP alpha secreted into the media were unaffected. We discover that DC2 and KCP2 depletion affects only the gamma-secretase complex, resulting in a reduction of the PS1 active fragment blocking A beta production. Conversely, we show that the overexpression of DC2 and KCP2 causes an increase in the active gamma-secretase complex, particularly the N-terminal fragment of PS1 that is generated by endoproteolysis, leading to a stimulation of A beta production upon overexpression of DC2 and KCP2. Our findings reveal that components of the OST complex for the first time can interact with the gamma-secretase and affect the APP processing pathway.	[Wilson, Cornelia M.; Magnaudeix, Amandine; Yardin, Catherine; Terro, Faraj] Univ Limoges, Fac Med, Grp Neurobiol Cellulaire, Homeostasie Cellulaire & Pathol EA3842, F-87025 Limoges, France; [Wilson, Cornelia M.; Yardin, Catherine; Terro, Faraj] Hop Mere & Enfant, Lab Histol & Cytogenet, F-87042 Limoges, France	Universite de Limoges; CHU Limoges	Wilson, CM (corresponding author), Univ Limoges, Fac Med, Grp Neurobiol Cellulaire, Homeostasie Cellulaire & Pathol EA3842, 2 Rue Dr Raymond Marcland, F-87025 Limoges, France.	cornelia.wilson@unilim.fr	TERRO, FARAJ/O-8423-2016	TERRO, FARAJ/0000-0002-3655-3964; Wilson, Cornelia/0000-0001-6584-6179; Magnaudeix, Amandine/0000-0002-2806-1177	BQR Actions Internationales (Region Limousin)	BQR Actions Internationales (Region Limousin)	This project was supported by a BQR Actions Internationales (Region Limousin) (to C. M. W.).	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Busciglio J, 1997, J NEUROSCI, V17, P5101, DOI 10.1523/jneurosci.17-13-05101.1997; Campbell WA, 2002, BIOCHEMISTRY-US, V41, P3372, DOI 10.1021/bi015810h; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Greenfield JJA, 1999, J CELL SCI, V112, P1477; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holtzman DM, 1997, NAT MED, V3, P954, DOI 10.1038/nm0997-954; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wilson CM, 2005, J BIOL CHEM, V280, P4195, DOI 10.1074/jbc.M410329200; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wilson CM, 2010, METHODS MOL BIOL, V619, P389, DOI 10.1007/978-1-60327-412-8_23; Xie ZC, 2004, J BIOL CHEM, V279, P34130, DOI 10.1074/jbc.M401094200; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	55	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31080	31091		10.1074/jbc.M111.249748	http://dx.doi.org/10.1074/jbc.M111.249748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768116	Green Published, hybrid			2022-12-27	WOS:000294487500003
J	Laroui, H; Yan, YT; Narui, Y; Ingersoll, SA; Ayyadurai, S; Charania, MA; Zhou, F; Wang, BH; Salaita, K; Sitaraman, SV; Merlin, D				Laroui, Hamed; Yan, Yutao; Narui, Yoshie; Ingersoll, Sarah A.; Ayyadurai, Saravanan; Charania, Moiz A.; Zhou, Feimeng; Wang, Binghe; Salaita, Khalid; Sitaraman, Shanthi V.; Merlin, Didier			L-Ala-gamma-D-Glu-meso-diaminopimelic Acid (DAP) Interacts Directly with Leucine-rich Region Domain of Nucleotide-binding Oligomerization Domain 1, Increasing Phosphorylation Activity of Receptor-interacting Serine/Threonine-protein Kinase 2 and Its Interaction with Nucleotide-binding Oligomerization Domain 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; BACTERIAL TRIPEPTIDE FMLP; MACROMOLECULAR INTERACTIONS; MOLECULAR-INTERACTIONS; CROHNS-DISEASE; NOD1; PEPTIDOGLYCAN; RECOGNITION	The oligopeptide transporter PepT1 expressed in inflamed colonic epithelial cells transports small bacterial peptides, such as muramyl dipeptide (MDP) and L-Ala-gamma-D-Glu-meso-diaminopimelic acid (Tri-DAP) into cells. The innate immune system uses various proteins to sense pathogen-associated molecular patterns. Nucleotide-binding oligomerization domain (NOD)like receptors of which there are more than 20 related family members are present in the cytosol and recognize intracellular ligands. NOD proteins mediate NF-kappa B activation via receptor-interacting serine/threonine-protein kinase 2 (RICK or RIPK). The specific ligands for some NOD-like receptors have been identified. NOD type 1 (NOD1) is activated by peptides that contain a diaminophilic acid, such as the PepT1 substrate Tri-DAP. In other words, PepT1 transport activity plays an important role in controlling intracellular loading of ligands for NOD1 in turn determining the activation level of downstream inflammatory pathways. However, no direct interaction between Tri-DAP and NOD1 has been identified. In the present work, surface plasmon resonance and atomic force microscopy experiments showed direct binding between NOD1 and Tri-DAP with a K-d value of 34.5 mu M. In contrast, no significant binding was evident between muramyl dipeptide and NOD1. Furthermore, leucine-rich region (LRR)-truncated NOD1 did not interact with Tri-DAP, indicating that Tri-DAP interacts with the LRR domain of NOD1. Next, we examined binding between RICK and NOD1 proteins and found that such binding was significant with a K-d value of 4.13 mu M. However, NOD1/RICK binding was of higher affinity (K-d of 3.26 mu M) when NOD1 was prebound to Tri-DAP. Furthermore, RICK phosphorylation activity was increased when NOD was prebound to Tri-DAP. In conclusion, we have shown that Tri-DAP interacts directly with the LRR domain of NOD1 and consequently increases RICK/NOD1 association and RICK phosphorylation activity.	[Laroui, Hamed; Yan, Yutao; Ingersoll, Sarah A.; Ayyadurai, Saravanan; Charania, Moiz A.; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Narui, Yoshie; Salaita, Khalid] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Zhou, Feimeng] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA; [Wang, Binghe] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Emory University; California State University System; California State University Los Angeles; University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Laroui, H (corresponding author), Emory Univ, Dept Med, Div Digest Dis, 615 Michael St, Atlanta, GA 30322 USA.	hlaroui@emory.edu	Wang, Binghe/D-4257-2009; salaita, khalid/C-4414-2008	Wang, Binghe/0000-0002-2200-5270; 	National Institutes of Health [RO1-DK-071594]; NIDDK [RO1-DK-55850]; California State University, Los Angeles [P20-MD001824-01]; NINDS [SC1MS070155-01]; Department of Veterans Affairs; Crohn's and Colitis Foundation of America; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084987, R01DK071594, R01DK055850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California State University, Los Angeles; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); Crohn's and Colitis Foundation of America; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK-071594 and RO1-DK-55850 from the NIDDK (to D. M.) and Grant P20-MD001824-01 from the Research Infrastructure in Minority Institutions Program at California State University, Los Angeles and Grant SC1MS070155-01 from the NINDS (to F. Z.). This work was also supported by the Department of Veterans Affairs.; Recipient of a senior research award from the Crohn's and Colitis Foundation of America.	Amano A, 1999, INFECT IMMUN, V67, P2399, DOI 10.1128/IAI.67.5.2399-2405.1999; Buyse M, 2003, AM J PATHOL, V163, P1969, DOI 10.1016/S0002-9440(10)63555-9; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Charrier L, 2006, LAB INVEST, V86, P490, DOI 10.1038/labinvest.3700413; Dalmasso G, 2010, AM J PHYSIOL-GASTR L, V299, pG687, DOI 10.1152/ajpgi.00527.2009; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Enoksson M, 2011, J INNATE IMMUN, V3, P142, DOI 10.1159/000321933; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Lahiri J, 1999, LANGMUIR, V15, P7186, DOI 10.1021/la9815650; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Merlin D, 1998, J CLIN INVEST, V102, P2011, DOI 10.1172/JCI4179; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; O'Shannessy D J, 1994, Curr Opin Biotechnol, V5, P65, DOI 10.1016/S0958-1669(05)80072-2; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; OSHANNESSY DJ, 1994, METHOD ENZYMOL, V240, P323; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Torreri Paola, 2005, Ann Ist Super Sanita, V41, P437; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; van Heel DA, 2006, EUR J IMMUNOL, V36, P1629, DOI 10.1002/eji.200535636; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Watanabe T, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/476482; Yao X, 2006, ANAL BIOCHEM, V354, P220, DOI 10.1016/j.ab.2006.04.011; Zhu R, 2009, CHEMPHYSCHEM, V10, P1478, DOI 10.1002/cphc.200900245; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	38	69	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31003	31013		10.1074/jbc.M111.257501	http://dx.doi.org/10.1074/jbc.M111.257501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757725	Green Published, hybrid			2022-12-27	WOS:000294283600078
J	Fukushima, M; Villar, J; Tsai-Morris, CH; Dufau, ML				Fukushima, Masato; Villar, Joaquin; Tsai-Morris, Chon-Hwa; Dufau, Maria L.			Gonadotropin-regulated Testicular RNA Helicase (GRTH/DDX25), a Negative Regulator of Luteinizing/Chorionic Gonadotropin Hormone-induced Steroidogenesis in Leydig Cells CENTRAL ROLE OF STEROIDOGENIC ACUTE REGULATORY PROTEIN (StAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED STEROIDOGENESIS; CHOLESTEROL; TRANSLATION; MODULATION	Gonadotropin-regulated testicular RNA helicase (GRTH/DDX25) is a testis-specific gonadotropin-regulated RNA helicase that is present in Leydig cells (LCs) and germ cells and is essential for spermatid development and completion of spermatogenesis. Normal basal levels of testosterone in serum and LCs were observed in GRTH null (GRTH(-/-)) mice. However, testosterone production was enhanced in LCs of GRTH(-/-) mice compared with WT mice by both in vivo and in vitro human chorionic gonadotropin stimulation. LCs of GRTH(-/-) mice had swollen mitochondria with a significantly increased cholesterol content in the inner mitochondrial membrane. Basal protein levels of SREBP2, HMG-CoAreductase, and steroidogenic acute regulatory protein (StAR; a protein that transports cholesterol to the inner mitochondrial membrane) were markedly increased in LCs of GRTH(-/-) mice compared with WT mice. Gonadotropin stimulation caused an increase in StAR mRNA levels and protein expression inGRTH(-/-) mice versus WT mice, with no further increase in SREBP2 and down-regulation of HMG-CoA reductase protein. The half-life of StAR mRNA was significantly increased in GRTH(-/-) mice. Moreover, association of StAR mRNA with GRTH protein was observed in WT mice. Human chorionic gonadotropin increased GRTH gene expression and its associated StAR protein at cytoplasmic sites. Taken together, these findings indicate that, through its negative role in StAR message stability, GRTH regulates cholesterol availability at the mitochondrial level. The finding of an inhibitory action of GRTH associated with gonadotropin-mediated steroidogenesis has provided insights into a novel negative autocrine molecular control mechanism of this helicase in the regulation of steroid production in the male.	[Fukushima, Masato; Villar, Joaquin; Tsai-Morris, Chon-Hwa; Dufau, Maria L.] Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A-36, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov		Tsai Morris, Chon Hwa/0000-0002-8113-0979	NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the NICHD Intramural Research Program, National Institutes of Health.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; AQUILANO DR, 1984, ENDOCRINOLOGY, V114, P499, DOI 10.1210/endo-114-2-499; Barbar E, 2009, MOL CELL ENDOCRINOL, V300, P89, DOI 10.1016/j.mce.2008.12.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHARREAU EH, 1981, J BIOL CHEM, V256, P2719; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Dyson MT, 2008, BIOL REPROD, V78, P267, DOI 10.1095/biolreprod.107.064238; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; Haelens A, 1999, MOL CELL ENDOCRINOL, V153, P91, DOI 10.1016/S0303-7207(99)00079-9; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; Mascaro C, 2000, BIOCHEM J, V350, P785, DOI 10.1042/0264-6021:3500785; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Sato H, 2010, BBA-MOL CELL RES, V1803, P534, DOI 10.1016/j.bbamcr.2010.02.004; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Tang PZ, 1998, ENDOCRINOLOGY, V139, P4496, DOI 10.1210/en.139.11.4496; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tsai-Morris CH, 2004, GENE, V331, P83, DOI 10.1016/j.gene.2004.02.004; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsai-Morris CH, 2010, J ANDROL, V31, P45, DOI 10.2164/jandrol.109.008219; TSAIMORRIS CH, 1985, ENDOCRINOLOGY, V116, P31, DOI 10.1210/endo-116-1-31; Villar J, 2010, FASEB J, V24	23	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29932	29940		10.1074/jbc.M111.236083	http://dx.doi.org/10.1074/jbc.M111.236083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719703	hybrid, Green Published			2022-12-27	WOS:000294046600052
J	Keber, R; Motaln, H; Wagner, KD; Debeljak, N; Rassoulzadegan, M; Acimovic, J; Rozman, D; Horvat, S				Keber, Rok; Motaln, Helena; Wagner, Kay D.; Debeljak, Natasa; Rassoulzadegan, Minoo; Acimovic, Jure; Rozman, Damjana; Horvat, Simon			Mouse Knockout of the Cholesterogenic Cytochrome P450 Lanosterol 14 alpha-Demethylase (Cyp51) Resembles Antley-Bixler Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSOR WT1; HMG-COA REDUCTASE; EMBRYONIC LETHALITY; CORONARY VASCULOGENESIS; TARGETED DISRUPTION; P450 OXIDOREDUCTASE; GENE-EXPRESSION; RXR-ALPHA; MICE; RECEPTOR	Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. In some ABS patients, reduced activity of the cholesterogenic cytochrome P450 CYP51A1, an ortholog of the mouse CYP51, and accumulation of lanosterol and 24,25-dihydrolanosterol has been reported, but the role of CYP51A1 in the ABS etiology has remained obscure. To test whether Cyp51 could be involved in generating an ABS-like phenotype, a mouse knock-out model was developed that exhibited several prenatal ABS-like features leading to lethality at embryonic day 15. Cyp51(-/-) mice had no functional Cyp51 mRNA and no immunodetectable CYP51 protein. The two CYP51 enzyme substrates (lanosterol and 24,25-dihydrolanosterol) were markedly accumulated. Cholesterol precursors downstream of the CYP51 enzymatic step were not detected, indicating that the targeting in this study blocked de novo cholesterol synthesis. This was reflected in the up-regulation of 10 cholesterol synthesis genes, with the exception of 7-dehydrocholesterol reductase. Lethality was ascribed to heart failure due to hypoplasia, ventricle septum, and epicardial and vasculogenesis defects, suggesting that Cyp51 deficiency was involved in heart development and coronary vessel formation. As the most likely downstream molecular mechanisms, alterations were identified in the sonic hedgehog and retinoic acid signaling pathways. Cyp51 knock-out mice provide evidence that Cyp51 is essential for embryogenesis and present a potential animal model for studying ABS syndrome in humans.	[Keber, Rok; Motaln, Helena; Horvat, Simon] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Ljubljana 1000, Slovenia; [Debeljak, Natasa; Acimovic, Jure; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Inst Biochem, Ljubljana 1000, Slovenia; [Motaln, Helena] Natl Inst Biol, Dept Genet Toxicol Canc Biol, Ljubljana 1000, Slovenia; [Horvat, Simon] Natl Inst Chem, Ljubljana 1000, Slovenia; [Wagner, Kay D.] INSERM, U907, Sophia Antipolis, France; [Wagner, Kay D.; Rassoulzadegan, Minoo] Univ Nice, Sophia Antipolis, France; [Rassoulzadegan, Minoo] Fac Med Nice, INSERM, Ctr Biochim, U636, F-06034 Nice, France	University of Ljubljana; University of Ljubljana; National Institute of Biology - Slovenia; National Institute of Chemistry - Slovenia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Horvat, S (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Groblje 3, Domzale 1230, Slovenia.	simon.horvat@bf.uni-lj.si	Motaln, Helena/AAF-3489-2019; Motaln, Helena/AAD-1507-2022; Rassoulzadegan, Minoo/O-7939-2016; Wagner, Kay-Dietrich/E-6119-2016	Motaln, Helena/0000-0002-0646-7934; Wagner, Kay-Dietrich/0000-0001-5483-7760; Rozman, Damjana/0000-0002-6501-2163; Debeljak, Natasa/0000-0003-1294-292X	Association pour la Recherche sur le Cancer; Fondation Coeur et Arteres; Slovenian Research Agency [P4-0220, P4-0104, J1-9438, J2-2197]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Coeur et Arteres; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Association pour la Recherche sur le Cancer and Fondation Coeur et Arteres (to K. D. W.), and Slovenian Research Agency for core funding program P4-0220 and project 878 and project Syntol (to S. H.), program P4-0104 and projects J1-9438 and J2-2197 (to D. R.), a post-doctoral fellowship (to H. M.), and young researcher Ph.D. scholarship (to R. K.).	Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Antley R, 1975, Birth Defects Orig Artic Ser, V11, P397; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; BINNS WAYNE, 1959, JOUR AMER VET MED ASSOC, V134, P180; Bischoff SR, 2009, BIOL REPROD, V81, P906, DOI 10.1095/biolreprod.109.078139; Cragun DL, 2004, AM J MED GENET A, V129A, P1, DOI 10.1002/ajmg.a.30170; Cunningham D, 2005, J LIPID RES, V46, P1150, DOI 10.1194/jlr.M400462-JLR200; Debeljak N, 2000, ARCH BIOCHEM BIOPHYS, V379, P37, DOI 10.1006/abbi.2000.1859; Fakheri RJ, 2011, STEROIDS, V76, P211, DOI 10.1016/j.steroids.2010.10.003; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Gibbons GF, 2002, LIPIDS, V37, P1163, DOI 10.1007/s11745-002-1016-x; Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Hyett JA, 2002, PRENATAL DIAG, V22, P864, DOI 10.1002/pd.413; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Jiang XS, 2010, MOL CELL PROTEOMICS, V9, P1461, DOI 10.1074/mcp.M900548-MCP200; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kastner P, 1997, DEVELOPMENT, V124, P4749; KEMPEN HJ, 1987, BIOCHEM PHARMACOL, V36, P1245, DOI 10.1016/0006-2952(87)90077-3; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; Kim JH, 2001, J BIOL CHEM, V276, P18153, DOI 10.1074/jbc.M101661200; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; LEE BE, 1992, PEDIATR INFECT DIS J, V11, P1062, DOI 10.1097/00006454-199211120-00017; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; McGlaughlin KL, 2010, J CRANIOFAC SURG, V21, P1560, DOI 10.1097/SCS.0b013e3181ec6afe; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; Mirza R, 2009, AM J DERMATOPATH, V31, P446, DOI 10.1097/DAD.0b013e318196f10c; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; Rezen T, 2004, J MOL EVOL, V59, P51, DOI 10.1007/s00239-004-2603-1; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Shehu A, 2008, MOL ENDOCRINOL, V22, P2268, DOI 10.1210/me.2008-0165; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SIMMONS DL, 1985, J BIOL CHEM, V260, P515; Stromstedt M, 1996, ARCH BIOCHEM BIOPHYS, V329, P73, DOI 10.1006/abbi.1996.0193; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tanaka M, 1999, DEVELOPMENT, V126, P1439; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Walker DL, 2005, DEV BIOL, V284, P479, DOI 10.1016/j.ydbio.2005.06.004; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776	62	67	68	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29086	29097		10.1074/jbc.M111.253245	http://dx.doi.org/10.1074/jbc.M111.253245			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705796	Green Published, hybrid			2022-12-27	WOS:000293837000045
J	Hannan, S; Wilkins, ME; Dehghani-Tafti, E; Thomas, P; Baddeley, SM; Smart, TG				Hannan, Saad; Wilkins, Megan E.; Dehghani-Tafti, Ebrahim; Thomas, Philip; Baddeley, Stuart M.; Smart, Trevor G.			gamma-Aminobutyric Acid Type B (GABA(B)) Receptor Internalization Is Regulated by the R2 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE STABILITY; LYSOSOMAL DEGRADATION; ALPHA-BUNGAROTOXIN; GB2 SUBUNITS; BINDING; HETERODIMERIZATION; PATHWAY; PHOSPHORYLATION; TRAFFICKING; ENDOCYTOSIS	gamma-Aminobutyric acid type B (GABA(B)) receptors are important for slow synaptic inhibition in the CNS. The efficacy of inhibition is directly related to the stability of cell surface receptors. For GABA(B) receptors, heterodimerization between R1 and R2 subunits is critical for cell surface expression and signaling, but how this determines the rate and extent of receptor internalization is unknown. Here, we insert a high affinity alpha-bungarotoxin binding site into the N terminus of the R2 subunit and reveal its dominant role in regulating the internalization of GABA(B) receptors in live cells. To simultaneously study R1a and R2 trafficking, a new alpha-bungarotoxin binding site-labeling technique was used, allowing alpha-bungarotoxin conjugated to different fluorophores to selectively label R1a and R2 subunits. This approach demonstrated that R1a and R2 are internalized as dimers. In heterologous expression systems and neurons, the rates and extents of internalization for R1aR2 heteromers and R2 homomers are similar, suggesting a regulatory role for R2 in determining cell surface receptor stability. The fast internalization rate of R1a, which has been engineered to exit the endoplasmic reticulum, was slowed to that of R2 by truncating the R1a C-terminal tail or by removing a dileucine motif in its coiled-coil domain. Slowing the rate of internalization by co-assembly with R2 represents a novel role for GPCR heterodimerization whereby R2 subunits, via their C terminus coiled-coil domain, mask a dileucine motif on R1a subunits to determine the surface stability of the GABA(B) receptor.	[Hannan, Saad; Wilkins, Megan E.; Dehghani-Tafti, Ebrahim; Thomas, Philip; Smart, Trevor G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Hannan, Saad; Baddeley, Stuart M.] GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England	University of London; University College London; GlaxoSmithKline	Smart, TG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk	Hannan, Saad/AAX-6478-2020	Hannan, Saad/0000-0003-4594-0808; Wilkins, Megan/0000-0003-0150-4457	Medical Research Council; Biotechnology and Biological Sciences Research Council-GlaxoSmithKline; MRC [G0601529] Funding Source: UKRI; Medical Research Council [G0601529] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council-GlaxoSmithKline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and by a Biotechnology and Biological Sciences Research Council-GlaxoSmithKline studentship.	Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BOWERY N, 1989, TRENDS PHARMACOL SCI, V10, P401, DOI 10.1016/0165-6147(89)90188-0; Bowery NG, 2000, J PHARMACOL EXP THER, V292, P2; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Donnelly SR, 1999, HUM MOL GENET, V8, P1723, DOI 10.1093/hmg/8.9.1723; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Enna SJ, 2004, BIOCHEM PHARMACOL, V68, P1541, DOI 10.1016/j.bcp.2004.06.037; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; MERESSE S, 1995, J CELL SCI, V108, P3349; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pooler AM, 2009, EUR J NEUROSCI, V29, P869, DOI 10.1111/j.1460-9568.2009.06636.x; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Stenmark H, 2001, GENOME BIOL, V2; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	43	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24324	24335		10.1074/jbc.M110.220814	http://dx.doi.org/10.1074/jbc.M110.220814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21724853	Green Published, Bronze			2022-12-27	WOS:000292294900073
J	Nordstrom, T; Movert, E; Olin, AI; Ali, SR; Nizet, V; Varki, A; Areschoug, T				Nordstrom, Therese; Movert, Elin; Olin, Anders I.; Ali, Syed R.; Nizet, Victor; Varki, Ajit; Areschoug, Thomas			Human Siglec-5 Inhibitory Receptor and Immunoglobulin A (IgA) Have Separate Binding Sites in Streptococcal beta Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCI; PROLINE-RICH REGION; PHOSPHATASES SHP-1; SURFACE-PROTEINS; IDENTIFICATION; SEQUENCE; MOTIF; RECOGNITION; MONOCYTES; STRAINS	Sialic acid-binding immunoglobulin-like lectins (Siglecs) are receptors believed to be important for regulation of cellular activation and inflammation. Several pathogenic microbes bind specific Siglecs via sialic acid-containing structures at the microbial surface, interactions that may result in modulation of host responses. Recently, it was shown that the group B Streptococcus (GBS) binds to human Siglec-5 (hSiglec-5), an inhibitory receptor expressed on macrophages and neutrophils, via the IgA-binding surface beta protein, providing the first example of a protein/protein interaction between a pathogenic microbe and a Siglec. Here we show that the hSiglec-5-binding part of beta resides in the N-terminal half of the protein, which also harbors the previously determined IgA-binding region. We constructed bacterial mutants expressing variants of the beta protein with non-overlapping deletions in the N-terminal half of the protein. Using these mutants and recombinant beta fragments, we showed that the hSiglec-5-binding site is located in the most N-terminal part of beta (B6N region; amino acids 1-152) and that the hSiglec-5-and IgA-binding domains in beta are completely separate. We showed with BIAcore (TM) analysis that tandem variants of the hSiglec-5-and IgA-binding domains bind to their respective ligands with high affinity. Finally, we showed that the B6N region, but not the IgA-binding region of beta, triggers recruitment of the tyrosine phosphatase SHP-2 to hSiglec-5 in U937 monocytes. Taken together, we have identified and isolated the first microbial non-sialic acid Siglec-binding region that can be used as a tool in studies of the beta/hSiglec-5 interaction.	[Nordstrom, Therese; Movert, Elin; Areschoug, Thomas] Lund Univ, Dept Lab Med, Div Med Microbiol, S-22362 Lund, Sweden; [Olin, Anders I.] Lund Univ, Dept Clin Sci, Div Infect Med, S-22184 Lund, Sweden; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ali, Syed R.; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ali, Syed R.; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ali, Syed R.; Nizet, Victor; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Lund University; Lund University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Areschoug, T (corresponding author), Lund Univ, Dept Lab Med, Div Med Microbiol, Solvegatan 23, S-22362 Lund, Sweden.	Thomas.areschoug@med.lu.se	Ali, Syed/M-7418-2013; Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Royal Physiographic Society; Swedish Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	Royal Physiographic Society; Swedish Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Royal Physiographic Society, the Swedish Government Funding for Clinical Research (ALF), and the Foundations Crafoord, Ake Wibergs, Cornell, Zoegas, Ollie och Elof Ericsson, Osterlund, Goljes, and Hierta.	Ando M, 2008, BIOCHEM BIOPH RES CO, V369, P878, DOI 10.1016/j.bbrc.2008.02.111; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Areschoug T, 2002, J BACTERIOL, V184, P6376, DOI 10.1128/JB.184.22.6376-6393.2002; Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Avril T, 2005, J BIOL CHEM, V280, P19843, DOI 10.1074/jbc.M502041200; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; BRADY LJ, 1989, INFECT IMMUN, V57, P1573, DOI 10.1128/IAI.57.5.1573-1581.1989; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Edwards MS, 2011, INFECT DIS FETUS NEW, P419, DOI DOI 10.1016/B978-1-4160-6400-8.00012-2; HEDEN LO, 1991, EUR J IMMUNOL, V21, P1481, DOI 10.1002/eji.1830210623; JERLSTROM PG, 1991, MOL MICROBIOL, V5, P843, DOI 10.1111/j.1365-2958.1991.tb00757.x; Jerlstrom PG, 1996, INFECT IMMUN, V64, P2787; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Larsson C, 1996, INFECT IMMUN, V64, P3518, DOI 10.1128/IAI.64.9.3518-3523.1996; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; LINDAHL G, 1990, EUR J IMMUNOL, V20, P2241, DOI 10.1002/eji.1830201013; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; Paul SP, 2000, BLOOD, V96, P483; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; RUSSELLJONES GJ, 1984, J EXP MED, V160, P1467, DOI 10.1084/jem.160.5.1467; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	35	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33981	33991		10.1074/jbc.M111.251728	http://dx.doi.org/10.1074/jbc.M111.251728			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795693	Green Published, hybrid			2022-12-27	WOS:000295159200030
J	Alvira, D; Naughton, R; Bhatt, L; Tedesco, S; Landry, WD; Cotter, TG				Alvira, Daniel; Naughton, Ruth; Bhatt, Lavinia; Tedesco, Sara; Landry, William D.; Cotter, Thomas G.			Inhibition of Protein-tyrosine Phosphatase 1B (PTP1B) Mediates Ubiquitination and Degradation of Bcr-Abl Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; HUMAN BREAST-CANCER; MOLECULAR-BIOLOGY; EXPRESSION; TRANSFORMATION; KINASES; FIBROBLASTS; RECEPTOR; CELLS; SRC	Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized at the molecular level by the expression of Bcr-Abl, a chimeric protein with deregulated tyrosine kinase activity. The protein-tyrosine phosphatase 1B (PTP1B) is up-regulated in Bcr-Abl-expressing cells, suggesting a regulatory link between the two proteins. To investigate the interplay between these two proteins, we inhibited the activity of PTP1B in Bcr-Abl-expressing TonB.210 cells by either pharmacological or siRNA means and examined the effects of such inhibition on Bcr-Abl expression and function. Herein we describe a novel mechanism by which the phosphatase activity of PTP1B is required for Bcr-Abl protein stability. Inhibition of PTP1B elicits tyrosine phosphorylation of Bcr-Abl that triggers the degradation of Bcr-Abl through ubiquitination via the lysosomal pathway. The degradation of Bcr-Abl consequently inhibits tyrosine phosphorylation of Bcr-Abl substrates and the downstream production of intracellular reactive oxygen species. Furthermore, PTP1B inhibition reduces cell viability and the IC50 of the Bcr-Abl inhibitor imatinib mesylate. Degradation of Bcr-Abl via PTP1B inhibition is also observed in human CML cell lines K562 and LAMA-84. These results suggest that inhibition of PTP1B may be a useful strategy to explore in the development of novel therapeutic agents for the treatment of CML, particularly because host drugs currently used in CML such as imatinib focus on inhibiting the kinase activity of Bcr-Abl.	[Alvira, Daniel; Naughton, Ruth; Bhatt, Lavinia; Tedesco, Sara; Landry, William D.; Cotter, Thomas G.] Univ Coll Cork, Biosci Res Inst, Dept Biochem, Tumour Biol Lab, Cork, Ireland	University College Cork	Cotter, TG (corresponding author), Univ Coll Cork, Biosci Res Inst, Dept Biochem, Tumour Biol Lab, Cork, Ireland.	t.cotter@ucc.ie		Cotter, Thomas/0000-0003-4626-5613	Health Research Board of Ireland; Children's Leukemia Research Project; Irish Cancer Society	Health Research Board of Ireland; Children's Leukemia Research Project; Irish Cancer Society	This work was supported by grants from the Health Research Board of Ireland, the Children's Leukemia Research Project, and the Irish Cancer Society.	Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bhatt L, 2007, BIOCHEM BIOPH RES CO, V359, P277, DOI 10.1016/j.bbrc.2007.05.100; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BROWNSHIMER S, 1992, CANCER RES, V52, P478; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen J, 2007, BLOOD, V109, P778, DOI 10.1182/blood-2006-04-019141; Dadke S, 2003, J BIOL CHEM, V278, P40607, DOI 10.1074/jbc.M306772200; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khoudoli G.A., 2004, PROTEOME SCI, V2, P6, DOI DOI 10.1186/1477-5956-2-6; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Melo JV, 1996, LEUKEMIA, V10, P751; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Nanney LB, 1997, J CUTAN PATHOL, V24, P521, DOI 10.1111/j.1600-0560.1997.tb01456.x; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Perego RA, 2000, EUR J CANCER, V36, P1395, DOI 10.1016/S0959-8049(00)00128-3; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tedesco S, 2010, COMP BIOCHEM PHYS C, V151, P167, DOI 10.1016/j.cbpc.2009.10.002; Warabi M, 2000, EXP MOL PATHOL, V68, P187, DOI 10.1006/exmp.2000.2303; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401	42	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32313	32323		10.1074/jbc.M111.249060	http://dx.doi.org/10.1074/jbc.M111.249060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795709	hybrid, Green Published			2022-12-27	WOS:000294726800041
J	Cho, SH; Sun, BG; Zhou, YG; Kauppinen, TM; Halabisky, B; Wes, P; Ransohoff, RM; Gan, L				Cho, Seo-Hyun; Sun, Binggui; Zhou, Yungui; Kauppinen, Tiina M.; Halabisky, Brian; Wes, Paul; Ransohoff, Richard M.; Gan, Li			CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; AMYLOID-BETA-PEPTIDE; CHEMOKINE RECEPTORS; RECOGNITION MEMORY; TRANSGENIC MICE; DENTATE GYRUS; SYNAPSE LOSS; INTERLEUKIN-6; INFLAMMATION; DEPOSITION	Aberrant microglial activation has been proposed to contribute to the cognitive decline in Alzheimer disease (AD), but the underlying molecular mechanisms remain enigmatic. Fractalkine signaling, a pathway mediating the communication between microglia and neurons, is deficient in AD brains and down-regulated by amyloid-beta. Although fractalkine receptor (CX3CR1) on microglia was found to regulate plaque load, no functional effects have been reported. Our study demonstrates that CX3CR1 deficiency worsens the AD-related neuronal and behavioral deficits. The effects were associated with cytokine production but not with plaque deposition. Ablation of CX3CR1 in mice overexpressing human amyloid precursor protein enhanced Tau pathology and exacerbated the depletion of calbindin in the dentate gyrus. The levels of calbindin in the dentate gyrus correlated negatively with those of tumor necrosis factor alpha and interleukin 6, suggesting neurotoxic effects of inflammatory factors. Functionally, removing CX3CR1 in human amyloid precursor protein mice worsened the memory retention in passive avoidance and novel object recognition tests, and their memory loss in the novel object recognition test is associated with high levels of interleukin 6. Our findings identify CX3CR1 as a key microglial pathway in protecting against AD-related cognitive deficits that are associated with aberrant microglial activation and elevated inflammatory cytokines.	[Cho, Seo-Hyun; Sun, Binggui; Zhou, Yungui; Halabisky, Brian; Gan, Li] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cho, Seo-Hyun; Sun, Binggui; Kauppinen, Tiina M.; Halabisky, Brian; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Wes, Paul] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Ransohoff, Richard M.] Cleveland Clin Fdn, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Bristol-Myers Squibb; Cleveland Clinic Foundation	Gan, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Kauppinen, Tiina/I-1009-2019; Sun, Binggui/J-9028-2016	Sun, Binggui/0000-0002-0386-6569; Kauppinen, Tiina/0000-0001-7219-9862; Wes, Paul/0000-0002-8903-3102	National Institute on Aging [1R01AG030207]; Consortium for Frontotemporal Dementia Research; S. D. Bechtel Jr. Foundation; National Institutes of Health [NCRR CO6 RRO18928]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030207] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Consortium for Frontotemporal Dementia Research; S. D. Bechtel Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from National Institute on Aging 1R01AG030207, Consortium for Frontotemporal Dementia Research, and S. D. Bechtel Jr. Foundation (to L. G.).; We thank Drs. Lennart Mucke and Israel Charo for insightful discussions, Dr. Nino Devidze and the Gladstone/University of California, San Francisco (UCSF) Behavioral Core to help with behavioral analyses, Dr. Dan Littman from New York University for CX3CR1 null mice, Kaitlyn Ho for advice on measuring A beta dimers, Dr. Katerina Mancevska from New York Brain Bank at Columbia University, Dr. Yong Shen from Sun Health Institute (now Banner Health), Dr. Eliezer Masliah from UCSD for human brain samples, Gary Howard for editorial review, and Kelley Nelson for administrative assistance. The J. David Gladstone Institutes were supported by National Institutes of Health Grant NCRR CO6 RRO18928.	Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim HC, 2003, NEUROSCIENCE, V119, P399, DOI 10.1016/S0306-4522(02)00993-4; Kitazawa M, 2004, ANN NY ACAD SCI, V1035, P85, DOI 10.1196/annals.1332.006; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pittenger C, 2006, J NEUROSCI, V26, P2808, DOI 10.1523/JNEUROSCI.5406-05.2006; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	49	180	185	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32713	32722		10.1074/jbc.M111.254268	http://dx.doi.org/10.1074/jbc.M111.254268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771791	hybrid, Green Published			2022-12-27	WOS:000294726800080
J	Hammel, M; Rey, M; Yu, YP; Mani, RS; Classen, S; Liu, M; Pique, ME; Fang, SJ; Mahaney, BL; Weinfeld, M; Schriemer, DC; Lees-Miller, SP; Tainer, JA				Hammel, Michal; Rey, Martial; Yu, Yaping; Mani, Rajam S.; Classen, Scott; Liu, Mona; Pique, Michael E.; Fang, Shujuan; Mahaney, Brandi L.; Weinfeld, Michael; Schriemer, David C.; Lees-Miller, Susan P.; Tainer, John A.			XRCC4 Protein Interactions with XRCC4-like Factor (XLF) Create an Extended Grooved Scaffold for DNA Ligation and Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-JOINING FACTOR; CRYSTAL-STRUCTURE; LIGASE-IV; STRUCTURAL-ANALYSES; PROMOTES; REVEALS; BASE; KU; XLF/CERNUNNOS; COMPUTATION	The XRCC4-like factor (XLF)-XRCC4 complex is essential for nonhomologous end joining, the major repair pathway for DNA double strand breaks in human cells. Yet, how XLF binds XRCC4 and impacts nonhomologous end joining functions has been enigmatic. Here, we report the XLF-XRCC4 complex crystal structure in combination with biophysical and mutational analyses to define the XLF-XRCC4 interactions. Crystal and solution structures plus mutations characterize alternating XRCC4 and XLF head domain interfaces forming parallel superhelical filaments. XLF Leu-115 ("Leu-lock") inserts into a hydrophobic pocket formed by XRCC4 Met-59, Met-61, Lys-65, Lys-99, Phe-106, and Leu-108 in synergy with pseudo-symmetric beta-zipper hydrogen bonds to drive specificity. XLF C terminus and DNA enhance parallel filament formation. Super-helical XLF-XRCC4 filaments form a positively charged channel to bind DNA and align ends for efficient ligation. Collective results reveal how human XLF and XRCC4 interact to bind DNA, suggest consequences of patient mutations, and support a unified molecular mechanism for XLF-XRCC4 stimulation of DNA ligation.	[Hammel, Michal; Classen, Scott; Liu, Mona] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Rey, Martial; Yu, Yaping; Fang, Shujuan; Mahaney, Brandi L.; Schriemer, David C.; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Rey, Martial; Yu, Yaping; Fang, Shujuan; Mahaney, Brandi L.; Schriemer, David C.; Lees-Miller, Susan P.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Mani, Rajam S.; Weinfeld, Michael] Univ Alberta, Dept Oncol, Edmonton, AB T6G IZ2, Canada; [Mani, Rajam S.; Weinfeld, Michael] Cross Canc Inst, Edmonton, AB T6G IZ2, Canada; [Pique, Michael E.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Calgary; University of Calgary; University of Alberta; University of Alberta; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hammel, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	mhammel@lbl.gov; leesmill@ucalgary.ca; JATainer@LBL.gov	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020	Tainer, John/0000-0003-1659-2429; Lees-Miller, Susan/0000-0001-5809-2516; Hammel, Michal/0000-0002-5610-9289	National Institutes of Health [P01 CA92584]; Canadian Institutes of Health Research [69139]; Alberta Cancer Foundation [23817]; United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA92584 (Structural Cell Biology of DNA Repair Machines) (to J. A. T. and S. P. L.-M.). This work was also supported by Grant 69139 from the Canadian Institutes of Health Research and Grant 23817 from Alberta Cancer Foundation (to S. P. L.-M. and M. W.).; We thank the Berkeley Laboratory Advanced Light Source, SIBYLS beamline (BL 12.3.1) staff; Dr. Robert Rambo for helpful advice; Dr. Aaron Goodarzi for comments on the manuscript; James Holton and George Meigs at beamline 8.3.1 for aiding SAXS and PX data collection; and Wayne Moffat (Department of Chemistry, University of Alberta) for CD analysis. SIBYLS beamline efforts to combine SAXS and crystallography at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported in part by United States Department of Energy Program Integrated Diffraction Analysis Technologies under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Classen S, 2010, J SYNCHROTRON RADIAT, V17, P774, DOI 10.1107/S0909049510028566; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Malivert L, 2010, J BIOL CHEM, V285, P26475, DOI 10.1074/jbc.M110.138156; Malivert L, 2009, MOL CELL BIOL, V29, P1116, DOI 10.1128/MCB.01521-08; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015; Rambo RP, 2010, RNA, V16, P638, DOI 10.1261/rna.1946310; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yano K, 2011, FEBS LETT, V585, P841, DOI 10.1016/j.febslet.2011.02.020; Yu YP, 2008, DNA REPAIR, V7, P1680, DOI 10.1016/j.dnarep.2008.06.015	51	123	127	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32638	32650		10.1074/jbc.M111.272641	http://dx.doi.org/10.1074/jbc.M111.272641			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775435	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000294726800073
J	Kirkpatrick, CL; Wiederkehr, A; Baquie, M; Akhmedov, D; Wang, HY; Gauthier, BR; Akerman, I; Ishihara, H; Ferrer, J; Wollheim, CB				Kirkpatrick, Clare L.; Wiederkehr, Andreas; Baquie, Mathurin; Akhmedov, Dmitry; Wang, Haiyan; Gauthier, Benoit R.; Akerman, Ildem; Ishihara, Hisamitsu; Ferrer, Jorge; Wollheim, Claes B.			Hepatic Nuclear Factor 1 alpha (HNF1 alpha) Dysfunction Down-regulates X-box-binding Protein 1 (XBP1) and Sensitizes beta-Cells to Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; DEFECTIVE INSULIN-SECRETION; TRANSCRIPTION FACTOR; MITOCHONDRIAL DYSFUNCTION; MESSENGER-RNA; ER STRESS; TARGETED EXPRESSION; PANCREATIC-ISLETS; INS-1 CELLS; GENE	Correct endoplasmic reticulum (ER) function is critical for the health of secretory cells, such as the pancreatic beta-cell, and ER stress is often a contributory factor to beta-cell death in type 2 diabetes. We have used an insulin-secreting cell line with inducible expression of dominant negative (DN) HNF1 alpha, a transcription factor vital for correct beta-cell development and function, to show that HNF1 alpha is required for Xbp1 transcription and maintenance of the normal ER stress response. DN HNF1 alpha expression sensitizes the beta-cell to ER stress by directly down-regulating Xbp1 transcription, whereas Atf6 is unaffected. Furthermore, DN HNF1 alpha alters calcium homeostasis, resulting in elevated cytoplasmic calcium and increased store-operated calcium entry, whereas mitochondrial calcium uptake is normal. Loss of function of XBP1 is toxic to the beta-cell and decreases production of the ER chaperone BiP, even in the absence of ER stress. DN HNF1 alpha-induced sensitivity to cyclopiazonic acid can be partially rescued with the chemical chaperone tauroursodeoxycholate. Rat insulin 2 promoter-DN HNF1 alpha mouse islets express lower levels of BiP mRNA, synthesize less insulin, and are sensitized to ER stress relative to matched control mouse islets, suggesting that this mechanism is also operating in vivo.	[Kirkpatrick, Clare L.; Baquie, Mathurin; Akhmedov, Dmitry; Wollheim, Claes B.] Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Gauthier, Benoit R.] Andalusian Ctr Mol Biol & Regenerat Med, Seville 41092, Spain; [Wiederkehr, Andreas] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Akerman, Ildem; Ferrer, Jorge] Inst Invest Biomediques August Pi i Sunyer, Genom Programming Beta Cells Lab, Barcelona 08036, Spain; [Akerman, Ildem; Ferrer, Jorge] Hosp Clin Barcelona, E-08036 Barcelona, Spain; [Akerman, Ildem; Ferrer, Jorge] CIBER Diabet & Enfermedades Metab Asociadas, Barcelona 08036, Spain; [Ishihara, Hisamitsu] Nihon Univ, Sch Med, Div Diabet & Metab Med, Tokyo 1738610, Japan; [Wang, Haiyan] F Hoffmann La Roche & Cie AG, PRBD Metab Dis, CH-4070 Basel, Switzerland	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Nestle SA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Nihon University; Roche Holding	Wollheim, CB (corresponding author), Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	claes.wollheim@unige.ch	Kirkpatrick, Clare L/M-1890-2018; Ferrer, Jorge/A-3176-2012; Gauthier, Benoit R/C-3138-2017	Kirkpatrick, Clare L/0000-0001-8564-8559; Ferrer, Jorge/0000-0002-5959-5729; Gauthier, Benoit R/0000-0001-8146-7486; Akerman, Ildem/0000-0002-9875-1421	European Foundation for the Study of Diabetes/Lilly; Swiss National Science Foundation [310000-116750/1]; EuroDia 6th Framework Programme [LSHM-CT-2006-518153]	European Foundation for the Study of Diabetes/Lilly(Eli Lilly); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EuroDia 6th Framework Programme	This work was supported by an European Foundation for the Study of Diabetes/Lilly grant, Swiss National Science Foundation Grant 310000-116750/1, and EuroDia 6th Framework Programme Grant LSHM-CT-2006-518153.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kennedy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011211; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; Maechler P, 1999, J BIOL CHEM, V274, P12583, DOI 10.1074/jbc.274.18.12583; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okita K, 1999, BIOCHEM BIOPH RES CO, V263, P566, DOI 10.1006/bbrc.1999.1412; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; Pongratz RL, 2009, J BIOL CHEM, V284, P16808, DOI 10.1074/jbc.M807723200; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Winzell MS, 2004, DIABETES, V53, pS92, DOI 10.2337/diabetes.53.suppl_3.S92; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	58	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32300	32312		10.1074/jbc.M111.247866	http://dx.doi.org/10.1074/jbc.M111.247866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784843	hybrid, Green Published			2022-12-27	WOS:000294726800040
J	Rauen, T; Benedyk, K; Juang, YT; Kerkhoff, C; Kyttaris, VC; Roth, J; Tsokos, GC; Tenbrock, K				Rauen, Thomas; Benedyk, Konrad; Juang, Yuang-Taung; Kerkhoff, Claus; Kyttaris, Vasileios C.; Roth, Johannes; Tsokos, George C.; Tenbrock, Klaus			A Novel Intronic cAMP Response Element Modulator (CREM) Promoter Is Regulated by Activator Protein-1 (AP-1) and Accounts for Altered Activation-induced CREM Expression in T Cells from Patients with Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; CYCLIC-AMP; MESSENGER-RNA; IL-2 PROMOTER; BINDING; GENE; ISOFORMS; SITE; FOS	The transcriptional repressor cAMP response element modulator (CREM) alpha has important roles in normal T cell physiology and contributes to aberrant T cell function in patients with systemic lupus erythematosus (SLE). Recently, we characterized a specificity protein-1-dependent promoter located upstream of the CREM gene that accounts for increased basal CREM expression in SLE T cells and reflects disease activity. Here, we identify a novel intronic CREM promoter (denoted P2) in front of the second exon of the CREM gene that harbors putative binding sites for TATA-binding proteins and the transcriptional activator AP-1. DNA binding studies, chromatin immunoprecipitation, and reporter assays confirmed the functional relevance of these sites, and T cell activation through CD3/CD28 stimulation or phorbol 12-myristate 13-acetate/ionomycin treatment enhances P2 promoter activity. Although the basal CREM levels are increased in T cells from SLE patients compared with healthy controls, there are remarkable differences in the regulation of CREM expression in response to T cell activation. Whereas T cells from healthy individuals display increased CREM expression after T cell activation, most likely through AP-1-dependent up-regulation of the P2 promoter, SLE T cells fail to further increase their basal CREM levels upon T cell activation due to a decreased content of the AP-1 family member c-Fos. Because CREM trans-represses c-fos transcription in SLE T cells, we propose an autoregulatory feedback mechanism between CREM and AP-1. Our findings extend the understanding of CREM gene regulation in the context of T cell activation and disclose another difference in the transcriptional machinery in SLE T cells.	[Tenbrock, Klaus] Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany; [Rauen, Thomas; Juang, Yuang-Taung; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Benedyk, Konrad; Kerkhoff, Claus; Roth, Johannes; Tenbrock, Klaus] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Benedyk, Konrad; Tenbrock, Klaus] Univ Munster, Interdisciplinary Ctr Clin Res IZKF Res Grp 5, D-48149 Munster, Germany	RWTH Aachen University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University; University of Munster; University of Munster	Tenbrock, K (corresponding author), Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany.	ktenbrock@ukaachen.de	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	Interdisciplinary Center for Clinical Research (IZKF) Munster Research Group 5; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055672] Funding Source: NIH RePORTER	Interdisciplinary Center for Clinical Research (IZKF) Munster Research Group 5; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the Interdisciplinary Center for Clinical Research (IZKF) Munster Research Group 5 (to K.T.) and Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T.R.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Bodor J, 2001, J LEUKOCYTE BIOL, V69, P1053; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Fimia GM, 2001, MOL CELL ENDOCRINOL, V179, P17, DOI 10.1016/S0303-7207(01)00463-4; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; FUJIMOTO T, 1994, J BIOCHEM-TOKYO, V115, P298, DOI 10.1093/oxfordjournals.jbchem.a124332; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Halder SK, 2002, MOL ENDOCRINOL, V16, P1853, DOI 10.1210/me.2001-0262; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Jung SH, 2006, INT J CANCER, V118, P490, DOI 10.1002/ijc.21356; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Powell JD, 1999, J IMMUNOL, V163, P6631; Ragheb JA, 1999, J IMMUNOL, V163, P120; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2004, INT REV IMMUNOL, V23, P333, DOI 10.1080/08830180490452558; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Tsokos GC, 2000, CURR OPIN RHEUMATOL, V12, P355, DOI 10.1097/00002281-200009000-00001	32	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32366	32372		10.1074/jbc.M111.245811	http://dx.doi.org/10.1074/jbc.M111.245811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757709	Green Published, hybrid			2022-12-27	WOS:000294726800046
J	Suzuki-Anekoji, M; Suzuki, M; Kobayashi, T; Sato, Y; Nakayama, J; Suzuki, A; Bao, XF; Angata, K; Fukuda, M				Suzuki-Anekoji, Misa; Suzuki, Masami; Kobayashi, Tatsuya; Sato, Yoshiko; Nakayama, Jun; Suzuki, Atsushi; Bao, Xingfeng; Angata, Kiyohiko; Fukuda, Minoru			HNK-1 Glycan Functions as a Tumor Suppressor for Astrocytic Tumor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MYELIN-ASSOCIATED GLYCOPROTEIN; CARBOHYDRATE EPITOPE HNK-1; MONOCLONAL-ANTIBODY HNK-1; NERVOUS-SYSTEM; L2/HNK-1 CARBOHYDRATE; EXPRESSION CLONING; ALPHA-DYSTROGLYCAN; MICE DEFICIENT; BRAIN-TUMORS	Astrocytic tumor is the most prevalent primary brain tumor. However, the role of cell surface carbohydrates in astrocytic tumor invasion is not known. In a previous study, we showed that polysialic acid facilitates astrocytic tumor invasion and thereby tumor progression. Here, we examined the role of HNK-1 glycan in astrocytic tumor invasion. A Kaplan-Meier analysis of 45 patients revealed that higher HNK-1 expression levels were positively associated with increased survival of patients. To determine the role of HNK-1 glycan, we transfected C6 glioma cells, which lack HNK-1 glycan expression, with beta 1,3-glucuronyltransferase-P cDNA, generating HNK-1-positive cells. When these cells were injected into the mouse brain, the resultant tumors were 60% smaller than tumors emerging from injection of the mock-transfected HNK-1-negative C6 cells. HNK-1-positive C6 cells also grew more slowly than mock-transfected C6 cells in anchorage-dependent and anchorage-independent assays. C6-HNK-1 cells migrated well after treatment of anti-beta 1 integrin antibody, whereas the same treatment inhibited cell migration of mock-transfected C6 cells. Similarly, alpha-dystroglycan containing HNK-1 glycan is different from those containing the laminin-binding glycans, supporting the above conclusion that C6-HNK-1 cells migrate independently from beta 1-integrin-mediated signaling. Moreover, HNK-1-positive cells exhibited attenuated activation of ERK 1/2 compared with mock-transfected C6 cells, whereas focal adhesion kinase activation was equivalent in both cell types. Overall, these results indicate that HNK-1 glycan functions as a tumor suppressor.	[Suzuki-Anekoji, Misa; Suzuki, Masami; Suzuki, Atsushi; Bao, Xingfeng; Angata, Kiyohiko; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Canc Res Ctr, La Jolla, CA 92037 USA; [Kobayashi, Tatsuya] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan; [Sato, Yoshiko; Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan	Sanford Burnham Prebys Medical Discovery Institute; Shinshu University; Shinshu University	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org	Angata, Kiyohiko/M-2749-2018	Angata, Kiyohiko/0000-0001-5561-1368	National Institutes of Health [CA33895, P0l CA71932]; NATIONAL CANCER INSTITUTE [P01CA071932, R01CA033895] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390104] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA33895 and P0l CA71932.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; ABO T, 1981, J IMMUNOL, V127, P1024; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; ARIGA T, 1987, J BIOL CHEM, V262, P848; Ariga T, 2008, NEUROSIGNALS, V16, P226, DOI 10.1159/000111565; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Bhunia A, 2010, J AM CHEM SOC, V132, P96, DOI 10.1021/ja904334s; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; FIGARELLABRANGER DF, 1990, CANCER RES, V50, P6364; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; GENNARINI G, 1989, J NEUROSCI RES, V22, P1, DOI 10.1002/jnr.490220102; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; He H, 2010, J PROTEOME RES, V9, P2098, DOI 10.1021/pr900793a; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klinowska TCM, 1999, DEV BIOL, V215, P13, DOI 10.1006/dbio.1999.9435; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; LIZARDNACOL S, 1989, AM J PATHOL, V135, P847; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; PAULUS W, 1993, AM J PATHOL, V143, P154; PEEHL DM, 1981, P NATL ACAD SCI-BIOL, V78, P3053, DOI 10.1073/pnas.78.5.3053; Petridis AK, 2009, ACTA NEUROCHIR, V151, P601, DOI 10.1007/s00701-009-0324-3; REIFENBERGER G, 1989, ACTA NEUROPATHOL, V78, P270, DOI 10.1007/BF00687757; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Soriano P, 2004, VIRCHOWS ARCH, V445, P292, DOI 10.1007/s00428-004-1041-1; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Thies A, 2004, J PATHOL, V203, P933, DOI 10.1002/path.1595; Todaro L, 2007, J NEURO-ONCOL, V83, P135, DOI 10.1007/s11060-006-9312-0; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200; Yuen CT, 1997, J BIOL CHEM, V272, P8924; ZHU W, 1992, J NEUROSCI RES, V31, P745, DOI 10.1002/jnr.490310418	47	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32824	32833		10.1074/jbc.M111.245886	http://dx.doi.org/10.1074/jbc.M111.245886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784847	hybrid, Green Published			2022-12-27	WOS:000294726800089
J	Thom, SR; Bhopale, VM; Yang, M; Bogush, M; Huang, SH; Milovanova, TN				Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming; Bogush, Marina; Huang, Shaohui; Milovanova, Tatyana N.			Neutrophil beta(2) Integrin Inhibition by Enhanced Interactions of Vasodilator-stimulated Phosphoprotein with S-Nitrosylated Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERBARIC-OXYGEN THERAPY; LEUKOCYTE B-2 INTEGRINS; INTACT HUMAN PLATELETS; MYOCARDIAL-INFARCTION; FUNCTIONAL INHIBITION; MEDIATED ADHESION; VASP; KINASE; RAC; CGMP	Production of reactive species in neutrophils exposed to hyperoxia causes S-nitrosylation of beta-actin, which increases formation of short actin filaments, leading to alterations in the cytoskeletal network that inhibit beta(2) integrin-dependent adherence (Thom, S. R., Bhopale, V. M., Mancini, D. J., and Milovanova, T. N. (2008) J. Biol. Chem. 283, 10822-10834). In this study, we found that vasodilator-stimulated protein (VASP) exhibits high affinity for S-nitrosylated short filamentous actin, which increases actin polymerization. VASP bundles Rac1, Rac2, cyclic AMP-dependent, and cyclic GMP-dependent protein kinases in close proximity to short actin filaments, and subsequent Rac activation increases actin free barbed end formation. Using specific chemical inhibitors or reducing cell concentrations of any of these proteins with small inhibitory RNA abrogates enhanced free barbed end formation, increased actin polymerization, and beta(2) integrin inhibition by hyperoxia. Alternatively, incubating neutrophils with formylmethionylleucylphenylalanine or 8-bromo-cyclic GMP activates either cyclic AMP-dependent or cyclic GMP-dependent protein kinase, respectively, outside of the short F-actin pool and phosphorylates VASP on serine 153. Phosphorylated VASP abrogates the augmented polymerization normally observed with S-nitrosylated actin, VASP binding to actin, elevated Rac activity, and elevated formation of actin free barbed ends, thus restoring normal beta(2) integrin function.	[Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming; Bogush, Marina; Huang, Shaohui; Milovanova, Tatyana N.] Univ Penn, Inst Environm Med, Med Ctr, Philadelphia, PA 19104 USA; [Thom, Stephen R.] Univ Penn, Dept Emergency Med, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thom, SR (corresponding author), Univ Penn, Inst Environm Med, Med Ctr, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu	Shaohui Huang, Shaohui Huang Huang Shaohui/AAW-4531-2021		Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Anderson SI, 2003, CELL MOTIL CYTOSKEL, V54, P135, DOI 10.1002/cm.10091; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chen QP, 1996, J PHARMACOL EXP THER, V276, P929; Deevi RK, 2010, J IMMUNOL, V184, P6575, DOI 10.4049/jimmunol.0903910; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; Eckert RE, 2007, J LEUKOCYTE BIOL, V82, P1311, DOI 10.1189/jlb.0206107; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Goldberg N D, 1975, Adv Cyclic Nucleotide Res, V5, P307; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Schlegel N, 2009, J CELL PHYSIOL, V220, P357, DOI 10.1002/jcp.21772; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; WONG HP, 1996, SURG FORUM, P705; Worner R, 2007, AM J PHYSIOL-HEART C, V292, pH237, DOI 10.1152/ajpheart.00079.2006; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022	50	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32854	32865		10.1074/jbc.M111.255778	http://dx.doi.org/10.1074/jbc.M111.255778			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795685	hybrid, Green Published			2022-12-27	WOS:000294726800092
J	Yao, SYM; Ng, AML; Cass, CE; Baldwin, SA; Young, JD				Yao, Sylvia Y. M.; Ng, Amy M. L.; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			Nucleobase Transport by Human Equilibrative Nucleoside Transporter 1 (hENT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; HIGH-AFFINITY; RECOMBINANT HUMAN; EPITHELIAL-CELLS; CELLULAR UPTAKE; GUINEA-PIG; NITROBENZYLTHIOINOSINE; IDENTIFICATION; PURINE	The human equilibrative nucleoside transporters hENT1 and hENT2 (each with 456 residues) are 40% identical in amino acid sequence and contain 11 putative transmembrane helices. Both transport purine and pyrimidine nucleosides and are distinguished functionally by a difference in sensitivity to inhibition by nanomolar concentrations of nitrobenzylmercaptopurine ribonucleoside (NBMPR), hENT1 being NBMPR-sensitive. Previously, we used heterologous expression in Xenopus oocytes to demonstrate that recombinant hENT2 and its rat ortholog rENT2 also transport purine and pyrimidine bases, h/rENT2 representing the first identified mammalian nucleobase transporter proteins (Yao, S. Y., Ng, A. M., Vickers, M. F., Sundaram, M., Cass, C. E., Baldwin, S. A., and Young, J. D. (2002) J. Biol. Chem. 277, 24938-24948). The same study also revealed lower, but significant, transport of hypoxanthine by h/rENT1. In the present investigation, we have used the enhanced Xenopus oocyte expression vector pGEMHE to demonstrate that hENT1 additionally transports thymine and adenine and, to a lesser extent, uracil and guanine. Fluxes of hypoxanthine, thymine, and adenine by hENT1 were saturable and inhibited by NBMPR. Ratios of Vmax (pmol/oocyte.min(-1)): K-m (mM), a measure of transport efficiency, were 86, 177, and 120 for hypoxantine, thymine, and adenine, respectively, compared with 265 for uridine. Hypoxanthine influx was competitively inhibited by uridine, indicating common or overlapping nucleobase and nucleoside permeant binding pockets, and the anticancer nucleobase drugs 5-fluorouracil and 6-mercaptopurine were also transported. Nucleobase transport activity was absent from an engineered cysteine-less version hENT1 (hENT1C-) in which all 10 endogenous cysteine residues were mutated to serine. Site-directed mutagenesis identified Cys-414 in transmembrane helix 10 of hENT1 as the residue conferring nucleobase transport activity to the wild-type transporter.	[Yao, Sylvia Y. M.; Ng, Amy M. L.; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 2H7, Canada; [Baldwin, Stephen A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			Canadian Institutes of Health Research; Alberta Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation	This work was supported in part by the Canadian Institutes of Health Research and the Alberta Cancer Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; ARONOW B, 1986, J BIOL CHEM, V261, P2014; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; BARROS LF, 1994, AM J OBSTET GYNECOL, V171, P111, DOI 10.1016/S0002-9378(94)70086-9; BELT JA, 1985, BIOCHEM J, V232, P681, DOI 10.1042/bj2320681; Cabrita MA, 2002, BIOCHEM CELL BIOL, V80, P623, DOI 10.1139/O02-153; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Crawford CR, 1998, J BIOL CHEM, V273, P5288, DOI 10.1074/jbc.273.9.5288; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; GATI WP, 1992, J BIOL CHEM, V267, P22272; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; GRIFFITH DA, 1992, BIOCHIM BIOPHYS ACTA, V1106, P303, DOI 10.1016/0005-2736(92)90010-J; GRIFFITH DA, 1994, BIOCHEM J, V303, P901, DOI 10.1042/bj3030901; GRIFFITH DA, 1993, J BIOL CHEM, V268, P20085; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Hoque KM, 2008, AM J PHYSIOL-REG I, V294, pR1988, DOI 10.1152/ajpregu.00016.2008; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kato R, 2006, AM J PHYSIOL-ENDOC M, V290, pE968, DOI 10.1152/ajpendo.00160.2005; Kato R, 2009, BIOL PHARM BULL, V32, P450, DOI 10.1248/bpb.32.450; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Nagai K, 2007, INT J PHARM, V333, P56, DOI 10.1016/j.ijpharm.2006.09.044; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Shayeghi M, 1999, BBA-BIOMEMBRANES, V1416, P109, DOI 10.1016/S0005-2736(98)00213-2; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Stein WD, 1986, TRANSPORT DIFFUSION, P231; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; ULLMAN B, 1987, MOL CELL BIOL, V7, P97, DOI 10.1128/MCB.7.1.97; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; WASHINGTON CB, 1995, J BIOL CHEM, V270, P22816, DOI 10.1074/jbc.270.39.22816; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yao SYM, 2000, PRACT APPROACH SER, P47; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young J. D., 2000, CURRENT TOPICS MEMBR, P329; YOUNG JD, 2003, EQUILIBRATIVE NUCLEO, P321; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	57	85	86	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32552	32562		10.1074/jbc.M111.236117	http://dx.doi.org/10.1074/jbc.M111.236117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795683	hybrid, Green Published			2022-12-27	WOS:000294726800065
J	Luk, JM; Burchard, J; Zhang, CS; Liu, AM; Wong, KF; Shek, FH; Lee, NP; Fan, ST; Poon, RT; Ivanovska, I; Philippar, U; Cleary, MA; Buser, CA; Shaw, PM; Lee, CN; Tenen, DG; Dai, HY; Mao, M				Luk, John M.; Burchard, Julja; Zhang, Chunsheng; Liu, Angela M.; Wong, Kwong F.; Shek, Felix H.; Lee, Nikki P.; Fan, Sheung Tat; Poon, Ronnie T.; Ivanovska, Irena; Philippar, Ulrike; Cleary, Michele A.; Buser, Carolyn A.; Shaw, Peter M.; Lee, Chuen-Neng; Tenen, Daniel G.; Dai, Hongyue; Mao, Mao			DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-CANCER; EXPRESSION; CELLS; PROGNOSIS; MOUSE-CHROMOSOME-12; IDENTIFICATION; PROGRESSION; ACTIVATION; BIOMARKERS; TARGETS	Hepatocellular carcinoma (HCC) is a heterogeneous and highly aggressive malignancy, for which there are no effective cures. Identification of a malignant stemlike subtype of HCC may offer patients with a dismal prognosis a potential targeted therapy using c-MET and Wnt pathway inhibitors. MicroRNAs (miRNAs) show promise as diagnostic and prognostic tools for cancer detection and stratification. Using a TRE-c-Met-driven transgenic HCC mouse model, we identified a cluster of 23 miRNAs that is encoded within the Dlk1Gtl2 imprinted region on chromosome 12qF1 overexpressed in all of the isolated liver tumors. Interestingly, this region is conserved among mammalian species and maps to the human DLK1-DIO3 region on chromosome 14q32.2. We thus examined the expression of the DLK1-DIO3 miRNA cluster in a cohort of 97 hepatitis B virus-associated HCC patients and identified a subgroup (n = 18) of patients showing strong coordinate overexpression of miRNAs in this cluster but not in other cancer types (breast, lung, kidney, stomach, and colon) that were tested. Expression levels of imprinted gene transcripts from neighboring loci in this 14q32.2 region and from a subset of other imprinted sites were concomitantly elevated in human HCC. Interestingly, overexpression of the DLK1-DIO3 miRNA cluster was positively correlated with HCC stem cell markers (CD133, CD90, EpCAM, Nestin) and associated with a high level of serum alpha-fetoprotein, a conventional biomarker for liver cancer, and poor survival rate in HCC patients. In conclusion, our findings suggest that coordinate up-regulation of the DLK1-DIO3 miRNA cluster at 14q32.2 may define a novel molecular (stem cell-like) subtype of HCC associated with poor prognosis.	[Luk, John M.; Liu, Angela M.] NUS, Dept Pharmacol, Singapore 117597, Singapore; [Luk, John M.; Wong, Kwong F.; Tenen, Daniel G.] NUS, Canc Sci Inst, Singapore 117597, Singapore; [Luk, John M.; Lee, Chuen-Neng] NUS, Dept Surg, Singapore 117597, Singapore; [Burchard, Julja; Zhang, Chunsheng; Ivanovska, Irena; Dai, Hongyue; Mao, Mao] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Burchard, Julja; Cleary, Michele A.] Merck & Co Inc, Sirna Therapeut Inc, San Francisco, CA 94158 USA; [Zhang, Chunsheng; Ivanovska, Irena; Philippar, Ulrike; Dai, Hongyue] Merck Res Labs, Boston, MA 02115 USA; [Liu, Angela M.; Shek, Felix H.; Lee, Nikki P.; Fan, Sheung Tat; Poon, Ronnie T.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Cleary, Michele A.; Buser, Carolyn A.] Merck & Co Inc, West Point, PA 19486 USA; [Shaw, Peter M.] Merck & Co Inc, Upper Gwynedd, PA 19454 USA; [Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA 02115 USA	National University of Singapore; National University of Singapore; National University of Singapore; Merck & Company; Merck & Company; Merck & Company; University of Hong Kong; Merck & Company; Merck & Company; Harvard University	Luk, JM (corresponding author), NUS, Dept Pharmacol, Singapore 117597, Singapore.	jmluk@nus.edu.sg; Hongyue_dai@merck.com; mao.mao@pfizer.com	liang, yan/H-3894-2011; Lee, Chuen Neng/B-4516-2011; Luk, John/A-4085-2008	Lee, Chuen Neng/0000-0001-9748-4424; Luk, John/0000-0002-6323-7940; Tenen, Daniel/0000-0002-6423-3888; Zhang, Chengfei/0000-0002-6016-9436				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Lee NP, 2009, J PROTEOME RES, V8, P1293, DOI 10.1021/pr800637z; Lee TKW, 2009, LIVER INT, V29, P955, DOI 10.1111/j.1478-3231.2009.02040.x; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Mok BW, 1999, FEBS LETT, V453, P243, DOI 10.1016/S0014-5793(99)00714-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Thorvaldsen JL, 2007, CELL, V130, DOI 10.1016/j.cell.2007.08.033; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wu J, 2008, GENOMICS, V91, P443, DOI 10.1016/j.ygeno.2008.01.007; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yao XM, 2003, J CLIN INVEST, V111, P265, DOI 10.1172/JCI200315109	39	121	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30706	30713		10.1074/jbc.M111.229831	http://dx.doi.org/10.1074/jbc.M111.229831			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737452	Green Published, hybrid			2022-12-27	WOS:000294283600050
J	Ando, T; Ohashi, K; Ochiai, A; Mikami, B; Kawai, S; Murata, K				Ando, Takuya; Ohashi, Kazuto; Ochiai, Akihito; Mikami, Bunzo; Kawai, Shigeyuki; Murata, Kousaku			Structural Determinants of Discrimination of NAD(+) from NADH in Yeast Mitochondrial NADH Kinase Pos5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; ATP; ARABIDOPSIS; INHIBITION; CLONING	NAD kinase catalyzes the phosphorylation of NAD(+) to synthesize NADP(+), whereas NADH kinase catalyzes conversion of NADH to NADPH. The mitochondrial protein Pos5 of Saccharomyces cerevisiae shows much higher NADH kinase than NAD kinase activity and is therefore referred to as NADH kinase. To clarify the structural determinant underlying the high NADH kinase activity of Pos5 and its selectivity for NADH over NAD(+), we determined the tertiary structure of Pos5 complexed with NADH at a resolution of 2.0 angstrom. Detailed analysis, including a comparison of the tertiary structure of Pos5 with the structures of human and bacterial NAD kinases, revealed that Arg-293 of Pos5, corresponding to His-351 of human NAD kinase, confers a positive charge on the surface of NADH-binding site, whereas the corresponding His residue does not. Accordingly, conversion of the Arg-293 into a His residue reduced the ratio of NADH kinase activity to NAD kinase activity from 8.6 to 2.1. Conversely, simultaneous changes of Ala-330 and His-351 of human NAD kinase into Ser and Arg residues significantly increased the ratio of NADH kinase activity to NAD kinase activity from 0.043 to 1.39; human Ala-330 corresponds to Pos5 Ser-272, which interacts with the side chain of Arg-293. Arg-293 and Ser-272 were highly conserved in Pos5 homologs (putative NADH kinases), but not in putative NAD kinases. Thus, Arg-293 of Pos5 is a major determinant of NADH selectivity. Moreover, Ser-272 appears to assist Arg-293 in achieving the appropriate conformation.	[Ando, Takuya; Ohashi, Kazuto; Ochiai, Akihito; Kawai, Shigeyuki; Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp	Ohashi, Kazuto/M-8377-2019	Ohashi, Kazuto/0000-0002-6517-1156	Ministry of Education, Culture, Sports, Science and Technology of Japan [21780069]; Program for Promotion of Basic Research Activities for Innovative Biosciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by Grant-in-Aid for Scientific Research 21780069 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. K.) and by the Program for Promotion of Basic Research Activities for Innovative Biosciences.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kawai S, 2000, BIOCHEM BIOPH RES CO, V276, P57, DOI 10.1006/bbrc.2000.3433; Kawai S, 2008, BIOSCI BIOTECH BIOCH, V72, P919, DOI 10.1271/bbb.70738; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Liu JY, 2005, J MOL BIOL, V354, P289, DOI 10.1016/j.jmb.2005.09.026; Miyagi H, 2009, J BIOL CHEM, V284, P7553, DOI 10.1074/jbc.M804100200; Mori S, 2005, BIOCHEM BIOPH RES CO, V327, P500, DOI 10.1016/j.bbrc.2004.11.163; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai A, 2004, PROTEIN EXPRES PURIF, V36, P124, DOI 10.1016/j.pep.2004.03.012; Oganesyan V, 2005, ACTA CRYSTALLOGR F, V61, P640, DOI 10.1107/S1744309105019780; OHASHI K, 2011, MOL CELL BI IN PRESS; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrelli R, 2009, BIOORGAN MED CHEM, V17, P5656, DOI 10.1016/j.bmc.2009.06.013; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Poncet-Montange G, 2007, J BIOL CHEM, V282, P33925, DOI 10.1074/jbc.M701394200; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	31	13	13	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29984	29992		10.1074/jbc.M111.249011	http://dx.doi.org/10.1074/jbc.M111.249011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730068	hybrid, Green Published			2022-12-27	WOS:000294046600057
J	Holla, VR; Wu, H; Shi, Q; Menter, DG; DuBois, RN				Holla, Vijaykumar R.; Wu, Hong; Shi, Qiong; Menter, David G.; DuBois, Raymond N.			Nuclear Orphan Receptor NR4A2 Modulates Fatty Acid Oxidation Pathways in Colorectal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; NGFI-B; METABOLISM; GROWTH; CELLS; ACTIVATION; NURR1	Although cancer cells have traditionally been thought to rely on the glycolytic pathway to generate ATP, recent studies suggest that cancer cells can shift to the fatty acid oxidation pathway as an alternative energy source. All of the factors that induce and regulate this adaptive shift in metabolism are not known. Cyclooxygenase-2-derived prostaglandin E-2 (PGE(2)) is produced at high levels in colon cancer, and multiple lines of evidence from human-, animal-, and cell line-based studies indicate that PGE(2) plays a pro-oncogenic role in colorectal cancer progression. We have shown previously that exposure of colon cancer cells to PGE(2) promotes cell survival, in part by inducing the expression of the nuclear orphan receptor NR4A2. Here, we report that PGE(2)-induced NR4A2 increased fatty acid oxidation by inducing the expression of multiple proteins in the fatty acid oxidation pathway. NR4A2 was found to bind directly to Nur77-binding response elements located within the regulatory region of these genes. Nur77-binding response element binding also resulted in the recruitment of transcriptional coactivators and induction of gene expression. Collectively, our findings suggest that NR4A2 plays a key role as a transcriptional integration point between the eicosanoid and fatty acid metabolic pathways. Thus, PGE(2) is a potential regulator of the adaptive shift to energy utilization via fatty acid oxidation that has been observed in several types of cancer.	[DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1492, Houston, TX 77030 USA; [DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Shi, Qiong] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	DuBois, RN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1492, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rdubois@mdanderson.org	DuBois, Raymond N./AAX-8869-2020		NCI [5R01 DK062112]; National Colorectal Cancer Research Alliance; Ellen F. Knisley Distinguished Chair in Colon Cancer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062112] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Colorectal Cancer Research Alliance; Ellen F. Knisley Distinguished Chair in Colon Cancer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 DK062112 from NCI. This work was also supported the National Colorectal Cancer Research Alliance and the Ellen F. Knisley Distinguished Chair in Colon Cancer (to R. N. D.).	Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Luo J, 2002, CANCER RES, V62, P2220; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Wang F, 2009, METABOLISM, V58, P1131, DOI 10.1016/j.metabol.2009.03.027; WARBURG O, 1956, SCIENCE, V124, P269; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Zagani R, 2009, GASTROENTEROLOGY, V137, P1358, DOI 10.1053/j.gastro.2009.06.039; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177	21	34	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30003	30009		10.1074/jbc.M110.184697	http://dx.doi.org/10.1074/jbc.M110.184697			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757690	Green Published, hybrid			2022-12-27	WOS:000294046600059
J	Uranga, LA; Balise, VD; Benally, CV; Grey, A; Lusetti, SL				Uranga, Lee A.; Balise, Victoria D.; Benally, Candice V.; Grey, Angelina; Lusetti, Shelley L.			The Escherichia coli DinD Protein Modulates RecA Activity by Inhibiting Postsynaptic RecA Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; NUCLEOPROTEIN FILAMENTS; BINDING-PROTEIN; DUPLEX DNA; GENETIC-RECOMBINATION; RDGC PROTEIN; MECHANISM; EXCHANGE; EXPRESSION; IDENTIFICATION	Escherichia coli dinD is an SOS gene up-regulated in response to DNA damage. We find that the purified DinD protein is a novel inhibitor of RecA-mediated DNA strand exchange activities. Most modulators of RecA protein activity act by controlling the amount of RecA protein bound to single-stranded DNA by affecting either the loading of RecA protein onto DNA or the disassembly of RecA nucleoprotein filaments bound to single-stranded DNA. The DinD protein, however, acts postsynaptically to inhibit RecA during an on-going DNA strand exchange, likely through the disassembly of RecA filaments. DinD protein does not affect RecA single-stranded DNA filaments but efficiently disassembles RecA when bound to two or more DNA strands, effectively halting RecA-mediated branch migration. By utilizing a nonspecific duplex DNA-binding protein, YebG, we show that the DinD effect is not simply due to duplex DNA sequestration. We present a model suggesting that the negative effects of DinD protein are targeted to a specific conformational state of the RecA protein and discuss the potential role of DinD protein in the regulation of recombinational DNA repair.	[Uranga, Lee A.; Balise, Victoria D.; Benally, Candice V.; Grey, Angelina; Lusetti, Shelley L.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Lusetti, SL (corresponding author), POB 30001,MSC 3C, Las Cruces, NM 88003 USA.	slusetti@nmsu.edu		Balise, Victoria/0000-0002-5088-8752	National Institutes of Health, NM-INBRE [P20 RR016480];  [SC2 GM083697];  [R25 GM06122];  [T34 GM07667-34];  [R25 GM048998-13]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM048998, SC2GM083697, T34GM007667, R25GM061222] Funding Source: NIH RePORTER	National Institutes of Health, NM-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR016480 from the NM-INBRE Program and SC2 GM083697 (to S. L. L.), and R25 GM06122 (to L. A. U. and V. D. B.), T34 GM07667-34 (to C. V. B.), and R25 GM048998-13 (to C. V. B. and A. G.).	ADAMS DE, 1994, P NATL ACAD SCI USA, V91, P9901, DOI 10.1073/pnas.91.21.9901; Briggs GS, 2010, NUCLEIC ACIDS RES, V38, P6433, DOI 10.1093/nar/gkq509; Britt RL, 2010, J BIOL CHEM, V285, P3211, DOI 10.1074/jbc.M109.028951; Bugreev DV, 2011, NAT STRUCT MOL BIOL, V18, P56, DOI 10.1038/nsmb.1946; CHOW SA, 1988, J BIOL CHEM, V263, P3335; CHOW SA, 1986, J BIOL CHEM, V261, P6961; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Drees JC, 2006, J BIOL CHEM, V281, P4708, DOI 10.1074/jbc.M513592200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KRUEGER JH, 1983, J BACTERIOL, V153, P1368, DOI 10.1128/JB.153.3.1368-1378.1983; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lomba MR, 1997, FEMS MICROBIOL LETT, V156, P119, DOI 10.1111/j.1574-6968.1997.tb12715.x; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P55073, DOI 10.1074/jbc.M410371200; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; Oh TJ, 1999, FEMS MICROBIOL LETT, V177, P271, DOI 10.1111/j.1574-6968.1999.tb13743.x; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; PUGH BF, 1987, J BIOL CHEM, V262, P1337; REDDY G, 1995, BIOCHEMISTRY-US, V34, P10194, DOI 10.1021/bi00032a013; Renzette N, 2007, MOL MICROBIOL, V63, P103, DOI 10.1111/j.1365-2958.2006.05496.x; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; ULLSPERGER CJ, 1995, BIOCHEMISTRY-US, V34, P10859, DOI 10.1021/bi00034a019; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3	55	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29480	29491		10.1074/jbc.M111.245373	http://dx.doi.org/10.1074/jbc.M111.245373			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697094	Green Published, hybrid			2022-12-27	WOS:000294046600005
J	Akabayov, B; Kulczyk, AW; Akabayov, SR; Theile, C; McLaughlin, LW; Beauchamp, B; van Oijen, AM; Richardson, CC				Akabayov, Barak; Kulczyk, Arkadiusz W.; Akabayov, Sabine R.; Theile, Christopher; McLaughlin, Larry W.; Beauchamp, Benjamin; van Oijen, Antoine M.; Richardson, Charles C.			Pyrovanadolysis, a Pyrophosphorolysis-like Reaction Mediated by Pyrovanadate, Mn2+, and DNA Polymerase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; RAY-ABSORPTION SPECTROSCOPY; EXONUCLEASE ACTIVITY; SEQUENCE ANALYSIS; CRYSTAL-STRUCTURE; TRANSITION-STATE; METAL-IONS; VANADATE; REPLICATION; BINDING	DNA polymerases catalyze the 3'-5'-pyrophosphorolysis of a DNA primer annealed to a DNA template in the presence of pyrophosphate (PPi). In this reversal of the polymerization reaction, deoxynucleotides in DNA are converted to deoxynucleoside 5'-triphosphates. Based on the charge, size, and geometry of the oxygen connecting the two phosphorus atoms of PPi, a variety of compounds was examined for their ability to carry out a reaction similar to pyrophosphorolysis. We describe a manganese-mediated pyrophosphorolysis-like activity using pyrovanadate (VV) catalyzed by the DNA polymerase of bacteriophage T7. We designate this reaction pyrovanadolysis. X-ray absorption spectroscopy reveals a shorter Mn-V distance of the polymerase-VV complex than the Mn-P distance of the polymerase-PPi complex. This structural arrangement at the active site accounts for the enzymatic activation by Mn-VV. We propose that the Mn2+, larger than Mg2+, fits the polymerase active site to mediate binding of VV into the active site of the polymerase. Our results may be the first documentation that vanadium can substitute for phosphorus in biological processes.	[Akabayov, Barak; Kulczyk, Arkadiusz W.; Akabayov, Sabine R.; Theile, Christopher; Beauchamp, Benjamin; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [McLaughlin, Larry W.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [van Oijen, Antoine M.] Univ Groningen, Ctr Synthet Biol, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	Harvard University; Harvard Medical School; Boston College; University of Groningen	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019; Institute, Zernike/W-7033-2019; Akabayov, Barak/D-1551-2011; van Oijen, Antoine/I-3167-2014	Akabayov, Barak/0000-0002-3882-2742; van Oijen, Antoine/0000-0002-1794-5161	National Institutes of Health [GM54397]; National Institute of Biomedical Imaging and Bioengineering [P30-EB-009998]; National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.) and by Center for Synchrotron Biosciences Grant P30-EB-009998 from the National Institute of Biomedical Imaging and Bioengineering. This work was supported by Grant from the National Science Foundation (to L. W. M.).	Akabayov B, 2005, J SYNCHROTRON RADIAT, V12, P392, DOI 10.1107/S0909049505010150; Akabayov B, 2011, POWDER DIFFR, V26, P159, DOI 10.1154/1.3583156; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Arion D, 1999, DRUG RESIST UPDATE, V2, P91, DOI 10.1054/drup.1999.0076; Borden J, 2006, J PHYS CHEM B, V110, P14988, DOI 10.1021/jp060168s; Brandao TAS, 2009, J AM CHEM SOC, V131, P778, DOI 10.1021/ja807418b; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; CALVO C, 1967, ACTA CRYSTALLOGR, V23, P289, DOI 10.1107/S0365110X67002610; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; DEUTSCHER MP, 1969, J BIOL CHEM, V244, P3019; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fekry MI, 2011, ACS CHEM BIOL, V6, P127, DOI 10.1021/cb2000023; Gabbara S, 1996, METHOD ENZYMOL, V275, P276; GRESSER MJ, 1986, J AM CHEM SOC, V108, P6229, DOI 10.1021/ja00280a020; GRIENGL H, 1988, J MED CHEM, V31, P1831, DOI 10.1021/jm00117a026; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; HEINONEN JK, 2001, BIOL ROLE INORGANIC, P10; HOLLOWAY CE, 1986, REV INORG CHEM, V8, P287; JENCKS WP, 1987, CATALYSIS CHEM ENZYM, P111; KORNBERG A, 1992, DNA REPLICATION, P115; KRAUSS M, 1992, J AM CHEM SOC, V114, P3630, DOI 10.1021/ja00036a008; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Patel PH, 2001, NAT STRUCT BIOL, V8, P656, DOI 10.1038/90344; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; ROZOVSKAYA TA, 1984, BIOCHEM J, V224, P645, DOI 10.1042/bj2240645; SCOTT RA, 1985, J INORG BIOCHEM, V23, P199, DOI 10.1016/0162-0134(85)85026-1; SIGEL H, 1995, MET IONS BIOL SYST, P153; Solomon A, 2007, P NATL ACAD SCI USA, V104, P4931, DOI 10.1073/pnas.0700066104; STANKIEWICZ PJ, 1987, BIOCHEMISTRY-US, V26, P1264, DOI 10.1021/bi00379a010; Steens N, 2009, CHEM COMMUN, P965, DOI 10.1039/b816785k; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STERN EA, 1993, PHYS REV B, V48, P9825, DOI 10.1103/PhysRevB.48.9825; TABOR S, 1990, J BIOL CHEM, V265, P8322; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; TABOR S, 1989, J BIOL CHEM, V264, P6447; TRACEY AS, 1986, P NATL ACAD SCI USA, V83, P609, DOI 10.1073/pnas.83.3.609; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; YOSHIKAWA M, 1967, TETRAHEDRON LETT, P5065	48	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29146	29157		10.1074/jbc.M111.250944	http://dx.doi.org/10.1074/jbc.M111.250944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697085	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000293837000051
J	Hoffmann, DC; Textoris, C; Oehme, F; Klaassen, T; Goppelt, A; Romer, A; Fugmann, B; Davidson, JM; Werner, S; Krieg, T; Eming, SA				Hoffmann, Daniel C.; Textoris, Christine; Oehme, Felix; Klaassen, Tobias; Goppelt, Andreas; Roemer, Axel; Fugmann, Burkhard; Davidson, Jeffrey M.; Werner, Sabine; Krieg, Thomas; Eming, Sabine A.			Pivotal Role for alpha 1-Antichymotrypsin in Skin Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; CATHEPSIN-G; WOUND REPAIR; PROTEOLYTIC INACTIVATION; GROWTH-FACTOR; HOST-DEFENSE; LEG ULCERS; INHIBITOR; ALPHA(1)-ANTICHYMOTRYPSIN; DISEASE	alpha 1-Antichymotrypsin (alpha 1-ACT) is a specific inhibitor of leukocyte-derived chymotrypsin-like proteases with largely unknown functions in tissue repair. By examining human and murine skin wounds, we showed that following mechanical injury the physiological repair response is associated with an acute phase response of alpha 1-ACT and the mouse homologue Spi-2, respectively. In both species, attenuated alpha 1-ACT/Spi-2 activity and gene expression at the local wound site was associated with severe wound healing defects. Topical application of recombinant alpha 1-ACT to wounds of diabetic mice rescued the impaired healing phenotype. LC-MS analysis of alpha 1-ACT cleavage fragments identified a novel cleavage site within the reactive center loop and showed that neutrophil elastase was the predominant protease involved in unusual alpha 1-ACT cleavage and inactivation in nonhealing human wounds. These results reveal critical functions for locally acting alpha 1-ACT in the acute phase response following skin injury, provide mechanistic insight into its function during the repair response, and raise novel perspectives for its potential therapeutic value in inflammation-mediated tissue damage.	[Hoffmann, Daniel C.; Textoris, Christine; Krieg, Thomas; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Oehme, Felix] Bayer HealthCare, Biotech Dev, D-42117 Wuppertal, Germany; [Klaassen, Tobias; Roemer, Axel] A&M Lab GmbH, D-50126 Bergheim, Germany; [Goppelt, Andreas] Baxter Innovat GmbH, A-1020 Vienna, Austria; [Fugmann, Burkhard] Bayer Innovat GmbH, D-40225 Dusseldorf, Germany; [Davidson, Jeffrey M.] Vet Affairs Tennessee Valley Healthcare Syst, Res Serv, Nashville, TN 37212 USA; [Davidson, Jeffrey M.] Vanderbilt Univ, Sch Med, Nashville, TN 37240 USA; [Werner, Sabine] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Krieg, Thomas; Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany	University of Cologne; Bayer AG; Bayer Healthcare Pharmaceuticals; Baxter International Inc; Baxter Innovations GmbH; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, Joseph Stelzmann Str 9, D-50931 Cologne, Germany.	sabine.eming@uni-koeln.de	Davidson, Jeff/AAI-7288-2021	Werner, Sabine/0000-0001-7397-8710	Deutsche Forschungsgemeinschaft [SFB829]; Bayer Innovation GmbH; European Union [NMP-LA-2008-214402]; Bundesministerium fur Wirtschaft und Technologie [KF2429603SB0]; NATIONAL INSTITUTE ON AGING [R01AG006528] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayer Innovation GmbH; European Union(European Commission); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB829 (to S. A. E. and T. K.), Bayer Innovation GmbH(to B. F.), the European Union Project Angioscaff Grant NMP-LA-2008-214402 (to S. A. E.), and the Bundesministerium fur Wirtschaft und Technologie Grant KF2429603SB0 (to S. A. E.).	ABBINK JJ, 1993, ARTHRITIS RHEUM, V36, P168, DOI 10.1002/art.1780360206; ARONSEN KF, 1972, SCAND J CLIN LAB INV, V29, P127, DOI 10.3109/00365517209102760; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; BURNETT D, 1984, AM REV RESPIR DIS, V129, P473; CAPODICI C, 1989, INFLAMMATION, V13, P137, DOI 10.1007/BF00924785; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CICHY J, 1995, J CLIN INVEST, V95, P2729, DOI 10.1172/JCI117975; DESROCHERS PE, 1991, J CLIN INVEST, V87, P2258, DOI 10.1172/JCI115262; Egelund R, 1998, BIOCHEMISTRY-US, V37, P6375, DOI 10.1021/bi973043+; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han YP, 2008, J INVEST DERMATOL, V128, P2334, DOI 10.1038/jid.2008.77; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; Herrick S, 1997, LAB INVEST, V77, P281; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huttunen M, 2005, BRIT J DERMATOL, V152, P1149, DOI 10.1111/j.1365-2133.2005.06428.x; Kapui Z, 2003, J PHARMACOL EXP THER, V305, P451, DOI 10.1124/jpet.102.044263; KILPATRICK L, 1991, J IMMUNOL, V146, P2388; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOMAS DA, 1995, J BIOL CHEM, V270, P23437, DOI 10.1074/jbc.270.40.23437; MALEMUD CJ, 1975, ARTHRITIS RHEUM-US, V18, P361, DOI 10.1002/art.1780180413; MAST AE, 1991, J BIOL CHEM, V266, P15810; MCRAE B, 1980, BIOCHEMISTRY-US, V19, P3973, DOI 10.1021/bi00558a013; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Porcellini E, 2008, CURR PHARM DESIGN, V14, P2659, DOI 10.2174/138161208786264151; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; REILLY CF, 1980, BIOCHIM BIOPHYS ACTA, V621, P147, DOI 10.1016/0005-2795(80)90070-7; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; RUBIN H, 1994, BIOCHEMISTRY-US, V33, P7627, DOI 10.1021/bi00190a016; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Shrikumar A, 1998, J BIOL CHEM, V273, P17459, DOI 10.1074/jbc.273.28.17459; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P1301, DOI 10.1021/bi00379a015; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; TAKADA S, 1986, CANCER RES, V46, P3688; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; vanBergen BH, 1996, ARCH DERMATOL RES, V288, P458, DOI 10.1007/s004030050083; VARTIO T, 1981, J BIOL CHEM, V256, P471; WEISS SJ, 1986, J IMMUNOL, V136, P636; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	59	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28889	28901		10.1074/jbc.M111.249979	http://dx.doi.org/10.1074/jbc.M111.249979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21693707	Green Published, hybrid			2022-12-27	WOS:000293837000026
J	Xu, M; Joo, HJ; Paik, YK				Xu, Mo; Joo, Hyoe-Jin; Paik, Young-Ki			Novel Functions of Lipid-binding Protein 5 in Caenorhabditis elegans Fat Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENE-EXPRESSION; LIVER; IDENTIFICATION; NEMATODES; INSIGHTS; OBESITY; NHR-49; DAUER; ACIDS	The lipid-binding protein (LBP) family is conserved from Caenorhabditis elegans to mammals and essential for fatty acid homeostasis. RNAi-mediated knockdown of nine C. elegans lbp family members revealed that lbp-5 regulates fat accumulation. C. elegans LBP-5 bound directly to various fatty acids with varying affinities. lbp-5 expression in nhr-49(nr2041) worms was much lower than in N2 worms. Nhr-49 transcriptional activity also decreased with lbp-5 deletion, suggesting that they may work together as functional partners in fat metabolism. In support of this notion, LBP-5 translocated into nuclei, where it appeared to influence C. elegans NHR-49 target genes involved in energy metabolism. Interestingly, LBP-5 is required for stearic acid-induced transcription of NHR-49 target genes. Thus, this knowledge could help identify therapeutic targets to treat obesity and diseases associated with nematode-host interactions.	[Xu, Mo; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Dept Biochem & Biomed Sci, Coll Life Sci & Biotechnol, World Class Univ Program,Yonsei Proteome Res Ctr, Seoul 120749, South Korea	Yonsei University	Paik, YK (corresponding author), 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr			Ministry of Education, Science and Technology [R31-2008-000-10086-0]; Ministry of Health and Welfare, Republic of Korea [A030003]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the World Class University program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant R31-2008-000-10086-0 and Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea Grant A030003 (to Y.-K. P.).	Bradley JE, 2001, TRENDS PARASITOL, V17, P471, DOI 10.1016/S1471-4922(01)02036-0; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Di Pietro SM, 1999, EUR J BIOCHEM, V259, P127, DOI 10.1046/j.1432-1327.1999.00015.x; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; GLATZ JFC, 1995, PROSTAG LEUKOTR ESS, V52, P121, DOI 10.1016/0952-3278(95)90010-1; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; JANSSEN D, 1995, BIOCHEM J, V311, P49, DOI 10.1042/bj3110049; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kennedy Malcolm W., 2001, P309, DOI 10.1079/9780851994239.0309; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; MAATMAN RGHJ, 1994, BBA-LIPID LIPID MET, V1214, P1, DOI 10.1016/0005-2760(94)90002-7; Michalik L, 2008, PPAR RES, V2008, DOI 10.1155/2008/134059; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Oh WS, 2009, PLOS ONE, V4, pA22, DOI 10.1371/journal.pone.0007593; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; Porter MY, 2005, J NEUROSCI RES, V79, P836, DOI 10.1002/jnr.20403; RIDDLE DL, 1997, GENETIC ENV REGULATI, V26, P739; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; Samulin J, 2008, COMP BIOCHEM PHYS B, V151, P147, DOI 10.1016/j.cbpb.2008.06.010; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stewart JM, 2000, CELL MOL LIFE SCI, V57, P1345, DOI 10.1007/PL00000620; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Zendzian-Piotrowska M, 1994, Postepy Hig Med Dosw, V48, P753; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	40	15	18	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28111	28118		10.1074/jbc.M111.227165	http://dx.doi.org/10.1074/jbc.M111.227165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697096	Green Published, hybrid			2022-12-27	WOS:000293557800029
